TWI235157B - Inhibitors of interleukin-1beta converting enzyme - Google Patents

Inhibitors of interleukin-1beta converting enzyme Download PDF

Info

Publication number
TWI235157B
TWI235157B TW091132804A TW91132804A TWI235157B TW I235157 B TWI235157 B TW I235157B TW 091132804 A TW091132804 A TW 091132804A TW 91132804 A TW91132804 A TW 91132804A TW I235157 B TWI235157 B TW I235157B
Authority
TW
Taiwan
Prior art keywords
group
cns
disease
ministry
paper
Prior art date
Application number
TW091132804A
Other languages
Chinese (zh)
Other versions
TW200300761A (en
Inventor
Mark J Batchelor
David Bebbington
Guy W Bemis
Wolf Herman Fridman
Roger J Gillespie
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/575,641 external-priority patent/US6008217A/en
Priority claimed from US08/598,332 external-priority patent/US5874424A/en
Priority claimed from US08/712,878 external-priority patent/US5985863A/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of TW200300761A publication Critical patent/TW200300761A/en
Application granted granted Critical
Publication of TWI235157B publication Critical patent/TWI235157B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to novel classes of compounds which are inhibitors of interleukin-1beta converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-gamma-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-gamma-mediated diseases and decreasing IGIF and IFN-gamma production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds.

Description

1235157 A7 B7 五、發明説明(1 ) 發明技銜領域 本發明是有關新穎一類的化合物,其爲間白素-1 轉化 酶(”ICEn)的抑制劑。本發明也是有關含有這些化合物的藥 學組成物。本發明的化合物及藥學組成物特別適於抑制 ICE活性且因此可有益地充作拮抗間白素-l-(nIL-r),細胞 預後死亡-,干擾素r謗導分子-riGIF”)及干擾素-r -(nIFN- r ")調介疾病之作用物,特別是發炎疾蒺,自體免 疫疾病,破壞性骨骼疾病,增殖失調症,感染性疾病及退 化性疾病。本發明也是有關#制ICE活性,及降低IGIF產 製及IFN- r產製之方法,及利用本發明化合物及組成物治 療間白素-1-,細胞預期死亡-,IGIF-及IFN- r -調介疾病之 方法。本發明也是有關製備N-醯基胺基化合物之方法。 發明背景 經濟部中央糅準局負工消費合作社印製 間白素1 ("IL-1")爲一種主要的初-發炎及免疫調節性蛋 白質,其可刺激纖維母細胞分化及增殖,甴滑膜细胞及款 骨細胞產製前列腺素,醪原蛋白酶及磷脂酶,嗜鹼性白血 球及嗜伊紅白血球之去粒作用及嗜中性白血球活化作用。 Oppenheim, J.H. et al., Immunology Today, 7, pp. 45-56 (1986)。如此,其涉及於慢性及急性發炎及自體免疫疾病 之致病過程。如,於類風濕性關節炎中,IL-1是受損關節 中發炎症狀之調介物,也是軟骨'蛋白多糖破壞之調介物。 Wood, D.D. et al., Arthritis Rheum. 26, 975 (1983); Pettipher, E.J. et al., Proc· Natl. Acad· Sci· UNITED STATES OF AMERICA 71, 295 (1986); Arend, W.P. and Dayer, J.M., -4- 本纸伕尺度適用中國國家標孪(CN’S ) A4規格(2丨0·;<297公釐) Γ235157 經濟部中央標準局員工消费合作社印¾ A7 B7 五、發明説明(2 )1235157 A7 B7 V. Description of the invention (1) Field of the invention The invention relates to a novel class of compounds, which are inhibitors of melanin-1 converting enzyme ("ICEn). The invention also relates to the pharmaceutical composition containing these compounds The compounds and pharmaceutical compositions of the present invention are particularly suitable for inhibiting ICE activity and can therefore be beneficially used to antagonize interleukin-l- (nIL-r), prognosis of cell death-, interferon r-deficient molecule-riGIF " ) And interferon-r- (nIFN-r ") mediate the effects of diseases, especially inflammatory diseases, autoimmune diseases, destructive bone diseases, proliferative disorders, infectious diseases and degenerative diseases. The present invention is also related to the method of making ICE activity, reducing the production of IGIF and IFN-r production, and using the compounds and compositions of the present invention to treat interleukin-1-, expected cell death-, IGIF- and IFN-r -Methods for mediating diseases. The present invention also relates to a method for preparing an N-fluorenylamino compound. BACKGROUND OF THE INVENTION Printed Interleukin-1 (" IL-1 "), a work-consumption cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, is a major pro-inflammatory and immunomodulatory protein that stimulates fibroblast differentiation and proliferation. Synoviocytes and osteocytes produce prostaglandins, prionases and phospholipases, degranulation of basophilic leukocytes and eosinophils, and activation of neutrophils. Oppenheim, J.H. et al., Immunology Today, 7, pp. 45-56 (1986). As such, it is involved in the pathogenesis of chronic and acute inflammation and autoimmune diseases. For example, in rheumatoid arthritis, IL-1 is a mediator of inflammation symptoms in damaged joints and a mediator of cartilage 'proteoglycan destruction. Wood, DD et al., Arthritis Rheum. 26, 975 (1983); Pettipher, EJ et al., Proc. Natl. AcadSci. UNITED STATES OF AMERICA 71, 295 (1986); Arend, WP and Dayer, JM , -4- The standard of this paper is applicable to the Chinese National Standard (CN'S) A4 specification (2 丨 0 ·; < 297 mm) Γ235157 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs ¾ A7 B7 V. Description of the invention (2)

Arthritis Rheum. 38, 15 1 (1995)。IL-1 也是高度 fl 力的骨骼 耗損劑。Jandiski, J.J., J. Oral Path 17, 145 (1988); Dewhirst, F.E. et al., J. Immunol. 8, 2562 19-85)。其另夕卜在 破壞性骨骼疾病中稱之爲"破骨細胞活化因子",如骨關節 炎及多發性骨髓瘤。Bataille,R. et al.,Int. J. Clin. Lab. 民^21 (4),283 (1992)。在某些增殖失調症中,如急性骨 髓性白血病及多發性骨髓瘤,IL-1可促進腫瘤細-胞生長及 粘附。Bani,M.R,,J· Natl· Cancer Inst/83· 123 Π991): Vidal· Vanaciocha, F., Cancer Res. 54. 2δ67 (1994)。在這些失調症 中,IL-1也可刺激其他細胞動素之產製,如il-6,其可調 節腫瘤發展。(Tartour et al·,Cancer Res. 54, 6243 (1994)。 IL-1主要由周邊血液單核細胞因部份發炎反應所製笔,且 以二個不同的激動劑型式存在,IL-戊及IL·点。Mosely, B.S. et al·,Proc· Nat· Acad· Sci·· 84, pp. 4572-4576 (1987); Lonnemann, G. et aL, Eur. J· Immunol” 19, pp;. 153 1-1536 (1989)。 IL-/?呈生物上不活性前軀體型式被合成,pIL-1/?。pIL-1 缺少傳統的領導子序列,,且並不爲訊號肽酶所處理修 飾。March,C.J·,Nature, 315· dd· 641-647 (1985)。反之, pIL-1/?爲間白素·1/?轉化酶("ICE”)在 Asp-116 及 AU-117 間 解離,產生於人類血清及滑液中‘可見的具生物活性的(-末 端片段。Sleath, P.R·,et al·,J. Biol· Chem·,265, pp. 14526· 14528 (1992); A-D. Howard et al., J· Immunol·,147, pp· 2964-2969 (1991)。ICE是一種半胱胺酸蛋白酶,主要位於 -5- 本纸伕尺度通用中国國家標卒(CNS ) A4说格(210X297公釐) (請先閨讀背面之注意事項再頁)Arthritis Rheum. 38, 15 1 (1995). IL-1 is also a high fl force bone loss agent. Jandiski, J.J., J. Oral Path 17, 145 (1988); Dewhirst, F.E. et al., J. Immunol. 8, 2562 19-85). It is also called " osteoclast activating factor " in destructive bone diseases, such as osteoarthritis and multiple myeloma. Bataille, R. et al., Int. J. Clin. Lab. Min 21 (4), 283 (1992). In some dysplasias, such as acute myeloid leukemia and multiple myeloma, IL-1 promotes tumor cell growth and adhesion. Bani, M.R., J. Natl. Cancer Inst / 83. 123 Π991): Vidal. Vanaciocha, F., Cancer Res. 54.2 67 (1994). In these disorders, IL-1 can also stimulate other cytokines, such as il-6, which can regulate tumor development. (Tartour et al., Cancer Res. 54, 6243 (1994). IL-1 is mainly produced by peripheral blood mononuclear cells due to a part of the inflammatory response, and exists in two different agonist types. IL · point. Mosely, BS et al ·, Proc · Nat · Acad · Sci · 84, pp. 4572-4576 (1987); Lonnemann, G. et aL, Eur. J · Immunol "19, pp ;. 153 1-1536 (1989). IL- /? Is synthesized as a biologically inactive precursor, pIL-1 / ?. pIL-1 lacks a traditional leader sequence and is not modified by signal peptidases. March, CJ ·, Nature, 315 · dd · 641-647 (1985). Conversely, pIL-1 /? Is a melanin · 1 /? Invertase (" ICE ") between Asp-116 and AU-117 Dissociation, produced in human serum and synovial fluid 'Visible bioactive (-terminal fragment. Sleath, PR ·, et al ·, J. Biol · Chem ·, 265, pp. 14526 · 14528 (1992); AD Howard et al., J. Immunol., 147, pp. 2964-2969 (1991). ICE is a cysteine protease, which is mainly located on the -5- paper scale and is commonly used by the Chinese National Standards Officer (CNS) A4. Grid (210X297 mm) (Please read it first Notes on another page)

ii 1235157 A7 B7 r-J.‘ 經濟部中央揉準局貝工消费合作社印製 五、發明説明(3 早核細胞。其可將七驅體IL -点轉化成成熟^{式0 B1 a c k, R.A. et al., FEBS Lett” 247, pp. 386-390 (1989); Kostura, M.J. et al., Proc· Natl· Acad, Sci· UNITED^STATES OF AMERICA,86, pp· 5227-523 1 (1989)。以 ICE處理修飾也是 經甴細胞膜運送成熟的IL·卢所必要的3 ICE,或其同系物’似乎也涉及於預定細跑死亡或細胞 預期死亡之調控作用中。Yuan, J. et al.,Cell, 75, pp. 641-652 (1993); Miura, M. et al., Cell,75, pp. 653-660 (1993); Nett-Fiordalisi, M.A. et al., J. Cell Biochem. 17B, p. 117 (1993)。特言之,ICE或ICE同系物被視爲與神經退化性疾 病中細胞預期死亡之調控有關,如阿滋海默爾氏及巴金森 氏病。Marx, J. and M· Baringa, Science,259 pp. 760-762 (1993) ; Gagliardini, V. et al., Science, 263, pp. 826-828 (1994) 。細胞預期死亡抑制之治療性應用可包括治療阿滋 海默爾氏病,巴金森氏病,中風,心肌便塞,脊柱萎缩及 老化。 已證明ICE可調介特定組織型態中之細胞預期死亡。 Steller, H·,Science,267, p. 1445 (1995); Whyte, M. and Evan, G., Nature, 376, p. 17 (1995); Martin, S.J. and Green, D.R., Cell, 82, p. 349 (1995); Alnemri, E.S., et al., J· Biol· Chem·,270, p. 4312 (1995); Yuan, J. Curr. Opin. Cell BioL y, p. 21 1 (1995)。ICE基因瓦解的導入外來基因老鼠,在Fas· 調介的細胞預期死亡中有所缺陷(Kuida,Κ· et al·,Science 267, 2000 (1995))。ICE此活性和其在充作pro-lLl卢處理修 本纸伕尺度適用中國國家標準(CNS ) A4規格(2i0*X297公釐) ( (請先閣讀背面之注意事項本頁) 1235157 A7 B7 經濟部中央揉準局另工消资合作社印¾ 五、發明説明(4 ) 飾酵素的角色上截然不同。可感知的是在特定組織型態中 ,:[CE的抑制作用可能不會影響成熟IL->5的分泌,但也可 能會抑制細胞預期死亡。 ’ 具酵素活性的ICE先前已被描述是由二個亞單位p20及 plO組成的雜二體(20kDa及lOkDa分別的分子量)。這些亞單 位經由p30型式衍生自45kDa酶原(p45),經由一種自身催化 作周的活化作用機制 e Thornberry, Ν·Α· et al·,Nature, 356, pp. 768-774 (1992)。ICE酶原已分成許多功能性區域:一 個前區(pl4),一個p22/20亞單位,一個多肽連接子及一個 plO亞單位。Thornberry et al·,上文,Casano et al·, Genomics, 20,ρρ· 474-481 (1994) 〇 全長的p45已由其cDNA及胺基酸序列予以特性化。PCT 案 WO 9 1/1 5577及 WO 94/00154。p20及 p 10 cDNA及胺基酸 序列也是已知的。Thornberry et al”上文。鼠及大鼠ICE也 已定序及選殖。其有與人類ICE高度同質的胺基酸及核酸 序列。Miller, D.K· et al·,Ann· Ν·Υ. Acad· Sci·,696,pp. 133-148 (1993); Molineaux, S.M. et al., Proc. Nat· Acad. Sci” 90, pp. 1809-1813 (1993)。ICE的三度空問結構已可經甴X-射線結晶學在原子解析下決定。Wilson, Κ·Ρ·, et al·,Nature, 370, pp. 270-275 (1994)。活性酵素呈二個 p20及二個 plO亞 單位之四聚體型式。 ‘ 另外,此中也存在有ICE之人類同系物,其序列和酵素 之活性位置區域相似。此同系物包括TX(或ICEmMI或ICH· 2) (Faucheu, et al., EMBO J·,14, p. 1914 (1995); Kamens J., 本纸铁尺度適用中国国家標牟(CNS ) A4規格(210X297公釐) I---------•裝-- (請先閱讀背面之:vi意事項一 本買) 訂 1235157 Α7 Β7 五、發明説明(5 ) et al·,J· Biol· Chem·,270, p. 15250 (1995); Nicholson et al., J. Biol. Chem., 270 15870 (1995)),TY(或 ICErel.in) (Nicholson et al., J. Biol· Chem·,270, p. 15870 (1995); ICH· 1 (或 Nedd-2) (Wang,L. et al·,Cell,78, p. 739 (1994)), MCH-2, (Fernades-Alnemri, T. et al., Cancer Res.,55, p. 2737 (1995),CPP32(或 YAMA‘apopain)(Fernandes-Alnemri, T. et al., J· Biol· Chem·,269, p. 30761 (1994); Nicholson, D.W. et al., Nature, 376, p· 37 (1995)),及CMH-1 (或 MCH-3) (Lippke, et al·,J. Biol. Chem., (1996); Fernandes-Alnemri, T. et al., Cancer Res.,(1995))。這些 ICE 同系物以及ICE本身各自可在轉感的細胞株過度表現時誘 導細胞預期死亡。一種以上的這些同系物爲肽性ICE抑制 劑Tyr-VaNAla-Asp-氣甲基酮抑制作两之結果可造成在初級 細胞或細胞株中預期細胞死亡之抑制作用。Lazebnik et aL, Nature, 37 1,ρ· 346 (1994)。此中所述的化合物也可抑制 ICE —種以上的同系物(見實例5 )。因此,這些化合物可周 來抑制含有ICE同系物之组織型式中之细胞預期死亡,但 其並不含有具活性的ICE或可產生成熟的IL-卢。 經濟部中央標準局系工消費合作社印製 (請先《讀背面之注意事項本頁) r -干擾素誘導因子(IGIF)是一種约18-kDa的多肽,其可 刺激r -干擾素產生丁-細胞(r -IFN) MGIF於活體内可爲經 活的庫弗氏细胞(Kupffer cell)及巨噬細胞產製,且於内毒 素刺激時可自此細胞中出來。因此,可降低IGIF產製之化 合物可用於充作此Τ-細胞刺激作用之抑制劑,其依次可減 低這些鈿胞產製7··ΙΡΝ的水平。 各紙法尺度適用中國國家揉準(CNS ) Α4規格(21〇χ297公釐) 1235157 經濟部中央標準局W3C工消費合作社印¾ A7 ____B7_^_ 五、發明説明(6 ) r -IFN是一種細胞動素,可在各樣的免疫纟曰胞上具免疫 調控作周。特別地,IFN- r涉及於巨噬細胞的活化作用及 Thl 細胞之選擇中(F· Belardelli,APMIS,]03, P. 161 (1995)) 。r -IFN展現其作用有部份是經由STAT及IRF路徑調控基 因表現而成(C· Schindler and J.E. Darnell,Ann. Rev. Biochem., 64, p. 621 (1995); T. Taniguchi, J. Cancer Res. Clin. Oncol.. Π1, p· 516 (1995))。 ’ 缺少IFN- r或其多受禮的老鼠在免疫細胞功能上有許多 的缺失,且可抗阻内毒性體克(S· Huang et al·,Science· 259, p. 1742 (1993); D. Dalton et al., Science, 259, p. 1739 (1993); B. D. Car et al., J. Exp. Med·, 179, p. 1437 (1994)) 。加上IL-12,IGIF似乎是丁細胞產製r-IFN的強力誘導物 (H. Okamura et al., Infection and Immunity, 63, p. 3966 (1995); H, Okamura et al., Nature, 378, p. 88 ( 1995); S. Ushio et al., J· Immunol” 156,p. 4274 (1996))。 已示出IFN- r成爲與各種發炎,感染性及自體免疫失詞 症及疾病相關的病理的原因。因此,可減少IFN- r產製的 化合物將可用以舒缓IFN- r相關病理之作用。 IGIF及因此的r -IFN之生物性調節作用尚未闡明。已知 IGIF以前軀體蛋白質型式被合成,稱爲”前-IGIF"。然而 尚未明瞭前-IGIF如何被解離及'其處理修飾是否具有生物 學重要性。 因此,可調節前-IGIF轉化成IGIF的組成物及方法可於活 體内用於降低IGIF及IFN· r產製,且因此可舒缓這些造成 (請先:^讀背面之注意事項本頁) -裝 訂 旅ii 1235157 A7 B7 rJ. 'Printed by the Central Government Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperative, V. Invention Description (3 Early nucleus cells. It can convert hepta-IL-dots to mature ^ {Formula 0 B1 ack, RA et al., FEBS Lett "247, pp. 386-390 (1989); Kostura, MJ et al., Proc. Natl. Acad, Sci. UNITED ^ STATES OF AMERICA, 86, pp. 5227-523 1 (1989). Modification with ICE is also necessary for the transport of mature IL·Lu through the 甴 cell membrane. 3 ICE, or its homologues, also appears to be involved in the regulation of scheduled sprint death or expected cell death. Yuan, J. et al., Cell, 75, pp. 641-652 (1993); Miura, M. et al., Cell, 75, pp. 653-660 (1993); Nett-Fiordalisi, MA et al., J. Cell Biochem. 17B, p. 117 (1993). In particular, ICE or ICE homologues are considered to be involved in the regulation of expected cell death in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Marx, J. and M. Baringa, Science, 259 pp. 760-762 (1993); Gagliardini, V. et al., Science, 263, pp. 826-828 (1994). Therapeutic applications of cell death suppression may include treatment Zheimer's disease, Parkinson's disease, stroke, myocardial congestion, spinal atrophy, and aging. ICE has been shown to mediate the expected death of cells in specific tissue types. Steller, H., Science, 267, p. 1445 (1995); Whyte, M. and Evan, G., Nature, 376, p. 17 (1995); Martin, SJ and Green, DR, Cell, 82, p. 349 (1995); Alnemri, ES, et al., J. Biol. Chem., 270, p. 4312 (1995); Yuan, J. Curr. Opin. Cell BioLy, p. 21 1 (1995). Introduction of ICE gene disruption into foreign gene mice, Fas Deficiencies in the expected death of mediated cells (Kuida, K. et al., Science 267, 2000 (1995)). ICE This activity and its use as a pro-lLl Lu processing paper size standards apply to Chinese National Standard (CNS) A4 specifications (2i0 * X297 mm) ((Please read the precautions on the back page first) 1235157 A7 B7 Printed by the Central Government Bureau of the Ministry of Economic Affairs and the Industrial and Commercial Cooperatives Co., Ltd. Ⅴ. Description of Invention (4) The role of enzymes is quite different. It is perceptible that in certain organizational types: [CE's inhibitory effect may not affect maturity IL- > 5 secretion, but it may also inhibit the expected cell death. 'The enzyme-active ICE has been previously described as a heterodimer (20kDa and 10kDa molecular weight) composed of two subunits p20 and plO. These subunits are derived from the 45kDa zymogen (p45) via the p30 form, and via an autocatalytic activation mechanism e Thornberry, ΝΑΑ et al., Nature, 356, pp. 768-774 (1992) .ICE The zymogen has been divided into many functional regions: a predomain (pl4), a p22 / 20 subunit, a polypeptide linker, and a plO subunit. Thornberry et al., Supra, Casano et al, Genomics, 20, ρρ · 474-481 (1994) 〇The full length of p45 has been Its cDNA and amino acid sequences are characterized. PCT cases WO 9 1/1 5577 and WO 94/00154. P20 and p 10 cDNA and amino acid sequences are also known. Thornberry et al "supra. Murine ICE has also been sequenced and cloned. It has amino acids and nucleic acid sequences that are highly homologous to human ICE. Miller, DK · et al ·, Ann · N · Υ. Acad · Sci ·, 696, pp. 133- 148 (1993); Molineaux, SM et al., Proc. Nat · Acad. Sci "90, pp. 1809-1813 (1993). The three-dimensional space structure of ICE can be resolved by atomic X-ray crystallography in atom Next decision. Wilson, K.P., et al., Nature, 370, pp. 270-275 (1994). The active enzyme presents a tetrameric form of two p20 and two plO subunits. In addition, here There is also a human homologue with ICE, whose sequence is similar to the active site region of the enzyme. This homologue includes TX (or ICemMI or ICH · 2) (Faucheu, et al., EMBO J ·, 14, p. 1914 (1995 ); Kamens J., The iron scale of this paper is applicable to China National Standards (CNS) A4 specification (210X297 mm) I --------- • Installation-(Please read the back: vi intended matter one) (Buy) Order 1235157 Α7 Β7 V. Description of the invention (5) et al., J. Biol. Chem., 270, p. 15250 (1995); Nicholson et al., J. Biol. Chem., 270 15870 (1995)), TY (or ICErel .in) (Nicholson et al., J. Biol · Chem ·, 270, p. 15870 (1995); ICH · 1 (or Nedd-2) (Wang, L. et al ·, Cell, 78, p. 739 (1994)), MCH-2, (Fernades-Alnemri, T. et al., Cancer Res., 55, p. 2737 (1995), CPP32 (or YAMA'apopain) (Fernandes-Alnemri, T. et al. , J. Biol. Chem., 269, p. 30761 (1994); Nicholson, DW et al., Nature, 376, p. 37 (1995)), and CMH-1 (or MCH-3) (Lippke, et. al., J. Biol. Chem., (1996); Fernandes-Alnemri, T. et al., Cancer Res., (1995)). Each of these ICE homologs, as well as the ICE itself, can induce expected cell death when the transfected cell line is overexpressed. Inhibition of more than one of these homologs by the peptide ICE inhibitor Tyr-VaNAla-Asp-pneumomethyl ketone can result in the inhibition of expected cell death in primary cells or cell lines. Lazebnik et aL, Nature, 37 1, p. 346 (1994). The compounds described herein can also inhibit ICE—more than one homologue (see Example 5). Therefore, these compounds can inhibit the expected death of cells in tissue types containing ICE homologues in the past, but they do not contain active ICE or can produce mature IL-Lu. Printed by the Central Bureau of Standards, Ministry of Economic Affairs, Industrial and Consumer Cooperatives (please read the “Precautions on the back page”) r-interferon-inducing factor (IGIF) is an approximately 18-kDa peptide that stimulates r-interferon production. -Cells (r-IFN) MGIF can be produced in vivo by living Kupffer cells and macrophages, and can come out of this cell when stimulated by endotoxin. Therefore, compounds that can reduce the production of IGIF can be used as inhibitors of this T-cell stimulating effect, which in turn can reduce the levels of these cells producing 7. · IPN. Each paper scale applies Chinese National Standard (CNS) A4 specification (21 × 297 mm) 1235157 Printed by W3C Industrial and Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs ¾ A7 ____ B7 _ ^ _ 5. Description of the invention (6) r-IFN is a cellular activity It can be used for immune regulation on various immune cells. In particular, IFN-r is involved in the activation of macrophages and the selection of Thl cells (F. Belardelli, APMIS, 03, P. 161 (1995)). r-IFN exhibits its effects in part by regulating genes through STAT and IRF pathways (C. Schindler and JE Darnell, Ann. Rev. Biochem., 64, p. 621 (1995); T. Taniguchi, J. Cancer Res. Clin. Oncol .. Π1, p. 516 (1995)). '' Mice lacking IFN-r or its polite mice have many deficiencies in immune cell function and are resistant to endotoxicity (S · Huang et al ·, Science · 259, p. 1742 (1993); D. Dalton et al., Science, 259, p. 1739 (1993); BD Car et al., J. Exp. Med., 179, p. 1437 (1994)). With IL-12, IGIF appears to be a potent inducer of r-IFN production by Ding cells (H. Okamura et al., Infection and Immunity, 63, p. 3966 (1995); H, Okamura et al., Nature, 378, p. 88 (1995); S. Ushio et al., J. Immunol "156, p. 4274 (1996)). IFN-r has been shown to be associated with various inflammatory, infectious, and autoimmune aphasia. And disease-related pathological reasons. Therefore, compounds that reduce the production of IFN-r will be used to ease the effects of IFN-r-related pathologies. The biological regulatory effects of IGIF and therefore r-IFN have not been elucidated. IGIF was previously known The body protein pattern is synthesized and is called "pre-IGIF". However, it is unclear how pre-IGIF is dissociated and whether its modification is biologically important. Therefore, the composition and method that can regulate the conversion of pre-IGIF to IGIF can be used in vivo to reduce the production of IGIF and IFN · r, and therefore can alleviate these causes (please first: ^ read the precautions on the back page)- Bookbinding Brigade

本纸银尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) 1235157 Α7 Β7 經濟部中央揉準局員工消费合作社印装 五、發明説明(7 ) 人類失調症及疾病原因的蛋白質的有害作用。 然而,ICE及ICE/CED-3族中其他的成員先前並未知與前 -IGIF至IGIF或至活體内IFN-r產製之轉化作用中有何關聯。 ICE抑制劑代表一類可用於控制發炎或細胞預翔死亡或 二者之有用的化合物。ICE之肽及肽性抑制劑已有所描述 。PCT案 WO 91/15577 ; WO 93/05071 : WO 93/09135 : W〇 93/14777及 WO 93/16710 ;及歐洲專利案 0 547 6·99。ICE此 種肽性抑制劑已觀察知可阻斷老鼠發炎模式中成熬IL-1 y? 之產製(見以下)及可遏止試管、白血病細胞之生長(Estrov et al·,Blood 84, 3 80a (1994))。然而,由於其肽性本質,此 抑制劑典型的特性爲非欲求的藥理特性,如不良的细胞穿 透及細胞活性,不良的口服吸收,不良的穩定性及快速的 新陳代謝。Plattner, J.J. and D.W. Norbeck, in Drug Discovery Technologies, C.R. Clark and W.H. Moos, Eds. (Ellis Horwood,Chichester,England,1990),pp· 92-126。此 已阻礙其發展成有效的藥物β 也有報告指出非肽性化合物可於說管内抑制ICE。PC丁案 WO 95/26958 : US專利 5,552,400 ; Dolle et al., J. Med. Chem·,39,pp. 2438-2440 (1996);然而 不清楚這些化合 物是否有適合的藥理概狀可供治療應用。 另外,目前製備此化合物之方法並非有益的。這些方法 中使用氩化三丁錫,一種具有毒性且對濕氣敏感之試剤。 因此這些方法不合宜實行,有健康危險性且會產生毒性廢 料丟棄問題。再者,難以纯化由這些方法製備的化合物。 -10· 本纸乐尺度適用中國國家揉率(CNS ) Α4規格(210Χ297公釐) 抑衣-- (诗先·¾讀背δ之注意事項再JIKTI ) 訂 .Λ 1235157 A7 B7 五、發明説明(8 ) 因此,極需有可於活體内有效抑制ICE作闫之化合物, 以充作預防及治療IL -1 -調介之疾病,細胞預期汔亡-, IGIF-,或IFN-r-調介的疾病,以及發炎「自體免疫,破壞 性骨籍,增殖,感染性或退化性疾病慢性及急性型式之作 用物。製備此化合物的方法也是需要的。 發明要點 本發明提出新一類型的化合物,及其藥學上寸接受的衍 生物,其可充作ICE之抑制劑。這些化合物也可單獨使用 或組合其他治療性或預防性作用物使用,如抗生素,免疫 調控劑或其他抗炎劑,以治療或預防由IL· 1,細胞預期死 亡,IGIF或IFN-r的調介的疾病。依據較佳的具體實例, 本發明的化合物可結合至ICE的活性位置及抑制酵素的活 性。額外地,其具有經改進的細胞效力,改進的藥物動力 及/或改進的口服生物利用率,此係與肽性ICE抑制劑比較 而言。 本發明的主要目的是提出新一類的化合物,其爲ICE抑 制劑並以下化式代表之··The silver scale of this paper applies the Chinese National Standard (CNS) M specification (210X297 mm) 1235157 Α7 Β7 Printed by the Consumer Cooperatives of the Central Bureau of the Ministry of Economic Affairs. 5. Description of the invention (7) The harmful effects of proteins on human disorders and disease causes . However, the ICE and other members of the ICE / CED-3 family have not previously been known to be involved in the conversion of pre-IGIF to IGIF or to in vivo IFN-r production. ICE inhibitors represent a class of compounds useful for controlling inflammation or cell death, or both. ICE peptides and peptide inhibitors have been described. PCT case WO 91/15577; WO 93/05071: WO 93/09135: WO 93/14777 and WO 93/16710; and European patent case 0 547 6.99. This peptide inhibitor of ICE has been observed to block the production of IL-1 y? In the inflammation mode of mice (see below) and to inhibit the growth of test tubes and leukemia cells (Estrov et al., Blood 84, 3 80a (1994)). However, due to its peptidic nature, the typical characteristics of this inhibitor are non-desired pharmacological properties, such as poor cell penetration and cell activity, poor oral absorption, poor stability, and rapid metabolism. Plattner, J.J. and D.W. Norbeck, in Drug Discovery Technologies, C.R. Clark and W.H. Moos, Eds. (Ellis Horwood, Chichester, England, 1990), pp. 92-126. This has hindered its development into an effective drug β. There are also reports that non-peptidic compounds can inhibit ICE in vitro. PC Ding WO 95/26958: US Patent 5,552,400; Dolle et al., J. Med. Chem., 39, pp. 2438-2440 (1996); however it is unclear whether these compounds have suitable pharmacological profiles for treatment application. In addition, current methods of preparing this compound are not beneficial. Tributyltin argon is used in these methods, a test that is toxic and sensitive to moisture. Therefore, these methods are not suitable for implementation, there are health risks and there will be problems of toxic waste disposal. Furthermore, it is difficult to purify compounds prepared by these methods. -10 · This paper music scale is applicable to China's national kneading rate (CNS) Α4 specification (210 × 297 mm) Yi Yi-(Poem first · ¾ read the note of δ and then JIKTI) Order. Λ 1235157 A7 B7 V. Description of the invention (8) Therefore, there is a great need for compounds that can effectively inhibit ICE as an in vivo in vivo in order to prevent and treat IL-1 -mediated diseases, and the cells are expected to die-, IGIF-, or IFN-r-regulated Disease, as well as inflammation, "autoimmune, destructive bone disease, proliferative, infectious or degenerative diseases of chronic and acute types of agents. Methods of preparing this compound are also needed. Summary of the invention The present invention proposes a new type Compounds, and their pharmaceutically acceptable derivatives, which can act as inhibitors of ICE. These compounds can also be used alone or in combination with other therapeutic or prophylactic agents, such as antibiotics, immunomodulators or other anti-inflammatory agents In order to treat or prevent diseases mediated by IL · 1, expected cell death, IGIF or IFN-r. According to a preferred embodiment, the compounds of the present invention can bind to the active site of ICE and inhibit the activity of enzymes. Field It has improved cell potency, improved pharmacokinetics, and / or improved oral bioavailability, which is compared with peptide ICE inhibitors. The main object of the present invention is to propose a new class of compounds, which are ICE inhibitors The agent is represented by the following formula ...

經濟部令夬標孪局W3C工消費合作社印製 -11 - 本纸伕尺度適用中國國家標準(CNTS ) A4規格(210X297公釐) 1235157 Λ i Β7 五、發明説明(9 ) S1 (工),(VI)Printed by the Ministry of Economic Affairs and Standards Bureau W3C Industrial and Consumer Cooperatives -11-The standard of this paper is applicable to the Chinese National Standard (CNTS) A4 (210X297 mm) 1235157 Λ i Β7 5. Description of the invention (9) S1 (Industrial), (VI)

(CJ2)m-T(CJ2) m-T

Ri-NH-X]Ri-NH-X]

t H (CH2)g-R3 及 (請先53讀背面之注意事項t H (CH2) g-R3 and (Please read the notes on the back first 53

(II)-(V) and (VII) RrH(II)-(V) and (VII) RrH

OR13 本瓦) •裝 其中各取代基如此中所述e 本發明進一步目的是提出將羧酸.與別位一經保護之胺偶 合之N-醯基胺基化合物之製法。 附圖説明 圖1A ICE可於活體内解離前-IGIF。來自Cos細胞,且經 所示的各種表現質體或對照组轉感的溶胞產物分析是否有 IGIF之存在,即以SDS-PAGE分離蛋白質並以抗-IGIF抗血 __ ·—〆—------ 身_見疫运漬(1列,空白的經轉感細胞;2列,單獨的前 -IGIF: 3-12列,前-IGIF 组合 ICE,ICE-C285S,CPP32, CPP32-C163S,CMH-1,CMH-1-C186S,Tx,TX-C258S) 。前-IGIF及18-kDa成熟IGIF之移動示於右。按匕0&計之分 子量示於左(實例23)。 12 本纸朵尺度適用中國國家標準(CNS M4規路(2丨0X297公釐) 訂 :^ 經濟邓中央揉率局貝工消費合作社印装 1235157 Λ7 B7 五、發明说明(1〇 )OR13 Benwa) • Each of the substituents is as described herein. A further object of the present invention is to propose a method for preparing an N-fluorenylamino compound in which a carboxylic acid is coupled with an protected amine in the other position. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1A ICE can dissociate in vivo before-IGIF. From Cos cells, and analyze the presence of IGIF by the lysates showing various plastids or control groups, that is, the protein was separated by SDS-PAGE and anti-IGIF anti-blood. ----- Body _ see epidemic transport stains (1 column, blank transfected cells; 2 columns, separate front-IGIF: 3-12 columns, front-IGIF combination ICE, ICE-C285S, CPP32, CPP32- C163S, CMH-1, CMH-1-C186S, Tx, TX-C258S). Movements of pre-IGIF and 18-kDa mature IGIF are shown on the right. The molecular weight as shown in Figure 0 is shown on the left (Example 23). 12 The size of this paper is applicable to the Chinese national standard (CNS M4 Regulations (2 丨 0X297 mm). Order: ^ Printed by Deng Central Government Bureau, Shellfish Consumer Cooperative, 1235157 Λ7 B7 V. Description of Invention (1)

圖1B ICE在試管内可於確實的處理修飾位置上解藉.前-IGIF,此可甴考馬斯藍對經SDS-PAGE分離的蛋白水解反 應產物染色而示出(實例23)。所使用的蛋治酶及抑制劑爲 ·· 1列,缓衝溶液對照組;2列,0·1 nM ICE ; 3列,1 nM ICE : 4及 5列,1 nM ICE分別加上 10 nM Cbz-Val-Ala-Asp-[(2,6-二氯芊醯基)氧基]甲基調及100 nMFigure 1B. ICE can be borrowed at the exact processing modification position in the test tube. Pre-IGIF, which can be shown by Coomassie blue staining the proteolytic reaction product separated by SDS-PAGE (Example 23). The egg enzymes and inhibitors used are: 1 column, buffer solution control group; 2 columns, 0.1 nM ICE; 3 columns, 1 nM ICE: 4 and 5 columns, 1 nM ICE plus 10 nM respectively Cbz-Val-Ala-Asp-[(2,6-dichlorofluorenyl) oxy] methyl to 100 nM

Asp-兹:6及 7列,15 nM CPP32分別自或無400 nM Ac-Asp-Glu-Val-Asp-^ (D. W. Nicholson et aL, Nature, 376, p. 37 (1995)); 8列,lOOnMCMH-1·· 9列,10單位 /毫升 granzyme B :及按kDa計之分子量標幟β 圖1C ICE解離可將無活性的前-IGIF轉化成具有活性的 IGIF,其可誘導Thl輔助細胞中產生IFN-r。未解燊的(前· IGIF/ICE),CPP32-解離的(前-IGIF/CPP32),及重組禮成熟 IGIF(rlGIF)與A.E7 Thl细胞在12毫微克/毫升(空心框)及I20 毫微克/毫升(有陰影的框)下培育18小時,再以ELISA分析 釋放至細胞培養基之IFN- r (實例23)。Α·Ε7细胞以缓衝溶 液,單獨的ICE (ICE),或單獨的CPP32 (CPP32)培育,類 似陰性對照組般分析。數字代表三次決定値之平均3 圖2A成熟IGIF(18-kDa)由經前-IGIF及ICE·表現質鳢共轉 感之Cos知胞所產生。來自Cos封胞之溶胞產物(T2)及調適 培養基(右)以前-IGIF表現質體轉'感,並在無㈠或有可编爲 野生型(ICE)或無活性突變株(ICE-C285S) ICE之表現質韹 存在下。經轉感的細胞以35S-曱硫胺酸代謝地標記,來自 落胞產物及調適培養基之蛋白質再以-IGIF抗血清免疫 _ ·13· 本纸伕尺度適同中国國家標率(CNS ) Α4規格(210X297公釐) (讀先秀效背云之洼意事f 一 尽買 裝 訂 經濟部中夬揉李局員工消費合作社印* 1235157 經濟部中央標準局負工消费合作社印裝 A7 . ____ B7___ 五、發明説明(11 ) ;殿,並以SDS-PAGE分離(實例24)。前-IGIF及〖8-kDa成熟 IGIF之移動示於右。按kDa計之分子量標織示於左3 圖2B 在以前-IGIF及ICE-表現質體共轉感之Cos細胞中读 測IFN- r诱導活性。來自Cos細胞之溶胞產物(實心捏)及詞 適培養基(空心框)以前-IGIF表現質體轉感,並在無(前、 IGIF)或有(前-IGIF/ICE)编碼野生型(ICE)之表現質禮存在 下,以ELISA分析IFN-r之水平。以缓衝溶液(空白組)或 ICE-表現質體單獨的(ICE)轉感的Cos細胞爲陰性對照組(實 例24)。 * 圖3 A 來自缺乏ICE之老鼠,其庫弗氏細胞於IGIF運送上 也有缺陷。分離野生型老鼠(ICE +/+)或ICE突變呈同種接 合子之ICE有缺陷老鼠(ICE-Λ)之庫弗氏細胞,並以LPS充 滿3小時。於野生型細胞調適培養基(毫微克/毫升)中之免 疫反應性IGIF多肽水平以ELISA偵測(實例25)。N· D·(無可 測及的)表示IGIF濃度少於0.1毫微克/毫升。 圖3B 來自缺乏ICE之老鼠,其庫弗氏細胞於IGIF運送上 也有缺陷。分離野生型老鼠(ICE +/+)或ICE爲同種接合子 之ICE有缺陷老鼠(ICE -/-)之庫弗氏細胞,並以LPS充渴3 小時。經充滿的細胞以35S·甲硫胺酸代謝地標記,來自溶 胞產物及調適培養基之蛋白質以抗-IGIF抗血清沉澱,再 以SDS-PAGE分離(實例25)。前:IGIF及18-kDa成熟IGIF之 移動示於右。按kDa計之分子量示於左。. 圖3C來自ICE-有缺陷老鼠之血清中含有減量的IGIF。利 用ELISA分析野生型老鼠(ICE +/+)或ICE突變爲同種接合子 -14 - 本紙ft尺度通㈤中国國家標準(CNS ) Μ規格(210X 297公沒) ' -------- f請先闔讀背面之:这意事^Asp: 6 and 7 columns, 15 nM CPP32 from or without 400 nM Ac-Asp-Glu-Val-Asp- ^ (DW Nicholson et aL, Nature, 376, p. 37 (1995)); 8 columns, lOOnMCMH-1 · 9 columns, 10 units / ml granzyme B: and molecular weight markers in kDa β Figure 1C ICE dissociation can convert inactive pre-IGIF into active IGIF, which can induce Th1 helper cells Production of IFN-r. Undissociated (pre-IGIF / ICE), CPP32-dissociated (pre-IGIF / CPP32), and recombinant mature IGIF (rlGIF) and A.E7 Thl cells at 12 ng / ml (open frame) and I20 Incubate at ng / ml (shaded box) for 18 hours, and then analyze IFN-r released into the cell culture medium by ELISA (Example 23). Α7 cells were cultured in buffered solution, ICE (ICE) alone, or CPP32 (CPP32) alone, and analyzed like a negative control group. Figures represent the average of three decisions. Figure 2A Mature IGIF (18-kDa) is produced by pre-IGIF and ICE co-infected cosponsors. The lysates (T2) from Cos sealed cells and the adapted medium (right) -IGIF showed a sense of plastid translocation, and could be classified as wild type (ICE) or inactive mutant (ICE-C285S) ) The performance of ICE exists. The transfected cells were metabolically labeled with 35S-sulfanthionine, and the proteins from the falling spore product and the adapted medium were immunized with -IGIF antiserum. · 13 · This paper has the same scale as the Chinese National Standard (CNS) Α4 Specifications (210X297 mm) (Read the first show of the effect of the cloud f f buy all the bindings printed by the Ministry of Economic Affairs of the Central Bureau of the Bureau of the Consumer Consumption Cooperatives * 1235157 Central Standards Bureau of the Ministry of Economic Affairs Consumer Cooperatives printed A7. ____ B7___ V. Description of the invention (11); and separated by SDS-PAGE (Example 24). The movement of pre-IGIF and [8-kDa mature IGIF is shown on the right. The molecular weight in kDa is shown on the left 3 Figure 2B Read IFN-r-inducing activity in Cos cells that previously expressed IGIF and ICE-plastid sympathy. Lysates from Cos cells (solid pinch) and Ci Shi medium (open box) Body sensation, and in the absence of (pre-, IGIF) or (pre-IGIF / ICE) encoding wild-type (ICE) performance qualitative analysis, ELISA analysis of IFN-r levels. Buffer solution (blank Group) or ICE-Cos cells expressing plastid alone (ICE) transduction were the negative control group (Example 24). * Figure 3 A From mice lacking ICE, their Coffer cells are also defective in IGIF transport. Isolate the pool of wild-type mice (ICE + / +) or ICE-deficient mice (ICE-Λ) with ICE mutations in the same spliceosome. Freund's cells and filled with LPS for 3 hours. The level of immunoreactive IGIF polypeptide in wild-type cell conditioning medium (nanograms / ml) was detected by ELISA (Example 25). N · D · (No detectable ) Indicates that the IGIF concentration is less than 0.1 nanograms / ml. Figure 3B From mice lacking ICE, their Cuffs cells are also defective in IGIF transport. Isolate wild-type mice (ICE + / +) or ICE as the same zygote ICE Defective mice (ICE-/-) of Cooper's cells, and thirst with LPS for 3 hours. The filled cells were metabolically labeled with 35S · methionine, and proteins from the lysate and the culture medium were adapted for anti- IGIF antiserum was precipitated and separated by SDS-PAGE (Example 25). Front: The movements of IGIF and 18-kDa mature IGIF are shown on the right. Molecular weight in kDa is shown on the left. Figure 3C from ICE-defective mice Serum contains a reduced amount of IGIF. Wild type mice (ICE + / +) Or ICE mutation to the same zygote-14-This paper ft standard is in accordance with Chinese National Standards (CNS) M specifications (210X 297 public). -------- f Please read the following first: this means Thing ^

衣 FC 訂 1235157 Λ7 B7 五、發明説明(12) 之ICE有缺陷老鼠(ICE -/-)之IGIF水平(毫微克/毫升)(實例 25)。 圖3D 來自ICE-有缺陷老鼠之血清中含有-減量的IFN- r。 利用EUSA分析野生型老鼠(ICE +/+)或ICE突變爲同種接合 子之ICE有缺陷老鼠(ICE -/-)之IFN- Γ水平(毫微克/毫升)( 實例25)。 圖4 經過LPS急性挑戰後,ICE-有缺陷老鼠之'血清IFN-r 水平顯著地減低。以EUSA分析野生型老鼠(實心正方形) 或ICE-有缺陷老鼠(實心圈)血> 樣品中之IFN- r水平(毫微 克/毫升),爲LPS挑戰後之時間(小時)函數關係。在此時翔 動物按攝氏度數計之溫度,於野生型老.鼠(空心正方形)或 ICE-有缺陷老鼠(空心圈)示出。 圖5 ICE抑制劑,AcYVAD·醛(AcYVAD-CH〇)可抑制人 類周邊血液單核細胞(PBMC)之LPS-刺激的IL-1 /?及IFN- r 合成。示出IL-1万(空心正方形)及IFN- r (空心星形)合成之 呈抑制劑濃度(A M)函數關係之抑制百分率(%)。Clothing FC Order 1235157 Λ7 B7 V. IGIF level (nanograms / ml) of the ICE-deficient mouse (ICE-/-) in the description of the invention (12) (Example 25). Figure 3D. Serum from ICE-deficient mice contains -reduced IFN-r. EUSA was used to analyze IFN-Γ levels (nanograms / ml) in wild-type mice (ICE + / +) or ICE-deficient mice (ICE-/-) mutated to the same zygote (Example 25). Figure 4 The serum IFN-r levels of ICE-deficient mice were significantly reduced after acute challenge with LPS. The IFN-r levels (nanograms / ml) in wild type mice (filled squares) or ICE-defective mice (filled circles) were analyzed by EUSA as a function of time (hours) after LPS challenge. The temperature of the animal at this time in degrees Celsius is shown in wild-type old rats (open squares) or ICE-defective rats (open circles). Figure 5 ICE inhibitor, AcYVAD · aldehyde (AcYVAD-CH〇) can inhibit LPS-stimulated IL-1 /? And IFN-r synthesis in human peripheral blood mononuclear cells (PBMC). The percent inhibition (%) as a function of inhibitor concentration (A M) for IL-110,000 (open square) and IFN-r (open star) synthesis is shown.

經濟部中央橾隼局系工消費合作社印5L (請先閱讀背面之注意事項異頁) 圖6 化合物214e可抑制LPS-挑戰老鼠之IL-I/?產製。以 £]:15八分析001老鼠血清樣品中之1]^1;?水平(微微克/毫升),此 在LPS-挑戰後進行。化合物214e於LPS-挑戰後卜彳、時經腹 膜内(IP)注射投藥。LPS-挑戰後7小時收集血樣(見實例7)。 圖7 化合物217e可抑制LPS-挑~戰老鼠之IL-1/?產製。於 LPS-挑戰後以ELISA分析CD1老鼠血清樣品中之IL-1冷水 平(微微克/毫升)。化合物217e在LPS-挑戰後卜!、時經由腹 膜内(IP)注射投藥。於LPS-挑戰後7小時收集血液(見實例7)。 •15· 本纸乐尺度適用中国國家揉準(CNS ) A4^格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(13 ) 圖8化合叻2 14 e,但非化合物2 1 7 e,當經口灌食時可在 a LPS-挑戰的老鼠中抑制IL-1冷產製。此分析可偵測在如 圖6及7所巡之相似條件下之口服吸收作用、這些結杲顯示 2 !4e可充作潛在口服具活性之ICE抑制劑(見實例7)。 圖9化合物2l4e及214e的同系物於ip投藥後也可抑制il· 1点產製。這些結果於圖6及7及實例7所述之分析中獲得。 圖10化合物214e及214e的同系物於口服投藥後(ρ〇)也可 抑制IL-1 /?的產製。這些結果可於圖6及7及實例7所述的 分析中獲得。 _ 圖11Α/Β化合物302及304a當口服至老鼠(5〇毫克/公斤, 於0·5ο/〇羧甲基纖維素中)時示出可偵測之血液水平。於給 藥後1及7小時時收集血液樣品。化合物3〇2及3〇4&爲21^ 之前藥,可於活體内代謝成214e。化合物214e當π服時無 超過0.10微克/毫升之血中水平(實例8)。 圖12化合物412f可阻斷雄的DBA/1J老鼠中Π型膠原吞白· 誘導之關節炎之進行。(Wooley, Ρ·Η·,Methods in Enzymology, 162, ΡΡ· 361-373 (1988)及 Geiger, 丁·,Clinical and Experimental Rheumatology, 11, pp. 515-522 (1993)) 〇 化合物412f經口灌食每天二次(i〇,25及50毫克/公斤)约間 隔7小時。以關節炎嚴重分數的1至4個漸強等級測度發炎 作用。加上二個前腳的分數以得‘最終分數(見實例21)。 圖13 化合物412d可阻斷雄的DBA/1J老鼠中II型勝原蛋白 誘導之關節炎之進行。結果如圖12及實例21中所述3 圖14 化合物696a可阻斷雄的DBA/1J老鼠中II型膠原蛋白· -16 - 本纸乐又度通用中国國家標孳(CNS ) A4規格(210X297公釐) ·-· l;i t —1 ·1·· · ^-- (诗先絮讀背云之注意事^本頁) 訂 經濟部中央標隼局員工消費合作社印¾ 1235157 A 7 . B7五、發明説明(14 ) 誘導之關節炎之進行。結果如圖12及實例2 1中所述。 縮寫及定義 縮寫 , 經濟部中央標準局貝工消资合作社印装 命名 試劑或片 Ala 丙胺酸 Arg 精胺酸 Asn 天冬醢胺 Asp 天冬胺酸 Cys 半胱胺酸 Gin 穀胺醯胺 Glu 穀胺酸 Glv 甘胺酸 His 組織胺酸 lie 異白胺酸 Leu 白胺酸 Lys 賴胺酸 Met 甲硫胺酸 Phe 苯丙胺酸 Pro 脯胺酸 Ser 絲胺酸 Thr 蘇胺酸 Trp 色胺酸 Tvr 駱胺酸 Val 纈胺酸 -17- 本纸乐尺度適周中国國家標準(〔知)六4規格(2〖0>:297公釐) (讀先聞讀背面之注意事項 --裝-- 本頁) 訂5L printed by the Central Government Bureau of the Ministry of Economic Affairs and Industrial Cooperatives (please read the different pages on the back of the note) Figure 6 Compound 214e can inhibit the production of IL-I /? By LPS-challenge mice. The 1] ^ 1 ;? levels (picograms / ml) in 001 mouse serum samples were analyzed at £]: 15, which was performed after the LPS-challenge. Compound 214e was administered intraperitoneally (IP) after LPS challenge. Blood samples were collected 7 hours after LPS-challenge (see Example 7). Figure 7 Compound 217e can inhibit the production of IL-1 /? By LPS-pick ~ war rats. After LPS-challenge, the cold level of IL-1 (picograms / ml) in CD1 mouse serum samples was analyzed by ELISA. Compound 217e was administered via intraperitoneal (IP) injection after LPS-challenge! Blood was collected 7 hours after the LPS-challenge (see Example 7). • 15 · This paper music scale is applicable to the Chinese national standard (CNS) A4 ^ grid (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (13) Figure 8 Chemical compound 2 14 e, but not compound 2 1 7 e Inhibition of IL-1 cold production in a LPS-challenged mice when administered orally. This analysis can detect oral absorption under similar conditions as shown in Figures 6 and 7. These crusts show that 2! 4e can be used as a potential oral active ICE inhibitor (see Example 7). The homologues of compounds 214e and 214e in FIG. 9 can also inhibit il · 1 point production after ip administration. These results were obtained in the analyses described in Figures 6 and 7 and Example 7. The homologues of compounds 214e and 214e in Fig. 10 can also inhibit the production of IL-1 /? After oral administration (ρ0). These results can be obtained in the analyses described in Figures 6 and 7 and Example 7. Figure 11A / B compounds 302 and 304a show detectable blood levels when taken orally in mice (50 mg / kg in 0.5o / o carboxymethyl cellulose). Blood samples were collected at 1 and 7 hours after administration. Compounds 300 and 300 are prodrugs of 21 ^ and can be metabolized to 214e in vivo. Compound 214e did not exceed a blood level of 0.10 µg / ml when taken at π (Example 8). Figure 12 Compound 412f blocks the progress of type II collagen bleaching-induced arthritis in male DBA / 1J mice. (Wooley, PP ·, Methods in Enzymology, 162, PP · 361-373 (1988) and Geiger, D ·, Clinical and Experimental Rheumatology, 11, pp. 515-522 (1993)) 〇 Compound 412f is administered orally Food is taken twice daily (10, 25 and 50 mg / kg) at intervals of about 7 hours. Inflammation was measured on a scale of 1 to 4 with increasing severity of arthritis. Add the two forefoot scores to get the ‘final score (see Example 21). Figure 13 Compound 412d blocks the progression of type 2 victorin-induced arthritis in male DBA / 1J mice. The results are shown in Figure 12 and Example 21. 3 Figure 14 Compound 696a can block type II collagen in male DBA / 1J mice. -16-Benzhile is again in compliance with China National Standard (CNS) A4 (210X297) (Mm) ·-· l; it —1 · 1 ··· ^-(Notes on reading the poem before reading the cloud ^ this page) Ordered by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economy ¾ 1235157 A 7. B7 5. Description of the invention (14) The progress of induced arthritis. The results are shown in Figure 12 and Example 21. Abbreviations and definitions. Named reagents or tablets printed by the Central Bureau of Standards of the Ministry of Economic Affairs of the Consumers' Cooperatives. Ala Alanine Arg Arginine Asn Asparagine Asp Asp Cys Cysteine Gin Glutamine Glu Valley Glycine Gly Glycine His Histamine Lie Isoleucine Leu Leucine Lys Lysine Met Methionine Phe Phenylalanine Pro Proline Ser Serine Thr Threonine Trp Tryptophan Tvr Carotamine Acid Val valine acid -17- this paper music scale suitable for Chinese national standards ([knowledge] six 4 specifications (2 〖0 >: 297mm) (read first read the precautions on the back-installed-this page) ) Order

1235157 A7 B7 五、發明説明(15 ) S?濟部中央揉準局员工消费合作社印衮1235157 A7 B7 V. Description of the invention (15) S?

Ac20 醋酐 n-Bu 正丁基 DMF 二甲替甲醯胺 , DIEA N,N-二異丙基乙胺 EDC 1-(3-二甲胺基丙基)-3-乙基碳化二亞胺鹽酸 Et20 二乙醚 EtOAc 乙酸乙酯 ’ Fmoc 9-易基甲氧羰基 HBTU 0-苯並三唑-f-基-N,N,N’,N’-四甲鎵六氟磷 酸鹽 Η0ΒΤ 1 -羥基苯並三唑水合物 MeOH 甲酵 丁FA 三氟醋酸 Alloc 烯丙氧羰基 定義 此中應用以下術語: ·· r干擾素謗導因子n或n IGIF”指可刺激IFN- r内源性產 製的一種因子。 ” ICE-抑制劑”指可抑制ICE酵素之化合物。ICE抑制作同 可利用所述方法決定,且已列入此中參考。精藝者明瞭活 體内的ICE抑制劑未必是試管内iCE抑制劑。如,化合物之 前藥型式通常於諸管内分析中少有或無活性。此種前藥型 式可在病人體内經由代謝或其他生化過程而改變,生成活 體内的ICE抑制劑。 -18- 本纸伕尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) (讀先¾讀背面之注意事項 I ml n n 本 K ) 訂Ac20 acetic anhydride n-Bu n-butyl DMF dimethylformamide, DIEA N, N-diisopropylethylamine EDC 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide Et20 hydrochloride diethyl ether EtOAc ethyl acetate 'Fmoc 9-easylmethoxycarbonyl HBTU 0-benzotriazole-f-yl-N, N, N', N'-tetramethylgallium hexafluorophosphate Η0ΒΤ 1-hydroxyl Benzotriazole hydrate MeOH formadol FA trifluoroacetic acid Alloc Allyloxycarbonyl definition The following terms are used here: · · r interferon deflecting factor n or n IGIF "means can stimulate IFN- r endogenous production "ICE-inhibitor" refers to a compound that inhibits ICE enzymes. ICE inhibition can be determined using the method described and is incorporated herein by reference. The artisan knows that ICE inhibitors in vivo are not necessarily a trial. Intratubular iCE inhibitors. For example, the compound's previous drug form is usually rare or inactive in tube analysis. This prodrug form can be altered in patients by metabolism or other biochemical processes to generate in vivo ICE inhibitors. -18- The size of this paper is applicable to the Chinese National Standard (CNS) M specifications (210X297 mm) (read first ¾ read the back Note this I ml n n K) Order

經濟部中央標準局貝工消费合作杜印装 1235157 Λ7 一·· B 7 五、發明説明(16^ - 所謂”细胞動素”係指可調介細胞交互作周之分子s ,•牧況”指可在個體中產生有害的生物學因果關係之任何 疾病’八调症或作用。 一 •,個體”指動物,或由動物衍生的一種以上細胞。較好勤 物是哺乳動物,最好是人類,細胞可呈任何型式,包括下 列但不限於保留在组織中之細胞,細胞義集,不、死的細胞 ,經轉感或轉形的細胞,及衍生自動物且已經杨理上或表 現型上改變之細胞。 活性位置指在ICE中下列存一或全部位置:受質結合 位且’抑市i 可結合的位置及發生受質解離的位置。 '•雜環π或”雜環的"指穩定的單或多環化合物,其視所需 可含有一或二個雙鍵,或可視所需含有一個以上的芳族環 。各雜環由硬原子及1至4個獨立選自氮,氧及硫的雜原子 組成。如此中所用的,•’氮雜原子"及"硫雜原子”,包括氮 或硫的任何氧化型式,及任何驗性氮之四級化型式^此中 定義的雜環包括如:嘧啶基,四氩峻琳基,四氫異4 4基 ’辱+基’在咬基’ 4卜朵ν林基,苯並咪4基,咪峻基,味 唑琳基,咪唑啶基,,奎琳基,異”奎嗛基,啕哚基,,比啶基 ’ g比哈基’ 〃比洛林基’ 〃比4基’ V比呼基,cr查嗔α林基,六氫 吡啶基,嗎福啪基,。i嗎福琳基,呋喃基,β塞吩基,三唑 基,嘍唑基,咔琳基,四唑'基,噻唑啶基,苯益呋嘀 甲基,4嗎福琳基躐,苯並噁唑基,氧六氩吡啶基,氧毗 洛遠基,氧氮雜革基,氮雜革基,異兔嗤基,四氫沒喃基 ,四氫呋喃基,4二唑基,苯並二氧基,苯並4吩基,四 -19- 本纸ffc尺度逑同中國國家標準(CNS ) Α4規格(210X297公4 )Central Bureau of Standards, Ministry of Economic Affairs, Shellfish Consumer Cooperation, Du Yinzhuang 1235157 Λ7 ··· B 7 V. Description of the invention (16 ^-The so-called "cytokines" refers to molecules that can mediate the interaction of cells to interact with each other, and animal husbandry conditions " Refers to any disease that can produce harmful biological cause-effect relationships in individuals. Eight disorders or effects. I. An individual means an animal, or more than one type of cell derived from an animal. Preferably, mammals, most preferably In humans, cells can be of any type, including the following but not limited to cells retained in tissues, cell sense sets, non-dead cells, transfected or transformed cells, and derived animals that have already Cells with phenotypic changes. Active positions refer to one or all of the following positions in ICE: sites that are bound by the mass and where the inhibitory i can bind and sites that undergo dissociation by the mass. &Quot; refers to a stable mono- or polycyclic compound, which may contain one or two double bonds as required, or more than one aromatic ring as required. Each heterocyclic ring is independently selected by hard atoms and 1 to 4 Composition of heteroatoms from nitrogen, oxygen and sulfur As used herein, "'nitrogen " and " sulfur heteroatom " includes any oxidized form of nitrogen or sulfur, and any quaternized form of any qualitative nitrogen ^ Heterocyclic rings defined herein include, for example: pyrimidine Base, tetrahydrojunyl, tetrahydroiso-4, 4-'isopropyl + radical 'in octayl, 4-butorimyl, benzimidyl, imidyl, misazolinyl, imidazolidinyl ,, Quelinyl, iso "quinolyl, fluorinyl, bipyridyl 'g bihalki' 〃birolinyl '〃bi 4yl' v bihyl, cr char 嗔 α linyl, hexahydropyridine Molybdenyl, mofapyl, i-mofrinyl, furyl, β-secenyl, triazolyl, oxazolyl, carinyl, tetrazolyl, thiazolyl, benzilfurylmethyl, 4 morpholinyl, benzoxazolyl, oxetyryl, oxopyridoryl, oxaziridyl, azapicyl, isotudinyl, tetrahydrometanyl, tetrahydrofuranyl, 4 diazolyl, benzodioxy, benzo 4 phenyl, tetra-19- This paper fcf scale is the same as China National Standard (CNS) A4 specification (210X297 male 4)

1235157 Λ7 _B7 五、發明説明(17 ) 氫硫苯基及磺酸甲基3進一步的雜環述於八.11.〖2〖出21^ and C.W. Rees,eds·,Comprehensive Heterocyclic Chemistry: The Structure, Reactions, Synthesis and Use'of Heterocyclic Compounds, Vol. 1-8, Pergamon Press, NY (1984) « n雜烷基”指單或多環基,其含有3至1 5個碳及視所需含 有一或二個雙鍵。實例包括環己基,金剛烷基及正葙基。 〃芳基〃指單或多環基,其含有6,10,12或14彻碳其中至 少一個環是芳族的。實例包括苯基·,葚基及四氫莕。 所謂”雜芳族"指單或多環基' 其含有1至15個碳原子及由 1至4個雜原子,其各自獨立選自下列包括疏,氮及氧,且 其額外地含有1至3個五或六員環,其中至少一個是芳族的。 M濟部中央標準局员工消费合作社印裂 所謂” c -胺基酸"(α -胺基酸)指自然生成的胺基酸及當製 備自然生成肽之類似物時常用於肽化學技藝中之其他,•非 蛋白質” c -胺基酸,包括D及L型。自然生成的胺基酸有甘 胺酸,丙胺酸,纈胺酸,白胺酸,異白胺酸,絲胺酸,甲 疏胺酸,蘇胺酸,苯丙胺酸,路腔酸,色胺酸,半胱腔酸 ,脯胺酸,组胺酸,天冬胺酸,天冬醯胺,穀胺酸,穀胺 _胺,r ·羧基穀胺酸,精胺酸,烏胺酸及賴胺酸。"非蛋 白質” c -胺基酸之實例包括羥基賴胺酸,高絲胺酸,高酷 胺酸,高苯丙胺酸,瓜胺酸,犬尿素,4·胺基-苯丙胺酸, 3-(2-篇基)-丙按酸’ 3·(1·篇基)-丙胺酸,甲疏胺酸垣,第 三丁基-丙胺酸,第三丁基甘胺酸,4-羥基苯基甘胺酸,胺 基丙胺酸,苯基甘胺酸,丙烯基丙按酸,丙块基-甘胺酸 ,1,2,4-三嗖基-3·丙胺酸,4,4,4-三氟-蘇胺酸,曱線胺酸 •20· ^紙ft尺度通用中11國家標率(CNS )八4現格(21GX297公釐)" 一 一 Μ濟部中央標準局貝工消费合作杜印¾ 1235157 A7 B7 五、發明説明(18) ,6-羥基色胺酸,5-裎基色胺酸’ 經基犬尿素’ 3·胺基 酪胺酸,三氟甲基丙胺酸’ 2·邊吩基两胺酸’(2-(4-。比这 基)乙基)-半胱胺酸,3,4-二曱氧基-苯两胺"酸’ 3-(2-噻唑基) -丙腔酸,鹤膏革胺酸’卜胺基-1-環戊虎-幾酸’ 按基-1- 環己烷致酸,使君子胺酸’ 3-三氟甲基苯基丙胺酸,三 氟-甲基苯丙胺酸,環己基丙胺酸’環己基甘胺酸,硫組 胺酸,3-甲氧基駱胺酸,elastatinal,正白胺酸,正纈腔酸 ,別異白胺酸,高精胺酸,硫脯胺酸,去氫脯胺酸,羥基 -脯胺酸,異旅咬酸,高脯胺叙’環己基甘胺酸’ C -胺基-正丁酸,環己基丙胺酸,胺基苯基丁酸,苯丙胺酸在苯基 部份之鄰,間或對位上爲下列、或二個所取化:(<^-(:4)烷 基,(crc4)烷氧基,齒或硝基或以甲二氧基所取代:-2-及3-喳吩基-丙胺酸,卢-2·及3-呋喃基丙胺酸,y5 -2-,3· 及4-吡啶基丙胺酸,(苯並噻吩基-2-及3-基)丙胺酸,点 -(1-及2-莕基)丙胺酸,絲胺酸,蘇胺酸或酪胺酸之0-烷基 化之衍生物,S-烷基化之半胱胺酸,S-烷基化之高半胱胺 酸,輅胺酸之〇·硫酸,0·磷酸及0-羧酸酯,3-磺基-駱胺酸 ,3-羧基-酪胺酸,.3-磷基·賂胺酸,輅胺酸的4-曱烷續酸 酯,酪胺酸的4-甲烷膦酸酯,3,5-二碘酪胺酸,3-硝基·輅 胺酸,S-烷基賴胺酸及S-烷基烏胺酸。這些α ·胺基竣任一 者均可被甲基在α位置上,卣左胺基側鏈任一芳基殘 基,或適合的保護基在側鏈殘基之0,Ν或S原子上取代。 適合的保護基福示於’’Protective Groups In Organic Synthesis, nT.W. Greene and P.G.M. Wuts, J. Wiley & Sons, -21 - 本紙伕尺度適用中國國家揉準(CNS ) M規路(2丨OX297公釐) I t衣-- C锖先閱讀背面之注意事項^本頁) 訂 1235157 A 7 . B7 五、發明説明(19 ) NY, NY, 1991 ^ 所謂π取代〃指化合物中之氫原子爲取代基所置換。於本 發明中,將可形成部份氫鍵結部份且其可與ICE之Arg-341 之羰基氧或ICE Ser-339之羰基氧形成氫鍵之氫原子排除在 取代作用之外β這些經雜除的氫原子包括含有-NH-基者, 其爲-C0-基泛位置,且在下圖式:(a)至⑴,(ν)至(ζ)中以 ——NH-表示而非X基或其他命名。 ' 所謂π直鏈π指共價結合原子之連續未分支串。直鏈可技 取代,但這些取代基非直鏈Θ—部份。 π ••指化合物在抑制標的酵素活性上效力的許多測度, 酵素如ICE。心的較低値反玦出較高的效力。心値甴經實 驗決定之速率數據配合標準酵素動力學方程式而衍算.出來 (見 I. H. Segel, Enzyme Kinetics, Wiley-Interscience, 1975) 0 所謂"病人"在本案中指任何的哺乳動物,尤其是人類。 所謂”藥學上有效劑量”指可有效治療或舒缓病人中IL-1-,細胞預期死亡-,IGIF·或IFN-r-調介之疾病之劍量。所 謂π預防有效劑量"指可有效預防或實質地減輕病人中IL-1-,細胞預期死亡-,IGIF或IFN-r-調介的疾病之劑量。 經濟部中央標準局員工消费合作社印製 "藥學上可接受之載劑或佐劑π指可與本發明化合物一起 投予至病人之無毒性的載劑或佐劑,且其不會玻壞其藥理. 活性。 ’ ”藥學上可接受的衍生物”表示本發明化合物或其他任何 化合物之任何藥學上可接受的鹽,酯,或此i旨之鹽,其一 旦投予至受者可提供本發明化合物(直接或間接的)或其抗 -22- 本紙乐尺度適周中國國家標準(CNS ) A4規格(210X297公釐) 1235157 經濟部中央標準局貝工消费合作社印衮 Λ 7 _ Β7五、發明説明(20 ) -ICE活性代諸物或殘基。 本發明化合物藥學上可接受墼,如衍生自藥學上可接受 之矣機及有機酸及鹼者。適合的酸實例包括氫氯酸,氫溴 酸,硫酸,靖酸,高氯酸,延胡索酸,馬來酸,壤酸,甘 酵酸,乳酸,水楊酸,琥珀酸,曱苯-對位-磺酸,酒石酸 ,錯酸,檸檬酸,甲燒續酸,甲酸,苯甲酸,丙二缝,茶 -2-讀酸及苯續酸。其他的酸,如草酸,本身雖珠非藥學上 可接受的,但可用來製備成充作中間物之鹽,以獲得本發 明的化合物及其藥學上可接€的酸加成鹽。衍生自適合鹼 之鹽,包括鹼金屬(如鈉),鹼土金屬(如鎂),銨及n-(c1-4 烷基)4+鹽。 本發明也包括此中所揭示化合物的任何鹼性的含氮基之 ”成季鹼反應"。鹼性氮可以精藝者已知的任何作用物季鹼 化之,包括有:低竣燒基鹵,如甲基,乙基,丙基及丁基 氯,溴及碘;二烷基硫酸鹽包括二甲基,二乙基,二丁基 及二戊基硫酸莹;長鏈齒化物如癸基,月桂基,肉豆蔻基 及硬脂基氯,溴及碘·•及芳烷基卣包括苄基及苯乙基溴 。水或®溶性或可分散產物可以此成季銓反應獲得3 本發明的ICE抑制劑可含有一個以上的”不對稱"碳原子 ,且因此可呈外消旋物及外消旋混合物,單一對玦鳢,非 對映立鳢異構混合物及個別的非‘對映立體異構物。這些化 合物的所有此種異構物型式可特別地包括於本發明中。各 立體區域之碳可爲R或S構型。雖然在本發明書中示範的 特異化合物及骨架,可以特殊的立體化學構型示出,具有 -23· 本纸伕尺度遝用中国國家標孪(CNS ) Μ規格(210X297公釐) (請先閱讀背面之注意事項1235157 Λ7 _B7 V. Description of the invention (17) Further heterocyclic ring of hydrothiophenyl and sulfonic acid methyl group 3 is described in 8.1.1. 2 〖出 21 ^ and CW Rees, eds ·, Comprehensive Heterocyclic Chemistry: The Structure, Reactions, Synthesis and Use'of Heterocyclic Compounds, Vol. 1-8, Pergamon Press, NY (1984) «nheteroalkyl" refers to a single or polycyclic group containing 3 to 15 carbons and optionally one Or two double bonds. Examples include cyclohexyl, adamantyl, and n-fluorenyl. "Aryl" refers to a single or polycyclic group containing 6, 10, 12, or 14 carbons in which at least one of the rings is aromatic. Examples include phenyl, fluorenyl, and tetrahydrofluorene. The so-called "heteroaromatic" refers to a mono or polycyclic group, which contains 1 to 15 carbon atoms and from 1 to 4 heteroatoms, each of which is independently selected from the following It includes sulphur, nitrogen and oxygen, and it additionally contains 1 to 3 five- or six-membered rings, at least one of which is aromatic. The Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs of the People's Republic of China printed the so-called "c-amino acid" (α-amino acid) refers to naturally occurring amino acids and is often used in peptide chemistry when preparing analogs of naturally occurring peptides. Among others, • Non-protein "c-amino acids, including D and L forms. Naturally occurring amino acids are glycine, alanine, valine, leucine, isoleucine, serine, methanoic acid, threonine, phenylalanine, luminal acid, tryptophan acid , Cysteine, proline, histamine, aspartic acid, asparagine, glutamine, glutamine_r, carboxyglutamate, arginine, uramine, and lysine acid. " Non-protein "c-amino acids include hydroxylysine, homoserine, homoglutamic acid, homophenylalanine, citrulline, canine urea, 4-amino-phenylalanine, 3- (2 -Title)-Propionate '3 · (1 · Title) -Alanine, Methyl Morsine, Third Butyl-Alanine, Third Butyl Glycine, 4-Hydroxyphenyl Glycine Acid, Alanine, Phenylglycine, Propylpropanoic Acid, Propyl-Glycine, 1,2,4-Trisino-3 -Alanine, 4,4,4-Trifluoro -Threonine, glycosine • 20 · ^ Paper ft scale universal 11 national standard (CNS) 8 4 standard (21GX297 mm) " 11th Ministry of Economic Affairs Central Standards Bureau shellfish consumer cooperation Du Yin ¾ 1235157 A7 B7 V. Description of the invention (18), 6-hydroxytryptophan, 5-amyl tryptophan 'via canine urea' 3. Aminotyrosine, trifluoromethylalanine '2 Diamino acid '(2- (4-. Than this group) ethyl) -cysteine, 3,4-dioxo-phenylenediamine " acid' 3- (2-thiazolyl)- Propionate, tartaric acid glutamate 'Phenyl-1-cyclopentane-chitoic acid' Pressuyl-1-cyclohexane causes acid to make gentisine ' 3-trifluoromethylphenylalanine, trifluoro-methylphenylalanine, cyclohexylalanine'cyclohexylglycine, thiohistamine, 3-methoxycarbamate, elastatinal, n-leucine , Valeric acid, allo-isoleucine, high spermine, thioproline, dehydroproline, hydroxy-proline, isoproline, homoproline 'cyclohexyl glycine' C-amino-n-butyric acid, cyclohexyl alanine, amine phenyl butyric acid, phenylalanine ortho, meta or para to the phenyl moiety are the following, or two selected: (< ^- (: 4) alkyl, (crc4) alkoxy, dentate or nitro or substituted with methyldioxy: -2- and 3-fluorenyl-alanine, Lu-2 · and 3-furylpropylamine Acid, y5-2-, 3 · and 4-pyridyl alanine, (benzothienyl-2- and 3-yl) alanine, dot- (1- and 2-fluorenyl) alanine, serine , 0-alkylated derivatives of threonine or tyrosine, S-alkylated cysteine, S-alkylated homocysteine, sulfamic acid 0 · sulfuric acid, 0 · Phosphoric acid and 0-carboxylic acid ester, 3-sulfo-carbamic acid, 3-carboxy-tyrosine, .3-phosphono Continuing acid esters, 4-methanephosphonic acid esters of tyrosine, 3,5-diiodotyrosine, 3-nitro · amidate, S-alkyllysine and S-alkyluronic acid. Either of these α · amino groups can be substituted by a methyl group at the α position, any aryl residue on the left amino group side chain, or a suitable protecting group on the 0, N or S atom of the side chain residue. Appropriate protective groups are shown in `` Protective Groups In Organic Synthesis, nT.W. Greene and PGM Wuts, J. Wiley & Sons, -21-This paper's standard is applicable to China National Standards (CNS) M Regulations (2丨 OX297mm) I t-shirt-C 锖 Read the notes on the back ^ This page) Order 1235157 A 7. B7 V. Description of the invention (19) NY, NY, 1991 ^ The so-called π-substituted 〃 refers to the hydrogen in the compound The atom is replaced by a substituent. In the present invention, hydrogen atoms which can form a partial hydrogen bonding portion and which can form a hydrogen bond with the carbonyl oxygen of Arg-341 of ICE or the carbonyl oxygen of ICE Ser-339 are excluded from the substitution β Miscellaneous hydrogen atoms include those containing -NH- groups, which are -C0- radicals in general, and are represented by -NH- instead of X in the following schemes: Base or other name. 'The so-called π straight chain π refers to a continuous unbranched string of covalently bonded atoms. Linear substitution is possible, but these substituents are not linear Θ-parts. π •• refers to many measures of the potency of a compound in inhibiting the activity of a target enzyme, such as ICE. The lower heart is more effective. The experimentally determined rate data of palpitations are calculated in conjunction with standard enzyme kinetic equations. (See IH Segel, Enzyme Kinetics, Wiley-Interscience, 1975) 0 The so-called "patient" in this case refers to any mammal, especially Is human. The so-called "pharmaceutically effective dose" refers to the amount of a disease that can effectively treat or relieve IL-1-, expected cell death-, IGIF ·, or IFN-r-mediated diseases in a patient. The "π preventive effective dose" refers to a dose effective to prevent or substantially reduce the disease of IL-1-, expected cell death-, IGIF or IFN-r-mediated disease in a patient. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs " Pharmaceutically acceptable carrier or adjuvant π means a non-toxic carrier or adjuvant that can be administered to patients with the compound of the present invention, and it will not be damaged Its pharmacology. Activity. "" Pharmaceutically acceptable derivative "means any pharmaceutically acceptable salt, ester, or salt of this compound, or any other compound, which, once administered to a recipient, provides the compound of this invention (directly (Or indirect) or its anti-22-22 paper size suitable for Chinese National Standards (CNS) A4 specifications (210X297 mm) 1235157 Central Standards Bureau of the Ministry of Economic Affairs of the Bayer Consumer Cooperatives Seal 衮 Λ 7 _ B7 V. Description of the invention (20 ) -ICE activity substitutes for substances or residues. The compounds of the present invention are pharmaceutically acceptable, such as those derived from pharmaceutically acceptable solvents and organic acids and bases. Examples of suitable acids include hydrochloric acid, hydrobromic acid, sulfuric acid, phosphonic acid, perchloric acid, fumaric acid, maleic acid, oxalic acid, glycamic acid, lactic acid, salicylic acid, succinic acid, toluene-para- Sulfuric acid, tartaric acid, citric acid, citric acid, formic acid, formic acid, benzoic acid, malonic acid, tea-2-reading acid and benzoic acid. Other acids, such as oxalic acid, are not pharmaceutically acceptable by themselves, but can be used to prepare salts that act as intermediates to obtain the compounds of the present invention and their pharmaceutically acceptable acid addition salts. Derived from suitable base salts, including alkali metals (such as sodium), alkaline earth metals (such as magnesium), ammonium, and n- (c1-4 alkyl) 4+ salts. The invention also includes any of the basic nitrogen-containing groups of the compounds disclosed herein, "quaternary alkali reaction". Basic nitrogen can be quaternized with any substrate known to the artisan, including: Basic halides such as methyl, ethyl, propyl and butyl chloride, bromine and iodine; dialkyl sulfates include dimethyl, diethyl, dibutyl and dipentyl sulfate; long chain tooth compounds such as Decyl, lauryl, myristyl and stearyl chloride, bromine and iodine, and aralkyl hydrazones include benzyl and phenethyl bromide. Water or ® soluble or dispersible products can be converted into quaternary hydrazone to obtain 3 The ICE inhibitors of the present invention may contain more than one "asymmetric" carbon atom, and may therefore be present as racemates and racemic mixtures, single antipodes, diastereoisomeric mixtures and individual non 'Enantiomers. All such isomeric forms of these compounds may be specifically included in the present invention. The carbon of each three-dimensional region may be in the R or S configuration. Although the specific compounds and skeletons exemplified in the present invention can be shown in a special stereochemical configuration, they have -23 · paper size and use China National Standard (CNS) M specifications (210X297 mm) (please first Read the notes on the back

本頁) 訂 1235157 A7 . 一 _____B7 五、發明説明(21 ) 在任何給定對掌性中心相反立體化學的化合物及骨架或其 ;'昆合物也包括在此。 本發明的抑制劑可含有濃結構,其視所需〜可在碳,氮或 其他原子上爲各種取代基所取代。此種環結構可被單一或 一-多-重取代-。較妤,環結構中可含有〇至3個取代基。當多重 取代時,各取代基可獨立選擇其他任何取代基只要取代基 之組合可造成穩定化合物之形成。 , 本發明所包括的取代基及變數之組合,僅爲造成穩定化 合物形成者。所謂的"穩定,•如-此中所用的係指其有足以今 以技藝中已知方法可製造及投予至哺乳動物之穩定性之化 合物。典型而言,此化合物在缺少濕氣或其他化學反應條 件下,可在40°C ·以下之溫度中穩定至少一週3 取代基可以各種型式代表。這些各種型式爲精藝者已知 的,且可交互使用。例如,在苯基環上的曱基取代基,可 以下列任何型式代表: 〇"' σ' σ. 取代基的各種型式,如甲基在此中可交互使用。 經濟部中央橾琅局員工消费合作社印袈. 發明詳细説明 爲了使此處所述的本發明更被才解,示出以下詳細說明。 本發明的ICE抑制劑·實例(Α)爲式π :This page) Order 1235157 A7. I _____B7 V. Description of the invention (21) Compounds and skeletons or their opposite stereochemistry at any given pair of palm centers; 'Kun compounds are also included here. The inhibitor of the present invention may contain a concentrated structure, which may be substituted with various substituents on carbon, nitrogen, or other atoms, as necessary. Such a ring structure may be mono- or multi-substituted. In comparison, the ring structure may contain 0 to 3 substituents. When multiple substitutions are made, each substituent can be independently selected from any other substituent as long as the combination of substituents can result in the formation of a stable compound. The combinations of substituents and variables included in the present invention are only those that cause the formation of stable compounds. The so-called " stable " as used herein refers to compounds which are stable enough to be manufactured and administered to mammals by methods known in the art today. Typically, this compound is stable for at least one week at a temperature of 40 ° C · below in the absence of moisture or other chemical reaction conditions. 3 The substituents can be represented by various types. These various types are known to artisans and can be used interactively. For example, the fluorenyl substituent on the phenyl ring can be represented by any of the following types: 〇 '' σ 'σ. Various types of substituents, such as methyl, can be used interchangeably herein. Employees' Cooperatives of the Central Economic Bureau of the Ministry of Economic Affairs, India. Detailed Description of the Invention In order to make the invention described herein more comprehensible, the following detailed description is shown. The ICE inhibitor of the present invention · Example (A) is of formula π:

jCJ2)m-TjCJ2) m-T

Ri—NH-Xi \ (CH2) •24- 1235157 Α7 Β7Ri—NH-Xi \ (CH2) • 24- 1235157 Α7 Β7

經#部中夬橾準局貝工消费合作社印5L 五、發明説明(22 )其中: XA-CH ; g是0或1 : ―一各個獨立選自下列包括,-0H及-F,限制條件爲當一 個Ί 一及第二J結合至C且該第一 j是-0H,該第二j是_H ; m是0,1或2 ; 丁是-OH,-C0-C02H,·<:〇2ϋ ,或-(:〇0任何的生物電子 等排的置換; Ri選自下列包括下化式,其中任何環可視所需技單或多 取代,於任何竣上爲卩!,於任何氮上爲心,或於任何原子 上爲=0,-OH,-C02H,或鹵取代;任何飽和環可視所需 在一或二個鍵上不鉋和;且其中Ri(e)及Ri(y)可視所需地 苯並稠合: (ar ΧΝ 2-N--C-C— ; I R7 〇 Η λ ΧΝ I II ; I R? 〇 Η · (請先33讀背&之注意事項具^|^本頁) -裝. 訂 本纸伕尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 1235157 A7 B7 五、發明説明(23 )Printed by # 部 中 夬 橾 准 局 贝 工 consuming cooperatives 5L 5. Description of the invention (22) where: XA-CH; g is 0 or 1: ― one each independently selected from the following including -0H and -F, restrictions When a unitary and second J are bound to C and the first j is -0H, the second j is _H; m is 0, 1 or 2; D is -OH, -C0-C02H, < : 〇2ϋ, or-(: 〇〇 Any bioelectronic isobaric replacement; Ri is selected from the following including the following formula, where any ring can be based on the required technical list or multiple substitutions, 任何! Nitrogen is at the heart, or at any atom is = 0, -OH, -C02H, or halogen substitution; any saturated ring may not be coordinated on one or two bonds as required; and where Ri (e) and Ri ( y) Benzene can be fused as required: (ar χΝ 2-N--CC—; I R7 〇Η λ χΝ I II; IR? 〇Η · (please read the precautions for 33 first reading & ^ | ^ This page)-Binding. The size of the bound paper is applicable to the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 1235157 A7 B7 V. Description of the invention (23)

ΙΓΟ R61--C1H 〇ΙΓΟ R61--C1H 〇

kL (g) X'kL (g) X '

(請先閎讀背云之注意事項再本頁) —裝— f 訂 超濟部中央採孪局負工消费合作杜印製 X·ΝΗ(Please read the Precautions for Back Cloud first, then this page) —Installation— f Order

26 本纸伕尺度適用中國國家標率(CNS ) A4規格(210X297公釐) yr: 1235157 a7 B7 五、發明説明(24) 较濟部中央標準局兵工消費合作社印¾ (j) (k) (1) (m) (n)26 This paper scale is applicable to China's National Standards (CNS) A4 specification (210X297 mm) yr: 1235157 a7 B7 V. Description of the invention (24) Printed by the Military Industry Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ¾ (j) (k) (1) (m) (n)

X4X4

k(CH2)d (CH2)3k (CH2) d (CH2) 3

Rs Rs 、Ο— C— c- i II 1 11 H 〇 R7 〇 N(CH2)dI人 (CHjJa-、C-R2〇-Z- (V# Η η p, -C- .. II o r7 oRs Rs 〇— C— c- i II 1 11 H 〇 R7 〇 N (CH2) dI human (CHjJa-, C-R2〇-Z- (V # Η η p, -C- .. II o r7 o

---------襞-- C (請先閱讀背面之注意事項再^^本頁)--------- 襞-C (Please read the notes on the back before ^^ this page)

•1T• 1T

C •27 本纸伕尺度適用中國國家揉準(CNS ) A4規格(210X297公釐) 1235157 A7 B7 五 '奁明说明(25 ) r \y P /|\C • 27 The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 B7 Five 'Instructions for Ming (25) r \ y P / | \

\7 q /v\ 7 q / v

(請先閱讀背面之注意事項 本買) 絮(Please read the precautions on the back first)

1T1T

I H Μ濟部中央橾準局员工消费合作社印裝I H Μ Printed by the Consumer Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs

28 本纸铁尺度適用中國國家揉牟(CNS ) Α4規格(210Χ297公釐) 1235157 A7 B7 經濟部中央樣準局負工消资合作社印¾28 The paper and iron scales are applicable to China National Standards (CNS) Α4 (210 × 297 mm) 1235157 A7 B7 Printed by the Central Office of the Ministry of Economic Affairs

本纸法尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(27 ) (aa5) (bb) [cc] (dd) (〇)dThe size of the paper method applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (27) (aa5) (bb) [cc] (dd) (〇) d

本纸伕尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(28 ) (ggb) (CH2)aThe paper scale is applicable to Chinese National Standard (CNS) A4 (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (28) (ggb) (CH2) a

及 (ggc) 其中各環C獨立選自下列包括苯並,吡啶並,噻吩並, 竹匕嘻並,嗓喃並,邊咬並,異違峻並,嘆咬並,異噁全益 ,嘧啶並,咪唑並,環戊基,及環己基: r3是: -CN, -CH=CH-R9 , -CH=N-0-R9, 經濟部中央揉準\v员工消费合作社印¾ -(CH2)10-TrR9 V -CJ,-R9 ’ " -C0-R13,成一, ~ R;And (ggc) wherein each ring C is independently selected from the group consisting of benzo, pyrido, thieno, bamboo dipper, whisper, while biting, violating and sighing, sighing and binding, all-evil and beneficial, pyrimidine And, imidazo, cyclopentyl, and cyclohexyl: r3 is: -CN, -CH = CH-R9, -CH = N-0-R9, printed by the Central Ministry of Economic Affairs \ vEmployee Cooperative Cooperative Seal ¾-(CH2 ) 10-TrR9 V -CJ, -R9 '" -C0-R13, into one, ~ R;

CO-CO-N •31 - 本纸乐尺度適用中国國家#準(OS’s ) A4規袼(210X297公釐) 1235157 A7 _^_B7^ 五、發明説明(29 ) 各獨立選自下列包括: -H, -Aq , -R9 ’ •丁 t -R9,及 -(CH2)K2,3-TrR9 ; 各丁1獨立選自下列包括: CH=CH-, -〇·, -S-, -s〇-, -SO,-’ -NR丨〇- ’ -NRjq-CO- j -c〇-, -〇-C〇-, -C〇-〇-, -CO-NRjq- 9 -0 - C 0 - N R1。,’ 經濟部中央標準局員工消费合作·社印装 -NRjq-CO-O- j -NRjq-CO-NRjq- j -S0,-NRi。- ’ -NRiq-SO,- ’ 及 -NRIq-S0-)-NRjq- * •32· 本纸法尺度通用中国國家標率(CNS ) M規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(30) 各115獨立選自下列包括: -H, (請先閱讀背面之注意事項本頁) -Ar!, , -CO-Ar j 9 -S 〇,-Ar 1 ’ -C〇-NH2, -S〇rNH2, ' -R9, -C O-R9 1 -C 0 - 0-7 -S 〇 7 -R9 ’ /ArlCO-CO-N • 31-This paper scale is applicable to China National Standard #OS (s) A4 (210X297mm) 1235157 A7 _ ^ _ B7 ^ V. Description of the Invention (29) Each is independently selected from the following including: -H , -Aq, -R9 ', butt-R9, and-(CH2) K2,3-TrR9; each butan 1 is independently selected from the following: CH = CH-, -〇 ·, -S-, -s〇- , -SO,-'-NR 丨 〇-' -NRjq-CO- j -c〇-, -〇-C〇-, -C〇-〇-, -CO-NRjq- 9 -0-C 0 -N R1. ’Consumption cooperation and social printing of employees of the Central Bureau of Standards of the Ministry of Economic Affairs -NRjq-CO-O- j -NRjq-CO-NRjq- j -S0, -NRi. -'-NRiq-SO,-' and -NRIq-S0-)-NRjq- * • 32 · The paper method is common Chinese National Standard (CNS) M specification (210X297 mm) 1235157 Λ7 B7 V. Description of the invention ( 30) Each 115 is independently selected from the following: -H, (Please read the note on the back page first) -Ar !,, -CO-Ar j 9 -S 〇, -Ar 1 '-C〇-NH2,- S〇rNH2, '-R9, -C O-R9 1 -C 0-0-7 -S 〇7 -R9' / Arl

-CO-N 、丨〇, /Arl-CO-N, 丨 〇, / Arl

-S〇9-N 、10, r9-S〇9-N, 10, r9

-CO-N-CO-N

\r10,及 /R9 •SO,-N 經濟部中央標準局員工消費合作社印装 * \R · 116及117—起形成一個飽和的4,8成員碳環或含有-0-,-s-,或-NH-的雜環;或R7是-Η且116是 -Η, -Aq, •33- 本纸乐尺度適用中囷國家標孪(CNS〉A4規格(2!0X297公釐) 1235157 經濟部中央標準局員工消费合作社印装\ r10, and / R9 • SO, -N Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs * \ R · 116 and 117—to form a saturated 4,8-membered carbon ring or contain -0, -s ,, Or -NH- heterocyclic ring; or R7 is -Η and 116 is -Η, -Aq, • 33- The paper scale is applicable to the Chinese national standard twin (CNS> A4 specification (2! 0X297 mm) 1235157 Ministry of Economic Affairs Printed by the Central Bureau of Standards Consumer Cooperatives

AT B7 五、發明説明(31 ) -R9 ’ α -胺基酸側鏈殘基: 各R9是CN6直或分支烷基,視所需爲-OH,-F或=〇單或 多重取代,及視所需爲一或二個Aq基所取代; 各R1Q獨立選自下列包括-H或Cle6直或分支烷基: 各R13獨立選自下列包括·Αγ2,-R41-N-〇H ' R5 : 各Αη是環基,獨立選自下列包括芳基其含有6,10,12 或14個碳原子,及介於1至3個環,環烷基其含有3至15個 碳原子及1至3個環,該環烷基可視所需被苯並稠合,及雜 環基含有5至15個環原子及1至3個環,該雜環含有至少一 個雜原子選自-〇-,,-SO·,-S02-,=Ν-及-ΝΗ-,該雜環 .基視所需含有一個以上的雙鍵,該雜環基視所需含有一個 以上的芳族環,且該環基視所需爲·ΝΗ2,-C〇2H,-Cl,-F ,-Br·,-I,-NO,,-CN, 〇 =0,-OH,全氟0卜3烷基,/\:士,或-Qi所單或多取代: \r 〇 各Ar2獨立選自下列,其中任何環可視所需爲-(^及42所 單或多取代: I (請先閎讀背δ之注意事項 本買) 裝 訂 次: -34- 本纸铁尺度递用中國國家標李(CNS ) A4規袼(2丨0X297公釐) 1235157 AT B7 五、菸明説明(32 (hh)AT B7 V. Description of the invention (31) -R9'α-amino acid side chain residues: each R9 is a CN6 straight or branched alkyl group, and -OH, -F or = single or multiple substitution as required, and Optionally substituted by one or two Aq groups; each R1Q is independently selected from the following including -H or Cle6 straight or branched alkyl groups: each R13 is independently selected from the following including · Αγ2, -R41-N-OH 'R5: Each Aη is a cyclic group, independently selected from the following including aryl groups containing 6, 10, 12 or 14 carbon atoms, and between 1 to 3 rings, cycloalkyl groups containing 3 to 15 carbon atoms and 1 to 3 Ring, the cycloalkyl group can be optionally fused with benzo, and the heterocyclic group contains 5 to 15 ring atoms and 1 to 3 rings, and the heterocyclic ring contains at least one heteroatom selected from -0-,,- SO ·, -S02-, = N- and -NΗ-, the heterocyclic ring needs to contain more than one double bond, the heterocyclic ring contains more than one aromatic ring, and the ring is The required is · NΗ2, -C02H, -Cl, -F, -Br ·, -I, -NO ,, -CN, = 0 = 0, -OH, perfluoro 0.3 alkyl, / \: , Or single or multiple substitutions by -Qi: \ r 〇 Each Ar2 is independently selected from the following, where any ring may be-(^ Replacement of 42 orders or more: I (please read the precautions of δ before buying this book) Binding times: -34- Chinese paper standard iron (CNS) A4 rule (2 丨 0X297 mm) 1235157 AT B7 V. Yanming Instructions (32 (hh)

γ· (ii)γ (ii)

- X (jj) (kk) c x_ N. Y· Λ Λ 及 各1獨立選自下列包括: -Ar j -0 - A r 1 -R9 ’ -丁 1 -R9 ’ 及 •(CH2)1,2,3-T1-R9 ; 各Q2獨立選自下列包括-OH,-NH2,-C02H,-Cl,-F, -Br,-I,·Ν〇7,-CN,-CF. 及 / Ο.-X (jj) (kk) c x_ N. Y · Λ Λ and each 1 are independently selected from the following including: -Ar j -0-A r 1 -R9 '-丁 1 -R9' and • (CH2) 1, 2,3-T1-R9; each Q2 is independently selected from the group consisting of -OH, -NH2, -C02H, -Cl, -F, -Br, -I, · NO7, -CN, -CF. And / 0 .

CH 2 · Ο 經濟部中央標率局員工消贫合作社印製 限制條件爲當一-八^爲(^基所取代,其含有一個以上額 外的-八^基,該額外的-Aq基非爲Qi所取代: 各X獨立選自下列包括=N-,及=CH-; 各X2獨立選自下列包括-O-• S 〇,:CH 2 · 〇 The central government ’s Bureau of Poverty Alleviation Cooperatives of the Ministry of Economic Affairs prints the restriction that when one-eight ^ is replaced by ^, it contains more than one additional-eight ^, and the additional -Aq group is not Qi is replaced by: each X is independently selected from the following including = N-, and = CH-; each X2 is independently selected from the following including -O- • S 〇 ,:

CH 2* -NH-,-S-,-SO-,及 -35- (請先閱讀背面之注意事項再填寫本頁)CH 2 * -NH-, -S-, -SO-, and -35- (Please read the precautions on the back before filling this page)

本纸杀尺度適用中國國家標準(CNS M4規格(210X297公釐) 1235157 Λ7 _B7 五、發明説明(33 ) 各X3獨立選自下列包括-CH2-,-S-,-SO-,及-s〇2-: 各X4獨立選自下列包括-CH2-及-NH-: 各X5獨立選自下列包括-CH-及-N·; , | | X6*-CH-或; 各Y獨立選自下列包括-〇-,-S·,及-NH : 各Z獨立爲c〇或s〇2 : 各a獨立爲0或1 ; * 各c獨立爲1或2 ; 各d獨立爲0,1或2:且 · 各e獨立爲0,1,2或3: 限制條件爲當 心是⑴, R6是泛-胺基酸側鏈殘基,且 117是-11, 貝Uaal)及(aa2)必須爲1所取代; 限制條件也有當 RA(〇), g是0, ¾濟邦中央樣李局貝工消費合作社印衷 J 是-Η, m是1, R6是江·胺基酸側鏈殘基,· RA-H , X2是-CH2·, X5S-CH-,The paper scale is applicable to Chinese national standards (CNS M4 specification (210X297 mm) 1235157 Λ7 _B7 V. Description of the invention (33) Each X3 is independently selected from the following including -CH2-, -S-, -SO-, and -s. 2-: each X4 is independently selected from the following including -CH2- and -NH-: each X5 is independently selected from the following including -CH- and -N ·;, | | X6 * -CH-or; each Y is independently selected from the following including -〇-, -S ·, and -NH: each Z is independently c0 or s02: each a is independently 0 or 1; * each c is independently 1 or 2; each d is independently 0, 1 or 2: And · each e is independently 0,1,2, or 3: the restriction is that beware of ⑴, R6 is a pan-amino acid side chain residue, and 117 is -11, Uaal) and (aa2) must be 1. Replacement; the restrictions are also when RA (〇), g is 0, ¾ Jebang Central-like Li Bureau Shellfish Consumer Cooperative Co., Ltd. J is -Η, m is 1, R6 is a Jiang · amino acid side chain residue, · RA-H, X2 is -CH2 ·, X5S-CH-,

Xg是’且 -36- 本纸伕尺度適用中国国家標车(CNS ) Α4規格(210X297公釐) 1235157Xg is ’and -36- The standard of this paper is applicable to China National Standard Car (CNS) Α4 specification (210X297 mm) 1235157

AT _B7_·__ 五、發明説明(34 ) R;是 /hoAT _B7_ · __ V. Description of the Invention (34) R; Yes / ho

-CO-N \r10,或-c〇-r13,當 / R13 是·· -CH,-0-C0-Ari ’ -CH2-S-C〇-Ari, -CH^-O-Ar! ’ •CH,-S-Ai:i,或 -114當-114是-Η : - 則Ri(〇)基之環必需爲(^所取代或苯並稠合:且 限制條件爲當 (w), g是0, J 是·Η, m是1, J是-C〇2H, 乂2是〇, R5是芊氧羰基,且 環C是苯並, 超濟部中央揉孪局員工消費合作社印製 (讀先間讀背面之注意事項再填寫本頁) 則113不可爲-(:0-1113當·· R13 是-CHrO-Aqa · ΑΓι是1-苯基-3-三氟甲基-哄唑-5-基,其中苯基視所需 爲氯原子所取代; 或當 -37· 本纸張尺度適用中國國家標率(CNS ) Α4規格(210Χ297公釐) 1235157 A7 B7 五、發明説明(35 ) R13是’其中 Ar*i是2,6-二氯苯基。 一一~應^厂式泛ΊΓ具體實例A之較佳化合物,其冲&是(w) (w) Rs-CO-N \ r10, or -c〇-r13, when / R13 is ... -CH, -0-C0-Ari '-CH2-SC〇-Ari, -CH ^ -O-Ar!' • CH, -S-Ai: i, or -114 when -114 is -Η:-then the ring of Ri (〇) group must be (^ substituted or benzo-fused: and the restriction is when (w), g is 0 , J is · Η, m is 1, J is -C02H, 乂 2 is 0, R5 is oxocarbonyl, and ring C is benzo. Printed by the Consumer Cooperative of the Central Ministry of Economic Affairs of the Ministry of Economic Affairs. Note on the back of the occasional reading and then fill out this page) Then 113 cannot be-(: 0-1113 When · · R13 is -CHrO-Aqa · ΑΓι is 1-phenyl-3-trifluoromethyl-cozazole-5- Phenyl group, where phenyl is optionally substituted by a chlorine atom; or -37 · This paper size applies Chinese National Standard (CNS) A4 specifications (210 × 297 mm) 1235157 A7 B7 V. Description of the invention (35) R13 is 'Where Ar * i is 2,6-dichlorophenyl. One-to-one ^ factory formula 较佳 之 is a preferred compound of specific example A, and the impact is (w) (w) Rs

其中其他取代基如上文所述。 應用式c旳具體實例A之-其他較佳化合物,其中&是 (y) (y) ο (請先閱讀背面之注意事項再填寫本頁) .嗜 訂 經濟部中央標準局員工消費七作社印«. 其中其他取代基如上述。 庭用式or之具禮實例Α之更佳化合物,其中: X4-CH : g是0 ; J 是-H : m是0或1且T是-C0-C02H,或〜C02H任何的生物電子等 排之置換,或 m是1且T是-C02H ; 選自下列包括下式,其中任何環可視所需被單或多重 •38- 本纸伕尺度適用中国國家標孪(CNS ) A4規格(210X297公釐) 辞 1235157 A7 B7The other substituents are as described above. Apply Formula c 旳 Specific Example A-Other preferred compounds, where & is (y) (y) ο (Please read the notes on the back before filling this page) The press «. Other substituents are as described above. A better compound of courtesy example A of the formula or, where: X4-CH: g is 0; J is -H: m is 0 or 1 and T is -C0-C02H, or any of ~ C02H bioelectronics, etc. Row replacement, or m is 1 and T is -C02H; selected from the following including the following formula, where any ring can be based on the required sheet or multiple • 38- This paper's standard is applicable to China National Standard (CNS) A4 specifications (210X297) (Centimeter) 1235157 A7 B7

1235157 A7 B7 五、發明説明(37 (〇) (r)1235157 A7 B7 V. Description of the invention (37 (〇) (r)

及 (w)And (w)

r20 是 (aal)r20 is (aal)

A 或 ---------¾-- (讀先閱讀背面之注意事項真^^本頁) 訂 (aa2) 5?濟部中央揉準局系工消费合作社印^ ,N、/(CHz)c 且c是1 ; c環是苯並,視所需爲-c卜3烷基,-o-Cu烷基,-cn,-f 或-CF//f取代: 當R丨是(a)或(b),R5較好是-Η,且 當心是⑷,(e),(f),(〇),⑴,(w),(X)或(y),R5較好 -40 本纸乐尺度適用中國國家標牟(CNS M4規袼(2丨0X297公釐) 1235157 Λ7 B7 五、發明説明(38) 是: -C 0 - A r j • S 〇,-A r 1 ’ -- -C〇-NH2, -CO-NH-Aq -CO-R9 ? -C〇-〇-R9, · -S〇2-R9 ,或 -C〇-NH-R9, · 117是-1·!且 116是:-Η, -R9,或 -Art * 是直或分支的烷基,視所需爲=0取代,且視所需 爲-八1^取代:A or --------- ¾-- (read the precautions on the back of this page first ^^ this page) Order (aa2) 5? Printed by the Central Ministry of Economic Affairs and the Bureau of Industrial and Consumer Cooperatives ^, N, / (CHz) c and c is 1; ring c is benzo, optionally substituted with -c 3 alkyl, -o-Cu alkyl, -cn, -f or -CF // f: when R 丨 is (A) or (b), R5 is preferably -Η, and beware of ⑷, (e), (f), (〇), ⑴, (w), (X) or (y), R5 is preferably- 40 This paper scale is applicable to Chinese National Standards (CNS M4 Regulations (2 丨 0X297 mm) 1235157 Λ7 B7 V. Description of the Invention (38) Yes: -C 0-A rj • S 〇, -A r 1 '- --C〇-NH2, -CO-NH-Aq -CO-R9? -C〇-〇-R9, · -S〇2-R9, or -C〇-NH-R9, · 117 is -1 ·! And 116 is: -Η, -R9, or -Art * is a straight or branched alkyl group, and is optionally substituted with = 0, and optionally substituted with -eight 1 ^:

RlQ是-H或-Cu直或分支的燒基;RlQ is a straight or branched alkyl group of -H or -Cu;

Aq是苯基,莕基,吡啶基,苯並4唑基,嗜吩基,苯 並喳吩基,苯並噁唑基,2-氫莽.基,或4哚基,視所需爲 -O-Cu烷基,-NH-C卜3烷基,,NKCw烷基)2,-Cl,-F,-CF3,-CP3烷基,或 0 (請先閱讀背面之注意事項寫本頁) 0 裝 訂 經濟部中央標準局貝工消费合作·社印製 \〇/ CH- (51是以9或-(。1^2)〇,1,2-丁1-(〇^)〇,1,2-八1>1’其中丁1是-〇-或-$· 各X獨立選自下列包括=N-,及=CH-: 各X,獨立選自下列包括·0-,-CH,-,·ΝΗ- -SO-,及 .41 - 本纸伕尺度逍用中国國家揉率(〇^)以規格(210父297公釐) 1235157Aq is phenyl, fluorenyl, pyridyl, benzo4azolyl, phenophil, benzofluorenyl, benzoxazolyl, 2-hydromandyl, or 4indolyl, as required- O-Cu alkyl, -NH-C 3 alkyl, NKCw alkyl) 2, -Cl, -F, -CF3, -CP3 alkyl, or 0 (Please read the precautions on the back to write this page) 0 Binding Printed by Shellfish Consumer Cooperative, Ltd., Central Standards Bureau, Ministry of Economic Affairs \ 〇 / CH- (51 is 9 or-(. 1 ^ 2) 〇, 1,2-but 1- (〇 ^) 〇, 1, 2-eight 1 > 1 'wherein D 1 is -0- or-$. Each X is independently selected from the following including = N-, and = CH-: each X, independently selected from the following including -0-, -CH,- , · ΝΗ- -SO-, and .41-The standard of this paper is used in the Chinese national rubbing rate (〇 ^) to the specifications (210 parent 297 mm) 1235157

Λ7 B7 五、發明説明(39 ) -S 〇,-: 各獨立選自下列包括-CH-及-N-; | | X6*-CH-或-N-, ,Λ7 B7 V. Description of the invention (39) -S 〇,-: each independently selected from the following including -CH- and -N-; | | X6 * -CH- or -N-,

1 I 限制條件爲當: 1^是(0), X2S-CHr, X5S-CH-,且 · , 則R丨(〇)基之環必定爲Qi所取代或苯並稠合:且 Z是C =〇。 較好此較佳具體實例之化合物爲其中心基是·· (請先閲讀背面之注意事項^¾寫本頁)The limiting condition of 1 I is when: 1 ^ is (0), X2S-CHr, X5S-CH-, and ·, then the ring of R 丨 (〇) group must be substituted by Qi or fused with benzo: and Z is C = 〇. The compound which is better for this preferred embodiment is its central group ... (Please read the precautions on the back ^ ¾ write this page)

W 裝. eW. e

或 訂 經濟部中央揉準局系工消费合作社印装 且c是2 :或 (e4)Or order printed by the Department of Industry and Consumer Cooperatives of the Central Bureau of the Ministry of Economic Affairs and c is 2: or (e4)

Rs> Η Ο 0 或 -42- 本纸伕尺度適用中國國家標準(CNS ) A4規格(2I0X297公釐) 1235157 A7 B7 五、發明説明(40 ) (e7) (CHzJcRs > Η 〇 0 or -42- This paper's standard is applicable to Chinese National Standard (CNS) A4 (2I0X297 mm) 1235157 A7 B7 V. Description of the invention (40) (e7) (CHzJc

Λ τ_ % $ « 乂 % i Ψft 其可視所需地被苯並稠合, 且c是1或2 : 限制條件爲當1^是(€4), · g是〇, J 是-H, · · m是1, 丁是-C02H, R5是芊氧羰基,且 c是1, 則R3不可爲-(:0-1113當 R13 是-CHyO-Aqa 八^是卜苯基-3-三氟曱基-吡唑-5-基,其中苯基視所需 爲氯原子所取代;或當 Rl3 是·CH2-0-C0-Ar1,其中 Aq是2,6 -二氯苯基, 一且受H環上的2-位置爲對位-氟-苯基取代;且 限制條件也有當 ·R#(e7), g是〇, ,I是·Η, -43 本纸張尺度逋用中國國家標率(CNS } Α4規格(210Χ297公釐) (請先閱讀背面之注意事項再填寫本頁) 1235157 A7 B7 * 五、發明説明(41 ) m是1, T是-C〇2H或-C〇-NH-〇H, R5是胺基酸側鏈殘基N原子之保護基^且 各c是1, 則R 3無法爲-C 0 - R i $當 r13 是: -CH2· 0*C0-Ar j 7 -C*S-C0-Arj j -CH’-O-Ar! ’ 或 -CH’-S-Ar! 0 此具體實例的最佳化合物爲其中: 心是: (請先閔讀背面之注意事項再Ϊ本頁)Λ τ_% $ «乂% i Ψft which can be optionally fused with benzo, and c is 1 or 2: the limitation is when 1 ^ is (€ 4), · g is 0, J is -H, · · M is 1, D is -C02H, R5 is fluorenyloxycarbonyl, and c is 1, then R3 cannot be-(: 0-1113 when R13 is -CHyO-Aqa, and ^ is phenylphenyl-3-trifluorofluorene -Pyrazol-5-yl, in which phenyl is optionally substituted by a chlorine atom; or when Rl3 is · CH2-0-C0-Ar1, where Aq is 2,6-dichlorophenyl, and The 2-position on the ring is para-fluoro-phenyl substitution; and the restrictions are also when · R # (e7), g is 0,, I is · Η, -43 This paper uses the Chinese national standard (CNS) Α4 specification (210 × 297 mm) (Please read the notes on the back before filling out this page) 1235157 A7 B7 * 5. Description of the invention (41) m is 1, T is -C〇2H or -C〇-NH -OH, R5 is a protecting group for the N atom of the amino acid side chain residue and each c is 1, then R3 cannot be -C 0-R i $ When r13 is: -CH2 · 0 * C0-Ar j 7 -C * S-C0-Arj j -CH'-O-Ar! 'Or -CH'-S-Ar! 0 The best compound for this specific example is among them: The heart is: (Please read the note on the back first thing (Item again on this page)

(el) Ν Ν-(el) Ν Ν-

Ο (CHz)cΟ (CHz) c

X 或 訂X or order

Ν I ΗΝ I Η

(ο 經濟部中央標準局貝工消費合作·社印¾ 且c是2 ; m是1 : 丁是<02Η :且 -44 本纸乐尺度通用中國國家揉孪(CNS ) Μ規格(210X297公釐) 1235157 Α7 Β7 五、發明説明(42) R3是-CO-R13。 此具體實例的其他最佳化合物爲其中 Rj :〜一―一 (wl)(ο The Central Bureau of Standards, Ministry of Economic Affairs, Shellfish Consumer Cooperation · Social Printing ¾ and c is 2; m is 1: Ding < 02Η: and -44 This paper music standard is universal China National Standard (CNS) M specifications (210X297) 1235157 Α7 Β7 V. Description of the invention (42) R3 is -CO-R13. The other best compounds in this specific example are among them Rj: ~ one-one (wl)

:其中 X2 是: - · -〇-, -S-,•s〇r,或 -NH-; 視所需爲心或卩丨在:^上取代,當是-NH-;且 環C是苯並,爲-Cu烷基,-〇-Ci.3烷基,-Cl,-F或-CF: 所取代^ 本發明另一具體實例(B)之ICE抑制劑爲式(I): (請先閲讀背面之注意事項再^:本頁) 訂 經菸部中央榇準局員工消费合作社印«. (X) RX-N-R2 Η 其中: , * 11丨選自下列包括下列化式·· .45 本纸伕尺度適用中國國家標準(CNS ) A^Jl格(210Χ297公釐) 1235157: Where X2 is:-· -〇-, -S-, • s〇r, or -NH-; as desired, or 卩 丨 Substitute on: ^ when -NH-; and ring C is benzene And, it is -Cu alkyl, -0-Ci.3 alkyl, -Cl, -F or -CF: substituted ^ Another ICE inhibitor of the present invention (B) is the formula (I): (Please Please read the precautions on the back before ^: this page) Ordered by the Consumers' Cooperatives of the Central Ministry of Tobacco Bureau of the Ministry of Tobacco «. (X) RX-N-R2 Η where:, * 11 丨 is selected from the following including the following formulas ·· .45 The size of this paper is applicable to Chinese National Standard (CNS) A ^ Jl (210 × 297 mm) 1235157

A B7五、發明説明(43 ) (elO) F Rs ^---- · - - (ell) Rs (el2) R2A B7 V. Description of the Invention (43) (elO) F Rs ^ ---- ·--(ell) Rs (el2) R2

(請先¾讀背面之注意事項再^:本頁)(Please read the notes on the back ^: this page)

訂 經濟部中央標準局黃Η消費合作社印-¾Ordered by the Central Bureau of Standards of the Ministry of Economic Affairs

•46- 本纸伕尺度適用中國國家揉準(CNS M4说格(210X297公釐) 1235157 A7 B7 五、發明説明(44 ) 環C送έ]下列包括··笨並,攻啶並,《塞吩並,吹洛並, 啥喃並,5塞咬並,異邊4並,°惡峻並’異嗔士並’卷咬益 ,咪咬並,環戊基,及環己基; ’ R,是: 或 (b)• 46- The standard of this paper is applicable to Chinese national standards (CNS M4 grid (210X297 mm) 1235157 A7 B7 V. Description of the invention (44) Ring C to send)] The following includes: Fenbin, Luoluo, Hanran, 5 plugs, 4 different sides, ° Evil and 'heterosexual', and bite benefits, microphones, cyclopentyl, and cyclohexyl; 'R, Yes: or (b)

(請先閲讀背面之注意事項再填寫本頁) m是1或2 ; R5選自下列包括 -C(〇)-R丨0, -C(〇)〇-R9 ,(Please read the notes on the back before filling out this page) m is 1 or 2; R5 is selected from the following including -C (〇) -R 丨 0, -C (〇) 〇-R9,

Ri 訂Ri order

-C(0)-N kR, 經4中央標準局M3C工消費合作杜印製 -S(〇)2-R9, •C(〇)-CHr〇-R9, -C(b)C(0)-R1{>, -Rg 9 -H,及 -C(O)C(O)-OR10 : -47- 本纸杀尺度適用中国國家揉準(CNS ) A4視袼(2丨0X297公釐) S?濟部中央標準局員工消費合作•杜印製 1235157 Λ7 B7 五、發明説明(45) X5*-CH-或-N-;-C (0) -N kR, printed by 4 Central Standards Bureau M3C industrial and consumer cooperation Du-S (〇) 2-R9, • C (〇) -CHr〇-R9, -C (b) C (0) -R1 {>, -Rg 9 -H, and -C (O) C (O) -OR10: -47- The standard for this paper is applicable to China National Standards (CNS) A4 (2 丨 0X297 mm) S? Consumption cooperation among employees of the Central Bureau of Standards of the Ministry of Economic Affairs • Du Yin 1235157 Λ7 B7 V. Description of the invention (45) X5 * -CH- or -N-;

| I 丫2是4或0 : x7是-N(R8)-或-0·: - R6選自下列包括-H及-CH3 ;| I Ya 2 is 4 or 0: x7 is -N (R8)-or -0:-R6 is selected from the following including -H and -CH3;

Rs選自下列包括: -C(〇)-R10, -C(〇)〇-R9 , - -C(O)-N(H)-R10, -s(〇)2-r9, - -S(O)rNH-R10, -C(O)-CHrOR10, -C(O)C(O)-R10 ·· -C(O)-CH2N(R1(3)(R10), -C(0)-CH2C(0)-0-R9, -C(0)-CH2C(0)-R9, -H,及 -C(O)-C(O)-OR10 ; 各119獨立選自下列包括直或分支的烷基,視 所需爲Αγ3所取代,其中-C^6烷基視所需不飽和; 各111()獨立選自下列包括-H,-Ar3,C3.6環烷基,及-C^6 直或分支烷基視所需爲Αιγ3所取代,其中-C^6烷基視所需 不飽和: R13選自下列包括Η,Αγ3,及(:μ6直或分支的烷基,視所 需爲 Ar3,-CONH2,-0R5,-OH,-〇R9,或-C〇2H所取代·· -48- 本纸法尺度適用中國國家標準(CNS ) A4規格(210X297公釐〉Rs is selected from the following including: -C (〇) -R10, -C (〇) 〇-R9,--C (O) -N (H) -R10, -s (〇) 2-r9,--S ( O) rNH-R10, -C (O) -CHrOR10, -C (O) C (O) -R10 ·· -C (O) -CH2N (R1 (3) (R10), -C (0) -CH2C (0) -0-R9, -C (0) -CH2C (0) -R9, -H, and -C (O) -C (O) -OR10; each 119 is independently selected from the following including straight or branched alkanes Base, optionally substituted by Aγ3, where -C ^ 6 alkyl is unsaturated as desired; each 111 () is independently selected from the following including -H, -Ar3, C3.6 cycloalkyl, and -C ^ 6 Straight or branched alkyl is optionally substituted with Aιγ3, where -C ^ 6 alkyl is optionally unsaturated: R13 is selected from the following including fluorene, Aγ3, and (: μ6 straight or branched alkyl, as required as Replaced by Ar3, -CONH2, -0R5, -OH, -〇R9, or -C〇2H ... -48- The size of this paper method is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm>

1235157 Λ7 B7 五、發明説明(#) 各 R31獨立選自下列包 ^R9,,-C(〇)-N(H)-R9, 或各1^一起形成飽和的4_8員唛環,或含有·〇·,·5•,或· ΝΗ-的雜環: 一 各R”獨立還自下列包括-Η或-c,亩4、、 ^ ^ . U6旦或分支的烷基; 各Aq是環基,獨乂运自下列包括葵 <人 方基其含有6,10,12 或14個碳原子及介於1及3個環,及,、 環原子及1至3個環,該雜環含有至族_ 3衣含有〕至1〕個7 ―個選自:〇-,-S-,- SO-,S〇2,,及-ΝΗ-之雜原子, 謗雜 或多個雙鍵,該雜環視所需含·有〜你”% %視所需含有一 環基視所需玎爲-Ql所單或多重取代·工的芳族環,且該 各Q丨獨立遂自下列包括-NH,,<〇 pj ,-N02,-CN,,-OH,-全氣 c 、 NHR5,〇R9,-賴9,R9,-C(〇),Ri 〇 •Cl,-F,-Br,.1 N3运基,R5,.〇H5,- ,及 --------r#II (請先聞讀背^之注意事項荐填寫本肓) 訂 \〇/ CH- 超濟部中央標挛局员工消費合作·杜印衷 限制條件爲當基取代,其含有 Αγ3基,該額外的·Αγ3基不爲另·Αγ3取代。 較妤,R5逡自下列包括·· •C(O)-R10, •c(o)〇.r9,及 · -C(0)-NH-Ri〇 3另外,R5it自下列包括: -S(0)rR9, 個以上額外的 -49 本纸伕尺度通用中囷國家樣绛(CNS ) a4規格(2丨0X297公釐) 1235157 ¾濟部中央標隼局貝工消费合作社印裝 A7 B7 立、發明説明(47) 'S(O)2-NH.Rl0 ^ -C(O)-C(〇)-R10, -R9,及 -C(O)-C(〇)-〇R10。 較好: m是1 : 是Η或-CN4直或分支的燒基,視所需爲-Ar3,-0H, -〇R9,或-C02H取代,其中R91-CN4直或分支的烷基,其 中Ar3是嗎福喵基或苯基,其中苯基視所需爲所取代: R2丨是-H或-CH3 ; ^5111.6直或分支的燒基’視所需爲Αγ3取代,其中Αγ3 是笨基,視所需爲-Q!取代: Α Γ 3是笨基,審基’嗟吩基,V奎淋基,異0臺你基,σ比咬 基,4唑基,異噁唑基,苯並三唑基,苯並咪唑基,違吩 並嚐吩基,咪唑基,4二唑基,苯並[b]硫苯基,咣受基, 笨並呋嘀基,及4哚基; 各Qi獨立選自下列包括-NH2,-C丨,-F,-Br,-〇H,.r9 , -NH-R5 其中 R5 是-C(O)-R10 或-S(0)2-R9,-0R5 其中 & 是 -C(0)-R1〇,-〇R9,-NHR9,及 〇1235157 Λ7 B7 V. Description of the invention (#) Each R31 is independently selected from the following: ^ R9, -C (〇) -N (H) -R9, or 1 ^ each together to form a saturated 4-8 member ring, or contains · 〇 ·, · 5 •, or · ΝΗ- heterocyclic ring:-each R "independently also includes the following-or -c, M4, ^^ U6 denier or branched alkyl groups; each Aq is a cyclic group It is transported from the following including Kwai < human square base which contains 6, 10, 12 or 14 carbon atoms and between 1 and 3 rings, and, ring atoms and 1 to 3 rings, the heterocyclic ring contains Zhizu_3 contains] to 1] 7 7-heteroatoms selected from the group consisting of: 0-, -S-, -SO-, S〇2, and -N 杂-, hetero or multiple double bonds, the Heterocyclic ring contains as much as you want %% contains a ring base as needed, which is a single or multiple substitution or an aromatic ring of -Ql, and each of Q is independently from -NH, ≪ opj, -N02, -CN ,, -OH, -total gas c, NHR5, OR9, -Lai 9, R9, -C (〇), Ri 〇 · Cl, -F, -Br ,. 1 N3 transport base, R5, .〇H5,-, and -------- r # II (Please read and read the notes of ^ first, please fill out this note) Order \ 〇 / CH- Chaoji Ministry Central Standard contracture Consumption Cooperation of Bureau Staff · Du Yinzhong The restriction is that when the group is substituted, it contains Αγ3 group, and this additional Αγ3 group is not replaced by another Αγ3 group. In comparison, R5 includes the following: C (O) -R10, • c (o) 〇r9, and -C (0) -NH-Ri〇3 In addition, R5it includes the following: -S ( 0) rR9, more than -49 additional paper-size universal medium-sized national samples (CNS) a4 specifications (2 丨 0X297 mm) 1235157 ¾ printed by the Central Bureau of Standards of the Ministry of Economy DESCRIPTION OF THE INVENTION (47) 'S (O) 2-NH.R10 ^ -C (O) -C (〇) -R10, -R9, and -C (O) -C (〇) -OR10. Preferably: m is 1: a straight or branched alkyl group of fluorene or -CN4, optionally substituted by -Ar3, -0H, -〇R9, or -C02H, wherein R91-CN4 is a straight or branched alkyl group, wherein Ar3 is morphoyl or phenyl, where phenyl is optionally substituted: R2 丨 is -H or -CH3; ^ 5111.6 straight or branched alkynyl 'is optionally substituted by Αγ3, where Αγ3 is benzyl If necessary, it is -Q! Substitution: Α Γ 3 is a benzyl group, a stilbene group, a fluorenyl group, a quinolyl group, a isothiol group, a sigma group, a 4zolyl group, an isoxazolyl group, and benzene Benzotriazolyl, benzimidazolyl, phenanthryl, imidazolyl, 4diazolyl, benzo [b] thiophenyl, fluorenyl, benzofuryl, and 4indolyl; each Qi is independently selected from the group consisting of -NH2, -C 丨, -F, -Br, -OH, .r9, -NH-R5 where R5 is -C (O) -R10 or -S (0) 2-R9, -0R5 where & is -C (0) -R1〇, -〇R9, -NHR9, and

0 其中各及R10獨立地爲-Cw直或分支的烷基,视所需爲 Αγ3所取代,其中Αγ3是苯基: (请先¾讀背云之注意事項再填寫本I )0 wherein each and R10 are independently -Cw straight or branched alkyl groups, and are optionally substituted by Αγ3, where Αγ3 is a phenyl group: (Please read the precautions of Back Cloud before filling out this I)

1 50 · ^紙伕尺度通用中家標準(CnT) Α4規格(2丨0X297公釐)~ " --- 1235157 A., B7 五、發明説明(48 ) 限制條件爲當-八1:3爲h基所取代,其含有一個以上額外 的-Αγ3基,該額外的-Αγ3基不爲另- Ar3基所取代。 本發明另一具體實例(C)之ICE抑制劑爲/式(II): (IX) ·••鳥1 50 · ^ Common paper standard (CnT) Α4 specification (2 丨 0X297 mm) ~ " --- 1235157 A., B7 V. Description of the invention (48) The limiting condition is when-8 1: 3 It is substituted by the h group, which contains more than one additional -Aγ3 group, and the additional -Aγ3 group is not substituted by another -Ar3 group. The ICE inhibitor of another specific example (C) of the present invention is / formula (II): (IX) ··· bird

其中·· m是1或2 ; Ri選自下列包括下式: (請先鼕讀背面之Li意事項一 寫本頁) (elO)Where m is 1 or 2; Ri is selected from the following including the following formula: (please read the first Li meaning on the back of the winter first write this page) (elO)

(ell)(ell)

本纸铁尺度通用中国國家揉準(CNS ) A4規格(210X297公釐) 1235157 AT B7 五、發明説明(49 ) (yi)This paper iron standard is generally Chinese National Standard (CNS) A4 (210X297 mm) 1235157 AT B7 V. Description of Invention (49) (yi)

(y2)(y2)

[z)[z)

且 (請先¾讀背S之注意事項再填寫本頁) 經濟部中央標準居系工消费合作社印«. 環C選自下列包括苯並,吡啶並,4吩並,吡咯並,呋 骑亚·名政祓,異α塞峻並,嗓咬並,異嗔峻並,居这並, 咪唑並,環戊基,及環己基; R3選自下列包括: -CN, -C(〇)-H, -C(0)-CH2-TrRu, -C(〇)-CH2-F, -C=N-0-R9 1 及 -C0-Ar,: * R5選自下列包招··-C(0),R丨〇, -c(o)o-r9 , -52 本纸铁尺度適用中國國家標準(CNS ) A4坑格(2丨0X297公釐) 1235157 A 7 _ _B7_五、發明説明(5°) ^RiO -C(〇)-N \ -S(〇)2-R9, -C(〇)-CH2-〇-R9 , -C(〇)C(〇)-R10, -R9, ·-H,及 -C(〇)C(〇)-〇Rl0, - 是-CH-或-N-; I I Y2*H24〇; X7是·Ν(Ι18)-或-0-;. 各Τι獨立選自下列包括-0-,-s-,-S(0)-,及-s(o)2-: R6選自下列包括-Η及-CH3 : Rs選自下列包括: -C(〇)-R丨〇, -C(〇)〇-R9 , -C(O)-NH-R10, -S(0)rR9, •S(O)rNH-R10, -C(O)-CH2-OR10, · -C(O)C(O)-R10, •C(O)-CH2-N(R10)(R10), -C(0)-CH2C(0)-0-R9, •53- (請先聞讀背δ之注意事項再填寫本頁) :裝. 訂And (please read the precautions of S before filling out this page) The seal of the Central Standard Department of Industry and Consumer Cooperatives of the Ministry of Economic Affairs «. Ring C is selected from the following including benzo, pyrido, 4-pheno, pyrrolop, furania · Famous government officials, iso-alpha succinate, vocal bite, hetero-isode, jude, imidazo, cyclopentyl, and cyclohexyl; R3 is selected from the following: -CN, -C (〇)- H, -C (0) -CH2-TrRu, -C (〇) -CH2-F, -C = N-0-R9 1 and -C0-Ar ,: * R5 is selected from the following formulas: -C ( 0), R 丨 〇, -c (o) o-r9, -52 This paper iron scale is applicable to Chinese National Standard (CNS) A4 pit (2 丨 0X297 mm) 1235157 A 7 _ _B7_ V. Description of the invention ( 5 °) ^ RiO -C (〇) -N \ -S (〇) 2-R9, -C (〇) -CH2-〇-R9, -C (〇) C (〇) -R10, -R9, · -H, and -C (〇) C (〇) -〇R10,-is -CH- or -N-; II Y2 * H24〇; X7 is · N (Ι18)-or -0 ;; each T independently Selected from the following including -0-, -s-, -S (0)-, and -s (o) 2-: R6 is selected from the following including -Η and -CH3: Rs is selected from the following including: -C (〇) -R 丨 〇, -C (〇) 〇-R9, -C (O) -NH-R10, -S (0) rR9, • S (O) rNH-R10, -C (O) -CH2-OR10, -C (O) C (O) -R10 • C (O) -CH2-N (R10) (R10), -C (0) -CH2C (0) -0-R9, • 53- (Please read the precautions of δ before filling this page): Loading. Order

•-ir··· p.' Φ -...' %v 本纸伕尺度適用中§國家標孳(CNS ) A4規格(210X297公釐) !235157 Λ7 B7 *-----^___________ 五、發明説明(51 ) -c(〇)-ch2c(0)-r9, -Η,及 .C(O)-C(O)-〇Rl0 : 各R9獨立選白下列包括-Ar3及Cu直或分支的烷基視所 需爲Αγ3取代,其中-Cl-6燒基視所需不鉋和: 各Rl0獨立選自下列包括-H ’ -Ar3 ’ C3-6環烷基,及_CU6 直或分支的烷基視所需爲Αγ3取代’其中-CN6烷基視所需 ! 不飽和; 各Rn獨立選自下列包括:· •Αγ4, -(CH2)丨·厂Αγ4, -Η,及 -C(0)-Ar4 ;• -ir ··· p. 'Φ -...'% v The standard of this paper is applicable § National Standard (CNS) A4 (210X297 mm)! 235157 Λ7 B7 * ----- ^ ___________ 5 Description of the invention (51) -c (〇) -ch2c (0) -r9, -Η, and .C (O) -C (O) -〇Rl0: Each R9 is selected independently and the following includes -Ar3 and Cu or The branched alkyl group is optionally substituted by Aγ3, wherein the -Cl-6 alkyl group is optionally removed: each R10 is independently selected from the following including -H'-Ar3'C3-6 cycloalkyl, and -CU6 is directly or The branched alkyl group is optionally substituted by Αγ3, where -CN6 alkyl is optional! Unsaturated; each Rn is independently selected from the following including: • Aγ4,-(CH2) 丨 · Aγ4, -Η, and -C (0) -Ar4;

Rl3選自下列包括H ’ Ars ’及Cl·6直或分支的烷基,視所 需爲 Ar3,-CONH2,,-〇H,-OR9或-C02H% 取代· • 0Rn爲視所需的-Ν(Η)β〇Η ; 各R2l獨立選自下列包括-直或分支的烷基:Rl3 is selected from the following including H'Ars' and Cl.6 straight or branched alkyl, optionally Ar3, -CONH2, -OH, -OR9, or -C02H% substituted · 0Rn is optionally- Ν (Η) β〇Η; each R2l is independently selected from the group consisting of-straight or branched alkyl:

Ar2獨立選自下列,其中任一環可視所需爲-卩丨單或多重 取代;.Ar2 is independently selected from the following, in which any ring may be-卩 丨 single or multiple substitution as required;

1235157 Λ7 B7 五、發明説明(52 其中各Y獨立還自下列包括0及S : 各Ar3是環基’獨立選自下列包括芳基其含有6,1 〇 , D ,或14個竣原子及1主J個環’及芳族雜環/基含有5至1 5偏 環原子及1至3個環’該雜環含有至少一個選自 -SO-,S02,及-NH-,·Ν(Ι15)·,及-N(R9)-之雜原子,診 雜環視所需含有一個以上的雙鍵,該雜環視所需含一個以 上的芳族環,且該環基視所需爲-(^所單或多重軚代: 各Αγ4是環基,獨立選自下列包括芳基其含有6,1〇,u 或14個碳原子及1至3個環,犮雜環基其含有5至15侄環辱 子及1至3個環,該雜環含有至少一個選自-〇-,_s· , _s〇、, SO: ’ =N-,-NH- ’ -Nd)-,及-N(R9)·之雜原子,該雜環基 視所需含有一個以上的雙鍵,該雜環視所需含一個以上的 芳族環,且該環狀基視所需爲_(^所單或多重取代: 各Q[獨立選自下列包括-NH2,-C〇2H,-cn , -F,,心 茇1· { fTr氣讀背f/λέ意事項再與装頁) 訂 •N02,-CN ’ =〇 ’ ·0Η,-全氟 cN3烷基,&,e〇R5 超濟部中央橾率局員工消費合作杜印製 NHR5 ^ 0R9 , .NHR9 , r9 , -C(0).Rl Ό、,V - 限制條件爲當爲Ql基所取代,其含有一個以上額外 的·Αγ3爲另·Αγ3取代。 · 此/、/ϊα κ句之較佳化合物包括下列,但並不限於此: 及 ,Α 55 本紙故尺“国國家縣τ^τ^(7^297公沒) 1235157 AT B7 jn. 發明説明(53)1235157 Λ7 B7 V. Description of the invention (52 where each Y is independently from the following including 0 and S: each Ar3 is a cyclic group 'is independently selected from the following including an aryl group which contains 6, 10, D, or 14 atoms and 1 The main J rings 'and aromatic heterocycles / groups contain 5 to 1 5 partial ring atoms and 1 to 3 rings'. The heterocyclic ring contains at least one selected from -SO-, S02, and -NH-, · N (Ι15 ), And heteroatoms of -N (R9)-, the heterocyclic ring contains more than one double bond as needed, the heterocyclic ring contains more than one aromatic ring, and the ring base is-(^ Single or multiple fluorenes: Each Aγ4 is a cyclic group, independently selected from the following including aryl groups containing 6, 10, u or 14 carbon atoms and 1 to 3 rings, and fluorene heterocyclic groups containing 5 to 15 A cyclosaccharid and 1 to 3 rings, the heterocyclic ring containing at least one selected from -〇-, _s ·, _s〇, SO: '= N-, -NH -'- Nd)-, and -N (R9 ) · Heteroatom, the heterocyclic group may contain more than one double bond as required, the heterocyclic group may contain more than one aromatic ring, and the cyclic group may be a single or multiple substitution as required by _ (^ : Each Q [is independently selected from the following including -NH2, -C〇2H, -cn, -F ,, palpitations 1 · {FTr gas reads back f / λ and then attaches it to the page) Order • N02, -CN '= 〇' · 0 页, -perfluoro cN3 alkyl, &, e〇R5 The staff of the Central Ministry of Economic Affairs of the Ministry of Economic Affairs Consumption cooperation printed NHR5 ^ 0R9, .NHR9, r9, -C (0) .Rl Ό ,, V-The restriction is that when substituted by Ql group, it contains more than one additional Αγ3 is another Αγ3 substitution. · The preferred compounds of this /, / ϊα κ sentence include the following, but are not limited to them: and, Α 55 This paper has the old rule "Guo Guoxian τ ^ τ ^ (7 ^ 297)" 1235157 AT B7 jn. Description of the invention (53)

226e226e

0 227e0 227e

oo

1235157 A7 B7 五、發明説明(54) ο 307b1235157 A7 B7 V. Description of the invention (54) ο 307b

429 CPA»叫 0〇VvH Η ο ο429 CPA »called 0〇VvH Η ο ο

Ο 826eΟ 826e

827e827e

α -57- 本纸杀Λ度適用中国國家揉率(CNS ) Α4規格(210Χ297公釐) t« ittsumlitinf «V» I·:丨·,·丨 ---------扣衣-- c (請先a讀背面之注意事項再填寫本頁) 訂α -57- The paper Λ degree is suitable for China National Kneading Rate (CNS) Α4 size (210 × 297 mm) t «ittsumlitinf« V »I ·: 丨 ·, · 丨 --------- button clothes- -c (please read the notes on the back before filling in this page)

C 1235157 A7 B7 五、發明説明(55 ) 〇 9〇7〇C 1235157 A7 B7 V. Description of the invention (55) 〇 9〇07

907b (請先si讀背面之注意事項再填寫本頁) 0907b (Please read the precautions on the back before filling this page) 0

1029 具體實例C應用式(Π)之較佳化合物,其中且 其他的取代基如上文所定義。 具禮實例C應用式(II)之其他較佳化合物,其中R1是 (el2)且另外取代基如上文所定義。 具體實例c應用式(π)之其他較佳化合物,其中Ris(yl) 且另外取代基如上文所定義。 具韹實例c應用式(π)之其他較佳化合物,其中Ri;|:(y2) 且另外取代基如上文所定義。 具體實例C應用式(II)之其他較佳化合物,其中R丨是⑴ 且其他取代基如上文所定義。 58- 本纸乐尺度適用中國國家標準(CNS ) AA規格(210X297公釐) 1235157 A7 ~_ --—-· 五、發明説明(56 ) ~ 具也只例c悠周式(II)之其他較佳化合物,其中&是 (w2)^其他取代基如上文所定義。 罕又好’ R丨是(W2)且 m是1 : 環C是笨並,咄啶並或嘍吩並; R3k 自下列包括-C(〇)、h , -C(〇>Ai,,及-C(〇)CH2·丁厂R"; R5選自下列包括: - / -C(〇)-Rl〇,其中 ri〇是-Ar; ·· -c(〇)-〇r9,其中; <(〇)(:(〇)汛1〇,其中 Rl〇是-CH2Ar3 ; •R9,其中^是匚丨·2烷基,爲·A。所取代··及 -C(0)C(〇)-〇R1〇,其中 Ri〇是·CH2Ar;; ^是。或S : - R6 是 Η : R8 選自下列包括.C(〇)-R1〇 , -C(0)-CHr〇Ri〇,及 -C(0)CH2-N(R1〇)(R1〇),其中 ri〇是 η , ch3 ,或 CH2CH3 :1029 Specific Example C applies a preferred compound of formula (Π), wherein the other substituents are as defined above. Elite Example C applies other preferred compounds of formula (II), wherein R1 is (el2) and the additional substituents are as defined above. Specific example c applies other preferred compounds of formula (π), where Ris (yl) and additional substituents are as defined above. Other preferred compounds of formula (π) with example c, wherein Ri; |: (y2) and the additional substituents are as defined above. Specific Example C applies to other preferred compounds of formula (II), wherein R is ⑴ and the other substituents are as defined above. 58- This paper music scale is applicable to the Chinese National Standard (CNS) AA specification (210X297 mm) 1235157 A7 ~ _ ------- V. Description of the invention (56) ~ There are only other examples of the c-type (II) Preferred compounds wherein & are (w2) ^ other substituents are as defined above. R 'is good (R2) is (W2) and m is 1: ring C is benzopyridine, pyridino or phenenopyrene; R3k from -C (〇), h, -C (〇 > Ai ,, And -C (〇) CH2 · 丁 厂 R " R5 is selected from the following including:-/ -C (〇) -Rl〇, where ri〇 is -Ar;---c (〇) -〇r9, where; < (〇) (: (〇) Xun 10, where R10 is -CH2Ar3; R9, where ^ is 匚 2 alkyl, is A. Substituted ... and -C (0) C ( 〇) -〇R1〇, where Ri〇 is · CH2Ar ;; ^ Yes. Or S:-R6 is Η: R8 is selected from the following including C (〇) -R1〇, -C (0) -CHr〇Ri. , And -C (0) CH2-N (R1〇) (R1〇), where ri〇 is η, ch3, or CH2CH3:

Rh選自下列包括-Ai:4,-(cha丁 Αγ4,及·〇(〇)-ΑΓ4 :Rh is selected from the following including -Ai: 4,-(cha 丁丁 γγ4, and · 〇 (〇) -ΑΓ4:

Rl3是Η或直或分支烷基視所需爲- Αγ3,-〇η,-〇r9 或-C02H取代,其中心是^^分支的或直鏈烷基,其中Αγ3 是嗎福》林基或苯基’其中苯基視所需爲h所取代: Αγ2是(hh) : · Y是0 : Αγ3是苯基,葚基,”塞吩基,喹琳基,異蝰”林基,,塞唑 基,苯並咪唑基,。ί吩並喳吩基,tr塞二唑基,苯並三唑基 •59· 大紙杀尺度速用中國國家標孪(CNS ) A4規為·( 210X297公釐) —Rl3 is a fluorene or a straight or branched alkyl group optionally substituted with-Αγ3, -〇η, -〇r9 or -C02H, the center of which is ^^ branched or linear alkyl group, where Αγ3 is morpholinyl or Phenyl 'where phenyl is optionally substituted by h: Aγ2 is (hh): · Y is 0: Aγ3 is phenyl, fluorenyl, "selphenyl, quinolinyl, isofluorene", linyl, Oxazolyl, benzimidazolyl,. Fluorobenzophenoyl, tr thiadiazolyl, benzotriazolyl • 59 · Large-scale paper-killing scale quick-use China National Standard (CNS) A4 regulations are · (210X297 mm) —

1、. 1235157 Λ7 Β7 五、發明説明(57) ,苯並[b]硫苯基,苯並呋喃基及旬哚基; A r4是苯基,四咬基,篇基,说咬基,嗔4基,邊淀基 或Η丨嗓基: , 各(^獨立選自下列包括-NH2,-Cl,-F,-Br,-OH,-R9, -NH-R5,其中心是-匚⑴卜以⑺或-S(〇)2-R9,-〇R5其中R5是 -C(O)-R10,-〇R9,-NHR9,及 〇 */\Ch2,\/ . 〇 其中各R9&R1q獨立地爲-Cle6直或分支烷基,視所需爲Ar3 所取代,其中八1*3是苯基; 限制條件爲當-八1*3爲Qi基取代,其含有一個以上額外的 -Αγ3基,該額外的-八〇基不爲另- Αγ3基所取代。 較佳的此具體實例之化合物包括下列,但不限於此·· (請先¾讀背*之注意事項 P. 本頁) -裝 訂 經濟部中央標孪局貝工消费合作社印製 •60- 本纸乐尺度適用中國國家標孪(CNS ) A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(58 ) 605a1. 1235157 Λ7 B7 V. Description of the invention (57), benzo [b] thiophenyl, benzofuryl and pentanyl; A r4 is phenyl, tetrabenzyl, amyl, said radon, hydrazone 4-based, edge-based or Η-based: each independently selected from the following including -NH2, -Cl, -F, -Br, -OH, -R9, -NH-R5, and its center is-中心Ib or -S (〇) 2-R9, -〇R5 where R5 is -C (O) -R10, -〇R9, -NHR9, and 〇 * / \ Ch2, \ /. 〇 Wherein each R9 & R1q Independently -Cle6 straight or branched alkyl, optionally substituted by Ar3, where eight 1 * 3 is phenyl; the limitation is that when -eight 1 * 3 is Qi group substitution, it contains more than one additional -Aγ3 This additional -octyl group is not substituted by another-Αγ3 group. The compounds of this specific example are preferred, but are not limited thereto ... (Please read the notes on the back of the page P. This page) -Printed by the Central Government Bureau of the Ministry of Economic Affairs, Printed by the Bayer Consumer Cooperatives • 60- The paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (58) 605a

OH Η 605b 605cOH Η 605b 605c

請 先 讀 背 δ 之 注 i 言 ¥ 本 買 裝 訂 605d 超濟部中央標準局员工消費合作社印製 605e 0Please read the note of δ first. ¥ ¥ Buy Binding 605d Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 605e 0

ο 61 · 本纸伕尺度適用中國囯家揉率(CNS ) A4規格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(59) 605fο 61 · The size of this paper is applicable to China's national kneading rate (CNS) A4 specification (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (59) 605f

S05g 0S05g 0

ΌΗ 605h -Ο ΟΌΗ 605h -Ο Ο

605i 經濟部中央標準局員工消費合作.社印製 605j 0¾ -62- 本纸铁尺度適用7國國家標準(CNS ) A4規格(210X297公釐) --------續------.訂------_ (請先閱讀背>8之注意事項再填寫本頁) 1235157 Λ7 B7 605m 605η 五、發明説明(60 )605i Consumption cooperation among employees of the Central Bureau of Standards of the Ministry of Economic Affairs. Printed by the agency 605j 0¾ -62- This paper iron standard is applicable to 7 national standards (CNS) A4 specifications (210X297 mm) -------- continued ---- -. Order ------_ (Please read the notes of back > 8 before filling out this page) 1235157 Λ7 B7 605m 605η V. Description of the invention (60)

I 又 ΟI again Ο

經濟部r央橾準局系工消費合作.社印^- . 605p 605qMinistry of Economic Affairs, Central Bureau of quasi-bureau, Department of Industrial and Consumer Cooperation. Society Printing ^-. 605p 605q

Ο •63 本紙伕尺度適用中國國家標李(CNS ) A4規格(210X297公釐) 1235157 AT B7 五、發明説明(61 ) 經濟部中央揉準局员工消費合作杜印裝〇 • 63 The size of this paper is applicable to Chinese national standard (CNS) A4 specification (210X297 mm) 1235157 AT B7 V. Description of the invention (61) Staff consumption cooperation of the Central Bureau of the Ministry of Economic Affairs

(請先yT讀背云之注意事項再填寫本頁) -64 - 本纸杀尺度適用中國国家標孪(CNS M4規格(210X297公釐) 1235157 A7 B7 五、發明説明(62 619 0(Please read the precautions of yT before filling out this page) -64-The paper size is applicable to the Chinese national standard (CNS M4 specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (62 619 0

0H Η 6 020 Ο0H Η 6 020 Ο

(請先閱讀背面之注意事項再填寫本I) 621(Please read the notes on the back before filling in this I) 621

訂 622Order 622

身 HO Μ濟部中央揉準局貝工消費合作杜印¾ 623In the HO Μ Central Ministry of Economic Affairs, Central Bureau of quasi-government, shellfish consumer cooperation, Du Yin ¾ 623

65 本紙伕尺度適周中国國家標车(CNS ) Μ規袼(210X297公釐) 1235157 AT B7 五、發明説明(63) 62465 Paper size suitable for China National Standard Vehicle (CNS) M Regulation (210X297 mm) 1235157 AT B7 V. Description of Invention (63) 624

625 626 CH3 - 627625 626 CH3-627

(請先閱讀背面之注意事項再填寫本頁) 經濟部中央4局炎工消费合作社印衷 628(Please read the precautions on the back before filling out this page.) The 4th Central Bureau of the Ministry of Economic Affairs, the Inflammation Consumer Cooperatives 628

-66 本纸铁尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 1235157 A7 B7 五、發明説明(64 ) 629 630 0-66 This paper iron scale is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (64) 629 630 0

Ο 631 〇Ο 631 〇

ΟΟ

(請先¾讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

訂 632Order 632

633633

634 0634 0

•67 本纸杀尺度適用中國國家標孪(CNS ) A4規袼(210X297公釐) 1235157 A7 B7 *恕. 五、發明説明(坊) 635 具體實例C應用式(II)之其他較佳化合物,其中\是(el 0) ,乂5疋CH’且其他取代基如上文定義。 具體實例C應用式(II)之較佳化合物,其中1^是卜10),x5 是CH,R3是CO-Ar2,其他取代基如上文定義。 具體實例C應用式(II)之其他較佳化合物,其中\是〇10) ,X5是 CH,R3是-C^OhCHrTVR",Rh是-(CHJw-Aq, 且其他取代基如上文定義。 具體實例C應用式(Π)之其他較佳化合物,其中1^是卜1〇) ,且X5SCH且 R3是-C(0)-CHrTrRn ; 丁丨是0 ;且 Rh 是-C(0)-Ar4, 且其他取代基如上文定義。 較好,於這些較佳化合物中,r5選自下列包括··-c(〇)-Rl0, -c(〇)o-r9,及 -C(O)-NH-R10 〇 · & 列包括: 另外,於這些較佳化合物中,R5it自Τ -S(0)rR9,_ -s(o)2-NH-R10, •68 本纸铁尺度適周中g國家揉準(CNS ) A4規格(210 x 297公釐) 0辦衣-- (請先閱讀背面之注意事項再填寫本頁) 訂 :7 I/-·— 1235157 Λ7 . ______B7 ___ 五、發明説明(部) -C(O)-C(O)-R10, -R9,及 -C(〇)-C(O)-ORl0 ο / 最好,於這些較佳化合物中, m是1 ; 丁丨是〇或S : R丨3是Η或-C卜4直或分支燒基視所需爲-Ar3,·_0Η,-OR9 或-C O^H取代’其中Rg是- Cl〆分支或直鍵炫基’其中疋 嗎福啉基或苯基,其中苯基視·所需爲Q 1取代; R21 是-H或-CH3 : R5i是CN6直或分支烷基,視所需爲Ar3取代,其中Ar3昃 笨基,視所需爲-Qi取代; 八112是(hh): Y是0,且 Αγ3是苯基’審基’ β塞吩基,咬令咕基,異咬令咕基, 吡唑基,。塞唑基,異噁唑基,苯並三唑基,苯並咪唑基, 4吩並4吩基,咪唑基,〃塞二唑基,苯並[b]硫笨基,吡啶 基,苯並呋喃基,及吲哚基: 經濟部中央揉準局員工消费合作社印¾• 67 The standard for this paper is Chinese National Standard (CNS) A4 (210X297 mm) 1235157 A7 B7 * Should be used. 5. Invention Description (Fang) 635 Specific Example C Application of other preferred compounds of formula (II), Where \ is (el 0), 乂 5 疋 CH 'and the other substituents are as defined above. Specific example C applies a preferred compound of formula (II), wherein 1 ^ is Bu 10), x5 is CH, R3 is CO-Ar2, and other substituents are as defined above. Specific example C uses other preferred compounds of formula (II), where \ is 〇10), X5 is CH, R3 is -C ^ OhCHrTVR ", Rh is-(CHJw-Aq, and other substituents are as defined above. Specific Example C applies other preferred compounds of formula (Π), where 1 ^ is Bu 1), and X5SCH and R3 are -C (0) -CHrTrRn; Ding is 0; and Rh is -C (0) -Ar4 And the other substituents are as defined above. Preferably, among these preferred compounds, r5 is selected from the group consisting of: -c (〇) -R10, -c (〇) o-r9, and -C (O) -NH-R10. Columns include : In addition, among these preferred compounds, R5it is from Τ-S (0) rR9, _-s (o) 2-NH-R10, • 68 paper size iron standard suitable for middle-g countries (CNS) A4 specifications (210 x 297 mm) 0 Office clothes-(Please read the precautions on the back before filling this page) Order: 7 I /-· — 1235157 Λ7. ______B7 ___ V. Description of the Invention (Part) -C (O) -C (O) -R10, -R9, and -C (〇) -C (O) -ORl0 ο / best, among these preferred compounds, m is 1; Ding is 0 or S: R 3 Is Η or -CC4 or straight or branched, as required -Ar3, · _0Η, -OR9 or -CO ^ H substituted 'where Rg is -Cl〆 branched or straight-bonded xyl' where 疋 morpholinyl Or phenyl, where phenyl is optionally substituted with Q 1; R21 is -H or -CH3: R5i is CN6 straight or branched alkyl, optionally substituted with Ar3, of which Ar3 昃 benzyl, as required -Qi substitution; 112112 is (hh): Y is 0, and Aγ3 is phenyl 'triyl' β-sedenyl, tetrabenzyl, heterobenzyl, pyrazolyl. Sedazolyl, isoxazolyl, benzotriazolyl, benzimidazolyl, 4-pheno-4phenyl, imidazolyl, oxadiazolyl, benzo [b] thiobenzyl, pyridyl, benzo Furanyl, and indolyl: printed by the Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs

Ar4是苯基,四唑基,吡啶基,噁唑基,莕基,嘧啶基 ,或4吩基: 各Qi獨立選自下列包括-NH2,、C1,-F,-Br,-OH,-R9, -NH-R5 其中 R5 是-c(o)-r10 或-S(0)2-R9,·〇Ι15 其中 R5 是 -C(O)-R10,-0R9,-NHR9,及 1 69 - 本纸铁尺度通周中國國家標準(CNS )八4说格(210X297公釐) 1235157 A7 __—_B7 五、發明説明(67 ) 〇 / 乂 CH,, \〇/ - 其中各R9AR1(3獨三地爲-C1-6直或分支的燒基視所需爲 所取代,其中六1:3是苯基; 限制條件爲當-八^爲Q!取代時,其包括一個以上額外的 -Ar3基,該額外的·Αγ3基並不爲另·基所取代、 具體實例c應用式(π)的其他較佳化合物,其、Ris(el0) ,X5是CH ’ R;;是- C(0)-H,且另外的取代基如上文定義〇 較好,於這些較佳化合物中,R5選自下列包括: < -C(O)-Rl0, -c(o)o-r9 ,及 -C(O)-NH-R10。 另外,於這些較佳化合物中,R5選自下列包括: -S(0)2-R9 ’ -S(O)rNH-R10, -C(O)-C(〇)-Rl0, -R9 ’ 及 經濟部中央標率局貝工消费合作社印¾ -C(O)-C(O)-ORl0 0 最好,於這些較佳化合物中, m是1 ; 1^是0或S ; R13是Η或-Cm直或分支烷基視所需爲-Ar3,-0H,·〇κ9 或-C02H取代,其中R9*-Cm分支或直鏈烷基,其中Αγ3是 -7’Q- 本紙張尺度適用中国國家標牟(CNS ) A4規格(210X297公釐) " ' 1235157 A7 B7 五、發明説明(68) 嗎椅啦基或笨基,其中苯基視所需爲Q ^取代; 尺2〖是或-CH3 ; 是直或分支烷基,視所需爲Αγ3取代-,其中Αγ3是 苯基,視所需爲-Q、取代: Αγ2 是(hh); Y是0,且Ar4 is phenyl, tetrazolyl, pyridyl, oxazolyl, fluorenyl, pyrimidinyl, or 4phenyl: each Qi is independently selected from the group consisting of -NH2 ,, C1, -F, -Br, -OH,- R9, -NH-R5 where R5 is -c (o) -r10 or -S (0) 2-R9, · 〇Ι15 where R5 is -C (O) -R10, -0R9, -NHR9, and 1 69- The paper and iron scales are in accordance with Chinese National Standards (CNS), 8 and 4 grids (210X297 mm) 1235157 A7 __—_ B7 V. Description of the invention (67) 〇 / 乂 CH ,, \ 〇 /-where each R9AR1 (3 unique third A straight or branched alkynyl radical is substituted as desired, wherein six 1: 3 is a phenyl group; the limitation is that when -eight ^ is Q! Substitution, it includes more than one additional -Ar3 group The additional · Aγ3 group is not substituted by another group. Specific example c applies to other preferred compounds of formula (π), where, Ris (el0), X5 is CH'R; is -C (0) -H, and the other substituents are as defined above. In these preferred compounds, R5 is selected from the group consisting of: -C (O) -Rl0, -c (o) o-r9, and -C (O) -NH-R10. In addition, in these preferred compounds, R5 is selected from the following: -S (0) 2-R9 '-S (O) rNH-R10 -C (O) -C (〇) -Rl0, -R9 'and printed by Shelley Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs -C (O) -C (O) -ORl0 0 is the best, among these better compounds In the formula, m is 1; 1 ^ is 0 or S; R13 is fluorene or -Cm straight or branched alkyl, optionally substituted by -Ar3, -0H, · 〇κ9 or -C02H, wherein R9 * -Cm is branched or straight Alkyl group, where Αγ3 is -7'Q- This paper size is applicable to China National Standards (CNS) A4 specifications (210X297 mm) " '1235157 A7 B7 V. Description of the invention (68) Maeraki or stupid Where phenyl is optionally substituted by Q ^; 2 is or -CH3; is a straight or branched alkyl, optionally substituted by Aγ3, where Aγ3 is phenyl, and optionally -Q, substituted: Αγ2 is (hh); Y is 0, and

Ar*3是笨基,莕基,。塞吩基,咬喏咕基,異咬嗒基,的匕 也基’ 基’異《惡峻基’冬並三也基,苯並味味基,=塞 吩並4吩基,咪唑基,噻二f基,苯並[b]硫苯基,毗啶基 ,苯並呋喃基,及啕哚基: ΑΓ4是苯基,四峻基,〃比症基,嗔4基,審基,卷症基 ,或4吩基: 各h獨立選自下列包括-NH2,-cn, -F , -Br , -OH , -R9, •NH-R5,其中 115是-C(0)-R丨〇 或·5(0)2·Ι19,-〇R5 其中 R5 是 • C(O)-R10,-OR9,-NHR9,及 Ο CH- / \ \〇/ 經濟部中央標隼局員工消费合作杜印¾ 其中各119及1110獨立地爲-〇卜6直或分支的燒基,視所需爲 Αγ3所取代,其中Αγ3*苯基; 限制條件爲當-八”爲卩丨基取代·,其含有一個以上額外的 • Αγ3基,該額外的· Αγ3基不爲另-Αγ3基所取代, 具體實例C應周式(II)的其他較佳化合物,其中心是卜1〇) ,且 Χ5 是CH’ R;是 CO-CHyTi-Rii,且 R"是- Ar#’ 且其他 •71 - 本纸伕尺度適用中国國家標準(CNS ) A4祝格(2〖0χΜ7公釐) 1235157 7 A7 B7 經濟部中央榇準局貝工消費合作•社印¾ 五、發明説明(69 ) 取代基如上文定義。 較好在這些較佳化合物中,r5選自下列包括: -C(〇)-R10, - -C(0)0-R9 ,及 -C(O)-NH-R10。 另外,在這些較佳化合物中,r5選自下列包括: -s(o)2-r9, · -S(O)2-NH-R10, -C(〇)-C(O)-Rl0, · -R9,及 -C(〇)-C(〇)-OR10 ο 最好,在這些較佳化合物中, m是1 ; ^是。或S ; Rn是Η或-CN4直或分支烷基視所需爲-Ar3,-OH,-〇R9 ,或-C02H取代,其中R9*-CN4*支或直鏈烷基,其中Ai:3 是嗎福淋基或苯基,其中苯基視所需爲I取代: R21 是-H或-CH3 ; R5i是C^6直或分支烷基,視所需爲Ai*3所取代,其中Αγ3 是苯基,視所需爲-Qi取代; Ar2是(hh) ; ·Y是0,且 Ar3是苯基,葚基,嘍吩基,唼啉基,異呤啉基,吡哇 基,嘍唑基,異噁唑基,苯並三唑基,苯並味唑基,4吩 •72- (請先閲讀背面之注意事項 本頁) -裝 訂 本纸乐尺度適用中國國家揉孪(CNS ) A4規格(210X297公釐) 1235157 A7 ^____B7 _· 五 '發明説明(70 ) 並4吩基,咪唑基,噻二峻基,苯並[b]硫苯基,吆啶基, 苯並呋喃基,及4嗓基;Ar * 3 is BenQ, Yenki. Sedyl, glutamyl, isoctadyl, daggeryl, alkynyl, oxalyl, benzoyl, benzotrisyl, benzoyl stilbene, = sphenyl 4-phenyl, imidazolyl, Thiodifyl, benzo [b] thiophenyl, pyridyl, benzofuranyl, and fluorinyl: ΑΓ4 is phenyl, tetradecyl, fluorenyl, fluorenyl, fluorene, vol. Rhenyl, or 4-phenyl: each h is independently selected from the group consisting of -NH2, -cn, -F, -Br, -OH, -R9, and NH-R5, where 115 is -C (0) -R 丨. Or · 5 (0) 2 · Ι19, -〇R5 where R5 is • C (O) -R10, -OR9, -NHR9, and Ο CH- / \ \ 〇 / Consumer Consumption Cooperation of the Central Bureau of Standards, Ministry of Economic Affairs ¾ where each of 119 and 1110 are independently -0 or 6 straight or branched alkyl groups, which are optionally substituted by Aγ3, where Aγ3 * phenyl; the limitation is that when -eight "is substituted with 卩, which contains One or more additional Aγ3 groups, the additional Aγ3 groups are not replaced by another -Aγ3 group. The specific example C should be other preferred compounds of formula (II), the center of which is Bu 1), and X5 is CH 'R; is CO-CHyTi-Rii, and R " is-Ar #' and others • 71-Paper ruler Applicable to China National Standard (CNS) A4 Zhuge (2 〖0χΜ7mm) 1235157 7 A7 B7 Shellfish Consumer Cooperation • Press of the Central Government Bureau of the Ministry of Economic Affairs Ⅴ. Description of Invention (69) The substituents are as defined above. Fortunately, among these preferred compounds, r5 is selected from the group consisting of: -C (〇) -R10, -C (0) 0-R9, and -C (O) -NH-R10. In addition, among these preferred compounds, In the formula, r5 is selected from the following: -s (o) 2-r9, -S (O) 2-NH-R10, -C (〇) -C (O) -Rl0, -R9, and -C ( 〇) -C (〇) -OR10 ο best, in these preferred compounds, m is 1; ^ is. Or S; Rn is Η or -CN4 straight or branched alkyl as desired -Ar3, -OH , -〇R9, or -C02H substitution, where R9 * -CN4 * branched or straight-chain alkyl, where Ai: 3 is morpholinyl or phenyl, where phenyl is optionally substituted by I: R21 is -H Or -CH3; R5i is a C ^ 6 straight or branched alkyl group, optionally substituted by Ai * 3, where Aγ3 is phenyl, optionally substituted by -Qi; Ar2 is (hh); Y is 0, And Ar3 is phenyl, fluorenyl, fluorenyl, fluorenyl, isorinolinyl, pyrawyl, oxazolyl, isoxazolyl, benzotriazolyl, benzotriazole 4-phen • 72- (Please read the note on the back page first)-Binding paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 ^ ____ B7 _ · Five 'invention description (70) 4-Phenyl, imidazolyl, thienyl, benzo [b] thiophenyl, pyridinyl, benzofuranyl, and 4-phenyl;

Ar4是苯基,四唑基,呲啶基,噁唑基,莕意,嘧啶基 ,或4吩基: 各(^獨立選自下列包括-NH2,-Cl,-F,-Bit,-oh,-R9, -NH-R5 其中 R5 是-C(0)-RI〇 或,s(〇)2-R9,-〇r5 其中 R〕·是 -C(0)-R1〇,-0R9,-nhr9,及 · 〇Ar4 is phenyl, tetrazolyl, pyridinyl, oxazolyl, pyridine, pyrimidinyl, or 4phenyl: each (^ is independently selected from the following including -NH2, -Cl, -F, -Bit, -oh , -R9, -NH-R5 where R5 is -C (0) -RI〇 or, s (〇) 2-R9, -〇r5 where R] · is -C (0) -R1〇, -0R9,- nhr9, and · 〇

\〇/ 其中各Rg及R 10獨立地爲-C直或分支燒基,視所需爲心, 所取代,其中Αγ3是苯基: 限制條件爲當-Ar>3爲Qi基取代時,其含有一個以上額外 的-Ar3基,該額外的· ΑΓ3基不爲另· Αγ3基所取代。 具體實例C應闬式(II)的其他較佳化合物,其中R丨是 (el 0),且X5是N,且其他的取代基如上文所定義。 具體實例C應用式(Π)的較佳化合物,其中Ri是(elQ), X5是N,R3是CO-Ai*2 ’且其他的取代基如上文所定義。 經濟部中央標準局貝工消费合作社印製 (請先閱讀背面之注意事項再填寫本頁} 具體實例C應用式(II)化合物的其他較佳化合物,其中 \是(^1〇),x#N,r3是<(〇κ:η2-τγιιπ,3. Αγ4,且其他取代基如上文定義·。 具體實例C應用式(II)的其他較佳化合物,其中Ri是 (elO),且X5*N,且 -73 - 本纸伕尺度適用中國國家標準(CNS )八4说格(210X297公釐) 1235157 A7 B7 五、發明説明(71) 丁丨是〇;且\ 〇 / wherein each Rg and R 10 are independently -C straight or branched alkyl groups, substituted as desired, where Aγ3 is phenyl: The limitation is that when -Ar > 3 is substituted by Qi group, Contains more than one additional -Ar3 group, this additional ΑΓ3 group is not replaced by another Αγ3 group. Specific example C should be other preferred compounds of formula (II), wherein R1 is (el0), X5 is N, and the other substituents are as defined above. Specific Example C applies a preferred compound of formula (Π), wherein Ri is (elQ), X5 is N, R3 is CO-Ai * 2 'and the other substituents are as defined above. Printed by Shellfish Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs (Please read the notes on the back before filling out this page} Specific Example C: Other preferred compounds using the compound of formula (II), where \ 是 (^ 1〇), x # N, r3 is < (〇κ: η2-τγιιπ, 3. Αγ4, and other substituents are as defined above. Specific Example C applies other preferred compounds of formula (II), wherein Ri is (elO), and X5 * N, and -73-This paper's scale applies to Chinese National Standards (CNS), 8 squares (210X297 mm), 1235157 A7 B7 V. Description of the invention (71) Ding is 0; and

Rh是-C(0)-Ar4,且其他取代基如上文所定義。 較好,於這些較佳化合物中,R5選自下列包括: -C(〇)-R10 ’ -C(〇)〇-R9 ,及 -C(〇)-NH-Rl0。 另外,於這些較佳化合物中,R5選自下列包括r -S(〇)2-R9 ’ -S(〇)rNH-Rl0, - -C(〇)-C(O)-R10, •R9,及 -C(O)-C(O)-OR10。 較好在這些較佳化合物中,r5選自下列包括·· -S(0)9-R9 ’ -S(O)2-NH-R10, -C(〇)-C(〇)-R10, -R9,及 · -C(〇)-C(〇)-OR10 〇 m是1 ; 經濟部中央標準局員工消费合作.社印製 :^是。或S ; 尺13是Η或-(:丨.4直或分支烷基視所需爲- Αγ3,-OH,-0R9 ,或-C02H取代,其中R9*-CN4分支或直鏈烷基,其中Αγ3 是嗎福琳基或苯基,其中苯基視所需爲I取代; R21 是-Η或-CH3 ; -74- 本纸張尺度適用中S國家標率(CNS M4規格(210X297公釐) 1235157 A/ B7 五、發明説明( 72 經濟部中央樣準局哭工消费合作·社印装 尺51是<^-6直或分支的垸基,視所需爲Ar3所取代,其中 Αγ3是苯基,視所需爲取代: Αγ2 是(hh): , Y是0,且 Αγ3是苯基,莕基’噻吩基,喹喏啉基,異唼喏琳基, 叶匕咬基,9塞咬基’異嗔嗅基’苯並三嗅基,苯並咪4基, 嚙吩並嘍吩基,咪峻基,噻二唑基,笨並[b]硫佘基,吡啶 基,笨並咬喃基’及4丨衣基: Ar4是苯基,四唑基,呲啶-基,噁唑基,莕基,嘧啶基 ,或魂吩基; 各卩丨獨立選自下列包括·ΝΗ2,-Cl,-F,-Br,-OH , -r9, -NH-R5,其中尺5 是·ε(0)·κιο 或-S(0)2-R9,-〇r5 其中 ^是 -C(O)-R10 ,观9,,NHR9 ,及/V, v 其中各R9及Rio獨立地爲_ci·6直或分支的烷基,視所需爲 Αγ3所取代,.其中Αγ3是苯基; 限制條件爲當-八1:3爲取代,其含有一個以上辣外的 -Αγ3基,該額外的· Αγ3基不爲另-Αγ3基所取代。 具體實例C另外較佳化合物·,應用式(II)其中1^是^1〇) ,Χ5是Ν,R3是-C(0)-H ,且其他取代基如上文所定義。 較好,於這些較佳化合物中,r5選自下列包括: -C(O)-R10, -75· 本纸伕尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項寫本I > 裝 訂 1235157 A7 B7 五、發明説明(73 ) -C(〇)0-R9 ,及 • C(O)-NH-Rl0。 另外,於這些較佳化合物中,r5選自下列包每, -S(0)2-R9 ’ -S(O)2-NH-R10, -C(O)-C(O)-R10, -R9,及 、 -C(O)-C(O)-OR10。 較妤,於這些較佳化合物中,_ m是1 : ^是。或S: · R13是Η或-CN4直或分支的烷基,視所需爲· ηΓ3 ' -0R9,或·0:Ο2Η所取代,其中119是彳卜4分支或直 υΗ, •其中Αγ3是嗎福啉基或苯基,其中苯基視所需爲 &基’ R21 是-Η或-CH3 : 尺51是C I ·6直或分支的燒基,視所需爲A1·3所取代 Ar3是苯基,視所需爲-Qi所取代: 八1:2是(hh); 代 其中 .馨批衣-- r'v f辞先閎讀背面之注意事項再填寫本頁} 訂 經濟部中央揉準局員工消費合作衽印¾ Y是0,且 Αγ3是苯基,茬基,,塞吩基,,I:喏味基,異,奎喏4基, 外匕唑基,4唑基,異噁唑基,苯'並三唑基,笨並咪唑基, 4吩並。塞吩基,咪唑基,4二唑基,苯並[b]硫苯基,毗嚏 基,苯並呋喃基,及钊哚基; Αγ4是苯基,四唑基,吡啶基,噁唑基,葚基,嘧咬基 -76- 本纸張尺度適用中国國家標率(CNS ) A4規格(2丨0X297公釐) 1235157 A7 B7 經濟部中央糅準局员工消費合作·杜印«. 五、發明説明(74) ,或屢令基: 各卩丨獨立選自下列包括·ΝΗ2,-Cl,-F,-Br,-OH,-R9, -NH-R5,其中 R5 是-C(〇)-Ri〇 或-S(0)2-R9,-or5 其中 r5 是 -C(0)-Ri〇 ’ ’ -NHR9 ’ 及 〇 / ) CH,, \ / ' 〇 其中各R9及Rl0獨立地爲-cle6直或分支的烷基,視所需爲 Αγ3所取代,其中Αγ3是苯基 限制條件爲當-Αγ3爲Qi基取代時,其含有一個以上額外 的-Ar3基,該額外的-Αγ3基不爲另·Αγ3基所取代。 具體實例C其他較佳化合物,應用式(π)其中Ri是(e10) ,且X5是N,113是CO-CHrTVRn,且11丨1是-Ar4,且其他 取代基如上文所定義。 較好,在這些較佳化合物中,R5選自下列包括: -C(O)-Rl0, -c(o)o-r9 ,及 -C(O)-NH-R10 〇 另外,於這些較佳化合物中,R5選自下列包栝: -S(0)rR9, -S(O)2-NH-Rl0 » · -C(O)-C(O)-R10, -R9 ’ 及 •C(O)-C(O)-OR10 〇 -77· 本紙伕尺度逋用中國國家標隼(CNS ) Α4規格(2丨0Χ297公釐) (請先«讀背δ之注意事項再填寫本X ) 裝- 訂 1235157 五、發明説明(75) 最好,於這些較佳化合物中: m是1 ; T1是0或S : RU是Η或·〜直或分支故基,视所需爲如 -〇'或.啊取代’其中尺9是、直或分支的坑某,其 中疋嗎描啪基或苯基,其中苯基視所需爲 R21 是-H 或-CH3; . 直或分支烷基,視所需爲Αγ]所取代,其中a卜 是苯基,視所需爲-Qi取代:- 八 3 Αγ2是(hh): Y是0,且 A1·3是苯基,莕基,,塞吩基,蝰喏琳基,異峻喏琳基, 吡唑基,嘍唑基,異噁唑基,苯並三唑基,苯並咪峻基, 嘍吩並嘍吩基,咪岐基,噻二唑基,苯並[b]硫苯基,吡啶 基,苯並吱喃基及,?I嗓基:Rh is -C (0) -Ar4 and the other substituents are as defined above. Preferably, among these preferred compounds, R5 is selected from the group consisting of: -C (〇) -R10 '-C (〇) 〇-R9, and -C (〇) -NH-Rl0. In addition, among these preferred compounds, R5 is selected from the following including r -S (〇) 2-R9 '-S (〇) rNH-R10,--C (〇) -C (O) -R10, R9, And -C (O) -C (O) -OR10. Preferably, among these preferred compounds, r5 is selected from the group consisting of -S (0) 9-R9'-S (O) 2-NH-R10, -C (〇) -C (〇) -R10,- R9, and--C (〇) -C (〇) -OR100m is 1; consumer cooperation of employees of the Central Standards Bureau of the Ministry of Economic Affairs. Or S; Ruler 13 is Η or-(: .. 4 straight or branched alkyl is optionally substituted by-Αγ3, -OH, -0R9, or -C02H, where R9 * -CN4 is branched or linear alkyl, where Αγ3 is morpholinyl or phenyl, of which phenyl is substituted by I as required; R21 is -Η or -CH3; -74- This paper size applies to the national S standard (CNS M4 specification (210X297 mm) 1235157 A / B7 V. Description of the invention (72 The Central Government Standards Bureau, Ministry of Economic Affairs, Crying, Consumer Cooperatives · Social Printing Feet 51 is a straight or branched cymbal base, which is replaced by Ar3 as needed, where Αγ3 is Phenyl, substituted if necessary: Aγ2 is (hh):, Y is 0, and Aγ3 is phenyl, fluorenyl'thienyl, quinolinolyl, isomerinyl, phyllyl, 9 plug Benzyl 'isopyridinyl' benzotriolyl, benzimidyl 4-yl, phenenofluorenyl, imidyl, thiadiazolyl, benzo [b] thiophenyl, pyridyl, benzo Aryl 'and 4'-Midyl: Ar4 is phenyl, tetrazolyl, pyridinyl-, oxazolyl, pyridyl, pyrimidinyl, or phenanthryl; each is independently selected from the following including N 包括 2, -Cl, -F, -Br, -OH, -r9, -NH-R5, where rule 5 is · Ε (0) · κιο or -S (0) 2-R9, -〇r5 where ^ is -C (O) -R10, guan 9, NHR9, and / V, v where each R9 and Rio are independently _ci · 6 straight or branched alkyl, optionally substituted by Aγ3, where Aγ3 is phenyl; the limitation is that when -eight 1: 3 is substituted, it contains more than one -Aγ3 group, In addition, the Aγ3 group is not substituted by another -Aγ3 group. Specific Example C Another preferred compound, using formula (II) where 1 ^ is ^ 1〇), X5 is N, and R3 is -C (0) -H And other substituents are as defined above. Preferably, among these preferred compounds, r5 is selected from the following including: -C (O) -R10, -75 · The standard of this paper applies the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the notes on the back of the book I > Binding 1235157 A7 B7 V. Invention Description (73) -C (〇) 0-R9, and • C (O) -NH-Rl0. In addition, In these preferred compounds, r5 is selected from the group consisting of -S (0) 2-R9 '-S (O) 2-NH-R10, -C (O) -C (O) -R10, -R9, And -C (O) -C (O) -OR10. Compared with 妤, in these preferred compounds, _ m is 1: ^ is. Or S: · R13 is Η or -CN4 or Branched alkyl, optionally substituted by ηΓ3 '-0R9, or · 0: Ο2Η, where 119 is 分支 4 branch or straight υΗ, where Αγ3 is morpholinyl or phenyl, where phenyl is A & radical 'R21 is -Η or -CH3: Chi 51 is a straight or branched alkyl group of CI · 6, if necessary, A1 · 3 is substituted, Ar3 is phenyl, and if required, substituted by -Qi : 8 1: 2 Yes (hh); On behalf of them. Xin batch of clothes-r'v f resign and read the precautions on the back before filling out this page} Order the Ministry of Economic Affairs Central Government Bureau of Procurement Bureau's consumer cooperation seal YYes 0, and Aγ3 is a phenyl group, a stilbene group, a sedenyl group, I: stilbyl group, iso, quinoxaline 4 group, exoxazolyl group, 4 oxazolyl group, isoxazolyl group, benzo'triazole group , Benzimidazolyl, 4pheno. Sedphenyl, imidazolyl, 4-diazolyl, benzo [b] thiophenyl, bishexyl, benzofuryl, and azinyl; Aγ4 is phenyl, tetrazolyl, pyridyl, oxazolyl , Benzyl, Pyridyl-76- This paper size applies to China's National Standards (CNS) A4 specifications (2 丨 0X297 mm) 1235157 A7 B7 Consumption cooperation between employees of the Central Provincial Bureau of the Ministry of Economic Affairs · Du Yin «. V. Description of the invention (74), or fluorenyl: each 卩 丨 is independently selected from the group consisting of: NH2, -Cl, -F, -Br, -OH, -R9, -NH-R5, where R5 is -C (〇) -Ri〇 or -S (0) 2-R9, -or5 where r5 is -C (0) -Ri〇 '' -NHR9 'and 〇 /) CH,, / /' 〇 wherein each of R9 and R10 is independently -cle6 straight or branched alkyl, optionally substituted by Aγ3, where Aγ3 is phenyl. The restriction is that when -Aγ3 is substituted with a Qi group, it contains more than one additional -Ar3 group, and the additional -Αγ3 Not substituted by another Aγ3 group. Specific Example C Other preferred compounds, where formula (π) is used where Ri is (e10), X5 is N, 113 is CO-CHrTVRn, and 11 丨 1 is -Ar4, and other substituents are as defined above. Preferably, among these preferred compounds, R5 is selected from the group consisting of: -C (O) -Rl0, -c (o) o-r9, and -C (O) -NH-R10. In addition, in these preferred compounds In the compound, R5 is selected from the following: -S (0) rR9, -S (O) 2-NH-Rl0 »· -C (O) -C (O) -R10, -R9 ', and • C (O ) -C (O) -OR10 〇-77 · The paper size is in accordance with Chinese National Standards (CNS) A4 specification (2 丨 0 × 297 mm) (please read «Notes on back δ before filling in this X) Pack- Order 1235157 V. Description of the invention (75) The best, among these preferred compounds: m is 1; T1 is 0 or S: RU is Η or · ~ straight or branched base, as necessary-such as -0 'or . Ah substituted 'where the rule 9 is, straight or branched pit, where is stilbyl or phenyl, where phenyl is R21 is -H or -CH3 as needed;. Straight or branched alkyl, as Needs to be substituted by Aγ], where a is phenyl, optionally substituted by -Qi:-8 3 Aγ2 is (hh): Y is 0, and A1 · 3 is phenyl, fluorenyl, and sephenyl Stilbene, stilbene, stilbyl, isoxazolyl, isoxazolyl, benzotriazolyl, benzimidyl, stilbene, stilbene, stilbene ?, Thiadiazolyl, benzo [b] thiophenyl, pyridyl, benzo squeak and tetrahydrothiopyranyl, the I voice group:

Ai:4是苯基,四唑基,吡啶基,噁唑基,莕基,嘧啶基 或β塞吩基: 各Ch獨立選自下列包括·ΝΗ2,-Cl,-F,-Br,-OH , -R9, -NH-R5,其中115是-(:(0)-11丨 〇 或·5(0)2·Ι19, -〇R5 其中 r5i •C(0)-R1〇,-〇R9,-NHR9,及 • · o ./、CH,, \/ -〇 其中各R9&R1()獨立地爲-Cw直或分支的烷基’視所需爲 -78· 本纸伕尺度適用中國国家揉率(CN,S M4说格(2l〇X297公釐) ·τ /TV (請先閲讀背面之注意¾項再填寫本頁) 訂 經濟部中央揉準局貝工消费合作社印¾ 1235157 Α7 Β7 立·菸明説明(76) Αγ3所取代,其中八1*3是苯基; … 限制條件爲當-八1:3爲Qi基取戎時,其含有一個以上額外 的-Ar3基’孩額外的-Arj基不爲另· Ar$基所取-代。 具體實例B之較佳化合物包括下列,但不限於此: 〇 213eAi: 4 is phenyl, tetrazolyl, pyridyl, oxazolyl, fluorenyl, pyrimidinyl, or β-secenyl: each Ch is independently selected from the group consisting of: ΝΗ2, -Cl, -F, -Br, -OH , -R9, -NH-R5, where 115 is-(:( 0) -11 丨 〇 or · 5 (0) 2 · Ι19, -〇R5 where r5i • C (0) -R1〇, -〇R9, -NHR9, and • · o ./, CH ,, \ / -〇 where each R9 & R1 () is independently -Cw straight or branched alkyl 'if necessary -78 Kneading rate (CN, S M4 grid (2l0 × 297 mm) · τ / TV (Please read the note on the back ¾ before filling out this page) Order printed by the Central Ministry of Economic Affairs, Bureau of Shellfish Consumer Cooperative ¾ 1235157 Α7 Β7 Li Yanming explained (76) that Αγ3 was substituted, in which eight 1 * 3 was phenyl; ... the limitation is that when -eight 1: 3 is Qi group, it contains more than one additional -Ar3 group. The -Arj group is not substituted by another Ar $ group. Preferred compounds of Specific Example B include the following, but are not limited thereto:

302302

(請先閱讀背面之注意事項再填寫本頁) 304a(Please read the notes on the back before filling out this page) 304a

Η 〇. Χη3 經濟邻中央褅準局貝工消費合作杜印裂 ci3eΗ 〇. Χη3 Economic cooperation with the Central Central Bureau of quasi-government, shellfish consumer cooperation, Du Yinli ci3e

-79 本纸伕尺度適周中國國家標孪(CNS ) A4規格(210X297公麥) 1235157 B7 五、發明説明(77) 902 904a Ο-79 The size of this paper is suitable for Chinese National Standard (CNS) A4 specification (210X297 gram) 1235157 B7 V. Description of the invention (77) 902 904a 〇

CH3 較佳的具體實例C化合物包括下列但不限於此 •80Preferred specific examples of CH3 C compounds include but are not limited to the following: • 80

本紙伕尺度逋用中国國家標準(CNS ) A4規格(2丨0X29?公釐) 1235157 Α7 Β7 五、發明説明(78 214c 0The size of this paper adopts Chinese National Standard (CNS) A4 specification (2 丨 0X29? Mm) 1235157 Α7 Β7 5. Description of the invention (78 214c 0

0H Η 0 214e Ο0H Η 0 214e Ο

OH Η Ο Ο 217 cOH Η Ο Ο 217 c

Ο 217dΟ 217d

經濟部中央揉率局貝工消费合作杜印装 ΟCentral Government Bureau of the Ministry of Economic Affairs

6 4 2 ΝΗ6 4 2 ΝΗ

ΝΝ ο Η ο ο ΝΗΝΝ ο Η ο ο ΝΗ

OH 81 (讀先閱讀背面之注意事項再填寫本莧)OH 81 (Read the precautions on the back before filling in this card)

本纸張尺度適用中國國家揉準(CNS ) Α4規格(210Χ297公釐) 1235157 五、發明説明(79 ) 257 265 280 281 Λ7 B7This paper size is applicable to China National Standard (CNS) A4 (210 × 297 mm) 1235157 V. Description of the invention (79) 257 265 280 281 Λ7 B7

0H Η 0 00H Η 0 0

經濟部中央標隼局負工消費合作社印製 283 〇 282Printed by the Central Standards Bureau of the Ministry of Economic Affairs, Consumer Cooperatives 283 〇 282

ΟΟ

-82· (請先閲讀背面之注意事項再填寫本頁)-82 · (Please read the precautions on the back before filling this page)

本紙乐尺度適用中國國家標隼(CNS ) Α4規格(210Χ297公釐) 1235157 Λ7 B7 五、發明説明(80 )This paper music scale is applicable to the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 1235157 Λ7 B7 V. Description of the invention (80)

本纸伕尺度適用中国國家標準(CNS ) A4規格(210 X 297公釐) 1235157 A7 B7 五、發明説明(81 406 Η Ο 407 0The paper size of the paper applies to the Chinese National Standard (CNS) A4 (210 X 297 mm) 1235157 A7 B7 V. Description of the invention (81 406 Η Ο 407 0

--------衣-- (請先閲讀背vB之注意事項再填寫本f ) 408 0-------- Clothing-(Please read the precautions for the back of vB before filling in this f) 408 0

OH 訂 409 ΟOH order 409 Ο

濟部 中 央 橾 李為 Ά 工 消 费 合 作 社 印 装 411 Ο 410Printed by the Central Government of the Ministry of Economic Affairs of the People's Republic of China, Li Weiying, Industrial and Commercial Cooperatives 411 Ο 410

Ο ΟΟ Ο

本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 1235157 A7 B7 五、發明説明(82 ) 412 0This paper size applies to Chinese National Standard (CNS) A4 specification (210 × 297 mm) 1235157 A7 B7 V. Description of invention (82) 412 0

0 413 Η 0 (請先聞讀背面之注意事項再填寫本頁) /*、 •裝 4150 413 Η 0 (Please read the notes on the back before filling in this page) / * 、 • equipment 415

訂 416 417 I 〇 οOrder 416 417 I 〇 ο

.0 c'v〆.;· 418 Ο.0 c'v〆 .; · 418 Ο

本纸伕尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1235157 A7 B7 五、發明説明(83 ) 9 1 4 ο ΟΛThe paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (83) 9 1 4 ο Λ

OHH ο 2 4 ΝΗ ΟΑOHH ο 2 4 ΝΗ ΟΑ

O^N.N^OO 2 2 4 ο /\Ν. ΝO ^ N.N ^ OO 2 2 4 ο / \ Ν. Ν

3 2 4 ΟΗΟΠΟ . on^vo ouff ο£。命 :ΝΗΟΛν #衣丨— (請先W讀背面之注意事項再填寫本頁) 訂 I經濟部中央標準局兵工消费合作社印製 4 2 4 5 2 43 2 4 ΟΗΟΠΟ. On ^ vo ouff ο £.命: ΝΗΟΛν # 衣 丨 — (Please read the precautions on the back before filling out this page) Order I Printed by the Military Industry Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy 4 2 4 5 2 4

ΗΗ

86 本纸伕尺度適用中国國家揉準(CNS ) Α4規格(210X297公釐) 1235157 A7 B7 五、發明説明(84 ) 426 Ο86 The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (84) 426 Ο

0H Η 0 430 00H Η 0 430 0

OH Ο 431 ΟOH Ο 431 Ο

/?/〇Η°〇λΝΛΤΗ 432 Ο Η/? / 〇Η ° 〇λΝΛΤΗ 432 Ο Η

433433

434 87434 87

本纸伕尺度適用中國國家標率(CNS ) Α4規格(2丨ΟΧ297公釐) 1235157 A7 B7 五、發明説明(85 ) 435 0The paper scale is applicable to China National Standards (CNS) A4 specifications (2 丨 〇 × 297 mm) 1235157 A7 B7 V. Description of the invention (85) 435 0

0H Η 4360H Η 436

(請先閏讀背面之注意事項再填寫本頁) 437 0(Please read the notes on the back before filling out this page) 437 0

0Η Η Ο Ο 438 439 Ο0Η Η Ο Ο 438 439 Ο

440 Ο440 Ο

ΟΗ 88 · 本纸伕尺度適用中國國家標孪(CNS ) Μ規格(2丨0X297公釐) 1235157ΟΗ 88 · The size of this paper is applicable to China National Standards (CNS) M specifications (2 丨 0X297 mm) 1235157

五、發明説明(86)V. Invention Description (86)

本纸伕尺度適用中國国家標率(CNS ) A4規格(210X297公釐) 1235157 AT B7 五、發明説明( 87 S 4 4The paper scale is applicable to China National Standards (CNS) A4 specifications (210X297 mm) 1235157 AT B7 V. Description of the invention (87 S 4 4

4 4 ΗΝ4 4 ΗΝ

OHH ΟΛνο )*ΝΗ ^ Χ3 Λ° (請先閱讀背面之注意事項再填寫本頁) δ 4 4OHH ΟΛνο) * ΝΗ ^ Χ3 Λ ° (Please read the precautions on the back before filling this page) δ 4 4

Η 4 4Η 4 4

οηη0=0=0 經$中央揉準局負工消費合作杜印製 οοηη0 = 0 = 0 Printed by the Central Government Office of the Central Government Bureau of Work and Consumer Cooperation ο

Η V οηη0=0=0 ο 90 本纸伕尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 1235157 A7 B7 五、發明説明(88 ) 0 451Η V οηη0 = 0 = 0 ο 90 The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (88) 0 451

0 452 0 JD10 452 0 JD1

0H Η 0 453 454 00H Η 0 453 454 0

0 —··*.·、,-i: --.1.( , f i .----17 455 456 00 — ·· *. · ,, -i:-. 1. (, f i .---- 17 455 456 0

0 CI 00 CI 0

本纸伕尺度適用中國國家揉準(CNS ) A4規格(210X297公釐) 1235157 A7 B7 五、發明説明(89 ) 457 0The paper scale is applicable to China National Standard (CNS) A4 (210X297 mm) 1235157 A7 B7 V. Description of the invention (89) 457 0

0H Η 458 00H Η 458 0

(讀先閱讀背面之注意事項再填寫本頁) 459(Read the precautions on the back before filling this page) 459

460 0460 0

OH Η 4S1 462 ΟOH Η 4S1 462 Ο

•92- 本纸伕尺度適用中國國家標準(CN’S ) Α4規格(210X297公釐) 1235157 A7 B7 五、發明説明(90 ) 463 A他Η 464 Ο^νΟ?Λη Η Ο ο 465• 92- The standard of this paper is applicable to Chinese National Standard (CN ’S) A4 specification (210X297mm) 1235157 A7 B7 V. Description of the invention (90) 463 A Η 464 Ο ^ νΟ? Λη Η Ο ο 465

Η Ο (請先聞讀背面之注意事項再填寫本頁) J裝 466 ΟΗ Ο (Please read the precautions on the back before filling this page) J Pack 466 Ο

ΟΗ CI 訂 Ο 467 468 ΟΟΗ CI Order 〇 467 468 Ο

-93 本纸張尺度逋用中國國家標準(CNS > A4規格(210X297公釐) 1235157 AT B7 五、發明説明(91 ) 4S9 0-93 This paper uses the Chinese national standard (CNS > A4 size (210X297 mm) 1235157 AT B7 V. Description of the invention (91) 4S9 0

OH 470 ΟOH 470 Ο

471471

ο HPο HP

H3C Ο 472 ο 473H3C Ο 472 ο 473

Ο •94- 本纸張尺度適用中国國家標準(CNS ) A4規格(210:<297公釐) (請先閱讀背面之注意事項再填寫本頁)〇 • 94- This paper size applies to Chinese National Standard (CNS) A4 specification (210: < 297 mm) (Please read the precautions on the back before filling this page)

12351571235157

-95· 本纸伕尺度適用中国11家揉孪(CNS ) Μ規格(210X297公釐) 1235157 五、發明説明(93 ) 479 482 A7 B7 0-95 · The size of this paper is applicable to 11 Chinese twins (CNS) M specifications (210X297 mm) 1235157 V. Description of the invention (93) 479 482 A7 B7 0

00

Ο 481Ο 481

0 481s0 481s

ΟΟ

-96·-96 ·

本紙張尺度適用中家標隼(CNS )M坑格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(94 ) 483This paper size applies to the Chinese standard 隼 (CNS) M pit (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (94) 483

0 482S0 482S

cA 0cA 0

OH ,Η Ο (讀先閱讀背面之注意項再填寫本頁) Ο 484 ΟOH, Η Ο (Read the notes on the back before filling in this page) Ο 484 Ο

ΟΗ 485 Ο 486 Η Η 〇 -97 本纸伕尺度適用中囯S家標準(CNS ) Α4規^格(2Ι0Χ297公釐) 1235157ΟΗ 485 Ο 486 Η Η 〇 -97 The standard of this paper is applicable to China Standard S (CNS) A4 standard (2Ι0 × 297 mm) 1235157

i、發明説明(95 487i. Description of the invention (95 487

Hj ΟHj Ο

488 Ο488 Ο

OH Η (請先閲讀背面之注意事項再填寫本頁) 489 ΟOH Η (Please read the notes on the back before filling in this page) 489 Ο

490 Η Η Ο 491 Ο490 Η Η Ο 491 Ο

ΟΗ Η -98ΟΗ Η -98

本纸伕尺度適用中國國家揉準(CNS ) Α4規格(2U3X297公釐) 1235157 AT B7 五、發明説明(96 ) 0 C0The paper scale is applicable to China National Standard (CNS) Α4 size (2U3X297 mm) 1235157 AT B7 5. Description of the invention (96) 0 C0

F OHHX"-ο-F OHHX " -ο-

OHHOHH

bb

α 99 (請先«讀背面之注意事項再填寫本頁) 訂 本纸張尺度適用中國國家標準(CNS ) Μ規格(210X297公釐) 1235157 A7 B7 五、發明説明(97 ) 498 0α 99 (please «read the precautions on the reverse side before filling out this page). The size of this paper is applicable to the Chinese National Standard (CNS) M specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (97) 498 0

499 0499 0

(諸先聞讀背面之注意事項再填寫本莧) 814c 〇(Please read the notes on the back before filling in this book) 814c 〇

Ο 817cΟ 817c

Ο 817dΟ 817d

100· 本纸伕尺度適用中國國家標孪(CNS ) A4说格(210X297么釐) 1235157 五、發明説明(98 ) 817e Ο100 · The size of this paper is applicable to the Chinese National Standard (CNS) A4 grid (210X297 mm) 1235157 V. Description of the invention (98) 817e Ο

A7 B7A7 B7

Η 〇Η 〇

880 Ο880 Ο

Ο 881 882Ο 881 882

•竣齊部中夬樣隼局貝工消費合作枉印裝 883 Ο• Consumer Co-operation of Shellfish Consumers in the China Provincial Bureau of Samples and Printing 883 Ο

-101 (請先閣讀背面之注意事項再填寫本頁)-101 (Please read the precautions on the back before filling out this page)

本纸伕尺度適用中11国家標準(CNS Μ4規格(210X297公釐) 1235157 A7 B7 五、發明説明(39) 884 0The paper size is applicable to 11 national standards (CNS M4 specification (210X297 mm) 1235157 A7 B7 V. Description of invention (39) 884 0

885 〇885 〇

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

冬 C 886 〇Winter C 886 〇

訂 887 〇Order 887 〇

經濟部中央揉準局員工消费合作社印«. Ο 1004Printed by the Consumers Cooperative of the Central Government Bureau of the Ministry of Economic Affairs «. Ο 1004

102 本紙張尺度適用中國國家標準(CNS ) Μ規格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(1〇°) 1005 1006 1007 1008 1009 Ο102 This paper size applies to Chinese National Standards (CNS) M specifications (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (10 °) 1005 1006 1007 1008 1009 Ο

00

本紙伕尺度適用中國國家標準(CNS )六4说格(210X297公釐〉 (請先聞讀背面之注意事項再填寫本頁) 1235157 A7 B7 五、發明説明(1Q1) 1010 〇The dimensions of this paper are in accordance with Chinese National Standards (CNS), 6.4 (210X297 mm) (please read the precautions on the back before filling out this page) 1235157 A7 B7 5. Description of the invention (1Q1) 1010 〇

1011 〇1011 〇

(請先閲讀背面之注意事項再填寫本頁) 1012 〇(Please read the notes on the back before filling this page) 1012 〇

訂 1013 〇Order 1013 〇

1015 〇1015 〇

104 本纸杀尺度適用中囷國家標率(CNS ) A4規格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(1〇2) 1016 Ο104 The paper kill scale is applicable to the Chinese National Standard (CNS) A4 specification (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (102) 1016 〇

OH 1017 ΟOH 1017 Ο

(請先聞讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

1018 Ο1018 Ο

丁 1019 ΟDing 1019 Ο

1020 Ο1020 Ο

105· 本紙張尺度適用中§國家標率(CNS ) Α4说格(210Χ297公釐) 1235157 A7105 · The national standard rate (CNS) of this paper is applicable. A4 grid (210 × 297 mm) 1235157 A7

本纸伕尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1235157 A7 B7 乙 發明説明(1〇4) 1030 〇The size of this paper is applicable to China National Standard (CNS) A4 specification (210X297 mm) 1235157 A7 B7 B Description of invention (104) 1030 〇

1031 10321031 1032

NN

---------Ί裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 1033 Ο--------- Outfit-(Please read the precautions on the back before filling this page) Order 1033 Ο

X034 ΟX034 Ο

-107- 本纸乐尺度適用中国國家標準(CNS ) A4说格(210X297公釐) 1235157 AT B7 五、發明説明(105) 1035 Ο-107- The paper scale is applicable to the Chinese National Standard (CNS) A4 grid (210X297 mm) 1235157 AT B7 V. Description of the invention (105) 1035 Ο

1036 Ο1036 Ο

(讀先間讀背δ之注意事項再填寫本頁) 1037 Ο(Notes on reading δ in the first reading before filling out this page) 1037 Ο

1038 Ο1038 Ο

ΟΗ S?濟部冲央猱準局貝工消费合作社印«. 1039 ΟΟΗ S? Printed by the Ministry of Economic Affairs, Chongyang Municipal Standard Bureau, Shellfish Consumer Cooperative «. 1039 Ο

本纸張尺度適用中S國家標率(CNS ) Α4規格(210Χ297公釐) 1235157 A7 B7 五、發明説明(1〇6) 1040 ΟThe standard of this paper applies to the national standard rate of China (CNS) A4 specification (210 × 297 mm) 1235157 A7 B7 V. Description of the invention (106) 1040 〇

1041 〇1041 〇

(請先閲讀背面之注意事項再填寫本頁) 1042 0(Please read the notes on the back before filling out this page) 1042 0

訂 1043 經濟部中央標準局員工消費合作社印衷 1044 ΟOrder 1043 Employee Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 1044 〇

ΟΟ

本纸張尺度適用中国國家揉率(CNS ) A4規格(210X297公釐) 1235157 A7 B7 五、發明説明(1Q7) 1045 ΟThis paper size applies to China's national kneading rate (CNS) A4 specification (210X297 mm) 1235157 A7 B7 V. Description of the invention (1Q7) 1045 Ο

1046 Ο1046 Ο

(請先M讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

1047 Ο1047 Ο

訂 1048 ΟOrder 1048 Ο

經濟部中央標琅局員工消费合作社印装 1049 〇Printed by the Consumer Standards Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs 1049 〇

•110 本纸伕尺度適用中國囷家揉準(CNS ) A4規格(210X297公釐) 二 1235157 A7 B7 五、發明説明(10S) 1050 1051 1052 0• 110 paper size is applicable to Chinese standard (CNS) A4 (210X297 mm) 2 1235157 A7 B7 V. Description of invention (10S) 1050 1051 1052 0

Ο ΟΟ Ο

Η 〇Η 〇

OH (請先聞讀背面之注意事項 本頁) 裝OH (Please read the notes on the back page first)

•1T• 1T

I 央 1 >準 局 貝 .工 消 合 作 社 印 % 1054 Ο 1053I Central 1 > quasi bureau. Industrial and consumer cooperative seal% 1054 Ο 1053

-111 本纸伕尺度適用中國S家揉準(CNS ) Α4規格(210Χ297公釐) 1235157 Λ7 B7 五、發明説明(109) 1055 0-111 The size of this paper is suitable for Chinese standard (CNS) A4 size (210 × 297 mm) 1235157 Λ7 B7 V. Description of the invention (109) 1055 0

1056 Ο1056 Ο

(請先¾讀背面之注意事項再3本頁) ——裝 1057 1058 〇(Please read the precautions on the back and then 3 pages) ——Install 1057 1058 〇

訂 經濟部中央標準局貝工消費合作社印製 1059 0Order Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy 1059 0

112 本纸張尺度適用中國1家標準(CNS〉A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(110) 1060 Ο112 This paper size applies to one Chinese standard (CNS> A4 size (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (110) 1060 Ο

ΟΟ

,Η Ο 1061 (請先閱靖背面之注意事項再填寫本頁) 1062 1063, Η Ο 1061 (Please read the precautions on the back of Jing before filling this page) 1062 1063

〇 訂 經濟部中央標準局员工消費合作·杜印製 1064 〇 a;〇Vt: -113 本纸伕尺度通用中g国家標孪(CNS ) Α4規袼(210Χ297公釐) 1235157 _ Λ/ Β7〇 Order Consumption Cooperation of Employees of the Central Standards Bureau of the Ministry of Economic Affairs · Du printed 1064 〇 a; 〇Vt: -113 This paper is a universal medium-sized national standard (CNS) A4 Regulation (210 × 297 mm) 1235157 _ Λ / Β7

五、發明説明(11V 〇V. Description of the invention (11V 〇

1065 1066 1067 〇1065 1066 1067 〇

〇 1068 〇 〇 Ο 'ηΥ 經濟部中央橾準局員工消費合作社印衷 1069 ο •114- 本纸伕尺度通用中国國家標孪(CNS ) Μ規格(210X297公釐) 1235157 A7 B7 五、發明説明(112) 1070 〇〇1068 〇〇〇 'ηΥ The Ministry of Economic Affairs, Central Bureau of Standards, Staff Consumption Cooperatives, 1069 ο • 114- The paper size is common Chinese National Standard (CNS) M specifications (210X297 mm) 1235157 A7 B7 V. Description of the invention ( 112) 1070 〇

1071 〇1071 〇

(請先閱讀背面之注意事項再填寫本I) "^一衣 1073 〇 〇 〇(Please read the notes on the back before filling in this I) " ^ 一 衣 1073 〇 〇 〇

〇 訂 1074 〇 經濟部中央糅準局貝工消費合作杜印¾ 1075 •115· 本纸伕尺度通用中国国家標车(CNS )以祝格(2ί〇Χ297公釐) 1235157〇 Order 1074 〇 Duiyin Consumer Cooperation of the Central Bureau of Standards, Ministry of Economic Affairs, Du Yin ¾ 1075 • 115 · This paper is a standard Chinese National Standard Vehicle (CNS) with a wish box (2ί〇 × 297 mm) 1235157

AT B7 五、發明説明(113) 1077AT B7 V. Description of Invention (113) 1077

Ο (請先閱讀背面之注意事項再本頁) U5* 1078 ΟΟ (Please read the precautions on the back before this page) U5 * 1078 Ο

ο ο ο -" 丁 1079 ο w σ。人 οο ο ο-" Ding 1079 ο w σ. Person ο

ο 經濟部中央揉在局兵工消背合作·社印製 1080ο Printed by the Central Government of the Ministry of Economy

HjC .Ο ΗΝ HaC 人。 ο Η °〇ΛΝ-γΗ -116· 本袄尜尺度通用中S國家標挛(CNS ) Α4規格(2丨0Χ297公釐) 1235157HjC .Ο ΗΝ HaC people. ο Η ° 〇ΛΝ-γΗ -116 · This standard is commonly used in S countries (CNS) Α4 size (2 丨 0 × 297 mm) 1235157

AT Β7 五、發明説明(114) 1081 Ο ΗζΝAT Β7 V. Description of the invention (114) 1081 Ο ΗζΝ

α 1081sα 1081s

1082 ο1082 ο

α 1083 ο β麵 經濟部中央揉準局员工消资合作·社印製 1082s οα 1083 ο β side Printed by the Central Government Bureau of the Ministry of Economy

α -117- (請先聞讀背δ之注意事項再填寫本買)α -117- (Please read the precautions of δ before filling in this purchase)

本纸铁尺度適用中国II家標李(CNS ) Α4洗格(2丨0·Χ297公釐) 1235157 AT Β7 五、發明説明(1Ί5) 1084The iron scale of this paper is applicable to China II house mark (CNS) Α4 wash case (2 丨 0 · × 297mm) 1235157 AT Β7 5. Description of the invention (1Ί5) 1084

1085 〇1085 〇

(請先聞讀背云之注意事項再填寫本買) ·€衣· 1086 Ο(Please read the precautions of Back Cloud before filling in this purchase) · € 1010

Ο 訂 1087 〇〇 Order 1087 〇

..Hr Ϊ濟部中央標率局員工消費合作·社印衷 .088 〇 Η Η Ο 118 本纸伕尺度通用中國国家標孪(CNS ) A4規格(2I0X297公釐) 1235157 B7 五、發明説明(116) 1089 1090 1091 〇..Hr Consumption Cooperation of Employees of the Central Standards Bureau of the Ministry of Economic Affairs · Institute of Social Responsibility. 088 〇 Η 〇 118 This paper is in accordance with China National Standard (CNS) A4 (2I0X297 mm) 1235157 B7 V. Description of the invention ( 116) 1089 1090 1091 〇

(#先53讀背1&之注意事項再填寫本頁) ,ιτ 1093(#First 53 Read Back 1 & Precautions before filling out this page), ιτ 1093

〇 H3C〇 H3C

10941094

适齊年令失嗓隼¾貝1:¾費合痄纭午$L 1095 οLosing voice at an appropriate age 隼 贝 1: ¾ Fees 痄 纭 $ L 1095 ο

Η Ο -119· 本纸伕尺度適用中国國家標孪(CNS ) A4規格(210X 297公釐) 1235157 Λ; Β7 五、發明説明(117) 1096 〇Ο 〇 -119 · The paper size of this paper applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) 1235157 Λ; B7 V. Description of the invention (117) 1096 〇

1097 Η,Ο 1098 ο1097 Η, 〇 1098 ο

αα

OH 1099 (Τ° jO1: H ο 經濟部中央標率扃員工消費合作社印51 421 Ο CH3CH2OH 1099 (Τ ° jO1: H ο Central Standards of the Ministry of Economy 扃 Employee Consumer Cooperatives Seal 51 421 Ο CH3CH2

本纸伕尺度通用中国國家標孪(CNS ) Α4規袼(210Χ297公釐) 1235157 Λ7 Β7 五、發明説明(118)The standard of this paper is the Chinese National Standard (CNS) A4 Regulation (210 × 297 mm) 1235157 Λ7 Β7 V. Description of the Invention (118)

1021 Ο1021 Ο

ΟΟ

Η --------•衣-- (請先閱讀背>Β之注意事項再填寫本頁) 訂 1027 經濟部中央梂準局員工消費合作杜印¾ 1028 ΟΗ -------- • Clothing-(Please read the precautions for back > B before filling out this page) Order 1027 Consumption Cooperation between Employees of the Central Bureau of the Ministry of Economic Affairs Du Yin ¾ 1028 Ο

ΟΟ

-121 - 本紙伕尺度逑用中1國家標孪(〇卜3)六4規格(2丨0/297公釐) 1235157 Λ: B7 經濟邶中央標孪局負工消費合作杜印¾ 五、發明説明(119) 本發明特異化合物也包括其結構包括骨架卜22之化合 物,但亦不限於此:-121-Standard of this paper: 1 national standard (0 3) 6 4 specifications (2 丨 0/297 mm) 1235157 Λ: B7 economy 邶 Central Standards Bureau, work and consumption cooperation Du Yin ¾ 5. Invention Note (119) The specific compounds of the present invention also include compounds whose structures include the structure of the structure, but are not limited thereto:

(請先¾讀背VS7之注意事項本頁)(Please read the VS7 precautions page first)

RR

R -裝 訂 線R-gutter

IIII

1010

•122· 本纸伕尺度通用中国國家標车(CNS ) A4規格(2丨0>:297公釐) 1235157 A7 B7 五、發明説明(12Q)• 122 · This paper is a standard Chinese National Standard Vehicle (CNS) A4 specification (2 丨 0 >: 297mm) 1235157 A7 B7 V. Description of the invention (12Q)

本纸伕尺度適用?國a家標李(CNS ) A4規格(2丨0X297公釐) 1235157 Λ7 B7 五、發明説明(121: 21 H30 』、What is the paper size? National Standard A (CNS) A4 specification (2 丨 0X297 mm) 1235157 Λ7 B7 V. Description of the invention (121: 21 H30 ",

R^〇K 其中: R是 .C02H %人0"1〇 ΗX〇2Rl3 、N ΗR ^ 〇K where: R is .C02H% person 0 " 1〇 ΗX〇2Rl3 , N Η

其中 η 先 33 讀 背 云 之 意 項 寫 太 買Among them η first 33 read the meaning of the cloud and write too buy

HO 尺丨3是-ch3,-ch2ch3,-ch2ch2ch3,-ch(ch3)(ch3) •CH2CH2CH2CH3,-CHrCH(CH3)CH3,-C(CH3)3,-CH2Ph,或HO rule 3 is -ch3, -ch2ch3, -ch2ch2ch3, -ch (ch3) (ch3) • CH2CH2CH2CH3, -CHrCH (CH3) CH3, -C (CH3) 3, -CH2Ph, or

經濟部中央標率局負工消资合作社印¾Printed by the Central Standards Bureau of the Ministry of Economic Affairs

,其中 -124 本纸伕尺度適用中国国家標辛(CNS ) A4規格(210X297公釐) 1235157 A7 . B7 五、發明説明(122) r13 是-CH3,-CH2CH3,-CH2CH2CH3,-CH(CH3)(CH3), -CH2CH2CH2CH3,-CH2-CH(CH3)CH3,·ί:((:Η3)3,-CH:Ph, (請先«讀背δ之注意事項再填寫本頁) 或,且 各 r51 是-CH3,-CH2CH3,:CH2CH2CH3,-CH(CH3)(CH3), -CH2CH2CH2CH3,-CHrCH(CH3)CH3,-C(CH3)3 ; -CH2Ph, 或一起形成乙二氧基縮醛或丙二氧基縮醛:或 4 — 一Η ,其中 Η Ο r5/ r5I 是-ch3,-ch2ch3,-ch2ch2ch3,-ch(ch3)(ch3), -CH2CH2CH2CH3,-CHrCH(CH3)CH3,-C(CH3)3,-CH2Ph, -C(〇)-CH3 或-C(0)-Ph : R5在上述化合物各自中是和化合物139,214c,2 Me, 404-413,415-491,493〇01中任一者所示之R5部份任一者 相同3 本發明的特異化合物也包括含有骨架1-28之化合物,但 並不限於此,其中R,R5l及115如·上文所定義,且其中於化 合物214(:,21心*4〇4-413,415-418,422-426,430-456,458-466,468,470-471,473-491,493,495,497-50 1 中任一者之 115部份之-C(O)-以-CHr,-C(0)C(0)-或-CH2C(〇)C(〇)-置換。 -125- 本纸伕尺度通用中ϋϋ家標率(CNS )八4祝格(210X297公釐) [235157 Λ7 B7 五、發明説明(123) 另一具韹實例(D)的本發明ICE抑制劑爲式⑴ (I), Of which -124 paper scale is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 A7. B7 V. Description of the invention (122) r13 is -CH3, -CH2CH3, -CH2CH2CH3, -CH (CH3) (CH3), -CH2CH2CH2CH3, -CH2-CH (CH3) CH3, · ί: ((: Η3) 3, -CH: Ph, (please «read the notes on δ before filling out this page) or or each r51 is -CH3, -CH2CH3 ,: CH2CH2CH3, -CH (CH3) (CH3), -CH2CH2CH2CH3, -CHrCH (CH3) CH3, -C (CH3) 3; -CH2Ph, or together form ethylenedioxyacetal or Propylenedioxyacetal: or 4—one, where Η Ο r5 / r5I is -ch3, -ch2ch3, -ch2ch2ch3, -ch (ch3) (ch3), -CH2CH2CH2CH3, -CHrCH (CH3) CH3, -C (CH3) 3, -CH2Ph, -C (〇) -CH3 or -C (0) -Ph: R5 in each of the above compounds is compound 139, 214c, 2 Me, 404-413, 415-491, 493. Any of the R5 parts shown in any one of 01 is the same. 3 The specific compounds of the present invention also include compounds containing skeletons 1-28, but are not limited thereto, in which R, R5l and 115 are as defined above. And in compound 214 (:, 21 heart * 4〇4-413,415-418,422-426,430-456,458- 466,468,470-471,473-491,493,495,497-50 1 of -C (O)-to -CHr, -C (0) C (0)-or -CH2C (〇) C (〇) -replacement. -125- Common paper standard (CNS) standard of this paper (CNS) 8 4 Zhuge (210X297 mm) [235157 Λ7 B7 V. Description of the invention (123) Another The ICE inhibitor according to the invention (D) is of formula (I)

Ri-N-R2 I Η 其中:R,選自下列包括下式 (elO)Ri-N-R2 I Η where: R is selected from the following and includes the following formula (elO)

----------- (請先兒讀背s之注意事項再¾寫本I ) (ell)----------- (Please read the precautions of s before writing ¾) (ell)

(e!2)(e! 2)

RR

(w2) 經濟部中央標準局貝工消費合作社印製 (yi)(w2) Printed by Shellfish Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs (yi)

ReRe

•126· 本纸杀尺度適用中囯囯家標率(CNS) Α4規格(210Χ297公釐) 1235157 A7 B7 五、發明説明(124) (Z)• 126 · The paper kill scale is applicable to China National Standards (CNS) A4 specifications (210 × 297 mm) 1235157 A7 B7 V. Description of the invention (124) (Z)

;且 環C選自下列包括笨並,说·啶並 喃並,4唑並,異σ塞唑並,噁唑並 咪4並,環戊基及環己基·· 是: 5塞吩並,说洛並,兮 異嗔嗅並,^淀並, (請先緊讀背云之注意事項再填^本頁) (a) 〇And ring C is selected from the group consisting of benzopyridine, pyridopyrano, 4 azo, isoσsedazo, oxazomidimide, cyclopentyl and cyclohexyl. Is: 5 thiopheno, Speaking of Luo Bing, Xi Yi Bing sniffs, ^ Dian Bing, (please read the precautions of Behind the Cloud and fill in this page) (a) 〇

R5t ,或 οR5t, or ο

ORq ORst ORst (b) m是1或2 : 各115獨立選自下列包括 -C(〇),R丨〇, -C(〇)〇-R9 , •127 本饫伕尺度適用中§国家標準(CNS ) Μ規格(2[〇X297公釐) 1235157 Λ" Β7 五、發明説明(125) -C(〇)-N(Ri〇)(R10), -S(〇)2-R9, • S(〇)2-NH-R10, -C(〇)-CH2-〇-R9, •C(〇)C(〇)-Rl0, -R9 ’ -H, -C(〇)C(〇)-〇Rl0,及 -c(〇)c(〇)-n(r9)(r10) : · ,\是-CH-或-N-: I I 丫2是^{2或〇: χ7是-N(R8)-或-0-: R6選自下列包括-H及-CH3 :ORq ORst ORst (b) m is 1 or 2: each 115 is independently selected from the following including -C (〇), R 丨 〇, -C (〇) 〇-R9, • 127 This national standard applies to § national standards ( CNS) M specification (2 [〇297297 mm) 1235157 Λ " B7 V. Description of the invention (125) -C (〇) -N (Ri〇) (R10), -S (〇) 2-R9, • S ( 〇) 2-NH-R10, -C (〇) -CH2-〇-R9, • C (〇) C (〇) -Rl0, -R9'-H, -C (〇) C (〇) -〇Rl0 , And -c (〇) c (〇) -n (r9) (r10): ·, \ is -CH- or -N-: II ^ 2 is ^ {2 or 〇: χ7 is -N (R8)- Or -0-: R6 is selected from the following including -H and -CH3:

Rs選自下列包括·· -C(〇)-Rl0, -C(〇)〇-R9 , -C(〇)-N(H)-Rl0, -S(〇)rR9, -S(〇)2-NH-R10, 經濟部中夬標绛局员工消費合作.杜中裝 -C(〇)-CHrOR10, •C(〇)C(O)-Rl0, · -C(〇)-CH2N(Rl0)(R10), -C(〇)-CH2C(0)-〇-R9, -C(〇)-CH2C(〇)-R9, -128- 本纸法尺度逑用中SS家標李(CNS ) A4規袼(210X297公釐) 1235157 Λ7 B7 五、發明説明(12S) -Η,及 -C(〇)-C(〇)_〇Rl〇 ·· 各R9獨立選自下列包括-Αιγ3及-Cu直或分支-烷基祝所需 爲Αγ3所取代,其中-Cle6烷基視所需不鉋和·· 各R1 〇獨三送自下列包括-Η ’ -ΑΓ3 ’ C3.6’衣》元卷’及Ci.6 直或分支烷基視所需爲Ai*3取代,其中-C!e6坑基視所需不 乾和; - R13選自下列包括Η,Ai:3,及Cw直或分支的烷基,視所 需爲 Ar3,-CONH2,-0R5,-〇H,-〇119或-C〇2H所取代: 各r51獨立選自下列包括R9,·α〇)·ιι9,-C(〇)-N(H)-R9 ’ 或各r51—起形成鉋和的4·8員碳環或含有-0·,-S-或-NH- 的雜環: 各R21獨立選自下列包括-H或直或分支的这基; 各Αγ3是環狀基,獨立選自下列包括芳基’其含$ 6 ’ 1 〇 ,12或14個碳原子及1至3個環,及芳族雜環基含—5至1〕 個環原子及1至3個環,該雜環含有至少一個選自^ ^ ,-SO-,S〇2,=N-,及-NH-的雜原子,該雜環視所需含β 一個以上的雙鍵,該雜環視所需含有一個以上的芳族辜 且該環狀基視所需爲-Q!所單或多重取代: 各Q丨獨立選自下列包栝-NH2,eC02H,-Cl ’圩,-ΒΓ ,-N02,-CN,=0,-〇H,-全氣 Cu烷基,R5 …0R5 ’ -NHR5,0R9,-N(R9)(Ri〇),R9 ’ -C(〇)-Ri〇,及Rs is selected from the following including: -C (〇) -R10, -C (〇) 〇-R9, -C (〇) -N (H) -Rl0, -S (〇) rR9, -S (〇) 2 -NH-R10, the consumer cooperation of the Ministry of Economic Affairs, China Standards Bureau. Du Zhongzhuang-C (〇) -CHrOR10, • C (〇) C (O) -Rl0, · -C (〇) -CH2N (Rl0) (R10), -C (〇) -CH2C (0) -〇-R9, -C (〇) -CH2C (〇) -R9, -128- Chinese standard SS Lee (CNS) A4 Regulation (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (12S) -Η, and -C (〇) -C (〇) _〇Rl〇 ·· Each R9 is independently selected from the following including -Αιγ3 and -Cu Direct Or the branch-alkyl group needs to be replaced by Αγ3, of which -Cle6 alkyl group is not required, and each R1 is sent from the following including -Η '-ΑΓ3' C3.6 '衣》 元 卷' And Ci.6 straight or branched alkyls are optionally substituted by Ai * 3, where -C! E6 pit bases are desirably non-existent;-R13 is selected from the following including Η, Ai: 3, and Cw straight or branched Alkyl, optionally substituted by Ar3, -CONH2, -0R5, -0H, -〇119, or -CO2H: each r51 is independently selected from the following including R9, · α〇), ιι9, -C (〇 ) -N (H) -R9 'or each r51-to form a 4 · 8 member carbon ring Heterocyclic ring containing -0, -S- or -NH-: each R21 is independently selected from the group including -H or straight or branched; each Aγ3 is a cyclic group independently selected from the following including aryl ' $ 6 '1 0, 12 or 14 carbon atoms and 1 to 3 rings, and aromatic heterocyclic group containing -5 to 1] ring atoms and 1 to 3 rings, the heterocyclic ring contains at least one selected from ^ ^, -SO-, S〇2, = N-, and -NH- heteroatoms, the heterocyclic ring may contain more than one double bond, β, the heterocyclic ring may contain more than one aromatic ring, and the ring The base is, depending on the need, a single or multiple substitution of -Q !: each Q 丨 is independently selected from the group consisting of -NH2, eC02H, -Cl ', -BΓ, -N02, -CN, = 0, -0H, -All gas Cu alkyl, R5 ... 0R5'-NHR5, 0R9, -N (R9) (Ri〇), R9'-C (〇) -Ri〇, and

CFL 〇 -129· 本纸ft尺度適用中g國家鮮(CNS )/\4紗(2lGX297公次) -I—--------- (訝先閑讀背面之注意事^一存填寫本育) 訂 -ΦΙ. 經濟部中央標窣局貝工消资合作社印¾ 1235157 Λ 7 _ Β7 五、發明説明(127) 限制條件爲當-Αγ3爲Q i基所馭代時,其含有一個以上額 外的- Ar;基,該額外的·Αγ3基不爲另外的-Ar3基所取代= 較好,R。-選自下列包括: , -C(〇)-Rl0, -C(〇)〇-R9 ,及 -C(O)-NH-Rl0。 另外,R5選自下列包括: _ -S(〇),-R9, -S(〇)2-NH-Rl0, - -C(〇)-C(〇)-R丨ο, -R9,及 -C(〇)-C(〇)-〇Rl0。 較好: m是1 : R13是H或-(:卜4直或分支的烷基,視所需爲-Αγ3,-〇H, -〇R^IC〇2H所取代,其中心是^丨^分支或直鏈烷基,其 中Αγ3是嗎福哧基或苯基,其中笨基視所需爲Q i所取代·· R2l 是-H 或-CH3 : 經濟部中央標準局員工消費合作社印?衣 (請先閱讀背面之注意事項再填寫本I) hi是q.6直或分支的燒基’視所需爲Αιγ3所取代’其中 Ai*3是苯基,視所需爲所取代: 各Ar3是環基,獨立選自下列括苯基,葚基,嗱啥基, 喹諾嗒基,異唼諾嗒基,吡唑基,唁唑基,異噁嗖基,笨 並三。i基,苯並咪峻基,〃塞吩並邊吩基,咪唑基,違二4 基,苯益[b]硫笨基,吡啶基,苯並呋喃基,及吲哚基, -130- 本紙伕尺度遝用中ga家標李(CNS ) A4規格(2丨0X297公釐) 1235157 Λ7 Β7 五、發明説明(128) 且該環基視所需可爲-Q1所單或多重取代: 各Q丨獨立」a自下列包备-MW:,-Cl,-F,-Bf,-OH,R9, -NH-R5其中115是-C(〇)-Ri〇或-S(〇)2-R9、-〇R5其中心是- C(〇)·!^。,-0R9,-N(R9)(R10),及 〇 〉CH2 ’ 〇 其中各119及111(3獨立爲直或分支的烷基,視>斤需爲Αγ3 所取代,其中Αι:3是苯基: 限制條件爲當-Αγ3爲Q丨基所_取代,其含有一個以上額外 的-Ar;基’該額外的-Αγ;基不爲另- ΑΓ3所取代。 本發明另一具體實例(Ε)之ICE抑制劑爲式(Π): (請先閱讀背云之注意事項本頁) 裝 (II) 其中: m是1或2 : 選自下列包括 (ρίτι R-6 Rt-N 入 R3 Η 訂 線 經濟部中夬標孪局貝工消^合作.杜印¾ -131 - 本袄法尺度逑用中§S家標李(CNS ) A4規格(2丨0 X297公釐) 1235157CFL 〇-129 · The paper ft scale is applicable to fresh food from China and China (CNS) / \ 4 yarn (2lGX297 times) -I —--------- (Suddenly read the notes on the back ^ Fill in this education) --ΦΙ. Printed by the Bei Gong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs ¾ 1235157 Λ 7 _ Β7 V. Description of the invention (127) The limitation is that when -Αγ3 is a Q i-based generation, it contains More than one additional -Ar; group, this additional Aγ3 group is not replaced by another -Ar3 group = better, R. -Selected from the group consisting of: -C (0) -Rl0, -C (0) 0-R9, and -C (O) -NH-Rl0. In addition, R5 is selected from the group consisting of: -S (〇), -R9, -S (〇) 2-NH-R10, -C (〇) -C (〇) -R 丨 ο, -R9, and- C (〇) -C (〇) -〇R10. Preferably: m is 1: R13 is H or-(: Bu 4 is a straight or branched alkyl group, optionally substituted by -Aγ3, -〇H, -〇R ^ IC〇2H, and its center is ^ 丨 ^ Branched or straight-chain alkyl, where Aγ3 is morphoyl or phenyl, where benzyl is optionally substituted by Q i · R2l is -H or -CH3: Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs? (Please read the notes on the back before filling in this I) hi is a straight or branched alkynyl group of q.6 'replaced by Αιγ3 if necessary', where Ai * 3 is phenyl and substituted as necessary: each Ar3 Is a cyclic group and is independently selected from the group consisting of phenyl, fluorenyl, hydrazyl, quinolyl, isoprotolyl, pyrazolyl, oxazolyl, isoxazolyl, and benzotriphenyl. Benzimidyl, acetophenenyl, imidazolyl, dioxo, phenyl [b] thiobenzyl, pyridyl, benzofuranyl, and indolyl, -130- paper scale遝 In the standard of domestic standard Li (CNS) A4 (2 丨 0X297 mm) 1235157 Λ7 B7 V. Description of the invention (128) And the ring base can be replaced by -Q1 single or multiple substitutions: each Q 丨 independent "A-MW :, -Cl, -F, -Bf, -OH, R9, -NH-R5 where 115 is -C (〇) -Ri〇 or -S (〇) 2-R9, -〇R5 whose center is-C (〇) ·! ^., -0R9,- N (R9) (R10), and 〇> CH2 '〇 wherein each of 119 and 111 (3 is independently a straight or branched alkyl group, depending on the need to be replaced by Αγ3, where Αι: 3 is phenyl: restriction conditions When -Αγ3 is substituted by a Q group, it contains more than one additional -Ar; group, the additional -Αγ; group is not substituted by another-ΑΓ3. ICE inhibition of another specific example (E) of the present invention The agent is formula (Π): (Please read the Precautions for Back Cloud page first) Packing (II) where: m is 1 or 2: It is selected from the following including (ρίτι R-6 Rt-N into R3 Η Ministry of Economics of Threading The Chinese Bureau of Standards and Technology Co., Ltd. has eliminated the cooperation. Du Yin ¾ -131-This standard is used in §S Family Standard Li (CNS) A4 Specification (2 丨 0 X297 mm) 1235157

AT B7 五、發明説明(129)AT B7 V. Description of Invention (129)

(elQ) (ell) (el2)(elQ) (ell) (el2)

Re· (w2) Ί 0Re · (w2) Ί 0

Re (yi) 0 Re Rs-Re (yi) 0 Re Rs-

H 經濟部中央榡毕局貝工消費合作杜印¾ (y2)H Duyin, Consumer Affairs Cooperation, Central Bureau, Ministry of Economic Affairs ¾ (y2)

RsRs

H 〇〇人 且 -132· 本紙伕尺度通用中§1家標李(CNS ) A4規格(2丨0X297公釐) 1235157 Λ7 _ B7 五、發明説明(130) (請先閨讀背云之注意事項再填寫本頁) 環C選自下列包括苯並,咄啶並,4吩益,呲喙益,吟 嘀益,4唑並,異5塞唑並,嗓唑並,異噁唑並,嘧啶益, 咪唑並,環戍基及環己基: : R;選自下列包括: -CN, -C(〇)-H, -C(0)-CH2-TrRn ^ ' -C(〇)-CHrF, -C=N-〇-R9,及 * -C Ο - A r,: 各獨立選自下列包括: -C(〇)-Rl0, -C(〇)〇-R9 ’ -C(O)-N(R10)(Rl0) •S(〇)rR9, -S(〇)2-NH-Rl0, •C(〇)-CH2-〇-R9, -C(〇)C(〇)-Rl0, -R9, -H, -C(〇)C(〇)-〇Rl0,及 · -C(〇)C(O)-N(R9)(Rl0): 是-CH-或-N-;H 〇〇 人和 -132 · This paper is common in the standard §1 Standard Li (CNS) A4 specifications (2 丨 0X297 mm) 1235157 Λ7 _ B7 V. Description of the invention (130) Please fill in this page again.) Ring C is selected from the following including benzo, pyridino, 4phenyi, tadpole, yinyi, 4 azo, iso-5 thiazo, thiazo, isoxazo, Pyrimidine, imidazo, cyclofluorenyl and cyclohexyl:: R; selected from the following: -CN, -C (〇) -H, -C (0) -CH2-TrRn ^ '-C (〇) -CHrF -C = N-〇-R9, and * -C Ο-A r ,: each independently selected from the following: -C (〇) -R10, -C (〇) 〇-R9 '-C (O)- N (R10) (Rl0) • S (〇) rR9, -S (〇) 2-NH-Rl0, • C (〇) -CH2-〇-R9, -C (〇) C (〇) -Rl0,- R9, -H, -C (〇) C (〇) -〇R10, and -C (〇) C (O) -N (R9) (R10): Yes -CH- or -N-;

I I 丫2是1或〇: -133- 本紙伕尺度適用中gg家標準(CNS )八4見格(210:<297公釐) 1235157 A7 . B7 五、發明説明(131) X7{-N(RS)-或: 各Τι獨立選自下列包括·〇-,-S-,-s(〇)-,及,s(〇):-: R6選自下列包括-H及-CH3 : ,II Ya 2 is 1 or 0: -133- The standard of this paper is applicable to China Standards (CNS) 8 and 4 (210: < 297 mm) 1235157 A7. B7 V. Description of the invention (131) X7 {-N (RS) -or: each Ti is independently selected from the group consisting of: 〇-, -S-, -s (〇)-, and s (〇):-: R6 is selected from the following including -H and -CH3:

Rs選自下列包括: -C(〇)-R10, •C(〇)〇-R9 , -C(〇)-NH-R10, - -S(〇)rR9, -S(〇)2-NH-R10, - -C(〇)-CH2-〇R10, -C(〇)C(O)-Rl0, -C(O)-CH2N(RI0)(RI0) ^ -C(0)-CH2C(0)-0-R9 ^ -C(〇)-CH2C(〇)-R9, -H,及 •C(〇)-C(〇)-〇Rl0 ·· 各R9獨立選自下列包括· Ar3&-C卜6直或分支的烷基,視 所需爲Αγ3所取代,其中-Cw烷基視所需不铯和: 各Rw獨立選自下列包括-H,-Ar3,(:八6環烷基,及-匚卜6 直或分支的烷基,視所需爲Αγ3所取代,其中烷基視 所需不铯和: ‘ 各Rn獨立選自下列包括: -Ar4, •(CH:)卜;-Αγ4 ’ -134· 本扶法尺度边用中§1家標窣(CNS ) A4規格(210X 297公澄) (請先閱讀背面之注意事項再填寫本頁) -裝 訂 0 1235157Rs is selected from the following including: -C (〇) -R10, C (〇) 〇-R9, -C (〇) -NH-R10, -S (〇) rR9, -S (〇) 2-NH- R10,--C (〇) -CH2-〇R10, -C (〇) C (O) -R10, -C (O) -CH2N (RI0) (RI0) ^ -C (0) -CH2C (0) -0-R9 ^ -C (〇) -CH2C (〇) -R9, -H, and C (〇) -C (〇) -〇R10 Each R9 is independently selected from the following including: Ar3 & -C 6 straight or branched alkyl, optionally substituted by Aγ3, where -Cw alkyl is optionally Cs and: each Rw is independently selected from the following including -H, -Ar3, (: octacyclocycloalkyl, and -匚 6 straight or branched alkyl, optionally substituted by Aγ3, wherein the alkyl is optionally cesium and: 各 Each Rn is independently selected from the following including: -Ar4, ((CH:) bu;-Αγ4 '-134 · §1 standard in the use of this Fufa standard (CNS) A4 size (210X 297 Gongcheng) (Please read the precautions on the back before filling this page)-Binding 0 1235157

AT B; 五、發明説明(132: •Η,及 "C(0)-Ar4 * 請 先 讀 背 之 t 畜 再 i 寫 本 頁 R15選自下列包括-OH ’ ·ΟΑγ3 ’ -N(H)-〇H,及- OCu直或 分支的死基’視所荔爲-Αγ3 ’ -C〇NH2,.〇R5,.〇h,.〇il9 ,或-C02H所取代·· 各獨立選自下列包括-Η或直或分支的烷基: Αι*2獨立選自下列,其中任何環可視所需爲-q【所單或多 重取代; (hh) 及 (ii) γ 訂 ^ . 其中各Y獨立選自下列包括〇及S : 各Ar3是環基,獨立還自下列包括芳基其含有6,10 , 12 或14個竣原子及1至3個線’及方族雜每基含有5至15個環 原子及1至3個環,該雜環含有至少一個選自-0-hS-,-S〇-,S〇2,及-NH-,-N(R5)- ’ 及-N(R9)-之雜原子,該 錐環視所需含有一個以上的雙鍵,該雜環基視所需含一個 以上的芳族環,且該環基可視所需爲· Q1所單或多重取代: 各Arj是環基·.獨彡還白下列包括芳基其含有6,10,12 或14個碳原子及丨至3個環,及雜環基含有5至15個環原子 及1至3個環,該雜環基含有至少一個選自-〇-,-S-,-SO· ,S〇2,二,及-N(R9)-之雜原子,該雜環 135- 、成块^5用中(—CN$ ) ;^ ( 210X297公f 1235157 AT · B7 五、發明説明(133) 基視所需含有一個以上的雙鍵,該雜環基視所需含有一信 以上的芳族環,且該環基視所需可爲-Qi所單或多重取代: 各Qi獨立選自下列包括-NH2,-C〇2H,-Ck,-F,-Br,] ,-NO〕· -CN,=〇,-〇Η,-全氟 基,R5,-〇R5, -NHR5,OR9,-N(R9)(R10),R9,-C(〇)-R10,及 〇 / \ CH,, , \ / ~ 〇 限制條件爲當-Ar3爲Q丨取代#時,其含有一個以上額外的 -Αγ3基,該額外的- Αγ3基不爲另外的-Αγ3所取代。 具體實例Ε之較佳化合物應用式(II),其中1^是卜11)且其 他取代基如上文所定義。 具體實例Ε其他較佳化合物應用式(II),其中1^是卜12)且 其他取代基如上文所定義。 具體實例Ε其他較佳化合物應用式(II),其中1^是(yl)且 其他取代基如上文所定義。 具體實例E其他較佳化合物應用式(II),其中1^是(y2)旦 其他取代基如上文所定義。 超濟部中央標孪局貝工消費合作社印¾ (讀先33讀背面之注意事項再填寫本I ) 具體實例E其他較佳化合物應用式(II),其中1^是(2)且其 他取代基如上文所定義。 具體實例E其他較佳化合物應用式(II),其中1^是(w2)且 其他取代基如上文所定義。 較好,1是卜2)且 m 是 1 ·· -136· 本纸伕尺度逑;?!中g國家標李(CNS ) A4規格(210X 297公釐) 1235157 經濟部中央標準局負工消背合作杜印¾ Λ. B7 五、發明説明(134) 環C是苯显,咄啶並,或嘍令益: R3選自下列包括-C(〇)-H,-C(〇)-Ar2,及-C(〇)CH2-TrRn : R5選自下列包括: / -C(O)-ill0,其中 Rl0是-Ar3 : -C(〇)-OR9,其中 R9是-CH2.Ar3 : -C(〇)C(〇)-R1〇,其中 Rl〇是-ΑΓ3 : •R9,其中119是C卜2坑基,爲-Ar3所取代:及’ •C(〇)C(0)-〇R1〇,其中 R1〇是-CH2Ar3 : 丁1是0 或 S ·· · R6 是 Η : , R8 選自下列包括-C(0)-Rl(),-C(〇)-CH2-ORl(),及 •C(〇)CHrN(R1〇)(Rl〇),其中 Rl〇是 Η,CH;,或 CH2CH3 : 丨送自 Γ 列包括-ΑΓ4,-(CH,)i.3-Ar4,及-C(〇)-Ar4 : 民15是-〇H4 -OCm直或分支的.烷基視所需爲-Aq,-〇H ,-〇R9,或-C02H所取代,其中119是<卜4分支或直鏈烷基 ,其中Ar3是嗎福啉基或苯基,其中苯基視所需爲Q t所取 代: Αγ2是(hh): Y是0 : 各八〇環基獨立選自下列包括··苯基,萘基,邊吩基,"查 諾喵基,異喹詰啉基,。塞唑基,·苯並咪唑基,4吩並,塞令 基,4二唑基,笨並三唑基,笨並[b]硫笨基,苯庄攻喃基 及吲哚基,且該環基視所需可爲-Q丨單或多重取代: 各八1*4環基獨立選自下列包括:笨基,四唑基’奈基’〜 -137- (請先聞讀背^之泾意事項再填寫本買) 衣 訂 本紙铁尺度通用中§1[家標车(〇>^)/^見格(210><297公釐) 1235157 B7 五、發明説明(135) 啶基,噁唑基,嘧啶基或4哚基,該環基視所需可爲-Qi 單或多重取代: 各Qi獨立選自下列包括-NH2,-C卜-F,-Br,-OH,-R9, -NH-R5,其中 115是-(:(〇)-ΙΙι〇 或-S(〇)2-R9,-〇r5 其中 R5 是 -C(〇)-Rl0,-〇R9,-N(R9)(Rl0),及 Ο / \況, \ / 〇 其中各119及111()獨立地爲-Cle6直或分支的烷基視所需爲Ar3 所取代,其中Αγ3是苯基: 限制條件爲當-Αγ3爲Q丨所取代時,其含有一個以上額外 的-八1*3基,該額外的·Αγ3基不爲其他-Arv听取代3 具體實例E其他較佳化合物,應用式(Π)其中1^是(el 0) ,X。·是CH,且其他取代基如上文所定義。 具體實例E其他較佳化合物,應用式(II)其中心是(el 0) ,X5是CH,R3是CO-Ar2,且其他取代基如上文所定義。 具體實例E其他較佳化合物,應用式(II)其中心是㈠10) ,X5是 CH,R3S-C(0)-CH2-TrRn,Re-CCHJwAq, 且其他取代基如上文所定義β 經濟部中央標率局員工消費合作杜印製AT B; V. Description of the invention (132: • Η, and "C (0) -Ar4 * Please read the back of the book before you write this page. R15 is selected from the following including -OH '· ΟΑγ3' -N (H ) -〇H, and-OCu straight or branched dead group 'deemed as -Aγ3'-CONH2, .〇R5, .〇h, .〇il9, or -C02H substituted ... each independently selected from The following includes -Η or straight or branched alkyl groups: Aι * 2 is independently selected from the following, in which any ring may be -q [single or multiple substitutions as desired; (hh) and (ii) γ order ^. Where each Y Independently selected from the following including 0 and S: each Ar3 is a cyclic group, and independently from the following includes an aryl group containing 6, 10, 12 or 14 complete atoms and 1 to 3 lines' and a square heterocyclic group containing 5 to 15 ring atoms and 1 to 3 rings, the heterocyclic ring contains at least one selected from -0-hS-, -S〇-, S〇2, and -NH-, -N (R5)-'and -N ( A heteroatom of R9)-, the cone ring may contain more than one double bond, the heterocyclic group may contain more than one aromatic ring, and the ring group may be single or multiple substitutions as required by Q1: Each Arj is a cyclic group .. It is also white. The following includes aryl groups which contain 6, 10, 12, or 14 carbons. Atom and 丨 to 3 rings, and heterocyclic group containing 5 to 15 ring atoms and 1 to 3 rings, the heterocyclic group contains at least one selected from -0-, -S-, -SO ·, S〇2 , Two, and -N (R9)-heteroatoms, the heterocycle 135-, block ^ 5 is used in (-CN $); ^ (210X297 male f 1235157 AT · B7 V. Description of the invention (133) Base view It is necessary to contain more than one double bond, the heterocyclic group may contain more than one letter of aromatic ring as required, and the ring group may be mono- or multiple-substitution as required by -Qi: each Qi is independently selected from the following including- NH2, -CO2H, -Ck, -F, -Br,], -NO]--CN, = 〇, -〇Η, -perfluoro group, R5, -〇R5, -NHR5, OR9, -N (R9) (R10), R9, -C (〇) -R10, and 〇 / \ CH,,, / / ~ 〇 The limitation is that when -Ar3 is Q 丨 instead of #, it contains more than one additional -Αγ3 Group, the additional-Αγ3 group is not substituted by another-Αγ3. Preferred compounds of specific example E apply formula (II), where 1 ^ is 11) and other substituents are as defined above. Specific examples E other Preferred compounds are of formula (II), where 1 ^ is 12) and other substituents are as defined above . Specific Example E Other preferred compounds employ formula (II), wherein R is (yl) and other substituents are as defined above. Specific Example E Other preferred compounds use formula (II), wherein 1 ^ is (y2) denier Other substituents are as defined above. Printed by the Central Laboratories of the Ministry of Chaoji, Beige Consumer Cooperatives (Read the 33 notes on the back and then fill out this I) Specific Example E Other preferred compounds apply formula (II), where 1 ^ is (2) and other substitutions Basis is as defined above. Specific Example E Other preferred compounds employ formula (II), wherein 1 ^ is (w2) and the other substituents are as defined above. Better, 1 is Bu 2) and m is 1 ·· -136 · The size of the paper 伕;?! China National Standard Li (CNS) A4 specification (210X 297 mm) 1235157 Central Bureau of Standards, Ministry of Economic Affairs Back cooperation Du Yin ¾ Λ. B7 V. Description of the invention (134) Ring C is benzene, pyridino, or hydrazone: R3 is selected from the following including -C (〇) -H, -C (〇) -Ar2 And -C (〇) CH2-TrRn: R5 is selected from the following including: / -C (O) -ill0, where R10 is -Ar3: -C (〇) -OR9, where R9 is -CH2.Ar3: -C (〇) C (〇) -R1〇, where R10 is -ΑΓ3: • R9, where 119 is C2 pit group, substituted by -Ar3: and '• C (〇) C (0) -〇R1 〇, where R1〇 is -CH2Ar3: but 1 is 0 or S · · · R6 is Η:, R8 is selected from the following including -C (0) -Rl (), -C (〇) -CH2-ORl (), And • C (〇) CHrN (R1〇) (R10), where R10 is Η, CH ;, or CH2CH3: 丨 is sent from the Γ column including -ΑΓ4,-(CH,) i.3-Ar4, and- C (〇) -Ar4: Min 15 is -〇H4 -OCm straight or branched. The alkyl group is optionally substituted with -Aq, -〇H, -〇R9, or -C02H, where 119 is < Bu 4 Branched or straight chain alkyl, where Ar3 is morpholinyl or phenyl, The middle phenyl group is optionally substituted by Q t: Aγ2 is (hh): Y is 0: each octacyclic group is independently selected from the following including: · phenyl, naphthyl, side phenyl, " Chanoryl , Isoquinoxaline. Sedazolyl, benzimidazolyl, 4pheno, seleno, 4diazolyl, benzotriazolyl, benzo [b] thiobenzyl, benzazolyl and indolyl, and the The ring base may be -Q 丨 single or multiple substitutions as required: Each 8 * 4 ring group is independently selected from the following including: benzyl, tetrazolyl 'nyl' ~ -137- (please read the following first) Please fill in this matter if you want to buy it) Binding book paper iron standard universal §1 [Family standard car (〇 > ^) / ^ 见 格 (210 > < 297mm) 1235157 B7 V. Description of the invention (135) Group, oxazolyl, pyrimidinyl or 4-indolyl, the cyclic group may be -Qi single or multiple substitutions as required: each Qi is independently selected from the group consisting of -NH2, -Cb-F, -Br, -OH, -R9, -NH-R5, where 115 is-(: (〇) -ΙΙι〇 or -S (〇) 2-R9, -〇r5 where R5 is -C (〇) -Rl0, -〇R9, -N (R9) (Rl0), and 0 / \, where // wherein 119 and 111 () are each independently -Cle6 straight or branched alkyl, optionally substituted with Ar3, where Aγ3 is phenyl: Restrictions When -Aγ3 is replaced by Q 丨, it contains more than one additional -eight 1 * 3 group, and this additional Aγ3 group is not other -Arv. Substitution 3 Specific Example E Other preferred compounds, using formula (Π) where 1 ^ is (el 0), X. is CH, and other substituents are as defined above. Specific Example E Other preferred compounds, using formula ( II) its center is (el 0), X5 is CH, R3 is CO-Ar2, and other substituents are as defined above. Specific Example E Other preferred compounds, using formula (II) whose center is ㈠10), X5 is CH, R3S-C (0) -CH2-TrRn, Re-CCHJwAq, and other substituents are as defined above.

(請先¥讀背云之注意事項再填寫本頁W 具鳢實例Ε其他較佳化合物,應用式(II)其中1^是(el 0) ,X5 是 CH,R3 是-C(〇)-CH2-TrRn,丁!是〇,Rn 是-C(O)-Ar*4,且其他取代基如上文所定義。 較好,在這些較佳化合物中,Rj選自下列包括: •C(〇)-Rl0, -138- 本纸铁尺度逯用中SS家標窣(CNS ) A4規格(210X297公釐) 1235157 Α 一 B7 五、發明説明(136) -C(〇)0-R9 ,及 -C(O)-NH^Rl0 ^ 另外,在這些較佳化合物中,R5選自下列包老: -S(〇)rR9, -S(O)2-NH-Rl0 ^ -C(〇)-C(〇)-R10, -R9,及 · -C(〇)-C(〇)-〇Rl0 〇 最好,在這些較佳化合物中·, m是1 : 丁丨是。或S : R15是-OH或-OCm直或分支的烷基,視所需爲-Ar3,-〇H ,-〇R9,或-C〇2H所取代,其中分支或直鏈烷基 ,其中Αγ3是嗎福啉基或苯基,其中苯基視所需爲Q 1所馭 代: R21 是-Η或-CH3 : Αγ2是(hh): Y是〇,且(Please read the precautions of Back Cloud before filling in this page. W. Example E. Other preferred compounds, apply formula (II) where 1 ^ is (el 0), X5 is CH, and R3 is -C (〇)- CH2-TrRn, Ding! Is 0, Rn is -C (O) -Ar * 4, and the other substituents are as defined above. Preferably, among these preferred compounds, Rj is selected from the group consisting of: C (〇 ) -Rl0, -138- SS House Standard (CNS) A4 Specification (210X297 mm) 1235157 Α 一 B7 in the paper iron standard (136) -C (〇) 0-R9, and -C ( O) -NH ^ RlO ^ In addition, in these preferred compounds, R5 is selected from the following: -S (〇) rR9, -S (O) 2-NH-Rl0 ^ -C (〇) -C (〇 ) -R10, -R9, and -C (〇) -C (〇) -〇R10 〇 best, among these preferred compounds, m is 1: but 丨 or S: R15 is -OH or -OCm straight or branched alkyl, optionally substituted by -Ar3, -OH, -OR9, or -CO2H, where branched or linear alkyl, where Aγ3 is morpholinyl or phenyl , Where phenyl is optionally substituted by Q 1: R21 is -Η or -CH3: Αγ2 is (hh): Y is 0, and

-¾濟部中央標生局貝工消资合作.社印5L 各Αγ3是環基獨立選自下列包括苯基,莕基,4吩基,呤 諾琳基,異呤諾琳基,毗唑基,嘍唑基,異噁唑基,苯主 三唑基,笨並咪唑基,。i吩並4吩基,咪4唑基,喳二吃基 ,笨並[b]硫笨基,毗啶基,苯並呋喃基及啕哚基,且該環 狀基視所需可爲-(^所單或多重取代: 各Aq環基獨立選自下列包括苯基,四唑基,呲啶基,鳴 •139· 本纸伕尺度退用中§国家標李(〇“)八4汉格(210:<297公釐) 1235157 B* 五、發明説明(137) 咬基,莕基,續症基,或5塞吩基,該環基可爲-Q ι單或多 重取代: 各(^獨立選自下列包括-NH2,-Ci,-F,-Br,-〇H,-R9, -N’H-R5,其中 115是0 或-S(〇)2-R9,-〇R5 其中 115是 -C(〇)-Rl0,-〇R9,-N(R9)(R10),及 〇 / \ CH,, , \ / ^ 〇 其中R9Sl Rw各獨立地爲-〔丨.,直或分支的烷基,視所需爲 Ai*3所取代,其中Ar3是苯基: 限制绦件爲當-Αγ3爲Q i取代時,其含有一個以上額外的 -Ar;基,該額外的-基不爲其他-Αγ3基所取代。 其他具體實例Ε的較佳化合物,應用式(1[)其中{^是 (elO),乂5是CH,113是-C(〇)-H,且其他取代基如上文所定 義3 較好,在這些較佳化合物中,R3-選自下列包括: -C(〇)-R10 ’ -C(〇)〇-R9 ,及 -C(〇)-NH-R丨0。 經濟部中央標準局負二消费合作杜印¾ 另外,於這些較佳化合物中,R5選自下列包括·· -S(0)2-R9, · : -S(〇)rNH-Rl0, -C(〇)-C(〇)-R10, •R9,及 •140· 本.¾¾尺度送用中SS家標孪(CNS ) A4規格(2l〇X29H$ ) 1235157-¾Beijing Central Laboratories Bureau, Ministry of Economics, Labor and Investment Cooperation. 5A, each Aγ3 is a cyclic group independently selected from the following including phenyl, fluorenyl, 4phenyl, pyrinorinyl, isorinorinyl, pyrazole , Oxazolyl, isoxazolyl, benzenetriazolyl, benzimidazolyl. ipheno 4-phenyl, imidazolyl, perylene, benzo [b] thiobenzyl, pyridyl, benzofuranyl, and fluorinyl, and the cyclic group may be- (^ All single or multiple substitutions: Each Aq ring group is independently selected from the following including phenyl, tetrazolyl, pyridinyl, and naruto. 139 · This paper is retired in the standard § National Standard Li (〇 ") 8 4 Han Lattice (210: < 297 mm) 1235157 B * V. Description of the invention (137) Bite group, fluorenyl group, continuation group, or 5-sedenyl group, the ring group may be -Q ι single or multiple substitution: each (^ Is independently selected from the following including -NH2, -Ci, -F, -Br, -OH, -R9, -N'H-R5, where 115 is 0 or -S (〇) 2-R9, -〇R5 Where 115 is -C (〇) -Rl0, -〇R9, -N (R9) (R10), and 〇 / \ CH,,, / / ^ 〇 where R9S1 Rw are each independently-[丨., Straight or Branched alkyl, optionally substituted by Ai * 3, where Ar3 is phenyl: The limitation is that when -Aγ3 is substituted with Q i, it contains more than one additional -Ar; group, the additional-group Not substituted by other -Aγ3 groups. Preferred compounds of other specific examples E, using formula (1 [) where {^ is (elO), 乂 5 is CH, 113 is -C (〇) -H, and other substituents are preferably as defined above. In these preferred compounds, R3- is selected from the following including: -C (〇) -R10 '-C (〇 ) 〇-R9, and -C (〇) -NH-R 丨 0. Duminal Cooperative Consumption Du Yin, Central Bureau of Standards, Ministry of Economic Affairs In addition, among these preferred compounds, R5 is selected from the following including--S (0 ) 2-R9, ·: -S (〇) rNH-Rl0, -C (〇) -C (〇) -R10, • R9, and • 140 ·. ¾¾ standard SS family standard twin (CNS) A4 specifications (2l0X29H $) 1235157

AT B7 五、發明説明(13S) -C(〇)-C(〇)-〇Ri0 : 最好,於這些較佳化合物中, m 是 1 : ’AT B7 V. Description of the Invention (13S) -C (〇) -C (〇) -〇Ri0: Best. Among these preferred compounds, m is 1: ’

R15是-0H或-OCy直或分支的烷基,視所需爲- Ar3, -〇H,-〇R9,或-C〇2H所取代,其中119是-Cle4分支或直的 烷基,其中A”是嗎福啉基或苯基,其中笨基視所需爲I 所取代: ' R21 是-H或·(:% ; 各Ar^f基獨立選自下列包括:笨基,笨基,嚐吩基,4 諾淋基,異喹諾琳基,吡唑基,4唑基,異噁唑基,苯显 三唑基,苯並咪唑基,塞吩並3塞吩基,味唑基,4二唑基 ,苯並[b ]疏笨基,说这基,苯並吱喃基,及^丨噪基,該環 基視所需可爲-Qi所單或多重取代: 各Q丨獨立選自下列包括:-NH2,-CM,-F,-Br,·〇Η,-R9 ,-NH-R5,其中 115是-(:(〇)-1110或-5(〇)2-{19,-OR5其中 115是 -C(O)-Rl0,-〇R9,-N(R9)(R10),及 〇 / \ CH,, 〇 經濟部中夬糅準局員工消費合作·杜印裂 (請先閨讀背面之注意事項再填寫本買) 其中119及111()各獨立地爲 <卜6直或分支的烷基,視所需爲 Αγ3所取代,其中Αγ3是苯基:· 限制條件爲當-Ar;;爲Q丨基所取代,其含有一個以上額外 的-八”基,該額外的-Αγ3基不爲另外的-八”所取代, 其他具謹實例Ε較佳化合物,應用弍(II)其中1^是(el0) -141 · 本纸杀尺度適用中国國家標準(CNS ) A4也格(2〖0X 297公釐) 1235157 Λ7 ^ B7 五、發明説明(139) ,且Χ,-是 CH,R3是-C(0)-CH2-TrRn,且 Rn是-Aq,其他 的取代基如上文所足義3 較好在這些較佳化合物中,R5選自下列包括:/ -C(〇)-Rl0, -C(〇)〇-R9 ,及 -C(〇)-NH-Ri〇。 另外,於這些較佳化合物中,R5選自下列包括Γ -S(〇)rR9, -S(〇)2-NH-Rl0, - -C(〇VC(〇)-Ri〇, -R9,及 -C(〇)-C(〇)-〇Rl0。 最好,於這些較佳化合物中, m 是 I ·· 。是。或S : R15是-0H或-OCu直或分支的烷基,視所需爲·Αι^, -〇H,-〇R9,或·C02H所取代,其中119是-CN4分支或直鏈 烷基,其中Aq是嗎福啪基或笨基,其中苯基視所需爲I 所取代: 經濟部中央標在局負工消費合作社印^ (請先试讀背云之洼意事項再禎寫本頁) 尺21是-幵或-CH3 : 各Ar3環基是笨基,莕基,嗒吩' 基,喹詰嗒基,異,查諾嗒 基,说4基,違•基,異0S 4基,笨並三咬基,苯並咪啥 基,4呤並4呤基,咪唑基,喹二唑基,苯並[b]碇苯基, 吡啶基,笨显呋嘀基,及啕哚基,且該環基可視所需爲 -142· 本饫伕尺度適用中1國家標李(CNS)A4規格(210X297公釐) 1235157 A: B7 五 '發明説明( -Qpf單或多重取代: 各Ar4環基獨立地選自下列,包括苯基,Θ哇基,咬達基 ,噁唑基,莕基,嘧啶基或4吩基,該環基視所需爲-Ql 所單或多取代: 各(^丨獨立選自下列包括-NH2,-C卜-F,-Br,-〇H,-R9, -N’H-R5,其中 115是-€:(〇)-1110或-S(〇)2-R9,-0R5 其中 115是 -C(〇)-R1(),-〇R9,-N(R9)(R10),及 、 〇 / \ CH,, - \ / " 〇 其中各119及Ri0獨立地爲-C^6直或分支的烷基,視所需爲 Αγ3所取代,其中Αγ3是苯基: F艮制條件爲當-Αγ3爲Q丨基取代,其含有一個以上額外的 -八[*3基,該額外的-Αγ3基不爲其他的-Ar*3基所取代。 具體實例E其他較佳化合物,應用式(II)其中Ri是(el 0), X5是N,且其他取代基如上文所定義。 具體實例E的較佳化合物,應用式(II)其中\是(6[0),乂5 是N,R3{C〇-Ar2,且其他取代基如上文所定義。 M濟部中央樣孪局员工消费合作钍印^ (請先閱讀背面之注意事項再4·寫本頁) 具體實例E其他較佳化合物,應用式(II)其中{^是(el 0), X5是 N,R3是-C^CO-CHrTVRH,Rn 是-C(CH2)1〇-Ar4,且 其他取代基如上文所定義。 ' 具ft實例E其他較佳化合物,應用式(II)其中1^是(el 0), 乂5是?^,且: R3 是-C(〇)-CHrTrRn : -143- 本.¾¾尺度边用中S国家標李(CNS ) A4規格(210/ 297公釐) 1235157 A B7 五、發明説明(141) 丁丨是0 :且 RM{-C(〇)-Ar4,且其他取代基如上文所定義: 較好,於這些較佳化合物中,R5選自下列包括: -C(〇)-R10, -C(〇)〇-R9 ,及 -C(〇)-NH-R10。 另外,於這些較佳化合物中,115選自下列包括, •S(〇)2-R9, -S(〇)2-NH-Rl0, - -C(〇)-C(〇)-R丨0, -R9 ’ 及 -C(〇)-C(〇)-〇Rl0。 較好,於這些較佳化合物中, m是1 : ^是。或S : 尺15是-0H或-Ci.4直或分支的烷基,視所需爲-Αγ3,-〇H ,-〇R9,或-C〇2H所取代,其中119是-Cy分支的或直鏈这 基,其中Aq是嗎福嗒基或苯基,其中苯基視所需爲1所 取代: 經濟部中央標準局貝工消費合作杜印¾ (請先另讀背云之注意事項具填寫本頁) R21 是-H或-CH3 : Αγ2是(hh) : · Y是0,且 各Α。環基獨立選自下列包括笨基,莕基,嗱吩基,喹諾 啉基,異喹諾哧基,毗唑基,4唑基,異嗳唑基,笨並三 • 144· 本紙伕尺度適用中Sg家標孪(CNS ) ( 210/ 297公釐) 1235157 A 7 _ B7 五、發明説明(142) 嗖基,笨显味唑基,邊吩並2塞吩基,咪唑基,。塞二吱基, 苯並[b]硫笨基,吡啶基,苯並呋喃基,及峭哚基,旦該環 基視所需可爲-Qi所單或多重取代: / 各Ara環基獨立選自下列包括苯基,四唑基,^:唸基,嗓 唑基,莕基,嘧啶基或嘍啥基,視所需可爲-(^所單或多 重取代: 各Qi獨立選自下列包括-NH2,-cn,-F,-Βγ,-ΌΗ,-R9, ,其中民5是-C(〇)-R丨〇或-S(〇)2-R9,-0R5其中115是 •C(〇)-Ri〇,-〇R9,-N(R9)(Rl0)·及 〇 〇 CH2 ,R15 is -H or -OCy straight or branched alkyl, optionally substituted by -Ar3, -OH, -ORR9, or -CO2H, where 119 is -Cle4 branched or straight alkyl, where A "is a morpholinyl or phenyl group, wherein the benzyl group is optionally substituted by I: 'R21 is -H or · (:%; each Ar ^ f group is independently selected from the following including: benzyl, benzyl, Tryphenyl, 4-noryl, isoquinolyl, pyrazolyl, 4-azolyl, isoxazolyl, benzotriazolyl, benzimidazolyl, cepheno-3 cephenyl, tazolyl , 4 diazolyl, benzo [b] succinyl, said this group, benzo squeenyl, and ^ 丨 noise group, the ring base may be single or multiple substitutions as required by -Qi: each Q 丨Independently selected from the following: -NH2, -CM, -F, -Br, · 〇Η, -R9, -NH-R5, where 115 is-(: (〇) -1110 or -5 (〇) 2- { 19, -OR5 of which 115 is -C (O) -Rl0, -〇R9, -N (R9) (R10), and 〇 / \ CH,, 〇 Employees' cooperation cooperation of China Economic and Trade Standards Bureau, Ministry of Economic Affairs (Please read the notes on the back before you fill in this purchase) Among them, 119 and 111 () are each independently a < bu 6 straight or branched alkyl group, which is replaced by Αγ3 if necessary, which Αγ3 is a phenyl group: · The limitation is when -Ar; is substituted by a Q group, which contains more than one additional -eight "group, the additional -Αγ3 group is not replaced by another -eight", other Exemplary preferred compounds, using 弍 (II) where 1 ^ is (el0) -141 · The standard for this paper is Chinese National Standard (CNS) A4 (2 〖0X 297mm) 1235157 Λ7 ^ B7 V. Description of the invention (139), and X,-is CH, R3 is -C (0) -CH2-TrRn, and Rn is -Aq. Other substituents are as defined above. 3 is preferred among these preferred compounds. R5 is selected from the group consisting of: -C (〇) -R10, -C (〇) 〇-R9, and -C (〇) -NH-Ri〇 In addition, among these preferred compounds, R5 is selected from the following including Γ-S (〇) rR9, -S (〇) 2-NH-R10, -C (〇VC (〇) -Ri〇, -R9, and -C (〇) -C (〇) -〇Rl0. Most preferably, among these preferred compounds, m is I .. Yes. Or S: R15 is -0H or -OCu straight or branched alkyl, as required. Αι ^, -〇H, -〇R9 , Or · C02H, where 119 is -CN4 branched or straight chain alkyl, where Aq is morphoyl or benzyl, where phenyl Replaced by I if necessary: Printed by the Central Ministry of Economic Affairs of the Ministry of Economic Affairs and Consumer Cooperatives ^ (Please read the meaning of the cloud before writing this page) Rule 21 is-幵 or -CH3: Each Ar3 ring base Benzoyl, fluorenyl, daphthyl ', quinolyl, iso, chanothyl, say 4yl, isopropyl, iso0S 4yl, benzylidene, benzimidyl, 4 Pyridino-4pyridyl, imidazolyl, quindiazolyl, benzo [b] pyrene, pyridyl, benzofuranyl, and fluorinyl, and the cyclic group may be -142 The 伕 scale is applicable to China 1 National Standard (CNS) A4 specifications (210X297 mm) 1235157 A: B7 Five 'invention description (-Qpf single or multiple substitution: each Ar4 ring group is independently selected from the following, including phenyl, Θ wow Group, oxidyl group, oxazolyl group, fluorenyl group, pyrimidinyl group, or 4-phenyl group, and the cyclic group may be mono- or poly-substituted as required by -Q1: each (^ 丨 is independently selected from the following including -NH2, -C) -F, -Br, -OH, -R9, -N'H-R5, where 115 is-€: (〇) -1110 or -S (〇) 2-R9, -0R5 where 115 is -C (〇 ) -R1 (), -〇R9, -N (R9) (R10), and 〇 / \ CH,,-\ / " 〇 of which 119 each And Ri0 are independently -C ^ 6 straight or branched alkyl groups, optionally substituted by Aγ3, where Aγ3 is phenyl: Fgen is prepared when -Αγ3 is substituted by Q, which contains more than one additional -Octa [* 3 group, this additional -Aγ3 group is not substituted by other -Ar * 3 groups. Specific Example E Other preferred compounds, where formula (II) is used where Ri is (el 0), X5 is N, and other substituents are as defined above. The preferred compound of the specific example E uses formula (II) wherein \ is (6 [0), 乂 5 is N, R3 {Co-Ar2, and the other substituents are as defined above. Seal of consumption cooperation of employees of the Central Ministry of Economic Affairs of the Ministry of Economic Affairs ^ (Please read the notes on the back before writing this page) Specific Example E Other preferred compounds, applying formula (II) where {^ 是 (el 0), X5 is N, R3 is -C ^ CO-CHrTVRH, Rn is -C (CH2) 10-Ar4, and other substituents are as defined above. 'With ft Example E other preferred compounds, using formula (II) where 1 ^ is (el 0), 乂 5 is? ^, And: R3 is -C (〇) -CHrTrRn: -143- Ben. ¾¾ standard Chinese national standard (CNS) A4 specifications (210/297 mm) 1235157 A B7 V. Description of the invention (141) Ding is 0: and RM {-C (〇) -Ar4, and other substituents are as defined above: Preferably, among these preferred compounds, R5 is selected from the following including: -C (〇) -R10,- C (〇) 〇-R9, and -C (〇) -NH-R10. In addition, among these preferred compounds, 115 is selected from the group consisting of: S (〇) 2-R9, -S (〇) 2-NH-Rl0,--C (〇) -C (〇) -R 丨 0 -R9 'and -C (〇) -C (〇) -〇R10. Preferably, in these preferred compounds, m is 1: ^ yes. Or S: Rule 15 is -0H or -Ci.4 straight or branched alkyl, optionally substituted with -Aγ3, -〇H, -〇R9, or -CO2H, where 119 is -Cy branched Or straight-chain this group, where Aq is morphoyl or phenyl, where phenyl is replaced by 1 as needed: Central Bureau of Standards, Ministry of Economic Affairs, Shellfish Consumer Cooperation Du Yin ¾ (Please read the precautions of Beyond Please fill in this page) R21 is -H or -CH3: Αγ2 is (hh): · Y is 0, and each Α. The cyclic group is independently selected from the group consisting of benzyl, fluorenyl, fluorenyl, quinolyl, isoquinolyl, pyrazolyl, 4-oxazolyl, isoxazolyl, benzazolyl • 144. Paper size Applicable Sg family standard (CNS) (210/297 mm) 1235157 A 7 _ B7 V. Description of the invention (142) fluorenyl, stupid oxazolyl, side pheno 2 selphenyl, imidazolyl. Cydiacryl, benzo [b] thiobenzyl, pyridyl, benzofuranyl, and andolyl, which may be mono- or multi-substituted as required by -Qi: / each Ara ring group is independent It is selected from the following including phenyl, tetrazolyl, ^: aryl, oxazolyl, fluorenyl, pyrimidinyl, or hydrazyl, and may be-(^ single or multiple substitutions as required: each Qi is independently selected from the following Including -NH2, -cn, -F, -Bγ, -ΌΗ, -R9, where min 5 is -C (〇) -R 丨 〇 or -S (〇) 2-R9, -0R5 where 115 is • C (〇) -Ri〇, -〇R9, -N (R9) (R10), and 〇〇CH2,

(請先閱讀背面之泾意事項再填寫本頁) 其中各119及Rl()獨立地爲-CN6,或分支的烷基,視所需爲 Αγ3所取代,其中Αιγ3是笨基: 限制條件爲當-Α。爲Q1基所取代時,其含有一個以上額外 的· Αγ3基,該額外的-Αγ3基不爲另外的· Αγ3基所取代。 具體實例Ε其他較佳化合物,應用式(II)其中是(elO) ,X5是N,R3{-C(0)-H,且其他取代基如上文所定義。 較好,於這些較佳化合物中,R5選自下列包括·· 經濟部中央標準局員工消費合作社印製 -C(〇)-Rl0, -C(〇)CMl9,及 , -C(〇)-NH-R10 〇 另外,於這些較佳化合物中,R5選自下列包括: -S(〇)2-R9, -145- 本紙伕尺度遝用中sa家標李(CNS ) A4規格(210X297公釐) 1235157 Λ / Β7 Μ濟部中央螵準局貝工消费合作社印¾ 五、發明説明(143) -S(〇)rNH-Rl0, -C(〇)-C(〇)-R10, -R 9 ’ 及 - -C(〇)-C(〇)-〇Rl0。 較好,於這些較佳化合物中, m是1 : 民15是·〇Η或-〇Cle4直或分支的烷基,視所需·爲-Αγ3,-〇Η,·〇Ι19,或-C〇2H所取代,其中心是-匸“直或分支的烷 基·其中Αγ3是嗎福琳基或苯1,其中苯基視所需爲h所 取代: r21 是-H或-CH3 : 各A。環基獨立地選自下列包括笨基,莕基,4啥基,4 諾哧基,異喹諾琳基,吡唑基,4唑基,異噁唑基,苯益 三唑基,苯並咪唑基,p塞吩並4吩基,咪咬基,4二咬基 ,笨並[b ]硫笨基,〃比咬基,苯並吱味基,及4嗓基,且該 環狀基視所需可爲-(^所單或多重取代: 各1獨立選自下列包括·ΝΗ2,-Cl,-F,-Br,-〇H,-R9, -NH-R5,其中 115是-(:(〇)-1110或-S(〇)2-R9,-0R5 其中 115是 -C(〇)-R1(J,-〇R9,-N(R9)(R1{3),及 〇 / \ CH,, *\ / ^ 〇 其中各R91R1()獨立地爲-(:卜6直或分支的烷基,視所需爲 Ar0f取代,其中Αγ3是苯基: -146- (請先试讀背面之:!!一意事項一本頁) 裝 訂 ,1 本紙尜尺度通同中g國家標挛(CNS ) A4規格(210X297公釐) 1235157 B7 五、發明説明(144) 限制條件爲當-Αγ3爲Q丨基所取代時,其含有一信以上額 外的-Αγ3基,該額外的-Αγ3基不爲另外的-Αγ3基所取代5 具謹實例Ε其他較佳化合物,應/?]式(Π),其中心是 (elO),Χ5是 Ν,113是-CO-CHylVI^ [,Ri【是-Ar4,且其他 取代基如上文所定義。 較好,於這些較佳化合物中,R5選自下列包括: -C(〇)-Ri0, ' -C(〇)0-R9,及 -C(O)-NH-R10。 - 另外,在這些較佳化合物中,R,·選自下列包括: -S(〇)rR9, -S(〇)rNH-Rl0, -C(〇)-C(〇)-R10, -R9,及 -C(〇)-C(〇)-〇Rl0 〇 最好,於這些較佳化合物中, m是1 : ^是。或S : 經濟部中央標準局負工消費合作·杜印¾ (請先另讀背云之注意事項再填寫本I) R15是-OH或-OCm直或分支烷基視所需爲-Αγ3,-〇H, -OR9,或-C02H所取代,其中R9*-CU4分支或直鏈烷基, 其中Ai*3是嗎福琳基或苯基,其中苯基視所需爲h所取代: R21*-H或-CH3 : 各Αγ3環基獨立選自下列包括笨基,葚基,4吩基,喹謹 嗒基,異唼諾琳基,毗唑基,噻唑基,異噁唑基,苯並三 -147- 本纸伕尺度逑用中§國家糅李(CNS〉Α4規袼(2丨0:<297公釐) 1235157 AT . __B7__ 五、發明説明(145) 4基,笨並咪咬基,違吩並^塞吩基,咪峻基,s塞二峻基, 笨並[b]硫笨基,哒啶基,苯並呋喃墓,及吲哚基,旦該環 基可爲-Qi所單-或多重取代: , 各Ar4環基獨立選自下列包括苯基,四唑基,咄啶基,鳴 唑基,莕基,嘧啶基,或噻吩基,且該環基可爲-(^單或 多重取代: 各1獨立選自下列包括-NH2,-Cl,-F,-Βγ,-ΌΗ,-R9, -NH-R5,其中 115是-C(〇)-R丨0 或-S(〇)2-R9,-〇R5 其中 R5 是 -C(〇)-R(。,-〇R9,-N(R9)(R10r,及 〇 / \ CH9, \ / ' 〇 其中各119及R1Q獨立地爲-CN6直或分支的烷基且視所需爲 Αγ3所取代,其中Αγ;5是苯基; 限制條件爲當-A。爲Q t所取代時,其含有一個以上額外 的-Ar;基,該額外的-Αγ3基不爲另外的-Αγ3基所取代。 衣發明另外具體實例(F)之ICE抑制劑爲式(m) ·· (III) R1-N-R2 經濟部中央这孪局貝工消背合作社印製 (請先玥讀背面之注意事項再4·寫本買) Η 其中: · 心選自下列包括下式: -148 - 本紙乐尺度边闫中国國家標牟(〇\5)/\4祝格(2丨0:<297公釐) 1235157 A- B7 五、發明説明(14δ) (elO)(Please read the notice on the back before filling out this page) where each of 119 and Rl () are independently -CN6, or a branched alkyl group, which is replaced by Αγ3 as required, where Αγ3 is a stupid group: the restriction is When-Α. When it is substituted with a Q1 group, it contains one or more additional Aγ3 groups, and the additional -Aγ3 group is not substituted with another Aγ3 group. Specific Example E Other preferred compounds, wherein (elO) is used in formula (II), X5 is N, R3 {-C (0) -H, and other substituents are as defined above. Preferably, among these preferred compounds, R5 is selected from the group consisting of: -C (〇) -R10, -C (〇) CM19, and -C (〇)- NH-R10 〇 In addition, among these preferred compounds, R5 is selected from the following including: -S (〇) 2-R9, -145- This paper is in standard size and used in domestic standard plum (CNS) A4 specifications (210X297 mm) ) 1235157 Λ / Β7 Μ Printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs of the People's Republic of China 5. Description of the invention (143) -S (〇) rNH-R10, -C (〇) -C (〇) -R10, -R 9 'And -C (0) -C (〇) -〇R10. Preferably, in these preferred compounds, m is 1 to 15 and 15 is · 〇Η or -〇Cle4 straight or branched alkyl, as necessary-is -Aγ3, -〇Η, · 〇19, or -C 〇2H is substituted, its center is-匸 "straight or branched alkyl · where Aγ3 is morpholinyl or benzene 1, where phenyl is optionally substituted by h: r21 is -H or -CH3: each A The cyclic group is independently selected from the group consisting of benzyl, fluorenyl, 4 hydroxy, 4 noroxy, isoquinolyl, pyrazolyl, 4 azolyl, isoxazolyl, phenyltriazole, benzene Benzimidazolyl, p-pheneno-4phenyl, imidino, 4-dibenzyl, benzo [b] thiobenzyl, pyrimidinyl, benzosyl, and 4-benzyl, and the ring The base view may be-(^ single or multiple substitutions: each 1 is independently selected from the group consisting of: NH2, -Cl, -F, -Br, -OH, -R9, -NH-R5, where 115 is- (: (〇) -1110 or -S (〇) 2-R9, -0R5 where 115 is -C (〇) -R1 (J, -〇R9, -N (R9) (R1 {3), and 〇 / \ CH ,, * \ / ^ 〇 Wherein each R91R1 () is independently-(: Bu 6 straight or branched alkyl, if necessary Ar0f substitution, where Αγ3 is phenyl: -146- (Please read first Back No.: !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! When substituted with a group, it contains more than one additional -Aγ3 group, and the additional -Aγ3 group is not substituted by another -Aγ3 group. Example 5: Other preferred compounds, should be represented by formula (Π) , Its center is (elO), X5 is N, 113 is -CO-CHylVI ^ [, Ri [is -Ar4, and other substituents are as defined above. Preferably, among these preferred compounds, R5 is selected from the following Including: -C (〇) -Ri0, '-C (〇) 0-R9, and -C (O) -NH-R10.-In addition, among these preferred compounds, R, · is selected from the following including:- S (〇) rR9, -S (〇) rNH-R10, -C (〇) -C (〇) -R10, -R9, and -C (〇) -C (〇) -〇R10 〇 are best, in Among these preferred compounds, m is 1: ^ Yes. Or S: Central Laboratories of the Ministry of Economic Affairs, Consumer Cooperation, Du Yin ¾ (please read the precautions for the cloud before filling in this I) R15 is -OH or- OCm straight or branched alkyl is optionally substituted with -Aγ3, -OH, -OR9, or -C02H, Where R9 * -CU4 is a branched or linear alkyl group, where Ai * 3 is morpholinyl or phenyl, where phenyl is optionally substituted by h: R21 * -H or -CH3: each Aγ3 ring group is independently selected From the following including benzyl, fluorenyl, 4-phenyl, quinolyl, isorinoline, pyrazolyl, thiazolyl, isoxazolyl, benzotri-147- National Li Li (CNS> Α4 Regulations (2 丨 0: < 297 mm) 1235157 AT. __B7__ V. Description of the invention (145) 4-base, stupid and imidyl, phenidyl, mijun Group, s-diphenyl group, benzo [b] thiobenzyl group, pyridyl group, benzofuran tomb, and indolyl group, once the ring group may be mono- or multiple substitution by -Qi:, each Ar4 ring The group is independently selected from the group consisting of phenyl, tetrazolyl, pyridinyl, oxazolyl, fluorenyl, pyrimidinyl, or thienyl, and the cyclic group may be-(^ single or multiple substitutions: each 1 is independently selected The following includes -NH2, -Cl, -F, -Bγ, -ΌΗ, -R9, -NH-R5, where 115 is -C (〇) -R 丨 0 or -S (〇) 2-R9, -〇R5 Where R5 is -C (〇) -R (. , -〇R9, -N (R9) (R10r, and 〇 / \ CH9, \ / '〇 where each 119 and R1Q are independently -CN6 straight or branched alkyl group and optionally substituted by Αγ3, where Αγ 5 is a phenyl group; the limitation is that when -A. Is substituted by Qt, it contains more than one additional -Ar; group, the additional -Aγ3 group is not substituted by another -Aγ3 group. The specific example (F) of the ICE inhibitor is the formula (m) ··· (III) R1-N-R2 Printed by the Shell Bureau Consumers Cooperative of the Central Bureau of the Ministry of Economic Affairs (please read the precautions on the back before writing the 4 copy) (Buy) Η Among them: · The heart is selected from the following including the following formula: -148-The scale of this paper is Yan Yan Chinese national standard (0 \ 5) / \ 4 Zhuge (2 丨 0: < 297 mm) 1235157 A- B7 V. Description of the Invention (14δ) (elO)

(ell)(ell)

(e!2)(e! 2)

(w2)(w2)

ReRe

(yi)(yi)

經濟部中央標準局員工冰貧合作社印裝 (y2)Printed by the Ice Poor Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (y2)

-149- (辞先閱讀背面之注意事項再填寫本I )-149- (Review the notes on the back before filling in this I)

本紙法尺度逑周中gS家標李(CNS )八心見格(210X 297公衮)Chinese paper standard gS house mark Li (CNS) with eight hearts (210X 297)

;及 1235157 入了 B7 五、發明説明(147) (Z) R5— 環C選自下列包括苯並,说矣並,這吩並,p比啥益,"κ 痛並,塞峻並,異σ塞嗓並,嗔咬並,異邊咬並,癌这並, 味座並^壤戍基及球C»基: R2是: (讀先父讀背云之洼意事項再填寫本買) (b) oAnd 1235157 into B7 V. Description of the invention (147) (Z) R5— ring C is selected from the following including benzo, said pyrene, this pheno, p is more beneficial, " κ pain union, Sai Jun union, Different sigmoids, bite and bite, bite and bite, cancer, and taste. ^ And ^ C and CC »: R2 is: (read the first father read the meaning of the back of the cloud and fill in this purchase ) (b) o

或 m是1或2 : …各R5獨立選自下列包括: -c(〇)-R丨〇, -c(o)〇-r9 , •C(〇)-N(Rl0)(R10), -S(0)rR9, -S(0)rNH-Ri〇, -150- 本紙乐尺度通用中国g家標孪(CNS ) A4規格(2丨0X29?公爻) 1235157 Λ7 B7 * 五、發明説明(撕) -C(〇)-CH2-〇-R9, -C(〇)C(〇)-R10, -R 9 ’ - -Η, -C(〇)C(〇)-〇R10,及 -C(〇)C(〇)-N(R9)(R10): X51CH 或 N: ' 是h或〇 : X71-N(R8)-或-〇·: - R6選自下列包括-H及-CH3 : 選自下列包括: -C(〇)-Ri〇, •C(〇)0-R9 , -C(〇)-N(H)-Rl0, -S(〇)rR9, -s(〇)2-nh-r10, -C(〇)-CH2-〇Rl0, -C(〇)C(〇)-R10, -C(〇)-CH2N(Rl0)(Rl0), 經濟部中央樣準局員工消资合作社印¾ (請先艺讀背云之注意事蕷再填寫本I) -C(〇)-CH2C(〇)-0-R9, -C(〇)-CH2C(〇)-R9, · -H,及 -C(O)-C(O)-ORl0 : 各119獨立選自下列包括直或分支的烷基,視 •151 · 本饫乐尺度通用中ϋ國家標窣(CNS ) A4現格(2丨0X 297公釐) 1235157 A ·, B7 五、發明説明( 所需爲.“3所取代,其中-C^3烷基視所需不鉋和: (請先>T讀背云之:;·χ意事項再填寫本I ) 各R10獨立缉..自下列包括-H,-Ar3,C3-6環烷基,及 直或分支的坑基視所需爲A。所取代,其中-C 1:6这基視所 需不绝和:Or m is 1 or 2: each R5 is independently selected from the following: -c (〇) -R 丨 〇, -c (o) 〇-r9, • C (〇) -N (Rl0) (R10),- S (0) rR9, -S (0) rNH-Ri〇, -150- This paper scale is universal Chinese g family standard (CNS) A4 specification (2 丨 0X29? Public 爻) 1235157 Λ7 B7 * 5. Description of the invention ( Tear) -C (〇) -CH2-〇-R9, -C (〇) C (〇) -R10, -R 9 '--Η, -C (〇) C (〇) -〇R10, and -C (〇) C (〇) -N (R9) (R10): X51CH or N: 'is h or 〇: X71-N (R8)-or -〇:-R6 is selected from the following including -H and -CH3: Selected from the following including: -C (〇) -Ri〇, • C (〇) 0-R9, -C (〇) -N (H) -Rl0, -S (〇) rR9, -s (〇) 2- nh-r10, -C (〇) -CH2-〇Rl0, -C (〇) C (〇) -R10, -C (〇) -CH2N (Rl0) (Rl0), employees of the Central Prototype Bureau of the Ministry of Economic Affairs Cooperative cooperative seal ¾ (Please read the note of Yun Yun first and then fill out this I) -C (〇) -CH2C (〇) -0-R9, -C (〇) -CH2C (〇) -R9, · -H , And -C (O) -C (O) -ORl0: Each 119 is independently selected from the following including straight or branched alkyl groups, depending on • 151 · The national standard (CNS) A4 of this standard is not applicable ( 2 丨 0X 297 mm) 1235157 A ·, B7 V. Description of the invention (need to be replaced by "" 3, of which -C ^ 3 alkyl is not necessary if necessary: (Please read > T read the back of the cloud :; χ Italian matter before filling in this I)) Each R10 is independent. From the following including -H, -Ar3, C3-6 cycloalkyl, and straight or branched pit bases as required A. Replaced, where -C 1: 6 bases are not required Juehe:

Rn選自下列包括Η,Αι·3,及(:丨.6直或分支烷基,視所需 爲 Ar3,-CONTH2,-〇R5,-OH,-〇R9或-C〇2H所取代: 各Ry獨立選自下列包括-Η或不卜6直或分支烷基: 各R5l獨立選自下列包括R9,-C(〇)-R9,-C(〇)-N(H)-R9, 氧各R51 —起形成绝和的4-8員礙環或含有-〇-,-S -或- NH-的維疼: 备是環基獨立選自下列包括芳基其含有6,10,12或 1 4 ίίϋ琰原子及1至3個環,及芳族雜環含有5至15個環原子 及1至3個環,該雜環基含有至少一個選自-〇-,-S-,-SO-, S〇2,及-NH-的雜原子,該雜環基視所需含有一個以上 雙鍵•該雜環基視所需含有一個以上的芳族環,且該環基 視所需可被-Q丨所單或多取代: 各(5丨獨立選自下列包括-NH2,-C〇2H,-CM,-F,-Br·,-I ,-N〇2,-CN,=〇,-〇H,··全氟 Cu 烷基,R5,-〇R5, -NHR5,〇R9,-N(R9)(R10),R9,-C(〇)-Rl0,及〇 / \ CH7, \ I 2 • 〇 限制條件爲當-Ar3爲Q丨所取代,其含有一個以上額外的 -Αγ3基,該額外的Αγ3基不爲另外的-Αγ3基所取代。 較佳的具體實例F化合物應用式(III),其中!^是卜2),及 其他取代基如上文所定義。 •152· 本饫杀尺度逍用國家標孪(CNS ) Α4規格(210X 297公釐) 1235157 B7 五、發明説明(15°) 較好,當Ri是(w2) ·· m是1 : 環C是苯並,吹啶並,或4吩並: , 選自下列包括: -C(〇)-Ri〇 ’ 头中 Ri〇是-Ar;: -C(〇)〇-R9,其中 R9是-CH2-Ar3 : -C(〇)C(〇)-Ri〇 ’ 其中 Rjo是-Ar;: -R9,其中R9SCle2烷基爲- Αγ3所取代:及 -C(〇)C(〇)-〇R10,其中 R10*是-CH2Ar*3 : R6SH : R8選自下列包括·· -C(〇)-Rl0,-C(〇)-CH2-〇Rl0,及 -C(〇)CHrN(R10)(R10),其中 R10是 Η,CH3,或 CH2CH3 ·· R13是Η或Cm直或分支的烷基,視所需爲,-〇H, -〇反9或-0〇21"1所取代,其中119是(:1.4分支或直鏈烷基:其 中Αγ3是嗎福啉基或苯基,其中苯基可視所需爲I所取代; ΑΓ;5是苯基,茶基,遠吩基,峻謹味基,異4語每基, 4唑基,苯並咪唑基,4吩並遑呤基,噻二嗖基,笨並三 唑基,笨並[b]硫苯基,苯並呋嘀基,及4哚基: 經濟部中央標準局員工消費合作社印¾ (請先MT讀背£r之·>±意事項再填寫本頁) 各Q丨獨立選自下列包括·ΝΗ2,-Cl,-F,-Br,-〇H,-R9, -NH-R5,其中 115是-C(〇)-Rl0 或-S(〇)2-R9,-OR5 其中 115是 -C(O)-R10,-OR9,-NHR9,及 ·Rn is selected from the group consisting of Η, Al · 3, and (: .6 straight or branched alkyl, optionally substituted by Ar3, -CONTH2, -OR5, -OH, -OR9, or -CO2H: Each Ry is independently selected from the group consisting of -H or Bu 6 straight or branched alkyl groups: Each R5l is independently selected from the group consisting of R9, -C (〇) -R9, -C (〇) -N (H) -R9, oxygen Each R51 together forms a 4-8 member hindrance ring or contains -0-, -S-or-NH-: It is a ring group independently selected from the following including an aryl group which contains 6, 10, 12 or 1 4 ϋ 琰 ϋ 琰 atom and 1 to 3 rings, and the aromatic heterocyclic ring contains 5 to 15 ring atoms and 1 to 3 rings, the heterocyclic group contains at least one selected from -〇-, -S-, -SO -A heteroatom of-, S〇2, and -NH-, the heterocyclic group may contain more than one double bond as required. The heterocyclic group may contain more than one aromatic ring, and the ring group may Single or multiple substitutions by -Q: each (5 丨 is independently selected from the group consisting of -NH2, -CO2H, -CM, -F, -Br ·, -I, -N〇2, -CN, =. , -OH, perfluoroCu alkyl, R5, -〇R5, -NHR5, OR9, -N (R9) (R10), R9, -C (〇) -Rl0, and O / \ CH7, \ I 2 • 〇 Limit The condition is that when -Ar3 is substituted by Q 丨, it contains more than one additional -Aγ3 group, and the additional Aγ3 group is not substituted by another -Aγ3 group. A preferred specific example F is a compound of formula (III), wherein ^ Yes 2), and other substituents are as defined above. • 152 · This standard of killing is used as the national standard (CNS) A4 specification (210X 297 mm) 1235157 B7 5. Description of the invention (15 °) Well, when Ri is (w2) · · m is 1: ring C is benzo, pyridino, or 4 benzo: selected from the following: -C (〇) -Ri〇 'In the head Ri〇 is- Ar ;: -C (〇) 〇-R9, where R9 is -CH2-Ar3: -C (〇) C (〇) -Ri〇 'where Rjo is -Ar ;: -R9, where R9SCle2 alkyl is-Αγ3 Substituted: and -C (〇) C (〇) -〇R10, wherein R10 * is -CH2Ar * 3: R6SH: R8 is selected from the group consisting of -C (〇) -Rl0, -C (〇) -CH2 -〇R10, and -C (〇) CHrN (R10) (R10), where R10 is fluorene, CH3, or CH2CH3 · · R13 is fluorene or Cm straight or branched alkyl, as required, -〇H, -〇 trans 9 or-0 02 " 1, where 119 is (: 1.4 branched or linear alkyl: where Aγ3 is Fluorolinyl or phenyl, where phenyl can be substituted by I as required; ΑΓ; 5 is phenyl, theophyl, farphenyl, succinyl, 4 isopropyl, 4azolyl, benzimidazole Benzyl, 4-Phenopyridine, Thiodifluorenyl, Benzotriazolyl, Benzo [b] thiophenyl, Benzofuryl, and 4-Indolyl: Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ¾ (Please read the MT first and then read the meanings before filling out this page) Each Q 丨 is independently selected from the following including: ΝΗ2, -Cl, -F, -Br, -〇H, -R9, -NH- R5, where 115 is -C (〇) -R10 or -S (〇) 2-R9, -OR5 where 115 is -C (O) -R10, -OR9, -NHR9, and ·

-153- 本纸伕尺度適同中國國家標孪(CNS ) A4規格(210X 297公;5 ) 1235157 Λ 五、發明説明(151)-153- The size of this paper is in accordance with China National Standards (CNS) A4 specifications (210X 297 male; 5) 1235157 Λ 5. Description of the invention (151)

一 ,、η η 话二砧氢Γ 吉成分支淀基,視所需爲ΑΓ, ;〒各119及R丨〇獨三地馬-lN6旦乂 J 所取代,其中Ar3是苯基;First, η η, the two anvil hydrogen Γ Jicheng branched base, if necessary, ΑΓ; 〒 each 119 and R 〇 地 San Di Ma-1N6 乂 乂 J, where Ar3 is phenyl;

限制婊件爲當-Αγ3爲Qi所取代,其含有一W§1以上額外的 -Ar:1基,該額外的· ΑΓ3基不爲另外妁Ar:3所4 K 具鳢實例F的其他較佳化合物,應用式(ΙΠ),卉甲\是 (e 1丨),且其他的取代基如上文所定義。 · 具體實例F的其他較佳化合物,應用式(ΙΠ),長中\是 (el 2),且其他的取代基如上文所定義。 具體實例F的其他較佳化合-物,應用式(ΠΙ),卉中心是 (y 1 ),且其他的取代基如上文所定我 具體實例F其他較佳化合物,應用式(ΠΙ),其中Ri是(>.2) 且其他的取代基如上文所定義° 具體實例F的其他較佳化合物,應用式(ΙΠ) ’其中Ri是(z) 且其他的取代基如上文所定義° 具體實例F的其他較佳化合物,應用式(ΠΙ),其中Ri是 (elO)且\5是CH(也在此稱爲elO-B) ’且其他的取代基如上 文所定義。 經濟部中夬標孪局員工消費合作杜印¾ (請先3讀背云之注意事項再填寫本I) 具體實例F其他較佳化合物,應用式(ΠΙ) ’其中民【是(el〇) 且\5是1>1(在此也稱爲elO-A),且其他的取代基如上文所定 義a 較好,當 R丨是(ell),(ei2),卜1),(y2),(z),(elO,A)及 (elO-B),R5選自下列包括: •C(0)-Ri〇, -C(〇)〇-R9 ,及 •154- 本纸法尺度逑用中gS家標率(CNS ) A4規袼(210X 297公度Ί " 1235157 Λ7 B7 五、發明説明(152) -C(〇)-NH-Rl0。 另外,當 1^是(ell),(el2),(yl),(>,2),(z),(elO-A)及 (e 1 O-B),R5選自下列包括·· ’ -S(〇)rR9, -S(〇)2-NH-Rl0, -C(〇)-C(〇)-R10, -R9, -(:(0)-0(0)-01110,及 -c(〇)c(〇)-n(r9)(r10)。 - 最好,R54R-C(〇)-C(〇)-R10。 另外,115是-(:(〇)-0:(〇)-〇111()。 較好,當 Ri 是(ell),(el2),(yi),(y2),(2:),(elO-A)及 (eiO-B): m 是 1 ·· R21 是·Η或-CH3 : hi是ci.6直或分支燒基’視所需爲八『3所取代’其中Ar3 環基是笨基,該環基視所需爲-Q i所多重或單取代: 經濟部中央標绛局貝工消費合作社印¾ (t··先试讀背§之注意事項再填寫本頁) 各環基獨立選自下列包括笨基,葚基,4:吩基,喹諾 嗒基,異呤詰喵基,毗唑基,嘍唑基,異噁唑基,苯並三 唑基,苯並咪唑基,遠吩並β塞吩基,咪唑基,塞二唑基, 笨並[b]硫笨基,咄啶基,苯並唉喃基,或4哚基,且該環 基視所需爲-(^所單或多重取代: 各(^獨立選自下列包括-NH2,-Cl,-F,-Br1,-〇H,-R9, -NH-R5,其中 115是-C(0)-Ri〇 或-S(〇)2-R9,-0R5 其中 115是 1 155- 本纸伕尺度边用中§ a家揉李(CNS ) A4規格(2丨OX 297公坌) 1235157 Β7 五、發明説明(153) -C (〇)-R 1 Q ’ -〇 R9 ’ -N(R9 ) (R I Q ) ’ 及 〇 / \ CH,, \/ — 〇 , 其中各119及Rl(3獨立地爲-Cw直或分支坑基,視所需爲 Αγ3所取代,其中Ar*3環基是笨基,且該環基視所需爲 單或多重取代: 限制條件爲當-Ar3爲Q丨基所取代時,其含有一信以上額 外的-Αγ3基,該額外的-Ar3基不爲另外的-Αγ3基所馭代。 訂 較好,於這些較佳化合物平,Αγ3環基選自下列包括: 苯基,篇基,rt吩基,g查語σ林基,異:語命基,吩嗅基, &塞σ坐基.,異噁唑基,苯並三也基,笨並咪唑基,4吩並違 吩基,咪唑基,4二唑基,笨並[b]硫笨基,笨並呋喃基及 4哚基,且該環基視所需爲-Q丨所單或多重取代。 本具體實例F呈較佳型式之化合物爲其中: r5*-c(〇)-r10,其中 R1Q是Ar3,其中Ar3環基是笨基,該環基視所需爲下列單 或多重家代: -F, •α, 經濟部中央標孪局員工消资合作社印製 -N(H)-R5,其中-R5是·Η或-C(〇)-Ri〇,其中Rl0是 <卜6直 或分支烷基,視所需爲Ar3所取代,其中A。環基是苯基, 該環基視所需爲-Qi單或多重取代, -Νααυ,其中119及111()獨立爲-Cy直或分支的烷基,或 -〇-R5,其中115是1·!或-Cw直或分支的烷基。 •156· 本纸伕尺度適用中§国家標李(〇^)44汉袼(210/297公釐) 1235157The limitation is that when -Αγ3 is replaced by Qi, it contains an additional -Ar: 1 group above W§1, and this additional ΑΓ3 group is not another. Ar: 3, 4K with other comparisons of Example F A good compound, using the formula (II), is a (e 1 丨), and the other substituents are as defined above. · Other preferred compounds of Specific Example F, using formula (II), are (el 2), and other substituents are as defined above. Other preferred compounds of specific example F are applied by formula (ΠI), the center of the plant is (y 1), and other substituents are as defined above. Other preferred compounds of specific example F are applied by formula (ΠΙ), where Ri Yes (> .2) and other substituents are as defined above. For other preferred compounds of specific example F, apply formula (III) 'wherein Ri is (z) and other substituents are as defined above. Specific examples Other preferred compounds of F apply formula (III), where Ri is (elO) and \ 5 is CH (also referred to herein as elO-B) 'and the other substituents are as defined above. Du Yin of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China (please read the precautions of the cloud 3 before filling in this I) Specific Example F Other preferred compounds, apply the formula (ΠΙ) '中 民 【是 (el〇) And \ 5 is 1 > 1 (also referred to herein as elO-A), and the other substituents are as defined above, a is better, when R 丨 is (ell), (ei2), Bu 1), (y2) , (Z), (elO, A) and (elO-B), R5 is selected from the following including: • C (0) -Ri〇, -C (〇) 〇-R9, and • 154-paper scale 逑Use the gS family standard rate (CNS) A4 standard (210X 297 degrees) " 1235157 Λ7 B7 V. Description of the invention (152) -C (〇) -NH-Rl0. In addition, when 1 ^ is (ell), (El2), (yl), (>, 2), (z), (elO-A) and (e 1 OB), R5 is selected from the following including: -'- S (〇) rR9, -S (〇 ) 2-NH-R10, -C (〇) -C (〇) -R10, -R9,-(:( 0) -0 (0) -01110, and -c (〇) c (〇) -n ( r9) (r10).-Preferably, R54R-C (〇) -C (〇) -R10. In addition, 115 is-(:( 〇) -0: (〇) -〇111 (). Better, when Ri is (ell), (el2), (yi), (y2), (2 :), (elO-A) and (eiO-B): m is 1 ·· R2 1 is · Η or -CH3: hi is ci. 6 straight or branched alkynyl group 'as required is eight "substituted by 3' where Ar3 ring group is a benzyl group, which ring base is required as -Q i multiple or Single Replacement: Printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (t ·· Please read the precautions of § before filling out this page) Each ring group is independently selected from the following including benzyl, fluorene, and 4: phenyl , Quinolyl, isopyridinyl, pyrazolyl, oxazolyl, isoxazolyl, benzotriazolyl, benzimidazolyl, telephenoβ-secenyl, imidazolyl, cedadiazole Group, benzo [b] thiobenzyl, pyridinyl, benzopyranyl, or 4indolyl, and the cyclic group is optionally substituted by-(^ selected from the following: single or multiple substitutions: each (^ is independently selected from the following) Including -NH2, -Cl, -F, -Br1, -〇H, -R9, -NH-R5, where 115 is -C (0) -Ri〇 or -S (〇) 2-R9, -0R5 where 115 Yes 1 155- This paper is in the standard side of the paper. § A home rubs (CNS) A4 size (2 丨 OX 297 gong) 1235157 B7 V. Description of the invention (153) -C (〇) -R 1 Q '-〇 R9 '-N (R9) (RIQ)' and 〇 / \ CH,, \ / — 〇, where each of 119 and Rl (3 are independently -Cw straight or branched Base, if necessary, is substituted by Αγ3, wherein the Ar * 3 ring group is a benzyl group, and the ring base is optionally a single or multiple substitutions: The limitation is that when -Ar3 is substituted by a Q group, it contains a It is believed that the additional -Aγ3 group above is not controlled by another -Aγ3 group. It is better to be selected from these preferred compounds. The Aγ3 ring group is selected from the following: phenyl, phenyl, rt phenyl, g-sigma linyl, iso: denomination, phenolyl, & sigma Xyl., Isoxazolyl, benzotriyl, benzimidazolyl, 4-phenazophenylyl, imidazolyl, 4-diazolyl, benzo [b] thiobenzyl, benzyfuryl and 4 An indolyl group, and the cyclic group may be mono- or multiple-substituted as desired by -Q. The compounds in the preferred form of this specific example F are: r5 * -c (〇) -r10, where R1Q is Ar3, where the Ar3 ring group is a benzyl group, and the ring base may be the following single or multiple family generations as required: -F, • α, -N (H) -R5 printed by the Consumers' Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs, where -R5 is · Η or -C (〇) -Ri〇, where R10 is < Or branched alkyl, optionally substituted by Ar3, where A. The cyclic group is phenyl, and the cyclic group is optionally -Qi single or multiple substitution, -Nααυ, where 119 and 111 () are independently -Cy straight or branched alkyl, or -〇-R5, where 115 is 1 ·! Or -Cw straight or branched alkyl. • 156 · The standard of this paper is applicable to § National Standard Li (〇 ^) 44 Han (210/297 mm) 1235157

AT B7 五、發明説明(说) 較好Aq環基是苯基,視所需在3·或5-位置上爲-C1或在 4-位置上爲·ΝΗ-Ι15,-N(R9)(Rl(3),或-〇-115所單或多重取代, 實例F其他較佳化合物包括其中115是-(:(〇卜R10,其中R1〇 是八[3且Aq環基選自下列包括4哚基,笨並咪唑基,遑啥 基,及笨並[b]硫苯基,且該環基視所需爲-Qi所單或多重 取代:AT B7 V. Description of the Invention (Speaking) The preferred Aq ring group is phenyl, optionally -C1 at the 3 · or 5-position or · NΗ-Ι15 at the 4-position, -N (R9) ( R1 (3), or -0-115 single or multiple substitutions, Example F. Other preferred compounds include where 115 is-(: (R10, where R1O is eight [3 and the Aq ring group is selected from the following including 4 Indyl, benzimidazolyl, hydrazyl, and benzo [b] thiophenyl, and the ring group is optionally substituted by -Qi single or multiple:

具ft實例F其他較佳化合物包括其中115是&lt;(0)-111(),其 中R1(3是A”且Aq環基選自峻4基及異4啉基,且該環基 視所需爲-Q i所單或多重取代I 具體實例F其他較佳化合物包括其中115是&lt;(〇)-111(3,其 中R1Q是Αγ3,其中Αγ3環基是苯基,爲 〇 / \ CH,, \〇/ - 所取代= 於·具禮實例F另一型式中,化合物如上述,進一步限制 條件爲當: m是1 : R#(elO): 超漭部中央標準局員工消費合作.社印¾ (請先试讀背面之注意事項再填寫本頁) X5是 CH : R|5是-0H : ' R2i是-Η :且 丫2是0且R;是-C(〇)-H,則R5不可爲: -C(〇)-R丨〇 ’其中Ri〇疋- 且Ar^環基是尽基,不爲下列 -157- 本纸伕尺度逍用中1国家標李(CNS ) Μ規格(210X297公釐) 1235157 Λ7 B7 &quot; 五、發明説明(155) 取代:-Qi,4-(羧曱氧基)苯基,2-氟苯基,2-畎啶基,N- (4-甲基六氫吆4基)甲基苯基,或 • C(〇)-〇R9,其中R9是-CH2-Ar3,且Ar3環基‘是笨基,不 爲-Qi馭代;且其中當: Y2是〇,R;是,丁 i是〇,且尺丨丨是Αγ4, 其中Αγ4環基是5-(1-(4-氯苯基)-3-三氟甲基)说唑基),則R5 不可爲: ' -C(〇)-Rl0,其中R10是-八1*3且Αγ3環基是4-(二甲胺基甲基) 笨基,笨基,4-(羧甲硫基)象基,4-(羧乙硫基)苯基,4-( 羧乙基)苯基,4-(羧丙基)苯基,2-氟苯基,2-咄啶基,Ν-(4-甲基六氫畎喑基)甲基苯基,或 •C(0)-〇R9,其中R9是-CH2-Ar3,且Ar3環基是苯基: 且當Rn是Ar*4,其中Αγ4環基是5-(1·笨基·3·三氣甲基)。比 唑基),則R5不可爲: -C(〇)-〇R9,其中119是-CH2-Ai:3,則A。環基是苯基: 且當Ri丨是Ar4,其中Ar*4環基是5-(1-(2-咄啶基)-3-三氣曱 基K唑基),則R5不可爲: -C(〇)-R丨〇,其中Ri〇是-Αγ3且Αι:3環基是4-(二曱胺基甲基) 笨基,或Other preferred compounds with ft Example F include where 115 is &lt; (0) -111 (), where R1 (3 is A &quot; Single or multiple substitutions required by -Q i Specific examples F Other preferred compounds include 115 in which <(〇) -111 (3, where R1Q is Αγ3, where Αγ3 ring is phenyl, and 〇 / \ CH , \ 〇 /-Substituted = In Yuli Example F In another form, the compound is as described above, and the further restrictions are when: m is 1: R # (elO): Supervisory Ministry of Standards Bureau staff consumer cooperation. Company seal ¾ (Please read the precautions on the back before filling out this page) X5 is CH: R | 5 is -0H: 'R2i is -Η: and y2 is 0 and R; yes -C (〇) -H , Then R5 cannot be: -C (〇) -R 丨 〇 'where Ri〇 疋-and Ar ^ ring group is the best basis, not the following -157- Chinese paper standard (CNS) M specifications (210X297 mm) 1235157 Λ7 B7 &quot; V. Description of the invention (155) Substitution: -Qi, 4- (carboxyfluorenyloxy) phenyl, 2-fluorophenyl, 2-fluoridinyl, N- ( 4-methylhexahydrofluorenyl 4-methyl) methylphenyl, or C (〇) -ORR9, where R9 is -CH2-Ar3, The Ar3 ring group is a stupid group, and is not -Qi, and when: Y2 is 0, R; Yes, Ding is 0, and the rule is Aγ4, where the Aγ4 ring group is 5- (1- ( 4-chlorophenyl) -3-trifluoromethyl) said azolyl), then R5 cannot be: '-C (〇) -R10, where R10 is -eight 1 * 3 and Aγ3 ring group is 4- (di Methylaminomethyl) benzyl, benzyl, 4- (carboxymethylthio) imidyl, 4- (carboxyethylthio) phenyl, 4- (carboxyethyl) phenyl, 4- (carboxypropyl ) Phenyl, 2-fluorophenyl, 2-fluoridinyl, N- (4-methylhexahydrofluorenyl) methylphenyl, or • C (0) -OR9, where R9 is -CH2- Ar3, and the Ar3 ring group is phenyl: and when Rn is Ar * 4, where the Aγ4 ring group is 5- (1 · benzyl · 3 · trifluoromethyl), then R5 cannot be:- C (〇) -〇R9, where 119 is -CH2-Ai: 3, then A. The ring group is phenyl: and when Ri is Ar4, where the Ar * 4 ring group is 5- (1- (2- 咄(Pyridyl) -3-trisiofluorenylKazolyl), then R5 cannot be: -C (〇) -R 丨 〇, where Ri〇 is -Αγ3 and Aι: 3 ring group is 4- (diamidoamine group Methyl) benzyl, or

經濟部中央標準局貝工消资合作社印2L (請先閨讀背面之洼意事項再填寫本頁) -C(〇)-〇R9 ’其中R9是-CHs.Ar^ ’且•卷是表基’不 爲-Qi取代:且當 ' Y2 是 〇,R3 是-C(0)-CH2-丁 1-R11,丁1是 〇,且 R 丨 I 是-C(〇)-Ar4,其中Αγ4環基是2,5-二氣笨基,則R5不可爲·· -C(0)-Rl(),其中Rl()是-八1:3且Ar3環基是4·(二甲胺基甲基) -158- 本纸伕尺度逍用中1国家標孪(CNS M4規格(210X 297公釐) 經济部中夬樣準局貝工消費合作社印裝 1235157Central Standards Bureau of the Ministry of Economic Affairs, Beigong Consumer Cooperatives Co., Ltd. 2L (please read the information on the back before filling out this page) -C (〇) -〇R9 'Where R9 is -CHs.Ar ^' Is not substituted by -Qi: and when 'Y2 is 0, R3 is -C (0) -CH2-but1-R11, but 1 is 0, and R 丨 I is -C (〇) -Ar4, where Aγ4 The cyclic group is 2,5-difluorobenzyl, so R5 cannot be ... -C (0) -Rl (), where R1 () is -eight 1: 3 and the Ar3 ring group is 4 (dimethylamino (Methyl) -158- This paper is a small size paper with a Chinese national standard (CNS M4 specification (210X 297 mm). Printed by the Shellfish Consumer Cooperative of the China Prototype Bureau of the Ministry of Economic Affairs. 1235157

五、發明説明(15δ) 笨基,4-(Ν-嗎福嗾基曱基)苯基,4·(Ν·曱基六氩η七4凑)^ 基)笨基,4-(N-(2-曱基)咪唑基曱基)笨基,5-笨並味嶁泰 ’ 5-笨並三嗖基,N-乙醏基-5-苯益三唑基,N-乙酯基^一 篆並味唑基,或 ,C(0)-〇r9,其中以是-CH2-Ar3,且Αι·3環基是笨基,未 取代:且當 γ2是H2,R;是-C(〇)-CH2-TrRn,T丨是〇,且泛丨丨是 •C(0)-Ar4,其中Ar4環基是2,5-二氯笨基,則R5不可爲: •C(〇)-〇r9,其中R9*-CH2-Ar3,且Ar3環基是苯基。 於具體實例F另一型式中,較佳的化合物爲其中R2l是-H 者。 另外,較佳化合物爲其中r21是-CH3者。 具體實例F較佳化合物應用式(III),其中1^是(^/2)且另外 的取代基如上文定義。 較好,!1丨是(w2)且 xn 是 I : 環C是笨並,说咬並,或::塞吩並: R3選自下列包括-C(0)-H,-C(0)-Ar2,及-C(0)CHrTrRu : R5選自下列包括: •C(O)-R10,其中 R10是-Αγ3 : -C(0)0-R9,其中119是-〇^2-入1*3 : -C(〇)C(〇)-Rl0,其中 R1〇是-Ar;: -R9 ’其中R9是Ci.2燒基,爲· Αγ3所取代:及 -C(〇)C(O)-〇R10,其中 Rl〇是 &lt;η2Αγ3 : •159· 本纸乐尺度適用中国国家標李(CNS ) Α4規袼(2[Οχ 297公沒)一 一' 广#先纪讀背^之注意事項再填寫本買)V. Description of the invention (15δ) benzyl, 4- (N-morphofluorenylfluorenyl) phenyl, 4 · (N · fluorenylhexaargin η 七 4 凑) ^ yl) benzyl, 4- (N- (2-fluorenyl) imidazolylfluorenyl) benzyl, 5-benzyl misotai '5-benzyltrisyl, N-ethylfluorenyl-5-benzyltriazolyl, N-ethylethyl ^ Monopyrazolyl, or, C (0) -〇r9, where is -CH2-Ar3, and the A · 3 ring group is a benzyl, unsubstituted: and when γ2 is H2, R; is -C ( 〇) -CH2-TrRn, T 丨 is 〇, and the general 丨 丨 is • C (0) -Ar4, where the Ar4 ring group is 2,5-dichlorobenzyl, then R5 cannot be: • C (〇)- Or9, wherein R9 * -CH2-Ar3, and the Ar3 ring group is phenyl. In another form of Specific Example F, the preferred compound is one in which R2l is -H. In addition, preferred compounds are those in which r21 is -CH3. Specific Example F Preferred compounds employ formula (III), wherein 1 ^ is (^ / 2) and the other substituents are as defined above. better,! 1 丨 is (w2) and xn is I: the ring C is succinyl, said bite, or :: sepheno: R3 is selected from the following including -C (0) -H, -C (0) -Ar2, and -C (0) CHrTrRu: R5 is selected from the following including: • C (O) -R10, where R10 is -Αγ3: -C (0) 0-R9, where 119 is -〇 ^ 2- 入 1 * 3:- C (〇) C (〇) -R10, where R1〇 is -Ar ;: -R9 'wherein R9 is Ci.2 alkyl, substituted by · Αγ3: and -C (〇) C (O) -〇R10 , Where Rl0 is &lt; η2Αγ3: • 159 · This paper music scale is applicable to Chinese National Standard Li (CNS) Α4 Regulations (2 [Οχ 297 公 未) one by one '广 # 先 纪 读 背 ^ Note before filling in (This buy)

1235157 Λ7 B7 五、發明説明(157) 丁1是〇或S :1235157 Λ7 B7 V. Description of the invention (157) D1 is 0 or S:

RgH :RgH:

Rs選自下列包括-C(〇)-R10,-C(〇)-CH2-CXR101-C(〇)CH2-N(Ri0)(R10),其中 R10是 Η,CH3,或 CH2CH3 : R1丨送目下列包括- ΑΓ4 ’ -(CH2)卜3-ΑΓ4及- C(〇)-Ar4 :Rs is selected from the following including -C (〇) -R10, -C (〇) -CH2-CXR101-C (〇) CH2-N (Ri0) (R10), where R10 is H, CH3, or CH2CH3: R1 The following items include-ΑΓ4 '-(CH2) bu 3-ΑΓ4 and-C (〇) -Ar4:

Rb-是-〇H或-〇(:卜4直或分支烷基,視所需爲-,-〇H ,-〇Ryt-C〇2H取代,其中R9*-CN4分支或直缝烷基,其 中八1*3是嗎福嗒基或苯基,其中苯基視所需爲I所取代: Αγ2 是(hh); &quot; Y是〇: 各Αγ3環基獨立選自下列包括苯基,莕基,4吩基,喹諾 淋基,異4語郝基,11塞峻基,苯並咪峻基,。塞吩並3塞兮基 ,4二唑基,苯並三唑基,苯並[b]硫苯基,笨並呋嘀基, 及吲哚基,且該環基視所需可爲-(^所單或多重取代: 各Ar4環基獨立選自下列包括苯基,四唑基,葚基,:比啶 基,σ惡咬基,喊症基,或erf丨嗓基,該環基視所需爲-Q t所 # 單或多重取代: 經濟部中央標孪局員工消費合作杜印袈 各Qi獨立選自下列包括-NH2,-Cl,-F,-Br,-〇H,-R9, -NH-R5 其中 R5 是-C(O)-Rl0 或-S(0)2-R9,-0R5 其中 R5 是 -C(〇)-Rl(),-〇R9,·Ν(Ι19)(ΙΙι())及 〇Rb- is -0H or -〇 (: a straight or branched alkyl group, optionally substituted by-, -〇H, -〇Ryt-C〇2H, wherein R9 * -CN4 is a branched or straight alkyl group, Among them, 1 * 3 is morpholyl or phenyl, where phenyl is optionally substituted by I: Aγ2 is (hh); &quot; Y is 0: each Aγ3 ring group is independently selected from the following including phenyl, 荇Group, 4-phenyl group, quinolyl group, iso-4 group haloyl group, 11 cetylenyl group, benzimidyl group, cepheno-3 cetylenyl group, 4 diazolyl group, benzotriazolyl group, benzo [b] Thiophenyl, benzofuryl, and indolyl, and the cyclic group may be-(^ single or multiple substitutions as required: each Ar4 ring group is independently selected from the following including phenyl, tetrazole Base, pyridyl, pyridyl, sigma, ergo, or erf, which is based on the need for -Q t # single or multiple substitution: consumption by the Central Bureau of Standards of the Ministry of Economic Affairs Cooperative Du Yinqi Each Qi is independently selected from the following including -NH2, -Cl, -F, -Br, -OH, -R9, -NH-R5 where R5 is -C (O) -Rl0 or -S (0) 2-R9, -0R5 where R5 is -C (〇) -Rl (), -〇R9, · Ν (Ι19) (ΙΙι ()) and 〇

〇 其中各119及111()獨立地爲-Cw直或分支的烷基,視所需爲 -160· 本纸乐尺度通用中HS家揉孪(CNS ) A4規格(210X297公釐) 1235157 Λ&quot; Β7 五、發明説明(158) Αγ3所取代,其中Ar3是苯基: F良制條件爲當-Αγ3爲Q l取代,其含有一侄以上額外的 -Αγ3基,該額外的-Aq基不爲另外的-Air;基-所氧代3 具韹實例F其他較佳化合物,應用式(III)其中心是(ell) ,且其他的取代基如上文所定義。 具韹實例F其他較佳化合物,應用式(III)其中心是(el2) 且其他的取代基如上文所定義。 具Ιί實例F其他較佳化合物,應用式(III)其中心是(yl) 且其他的取代基如上文所定義。 具體實例F其他較佳化合物,應用式(III)其中1^是(y2) 且其ί也的取代基如上文所定義3 具韹實例F其他較佳化合物,應用式(III)其中1^是(2)且 其他的取代基如上文所定義。 具禮實例F其他較佳化合物,應用式(III)其中!^是(el0) 且X5{CH且其他的取代基如上文所定義。 具韹實例F其他較佳化合物,應用式(III)其中1^是&amp; 10) 且X5是N,且其他取代基如上文所定義。 較好,於這些較佳化合物中,選自下列包括: -C(O)-Rl0 ’ 經濟部中央標.李局貝工消費合作社印¾ (請先閱讀背面之注意畜.項再1||本頁) -C(〇)〇-R9 ’及 •C(〇)-NH-Rl0。 · 另外,於這些較佳化合物中,RD•選自下列包括: -S(〇)rR9, -S(〇)rNH-Rl0, -161 - 本纸法尺度適用中IS家標车(CNS ) A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(159) -C(〇)-C(〇)-R10, -R9, -C(〇)-C(〇)-〇R10,及 - -C(〇)C(O)-N(R9)(R10)。 最好,於這些較佳化合物中, m是1 : 尺13是Η或-Cm直或分支烷基,視所需爲-Ai3,-0H,-〇R9,或-C〇2H所取代,其中119是-Cm分支或直鏈烷基, 其中Ai*3是嗎福啉基或笨基,其中苯基視所需爲h取代: R2l 是-H或-CH3 ; R5l是(:卜6直或分支烷基,視所需爲Αγ3所取代,其中Αγ3 是苯基,視所需爲-Q t所取代: 各Ar*3環基獨立選自下列包括苯基,笨基,4吩基,4諾 啉基,異4諾啉基,吡唑基,嘍唑基,異噁唑基,苯並三 峻基,苯並咪0^基,σ塞吩並β塞吩基,咪座基,σ塞二峻基, 笨並[b]硫笨基,吡啶基,苯並呋喃基,及4哚基,且該環 基視所需爲所單或多重取代; 經濟部中央標準局員工消費合作杜印«. (請先另讀背云之泾意事殯再填寫本頁) 各&lt;5丨獨立選自下列包括-NH2,-Cl,-F,-Bi:,-〇H,-R9, -NH-R5,其中 115是-C(〇)-Rl0 或-S(〇)2-R9,-0R5 其中 115是 -C(〇)-Rl0,-〇R9,-N(R9)(R10),及 〇 . \ CH,, γ _ 其中各119及R1Q獨立地爲-(:卜6直或分支的烷基,視所需爲 -162- 本纸伕尺度通用中国國家標李(CNS )六4汉格(2I0X 297公釐) 1235157 A: B7 五、發明説明(1S0)〇 Among them, each of 119 and 111 () are independently -Cw straight or branched alkyl groups, and -160 as required. The paper scale is universal, and it is a HS standard (CNS) A4 specification (210X297 mm). 1235157 Λ &quot; Β7 V. Description of the invention (158) Aγ3 is substituted, where Ar3 is phenyl: The good condition is that when -Αγ3 is Q l substituted, it contains more than one additional -Aγ3 group, and the additional -Aq group is not Another -Air; group-so-oxo 3 is a preferred compound of Example F. Formula (III) is applied with its center at (ell) and the other substituents are as defined above. With other preferred compounds of Example F, formula (III) is used with its center at (el2) and the other substituents are as defined above. With other preferred compounds of Example F, Formula (III) is used with its center at (yl) and the other substituents are as defined above. Specific Example F Other preferred compounds, using formula (III) where 1 ^ is (y2) and its substituents are as defined above 3 Example F Other preferred compounds, using formula (III) where 1 ^ is (2) and the other substituents are as defined above. Elite Example F Other preferred compounds, where formula (III) applies! ^ Is (el0) and X5 {CH and the other substituents are as defined above. With other preferred compounds of Example F, formula (III) is used where 1 ^ is &amp; 10) and X5 is N, and the other substituents are as defined above. Preferably, among these preferred compounds, selected from the following include: -C (O) -Rl0 'Central Standard of the Ministry of Economic Affairs. Printed by Li Bureau Beigong Consumer Cooperative ¾ (Please read the note on the back first. Item then 1 || (This page) -C (〇) 〇-R9 'and • C (〇) -NH-R10. · In addition, among these preferred compounds, RD • is selected from the following including: -S (〇) rR9, -S (〇) rNH-Rl0, -161-IS Standard Car (CNS) A4 Specifications (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (159) -C (〇) -C (〇) -R10, -R9, -C (〇) -C (〇) -〇R10, and--C (0) C (O) -N (R9) (R10). Most preferably, in these preferred compounds, m is 1: chi 13 is fluorene or -Cm straight or branched alkyl, optionally substituted with -Ai3, -0H, -OR9, or -CO2H, where 119 is -Cm branched or straight chain alkyl, where Ai * 3 is morpholinyl or benzyl, where phenyl is optionally substituted by h: R2l is -H or -CH3; R5l is (: Branched alkyl, optionally substituted with Aγ3, where Aγ3 is phenyl, and optionally substituted with -Qt: Each Ar * 3 ring group is independently selected from the following including phenyl, phenyl, 4phenyl, 4 Norolinyl, iso4-norolinyl, pyrazolyl, oxazolyl, isoxazolyl, benzotrisyl, benzimidyl, σ-sedenoβ-sedenyl, imidyl, σ Selenium, benzo [b] thiobenzyl, pyridyl, benzofuranyl, and 4-indolyl, and the cyclic base may be replaced by a single or multiple substitutions as required; consumption cooperation of employees of the Central Standards Bureau of the Ministry of Economic Affairs Seal «. (Please read the meaning of the back of the cloud and fill in this page) each &lt; 5 丨 independently selected from the following including -NH2, -Cl, -F, -Bi :, -〇H, -R9, -NH-R5, where 115 is -C (〇) -Rl0 or -S (〇) 2-R9, -0R5 where 115 is -C (〇) -Rl0, -〇R9 , -N (R9) (R10), and. \ CH ,, γ _ wherein each of 119 and R1Q are independently-(: Bu 6 straight or branched alkyl groups, if necessary -162- the size of this paper) General Chinese National Standard Li (CNS) 6 4 Han (2I0X 297 mm) 1235157 A: B7 V. Description of the invention (1S0)

Ar;所致代,其中Αγ3是苯基: 限制條件爲當-Αγ3爲Q丨取代時,其含有一儒以上額外的 -Ar;基,該額外的-Ar3基不爲另-Ar3基所取代。 具ft實例(F)較佳化合物包括下列,但並不限於此: 2001 2100a 〇Ar; caused generation, wherein Aγ3 is phenyl: The limitation is that when -Αγ3 is substituted by Q 丨, it contains more than -Ar; group, the additional -Ar3 group is not substituted by another -Ar3 group . Examples of preferred compounds with ft (F) include the following, but are not limited thereto: 2001 2100a.

訂 ---------^1 (請先絮讀背云之·.Vi意事V?異本一貝 2100b 〇Λ 〇Order --------- ^ 1 (Please read the back of the cloud .. Vi Ideas V? Different Versions 1100b 〇Λ 〇

〇 ο OiPr o 東 經濟部中·夭標孪局員工消費合作社印¾〇 ο OiPr o East China Ministry of Economic Affairs, China · Biaobi Bureau Employee Consumption Cooperatives ¾

163 本祅法尺度边用中§國家標孪(CNS ) A4規格(2丨0X297公釐) 1235157 A7 B7 2100c163 National Standard Twin (CNS) A4 Specification (2 丨 0X297 mm) 1235157 A7 B7 2100c

2100d Ο2100d Ο

(許先閱讀背5之注意事項再4.寫本頁) 21〇〇e 〇(Xu first read the precautions for back 5 and then 4. write this page) 21〇〇e 〇

訂 經濟部中央標绛局員工消費合作·社印¾Consumption Cooperation of Employees of the Central Bureau of Standards, Ministry of Economic Affairs · Social Printing ¾

另-具體賞例(G)之本發明ICE抑制劑爲式(IX) (IV) 其中: m是1或2 : 1^選自下列包括下列化式 •164 本纸伕尺度適同〒SS家镖孪(CNS ) A4規格(210X297公没) 1235157 AT B7 五、發明説明(1°2: (elO-A) (ell)Another-specific example (G) of the ICE inhibitor of the present invention is formula (IX) (IV) where: m is 1 or 2: 1 ^ selected from the following including the following formulas: Dart twin (CNS) A4 specification (210X297 publicly) 1235157 AT B7 V. Description of invention (1 ° 2: (elO-A) (ell)

(el2)(el2)

(請先¥讀背5之:V〗意事項一一貝 (w2)(Please read back 5 of V: V〗 One by one (w2)

(yl)(yl)

經濟部中央標準局員工消費合作社印製 (y2)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (y2)

及 本纸伕尺度適用tl国家標李(CNS ) A4規格(210X297公釐) M濟部中央榡孪局員工消背合作杜印製 1235157 Λ7 . B7 五、發明説明(阳) 環C選自下列包括苯並,咄啶並,4吩並,畎喀並,唉 喃並,4吐益,異違0i並,嗔嗤並,異σ惡也並,嘧啶並, 味唑並·環戍基及環己基: / R3選自下列包括: •CN, -C(〇)-H, -C(0)-CH-&gt;-T|-R|j y -C(〇)-CHrF, -C^N^O-Rg ^ 及 -C 0 - A r i · 各115獨立選自下列包括: -C(〇)-R丨ο, -C(〇)〇-R9 , -C(O)-N(Rl0)(Rl0) -S(〇)2-R9, -S(〇)rNH-R10, -C(〇)-CHr〇-R9, -C(〇)C(〇)-Rl0, -R9, •H, -C(〇)C(〇)-〇R10,及 · -C(〇)C(〇)-N(R9)(Rl0): 丫2是七或〇 : X *7 是· N (R g)-或-〇-: -166· 本纸伕尺度適用令SS家禕孪(CNS ) A4規格(210X297公釐) 衣I (請先¾讀背s之注意事項再填寫本頁 訂 •1 1235157 Λ7 37 五、發明说明(1S4) 各丁丨獨立選自下列包括-〇-,-S-,-s(〇)-,及-s(〇)2-: R6選自下列包括-H及-CH3 :And the standard of this paper is applicable to the national standard (CNS) A4 specification (210X297 mm). The staff of the Ministry of Economic Affairs of the Central Government Bureau of the Ministry of Economic Cooperation and Cooperation Du printed 1235157 Λ7. B7 V. Description of the invention (yang) Ring C is selected from the following Including benzo, pyridino, 4pheno, pyrene, thiopyridine, 4 tocopherol, diisothiophene, dipyridine, isoσxylpyridine, pyrimidinyl, azozolopyryl, and Cyclohexyl: / R3 is selected from the following: CN, -C (〇) -H, -C (0) -CH- &gt; -T | -R | jy -C (〇) -CHrF, -C ^ N ^ O-Rg ^ and -C 0-A ri · Each 115 is independently selected from the following: -C (〇) -R 丨 ο, -C (〇) 〇-R9, -C (O) -N (Rl0) (Rl0) -S (〇) 2-R9, -S (〇) rNH-R10, -C (〇) -CHr〇-R9, -C (〇) C (〇) -Rl0, -R9, • H, -C (〇) C (〇) -〇R10, and -C (〇) C (〇) -N (R9) (R10): 丫 2 是 七 or 〇: X * 7 是 · N (R g) -Or-〇-: -166 · The paper size is applicable to make SS furniture (CNS) A4 size (210X297 mm) clothing I (please read the precautions of s before filling in this page to order • 1 1235157 Λ7 37 V. Description of the Invention (1S4) Each Ding is independently selected from the following including -〇-, -S-, -s (〇)- And -s (square) 2-: R6 is selected from -H and -CH3 comprising:

Rs選自下列包括: , -C(〇)-R10, -C(〇)〇-R9 , -C(O)-NH-R10, -S(〇)2-R9, - -S(〇)rNH-R10, -C(〇)-CH2-〇Rl0, - -C(〇)C(〇)-Rl0, • C(〇)-CH2-N(Rl0)(Rl0), -C(〇)-CH2C(〇)-0-R9, -C(〇)-CH2C(〇)-R9, -H,及 -C(〇)-C(〇)-〇R[〇 ·· 各119獨立選自下列包括-Aq及-Cw直或分支烷基視所需 爲Αγ3所取代,其中-Ct.6烷基視所需不绝和: 經濟部中央樣準局員工消资合作社印¾ (請先聞讀背*之注意事項異^^本頁) 各Ri〇獨立選自下列包括·Η,-Ar3,(:3.6環烷基,反-Cm 直或分支烷基視所需爲Αιγ3所取代,其中-Ci.6烷基視所需 不绝和: &amp;Rn獨立選自下列包括: ‘ -Αγ4, 卜ΑΓ4 ’ •Η,及 -167- 本紙尜尺度送用中茗國家標李(CNS) A4規格(210X297公釐) 1235157 '· -*Λ ; 3, 五、發明説明(細 • C(〇)-Ar4 : r15選自下列包括-〇H,-〇Ar3,-N(H)-〇H,及-0C卜6,其 中Cu是星或分支坑基視所窝爲-Αγ:、,-βΟΝΗ] ’ -ORj ’ •〇H,-〇R9,或-C〇2H所取代: 各Rh獨立選自下列包括-H或-C卜6直或分支虎基: Αγ2獨立選自下列,其中任何環可視所需爲-(^所單或多 重取代,或苯基,視所需爲Q1所馭代: ·Rs is selected from the group consisting of: -C (〇) -R10, -C (〇) 〇-R9, -C (O) -NH-R10, -S (〇) 2-R9,--S (〇) rNH -R10, -C (〇) -CH2-〇Rl0,--C (〇) C (〇) -Rl0, • C (〇) -CH2-N (Rl0) (Rl0), -C (〇) -CH2C (〇) -0-R9, -C (〇) -CH2C (〇) -R9, -H, and -C (〇) -C (〇) -〇R [〇 ... Each of 119 is independently selected from the following including- Aq and -Cw straight or branched alkyl groups are replaced by Αγ3 as required, of which -Ct.6 alkyl groups are continuously required: printed by the Consumers' Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs Note on the difference ^^) Each Ri0 is independently selected from the group consisting of: Η, -Ar3, (: 3.6 cycloalkyl, trans-Cm straight or branched alkyl is optionally substituted by Αγ3, where -Ci. 6 alkyls as necessary: &amp; Rn is independently selected from the following including: '-Αγ4, BU ΑΓ4' • Η, and -167- This paper is sent to the Chinese National Standard (CNS) A4 specification (210X297) Mm) 1235157 '·-* Λ; 3, V. Description of the invention (fine • C (〇) -Ar4: r15 is selected from the following including -〇H, -〇Ar3, -N (H) -〇H, and- 0C bu 6, where Cu is a star or branch pit base view as -Αγ: , -ΒΟΝΗ] '-ORj' • OH, -〇R9, or -CO2H is substituted: each Rh is independently selected from the following including -H or -C and 6 straight or branched tiger groups: Aγ2 is independently selected from the following, Any of the rings may be a single or multiple substitutions as required by-(^, or a phenyl group, as required by the generation controlled by Q1:

其中各Y獨立選自〇及S ; 各Aq是環基,獨立選自下列包括芳基其含有6,1 0,1 2 或14個碳原子及1至3個環,及芳族雜環基含有5至1 5個環 原子及1至3個環,該雜環含有至少一個選自-〇-,-S-, -S〇-,S〇2,=N-,及-NH-,-N(R5)-,及-N(R9)-之雜原子, 經濟部中央樣孪局員工消费合作社印¾ (4¾¾讀背f/泾意事大二貝) 該雜環基視所需含有一個以上雙鍵,該雜環基就所需含有 一個以上芳族環,且該環基視所需爲-Q丨所單或多重取代; 各Αγ4是環基,獨立選自下列包括芳基其含有6,10,12 或14個碳原子及1至3個環,該雜環基含有5至1 5個環原子 及1至3個環,該雜環含有至少一個選自-〇-,-S·,-SO-, S〇2,=N-,-NH-,-N(R5)-,及-N(R9)-之雜原子,該雜環視 所需含有一個以上的雙鍵,該雜環基視所需含有一個以上 -168- 本纸ft尺度遝用中S3家標牮(CNS ) Α4規格(2丨0Χ 297公釐) 1235157 A: _ B7__ 五、發明説明(1S6) 的芳族環,旦該環基視所需爲-Q i所單或多重取代: 各Qi獨立選自下列包括-NH,,-CC^H ’ -Cl ’ -F ’ -Br ’ -I ,-Ν〇2,-CN,=〇,-OH,-全氟 C^3 燒基 / R5,-〇R5, -NHR5,〇R9,-N(R9)(R10),R9,,及〇 〜· / \ CH,, \〇/ - ?艮制條件爲當-Ar3爲Q丨基取代,其含有一個以上額外的 -Αγ3基,該額外的- Ar3基不爲另外的-Ar3所取代: 具禮實例G之較佳化合物,應用式(IV),其中\是卜2)且 其他的取代基如上文所定義。 較好,當R#(w2) ·· m是1 : 環C是笨並,岐咬並,或σ塞吩並: R3選自下列包括: -C(〇)-R|〇 ’ 其中 R|〇是-Αγ3 ; -C(〇)〇-R9 ’ 其中 R9是-CH2-Ar;5 : -C(〇)C(〇)-Ri〇 ’ 其中 Ri〇是-Αχ*]: -r9,其中r9是cN2烷基爲·Αι:3所取代:及 -C(O)C(O)-〇R10,其中 R1〇是.(:?12八1·;: ¾濟部中央樣準局貝工消費合作杜印製 {請先閱讀背一Β之注意事項再填寫本頁}Wherein each Y is independently selected from 0 and S; each Aq is a cyclic group and is independently selected from the following including aryl groups which contain 6, 10, 12 or 14 carbon atoms and 1 to 3 rings, and aromatic heterocyclic groups Contains 5 to 15 ring atoms and 1 to 3 rings, and the heterocyclic ring contains at least one selected from -0-, -S-, -S〇-, S〇2, = N-, and -NH-,- Heteroatoms of N (R5)-, and -N (R9)-, printed by the Consumer Cooperative Cooperative of the Central Bureau of the Ministry of Economic Affairs (4¾¾reading f / 背 事 大二 贝) The heterocyclic group contains one as needed For the above double bond, the heterocyclic group needs to contain more than one aromatic ring, and the cyclic group is optionally substituted by -Q 丨 single or multiple substitutions; each Aγ4 is a cyclic group, independently selected from the following including aryl groups which contain 6, 10, 12 or 14 carbon atoms and 1 to 3 rings, the heterocyclic group containing 5 to 15 ring atoms and 1 to 3 rings, the heterocyclic ring containing at least one selected from -0-, -S ·, -SO-, S〇2, = N-, -NH-, -N (R5)-, and -N (R9)-heteroatoms, the heterocycle optionally contains more than one double bond, the hetero Cyclops needs to contain more than one -168- ft-size paper (S3 house standard in use) (CNS) Α4 size (2 丨 0 × 297 mm) 1235 157 A: _ B7__ V. Aromatic ring of invention description (1S6), once the ring base is required to be single or multiple substitution by -Q i: Each Qi is independently selected from the following including -NH, -CC ^ H ' -Cl '-F' -Br '-I, -NO2, -CN, = 〇, -OH, -perfluoroC ^ 3alkyl, / R5, -〇R5, -NHR5, 〇R9, -N ( R9) (R10), R9, and 〇 ~ · / \ CH ,, 〇〇 /-The conditions are when -Ar3 is substituted with a Q group, which contains more than one additional -Aγ3 group, the additional- The Ar3 group is not substituted by another -Ar3: A preferred compound of exemplified G applies formula (IV), where \ is Bu 2) and the other substituents are as defined above. Preferably, when R # (w2) ·· m is 1: the ring C is benzopyridine, bispyridene, or σ-phenidene: R3 is selected from the following: -C (〇) -R | 〇 'where R | 〇 is -Αγ3; -C (〇) 〇-R9 'where R9 is -CH2-Ar; 5: -C (〇) C (〇) -Ri〇' where Ri〇 is -Αχ *]: -r9, where r9 is a cN2 alkyl group substituted with Aι: 3: and -C (O) C (O) -〇R10, where R1〇 is. (:? 12 eight 1 · ;: Consumption cooperation printed by Du {Please read the precautions of the first one before filling out this page}

RgH :RgH:

Rs 選自下列包括-C(0)-RlQ,-C(O)-CH2-〇Rl0,及 -C(O)CH2-N(R10)(R10),其中 Ri〇是 Η,CH3,或-CH2CH3 : R〖3是Η或-Cl-4直或分支烷基,視所需爲Ar3,-〇H,-〇R9 或-c〇2H所取代,其中心是^·4分支或直鏈烷基,其中Αγ3 •169· 本紙伕尺度通用中SS家榡李(CNS ) Α4^;^ 210&gt;&lt;297公屋^----—- 1235157 經濟部中央標準局員工消费合作·社印¾ B7五、發明説明(1δ7) 是鳴福嗒基或苯基,其中苯基視所需爲Qi所取代: Ar:、是笨泰’茶基’這令基,嗜运5林基’異^窃7沐卷, 遙唑基,苯並咪唑基,4吩並4吩基,4二唑基,苯並三 哇基,苯並[b]硫苯基,苯並呋喃基,及啕哚基: 各獨立選自下列包括-NH2,-CM,-F,-Br,-〇H,-R9, •XH-R5,其中 115是-C(〇)-Ri〇 或-S(〇)2-R9,-0R5 其中 115是 -C(〇)-R^q ’ -ORg ’ -NHRg ’ 及 〇/ \ CH,, - \/ -〇 其中各119及111()獨立地爲-C^直或分支烷基,視所需爲Ar3 所取代,其中八1*3是苯基; 限制條件爲當-Αγ3爲Q i取代時,其含有一個以上額外的 -Αγ3基,該額外的-Ar3基不爲另外的-Αι·3所取代ύ 具體實例G其他較佳化合物,應用式(IV)其中1^是(610-八) 且其他取代基如上文所定義。 具體實例G其他較佳化合物,應闫式(IV)其中1^是(el 1) 且其他馭代基如上文所定義。 具體實例G其他較佳化合物,應用式(IV)其中心是(el2) ,且其他取代基如上文所定義。 請 先 讀 背 面 之 注 意 畜Rs is selected from the group consisting of -C (0) -RlQ, -C (O) -CH2-〇R10, and -C (O) CH2-N (R10) (R10), where Ri0 is H, CH3, or- CH2CH3: R 〖3 is a fluorene or -Cl-4 straight or branched alkyl group, optionally substituted by Ar3, -〇H, -〇R9 or -c〇2H, and its center is ^ · 4 branched or linear alkyl Basic, of which Αγ3 • 169 · This paper is commonly used in standard SS furniture (CNS) Α4 ^; ^ 210 &gt; &lt; 297 public housing ^ ----—- 1235157 Employees' Cooperative Cooperation of the Central Standards Bureau of the Ministry of Economic Affairs · Social Printing ¾ B7 V. Description of the invention (1δ7) is fluorinyl or phenyl, in which phenyl is substituted by Qi as required: Ar :, is Bentai's "tea-based" this ordering group, and is indifferent to 5 lin-based 'iso ^ Tumblr, telezolyl, benzimidazolyl, 4-pheno-4phenyl, 4-diazolyl, benzotriowyl, benzo [b] thiophenyl, benzofuryl, and pyridyl : Each independently selected from the group consisting of -NH2, -CM, -F, -Br, -OH, -R9, XH-R5, where 115 is -C (〇) -Ri〇 or -S (〇) 2- R9, -0R5 where 115 is -C (〇) -R ^ q '-ORg' -NHRg 'and 〇 / \ CH,,-\ / -〇 where each of 119 and 111 () are independently -C ^ or Branched alkyl, Ar3 if required Substituted, where 1 * 3 is phenyl; the limitation is that when -Αγ3 is Q i substituted, it contains more than one additional -Αγ3 group, the additional -Ar3 group is not substituted by another -Αι · 3 Specific examples G Other preferred compounds, where formula (IV) 1 ^ is (610-eight) and other substituents are as defined above. Specific Example G Other preferred compounds should be formula (IV) where 1 ^ is (el 1) and the other substituents are as defined above. Specific Example G: Other preferred compounds, using formula (IV) whose center is (el2), and other substituents are as defined above. Please read the note on the back first

具鳢實例G其他較佳化合物 其他取代基如上文所定義。 具體實例G其他較佳化合物 其他取代基如上文所定義3 應用式(IV)其中1^是以1)且 應用式(IV)其中Ril(y2)且 -170· 本纸伕又度逑用t§S家標孪(CNS ) A4規格(2丨0X 297公釐) 1235157 Λ 7 B7 五、發明説明(1SS) 具ft實例G其他較佳化合物,應闫式(IV)其中1^是(2)且 其他取代基如上文所定義。 具韹實例G較佳化合物爲其中R3是-C〇-Ar2者。 較好,當是-C〇-Ar2時,Y是〇。 其他較佳化合物爲其中R3是-C(〇)-CH2-TVRn且Rn是 •(CHj) \ .3&quot;Ar4 c 最好,當 R3 是-C(〇)-CHrTrRniRn*-(CH-2)h3-Ar4, 丁丨是〇。 其他較佳化合物爲其中:· R3是-C^OlCHrTVRH : Τ#〇:且 Rn 是-C(〇)-Ar4。 其他較佳化合物爲其中R3*-C(〇)-H。 其他較佳化合物爲其中11:;是-(:(〇)-0^2-丁「11[1且1111是-八1*4。 較好,當R;是&lt;(0)-(:只2-1&gt;11丨1且11丨|是-△。,丁丨是。或S。 較好,當 Ri 是(ell),(el2),(yl),(y2),(z),(elO-A)及 (elO-B)時,R5選自下列包括: -C(〇)-Ri〇, 經濟部中央標孪局貝工消背合作社印裝 -C(〇)〇-R9 ,及 -C(O)-NH-RI0 » 另外,當 1^是(el 1),(el2),(yl),(y2),(z),(elO-A)及 (elO-B)時,R5選自下列包括: -S(〇)2-R9 ’ -S(O)2-NH-R10, -171· 本纸伕尺度適用中SS家標孪(CNS ) Α4規格(210X 297公釐) 1235157 Λ: _ Β7 五、發明説明(139) -C(〇)-C(〇)-R1〇, -R9 , -C(〇)-C(O)-〇R10,及 / -C(O)C(〇)-N(R9)(R10) 3 較好,R5是-C(〇)-C(〇)-R10。 另外,115是-€:(〇)-(:(〇)-〇111(}。 最好當 Ri 是(ell),(el2),(yl),(y2),(z),(el(J-A)及(elO-B),: m 是 1 : _ R21 是-H 或-CH3 : 是ci.6直或分支烷基視所需爲Ar3所取代,其中八1*3環 基是笨基,該環基視所需爲-Qi所多重或單一取代: 各Αγ3環基獨立選自下列包括笨基,莕基,嘍吩基,:έ語 啉基,異喹諾嗒基,吡嗖基,4唑基,異噍唑基,苯並三 σ坐基,苯並咪咬基,β塞吩並4吩基,咪嗅基,σ塞二4基, 笨並[b ]硫笨基,吡啶基,苯並呋喃基,或吲哚基,且該 環基視所需爲-Q i所單或多重取代。 各卩丨獨立地選自下列包括·ΝΗ2,-Cl,-F,-Br,-OH,R9 ,-NH-R5 其中 115是-C(〇)-R10 或-S(0)2-R9,-〇R5 其中 115是 經濟部中夬糅準局員工消費合作社印製 (請先閔讀背云之注意事項再填寫本I) •C(〇)-Rl0,-〇R9,-N(R9)(Rl0),及 〇 / \ e CH,, \〇/ - 其中各119及RlQ獨立地爲-cle6直或分支的烷基,視所需 爲Ar3所取代,其中Ar3環基是苯基,且該環基視所需爲 -172· 本纸伕尺度逯周中S國家標孪(CNS ) A4規格(210X297公衮) 1235157 Λ&quot; 37 五、發明説明(17〇) -Ql單或多重取代: 哏制條件爲當-Ar3是爲-Q 1基所取代時,其含有一個以上 額外的- Ar3丞,該額外的-Ar3基不爲另外的,Aq所取代。 較好,於這些敉佳化合物中’ Ar3環基選自下列包括笨 基,^卷,5塞吩基,奎謹7休墓,異峻爸沐基,:比峻基,這 唑基,異囔唑基,苯並三唑基,苯並咪唑基,這吩益4吩 基,咪唑基,4二唑基,苯並[b ]硫笨基,苯並呋嘀基及 4哚基,且該環基視所需爲-Q i單或多取代。 具體實例G較佳型式之化合-物,爲其中尺21是Η且其他裒 代基如上文所定義。 具體實例G另外較佳型式之化合物爲其中R2i是CH;且其 ί也取代基如上文所定義。 本發明另外具體實例(Η)之ICE抑制劑爲式(V): (V)Examples G Other preferred compounds Other substituents are as defined above. Specific example G Other preferred compounds Other substituents are as defined above 3 Application formula (IV) where 1 ^ is 1) and application formula (IV) where Ril (y2) and -170 §S Standard Twin (CNS) A4 specification (2 丨 0X 297 mm) 1235157 Λ 7 B7 V. Description of the invention (1SS) With ft example G other preferred compounds, should be formula (IV) where 1 ^ is (2 ) And the other substituents are as defined above. Preferred compounds with Example G are those in which R3 is -C0-Ar2. Preferably, when it is -C0-Ar2, Y is 0. Other preferred compounds are where R3 is -C (〇) -CH2-TVRn and Rn is • (CHj) \ .3 &quot; Ar4 c is best, when R3 is -C (〇) -CHrTrRniRn *-(CH-2) h3-Ar4, Ding is 0. Other preferred compounds are among them: R3 is -C ^ OlCHrTVRH: T # 〇: and Rn is -C (〇) -Ar4. Other preferred compounds are among them R3 * -C (0) -H. Other preferred compounds are 11 :; is-(:( 〇) -0 ^ 2- 丁 「11 [1 and 1111 is -eight 1 * 4. Better, when R; is &lt; (0)-(: Only 2-1 &gt; 11 丨 1 and 11 丨 | are-△., Ding 丨 is. Or S. Better, when Ri is (ell), (el2), (yl), (y2), (z), For (elO-A) and (elO-B), R5 is selected from the following including: -C (〇) -Ri〇, printed by the Central Standards Bureau of the Ministry of Economic Affairs, Beige Consumer Cooperatives-C (〇) 〇-R9, And -C (O) -NH-RI0 »In addition, when 1 ^ is (el 1), (el2), (yl), (y2), (z), (elO-A), and (elO-B) , R5 is selected from the following including: -S (〇) 2-R9 '-S (O) 2-NH-R10, -171 · SS family standard (CNS) A4 size (210X 297 mm) ) 1235157 Λ: _ B7 V. Description of the invention (139) -C (〇) -C (〇) -R1〇, -R9, -C (〇) -C (O) -〇R10, and / -C (O ) C (〇) -N (R9) (R10) 3 is preferred, and R5 is -C (〇) -C (〇) -R10. In addition, 115 is-€: (〇)-(:( 〇) -〇 111 (}. Best when Ri is (ell), (el2), (yl), (y2), (z), (el (JA), and (elO-B), m is 1: _ R21 is- H or -CH3: ci.6 straight or branched alkyl as required Substituted by Ar3, in which the eight 1 * 3 ring group is a benzyl group, which is optionally a multiple or single substitution by -Qi: each Aγ3 ring group is independently selected from the group consisting of benzyl, amidino, and fluorenyl, : Zolinyl, isoquinolyl, pyridoxyl, 4-oxazolyl, isoxazolyl, benzotrisigmato, benzimidyl, betathiopheno 4-phenyl, imidyl, Sigma phenyl, 4-benzyl, benzo [b] thiobenzyl, pyridyl, benzofuranyl, or indolyl, and the cyclic group is optionally substituted by -Q i single or multiple. Each 卩 丨 independently Is selected from the group consisting of: ΝΗ2, -Cl, -F, -Br, -OH, R9, -NH-R5 where 115 is -C (〇) -R10 or -S (0) 2-R9, -〇R5 where 115 Printed by the Consumers' Cooperative of the China Standard and Quarantine Bureau of the Ministry of Economic Affairs (please read this note before filling in this I) • C (〇) -Rl0, -〇R9, -N (R9) (Rl0), and 〇 / \ e CH ,, \ 〇 /-wherein each of 119 and RlQ are independently -cle6 straight or branched alkyl groups, optionally substituted by Ar3, wherein the Ar3 ring group is phenyl, and the ring group is Need to be -172 · The size of this paper, the national standard (CNS) A4 size in the middle of the week (210X297 male), 1235157 Λ &quot; 37 V. Description of the invention (17〇) -Ql single or multiple substitutions: The conditions are that when -Ar3 is substituted with -Q 1 group, it contains more than one additional -Ar3 丞, the additional -Ar3 group does not In addition, Aq is substituted. Preferably, the 'Ar3 ring group in these good compounds is selected from the group consisting of benzyl, vol, 5 sedenyl, Kuijin 7 tomb, Yijun Baji ,: Bijunji, this azole group, iso Oxazolyl, benzotriazolyl, benzimidazolyl, which are 4-phenyl, imidazolyl, 4-diazolyl, benzo [b] thiobenzyl, benzofuryl and 4indolyl, and The ring base is optionally -Q i mono- or poly-substituted. Specific example G is a compound of a preferred type, in which ruler 21 is Η and other 裒 groups are as defined above. Specific example G Another preferred form of the compound is wherein R2i is CH; and its ί also has a substituent as defined above. The ICE inhibitor of another specific example (i) of the present invention is the formula (V): (V)

(請先聞讀背面之注意事項再本頁) 超濟部中央標準局員工消費合作社印¾ 其中: m是1或2 ; (elO-B) Y:(Please read the notes on the back before reading this page) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ¾ where: m is 1 or 2; (elO-B) Y:

•173· 本紙杀尺度通用中国国家標辛(CNS ) A4規格(2丨0X 297公坌) 1235157 - A : B7 五、發明説明(171) R3選自下列包括: •CN, -C(〇)-H, , -C(0)-CH2-TrRn ^ -C(〇)-CH2-F, -C^N-O-Rg ^ 及 -C 〇-A r,: 各113•獨立選自下列包括: •C(〇)-Rl0, · -C(〇)〇-R9 , -C(O)-N(R10)(R10) -S(〇)2-R9, -S(〇)2-NH-Rl0, -C(〇)-CH2-〇-R9, -C(〇)C(〇)-Rl0, -R9 ’ -H,及 -C(〇)C(〇)-N(R9)(Rl0),及 -C(〇)C(〇)-〇Rl0,• 173 · The standard for this paper is Chinese National Standard Xin (CNS) A4 specification (2 丨 0X 297 gong) 1235157-A: B7 V. Description of the invention (171) R3 is selected from the following: • CN, -C (〇) -H,, -C (0) -CH2-TrRn ^ -C (〇) -CH2-F, -C ^ NO-Rg ^ and -C 〇-A r ,: 113 each independently selected from the following including: • C (〇) -Rl0, -C (〇) 〇-R9, -C (O) -N (R10) (R10) -S (〇) 2-R9, -S (〇) 2-NH-Rl0, -C (〇) -CH2-〇-R9, -C (〇) C (〇) -R10, -R9 '-H, and -C (〇) C (〇) -N (R9) (R10), and -C (〇) C (〇) -〇R10,

S?濟部中央標準局員工消費合作社印5L Y2SH2或〇: 各丁丨獨立選自下列包括·0-,,-s(〇)-,及-s(〇)2-: Rg選自下列包括: -C(〇)-R10, -C(0)0-R^ y -174· 本纸法尺度適用中1国家標孪(〇^)六4規格(2[0乂297公釐) 1235157 Λ7 B7 經濟部中夬標率局員工消費合作杜印製 五、發明説明(172)-C(〇)-NH-R1〇, -S(〇)2-R9, -S(〇)2-NH-R10, - -C(〇)-CH,-〇R【〇 ’ -C(〇)C(〇)-Rl0, -C(〇)-CHrN(Rl0)(R10), -C(〇)-CH2C(〇)-〇-R9, · -C(〇)-CH2C(0)-R9, -H,及 ’ -C(〇)-C(〇)-〇Rl0 : 各R9獨立選自下列包括-Ar3&amp;-C^直或分支烷基,視所 需爲Αγ3所取代,其中烷基視所需不飽和: 各Ri〇獨立選自下列包括-H,-Ar3,C3.6環烷基,及-Cy 直或分支烷基視所需爲Ar3所取代,其中-CN6烷基視所需 不飽和: 各Ru獨立選自下列包括:-A r;, •(CH〕)卜3-ΑΓ4, -Η,及 -C(〇)-Ai*4 : Rl5選自下列包括-〇Η,·ΟΑγ3,· -N(H)-OH,及-0(^.6,其 中Ci.6是直或分支烷基視所需爲八1*3所取代, -C〇NH2,-〇R5,-〇H,-〇R9,或-C〇2H : R2丨是-CH3 : •175- (請先.V1T讀背一Β之注意事項一 本頁 -裝 訂 旅 本纸伕尺度逑用中国S家標準(CNS ) A4規格(210Χ297公釐) 1235157 A- B7 五、發明説明(173) A r,獨立選自下列’其中任一環視所冥爲-Q 1旱氧多重私 代,或苯基,視所需爲Qi所取代:5? Y2SH2 or 0 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs: Each Ding is independently selected from the following including -0-, -s (〇)-, and -s (〇) 2-: Rg is selected from the following including : -C (〇) -R10, -C (0) 0-R ^ y -174 · This paper method is applicable to 1 national standard (0 ^) six 4 specifications (2 [0 乂 297mm) 1235157 Λ7 B7 Printed by the Ministry of Economic Affairs of the Bureau of Consumers and Consumers of the Ministry of Economic Affairs of the People's Republic of China Du 5. Production Description (172) -C (〇) -NH-R1〇, -S (〇) 2-R9, -S (〇) 2-NH- R10,--C (〇) -CH, -〇R [〇 '-C (〇) C (〇) -R10, -C (〇) -CHrN (R10) (R10), -C (〇) -CH2C (〇) -〇-R9, -C (〇) -CH2C (0) -R9, -H, and '-C (〇) -C (〇) -〇Rl0: Each R9 is independently selected from the following including -Ar3 & amp -C ^ straight or branched alkyl, optionally substituted by Aγ3, wherein the alkyl is optionally unsaturated: each Ri is independently selected from the following including -H, -Ar3, C3.6 cycloalkyl, and- Cy straight or branched alkyl is optionally substituted by Ar3, where -CN6 alkyl is optionally unsaturated: Each Ru is independently selected from the following: -A r ;, • (CH)) Bu 3-ΑΓ4, -Η And -C (〇) -Ai * 4: R15 is selected from the following including -〇Η, · Αγ3, · -N (H) -OH, and -0 (^. 6, where Ci.6 is a straight or branched alkyl group optionally substituted with eight 1 * 3, -CONH2, -〇R5,- 〇H, -〇R9, or -C〇2H: R2 丨 is -CH3: • 175- (Please read the precautions for V1T first page B page-bound travel paper (standards) using Chinese standards (CNS) A4 specification (210 × 297 mm) 1235157 A- B7 V. Description of the invention (173) A r, independently selected from the following 'any one of the following is viewed as -Q 1 dry oxygen multiple private generation, or phenyl, as Need to be replaced by Qi:

其中各Y獨立選自下列包括〇及S : 各Aq是環基獨立選自下列包括芳基,其含有6,10,12 或丨4個碳原子及1至3個環,及芳族雜環含有5至〖5信環原 子及1至3個環,該雜環含有至少一個選自-〇-,,-SO-, S〇2,二N-,及-NH-,-N(R5)-,及-N(R9)-之雜原子基,該雜 環視所需含有一個以上的雙鍵,該雜環視所需含有一個以 上的芳族環,且該環視所需爲-Q丨單或多重取代: 各八[4是環基獨立選自下列包括芳基其含有6,10,12或 14個碳原子及1至3個環,該雜環基含有5至1 5個環原子及 I至3個環,該雜環含有至少一個選自-〇-,-S-,-S〇-,S〇2 ,=N-,-NH-,-N(R5)-,及-N(R9)-之雜原子基該雜環基視 經濟部中夬標準局負工消費合:;;:·社印製 (讀先父讀背&gt;8之注意事項本頁 所需含有一個以上的雙鍵,該雜環基視所需含有一個以上 的芳族環,且該環基視所需爲-Q i單或多重取代: 各&lt;5丨獨立選自下列包括-ΝΗ2,·-(:〇2Η,-C1,-F,-Br,·Ι ,-Ν〇2,-CN,=0 :-〇Η,-全氟(:卜;炫基,R5,-〇R5, •NHR5,0R9,-N(R9)(R10),R9,-C(〇)-R1〇,及 •176- 本纸伕尺度通用中S1家標孪(CNS ) A4規格(210X 297公釐) 1235157 Λ7 Β7 五、發明説明(〃4) CH- \〇/ 限制條件爲當-Αγ3爲Q丨基所取代,其含有一個以上的額 外的-Ar3基,該額外的-Αγ3基不爲另外的-Ar3基所取代: 具鳢實例(I)另一型化合物(型1)爲式(V): 一 (V) 〇 ((Jrn R5Wherein each Y is independently selected from the following including 0 and S: each Aq is a cyclic group independently selected from the following including an aryl group containing 6, 10, 12 or 4 carbon atoms and 1 to 3 rings, and an aromatic heterocyclic ring Contains 5 to 5 ring atoms and 1 to 3 rings, the heterocyclic ring contains at least one selected from -0- ,, -SO-, S〇2, di-N-, and -NH-, -N (R5) -, And -N (R9)-heteroatoms, the heterocyclic ring may contain more than one double bond, the heterocyclic ring may contain more than one aromatic ring, and the ring may be -Q 丨 single or Multiple substitutions: each octa [4 is a ring group independently selected from the following including aryl groups which contain 6, 10, 12 or 14 carbon atoms and 1 to 3 rings, the heterocyclic group contains 5 to 15 ring atoms and I To 3 rings, the heterocyclic ring contains at least one selected from -0-, -S-, -S〇-, S〇2, = N-, -NH-, -N (R5)-, and -N (R9 )-'S heteroatom group This heterocyclic group depends on the Ministry of Economic Affairs, China Standards Bureau's off-line consumer spending: ;;: · Printed by the Society Bond, the heterocyclic group may contain more than one aromatic ring, and the ring group may be -Q i : Each &lt; 5 丨 is independently selected from the group consisting of -NΗ2, ·-(: 〇2Η, -C1, -F, -Br, · 1, -NO2, -CN, = 0: -〇Η, -all Fluorine (: Bu; Hyunyl, R5, -〇R5, • NHR5, OR9, -N (R9) (R10), R9, -C (〇) -R1〇, and • 176- S1 in paper standard Family standard (CNS) A4 specification (210X 297 mm) 1235157 Λ7 B7 V. Description of the invention (〃4) CH- \ 〇 / The restriction is that when -Αγ3 is replaced by a Q 丨 group, it contains more than one additional -Ar3 group, the additional -Aγ3 group is not replaced by another -Ar3 group: Example (I) Another type of compound (Form 1) is Formula (V): One (V) 〇 ((Jrn R5

R1—N R3 Η 2Γ;·先讀背*之注意事項 本頁) 裝 其中·· m是1或 心是 (elO-B) v2R1—N R3 Η 2Γ; · Precautions for reading first (this page) equipment where m is 1 or heart is (elO-B) v2

泉 經蓊部r央標孪局員工消費合作社印製 R3選自下列包括: •CN, -C(〇)-H · -C(0)-CH2-TrRn ^ -C(〇)-CHrF, -C=N-〇-R9 ’ 及 -C 〇-A r,: -177· 本纸伕尺度通用中国国家標導(〔&gt;^)六4規格(2〖0:&lt; 297公釐) 1235157 Β7 五、發明説明(Ί7°) 各 115是-€:(〇)〇(〇)-〇1110 ·· Υ2是H:或〇: η 先 閱 讀 背 之 注 意 % 再 填 寫 本 頁 各丁(獨立選自下列包括-〇-,,-S(〇)-匕及-S(〇):-:The R3 printed by the Consumers' Cooperative of the Central Bureau of Quanjing Economic Development Bureau is selected from the following: CN, -C (〇) -H · -C (0) -CH2-TrRn ^ -C (〇) -CHrF,- C = N-〇-R9 'and -C 〇-A r ,: -177 · The standard of this paper is in accordance with the national standard of China ([&gt; ^) 6 4 specifications (2 〖0 : &lt; 297 mm) 1235157 Β7 V. Description of the invention (Ί7 °) Each 115 is-€: (〇) 〇 (〇) -〇1110 ·· 2 is H: or 〇: η Read the note on the back first, then fill in each page of this page (select independently) From the following include -〇-, -S (〇) -dagger and -S (〇):-:

Rs選自下列包括: -C(〇)-R10, -C(〇)〇-R9 , -C(〇)-NH-R10, , -S(〇)2-R9, -S(〇)rNH-R10, - -C(O)-CHr〇R10, -C(〇)C(〇)-Rl0, -C(〇)-CHrN(R10)(Rl0), -C(〇)-CH2C(〇)-〇-R9, -C(〇)-CH2C(〇)-R9, -H,及 -C(〇)-C(〇)-〇R10 : 各R9獨立選自下列包括-A〇及-C^直或分支的烷基,視 所需爲Ar*3所取代,其中烷基視所需不绝和: 經濟部中夬糅李局員工消費合作社印袈 各Rl0獨立選自下列包括·Η,-Ar3,C3.6環烷基,及-C^ 直或分支的烷基視所需爲Αιγ3所取代,其中 &lt;卜6烷基視所 需不绝和: ^ 各R丨t獨立選自下列包括: -Αγ4, -(CH2) ι·3-Αγ4, 178 本纸法尺度適用中SS家標孪(CNS )六4緹格(2丨0X297公釐) 超濟部中央標绛局员工消贫合作社印製 1235157 Λ&quot; Β7 五、發明説明(17S) -Η,及 -C(〇)-Ar4 : ,Ri5選自下列包括-〇H,-〇Aq,-N(H)-〇R,及-〇C卜6,其 中(:“是直或分支的烷基視所需爲Ar3,-CONH2,-〇R5, -〇H,-〇R9,或-C02H所馭代: 各R2l獨立選自下列包括-H或-Cw直或分支烷基·· Αγ2獨立選自下列,其中任何環可視所需爲-Q、所單或多 重取代,或苯基,視所需爲Q 1取代:Rs is selected from the following including: -C (〇) -R10, -C (〇) 〇-R9, -C (〇) -NH-R10,, -S (〇) 2-R9, -S (〇) rNH- R10,--C (O) -CHr0R10, -C (〇) C (〇) -R10, -C (〇) -CHrN (R10) (R10), -C (〇) -CH2C (〇)- 〇-R9, -C (〇) -CH2C (〇) -R9, -H, and -C (〇) -C (〇) -〇R10: Each R9 is independently selected from the following including -A〇 and -C ^ Or branched alkyl, which is replaced by Ar * 3 as needed, where the alkyl is as incessant as required: each of the R10 is independently selected from the following including-包括, -Ar3 , C3.6 cycloalkyl, and -C ^ straight or branched alkyl are optionally substituted by Αγγ3, where &lt; 6 alkyl is as incessant as necessary: ^ each R, t is independently selected from the following including : -Αγ4,-(CH2) ι · 3-Αγ4, 178 The paper method is applicable to the SS family standard twin (CNS) six 4 Tig (2 丨 0X297 mm) The Ministry of Economic Affairs Central Standards Bureau staff poverty alleviation cooperative Print 1235157 Λ &quot; B7 V. Description of the Invention (17S) -Η, and -C (〇) -Ar4:, Ri5 is selected from the following including -〇H, -〇Aq, -N (H) -〇R, and- 〇Cb 6, where (: "is a straight or branched alkyl group Must be Ar3, -CONH2, -〇R5, -〇H, -〇R9, or -C02H: Each R2l is independently selected from the following including -H or -Cw straight or branched alkyl ... Aγ2 is independently selected from the following , Where any ring is optionally -Q, all or multiple substitutions, or phenyl, if necessary, Q 1 substitution:

其中各Υ獨立選自下列包括〇及S ; 各八1:3是環基獨立選自下列包括芳基,其含有6,10,12 或14個碳原子及1至3個環,及芳族雜環基含有5至15個環 原子及1至3個環,該雜環基含有至少一個選自-〇·,-S-,· S〇-,S02,=Ν-,及-ΝΗ-,-N(R5)-,及-N(R9)-之雜原子基, 該雜環基視所需含有一個以上的雙鍵,該雜環基視所需含 有一個以上的芳族環,且該環基視所需爲-Qi所單或多重 取代: · 各Αγ4是環基獨立選自下列包括:芳基其含有6,10,12 或[4個碳原子及I至3個環,又雜環基含有5至1 5個環原子 及1至3但艰,該雜環基含有至少一個選自-〇-,,-SO· -179- 本纸伕尺度逑用ts國家標李(CNS ) Α4規格(210/ 297公釐) (請先絮豸背云之:V〗意事項寫太買) 裝 訂 泉 1235157 - A .· B7 五、發明説明(1T7) ,S〇2,=Ν-,-ΝΗ-,-N(R5)-,及-N(R9)-之雜原子基,該雜 t基視所需含究二個以上的雙鍵,該雜環基視所需含有一 1以上的芳族環,且該環基視所需爲-Q丨/斤單或多重取代 各Qi獨立選自下列包括-NH2,-C〇2H,-C卜-F,-Br,-I ,-NO],-CN,二〇,-〇H,-全氟(:卜3 燒基,R)·,-〇R5, -NHR5,0R9,-N(R9)(Ri〇),R9,-C(〇)-Rl0,及· 〇 - / \ CH,·. \ / ^ 〇 限制條件爲當-Ar3爲Q i取代,其含有一個以上額外的 -Αγ3基,該額外的-Αγ3基不爲另外的-Αγ3基所取代: 另外,具體實例I此型化合物(型2)爲其中R21是-CH3者。 具體實例(J)另一型化合物(型1)爲式(V): 玉 -裝 (V)Wherein each Υ is independently selected from the following including 0 and S; each of 8: 3 is a cyclic group independently selected from the following including aryl, which contains 6, 10, 12 or 14 carbon atoms and 1 to 3 rings, and aromatic Heterocyclyl contains 5 to 15 ring atoms and 1 to 3 rings, and the heterocyclyl contains at least one selected from -〇 ·, -S-, · S〇-, S02, = N-, and -Ν ,-, -N (R5)-, and -N (R9)-hetero atom groups, the heterocyclic group contains more than one double bond as required, the heterocyclic group contains more than one aromatic ring as needed, and the Cyclic radicals are optionally single or multiple substitutions by -Qi: · Each Aγ4 is a cyclic radical independently selected from the following including: aryl radicals containing 6, 10, 12 or [4 carbon atoms and 1 to 3 rings, and heterocyclic The cyclic group contains 5 to 15 ring atoms and 1 to 3, but the heterocyclic group contains at least one selected from -0- ,, -SO · -179- This paper uses the ts national standard plum (CNS) Α4 specifications (210/297 mm) (please take a look at the back: V 〖Writing matters to write too buy) Binding spring 1235157-A. · B7 V. Description of the invention (1T7), S〇2, = Ν-, -NΗ-, -N (R5)-, and -N (R9)-are heteroatom radicals, and the heterot radical contains two as necessary Double bond, the heterocyclic group may contain one or more aromatic rings as required, and the ring group may be -Q 丨 / jin mono or multiple substitution as required, each Qi is independently selected from the following including -NH2, -C 〇2H, -C, -F, -Br, -I, -NO], -CN, 20, -0H, -perfluoro (: Bu 3 alkyl, R) ·, -〇R5, -NHR5, 0R9, -N (R9) (Ri〇), R9, -C (〇) -Rl0, and · 〇- / \ CH, ·. \ / ^ 〇 The restriction is that when -Ar3 is Q i substitution, it contains a The above additional -Aγ3 group, the additional -Aγ3 group is not replaced by another -Aγ3 group: In addition, Specific Example I A compound of this type (Form 2) is one in which R21 is -CH3. Specific Example (J) Another type of compound (Form 1) is formula (V): Jade-Equipment (V)

泉 經濟部中央橾準局只工消費合作社印製 其中: m是1或2 : 心是 (elO-B) y2Quan Printed by the Central Government Bureau of the Ministry of Economic Affairs of the People's Republic of China, where: m is 1 or 2: heart is (elO-B) y2

-180- 本纸铁尺度適用宁§ S家標李(CNS ) A4規格(2丨0 X 297公;$ ) 1235157 Λ7 B7 五、發明説明(178) R3選自下列包括: -CN, -C (〇)-Η ’ -C(〇)-CH2-TVRn, -C(〇)-CHrF, -C = N-〇-R9,及 -C 〇-A r 7 : 各115獨立選自下列包括: -C(0)-Rj 0 ? -C(〇)〇-R9 , -C(O)-N(Rl0)(Rl0)-180- The iron scale of this paper is suitable for Ning § S House Standard Li (CNS) A4 specification (2 丨 0 X 297 male; $) 1235157 Λ7 B7 V. Description of the invention (178) R3 is selected from the following including: -CN, -C (〇) -Η ′ -C (〇) -CH2-TVRn, -C (〇) -CHrF, -C = N-〇-R9, and -C 〇-A r 7: Each 115 is independently selected from the following including: -C (0) -Rj 0--C (〇) 〇-R9, -C (O) -N (Rl0) (Rl0)

-S(0)2-R9 J -S(〇)2-NH-R1〇, -C(〇)-CHr〇-R9, -C(〇)C(〇)-R10, -R9, -H, •C(〇)C(〇)-〇Rl0,及 -C(〇)C(〇)-N(R9)(R10): 經濟部中央標準局員工消背合作杜印¾ (請先¥讀背云之··:ί!意事項大二貝) 丫2是七或0 : 各T丨獨立選自下列包括-〇-,-ST-,-S(〇)-,及4(0)2-: Rs選自下列包括: -C(〇)-Ri〇, -C(〇)0-R9 , -181 - 本紙法尺度逯闫中§国家標孪(CNS ) Α4現格(210X297公釐) 1235157 Λ; B7 經濟部中央標绛局員工消f合作社印¾ 五、發明説明(179) -C(〇)-NH-R10, •S(〇)2-R9, -s(〇)2-nh-r10, , -C(〇)-CH厂〇Ri〇, -C(〇)C(〇)-R10, -C(〇)-CH2-N(R10)(R10), -C(〇)-CH2C(〇)-〇-R9, · -C(〇)-CH2C(〇)-R9, -H, * -C(〇)-C(〇)-〇R10,及 -C(〇)-C(O)-N(R9)(Rl0): 各尺9獨立選自下列包括·Α〇及-C^直或分支的烷基,視 所需爲所取代,其中-Cw烷基視所需不绝和: 各民1()獨立選自下列包括-Η,-Αγ3,0:3.6環烷基,及-(:卜6 直或分支的烷基視所需爲A”所取代,其中-Cu烷基視所 需不绝和: 各1^1獨立選自下列包括: •Ar4, -(CΗ2)ι.3*Αγ4 j -Η,及 -C(0)-Ar^ · R15選自下列包括-〇Η,-〇Αγ3,-Ν(Η)-ΟΗ,及-OCm,其中 Cy是直或分支烷基視所需爲Αι·3取代, -C〇NH2,-OR5,-〇H,-〇R9,或-C〇2H : -182- (請先聞讀背面之:νϊ事項寫本頁) —裝 訂 旅 本技伕尺度逑用中国国家揉皁(CNS)A4規格(2ίΟΧ297公釐) 1235157 A: B7 五、發明説明( 各R2^ it自卜·刊包括4或直或分支的烷基: ΑΓ2獨立選自下列,其中任何環可視所需爲-Qi單或多重 取代,或苯基規所需爲QI取代; /-S (0) 2-R9 J -S (〇) 2-NH-R1〇, -C (〇) -CHr〇-R9, -C (〇) C (〇) -R10, -R9, -H, • C (〇) C (〇) -〇R10, and -C (〇) C (〇) -N (R9) (R10): Du Yin Du, staff of the Central Standards Bureau of the Ministry of Economic Affairs Yun Zhi ...: !! Matters of second nature) Ya 2 is seven or 0: each T 丨 is independently selected from the following including -〇-, -ST-, -S (〇)-, and 4 (0) 2- : Rs is selected from the following including: -C (〇) -Ri〇, -C (〇) 0-R9, -181-Paper method scale Yan Yan § National Standard Twin (CNS) A4 (210X297 mm) 1235157 Λ; B7 Employees of the Central Bureau of Standards, Ministry of Economic Affairs, Cooperative Cooperatives Ⅴ. Description of Invention (179) -C (〇) -NH-R10, • S (〇) 2-R9, -s (〇) 2-nh- r10,, -C (〇) -CH 厂 〇〇, -C (〇) C (〇) -R10, -C (〇) -CH2-N (R10) (R10), -C (〇) -CH2C (〇) -〇-R9, -C (〇) -CH2C (〇) -R9, -H, * -C (〇) -C (〇) -〇R10, and -C (〇) -C (O ) -N (R9) (R10): Each foot 9 is independently selected from the group consisting of: Α〇 and -C ^ straight or branched alkyl, substituted as necessary, wherein -Cw alkyl as necessary and : Each min 1 () is independently selected from the following including-包括, -Αγ3,0 : 3.6 cycloalkyl, and-(: Bu 6 straight or branched alkyl is optionally substituted by A ", wherein -Cu alkyl is optionally as follows: each 1 ^ 1 is independently selected from the following including: • Ar4,-(CΗ2) ι.3 * Αγ4 j -Η, and -C (0) -Ar ^ · R15 is selected from the following including -〇Η, -〇Αγ3, -Ν (Η) -ΟΗ, and -OCm, Where Cy is a straight or branched alkyl group, optionally substituted with Aι · 3, -C〇NH2, -OR5, -〇H, -〇R9, or -C〇2H: -182- (Please read the back: νϊMatters written on this page) —The technical specifications of the binding book use the Chinese National Soap Soap (CNS) A4 specification (2 ΙΟ × 297 mm) 1235157 A: B7 V. Description of the invention (Each R2 ^ it self-explanation includes 4 or straight Or branched alkyl group: ΑΓ2 is independently selected from the following, in which any ring may be -Qi single or multiple substitution as required, or phenyl substitution is required for QI substitution;

及 其中各Y獨立選自下列包括0及S: 各八1*3是環基镡立選自下列包括任何芳基其含有6,1〇, 12或14個竣原予及1至3個環及芳族雜環含有5至15個環原 子及1三:個每,該雜環含有至少一個選自-〇-,-S·,-SO-, S02 N 及’Η-,-N(R5)-,及-N(R9)-雜原子基,該雜環 基視所f含有-個以上的雙鍵,該雜環基視所需含有一個 ,上勺芳族/衣,且該環基視所需爲-Qi所單或多重取代: 各Al*4是環基,獨立選自下列包括芳基,其含有6,1〇, 12或14個碳原子及1至3個環,及雜環基含有5至15個碳原 子及1至3個環,該雜環基含有至少一個選自, ,· .??*部中夬橾车局員工消費合作枉印製 s〇 S02 Ν’ ’ -NH- , -N(R5)-及-N(R9)-之雜原子基,該 j環基視所f含有一個以上的雙鍵,該雜環基視所需含有 一個以上的方疾環,且該環基視所需被-Q丨單或多重取代: 各Q丨獨立選自下列包括: •I ’ -N〇2 ’ -CN,=〇,-〇H,.全氟 c卜;这基,R)·,·〇^, -nhr5,or9,-N(R9)(Ri〇),R9,.c(〇)·及 183- 1235157 A* B7 CH- F艮制條件爲當-ΑΓ3爲Q1基取代時,其含有一個以上額外 的- A”基,該額外的·Αγ3基不爲另外的-八1:3基所取代: 哏制條件爲當: m是1 :And each Y is independently selected from the following including 0 and S: each of 1 * 3 is a cyclic group and is selected from the following including any aryl group which contains 6, 10, 12 or 14 quaternions and 1 to 3 rings And aromatic heterocyclic rings contain 5 to 15 ring atoms and 1 to 3: each, the heterocyclic ring contains at least one selected from -0-, -S ·, -SO-, S02 N and 'Η-, -N (R5 )-, And -N (R9) -heteroatom group, the heterocyclic group contains more than one double bond depending on f, the heterocyclic group contains one if necessary, aromatic / coating, and the ring group Single or multiple substitutions as required by -Qi: each Al * 4 is a cyclic group, independently selected from the following including aryl groups, which contain 6, 10, 12 or 14 carbon atoms and 1 to 3 rings, and hetero The cyclic group contains 5 to 15 carbon atoms and 1 to 3 rings, and the heterocyclic group contains at least one selected from the group consisting of,... -NH-, -N (R5)-and -N (R9)-heteroatomic group, the j ring group may contain more than one double bond, and the heterocyclic group may contain more than one square ring, if necessary. And the ring base is optionally substituted by -Q 丨 single or multiple: each Q 丨 is independently selected from the following: I'-N〇2 '-CN, = 〇, -〇H ,. perfluoroc, this group, R) ·, · 〇 ^, -nhr5, or9, -N (R9) (Ri〇), R9, .c (〇) · And 183-1235157 A * B7 CH-Fgen conditions are that when -ΑΓ3 is substituted with a Q1 group, it contains more than one additional -A "group, the additional · Aγ3 group is not another -8 1: 3 Substituted by: The control condition is when: m is 1:

Ri是(elO): X5 是 CH : - 民!5是-〇H ·· R2i是-Η :且 乂2是0且R3是·〇:(0)-Η,則R5不可爲: 未經 N-(4-曱基 -C(〇)-Rl(},其中R丨0是-Αγ3且Ar3環基是苯基 代,4-(羧甲氧基)笨基,2-氟苯基,2-吡啶基 六氫吡年基)甲基苯基,或 -C(〇)-〇R9,其中R9是-CH2-Ar3,且Ar3環基是笨基,未 被-Qi取代··且當: 丫2是〇,R3 是-CCOhCHrTVRH,^是。,且 Rn 是 Αγ4, 其中Ar4環基是5-( 1-(4-氯苯基)-3-三氟曱基)吡唑基),則R5 經濟部中夬標孪局員工消费合作枉印製 不可爲: -C(〇)-R|0,其中Rl0是-Αγ3且A&gt;3環基是4-(二甲胺基甲基) 笨基,笨基,4-(羧甲硫基)苯基,4-(羧乙硫基)笨基,4-( 羧乙基)苯基,4-(羧丙基)苯基,2-氟笨基,2-吡啶基,ΜΗ- 曱基 六氫吡 嘈基) 甲 基笨基 ,或 -184 - 本纸ft尺度通用中§国家標準(CNS ) A4規格(2i〇X297公釐) 1235157 Λ_ Β7 五、發明説明(132) -C(〇)-〇R9,其中R9{-CH2-Ar3iAr3環基是苯基: 且當Rn是Ar4,其中Αγ4環基是5-(1-苯基-3-三氣甲基)η七 哇基),則R5不可爲: , •C(〇)-〇R9,头中 R9是-CHyAr^ ’ Ar”冢 &amp; 是各;fe·: 且當Rn是Ar4,其中Ar4環基是5-(1-(2-吡啶基)-3-三氣曱 卷):比峻基)’則R 5不可A ·· •C(〇)-Ri〇,其中R丨0是-Ai*3,Ar3環基是4-(二申胺基甲基) 笨基,或 -C(〇)-〇R9 ’其中R*9疋-CH2-Ai*3 ’且基是苯基’禾 被-Q I所取代:且當 Υ2是〇,R3是-C(〇)-CHrTrR丨|,Τι是〇且Ru是-C(〇)-Aq,其中Αγ4環基是2,5-二氣笨基,則R5不可爲: -C(〇)-Ri〇,其中R|〇疋- Αγ]且Ai*3’篆卷是4-(二子胺卷甲卷) 苯基,4-(N-嗎福啉基甲基)笨基,4-(N-甲基六氫畎呤基)曱 基)苯基,4-(Ν-(2·甲基)咪唑基曱基)苯基,5-笨並咪唑基 ,5-苯ϋ三唑基,Ν-乙酯基-5-苯並三唑基,Ν·乙酯基〇-笨益咪唑基,或 -C(〇)-〇R9,其中尺9是-CH2-Ar3且Ar3環基是笨基,不爲 -Qi所取代:且當 Y2 是 H2,R3 是-CCOpCHyTt-RH,丁丨是〇’且 Ri 丨是 -C(0)-Ar4,其中Αγ4環基是2,5-二1笨基,則R5不可爲: -C(〇)-OR9,其中R9是-CH2-Ar3且Αγ3環基是笨基。 具體實例J另一型化合物(型2),爲其中R2l是-CH3。 具體實例J另一型(型3 ),爲其中115是-C(〇)-C(〇)- 185 本紙杀尺度適用中SS家糅李(CNS ) Μ規格(210X297公釐) 請 先 讀 背 δ 之 注 意 畜Ri is (elO): X5 is CH:-Min! 5 is -〇H · · R2i is -Η: and 乂 2 is 0 and R3 is · 〇: (0)-Η, then R5 cannot be: without N- (4-fluorenyl-C (〇) -R1 (}, Where R0 is -Aγ3 and the Ar3 ring group is phenyl, 4- (carboxymethoxy) benzyl, 2-fluorophenyl, 2-pyridylhexahydropyridinyl) methylphenyl , Or -C (〇) -〇R9, where R9 is -CH2-Ar3, and the Ar3 ring group is a benzyl group, which is not substituted with -Qi ... and when: γ2 is 〇, R3 is -CCOhCHrTVRH, ^ Yes. And Rn is Αγ4, where the Ar4 ring group is 5- (1- (4-chlorophenyl) -3-trifluorofluorenyl) pyrazolyl), then the R5 Ministry of Economic Affairs won the bid of the employee co-operation seal of the Twin Bureau. The system cannot be: -C (〇) -R | 0, where R10 is -Aγ3 and A &gt; 3 ring group is 4- (dimethylaminomethyl) benzyl, benzyl, 4- (carboxymethylthio) Phenyl, 4- (carboxyethylthio) benzyl, 4- (carboxyethyl) phenyl, 4- (carboxypropyl) phenyl, 2-fluorobenzyl, 2-pyridyl, MΗ-fluorenylhexa Hydroxypyridyl) Methylbenzyl, or -184-General ft dimensions of this paper § National Standard (CNS) A4 Specification (2i × 297 mm) 1235157 Λ_ B7 V. Description of the Invention (132) -C (〇) -〇R9, where R9 {-CH2-Ar3iAr3 The ring group is phenyl: and when Rn is Ar4, where the Aγ4 ring group is 5- (1-phenyl-3-trifluoromethyl) n-heptyl), then R5 cannot be:, C (〇)- 〇R9, R9 in the head is -CHyAr ^ 'Ar "Tsuk &amp; is each; fe ·: and when Rn is Ar4, where the Ar4 ring group is 5- (1- (2-pyridyl) -3-trifluorocarbamidine (Vol.): Bi Junji) 'R 5 cannot be A ··· C (〇) -Ri〇, where R 丨 0 is -Ai * 3, Ar3 ring group is 4- (dityaminoamino) benzyl , Or -C (〇) -〇R9 'wherein R * 9 疋 -CH2-Ai * 3' and the group is phenyl 'and substituted by -QI: and when Υ2 is 0, R3 is -C (〇)- CHrTrR 丨 |, Ti is 0 and Ru is -C (〇) -Aq, where the Aγ4 ring group is 2,5-diazyl, then R5 cannot be: -C (〇) -Ri〇, where R | 〇疋-Αγ] and Ai * 3 '篆 volume is 4- (diamine amine volume volume) phenyl, 4- (N-morpholinylmethyl) benzyl, 4- (N-methylhexahydroxanthine (Yl) fluorenyl) phenyl, 4- (N- (2.methyl) imidazolylfluorenyl) phenyl, 5-benzimidazolyl, 5-benzotriazolyl, N-ethyl-5- Benzotriazolyl, N · ethylethyl-benzimidazolyl, or -C (〇) -ORR9, where Chi9 is -CH2-Ar3 and Ar3 Is a stupid group and is not replaced by -Qi: and when Y2 is H2, R3 is -CCOpCHyTt-RH, Ding is 0 'and Ri is -C (0) -Ar4, where the Aγ4 ring group is 2,5 -Two 1-benzyl, then R5 cannot be:-C (〇) -OR9, where R9 is -CH2-Ar3 and the Aγ3 ring group is benzyl. Specific Example J Another type of compound (Form 2), wherein R2l is -CH3. Specific example J Another type (type 3), where 115 is -C (〇) -C (〇)-185 This paper is suitable for standard SS furniture (CNS) M size (210X297 mm) Please read the back δ attention animal

太 I 超濟部中夬標生局員工消费合作社印?冬 1235157 Λ&quot; S7 五、發明説明(183) 10Tai I Chaoji Ministry of Health, Standards and Health Bureau employee consumer cooperative seal? Winter 1235157 Λ &quot; S7 V. Description of Invention (183) 10

OR 請 % 讀 背 δ 意 % 弄 填 本 頁 具ft實例J另一塑化合物(型4),爲其中115是-C(〇)-C(〇)- OR^ 〇,且 R2 丨是-CH; 3 , 具ft實例Η,I及J較佳化合物應用式(V),其中R3是 -C〇-Ar,3 較好,當是-C〇-Ar2,Y是〇。 具體實例Η,I及J較佳化合物應用式(V),'其中R3是 -C^OPCHrTVI^ [且!^!是-(CHJw-Aq。 較好,當 R3 是-CCOhCHrTl-RH 且 Rn|-(CH2)「rAt*4,OR Please read δ %% to fill in this page. Example J Another plastic compound (type 4), where 115 is -C (〇) -C (〇)-OR ^ 〇, and R2 丨 is -CH 3, with ft Example VII, preferred compounds of I and J use formula (V), where R3 is -C0-Ar, 3 is more preferred, when -C0-Ar2, Y is 0. Specific Example Η, the preferred compounds of I and J use formula (V), 'wherein R3 is -C ^ OPCHrTVI ^ [and! ^! Is-(CHJw-Aq. Better, when R3 is -CCOhCHrTl-RH and Rn |-(CH2) "rAt * 4,

TjSO。 具體實例Η,I及J較佳化合物應用式(V),其中R3是 •C(〇)-CH2-TrRn,1^*0 且 Rn 是-C(〇)-Ar4。 具體實例Η,I及J較佳化合物應用式(V),其中R3是 -C(〇)-H。 具體實例Η,I及J較佳化合物應用式(V),其中R3是 -C(〇)-CH7-T「Rii ’ 且 R【丨疋-A ι*4 3 較好,當 R3 是-C(〇)-CH2-TrRniRn 是-Αι·4,丁1 是〇或 S。 較佳的具體實例Η及J化合物(型I及型2 )爲其中R5選自 下列包括: •避濟部中央標準局員工消资合作杜印¾ -C(〇)-R10, -C(〇)CMl9,及 · -C(〇)-NH-Rl0。 另外,較佳的具體實例Η及J (型1及型2 )爲其中R5選自 下列包括: -186 本纸伕尺度遝用中国囯家標孪(CNS ) A4規格(210X 297公釐) 經濟部中央糅孪局員工消資合作社印^ 1235157 Λ7 Β7 五、發明説明(184) -S(〇),-R9 ’ -S(〇)”NH-Ri〇 ’ -C(〇)-C(〇)-Rl0, , -R9, -C(〇)-C(〇)-〇Rl0,及 •C(〇)C(〇),N(R9)(Rl0)。 最好,R5{-C(〇)-C(0)-Ri〇。 - 另外,115是-匸(〇)-匸(〇)-〇1110。 具體實例Η,1(型2)及J(型2犮型4)較佳化合物爲其中: m是1 : 是〇: R15是-〇H或-OCm直或分支烷基視所需爲Ar3,-〇H,-〇R9,-C〇2H取代,其中119是-Ct.4分支或直鏈烷基:其中 Αγ3是嗎福嗒基或苯基,其中笨基視所需爲I所取代: Αγ2 是(hh): Y是〇:且 各Aq環基獨立選自下列包括苯基,莕基,這吩基,喹諾 沐基,異7查語琳基,7比吐基,5塞峻基,異3惡咬基,苯益三 唑基,苯並咪唑基,邊吩並4吩基,咪唑基,s塞二唑基, 苯並[b]硫笨基,吡啶基,笨並呋喃基,及4哚基,且該環 狀基視所需爲單或多重取代:' 各Ar4環基獨立選自下列包括笨基,四唑基,α比啶基,鳴 唑基,莕基,嘧啶基及噻吩基,且該環基視所需爲單 或多重取代: -187- 本纸法尺度通用中家猱淳ί CNS ) Α4規格(210Χ297公釐) (請先笑讀背云之:意事項尽頁 1Τ 1235157 A*&quot; B7 五、發明説明(135) 各卩丨獨立選自下列包括-NH2,-Cl,-F,-Br,-〇H,-R9, -NH-R5,其 t R5 是0或-S(〇)2-R9,-0115其 t 115是 -C(〇)-R1{},·0Ι19,-N(R9)(R10),及 , 〇 八 ch2,TjSO. Specific Example VII. Preferred compounds of I and J use formula (V), wherein R3 is C (〇) -CH2-TrRn, 1 ^ * 0 and Rn is -C (〇) -Ar4. Specific Example VII. Preferred compounds of I and J use formula (V), wherein R3 is -C (0) -H. Specific example Η, the preferred compounds of I and J use formula (V), wherein R3 is -C (〇) -CH7-T "Rii 'and R [丨 疋 -A ι * 4 3 is better, when R3 is -C (〇) -CH2-TrRniRn is -Al · 4, but 1 is 0 or S. Preferred specific examples Η and J compounds (type I and type 2) are wherein R5 is selected from the following including: Bureau's employee capital cooperation Du Yin ¾ -C (〇) -R10, -C (〇) CMl9, and -C (〇) -NH-Rl0. In addition, preferred specific examples Η and J (type 1 and type 2) where R5 is selected from the following including: -186 paper size, using the Chinese National Standard (CNS) A4 size (210X 297 mm), printed by the Consumers ’Cooperative of the Central Government Bureau of the Ministry of Economic Affairs ^ 1235157 Λ7 Β7 5 Description of the invention (184) -S (〇), -R9 '-S (〇) "NH-Ri〇' -C (〇) -C (〇) -R10,, -R9, -C (〇) -C (〇) -〇R10, and • C (〇) C (〇), N (R9) (R10). Preferably, R5 {-C (0) -C (0) -Ri0. -In addition, 115 is-匸 (〇)-匸 (〇) -〇1110. Specific examples Η, 1 (type 2) and J (type 2 犮 type 4) are preferred compounds among them: m is 1: yes 0: R15 is -0H or -OCm straight or branched alkyl is Ar3 if necessary, -〇H, -〇R9, -CO2H substitution, where 119 is -Ct.4 branched or straight-chain alkyl: where Aγ3 is a moffordyl or phenyl group, where the benzyl group is substituted by I if necessary: Αγ2 is (hh): Y is 0: and each Aq ring group is independently selected from the group consisting of phenyl, fluorenyl, phenenyl, quinolyl, iso- 7-Calinyl, 7-bitulyl, 5 Group, iso3-oxazyl group, phenyltriazolyl group, benzimidazolyl group, side pheno 4-phenyl group, imidazolyl group, sedadiazole group, benzo [b] thiobenzyl group, pyridyl group, benzofuranyl group And 4 indolyl, and the cyclic radical is optionally single or multiple substitutions: 'Each Ar4 cyclic radical is independently selected from the group consisting of benzyl, tetrazolyl, alphapyridyl, omnazolyl, fluorenyl, Pyrimidinyl and thienyl, and the cyclic base may be a single or multiple substitutions as required: -187- The size of the paper method is commonly used in Chinese homes, ίCNS) Α4 specification (210 × 297 mm) (please read with a smile: Notes at the end of the page 1Τ 1235157 A * &quot; B7 V. Description of the invention (135)卩 丨 is independently selected from the group consisting of -NH2, -Cl, -F, -Br, -OH, -R9, -NH-R5, where t R5 is 0 or -S (〇) 2-R9, -0115 and t 115 is -C (〇) -R1 {}, · 019, -N (R9) (R10), and 〇 八 ch2,

經濟部中夬標孪局負工消費合作社印¾ 其中各^^及尺丨0獨立地爲-Cw直或分支的烷基視所需爲 Ar3所取代,其中Ar3環基是苯基,且該環基視所需爲- 單或多重取代: 限制條件爲當-Ar3爲-Q |取代,其含有一個以上額外的 -Αγ3|,該額外的· Ar3基不爲另外的-Αγ3基所取代。 較ί圭的具鳢實例I (型1 )及J (型3 )化合物爲其中: m是1 : R:n 是-H或-CH3 : R5l是(^.6直或分支烷基視所需爲Αγ3所取代,其中八1*3環 基是笨基,該環基視所需爲-Qi多重或單取代: 各Ar3環基獨立選自下列包括苯基,莕基,4吩基,4諾 令基,異咬爸味基,p比咬基,也基,異喔唾基,笨並三 唑基,笨並咪唑基,嚎吩並違吩基,咪唑基,唁二唑基, 苯益[b]硫苯基,吡啶基,苯並呋喃基,或啕哚基,且該環 基視所需爲單或多取代; ‘ 各Q丨獨立選自下列包括-NH2,-Cl,-F,-Br,-〇H,-R9, -NH-R5,其中 R5 是-C(〇)-Rl0 或-S(〇)2-R9,-0R5 其中 115是 -C(〇)·!^。,-0R9 ’ -N(R9)(R10) ’ 及 -188· (請先聞讀背面之注意事3^-本£ 訂 .果 本紙伕尺度遝用中§S家標李(CNS ) A4規格(210X297公釐) 1235157 Λ · Β; 五、發明説明(18S) CH- 其中各119及111(}獨立地爲直或分支汔基,視所需爲 Ar3所馭代,其中Ar3環基是苯基,且該環基視所需爲-I 單或多取代: 限制條件爲當-Ar3爲Q丨基所取代,其含有一德以上額外 的· Ars基,該額外的-Αγ3基不爲另外的-基所取代。 較好,於這些較佳化合物冲,Ar;環基選自下列包括: 苯基,茶基,5塞吩基,4語7沐基,異4語母基,σ比峻基, 4唑基,異噁唑基,苯並三唑基,笨並咪唑基,4啥並遙 吩基,咪唑基,嚏二唑基,苯並[b]硫苯基,笨益呋嘀基, 及啕哚基,且該環基視所需爲-Q丨所單或多重取代。 具體實例Η及J (型1及1 )之較佳化合物爲其中: R3是-C(〇)-CH2-TrRn : 丁丨是0 :且Printed by the Ministry of Economic Affairs, the Bureau of Work and Consumer Cooperatives, where each of ^^ and 尺 0 is independently -Cw straight or branched alkyl, optionally substituted by Ar3, where the Ar3 ring group is phenyl, and the Cyclic radicals are optionally-single or multiple substitutions: The limitation is that when -Ar3 is substituted with -Q |, it contains more than one additional -Aγ3 |, and this additional Ar3 group is not substituted by another -Aγ3 group. More specific examples of compounds I (type 1) and J (type 3) are: m is 1: R: n is -H or -CH3: R5l is (^ .6 straight or branched alkyl as required Substituted by Aγ3, in which the eight 1 * 3 ring group is a benzyl group, and the ring group is optionally -Qi multiple or single substitution: each Ar3 ring group is independently selected from the following including phenyl, fluorenyl, 4phenyl, 4 Norlingyl, Isoamidine, p-Syrenyl, Yenyl, Isoxalyl, Benzotriazolyl, Benzimidazolyl, Methacene, Imidazolyl, Amadiazolyl, Benzene [B] thiophenyl, pyridyl, benzofuryl, or fluorinyl, and the cyclic group may be mono- or poly-substituted as desired; each Q is independently selected from the following including -NH2, -Cl,- F, -Br, -OH, -R9, -NH-R5, where R5 is -C (〇) -R10 or -S (〇) 2-R9, -0R5 where 115 is -C (〇) ·! ^ ., -0R9 '-N (R9) (R10)' and -188 · (Please read the notes on the back 3 ^ -book £ order. Fruit paper size standard in use §S House Standard Li (CNS) A4 Specifications (210X297 mm) 1235157 Λ · Β; 5. Description of the invention (18S) CH- where each of 119 and 111 () are independently straight or branched fluorene groups, if necessary A Generations controlled by r3, in which the Ar3 ring group is phenyl, and the ring group is -I mono- or poly-substituted as required: The limitation is that when -Ar3 is substituted with a Q 丨 group, it contains more than one German · Ars The additional -Aγ3 group is not substituted by another-group. Preferably, in these preferred compounds, Ar; the cyclic group is selected from the group consisting of: phenyl, theophyl, 5-sedenyl, 4- and 7- Molybdenum, iso-4 parent group, sigmadol, 4-oxazolyl, isoxazolyl, benzotriazolyl, benzimidazolyl, 4 benzotetralyl, imidazolyl, cydiazolyl, benzene And [b] thiophenyl, benzyfuryl, and fluorinyl, and the cyclic group may be mono- or multi-substituted as required by -Q. Specific examples Η and J (types 1 and 1) are preferred The compound is where: R3 is -C (〇) -CH2-TrRn: butyl is 0: and

Rh是-C(〇)-Ar4,其中Αγ4環基選自下列包括四唑基,咬 啶基,嚏唑基,嘧啶基,及4吩基,且該環基視所需爲-Qi 所單或多重取代。 經浒部中央標準局貝工消費合作社印製 (請先閱讀背云之泛意事項再填寫本頁) 具體實例Η,I及J較佳化合物應用式(V),其中R3是 •CO-CH2-TVRn,Rn是·Αγ4,其·中Αγ4環基是吡啶基,且 該環基視所需爲所單或多重取代。 具體實例J (型1 )之較佳化合物爲其中: R3是-C(〇)-H,且 -189- 本纸伕尺度適用中§國家標李(CNS ) Α4規格(210 Χ297公釐) 1235157 Λ7 . B7 五、發明説明(187) 是-C(〇)-R10,其中Rh is -C (〇) -Ar4, in which the Aγ4 ring group is selected from the group consisting of tetrazolyl, pyridyl, acrizolyl, pyrimidinyl, and 4phenyl, and the ring is as required by -Qi Or multiple substitutions. Printed by the Ministry of Standards and Technology of the People's Republic of China Standards Bureau (Consumer's General Matters before filling out this page) Specific examples Η, I and J preferred compounds apply formula (V), where R3 is • CO-CH2 -TVRn, Rn is -Aγ4, in which the Aγ4 ring group is pyridyl, and the ring group is mono- or multi-substituted as desired. The preferred compound for specific example J (type 1) is among them: R3 is -C (〇) -H, and -189- The paper size is applicable § National Standard Plum (CNS) A4 specification (210 x 297 mm) 1235157 Λ7. B7 V. Description of the invention (187) is -C (〇) -R10, where

RlQ是Αγ3,其中A”環基是笨基,視所需爲下列所單或多 重取代: / -F, -CM, -N(H)-R5,其中-115是-:9或-C(〇)-R1(),其中 R10是-(:卜6直 或分支的烷基,視所需爲Ar3所取代,其中八1*3是_苯基, -N(R9)(R1Q),其中119及111()獨立地爲&lt;卜4直或分支的烷基 ,或 - -〇-R5,其中R5是H或-Cy直或分支的烷基。 較好,Αγ;是笨基視所需在3-或5-位置上爲-C1或在4位置 上爲-NH-R5,-N(R9)(R丨〇)或-〇-R5所單或多重取代: 具體實例J其他較佳化合物(型1 )爲其中: R3 是-C(〇)-H : 115是-C(〇)-RlQ,其中R1()是八1*3且Αγ3環基選自下列包括 峭哚基,笨並咪唑基,4吩基,及笨並[b]硫笨基,且該環 基視所需爲-(^所單或多重取代: 具體實例J其他較佳化合物(型1 )爲其中·· R3是-C(〇)-H ·· R5S-C(〇)-Rl(),其中R1Q是八[3且Αγ3環基選自下列包括4 喵基及異4嗒基,且該環基視所需爲所單或多取代: 具體實例J其他較佳化合物(型1 )爲其中·· R3 是-C(〇)-H ; R5是-C(〇)-Ri〇 ’其中Ri〇是ΑΓ3且基是禾基’爲 本尺度通用中gg家標窣(CNS ) A4規格(210X 297公釐) (請先兒讀背S之注意事項再填寫本一貝) 裝- 訂 1235157 Λτ Β7 五、發明説明(18S) 0\/ CH, 所取代。具韹實例(J)較佳化合物包括下列 但不限於此: 2002R1Q is Αγ3, in which the A "ring group is a benzyl group, which may be single or multiple substitutions as required: / -F, -CM, -N (H) -R5, where -115 is-: 9 or -C ( 〇) -R1 (), where R10 is-(: Bu 6 straight or branched alkyl, optionally substituted by Ar3, where 1 * 3 is -phenyl, -N (R9) (R1Q), where 119 and 111 () are independently &lt; Bu 4 straight or branched alkyl, or--0-R5, where R5 is H or -Cy straight or branched alkyl. Preferably, Aγ; Requires -C1 at the 3- or 5-position or -NH-R5, -N (R9) (R 丨 〇) or -〇-R5 at the 4-position: Single or multiple substitutions: Specific example J Other preferred The compound (form 1) is: where R3 is -C (〇) -H: 115 is -C (〇) -RlQ, where R1 () is eight 1 * 3 and the Aγ3 ring group is selected from the following including indolyl, Benzimidazolyl, 4-phenyl, and benzo [b] thiobenzyl, and the cyclic group is-(^ single or multiple substitutions as required: Specific Example J Other preferred compounds (type 1) are among them ... R3 is -C (〇) -H .. R5S-C (〇) -R1 (), where R1Q is octa [3 and the Aγ3 ring group is selected from the following including 4-methyl and iso4-yl. Single or multiple substitutions required Specific Example J Other preferred compounds (type 1) are: where R3 is -C (〇) -H; R5 is -C (〇) -Ri〇 'where Ri〇 is ΑΓ3 and the group is hydroxy group' as the standard General Chinese gg house mark (CNS) A4 specification (210X 297 mm) (please read the precautions of S before filling in this one) Pack-order 1235157 Λτ Β7 5. Description of the invention (18S) 0 \ / CH , Substituted. Preferred compounds with example (J) include the following but are not limited thereto: 2002

.COOH ΧΗΟ Η 2201 OMe π.COOH ΧΗΟ Η 2201 OMe π

另外具鳢實例(Κ)之ICE抑制劑爲下式: (VI) 經濟部中央樣.华局貝工消賢合作社印製 其中: R,是 R1_N-R2 Η 191 · 本长伕尺度通用中gg家標李(CNS ) Α4規格(210X297公变) 1235157 Λ* B/ 五、發明説明(189) (el〇)In addition, the ICE inhibitor with the following example (K) is the following formula: (VI) Central sample of the Ministry of Economic Affairs. Printed by the China Bureau of Beige Consumers Co-operative Society where: R is R1_N-R2 Η 191 Family Mark Li (CNS) Α4 Specification (210X297 Public Transformer) 1235157 Λ * B / V. Description of Invention (189) (el〇)

或 (w2)Or (w2)

(請先兒讀背云之洼意事項再填寫本頁) C是一環選自下列包括:笨並,咣啶並,4吩並,毗洛 並,呋喃並,4唑並,異噻唑並,噁唑並,異噁唑並,邊 啶並,咪唑並,環戊基及環己基:環視所需爲所單或 多重取代; R,是: 〇 (〆〇 ^r-oRst 或 經濟部中央糅準忌員工消費合作社印¾ (b) 0(Please read the meanings of the back of the cloud before you fill out this page) C is a ring selected from the following: Benzo, pyridino, 4-pheno, pilo, furan, 4zozo, isothiazozo, Oxazo, isoxazo, edge pyrido, imidazo, cyclopentyl and cyclohexyl: single or multiple substitutions as required by the ring; R, is: 〇 (〆〇 ^ r-oRst or Central Ministry of Economic Affairs 糅Prohibited employee consumer cooperative seal ¾ (b) 0

ORa ORst ORsi m是1或2 : -192· 本纸伕尺度適用中gg家標孪(CNS )六4泛格(210X29?公釐) 1235157 Λ7 B7 五、發明説明(190) 各獨立選自下列包括: -C(〇)-Rl0 ’ -c(o)o-r9 , -C(〇)-N(R10)(Ri〇), -S(〇)rR9 ’ -S(〇)2-NH-Rl0, -C(〇)-CH2-〇-R9, -C(〇)C(〇)-Rl0, -R9 , · -H, -C(〇)C(〇)-〇R1〇,及 -C(O)C(O)-N(R9)(Rl0): X5是CH或N : Y2SH2或0 : R6選自下列包括-H及-CH3 :ORa ORst ORsi m is 1 or 2: -192 · This paper 伕 standard is applicable to the gg family standard (CNS) six 4 pans (210X29? Mm) 1235157 Λ7 B7 V. Description of the invention (190) Each independently selected from the following Including: -C (〇) -R10 '-c (o) o-r9, -C (〇) -N (R10) (Ri〇), -S (〇) rR9' -S (〇) 2-NH- R10, -C (〇) -CH2-〇-R9, -C (〇) C (〇) -R10, -R9, -H, -C (〇) C (〇) -〇R10, and -C (O) C (O) -N (R9) (R10): X5 is CH or N: Y2SH2 or 0: R6 is selected from the following including -H and -CH3:

Rs選自下列包括: -C(〇)-R|0, -C(0)0-Rg y -C(〇)-N(H)-Rl0, 經濟部占:夭揉準局員工消費合作社印製 (請先緊讀背云之洼意事項再填寫本頁) -S(〇)rR9 ’ •S(〇)rNH-Rl〇, · -C(〇)-CHr〇Rl0, -C(〇)C(〇)-R10, -C(〇)-CH2N(R10)(R10), •193- 本纸伕尺度適用中§8家標李(CNS M4規格(2I0X297公釐) 經涛部中夬樣孪局員工消費合作社印製 1235157 入7 B7 五、發明説明(W1) -C(〇)-CH2C(〇)-〇-R9, -C(〇)-CH2C(〇)-R9, -Η,及 , -C(〇)-C(〇)-〇Rl0 : 各119獨立選自下列包括-八^3及-〇卜6直或分支烷基視所需 爲.入1*3所取代,其中-Cw烷基視所需不飽和: 各R丨〇每三送自下列包括-Η ’ - A r 3 ’ - C $. 6疼泛卷’及-C 1.6 直或分支烷基視所需爲Ar3所取代,其中-Cy烷基視所需 未和··Rs is selected from the following including: -C (〇) -R | 0, -C (0) 0-Rg y -C (〇) -N (H) -Rl0, the Ministry of Economic Affairs: System (please read the meanings of the cloud before filling out this page) -S (〇) rR9 '• S (〇) rNH-Rl〇, · -C (〇) -CHr〇Rl0, -C (〇) C (〇) -R10, -C (〇) -CH2N (R10) (R10), • 193- This paper is applicable to the standard § 8 standard li (CNS M4 specification (2I0X297mm)) Printed by the Consumer Cooperatives of the Twin Bureau 1235157 Enter 7 B7 V. Description of Invention (W1) -C (〇) -CH2C (〇) -〇-R9, -C (〇) -CH2C (〇) -R9, -Η, and -C (〇) -C (〇) -〇R10: Each 119 is independently selected from the group consisting of -8 ^ 3 and -〇β6 straight or branched alkyl as required. Substituted by 1 * 3, where- Cw alkyl is unsaturated as required: Each R 丨 〇 is sent from three of the following including -Η '-A r 3'-C $. 6 泛泛 卷 'and -C 1.6 straight or branched alkyl as Ar3 as required Substituted, where -Cy alkyl is not as desired and ...

Ri3選自下列包括Η,Af3,及(:卜6直或分支烷基,視所需 爲 Ar;,-CONH2,-0R5,-〇H,-〇R9或-C〇2H所取代: 各民51獨立選自下列包括R9,-C(〇)-R9,-C(〇)-N(H)-R9, 或各R51—起形成飽和的4 - 8員碳環或含有-〇-,-S-或-NH- G維咳: 各R:l獨立選自下列包括-H或-Cy直或分支的烷基: 各A。是環基獨立選自下列包括芳基,其含有6,10,12 或14侄碜原子及1至3個環.,及芳族雜環基含有5至15個碳 尽子及I至3個環,該雜環含有至少一個選自-Od-S-,-S〇-,S〇2,=N-及-NH-的雜原子,且該雜環基視所f含有 一锢以上的雙鍵,該雜環基視所需含一個以上的芳族環, 且該環基視所需爲-(^所單或多重取代: 各Qi獨立選自下列包括:·ΝΗ2,-C〇2H,-Cl,-F,·Βι:, -I,-NO],-CN,=〇,-OH,-全氣 C卜3 烷基,R5,-〇R5, •NHR5,OR9,·Ν(Ι19)(Ι110),R9,-C(〇)-Rl0,及 -194- 本纸块尺度適用中S國家標绛(CNS ) A4規格(210 X 297公釐) (請先閱讀背面之洼意事項再填寫本頁)Ri3 is selected from the group consisting of fluorene, Af3, and (: Br 6 straight or branched alkyl, optionally Ar ;, -CONH2, -0R5, -〇H, -〇R9 or -CO2H substituted: 51 is independently selected from the group consisting of R9, -C (〇) -R9, -C (〇) -N (H) -R9, or each of R51 forms a saturated 4-8 member carbocyclic ring or contains -〇-,- S- or -NH-G: Each R: 1 is independently selected from the following including -H or -Cy straight or branched alkyl groups: Each A. is a cyclic group independently selected from the following including aryl, which contains 6,10 , 12 or 14 nephew atoms and 1 to 3 rings, and an aromatic heterocyclic group containing 5 to 15 carbons and 1 to 3 rings, the heterocyclic ring containing at least one selected from -Od-S-, -S〇-, S〇2, = N- and -NH- heteroatoms, and the heterocyclic group may contain more than one double bond, and the heterocyclic group may contain more than one aromatic ring as required And the ring base is optionally-(^ single or multiple substitutions: each Qi is independently selected from the group consisting of: ΝΗ2, -CO2H, -Cl, -F, · Βι :, -I, -NO] , -CN, = 0, -OH, -total C 3 alkyl, R5, -0R5, • NHR5, OR9, · N (1119) (1110), R9, -C (〇) -R10, and -194- This paper block size is suitable for S Home Standard Crimson (CNS) A4 size (210 X 297 mm) (Read depression precautions to fill out the back of this page)

訂 1235157Order 1235157

Ar B7 五、發明説明(192) CH. 限制條件爲當-Αι·3爲Q丨基取代,其含有一個以上額外的 -Ar·;基,該額外的-基不爲另外的-Ar3基所取代: 此具鳢實例之較佳化合物爲其中: m是1 : C是一環選自下列包括苯並,吆啶並,或4吩並,環視 所需爲齒,,-NH-R5,-NH-R9,-〇Rl{)或-119所單或多 重取代,其中是直或分支的(:μ4烷基且Rl(}是Η或直或分 支的(:卜4烷基: r6sh : 1113是Η或CN4直或分支的烷基視所需爲Ar;,-〇H,-〇R9 ,或-C〇2H所取代,其中分支或直鏈烷基:其中 Ar3是嗎福嗒基或苯基,其中苯基視所需爲Q t所取代; 尺21是4或-CH3 : R51是C μ直或分支的烷基,視所需爲Αγ3所取代,其中 Α”是苯基,視所需爲-Qi所取代: 經濟部中央標孪局貝工消費合作社印¾ (請先¥讀背*之洼意Ϋν? 一 i^prfr貝 各Αγ3環基獨立選自下列包括笨基,莕基,噻吩基,蝰 諾喵基,異呤諾啉基,毗唑基,噻唑基,異嗓唑基,苯显 三唑基,笨並咪唑基,4啥並善吩基,咪唑基,唁二唑基 ,笨並[b]硫笨基,吡啶基,苯並呋喃基,及4哚基,且該 環基視所需爲-(^所單或多重取代: 各Qi獨立選自下列包括-NH2,-Cl,-F,·Βι:,-OH,-R9, 195- 本紙伕尺度適用中§国家標孪(CNS) A4現格(210X297公釐) 1235157 Λ7 _ _ _B7_ 五、發明説明(193) -NH-R$,头中 R5 是-C(〇)-Ri〇 或-S(0)2-R9 ’ -〇反3头中 R5 走 -C(〇)-R[〇 ’ -〇R9 ’ -NHRg ’ 及Ar B7 V. Description of the invention (192) CH. The limitation is that when -Al · 3 is a Q¹ group substitution, it contains more than one additional -Ar ·; group, the additional-group is not another -Ar3 group. Substitution: The preferred compounds of this example are: where m is 1: C is a ring selected from the group consisting of benzo, pyridino, or 4-pheno, and the ring is as desired, -NH-R5, -NH A single or multiple substitution of -R9, -〇Rl {) or -119, wherein they are straight or branched (: μ4 alkyl and R1 () is Η or straight or branched (: p4 alkyl: r6sh: 1113) Straight or branched alkyl of fluorene or CN4 is optionally Ar ;, -OH, -OR9, or -CO2H substituted, wherein branched or linear alkyl: where Ar3 is morphoyl or phenyl Where phenyl is optionally substituted by Q t; Chi 21 is 4 or -CH3: R51 is C μ straight or branched alkyl, optionally substituted by Aγ3, where A "is phenyl and optionally Replaced by -Qi: Printed by the Central Laboratories of the Ministry of Economic Affairs, Shellfish Consumer Cooperative, ¾ (Please read the meaning of 背? ??) i ^ prfr Bego Αγ3 ring groups are independently selected from the following including benzyl, hydrazone, Thienyl , Pyrazolyl, thiazolyl, isoxazolyl, benzotriazolyl, benzoimidazolyl, 4 benzophenazolyl, imidazolyl, amidazolyl, benzo [b] thiobenzyl, pyridyl , Benzofuranyl, and 4 indolyl, and the cyclic group is optionally substituted by-(^ single or multiple substitutions: each Qi is independently selected from the following including -NH2, -Cl, -F, · Bι :, -OH , -R9, 195- The standard of this paper is applicable § National Standard Twin (CNS) A4 is now (210X297 mm) 1235157 Λ7 _ _ _B7_ 5. Description of the invention (193) -NH-R $, R5 in the header is -C (〇) -Ri〇 or -S (0) 2-R9 '-〇 R5 in the 3 heads -C (〇) -R [〇' -〇R9 '-NHRg' and

其中各119及111(3獨立地爲-0:卜6直或分支的烷基,視所需爲 Ar3所取代,其中Αγ3是笨基: · 限制條件爲當-Αγ3爲Qi基所取代時,其含有一個以上額 外的-Αγ3基,該額外的-Ar3基-不爲另外的- Ar3基所取代。· 較好,於這些較佳具體實例中,{^是~2)且其他取代 基如上文所定義。 此較佳具鳢實例之化合物包括下列,但不限於此: (請先¾讀背δ之注意事項再填寫本頁)Each of 119 and 111 (3 is independently -0: Bu 6 straight or branched alkyl, optionally substituted by Ar3, where Aγ3 is a benzyl group: the restriction is when -Aγ3 is substituted with a Qi group, It contains more than one additional -Aγ3 group, the additional -Ar3 group-is not replaced by another -Ar3 group. · Better, in these preferred specific examples, {^ is ~ 2) and other substituents are as above Defined by the text. The compounds with the preferred examples include the following, but are not limited to them: (Please read the precautions for δ before filling this page)

經涛部中夬樣绛局員工消費合作枉印¾Consumption Co-operation of Employees of China Bureau of Economic Affairs, Ministry of Economic Affairs ¾

較好,R8選自下列包括: -196- 本纸伕尺度適闫中SS家標李(CNS ) A4^t格(210^&lt; 297公釐) 1235157 Λ7 B7 五、發明説明(1θ4) -C(〇)-R丨〇, -C(〇)〇-R9 , (請先閱讀背云之注意事項妥本頁 -C(〇)-CH2-〇Rl0,及 / -C(〇)-CH2C(〇)-〇-R9, 最好, 另外,於此較佳具韹實例中,1^是卜10)且x5是CH,且 其他的取代基如上文所定義。 ’ 另外,於此較佳具體實例中,心是㈠⑺)且x5in,且 其他取代基如上文所定義。- 較好,於具體實例(K)的上述任一化合物中,115是&lt;(〇)-Rio或-(:(〇)-(:(〇)-111(),且其他取代基如上文所定義。 較好,Rio是-Αγ3且其他取代基如上文所定義。 較好,於這些較佳化合物中·· R5是-C(〇)-R|〇且 Riq是 Αγ; ’ 其中Αγ3環基是苯基,視所需爲下列所單或多重取代: -R9,其中R9SCle4直或分支的烷基: -F, -C1, 經濟部中夬標绛局負工消费合作枉印¾ -N(H)-R5,其中-R5 是-H 或-C(〇)-Ri〇,其中 Rl()是-(:丨.6 直 或分支的烷基,視所需爲Ar3所取代,其中八「3是苯基, -N(R9)(R丨〇),其中119及111()獨立3也爲-Cw直或分支的烷基 ,或 -〇-R5,其中R5*H或-CN4直或分支的烷基。 此較佳具體實例之較佳化合物包括下列,但並不限於此: -197- 本紙法尺度逑用中§S家標孪(CNS M4規格(2丨0/ 297公沒) 1235157 Λ* Β7 五、發明説明(195)Preferably, R8 is selected from the following including: -196- The standard of the paper is suitable for the SS family standard (CNS) A4 ^ t (210 ^ &lt; 297 mm) 1235157 Λ7 B7 V. Description of the invention (1θ4)- C (〇) -R 丨 〇, -C (〇) 〇-R9, (please read the precautions of the back page first) -C (〇) -CH2-〇R10, and / -C (〇) -CH2C (〇) -〇-R9, the best, In addition, in this preferred embodiment, 1 ^ is Bu 10) and x5 is CH, and the other substituents are as defined above. In addition, in this preferred embodiment, the heart is ㈠⑺) and x5in, and the other substituents are as defined above. -Preferably, in any of the above compounds of specific example (K), 115 is &lt; (〇) -Rio or-(:( 〇)-(:( 〇) -111 (), and the other substituents are as above As defined. Preferably, Rio is -Αγ3 and the other substituents are as defined above. Better, in these preferred compounds ... R5 is -C (〇) -R | 〇 and Riq is Αγ; 'wherein Αγ3 ring The radical is phenyl, which may be mono- or multi-substituted as follows: -R9, in which R9SCle4 is a straight or branched alkyl group: -F, -C1, in the Ministry of Economic Affairs, Bureau of Standards, Offset and Consumer Cooperation Cooperation--N (H) -R5, where -R5 is -H or -C (〇) -Ri〇, where R1 () is-(: 丨. 6 straight or branched alkyl, optionally substituted by Ar3, of which eight "3 is phenyl, -N (R9) (R 丨 〇), where 119 and 111 () independently 3 is also -Cw straight or branched alkyl, or -〇-R5, where R5 * H or -CN4 is straight Or branched alkyl group. The preferred compounds of this preferred embodiment include the following, but are not limited to them: -197- §S House Standard Twin (CNS M4 Specification (2 丨 0/297)) ) 1235157 Λ * Β7 V. Description of the invention (195)

HaCHaC

ΠΠ

(請先&gt;τ1ί背云之注意事項 ?本一貝) 裝(Please first &gt; τ1ίNotes on back cloud? Ben Yibei)

•IT 經漭部中夬標夺局員工消費合作社印¾• IT Ministry of Economic Affairs won the bid of the Bureau's employee consumer cooperative ¾

.&gt;1 本纸伕尺度適用中§国家揉李(CNS ) A4規格(210X297公釐) 1235157 Λ7 _ B7 五、發明説明(196) 最好,A 4是笨基,在3 -或5 -位置上爲-Cl或在4 -位置上爲 -NH-R5,-N(R9)(R1{})或-〇-R5所取代 3 ---ϋ鉸诖具體j _例的化合物爲下列,但不/限於此·· (請先^讀背云之注意事項再填寫本頁). &gt; 1 The size of this paper is applicable. § National Kneaded Plum (CNS) A4 specification (210X297 mm) 1235157 Λ7 _ B7 V. Description of the invention (196) The best, A 4 is a stupid base, at 3-or 5- The compounds substituted with -Cl at the position or -NH-R5 at the 4-position, -N (R9) (R1 {}), or -0-R5 are substituted with the following examples: But not / limited to this ... (please read ^ Notes of Back Cloud before filling this page)

本纸祛尺度逑用中gg家揉李(CNS ) A4規袼(210X297公釐) 1235157This paper removes the scale, using Chinese gg home rubs (CNS) A4 rules (210X297 mm) 1235157

AT 五、發明説明(197) i匕最佳具體實例的其他較佳化合物包括下列,但亦不?良 於此: …一 〇 213kAT V. Explanation of the Invention (197) Other preferred compounds of the best specific examples include the following, but not the same? Good for this: ... one 〇 213k

α ο 213mα ο 213m

〇 550k〇 550k

及 (請先聞讀背S之注意事項再填寫本I ) 訂 經濟却中夬揉毕局員工消費合作杜印製 Ο 550mAnd (please read the precautions of S before filling in this I)

-200· ‘纸法尺度適用中g国家揉準(CNS M4規格(2丨0X297公釐) 1235157 Λ7 B7 五、發明説明(撕) 另外,Ar3是笨基,可在3-或5-位置上爲R9所單或多重取 代,其中R9是CN4直或分支的烷基;及在4-位置上爲-〇-R5 (請先駕讀背云之注意事項再填寫本I) 所單或多重取代。 / 此最佳具體實例的其他較佳化合物包括下列,但並不限 於此:-200 · 'Paper scale is suitable for Chinese g countries (CNS M4 specification (2 丨 0X297 mm) 1235157 Λ7 B7 V. Description of the invention (tear) In addition, Ar3 is a stupid base, which can be in 3- or 5-position Is a single or multiple substitution by R9, where R9 is a straight or branched alkyl group of CN4; and -0-R5 at the 4-position (please read the precautions of Beiyun before filling in this I) single or multiple substitution / Other preferred compounds of this best embodiment include, but are not limited to:

•201 - 本纸伕尺度適同中gg家標车(CNS ) A4規格(2丨0X 297公釐) 1235157 Λ: B7 五、發明説明(1S9)• 201-The size of this paper is the same as that of the standard gg domestic standard car (CNS) A4 (2 丨 0X 297 mm) 1235157 Λ: B7 V. Description of the invention (1S9)

此最佳具ft實例的其他較佳化合物包括下列;但並不在Other preferred compounds of this preferred embodiment include the following;

(請先试請背面之:VJ意事項再填寫本頁) ·νύ 經濟邦中央標孪局員工消费合作社印¾ 〇(Please try the following first: Please fill in this page with VJ matters) · νύ Printed by the Consumer Standards Cooperative of the Central Standard Bureau of the Economic State ¾ 〇

•202- __ 本纸伕尺度通用中§S家標洋(CNS ) A4規格(2丨0X297公釐) 1235157 B~ 五、發明説明(20°) 〇• 202- __ The standard of this paper is universal. §S Domestic Standard (CNS) A4 specification (2 丨 0X297mm) 1235157 B ~ 5. Description of the invention (20 °) 〇

經濟部中央標準局負工消费合作.杜印¾ 另外,於此較佳具體實例中,115是0,其中r1q 是Αγ3且Αγ3環基選自下列包括峭嗓基,苯显咪唑基,4呤 基,喹咩基,異,奎喵基及笨並[b]硫笨基,且該環基視所需 爲-Qi所單或多重取代。 最好,Ar3環基是異喹琳基。 此最佳具體實例之較佳化合物包括下列,但亦不限於此:Du Yin ¾ In addition, in this preferred embodiment, 115 is 0, where r1q is Αγ3 and Αγ3 ring group is selected from the following: Group, quinolyl, iso, quinolyl, and benzo [b] thiobenzyl, and the ring base is optionally substituted by -Qi. Preferably, the Ar3 ring group is isoquinolinyl. Preferred compounds of this best embodiment include, but are not limited to:

本纸伕尺度通用中1國家標李(CNS ) A4規格(210X 297公5 ) 1235157 A 了 B7 五、發明説明(2(D1) 經濟部中央標李局負工消费合作社印¾The standard of this paper is commonly used in 1 national standard (CNS) A4 specification (210X 297 male 5) 1235157 A. B7 V. Description of invention (2 (D1) Printed by the Central Bureau of Standards of the Ministry of Economic Affairs and Consumer Cooperatives ¾

-204- 本纸乐尺度適用中Sg家標隼(CNS ) A4規格(210X 297公釐) (請先VT讀背云之·注意事項再填寫本頁) 訂 1235157 B7 五、發明説明(2Q2)-204- The Sg family standard (CNS) A4 specification (210X 297 mm) applicable to this paper music standard (Please read VT's back and notes before filling out this page) Order 1235157 B7 V. Description of the invention (2Q2)

(請先&gt;T1i背云之洼意事IT再填寫本頁) 訂 此最佺具體實例的其他較佳化合物包括下列,但益不限 經濟部中夬糅準局員工消費合作·杜印製 於此: -205- 本袄伕尺度这汚中§§家標挛(CNS ) A4規格(210X297公釐) 經濟部r央標孪局貝工消费合作·社印裝 1235157 Λ7 Β7 五、發明説明(2D3) 〇(Please fill in this page first with T1i's IT), other preferred compounds for ordering this specific example include the following, but the benefits are not limited to the cooperation of employees of the China Prospective Bureau of the Ministry of Economic Affairs. Here: -205- The standard of this standard §§ Family standard (CNS) A4 specification (210X297mm) Ministry of Economic Affairs Central Standards Bureau Shellfish Consumer Cooperative · Printing 1235157 Λ7 Β7 V. Description of the invention (2D3) 〇

(請先试讀背云之注意事項再填寫本一貝) -裝 訂 •206· 本纸铁尺度逑用tl!國家標率(CNS ) A4規格(2丨0X297公釐) 1235157 五、發明説明(204) 〇 412d(Please read the precautions of Back Cloud first and then fill out this book)-Binding • 206 · This paper uses iron scale for tl! National Standard (CNS) A4 specification (2 丨 0X297 mm) 1235157 V. Description of the invention ( 204) 〇412d

Ο 412eΟ 412e

〇 Η 〇 412f〇 Η 〇 412f

412g412g

(請先另讀背&amp;之注意事項再填寫本頁) 訂 經濟部中央格隼局員工消費合作社印製 412h(Please read the notes on the back &amp; before filling out this page) Order Printed by the Central Government Bureau of the Ministry of Economy Staff Consumer Cooperatives 412h

ΟΟ

-207· 本紙伕尺度適用中國国家標孪(CNS ) A4規格(210X297公釐) 1235157 . Λ/ Β7 五、發明説明(205) Ο 550q-207 · The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157. Λ / Β7 V. Description of the invention (205) Ο 550q

另外,於此較佳具體實例中,R5是-C(〇)-Ri〇,其中R 是Ar;且Ar3環基是苯基,爲 〇 / \ \/ '所取代In addition, in this preferred embodiment, R5 is -C (〇) -Ri〇, where R is Ar; and the Ar3 ring group is phenyl, which is substituted by 〇 / \ \ / '

CH 2 (分·先絮讀背云之注意事Vf再本一貝 裝 此較佳具ft實例的較佳化合物包括下列,但並不限於此: 213η M濟部中A祐车局員工消費合作社印¾ Ο 415aCH 2 (Finally, read the notes on the back of the cloud, Vf, and then this one. The preferred compounds for this example include the following, but are not limited to this: 213η M Ministry of Economic Affairs, Ayou Automobile Bureau, Employee Consumer Cooperatives India ¾ Ο 415a

Ο 415bΟ 415b

訂 ¾ 及 •208 本纸&amp;尺度逑用中国國家標窣(CNS ) A4規格(210X 297公釐) 1235157 Β7 五、發明説明(206) 415cOrder ¾ and • 208 paper &amp; standard (Chinese national standard) (CNS) A4 size (210X 297 mm) 1235157 B7 5. Description of the invention (206) 415c

具體實例(K)的其他化合物包括下列,但亦不卩X於此 (請先闵讀背面之:/X意事項再本一貝) 213fOther compounds of the specific example (K) include the following, but it is not limited to X (please read the following first: / X meaning matters and then copy) 213f

〇 213g〇 213g

Ί *τ #神部中央標举局員工消资合作社印¾ •209- 本祆法尺度边用t国国家樣孪(CNS ) A4規格(2丨0X297公釐) 1235157 Λ. Β7 五、發明説明(207) 213hΊ * τ #Printed by the Consumers' Cooperatives of the Ministry of the Central Ministry of Standards and Labeling ¾ • 209- National Standards (CNS) A4 (2 丨 0X297 mm) 1235157 Λ. Β7 V. Description of the Invention (207) 213h

α 2131α 2131

ο 213jο 213j

2131 經濟部中央標隼局消費合作社印^ Ο Λ2131 Seal of Consumer Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs ^ Ο Λ

•210 (請先父讀背云之·.vi意事項再填寫本頁)• 210 (please read the meaning of .vi before the father first fill in this page)

本纸法尺度通周中g国家標準(CNS ) A4規格(210X 297公釐) 1235157 Λ- A/ B7 五、發明説明(203) 0 經濟部中大標李局員工消費合作社印¾The standard of this paper is the national standard (CNS) A4 specification (210X 297 mm) throughout the week 1235157 Λ- A / B7 V. Description of the invention (203) 0 Printed by the Consumer Affairs Cooperative of Lida Bureau of the Ministry of Economic Affairs ¾

装 訂 % -211 - 本祇法尺度通泻中§§家標孪(CNS M4規格(210X 297公釐) 37 1235157 五、發明説明(2〇9)Binding% -211-§§ Family standard twins (CNS M4 specification (210X 297 mm)) 37 1235157 V. Description of the invention (209)

213t Ο :0 〇213t 〇: 0 〇

(請先另讀背面之·.VI意事項本I •装 Η Η(Please read the other ..I notices on the back of this book. I. Installation Η Η

213u213u

訂 Μ濟部由央標準局員工消贫合作·杜印製 〇Ordered by the Ministry of Economic Affairs by the Central Bureau of Standards, poverty alleviation cooperation, Du printed 〇

-212 本.¾¾尺度通用中ag家禕孪(CNS ) Α4規格(210Χ 297公釐) 1235157 AT B7 五、發明説明(211) 〇-212. ¾¾ standard universal house (CNS) A4 specifications (210 × 297 mm) 1235157 AT B7 V. Description of the invention (211) 〇

〇 264e 264f M濟部中夬標.洋局員二消费合作杜印製 α^4〇 2〇4g〇 264e 264f M awarded by the Ministry of Economic Affairs of the Ministry of Foreign Affairs of the People's Republic of China. Printed by the Consumer Affairs Department of the Bureau of Foreign Affairs.

-214 本·长法尺度適用中gg家標辛(CNS ) A4規格(210X 297公釐〉 1235157 λ- 37 五、發明説明(212) 2 64h u-214 This long method scale is applicable to the standard gg standard (CNS) A4 (210X 297 mm) 1235157 λ- 37 V. Description of the invention (212) 2 64h u

ο ο Ν Η Ο.ο ο Ν Η Ο.

264i 〇264i 〇

ΟΟ

Ο i Ύ 一Η °-ο (請先另讀背云之洼意事項再^^本買 * ml Hr · 2S4j 〇Ο i Ύ 一 Η ° -ο (Please read the meanings of the back of the cloud before you buy ^^ buy this * ml Hr · 2S4j 〇

ο 訂 經濟部中夬糅.洋局員工消費公作社印¾ο Ordered by the Ministry of Economic Affairs of China

本.¾¾尺度迻用宁§1家標李(CNS Μ4規格(2!0Χ297公釐) 1235157 超濟部中央杯孪局員工消費合作ii印¾Ben. ¾¾ scale transfer to Ning §1 standard Li (CNS Μ4 specifications (2! 0 × 297 mm) 1235157 Superconsumer Ministry Central Cup Twin Bureau staff consumer cooperation ii India

1235157 Λ7 B7 Μ濟部中夬標李局員工消費合作.杜印¾1235157 Λ7 B7 Μ The Ministry of Economic Affairs won the bid for the cooperation of the staff of the Li Bureau. Du Yin ¾

1235157 五 '發明説明(215) 2100f1235157 Five 'Description of the Invention (215) 2100f

2100g Ο2100g Ο

〇 0 (讀先&gt;τ讀背云之注意事項再填寫本I ) 裝---- 訂 2100h 〇〇 0 (Read first &gt; τ Read the notes of the cloud before filling in this I) Pack ---- Order 2100h 〇

ο ο Τ3 ο 2100!&lt;ο ο Τ3 ο 2100! &lt;

-218- 本饫乐尺度適同中ga家標李(CNS ) Α4堤格(210X29了公釐)-218- The standard of this music is the same as the standard of the Chinese family (CNS) Α4 Teg (210X29mm)

I 1235157 Λ7 Β7 五、發明説明(2Ίδ) 21001 21〇〇mI 1235157 Λ7 Β7 V. Description of the invention (2Ίδ) 21001 21〇〇m

〇 (請先¾二夺背云之&gt;1一意事V?再填写本頁 裝 21〇〇π〇 (Please fill in this page first &gt; 1 intent V ?, then fill in this page and install 21〇〇π

Η ΟΗ Ο

ΗΗ

訂 2100ο νOrder 2100ο ν

Η 〇Η 〇

Η 〇 另一具體實例(L)的本發明ICE抑制劑爲下弍〇 〇 Another specific example (L) of the ICE inhibitor of the present invention is the following

Η (VII) -219- 本紙伕尺度適用中家糅李(CNS ) ·Α4規格(210X29了公荽) 1235157VII (VII) -219- Dimensions of this paper are applicable to Zhongjia Li (CNS) · A4 size (210X29) 12 1235157

AT B7 L、發明説明(217) 其中: m是1或2 ·· 選自下列包括下式:AT B7 L. Description of the invention (217) where: m is 1 or 2... Is selected from the following including:

ReRe

(請先絮讀背云之注意事項再填寫本買) (w2) c是一環選自下列包括苯並,〃比症並,嘆吩並,。比洛ϋ ,吱喃並,唁峻並,異邊咬並*,°惡峻並,異0§,咬並,嘧咬 並,咪唑並,環戊基及環己基,環視所需爲-Q i所單或多 重取代: R;;選自下列包括: -CN, -C(〇)-H, -C(〇)-CHrTrRn, -C(〇)-CH2-F, -C^N-O-Rg ’ 及 -C 0 - A r,· 各R3·獨立選自下列包括: -C(〇)-Rl0, •C(〇)〇-R9 , · -C(〇)-N(R 丨 0)(R|0) -S(〇)2-R9, -s(〇)2-nh-r10, 220 纸法尺度適用中§国家禱孪(CNS〉A4規格(210X297公釐) 1235157 Λ 7 . Β7 五、發明説明(213) -C(0)-CH2-CM19, -C(〇)C(〇)-R丨ο, -R9, ^ •Η, -C(〇)C(〇)-〇Rl0,及 -C(〇)C(〇)-N(R9)(R10): 各丁丨獨立選自下列包括-〇-,-s-,-s(〇)-,及-s(〇)2-; r6選自下列包括-Η及-CH;:(Please read the precautions of Beunyun before filling out this purchase) (w2) c is a ring selected from the following including benzo, pyrene, and benzophenone. Biloxipine, squeaking, stubborn, heterosexual bite *, ° Severe spleen, iso0§, bite, pyrimide, imidazo, cyclopentyl and cyclohexyl, -Q as required Single or multiple substitutions: i; R ;; selected from the following: -CN, -C (〇) -H, -C (〇) -CHrTrRn, -C (〇) -CH2-F, -C ^ NO-Rg 'And -C 0-A r, · each R3 · are independently selected from the following including: -C (〇) -R10, • C (〇) 〇-R9, -C (〇) -N (R 丨 0) ( R | 0) -S (〇) 2-R9, -s (〇) 2-nh-r10, 220 Applicable paper scales § National Prayer (CNS> A4 specification (210X297 mm) 1235157 Λ 7. Β7 5 Description of the invention (213) -C (0) -CH2-CM19, -C (〇) C (〇) -R 丨 ο, -R9, ^ • Η, -C (〇) C (〇) -〇Rl0, And -C (〇) C (〇) -N (R9) (R10): each D is independently selected from the following including -〇-, -s-, -s (〇)-, and -s (〇) 2- r6 is selected from the following including -Η and -CH ;:

Rs選自下列包括: · •C(〇)-Rl0, -C(〇)〇-R9 , -C(〇)-NH-Rl0, -S(〇)2-R9 ’ -S(〇)rNH-R10, -C (0) - C H ^ - 0 R j q 7 -C(〇)C(O)-Rl0, -C(〇)-CH2N(Rl(3)(Rl0), -C(〇)-CH2C(0)-0-R9, -C(0)-CH2C(0)-R9, 經濟部中央標準局員工消費合作·社印ϊ衣 (請先聞讀背面之注意事項再填寫本頁) -H,及 •C(〇)-C(O)-〇R10 ; · 各R9獨立選自下列包括-Ar3及- 直或分支的烷基,視 所需爲Αγ3所馭代,其中烷基視所需不铯和: 各R10獨立選自下列包括-H,-Ar3,C3.6環坑基,及-CN6 •221 - 本饫法尺度適用中S國家標準(CNS ) A4規袼(2丨0 X 297公釐) 1235157 B7 五、發明说明(219) 直戋分支的烷基,視所需爲Ars所取代,其中-Ci-6烷基視 所需不绝和: 各Rn獨立選自下列包括: , -Αγ4, -(CH2)l.3-Ar4 J -Η,及 -C(0)-Ar4 : ’Rs is selected from the following including: • C (〇) -R10, -C (〇) 〇-R9, -C (〇) -NH-Rl0, -S (〇) 2-R9 '-S (〇) rNH- R10, -C (0)-CH ^-0 R jq 7 -C (〇) C (O) -Rl0, -C (〇) -CH2N (Rl (3) (Rl0), -C (〇) -CH2C (0) -0-R9, -C (0) -CH2C (0) -R9, Consumption Cooperation of the Central Standards Bureau of the Ministry of Economic Affairs · Social Printing (Please read the precautions on the back before filling this page) -H , And • C (〇) -C (O) -〇R10; Each R9 is independently selected from the following including -Ar3 and-straight or branched alkyl groups, which are optionally substituted by Aγ3, where alkyl groups are required Not cesium and: Each R10 is independently selected from the following including -H, -Ar3, C3.6 ring pit base, and -CN6 • 221-The national standard (CNS) A4 regulations (2 丨 0 X) 297 mm) 1235157 B7 V. Description of the invention (219) A straight branched alkyl group may be substituted by Ars if necessary, of which -Ci-6 alkyl group may be continuously added as required: Each Rn is independently selected from the following including: , -Αγ4,-(CH2) l.3-Ar4 J -Η, and -C (0) -Ar4: '

Rl5選自下列包栝-〇H,-〇Αγ3,-N(H)-〇H&amp;-〇Cn6,其中 Cl.6是直或分支的烷基視所需-爲Ar3,-CONH2,-〇R5,-OH ,-〇R9,或-C〇2H所取代:Rl5 is selected from the group consisting of -OH, -〇Αγ3, -N (H) -〇H &amp; -OCn6, where Cl.6 is a straight or branched alkyl, as desired-Ar3, -CONH2,-. R5, -OH, -OR9, or -CO2H:

Ar2獨立選自下列,其中任一環可視所需爲-Qi所單或多 重取代,或苯基視所需爲Q丨所取代: (hh) 及 (ϋ) {請先35讀背云之:VJ意事項再一^马本肓 經 一宁 央 標 率 局 貝 工 消 費 合 作 社 印 其中各Y獨立選自下列包括〇及S ·· 各Αγ3是環基,獨立選自下列包括芳基,其含有6,10, 12或14個碳原子及1至3個環,及芳族雜環基,含有5至15 —.—- 個環原子及1至3個環,該雜環基含有至少一個選自-〇_, I ’ *S〇-,S02,=Ν-及-ΝΗ- , ·Ν(ί15)-,及-N(R9)之雜原子 基’ 2雖環基視所需含有一個以上的雙鍵,該雜環基視所 需含a 一個以上的芳族環,且該環基視所需爲-Q丨所單或 222·Ar2 is independently selected from the following, in which any ring may be substituted by -Qi single or multiple, or phenyl may be substituted by Q 丨 as required: (hh) and (ϋ) {please read 35 of the back: VJ The matter is one more thing ^ Ma Benxi is printed by Yi Ning Central Standards Bureau Shellfish Consumer Cooperatives, where each Y is independently selected from the following including 0 and S each Aγ3 is a cyclic group, independently selected from the following including aryl, which contains 6 , 10, 12 or 14 carbon atoms and 1 to 3 rings, and an aromatic heterocyclic group containing 5 to 15 —. — Ring atoms and 1 to 3 rings, the heterocyclic group containing at least one selected from -〇_, I '* S〇-, S02, = N- and -ΝΗ-, · N (ί15)-, and -N (R9) heteroatom group' 2 Although the cyclic group contains more than one Double bond, the heterocyclic group may contain more than one a aromatic ring as required, and the ring group may be -Q 丨 or 222 ·

-{ i— - I -I 1 · S ) Α4^/^ ( 210X297公没) 本纸铁尺度通用中§ g 1235157 Λ7 B7 五、發明説明(220) 多重取代: 各是環基,獨立選自下列包括芳基其含有6,1 0,1 2 或丨4伺碳原子及1至3個環,及雜環基含有/5至1 5個環原子 及1至3信環,該雜環基含有至少一個選自-〇-,-5-,-5〇· ,S〇:· =Ν-,-ΝΗ-,-N(R5)-,及-N(R9)-之雜原子基,該雜 環基視所需含有一個以上的雙鍵,該雜環基視所需含有一 信以上的芳族環,且該環基視所需爲-Q丨所單或多重取代; 各Qi獨立選自下列包括-NH2,-C〇2H·,-Cl,-F,-Br,-I ,-NO],-CN,=〇,-〇Η,-全氟C卜3夫完基,R5,-〇R5, -NrHR5,OR9,-N(R9)(Ri〇),R9,-C(O)-R10,及〇-{i—-I -I 1 · S) Α4 ^ / ^ (210X297 publicly available) General paper iron scale § g 1235157 Λ7 B7 V. Description of the invention (220) Multiple substitutions: Each is a cyclic group and is independently selected from The following includes aryl groups containing 6,1 0,1 2 or 4 carbon atoms and 1 to 3 rings, and heterocyclic groups containing / 5 to 15 ring atoms and 1 to 3 letter rings, the heterocyclic group Containing at least one heteroatom group selected from the group consisting of -0-,-5-,-5o ·, S0: · N-, -NΗ-, -N (R5)-, and -N (R9)-, the Heterocyclyl contains more than one double bond as required, the heterocyclyl contains more than one letter of aromatic ring as required, and the ring group is optionally substituted by -Q 丨 single or multiple substitutions; each Qi is independently selected From the following include -NH2, -C02H ·, -Cl, -F, -Br, -I, -NO], -CN, = 〇, -〇Η, -perfluoroC, 3, and 5 -〇R5, -NrHR5, OR9, -N (R9) (Ri〇), R9, -C (O) -R10, and

(請先¾讀背云之注意事項再m大·.頁 裝 經濟部中央樣準局員工消費合作钍印¾ 限制條件爲當-八。爲1所取代時,其含有一個以上額外 的-Ar;基,該額外的- Αγ3基不爲另外的-八1:3基所取代: 較好, m是1 : C是一環選自下列包括苯並,说症並,及4兮並,環視 所需爲 3,-NH2,-NH-R5&lt;-NH-R9,-〇Ri〇或-R9單或多取 代,其中R9是直或分支的-Cle4烷基,且RlQ是或直或分 支的&lt;1.4烷基: 丁1是〇或S : 'R3H : Rii 是選自下列包括-Ar4,,及-C(〇)-Ar4 : Αγ2 是(hh): •223- 訂 ^ 本纸伕尺度通用中§国家標莩(CNS ) A4見格(210X297公釐) ,Βγ,·ΟΗ,-R9.’ -〇Ι^其中R、-是 1235157 Λ7 B7 五、發明説明(221) Y是〇: 各Ar^環基獨立選自下列包括苯基,萘基…塞啥基,嗉語 嗒基,異喹諾啉基,嗒唑基,苯並咪唑基^ 4吩並嗒吩基 •噻二唑基,苯並三峻基,苯並[b]硫笨基,苯並呋嘀基, 及啕哚基,且該環基視所需爲所單或多重取代: 各Αγ4環基獨立選自下列包括苯基,四唑基,莕基,咄啶 基,噫唑基,嘧啶基,或吲哚基,且該環基視·所需爲-Q1 所單或多重取代: 各Qi獨立選自下列包括-NHj,-Cl,-F -NH-R5 其中 R5 是-C(〇)-R丨〇 或-S(〇)rR9 -(:(0)-1^0,-〇R9,-NHR9&amp; (請先聞讀背VS7之注意事項具本一貝(Please read the precautions for back cloud first, and then make it larger .. Pages of the Ministry of Economic Affairs Central Procurement Bureau Staff Consumption Cooperation Seal ¾ Restrictions are when-eight. When replaced by 1, it contains more than one additional -Ar ; The additional-Αγ3 group is not replaced by another-eight 1: 3 group: preferably, m is 1: C is a ring selected from the group consisting of benzo, rho, and 4o Must be 3, -NH2, -NH-R5 &lt; -NH-R9, -〇Ri〇 or -R9 mono or poly substitution, where R9 is straight or branched -Cle4 alkyl, and R1Q is 1.4 alkyl: but 1 is 0 or S: 'R3H: Rii is selected from the following including -Ar4, and -C (〇) -Ar4: Αγ2 is (hh): • 223- order Chinese § National Standard (CNS) A4 (210X297 mm), Bγ, · ΟΗ, -R9. '-〇 ^^ where R and-are 1235157 Λ7 B7 V. Description of the Invention (221) Y is 〇: each The Ar ^ ring group is independently selected from the group consisting of phenyl, naphthyl ... sahyl, stubyl, isoquinolyl, tazozolyl, benzimidazolyl ^ 4phenolophenyl • thiadiazolyl , Benzotrisyl, benzo [b] thiobenzyl, benzofuryl And a pyridyl group, and the cyclic group may be a single or multiple substitutions as required: each Aγ4 ring group is independently selected from the group consisting of phenyl, tetrazolyl, fluorenyl, amidinyl, oxazolyl, pyrimidinyl, or Indolyl, and the cyclic group may be single or multiple substitutions as required by -Q1: each Qi is independently selected from the group consisting of -NHj, -Cl, -F -NH-R5 where R5 is -C (〇) -R丨 〇 or -S (〇) rR9-(:( 0) -1 ^ 0, -〇R9, -NHR9 &amp; (Please read the precautions for VS7 first.)

〇 / \\/〇 / \\ /

CH 2 訂 其中各119及Rl()獨立地爲-C^6直或分支的烷基,視所需爲 -Αγ3所取代,其中Αγ3是苯基;CH 2 is defined in which each of 119 and R1 () are independently -C ^ 6 straight or branched alkyl groups, optionally substituted by -Aγ3, where Aγ3 is a phenyl group;

限制條件爲當-Αι·3爲h基所取代,其含有一個以上額外 的-Αγ3基,該額外的-Αγ3基不爲另外的· Ar3基所取代。 此較佳具體實例的較佳化合物包括下列,但並不限於此: 經濟部中央標.SH員工消費合作祍印¾ 653The limitation is that when -Al · 3 is substituted with an h group, it contains more than one additional -Αγ3 group, and the additional -Αγ3 group is not substituted with another · Ar3 group. The preferred compounds of this preferred embodiment include, but are not limited to, the following: Central Standard of the Ministry of Economic Affairs. SH Employee Consumption Cooperation Seal ¾ 653

-224· 本紙伕尺度適用中家標李(CNS ) A4規袼(210X 297公沒) 1235157 Λ.· Β: 五、發明説明(您)-224 · The standard of this paper is applicable to the Chinese standard Li (CNS) A4 regulations (210X 297 public) 1235157 Λ. · Β: 5. Description of the invention (you)

(請先笑讀背云之注意事項再填寫本頁) -225· L纸伕尺度通用中§國家標孪(CNS ) Μ規袼(210X297公釐) 1235157 Λ: Β1 五、發明説明(23) 705 7〇6(Please read the precautions for Back Cloud first and then fill out this page) -225 · L Paper Size Standard § National Standard Twin (CNS) M Regulation (210X297 mm) 1235157 Λ: Β1 V. Description of Invention (23) 705 7〇6

Η H -J 〇 ν^ν^η (請先父讀背&amp;之:vJ意事項再填寫本頁) Ο 709Η H -J 〇 ν ^ ν ^ η (please read the text first and fill in this page with your vJ) 〇 709

Ν Ν^Λ CH3 〇 Η 〇 〇 ΟΝ Ν ^ Λ CH3 〇 Η 〇 〇 〇

ΟΗ N^V-H Η Ο 710ΟΗ N ^ V-H Η Ο 710

訂 4 經濟部中央樣準局Ji工消費合作杜印¾ 〇Order 4 Ji Industry and Consumer Cooperation of the Central Sample Bureau of the Ministry of Economic Affairs Du Yin ¾ 〇

及 226- 本饫法尺度遝月中国国家標李(CNS ) A4規袼(210X 297公釐) 1235157 Λ, Β7 224、 五、發明説明( HO 〇And 226- Chinese Standard Standard (Monthly) Chinese National Standard Plum (CNS) A4 Regulation (210X 297 mm) 1235157 Λ, Β7 224, V. Description of Invention (HO 〇 〇

較好,R3是-C(0)-Ar2且其他取代基如上文所述。 另外,R3*-C(〇)CH2-TrRn : . 另外,R3是-(:(〇)-Η。 鲛好,於具體實例(L)上述-任一化合物中,113選自下列 包括: -C(〇)-R丨〇, -C(〇)〇-R9 , -C(〇)-CHr〇R10,及 -C(〇)-CH2C(〇)-R9。 較好,R8*-C(〇)-CH2-ORl0且 R丨〇是-Η或-CH3。 另外,本發明具體實例(L)之ICE抑制劑爲下式: (V)Preferably, R3 is -C (0) -Ar2 and the other substituents are as described above. In addition, R3 * -C (〇) CH2-TrRn:. In addition, R3 is-(:( 〇) -Η. Good, in the specific example (L) above- any of the compounds, 113 is selected from the following including:- C (〇) -R 丨 〇, -C (〇) 〇-R9, -C (〇) -CHRO10, and -C (〇) -CH2C (〇) -R9. Preferably, R8 * -C ( 〇) -CH2-OR10 and R 丨 is -Η or -CH3. In addition, the ICE inhibitor of the specific example (L) of the present invention is the following formula: (V)

(請先閱讀背面之·注意事項再填寫本頁} 經濟部中央標率局貝工消费合作社印¾ 其中: m 是 1 ·· R1是: (elO-B) 丫2(Please read the notes on the back before filling out this page} Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy ¾ where: m is 1 ·· R1 is: (elO-B) YA2

本祅伕尺度边用中§§家標孪(CNS ) A4規袼(210X 297公沒) 1235157§§Family Standard (CNS) A4 Regulations (210X 297) in this standard scale 1235157

AT B7 五、發明説明(225) R3選自下列包拾·· -CN, •C(〇)-H, -- -C(〇)-CH2-T「Rn, -C(〇)-CHrF, -C=N-〇-R9,及 -C Ο - A r 7 : 各115獨立選自下列包括: -C(〇)-R丨〇, - -C(〇)〇-R9 , -C(O)-N(Rl0)(R10) -S(0)2-R9, -S(〇)2-NH-Rl(3, -C(〇)-CHr〇-R9, -C(〇)C(〇)-Rl0, -j •H, •C(〇)C(〇)-〇RI0,及 -C(O)C(O)-N(R9)(Rl0): 是 1*12或0 : 各!^獨立選自下列包括或-S二: 各119獨立選自下列包括- A。及-Cw直或分支烷基視所需 爲A。所取代,其中-C&quot;烷基視所需不绝和: 各Ri〇獨立選自下列包括-Η,-Αγ3,03.6環烷基,及-Cm •228 - 本纸杀尺度適用国家標李(CNS ) A4現格(210X 297公釐) (請先閱讀背δ之注意事項再填寫本頁) 裝 訂 1235157 A7 B7 五、發明説明(挪) 置氧分叉泛泰’視所冥爲Α Γ 3所取代’共中-C卜6汉基視/-斤 需不绝和·· 各尺丨丨獨立選自下列包括: / -Ar4, -(C Η 2) 1.3- Α Γ 4 ’ -Η,及 -C(0)-Ar_i · r15選自下列包括-〇H,-〇Αγ3,-N(H)-〇H及-〇(:卜6,其 中Cu是直或分支的烷基視所·需爲-Ar3,-C〇NH2,-〇R,, -〇H,-〇R9,或-C〇2H所取代: R〇 ^ 是-H 氧-C Η 3 : A r:是: (請先絮讀背云之注意事項再填寫.尽頁)AT B7 V. Description of the invention (225) R3 is selected from the following: -CN, • C (〇) -H, --- C (〇) -CH2-T "Rn, -C (〇) -CHrF, -C = N-〇-R9, and -C 0-A r 7: each 115 is independently selected from the following: -C (〇) -R 丨 〇, -C (〇) 〇-R9, -C (O ) -N (Rl0) (R10) -S (0) 2-R9, -S (〇) 2-NH-Rl (3, -C (〇) -CHr0-R9, -C (〇) C (〇 ) -Rl0, -j • H, • C (〇) C (〇) -〇RI0, and -C (O) C (O) -N (R9) (Rl0): 1 * 12 or 0: each! ^ Is independently selected from the following including or -S di: each 119 is independently selected from the following including-A. and -Cw straight or branched alkyl is optionally A. Substituted, wherein -C &quot; alkyl is as necessary and : Each Ri〇 is independently selected from the following including -Η, -Αγ3,03.6cycloalkyl, and -Cm • 228-This paper applies the national standard plum (CNS) A4 standard (210X 297 mm) (Please read first Note on the back δ and then fill out this page) Binding 1235157 A7 B7 V. Description of the Invention (Norway) Oxygenated Forking Pantai 'Deems the place as Α 3 Replaced by Gongzhong-C Bu 6 Hanji TV / -jin Needlessly, each ruler is selected independently from the following: / -Ar4,-(C Η 2) 1.3- Α Γ 4 '- And -C (0) -Ar_i · r15 is selected from the group consisting of -〇H, -〇Αγ3, -N (H) -〇H, and -〇 (: b6, where Cu is a straight or branched alkyl group) -Substituted by -Ar3, -CONH2, -〇R ,, -OH, -〇R9, or -CO2H: R〇 ^ is -H oxygen-C Η 3: A r: Yes: ( (Please read the precautions of Back Cloud before filling in. End page)

短*·部令夬樣华局貝工消費合阼枉印裝 其中Υ是〇: 各Ar3是環基獨立選自下列包括苯基,葚基,4吩基, ,!:語α沐基,異令語β林基,〃比咬基,β塞峻基,異免4基,笨 並三唑基,苯並咪4基,4吩並4吩基,咪峻基,違二唑 基,苯並[b]硫苯基,吡啶基,苯並呋喃基,及啕哚基,且 該環基視所需爲-Qi單或多重取代: 各Αγ4是環基獨立選自下列包括:苯基,四唑基,啶啶基 ,°惡4基,莕基,遺淀基,及邊吩基,且該環基視所需爲 -Q〆單或多重取代: -229· 本紙ft尺度適用中§§家標李(CNS ) Α4規格(2丨0X297公釐) 1235157 Λ 7 Β7 五、發明説明(227) 各Qi獨立選自下列包括:-NH2,-CM,-F,-Br,-〇H,-R9 ,-NPMI5,其中 R5*-C(〇)-Ri〇 或-S(〇)2-R9,-0R5 其令 115是 -C(〇)-Rι 〇,-〇Rg ’ -NHRg 及 ^ 〇 / \ CH,, \/ - 0 限制條件爲當-Ar3爲Q丨取代,其含有一個以上額外的 -Aq基,該額外的· Ar3基不爲另外的-Αγ3基所取代: 限制條件爲當: ~ m 是 1 ·· [^ 5是-OH : R:l是-Η :且 Y2l〇且R3*-C(〇)-H,則R5不可爲:-C(〇)-R丨〇,其中 R1Q是-八1*3且Ar3環基是苯基,未被-Qi所取代,4-(羧曱氧 基)苯基,2-氣苯基,2-咣啶基,N-(4-甲基六氫呔年基)甲 基笨基,或 -C(〇)-〇R9,其中119是-CH2-Ar3,且Αγ3環基是苯基,未 被所取代··且當: 經濟部,〒央樣这局員工消费合作杜印製 (請先閱讀背VS7之注意事項supr本頁) 丫2是〇,R3是-C^OhCHrTVR丨丨,丁 1是〇,且Rn是Αγ4, 其中八[4環基是5-(1-(4-氯笨基)-3-三氣甲基)哎唑基),則1^· 不可爲: · -Η ·· -C(〇)-RlQ,其中Ri〇是· 且Α。環基是4-(二曱胺基曱基) 苯基,苯基,4·(羧曱硫基)苯基,4-(羧乙硫基)笨基,4-( -230- 本饫块尺度逑用中§國家標李(CNS ) Α4規格(2i〇X29H$ ) 4 - 1235157 Β7 五 '發明説明(22δ) 羧乙基)笨基,4-(羧丙基)苯基,2-氣笨基,2-咬嚏基, (4-甲基六氫吆呤基)甲基苯基,或 • C(〇)-〇R9,其中R9是異丁基或-CHrAh且Ar3基是笨基; 且當Rn是Ar4,其中Αγ4環基是5-(1-(2-:比啶基)-3-三氣甲 基)咄唑基),則115不可爲: ,其中Rl(3是-Ar3且Ar;環基是4-(二甲铵基曱 基)苯基,或 -C(〇)-〇R9,其中119是-CH2-Ai:3,且Aq環基是苯基,不 爲取代··且當: - Y2*〇,R3 是-C(〇)-CH2-TrRM,Τι 是〇,且 Rn 是 •C(〇)-Ar*4,其中Αγ4環基是2,5-二氯笨基,則R5不可爲: •C(〇)-Rl(),其中Rl(}是-Ar;且Ar;環基是4-(二甲胺基甲基) 笨基,4-(Ν-嗎福琳基甲基)笨基,4-(N-甲基六氫吆喑基)曱 基)苯基,4·(Ν-(2-甲基)咪唑基甲基)苯基,5-苯並味哇基 ,5-苯並三唑基,Ν-乙酯基-5-笨並三唑基,Ν-乙il基〇-笨.並咪咬基,或 -C(〇)-〇R9,其中R9是·〇Η2-Αι*3,且Αγ3環基是苯基,未 被(^取代;且當 Μ濟部中央標率局員工消费合作杜印¾ Υ2 是 H2,R3 是·CCCO-CHrTrRH,Ti 是〇,且 Rn 是 -C(〇)-Ar4,其中Αγ4環基是2,5-二氣笨基,則R5不可爲: -C(0)-〇R9,其中R9*-CH2-Ai*3·且Αγ3環基是笨基。 較好於具體實例(L)上述任一化合物中,R3是4(0)·Η, 且115是-C(〇)-R1()或-C(〇)-C(〇)-Rl(},且其仡取代基如上文 所定義。 •231 - 本.¾¾尺度適用中2!國家標孪(CNS ) A4現格(2丨0X297公釐) 1235157 Λ. A ·, 3了 五、發明説明(22S) 較好R1Q*-Ar3,且其他取代基如上文所定義。 較好於這些化合物中: R5*-C(〇)-Ri〇且Rio是Αγ3,其中Ar3環基是苯基,視所 需爲下列所單或多重取代: -R9,其中R9是Cm直或分支的燒基: -F, -C1, · -N(H)-R5,其中-R5是-H或-C(〇)-R10, 其中RlQ是-Cy直或分支的烷基,且視所需爲Αγ3所取代 ,其中八”是苯基, -N(R9)(R1Q),其中119及111()獨立地爲-(:丨.4直或分支的烷基 ,或 -〇-R5,其中115是?1或-Cm直或分支的烷基。 此較佳具體實例的較佳化合物包括下列,但不限於此: (請先父讀背面之注意事項再_Short * · Ministry-like sample of Huahua Shellfish Consumption Packing where Υ is 0: Each Ar3 is a cyclic group independently selected from the following including phenyl, fluorenyl, 4-phenyl, and!: ΑαMulyl, Allologs β-linyl, stilbene, β-succinyl, iso-immunyl 4-yl, benzotriazolyl, benzimidyl 4-yl, 4-pheno-4phenyl, imidyl, diazolyl, Benzo [b] thiophenyl, pyridyl, benzofuryl, and fluorinyl, and the cyclic group is optionally -Qi single or multiple substitutions: each Aγ4 is a cyclic group independently selected from the following including: phenyl , Tetrazolyl, pyridinyl, ° oxo, fluorenyl, amido, and phenoyl, and the ring base may be -Q〆 single or multiple substitutions as required: -229 · This paper is suitable for ft dimensions § Family standard Lee (CNS) A4 specification (2 丨 0X297 mm) 1235157 Λ 7 B7 V. Description of the invention (227) Each Qi is independently selected from the following including: -NH2, -CM, -F, -Br, -〇 H, -R9, -NPMI5, where R5 * -C (〇) -Ri〇 or -S (〇) 2-R9, -0R5 Let 115 be -C (〇) -Rι 〇, -〇Rg '-NHRg And ^ 〇 / \ CH ,, \ /-0 The restriction is that when -Ar3 is replaced by Q 丨, it contains more than one additional -Aq group, the additional Ar3 group is not replaced by another -Aγ3 group: The limitation is when: ~ m is 1 · [^ 5 is -OH: R: l is -Η :, and Y2l0 and R3 * -C (〇) -H, then R5 cannot be: -C (〇) -R 丨 〇, where R1Q is -eight 1 * 3 and Ar3 ring group is phenyl, not substituted by -Qi, 4- ( Carboxymethyloxy) phenyl, 2-aminophenyl, 2-pyridinyl, N- (4-methylhexahydrohexanyl) methylbenzyl, or -C (〇) -OR9, of which 119 It is -CH2-Ar3, and the Αγ3 ring group is phenyl group, which has not been replaced. And when: The Ministry of Economic Affairs, the Central Bureau of the Central Government, the consumer cooperation printed by this bureau (please read the precautionary page of VS7 first) Y2 is 0, R3 is -C ^ OhCHrTVR 丨 丨, D1 is 0, and Rn is Aγ4, wherein the octa [4 ring group is 5- (1- (4-chlorobenzyl) -3-trifluoromethyl ) Heyzolyl), then 1 ^ · cannot be:--Η--C (〇) -RlQ, where Ri〇 is · and Α. The cyclic group is 4- (diamidoamino) phenyl, phenyl, 4 · (carboxyamidothio) phenyl, 4- (carboxyethylthio) benzyl, 4- (-230-benzidine Standards in use § National Standard Plum (CNS) A4 specification (2iOX29H $) 4-1235157 B7 5 'invention description (22δ) carboxyethyl) benzyl, 4- (carboxypropyl) phenyl, 2-gas Benzyl, 2-benzyl, (4-methylhexahydropyridinyl) methylphenyl, or • C (〇) -OR9, where R9 is isobutyl or -CHrAh and Ar3 is benzyl And when Rn is Ar4, wherein the Aγ4 ring group is 5- (1- (2-: pyridinyl) -3-trifluoromethyl) oxazolyl), then 115 cannot be:, where R1 (3 is- Ar3 and Ar; the ring group is 4- (dimethylammoniofluorenyl) phenyl, or -C (〇) -OR9, where 119 is -CH2-Ai: 3, and the Aq ring group is phenyl, not Substitution ... and when:-Y2 * 〇, R3 is -C (〇) -CH2-TrRM, Tι is 0, and Rn is • C (〇) -Ar * 4, where the Aγ4 ring group is 2,5-di Chlorobenzyl, then R5 cannot be: C (〇) -Rl (), where Rl (} is -Ar; and Ar; the cyclic group is 4- (dimethylaminomethyl) benzyl, 4- (N -Morpholinylmethyl) benzyl, 4- (N-methylhexahydrofluorenyl) fluorenyl) Phenyl, 4 · (N- (2-methyl) imidazolylmethyl) phenyl, 5-benzoamido, 5-benzotriazolyl, N-ethyl-5-benzytriazole Group, Ν-ethilyl group, 0-benzyl, and imidyl group, or -C (〇) -ORR9, wherein R9 is · 〇Η2-Αι * 3, and the Aγ3 ring group is phenyl, not substituted (^ ; And when the consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs of the People's Republic of China Du Yin ¾ Υ2 is H2, R3 is · CCCO-CHrTrRH, Ti is 〇, and Rn is -C (〇) -Ar4, where the Aγ4 ring group is 2,5 -A dikisyl group, then R5 cannot be: -C (0) -〇R9, where R9 * -CH2-Ai * 3 · and the Aγ3 ring group is a benzyl group. Better than the specific example (L) any of the above compounds In the formula, R3 is 4 (0) · Η, and 115 is -C (〇) -R1 () or -C (〇) -C (〇) -R1 (}, and its 仡 substituent is as defined above. 231-This .¾¾ standard is applicable in 2! National Standard Twin (CNS) A4 is present (2 丨 0X297 mm) 1235157 Λ. A ·, 3 V. Description of the invention (22S) Better R1Q * -Ar3, and others The substituents are as defined above. Preferred among these compounds: R5 * -C (〇) -Ri〇 and Rio is Aγ3, wherein the Ar3 ring group is phenyl, if necessary, the following single or multiple substitutions:- R9, where R9 is a straight or branched Cm alkyl group: -F, -C1, · -N (H) -R5, where -R5 is -H or -C (〇) -R10, where R1Q is -Cy or A branched alkyl group, optionally substituted with Aγ3, where eight "is phenyl, -N (R9) (R1Q), where 119 and 111 () are independently-(: .. 4 straight or branched alkane Or -0-R5, where is 115? 1 or -Cm straight or branched alkyl. The preferred compounds of this preferred embodiment include the following, but are not limited to them: (Please read the precautions on the back first before _

Order

經濟部中夬猱华居員工消費合作杜印製Printed by Duan Huaju, Ministry of Economic Affairs, Consumer Cooperation

本纸乐尺度適用tsa家標孪(CNS ) A4規格(2丨0X 297公釐) 1235157 五、發明説明(23〇) 911 691bThis paper music scale is applicable to the TSA family standard (CNS) A4 specification (2 丨 0X 297 mm) 1235157 V. Description of the invention (23〇) 911 691b

HO Ο 4 ΟHO Ο 4 Ο

ηΝ &quot;ο ΟΗ,Η ΗΟ ΟηΝ &quot; ο ΟΗ, Η ΗΟ Ο

(請先聞讀背云之:VJ意事項再(Please read the back of the cloud: VJ matters before

Order

培濟部·〒央標.洋局貝二消f合作社印 ΗΟ ΟPeiji Department · Yongyang Biao. Foreign Bureau Bei Erxiao Cooperative Cooperative Association Printing ΗΟ Ο

Η 〇Η Η ;及 -233- 本裱杀尺度逯用tg国家標率(CNS ) A4規格(210 X 297公釐) 1235157 經濟部中央樣準局員工消費合作杜印¾ 五、發明説明(231 916 HO4Η 〇 Η 及; and -233- This standard for frame killing uses tg national standard (CNS) A4 specification (210 X 297 mm) 1235157 Employees' cooperation cooperation of the Central Sample Bureau of the Ministry of Economy Du Yin ¾ 5. Description of the invention (231 916 HO4

〇 ΛhT Γ9 r ^oh HO Ο Μ:〜〇 ΛhT Γ9 r ^ oh HO Ο Μ: ~

N^A 最好,是苯基在3-或5-位置上爲-Cl及在4-位置上爲 •NH-R5,-N(R9)(R1(3),或-〇-R5所單或多重取代。 此最佳具體實例的較佳1合物包括下列,但不限於此:N ^ A is the best. The phenyl group is -Cl at the 3- or 5-position and • NH-R5 at the 4-position, -N (R9) (R1 (3), or -〇-R5 Or multiple substitutions. Preferred compounds of this preferred embodiment include, but are not limited to:

662662

CLCL

HCT (請.¾¾讀背云之注意事項再填寫本I ) HO 〇HCT (Please. ¾¾ Read the notes of back cloud and fill in this I) HO 〇

Cl HO 669Cl HO 669

•234 本紙法尺度逑用家標辛(CNS ) A4規格(2丨0X297公釐) 37 1235157 五、發明説明(232) 686 H2• 234 paper method scales, standard domestic standard (CNS) A4 (2 丨 0X297 mm) 37 1235157 V. Description of the invention (232) 686 H2

Cl ΟCl Ο

OH H H 〇 689aOH H H 〇 689a

914914

(請先&gt;T1t背云之放意事項再填寫本買)(Please fill in this item first before paying attention to T1t)

•IT 經濟部中夬糅这局員工消f合作杜印¾ 915• Staff of the Ministry of IT and Economic Affairs, China Bureau of Cooperation and Cooperation Du Yin ¾ 915

及 •235- 本紙法尺度通用_3国家標洋(CNS ) A4規格(210X297公釐) 1235157 Λ7 Β7 發明説明(233,And • 235- The paper scale is universal _3 National Standard Ocean (CNS) A4 specification (210X297 mm) 1235157 Λ7 Β7 Description of the invention (233,

此最佳具體實例的其他較佳化合物包括T列,但不 在於此: 〇 214kOther preferred compounds of this best embodiment include column T, but not here: 214k

及 (請先闳讀背云之注意事\^各買) 裝 訂 〇 214πιAnd (Please read the precautions of Beunyun \ ^ Buy separately) Binding 〇 214πι

泉 經濟部中夬樣準局員工消资合作社印製 另夕卜,Ar3是笨基,在3-或5-位置上爲-R9所單或多取 代,其中R9lCle4直或分支的烷基:及在4-位置上爲-〇-R5 所單或多取代。 此最佳具體實例的較佳化合物包括下列,但並不 限於此: -236- 本长Κ度逯汚tS國家標孪(CNS〉Α4規格(210 /29了公釐) 1235157 A: r\轉 五、發明説明(234) 671Printed by the Consumers' Cooperative of the China Prototype Bureau of the Ministry of Economic Affairs, Ar3 is a benzyl group, which is mono- or poly-substituted by -R9 at the 3- or 5-position, where R9lCle4 is a straight or branched alkyl group: and It is mono- or poly-substituted at the 4-position by -0-R5. The preferred compounds of this best embodiment include the following, but are not limited to the following: -236- This long κ degree stains the tS national standard (CNS> Α4 specification (210/29 mm) 1235157 A: r \ turn V. Invention Description (234) 671

η 684η 684

689b689b

〇b .¾濟部中央糅.毕局員工消費合作•社印製 691a HO a〇〇b. ¾ Central Ministry of Economic Affairs, Consumer Affairs Cooperation Bureau • Printed by the agency 691a HO a〇

0 H3C HO0 H3C HO

H3H3

。·、 Aoh人,九H. ·, Aoh people, nine H

Ο Ν' H 〇 -237 本紙法尺度逯用中家揉李(CNS )六心見格(2丨0X 297公釐) 1235157 3Τ 五、發Μ說明(235)〇 Ν 'H 〇 -237 Chinese paper knead plum (CNS) with six hearts (2 丨 0X 297 mm) 1235157 3Τ 5. Instructions for issuing M (235)

(讀先3讀背云之··V〗意事項再填寫本買) 訂 .¾濟部中夬详毕局員工消資合作·社印4H各 此最佳具體實例的另外較佳化合物包括下列,但亦 不限於此: ' 214w 0(Read the first 3 readings of the back of the cloud. · V 〖I want to fill out this purchase) Order. ¾ The Ministry of Economic Affairs of the People's Republic of China's detailed bureau of the consumer consumption cooperation · Social printing 4H each of the best specific examples of other best compounds include the following , But not limited to: '214w 0

-238- 本.¾¾尺度適用中SS家糅莩(CNS ) A4規格(210X297公釐) 37 1235157 五、發明説明(236) 另外,於此較佳具韹實例中:-238- This standard applies to SS furniture (CNS) A4 specifications (210X297 mm) 37 1235157 5. Description of the invention (236) In addition, in this preferred example:

Rf是-C(〇)-R10,其中Rl0是Αγ3且Αγ3環基選自下列包括 4 A I,完益咪咬基,s塞吩基,遣捧基,/異i咕基及苯並 [b]较苯基,且該環基視所需爲-1所單或多取代。 此較佳具體實例的較佳化合物包括下列,但並不限 t卜认匕:Rf is -C (〇) -R10, where R10 is Αγ3 and Αγ3 ring group is selected from the group consisting of 4 AI, complete imidyl, sphenenyl, sulfonyl, isoisopropyl and benzo [b ] Is more phenyl, and the cyclic group is optionally mono- or polysubstituted by -1. The preferred compounds of this preferred embodiment include, but are not limited to:

及 920And 920

4 經濟部中夬祐洋局員工消费合作枉印?衣 較好,Αγ3環基是異,奎琳基,且該環基視所需爲 所單或多重取代。 此最佳具體實例的較佳北合物包括下列,但並不 限於此: -239- 本纸泫尺度逯用申§國家標辛(〇^)‘*\4現格(2丨0乂297公釐) 3· 1235157 五、發明説明(237) 69β4 Consumption co-operation seals of employees of the Sino-Youyang Bureau of the Ministry of Economic Affairs? It is preferred that the Aγ3 ring group is iso, quelinyl, and the ring group is optionally substituted by single or multiple substitutions. The preferred compounds of this best embodiment include the following, but are not limited to the following: -239- Application Standards of this paper 国家 National Standard Xin (〇 ^) '* \ 4present grid (2 丨 0 乂 297 mm 3. 1235157 V. Description of the invention (237) 69β

Ρ 696-1Ρ 696-1

Μ濟部中央橾孪局員工消背合作社印51 及Employees of the Central Government Bureau of the Ministry of Economic Affairs of the People's Republic of China eliminated the cooperative seal 51 and

此最佳具體實例的另外較佳的化合物包括下列 但並不限於此: •240 本纸法尺度通用中§國家揉莩(CNS Μ4堤格(210X297公釐) 1235157 A: B7 五、發%説明(23δ)Another preferred compound of this best specific example includes the following but is not limited to this: • 240 paper-based methods in general § National Rubbing (CNS Μ4 Tiege (210X297 mm) 1235157 A: B7 V.% Description (23δ)

另外,於此較佳具體實例中,R5是-C(〇)-Rl0,其 中R1Q是-Ar;且Ar3環基是苯基,爲 〇所取代° CH, . \/ 一 〇 此較佳具體實例的較佳化合物包括下列但不卩艮於 910In addition, in this preferred embodiment, R5 is -C (〇) -Rl0, where R1Q is -Ar; and the Ar3 ring group is phenyl, which is substituted by 0 °. Examples of preferred compounds include the following but are not described below 910

超濟部中央·υ洋局員工消贫合作社印製 此較佳具體實例的較佳化合物包括下列,但不張 於此:Printed by the Anti-Poverty Cooperative of the Central and Foreign Affairs Bureau of the Ministry of Economic Affairs. The preferred compounds of this preferred embodiment include the following, but are not here:

具體實例(L)其他化合物包括下列但不限於泛 -241 - 本紙法尺度迖用中家標洋(CNS ) Α4規格(210X297公釐) 1235157 Λ* 3: 五、發明説明(239) 〇 2l4fSpecific examples (L) Other compounds include the following, but are not limited to the following: -241-Chinese paper standard (CNS) A4 size (210X297 mm) 1235157 Λ * 3: V. Description of the invention (239) 〇 2l4f

〇 214g〇 214g

Ο 214hΟ 214h

(請先,¾讀背云之··;x意事項再填寫本頁) 訂 經濟部中央樣毕局員工消贫合作杜印製(Please read ¾, read the back of the cloud, and then fill in this page.) Order Printed by the Central Bureau of the Ministry of Economic Affairs, poverty reduction cooperation

•242- 本紙ft尺度逯用_国國家揉莩(CNS M4規格(210X 297公釐) 1235157 214j• 242- ft paper size _ country and country (CNS M4 specification (210X 297 mm) 1235157 214j

246b246b

(4?二¥讀背云之-;1意事項弄填芎大二貝 - j - - , * - ......... · 裝 訂 265a COs.(4? 2 ¥ Read the back of the cloud-; 1 to fill in the matter of the second big shell-j--, *-......... Binding 265a COs.

、OH, OH

nH 265cnH 265c

OMe -243- 本:¾¾尺度適用中國國家標车(CNS ) A4規格(210X 297公燊) 1235157 AT B7 經濟部宁央標牟局員工消费合作·社印製OMe -243- This: ¾¾ standard is applicable to China National Standard Vehicle (CNS) A4 specification (210X 297 燊) 1235157 AT B7 Ningyang Standard Mou Bureau, Ministry of Economic Affairs, Consumer Consumption Co-operation · Social Printing

五、'昏明説明(24V 265dFifth, 'fainting explanation' (24V 265d

265f 280b 280c Ο α265f 280b 280c Ο α

οο

MeS〇2-MeS〇2-

Ο MeΟ Me

O 28CdO 28Cd

t/ 244-t / 244-

木袄泫尺度遇用t§S家標孳(CNS ) A4規格(2iOX 297公釐) 1235157 五、發明説明(242) 233bThe standard of wood cricket is t§S domestic standard 孳 (CNS) A4 specification (2iOX 297 mm) 1235157 V. Description of the invention (242) 233b

Ο 283c ΜΟ 283c Μ

Voh - A 〇 283dVoh-A 〇 283d

Ο 284 〇 — (請先¥讀背云之:vj意事項再填寫本頁) 訂 超濟部中央標·洋局员工消賢合作杜印¾Ο 284 〇 — (please read the back of the cloud: vj matters before filling in this page) Order Chaoyin Ministry of Economic Affairs, Central Bureau of Foreign Affairs, staff elimination cooperation Du Yin ¾

叫φ。.Called φ. .

Me〇' Η 0 285 Ο 〇 αMe〇 'Η 0 285 〇 〇 α

α ο Μ€〇 Η °α ο Μ € 〇 Η °

〇 OH 〇 Me〇 OH 〇 Me

Me •245· 本饫ft尺度通用中家標孪(CNS ) A4規格(210X 297公釐) 1235157 ^Me • 245 · Common Chinese Standard Twin (CNS) A4 size (210X 297 mm) in 饫 ft standard 1235157 ^

A . 3- 五、發明説明(243) 0A. 3- V. Description of the invention (243) 0

(請气Klstf/注意事 \iTr.l^f貝) 經濟部中央標技局員工消費合作杜印¾ Ο(Please be mad Klstf / Attention \ iTr.l ^ f 贝) Staff Consumption Cooperation of the Central Bureau of Standards and Technology of the Ministry of Economic Affairs Du Yin ¾ Ο

L.1· I 會 -246 - 本纸法尺度通用中gs家揉李(CNS ) A4規格(2i〇 X297公釐) 1235157 Λ.- B1 五、發明( 244) Ο 501L.1 · I Meeting -246-Standard Chinese Standard for Paper and Paper (CNS) A4 (2i0 X297mm) 1235157 Λ.- B1 V. Invention (244) Ο 501

KbC 〇 505b 505cKbC 〇 505b 505c

(讀先2讀背云之注意事頊再填寫本買) 訂 -¾濟部.〒夬糅华局員工消费合作枉印製 505c(Read the first 2 notes about the back of the cloud, and then fill out this purchase) Order-¾ Ministry of Economic Affairs. Economic Cooperation Bureau employee consumption cooperation print 505c

〇 5〇5e〇 5〇5e

__ 本紙杀尺度通用中§a家標卒(CNS ) A4規格(2丨0X 297公5 ) 1235157 Β7 五、/昏明it明(245)__ Common standard for paper killings: §a Standard Soldier (CNS) A4 specification (2 丨 0X 297 male 5) 1235157 Β7 V./Huangming itming (245)

〇 510a〇 510a

οο

510b 〇510b 〇

οο

Q Ο 510cQ Ο 510c

--------------ilr------Awl (請先《讀背^之注意事項再填寫本一貝) Μ濟部中央樣半局員工消贫合作祍印製 〇 510d-------------- ilr ------ Awl (Please read "Notes on reading back ^ before filling in this one") Ministry of Economic Affairs, Central Bureau of Sample and Anti-poverty Cooperation 员工Printed 510d

OH 〇 Η ΟOH 〇 Η Ο

-248- 本紙杀尺度逯;中3S家禱孳(CNS ) A4規格(210X2W公,¾ ) 1235157 五、發明説明(246) Μ濟部中央樣準局員工消費合作社印¾-248- Standards for this paper; Chinese 3S Family Prayer (CNS) A4 specification (210X2W, ¾) 1235157 V. Description of the invention (246) Printed by the Consumer Procurement Cooperative of the Central Sample Bureau of the Ministry of Economic Affairs ¾

MeO 〇 642MeO 〇 642

(請先^讀背云之洼意事項再填寫本頁) 249· 本纸杀尺度逑用中§国家琮李(〇:5)六4退格(210:&lt; 297公釐&gt; 37 1235157 五、發明説明(247)(Please ^ read the meanings of the cloud before you fill out this page) 249 · This paper is not in use § Country 琮 Li (0: 5) 6 4 backspace (210: &lt; 297 mm &gt; 37 1235157 V. Invention Description (247)

(請先3讀背云之.--5:}意事項再填寫本頁) 訂(Please read 3 of Behind Clouds .-- 5:} Issue before filling out this page) Order

超濟部中夬糅绛局員二消背合作枉印5LChinese Ministry of Chaoji, China Bureau of Civil Affairs and Cooperation

本长杀尺度通用中HS家漂辛(CNS M4規格(210X297公犮) 1235157 入· Β7 五、發明説明(挪) Ο 1013The standard of the long-term killing of general HS homes (CNS M4 specifications (210X297 male)) 1235157 Enter · Β7 V. Description of invention (Norway) 〇 1013

Η Ο 1052Η Ο 1052

〇 1053〇 1053

10561056

(請先父讀背云之注意事項J: 裝 訂 經濟部中央·U:.洋局員工消«·合作社印¾ 〇 1075(Please read the precautions for Beyond Clouds by the father, J: Binding, Central Ministry of Economic Affairs, U: U.S. Bureau of Staff Consumption «· Cooperative Seal ¾ 〇 1075

-251 本.¾¾尺度遝用中IS家揉李(CNS )人4迖格(2I0X 297公釐) 1235157 五、發明説明(2叫 經濟名中央標準局員工消资合作.社印¾ 〇-251 Ben. ¾ ¾ standard, used in the IS family of four people (2I0X 297 mm) 1235157 V. Description of the invention (2 called the economic name of the Central Standards Bureau staff consumption cooperation. Social seal ¾ 〇

(ίν&gt;τνί背云之-^意事項再一^大二貝 —裝 訂(ίν &gt; τνί Behind the Clouds-^ Italian Matters Again ^ Two Erbei-Binding

-252- 本紙伕尺度迻用中1S家標李(CNS ) A4規格(210X 297公釐) 1235157 - A. B7 五、發努说# \ 250) Ο :¾濟部中夬標达局員二消资合作··;}印¾-252- 1S domestic standard Li (CNS) A4 size (210X 297 mm) 1235157-A. B7 in the paper scale transfer Cooperation ··;} India ¾

---------11 #· 讀S之事Vi ill大二貝 丁 -5-β •Jy· -253- 本·枚疾尺度通用中gg家揉莩(CXS ) A4規格(2丨0X29?公釐) 1235157 Λ i Β: 五、發努説明(251) 1114--------- 11 # · Read the matter of S Vi ill sophomore betin-5-β • Jy · -253- Ben · Meiji Standard universal gg home rubbing (CXS) A4 specifications (2丨 0X29? Mm) 1235157 Λ i Β: V. Instructions (251) 1114

Ο .115Ο .115

〇 1116〇 1116

〇 1117〇 1117

經濟部中央禕泣局員工消费合作•社印装 Ο 1118Consumption cooperation of employees of the Central Weeping Bureau of the Ministry of Economic Affairs · Printed by the company Ο 1118

-254· (請先¾讀背δ之注意事項再填寫·尽頁)-254 · (Please read the precautions for δ first and then fill in the last page)

本紙ft尺度遝用tga家標李(CNS ) A4規格(210χ·297公沒) 1235157 Λ7 37 五、發明説明(252) 1119 〇This paper ft scale uses tga family mark Lee (CNS) A4 specification (210χ · 297 public) 1235157 Λ7 37 V. Description of the invention (252) 1119 〇

cr^Vcr ^ V

ο 1120ο 1120

(請先%讀背云之.-;1意事項再填寫本頁) -In =1vfm f I -1- -1 ml nn«,·*—· ami 0 1121 〇(Please read% of the back of the cloud first .-; 1, and then fill out this page) -In = 1vfm f I -1- -1 ml nn «, · * — · ami 0 1121 〇

-i · · i - tl —i - - · ..... ! - a— I I — 1122-i · · i-tl —i--· .....!-a— I I — 1122

.¾濟部中央標準局員工消费合作·社印¾ 1123.¾Consumer Cooperation of Employees of the Central Bureau of Standards of the Ministry of Economic Affairs · Social Printing ¾ 1123

OH -255 本纸法尺度適用中S國家標李(CNS〉以規格(210:&lt;297公釐) 1235157 A&quot; Β7 五、發明説明(253) .¾濟部中夬糅洋局貝二消资合作杜印¾OH -255 Standard for Chinese papers (CNS) with standard (210: &lt; 297 mm) 1235157 A &quot; Β7 V. Description of invention (253) Du Yin

〇 21001〇 21001

二^15 訂 2100j 〇2 ^ 15 Order 2100j 〇

具體實例(K)其他化合物包括下列但不限於此Specific Examples (K) Other compounds include the following but are not limited thereto

256 本紙乐尺度送用令g国家標李(CNS ) A4規格(2I0X297公釐) 1235157 Λ7 B? 五、發明説明(254)256 Paper Music Standard Delivery Order g National Standard Plum (CNS) A4 Specification (2I0X297 mm) 1235157 Λ7 B? 5. Description of Invention (254)

(請先聞讀背νβ之注意事項再填寫太貧) 裝 ,ιτ 泉 -257- 本汔乐又度逋用中18家標洋(〔&gt;^)人4堤格(:110/ 297公釐) 1235157 五、發明說明(255)(Please read and read the precautions of νβ before filling in too poor.) Install, ιτ Spring-257- Ben Le also used 18 Biaoyang ([&gt; ^) people 4 Tiege (110/297 public) %) 1235157 V. Description of the invention (255)

U Λ ΗU Λ Η

具體實例(L)其他化合物包括下列但不限於此 〇 684aSpecific Examples (L) Other compounds include the following but are not limited to this

(請先^.讀背云之:V〗意W.項填寫大二貝) Μ濟部中央標孪局員工消賢合作·社印¾(Please read ^. Read the back of the cloud: V 〖Italian W. fill in the second two shells) M The staff of the Central Bureau of Ministry of Economic Affairs of the People's Republic of China Co-operation and Social Seal ¾

本紙伕尺度適用tl国家標李(CNS ) A4現格(2丨0乂297公釐) 1235157The size of this paper is applicable to the national standard plum (CNS) A4. (2 丨 0 公 297mm) 1235157

AT Β7 五、發2/j説明(25δ) 經於部中央糅皁局員工消費合作·社印製AT Β7 Fifth, issued 2 / j instructions (25δ) Printed by the Ministry of Central People ’s Daily Soap Bureau Consumer Consumption Cooperation · Social Agency

-259- 本纸伕尺度遝用中§国家標李(CNS ) Α4規格(2丨0X297公釐) 3- 1235157 五、發贫説Μ ( 257) 超濟部中央糅準局負工消费合作杜印裂-259- National Standard Li (CNS) Α4 Specification (2 丨 0X297mm) 3- 1235157 V. Poverty Alleviation M (257) Ministry of Economic Affairs, Ministry of Economic Affairs, Central Bureau of Associated Work Crack

CH3 •260- (請先閱讀背面之注意事項再iPSf本頁) 訂CH3 • 260- (Please read the precautions on the back before iPSf page) Order

本.¾¾尺度边用中§g家標洋(CNS )六4堤格(210X 297公犮) 1235157 Λ* Β- 五、發明説明(2SS) 723 724Ben. ¾¾ scale side use §g Domestic Standard Ocean (CNS) Six 4 Tige (210X 297 cm) 1235157 Λ * Β- 5. Description of the invention (2SS) 723 724

---------— (請.^&gt;【讀背云之洼意事項再填寫本一貝) 丁 經濟部中央標準局員工消費合作杜印¾ 725 726---------— (Please. ^ &Gt; [Read the meaning of the cloud and then fill out this book] Ding Consumption Cooperation of Employees of the Central Standards Bureau of the Ministry of Economic Affairs Du Yin ¾ 725 726

-261 - 本纸伕尺度通用肀国國家祛莩(〔&gt;^)以規格(2丨0乂297公5) —dr 1235157 Λ7 B7 五、發%說明(259)-261-Standards on this paper are common in all countries and countries ([&gt; ^) Specification (2 丨 0 乂 297 male 5) —dr 1235157 Λ7 B7 V. Explanation of the percentage of delivery (259)

(請先父讀背云之·注意事項一r*rr填寫本買) 訂 ^濟部中夫糅李局員工消费合作杜印^(Please read the note of Yun Yun · Note 1 r * rr to fill in this purchase) Order ^ The Ministry of Economic Affairs, China and the Li Bureau Staff Consumption Cooperation Du Yin ^

-262- 本饫乐尺度逑用宁SS家糅李(CNS M4規格(210X 297公釐) 1235157 Λ 7 37 經濟部甲央禕孪局員工消費合作社印製-262- This standard is printed by Ning SS furniture (CNS M4 specification (210X 297 mm) 1235157 Λ 7 37

本绝泫尺度这用申13家標孪(〇&gt;^)^\4規格(210/ 297公5) 1235157 Λ / Β7 五、發%说明(261) 〇This absolute standard is applied to 13 standard twins (〇 &gt; ^) ^ \ 4 specifications (210/297 5) 1235157 Λ / Β7 5. Explanation of% issued (261) 〇

經濟部中央標準局貝工泫费合作杜印51 HO 〇Cooperate with the Central Bureau of Standards of the Ministry of Economic Affairs, Du Yin 51 HO 〇

•264- 本纸杀尺度逋用國家糅孪(CNS ) A4現格(210X 297公,5 ) --------费------IT------ψ, (封元&gt;τ讀背云之洼意事項再填寫本\貝) 1235157 經濟部令夬糅达局員工消资合作社印製• 264- The standard paper size of the paper (CNS) A4 (210X 297 males, 5) -------- Fees ------ IT ------ ψ, ( Feng Yuan &gt; τ Read the meaning of the cloud and fill in this question again \)) 1235157 Printed by the Ministry of Economic Affairs and the Bureau of Economic Development Cooperatives

本.¾¾疋度逆用tgS家標车(CNS ) A4規格(2丨0X297公釐) [235157 A B' 五、發明説明(263) HO 〇This ¾¾ 疋 degree reverse tgS domestic standard car (CNS) A4 specification (2 丨 0X297 mm) [235157 A B 'V. Description of the invention (263) HO 〇

OHOH

〇 HO 〇〇 HO 〇

(請先緊讀背云之注意事項再填寫本頁) 4今 訂 經濟部中央標华局貝工消费合作4印51 746(Please read the precautions of Back Cloud before filling out this page) 4Today

HO 〇 MHO 〇 M

oo

OO

-266- 本纸块足度逑用国家揉李(CNS ) ΛβΙ格(210X29?公釐) 1235157 五、發明説明(264) HO 〇 747-266- National paper rubbing plums (CNS) ΛβΙ grid (210X29? Mm) 1235157 V. Description of the invention (264) HO 〇 747

HO 〇 748HO 〇 748

Η 749Η 749

經牌部t央樣孪局員工消费合作社印¾ 750Printed by the Ministry of Trade and Industry Bureau of the Central Government Bureau of Consumer Cooperatives ¾ 750

Η 267· (讀先聞讀背云之注意事項耳填寫本一貝)Η 267 · (Read the first notes and read the notes of back cloud, fill in this book)

本纸伕尺度逑用中国国家標争(CNS ) A4規格(210X29?公釐) 1235157 Λ: Β7 五、發明说: 265) αThe size of this paper is in accordance with the Chinese National Standards (CNS) A4 specification (210X29? Mm) 1235157 Λ: Β7 V. Invention: 265) α

ο Ν Η ΛΛ V Οο Ν Η ΛΛ V Ο

ο αο α

ο Ν Ηο Ν Η

VV

ΟΠ^ΗΟ Ν Η (請先聞讀背云之注意事項再填寫本百;)ΟΠ ^ ΗΟ Ν Η (Please read the precautions of Back Cloud before filling this one hundred;)

Ν Η Η ΟΠΜ^ ^μμο 訂 經濟部宁央標这局員工消贫合作杜印?衣Ν Η Η ΟΠΜ ^ ^ μμο Order Ning Yangbiao, Ministry of Economic Affairs, the staff of this bureau to eliminate poverty? clothes

26 本紙ft又度逯用tas家標莩(CNS ) Α4規格(2[0:&lt; 297公釐) 1235157 Β: 五、發明説明(266) 755 H0 〇26 This paper ft uses the tas standard (CNS) A4 specification (2 [0: &lt; 297 mm) 1235157 Β: 5. Description of the invention (266) 755 H0 〇

ΌΗ 7 56 757ΌΗ 7 56 757

(請先聞讀背云之注意事項再填寫本頁) 經濟部中央樣準局負工消费合作社印¾ HO 〇 759(Please read the precautions of Back Cloud before filling out this page) Printed by the Consumer Procurement Cooperative of the Central Procurement Bureau of the Ministry of Economic Affairs ¾ HO 〇 759

269- 本·尺度逯用〒SS家揉李(CNS M4坑格(210X 297公釐) 1235157 Λτ 5: 五、發明説明(257) 經濟部中ί隼局員工消費合作杜印¾269- Ben · Standards 〒SS family rubbing (CNS M4 pit grid (210X 297 mm) 1235157 Λτ 5: 5. Description of the invention (257) Ministry of Economic Affairs Ministry of Economic Affairs employee consumption cooperation Du Yin ¾

-270· 本紙法尺度遝用肀11国家標孪(〇^).以規格(210乂 297公5) 37 1235157 263、 五、發明説明( HO 〇 7S3-270 · The standard of this paper method is 肀 11 national standard (〇 ^). To specifications (210 乂 297 5) 37 1235157 263. V. Description of invention (HO 〇 7S3

754754

Η Ο (诗色$讀背£之注意事項 ,尽頁 裝 訂 Μ濟部申央標注局員工消費合作ii.印¾ HO 7 65 766Ο Ο (Precautions for poetry $ reading and backing, end of page binding Μ SME Department Shenyang Marking Bureau staff consumer cooperation ii. Printing ¾ HO 7 65 766

〇 Η f^0; Η 〇 •271 · 本故法尺度逆用中国S家揉孳(CNS ) 格(2丨0X297公釐) 371235157 M濟部中夬樣挛局貝工消费合作社印¾〇 Η f ^ 0; 〇 〇 271 • The original method scale is reversed by the Chinese family (CNS) grid (2 丨 0X297 mm) 371235157 M printed by the Ministry of Economic Affairs of China Bureau of Plastics Cooperatives ¾

(诗先男讀背云之:Vi意事項 參 具ft實例(K)及(L)最佳化合物爲其中八1*3環基是異4嗒基 者: 本發明化合物述於共有的美國專利案系列No. 08/575,64 1 及08./5 9 8,3 32中,其揭示已列爲此中之參考文獻。 衣發明化合物具有約700道耳呑以下之分子量,旦較好 在約400及600道耳呑之間。這些較佳化合物可爲病人口股 後之血流十分容易地吸收。此口服利用率使此化合物爲拮 技IL-1-,細胞預期細胞-,IGIF-或IFN- Γ調介的疾病口股 可投予之治療及預防療法中之極佳作用物3 應了解此發明化合物可以各種平衡型式存在,依據的條 件包括··溶劑的選用,p Η,精藝者已知的其他。這些化 合物所有的此種塑式可在本發明'中自甴地納入。特別地, 本發明許多化合物,尤其是在Rj中含有飼或遂基及在丁上 含有羧酸基者,可呈半-縮酮(或半-縮迻)或水合型弍。如 ,具體實例(A)化合物可呈下示之型式: •272 · 本泛泫尺度逑玥tSS家糅争(CNS ) A*Ul格(210X 297公5 ) 本瓦) -裝 訂 泉 1235157 五、發明説明(270) 0I丨(The poem goes to the man who reads the back of the cloud: the meaning of Vi refers to the examples of ft. (K) and (L). The best compound is one in which the 8 * 3 ring group is an iso-4-yl group: The compounds of the present invention are described in the common US patent. No. 08 / 575,64 1 and 08./5 9 8,3 32, the disclosures of which have been included as references. The compounds of the present invention have a molecular weight of less than about 700 eardrums, preferably at Between about 400 and 600 ears. These preferred compounds can be easily absorbed by the bloodstream behind the patient's mouth and thighs. This oral utilization makes this compound an antagonistic IL-1-, cell-expected cell-, IGIF-or IFN- Γ is an excellent agent for the treatment and prevention of oral diseases that can be administered to the disease. 3 It should be understood that the compound of the invention can exist in various balanced forms, based on conditions including the choice of solvents, p Η, fine arts. The others are known. All such formulas of these compounds can be incorporated in the present invention. In particular, many of the compounds of the present invention, especially Rj contains a feed group or a sulfonyl group, and D contains a carboxylic acid. The base can be hemi-ketal (or hemi-condensation) or hydration type hydrazone. For example, specific examples (A ) The compound can take the form shown below: • 272 · The general scale (tSS family competition (CNS) A * Ul grid (210X 297 male 5) Ben tile)-binding spring 1235157 V. Description of the invention (270) 0I丨

CH 0II (〇j2y^~~c 水合型CH 0II (〇j2y ^ ~~ c hydrated

(0^)9— 0—· II 0II (0·^)τπ«—C•d/ 、。I CH 半-缩詞或 丰·缩痉型 依據溶劑之選用及其他精藝者已知之狀況,本發明化合 物也可呈醯氧基縮酮,醯氧基縮醛,縮酮或縮醛型式: 0(0 ^) 9— 0— · II 0II (0 · ^) τπ «—C • d /. The I CH semi-abbreviation or fengshui spasm type is based on the choice of solvent and other conditions known to those skilled in the art. The compounds of the present invention may also be in the form of acetoxy ketals, acetoxy acetals, ketals or acetals: 0

(cym—H从 V(cym-H from V

〇 (CJ2)nJ 、 R-p—ΓΨ—— η η \(〇^)〇-〇~七 醯氧基縮嗣或 矮氧基综趁 0.J、 -N—I \ ^ Η _〇^t-R3 综嗣或综兹型式 請 先 讀 背 云 之 茗〇 (CJ2) nJ, Rp—ΓΨ—— η η \ (〇 ^) 〇-〇 ~ Heptafluorene condensation or short oxygenation taking advantage of 0.J, -N—I \ ^ Η _〇 ^ t- R3 Syndrome or Synthetic Pattern

本 % 經濟部中央揉率局員工消费合作枉印裝 此外,應了解本發明化合物的平衡型式可包括互變異構 塑。這些化合物的所有此種型式均自甴地納入本發明中。 應了解本發明化合物可由適合的官能基修飾以加蕷選擇 性生物學特性。此種變化爲技藝中已知的,且包括可增加 至特定生物系統之生物穿透性(如血液,·揉巴系,中極神 經系),增加口服利用率,增加甴注射方式投藥之溶解度 ,改變代謝及改變排泄速率3此、卜,化合物可變化成前藥 型式,如此欲求的化合物甴於前藥代謝作用或其他生死過 程的結果可在病人ft内生成3此種前藥型式在試管内分析 法中通常少有或無活性3前藥型式的某些實例包括化合物 273- 本.¾¾尺度逍用中gg家標李(CNS ) A4規格(2【〇X 297公沒) 1235157 AT B7 五、發明説明(271 之縮鲷,縮醛,肪,亞胺,及腙型式,其中含有酮或醛基 ,尤其是其發生在本發明化合物之R3基時3前藥型式的其 請 先 讀 背 云 之 a 意 % 再 填 % 太 t 他f例包持半-縮詞,丰-縮趁,龜氧基縮_,ϋ氧基縮趁 ,縮酮及縮醛型式,其述於EQ1及EQ2中。The Central Government Bureau of the Ministry of Economic Affairs of the People's Republic of China has consumer cooperation and printing equipment. In addition, it should be understood that the equilibrium form of the compound of the present invention may include tautomerization. All such forms of these compounds are automatically incorporated in the present invention. It will be appreciated that the compounds of the present invention may be modified by suitable functional groups to enhance selective biological properties. Such changes are known in the art, and include biological penetrability (such as blood, rubbing, middle pole nervous system) that can be increased to specific biological systems, increase oral utilization, and increase the solubility of 甴 injections. Change the metabolism and change the excretion rate 3, Bu, the compound can be changed into a prodrug type, so the desired compound can be generated in the patient ft due to prodrug metabolism or other results of life and death 3 This type of prodrug Some examples of prodrug types that are usually rare or inactive in in-tube analysis include compound 273-benz. ¾¾ standard use gg family standard plum (CNS) A4 specifications (2 [〇X 297 publicly available] 1235157 AT B7 V. Description of the invention (271 bream, acetal, fatty, imine, and hydrazone type, which contains ketone or aldehyde group, especially when it occurs in the R3 group of the compound of the present invention, 3 prodrug type, please read it first The meaning of “a” in the back of the cloud is “%” and then “%” is too high. The “f” cases include half-abbreviations, abundance-condensation, turtle-condensation, acetoxy-condensation, ketal and acetal types, which are described in EQ1 and EQ2.

ICE及ΤΧ解離及甴是活化前-IGIF ICE蛋白酶先前之鑑定是經由其於試管内及活韹内處理 無活性之前成爲成熟的具活性IL-1/?,一種前-發 炎分子,之能力爲基礎。在此吾等示出,ICE及其密切的 同 質 TX (Caspase-4,C. Faucheu et al·,EMB〇,14,p. 1914 ( 1995))可蛋白水解地解離無活性之前-IGIF :此處理修鈽 步驟需將前-IGIF轉化成其具活性的成熟型式,IGIF。甴 ICE及可能的TX解離前-IGIF也有助於將IGIF運送出妇跑: 吾等先使用質韹轉感至Cos細胞之瞬時共表現來決定 ICE/CED-3蛋白薛族中是否有任何已知成員可在培養細绝 中將前-IGIF處理成爲IGIF(實例23)(圖1A)。 經濟部中央樣达‘局員工消费合作.社印袞 圖1A說明ICE解離Cos細跑中之pro-IGIF,該纟曰胞以在舌 性ICE存在下可表現pro-IGIF之質體所共轉感。Cos.^孢以 表現質體轉感,此質體或是單獨的pro-IGIF(第2列)或组合 所指示之質趑質趑,其编碼蛋白酶ICE/CED-3族之野生型 或失活之突變型(第3-12列)。製胞溶胞產物並以抗-IGIF抗 血清行免疫吸潰而分析IGIF蛋白質之存在^ 1列含有來自 空白轉感細胞之溶跑產物α pro-IGIF與ICE或ΤΧ之共同表現會造成pro-IGIF解難生成 多肽,其大小和自然生成的18- kDa成熟IGIF相似。此處涅 -274- 本袄法尺度適用中SS家標孳(CNS ) A4说格(210X297公釐) 1235157 經濟部中夬·达局貝工消费合作枉印复 Λ: Β- 五、發明説明(272) 修鈽事件可爲單一點突變所卩旦斷,此.¾突變係改變僅化之 丰统胺酸殘基,且因此使ICE及TX失去活性(Y. Gu et al., EMB〇,14, P. 1923 (1995))。 ’ 與CPP32 (Caspase-3)—種涉及於細跑預期泛亡之蛋白薛 (丁. Fernandes-Alnemri et al., J. Biol. Chem., 269, p. 3 0761 (1 994); D· W. Nicholson et al.,Nature,376,p. 3 7 (1 995))之 共表現,可造成pro-IGIF解離生成較小的多狀,而與CMH-1 (Caspase-7)—種與 CPP32極相似之同質物(J. A. Uppke et al., J. Biol· Chem·,271,p. 1 825 (1 996))共表現時,則無法 解離pro-IGIF至任何顯著程度。因此,ICE及TX似乎可蔣 pro-IGIF解離成大小類似自然生成的18 kDa IGIF之多肽。 接下來吾等檢查這些半胱胺酸蛋白§每於試管内解離pro-[GIF之能力,此中使用經純化且重组之加有(His)0之pro- IGIF爲受質(實例23)。 圖1 B示出pro-IGIF於試管内爲ICE所解離。經纯化且重 組的加有(His)6tpro-IGIF (2微克)與所示之半统铵酸蛋白 時在ICE或CPP32抑制劑有或無下培育,如實例23所述。 解離產物以SDS-PAGE及考馬斯藍染色分析。 ICE可解離24 kDa之pro-IGIF成爲二個約18 kDa及6 kDa之 多肽。ICE解離產物行N-末端胺基酸定序顯示,IS kDa多 肽含有和自然生成之IGIF相同θ N-末端胺基酸殘基(Asn-Phe-Gly-Arg-Leu)。此顙示ICE可在推想之處理修飾位置上 (Asp3 5-Asn36)解離 pro-IGIF (H. Okamura et al., Infection and Immunity, 63, p. 3966 (1995) : H. Dkamura et al., Nature, 378, -275- 本祆:¾尺度边用中gS家糅举(CNS ) A4規格(210X 297公釐) (請先翊讀背云之注意事 本頁) 裝 訂 次: 1235157 五、發明説明(273) p. 8 8 (1995)) 3 CPP32解離產物之N-末端按基酸定序顯示’ CPP32可於 Asp69-Ile70處解雜 pro-IGIF : ICE對pro-IGIF之解離具有高度特異性,具/有Μ X 1〇7 / (Κμ=0·6±0·1α M; kcai=8.6±0.3 s-1)之催化效率(kcat/KM), 且可爲特異的ICE抑制劑(Ac-Tyr-Val-Aia-Asp-兹)及Cbz-Val-Ala-Asp-[(2,6-二氯辛縫基)氧基]曱基調所抑制’(Ν·Α· Thornberry et al.’Nature,356 p. 768 (1992); R. E. Dolle et al.? J. Med· Chem·,37, p. 563 (1994)) 〇 圖1C證明於試管ή ICE之解離可活化pro-IGIF。未解離之 pro-IGIF,ICE-或CPP32-解離之pro-IGIF產物,或重组ft成 熟IGIF(rlGIF)各加至A.E7細胞培養中至12毫微克/毫升或 120毫微克/毫升之終濃度(見,實例23) : 18小時後,培養 基中之r-IFN以ELISA定量。雖然未解離的pro-IGIF無可測 及的r-IFN誘導活性,ICE-解離的pr〇-IGIF在誘導Thl細孢 產製r-IFN上仍具活性。 和ICE—樣的,ICE之同質物TX也可將pro-IGIF解雞成頹 似大小之多肽,然而,其催化效力較ICE少了二倍左右。 與上述Cos鈿胞實驗之觀察一致,CPP3 2可在不同位置上 (Asp69-Ile70)解離pro-IGIF,且生成的多肽少有r-IFN誘導 活性(圖1C)。CHM-1及granzyme B各自無法解離pro-IGIF至 任何顥著程度。 ' 一起地這些結果證明,於Cos钿跑及於試管内,ICE及TX 可在指想的成熟位置上處理修飾無活性的pro-1 GIF,生成 具生物活性之IGIF分子。 •276- 本纸伕尺度逑用中g國家標辛(CNS )八4緹格(2丨0X297公澄 诗 先 % 讀 背 之 注 意 事ICE and TX dissociation and 甴 are pre-activation-IGIF ICE protease was previously identified as a mature active IL-1 / ?, a pre-inflammation molecule, by its inactivation in a test tube and in vivo before being inactive. basis. Here we show that ICE and its close homogeneous TX (Caspase-4, C. Faucheu et al., EMB0, 14, p. 1914 (1995)) can proteolytically dissociate before inactivity-IGIF: this Processing the repair step requires converting pre-IGIF into its active, mature form, IGIF.甴 ICE and possible TX before dissociation-IGIF also helps to transport IGIF out of the women's run: We first use the transient co-expression of quality cells to transduce Cos cells to determine whether any of the ICE / CED-3 protein Xue family has been Known members can process pre-IGIF into IGIF (Example 23) in the culture excision (Figure 1A). Figure 1A shows the ICE dissociates the pro-IGIF from the Cos sprint. The cell is co-transformed by a plastid that can express pro-IGIF in the presence of tongue ICE. sense. Cos. Spores express plastids. This plastid is either a single pro-IGIF (column 2) or a combination of peptones, which encodes the protease ICE / CED-3 wild type or Inactive mutants (columns 3-12). Make lysates and analyze the presence of IGIF protein with anti-IGIF antiserum for immunosucking ^ 1 column contains the lysate α pro-IGIF from blank transfected cells and the common performance of ICE or TX will cause pro- IGIF solves difficult-to-produce peptides, which are similar in size to naturally occurring 18-kDa mature IGIF. Here Nirvana-274- This standard is applicable to the SS family standard (CNS) A4 format (210X297 mm) 1235157 Chinese Ministry of Economic Affairs · Dalian Bureau of Shellfisher Consumer Cooperatives Seal Reprint Λ: Ⅴ- Description of the invention (272) The repair event can be interrupted by a single point mutation. This mutation alters only the abundance amino acid residues and thus deactivates ICE and TX (Y. Gu et al., EMB. , 14, P. 1923 (1995)). 'And CPP32 (Caspase-3), a protein involved in sprinting that is expected to die (D. Fernandes-Alnemri et al., J. Biol. Chem., 269, p. 3 0761 (1 994); D. W. Nicholson et al., Nature, 376, p. 3 7 (1 995)) can cause dissociation of pro-IGIF to produce smaller polymorphisms, which is related to CMH-1 (Caspase-7) —a kind of When CPP32 is very similar in homogeneity (JA Uppke et al., J. Biol · Chem ·, 271, p. 1 825 (1 996)), it cannot dissociate pro-IGIF to any significant degree. Therefore, it seems that ICE and TX can dissociate pro-IGIF into peptides similar in size to naturally occurring 18 kDa IGIF. Next we checked the ability of these cysteine proteins to dissociate pro- [GIF in a test tube. Here, purified and reconstituted pro-IGIF with (His) 0 was used as the substrate (Example 23). Figure 1B shows pro-IGIF dissociated by ICE in a test tube. Purified and reconstituted (His) 6tpro-IGIF (2 micrograms) and the half ammonium protein shown were incubated with or without the ICE or CPP32 inhibitor as described in Example 23. Dissociation products were analyzed by SDS-PAGE and Coomassie blue staining. ICE can dissociate pro-IGIF from 24 kDa into two peptides of approximately 18 kDa and 6 kDa. The N-terminal amino acid sequencing of the ICE dissociation product showed that the IS kDa peptide contained the same θ N-terminal amino acid residue (Asn-Phe-Gly-Arg-Leu) as the naturally occurring IGIF. This shows that ICE can dissociate pro-IGIF at the putative modified position (Asp3 5-Asn36) (H. Okamura et al., Infection and Immunity, 63, p. 3966 (1995): H. Dkamura et al., Nature, 378, -275- This book: ¾-scale medium-use gS home furniture (CNS) A4 size (210X 297 mm) (please read the note on the back page first) Binding times: 1235157 V. Invention Explanation (273) p. 8 8 (1995)) 3 The N-terminus of the CPP32 dissociation product is shown in the sequence of the basic acid. 'CPP32 can dissociate pro-IGIF at Asp69-Ile70: ICE is highly specific for the dissociation of pro-IGIF. It has a catalytic efficiency (kcat / KM) of M X 107 / (Kμ = 0.6 ± 0 · 1α M; kcai = 8.6 ± 0.3 s-1), and can be a specific ICE inhibitor ( Ac-Tyr-Val-Aia-Asp-I) and Cbz-Val-Ala-Asp-[(2,6-dichlorooctyl) oxy] hydrazone keynotes' (N.A. Thornberry et al. 'Nature, 356 p. 768 (1992); RE Dolle et al.? J. Med. Chem., 37, p. 563 (1994)) Figure 1C demonstrates that dissociation of ICE in vitro can activate pro-IGIF. Undissociated pro-IGIF, ICE- or CPP32-dissociated pro-IGIF products, or recombinant ft mature IGIF (rlGIF) were added to A.E7 cell culture to the end of 12 ng / ml or 120 ng / ml Concentration (see, Example 23): After 18 hours, r-IFN in the medium was quantified by ELISA. Although undissociated pro-IGIF has no detectable r-IFN-inducing activity, ICE-dissociated pr0-IGIF is still active in inducing r-IFN produced by Th1 microspores. Like ICE, TX, a homogeneous substance of ICE, can also resolve pro-IGIF into chicken-like peptides. However, its catalytic efficiency is about twice that of ICE. Consistent with the observation of the above Cos germ cell experiment, CPP32 can dissociate pro-IGIF at different positions (Asp69-Ile70), and the resulting peptide has little r-IFN-inducing activity (Figure 1C). CHM-1 and granzyme B cannot dissociate pro-IGIF to any significant extent. Together, these results demonstrate that ICE and TX can process modified inactive pro-1 GIF at the desired mature position in Cos running and in test tubes to generate biologically active IGIF molecules. • 276- Chinese paper standard (Chinese national standard Xin (CNS) eight 4 Tig (2 丨 0X297 Gongcheng poems first% of memorizing notes

订 經濟部中央標率局員工消费合作杜印¾ 1235157 __B7 五、發明説明(274)Order the staff consumption cooperation of the Central Bureau of Standards of the Ministry of Economy Du Yin ¾ 1235157 __B7 V. Description of Invention (274)

Pro-IGIF爲ICE之處理修飾有助其運送 IGIF於洽禮内爲活化之庫弗氏細胞及巨噬钿跑所產生, 且一旦爲内每末刺激可運送出给胞(H· Okamura et al. Infection and Immunity,63, p. 3966 (1995); H, Okamura et al. Nature, 378, p. 88 (1995)。吾等使用Cos細胞共表現系統(實 例23)來檢查pro-IGIF於細胞外爲ICE解離是否有助於成熟 IGIF運送出Ssj胞3此如同pro-IL-1 —例,其可爲ICE解蔡 成具;古性之 IL-1(N·A· Thornberry et al·,Nature, 356,p 768 (1992))。 - 於圖2A中,Cos細胞以pro-IGIF單獨的表現質鳢(第2及6 列)或组合編碼野生型之表現質體(3及7列)或無活性之突變 ICE(4及8列)轉感,並代謝地標記以35S-甲硫胺酸(見實例 2句,溶胞產物(左)及調適培養基(右)以抗-IGIF抗血清免疫 沉澱3免疫沉澱的蛋白質以SDS-PAGE及螢光計分析。(圖 2A)。Pro-IGIF is a modification of ICE that helps it to transport IGIF produced by activated Couff ’s cells and macrophages in Qiaoli, and it can be transported to cells once it is stimulated (H. Okamura et al Infection and Immunity, 63, p. 3966 (1995); H, Okamura et al. Nature, 378, p. 88 (1995). We used the Cos cell co-expression system (Example 23) to examine pro-IGIF on cells Whether ICE dissociation helps mature IGIF to transport Ssj cells 3 is like pro-IL-1. For example, it can be solved by ICE Cai Chenggu; ancient IL-1 (N · A · Thornberry et al., Nature, 356, p 768 (1992)).-In Figure 2A, Cos cells express pro-IGIF alone (columns 2 and 6) or a combination encoding wild-type performance plastids (columns 3 and 7). Or inactive mutant ICE (columns 4 and 8) transfected, and metabolically labeled with 35S-methionine (see Example 2 sentence, lysate (left) and adaptation medium (right) with anti-IGIF antiserum Immunoprecipitation 3 Immunoprecipitated proteins were analyzed by SDS-PAGE and fluorometer (Figure 2A).

經濟部t夬糅窣局員工消f合作枉印X 於pro-IGIF及ICE共表現之Cos細胞調適培養基中可測及 大小和或成熟IGIF相當之18 kDa多肽,而共表現pro-iGlF 及無活性ICE突變株(ICE-C285S)之Cos細胞或單獨的pr〇-IGIF(-)則運送出僅極低水平之pro-IGIF及無可測及之成熱 IGIF。吾等估計約有10°/〇成熟IGIF可自共轉感的細跑中運 送出來,而大於99%的pro-IGIF則留在細胞内3 吾等也偵測溶胞產物及上述轉感細胞之調適培養基中, r -IFN誘生活性是否存在(見實例24)。可於溶胞產扬及共 表現pro-IGIF及ICE之Cos細胞調適培養基中均測及r -IFN詩 •277- 本.¾¾又度逑用_匡國家標毕(CNS ) A4说格(2丨0X 297公釐) 1235157 Λ/ 37 五、發明説明(275) 導活性,但僅表現pi*o-IGIF或單獨ICE之細跑則否(圖2B)。 這些結杲顯示,ICE解雜pro-IGIF有助於成熟且具洽性之 IGIF自钿孢之運輸。 ,The staff of the Ministry of Economic Affairs and the Ministry of Economic Affairs have cooperated to print X. In Cos cell adaptation medium co-expressed by pro-IGIF and ICE, 18 kDa peptides of the same size or mature IGIF can be measured, and the total expression of pro-iGlF and no Cos cells of active ICE mutant strain (ICE-C285S) or pr0-IGIF (-) alone delivered only very low levels of pro-IGIF and no detectable pyrogenic IGIF. We estimate that approximately 10 ° / 〇 mature IGIF can be transported from the co-transduced sprint, while more than 99% of pro-IGIF remains in the cells 3 We also detect lysates and the above-mentioned transfected cells Whether r-IFN induces viability in the adapted medium (see Example 24). R-IFN poems can be measured in Cos cell-adjusted culture medium that produces lysate and co-expresses pro-IGIF and ICE. 277-ben. ¾¾ Reuse _ 匡 National Standards Complete (CNS) A4 Saoge (2丨 0X 297 mm) 1235157 Λ / 37 V. Description of the invention (275) Conductive activity, but only showing pi * o-IGIF or sprint run alone (Figure 2B). These crusts show that ICE de-hybridization pro-IGIF facilitates the transport of mature and consistent IGIF from A. spores. ,

Pro-IGIF是ICE活體内之生理受質 爲了研究生理條件下ICE於IGIF蛋白水解活化作用及運 輸中之角色,吾等檢查pro-IGIF之處理修飾及成熟IGIF自 脂多醣(LPS)·活化之庫弗氏細胞中之運送,後者自瘡疱丙 酸桿菌-誘生之野生型及ICE缺失(ICE-/-)老鼠中回收而得( 實例25)。 _ 如圖3 A所示,來自ICE-/-老鼠之庫弗氏細胞於IGIF運送 上有所缺失。野生型及ICE-/-老鼠之庫弗氏細胞溶孢產物 ,經ELISA決定組合含有相似量之IGIF。然而,IGIF僅在 野生型之調適培養基中測及,而在ICE-Λ細跑中則否。因 此ICE-缺失的(ICE-/-)老鼠可合成pro-IGIF,但無法如細跑 外pro-或成熟IGIF般運送之。 爲決定ICE-缺失(ICE-/-)的老鼠是否可處理細皰内pro-IGIF但無法運送IGIF,於是野生型及ICE-/-老鼠之庫弗氏 細胞代謝地標記以35S-曱硫按酸,並如實例25所述的在溶 跑產物及調適培養基上進行IGIF免疫沉殺實狯。這些實驗 證明,未經處理的pro-IGIF存在於野生型及ICE-Λ庫弟氏細 胞中3然而,18-kDa成熟的IGIF^存於野生型之調適培養 基中而非ICE·/-庫弗氏細胞(圖3B)。此顯示將處理過的 IGIF運送出細胞有活性ICE。 此外,來自野生型而非ICE-/-庫弗氏細胞之調適培養基 -278- 本饫杀尺度逑用令国国家揉孪(CNS ) A4規格(210X 297公釐) (請先聞讀背®之注意事項 本I)Pro-IGIF is the physiological substrate in vivo of ICE. In order to study the role of ICE in the proteolytic activation and transport of IGIF under physiological conditions, we examined the processing and modification of pro-IGIF and the mature IGIF self-lipopolysaccharide (LPS). Transport in Coffer cells, which was recovered from Propionibacterium acnes-induced wild-type and ICE-deficient (ICE-/-) mice (Example 25). _ As shown in Figure 3A, Coffer cells from ICE-/-mice are missing from IGIF transport. Cooper's cell lysates from wild-type and ICE-/-mice were determined by ELISA to contain similar amounts of IGIF. However, IGIF is only detected in the wild-type adaptation medium and not in the ICE-Λ sprint. Therefore, ICE-missing (ICE-/-) mice can synthesize pro-IGIF, but they cannot be transported like sprinting outside pro- or mature IGIF. In order to determine whether ICE-deleted (ICE-/-) mice can process pro-IGIF but cannot transport IGIF, the Kuffert cells of wild-type and ICE-/-mice were metabolically labeled with 35S-sulfanthine. Acid, and perform IGIF immunoassay on lysate and conditioned medium as described in Example 25. These experiments demonstrate that untreated pro-IGIF is present in wild-type and ICE-ΛCurtis cells3 However, 18-kDa mature IGIF ^ is stored in a wild-type adaptation medium instead of ICE · / -Coffer Cells (Figure 3B). This shows active ICE transporting the treated IGIF out of the cell. In addition, the adaptation medium from wild-type rather than ICE-/-Cuff's cells -278- this standard of killing uses national standard (CNS) A4 size (210X 297 mm) (please read and read first) Precautions (I)

超濟部中央樣孪局員工消费合作杜印?L 1235157 B7 M濟部中央標準局貝工消費合作社印装 五、發明説明(276) 含有IFN- r謗導活性,此並不歸因於IL-12的作用因爲其對 中和技-IL-12沉謹是敏感的3 ICE-/-庫弟氏彡曰跑调i2L培養卷 中IGIF之铁少和於Cos海跑中所見的一致f在此ICE處理修 飾pro-IGIF是活性IGIF運送所必要的。 圖3C及3D示出,於洽體内ICE-Λ老鼠之IGIF及IFN- r血 清水平分別有所減低3以經熱滅活之瘡疱丙酸桿菌備妥之 野生型(ICE+/+)及ICE-/-老鼠,以LPS-排戰之(實例26),於 LPS後3小時再以EUSA偵測所挑戰老鼠血清中IGIF(圖3C) 及T-IFN(圖3D)之水平(實例25)。 以瘡疱丙酸桿菌及LPS刺激之ICE-/-老鼠,其血清中含有 減量的IGIF(圖3C)並在抗-IL-12抗體存在下無可測及之IFN-厂誘導活性。IGIF減少的血清水平似乎應爲ICE-/-老鼠血 清中IFN-r顯著較低的水平負貴(圖3D),因爲吾等觀察到 在這些條件下,ICE-/-老鼠產製IL-12並無顯著的差異,與 此闡述一致的是以下發現,即來自野生型及ICE-/-老鼠之 非粘附性脾細胞,當以重組體活性IGIF於試管内刺激時可 產生類似量之IFN-r。因此IFN-r受損的產力並非ICE-/-老 鼠T細胞中任何明顯的缺陷所致的。 總而言之這些結果於試管内及活體内確立了 ICE於處理 修飾IGIF前軀體及於活性IGIF利用方面的一個關鑑性角色。 爲了更詳細檢查IFN· r血清水’平及10£活趑内活性問之 相互關係,於以LPS-排戰野生型及ICE-缺失老鼠後進行時 間行程(實例26)(圖4)。 圖4示出於野生型老鼠中血清IFN-r隨時間經過之增加, • 279 - 本紙伕尺度通用中國國家標毕(CNS )人4说格(210X297公釐) (請先閑讀背云之:V」意事項 本頁 -裝- •V5 泉 1235157 B7 五、發明説明(277: 1請 i元 爆 I ¥ 讀 背 1 1 云 之 ••云 1 | ί % 1 1 • 本 丨A Ά 1 於LPS-#戮後9-1 8小時發生$ 17毫微克/毫升之持續水平, 如上述實驗所預測的,於ICE-/-老鼠中7-IFN血清水平顯 著較低,在相同時期時可達到2毫微克/毫寸之高點,此约 爲在野生塑老鼠中所見的15%(圖4)。 也觀察動物關於敗血症之臨床徵狀,及抗戰以30毫克/ 公斤或100毫克/公斤LPS(僅ICE-/-)後於野生型及ICE-Λ老鼠 每4小時間隔偵測體溫變化。示於圖4之結果顯示野生型老 鼠可在LPS-排戰12小時内經驗到體溫之顯著下降(甴36Ό 至26X:)。敗血症之臨床徵狀4*分明顯,且所有動物在24-48小時内死亡。 訂 相反的,施以30毫克/公斤LPS之ICE-/-老鼠經驗到S泾僅 33 - 43C之下降,及極少的痛苦徵狀且並無致死者。施以100 毫克/公斤LPS之ICE-Λ老鼠經驗到臨床症狀,鳢滠下降,死 亡率和30毫克/公斤LPS劑量下之野生型老鼠類似。 ICE抑制劑Ac-YVAD-CHO及IL-1 /?及IFN- r產製之等強度抑制劑 泉 甴於具生物活性之IGIF其處理修飾及分泌均甴ICE所調 介,吾等於週邊血液單核細胞(PBMC)分析法中比較ICE-可逆的抑制劑(Ac-YVAD-CHO)於IL-ly5及IFN- r產製上之洽 性(實例27), 經濟部申夬標洋局員工消贫合作枉印^ 圖5之結果顯示Ac-YVAD-CHO ICE抑制劑在降低人類 PBMCs中IL-lyS及IFN- r產製之私力具類似之強度,各爲 2.5 μ Μ之IC5Q。以野生型老鼠脾細胞研究可得相似的結果3 這些發現提供額外的證據,即pro-IGIF爲ICE生理上之受 質,並建議ICE抑制劑將是控制IGIF及IFN- r生理水平的 -280 本.¾¾尺度述用中§3家標李(CNS ) A4说格(2丨0X297公釐) 371235157 :迎濟部中夬標这局員二消资合作杜印¾ 五、發明説明(278) 有用的工具。 综合而言,吾等已發現ICE可於活鳢内及試管内控制 IGIF及IFN- r水平,且ICE抑制劑可降低人類細跑中之IGIF 反IFN- r水平。這些結果已述於共有的美國專利案No 08/7 12,878中,此揭示已列爲本案之參考。 組成物及方法 本發明的藥學組成物及方法可用於控制活鳢内之IL· 1, IGIF及IFN- r水平。本發明的方法及组成物因此可用於治 療或減少IL-1,IGIF-及IFN-r所調介狀況之進展,影響之 嚴重度3 本發明化合物爲ICE有效的配體。因此,這些化合物可 對準及抑制於IL-1-,細胞預期死亡·,IGIF-及IFN- r -調 介疾病中之事件,且因此於發炎疾病,自體免疫疾病,破 壞性骨骼,增殖性失調症,感染性疾病,及退化性疫病中 蛋白質之最終活性。例如,本發明化合物經甴抑制ICE而 可抑制甴前軀ft IL-1々轉化成爲成熟的IL-1 。甴於ICE爲 產生成熟IL-1所必要的,此酵素之抑制可有效地阻斷IL-1-調介之生理作用及症狀之啓始,如發炎,此係經甴抑制成 熟IL-1產製而成。因此由抑制IL-1/5前軀體活性,本發明 化合物可有效地作爲IL-1抑制劑。 類似地,本發明化合物可抑 &lt; 前艋鳢IGIF轉化成爲成熟 的IGIF。因此,經由抑制IGIF之產製,本發明化合物可有 效地作爲IFN- r製製之抑制劑3 因此,本發明的一個具體實例是提出於個鳢中降低IGIF -281 - 本.¾¾尺度通用中g國家揉莩(CNS ) A4規格(210X 297公釐) (诗先絮讀背面之泾意事項再!^本頁 -裝 訂 線 1235157 五、發明説明(279: 製製之方法,此方法包括對個鳢投予藥學組成物,其中含 有治療有效劑量之ICE抑制劑及藥學上可接受之載劑。 本發明另一具醴實例提出於個韹中降低IFN- r產製之方 法,此中包括對個體投予藥學组成物,其中含有治療有效 劑量之ICE抑制劑及藥學上可接受之載劑^ 於另一具體實例中,本發明方法包括對個體投予藥學组 成物,其中含有ICE-相關蛋白薛之抑制劑,其可將ριτο-IGIF解離生成具活性的IGIF,及藥學上可接受之載劑。此 種ICE-相關之蛋白酶之一是ΪΧ,如上述。本發明因此提 出方法及藥學組成物,即經甴投予Τ X抑制劑來控制IGIF 及IFN- r之水平。 也可見其他可將pro-IGIF處理修鈽成具活性IGIF型式的 其他ICE-相關之蛋白酶。因此可檢視到這些酵素之抑制劑 可由精藝者所鑑知,且也屬於本發明範圍之内3 本發明化合物可以傳統方式來應用,以治療甴IL-1,钿 胞預期死亡,IGIF或IFN- r所調介之疾病。此種治療方法 ,劑量水平及需求可由精藝者自可運用之方法及技術中加 以選擇。如,本發明化合物可組合以藥學上可接受之佐剤 ,以藥學上可接受方式及可有效減輕疾病嚴重度之劑量投 予至受IL-1 -,鈿胞預期死亡-,IGIF·或IFN- r -調介疾病 之苦之患者身上3 另外,本發明化合物可運用於组成物及方法中,以長期 治療或保護個體拮抗IL-1-,細胞預期死亡-,IGIF-或IFN-r -調介之疾病3化合物可單獨地或加上其他本發明化合 •282Consumer Co-operation Du Yin of the Central Bureau of Super Ministry of Economic Affairs Du Yin? L 1235157 B7 M Printed by the Shell Consumer Cooperative of the Central Standards Bureau of Ministry of Economic Affairs 5. Description of the invention (276) Contains IFN-r defamatory activity, which is not attributable to IL The role of -12 is because it is sensitive to the neutralization technique -IL-12 Shen Jing 3 ICE-/-Cooper's 彡 said that the iron content of IGIF in the i2L culture volume is low and it is consistent with that seen in the Cos sea run. ICE treatment of modified pro-IGIF is necessary for active IGIF transport. Figures 3C and 3D show that the serum levels of IGIF and IFN-r in ICE-Λ mice were reduced in mice 3, respectively, to prepare wild-type (ICE + / +) and P. acnes prepared by heat-inactivation, and ICE-/-mice, LPS- (vs. Example 26), and 3 hours after LPS, EUSA was used to detect the levels of IGIF (Figure 3C) and T-IFN (Figure 3D) in the serum of challenged mice (Example 25) ). ICE-/-mice stimulated with Propionibacterium acnes and LPS had a reduced amount of IGIF in their serum (Figure 3C) and had no detectable IFN-factor-inducing activity in the presence of anti-IL-12 antibodies. It seems that the reduced serum levels of IGIF should be at a premium to the significantly lower levels of IFN-r in the serum of ICE-/-mice (Figure 3D), because we have observed that under these conditions, ICE-/-mice produce IL-12 There is no significant difference, and this statement is consistent with the finding that non-adherent splenocytes from wild-type and ICE-/-mice can produce similar amounts of IFN when stimulated in vitro with recombinant active IGIF -r. Therefore, the impaired fertility of IFN-r is not caused by any obvious defect in ICE-/-old mouse T cells. Taken together, these results establish a critical role for ICE in the treatment of modified IGIF precursors and in the use of active IGIF in vitro and in vivo. In order to examine the interrelationship between IFN · r serum level and activity within 10 pounds in more detail, the time course was performed after pitting wild-type and ICE-deleted mice with LPS- (Example 26) (Figure 4). Figure 4 shows the increase in serum IFN-r over time in wild-type mice. • 279-The standard of this paper is the Chinese National Standard Complete (CNS) person 4 grid (210X297 mm). : V 」Issue page-installation- • V5 泉 1235157 B7 V. Description of the invention (277: 1 Please i Yuan burst I ¥ Read back 1 1 Cloud of •• Cloud 1 | ί% 1 1 • Book 丨 A Ά 1 Sustained levels of $ 17 nanograms / ml occurred 9 to 8 hours after LPS- # slaughter. As predicted by the experiments described above, 7-IFN serum levels were significantly lower in ICE-/-mice, which could be at the same time. Reaching a high of 2 nanograms per millimeter, which is about 15% seen in wild plastic mice (Figure 4). Also observe the clinical signs of sepsis in animals, and the anti-Japanese war at 30 mg / kg or 100 mg / kg After LPS (ICE-/-only), body temperature changes were detected every 4 hours in wild-type and ICE-Λ mice. The results shown in Figure 4 show that wild-type mice can experience significant body temperature within 12 hours of LPS-platform Decrease (甴 36Ό to 26X :). The clinical symptoms of sepsis are 4 * points, and all animals die within 24-48 hours. ICE-/-mice with 30 mg / kg LPS experienced a decrease in S 泾 of only 33-43C, with few symptoms of pain and no lethality. ICE-Λ mice administered with 100 mg / kg LPS experienced clinical symptoms , 鳢 滠 decreased, mortality is similar to wild-type mice at a dose of 30 mg / kg LPS. ICE inhibitors Ac-YVAD-CHO and IL-1 /? And IFN-r produced by the same intensity inhibitors quan The biologically active IGIF, its modification, and secretion are mediated by ICE. We compared the ICE-reversible inhibitor (Ac-YVAD-CHO) with IL-ly5 and IFN- in peripheral blood mononuclear cell (PBMC) analysis. Consistency in the production system (Example 27), poverty alleviation cooperation of employees of the Ministry of Economic Affairs and the International Bureau of Biaoyang Bureau ^ The results in Figure 5 show that Ac-YVAD-CHO ICE inhibitors reduce the production of IL-lyS and IFN-r in human PBMCs. The strength of the system is similar, with IC5Q of 2.5 μM each. Similar results were obtained with wild-type mouse spleen cells3 These findings provide additional evidence that pro-IGIF is the physiological substance of ICE, and It is suggested that the ICE inhibitor will be a -280 version that controls the physiological levels of IGIF and IFN-r. ¾¾ Standards are used in §3 domestic standard plum (CNS) A4 Speaking grid (2 丨 0X297 mm) 371235157: The Ministry of Economics and Economics has won the bid for the second consumer capital cooperation of the bureau Du Yin ¾ 5. Description of the invention (278) Useful tools. In summary, we have found that ICE can be used in living Control IGIF and IFN-r levels in vitro and in vitro, and ICE inhibitors can reduce IGIF anti-IFN-r levels in human sprinting. These results have been described in co-owned U.S. Patent No. 08/7 12,878, the disclosure of which is incorporated herein by reference. Compositions and methods The pharmaceutical compositions and methods of the present invention can be used to control the levels of IL · 1, IGIF and IFN-r in living organisms. The method and composition of the present invention can therefore be used to treat or reduce the progress of the conditions mediated by IL-1, IGIF- and IFN-r, and the severity of the effects. 3 The compounds of the present invention are effective ligands for ICE. As a result, these compounds can target and inhibit IL-1-, expected cell death, IGIF- and IFN-r-mediated events in diseases, and therefore in inflammatory diseases, autoimmune diseases, destructive bones, proliferation The final activity of proteins in sexual disorders, infectious diseases, and degenerative diseases. For example, the compounds of the present invention inhibit ICE from inhibiting the conversion of 甴 IL-1, the precursor of 甴, to mature IL-1.甴 It is necessary for ICE to produce mature IL-1. The inhibition of this enzyme can effectively block the physiological effects of IL-1-mediated and the onset of symptoms, such as inflammation, which inhibits mature IL-1 production through 甴制 制。 Made. Therefore, the compounds of the present invention can be effectively used as IL-1 inhibitors by inhibiting IL-1 / 5 precursor activity. Similarly, the compounds of the present invention inhibit &lt; precursor IGIF conversion into mature IGIF. Therefore, by inhibiting the production of IGIF, the compounds of the present invention can be effectively used as inhibitors of IFN-r production. 3 Therefore, a specific example of the present invention is proposed to reduce IGIF-281 in this case. gCountry Kneading (CNS) A4 (210X 297 mm) (Read poems on the back of the book! ^ This page-gutter 1235157 V. Description of the invention (279: method of manufacturing, this method includes An individual drug is administered to a pharmaceutical composition containing a therapeutically effective dose of an ICE inhibitor and a pharmaceutically acceptable carrier. Another example of the present invention proposes a method for reducing the production of IFN-r in an individual drug, which includes Administering a pharmaceutical composition to an individual, which contains a therapeutically effective dose of an ICE inhibitor and a pharmaceutically acceptable carrier ^ In another embodiment, the method of the present invention includes administering a pharmaceutical composition to an individual, which contains ICE-related An inhibitor of protein Xue, which can dissociate ριτο-IGIF to produce active IGIF, and a pharmaceutically acceptable carrier. One of such ICE-related proteases is YX, as described above. The present invention therefore proposes a method and a pharmacy The composition, that is, the administration of TX inhibitors to control the levels of IGIF and IFN-r. Other ICE-related proteases that can be modified by the treatment of pro-IGIF into active IGIF types can be seen. The inhibitors of these enzymes can be known by skilled artisans and are also within the scope of the present invention.3 The compounds of the present invention can be applied in a traditional manner to treat 甴 IL-1, expected cell death, IGIF or IFN-r modulation. Diseases, such treatment methods, dosage levels and needs can be selected by the skilled artisan from available methods and techniques. For example, the compounds of the present invention can be combined with pharmaceutically acceptable adjuvants in a pharmaceutically acceptable manner. And doses effective to reduce the severity of the disease to patients suffering from IL-1-, expected cell death-, IGIF · or IFN-r-mediating the disease 3 In addition, the compounds of the present invention can be applied to the composition In the method and method, in the long-term treatment or protection of an individual that antagonizes IL-1-, the cell is expected to die-, IGIF- or IFN-r-mediated disease 3 compounds can be used alone or in combination with other compounds of the present invention.282

% 讀 背 δ 之 意 % 太 I 裝 訂 il濟部中夬標準局員工消费合作社印製 ( CWS ^ » 210X 297/Si5·) 37 37 280, 1235157 五、發明説明( 物一起應用於此组成物中,方式符合ICE抑制劑於藥學组 成物中之傳統利用性。例如,本發明化合物可與傳統應用 於疫苗之藥學上可接受之佐劑組合,並以預防上有效劑量 來投予以長翔保護個體拮抗IL-1 -,細胞預期死亡-, IGIF-或IFN- r -調介之疾病。 本發明化合物也可與其他ICE抑制劑共同投予,以增加 拮抗各種IL-1 -,細胞預期死亡-,IGIF-或IFN-厂-調介疾 病之治療或預防作用3 此外,本發1月化合物可组合&quot;傳統的抗炎劑或基質金屬蛋 白§聲抑制劑,脂氧合g条抑制劑及IL-1 以外的細胞動素之 拮抗劑。 本發明化合物也可與免疫調控劑(如bropirimine,抗-人 類^干擾素抗體,IL-2,GM-CSF,甲硫胺酸腦啡肽,泛 干擾素,二硫胺基甲酸二乙酯,腫瘤壞死因子, naltrexone及rEP〇)或與前列腺素組合投藥,以預防或對抗 IL-1調介之疾病症狀,如發炎3 當本發明化合物與其他作用物组合治療投予時,其可依 序或同時投予至患者3另外,依據本發明之藥學或預防性 組成物包括本發明ICE抑制剤與其他治療或預防作用物之 组合3 本發明的藥學組成物包括本發'明任一化合物,及其藥學 上可接受的鹽,加上任何藥學上可接受之載劑,佐劑或溶 媒。可用於本發明藥學組成物中之藥學上可接受之載劑, 佐劑及溶媒包括下列但不限於此:離子交換劑,氧化链, -283 本虼乐尺度逯用tag家揉李(CNS )M規格(210X297公釐) 請 先 讀 背 面 之 意 容% Read the meaning of δ% Tai I Binding Printed by the Consumers' Cooperative of the China Standards Bureau of the Ministry of Economic Affairs (CWS ^ »210X 297 / Si5 ·) 37 37 280, 1235157 V. Description of the invention The method conforms to the traditional availability of ICE inhibitors in pharmaceutical compositions. For example, the compounds of the present invention can be combined with pharmaceutically acceptable adjuvants traditionally used in vaccines, and administered to Changxiang to protect individuals in a prophylactically effective dose. Antagonistic IL-1-, cell expected to die-, IGIF- or IFN-r-mediated diseases. The compounds of the present invention can also be co-administered with other ICE inhibitors to increase antagonistic IL-1-, expected cell death- , IGIF- or IFN-factory-mediated treatment or prevention of diseases 3 In addition, the compounds of this invention in January can be combined with "traditional anti-inflammatory agents or matrix metal protein § acoustic inhibitors, lipid-oxygenated bar inhibitors and Antagonists of cytokines other than IL-1. The compounds of the present invention may also interact with immunomodulators such as bropirimine, anti-human interferon antibodies, IL-2, GM-CSF, methionine enkephalin, Interferon, diethyl dithiocarbamate, Tumor necrosis factor, naltrexone and rEP) or in combination with prostaglandins to prevent or combat the symptoms of diseases mediated by IL-1, such as inflammation 3 When the compound of the present invention is administered in combination with other agents, they can be administered sequentially Or simultaneously administered to a patient 3 In addition, the pharmaceutical or prophylactic composition according to the present invention includes a combination of the ICE inhibitor of the present invention and other therapeutic or prophylactic agents 3 The pharmaceutical composition of the present invention includes any one of the compounds of the present invention, And pharmaceutically acceptable salts thereof, plus any pharmaceutically acceptable carrier, adjuvant or vehicle. The pharmaceutically acceptable carriers that can be used in the pharmaceutical composition of the present invention, adjuvants and vehicles include the following but not Limit to this: Ion exchanger, oxidation chain, -283 This standard is for domestic use (CNS) M specifications (210X297 mm) Please read the meaning on the back first

太 1 經濟部中央糅準局員工消资合作钍印裂 1235157 經濟部中夬嘌绛局員二消资合作杜印^ 3 了五、發明説明(281 ) 硬脂酸铝,卵磷脂,自我乳化之藥物遞送系(SEDDS)如αα -生育醇聚乙二酵1000琥珀酸養,或其他類似的聚合遞送 基質,血清蛋白質,如人類血清白蛋白,缓衝物質如磷酸 盪,甘治,山裂酸,山裂酸卸,錄和植物腊訪酸之部份甘 治昆合物,水,碧或電鲜質,如硫酸魚精蛋白,释酸氫 二鈉,場酸氫鉀,氯化氯,鋅鹽,膠態氧化碎,三矽酸镁 ,聚乙烯吡喀啶酮,以纖維素爲底的物質,聚乙二諄,羧 甲基纖維素鈉,聚丙烯酸鹽,蠟質,聚乙烯-聚氧丙烯·成 塊聚合物,聚乙二醇及羊毛脂。環翱精如G -,/3 -反Γ -環 糊精,或化學修飾之衍生物如羥烷基環糊精,包括2-及3-羥丙基--環糊精,或其他助溶之衍生物也可有益地用來 加強本發明化合物之遞送3 衣發明之藥學組成物可口服,經腸,經吸入喷霧,局部 ,經直陽,經鼻,頰,陰道或經植入之貯存所來投葵3吾 等較喜口服。本發明的藥學组成物可含有任何傳統上無毒 性之藥學上可接受的載劑,佐劑或溶媒。在某些例子中, 調和物之pH値可以藥學上可接受之酸,绘或緩衝物質來 調整以加強所調和化合物或其遞送型式之穩定性。此中之 陽外方式包括皮下,角質内,靜脈内,肌内,動腺内,滑 膜内,胸骨内,鞘内,傷口内,及顱骨内注射或輸液技術3 藥學組成物可呈無菌可注射製^劑型式,如呈無菌可注射 之水性或油性懸液。此懸液可依技藝中已知之技術來調和 ,利用適合的分散劑或沾濕劑(如Tween 80)及助懸劑。無 菌可注射製剤也可以是於無毒性經腸外-可接受之稀釋劑 -284 - 本紙法尺度送用中家標辛(CNS )六4規格(210X 297公釐) (請先緊讀背®之注意事項v -裝-- f 本 ) 訂太 1 The staff of the Central Economic and Technical Bureau of the Ministry of Economic Affairs of the People ’s Republic of China is responsible for the cooperation of capital and investment 1235157 The member of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People ’s Republic of China is responsible for the cooperation of the two industries. Du Yin ^ 3 V. Description of the invention (281) Aluminum stearate, lecithin, self-emulsifying Drug delivery systems (SEDDS) such as αα-tocopheryl polyethylene glycol 1000 succinate, or other similar polymeric delivery matrices, serum proteins such as human serum albumin, buffer substances such as phosphate, glycine, and lysate , Part of Ganzhikun compound, water, green or electric fresh matter, such as protamine sulfate, disodium hydrogen release, potassium hydrogen acid, chlorine chloride, zinc salt , Colloidal oxidative crushing, magnesium trisilicate, polyvinylpyridone, cellulose-based substances, polyethylene glycol, sodium carboxymethyl cellulose, polyacrylate, wax, polyethylene-polyoxygen Propylene · block polymer, polyethylene glycol and lanolin. Cyclodextrins such as G-, / 3-trans-Γ-cyclodextrin, or chemically modified derivatives such as hydroxyalkyl cyclodextrin, including 2- and 3-hydroxypropyl-cyclodextrin, or other solubilizers Derivatives can also be beneficially used to enhance the delivery of the compounds of the present invention. The pharmaceutical composition of the invention can be taken orally, enterally, by inhalation spray, topically, by direct sun, by nose, buccal, vaginal or by implantation. The store came to take sunflower 3 and we preferred to take it orally. The pharmaceutical composition of the present invention may contain any conventionally non-toxic pharmaceutically acceptable carrier, adjuvant or vehicle. In some examples, the pH of the blend can be adjusted with a pharmaceutically acceptable acid, paint or buffer substance to enhance the stability of the blended compound or its delivery form. The extra-yang methods include subcutaneous, intra-keratinous, intravenous, intramuscular, intra-glandular, intra-synovial, intra-sternal, intrathecal, intra-wound, and intra-cranial injection or infusion techniques. Injectable formulations, such as sterile injectable aqueous or oily suspensions. This suspension can be blended according to techniques known in the art, using suitable dispersing or wetting agents (such as Tween 80) and suspending agents. Sterile injectable tincture can also be used in non-toxic parenterally-acceptable diluent-284-This paper method is sent to the Chinese standard Xin (CNS) six 4 size (210X 297 mm) (Please read the back Precautions v-installed-f this) order

1235157 Α· A/ B7 五、發明説明(2叫 中之遠合的治膏調和之。本發明化合物局部投藥的載劑包 括有續治,液謹石蠟,白石蠟,丙二醇,聚氧乙烯聚氧丙 烯化合物,乳化蠟及水,但亦不限於此。/另外,藥學组成 物可以適合的洗劑或乳劑調和,其中含有活性化合物ϋ懸 浮或溶於載劑中。適合的載劑包括礦湳,山梨聚糖單硬脂 酸§旨,聚山梨醇60,鯨基酯蠟,鯨芳基醇,2-辛基十二烷 醇,芊醇及水。本發明的藥學组成物也可局部施用至較低 之腸道,經甴取門栓劑調和物或適合的灌腸劑調和物3局 部投藥之穿皮貼劑也包括於本發明中。 本發明的藥學组成物可經由鼻氣霧劑或吸入方弍投藥3 此種组成物依藥學調和物技藝中熟知之技術製備,且可製 備成於食鹽水中之溶液劑,應用芊醇或其他適合的保義剤 ,吸收促進劑以加強生物利用率,碳氟化物及/或技藝中 已知之其他助溶或分散劑。 .¾濟部令夬糅这局員工消費合作钍印製 活性组份化合物介於約0.01及約100毫克/公斤鳢重每天 ,較好介於約1及50毫克/公斤體重每天之劑量水平,可闫 於預防及治療IL-1-,細胞預期死亡,IGIF及IFN- r -調介 之疾病,包括發炎疾病,自體免疫疾病,破壞性骨貉失調 症,增殖性失調症,感染性疾病,退化性疾病,壞死性疾 病,骨關節炎,急性竣链炎,慢性跋臟炎,氣唉,成人呼 吸痛苦徵候群,血管球性腎炎,‘類風濕關節炎,全身性红 斑狼瘡,硬皮病,慢性曱狀腺炎,葛雷夫氏病,自g免疫 性胃炎,跋島素-依賴型糖尿病(I型),自體免疫性溶丘性 貧血,自ft免疫性嗜中性白血球減少症,血小板減少症, -286- 本.¾¾尺度適;^中§国家揉辛(CNS ) AUi格(210X 297公釐) 1235157 A_ B7 五、發明説明(2δ4) 慢性活動性肝炎,重症肌無力,發炎性緣疾,Crohn’s病, 牛皮奏,移植物對宿主疾病,骨質疏鬆症,多發性骨髓瘤 -相關之骨骼失調症,急性骨髓性白血病/慢性骨髓性白 ii病,轉移性黑色素瘤,卡波西氏肉瘤,多發性骨髓瘤敗 金症,敗血性休克,志賀氏桿菌病,阿滋海爾默氏病,巴 金森氏病,腦絕血,心肌缺血,脊髓性肌肉萎縮症,多發 性硬化病,AIDS-相關之腦炎,HIV-相關之腦炎,老化, 秀頭,及甴於中風造成的神經性傷害。典塑而言,本發明 藥學组成物可以每天投予約1至5次,或是呈連續輸注方 式·、此種投藥可充作慢性或急性治療。可與載劑混合使罔 以產生單一劑量型式的活性組份量受治療之宿主及特殊投 藥模式而言。典型製劑通常含有甴約5%至约95%的活性化 合物。較好,此製劑含有由約20%至約80°/。的活性化合物。 一旦病患的狀況有改善,若必要時可投予本發明化合物 ,组成物或組合之維持劑量。接下來,投藥之劑量或頻率 均可減少,與症狀呈函數關係,至保持改善狀況之么平, 而當症狀舒緩至欲求水平時可停止治療3然而,病人可能 需要長期問歇之治療,以防任何再復發或疾病敬狀3 M濟部中央樣往局員工消«·合作·社印¾ (請先聞讀背面之注意事項再 本頁) 至於精藝者應了解,可能需要較所示低或高些之剤量。 任何特殊病人之特異劑量及治療方法均依各種因素而定, 包括所應用之特殊化合物活性/病人的人齡,體重,一姣 健康狀況,性別,飲食,投藥時間,排始率,藥物配合禁 忌,疾病之嚴重性及過程,及病人對疾病之傾向及治療醫 師之判斷3 -287- 本饫乐尺度边3 tSS家標孪(CNS ) A4規格(210X 297公5 ) 1235157 B7 五、發明説明(285) ' 可以本發明化合物所治療或預防的IL-1調介疾病包括下 列,但並不限於此:發炎性疾病,自It免疫疾病,攱壞性 骨籍疾病,增殖性失調症,感染性疾病,及退化性疾病3 可以本發明化合物治療或預防之細胞預期死亡-調介之疾 病包括退化性疾病3 可治療或預防之發炎性疾病包括下列,但並不限於此: 骨關節炎,急性胰藏炎,慢性胰黛炎,氣喘,及成人呼吸 痛苦症狀3較好發炎疾病是骨關節炎或急性姨案炎3 可治療或預防之自體免疫疾病包括下列,但並不限於此 :血管球性腎炎,類風濕性關節炎,全身性紅斑狼瘡,硬 皮症,慢性曱狀腺炎,葛雷夫氏病,自鳢免疫性胃炎,胰 島素依賴型糖尿病(I型),自體免疫性溶血性貧血,自禮 免疫性令中性球減少症,血小板減少症,慢性活動性肝炎 ,重·症肌無力,多發性硬化症,發炎性猗疾,Crohn’s病, 牛皮癬及移植物對宿主病。較好自體免疫病是類風濕性關 節炎,發炎性腸疾,Crohn、病,或牛皮癣。 可被治療或預防之破壞性骨骼失調症包括骨質疏鬆症及 與多發性骨髓瘤有關之骨骼失調症3 經濟部中夬標準局員工消贫合作社印¾ (請先&gt;1讀背云之注意事項苒填寫本頁1235157 Α · A / B7 V. Description of the invention (2 called Zhongzhiyuanhe remedy for cream reconciliation. Carriers for topical administration of compounds of the present invention include continuous treatment, liquid paraffin, white paraffin, propylene glycol, polyoxyethylene polyoxyl Propylene compound, emulsified wax and water, but it is not limited to this./In addition, the pharmaceutical composition can be blended with a suitable lotion or emulsion, which contains the active compound ϋ suspended or dissolved in a carrier. Suitable carriers include mineral tincture, Sorbitan monostearic acid§ Polysorbate 60, cetyl ester wax, cetyl alcohol, 2-octyldodecanol, methyl alcohol and water. The pharmaceutical composition of the present invention can also be applied topically to Lower intestinal tracts, transdermal patches for topical administration via a tapping suppository blend or a suitable enemas blend 3 are also included in the present invention. The pharmaceutical composition of the present invention can be administered via a nasal aerosol or inhalation method.弍 Administration 3 This composition is prepared according to well-known techniques in pharmaceutical blending technology, and can be prepared as a solution in saline, using 芊 alcohol or other suitable Baoyi 剤, absorption enhancer to enhance bioavailability, fluorocarbon Chemicals and / or Craftsmanship Other known solubilizing or dispersing agents. ¾ Order from the Ministry of Economic Affairs of the People's Republic of China for consumption cooperation to print active ingredient compounds between about 0.01 and about 100 mg / kg per day, preferably between about 1 and 50 The daily dose level of mg / kg body weight can prevent and treat IL-1-, expected cell death, IGIF and IFN-r-mediated diseases, including inflammatory diseases, autoimmune diseases, and destructive epiphyseal disorders , Proliferative disorders, Infectious diseases, Degenerative diseases, Necrotic diseases, Osteoarthritis, Acute epistitis, Chronic viscera, Discouragement, Respiratory pain syndromes in adults, Globululonephritis, 'Rheumatoid joints Inflammation, systemic lupus erythematosus, scleroderma, chronic sacral glanditis, Grave's disease, autoimmune gastritis, island-dependent diabetes mellitus (type I), autoimmune thymocyte anemia, Immune neutrophilic leukopenia, thrombocytopenia, -286- Ben. ¾ ¾ appropriate size; ^ Chinese § country rubbing (CNS) AUi (210X 297 mm) 1235157 A_ B7 V. Description of the invention (2δ4 ) Chronic active hepatitis, myasthenia gravis, hair Sexually related diseases, Crohn's disease, psoriasis, graft-to-host disease, osteoporosis, multiple myeloma-related skeletal disorders, acute myeloid leukemia / chronic myeloid leukemia II, metastatic melanoma, Kaposi Osteosarcoma, multiple myeloma, sepsis, septic shock, shigellosis, alzheimer's disease, parkinson's disease, cerebral hemorrhage, myocardial ischemia, spinal muscular atrophy, multiple sclerosis Disease, AIDS-related encephalitis, HIV-related encephalitis, aging, hair loss, and neurological damage caused by stroke. For the sake of exemplification, the pharmaceutical composition of the present invention can be administered about 1 to 5 times a day, Or in the form of continuous infusion, this kind of administration can be used for chronic or acute treatment. It can be mixed with a carrier to produce a single dosage form of the active ingredient in the treated host and the particular mode of administration. Typical formulations usually contain about 5% to about 95% of the active compound. Preferably, the formulation contains from about 20% to about 80 ° /. Of active compounds. Once the patient's condition has improved, a maintenance dose of a compound, composition or combination of the invention can be administered if necessary. Next, the dose or frequency of administration can be reduced, which is a function of symptoms to maintain an improved condition, and treatment can be stopped when the symptoms have eased to the desired level3 However, patients may need long-term rest treatment to To prevent any recurrence or illness 3 M. Central Ministry of Economic Affairs, the staff of the Central Bureau to eliminate the «· Cooperation · Social Seal ¾ (Please read the precautions on the back before this page) As for the artisans, you may need to understand Lower or higher volume. The specific dose and treatment method for any particular patient depends on various factors, including the activity of the particular compound applied / the age of the patient, weight, health status, gender, diet, time of administration, initiation rate, and drug contraindications , The severity and course of the disease, and the patient's tendency to the disease and the judgment of the treating physician 3 -287- Ben Le scales 3 tSS family standard twin (CNS) A4 specifications (210X 297 5) 1235157 B7 V. Description of the invention (285) 'IL-1 mediated diseases that can be treated or prevented by the compounds of the present invention include, but are not limited to, the following: inflammatory diseases, autoimmune diseases, osteopathy, proliferative disorders, infections Diseases, and degenerative diseases 3 Cells that can be treated or prevented with the compounds of the present invention are expected to die-mediated diseases include degenerative diseases 3 Inflammable diseases that can be treated or prevented include the following, but are not limited to: osteoarthritis, Acute pancreatitis, chronic pancreatitis, asthma, and respiratory pain symptoms in adults. 3 Good inflammation is osteoarthritis or acute inflammation. 3 Autoimmune diseases that can be treated or prevented. Includes the following, but is not limited to: Angioglobulonephritis, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, chronic sigmoiditis, Grave's disease, autoimmune gastritis, insulin dependent Diabetes (type I), autoimmune hemolytic anemia, self-immunity causes neutropenia, thrombocytopenia, chronic active hepatitis, myasthenia gravis, multiple sclerosis, inflammatory dysentery, Crohn's disease, psoriasis and graft versus host disease. A better autoimmune disease is rheumatoid arthritis, inflammatory bowel disease, Crohn, disease, or psoriasis. Destructive skeletal disorders that can be treated or prevented include osteoporosis and skeletal disorders associated with multiple myeloma 3 Printed by the Poverty Alleviation Cooperative of the China Standards Bureau of the Ministry of Economic Affairs Matters: Fill out this page

可治療或預防之增殖性疾病包括下列,但不限於此:急 性骨髓性白血病,慢性骨趙性白血病,轉移性黑色素瘤, 卡波西氏肉瘤,及多發性骨趙瘤3 可治療或預防之感染性疾病包括敗血症,敗血性休克, 及志賀氏桿菌病,但並不限於此。 可以本發明化合物治療或預防之IL-1 -調介之退化性或 -288- 本袄法尺度逆用中3國家標孪(CNS ) A4規格(210X 297公5 ) 1235157 五、發明說明(286: 壞死性疾病包括阿滋海默爾氏病,巴金森氏病,摇絕血及 心肌缺血,但並不限於此。較好,退化性疾病是阿滋海默 爾氏病 3 可以本發明化合物治療或預防之預期钿胞死亡·調介之 退化性疾病包括阿滋海默爾氏病,巴金森氏病,稻絕向, 心肌缺血,脊髓肌肉萎縮症,多發性硬化,AIDS-相關之 蹈炎,HIV-相關之腦炎,老化,禿髮,及由於中風造成的 神經性傷害3 本發明方法可用於治療或減輕IGIF-或IFN- r-調介之發炎 ,血體免疫,感染性,增殖性,破壞性骨骼,壞死性及逗 化性狀兄之進展,嚴重性或作用,包括疾病,失調症或作 用,其中狀況之特徵在於IGIF或IFN-r產製之水平增高3 此種發炎狀:兄之實例包括下列,但不限於此··骨關節炎 ,急性姨锭炎,慢性胰臟炎,氣喘,類風濕性關節炎,發 炎性腸疾,CrohWs病,結腸潰瘍,腦絕血,心肌缺血,及 成人呼吸痛苦症候群。 較好發炎狀沉是類風濕性關節炎,結陽潰瘍,Crohn's病 ,肝炎及成人呼吸痛苦症候群。 此種感染性狀況之實例包括感染性肝炎,敗血症,敗血 性休克及志賀氏桿菌病,但不限於此3 此種自體免疫狀況之實例包括下列,但並不限於此:血 管球性腎炎,全身性紅斑狼瘡,硬皮症,慢性甲狀線炎, 葛雷夫氏病,自體免疫性胃炎,銕島素-依賴型糖尿病(I 型),動年型糖尿病,自St免疫性溶血性貧血,自g免疫 •289 本紙ft尺度逆用家標莩(CNS M4現格(210X 297公沒) 先 5c1 讀 背 云 之 a 意 % % 本 頁 經濟部中夬糅达局員二消费合作杜印¾ 1235157 287、 五、發明説明( 請 先 Μ 讀 背 面 之 注 意 事 再 填 寫 本 頁 性嗜中性球減少症,血小板減少症,重症肌無力,多發性 贫化·牛皮奏’局平台濟’移植物對宿三病,急性反机炎 ,溪療,初生硬化,肝炎,葡萄膜炎,Bekcefs病,急性 皮肌炎,異位性皮膚疾病,純紅血球成形不全,成形不全 性貧血,肌萎縮性側索硬化及腎病變症候群。 較妤,自禮免疫狀況是血管球性腎炎,跋島素依賴型糖 尿病(I塑),幼年塑糖尿病,牛皮癬,移植物對宿主疾病 ,包括移植排斥,及肝炎。 此種砝壞性骨骼失調症之實例包括骨質疏鬆症及多發性 骨髓瘤-相關之骨骼失調症。 此種增殖性狀況之實例包括下列,但亦不限於此:急性 骨趙性白jk病,慢性骨Μ性白血病,轉移性黑色素癌,卡 波西氏瘤,及多發性骨髓瘤。 此種神經退化性狀況之實例包括下列,但不限於此··阿 滏;每默爾氏病,巴金森氏病及亨丁頓氏病。 雖然本發明集中在於此處化合物於預防及治療IL-1,知 跑預期疙亡,IGIF-及IFN- r -調介之疾病之用法,本發明 化合物也可充作其他半耽胺酸蛋白薛之抑制劑3 Μ濟部t夬.贫:绛局員工消費合作社印袈 本發明化合物也可充作商品化試劑,其可有效地結合至 ICE或其他半統胺酸蛋白薛3在充作商品化試劑方面,本 發明化合物及其衍生物可用於IC^E及ICE同系物之生化或細 跑分析中以阻斷標的肽之蛋白水解,或可被衍生化以結合 至穩定的樹脂上充作親和力層析應用中之範圍受質。特徵 爲商品化半晄胺酸蛋白S每抑制劑之這些及其他的用法是精 -290· 本枚杀又度通用_§国家標卒(CNS ) A4規格(210X 297公茇) 1235157 Λ/ Β7 五、發明説明(283) 藝者明白的3 製備Ν-醢基胺基化合物之方法 本發明的ICE抑制劑可利用傳統技術合成。肴益的,化 合物可自易得的起始物中合宜地合成。 本發明化合物是已知ICE抑制劑中最易合成者:先前所 述之ICE抑制劑常含有4個以上的對掌性中心及許多肽缝 結。本發明化合物可相當容易地合成,此代表這些化合物 可大規模產製之優.¾ 3 例如,本發明化合物可利用此中所述之方法製備。就精 藝者已知的,這些方法並非於本案中所述及申請專利範圍 化合物被合成之僅有方法。進一步方法是精藝者顯而易見 的。另外,此中所述的各種合成步騍可以不同的次序或頑 序進行以生成欲求化合物。 本發明也提出製備本發明化合物之較佳方法3因此,於 另一具鳢實例(M)提出製備N-酷基胺基化合物之方法,其 中包括以下步驟: a) 混合羧酸與N-別位-保護之胺基,並存在有锖性溶 剤,之苯膦,親核性清除劑,及肆-三苯膦化鈀(0),於環 境溫度及惰性大氣下:及Proliferative diseases that can be treated or prevented include the following, but are not limited to: acute myeloid leukemia, chronic osteoblastic leukemia, metastatic melanoma, Kaposi's sarcoma, and multiple osteoblastoma 3 Infectious diseases include, but are not limited to, sepsis, septic shock, and Shigella disease. IL-1 which can be treated or prevented by the compounds of the present invention -Degenerate or -288- The standard method is reversed 3 national standard (CNS) A4 specifications (210X 297 5) 1235157 V. Description of the invention (286 : Necrotic diseases include Alzheimer's disease, Parkinson's disease, hemostasis, and myocardial ischemia, but are not limited to this. Better, the degenerative disease is Alzheimer's disease. 3 The present invention Expected cell death / mediated degenerative diseases treated or prevented by compounds include Alzheimer's disease, Parkinson's disease, rice despair, myocardial ischemia, spinal muscular atrophy, multiple sclerosis, AIDS-related Chronic inflammation, HIV-related encephalitis, aging, baldness, and neurological damage due to stroke3 The method of the present invention can be used to treat or reduce IGIF- or IFN-r-mediated inflammation, blood immunity, infection Sexual, proliferative, destructive bones, necrotic and amused traits. Progression, severity or effects, including diseases, disorders or effects. The condition is characterized by increased levels of IGIF or IFN-r production. 3 Inflammation: Examples of brothers include the following, but are not limited This · Osteoarthritis, acute adiposity, chronic pancreatitis, asthma, rheumatoid arthritis, inflammatory bowel disease, CrohWs disease, colon ulcer, cerebral hemorrhage, myocardial ischemia, and adult respiratory distress syndrome. Better inflammatory conditions are rheumatoid arthritis, yang ulcers, Crohn's disease, hepatitis, and respiratory distress syndrome in adults. Examples of such infectious conditions include infectious hepatitis, sepsis, septic shock, and Shigella disease, but Not limited to this 3 Examples of such autoimmune conditions include, but are not limited to: angioglobulonephritis, systemic lupus erythematosus, scleroderma, chronic thyroiditis, Grave's disease, autoimmunity Gastritis, island-dependent diabetes mellitus (type I), perennial diabetes mellitus, autoimmune hemolytic anemia, autoimmune • 289 paper ft scale reverse standard household standard 家 (CNS M4 is now (210X 297) No) First read 5c1 of the meaning of the cloud.%% On this page, the member of the Department of Economic Affairs of the People's Republic of China, the second consumer cooperation Du Yin ¾ 1235157 287, V. Description of the invention (please read the notes on the back before filling in this page) Neutropenia, thrombocytopenia, myasthenia gravis, multiple depletion · Cowhide's 'Local platform' graft for Susan disease, acute anti-inflammatory disease, creek therapy, primary sclerosis, hepatitis, uveitis , Bekcefs disease, acute dermatomyositis, atopic skin disease, pure red blood cell dysplasia, dysplasia anemia, amyotrophic lateral sclerosis, and nephrotic syndrome. Contrary, the self-respecting immune status is vascular glomerulonephritis. Island-dependent diabetes mellitus (I), juvenile diabetes, psoriasis, graft-to-host disease, including transplant rejection, and hepatitis. Examples of such weight-related skeletal disorders include osteoporosis and multiple myeloma-related Skeletal disorders. Examples of such proliferative conditions include, but are not limited to, the following: acute osteopenic JK disease, chronic bone M leukemia, metastatic melanoma, Kaposi's tumor, and multiple myeloma. Examples of such neurodegenerative conditions include, but are not limited to the following: Imam; Permel's disease, Parkinson's disease, and Huntington's disease. Although the present invention focuses on the use of the compounds here in the prevention and treatment of IL-1, known to be expected to die, IGIF- and IFN-r-mediated diseases, the compounds of the present invention can also be used as other hematins. Inhibitor 3 Μ. Ministry of Economic Affairs. Poverty: Consumers' cooperatives of the Bureau of Health. The compounds of the present invention can also be used as commercial reagents, which can be effectively bound to ICE or other semi-amino acid proteins. In terms of chemical reagents, the compounds of the present invention and their derivatives can be used in IC ^ E and ICE homologs for biochemical or sprint analysis to block the proteolysis of the target peptide, or they can be derivatized to bind to stable resins and act as A range of affinity chromatography applications. Characterized by these and other usages of each inhibitor of commercial hemicellin S is refined-290. This killer is universal again. § National Standard Soldier (CNS) A4 Specification (210X 297 Gong) 1235157 Λ / Β7 V. Description of the invention (283) 3 Methods understood by the artist 3 for preparing N-fluorenylamino compounds The ICE inhibitor of the present invention can be synthesized using conventional techniques. The compounds can be conveniently synthesized from readily available starting materials. The compounds of the present invention are the easiest to synthesize among the known ICE inhibitors: The ICE inhibitors previously described often contain more than 4 palmar centers and many peptide junctions. The compounds of the present invention can be synthesized relatively easily, which means that these compounds can be produced on a large scale. 3 For example, the compounds of the present invention can be prepared by the method described herein. To the best of the artisan's knowledge, these methods are not the only methods in which compounds described in this case and patented are synthesized. Further methods are obvious to the artisan. In addition, the various synthetic steps described herein can be performed in a different order or sequence to generate the desired compound. The present invention also proposes a preferred method 3 for preparing the compound of the present invention. Therefore, in another example (M), a method for preparing an N-acylamino compound is proposed, which includes the following steps: a) mixing a carboxylic acid with an N- Position-protected amine group, with the presence of ammonium solvents, phenylphosphine, nucleophilic scavengers, and triphenylphosphine palladium (0), at ambient temperature and inert atmosphere: and

¾耷.甲令^5:¾^¾員工消費合作.社印SL (請先聞讀背云之^一意事礦再填寫本一貝) b) 在a)步驟混合物中加入HOBT及EDC :並視所需包括 進*步: c) 水解b)步驟混合物,於含有酸及H2〇之溶液存在下 ,其中b)步骤混合物視所需於水解前先前濃縮。 較好,此惰性溶劑是CH2C12,DMF,或CH2Cl2&amp;DMF之 -291 - 本:¾¾尺度適用中§国家祐辛(CNS ) AUt格(2丨0X297公釐) 1235157 B7 經濟部中夬標準局員工消费合作社印製 五、發明説明( 其中R5i如具禮實例(B)所定義 (b) 或 較好,N-別位-保護之胺是:¾ 耷. Jialing ^ 5: ¾ ^ ¾ Employee consumption cooperation. Social seal SL (please read and read ^ Yiyi Mine and then fill out this one) b) Add HOBT and EDC to the mixture in step a): and If necessary, further steps are included: c) hydrolysis b) the step mixture in the presence of a solution containing an acid and H 2 0, wherein the b) step mixture is previously concentrated as required before hydrolysis. Preferably, this inert solvent is CH2C12, DMF, or CH2Cl2 &amp; DMF -291-The standard: ¾¾ Applicable § National Youxin (CNS) AUt grid (2 丨 0X297 mm) 1235157 B7 Employees of China Standards Bureau, Ministry of Economic Affairs Printed by the Consumer Cooperative V. Description of the invention (where R5i is as defined (b) or better in Gifted Example (B), the N-allo-protected amine is:

,其中如上文所定義3 於較佳製法中,取代基如具體實例(A)中所定義。 另外,N-醯基胺基化合物以式(VIII)代表,其中Rjo上 具鱧實例(B)所定義,且R2如具體實例(M)所定義。 較好於這些另外製法中,取代基如上具趑實例(B)所定義。 另外,N-醢基胺基化合物由式(VIII)代表,其中h如上 具鳢實例(C)所定義,且R2如上具體實例(M)所定義: 較好於這些另外的製程中,取代基如上具體實例(C)所 定義9 另外,N-醯基胺基化合物甴式(VIII)代表,其中如上 具鳢實例(C)所定義,且R2如具體實例(M)所定義, 較好於這·些另外的製程中,取代基如具體實例(D)中所 定義。 •293· 本紙法又度边用中gg家揉準(CNS ) Α4規格(210X 297公釐) (請先3讀背云之注意事項一 本頁) 37 1235157 五、發明説明(Μ) 另外,Ν-醯铵基化合物甴式(VIII)代表,其中&amp;如上具 靉實到(E)所定義,且R2如具體實例(M)所定義: 較好在這些另外的製程中,取代基如具諠實例(E)所定 義3 另夕卜,N-醯基胺基化合物甴式(VIII)代表,其中如上 具體實例(F)所定義,且R2如具鳢實例(M)所定義。 較好於這些另外製程中,取代基如具鳢實例(F)所定義。 太一貝) 另外,N-醯基胺基化合物由式(VIII)代表,其中h如具 體實例(G)所定義,且R2如具殪實例(G)所定義。 較好在這些不同製程中,取代基如具鳢實洌(G)所定義。 另外,N-醯基胺基化合物由弍(VIII)代表,其中如具 體實例(H)所定義,且R2如具體實例(M)所定義。 較妤於這些另外製程中,取代基如具體實例(H)所定義。 另夕卜,N-醯基胺基化合物由式(VIII)代表,其中反丨如具 體實例⑴所定義,且如具體實例(M)所定義5 較妤,於這些另外製程中,取代基如具鳢實例(I)所定義3 另外,N-藴基胺基化合物由弍(VIII)代表,其中心如具 體實例⑺所定義,且R2如具鳢實例(M)所定義。 較好,於這些另外製程中,取代基如具趑實例(J)所定義3In the preferred method, the substituents are as defined in the specific example (A). In addition, the N-fluorenylamino compound is represented by formula (VIII), wherein Rjo is defined by the fluorene example (B), and R2 is defined by the specific example (M). More preferably, in these alternative processes, the substituents are as defined above under Example (B). In addition, the N-fluorenylamino compound is represented by formula (VIII), where h is as defined in the above example (C), and R2 is as defined in the specific example (M) above: Preferably, in these other processes, the substituents As defined in the specific example (C) above 9 In addition, the N-fluorenylamino compound is represented by formula (VIII), in which it is defined by the above example (C), and R2 is defined by the specific example (M), which is better than In these other processes, the substituents are as defined in the specific example (D). • 293 · This paper method is also used in Chinese gg home standard (CNS) A4 size (210X 297 mm) (please read 3 precautions for back page first page) 37 1235157 V. Description of invention (Μ) In addition, The NH-ammonium compound is represented by formula (VIII), in which &amp; is as defined above (E), and R2 is as defined in specific example (M): Preferably, in these additional processes, the substituents are as follows: With the definition of Example (E) 3 In addition, the N-fluorenylamino compound is represented by formula (VIII), wherein it is defined as the specific example (F) above, and R2 is defined as the specific example (M). Preferably, in these additional processes, the substituents are as defined in the specific example (F). Taiyibei) In addition, the N-fluorenylamino compound is represented by formula (VIII), where h is as defined in specific example (G), and R2 is as defined in specific example (G). Preferably, in these different processes, the substituents are as defined in (G). In addition, the N-fluorenylamino compound is represented by fluorene (VIII), which is defined as a specific example (H), and R2 is defined as a specific example (M). In contrast to these alternative processes, the substituents are as defined in Specific Example (H). In addition, the N-fluorenylamino compound is represented by formula (VIII), in which the definition is as described in the specific example ⑴, and as defined in the specific example (M). 5 In the other processes, the substituents such as With the definition of the example (I) 3 In addition, the N-saturated amine compound is represented by the formula (VIII), the center of which is defined by the specific example ⑺, and R2 is defined by the example (M). Preferably, in these other processes, the substituents are as defined in Example (J) 3

經濟部中央樣準局員工消资合作社印X 另外,Ν-fii基胺基化合物甴式(VIII)代表,其中心如具 鳢實例(K)所定義,且R2如具體實例(M)所定義, 較好於這些另外製程中,取代基如具ft實例(K)所定義。 另外,N-醢基胺基化合物甴式(VIII)代表,其中如具 體實例(L)所定義,且R2如具體實例(M)所定義。 -294- 本.¾¾尺度逆周中§国家標李(CNS ) AWt珞(210X 297公沒)Employees of the Central Standards Bureau of the Ministry of Economic Affairs, Consumers' Cooperatives, Co. X In addition, the N-fii-based amine compound is represented by formula (VIII), the center of which is defined by the specific example (K), and R2 is defined by the specific example (M) Preferably, in these other processes, the substituents are as defined in the ft instance (K). In addition, the N-fluorenylamino compound represented by formula (VIII) is as defined in Specific Example (L), and R2 is defined as Specific Example (M). -294- Ben. ¾¾ Inverse Week § National Standard Li (CNS) AWt 珞 (210X 297 public)

超濟部中夬標孪局員工消费合作社印5L 1235157 B7 五、發明説明(況) 較好於這些另外製程中,取代基如具鳢實例(L)所定義: 爲了使本發明更被充份了解,示出以下實洌3這些實钙 僅供說明目的,不欲在任何方式下不限制本&quot;發明3 實例1 ICE之抑制作用 利闫以下三種方法可得本發明化合物之抑制常數(Κ〇及 仄50値: , 1 .以UV-可見光受質之酵素分析法 此分析之進行以燒珀Si基-Tyr-Val-Ala-Asp-對位梢基趋 替苯腔爲受質。同系物受質之合成述於L. A. Reitei* (Int. J Peptide Protein Res. 87-96 (1994))這些分析混合物中含 有: 65 微升緩衝溶液(10 mM Tris,1 mM DTT, 0.1% CHAPS @ pH 8.1) 10微升ICE (50 nM終澴度使有〜lm〇D/分之速率) 5微升DMS〇/抑制劑混合物 20微升400 ^ Μ受質(80 a Μ終濃度) 100微升總反應韹積 可見光之ICE分析在96孔洞之微滴定盤上進行,依所列 次序蔣缓衝物質,ICE及DMSO(若有抑制劑存在下)加至孔 洞内3 SL份在夏温下培育15分鐘,於所有组份均在所有孔 洞時開始。微滴定盤計讀器定在3 7°C培育下。經1 5分鐘的 培育,受質直接加至孔洞中,並於發色團(pNA)釋出後, 在405-603毫微米及37Ό下追踪20分鐘。進行數據之線性配 •295· 本紙乐尺度逯用宁国国家琮李(CNS ) A4規格(2丨0X 297公釐) (請先閾讀背云之注意事項再填寫本\貝 訂The Ministry of Foreign Affairs of the People's Republic of China wins the bid of the Employees' Co-operative Cooperatives 5L 1235157 B7 V. Description of the invention (conditions) Better than these other processes, the substituents are as defined in the specific example (L): In order to make the present invention more adequate It is understood that the following examples are shown. These examples of calcium are for illustrative purposes only, and are not intended to limit the present invention in any way. Example 1 Inhibition of ICE The inhibition constants of the compounds of the present invention (κ 〇 and 仄 50 値: 1, 1. UV-visible light receiving enzyme analysis method This analysis was carried out using the Si-Tyr-Val-Ala-Asp-para-terminal substitution benzene cavity as the substrate. Homologous Synthesis of substrates is described in LA Reitei * (Int. J Peptide Protein Res. 87-96 (1994)). These assay mixtures contain: 65 microliters of buffer solution (10 mM Tris, 1 mM DTT, 0.1% CHAPS @ pH 8.1) 10 μl ICE (50 nM final concentration gives ~ lmOD / min rate) 5 μl DMS〇 / inhibitor mixture 20 μl 400 μM substrate (80 a μ final concentration) 100 μl Total reaction ICE analysis of visible light was performed on a 96-well microtiter plate in the order listed. E and DMSO (in the presence of inhibitors) were added to the holes. 3 SL portions were incubated for 15 minutes at summer temperature, and all components started at all holes. The microtiter plate reader was set to incubate at 37 ° C. After 15 minutes of incubation, the substrate was directly added to the pores, and after the release of chromophore (pNA), it was followed for 20 minutes at 405-603 nm and 37 ° C. Linear matching of the data was performed. • 295 · Musical scale of this paper uses Ningguo National Standard (CNS) A4 specification (2 丨 0X 297 mm) (please read the precautions of the back cloud first and then fill in this book

1235157 3 一 五、發明説明(293) 合,旦以m〇D/分估計速率=實驗中DMSO僅於沒及抑制劑 時才存在,於其他實驗中以緩衝溶液製成100微升趑積: 2. 以螢光受質進行的酵素分析 ’ 上分析基本上依據 Thornberry et al.,(Nature 356: 768-774 ( 1992))進行,利用文獻中參考之受質12 3受質爲^乙韹基 -Tyr-Val-Ala-Asp-胺基-4-甲基香豆素(AMC)。混合以下組 份: 65 微升缓衝溶液(10 mM Tris,1 mM DTT,0.1% CHAPS @ pH 8.1) 10微升ICE (2-10 nM終濃度) 5微升DMSO/抑制劑溶液 20徵并150μ Μ受質(30 a Μ終濃度) 100微升總反應鳢積 分析於96孔洞微滴定盤上進行。緩衝物質及ICE加至孔 洞中。令組份在37°C之溫控孔洞盤上培育1 5分鐘。經1 5分 鐘培育後,反應加受質而開始,且在37T:下追玆反應達30 分鐘,係於AMC發螢光團釋出後利用3S0毫微米之激光波 長及460毫微米之射出波長進行。進行各孔洞數據之線性 配合,再決定每秒螢光單位計之速率3 •M漭部中央嘌达局貝二消貧合作杜印¾ 爲決定酵素抑制常數(KD或抑制模式(競爭性,未競爭的 或非競爭性),於各抑制劑濃度Y於酵素分析中所決定之 速率數據,利用電腦與標準的酵素動力方程式配合(見I. Η. Segel, Enzyme Kinetics, Wiley-Interscience 1975) 3 將螢光對時間數據與Mordon之演變方程式配合,進行 -296- 本汔杀又度迖用家揉莩(CNS ) AUI格(210X 297公5 ) 12351571235157 3 Ⅴ. Description of the invention (293) The estimated rate at mOd / min = DMSO only exists in the experiment without the inhibitor. In other experiments, 100 microliters of volume was made from the buffer solution: 2. Enzyme analysis using fluorescent substrates The above analysis is basically based on Thornberry et al., (Nature 356: 768-774 (1992)), using the substrate 12 referenced in the literature. -Tyr-Val-Ala-Asp-amino-4-methylcoumarin (AMC). Mix the following components: 65 μl buffer solution (10 mM Tris, 1 mM DTT, 0.1% CHAPS @ pH 8.1) 10 μl ICE (2-10 nM final concentration) 5 μl DMSO / inhibitor solution 150 μM substrate (30 a M final concentration) 100 μl total reaction volume analysis was performed on a 96-well microtiter plate. Buffer substances and ICE are added to the holes. Incubate the components on a temperature-controlled well plate at 37 ° C for 15 minutes. After 15 minutes of incubation, the reaction began with the addition of mass, and the reaction was followed at 37T for 30 minutes. After the AMC fluorophore was released, the laser wavelength of 3S0 nm and the emission wavelength of 460 nm were used. get on. Perform a linear combination of the data of each hole, and then determine the rate of fluorescence units per second. 3 • Metaplasty of the central purdon bureau, the second poverty alleviation cooperation, Du Yin ¾ In order to determine the enzyme inhibition constant (KD or inhibition mode (competitive, not Competitive or non-competitive), the rate data for each inhibitor concentration Y determined in the enzyme analysis, using a computer and standard enzyme kinetic equations (see I. Η. Segel, Enzyme Kinetics, Wiley-Interscience 1975) 3 Combining the fluorescence time data with Mordon's evolution equation, we performed -296- this killing again (CNS) AUI grid (210X 297 5) 1235157

AT B7 五、發明說明(况) 不可逆抑制劑二次速率常數之決定。Moirison,J.F.,Mol Cell. Biophys., 2,ρρ· 347-368 (1985) 3 丁hornberry et al·已發 表這些偵測ICE不可逆抑制劑逯率常數芝方法說明, Thornberry, N.A., et al., Biochemistry, 33, pp. 3923-3940 (1994)。對於並無先前複合物形成可被動力地觀察,二次 速率常數(Kinaei)直接自k。^ vs. [I]之直線劃圖斜率中衍生 出來。對於先前複合物之形成(與酵素)可被偵測之化合物 ,k。^ vs. [I]之雙西線圖與飽和動力學配合,以先產生心 及k,。再以k,/Ki生成二次速率f數kinact。 3. PBMC細胞分析法 以人類周邊血液單核細胞(PBMC)之混合族群或加豐的 粘附單核細胞進行IL-1/5分析法 ICE對pre-IL-ly5之處理修飾可在利用各樣細胞來源之麵 胞培養中偵測。得自健康供者之人類PBMC,可提供淋巴 細胞亞型及單核細胞之混合族群,其可產生反應許多類塑 生理性刺激物之間白素及細胞動素概況。來自PBMC之粘 附單核細胞可提供正常單核細胞加豐之來源,以供經活化 細胞產製·細胞動素之選擇性研究3 實驗步骤: M濟部中央糅準局貝工消費合作社印¾ (請先父讀背云之注意事項再填寫本買)AT B7 V. Description of the invention (condition) Determination of the secondary rate constant of the irreversible inhibitor. Moirison, JF, Mol Cell. Biophys., 2, ρρ · 347-368 (1985) 3 D. Hornberry et al. Have published a description of these methods for detecting the rate constant of irreversible inhibitors of ICE, Thornberry, NA, et al., Biochemistry, 33, pp. 3923-3940 (1994). For no previous complex formation can be observed dynamically, the quadratic rate constant (Kinaei) is directly from k. ^ Derived from the slope of the straight line plot vs. [I]. For compounds whose previous complex formation (and enzymes) can be detected, k. ^ The double-western line graph of vs. [I] cooperates with saturation dynamics to generate the heart and k, first. Then, k, / Ki is used to generate the quadratic rate f-number kinact. 3. PBMC cell analysis method: A mixed population of human peripheral blood mononuclear cells (PBMC) or enriched adherent monocytes is used for the IL-1 / 5 analysis method. ICE's treatment of pre-IL-ly5 can be modified in various ways. Detection of like-cell-derived face cell culture. Human PBMCs obtained from healthy donors can provide a mixed population of lymphocyte subtypes and monocytes, which can produce a profile of leukokines and cytokines in response to many plastic-like physiological stimuli. Adherent monocytes from PBMC can provide a source of normal monocyte enrichment for selective study of cytokinin production by activated cells. 3 Experimental steps: Printed by the Ministry of Economic Affairs, Central Bureau of Quasi-Bureau, Shellfish Consumer Cooperative ¾ (please read the precautions of back cloud before filling in this purchase)

製備受試化合物於DMSO或乙醇中之最初稀釋系列,接 下來稀釋至RPMI-10% FBS培養墓中(含有2 mM L-穀胺酸, 10 mM HEPES,50 U及50微克/毫升青黴素/鏈黴素),分別 在含有0.4% DMSO或0.4%乙醇中生成最終受試濃度4x之藥 物。DMSO之終澴度於所有藥物稀釋液中爲0.1%,於ICE -297- 本纸伕尺度通两中國國家標孪(CNS ) A4堤格(210X297公釐) 1235157 Λ7 B7 經濟部中央樣準局貝工消f合作杜印¾ 五、發明説明(295) 抑制分析法中決定的受試化合物表現Ki之澴度滴定,通常 可闫於一次化合物篩選。 通常測試5-6份化合物稀釋液,且細胞组份進行二次分 析,即各纟曰胞培養物上清液上進行二次ELISA決定: PBMC分離及IL-1分析: 自一品托人類血液中分離的血液黃層細胞(生成40-45毫 升終體積血槳加上細胞)以培養基稀釋至80毫升,並在 LeukoPREP分離管(Becton Dickinson)上各覆上10毫升#曰跑 懸液:在1500-1800 xg下離心分鐘後,吸出血漿/培養基 層再以Pasteur吸量管收集單核細胞層,並轉移至15毫升圓 錐的離心管(Corning)。加入培養基使體積達到1 5毫升,經 由反轉緩和地混合細胞,並以300 xg離心15分鐘。PBMC 團塊懸浮於少量培養基中,計數細胞並調整至6 X 106細跑 /毫升3 於甸胞分析中,於24孔洞之扁平底組織培養盤(Corning) 之各孔洞中加入1.0毫升細胞懸液,0.5毫升受試化合物稀 釋液,反0.5毫升LPS溶液(Sigma #L-3012 ; 20毫微克/毫升 溶液製備於完全RPMI培養基中;終LPS濃度爲5毫徵克/毫 升),所加入的0.5毫升受試化合物及LPS通常足以;尾合孔 洞之内容物。每次實驗進行三個對照混合物,有單獨的 LPS,溶劑溶媒對照相,及/或額 &gt;卜的培養基以將最终的培 養體積調至2.0毫升。细胞培養在37°C及5% (:02存在下歷 16-18小時。 於培育末了,回收細胞並轉移至15毫升圓錐型離心管中 -298- 本袄伕尺度逑用中国國家揉孪(CNS ) A4規格(210X297公茇) (請.5讀背面之注意事項本Ϊ 裝 訂 泉 1235157 236、 五、發明説明( 先 % 讀 背 5 ί 客 。經200 xg下難心10分鐘,上清液回收再轉移至1.5毫升之 Eppendorf管内。可注意到細胞團塊可利用於跑液萃取物 中pre-IL-ly?及/或成熟的IL-1 /5含量之生也評估,利用西 方墨點法或以pre-IL-1/?特具抗血清進行之ELISA進行3 粘附性單核細胞之分離: 如上述分離及製備PBMC。培養基(1.0毫升)先加至孔洞 中,再加0.5毫升PBMC懸浮液。經1小時培育後,團塊小 心地震盪再自各孔洞中吸出來粘附之細胞3孔洞再以1.0 毫升培養基緩和洗三次及最彳i懸浮在1.〇毫升培養基中, 已粘附細胞之加豐通常每孔洞可生成2.5-3.0 X 105钿胞。 如上述進行受試化合物,LPS之加入,钿胞培育條件及上 清液之處理修飾3 ELISA : 吾等使用Quantikine套組(R&amp;D Systems)來偵測成熟的IL-1卢 。依據廠商指示進行分析。成熟的IL-1 y?水平於PBMC及 粘附性單核細胞陽性對照组均可見到約1 -3毫微克/毫升。 ELISA分析於LPS-陽性對照組上清液之1:5 : 1:10及1:20稀 釋液上進行,以選擇在受說列中上清液最適宜之稀釋度3 化合物之抑制強度可以IC5Q値表示,其爲在上清液中與Prepare the initial dilution series of the test compound in DMSO or ethanol, and then dilute to the RPMI-10% FBS culture grave (containing 2 mM L-glutamic acid, 10 mM HEPES, 50 U, and 50 μg / ml penicillin / Streptomycin) to produce drugs with a final concentration of 4x in 0.4% DMSO or 0.4% ethanol. The final degree of DMSO is 0.1% in all drug diluents, and the standard of ICE-297-paper is the same as the Chinese National Standard (CNS) A4 Tige (210X297 mm) 1235157 Λ7 B7 Central Bureau of Standards, Ministry of Economic Affairs Bei Gong Xiao F, Du Yin ¾ 5. Description of the invention (295) The test compound determined in the inhibition analysis method exhibits a titration of Ki, which can usually be used for a compound screening. Usually 5-6 parts of compound dilutions are tested, and the cell components are subjected to secondary analysis, that is, a secondary ELISA determination is performed on the supernatant of each cell culture: PBMC isolation and IL-1 analysis: from a pinto human blood The separated blood yellow layer cells (producing 40-45 ml final volume blood paddles plus cells) were diluted to 80 ml with culture medium and covered with 10 ml each on a LeukoPREP separation tube (Becton Dickinson). After centrifugation at -1800 xg for a minute, the plasma / medium layer was aspirated and the monocyte layer was collected with a Pasteur pipette and transferred to a 15 ml conical centrifuge tube (Corning). The medium was added to a volume of 15 ml, the cells were gently mixed by inversion, and centrifuged at 300 xg for 15 minutes. PBMC pellets were suspended in a small amount of medium, and the cells were counted and adjusted to 6 X 106 sprints / ml. 3 In cell analysis, add 1.0 ml of cell suspension to each well of a 24-well flat-bottom tissue culture plate (Corning). 0.5 ml of the test compound dilution, 0.5 ml of LPS solution (Sigma # L-3012; 20 ng / ml solution was prepared in complete RPMI medium; final LPS concentration was 5 ngg / ml), 0.5 was added Milliliters of test compound and LPS are usually sufficient; the contents of the pores are tailed. Each experiment was performed with three control mixtures, with separate LPS, solvent vehicle controls, and / or culture medium to adjust the final culture volume to 2.0 ml. The cells were cultured at 37 ° C and 5% (: 02 for 16-18 hours. At the end of the incubation period, the cells were recovered and transferred to 15 ml conical centrifuge tubes -298- this standard was used in China. ( CNS) A4 size (210X297) 茇 (Please read the notes on the back of this book. Binding spring 1235157 236, V. Description of the invention (First read 背 5 back). After 200 xg difficult 10 minutes, the supernatant Recovered and transferred to a 1.5 ml Eppendorf tube. It can be noticed that cell clumps can be used for pre-IL-ly? And / or mature IL-1 / 5 content in the extract of running fluid. The life is also evaluated, using Western blots Method or ELISA with pre-IL-1 /? Special antiserum to perform 3 isolation of adherent monocytes: Isolate and prepare PBMC as described above. Add the culture medium (1.0 ml) to the holes first, and then add 0.5 ml PBMC suspension. After 1 hour of incubation, the pellet was carefully shaken and then sucked out the adhered cells from each hole. 3 holes were then gently washed three times with 1.0 ml of culture medium and suspended in 1.0 ml of culture medium. Plus cells with attached cells can usually generate 2.5-3.0 X 105 cells per hole. Test compounds, LPS addition, cell culture conditions and supernatant modification 3 ELISA: We used the Quantikine kit (R & D Systems) to detect mature IL-1 Lu. Analysis was performed according to the manufacturer's instructions Mature IL-1 y? Levels were found in PBMC and adherent monocyte positive control group at about 1-3 ng / ml. ELISA analysis in the supernatant of LPS-positive control group 1: 5: 1 : 10 and 1:20 dilutions to select the most appropriate dilution of the supernatant in the recipient column3 The inhibitory strength of the compound can be expressed by IC5Q 値, which is the

經濟部中央標孪局員工消费合作社印2L 陽性對照组比較下所測及之成熟IL-1 50%時之抑制劑濃 度, · 精藝者了解,於細跑分析中所得之數値,如此中所述的 ,可依多重的因素而定,如細胞型式,細胞來源,生長條 件等。 -299- 本裱法尺度送用中国國家標孪(CNS ) Α4規格(2丨0:&lt; 297公釐) 1235157 Λ 7 Β7 五、發明説明(297) 實例2 於老鼠之藥物動力學研究 肽性ICE抑制劑以大於100 a /分/公斤之脅除率可攱忮速 地清除3較低清除率的化合物相較於肽性抑制劑有較爲改 善之藥物動力特性3 利用下述方法,吾等可於老鼠中獲得本發明許多化合物 之清除率: 樣品製備及給藥 化合物溶於無菌的TRIS溶液中(0.02M或0.05M),;農度爲 2.5毫克/毫升。當需確定是完全的溶液時,樣品先溶於少 量二甲替乙醯胺中(最多爲總溶液體積之5%),再以TRIS溶 液稀釋3 藥物溶液投予至 CD-1 老氛(Charles River Laboratories-26-3 1公斤),以10毫克/公斤之劑量體積經由尾靜脈給予25毫 克/公斤之藥物劑量。 各時間點時(通常由2分鐘至2小時)老鼠每5隻一组給藥, 於適當時間時動物再以氟燒麻碎,再經甴頭靜脈切斷法收 集至個別的經肝素化管内。血樣冷卻至(TC,再分難血漿 並貯於-20°C直到分析爲止。 生物分析 血樣中藥物濃度以HPLC在UVk MS (ESP)偵測下分析而 決定。逆相層析法中應用由Cl到Cl 8的各種鍵結相,溶離 液則甴水性緩衝液/乙腈混合物在等密度條件下進行, 定量則採用外在標準方法,其中摻有藥物溶液之A漿構 -300 - 本紙伕尺度適用中国國家標辛(CNS ) Μ規格(210X297公釐) 本頁) 裝 訂 經濟部中央標準局負工消費合作社印¾ 1235157 Λ7 B7 五、發明説明(298) 成校正白線,濃度範圍0.5至50微克/毫升。 分析血槳樣品前,先加乙腈,曱醇,三氯乙酸或遇氯酸 再以10,000g離心10分鐘而去蛋白質之。注/乂 20微井至50微 升的樣品禮積以供分析3 化合物214e 給藥及取樣 藥物溶於無菌的0.02MTds中生成2.5毫克/毫升溶液,其 再以25毫克/公斤劑量經由尾靜脈投予至5隻一组共1 1组的 公CD-1老鼠。在下列.時間點4 :2,5,10,15,20,30, 45,60,90及120分鐘,各取一组動物麻醉再採血至經肝 素化之管内。分離出血漿後,貯於-20eC下直到分析爲止。 分析 一份血漿(150微升)以5%過氯酸(5微升)處理再渦旋混合 並令其靜置90分鐘再離心。生成的上清液分離再取20微升 注入HPLC内以分析之。 HPLC條件 本頁) 裝 訂 經濟部中央糅窣局員工消费合作杜印¾ 管柱 100x4.6 毫米 Kromasil KR 100 5 C4 移動相 0.1m Tris pH7.5 86% 乙腈 14% 流速 1毫升/分 偵測 在210毫微米下之UV 滯留時間 3·4分 * 分析結果顯示藥物之平均血漿水平由〜70微克/毫升(於2 分鐘)降至&lt;2微克/毫升(於90及120分鐘)。 泉 -301 - 本虼杀尺度逆用中國国家標準(CNS ) A4現格(2丨0X297公茇) 1235157 五、發明説明(2&quot;) 化合物217e 給藥及取樣 藥物溶於無菌的0.02MTris中以生成2.5毫克/毫井溶液, 其再經尾靜脈以25毫克/公斤劑量投予至每组5隻共11组的 公CD-1老鼠。在下列時間點時:2,5,10,15,20,30, 45,60,90及120分鐘,取一组動物麻醉並收集血樣至經 肝素化之管内。血漿於分離後貯於-20Ό直到分析爲止。 分析 一份血漿(100微升)以乙腈(100微升)稀釋,再渦旋混合 20秒再離心10分鐘。生成的上清液分離並取20微升注入 HPLC分析之, HPLC條件Concentration of inhibitors at 50% of mature IL-1 measured by the Consumers' Cooperatives printed by the Central Bureau of Standards of the Ministry of Economic Affairs, compared with 50% of mature IL-1 measured. The above can be determined by various factors, such as cell type, cell source, growth conditions, and the like. -299- Chinese standard twin (CNS) A4 specification (2 丨 0: &lt; 297 mm) 1235157 Λ 7 Β7 is used in this mounting method. Example 5 (297) Example 2 Pharmacokinetic peptides in mice Sexual ICE inhibitors can be eliminated quickly with a threatening rate of greater than 100 a / min / kg. 3 Compounds with lower clearance have improved pharmacokinetic properties compared to peptide inhibitors. 3 Using the following method, We can obtain the clearance of many compounds of the present invention in mice: sample preparation and dosing compounds were dissolved in sterile TRIS solution (0.02M or 0.05M); the agronomic level was 2.5 mg / ml. When it is determined that the solution is complete, the sample is first dissolved in a small amount of methetamine (maximum 5% of the total solution volume), and then diluted with TRIS solution. 3 The drug solution is administered to CD-1. River Laboratories-26-3 1 kg), and a drug dose of 25 mg / kg was administered via the tail vein at a dose volume of 10 mg / kg. At each time point (usually from 2 minutes to 2 hours), mice were administered in groups of 5 animals. At the appropriate time, the animals were pulverized with fluorescein and then collected into individual heparinized tubes by sacral vein cutting. . The blood sample was cooled to (TC), and the difficult plasma was divided and stored at -20 ° C until analysis. Bioanalysis The drug concentration in the blood sample was determined by HPLC analysis under UVk MS (ESP) detection. The application in reverse phase chromatography was determined by Various bonding phases from Cl to Cl 8; the eluent is 甴 aqueous buffer / acetonitrile mixture under equal density conditions, and the quantification is based on external standard methods. A pulp structure with drug solution -300-paper size Applicable to China National Standard Xin (CNS) M specifications (210X297mm) (this page) Binding Printed by the Central Standards Bureau of the Ministry of Economic Affairs and Consumer Cooperatives ¾ 1235157 Λ7 B7 V. Description of the invention (298) Corrected white line, concentration range 0.5 to 50 micrograms / Ml. Before analyzing the blood paddle samples, add acetonitrile, methanol, trichloroacetic acid or chloric acid, and then centrifuge at 10,000g for 10 minutes to remove the protein. Note / 乂 20 microwells to 50 microliters of sample accumulated for analysis 3 Compound 214e administration and sampling drug dissolved in sterile 0.02MTds to generate a 2.5 mg / ml solution, which was then passed through the tail vein at a dose of 25 mg / kg Five groups of 11 male CD-1 mice were administered. At the following time points 4: 2, 5, 10, 15, 20, 30, 45, 60, 90, and 120 minutes, a group of animals were each anesthetized and blood was collected into heparinized tubes. After the plasma was separated, it was stored at -20eC until analysis. Analysis An aliquot of plasma (150 µl) was treated with 5% perchloric acid (5 µl), vortexed and allowed to stand for 90 minutes before centrifugation. The resulting supernatant was separated and an additional 20 microliters were injected into the HPLC for analysis. HPLC conditions on this page) Binding of the staff of the Central Government Bureau of the Ministry of Economics and Consumer Cooperation Du Yin ¾ column 100x4.6 mm Kromasil KR 100 5 C4 mobile phase 0.1m Tris pH7.5 86% acetonitrile 14% flow rate 1ml / min UV retention time at 210 nm 3.4 minutes * Analysis results show that the average plasma level of the drug decreased from ~ 70 μg / ml (at 2 minutes) to <2 μg / ml (at 90 and 120 minutes). Quan-301-This standard for killing is reversed to the Chinese National Standard (CNS) A4 (2 丨 0X297 gong) 1235157 V. Description of the invention (2 &quot;) Compound 217e Administration and sampling Drugs are dissolved in sterile 0.02MTris to A 2.5 mg / milliwell solution was generated, which was administered to the male CD-1 mice in a total of 11 groups in a dose of 25 mg / kg via the tail vein. At the following time points: 2, 5, 10, 15, 20, 30, 45, 60, 90, and 120 minutes, a group of animals were anesthetized and blood samples were collected into heparinized tubes. Plasma was stored at -20 ° F after analysis until analysis. Analysis An aliquot of plasma (100 µl) was diluted with acetonitrile (100 µl) and vortexed for 20 seconds and centrifuged for 10 minutes. The resulting supernatant was separated and 20 microliters were injected and analyzed by HPLC. HPLC conditions

Zorbax SBC8 72% 28% 管柱 150x4.6毫米 移動相 0.05M鱗酸鹽 緩衝溶液,ρΗ7·1 乙腈 流速 1.4毫升/分 偵測 UV在210毫微米 滯留時間 3.0及3.6分(非對玦體) -¾濟部中央標窣局員工消費合作社印^ (請先間讀背®之洼意事項一 本頁 分析結杲顯示平均血漿澴度甴〜55微克/毫升(於2分鐘) 下降至&lt;0.2微克(60-120分鐘)。 實例3 · 肽性ICE抑制劑以大於80毫升/分鐘/公斤之清除率可被快 速的清除3具較低清除率的化合物有較肽性ICE抑制劑更 改善的藥物動力學特性。 吾等以下列方法可於老鼠中獲得本發明許多化合物之清 -302· 本纸法尺度通用中国国家標準(CNS M4規格(210X29?公釐) 1235157 A.' ___B7_:__ 五、發明説明(3〇〇) 除率(毫升/分鐘/公斤): 活鱧内大鼠清除率分析法 於藥物動力學研究前一天,在麻醉下對乂鼠之頸靜腺及 頸動脈血管插管M.J. Free, R.A. Jaffee : ·€3ηηιιΐΗΐίοη techniques for the collection blood and other bodily fluids':於 Animal Models ; p. 480-495 ; N.J. Alexander, Ed. ; Academic Press; (1978)。藥物(10毫克/毫升)經由頸靜脈於溶媒中投 藥,溶媒中通常含有丙二醇/食鹽水,及1:1比率之丨〇〇 mM 碳酸氫鈉。動物給予10-20毫克藥物/公斤,再於5,7,10 ,15,20,30,60及90分鐘時自在内的頸動脈導管採血。 血液離心出血漿,並貯於-2CTC下直到分析爲止,進行數 據之藥物動力分析,利用標準的款體如RStrip (MicroMath Software,UT)及 /或 Pcnonlin (SCI Software, NC)行非·缘性回 歸可得到清除率數値。 分析: 大鼠血漿以等趑積乙腈(含有0.1% TFA)萃取。樣品再以 約l,000 xg離心,上清液再以梯度HPLC分析。下文福述典 型的分析步驟3 經濟部中央標準局負工消貧合作社印裝 200微升血漿以200微升〇·1%三氟醋酸(TFA)於乙腈及1〇微 升50%氣化鋅水溶液沈澱,渦旋,再以〜1000 X g每心, .收集上清液並以HPLC分析。 -303· ^纸杀尺度通用中圉國家;^ ( CNS θ规格(公釐) 1235157 Λ7 B7 五、發明説明(3Q2) 無内毒素之氯化鈉溶液(0.9%)及HBSS脂多醣(Sigma ; Cat.# L-3012)貯液,在1毫克/毫升下於HBSS中 IL-ly? ELISA 質组(R&amp;D Systems; Cat# DL'B50) TNF 泛 ELISA質组(R&amp;D Systems : Cat # DTA50) 水浴或培育箱 全血分析之實驗步驟: 將培育箱或水浴定在3(TC。一份0.25毫升的血樣置於1.5 毫升eppendorf管内。註:於每二份後將全血ώ樣試管確實 反轉。若細胞沈降且未均勻懸浮可能會有重覆二次之差異 。使用正壓吸量管也可將重覆二份間之差異減至最小。 於無菌之無熱原食鹽水中以連續稀釋方式製備等物稀釋 液。於ICE抑制分析中所決定的受試化合物支撑表觀&amp;之 稀釋系列通常可用於初次化合物篩選。對於極疏水性之化 合物,吾等之化合物稀釋液係製備於得自相同血液供者之 於新鲜血漿中或含有5%DMS0之PBS中,以加強溶解。 加上25微升受試化合物稀釋液或溶媒對照组,並與樣品 缓和混合a再加5.0微升LPS溶液(250毫微克/毫升貯液,新 鲜製備:5.0毫微克/毫升終濃度LPS),並再次混合。管在30 eC之水浴中培育16-18小時,並經常混合。另外,管子置 於4 rpm之旋轉器内相同的培育期3此分析也可在以下内 照組下二次或三次構成:陰性對趑組-無LPS :陽性對照组-無受試抑制剤:溶媒對照组-實驗中所用的DMS0或化合物 溶劑之最高濃度3加入額外的食鹽水至所有的對照組管子 内,使對照组及實驗全血受試樣品有正常化之體積。 -305- 本纸伕尺度通用中S國家標孪(CNS ) Α4規格(2丨0Χ297公釐) (诗siiI.V/注意事項本頁 裝 訂 S?濟部中央樣準局兵工消资合作社印¾ 1235157 Λ 7 Β7 五、發明説明(3Q3) 於培育期後,全血樣品在〜2000 rpm之微量離心機内蘿 心,血蒙轉移至新鮮的微量離心管内,再以lOOOx g離心 使殘留的血小板於必要時成團塊。血漿樣品/可在-70°C下 冷凍貯存,再以ELISA進行細胞動素水平之分析。 ELISA: 於偵測IL-1/?及a -TNF中吾等使用R&amp;D System (614 McKinley Place Ν·Ε· Minneapolis, MN 55413) Quantikine套 組。分析依廠商之操作指示進行。在個別範圍内吾等於湯 性對照组中觀察到〜1-5毫微^ /毫升之IL-1/5水平,所有 樣品之1:200血漿稀釋倍數,使吾等實驗之ELISA結果足以 落在ELIS A標準西線之線性範圍上。若在全血分析中觀察 到差異,必要時可使標準稀釋液更臻理想3 Nerad,J.L. et al., J. Leukocyte Biol., 52, pp. 687-692 (1992) ° 實例5 I C E同系物之抑制作用 1. . ICE同系物之分離 .¾濟部中央標準局負工消費合作社印¾ (請先讀背ίτ之注意事項再填寫本買 TX利用標病毒表現系統於昆蟲細胞中之表現 吾等將Tx cDNA (Faucheu et al·,上文,1995)缰代選殖至 經修飾之PVL1393轉移載體,將生成的質趑(pVL1393/TX) 共轉感至昆蟲細胞,利用病毒DNA,再鑑定重组趑样狀病 毒。於產生高效價之重组體病姜貯品後,利用可視之ICE 分析法檢查培養基中之TX活性。典型而言,以重组趑病 毒貯品在 MOI 5 下感染 Spodoptera frugiperda (Sf9),於 48 小 時後有4.7微克/毫升之最大表現a以ICE爲分析中之標準 -306- 本纸ft尺度適用中國國家標孪(CNS ) A4現格(210X297公釐) 37 1235157 Λ7 五、發明説明(304) 品: (請先閱讀背面之注意事項本ί Μ濟部令夬樣孪局貝工消費合作社印¾ ICE或TX铵基末端T7加飾之型式也表現。原先之設計可 有助於重组禮蛋白質之鑑定及純化,各種翁鱧也可用來檢 查不同的表現水平及由不同同系物經驗到的相對的纟曰跑預 期死亡水平。在可表現ICE或TX之細胞株和以單獨病毒 DNA感染之細跑比較下,前者於受感染的Sf9纟曰胞中之刼 皰預期死亡(利用錐藍排阻分析法檢查)有所增加3 N-末端(His)6•加飾之CPP32於大腸桿菌中之表現及纟毛化 編碼 CPP32 多肽且始自 Ser (29)之 cDNA (Fernandes-Alnemh et al,上文,1994)以引子行PCR擴大作用,其$在 5·及端上均加上在架構之Xhol位置,且生成的Xhol片段 連接至經Xhol切割之pET-15b表現載體上以生成融合蛋白 質之N-末端有(his)0n飾之在架構之融合體3所預剠之重 組體蛋白質以MGSSHHHHHHSSGLVPRGSHMLE胺基緣序 列開始,其中LVPRGS代表凝血酶解離位置,缮以爸自 (29)之CPP32。攜有質體之大腸桿菌BL21 (DE3)在30,C下生 長至對數期,再與O.SmMIPTG共培育。加入IPTG2+ · 後回收纟曰胞,製備溶胞產物,可溶性蛋白質再以Ni-遠另曰 糖層析法纯化。所有表現的CPP32蛋白質均呈經處裒修# 塑式a N-末端定序分析顯示,處理修飾發生在Asp(l75)及 ΛZorbax SBC8 72% 28% column 150x4.6 mm mobile phase 0.05M scalylate buffer solution, ρΗ7.1 · acetonitrile flow rate 1.4ml / min Detect UV retention time at 210nm 3.0 and 3.6 minutes (non-antibody) -¾ Printed by the Consumers' Cooperative of the Ministry of Economic Affairs of the Central Bureau of Standards of China ^ (Please read the “Implications” on this page to analyze the results on this page. The average plasma level is shown to be ~ 55 μg / ml (in 2 minutes). 0.2 μg (60-120 minutes). Example 3 · Peptide ICE inhibitor can be quickly removed with a clearance rate of more than 80 ml / min / kg. 3 Compounds with lower clearance rates are more improved than peptide ICE inhibitors. The pharmacokinetic properties of many compounds of the present invention can be obtained in mice by the following methods: -302 · The size of the paper method is common Chinese national standard (CNS M4 specification (210X29? Mm) 1235157 A. '___ B7 _: __ V. Description of the invention (300) Removal rate (ml / min / kg): The rat clearance analysis method in live loops was performed one day before the pharmacokinetic study on the cervical jugular glands and carotid arteries of the moles under anesthesia. Intubation MJ Free, RA Jaffee: € 3ηηιΐΗΐ οη techniques for the collection blood and other bodily fluids': in Animal Models; p. 480-495; NJ Alexander, Ed .; Academic Press; (1978). The drug (10 mg / ml) was administered in the vehicle via the jugular vein, The vehicle usually contains propylene glycol / saline and 100 mM sodium bicarbonate in a 1: 1 ratio. Animals are given 10-20 mg of drug / kg, and then 5, 7, 10, 15, 20, 30, 60, and 90 Blood was collected from the internal carotid catheter at the minute. Blood was centrifuged out of the plasma and stored at -2CTC until analysis. Pharmacokinetic analysis of the data was performed using standard models such as RStrip (MicroMath Software, UT) and / or Pcnonlin ( SCI Software, NC) performed marginal regression to obtain the clearance rate. Analysis: Rat plasma was extracted with isovolume acetonitrile (containing 0.1% TFA). The samples were centrifuged at approximately 1,000 xg, and the supernatant was re-extracted. Analyze by gradient HPLC. The typical analysis steps are described below. 3 The Ministry of Economic Affairs Central Standards Bureau Work-Reduction Cooperative Society printed 200 μl of plasma with 200 μl of 0.1% trifluoroacetic acid (TFA) in acetonitrile and 10 μl. 50% gasified zinc aqueous solution precipitation Vortexed, then every heart ~1000 X g. The supernatant was collected and analyzed by HPLC. -303 · ^ Paper-killing standards are commonly used in China; ^ (CNS θ specification (mm) 1235157 Λ7 B7 V. Description of the invention (3Q2) Endotoxin-free sodium chloride solution (0.9%) and HBSS lipopolysaccharide (Sigma; Cat. # L-3012) stock solution at 1 mg / ml in HBSS IL-ly? ELISA proteome (R &amp; D Systems; Cat # DL'B50) TNF pan-ELISA (R &amp; D Systems: Cat # DTA50) Experimental steps for whole blood analysis in a water bath or incubator: Set the incubator or water bath at 3 (TC. A 0.25 ml blood sample is placed in a 1.5 ml eppendorf tube. Note: After every two samples, the whole blood is sold free. The test tube is indeed inverted. If the cells settle and are not evenly suspended, there may be a difference in repetition. Using a positive pressure pipette can also minimize the difference between repetitions. In sterile pyrogen-free saline Serial dilutions are used to prepare equal dilutions. The test compound supported apparent &amp; dilution series determined in the ICE inhibition analysis can often be used for initial compound screening. For extremely hydrophobic compounds, our compound dilutions are Prepared in fresh plasma from the same blood donor or contains 5 % DMS0 in PBS to enhance dissolution. Add 25 μl of the test compound dilution or vehicle control group, and gently mix with the sample a and then add 5.0 μl of LPS solution (250 ng / ml stock solution, freshly prepared: 5.0 ng / ml final concentration of LPS) and mix again. Tubes were incubated in a water bath at 30 eC for 16-18 hours and mixed frequently. In addition, the tubes were placed in a spinner at 4 rpm for the same incubation period. 3 This analysis was also performed. Can be constituted two or three times in the following internal photo group: negative contrast group-no LPS: positive control group-no test inhibition 剤: vehicle control group-the highest concentration of DMS0 or compound solvent used in the experiment 3 add additional Saline water was added to all the control tubes, so that the control group and experimental whole blood samples had normalized volumes. -305- This paper is generally used in the national standard S (CNS) A4 size (2 丨 0 × 297 mm). ) (Poem siiI.V / Notes on this page, printed on the page of the Ministry of Economic Affairs, Central Procurement Bureau, Soldiers and Consumers Cooperatives, etc. ¾ 1235157 Λ 7 Β7 V. Description of the invention (3Q3) After the incubation period, the whole blood sample is at ~ 2000 rpm In the microcentrifuge, the blood is transferred to the fresh Measure in a centrifuge tube and centrifuge at 1000x g to clump the remaining platelets if necessary. Plasma samples / can be stored frozen at -70 ° C, and then analyzed by ELISA for cytokinin levels. ELISA: For detection of IL We used the R &amp; D System (614 McKinley Place N.E. Minneapolis, MN 55413) Quantikine kit in -1 /? And a-TNF. The analysis was performed according to the manufacturer's instructions. In the individual range, we have observed IL-1 / 5 levels of ~ 1-5 nano ^^ / ml in the soup control group, and the 1: 200 plasma dilution multiples of all samples, so that the ELISA results of our experiments are sufficient to fall The linear range of the ELIS A standard west line. If differences are observed in whole blood analysis, standard dilutions can be made more ideal if necessary 3 Nerad, JL et al., J. Leukocyte Biol., 52, pp. 687-692 (1992) ° Example 5 ICE homologue Inhibition 1. Separation of ICE homologues. ¾ Printing by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions before filling in this purchase TX to use the performance of the standard virus expression system in insect cells. Tx cDNA (Faucheu et al., Supra, 1995) was selected and cloned into a modified PVL1393 transfer vector, and the resulting plastid (pVL1393 / TX) was co-transfected into insect cells. Viral DNA was used for identification. Recombinant prion-like virus. After producing high-potency recombinant diseased ginger stocks, the activity of TX in the culture medium was checked by visual ICE analysis. Typically, Spodoptera frugiperda was infected with recombinant prion stocks at MOI 5 ( Sf9), with a maximum performance of 4.7 μg / ml after 48 hours a. ICE is used as the standard in the analysis. -306- The paper ft scale is applicable to the Chinese National Standard (CNS) A4 standard (210X297 mm) 37 1235157 Λ7 5 、 Invention description (304) Note on the back This book is printed by the Ministry of Economic Affairs of the United States, and it is also printed on the ICE or TX ammonium terminal T7 decoration. The original design can help the identification and purification of recombinant proteins. Weng Yi can also be used to check different levels of performance and relative expected death levels from different homologues. In comparison with cell lines that can express ICE or TX and sprints infected with separate viral DNA, the former is Infected Sf9: Expected death of vesicles in cells (examined by cone blue exclusion analysis) increased 3 N-terminal (His) 6 • Performance of decorated CPP32 in Escherichia coli and hairiness coding The CPP32 peptide and the cDNA from Ser (29) (Fernandes-Alnemh et al, supra, 1994) were amplified by primer-line PCR. Its $ is added to the Xhol position on the 5 · and ends, and the generated The Xhol fragment was ligated to the Xhol-cut pET-15b expression vector to generate a fusion protein whose N-terminus has (his) 0n decoration in the framework of the recombinant 3 protein. The recombinant protein starts with the MGSSHHHHHHSSGLVPRGSHMLE amine margin sequence Of which LVPRGS Thrombin dissociation location, from father to Calligraphists (29) of CPP32. Harboring plasmid of Escherichia coli BL21 (DE3) at 30, C swells grow to log phase, then co-cultivation with O.SmMIPTG. After adding IPTG2 +, the cells were recovered to prepare a lysate, and the soluble protein was purified by Ni-distant sugar chromatography. All the expressed CPP32 proteins were shown through the 裒 # 修 # Plastic formula a N-terminal sequencing analysis showed that the processing modification occurred in Asp (l75) and Λ

Ser (176)間之推想位置上。來自200毫升培養物可得约) 微克的CPP32蛋白質。經活性位置滴定決定,經純化的贫 白質完全具有活性。蛋白酶製劑在解離PARP以及合成# DEVD-AMC受質上也極具試管内活性(Nicholson et al,Ser (176) is in the expected position. Approximately) micrograms of CPP32 protein are obtained from a 200 ml culture. It was determined by active site titration that the purified lean white matter was fully active. Protease preparations are also extremely in vitro active in dissociating PARP and synthesizing # DEVD-AMC substrates (Nicholson et al,

本紙乐尺度通用中国國家襟孪(CNS ) Α4規格(210X297公釐) 1235157 a7 B7 五、發明説明(305) ,1995” 2. ICE同系物之抑制作用 ICE同系物一系列可逆抑制劑之選擇性示於表1 3依抬 Wilson et al (上文,1994)利闫 YVAD-AMC受質(Thomberry et al,上文,1992)進行ICE酵素分析。利用ICE受質在和 ICE相同之條件下進行TX活性之分析。利用DEVD-AMC受 質進行CPP32之分析(Nicholson et al,上文,1995) 3 —般而 言,對大範圍之架構而言,ICE及TX間有低的選擇性,受 試的合成的ICE化合物無一者爲CPP32有效之抑制劑。在 最高濃度下分析可逆的化合物(1 A M)顯示並無抑制作用3 表1 化合物 kj ICE (nM) IqTX (nM) ^ CPP32 (nM) 214e 7.5 7.0±1.1 &gt;1000 135a 90 55±9 &gt;1000 125b 60 57±13 &gt;1000 137 40 40±7 &gt;1000 卞文示出經選出之不可逆抑制劑使ICE及ICE同系物失去 活性之二次速率常數(表2)。所研究之不可逆化合物爲ICE 及其同系物大範圍之抑制劑β然而,某些選擇性在與ICE 及CPP32抑制作用比較下以不可逆化合物可觀察得到3 表2 化合物 kmact (ICE) ^inact (TX) ‘(CPP32) M·1 s·1 NT1 s·1 M-1 s·1 138 120,000 150,000 550,000 217d 475,000 250,000 150,000 108a 100,000 25,000 nd 經濟部中央標孪局系工消費合作社印装 (請先¾•讀背£之&gt;1意事項具^^本頁) •308- 本纸杀尺度通用中国国家橾率(CNS ) A4現格(2丨0〉&lt;297公釐) 超濟部中央揉隼局员工消资合作社印製 1235157 Λ7 B7 五、發明説明(306) 實例6 細胞預期死亡之抑制作用 U937細跑中Fas-誘生之細胞預期死亡 ’ 評估化合物阻斷抗-Fas-謗生之細胞預期死亡之能力。在 利用RT-PCR之初步實驗中,吾等於未經刺激之U937钿跑 中偵測编碼 ICE,TX,ICH-1,CPP32及 CMH-1 之 mRNA。 吾等使用此細胞株於钿胞預期死亡之研究中。U937細跑 以1 X 105細胞/毫升種入培養基中,再生長至〜5x 106钿跑/ 毫升。於細胞預期死亡之實驗中,2 X 1 Οό細胞於1毫升 ΚΡΜΙ-1640-10%ΡΒ5中塗佈於24孔洞之组織培養盤内,並 以100毫微克/毫升抗-Fas抗原抗體刺激(Medical and Biological Laboratories, Ltd.) 3 經過在 37eC 下 24小時培育後 ,以ApoTag試劑行FACS分析來決定細胞預期死亡之細胞 百分率。 受試的所有化合物最初在20//Μ下,再以活性化合物進 行滴定以決定IC50値。於108a,136及138中可觀察到細跑 預期死亡之抑制作用(在20 下&gt;75%)。於217e決定出0.8 a 1^之1(:5(),和2146 20/^%下抗435-誘生之细胞預期死亡無抑 制作用相比較β 實例7 充作抗炎剤時活體内‘效力之急性分析 LPS-誘導之IL-ly3產製 於施以LPS (20毫克/公斤IP)之CD1老鼠中評估214e及217e 之效力(每種狀況下n=6)。受試化合物製備於撖欖沽 •309- 本纸ft尺度適用中國国家標準(CNS ) A4規格(210X297公釐)The paper scale is universal Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 a7 B7 V. Description of the invention (305), 1995 "2. Inhibition of ICE homologues Selectivity of a series of reversible inhibitors of ICE homologues The results are shown in Table 13. 3 The ICE enzyme analysis was performed by YVAD-AMC substrate (Thomberry et al, above, 1992) according to Wilson et al (above, 1994). The ICE substrate was used under the same conditions as ICE. Analysis of TX activity. Analysis of CPP32 using the DEVD-AMC substrate (Nicholson et al, supra, 1995) 3 In general, for a wide range of architectures, there is low selectivity between ICE and TX. None of the synthetic ICE compounds tested were effective inhibitors of CPP32. Analysis of reversible compounds (1 AM) at the highest concentration showed no inhibitory effect. 3 Table 1 Compounds kj ICE (nM) IqTX (nM) ^ CPP32 (nM ) 214e 7.5 7.0 ± 1.1 &gt; 1000 135a 90 55 ± 9 &gt; 1000 125b 60 57 ± 13 &gt; 1000 137 40 40 ± 7 &gt; 1000 The text shows that the selected irreversible inhibitor deactivates ICE and ICE homologues Quadratic rate constant (Table 2). The irreversible compound studied is ICE A wide range of inhibitors of β and its homologs β However, certain selectivities can be observed with irreversible compounds compared with the inhibitory effects of ICE and CPP32 3 Table 2 Compounds kmact (ICE) ^ inact (TX) '(CPP32) M · 1 s · 1 NT1 s · 1 M-1 s · 1 138 120,000 150,000 550,000 217d 475,000 250,000 150,000 108a 100,000 25,000 nd Printed by the Department of Industry and Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Notes (^^ this page) • 308- The standard of this paper is GM China National Standards (CNS) A4 (2 丨 0> &lt; 297 mm) Printed by the Consumers' Cooperative of the Central Government Bureau of the Ministry of Economic Affairs 1235157 Λ7 B7 V. Explanation of the invention (306) Example 6 Inhibition of expected death of cells Fas-induced cells expected death in U937 sprint 'Evaluation of compounds' ability to block anti-Fas-expected cells expected death. In use In the preliminary experiments of RT-PCR, we detected mRNAs encoding ICE, TX, ICH-1, CPP32 and CMH-1 during unstimulated U937 run. We have used this cell line in studies on the expected death of dysentery. U937 sprinting was seeded into the culture medium at 1 X 105 cells / ml, and regenerated to ~ 5x 106 run / ml. In experiments where cells were expected to die, 2 X 10 cells were plated in a 24-well tissue culture plate in 1 ml of KPMI-1640-10% PB5, and stimulated with 100 ng / ml anti-Fas antigen antibody ( Medical and Biological Laboratories, Ltd.) 3 After 24 hours incubation at 37eC, FACS analysis was performed with ApoTag reagent to determine the percentage of cells that were expected to die. All compounds tested were initially at 20 // M and titrated with the active compound to determine the IC50 値. Inhibition of expected sprinting death was observed in 108a, 136, and 138 (at 20% &gt; 75%). At 217e, it was determined that 0.8a 1 ^ 1 (: 5 (), and 2146 20 / ^% of anti-435-induced cells have no inhibitory effect on the expected death. Β Example 7 In vivo when used as an anti-inflammatory drug Acute analysis LPS-induced IL-ly3 produced in CD1 mice administered with LPS (20 mg / kg IP) was evaluated for the efficacy of 214e and 217e (n = 6 in each case). Test compounds were prepared in R. palmatum Gu • 309- The paper ft scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm)

1235157 Λ/ B7 五、發明説明(3σ7) ••DMSO-乙酵(90:5:5)中,再於lps後1小時經甴ip注射3 Lpi 施以7小時後採血3以ELISA偵測血清中IL-1 /5水平。圖( 之結果顯示甴214e分泌il-1 之劑量依輕塑抑制作用, ED30约爲15毫克/公斤。於第二實驗中可得類似的結杲3 也可在經217e處理之老鼠中觀察到IL-1/5分泌顯著的抑制 作用(圖7):然而,清楚的劑量反應並不明顯: 化合物214e及217e (50毫克/公斤)也以經口灌食方弍投藥 以評估吸收作用。於圖8之結果顯示214e,非217e苗口服 時可抑制IL-1 之分泌,建議「ICE抑制劑充作抗炎劑時之 口服效力潜力。 也評估2l4e同系物之效力,於IP投藥(圖9)及PO投藥後在 施以LPS之老鼠中進行(圖1〇) 3 查丄在施以LPS老鼠於PO及IP投藥後由214e同系物所致之 IL-/?產製之抑制%(50毫克/公斤)β (請先閱讀背面之注意事項1235157 Λ / B7 V. Description of the invention (3σ7) •• DMSO-acetase (90: 5: 5), and then injected with 甴 ip 3 Lpi 1 hour after lps and blood collection after 7 hours 3 ELISA to detect serum Medium IL-1 / 5 level. The results show that the dose of il-1 secreted by 甴 214e depends on the light-plastic effect, and the ED30 is about 15 mg / kg. Similar crusts 3 can be obtained in the second experiment and can also be observed in 217e-treated mice Significant inhibition of IL-1 / 5 secretion (Figure 7): However, a clear dose response was not obvious: Compounds 214e and 217e (50 mg / kg) were also administered by oral gavage to evaluate absorption. The results in Figure 8 show that 214e and non-217e vaccines can inhibit IL-1 secretion when taken orally. It is recommended that "ICE inhibitors act as anti-inflammatory agents for oral efficacy potential. The efficacy of 2l4e homologues is also evaluated when administered in IP (Figure 9 ) And PO after administration in mice administered with LPS (Figure 10) 3 Check the inhibition of IL- /? Production system caused by 214e homologues after administration of LPS mice in PO and IP (50 Mg / kg) β (Please read the notes on the back first

本頁) 訂 經濟部中央樣準局员工消资合作社印裴 表3 化合物 PO% 抑制作用 IP% 抑制作闬 2l4e 75 78 265 27 30 416 52 39 434 80 74 438 13 · 40 442 10 0 2002 - 78(This page) Order Employees of the Central Procurement Bureau of the Ministry of Economic Affairs, Consumer Cooperatives, India, Pei Table 3 Compound PO% Inhibition IP% Inhibition 2l4e 75 78 265 27 30 30 416 52 39 434 80 74 438 13 · 40 442 10 0 2002-78

-310- 本纸尺度通用宁国圉家揉卒(CNS ) Α4也洛(2丨0Χ297公变) !235157-310- Paper size General Ningguo's family rubbing (CNS) A4 Yeluo (2 丨 0 × 297 public transformer)! 235157

、發明説明(3〇β) 表4 2l4e可藥在LPS老鼠中效力之比較: IL-1卢產製之時間西線抑制作尉 --------- 化合物投藥時間 气藥時間,p〇二^亭克/公斤) 翅济部中夬襟率局员X消費合作·杜印袋3. Description of the invention (30β) Table 4 Comparison of the efficacy of 2l4e drugs in LPS mice: IL-1 Rosin-made time, Western-line inhibition as Wei --------- Compound dosing time, gas-dose time, p〇2 ^ Ting g / kg) Member of the Ministry of Economy and Trade of China

於接下來分析中所得之値 實例8 偵測214e前藥之血浚永平 .老鼠以化合物302及304a (50毫先/公斤)之ρ·〇·劑量投予, 藥物製備於0.5%羧甲基纖維素中。於給藥後1及7小.時時揉 血。以等禮積含有2%曱酸之乙腈沈:殿而萃取血清,再雜 心3上清液以液相層析一質量光譜(ESI-MS)分析,利用 311 本纸伕尺度逋用中国國家標準(CN?S )Μ規格(210XH97公釐) 1235157 A.' B7 五、發明説明(3〇9: 0.03至3微克/毫升之偵測水平。化合物302及304a當口服時 顯示出可偵測之血液水平,214e本身當口服時未有超遇 0.10微克/毫升之血中水平。化合物302及3b4a爲214e之前 藥,且可於活鳢内代謝成214e(見圖11)。 實例9 吾等利用實例1·8所述之方法可得本發明化合物下列數 據(見表5及6)。實例9化合物之結構示於實例10-17, 表5 經濟部中央標準局員工消费合作杜印¾ 化合物 uv-可見光 Ki (nM) 1 i 知 JfePBMC 乎均IC50 (nM) 全血IC50 (nM) 老氣清除率 i. v. 毫升/分/公斤 大氣清除率 i. v. 毫升/分/公斤 47b 27 1800 &lt;600 338 47a 19 2600 5100 79 32 135a 90 2800 5000 &gt;100 135b 320 1600 1700 • 125b 60 800 4500 j 108b 400 25000 1 ! &gt;100 137 40 1700 14000 : i 1 139 350 2000 i i 213e 130 900 600 400* 1 214c 1200 5000 214e 7.5 1600 1300 23 12 217c 1700 7000 70 217e 175 2000 &gt;50 220b 600 2125 • 1 223b 99 5000 - &gt;100 ί 223e 1,6 3000 &gt;20000 89 i 22 6e 15 1100 .1800 109 227e 7 234 550 230e 325 300 67 232e 1100 4500 22 26 I 235e 510 4750 36 ! 238e 500 4250 : | 246 12 950 10000 31 -312 請 先 % 讀 背 云 之 a 意 I % 寫、 本 Μ 本纸伕尺度適同中国国家標孪(CNS )义4%格(2丨OX297公釐) 1235157 , Λ I Β7 五、發明説明(31〇) ¾濟部中央標準局負工消费合作.社印製 i 化合物 UV-可見光 Ki (nM) 细&amp;PBMC 平均IC50 (nM) 全J0JC50 (nM) 老鼠清除率 i· ν· 毫升/分/公斤 ! 大民清涂率 i. V. 毫升/分/公斤 j 257 13 11000 6600* _ : - i 1 f | 265 47 4300 1400 j 23 20 281 50 600 2500* \ 302 4500 &gt;20000 &gt;20000 304a 200 1,400 2400 14000* - 307a 55 14500 16000 307b 165 14000 404 2.9 j 1650 ! ! 1800* 1100 64 24 405 i 6.5 j 1700 2100 406 j 4 ! 1650 2300 407 j 0.4 540 17〇〇 408 0.5 1100 1000 41 23 409 3.7 2500 410 17 2000 2800 32 20 411 0.9 540 1900 412 1·3 580 660* 700 1000* 25 | 413 750 6200 415 2.5 990 1000* 450 3500* 26 18 416 12 1200 3400 47 417 8 2000 6000 33 22 418 2.2 1050 2200* 7800 1800* 13 5.9 419 280 &gt;8000 420 1200 8000 &gt;8000^ 421 200 4300 4600* 1 422 50 2200 1200 423 10 2100 1800* 1500 45 | 1 1 424 45 2500 4000 \ 425 0.8 650 700+ 650 i 1 (請先閱讀背面之注意事項再!PF本頁) ―展 訂Example 8 obtained in the following analysis: Detecting the 214e prodrug of Xue Jun Yongping. Mice were administered at a ρ ··· dose of compounds 302 and 304a (50 milligrams / kg), and the drug was prepared in 0.5% carboxymethyl Based cellulose. Blood was rubbed at 1 and 7 hours after administration. Serum was extracted with acetonitrile containing 2% acetic acid: Dian Er, and the supernatant of Zanxin 3 was analyzed by liquid chromatography-mass spectrometry (ESI-MS). Standard (CN? S) M specification (210XH97 mm) 1235157 A. 'B7 V. Description of the invention (309: 0.03 to 3 μg / ml detection level. Compounds 302 and 304a show detectable when taken orally The blood level of 214e itself did not exceed the blood level of 0.10 μg / ml when taken orally. Compounds 302 and 3b4a are prodrugs of 214e and can be metabolized to 214e in living diarrhea (see Figure 11). Example 9 We Using the method described in Example 1.8, the following data of the compound of the present invention can be obtained (see Tables 5 and 6). The structure of the compound of Example 9 is shown in Examples 10-17. UV-Visible Ki (nM) 1 i Know JfePBMC Almost IC50 (nM) Whole blood IC50 (nM) Old gas clearance iv ml / min / kg Atmospheric clearance iv ml / min / kg 47b 27 1800 &lt; 600 338 47a 19 2600 5100 79 32 135a 90 2800 5000 &gt; 100 135b 320 1600 1700 • 125b 60 800 450 0 j 108b 400 25000 1! &Gt; 100 137 40 1700 14000: i 1 139 350 2000 ii 213e 130 900 600 400 * 1 214c 1200 5000 214e 7.5 1600 1300 23 12 217c 1700 7000 70 217e 175 2000 &gt; 50 220b 600 2125 • 1 223b 99 5000-&gt; 100 ί 223e 1,6 3000 &gt; 20000 89 i 22 6e 15 1100 .1800 109 227e 7 234 550 230e 325 300 67 232e 1100 4500 22 26 I 235e 510 4750 36! 238e 500 4250: 246 12 950 10000 31 -312 Please first read the meaning of the back of the cloud and write it. The size of this paper is in accordance with the Chinese National Standards (CNS) standard 4% grid (2 丨 OX297 mm) 1235157, Λ I Β7 V. Description of the invention (31〇) ¾ The Central Bureau of Standards of the Ministry of Economic Affairs and Consumer Cooperation. Printed i compounds UV-visible Ki (nM) fine & PBMC average IC50 (nM) all J0JC50 (nM) rat clearance i · ν · ml / min / kg! Damin clearing rate i. V. ml / min / kg j 257 13 11000 6600 * _:-i 1 f | 265 47 4300 1400 j 23 20 281 50 600 2500 * \ 302 4500 &gt; 20000 &gt; 20000 304a 200 1,400 2400 14000 *-307a 55 14500 16000 307b 1 65 14000 404 2.9 j 1650!! 1800 * 1100 64 24 405 i 6.5 j 1700 2100 406 j 4! 1650 2300 407 j 0.4 540 17〇〇408 0.5 1100 1000 41 23 409 3.7 2500 410 17 2000 2800 32 20 411 0.9 540 1900 412 1.3 · 580 660 * 700 1000 * 25 | 413 750 6200 415 2.5 990 1000 * 450 3500 * 26 18 416 12 1200 3400 47 417 8 2000 6000 33 22 418 2.2 1050 2200 * 7800 1800 * 13 5.9 419 280 &gt; 8000 420 1200 8000 &gt; 8000 ^ 421 200 4300 4600 * 1 422 50 2200 1200 423 10 2100 1800 * 1500 45 | 1 1 424 45 2500 4000 \ 425 0.8 650 700+ 650 i 1 (Please read the notes on the back first again! (PF page)

-313- 本纸伕尺度逑用中國国家標率(〇知)人4規格(210:&lt;297公釐) 1235157 B7 五、發明説明(311) 經濟部中央標準局系工消费合作·社印製 化合物 UV·可見光 Ki (nM) 細先PBMC 平均IC50 (nM) ±jhIC50 (m\I) 老鼠清涂率 i. v. 毫升/分/公斤 j 大鼠清除率 i. ν· 毫升/分/公斤 ! 426 I ! 90 4500 2500* ί ! ! 427 180 4500 36 | 428 280 ! 429 7000 | 430 60 &gt;8000 I 431 8 &gt;8000 8000 432 1.6 560 :: 2000 433 2.9 1000 i 1100 1100* | - 434 4.9 1600 1 1800 t 1200* 1 1300* 20 435 8 j 4400 ί 436 7.5 ί 2700 j 437 I 1 12 ί 1800 ! 5000 ί I t 438 28 1000 700 2900* 22 439 3.7 2800 3200 3400* i 440 2.3 5000 2000 441 1 2500 4500 442 3.2 900 2000 54 443 3.6 2800 1500 444 15 3500 3500 445 135 4000 446 62 3000 447 5·8 2500 1500 448 130 4000 449 12 1500 3200 13000^ 450 5 800 2200 1700* 18 12 1 451 4 1800 1500 9000* 452 4.5 600 800^ 650 1600* 27·3 453 0·65 1300 1900 1600* _L | (請先閉讀背面之注意事項-313- The standard of this paper is Chinese national standard (zero) person 4 specification (210: &lt; 297 mm) 1235157 B7 V. Description of invention (311) Department of Industrial and Consumer Cooperation, Central Standards Bureau, Ministry of Economic Affairs Compound UV · Visible light Ki (nM) Fine PBMC Average IC50 (nM) ± jhIC50 (m \ I) Rat clearance rate iv ml / min / kg j Rat clearance rate i. V · ml / min / kg! 426 I! 90 4500 2500 * ί!! 427 180 4500 36 | 428 280! 429 7000 | 430 60 &gt; 8000 I 431 8 &gt; 8000 8000 432 1.6 560 :: 2000 433 2.9 1000 i 1100 1100 * |-434 4.9 1600 1 1800 t 1200 * 1 1300 * 20 435 8 j 4400 ί 436 7.5 ί 2700 j 437 I 1 12 ί 1800! 5000 ί I t 438 28 1000 700 2900 * 22 439 3.7 2800 3200 3400 * i 440 2.3 5000 2000 441 1 2500 4500 442 3.2 900 2000 54 443 3.6 2800 1500 444 15 3500 3500 445 135 4,000 4000 446 62 3000 447 5 · 8 2500 1500 448 130 4000 449 12 1500 3200 13000 ^ 450 5 800 2200 1700 * 18 12 1 451 4 1800 1500 9000 * 452 4.5 600 800 ^ 650 1600 * 27 · 3 453 0 65 1300 1900 1600 * _L | (please read the Notes on the back of the closure

訂 -314- 本纸伕尺度逆用中國國家標率(CNS ) A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(312) 經濟部中夬樣準局貝工消费合作社印装 化合·物 uv-可見光 ’Ki (nM) 知絶PBMC 平均IC50 (nM) ^j6JC50 (nM) 老鼠清除率 i. v. 毫升/分/公斤 大鼠清除率 i. v. 毫升/分/公斤 t 454 45 2500 i 455 1.2 400 2800 2600* 1 j 54 456 4.5 600 1300* 600 1400* 12.7 457 6.2 2000 3500 j j 458 20 2900 j J j 459 5 1800 : • ! 4 60 115 400 | 2400 • 1 ;461 S 47 t ; ί 462 ί 40 1 - 1 1 463 ' 14 ! 2400 * ! 丨 2800, : ί ;464 j 1 2.5 j 1000 j &gt;1000 i ! 1 i 2500+ j I 1 465 3 1000 I 800 1 466 0-8 1400 600 i 4 67 11 1900 ί f 468 4.5 850 2500 i • 470 5 500 360 500* 63 : 1 471 1 750 400 17 472 140 473 1 1000 400 450* 474 85 475 5.5 690 650* 400 350^ 31 21 ί j 476 7 1600 2500 ! I 477 60 ! 478 380 壤 K 479 15 900 700 2400* i 1 480 25 2300 1 481 1.2 390 930* 600 500* 34 ; 4 82 &lt;0.2 340 380 260* i -315-ORDER-314- The paper scale is reversed to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (312) Printed compounds and materials by the Shellfish Consumer Cooperative of the China Prototype Bureau of the Ministry of Economic Affairs uv-visible light 'Ki (nM) PBMC average IC50 (nM) ^ j6JC50 (nM) rat clearance iv ml / min / kg rat clearance iv ml / min / kg t 454 45 2500 i 455 1.2 400 2800 2600 * 1 j 54 456 4.5 600 1300 * 600 1400 * 12.7 457 6.2 2000 3500 jj 458 20 2900 j J j 459 5 1800: •! 4 60 115 400 | 2400 • 1; 461 S 47 t; ί 462 ί 40 1- 1 1 463 '14! 2400 *! 丨 2800,: ί; 464 j 1 2.5 j 1000 j &gt; 1000 i! 1 i 2500+ j I 1 465 3 1000 I 800 1 466 0-8 1400 600 i 4 67 11 1900 ί f 468 4.5 850 2500 i • 470 5 500 360 500 * 63: 1 471 1 750 400 17 472 140 473 1 1000 400 450 * 474 85 475 5.5 690 650 * 400 350 ^ 31 21 ί j 476 7 1600 2500! I 477 60! 478 380 K 479 15 900 700 2400 * i 1 480 25 2300 1 481 1.2 390 930 * 600 500 * 34; 4 82 &lt; 0.2 340 380 260 * i -315-

本纸伕尺度適用中国國家標李(CNS ) A4規格(210X297公菝) 1235157 Λ7 B7 五、發明説明(313) M濟部中夬標準局負工消費合作社印装 ! . 化合场 UV-可見光 *Ki (nM) •鈿絶raM( 平均IC50 (nM) :±jklC50 (nM) 老鼠清除率 i. v. 毫升/分/公斤 大氣清除率 1·· V. .毫升/分/公斤 I 1 483 1-7 900 700 1 | 484 I I 2 1550 1400^ 5000 15 ! 485 f 2 900 900 ί 486 I I 2.3 480 570* 500 3Ί L I 487 I 2,4 650 950* 500 .400* ! 20 1 ! 488 1-5 940 I 750 ! : ί ! 489 f 6 2250 1700* I-15000 ι 丨 ί ! i 490 l ( 4·3 _ 980 j 700 1000* ! 1900* ! 491 ! 5 | 2500 i ---------- ! 493 ! 25 1 丨— i 1200 ; 800 ί 850* 494 15 1350 1500* 7000 495 43 496 16 1550 1600* 6000 497 3.5 .740 350 700* 498 1·5 560 500 400* 499 3.5 1200 800* 9000 605a 90 2600 &gt;20000 605b 45 10000 97 605c 615 4500 37 605d 95 5100 16000 5100* 33 605e 29 2250 &gt;10000 24 -J 605f 475 12500 605g 165 22500 605h 460 &gt;25000 605i 680 &gt;20000 i 605j 110 8750 71 605m 650 20000 -316- (請先聞讀背面之注意事項一| 本长伕尺度遝用中國8家標準(CNS ) A4規格(210X297公釐) 1235157 Λ7 B7 五、發明説明(314) 經濟部中央樣孪局負工消费合作杜印¾ 化合场 . UV-可見光 Ki (nM) 1 細絶PBMC 乎均IC50 (nM) 全血IC50 (nM) ! 老氣清涂季 i. v. 毫升/分/公斤 大鼠清除率| i. v. 1 毫升/分/公斤ί 605η 12 2100 &gt;20000 &gt;28 605〇 72 18000 605ρ 125 3200 &gt;20000 | 605q 1000 ! 605s 150 6000 ί 1 ! 605t 33 ! 609a 114 &gt;30000 I 609b 27 &gt;20000 ;619 300丨 620 35 ! 1000 19000 621 7.2 | 1300' &gt;20000 1 622 35 ! 1300 &gt;20000 t ! 623 9 ! 624 300 625 105 ; 626 260 627 43 3250 8000 628 36 2750 &gt;20000 I 629 230 i 630 270 631 805 632 148 633 92 5750 20000 i 634 1400 635 55 1900 3400* 4000 605v 1100 &gt;30000 2201 9 2000 3700* 3500 60 2100e 250 800 600 2100a 100 1100 850 « 2002 4 810 860* 70 1400* 32 : I t 2100d &gt;100000 &gt;20000 &gt;20000 ! 2100c 7400 &gt;20000 &gt;20000 1 2100b 8000 &gt;20000 &gt;20000 2001 135 1800 3500 : 1027 4000 &gt;20000 &gt;20000 60 1015 40 2500 1700 23 -317- (請先W讀背面之注意事項ν 裝-- '··- 尽頁) 訂 泉 本纸伕尺度通用中国國家標孪(〇^)/\4規格(210&gt;&lt; 297公釐) 1235157 A7 B7 五、發明説明(315) 表6 化合物 螢光分析 ^inact Nf1 il 細跑 reMC 平均 IC50 (βΜ) 全j6lI万50 (ηΜ) 老虱清除率 i· ν· 毫升/分/公斤 大民清除率i i. v. j 毫升/分/公斤! 108a ί 5 ~ &quot; 1 1x10 1 117500 I i r 1 136 j 5.4xl〇5 1 870 2800 93 . 138 1·2χ105 900 2900 116 217d 4·7χ105 340 4000 1 ^ 1 280 4χ1〇5 650 &gt;1000 187 | 283 ΙχΙΟ5 &lt;200 450 104 j 284 3·5χ105 470 550 77 100 285 4·3χ105 810 1000 130 50 . 9、: 寫本一f&lt; ) *數値由再分析而得。 實例1 〇 化合物139以類似合成47a之方法合成而得。The size of this paper is applicable to Chinese national standard (CNS) A4 specification (210X297 male) 1235157 Λ7 B7 V. Description of the invention (313) M printed by the Ministry of Economic Affairs, China Standards Bureau, Off-line Consumer Cooperatives! .Chemical field UV-visible light * Ki (nM) • Extreme raM (average IC50 (nM): ± jklC50 (nM) rat clearance iv ml / min / kg atmospheric clearance 1. · V. .Ml / min / kg I 1 483 1-7 900 700 1 | 484 II 2 1550 1400 ^ 5000 15! 485 f 2 900 900 ί 486 II 2.3 480 570 * 500 3Ί LI 487 I 2,4 650 950 * 500 .400 *! 20 1! 488 1-5 940 I 750 !: ί! 489 f 6 2250 1700 * I-15000 ι ί! i 490 l (4 · 3 _ 980 j 700 1000 *! 1900 *! 491! 5 | 2500 i ---------- ! 493! 25 1 丨 — i 1200; 800 ί 850 * 494 15 1350 1500 * 7000 495 43 496 16 1550 1600 * 6000 497 3.5 .740 350 700 * 498 1.5 · 560 500 400 * 499 3.5 1200 800 * 9000 605a 90 2600 &gt; 20000 605b 45 10000 97 605c 615 4500 37 605d 95 5100 16000 5100 * 33 605e 29 2250 &gt; 10000 24 -J 605f 475 12500 605g 165 22500 605h 460 &gt; 2500 0 605i 680 &gt; 20000 i 605j 110 8750 71 605m 650 20000 -316- (Please read the precautions on the back first | This long standard uses 8 Chinese standards (CNS) A4 specifications (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (314) Du Yin ¾ Cooperative Field, Central Government Bureau of the Ministry of Economic Affairs and Consumer Cooperation. UV-Visible light Ki (nM) 1 Exact PBMC IC50 (nM) and IC50 (nM) of whole blood! Iv ml / min / kg rat clearance rate | iv 1 ml / min / kg rat clearance rate 605η 12 2100 &gt; 20000 &gt; 28 605〇72 18000 605ρ 125 3200 &gt; 20000 | 605q 1000! 605s 150 6000 ί 1! 605t 33! 609a 114 &gt; 30000 I 609b 27 &gt;20000; 619 300 丨 620 35! 1000 19000 621 7.2 | 1300 '&gt; 20000 1 622 35! 1300 &gt; 20000 t! 623 9! 624 300 625 105; 626 260 627 43 3250 8000 628 36 2750 &gt; 20000 I 629 230 i 630 270 631 805 632 148 633 92 5750 20000 i 634 1400 635 55 1900 3400 * 4000 605v 1100 &gt; 30000 2201 9 2000 3700 * 3500 60 2100e 250 800 600 2100a 100 1100 850 «2002 4 810 860 * 70 1400 * 32: I t 2100d &gt; 100000 &gt; 20000 &gt; 20000! 2100c 7400 &gt; 20000 &gt; 20000 1 2100b 8000 &gt; 20000 &gt; 20000 2001 135 1800 3500 : 1027 4000 &gt; 20000 &gt; 20000 60 1015 40 2500 1700 23 -317- (Please read the precautions on the back first. Installation-'··-End page) The size of the book is in accordance with the Chinese standard. Twin (〇 ^) / \ 4 specifications (210 &gt; &lt; 297 mm) 1235157 A7 B7 V. Description of the invention (315) Table 6 Fluorescence analysis of compounds ^ inact Nf1 il Fine run reMC Average IC50 (βΜ) Full j6lI million 50 (ηΜ) clearance rate of old lice i · ν · ml / min / kg Damin clearance rate i iv j ml / min / kg! 108a ί 5 ~ &quot; 1 1x10 1 117500 I ir 1 136 j 5.4xl0 5 1 870 2800 93. 138 1 · 2χ105 900 2900 116 217d 4 · 7χ105 340 4000 1 ^ 1 280 4χ1〇5 650 &gt; 1000 187 | 283 ΙχΙΟ5 &lt; 200 450 104 j 284 3 · 5χ105 470 550 77 100 285 4 · 3χ105 810 1000 130 50. 9 ,: f-<) * The number is obtained by reanalysis. Example 10 Compound 139 was synthesized in a similar manner to that of 47a.

經濟部中央標準局員工消費合作社印¾ 化合物136及138以類似合成57b之方法合成而得。 -318 - 本纸伕尺度通用中§11家標孪(〇^)厶4規格(2〖0&gt;&lt;297公釐) 1235157 A7 B7 經濟部中央標準局員工消貧合作杜印¾ 五、發明説明(316) 〇Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Compounds 136 and 138 were synthesized in a similar manner to 57b. -318-Standards in this paper: §11 standard twins (〇 ^) 厶 4 specifications (2 〖0 &gt; &lt; 297mm) 1235157 A7 B7 Poverty Alleviation Cooperation Staff of the Central Standards Bureau of the Ministry of Economy Du Yin ¾ 5. Invention Explanation (316) 〇

化合物135a,135b及137以類似合成69a之方法合成。 〇Compounds 135a, 135b, and 137 were synthesized in a similar manner to 69a. 〇

本纸朵尺度逍用中g国家標率(CNS ) A4規格(210X297公釐) 1235157 Λ/ Β7 經濟部中央揉率局員工消費合作杜印¾ 五、發明説明(317) 化合物 813e,814c,814e,817c,817d,817e,820b, S23b,823e,826e,827e,830e,832e,835e,838e,846 ,857, 865, 902, 904a, 907a, 907b, 1004-1013, 1015-1045,1046-1068,1070-1091,及 1093-1099以類似合成化 合物264及實例10及11中相當化合物之方法合成3 化合物 47a,47b,108a,108b,125b,213e,214c,217c ,217d,217e,220b,223b,223e,226e,227e,230e, 232e , 235e , 238e , 246 , 257 , 264 , 265 , 280-287 , 302 , 304a,307 a及307b依下述合成' iL N-(N-乙醯基-酪胺醯基-纈胺醯基-哌可基)-3-铵基-4-酮丁酸 A步驟· N-(N-第三-丁氧羰基哌可基)-4-胺基〇-芊氧基 -2-飼四致咬喃 以類似 Chapman所報告的方法(Bioorg. &amp; Med. Chem. Lett. 2, ρρ· 613-618,(1992))進行N-第三-丁氧羰基哌可酸(460毫 克,2.0毫莫耳)與N-烯丙氧羰基-4-胺基-5-芊氧基-2-酮基 四氫呋喃(530毫克,1·82毫莫耳)之反應,可得654毫克的 標題化合物。 屯 NMR (500 MHz, CDC13 (呈幾何異構物型)&amp;7·35 (m, 5H), 6·88 (br· s,1H),4·9·4·45 (m, 4H),3.95+ (br· m,2H), 3.06 (m, 1H), 2.9 (m, 1H), 2.7 (br. m, 1H), 2.45 (m&gt; iH), 2.2 (m,1H), 1.7-1.5 (m,3H), 1.45 (二個 s,9H)。 B步鞣· N-哌可基-4-胺基〇-芊氧基-2-酮$氫〃夫嘀 N-(N-第三-丁氧羰基哌可基)-4-胺基-5-芊氧基嗣基-四 •320- 本纸ft尺度適用中舀樣率(CNS ) A4規格(210X297公釐) ~ &quot;The standard of this paper is Chinese standard rate (CNS) A4 (210X297 mm) 1235157 Λ / Β7 Employee consumption cooperation of the Central Rubbing Bureau of the Ministry of Economic Affairs Du Yin ¾ 5. Description of the invention (317) Compounds 813e, 814c, 814e , 817c, 817d, 817e, 820b, S23b, 823e, 826e, 827e, 830e, 832e, 835e, 838e, 846, 857, 865, 902, 904a, 907a, 907b, 1004-1013, 1015-1045, 1046-1068 3, Compounds 47a, 47b, 108a, 108b, 125b, 213e, 214c, 217c, 217d, 217e, 220b, 223b, 1070-1091, and 1093-1099 were synthesized in a similar manner to compound 264 and equivalent compounds in Examples 10 and 11. , 223e, 226e, 227e, 230e, 232e, 235e, 238e, 246, 257, 264, 265, 280-287, 302, 304a, 307a, and 307b were synthesized as follows: 'iL N- (N-ethenyl- Tyramine-valinyl-piperidinyl) -3-ammonyl-4-ketobutanoic acid A step · N- (N-third-butoxycarbonylpiperidinyl) -4-amino group 0- N-tertiary-2-methyltetrazolane was subjected to N-third-butoxycarbonyl in a similar manner to that reported by Chapman (Bioorg. &Amp; Med. Chem. Lett. 2, ρρ · 613-618, (1992)). The reaction of pipecolic acid (460 mg, 2.0 mmol) with N-allyloxycarbonyl-4-amino-5-fluorenoxy-2-one tetrahydrofuran (530 mg, 1.82 mmol) This gave 654 mg of the title compound. Tun NMR (500 MHz, CDC13 (in the form of geometric isomers) &amp; 7.35 (m, 5H), 6.88 (br · s, 1H), 4.9 · 4 · 45 (m, 4H), 3.95+ (br · m, 2H), 3.06 (m, 1H), 2.9 (m, 1H), 2.7 (br. M, 1H), 2.45 (m &gt; iH), 2.2 (m, 1H), 1.7-1.5 (m, 3H), 1.45 (two s, 9H). B-step tanning · N-pipecolyl-4-amino 0-methoxy-2-one -Butoxycarbonylpiperidyl) -4-amino-5-fluorenyloxy-tetra-320- This paper ft scale is suitable for medium sample rate (CNS) A4 specification (210X297 mm) ~ &quot;

(請先¾讀背VB之注意事項V 装-- Γ頁) 訂(Please read the precautions for VB first. V Pack-Γ pages) Order

1235157 Λ7 B7 I...... Ϋί s! 1· —I— I- I ----Η1 五、發明説明(318) 氳咬读(654¾兄)溶於15毫升的25%三氟乙酸於二氯曱燒中 ,在室溪下攪掉3混合物濃縮生成膠狀殘留物3殘留物溶 於二氯甲烷中再以10%碳酸氫鈉洗滌。有^機層在無水硫酸 鈉上乾缲,過濾,並濃縮生成422毫克標題化合物,呈褐 色固體5 lU NMR (500 MHz, CDC13) &amp; 7.38 (m, 5H), 7.15 (d, lH), 5.55 (d, 1H), 4.95-4.8 (m, 1H), 4.78 (m, 1H), 4.65 (d, 1H), 4.45 (m, 1H), 3.2 (m, 0.5H), 3.05 (m, 0.5H), 2.95 (m, 0.5H), 2.85 (m, 0.5H), 2.65 (m, 1H), 2.55-2.38 (m, 1H), 1.95 (m, 1H), 1.8 (m, 1H),1.6 (m,2H),1·38 (m, 2H)。 訂 京 經濟部中央榡準局員工消費合作钍印製 C步驟.N-(N-乙醯基-駱胺醯基-纈胺醯盖-wl可基)-4-胺基- 氧基-2-闕基-四氛啥喊 N-乙醯基-輅胺醯基-纈胺酸(464毫克,1.44毫莫耳)及N-哌可基-4-胺基-5-苄氧基-2-酮基四氫呋喃(412毫克,1.3毫 莫耳)溶於各毫升之二甲替甲醢胺及二氣甲烷中,再冷卻 至〇eC。冷卻溶液中加入卜羥基苯並三唑(HOBT: 210毫克 ,1.56毫莫耳)再加1-(3-二甲胺基丙基)-3·乙基碳化二亞膣 鹽酸(EDC : 326毫克,1.7毫莫耳)。於攪拌18小時後,混 合物以乙酸乙酯稀釋,再以水,10%硫酸氫鈉,10%碳酸 氫鈉,及水洗滌3有機層濃缩生成粗製固鳢,再以快速層 析(Si02)纯化並以94:6:1的(二氣‘甲烷:異丙醇:吡啶)溶雞可 生成370毫克標題化合物。 iH NMR (500 MHz, CD3〇D(呈非對映立體異構物及幾何 異構物型))&amp; 7.35 (m,5H),7.05 (m,2H),6.68 (m,2H),5.65 1 321 - 本紙伕尺度通用中gS家標孪(CNS ) A4規格(210X297公釐) 1235157 經涛部中央標孪局貝工消費合作社印¾ Λ7 _ B7五、發明説明(319) &amp; 5.25 (m, 1H), 4.9-3.95 (m, 8H), 3.4-2.6 (m, 4H), 2.5-2.1 (m5 1H)? 1.98 (s, 1H), 1.9 (s, 1H), 1.85 (s, 1H), 1.8-1.6 (m, 2H), 1.55-1.3 (m, 4H), 0.95-0.85 (m, 6H) ^ ’ D步驟· N彳N-乙醯基·辂胺醯基-纈胺醯基-哌可基 脖裏-4-酮基丁酸 於100毫克N-(N-乙醯基-酪胺醯基-纈胺醯基-哌可基)-4-胺基-5-芊氧基-2-酮基四氫呋喃於10毫升甲醇之溶液中, 加入60毫克Pd(OH)2/C,且混合物置於汽球之氫大氣中a 混合物經由Celite過;慮,並丨農縮生成白色固體。此粗製固 體溶於2毫升甲醇中,再以二乙醚研磨生成26毫克的標題 化合物3 [H NMR (500 MH2, CD3OD(呈非對映立體異構物以及幾 何異構物型)&amp; 7.1 (m, 2H), 6.7 (m, 2H), 5.2 (bi*· m,1H), 4.8-3.6 (m, 6H), 3.2-2.5 (m, 4H), 2·5·2·1 (m,1H),1·95 (三個 s, 3Η)1·9-1·3 (m, 6H),1·卜0·7 (m,6H)。 Κ^· Ν·「Ν-乙醢基-酪胺醢基-纈胺醢基-(4-芊氧基)脯铵醯基1 胺基-4-辆基丁酸° A步驟· Ν-(Ν·烯丙氧羰基-4-芊氧基脯胺醢基)-3-按基-4·酮基丁酸第三-丁酯半卡巴腙 標題化合物之製備係將N-烯丙氧羰基-4-芊氧基脯铵酸及 3-胺基·‘酮基丁酸第三-丁酯丰+巴腙(T.L. Graybill et. al., Abstracts of papers, 206th National Meeting of the American Chemical Society, Abstract MEDI-235。 Chicago, IL. (1993)) 在如上報告(化合物H,C步驟)之相似肽偶合條件下反應s •322- (請先閣讀背面之注意事項1235157 Λ7 B7 I ...... Ϋί s! 1 · —I— I- I ---- Η1 V. Description of the invention (318) 氲 Bite reading (654¾ brother) 25% trifluoroacetic acid dissolved in 15 ml In dichloromethane, the mixture was stirred and stirred under a room stream to form a gelatinous residue. The residue was dissolved in dichloromethane and washed with 10% sodium bicarbonate. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to give 422 mg of the title compound as a brown solid 5 lU NMR (500 MHz, CDC13) &amp; 7.38 (m, 5H), 7.15 (d, lH), 5.55 (d, 1H), 4.95-4.8 (m, 1H), 4.78 (m, 1H), 4.65 (d, 1H), 4.45 (m, 1H), 3.2 (m, 0.5H), 3.05 (m, 0.5 H), 2.95 (m, 0.5H), 2.85 (m, 0.5H), 2.65 (m, 1H), 2.55-2.38 (m, 1H), 1.95 (m, 1H), 1.8 (m, 1H), 1.6 (m, 2H), 1.38 (m, 2H). D-Beijing Ministry of Economic Affairs, Central Bureau of Associate Bureau, consumer cooperation, printing step C. N- (N-Ethyl-carbamoyl-valine-cap-wlco) -4-amino-oxy-2 -Fluorenyl-tetrahydrobenzyl-N-ethylfluorenyl-fluorenaminefluorenyl-valinic acid (464 mg, 1.44 mmol) and N-pipecolyl-4-amino-5-benzyloxy-2 -Ketotetrahydrofuran (412 mg, 1.3 mmol) was dissolved in dimethylformamide and digasmethane in each milliliter and cooled to 0eC. To the cooled solution was added hydroxybenzotriazole (HOBT: 210 mg, 1.56 mmol) and 1- (3-dimethylaminopropyl) -3 · ethylcarbodiimide hydrochloride (EDC: 326 mg , 1.7 millimoles). After stirring for 18 hours, the mixture was diluted with ethyl acetate, washed with water, 10% sodium bisulfate, 10% sodium bicarbonate, and water. The organic layer was concentrated to give a crude solid, and then subjected to flash chromatography (Si02) Purified and dissolved in 94: 6: 1 (digas'methane: isopropanol: pyridine) to produce 370 mg of the title compound. iH NMR (500 MHz, CD3OD (as diastereoisomeric and geometric isomers)) &amp; 7.35 (m, 5H), 7.05 (m, 2H), 6.68 (m, 2H), 5.65 1 321-General paper gS standard (CNS) A4 size (210X297 mm) 1235157 Printed by the Shell Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ¾ 7 _ B7 V. Description of the invention (319) &amp; 5.25 ( m, 1H), 4.9-3.95 (m, 8H), 3.4-2.6 (m, 4H), 2.5-2.1 (m5 1H)? 1.98 (s, 1H), 1.9 (s, 1H), 1.85 (s, 1H ), 1.8-1.6 (m, 2H), 1.55-1.3 (m, 4H), 0.95-0.85 (m, 6H) ^ 'DStepN 彳 N-Ethylamido -Piperidinyl-4-ketobutyric acid in 100 mg of N- (N-ethylamido-tyrosinamido-valinamido-pipecoyl) -4-amino-5-methoxy To a solution of -2-ketotetrahydrofuran in 10 ml of methanol, 60 mg of Pd (OH) 2 / C was added, and the mixture was placed in a hydrogen atmosphere of a balloon. The mixture was passed through Celite, and it was reduced to a white solid. . This crude solid was dissolved in 2 ml of methanol and triturated with diethyl ether to give 26 mg of the title compound 3 [H NMR (500 MH2, CD3OD (as diastereoisomeric and geometric isomers) & 7.1 ( m, 2H), 6.7 (m, 2H), 5.2 (bi * · m, 1H), 4.8-3.6 (m, 6H), 3.2-2.5 (m, 4H), 2.5 · 2.1 · 1 (m, 1H), 1.95 (three s, 3Η), 1 · 9-1 · 3 (m, 6H), 1 · 0 · 7 (m, 6H). Κ ^ · Ν · 「Ν- 乙 醢 基- Tyrosamidine-valineamidine- (4-amyloxy) prolaminoamidine 1 Amine-4-carboxybutyric acid ° A Step · Ν- (Ν · Allyloxycarbonyl-4-amyloxy Proline sulfonyl) -3-yl-4.ketobutyric acid third-butyl hemicarbazone title compound was prepared by mixing N-allyloxycarbonyl-4-fluorenylproline and 3-amine T'-ketobutyric acid tertiary-butyl ester + Babb (TL Graybill et. Al., Abstracts of papers, 206th National Meeting of the American Chemical Society, Abstract MEDI-235. Chicago, IL. (1993)) Reaction under similar peptide coupling conditions as reported above (compounds H, C steps) • 322- (Please read the precautions on the back first

本瓦) 訂 本·长法尺度逑周中S國家揉孪(CNS ) A4規格(2丨0X297公釐) 320、1235157 五、發明説明( 經濟部中央標準局負工消费合作社印裝 lR NMR (500 MHz, CDC13) &amp; 9.05 (br. s, lH), 7.85 (br. m, 1H), 7.4-7.2 (m, 5H), 7.15 (br. s, 1H), 6.55 (br. s, 1H), 5.9 (m, 1H), 5.1-4.9 (br. m, 2H), 4.65-4.4 (m, 4H), 4.2 (br. m, lH), 3.75-3.5 (m, 2H), 2.75-2.55 (m,2H),2.5 (br· m,1H), 2.2) (br· m, 1H) 1.4 (s, 9H)- B步驟· 乙醢基-輅胺醯基-纈 脯胺醯基))-3-胺基-4-酮丁笔呈 標題化合物之製備係將N-乙-醯基··酪胺醯基-顯腔毅與Ν· IN-烯丙氧羰基-4-;氧基脯胺醯基)-3-胺基I酮基丁跋第 三-丁酯半卡巴腙,由化合物Η,Α步驟所報告之反應條件 下反應3 lH NMR (500 MHz, CD3〇D) &amp; 7.35-7.2 (m, 6H), 7.0 (d, 2H), 6.65 (d, 2H), 4.85 (m, 1H), 4.6-4.45 (m, 4H), 4.3 (br. m, 1H), 4.15 (m, 1H), 3.7 (m, 1H), 2.95 (m, lH), 2.75-2.6 (m, 3H), 2.35 (m, 1H), 2.1 (m, 1H), 1.9 (s, 3H), 1.4 (s, 9H), 0.95 (d,3H),0.90 (s,3H)。 C步樣· N-(N-乙縫基·路胺酷基-綴胺趋基-(4-字乳基^ 脯胺醢基))-3-胺基-4-酮基丁酸 N-(N-乙殖基-路胺酷基··領胺臨基-(4 -卞乳基鋪按睡基))· 3·胺基一-明基丁酸第三-丁醋丰卡巴脖(2 70毫克)溶於1〇毫 升25%三氟乙酸於二氯曱烷,再於室溫下攪拌3小時。昆 合物濃缩以生成固體殘留物3殘留物溶液10毫升的甲醇: 乙酸:37%甲璲(3:1:1)混合物中,再於室溫下攪掉丨小時。落 323 本紙任尺度適用中ϋ國家標孪(CNS ) A4規洛(2丨0X297公釐) (請先閱讀背ώ之注意事項寫本頁) ^1.Benwa) Revision · Long French scale: S-country (CNS) A4 specification (2 丨 0X297 mm) in the middle of the week 320, 1235157 V. Description of the invention (printed by the Central Bureau of Standards, Ministry of Economic Affairs, Consumer Cooperatives, printed lR NMR ( 500 MHz, CDC13) &amp; 9.05 (br. S, lH), 7.85 (br. M, 1H), 7.4-7.2 (m, 5H), 7.15 (br. S, 1H), 6.55 (br. S, 1H ), 5.9 (m, 1H), 5.1-4.9 (br. M, 2H), 4.65-4.4 (m, 4H), 4.2 (br. M, lH), 3.75-3.5 (m, 2H), 2.75-2.55 (m, 2H), 2.5 (br · m, 1H), 2.2) (br · m, 1H) 1.4 (s, 9H)-B step · Ethyl-fluorenylamino-valpromininyl)) -3-Amino-4-ketobutyl pen was prepared as the title compound by combining N-ethyl-fluorenyl · · tyraminofluorenyl-Xianweiyi with N · IN-allyloxycarbonyl-4-; Amine group) -3-Amino I Ketobuta tertiary-butyl ester hemi-carbazone, reacted under the reaction conditions reported by compound VII, step A 3 lH NMR (500 MHz, CD30D) &amp; 7.35 -7.2 (m, 6H), 7.0 (d, 2H), 6.65 (d, 2H), 4.85 (m, 1H), 4.6-4.45 (m, 4H), 4.3 (br. M, 1H), 4.15 (m , 1H), 3.7 (m, 1H), 2.95 (m, lH), 2.75-2.6 (m, 3H), 2.35 (m, 1H), 2.1 (m, 1H), 1.9 (s, 3H), 1.4 ( s, 9 H), 0.95 (d, 3H), 0.90 (s, 3H). Step C · N- (N-Ethylamino · Lumidyl-Amine-Cyto- (4-word lactyl ^ prolyl))-3-amino-4-ketobutanoic acid N- (N-Ethyl-L-Crylamyl · · Leeminyl- (4 -Hydroxylactyl)-· Amino-Benyl Butyric Acid Tertiary-Butyl Acetate Fungaba Neck (2 70 mg) was dissolved in 10 ml of 25% trifluoroacetic acid in dichloromethane and stirred at room temperature for 3 hours. The compound was concentrated to produce a solid residue 3 residue solution in 10 ml of a methanol: acetic acid: 37% formamidine (3: 1: 1) mixture, and stirred at room temperature for 丨 hours. Drop 323 This paper is applicable to the Chinese National Standard (CNS) A4 gauge (2 丨 0X297 mm) (please read the precautions on the back page first to write this page) ^ 1.

•IT• IT

1235157 A7 B71235157 A7 B7

五、發明説明(321 合物滚縮且生成的殘留物以快速層析(Si〇j純化,以二氯 甲境/曱酵/曱酸(1〇〇:5:〇·5)溶離以生成37毫克標題化合物, $ NMR (500 MHz,CD3〇D(呈1:1半縮醛之非對峡立韹異 構混合物))&amp; 7.4-7.25 (m,5H),7.0 (d,2H),6.65 (d,2H), 4.65-4.05 (m, 7H), 3.75-3.4 (m, 2H), 3.05-2.3 (m, 5H), 2.2-1.95 (m,2H), 1.90 (s, 3H), 1.0 (d, 3H), 0.95 (d, 3H)。V. Description of the invention (321 compound was rolled and the resulting residue was purified by flash chromatography (Si0j, dissolved in dichloromethane / zyme / gallic acid (100: 5: 0.5)) to produce 37 mg of the title compound, $ NMR (500 MHz, CD30D (a non-parastilbene isomeric mixture as a 1: 1 hemiacetal)) &amp; 7.4-7.25 (m, 5H), 7.0 (d, 2H) , 6.65 (d, 2H), 4.65-4.05 (m, 7H), 3.75-3.4 (m, 2H), 3.05-2.3 (m, 5H), 2.2-1.95 (m, 2H), 1.90 (s, 3H) , 1.0 (d, 3H), 0.95 (d, 3H).

45 44 (請先閱讀背面之:V〗意事項wmpk本頁) 装45 44 (Please read the back of the first: V 〖Impact wmpk page)

4646

*1T (a) X = 〇 (b) X = H2 (IS, 9S) 6,10-二酮基-八氫-9-(3-苯基丙醢胺基)·6Η·嗒嘩並 [1,24][1,2]二氮雜箪-1-羧酸第三:丁酯(4乜)。* 1T (a) X = 〇 (b) X = H2 (IS, 9S) 6,10-diketo-octahydro-9- (3-phenylpropylamido) · 6Η · , 24] [1,2] Diazapyridine-1-carboxylic acid Third: Butyl ester (4 乜).

(IS, 9S) 9-胺基-6,10-二嗣基-八氫答啩並[l,2-a][l,2]二 氣雜箪小羧酸第三·丁酯(690毫克;2.32毫莫耳;GB 2128984)於二w号燒(16毫升)及水(4毫升)之溶液,在0°C下加 -324 本纸伕尺度適用中3国家標孪(CNS ) A4規格(2丨0X297公'变)(IS, 9S) 9-Amino-6,10-diamidino-octahydropyrido [l, 2-a] [l, 2] Digas heterocarboxylic small tert-butyl ester (690 mg ; 2.32 millimoles; GB 2128984) in a solution of No. 2 (16 ml) and water (4 ml), add -324 at 0 ° C. This paper is suitable for China 3 national standard (CNS) A4 specifications. (2 丨 0X297 male 'change)

經濟部中央標準局貝工消费合作社印裝 ------ 1235157 A/ B7 五、發明説明(322) 入固禮碳酸氫鈉(292毫克;3·48毫莫耳)再逐滴加入苯基 丙聽氯(470毫克:2.78毫莫耳)3混合物在室溫下攪掉2小 時,再加入更多的碳酸氫鈉(200毫克;2·#毫莫耳)及3·苯 基丙睡氯(丨⑼毫克;〇·6毫莫耳)°混合物再於室溫下攪摔 2h,以乙酸乙醋(50毫升)稀釋’以飽和的後酸氫鈞洗綠(2 X25毫升),再乾燥(MgS〇4)並濃縮3殘留物以快速層析廷 化(0-50%乙酸乙酯/氯仿)且最後以乙酸研磨使結晶,可生 成 S60毫克(86%)白色固醴 nip. 137-138T ; [a]D23-95.1° (c 0.549, CH2Ci2); IR (KBr) 3327,1736, 1677,1664,1536,1422, 1156; lH NMR (CDC13) &amp; 7.24 (5H, m), 6.50 (1H, d, J=7.5), 5.24 (1H, m), 4.90 (1H, m), 4.60 (1H, m), 3.44 (1H, m), 2.93 (2H? m)? 2.84 (lH, m), 2.64 (1H, m), 2.54 (2H, m), 2.26 (2H, m),1.70 (4H, m),1·70 (9H,s)· MS (FAB, m/z):430 (NT + 1), 374, 242, 105, 91 , .超濟部中夫·樣率局員工消費合作.杜印裏 (請先閱讀背t&amp;之注意事項本頁) (IS, 9S)八氫-10-嗣基-9·(3-本基丙驢基腔基)-6H·^ ρ井並-[l,2-a][l,2]二氮雜革-卜羧酸第三-丁酯(44b)如44a般製備自 (1S,9S) 9-胺基-八氫-10-酮基-6H-嗒啩並[l,2-a][l,2]二氮華 箪-1-羧酸第三-丁酯(Attwood et al·,J. Chem. Soc. Perkin 1 , pp. 101 1-19 (1986)),可生成810毫克(81%)無色治彳立]^^^ 33.53 (c 0.545, CH.Cl^; IR (film) 3334, 2935, 1737, 1728, 1659, 1642; lH NMR (CDC13) &amp; 7.24 (5H, m), 6.75 (1H, d, J=6.7), 5.27 (1H,m), 4.92 (1H, m), 3·39 (1H, m), 3·〇3 (4H, m), 2.55 (3H, m), 2.33 (1H, m), 2.17 (1H, m), 1.80 (5H, m), 1.47 (9H,s), 1.39 (1H, m) e MS (FAB, m/z):416 (M++ l), 360, •325- ( CNS ) ( 210X297/^ ) M濟部中央揉準局员工消费合作社印製 1235157 B7 五、發明説明(323) 211,Η3, 97。 (15,95)6,10-二酌基-八氮-9-(3-禾基円运膝基)-611-:7答唯並 [1,24][1,2]二氮韓苯-1-幾酸(45&amp;)。對(15,9旬6,10-二酮基-八氫-9-(3·苯基丙醯胺基)·6Η-嗒啩並[l,2-aHl,2]二氮雜箪-卜複酸第三-丁薛(44a) (8 00毫克;1.863毫莫耳)於無水二氯 甲烷(5毫升)在0°C之溶液中加入三氟醋酸(5毫升)。溶液在 室溫下授摔3小時再濃縮。加無水乙鞋(10毫升)至殘留物 中再於眞空下移去。此過程重覆三次以生成晶狀固禮。固 鱧以乙醚研磨並過濾生成590毫克(85%)的白色晶狀固鳢: πι·ρ· 196·197·5Χ:;[泛]D23-129.5。(c0.2,CH3〇H); IR(KBr) 3237, 1729, 1688, 1660, 1633, 1574, 1432, 1285, 1205; lR NMR (CD3OD) &amp; 8.28 (1H, d, J=7.4), 7.22 (5H, m), 5.32 (1H, dd, J=5.9, 2.9), 4.75 (1H, m), 4.51 (1H, m), 3.50 (1H, m), 3.01 (1H, m), 2.91, (2H, m), 2.55 (2H, m), 2.29 (3H, m), 1.95 (2H, m),1·71 (2H, m)。分析 C19H23N3〇5之計算値:C,61.12; H,.6.21; N,11.25。實測値:C, 60.80; H,6.28 : N,10.97。 MS (FAB, m/z) 374 (M++ 1),242, 105, 91。 (1S,9S)八氫-10-酮基-9-(3-苯基丙醯胺基)-6H-嗒呼並[1,2-a][l,2]二氮雜箪-卜羧酸(45b)。製備自(IS, 9S)八氫-10·酮基 -9-(3-苯基丙睡胺基)-6Η·^ α井並[l,2-a][l,2]二氮雜苯-1-¾ 酸第三-丁酯(44b),係以化合物'45a所述之方法,生成657 毫克(96%)的 45b,呈晶狀固體:mp.l98-202eC;[泛]d23-86.23 (c 0.5, CH3OH); IR (KBr) 3294, 2939, 1729, 1645, 1620, 1574, 1453, 1214; lR NMR (CD3OD) &amp; 7.92 (1H, d, J=7.9), 7.20 -326 - 本纸伕尺度適用中國國家樣準(CNS ) A4規格(2丨OX 297公釐)Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ------ 1235157 A / B7 V. Description of the invention (322) Guli sodium bicarbonate (292 mg; 3.48 mmol) is added dropwise Chlorine (470 mg: 2.78 mmol) 3 mixture was stirred at room temperature for 2 hours, then more sodium bicarbonate (200 mg; 2. # mmol) was added and 3.phenylpropane Chlorine (丨 ⑼mg; 0.6 mmol) ° C The mixture was stirred at room temperature for 2h, diluted with ethyl acetate (50 ml), washed with saturated hydrogen chloride (2 x 25 ml), and then 137 Dry (MgS04) and concentrate the 3 residues for flash chromatography (0-50% ethyl acetate / chloroform) and finally triturate with acetic acid to crystallize. S60 mg (86%) of white solid nip. 137. -138T; [a] D23-95.1 ° (c 0.549, CH2Ci2); IR (KBr) 3327, 1736, 1677, 1664, 1536, 1422, 1156; lH NMR (CDC13) &amp; 7.24 (5H, m), 6.50 (1H, d, J = 7.5), 5.24 (1H, m), 4.90 (1H, m), 4.60 (1H, m), 3.44 (1H, m), 2.93 (2H? M)? 2.84 (lH, m ), 2.64 (1H, m), 2.54 (2H, m), 2.26 (2H, m), 1.70 (4H, m), 1.70 (9H, s), MS (FAB, m / z): 43 0 (NT + 1), 374, 242, 105, 91,. The consumer cooperation of Zhongfu · Sarate Bureau of Chaoji Ministry. Du Yinli (please read the precautions on this page first) (IS, 9S) Octahydro-10-fluorenyl-9 · (3-benzylpropionyl) -6H · ^ ρ well- [l, 2-a] [l, 2] diaza leather-dicarboxylic acid Tri-butyl ester (44b) is prepared like (44a) from (1S, 9S) 9-amino-octahydro-10-keto-6H-dapyrono [l, 2-a] [l, 2] diazepine Tertiary-1-butylcarboxylic acid (Attwood et al., J. Chem. Soc. Perkin 1, pp. 101 1-19 (1986)), yielding 810 mg (81%) of colorless treatment ^^^ 33.53 (c 0.545, CH.Cl ^; IR (film) 3334, 2935, 1737, 1728, 1659, 1642; lH NMR (CDC13) &amp; 7.24 (5H, m), 6.75 (1H, d, J = 6.7), 5.27 (1H, m), 4.92 (1H, m), 3.39 (1H, m), 3.03 (4H, m), 2.55 (3H, m), 2.33 (1H, m) , 2.17 (1H, m), 1.80 (5H, m), 1.47 (9H, s), 1.39 (1H, m) e MS (FAB, m / z): 416 (M ++ l), 360, • 325- ( CNS) (210X297 / ^) M Printed by the Consumer Cooperatives of the Central Bureau of the Ministry of Economic Affairs of the People's Republic of China 1235157 B7 V. Invention Description (323) 211, Η3, 97. (15,95) 6,10-Dikisyl-octazine-9- (3-Hydroxybenzyl) -611-: 7 Answers [1,24] [1,2] Diazabenzyl -1-Chinic acid (45 &amp;). P- (15,9,6,10-diketo-octahydro-9- (3 · phenylpropionamido) · 6Η-dapyrido [l, 2-aHl, 2] diazepine-bu Tris (4-a) tetracarboxylic acid (800 mg; 1.863 mmol) was added to a solution of anhydrous dichloromethane (5 ml) at 0 ° C. Trifluoroacetic acid (5 ml) was added. The solution was at room temperature. Allow to fall for 3 hours and concentrate. Add anhydrous B shoes (10 ml) to the residue and remove under empty space. This process is repeated three times to form a crystalline solidification. The solid is ground with ether and filtered to produce 590 mg (85 %) Of white crystalline solids: π · ρ · 196 · 197 · 5 × :; [Pan] D23-129.5. (C0.2, CH3〇H); IR (KBr) 3237, 1729, 1688, 1660, 1633 , 1574, 1432, 1285, 1205; lR NMR (CD3OD) &amp; 8.28 (1H, d, J = 7.4), 7.22 (5H, m), 5.32 (1H, dd, J = 5.9, 2.9), 4.75 (1H , m), 4.51 (1H, m), 3.50 (1H, m), 3.01 (1H, m), 2.91, (2H, m), 2.55 (2H, m), 2.29 (3H, m), 1.95 (2H , m), 1.71 (2H, m). Analysis of the calculation of C19H23N305: ,: C, 61.12; H, .6.21; N, 11.25. Measured 値: C, 60.80; H, 6.28: N, 10.97. MS (FAB, m / z) 374 (M ++ 1), 242, 105, 91. (1S, 9S) Hydrogen-10-keto-9- (3-phenylpropanamido) -6H-daphtho [1,2-a] [l, 2] diazapyridine-carboxylic acid (45b). Preparation From (IS, 9S) octahydro-10 · keto-9- (3-phenylpropanylamino) -6 ^ · ^ α wells [l, 2-a] [l, 2] diazabenzene- 1-¾ acid tert-butyl ester (44b), produced by the method described in compound '45a, yielding 657 mg (96%) of 45b as a crystalline solid: mp.l98-202eC; [PAN] d23-86.23 (c 0.5, CH3OH); IR (KBr) 3294, 2939, 1729, 1645, 1620, 1574, 1453, 1214; lR NMR (CD3OD) &amp; 7.92 (1H, d, J = 7.9), 7.20 -326-this Paper reel size applies to China National Standard (CNS) A4 (2 丨 OX 297 mm)

A7 B7 1235157 五、發明说明(324) (5H, m)? 5.29 (1H? m), 4.90 (1H, m), 3.47 (1H, m), 3.08 (2H, m), 2.90 (2H, m), 2.55 (3H, m), 2.36 (1H, m), 1.81 (5H, m), 1.43 (2H,m)。MS (FAB, m/z) 360 (M++ 1),2ή,143,9卜 [3S,2R,S,(1S,9S)] N-(2-苄氧基-5-酮四氫呋喃-3-基)·ό,1〇· 二酮基-八氫-9-(3·苯基丙醯胺基)-6Η-嗒呼並H,2-a][l,2]二 氮雜箪-1-羧醯胺(46a)。對(IS, 9S) 6,10-二酮基-八氫-9-(3-苯基-丙醯胺基)-6H-嗒畊並[l,2-a][l,2]二氮雜箪-1-羧酸 (45a)(662毫克;1.773毫莫耳)於無水二氣甲烷(9毫升)及無 水二甲替甲醯胺(3毫升)之溶液中,於室溫下加入雙(三苯 膦)鈀化氣(30毫克)及(3S, 2R,S)-3-烯丙氧羰基胺基-2-芊氧 基-5-嗣基四氫咬喃(Chapman, Bioorg· Med· Chem· Lett丄,2, pp. 613-18 (1992))(568毫克;1.95毫莫耳)再逐滴加入氫化 三正丁錫(1.19克:4.09毫莫耳)。加1-羥基-苯並三唑(479 毫克,3.546毫莫耳)至混合物中,且混合物冷卻至再加 1-(3·二曱胺基丙基)-3-乙基碳化二亞胺鹽酸(408毫克: 2.128毫莫耳)。混合物在室溫下攪摔3.25小時,再以乙酸 乙酯(50毫升)稀釋,以稀鹽酸(20毫升)洗二次,以鉋和的 碳酸氫鈉洗二次(20毫升),以鹽水洗一次再乾燥(MgS04)及 濃缩β生成的油以快速層析純化(0-100%乙酸乙酯/氣仿)生 成810毫克(81%)的46a,呈異頭物之混合:mp· 92-94eC; IR (KBr) 33 1 1, 1791,1659, 1651, 153·6; lH NMR (CDC13) &amp; 7·49, 6.56 (1H, 2d, J=6.7, 7.8), 7.29 (10H, m), 6.37, 6.18 (1H, 2d, J-7.7, 7.6), 5.56, 5.34 (1H, d, s, J=5.2), 5.08-4.47 (6H), 3.18-2.80 (5H), 2.62-2.28 (5H),2·04·1·53 (5H)。 MS (FAB, m/z), -327 - 本紙張尺度適用中国國家標李(CNS ) A4規格(210X297公釐) ' (請先聞讀背面之注意事項再填寫太頁) 4 訂 經濟部中央糅準局負工消費合作社印¾ ΐί濟部中夬糅準局员工消费合作杜印¾ 1235157 Λ7 B7 五、發0说明(325) 563 〇Γ + 1),328, 149, 9卜 [3S,2R,S,(IS, 9S)] Ν-(2·苄氧基〇-酮四氫呋嘀-3-基)八氫-10-酮基-9-(3-苯基丙醢胺基)-61^嗒嗜並[1,;^4][1,2]二氮雜 箪-卜致SS胺(46b),製備自45b,以46a所述方法可生成790 毫克(96%)的玻璃狀:mp 58-6(TC; IR (KBr) 3316,2940,1793, 1678, 1641, 1523, 1453, 1120; !H NMR (CDC13) &amp; 7.28 (10H, m)? 6.52, 6.42 (1H, 2d, J=7.2, 7.1), 5.53, 5.44 (1H, d, s, J=5.2), 5.35 (1H, m), 4.6-4.9, 4.34 (4H, m), 3.1-2.8 (6H, m), 2.6-2.1 (7H),1.95-1.05 (5H)。 MS (FAB, m/z),549 (M+ + 1), 400, 310, 279, 91,A7 B7 1235157 V. Description of the invention (324) (5H, m)? 5.29 (1H? M), 4.90 (1H, m), 3.47 (1H, m), 3.08 (2H, m), 2.90 (2H, m) , 2.55 (3H, m), 2.36 (1H, m), 1.81 (5H, m), 1.43 (2H, m). MS (FAB, m / z) 360 (M ++ 1), 2 price, 143, 9 [3S, 2R, S, (1S, 9S)] N- (2-benzyloxy-5-one tetrahydrofuran-3-yl ) · , 1 ·· Diketo-octahydro-9- (3 · phenylpropionamido) -6Η-daphthoH, 2-a] [l, 2] diazepine-1- Carboxamide (46a). P- (IS, 9S) 6,10-diketo-octahydro-9- (3-phenyl-propanamido) -6H-thalco [l, 2-a] [l, 2] diazepine Hexa-1-carboxylic acid (45a) (662 mg; 1.737 mmol) in a solution of anhydrous digas methane (9 ml) and anhydrous dimethylformamidine (3 ml). (Triphenylphosphine) palladium (30 mg) and (3S, 2R, S) -3-allyloxycarbonylamino-2-fluorenyl-5-fluorenyltetrahydrooctane (Chapman, Bioorg · Med Chem Lett 丄, 2, pp. 613-18 (1992)) (568 mg; 1.95 mmol) and tri-n-butyltin hydride (1.19 g: 4.09 mmol) was added dropwise. Add 1-hydroxy-benzotriazole (479 mg, 3.546 mmol) to the mixture, and cool the mixture to add 1- (3. Diamidopropyl) -3-ethylcarbodiimide hydrochloride (408 mg: 2.128 mmol). The mixture was stirred at room temperature for 3.25 hours, diluted with ethyl acetate (50 ml), washed twice with dilute hydrochloric acid (20 ml), washed twice with planed sodium bicarbonate (20 ml), and washed with brine. The oil which was re-dried once (MgS04) and concentrated β was purified by flash chromatography (0-100% ethyl acetate / aerosol) to yield 810 mg (81%) of 46a, which was an anomer mixture: mp · 92 -94eC; IR (KBr) 33 1 1, 1791, 1659, 1651, 153.6; lH NMR (CDC13) &amp; 7.49, 6.56 (1H, 2d, J = 6.7, 7.8), 7.29 (10H, m ), 6.37, 6.18 (1H, 2d, J-7.7, 7.6), 5.56, 5.34 (1H, d, s, J = 5.2), 5.08-4.47 (6H), 3.18-2.80 (5H), 2.62-2.28 ( 5H), 2.004.53 (5H). MS (FAB, m / z), -327-This paper size is applicable to Chinese National Standard Li (CNS) A4 size (210X297 mm) '(Please read the notes on the back before filling in the page) 4 Order the Central Ministry of Economic Affairs Printed by the Consumer Goods Cooperative of the Zhuanju Bureau ¾ ΐ ¾Industry Consumers' Cooperative of the Ministry of Economic Affairs of the People's Republic of China Du Yin ¾ 1235157 Λ7 B7 V. Issue 0 Instructions (325) 563 〇Γ + 1), 328, 149, 9b [3S, 2R, S, (IS, 9S)] N- (2 · benzyloxy0-ketotetrahydrofuran-3-yl) octahydro-10-keto-9- (3-phenylpropanamido) -61 ^ Da [1,; ^ 4] [1,2] diazapyridine-Bus SS amine (46b), prepared from 45b, can produce 790 mg (96%) of glass by the method described in 46a Status: mp 58-6 (TC; IR (KBr) 3316, 2940, 1793, 1678, 1641, 1523, 1453, 1120;! H NMR (CDC13) &amp; 7.28 (10H, m)? 6.52, 6.42 (1H, 2d, J = 7.2, 7.1), 5.53, 5.44 (1H, d, s, J = 5.2), 5.35 (1H, m), 4.6-4.9, 4.34 (4H, m), 3.1-2.8 (6H, m) , 2.6-2.1 (7H), 1.95-1.05 (5H). MS (FAB, m / z), 549 (M + + 1), 400, 310, 279, 91,

[jS (lS,9S)] j-(6,10 -—銅基-八氣-9-(3·本基两 Ss 脖基)-6H-嗒啩益[l,2-a][l,2]二氮雜箪-卜羧醯胺基)-4-酮基丁酸(47a) 。[3S, 2R,S,(IS, 9S)] N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6,10-二酮基-八氫-9-(3·苯基丙醯胺基)-6H-嗒畊並[1,2-a][l,2]二氮雜箪-1-羧醯胺(46a)(205毫克:0.364毫莫耳), 10% Pd/c(200毫克)及甲醇(20毫升)的混合物在氫下之大氣 壓力下攪捽5小時。混合物過濾再濃缩生成154毫克(90%) 的波璃狀:mp. 116-118eC;[泛]D23-140。(c 0·1,CH3OH); IR (KBr) 3323 (br), 1783, 1731, 1658, 1539, 1455, 1425; NMR (CD3OD) &amp; 7·21 (5H, m), 5·17 (1H, m), 4.73 (1H,m), 4.50 (2H, m), 4.23 (1H, m), 3.38 (1H, m), 3.06 (1H, m), 2.91 (2H, m), 2.73-2.1 8 (6H, m)及 2.01-1.59 (5H,m)。 分析 C23H27N4O7 + Η]〇之計异値:C,56.32; Η, 6· 16; N,11 ·42 3 耳 測値:C,56·29; Η,6.11; Ν,11·25。MS (FAB, m/z) 473 (Μ+ + -328- 本纸乐尺度逑用宁國國家標準(CNS ) A4規接(2丨0X297公釐) (請先聞讀背®之注意事項再本頁) 訂 1235157 - A / B7 五、發明説明(327) 义2-(3-苄氧談基按基-1,2-二氫-2-酮基-1-〃比咬基)乙盛基-3-胺基-5-(2,6-二氯-芊醢氧基)4-酮基-戊酸第三-丁酯(56a)。 醋酸(55a)(WO 93 21213)於THF (2毫升)在室溫下授摔並以 1-經基苯並三峻(60毫克,〇·448毫莫耳)及二曱腔基丙基-3-乙基竣化二亞胺鹽酸(47毫克’ 〇.246毫莫耳)處理3 5分鐘 後加水(2滴)並繼續攪捽20分鐘3加入雙(三苯膦)纪(Π)化 氣(6毫克)缮以3-(烯丙氧談胺基)·4·酮基-5-(2,6-二氯芊睡基 -氧基)戊酸第三-丁酯(W0 93 16710)(103毫克,〇·224毫莫 耳)於THF (1毫升)之溶液。在室溫下以1小時逐滴加入氫化 三丁錫(0.09毫升’ 0.336毫莫耳)。混合物再授掉3小時並 倒入乙酸乙薛中,以1M HC1 ’ NaHC03水溶液’鹽水洗綠 ,於MgS04上乾澡再眞空濃縮。殘留物以戊燒研磨再丢棄 上清液。留下的固體以快速層析純化(50%乙酸乙酯/己烷) 生成標題化合物92毫克(63%),呈無色油狀:[a]D29-29.6° (c 1.1, CR2C\^ IR (film) 3377, 3365, 3332, 3312, 1733, 1691, 1650, 1599, 1515, 1366, 1261, 1153, 1068, 747; !H NMR (CDC13) &amp; 8.09 (1H, d, J=6.8), 7·84 (1H,s), 7_58 (1H, d, &gt;8·3),7·33 (8H, m), 7·02 (1H, dd,J=6.9, 1.7),6·33 (1H,t, J=7.2),5.20 (2H, s),5-12 (2H, m),4·89 (1H,dt),4·65 (2H,m), 經濟部中央標準局貝工消费合作杜印¾ 2.80 (2H,m),1·38 (9H,s)。 Ν·2·(6-芊基-1,2·二氩-2-酮基·3·(夂苯基丙醢基)胺基-1-吡啶 基)乙睦基-3-胺基- 5-(2,6- —氣;氧基)-4-嗣基-戊酸第三·丁 酯(56b),以(56a)所述方法製備,可生成標題化合物(66%) 爲無色油狀:IR(薄膜)3364, 3313, 1738, 1688, 1648, 1600, -330 - 本纸伕尺度逑用中国國家標孳(CNS ) A4規格(2丨0X297公釐) 、 1235157 A7 B7[jS (1S, 9S)] j- (6,10 -—copper-based octadecane-9- (3 · base two Ss neck bases) -6H-Dalaiyi [l, 2-a] [l, 2] Diazapyridine-p-carboxamido) -4-ketobutyric acid (47a). [3S, 2R, S, (IS, 9S)] N- (2-methoxy-5-ketotetrahydrofuran-3-yl) -6,10-diketo-octahydro-9- (3 · benzene Propyl amidino) -6H-da- [1, 2-a] [1,2] diazapyridine-1-carboxamide (46a) (205 mg: 0.364 mmol), 10% Pd / c (200 mg) and methanol (20 ml) were stirred at atmospheric pressure under hydrogen for 5 hours. The mixture was filtered and concentrated to give 154 mg (90%) of a glassy glass: mp. 116-118eC; [PAN] D23-140. (C 0 · 1, CH3OH); IR (KBr) 3323 (br), 1783, 1731, 1658, 1539, 1455, 1425; NMR (CD3OD) &amp; 7.21 (5H, m), 5.17 (1H , m), 4.73 (1H, m), 4.50 (2H, m), 4.23 (1H, m), 3.38 (1H, m), 3.06 (1H, m), 2.91 (2H, m), 2.73-2.1 8 (6H, m) and 2.01-1.59 (5H, m). Analysis of C23H27N4O7 + Η] 〇: C, 56.32; Η, 6.16; N, 11 · 42 3 ear Test: C, 56 · 29; Η, 6.11; Ν, 11.25. MS (FAB, m / z) 473 (Μ + + -328- Paper scale, Ning National Standard (CNS) A4 connection (2 丨 0X297 mm) (Please read the precautions before reading the back ® This page) Order 1235157-A / B7 V. Description of the invention (327) Meaning 2- (3-benzyloxytantyl-1,2-dihydro-2-keto-1-pyridyl) ethene 3-Amino-5- (2,6-dichloro-fluorenyloxy) 4-keto-pentanoic acid tert-butyl ester (56a). Acetic acid (55a) (WO 93 21213) in THF ( 2 ml) at room temperature and treated with 1-benzylbenzotrimethylene (60 mg, 0.448 mmol) and difluorenyl propyl-3-ethyl diimine hydrochloride (47 Mg '(.246 millimolar) treatment 3 5 minutes later add water (2 drops) and continue stirring for 20 minutes 3 add bis (triphenylphosphine) period (Π) gas (6 mg) 缮 3- (allyl Oxyamino group) · 4 · keto-5- (2,6-dichlorosulfanyl-oxy) tert-butyl valerate (W0 93 16710) (103 mg, 0.224 mmol) In THF (1 ml). Tributyltin hydride (0.09 ml '0.336 mmol) was added dropwise at room temperature over 1 hour. The mixture was drained for another 3 hours and poured into ethyl acetate, 1M HC1 ' NaHC03 aqueous solution 'brine washed green, dried on MgS04 and concentrated in air. The residue was triturated with pentagon and discarded the supernatant. The remaining solid was purified by flash chromatography (50% ethyl acetate / hexane) to generate the title Compound 92 mg (63%) as a colorless oil: [a] D29-29.6 ° (c 1.1, CR2C \ ^ IR (film) 3377, 3365, 3332, 3312, 1733, 1691, 1650, 1599, 1515, 1366 , 1261, 1153, 1068, 747;! H NMR (CDC13) &amp; 8.09 (1H, d, J = 6.8), 7.84 (1H, s), 7_58 (1H, d, &gt; 8 · 3), 7.33 (8H, m), 7.02 (1H, dd, J = 6.9, 1.7), 6.33 (1H, t, J = 7.2), 5.20 (2H, s), 5-12 (2H, m), 4.89 (1H, dt), 4.65 (2H, m), Shellfish Consumer Cooperation of the Central Bureau of Standards, Ministry of Economic Affairs, Du Yin ¾ 2.80 (2H, m), 1.38 (9H, s). Ν · 2 · (6-fluorenyl-1,2 · diargin-2-one · 3 · ((phenylphenylpropionyl) amino-1-pyridyl) ethoxy-3-amino- 5- (2,6-Gas; oxy) -4-fluorenyl-valeric acid tert-butyl ester (56b), prepared by the method described in (56a), can produce the title compound (66%) as a colorless oil: IR (thin film) 3364, 3313, 1738, 1688, 1648, 1600, -330-This paper is used in China Standard family breeding (CNS) A4 size (2 Shu 0X297 mm), 1235157 A7 B7

56 五、發明説明(328) 1566, 1514, 1433, 1369, 1254, 1152; XH NMR (CDC13) &amp; 8.40 (1H, d, J 7.6), 8.30 (1H, s), 7.28 (13H, m), 6.20 (1H, d, J=7.6), 5.12 (2H, q), 4.86 (1H, m), 4.65 (2H, q)9 4.06 (2H, s), 3.07-2.61 (6H, m), 1·39 (9H,s)。 n 先 閲 背 面 之 注 意 事 項56 V. Description of the invention (328) 1566, 1514, 1433, 1369, 1254, 1152; XH NMR (CDC13) &amp; 8.40 (1H, d, J 7.6), 8.30 (1H, s), 7.28 (13H, m) , 6.20 (1H, d, J = 7.6), 5.12 (2H, q), 4.86 (1H, m), 4.65 (2H, q) 9 4.06 (2H, s), 3.07-2.61 (6H, m), 1 39 (9H, s). n Read the notes on the back first

1« 頁 I O (a) PhCH2 cA o (b) PhCH2CH2人1 «page I O (a) PhCH2 cA o (b) PhCH2CH2

HH

H 訂H order

Ν-2-(3·苄氧羰基胺基-1,2-二氫-2-酮基-1-吡啶基)乙迻基-3· 胺基- 5-(2,6-一氯卞磁基氧基)-4·明基-戊酸(57a; OJ 3 §i 56a (210毫克,0·356毫莫耳)於二氣甲烷(〇·5毫升)冷卻至cTC , 再以三氟醋酸(0.5毫升)處理,攪拌並加溫至2〇eC歷30分鐘 。溶液於減壓下蒸發至乾,再溶於二氯甲烷中並滾缩3) 。殘留物以乙酸乙酯研磨並以乙瞇稀釋生成標題化合物 162毫克(85%)呈無色固體:111|165-81(分解);[泛]023-38.8。 (c 0.1, CH3〇H); IR (KBr) 3332, 3275, 1723, 1658, 1649, 1597, 1581, 1562, 1526, 1432, 1385, 1258, 1218, 1206; NMR (d6- DMSO) &amp; 8.96 (1H, d, J=7.3), 8.34 (1H, s), 7.85 (1H, dd, 331· 本纸伕尺度逑用中国國家標準(CNS ) A4規格(2丨0X297公没)Ν-2- (3 · benzyloxycarbonylamino-1,2-dihydro-2-keto-1-pyridyl) ethynyl-3 · amino- 5- (2,6-monochlorofluorene Alkoxy) -4 · benzyl-valeric acid (57a; OJ 3 §i 56a (210 mg, 0.356 mmol) in digas methane (0.5 ml) was cooled to cTC, followed by trifluoroacetic acid ( 0.5 ml), stirred and warmed to 20 eC for 30 minutes. The solution was evaporated to dryness under reduced pressure, redissolved in methylene chloride and rolled 3). The residue was triturated with ethyl acetate and diluted with acetamidine to give the title compound 162 mg (85%) as a colorless solid: 111 | 165-81 (decomposed); [PAN] 023-38.8. (c 0.1, CH3〇H); IR (KBr) 3332, 3275, 1723, 1658, 1649, 1597, 1581, 1562, 1526, 1432, 1385, 1258, 1218, 1206; NMR (d6- DMSO) &amp; 8.96 (1H, d, J = 7.3), 8.34 (1H, s), 7.85 (1H, dd, 331 · Chinese paper standard (CNS) A4 specification (2 丨 0X297))

超濟部中央樣孪局W3C工消费合作杜印衷 1235157 A7 _ _____B7 五、發明説明(329) J=7.3), 7.58 (3H, m), 7.35 (5H, m), 6.29 (1H, t, J=7.3), 5.26 (2H, m), 5.15 (2H, s), 4.69 (3H, m), 2.75 (2H, m) ^ 分析 C27H23N3O9CI2之計鼻値:C, 53·66; H,3.84; N, 6.93 3 實測値 :C, 53.36; Η, 3.90; N, 6.81 - M.S. (+ FAB); 604 (M+ + 1), 285, 241, 195, 173, 149, 91。 N-2-(6-+基-1,2-二氫-2-萌基-3-(3-苯基丙睦基)胺基- 比咬 基)乙酷基-3-腔基-5-(2,6-二氣亨酷氧基)-4-調基-戍酸(5 7b :R),以57a之方法製備,可生成標題化合物(78%),呈無 色晶體:m.p. 116-12(TC(分解):[yD26-41.1。(c 0.1, CH3OH); IR (KBr) 3299, 1739, 1715, 1689, 1666, 1645, 1598, 1563, 1518, 1432, 1209, 1151; lH NMR (d6-DMSO) &amp; 9.24 (1H, s), 8.88 (1H, d, J=7.6), 8.18 (1H, d, J=7.7), 7.60 (3H, m), 7.26 (10H, m), 6.06 (1H, d, J=7.7), 5.23 (2H, ABq), 4.69 (3H, m), 3·93 (2H, s),2·78 (6H, m)。分析 C35H31N308C12 . H20之計算 値:C,59.16; H,4·68; N,5·91。實測値:C, 59.38; Η, 4·53; N, 5.84。M.S.(+FAB);694,(C1=35,37), (M 十+1);692 (C1=35, 35),(NT+ 1)。 -332- 本纸杀尺度逑用中国國家揉孪(CNS M4規格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(330) 〇W3C Industrial and Consumer Cooperation of Central Ministry of Chaoji Du Yinzhong 1235157 A7 _ _____B7 V. Description of Invention (329) J = 7.3), 7.58 (3H, m), 7.35 (5H, m), 6.29 (1H, t, J = 7.3), 5.26 (2H, m), 5.15 (2H, s), 4.69 (3H, m), 2.75 (2H, m) ^ Analysis of C27H23N3O9CI2's epistaxis: C, 53 · 66; H, 3.84; N, 6.93 3 Measured 値: C, 53.36; Η, 3.90; N, 6.81-MS (+ FAB); 604 (M + + 1), 285, 241, 195, 173, 149, 91. N-2- (6- + yl-1,2-dihydro-2-germanyl-3- (3-phenylpropionyl) amino-specific aceto) ethoxy-3-cavity-5 -(2,6-Difluorohenyloxy) -4-tunyl-arsinic acid (57b: R), prepared by 57a method, can produce the title compound (78%) as colorless crystals: mp 116- 12 (TC (decomposition): [yD26-41.1. (C 0.1, CH3OH); IR (KBr) 3299, 1739, 1715, 1689, 1666, 1645, 1598, 1563, 1518, 1432, 1209, 1151; lH NMR ( d6-DMSO) &amp; 9.24 (1H, s), 8.88 (1H, d, J = 7.6), 8.18 (1H, d, J = 7.7), 7.60 (3H, m), 7.26 (10H, m), 6.06 (1H, d, J = 7.7), 5.23 (2H, ABq), 4.69 (3H, m), 3.93 (2H, s), 2.78 (6H, m). Analyze C35H31N308C12. Calculation of H20: C, 59.16; H, 4.68; N, 5.91. Measured 値: C, 59.38; Η, 4.53; N, 5.84. MS (+ FAB); 694, (C1 = 35, 37), ( M ten +1); 692 (C1 = 35, 35), (NT + 1). -332- This paper uses the Chinese national standard (CNS M4 specification (2 丨 0X297 mm) 1235157 A7 B7 V. Invention Description (330) 〇

AA

COjtBu TjCOjtBu Tj

6S6S

OH 69 一 50:50OH 69 a 50:50

經濟部中央標隼局员工消費合作社印衮Employees' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

(a) R1 = OCH3/ R2 = H (b) R1 = H, R2 = 〇CH3 · 7-曱氧基苯並呤唑(65a)。2-硝基-6-甲氧基酚(2.62克,15.5 毫莫耳)(EP 333 176)及10% Pd/c (130毫克)於乙醇(50.0毫升) 之混合物在H,大氣下攪拌75分鐘。混合物經由Celite®過瀘 -333· 本纸ft尺度通用中國國家標孪(CNS ) Μ規格(210X297公釐) 1235157 A7 B7___;__ 五、發明説明(331)(a) R1 = OCH3 / R2 = H (b) R1 = H, R2 = 〇CH3 · 7-methoxybenzobenzoxazole (65a). A mixture of 2-nitro-6-methoxyphenol (2.62 g, 15.5 mmol) (EP 333 176) and 10% Pd / c (130 mg) in ethanol (50.0 ml) was stirred under H in air at 75 minute. The mixture is passed through Celite® -333 · This paper is ft-size universal Chinese National Standard (CNS) M size (210X297 mm) 1235157 A7 B7___; __ 5. Description of the invention (331)

再以對位-苯磺酸(32·0毫克)及三乙基原甲酸酯(6·45毫升, 38.S毫莫耳)立即處理,再於Ν2大氣下迴流加熱。經20小時 後,對位-甲苯績酸(30.0毫克)及三乙基原曱酸‘旨(6·45毫升 ,38.8毫莫耳)加入。共44小時的加熱後’會反應冷卻再於 眞空下減量。生成的殘留物以快速層析純化(25:75乙酸乙 酯/己烷)可生成1.97克(85%)標題化合物爲黃色固鳢:m.p· 28-315C ; IR (film) 1629, 1497, 1434, 1285, 1097; lH NMR (CDC13) &amp; 8.09 (1H, s),7.40 (1H, d, J=8.0),7.28 (IHj, J=S.O), 6.89 (1H, d, J=8.0), 4.02 (3H, s); 13C NMR (CDC13) &amp; 152.84, 145.82, 142.50, 139.99, 125.75, 1 13.42, 108.80, 56.97 。分析· 0·1Η2Ο; C,63·65; Η, 4·81; N, 9.29 :實測 値:C, 63.43, H, 4.88, N, 9·05。M.S.(十 FAB); 150 (ΓνΓ + I),It was then treated immediately with para-benzenesulfonic acid (32.0 mg) and triethyl orthoformate (6.45 ml, 38.S mmol), and then heated under reflux in the atmosphere of N2. After 20 hours, p-toluene acid (30.0 mg) and triethylorthopic acid (6.45 ml, 38.8 mmol) were added. After heating for a total of 44 hours, the reaction will be cooled and then reduced in air. The resulting residue was purified by flash chromatography (25:75 ethyl acetate / hexane) to give 1.97 g (85%) of the title compound as a yellow solid: mp · 28-315C; IR (film) 1629, 1497, 1434 , 1285, 1097; lH NMR (CDC13) &amp; 8.09 (1H, s), 7.40 (1H, d, J = 8.0), 7.28 (IHj, J = SO), 6.89 (1H, d, J = 8.0), 4.02 (3H, s); 13C NMR (CDC13) &amp; 152.84, 145.82, 142.50, 139.99, 125.75, 1 13.42, 108.80, 56.97. Analysis · 0 · 1Η20; C, 63 · 65; Η, 4.81; N, 9.29: Measured 値: C, 63.43, H, 4.88, N, 9.05. M.S. (ten FAB); 150 (ΓνΓ + I),

4-曱氧基笨並,号唑(65b)。對4·羥基苯並呤唑(2.00克14· 8毫 莫耳)(Musser et al·,J. Med· Chem·,30, pp. 62-67 (1987))於 丙酮(80.0毫升)之懸液中加入無水K2C03 (2.25克,16.3毫 莫耳)再加碘曱烷(1.38毫升,22.2毫莫耳反應在N2下迴 流加熱4.5小時,再過濾並眞空下減量生成粗製產物3生 成的殘留物以快速層析純化(25:75乙酸乙酯/己烷)可生成 2·0克(91%)標題化合物,呈白色晶狀固饉:mp 72-74ec ; IR 适齊年t5t·*隼馬貝工消費合作狂印裝 f辞先閱請背面之注意寧項再填寫本頁) (KBr) 3089, 1619, 1610, 1503, 1496, 1322, 1275, 1090, 1071, 780, 741; lH NMR (CDC13) &amp; 8·02·(1Η,s), 7·32 (1H,t,J=8.0), 7.18,(1H,d,J=8.0),6·81 (1H,d,J=8.〇), 4·〇4 (3H, s) 3 分析 CsH7N02:C, 64·42; H, 4.73; N,9.39。實測値:C, 64.40; H, 4.84; N, 9.31; m/2 (El) 149 (M++ 1, 1〇〇〇/0) 〇 • 334 - 本纸伕尺度通用中国§家標孪(CNS ) A4規格(210X297公笼) 1235157 Λ7 37 五、發明説明(咖) (3S,4R,S)N-(稀丙氧馥基)-3-胺基超基-4-(2-(7-曱氧基苯 並57亏岭基))丁酸第三·丁酯(66a)。對7-甲氧基琴显,号峻65a (548.6毫克’ 3.68毫莫耳)於無水thf(18.5$升)在-789C, &amp;下之授拌溶液,逐滴加入ι·56Μ正丁基赶/己燒(2.47毫升 ’ 3.86毫莫耳)可產生黃色溶液。經在下擾掉20分鐘 後,加入呈固禮之無水MgBr20Et2(l.〇45克,4.05毫莫耳) 3生成的異質混合物加溫至-453C再攪掉1 5分鐘。反應混 合物再冷卻至-78&quot;C,並逐滴加入(s)-All〇c-Asp(第三-丁基 )H (946.4毫克,3.68毫莫耳)4Thf (18.5毫升)之溶液。反 應在-78°C下授捍30分鐘,加溫至6°C再授掉1小時3生成 的異質反應加溫至室溫並授拌16小時3反應以5%疾酸氫 鈉(3.5毫升)再驟冷,之後THF於眞空下移去3生成的水性 殘留物以一乱甲燒(X 6)萃取。混合的萃取物以鹽水洗務, 乾燥(MgS04),過濾並眞空下減量生成is克粗製產物。伕: 速層析(40:60乙酸乙醋/己燒)可生成ι·2ΐ克(81%)標題化合 物.,呈油狀,爲C-4:非對映立體異構物之混合:iR(CH,Cl2) 3425, 2983, 1725, 1504, 1290, 1 157, 1101; [Η NMR (CDC13) &amp; 7.35-7.19 (2H, m), 6.89-6.81 (1H, m), 6.00-5.57 (2H? m), 5.32-5.05 (3H, m), 4.68-4.35 (3H, m), 4.01 (3H, s), 2.86-2.59 經濟部中央揉準局貝工消费合作社印製 (2H, m), 1.45 (9H,s), 1.41 (9H, s); 13C NMR (CDC13) &amp; .171.18, 171.09, 165.80, 165.30, 156.71, 156.60, 145.65, 142.76, 142.71, 140.82, 140.72, 133.23, 125.81, 125.72, 118.41, 1 18.21, 113.07, 112.87, 108.95, 82.16, 70.28, 69.98, 66.52, 66.39, 57.03, 52.57, 52.29, 37.83, 36.86, 28.65,分析 -335- 本紙伕尺度逑用中國國家揉李(CNS )戎4故格(2! Οχ 297公釐) 1235157 Λ: _ Β7_______ i、發明説明(如) (請先¾讀背云之注意事項再填寫本頁) C20H26N2O7· 〇·6Η2〇:C,57·57; Η,6·57; N,6·72。實測値:C, 57.49, Η, 6.34, N, 6.60 3 M.S. (+ FAB); 407 (M&quot; + 1); 351, 307, 154。 (3S, 4R, S)N-(烯丙氧羰基)-3-胺基-4-羥基-4-(2-(4-甲氧基苯 並哼唑基))丁酸第三-丁酯(66b),依66a所述方法製備,可 生成1.29克(依回收之起始物爲68%,26%)標題化合物,呈 油狀爲C-4非對玦立體異構混合物:IR (CHflJ 3400, 1725, 1625, 1505, 1369, 1354, 1281, 1263, 1226, 1 158, 1092, 1048; lH NMR (CDC13) &amp; 7.34-7.24 (1H, m), 7.16 (1H, d, J=8.2), 6.79 (1H, d, J=7.9), 6.00-5.50 (2H, m), 5.30-5.05 (3H, m), 4.70-4.35 (4H, m)? 4.02 (3H, s), 2.90-2.45 (2H, m), 1.45-1.41 (9H, 2 x s) 0 分析 C20H26N2〇7 · 〇·4Η20之計算値:C, 58·07; H, 6.53; N, 6.77。實測値:C, 58·09; H, 6.41; N,6·63。M.S. (+ FAB); 407 (NT + 1,88%); 351 (100)。 (3S, 4R, S)N-(N-乙醯基-(SH〇-第三-丁基-輅胺醯基)-(S)-纈 胺醢基-(S)-丙胺醯基)-3-胺基-4-羥基·4-(2-(7-甲氧基苯並 呤唑基))丁酸第三-丁酯(67a) β對苯並呤唑66a (481.9毫克 ,1.19毫莫耳)及 Ac-TyK^uVVal-Ala-OH (586.3毫克,ι·3〇 毫莫耳)於二氣甲烷(3·5毫升)及DMF (3·5毫升)之攪掉溶液 中加入雙(三苯膦)鈀(II)化氣(18·0毫克),再逐滴加入氩化 三丁錫(0·80毫升,2.96毫莫耳)3加入羥基苯並三唑(320.4 毫克,2.37毫莫耳)且混合物冷卻至〇eC,加入1-乙基·3-[3-(二甲胺基)丙基]碳化二亞胺鹽酸(278.2毫克,1·42毫莫耳) ,且令混合物加溫至室溫並攪掉16.5小時。反應以乙酸乙 -336· 、紙乐尺度適用中S國家標孪(CNS ) A4規格(2I0X297公釐) !235157 A1 --- 五、發明説明(议) 酯稀釋,並以1M硫酸氫鈉洗二次,以鉋和的凝酸氫詞, 水及鹽水洗二次。有機層乾燥(MgS〇4),過濾並眞空下減 量以生成2.0克粗製產物。快速層析(95:5二£甲烷/曱醇)可 生成844.0毫克(94%)的標題化合物,呈白色固體:m.p. 2〇5χ:; IR (ΚΒγ) 3399, 3304, 2977, 1729, 1643, 1506, 1367, 1290, 1161; [Η NMR (d6-DMSO) &amp; 8.24-7.78 (4H, m), 7.43-7.32 (2H, m), 7.23 (2H, d, J=8.5), 7.16-7.07 (1H, m), 6.93 (2H, d; J=8.5),6.52, 6.40 (1H, 2 x d,J=5.5, J=5.0), 5·〇3, 4.78-4.49, 4.45-4.16 (5H, brt, 2 x m), 4.05, 4.04 (3H, 2 x s), 3.08-2.35 (14H, m), 2.11-1.89 (1H, m), 1.83 (3H, s), 1.49-1.32, 1.15, 1.0-0.81 (27H, s, 2 x m, J=7.0); 13C NMR (d6-DMSO) &amp; 175.55, 175.18, 173.88, 173.75, 173.05, 169.23, 157.28, 148.55, 146.16, 143.21, 136.63, 133.55, 128.87, 127.17, 1 15.78, 1 1 1.92, 84.02, 81.50, 71.40, 61.15, 60.05, 57.79, 53.39, 51.62, 43.76, 40.52, 34.58, 32.52, 31.60, 26.35, 23.1 1, 22.71, 21.76 e 分析 C39H55N5O10 · 0.5H2〇之計算値:C, 61.40; H, 7.40; N,9.81。實測値:C, 61,43; H,7·31; N, 9.07。M.S. (+ FAB); 754 (M++ 1); 698, 338, 267。 (3S,4R,S)N-(N-乙睡基-(S)-(0-第三-丁基.路腔臨基)-($)·缚 胺酷基-(S)·丙按睡基)·3·胺基-4·經基-4-(2-(4-甲氧基苯並 呤唑基))丁酸第三-丁酯(67b),棱67a之方法製備,可生成4-Methoxybenzyl, azole (65b). Suspension of 4-hydroxybenzoxazole (2.00 g 14.8 mmol) (Musser et al., J. Med. Chem., 30, pp. 62-67 (1987)) in acetone (80.0 ml) Anhydrous K2C03 (2.25 g, 16.3 mmol) was added to the solution followed by iodopanane (1.38 ml, 22.2 mmol). The reaction was heated at reflux under N2 for 4.5 hours, and then filtered and emptied to reduce the residue to a crude product 3. Purification by flash chromatography (25:75 ethyl acetate / hexane) yielded 2.0 g (91%) of the title compound as a white crystalline solid: mp 72-74ec; IR suitable year t5t · * 隼 马The paperwork of consumerism and cooperation is printed, please read the note on the back, and then fill out this page) (KBr) 3089, 1619, 1610, 1503, 1496, 1322, 1275, 1090, 1071, 780, 741; lH NMR ( CDC13) &amp; 8.02 · (1Η, s), 7.32 (1H, t, J = 8.0), 7.18, (1H, d, J = 8.0), 6.81 (1H, d, J = 8 〇), 4.04 (3H, s) 3 analysis CsH7N02: C, 64 · 42; H, 4.73; N, 9.39. Measured 値: C, 64.40; H, 4.84; N, 9.31; m / 2 (El) 149 (M ++ 1, 1〇00 / 0) 〇 • 334-The paper standard is universal Chinese § family standard twin (CNS) A4 specification (210X297 male cage) 1235157 Λ7 37 V. Description of invention (coffee) (3S, 4R, S) N- (dilute propoxyfluorenyl) -3-amino super group-4- (2- (7- 曱Oxybenzo 57 oxalyl)) tert-butyl butyrate (66a). For 7-methoxyqin, No. 65a (548.6 mg '3.68 mmol) was added to anhydrous thf (18.5 $ liters) at -789C, & the solution was added dropwise ι · 56M n-butyl Catch / Hex Burn (2.47 ml '3.86 mmol) can produce a yellow solution. After stirring for 20 minutes, an anhydrous MgBr20Et2 (1.045 g, 4.05 mmol) was added as a solid solution. The resulting heterogeneous mixture was warmed to -453C and stirred for 15 minutes. The reaction mixture was re-cooled to -78 &quot; C, and a solution of (s) -Alloc-Asp (tertiary-butyl) H (946.4 mg, 3.68 mmol) 4Thf (18.5 ml) was added dropwise. The reaction was defended at -78 ° C for 30 minutes, heated to 6 ° C and then taught for 1 hour. 3 The resulting heterogeneous reaction was warmed to room temperature and stirred for 16 hours. ) It was quenched again, after which the THF was removed under a vacuum and the resulting aqueous residue was extracted with a messy beaker (X 6). The combined extracts were washed with brine, dried (MgS04), filtered and decanted to yield is-grams of crude product.伕: Flash chromatography (40:60 ethyl acetate / hexane) produces ι · 2ΐg (81%) of the title compound. It is oily and is a mixture of C-4: diastereoisomeric compounds: iR (CH, Cl2) 3425, 2983, 1725, 1504, 1290, 1 157, 1101; [Η NMR (CDC13) & 7.35-7.19 (2H, m), 6.89-6.81 (1H, m), 6.00-5.57 ( 2H? M), 5.32-5.05 (3H, m), 4.68-4.35 (3H, m), 4.01 (3H, s), 2.86-2.59 Printed by the Shellfish Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs (2H, m) , 1.45 (9H, s), 1.41 (9H, s); 13C NMR (CDC13) &amp; .171.18, 171.09, 165.80, 165.30, 156.71, 156.60, 145.65, 142.76, 142.71, 140.82, 140.72, 133.23, 125.81, 125.72 , 118.41, 1 18.21, 113.07, 112.87, 108.95, 82.16, 70.28, 69.98, 66.52, 66.39, 57.03, 52.57, 52.29, 37.83, 36.86, 28.65, analysis-335- This paper uses the Chinese national rubbing plum (CNS) Rong 4 Old Case (2! 〇χ 297 mm) 1235157 Λ: _ Β7 _______ i. Description of the invention (if) (please read the precautions of the back of the cloud before filling this page) C20H26N2O7 · 〇 · 6Η2〇: C, 57 · 57; Η, 6.57; N, 6.72. Measured 値: C, 57.49, Η, 6.34, N, 6.60 3 M.S. (+ FAB); 407 (M &quot; + 1); 351, 307, 154. (3S, 4R, S) N- (allyloxycarbonyl) -3-amino-4-hydroxy-4- (2- (4-methoxybenzoxazolyl)) butyric acid tert-butyl ester (66b), prepared according to the method described in 66a, which can produce 1.29 g (68%, 26% of the recovered starting material) of the title compound as an oily C-4 non-isomeric stereoisomeric mixture: IR (CHflJ 3400, 1725, 1625, 1505, 1369, 1354, 1281, 1263, 1226, 1 158, 1092, 1048; lH NMR (CDC13) &amp; 7.34-7.24 (1H, m), 7.16 (1H, d, J = 8.2 ), 6.79 (1H, d, J = 7.9), 6.00-5.50 (2H, m), 5.30-5.05 (3H, m), 4.70-4.35 (4H, m)? 4.02 (3H, s), 2.90-2.45 (2H, m), 1.45-1.41 (9H, 2 xs) 0 Analysis of the calculation of C20H26N20.7 · 0.42 20: C, 58 · 07; H, 6.53; N, 6.77. Found: C, 58 · 09 H, 6.41; N, 6.63. MS (+ FAB); 407 (NT + 1.88%); 351 (100). (3S, 4R, S) N- (N-ethenyl- (SH 〇-Third-butyl-amidinofluorenyl)-(S) -valineamino- (S) -propylaminofluorenyl) -3-amino-4-hydroxy · 4- (2- (7-methyl Oxybenzoxazolyl)) tert-butyl butyrate (67a) β-benzoxazol 66a (481.9 mg, 1.19 mmol) and Ac-TyK ^ uVVal-Ala-OH (586.3 mg, ι · 3 〇mmol) Add bis (triphenylphosphine) palladium (II) gasification (18.0mg) to the stirred solution of methane (3.5ml) and DMF (3.5ml), and then Tributyltin argon (0.80 ml, 2.96 mmol) was added dropwise. 3 Hydroxybenzotriazole (320.4 mg, 2.37 mmol) was added and the mixture was cooled to 0 eC. 1-ethyl · 3- [ 3- (dimethylamino) propyl] carbodiimide hydrochloride (278.2 mg, 1.42 mmol), and the mixture was warmed to room temperature and stirred for 16.5 hours. The reaction was ethyl acetate-336 ·, The paper music scale is applicable to the Chinese National Standard (CNS) A4 specification (2I0X297 mm)! 235157 A1 --- V. Description of the invention (Negotiation) The ester is diluted and washed twice with 1M sodium hydrogen sulfate to plan and condense. The acid and hydrogen were washed twice with water and brine. The organic layer was dried (MgS04), filtered and reduced in volume to yield 2.0 g of crude product. Flash chromatography (95: 5 dimethane / methanol) yielded 844.0 mg (94%) of the title compound as a white solid: mp 2 05 × :; IR (ΚΒγ) 3399, 3304, 2977, 1729, 1643, 1506, 1367, 1290, 1161; [Η NMR (d6-DMSO) &amp; 8.24-7.78 (4H, m), 7.43-7.32 (2H, m), 7.23 (2H, d, J = 8.5), 7.16-7.07 (1H, m), 6.93 (2H, d; J = 8.5), 6.52, 6.40 (1H, 2 xd, J = 5.5, J = 5.0), 5.0 · 3, 4.78-4.49, 4.45-4.16 (5H, brt, 2 xm), 4.05, 4.04 (3H, 2 xs), 3.08-2.35 (14H, m), 2.11-1.89 (1H, m), 1.83 (3H, s), 1.49-1.32, 1.15, 1.0-0.81 (27H, s, 2 xm, J = 7.0); 13C NMR (d6-DMSO) &amp; 175.55, 175.18, 173.88, 173.75, 173.05, 169.23, 157.28, 148.55, 146.16, 143.21, 136.63, 133.55, 128.87, 127.17, 1 15.78, 1 1 1.92, 84.02, 81.50, 71.40, 61.15, 60.05, 57.79, 53.39, 51.62, 43.76, 40.52, 34.58, 32.52, 31.60, 26.35, 23.1 1, 22.71, 21.76 e Analysis of C39H55N5O10 · 0.5H2〇値: C, 61.40; H, 7.40; N, 9.81. Found 値: C, 61, 43; H, 7.31; N, 9.07. M.S. (+ FAB); 754 (M ++ 1); 698, 338, 267. (3S, 4R, S) N- (N-Ethyl- (S)-(0-Third-Butyl. Lumen Proyl)-($) · Aminopyridyl- (S) · Proton Pyridyl) · 3 · Amino-4 · Ethyl-4- (2- (4-methoxybenzoxazolyl)) tert-butyl butyrate (67b), prepared by the method of edge 67a generate

I. 05克(94%)標題化合物,呈細碎白色粉末:m.p. 210-213*C (dec); IR (KBr) 3284, 2977, 1736, 1691, 1632, 1536, 1505, 1452, 1392, 1367, 1258, 1236, 1161, 1091; NMR (d6- •337- 本纸ft尺度適用中国國家標李(CNS ) A4規格(210X297公釐) 先 讀 背 面 之 注I. 05 g (94%) of the title compound as a finely divided white powder: mp 210-213 * C (dec); IR (KBr) 3284, 2977, 1736, 1691, 1632, 1536, 1505, 1452, 1392, 1367, 1258, 1236, 1161, 1091; NMR (d6- • 337- This paper ft scale applies to China National Standard Plum (CNS) A4 specification (210X297 mm) Read the note on the back

M濟部中央樣牟局貝工消费合作社印«. 1235157Printed by the Ministry of Economic Affairs, Central Sample Mou Bureau, Shellfish Consumer Cooperative «. 1235157

AA

B 五、發明説明(雄) DMSO) &amp; 8.20-7.75 (4H, m), 7.40-7.10 (4H, m), 7.00-6.80 (3H, m), 6.45, 6.34 (1H, 2 x d, J=5.3, J=5.0), 5.00-4.10 (5H, m), 4.00, 3.99 (3H, 2 x s), 3.00-2.25 (4H, m), 1.95 (1H? m), 1.78 (3H,s),1·39-0·80 (27H, m)。分析 C39H55N5O10 , 〇.5H20 之計算値:C,61.40; H,7.40; N,9.18 3 實測値:C,61.58; H, 7.38; N,8.91。M.S· (+ FAB); 754 (M+ + 1,30%); 72 (100)。 (3S)N-(N-乙醯基-(S)-(〇-第三-丁基-酪胺醯基)-(S)-纈胺醯基 •(S)·丙胺醯基)-3-胺基-4-(2-(7-甲氧基苯並呤唑基))-4-酮基 丁 酸第三-丁酯(68a)。加 Dess-Martin 試劑(1.082 克,2.55 毫 莫耳)(Ireland et al·,J. Org· Chem·,58, p. 2899 (1 993); Dess et al., J· Org· Chem. 48, pp· 4155-4156 (1983))至 67a (641.0毫克,0·85毫莫耳)於二氣曱烷(46.0毫升)之攪袢懸液 中3生成的混合物攪摔1小時再分配於飽和的硫代硫酸鈉: 铯和的碳酸氫鈉(1:1,86·0毫升)及乙酸乙酯(86.0毫升)之 間3生成的有機相再依序以下列洗務,绝和的疏代疏酸釣: 绝和的後酸氫納(1:1),餘和的碳酸氫纳,及鹽水3有機相 乾燥(MgS04),過濾,並眞空下減量以生成660.0毫克的耝 製產物。快速層析(94:6二氣甲烷/曱醇)可生成636.0毫克 (100%)標題化合物爲白色固體:m.p· 209eC ; [ a]D24-21.8。(c 經濟部中央標準局員工消费合作社印装 〇·16,曱醇);IR (KB〇 3395, 3294, 2977, 1722, 1641,1535, 1505, 1161; !H NMR (CDC13) &amp; 8.43-8.16 (1H, m), 7.97-7.62 (2H, m), 7.49-7.14 (3H, m), 7.08-6.95 (3H, m), 6.89-6.73 (2H, m), 5.81-5.68 (1H, m), 5.16-4.86 (2H, m)4.53 (1H, brt), 4.03 (3H, s), 3.16-2.84 (4H, m), 2.11-1.84 (4H, m), 1.46-1.14 (21H, • 338 - 本紙伕尺度通用中S國家揉率(CNS )以说格(210X 297公釐) 經濟部中央樣率局貝工消费合作·杜印袋 1235157 Α7 Β7 五、發明説明(雄) m), 0.92-0.78 (6H? m); 13C NMR (CDC13) &amp; 186.28, 173.39, 171.90, 171.19, 171.03, 169.89, 156.43, 154.75, 146.32, 142.88, 140.9S, 132.31, 130.54, 126.98, 124.73, 114.95, 111.42, 82.44, 78.71,58.92, 57.20, 54.91,53.47, 48.77, 39.43, 38.15, 32.79, 29.44, 28.60, 23.55, 20.27, 19.70, 19.34, M.S. (+ FAB); 752 (M+ + 1); 696, 336, 265 » (3S)N-(N-乙醯基-(S)-10)-第三-丁基-酪胺醢基)-(S)·纈胺鲦 基-(S)-丙胺醯基)-3-胺基-4-(2·4·甲氧基苯並&quot;号唑基))·4-酮 基丁酸第三-丁酯(68b),依酮68a所述方法製備,其可生成 420毫克(55%)標題化合物,呈白色固體:m.p· 211-213X: (dec); [“]D24-23.93 (c 0.82,甲醇);IR (KB〇 3277, 3075, 1723, 1690, 1632, 1530, 1506, 1392, 1366, 1269, 1234, 1 160, 1094; lH NMR (CDCi3) &amp; 8.15 (1H, brs), 7.7 (2H, brs), 7.46 (1H, t, 1=8.3), 7.24 (2H, d, J-8.3), 7.10 (1H, brs), 7.03 (2H, d, J=8.3), 6.83 (3H, m), 5.74 (1H, q, J=6.9), 5.00 (2H, m), 4.51 (1H, t, J=7.0), 4.07 (3H, s), 3.20-2.95 (4H, m), 2.00 (4H, m), 1.42 (3H, d, J=6.8), 1.35 (9H, s), 1.23 (9H, s), 0.86 (6H, d, J=6.7)。M.S· (+ FAB); 752 (M+ + 1, 7%); 72 (100)。 (3S)N-(N-乙醢基-(S)-酪胺醢基-(S)-纈胺醢基-(S)-丙按醢基) -3·胺基-4-(2-(7-曱氧基苯並”号唑基))-4-酮基丁酸(69a ; R) 。酯68a(600.0毫克,0·80毫莫耳·)於1:1二氣甲烷及三氟醋 酸(65.0毫升)混合物之溶液,在1^2無水大氣下攪拌1小時a 溶液再於眞空下減量,以乙瞇吸收並再次減量。此過程重 覆6次以生成粗製產物爲摻白色固體。快速層析(梯度95:5 -339- 本纸張尺度適用中國國家標準(CNS ) Α4規格(210*Χ297公釐)B. Description of the invention (male) DMSO) &amp; 8.20-7.75 (4H, m), 7.40-7.10 (4H, m), 7.00-6.80 (3H, m), 6.45, 6.34 (1H, 2 xd, J = 5.3, J = 5.0), 5.00-4.10 (5H, m), 4.00, 3.99 (3H, 2 xs), 3.00-2.25 (4H, m), 1.95 (1H? M), 1.78 (3H, s), 1 39-0 · 80 (27H, m). Analytical calculations for C39H55N5O10, 0.5H20: C, 61.40; H, 7.40; N, 9.18 3 Found: C, 61.58; H, 7.38; N, 8.91. M.S · (+ FAB); 754 (M + + 1, 30%); 72 (100). (3S) N- (N-Ethylfluorenyl- (S)-(〇-Third-butyl-tyrosinamino)-(S) -Valamine (•) (propyl) amino) -3 -Amino-4- (2- (7-methoxybenzoxazolyl))-4-ketobutyric acid tert-butyl ester (68a). Add Dess-Martin reagent (1.082 g, 2.55 mmol) (Ireland et al., J. Org. Chem., 58, p. 2899 (1 993); Dess et al., J. Org. Chem. 48, pp · 4155-4156 (1983)) to 67a (641.0 mg, 0.85 mmol) in a stirred suspension of dioxane (46.0 ml). The resulting mixture was stirred for 1 hour and then partitioned into saturated Sodium thiosulfate: The organic phase formed between 3 cesium and sodium bicarbonate (1: 1, 86.0 ml) and ethyl acetate (86.0 ml) was sequentially washed in the following order. Acid fishing: Penetrated post-sodium bicarbonate (1: 1), Yuhe sodium bicarbonate, and brine 3 organic phases are dried (MgS04), filtered, and reduced in volume to produce 660.0 mg of the prepared product. Flash chromatography (94: 6 digas methane / methanol) yielded 636.0 mg (100%) of the title compound as a white solid: m.p. 209eC; [a] D24-21.8. (C Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 〇16, methanol); IR (KB〇3395, 3294, 2977, 1722, 1641, 1535, 1505, 1161;! H NMR (CDC13) &amp; 8.43- 8.16 (1H, m), 7.97-7.62 (2H, m), 7.49-7.14 (3H, m), 7.08-6.95 (3H, m), 6.89-6.73 (2H, m), 5.81-5.68 (1H, m ), 5.16-4.86 (2H, m) 4.53 (1H, brt), 4.03 (3H, s), 3.16-2.84 (4H, m), 2.11-1.84 (4H, m), 1.46-1.14 (21H, • 338 -The paper scale is commonly used in the Chinese S country kneading rate (CNS). (210X 297 mm) The Central Sample Rate Bureau of the Ministry of Economic Affairs, Shellfish Consumption Cooperation · Du printed bags 1235157 Α7 Β7 5. Description of the invention (male) m), 0.92 -0.78 (6H? M); 13C NMR (CDC13) &amp; 186.28, 173.39, 171.90, 171.19, 171.03, 169.89, 156.43, 154.75, 146.32, 142.88, 140.9S, 132.31, 130.54, 126.98, 124.73, 114.95, 111.95 82.44, 78.71, 58.92, 57.20, 54.91, 53.47, 48.77, 39.43, 38.15, 32.79, 29.44, 28.60, 23.55, 20.27, 19.70, 19.34, MS (+ FAB); 752 (M + + 1); 696, 336, 265 »(3S) N- (N-Ethylfluorenyl- (S) -10) -Third-butyl-tyrosinamino)-(S) · Valamine (-)-(S) -propylamino)- 3-amino- 4- (2 · 4 · methoxybenzo &quot; oxazolyl)) · 4-ketobutyric acid third-butyl ester (68b), prepared according to the method described in ketone 68a, which can produce 420 mg (55 %) The title compound as a white solid: mp 211-213X: (dec); ["] D24-23.93 (c 0.82, methanol); IR (KB〇3277, 3075, 1723, 1690, 1632, 1530, 1506, 1392, 1366, 1269, 1234, 1 160, 1094; lH NMR (CDCi3) &amp; 8.15 (1H, brs), 7.7 (2H, brs), 7.46 (1H, t, 1 = 8.3), 7.24 (2H, d , J-8.3), 7.10 (1H, brs), 7.03 (2H, d, J = 8.3), 6.83 (3H, m), 5.74 (1H, q, J = 6.9), 5.00 (2H, m), 4.51 (1H, t, J = 7.0), 4.07 (3H, s), 3.20-2.95 (4H, m), 2.00 (4H, m), 1.42 (3H, d, J = 6.8), 1.35 (9H, s) , 1.23 (9H, s), 0.86 (6H, d, J = 6.7). M.S · (+ FAB); 752 (M + + 1, 7%); 72 (100). (3S) N- (N-Ethylfluorenyl- (S) -tyraminofluorenyl- (S) -valaminofluorenyl- (S) -propanthinomethyl) -3 · amino-4- (2- (7-Methoxybenzo "oxazolyl))-4-ketobutyric acid (69a; R). Ester 68a (600.0 mg, 0.80 mmol) at 1: 1 digas methane and three A solution of fluoroacetic acid (65.0 ml) mixture was stirred for 1 hour in 1 ^ 2 anhydrous atmosphere. The solution was reduced in air, absorbed by acetamidine and reduced again. This process was repeated 6 times to produce a crude product as a white solid. .Fast chromatography (gradient 95: 5 -339- This paper size applies to China National Standard (CNS) Α4 size (210 * × 297 mm)

1235157 經濟部中央標準局貝工消贫合作社印¾ Λ7 B7 五、發明説明(337) 至80:20二氯曱烷/曱醇)可生成420.8毫克(83%)標題化合物 ,呈吸潮性白色固體。產物爲三種異構物於CD3〇D之混合1235157 Printed by the Peasant Poverty Alleviation Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ¾ Λ7 B7 V. Description of the invention (337) to 80:20 dichloromethane / methanol can produce 420.8 mg (83%) of the title compound, which is hygroscopic white solid. The product is a mixture of three isomers in CD3OD

,含有酮型(c 50%)及其無環氧酮型(在C-4i的二種異構物 (c 50%):m.p·在 150eC上分解··[泛]七33.2。(c 0·17,曱鞟);IR (KBr) 3300, 1715, 1658, 1650, 1531, 1517, 1204; LH NMR (CD3OD) &amp; 7.46-7.19 (2H, m), 7.16-6.91 (3H, m), 6.70-6.59 (2H, m), 5.62-5.49 (1H, m), 5.00-4.72 (1H, obscurred m), 4.69-4.51 (1H, m)? 4.49-4.08 (2H, m), 4.05-3.89 (3H, m), 3.16-2.47 (4H, m), 2.05-1.78 (4H, m), 1.41-1.11, 1.05-0.70 (9H, 2 x m)。分析 C31H37N501〇 · 3H20之計算値:C,53·67; H, 6.25; N,10.10,實測値:C, 53·76; Η, 5·56; N,10.28。M.S. (+ FAB); 640 (M++ 1); 435, 147。 (3S)N-(N-乙醯基-(S)-酪胺醢基-(S)-纈胺醢基-(S)-丙按醢基) -3-胺基-4-(2-(4·甲氧基苯並α号唑基))-4-酮基丁酸第三-丁酯 (69b, S),依酸69a之方法製備,其可生成具吸潮性標題化 合物252毫克(96%)。產物爲三種異構於CD30D之混合物, 含有酮型,及其無環氧之缩酮型式(二個C-4上之異樣物), 產物爲在d6-DMS0中之單一異構物:m.p· 200-203O(dec·);[泛] D24-38.0° (c 0.23,甲醇);IR (KBr) 3289, 2968, 1718, 1713, 1658, 1634, 1548, 1517, 1506, 1461, 1453, 1393, 1369, 1268, 1228, 1174, 1092; !H NMR (d6-DMS0) &amp; 9.20 (1H, brs), 8.71 (1H, d, J=6.2), 8.10 (2H, m), 7.83 (1H, d, J=8.7), 7.61 (1H, t, J=8.2), 7.46 (1H, d, J=8.2), 7.08 (3H, m), 6.65 (2H, d, J=8.3), 5.50 (1H, q J=6.5), 4.50 (1H, m), 4.37 (1H, m), 4.20 (1H, m), •340- ^纸乐尺度逯用中國國家標準(CNS ) A4規格(2丨〇·χ297公袋^ ' (許先閏讀背面之注意事項再頁) 訂Contains keto form (c 50%) and its epoxy-free ketone form (two isomers (c 50%) at C-4i: mp · decomposes at 150eC ·· [ubi]] 73.3.2. (C 0 · 17 , 曱 鞟); IR (KBr) 3300, 1715, 1658, 1650, 1531, 1517, 1204; LH NMR (CD3OD) &amp; 7.46-7.19 (2H, m), 7.16-6.91 (3H, m), 6.70-6.59 (2H, m), 5.62-5.49 (1H, m), 5.00-4.72 (1H, obscurred m), 4.69-4.51 (1H, m)? 4.49-4.08 (2H, m), 4.05-3.89 ( 3H, m), 3.16-2.47 (4H, m), 2.05-1.78 (4H, m), 1.41-1.11, 1.05-0.70 (9H, 2 xm). Analyze the calculation of C31H37N501. 3H20 値: C, 53 · 67; H, 6.25; N, 10.10, measured 値: C, 53 · 76; Η, 5.56; N, 10.28. MS (+ FAB); 640 (M ++ 1); 435, 147. (3S) N- (N-Ethylfluorenyl- (S) -tyrosinaminofluorenyl- (S) -valinylfluorenyl- (S) -propylaminomethyl) -3-amino-4- (2- (4 · methoxy Benzyl α-oxazolyl))-4-ketobutyric acid tert-butyl ester (69b, S), prepared according to the method of acid 69a, which can produce 252 mg (96%) of the title compound with moisture absorption. The product is a mixture of three isomeric forms of CD30D, containing a ketone type and its epoxy-free ketal form (two different substances on C-4). The product is Single isomers in d6-DMS0: mp · 200-203O (dec ·); [ubiquitous] D24-38.0 ° (c 0.23, methanol); IR (KBr) 3289, 2968, 1718, 1713, 1658, 1634, 1548, 1517, 1506, 1461, 1453, 1393, 1369, 1268, 1228, 1174, 1092;! H NMR (d6-DMS0) &amp; 9.20 (1H, brs), 8.71 (1H, d, J = 6.2), 8.10 (2H, m), 7.83 (1H, d, J = 8.7), 7.61 (1H, t, J = 8.2), 7.46 (1H, d, J = 8.2), 7.08 (3H, m), 6.65 (2H , d, J = 8.3), 5.50 (1H, q J = 6.5), 4.50 (1H, m), 4.37 (1H, m), 4.20 (1H, m), • 340- ^ Paper scale uses China Standard (CNS) A4 size (2 丨 〇 · χ297 male bag ^ '(Xu Xianyi read the precautions on the back page)

1235157 A7 _ __ B7 五、發明説明·( 338) 4*05 (3H, s), 3.09-2.77 (4H, m), 1.94 (1H, m), 1.79 (3H, s), 123 (3H,d, J=7.0),0·82 (6H, m)。 分 析 C3iH37N5O10 · UHjOX,55·85; H,6.05; N,10.51。實測値:C,h.21; Η,5·69; N,10.13。M.S· (+ FAB); 640 (M+ + 1,22%); 107 (100)。1235157 A7 _ __ B7 V. Description of the invention · (338) 4 * 05 (3H, s), 3.09-2.77 (4H, m), 1.94 (1H, m), 1.79 (3H, s), 123 (3H, d , J = 7.0), 0 · 82 (6H, m). Analysis for C3iH37N5O10 · UHjOX, 55 · 85; H, 6.05; N, 10.51. Found 値: C, h.21; Η, 5.69; N, 10.13. M.S · (+ FAB); 640 (M + + 1, 22%); 107 (100).

(請先閲讀背S之注意事項再填寫本頁) 經濟部中央樣率局貞工消费合作社印装(Please read the precautions of S before filling out this page) Printed by Zhengong Consumer Cooperative, Central Sample Rate Bureau

J(S)-(稀丙乳裝基)胺基-4-[(2,6-二乳-革·基号咬-2-基]-4(R ,S)-羥基-丁酸第三-丁酯(99)。5-(2,6-二氣苯基)哼唑(2·71 克,12.7毫莫耳;以類似 Tet· Lett· 23, ρ. 2369 Π972)的方 法製備)於四氫呋喃(65毫升)之溶液,在氮大氣下冷卻至 -78eC。對此溶液中加入正丁基鋰(1.5M於己烷之溶液,8.5 毫升,13.3毫莫耳)並在-781下攪拌30分鐘。加入鎂化溴 趟化物(3.6克,13·9毫莫耳)且溶液令其加溫至-45°C歷15分 鐘。反應冷卻至-781,再逐滴加入醛58 (3.26克,12.7毫 莫耳:Graybill et al·, Int· J. Protein Res·, 44, p. 173-182 (1993))於四氩呋喃(65毫升)e反應攪拌25分鐘,再令其加 溫至-40eC並攪拌3小時,再於室溫下1小時。反應加5〇/〇 NaHC〇3 (12毫升)驟冷並攪掉3小‘時。於眞空下移去四氫唉 喃,且生成的殘留物以二氣曱烷萃取。有機層以铯和的氣 化釣溶液萃取,再於硫酸鎂上乾燥,過濾及濃縮以生成 6·14克標題化合物。純化生成4 79克(8〇%) 99: !h NMH -341 - 本纸乐尺度適用中US家標準(CNS ) A4規格(210X29*7公沒)J (S)-(dilute acryloyl group) amino-4-[(2,6-dilactate-leather-base # -2-yl] -4 (R, S) -hydroxy-butyric acid -Butyl ester (99). 5- (2,6-difluorophenyl) humidazole (2.71 g, 12.7 mmol; prepared by a method similar to Tet · Let · 23, ρ. 2369 Π972) in A solution of tetrahydrofuran (65 ml) was cooled to -78 eC under a nitrogen atmosphere. To this solution was added n-butyllithium (1.5 M in hexane, 8.5 ml, 13.3 mmol) and stirred at -781 for 30 minutes. Bromide magnesium bromide (3.6 g, 13.9 mmol) was added and the solution was allowed to warm to -45 ° C for 15 minutes. The reaction was cooled to -781, and then aldehyde 58 (3.26 g, 12.7 mmol) was added dropwise: Graybill et al., Int. J. Protein Res., 44, p. 173-182 (1993)) in tetrahydrofuran ( 65 ml) e reaction was stirred for 25 minutes, then it was warmed to -40eC and stirred for 3 hours, and then at room temperature for 1 hour. The reaction was quenched with 50/0 NaHC03 (12 mL) and stirred for 3 hours. Tetrahydrofuran was removed under aerosol, and the resulting residue was extracted with dioxane. The organic layer was extracted with a caesium and gasification fishing solution, dried over magnesium sulfate, filtered and concentrated to give 6.14 g of the title compound. Purified to produce 4 79 g (80%) 99:! H NMH -341-The paper scale is applicable to the US standard (CNS) A4 specification (210X29 * 7)

1235157 Α7 Β7 五、發明説明(w) (CDCI3) &amp; 1.45 (s, 9H), 2.7-2.5 (m, 2H), 2.8 (dd, 1H), 4.2, 4.4 (2 x d , 1H), 4.7-4.5 (m, 3H), 5.35-5.1 (m, 2H), 5.6, 5.7 (2 x d, 1H), 6.0-5.8 (m, 1H), 7.2 (m, lH), 7:3 (m, 1H), 7.4 (m, 2H)。 (#.先兒讀背面之注意事項 本瓦)1235157 Α7 Β7 V. Description of the Invention (w) (CDCI3) &amp; 1.45 (s, 9H), 2.7-2.5 (m, 2H), 2.8 (dd, 1H), 4.2, 4.4 (2 xd, 1H), 4.7- 4.5 (m, 3H), 5.35-5.1 (m, 2H), 5.6, 5.7 (2 xd, 1H), 6.0-5.8 (m, 1H), 7.2 (m, lH), 7: 3 (m, 1H) , 7.4 (m, 2H). (# .Notes on the back of the first reading first benwa)

3l R ― H b R = COCH2CH2Ph c R = CH2Ph3l R ― H b R = COCH2CH2Ph c R = CH2Ph

經濟部中央揉準局男工消费合作社印装 [2-酮基-3(3)-(3-苯基丙琏胺基)-2,3,4,5-四氩-苯並[1)][1,4]二 氮雜箪-1-基]乙酸曱酯(104a)。無水氯化氩泡騰至(3(S)-第 三-丁氧羰基胺基-2-酮基-2,3,4,5-四氫·苯並[b][l,4]二氮雜 萆-1-基)乙酸甲酯(103,1克,2·8‘6毫莫耳)於25毫升乙酸乙 酯之溶液中2分鐘,再於室溫下攪摔1小時。反應蒸發可生 成^2-酮基-3(5)-胺基-2,3,4,5-四氫苯並[1)][1,4]二氛雜萆-1-基 醋酸曱酯鹽酸,呈白色固趑。鹽酸鹽及氩化肉桂酸(0β47 -342- 本纸杀尺度適用中国国家揉準(CNS Μ4規格(210Χ297公釐) 1235157 Α7 Β7 經濟部中央標準局貝工消費合作·杜印¾ 五、發明説明( 340) 克,3.15毫莫耳)溶入20毫升二曱替曱醢胺中,並冷郤至 。二異丙基乙胺(1毫升,5.72毫莫耳)加至溶液中,再加N-每基笨並三唑及1·(3·二甲胺基丙基)-3-乙|碳化二亞按鹽 說3經在;I:溫下挽拌18小時後,混合物以15 0毫升乙酸乙 醋稀釋,再以10。/❶硫酸氫鈉,1〇%碳酸氫鈉,及鹽水洗滌 3有機層於無水硫酸鈉上乾燥,過濾,並蒸發生成粗製固 鳢,其再以快速層析純化並以7:3乙酸乙酯/二氯曱烷溶雜 可生成600毫克(55%)標題化合物呈白色固鳢。1H NMR (CDCi3) &amp; 7.3-6.85 (9H, m), 6.55-6.0 (1H, d), 4.88-4.82 (1H, m), 4.72-4.65 (1H, d), 4.28-4.22 (1H, m), 3.95-3.9 (1H, m), 3.78 (3H, s), 3.65 (1H, br, s), 3.28-3.2 (1H, m), 2.95-2.84 (2H, m), 2.55-2.4 (2H,m)。 (3〇(3-苯基丙醯胺基)-2-酮基-2,3,4,5-四氫苯並〇][1,4]二 氮雜箪-1-基)乙酸(1〇5a)(3(S)-(3-苯基丙醯胺基)-2-酮基-2,3,4,5·四氫-苯並[b][l,4]二氮雜箪-1-基)乙酸甲酯(l〇4a)溶 於90%甲醇。加氫氧化鋰-水合物至反應中,反應在室溫下 攪摔4小時。反應於眞空下蒸發以生成白色固體。此溶於 20毫升水中,再酸化至ρΗ5,並以乙酸乙酯萃取以生成304 毫克(88%)標題化合物爲白色固鳢。111讨%11(〇0(:13)&amp;7.5- 6.9 (11Η, m), 4.92-4.8 (1H, m), 4.7-4.58 (1H, d), 4.38 -4.25 (1H, d), 3.88-3.78 (1H, m), 3.45-3.25 (1H, m), 3.05-2.85 (2H, m), 2.55-2.45 (2H, m)。 4-酮基-3(S)-{2-[2-酮基-3(SH3-苯基丙醢胺基)·2,3,4,5-四氩 -笨並[b][l,4]二氣雜苯-1-基乙睡胺基}丁酸(1〇6a)。Ν·[1-(2- -343· (請先《讀背面之注意事項 -Kl^lPrinted by the Male Workers Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs of China [2-keto-3 (3)-(3-phenylpropanamido) -2,3,4,5-tetra-argon-benzo [1] ] [1,4] Diazafluoren-1-yl] fluorenyl acetate (104a). Anhydrous argon chloride effervesces to (3 (S) -third-butoxycarbonylamino-2-keto-2,3,4,5-tetrahydro · benzo [b] [l, 4] diazepine Hetero-1-yl) methyl acetate (103,1 g, 2.8'6 mmol) in 25 ml of ethyl acetate solution for 2 minutes, and then stirred at room temperature for 1 hour. Evaporation of the reaction can generate 2-keto-3 (5) -amino-2,3,4,5-tetrahydrobenzo [1]] [1,4] diazepine-1-ylfluorenyl acetate Hydrochloric acid, white solid. Hydrochloride and arginized cinnamic acid (0β47 -342- This paper is suitable for Chinese national standards (CNS M4 specification (210 × 297mm)) 1235157 Α7 Β7 Shellfish consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs · Du Yin Instructions (340) grams, 3.15 mmoles are dissolved in 20 ml of diamidine, and cooled to. Diisopropylethylamine (1 ml, 5.72 mmoles) is added to the solution, then N-perbenztriazole and 1 · (3 · dimethylaminopropyl) -3-ethyl | carbodiimide according to the salt 3 times; I: After stirring at room temperature for 18 hours, the mixture starts at 15 0 The organic layer was diluted with 10 mL of ethyl acetate, washed with 10% sodium bisulfate, 10% sodium bicarbonate, and brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and evaporated to form a crude solid. Analysis and purification with 7: 3 ethyl acetate / dichloromethane produced 600 mg (55%) of the title compound as a white solid. 1H NMR (CDCi3) &amp; 7.3-6.85 (9H, m), 6.55- 6.0 (1H, d), 4.88-4.82 (1H, m), 4.72-4.65 (1H, d), 4.28-4.22 (1H, m), 3.95-3.9 (1H, m), 3.78 (3H, s), 3.65 (1H, br, s), 3.28-3.2 (1H, m), 2.95-2.84 (2H, m), 2. 55-2.4 (2H, m). (3〇 (3-phenylpropylamido) -2-one-2,3,4,5-tetrahydrobenzo 0] [1,4] diaza Fluoren-1-yl) acetic acid (105a) (3 (S)-(3-phenylpropionamido) -2-one-2,3,4,5 · tetrahydro-benzo [b] [1,4] Diazapyridin-1-yl) methyl acetate (104a) was dissolved in 90% methanol. Lithium hydroxide-hydrate was added to the reaction, and the reaction was stirred at room temperature for 4 hours. Reaction Evaporate under vacuum to form a white solid. This was dissolved in 20 ml of water, acidified to pH 5 and extracted with ethyl acetate to yield 304 mg (88%) of the title compound as a white solid. 111% 11 (〇0 ( : 13) &amp; 7.5- 6.9 (11Η, m), 4.92-4.8 (1H, m), 4.7-4.58 (1H, d), 4.38 -4.25 (1H, d), 3.88-3.78 (1H, m), 3.45-3.25 (1H, m), 3.05-2.85 (2H, m), 2.55-2.45 (2H, m). 4-keto-3 (S)-{2- [2-keto-3 (SH3- Phenylpropylamido). 2,3,4,5-tetraargon-benz [b] [l, 4] digasheterophenyl-1-ylethoxyamino} butanoic acid (106a). Ν · [1- (2- -343 · (Please read "Precautions on Back" -Kl ^ l

•IT• IT

本绝杀尺度適用中國國家揉準(CNS ) A4規格(210X297公釐) 1235157 Λ7 Β7 起濟部中央揉率局負工消費合作·杜印衷 五、發明説明(糾)爷氧基-5-酌基四氫g夫喘-3-基胺曱趋基·曱基)_2-·基-2,3,4,5·四氫-1H-苯並[b][l,4]二氮雜萆·3_基]-3-苯基丙醢胺,以製備化合物Η (Α步驟)之方法製備自1(35a,可生成390 毫克(93%)產物,呈#對映;立體異構物3 NMR (CD3OD)&amp; 7.58-7.22 (14H,m),5·78ο·73 (0.5H,d),5.64 (0.5H,s), 5.0-4.72 (4H, m), 4.54-4.42 (2H, m), 3.82-3.76 (0.5H, m), 3.68-3.62 (0.5H, m), 3.28-3.21 (0.5H, m), 3.19-3.12 (0.5H, m), 3.07-2.98 (2H, m)? 2.78-2.48 (4H, m) 〇 生成的產物以製備化合物H _(D步驟)之方法轉化成丨06a ,可生成標題化合物呈白色固體(17%)..¾ NMR (CD3〇D) &amp; 7.54^6.98 (9H, m), 5.58-5.44 (1H, m), 4.8-4.2 (4H, m), 3.96· 3.3 (2H, m), 3.30-3.05 (1H, m), 2.98-2.25 (5H, m)-[2-酮基-5-(3-苯基丙醯基)-3(SH3-苯基丙醯胺基)-2,3,4,5-四氩苯並[b][l,4]二氮雜箪-1-基]醋酸甲酯(104b) 3無水的 氯化氫泡騰至(3(S)-第三-丁氧羰基胺基-2-酮基-2,3,4,5-四 氩,笨並[b][l,4]二氮雜箪-1·基)醋酸甲酯(1〇3,1克,2.86毫 莫耳)於25毫升乙酸乙酯的溶液中歷2分鐘,再於室滠下攪 拌1小時。反應蒸發可生成2-酮基-3(S)-胺基·2,3,4,5-四氫 苯並[b] [1,4]二氮雜箪-1-基乙酸甲酯鹽酸鹽爲白色固體3 鹽酸鹽懸浮於20毫升二氣甲烷中再冷卻至〇aC。加三乙胺 (1.6毫升,ΐι·5毫莫耳)至懸液中·,再逐滴加入二氫肉桂睦 基氣(〇·9毫升,6毫莫耳)。混合物加温至室溫再攪拌18小 時。混合物以25毫升二氣甲烷稀釋,再以50毫升水洗二次 及以50毫升鹽水洗一次。有機層於無水硫酸鈉上乾燥,過 -344- 本纸伕尺度逯用中国國家標率(CNS )从坑袼(2l0x297公釐) 讀先之注奉項 7冬頁) .装· 訂This lore scale applies to China's National Standards (CNS) A4 (210X297 mm) 1235157 Λ7 Β7 Duo Yinzhong, Central Government Bureau of Ministry of Economic Affairs, Consumer Affairs Cooperation, Du Yinzhong V. Invention Description (Correction) Yeoxy-5- Syltetrahydrog-pentan-3-ylamine, fluorenyl, fluorenyl) _2- · yl-2,3,4,5 · tetrahydro-1H-benzo [b] [l, 4] diaza萆 · 3-yl] -3-phenylpropanamide, prepared from 1 (35a) by the method of preparing compound Η (step A), can produce 390 mg (93%) of the product, which is the # enantiomer; stereoisomers 3 NMR (CD3OD) &amp; 7.58-7.22 (14H, m), 5.78ο · 73 (0.5H, d), 5.64 (0.5H, s), 5.0-4.72 (4H, m), 4.54-4.42 (2H , m), 3.82-3.76 (0.5H, m), 3.68-3.62 (0.5H, m), 3.28-3.21 (0.5H, m), 3.19-3.12 (0.5H, m), 3.07-2.98 (2H, m)? 2.78-2.48 (4H, m). The produced product was converted to 06a by the method of preparing compound H (step D). The title compound was obtained as a white solid (17%). ¾ NMR (CD3〇D ) &amp; 7.54 ^ 6.98 (9H, m), 5.58-5.44 (1H, m), 4.8-4.2 (4H, m), 3.96 · 3.3 (2H, m), 3.30-3.05 (1H, m), 2.98- 2.25 (5H, m)-[2-keto-5- (3-phenylpropanyl) -3 (SH3-phenylpropanylamino) -2,3,4,5-Tetraargon benzo [b] [l, 4] diazafluoren-1-yl] methyl acetate (104b) 3 Anhydrous hydrogen chloride effervesces to (3 (S) -th Tris-butoxycarbonylamino-2-keto-2,3,4,5-tetraargon, benzo [b] [l, 4] diazafluoren-1 · yl) methyl acetate (103 , 1 g, 2.86 mmol) in 25 ml of ethyl acetate solution for 2 minutes, and then stirred for 1 hour under room temperature. Evaporation of the reaction can produce 2-keto-3 (S) -amino · 2, 3,4,5-Tetrahydrobenzo [b] [1,4] Diazapyridin-1-ylacetic acid methyl ester hydrochloride is a white solid. 3 The hydrochloride is suspended in 20 ml of digas methane and cooled to 〇aC. Add triethylamine (1.6 ml, 5 mmol) to the suspension, and then add dihydrocinnamo (0.9 ml, 6 mmol) dropwise. Warm the mixture to Stir for another 18 hours at room temperature. The mixture was diluted with 25 ml of digas methane, washed twice with 50 ml of water and once with 50 ml of brine. The organic layer was dried over anhydrous sodium sulfate and used at -344- China's National Standards (CNS) read from the first note (2l0x297 mm) from Fengxiang 7 Winter Pages.

1235157 A7 B7 經濟部中央標隼局員工消费合作社印裂 五、發明説明(w) 濾,並蒸發生成黏稠的黃色油,再以快速層析純化並以 1:1乙酸乙錯/二氣甲烷溶離可生成1.35克(92%)標題產物爲 白色固體。1H NMR (CDC13) &amp; 7.45-7.02 (14H,m),6.37-6.32 (1H,d),4.78-4.72 (1H, m), 4·52-4·3 (3H, m), 3.82-3.77 (1H, m), 3.74 (3H, s), 3.03-2.87 (4H, m), 2.58-2.45 (2H, m), 2.45-2.35 (1H,m),2.25-2.16 (1H, m)。 ^ [2-酮基-5-(3-苯基丙醯基)-3-(3-(S)-苯基丙醢胺基)·2,3,4,5-四氫苯並[b][l,4]二氮雜箪-1-基]乙酸(105b) M2-酮基-5-(3-苯基丙臨基)-3-(3-本基丙酶胺基)-2,3,4,5-四風本並[b][l,4] 二氮雜箪-1-基]乙酸甲酯(l〇4b; 680毫克,1·32毫莫耳)以 水解105a之步驟水解可生成645毫克(98%)標題化合物呈白 色固體。1HNMR(CDC13)&amp;7.58(lH,br,s),7.5-7.42(lH, m), 7.35-6.95 (14H, m), 4.95-4.88 (1H, m), 4.64-4.55 (1H, d), 4.54-4.45 (1H, t), 4.15-4.05 (1H, d), 3.75 (1H, m), 3.05-2.75 .(4H, m), 2.58-2.45 (2H, m), 2.45-2.28 (1H, m), 2.25-2.14 (1H, m)。 2-網基-3(S)-{2-[2-網基-5-(3-苯基丙基)-3(S)-(3-苯基·丙 醢胺基)-2,3,4,5-四氫苯並[13][1,4]二氮雜箪-卜基]乙琏胺基} 丁酸(106a)。[2-酮基-5-(3•苯基丙醢基)-3·(3-苯基丙醯胺基) -2,3,4,5-四氫苯並[b][1,4]二氮雜箪-1-基]乙酸及3·胺基-4-酮基丁酸第三-丁酯半卡巴腙,以化合物K (A步驟)之製備 步驟偶合以生成350毫克(85%)白色固體。iH NMR (CDC13) &amp; 9.05 (1H, br. s)? 7.58-7.55 (1H, d), 7.5-7.35 (1H, m), 7.35-6.95 (14H, m), 6.75-6.72 (1H, d), 6.25 (1H, br. s), 5.25 (1H, -345- (請先閱讀背面之洼意事項本頁)1235157 A7 B7 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. Description of the invention (w) It is filtered and evaporated to form a thick yellow oil. It is then purified by flash chromatography and dissolved in 1: 1 ethyl acetate / digas methane. This gave 1.35 g (92%) of the title product as a white solid. 1H NMR (CDC13) &amp; 7.45-7.02 (14H, m), 6.37-6.32 (1H, d), 4.78-4.72 (1H, m), 4.5-52-4 · 3 (3H, m), 3.82-3.77 (1H, m), 3.74 (3H, s), 3.03-2.87 (4H, m), 2.58-2.45 (2H, m), 2.45-2.35 (1H, m), 2.25-2.16 (1H, m). ^ [2-keto-5- (3-phenylpropionamido) -3- (3- (S) -phenylpropionamido) · 2,3,4,5-tetrahydrobenzo [b ] [l, 4] Diazapyridin-1-yl] acetic acid (105b) M2-keto-5- (3-phenylpropionyl) -3- (3-benzylpropionylamine) -2 , 3,4,5-Tetrabenzyl [b] [l, 4] Diazapyridin-1-yl] acetic acid methyl ester (104b; 680 mg, 1.32 mmol) to hydrolyze 105a Step hydrolysis gave 645 mg (98%) of the title compound as a white solid. 1HNMR (CDC13) &amp; 7.58 (lH, br, s), 7.5-7.42 (lH, m), 7.35-6.95 (14H, m), 4.95-4.88 (1H, m), 4.64-4.55 (1H, d) , 4.54-4.45 (1H, t), 4.15-4.05 (1H, d), 3.75 (1H, m), 3.05-2.75. (4H, m), 2.58-2.45 (2H, m), 2.45-2.28 (1H , m), 2.25-2.14 (1H, m). 2-netyl-3 (S)-{2- [2-netyl-5- (3-phenylpropyl) -3 (S)-(3-phenyl · propylamido) -2,3 , 4,5-tetrahydrobenzo [13] [1,4] diazapyrene-b-yl] acetamido} butanoic acid (106a). [2-keto-5- (3 • phenylpropionamido) -3 · (3-phenylpropionamido) -2,3,4,5-tetrahydrobenzo [b] [1,4 ] Diazapyridin-1-yl] acetic acid and 3 · amino-4-ketobutyric acid third-butyl hemicarbazone, coupled with the preparation step of compound K (step A) to yield 350 mg (85% ) White solid. iH NMR (CDC13) &amp; 9.05 (1H, br. s)? 7.58-7.55 (1H, d), 7.5-7.35 (1H, m), 7.35-6.95 (14H, m), 6.75-6.72 (1H, d ), 6.25 (1H, br. S), 5.25 (1H, -345- (Please read this page's notice on the back page)

Order

本纸伕尺度適用中国国家標率(CNS ) A4規格(210X297公釐) 1235157 AT B7The paper scale is applicable to China National Standards (CNS) A4 specifications (210X297 mm) 1235157 AT B7

br. s),4.95-4.88 (1H,m),4.8-4.72 (1H,m),4.554 mu (2H, m), 3.92-3.88 (1H,d), 3.73.3.68 (1H, m),2·95-2·8 (4H m) ? 8 2.72 (1H, m), 2.62-2.55 (1H, m), 2.55-2.45 (iu ’ V m), 2.4-2.3^ (1H, m), 2.2-2.12 (1H, m), 1.45 (9H, s) 1 4-酮基-3-{2-[2-酮基-5-(3-苯基丙醯基贫甘 P本基丙醯胺基 )-2,3,4,5,-四氫苯並[b][l,4]二氮雜箪-1-基]•乙螓基铵基}丁_ 酸第三·丁酯半卡巴脖,如化合物K (C步樣)製備之方法▲ 保護之可生成118毫克(47%)的標題化合物呈白备田祕 7 NMR (CD3OD) &amp; 7·48-6·95 (14H,m),4·65·4·15 (6H m) 3 5 3·4 (1H,m),2.85-2.72 (4H,m), 2·65-2·5 (1H,m),2 5·2 34 (3H,m),2.34-2.15 (2H, m)。 經濟部中央標準局员工消费合作社印¾ [5-芊基-2-酮基-30)-(3-苯基丙醢胺基)·2,3,4,5-四氫笨並 [b][M]二氮雜箪-1-基]乙酸甲酯(104c)。[2-酮基笨基 丙醯基胺基)-2,3,4,5-四氫苯並[b][l,4]二氮雜箪-丨·基]乙酸 曱酯(104a : 500毫克,1.31毫莫耳,碳酸鈣(155毫克,us 毫莫耳)及芊基溴(170微升,1.44毫莫耳)以10毫升二曱替 曱醯胺吸收,再加熱至80eC歷8小時。混合物以150毫升乙 酸乙酯稀釋,再以50毫升水洗4次。有機層於無水碳酸鈉 上乾燥,過濾並蒸發生成黏稠的黃色油狀物,其以快速層 析纯化並以二氣甲烷/乙酸乙酯(8:2)溶離以生成460毫克 (75%)標題化合物呈白色固^'iHNMRCCDCld&amp;TJ#- 7.05 (14H, m), 6.32-6.28 (1H, d), 4.84-4.76 (1H, d), 4.76-4.70 (1H, m), 4.43-4.37 (1H, d), 4.26-4.18 (1H, d), 4.06-4.00 (1H, d), 3.79 (3H, s), 3.45-3.37 (1H, m), 3.02-2.95 (1H, m), 2.90- 1 346· 本纸伕尺度速用中国国家標率(CNS &gt; A4規格(210X297公釐) Ϊ235157 翅濟部中夬樣準局貝X消费合作社印«. Λ 7 Β7五、發明説明( 344) ' 2.82 (2H, m), 2.5-2.34 (2H, m) ^ [54基-2-闕基-3(S)-(3-苯基两龜胺基)·2,3,4 5•四氫-苯並 [b][l,4]二氮雜箪-1-基]乙酸(l〇5c)之製備係以實例⑶“之 方法水解酿(102c)而得’生成450毫克(98%)的標題化合物 爲白色固體:¾ NMR (CD3OD) &amp; 7·5-7·05 (14H,m), 6 /(1H, br· s),4.85-4.55 (2H,m),4·5-4·21 (2H,m),4.12-3.92 (1H,d), 3.45-3.3 (1H, m), 3.1-2.8 (3H, m), 2.55^2.28 (3H, m) 3 ,’ 3(S)-{2-[5-芊基-2-酮基-3-(3-(S)·苯基丙醯胺基^2 3 4 5-四 氫苯並[b][l,4]二氮釋革-1-基丁乙驢胺基卜‘網某丁酸 (106c) 3 [5-苄基-2-酮基-3(S)-(3-苯基丙醯胺基)_2,345_四 氣-豕並[b][l,4] 一亂雜革-1-基]乙酸及3(S)-胺基-4-飼某丁 酸第三-丁醋半卡巴膝’以化合物K(步黎A)製法的偶合, 並可生成260毫克(85%)的白色固體:【Η NMR (CD3OD) &amp; 7.35-7.0 (15H, m)? 4.94-4.88 (1H, m), 4.68-4.58 (1H, d), 4.57-4.52 (1H, m)? 4.41-4.34 (1H, d), 4.3^4.23 (1H, d), 4.1-4.04 (1H, d), 3.18-3.11 (1H, m), 3.09-2.98 (1H, m), 2.78-2.72 (2H,t),2.65-2.57 (1H, m),2·42,2·33 (3H,m)。 3(3)-{2-[5-字基-2-明基-3(5)-(3-苯基丙睦胺基)-2,3,4,5-四氫 表並[b][l,4]« —乳雜卓-1-基]乙酷胺基}-4·嗣基丁酸第三-丁 酯半卡巴腙,如化合物K之製法(C步骤)般去保護,可生成 .168毫克(81%)的標題化合物爲白' 色固體。lH NMR (CD3OD) &amp; 7.37-7.0 (14H, m), 4.75-4.62 (1H, m), 4.6-4.45 (2H, m), 4.4-4.21 (2H, m), 4.15-3.95 (2H, m), 3.15-3.0 (2H, m), 2.82-2·67 (2H, m),2.65-2.52 (1H, m), 2.5-2.32 (3H,m)。 -347- 本纸尺度通用中g國家標李(CNS )以故格(210X297公釐) (請先聞讀背面之注意事項br. s), 4.95-4.88 (1H, m), 4.8-4.72 (1H, m), 4.554 mu (2H, m), 3.92-3.88 (1H, d), 3.73.3.68 (1H, m), 2 95-2 · 8 (4H m)? 8 2.72 (1H, m), 2.62-2.55 (1H, m), 2.55-2.45 (iu 'V m), 2.4-2.3 ^ (1H, m), 2.2- 2.12 (1H, m), 1.45 (9H, s) 1 4-keto-3- {2- [2-keto-5- (3-phenylpropylamidino lean P-propylpropylamidoamino) -2,3,4,5, -tetrahydrobenzo [b] [l, 4] diazafluoren-1-yl] • ethylammonium} butyric acid third · butyl ester half-carbaba neck, For example, the preparation method of compound K (step C) ▲ Protected to produce 118 mg (47%) of the title compound was Bai Beitian 7 NMR (CD3OD) &amp; 7 · 48-6 · 95 (14H, m), 4 · 65 · 4 · 15 (6H m) 3 5 3 · 4 (1H, m), 2.85-2.72 (4H, m), 2.65-2 · 5 (1H, m), 2 5 · 2 34 (3H, m), 2.34-2.15 (2H, m). Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs [5-fluorenyl-2-keto-30)-(3-phenylpropanamido) · 2,3,4,5-tetrahydrobenz [b] [M] Diazafluoren-1-yl] methyl acetate (104c). [2-ketobenzylpropylamidoamino) -2,3,4,5-tetrahydrobenzo [b] [l, 4] diazapyrene- 丨 · yl] fluorenyl acetate (104a: 500 Mg, 1.31 millimoles, calcium carbonate (155 mg, us millimoles) and fluorenyl bromide (170 microliters, 1.44 millimoles) were absorbed in 10 milliliters of dimethoxamine and heated to 80eC for 8 hours The mixture was diluted with 150 ml of ethyl acetate and washed 4 times with 50 ml of water. The organic layer was dried over anhydrous sodium carbonate, filtered and evaporated to give a viscous yellow oil, which was purified by flash chromatography and evaporated with methane / Ethyl acetate (8: 2) was dissolved to produce 460 mg (75%) of the title compound as a white solid ^ iHNMRCCDCld &amp; TJ #-7.05 (14H, m), 6.32-6.28 (1H, d), 4.84-4.76 (1H , d), 4.76-4.70 (1H, m), 4.43-4.37 (1H, d), 4.26-4.18 (1H, d), 4.06-4.00 (1H, d), 3.79 (3H, s), 3.45-3.37 (1H, m), 3.02-2.95 (1H, m), 2.90- 1 346 · This paper's standard scale is a fast-moving Chinese national standard (CNS &gt; A4 size (210X297 mm)) Bei X consumer cooperative seal «. Λ 7 Β7 V. Description of the invention (344) '2.82 (2H, m), 2.5-2.34 (2H, m) ^ [54 基 -2 -Fluorenyl-3 (S)-(3-phenylbispyridylamine) · 2,3,4 5 · tetrahydro-benzo [b] [l, 4] diazafluoren-1-yl] acetic acid The preparation of (105c) was carried out by hydrolysis of (102c) by the method of Example (3) to give 450 mg (98%) of the title compound as a white solid: ¾ NMR (CD3OD) &amp; 7. · 5-7.05 (14H, m), 6 / (1H, br · s), 4.85-4.55 (2H, m), 4.5-5-4.21 (2H, m), 4.12-3.92 (1H, d), 3.45-3.3 (1H, m), 3.1-2.8 (3H, m), 2.55 ^ 2.28 (3H, m) 3, '3 (S)-{2- [5-fluorenyl-2-keto-3- (3- (S) · Phenylpropionamido ^ 2 3 4 5-tetrahydrobenzo [b] [l, 4] diazepine-1-ylbutanylaminobutyric acid (106c) 3 [5-Benzyl-2-keto-3 (S)-(3-phenylpropylamidoamino) _2,345_tetrakis-pyrono [b] [l, 4] Yiranza leather-1 -Yl] acetic acid and 3 (S) -amino-4-butyric acid butyric acid third-butyric acid semi-carbaba knee 'coupling by compound K (Bu Li A) production method, and can produce 260 mg (85%) White solid: [Η NMR (CD3OD) &amp; 7.35-7.0 (15H, m)? 4.94-4.88 (1H, m), 4.68-4.58 (1H, d), 4.57-4.52 (1H, m)? 4.41-4.34 (1H, d), 4.3 ^ 4.23 (1H, d), 4.1-4.04 (1H, d), 3.18-3.11 (1H, m), 3.09-2.98 (1H, m), 2.78-2.72 (2H, t), 2.65-2.57 (1H, m), 2.42, 2.33 (3H, m). 3 (3)-{2- [5-wordyl-2-benzyl-3 (5)-(3-phenylpropylamino) -2,3,4,5-tetrahydroepi [b] [ l, 4] «—Lazazol-1-yl] ethoxyamido} -4. tertiary-butyric acid tertiary-butyl hemicarbazone, deprotected as in the method of compound K (step C), can be generated .168 mg (81%) of the title compound was a white 'colored solid. lH NMR (CD3OD) &amp; 7.37-7.0 (14H, m), 4.75-4.62 (1H, m), 4.6-4.45 (2H, m), 4.4-4.21 (2H, m), 4.15-3.95 (2H, m ), 3.15-3.0 (2H, m), 2.82-2 · 67 (2H, m), 2.65-2.52 (1H, m), 2.5-2.32 (3H, m). -347- This paper is standard Chinese national standard plum (CNS) with the old standard (210X297 mm) (please read the precautions on the back first)

本頁) 訂(This page)

1235157 Λ / Β7 五、發明説明(w)1235157 Λ / Β7 V. Description of the invention (w)

107 R: ο α107 R: ο α

b R: 108b R: 108

CHj R: jyp 2.6- 二氯苯曱酸4-第三e丁氧羰基·2.酮基·3⑻_{2-[2•萌基、二 (3-苯基丙醯基)-3(S)、(3_苯基丙醢胺基)-2,3,4 5-四氫·笨遂 [b][l,4]二氮雜卓-1-基]乙醢基·胺基丨丁酯(1〇7幻。生·成之丰 卡巴腙以化合物l〇5b與3·(烯丙氧羰基胺基)-4-酮基·5-(2,心 二氯苄鏟氧基)戊酸第三·丁酯(W〇 93 16710)偶合而製備, 生成256毫克(58%)標題化合物,呈白色固鳢3 lH nmr (CDC13) &amp; 7.45-7.04 (17H, m), 6.45-6.34 (2H, m), 5.28-5.21 * 經濟部中央標準局員工消費合作社印装 (1H, m), 5.1-5.0 (1H, m), 4.95-4.90 (1H, m), 4.75-4.70 (1H,-m), 4.55-4.44 (1H? m), 4.32-4.22 (1H, dd), 3.99-3.85 (1H, dd), 3.85-3.76 (1H, m)? 3.06-2.83 (5H, m), 2.83-2.74 (1H, m), 2.6-2.44 (2H, m), 2.43-2.33 (1H, m), 2.24-2.15 (1H, m), 1.45 (9H, s)。 2.6- 二氯苯曱酸4-羧基-2,酮基-3(S)-{2-[2-酮基-5-(3-苯基两 -348- 本紙伕Λ度逋用中§园家標準(CNS M4说格(2!〇X297公釐) 1235157 Λ7 B7 超濟部申央橾率局貝工消费合作社印¾ 五、發明説明(w) 醯基)-3(S)-(3-苯基两鏟胺基)-2,3,4,5·四氫苯並[b][i,4]二氮 雜苯-1-基]乙酸胺基}丁醋(108 a)製備自i〇7a,利用化合勃 57a所述之方法,可生成156毫克(68%)標題化合物呈白色 固鳢。^ NMR (CD3OD) &amp; 7.5-6.9 (17H, m), 5.16ο.02 (1Η, dd), 4.88-4.71 (2H, m), 4.62-4.44 (2H, m), 4.42-4.28 (2H, m), 4.27-4.18 (1H, m), 3.47-3,41 (1H, m), 2.90-2.60 (5H, m), 2.46·2·4 (2H, m), 2.39-2.18 (2H, m” · 4-(7-甲氧基苯並,号唑-2-基)-4-酮基-3(S)-{2-[2-鲷基〇-(3-苯 基丙鏟基)-3(5)-(3-苯基丙醯胺基)-2,3,4,5-四氫笨显[1&gt;][1,4] 二II雜苯-卜基]-乙睡胺基}丁酸(108 b)以化合物69a所述之 方法製備,可生成標題化合物(50%)呈白色固體。iH NMR (CD3〇D) &amp; 7.41-6.88 (17H, m), 5.6-5.55 (0.5H, t), 5.48-5.43 (0.5H, t), 4.64-4.45 (2H, m), 4.45-4.30 (1H, m), 3.93 (1.5H, s), 3.90 (1.5H, s), 3.47-3.34 (1H, m), 3.10-2.85 (2H, m), 2.84-2.63 (5H,m), 2·6-2·4 (2H, m), 2·3-2·1 (2H, m)。CHj R: jyp 2.6- dichlorophenylarsinic acid 4- tertiary e-butoxycarbonyl · 2. Keto · 3 {_ {2- [2 • moenyl, bis (3-phenylpropanyl) -3 (S) , (3-Phenylpropanamido) -2,3,4 5-tetrahydro · stupid [b] [l, 4] diazalide-1-yl] ethenylamino (107). Sengzhifeng Carbamate uses compound 105b and 3 · (allyloxycarbonylamino) -4-keto · 5- (2, cardiodichlorobenzyloxy) pentanoic acid Tertiary butyl ester (WO93 16710) was prepared by coupling to yield 256 mg (58%) of the title compound as a white solid 3 lH nmr (CDC13) &amp; 7.45-7.04 (17H, m), 6.45-6.34 ( 2H, m), 5.28-5.21 * Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (1H, m), 5.1-5.0 (1H, m), 4.95-4.90 (1H, m), 4.75-4.70 (1H,- m), 4.55-4.44 (1H? m), 4.32-4.22 (1H, dd), 3.99-3.85 (1H, dd), 3.85-3.76 (1H, m)? 3.06-2.83 (5H, m), 2.83- 2.74 (1H, m), 2.6-2.44 (2H, m), 2.43-2.33 (1H, m), 2.24-2.15 (1H, m), 1.45 (9H, s). 2.6- Dichlorobenzoic acid 4- Carboxyl-2, keto-3 (S)-{2- [2-keto-5- (3-phenylbis-348-)-This paper is used in § Garden Standards (CNS M4 Saoge (2 ! 〇X297 mm) 1235157 Λ 7 B7 Printed by the Shellfish Consumer Cooperative of Shenyang Municipal Bureau of the Ministry of Super Economy ¾ V. Description of the Invention (w) fluorenyl) -3 (S)-(3-phenyldiaminoamine) -2,3,4,5 Tetrahydrobenzo [b] [i, 4] diazaphen-1-yl] acetamido} butyl acetic acid (108 a) is prepared from i07a, using the method described in Chemical 57b, which can produce 156 Mg (68%) of the title compound as a white solid. ^ NMR (CD3OD) &amp; 7.5-6.9 (17H, m), 5.16ο.02 (1Η, dd), 4.88-4.71 (2H, m), 4.62-4.44 (2H, m), 4.42-4.28 (2H, m), 4.27-4.18 (1H, m), 3.47-3,41 (1H, m), 2.90-2.60 (5H, m), 2.46 · 2 · 4 ( 2H, m), 2.39-2.18 (2H, m "· 4- (7-methoxybenzo, zol-2-yl) -4-one-3 (S)-{2- [2-bream The group 0- (3-phenylpropanyl) -3 (5)-(3-phenylpropanamido) -2,3,4,5-tetrahydrobenzyl [1 &gt;] [1,4] DiIIheterophenyl-butyryl] -acetoamino} butanoic acid (108 b) was prepared by the method described in compound 69a to give the title compound (50%) as a white solid. iH NMR (CD3〇D) &amp; 7.41-6.88 (17H, m), 5.6-5.55 (0.5H, t), 5.48-5.43 (0.5H, t), 4.64-4.45 (2H, m), 4.45-4.30 (1H, m), 3.93 (1.5H, s), 3.90 (1.5H, s), 3.47-3.34 (1H, m), 3.10-2.85 (2H, m), 2.84-2.63 (5H, m), 2 6-2 · 4 (2H, m), 2 · 3-2 · 1 (2H, m).

122 o a 123 (請先閲讀背面之注意事項122 o a 123 (Please read the notes on the back first

本頁) 訂 124(This page) Order 124

125 O125 O

349- 本紙伕尺度通用中國國家橾孪(CNS ) 格(210X297公釐) 1235157 Λ/ B7 經濟部中央樣準局負工消费合作社印製 五、發明説明(撕) (jS)N-(烯丙氧羰基)·3-胺基-5-(2-氣苯基曱硫基酮基·戊 酸第三-丁酯(123)。氟化鉀(273毫克,4.70亳莫耳)及2-氯 笨基曱基硫醇(373毫克,2.35毫莫耳)先後j至(3S)N-(缔丙 氧基幾基)-3-腔基-5-漠基-戊酸第三-丁 g旨(122: 74 9毫 克,2.14毫莫耳;WO 93 16710)於二曱替曱醯胺(2〇毫升) 之授拌么液中3混合物授掉3.5小時,加水緣冷(5〇毫升)再 以乙酸乙醋萃取(2 X 50毫升)。混合的有機萃取物以水(4 χ 50毫升)再以鹽水(50毫升)洗滌。之後乾燥(MgS〇4)並濃縮 生成油狀物,以快速層析純化(10-35%乙酸乙酯/己烷)生成832毫克(91%)無色晶體:m.p. 45-6°C; [a]D20-i9.03 (c 1.0 CH2C12); IR (film) 3340, 2980, 293 5, 1725, 1712, 151 1,1503, 1474, 1446, 1421, 1393, 1368, 1281, 1244, 1157, 1052, 1040, 995, 764, 739; lR NMR (CDC13) &amp; 7.36 (2H, m), 7.21 (2H, m), 5.91 (2H, m), 5.27 (2H, m)4.76 (1H, m), 4.59 (2H, d), 3.78 (2H, s), 3.36 (2H, m), 2.91 (1H, dd), 2.74 (1H, dd), 1.43 (9H, s)。分析 C2〇H26C1N05S之計算値:C, 56.13; H, 6.12; N,3.27; S, 7.49 -實測値:C, 56.08; Η, 6·11; N,3.26; S, 7.54。MS (C.I.) 430/28 (M+ + 1, 3%), 374/2 (100) 〇 (3S) 3(2(6-苄基-1,2-二氫-2-酮基-3(3-苯基两醢胺基)-卜吡 啶基)乙醢胺基〇-(2-氯苯基曱硫基)-4-酮基戍酸第三-丁酯 (124a)。6·芊基-1,2-二氩-2-酮基:3-(3-苯基丙醯胺基)-吡啶 基乙酸(52b: 300毫克,〇·76毫莫耳)於THF (7毫升)以卜羥 基笨並三唑(205毫克,1·52毫莫耳)及1-(3-二甲胺基丙基-3· 乙基琰化二亞胺鹽酸)攪摔。3分鐘後,加水(2滴)且混合物 -350- 本紙伕尺度通用中g國家標孪(CNS ) A4規格(210X297公釐) (讀先聞讀背面之注意事項 kl 訂349- This paper is in the standard Chinese National Twin (CNS) format (210X297 mm) 1235157 Λ / B7 Printed by the Consumers ’Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (tear) Oxycarbonyl) · 3-Amino-5- (2-Gaphenylphenylsulfanylketone · Ter-butyl valerate (123). Potassium fluoride (273 mg, 4.70 mol) and 2-chloro Benzylfluorenyl mercaptan (373 mg, 2.35 mmol) j to (3S) N- (alanoxypropyl) -3-cavity-5-molyl-valeric acid tert-butyl g (122: 74 9 mg, 2.14 mmol; WO 93 16710) 3 mixtures were mixed in a solution of diazepam (20 ml) for 3.5 hours, and then water-cold (50 ml) was added. Extract with ethyl acetate (2 x 50 ml). The combined organic extracts were washed with water (4 x 50 ml) and then brine (50 ml). It was then dried (MgS04) and concentrated to form an oil, which was quickly Chromatographic purification (10-35% ethyl acetate / hexane) yielded 832 mg (91%) of colorless crystals: mp 45-6 ° C; [a] D20-i9.03 (c 1.0 CH2C12); IR (film) 3340, 2980, 293 5, 1725, 1712, 151 1, 1503, 1474, 1446, 1421, 1393, 1368, 1281, 1244, 1157, 1052, 1040, 995, 764, 739; lR NMR (CDC13) &amp; 7.36 (2H, m), 7.21 (2H, m), 5.91 (2H, m), 5.27 (2H, m) 4.76 (1H, m), 4.59 (2H, d), 3.78 (2H, s), 3.36 (2H, m), 2.91 (1H, dd), 2.74 (1H, dd), 1.43 (9H, s) Analysis of the calculation of C20H26C1N05SS: C, 56.13; H, 6.12; N, 3.27; S, 7.49-Measured 値: C, 56.08; Η, 6. · 11; N, 3.26; S, 7.54. MS (CI) 430/28 (M + + 1, 3%), 374/2 (100) 〇 (3S) 3 (2 (6-benzyl-1,2-dihydro-2-keto-3 (3-phenyl Fluorenylamino) -pyridinyl) acetamidinyl 0- (2-chlorophenylphosphoniumthio) -4-ketophosphonic acid tert-butyl ester (124a). 6.fluorenyl-1,2- Diargon-2-one: 3- (3-phenylpropionamido) -pyridylacetic acid (52b: 300 mg, 0.76 mmol) in THF (7 ml) (205 mg, 1.52 millimoles) and 1- (3-dimethylaminopropyl-3 · ethylphosphonium diimide hydrochloride). After 3 minutes, add water (2 drops) and the mixture -350- This paper has a common national standard (CNS) A4 size (210X297 mm) (read the first note and read the precautions on the back kl)

東· 1235157 Μ濟部中央標準局貝工消費合作杜印装 Λ7 _______B7__________ 五、發明説明(348) 授拌10分鐘再以(3S)N-(缔丙氧羧基)-3-按基氯笨基曱 硫基)·4-_基戊酸第三-丁酯(123)(325毫克,〇·76毫莫耳), 雙(三苯膦)鋁(II)化氣(20毫克)及氫化三丁病(〇·6毫升,2.28 毫莫耳)處理。混合物在室溫下授拌5小時,倒入乙酸乙薛 中再以1Μ HC1水溶液(X 2),碳酸氫鈉水溶液,鹽水冼滌 ,乾燥(iMgS04)並濃縮。殘留物以戊烷研磨再丟棄上清液 。層析(矽膠,50%乙酸乙酯/己烷)可生成無色的泡沫狀物 (439毫克,81%):[從]D2i-18.3。(c 〇·5, CH2C12); iR (KBr) 3356, 33 1 1,1722, 1689, 1646, 1599, 1567, 1513, 1367, 1 154; 屯 NMR (CDC13) &amp; 8·39 (1Η,d), 8·23 (1Η,s),7·24 (14Η,m), 6.16 (1H, d), 4.95 (1H, m), 4.63 (2H, m), 4.02 (2H, s), 3.74 (2H, s), 3.27 (2H, s), 2.85 (6H, m), 1.40 (9H, s) ^ 分析 C39H42C1N306S之計算値:C, 65·39; Η, 5·91; N, 5.87。實測値 :C,65.51; H,5.99; N, 5·77。 [3S(1S,9S)-3-(6,10-二酮基-1,2,3,4,7,8,9,10-八氫)-9-(3-苯基 丙醢胺基)-6H-嗒啩[l,2-a][l,2]二氮雜箪-1·羧醢胺〇-(2-氣 苯基曱硫基)-4-酮基戊酸第三-丁酯(124b)以類似124a之相 似方法製備自硫醚123及3S(1S,9S)-3-(6,10-二酮基-l,2,3,4,7,8,9,10-八氫)-9-(3_苯基丙醢胺基)-6ί^,答啩並[l,2-a][l,2]二氮雜萆-卜羧酸(45a),可生成452毫克(50%)無色泡 沫 imp 55-7eC ; [a ]D22-94.0° (c 0··12, CHflA IR (KBr) 3288, 2934, 1741, 1722, 1686, 1666, 1644, 1523, 1433, 1260, 1225, 1146, 757; 1H NMR (CDC13) &amp; 7.35 (3H, m), 7.20 (7H, m), 6.46 (1H, d), 5.21 (1H, m), 4.97 (2H, m), 4.56 (1H, m), 3.75 -351 - 本纸伕尺度通用中§國家標準(匚:^)八4说格(2丨(^297公釐) (請先絮讀背云之:Vi意事¾ ---裝-- 本一 aoEast · 1235157 Μ The Central Bureau of Standards of the Ministry of Economic Affairs of the People's Republic of China Shellfish Consumer Cooperation Du Yinzhang Λ7 _______B7__________ V. Description of the Invention (348) After 10 minutes of mixing, (3S) N- (propoxycarbonyl) -3-benzylchlorobenzyl Sulfenyl) -tertiary-butyl 4-- valerate (123) (325 mg, 0.76 mmol), bis (triphenylphosphine) aluminum (II) gasification (20 mg) and trihydrogen Ding disease (0.6 ml, 2.28 mmol) was treated. The mixture was stirred at room temperature for 5 hours, poured into ethyl acetate and then washed with 1M aqueous HC1 solution (X 2), aqueous sodium bicarbonate solution, brine, dried (iMgS04) and concentrated. The residue was triturated with pentane and the supernatant was discarded. Chromatography (silica gel, 50% ethyl acetate / hexane) gave a colorless foam (439 mg, 81%): [from] D2i-18.3. (C 〇 · 5, CH2C12); iR (KBr) 3356, 33 1 1, 1722, 1689, 1646, 1599, 1567, 1513, 1367, 1 154; Tun NMR (CDC13) &amp; 8.39 (1Η, d ), 8.23 (1Η, s), 7.24 (14Η, m), 6.16 (1H, d), 4.95 (1H, m), 4.63 (2H, m), 4.02 (2H, s), 3.74 ( 2H, s), 3.27 (2H, s), 2.85 (6H, m), 1.40 (9H, s) ^ Analysis of the calculation of C39H42C1N306S 値: C, 65 · 39;;, 5.91; N, 5.87. Found 値: C, 65.51; H, 5.99; N, 5.77. [3S (1S, 9S) -3- (6,10-diketo-1,2,3,4,7,8,9,10-octahydro) -9- (3-phenylpropionamido ) -6H-Da [1,2-a] [l, 2] diazepine-1 · carboxyamidoamine 0- (2-Gaphenylphenylsulfanyl) -4-ketovaleric acid Butyl ester (124b) was prepared from thioethers 123 and 3S (1S, 9S) -3- (6,10-diketonyl-1,2,3,4,7,8,9,10 in a similar manner to 124a. -Octahydro) -9- (3-phenylpropylamidoamino) -6ί ^, which can be combined with [l, 2-a] [l, 2] diazapyrene-carboxylic acid (45a), which can generate 452 mg (50%) colorless foam imp 55-7eC; [a] D22-94.0 ° (c 0 · 12, CHflA IR (KBr) 3288, 2934, 1741, 1722, 1686, 1666, 1644, 1523, 1433, 1260, 1225, 1146, 757; 1H NMR (CDC13) &amp; 7.35 (3H, m), 7.20 (7H, m), 6.46 (1H, d), 5.21 (1H, m), 4.97 (2H, m), 4.56 (1H, m), 3.75 -351-The standard of this paper is universal. § National Standard (匚: ^) 八四 格格 (2 丨 (^ 297 mm) (Please read the back of the cloud: Vi intentions first ¾ --- install-Ben Yi ao

•IT• IT

1235157 Λ/ . ___________Β7 五Λ發9說明() (2Η,s), 3.2〕〇Η,m),2.93 (5Η,m),2.71 (1Η,dd),2·55 (2Η, m),2.30 (1H,m),1.92 (3H,m),1·66 (2H,m),1·42 (9H,s)。 分析 C35H43C1N407S · 〇·25Η20之計算値:C,59:73; H,6.23; Cl, 5.04; N,7·96; S,4.56。實測値:C,59 73; H,6 19; cl,5 1〇; n, 7.79; S,4.58。MS (-FAB) 697 (M-l,100)。 (3S)3(2-(6-笮基·1,2·二氫-2-酮基-3-(3-苯基丙醢基铵基)-1- 吡啶基)乙酿胺基-5-(2-氯苯基曱硫基 酮基戊酸(125a)3- (2-(6-芊基- I,2·二氫·2·酮基-;3-(3-苯基丙醯胺基)_卜吡嚏基) 乙Si基-按基_5·(2-氣苯基甲疏基)·‘酮基戊酸第三·丁酯 (124a)(4〇〇毫克’ 〇·56毫莫耳)於二氣甲烷(3毫升),在yc 下以三氟醋酸(3毫升)處理再於0下攪掉1小時及室沍下〇.5 小時。溶液濃縮再溶於二氯甲烷並再濃缩。此步骤重覆三 次。殘留物於乙瞇中攪摔1小時並過濾生成無色固鳢(364 毫克,99%):165-7eC; 〇]d22-27.7。(c 0.2, CH2Cl2); IR (KBr) 3289, 1712, 1682, 1657, 1645, 1593, 1562, 1527, 1497, 1416, 1203? 1182; ιΗ NMR (CDC13) d 8.47 (1Η, d), 8.21 (1H? s), 7.70 (1H, d), 7.22 (14H, m), 6.24 (1H, d), 5.03 (1H, m), 4.65 (2H, m), 4.06 (2H, s), 3.69 (2H, m), 3.23 (2H, m), 2.88 (6H, m) 3 經濟部中央樣準局員工消费合作社印裝 [3S(1S,9S)]-3-(6,10-二酮基-1,2,3,4,7,8,9,10-八氫)-9-(3-苯 基丙酷胺基味並[l,2-a][l,2]二氮雜卓- l- 幾趋腔基· 5-(2-氣苯基-曱硫基)-4-酮戊酸(125b),以類似125a之方法 製備自第三-丁酯124b,可生成362毫克(93%)無色粉末:mp 76-80Ό ; [^ ]d2Li34° (c 0.10, MeOH); IR (ΚΒγ) 3309, 2935, •352- _大纸泫尺度遝用中国国家標準(CNS ) Α4規格(2丨0:&lt;297公度1 : ^ 1235157 Λ7 B7 五、發明説明(挪) 1725, 1658, 1528, 1445, 1417, 1277, 1219, 1 175; NMR (D6-DMSO) &amp; 8.80 (1H, d), 8.19 (1H, d), 7.31 (9H, m), 5.09 (1H, m), 4.74 (1H, m), 4.63 (1H? m), 4.35 (ΙΗ^ιη), 3.76 (2H, m), 3.28 (3H, m), 2.80 (5H, m), 2.52 (4H, m), 2.16 (2H, m), 1.90 (3H, m)。分析 C31H35C12N4〇7S . 0·25Η2Ο之計算値:C, 57.49; Η, 5.53; Ν,8·65; S,4.95。實測値:C,57·35; H,5·43; N,8.45; S,4.88。MS (-FAB) 641 (M-l,100)。1235157 Λ /. ___________B7 Five Λ issued 9 Explanation () (2Η, s), 3.2] 〇Η, m), 2.93 (5Η, m), 2.71 (1Η, dd), 2.55 (2Η, m), 2.30 (1H, m), 1.92 (3H, m), 1.66 (2H, m), 1.42 (9H, s). Analysis C35H43C1N407S. Calculated at 25.20: C, 59:73; H, 6.23; Cl, 5.04; N, 7.96; S, 4.56. Found 値: C, 59 73; H, 6 19; cl, 5 10; n, 7.79; S, 4.58. MS (-FAB) 697 (M-1, 100). (3S) 3 (2- (6-fluorenyl · 1,2, dihydro-2-keto-3- (3-phenylpropanyl ammonium) -1-pyridyl) ethylamino-5 -(2-chlorophenylphosphoniumthioketovaleric acid (125a) 3- (2- (6-fluorenyl-I, 2 · dihydro · 2 · keto-); 3- (3-phenylpropionamidine Amino group) -Pyridinyl group) Ethyl-Alkyl-5 · (2-aminophenylmethylsulfanyl) · 'Ketovaleric acid tert-butyl ester (124a) (400 mg' 〇 · 56 millimoles) in digas methane (3 ml), treated with trifluoroacetic acid (3 ml) under yc, and then stirred off at 0 for 1 hour and at room temperature for 0.5 hours. The solution was concentrated and then dissolved in dichloromethane. Methane and reconcentration. This step was repeated three times. The residue was stirred in acetone for 1 hour and filtered to form a colorless solid hydrazone (364 mg, 99%): 165-7eC; 〇] d22-27.7. (C 0.2, CH2Cl2); IR (KBr) 3289, 1712, 1682, 1657, 1645, 1593, 1562, 1527, 1497, 1416, 1203? 1182; ιΗ NMR (CDC13) d 8.47 (1Η, d), 8.21 (1H? S) , 7.70 (1H, d), 7.22 (14H, m), 6.24 (1H, d), 5.03 (1H, m), 4.65 (2H, m), 4.06 (2H, s), 3.69 (2H, m), 3.23 (2H, m), 2.88 (6H, m) 3 Printed by the Consumer Cooperatives of the Central Sample Bureau of the Ministry of Economic Affairs [3S (1S, 9S)]-3- (6, 10-diketo-1,2,3,4,7,8,9,10-octahydro) -9- (3-phenylpropionamine odor [[1,2, a]] [1,2] ] Diazatril-l-Chitosyl, 5- (2-Gasphenyl-fluorenylthio) -4-ketovaleric acid (125b), prepared from tertiary-butyl ester 124b in a similar manner to 125a, Can produce 362 mg (93%) of colorless powder: mp 76-80Ό; [^] d2Li34 ° (c 0.10, MeOH); IR (ΚΒγ) 3309, 2935, • 352- _ Large paper 泫 scale using Chinese national standards ( CNS) A4 specification (2 丨 0: &lt; 297 degrees 1: ^ 1235157 Λ7 B7 V. Description of the invention (Norway) 1725, 1658, 1528, 1445, 1417, 1277, 1219, 1 175; NMR (D6-DMSO) &amp; 8.80 (1H, d), 8.19 (1H, d), 7.31 (9H, m), 5.09 (1H, m), 4.74 (1H, m), 4.63 (1H? m), 4.35 (ΙΗ ^ ιη) , 3.76 (2H, m), 3.28 (3H, m), 2.80 (5H, m), 2.52 (4H, m), 2.16 (2H, m), 1.90 (3H, m). Analysis C31H35C12N4〇7S. Calculated from 0.25 to 20: C, 57.49; C, 5.53; N, 8.65; S, 4.95. Found 値: C, 57 · 35; H, 5.43; N, 8.45; S, 4.88. MS (-FAB) 641 (M-1, 100).

ilik! 201 2·氣苯基甲基碘。2-氯苯基甲基溴(4克,19.47毫莫耳)及 Nal (14克,97.33毫莫耳)於丙酮(40毫升)之混合物在迴流 下攪拌1小時。反應混合物冷卻,過濾並眞空濃縮3殘留 物以己烷研磨再過濾。溶液眞空濃縮,且生成的沽以快速 層析(矽膠,己烷)純化可生成標題化合物(4.67克,63%)呈 油狀:!Η NMR (CDC13) &amp; 7·34 (4H, m), 4.54 (2H, s)。 經濟部中央標準局5工消费合作社印衷 (3S)N·(烯丙氧羰基)-3-胺基-5-(2-氣苯基甲氧基)-4·酮基戊 酸第三-丁酯(201)。(3S)N-(烯丙氧羰基)-3-胺基-5-羥基-4-辆基戍酸第三-丁薛(81, Chapman, et al.,Bioorg. &amp; Med. Chem· Lett·· 2, ρρ· 613-618 (1992)0.144克,〇·5毫莫耳)及 2-氣苯基甲基碘(0.569克,1.5毫莫耳)於CH2C12(4毫升)與氧 化銀(0.231克,1毫莫耳)劇烈攪掉,並在38eC下加熱40小 -353 本纸伕尺度通用中國國家標率(CNS M4規格(2丨0X297公釐) 1235157 A, B7___ 五、發明説明(351 ) 時3反應混合物冷卻’過遽並条發遽液3殘留物以快迷層 析純化(麥鏐,0-20%乙酸乙酯於己燒)可生成產物呈無色ilik! 201 2 · Phenylmethyl iodide. A mixture of 2-chlorophenylmethyl bromide (4 g, 19.47 mmol) and Nal (14 g, 97.33 mmol) in acetone (40 ml) was stirred at reflux for 1 hour. The reaction mixture was cooled, filtered and concentrated in vacuo. The residue was triturated with hexane and filtered. The solution was concentrated in vacuo, and the resulting product was purified by flash chromatography (silica gel, hexane) to give the title compound (4.67 g, 63%) as an oil:! Η NMR (CDC13) &amp; 7.34 (4H, m) , 4.54 (2H, s). (3S) N · (allyloxycarbonyl) -3-amino-5- (2-aminophenylmethoxy) -4 · ketovaleric acid Butyl ester (201). (3S) N- (allyloxycarbonyl) -3-amino-5-hydroxy-4-carboxylic acid tertiary-butyrate (81, Chapman, et al., Bioorg. &Amp; Med. Chem. Lett · 2, ρρ · 613-618 (1992) 0.144 g, 0.5 mmol) and 2-Gaphenylphenyliodide (0.569 g, 1.5 mmol) in CH2C12 (4 ml) and silver oxide ( 0.231g, 1 millimolar) vigorously stirred, and heated at 38eC for 40 hours -353 paper standard standard Chinese national standard (CNS M4 specification (2 丨 0X297 mm) 1235157 A, B7___ V. Description of the invention ( 351) When the 3 reaction mixture was cooled, the residue was dried and purified, and the residue was purified by fast chromatography (Mai, 0-20% ethyl acetate in hexane). The product was colorless.

油狀(0.138克,67〇/〇);[a]D24+3.9° (c NMR (CDC13) &amp; 7.37 (4H, m), 5.88 (2H,m),5·26 (2H,m),4·69 (2H, s), 4.57 (3H, m), 4.50 (1H, d), 4.35 (1H, d), 3.03 (1H, dd), 2·76 (1H,dd),1.42 (9H,s)。Oily (0.138 g, 67〇 / 〇); [a] D24 + 3.9 ° (c NMR (CDC13) &amp; 7.37 (4H, m), 5.88 (2H, m), 5.26 (2H, m), 4.69 (2H, s), 4.57 (3H, m), 4.50 (1H, d), 4.35 (1H, d), 3.03 (1H, dd), 2.76 (1H, dd), 1.42 (9H, s).

202 203 204 經濟部中央標率局貝工消资合作杜印¾ 5,7·二氯苯並呤唑(203)。2,4-二氣·6-硝基酚(202,40克含 有20%永汽)於EtOAc(500毫升)的溶液,利用MgS04乾燥, 過濾且濾塊以少量EtOAc洗滌。加入Pd/c (5%硫化物化-2克) 且混合物氫化直到H2停止攝入爲止。加入原甲酸三乙裔 (160毫升)及對位甲苯磺酸(160毫克)且混合物迴流4小時, 冷卻及以過濾移去耗盡之催化劑後溶液以飽和的NaHC03 溶液,水及鹽水洗綠,以MgS〇4乾澡再蒸發至乾。以己运 研磨可生成固趑,過濾收集,以己烷洗再乾燥可生成標題 化合物(25.5克,88%)爲晶狀固體:mp 98-99Ό; IR (KBr) 3^119, 1610, 1590, 1510, 1452, 1393, 1296, 1067, 850; ιΚ NMR (CDCi3) &amp; 8.16 (1H, s), 7.69 (1H, d, J=1.9), 7.42 (1H, d, J=1.9);分析 C7H3C12N0之計算値:C, 44.72; Η, 1·61; N, 7.45; Cl, 37.70。實測値:C, 44.84; Η, 1·69; N, 7.31;.C1, 37.71。 -354· 本纸铗尺度通用中国國家標孪(CNS ) A4規格(210X297公釐) &quot;&quot; 1235157 Λ7 B7 五、發明説明(怒2)202 203 204 Shellfish consumer and capital cooperation of the Central Bureau of Standards, Ministry of Economic Affairs, Du Yin ¾ 5,7. Dichlorobenzoxazole (203). A solution of 2,4-digas · 6-nitrophenol (202, 40 g with 20% pervapor) in EtOAc (500 ml), dried over MgS04, filtered and the filter cake was washed with a small amount of EtOAc. Pd / c (5% sulfide-2 g) was added and the mixture was hydrogenated until the H2 intake ceased. Triethyl orthoformate (160 ml) and p-toluenesulfonic acid (160 mg) were added and the mixture was refluxed for 4 hours. After cooling and removing the spent catalyst by filtration, the solution was washed with saturated NaHC03 solution, water and brine, Dry with MgS04 and evaporate to dryness. Grinding with hexane can produce solid hydrazone, which can be collected by filtration, washed with hexane, and dried to give the title compound (25.5 g, 88%) as a crystalline solid: mp 98-99Ό; IR (KBr) 3 ^ 119, 1610, 1590 , 1510, 1452, 1393, 1296, 1067, 850; ικ NMR (CDCi3) &amp; 8.16 (1H, s), 7.69 (1H, d, J = 1.9), 7.42 (1H, d, J = 1.9); analysis Calculation of C7H3C12N0 値: C, 44.72; Η, 1.61; N, 7.45; Cl, 37.70. Found 値: C, 44.84; Η, 1.69; N, 7.31; .C1, 37.71. -354 · The standard of this paper is the standard of China National Standard (CNS) A4 (210X297mm) &quot; &quot; 1235157 Λ7 B7 V. Description of the invention (Ang 2)

經濟部中央樣準局貝工消費合作社印3L (3S,4RS)N-(烯丙氧羰基)-3-胺基-4·羥基-4-(5,7-二氯苯並吟 嗅-2-基)丁酸第三-丁薛(204)。溴化鎂之製備係蔣Mg (7.45 克,0.30莫耳)於tHf(516毫升)與12(50毫克)及1,2-二溴乙 烷(26.3毫升,57.3克,0.30莫耳)在迴流下反應2小時,再 冷卻至-4(TC。在上述經由導管快速加入2-鋰〇,7-二氯苯 並呤吱在7CTC之溶液(由5,7·二氯苯並哼唑(203,28.9克, 0.154莫耳)及丁基鋰(1〇〇毫升,1.52M於己烷)於THF(150毫 升)在7CTC下製備)。混合物在-40eC下攪拌1小時,再冷卻 至-7CTC,之後加入(3S)N-(烯丙氧羰基)-3-胺基-4·飼基-丁 酸第三-丁 §旨(Chapman, ei al·,Bioorg. &amp; Med. Chem. Lett·,2, pp· 613-618 (1992))(20.3 克,0.078莫耳)於 THF (160 毫升)之 溶液,於低於-60°C下進行。令反應加溫至環境溫度,攪 拌16小時再加氣化銨溶液中止,並以1:1己烷··乙酸乙酯600 毫升萃取。有機溶液以水及鹽水洗滌,以1^£504乾燥並蒸 發成糖漿狀(52.9克)。快速層析(Si〇2 250克己烷·· CH2C12 X 2,CH2C12,5% EtOAc於 CH2C12,10% EtOAc於 CH2C12,20%EtOAc於CH2C12)可生成不純產物24·6克,其 再進一步層析(Si02 1:1己烷:乙醚)可生成標題化合物,呈 金黃-综色玻璃狀物(22.7克,64%); IR(薄膜)3343, 2980, 1723, 1712, 1520, 1456, 1398, 1369, 1254, 1 158, 993; lR NMR (CDC13) &amp; 7.60 (1H, m), 7.3t (1H, m),5·72 (1H, m), 5.64 (0.5H, d), 5.10 (2.5H, m), 4.7-4.J (4H, m), 2.9-2.6 (2H, m),1.46及 1.42 (9H混合的,2 x s)。MS ES+ Da/e 445 (M + 1)+ Cl 35 62%,447 (M + 1)+ Cl 37 40%, 389 100%。 -355 - 本軼ft尺度逯用中国國家標準(CNS ) A4^格(2〖0X297々A ) 1235157 Λ7 Β: 經濟部中央標準局貝工消费合作社印51 五、發明説明( i-Bu 丨3L (3S, 4RS) N- (allyloxycarbonyl) -3-amino-4 · hydroxy-4- (5,7-dichlorobenzopyrinol-2 -Yl) Butyric acid tertiary-Ding Xue (204). The preparation of magnesium bromide was Jiang Mg (7.45 g, 0.30 mol) in tHf (516 ml) with 12 (50 mg) and 1,2-dibromoethane (26.3 ml, 57.3 g, 0.30 mol) under reflux. The reaction was allowed to proceed for 2 hours, and then cooled to -4 ° C. The 2-lithium 〇, 7-dichlorobenzoxine in 7CTC solution (from 5,7 · dichlorobenzohumazole (203 , 28.9 g, 0.154 mol) and butyl lithium (100 ml, 1.52 M in hexane) in THF (150 ml) prepared at 7 CTC). The mixture was stirred at -40 eC for 1 hour and then cooled to -7 CTC. Then, (3S) N- (allyloxycarbonyl) -3-amino-4 · pyroyl-butyric acid tertiary-butyric acid was added (Chapman, ei al ·, Bioorg. &Amp; Med. Chem. Lett · , 2, pp · 613-618 (1992)) (20.3 g, 0.078 mol) in THF (160 ml) was performed at a temperature below -60 ° C. The reaction was warmed to ambient temperature and stirred for 16 hours The addition of gasified ammonium solution was stopped and extracted with 600 ml of 1: 1 hexane · ethyl acetate. The organic solution was washed with water and brine, dried over 1 ££ 504 and evaporated to a syrupy form (52.9 g). Fast layer Analysis (Si〇2 250 g of hexane ·· CH2C12 X 2, CH2C12, 5% EtOAc in CH2C12, 10% EtOAc in CH2C12, 20% EtOAc in CH2C12) can produce 24.6 g of impure product, which can be further chromatographed (Si02 1: 1 hexane: ether) to generate the title Compound, golden-colored glass (22.7 g, 64%); IR (thin film) 3343, 2980, 1723, 1712, 1520, 1456, 1398, 1369, 1254, 1 158, 993; lR NMR (CDC13) &amp; 7.60 (1H, m), 7.3t (1H, m), 5.72 (1H, m), 5.64 (0.5H, d), 5.10 (2.5H, m), 4.7-4.J (4H, m), 2.9-2.6 (2H, m), 1.46 and 1.42 (9H mixed, 2 xs). MS ES + Da / e 445 (M + 1) + Cl 35 62%, 447 (M + 1) + Cl 37 40%, 389 100%. -355-This ft standard uses the Chinese National Standard (CNS) A4 ^ (2 〖0X297々A) 1235157 Λ7 Β: Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 51 V. Invention Description (i-Bu 丨

Alloc—NH (b) S R 205a 205b i-BuC^C^^^oH Alloc—NH 206a 206bAlloc—NH (b) S R 205a 205b i-BuC ^ C ^^^ oH Alloc—NH 206a 206b

HH

Alloc-NH 〇 208a 208bAlloc-NH 〇 208a 208b

(2S)-N-烯丙氧羰基-5-(1,卜二甲基乙基)穀胺酸(205a)。對 THF(200毫升)k水(100毫升)含有NaHC〇3(16.6克,0·2莫 耳)之混合物中加入穀胺酸第三-丁酯(10克,49.2毫莫耳) 3再以20分鐘逐滴加''入氯曱酸缔丙醋(6.8毫升,64毫莫耳) 。混合物攪掉2小時,以EtOAc萃取,以飽和碳酸氫鹽溶 液。水及鉋和鹽水溶液洗滌,乾燥並蒸發成油205a (9.5克 ,67.2%): [a ]D20-6o (c 1.5, MeOH)屯 NMR (D,6-DMSO) &amp; 6.10 (1H, d), 5.96-5.88 (1H, m), 5.31-5.12 (2H, m), 4.45 (2H, m), 3.90-3.84 (1H, t), 2.18 (2H, m), 1.85-1.76 (2H, m), 1.36 (9H,s)。 · · (2R)-N-烯丙氧羰基-5-(1,1,-二曱基乙基)穀胺酸酯(205b), 以類似205a之方法製備可生成無色油狀(6.27克,88%):[泛 ]D20+16e (c 0.095, MeOH); IR (KBr) 3678, 3332, 3088, 2980, -356-(2S) -N-allyloxycarbonyl-5- (1, dimethyldimethyl) glutamate (205a). To a mixture of THF (200 ml) and K water (100 ml) containing NaHC03 (16.6 g, 0.2 mol) was added tert-butyl glutamate (10 g, 49.2 mmol). Add chloropropanoic acid (6.8 ml, 64 mmol) dropwise over 20 minutes. The mixture was stirred for 2 hours, extracted with EtOAc, and a saturated bicarbonate solution. Washed with water and planer and saline solution, dried and evaporated to oil 205a (9.5 g, 67.2%): [a] D20-6o (c 1.5, MeOH) Tun NMR (D, 6-DMSO) &amp; 6.10 (1H, d ), 5.96-5.88 (1H, m), 5.31-5.12 (2H, m), 4.45 (2H, m), 3.90-3.84 (1H, t), 2.18 (2H, m), 1.85-1.76 (2H, m ), 1.36 (9H, s). (2R) -N-allyloxycarbonyl-5- (1,1, -dimethylethyl) glutamate (205b) can be prepared in a similar manner to 205a to produce a colorless oil (6.27 g, 88%): [PAN] D20 + 16e (c 0.095, MeOH); IR (KBr) 3678, 3332, 3088, 2980, -356-

本纸乐尺度通用中国國家揉準(CNS ) Α4規格(210X297公釐) :235157The paper scale is universal Chinese National Standard (CNS) Α4 size (210X297 mm): 235157

AT B7 五、發明説明(奴) 2937, 1724,1530, 1453, 1393, 1370, 133 1,1255, 1 155, 1056, 995, 935, 845, 778, 757, 636, 583; lH NMR (CDC13) &amp; 9.24 讀 讀 背 面 之 注 意 % (1H,寬 s), 5.94-5.79 (1H, m), 5.58 (1H, d),5·3ΐο·17 (2H, m), 4.55 (2H, d),4.3S-4.31 (1H,m),2.41-1.95 (4H,in), 1.42 (9H, s);分析 C13H21N〇6i 計算値:C,54.35; H,7.37; N,4.88。實 測値:C,54.4; H,7·5; N,4·8。 (4S)N-烯丙氧羰基-4-胺基o-羥基戊酸第三-丁酯(206a)。對 205a (3.6克,12.5毫莫耳)於THF (100毫升)之溶液,在(TC 下加入N-甲基鳴福琳(1.5毫升,13毫莫耳)再加氣甲酸異丁 酯(1.1毫升,13毫莫耳)。15分鐘後,此混合物加至-78X: 下 NaBH4(0.95 克,25 毫莫耳)於 THF(100 毫升)及 MeOH(25 M濟部中央樣準局員工消费合作杜印装 毫升)之懸液中。在-7(TC下2小時後,混合物加醋酸驟冷 ,以EtoAc稀釋,以铯和的碳酸氫鹽溶液洗3次,再以水及 飽和的鹽溶液洗滌,乾燥再蒸發。快速層析(2% MeOH於 CH2Cl2)可生成 206a呈無色油狀(2.4 克,70%):[泛]〇20-10。(c 3.88, CH2CI2); lH NMR (CDC13) &amp; 5.84 (1H, m), 5.34-5.17 (3H, m), 4.56-4.53 (2H, m), 3.68-3.59 (2H, m), 2.98 (1H, m), 2·40·2·30 (2H, t), 1·84·1·78 (2H, m), 1·43 (9H, s);分 析 C13H23N5之計算値:C, 57.13; H,8·48; N,5.12。實測値:C, 57.1; H,8.6; Ν, 6·0 〇 (4R)N-烯丙氧羰基·4·按基·5-控篡戊酸第三-丁酯(2〇6b), 以類似206a之方法製備,可生成標題化合物呈淺黃色油趺 (3.42克,57%)[以]D2〇+14 (c 〇 166, Me〇H); IR (KBr) 3341, 3083, 2976, 2936, 2880, 1724, 1533, 1454, 1419, 1369, 1332, -357· 本纸伕尺度適用中國國家標準(CNS ) Α4現格(21〇&gt;&lt;297公笼 1235157 Α7 Β7 五、發明説明(班) 1251,1156, 1062, 997, 933, 846, 777, 647;屯 NMR (CDC13) &amp; 5.980.81 (1H, m), 5.35〇;10 (3H, m), 4.55 (2H, d), 3.70-3·56 (3H,m), 2.50-2.47 (1H,寬 s),2·37-2·30 (2H,m),1 · 89, 1.74 (2H,m),1·44 (9H,s);分析 C13H23N05之計算値:c, H,8.48; N, 5.12。實測値:C,56.9; H,8·6; N,5.6 3 (4 S)N-缔丙氧裝基-4-腔基·5-萌基戊酸第三-丁旨旨(207 a) 3對 DMSO(1.51克,19·3毫莫耳)於CH2C12(25毫升)於-7〇3C之溶 液中加入單醯氣(1.34克,19.3毫莫耳)。在-70°(:下10分鐘 後,(206a)(2.4克,8.8毫莫耳]於CH2C12(10毫升)之溶液逐 滴加入,且混合物授掉於-7〇eC下15分鐘。加入二異丙基 乙胺(3.4克,26.3毫莫耳)且混合物在-25Ό下攪拌15分鐘, 再以EtoAc (50毫升)稀釋並以2M硫酸氩鈉溶液洗滌,濃缩 生成油狀物,可立即使用勿需再純化:iH NMR (CDC13) &amp; Μ濟部中央標牟局員工消费合作社印¾ 9.5 (1H, s), 6.0ο.5 (2H, m), 5.5-5.1 (2H, m), 4.5 (2H, m), 4.2 (1H, m), 2.4-2.10 (2H, m), 2.05 (2H, m), 1.36 (9H, s) ^ (4R)N-#丙氧羰基-4-胺基-5-酮基戊酸第三-丁酯(207b), 以類似207a之方法製備,可生成油狀物(2 95克,96%),此 可使用勿需於下一步驟中進一步純化:[dD2〇+2i° (c 0.942, MeOH); lH NMR (CDC13) &amp; 9.58 (1H, s), 6.05-5.80 (1H, m), 5.57 (1H,寬 s), 5·35-5·18 (2H,m), 4·56 (2H, d), 4.34-4.24 (1H, m), 2.38-2.16 (3H, m), 1.96-f.73 (1H, m), 1.43 (9H, s) ^ (4S)N-烯丙氧寒基-4-胺基·5-酮戊酸第三-丁酯半卡巴月宗 (208a)。對270a (2.39克,8.8毫莫耳)於MeOH (20毫升)之溶 液中加入酷酸鈉(〇·72克,8.8毫莫耳)及半卡巴賠(0.98克, -358 - 本紙佚尺度通用令国國家揉率(CNS M4規格(2丨0X297公釐) 1235157 Λ7 B7 五、發明说明(撕: S.8莫耳),攪拌一夜,濃縮並以CH2C12(100毫升)稀釋,以 水洗,乾燥再濃縮3快速層析(2% MeOH於CHfW可生成 208狂(2.1〇克,73%)呈沽狀:[泛]1)20-21(。2.53°,(:112(:12);111 NMR (CDC13) &amp; 9.98 (1H, s), 7.27 (1H, d), 5.8 (1H, m), 5.5 (1H, d), 5.35-5.19 (2H, m), 4.58 (2H, m), 4.14 (1H, m), 2.37 (2H, t), 2.09 (1H,m), 2.0-1.75 (2H,m);分析 C14H24N4〇5之計 算値:C,51.21; H, 7.37; N,17.06。實測値:C,50·2; H,7.3; N, 16.1 - (HR)N-烯丙氧羰基-4-胺基o-酮基戊酸第三-丁酯半卡巴腙 (208b),以類似208a之方法製備,可生成玻璃狀沽(2.37克 ,66%)[a]D20+ 30 (c 0.26, CHC13); IR (KBr) 3476, 3360, 2979, 2923, 1700, 1586, 1527, 1427, 1394, 1369, 1338, 1253, 1 156, 1060, 997, 929, 846, 775; 1H NMR (CDC13) &amp; 9.87 (1H, s), 7.09 (1H, d), 6.05-5.75 (3H, m), 5.58 (1H, d), 5.32-5.16 (2H, m), 4.54 (2H, d), 4.35 (1H, m), 2.32-2,26 (2H, m), 2.15-1.55 (2H, m),1·41 (9H, s);分析 C〖4H24N405之計算値:C,51.21; H, -裝-- (請先閎讀背面之注意事項本頁)AT B7 V. Description of Invention (Slave) 2937, 1724, 1530, 1453, 1393, 1370, 133 1, 1255, 1 155, 1056, 995, 935, 845, 778, 757, 636, 583; lH NMR (CDC13) &amp; 9.24 Read the note on the back% (1H, width s), 5.94-5.79 (1H, m), 5.58 (1H, d), 5. · 3ΐο · 17 (2H, m), 4.55 (2H, d), 4.3S-4.31 (1H, m), 2.41-1.95 (4H, in), 1.42 (9H, s); analysis C13H21N06i calculation 値: C, 54.35; H, 7.37; N, 4.88. Measured radon: C, 54.4; H, 7.5; N, 4 · 8. (4S) N-allyloxycarbonyl-4-amino o-hydroxyvaleric acid tert-butyl ester (206a). To a solution of 205a (3.6 g, 12.5 mmol) in THF (100 ml) was added N-methyl triamline (1.5 ml, 13 mmol) at TC followed by isobutyl formate (1.1 Ml, 13 millimoles). After 15 minutes, this mixture was added to -78X: NaBH4 (0.95 g, 25 millimoles) in THF (100 ml) and MeOH (25 M, Central Bureau of Standards, Ministry of Economic Affairs, Consumer Cooperation) Du printed in ml) suspension. After 2 hours at -7 (TC, the mixture was quenched with acetic acid, diluted with EtoAc, washed 3 times with cesium and bicarbonate solution, and then with water and saturated saline solution. Wash, dry and evaporate. Flash chromatography (2% MeOH in CH2Cl2) can produce 206a as a colorless oil (2.4 g, 70%): [PAN] 0-20-10. (C 3.88, CH2CI2); lH NMR (CDC13 ) &amp; 5.84 (1H, m), 5.34-5.17 (3H, m), 4.56-4.53 (2H, m), 3.68-3.59 (2H, m), 2.98 (1H, m), 2.40 · 2 · 30 (2H, t), 1.84 · 1 · 78 (2H, m), 1.43 (9H, s); Analysis of the calculation of C13H23N5 値: C, 57.13; H, 8.48; N, 5.12. Measured値: C, 57.1; H, 8.6; Ν, 6.0 · (4R) N-allyloxycarbonyl · 4 · yl group · 5-trimethylpentanoic acid tert-butyl ester (206b), Prepared in a similar manner to 206a, the title compound can be produced as a pale yellow oleic acid (3.42 g, 57%) [to] D20 + 14 (c 〇166, Me〇H); IR (KBr) 3341, 3083, 2976, 2936 , 2880, 1724, 1533, 1454, 1419, 1369, 1332, -357 · The standard of this paper is applicable to Chinese National Standard (CNS) Α4 (21〇 &gt; &lt; 297 public cage 1235157 Α7 Β7) 5. Description of the invention ( Class) 1251, 1156, 1062, 997, 933, 846, 777, 647; Tun NMR (CDC13) &amp; 5.980.81 (1H, m), 5.35〇; 10 (3H, m), 4.55 (2H, d) , 3.70-3 · 56 (3H, m), 2.50-2.47 (1H, width s), 2.37-2 · 30 (2H, m), 1.89, 1.74 (2H, m), 1.44 ( 9H, s); Analysis of the calculation of C13H23N05: c, H, 8.48; N, 5.12. Measured tritium: C, 56.9; H, 8.6; N, 5.6 3 (4 S) N-propionyl-4-cavity group; 5-Mengylvaleric acid, tertiary-butane purpose (207 a) To a solution of 3 pairs of DMSO (1.51 g, 19.3 mmol) in CH2C12 (25 ml) at -703C was added monogas (1.34 g, 19.3 mmol). After 10 minutes at -70 ° (:), (206a) (2.4 g, 8.8 mmol) was added dropwise in a solution of CH2C12 (10 ml), and the mixture was passed at -7OeC for 15 minutes. Add two Isopropylethylamine (3.4 g, 26.3 mmol) and the mixture was stirred at -25 ° F for 15 minutes, then diluted with EtoAc (50 ml) and washed with 2M sodium argon sulfate solution, concentrated to give an oil, which was immediately available. Use without further purification: iH NMR (CDC13) &amp; Μ printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 9.5 (1H, s), 6.0ο.5 (2H, m), 5.5-5.1 (2H, m) , 4.5 (2H, m), 4.2 (1H, m), 2.4-2.10 (2H, m), 2.05 (2H, m), 1.36 (9H, s) ^ (4R) N- # propyloxycarbonyl-4- Amino-5-ketovaleric acid third-butyl ester (207b), prepared in a similar manner to 207a, can form an oil (2 95 g, 96%), which can be used without further steps in the next step Purification: [dD20 + 2i ° (c 0.942, MeOH); lH NMR (CDC13) &amp; 9.58 (1H, s), 6.05-5.80 (1H, m), 5.57 (1H, width s), 5.35- 5.18 (2H, m), 4.56 (2H, d), 4.34-4.24 (1H, m), 2.38-2.16 (3H, m), 1.96-f.73 (1H, m), 1.43 (9H , s) ^ (4S) N-allyloxy-4-amino-5-ketopentanoic acid Tertiary-butyl ester hemicarbazine (208a). To a solution of 270a (2.39 g, 8.8 mmol) in MeOH (20 ml) was added sodium crucate (0.72 g, 8.8 mmol) and half Kappa (0.98g, -358-The standard of this paper is the same as the national kneading rate (CNS M4 specification (2 丨 0X297mm) 1235157 Λ7 B7) 5. Description of the invention (tear: S.8 Mor), stir overnight and concentrate Diluted with CH2C12 (100 ml), washed with water, dried and concentrated 3 flash chromatography (2% MeOH in CHfW can generate 208 mad (2.10 g, 73%) appears as: [PAN] 1) 20-21 ( 2.53 °, (: 112 (: 12); 111 NMR (CDC13) &amp; 9.98 (1H, s), 7.27 (1H, d), 5.8 (1H, m), 5.5 (1H, d), 5.35-5.19 (2H, m), 4.58 (2H, m), 4.14 (1H, m), 2.37 (2H, t), 2.09 (1H, m), 2.0-1.75 (2H, m); Analyze the calculation of C14H24N405 : C, 51.21; H, 7.37; N, 17.06. Found 値: C, 50 · 2; H, 7.3; N, 16.1-(HR) N-allyloxycarbonyl-4-amino o-ketovaleric acid third-butyl hemicarbazone (208b), Prepared in a similar way to 208a, which can produce glassy (2.37 g, 66%) [a] D20 + 30 (c 0.26, CHC13); IR (KBr) 3476, 3360, 2979, 2923, 1700, 1586, 1527, 1427, 1394, 1369, 1338, 1253, 1 156, 1060, 997, 929, 846, 775; 1H NMR (CDC13) &amp; 9.87 (1H, s), 7.09 (1H, d), 6.05-5.75 (3H, m) , 5.58 (1H, d), 5.32-5.16 (2H, m), 4.54 (2H, d), 4.35 (1H, m), 2.32-2,26 (2H, m), 2.15-1.55 (2H, m) , 1 · 41 (9H, s); Analysis of the calculation of C 【4H24N405 値: C, 51.21; H, -install-(Please read the precautions on the back page first)

*1T* 1T

經濟部中央標孪局員工消费合作社印装 211 7.3 7; N,17.06。實測値:C, 51.0; H,7.5; N,16.7。Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 211 7.3 7; N, 17.06. Found 値: C, 51.0; H, 7.5; N, 16.7.

(b) R1 = MeS02 (c) R1 = MeCO (d) R1 = PhCK2〇CO (e) R1 = PhCO (f) R1 = Fmoc(b) R1 = MeS02 (c) R1 = MeCO (d) R1 = PhCK2〇CO (e) R1 = PhCO (f) R1 = Fmoc

212 (b) (c) (d) (e) (f) R1 R1 1212 (b) (c) (d) (e) (f) R1 R1 1

R R RR R R

MeS02 MeCO PhCH2〇CO PhCO Fmoc 359 本纸伕尺度適用中國國家標孪(CNS Μ4说格(2丨0Χ 297公釐) 1235157 Λ: Β&quot; 五、發明説明(抓) (is, 9S)6,10-二酮基-9-甲基磺醢胺基-l,2,3,4,7,8,9,10·八氫-6H·嗒喑並[1,2-aH1,2]二氮雜箪·1-羧酸第三-丁酯(211b), 9-胺基-6,1〇·二酮基-1,2,3,4,7,8,9,10-八氫-6¾.嗒呼並[I,2· a][l,2]二氮雜箪小羧酸第三-丁酯(GB 2,128,984 ; 831毫克 ,2.79毫莫耳)及二異丙基乙胺(ΐ·22毫升,6.99毫莫耳, 2·5當量)於CH2C12 (10毫升)之溶液,在氮下以甲烷磺醯氯 (237微升,3.07毫莫耳,1.1當量)處理。混合物攪袢1小時 ,以EtOAc(75毫升)稀釋,並以飽和的NaHCO3(50毫升)及 飽和的氯化鈉水溶液(30毫升)k滌,乾燥(MgS04)並濃縮3 快速層析(10-35% EtOAc於CH2C12)可生成211b (806毫克, 77%)呈無色固體:mp 68-7CTC ;[泛]D23-109 (c 1.09, CH2Cl2); IR (KBr) 3270, 2980, 2939, 1735, 1677, 1458, 1447, 1418, 1396, 1370, 1328, 1272, 1252, 1232, 1222, 1156, 1131,991; lE NMR (CDC13) &amp; 6.15 (1H, d), 5.31 (1H, m), 4.65-4.11 (2H, m), 3.47 (1H, m), 2.99 (3H, s), 2.89 (1H, m), 2.72-2.51 (2H, m)·, 2.34 (1H, m), 2.26 (1H, m), 2.05-1.62 (4H, m), 1.47 (9H, s);分析 Cl5H23N306St 計算値:C, 47.97; H, 6.71; N,11.19; S, 8.54。實測値:C, 48·28; Η, 6·68; N, 10.86; S, 8.28。MS (+FAB) 376 (M++ 1, 660/〇), 320 (100)。 (IS, 9S)9·乙醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10·八氫-6H-嗒啩並[l,2-a][l,2]二氮雜苯-l-羧‘酸第三-丁酯(211c)。醋酐 (3〇7毫克,3·01毫莫耳)加至9-胺基-6,10-二酮基· 1,2,3,4,7,8,9,10-八氫-61^嗒啩並[1,2-3][1,2]二氮雜箪-1-致 酸第三-丁酯(GB 2,128,984; 813.7毫克,2.74毫莫耳),二異 360 本纸伕尺度適用中國國家標準(CNS》Α4緹格(210X297公釐) η 先 讀 背 之 注 意 % 寫 tMeS02 MeCO PhCH2〇CO PhCO Fmoc 359 The size of this paper is applicable to the Chinese national standard (CNS M4 scale (2 丨 0 × 297 mm) 1235157 Λ: Β &quot; V. Description of the invention (grabbing) (is, 9S) 6,10 -Diketo-9-methylsulfonamido-l, 2,3,4,7,8,9,10 · octahydro-6H · dapyrido [1,2-aH1,2] diaza箪 · 1-carboxylic acid tertiary-butyl ester (211b), 9-amino-6,1 · diketo-1,2,3,4,7,8,9,10-octahydro-6¾. Tera- [I, 2 · a] [l, 2] diazepine small carboxylic acid tert-butyl ester (GB 2,128,984; 831 mg, 2.79 mmol) and diisopropylethylamine (ΐ 22 ml, 6.99 mmol, 2.5 equivalents) in CH2C12 (10 ml), treated with methanesulfonyl chloride (237 μl, 3.07 mmol, 1.1 equivalents) under nitrogen. The mixture was stirred 1 Hours, diluted with EtOAc (75 mL) and washed with saturated NaHCO3 (50 mL) and saturated aqueous sodium chloride solution (30 mL), dried (MgS04) and concentrated. 3 flash chromatography (10-35% EtOAc in CH2C12) can produce 211b (806 mg, 77%) as a colorless solid: mp 68-7CTC; [Pan] D23-109 (c 1.09, CH2Cl2); IR (KBr) 3270, 2980, 2939, 1735, 1677, 145 8, 1447, 1418, 1396, 1370, 1328, 1272, 1252, 1232, 1222, 1156, 1131, 991; lE NMR (CDC13) &amp; 6.15 (1H, d), 5.31 (1H, m), 4.65-4.11 (2H, m), 3.47 (1H, m), 2.99 (3H, s), 2.89 (1H, m), 2.72-2.51 (2H, m), 2.34 (1H, m), 2.26 (1H, m) , 2.05-1.62 (4H, m), 1.47 (9H, s); Analyze Cl5H23N306St Calculate 値: C, 47.97; H, 6.71; N, 11.19; S, 8.54. Measured 値: C, 48 · 28; Η, 6 68; N, 10.86; S, 8.28. MS (+ FAB) 376 (M ++ 1, 660 / 〇), 320 (100). (IS, 9S) 9. Ethylamino-6,10-diketo -1,2,3,4,7,8,9,10 · octahydro-6H-daparo [l, 2-a] [l, 2] diazabenzene-l-carboxy 'acid third- Butyl ester (211c). Acetic anhydride (307 mg, 3.01 mmol) was added to 9-amino-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-61 ^ [1,2-3] [1,2] Diazapyridine-1-acid tertiary-butyl ester (GB 2,128,984; 813.7 mg, 2.74 mmol), Diiso 360 Paper Size Applicable to Chinese National Standards (CNS) Α4 Tig (210X297 mm)

經濟部中央標隼局負工消費合作社印3L 1235157 M濟部中央標準局員工消费合作杜印製 A7 B7 五、發明説明(358) 丙基乙按(884毫克,6.84毫莫耳)及CH2C12 (20毫升)之櫈拌 混合物中3混合物保持1小時再以EtOAc稀釋,以NaHC〇3 溶液再以曼水洗滌,乾燥(MgS04)並濃縮生 &lt; 無色浍狀3 產物以侠速層析純化(0.5-8% MeOH/CHflj可生成211c (S04毫克,71%)無色粉末:mp 162-3eC ; [c]D23-109 (c 1.03, CH2Ci2); IR (KBr) 3358, 2974, 1733, 1693, 1668, 1528. 1462, 1431,1406, 1371,1278, 1271,1250, 1233, 1217, 1 154· 1124; &amp; lH NMR (CDC13) d 6.32 (1H, d), 5.29-5.25 (1H, m), 4.98- 4.85 (1H, m), 4.68-4.58 (1H, m), 3.55-3.39 (1H, m), 2.91-2.66 (2H, m), 2.39-2.18 (2H, m), 2.03 (3H, s), 1.88-1.64 (4H7 m), 1.47 (9H,s);分析 C16H25N3〇5之計算値:C, 56.62; H,7·43; N, 12.38,實測値:C,56·62; Η, 7·43; N,12.36; MS (+ FAB) 340 (M+ + 1,40%), 284 (100)。 (IS, 9S)9-(芊氧羰基胺基)-6,10-二酮·l,2,3,4,7,8,9,10-八氫-6H-令啩並[l,2·a][l,2]二氮雜箪-l·羧酸第三-丁酯(21d)3氣 甲酸芊g旨(1.07克)逐滴加至(IS, 9S)9-胺基-6,10-二酮基-1,2,3,4,7,8,9,1〇-八氮-611-”答0井並[1,2-3][1,2] — 亂雜卓-1-敌 酸第三-丁酯(GB 2,128,984 ; 1.55克,5.21毫莫耳),NaHC03 (0·66克,7·82毫莫耳),二吟烷(32毫升)及水(8毫升)之攪掉 中的冰冷混合物中。混合物在5eC下保持15分鐘,再於室 溫下2小時。混合物以EtOAc (i〇毫升)稀釋’以贫和的 NaHC03溶液洗二次,乾燥(MgS04)並濃缩。油狀殘留物以 快速層析純化生成211d (1.98克,88%)無色ί由狀:[泛]024· 56.4 (c 1.0, CH2Cl2); IR (薄膜)3325, 2979, 2946, 1728, 1677, c -361 - 本纸伕尺度逆用中gg家揉孪(CNS ) A4規格(2丨0X297公釐) (請先另讀背t&amp;之注意事項再填寫本頁) 訂 Φ 經濟部中央標準局貝工消費合作社印装 1235157 Λ; Β7 五、發明説明(湖) 1528, 1456, 1422, 1370, 1340, 1272, 1245, 1156, 1122, 1056, 916, 734, 699; XH NMR (CDC13) &amp; 7.29 (5H, m), 5.8l〇.72 (1H, m), 5.26-5.20 (1H, m), 5.05 (2H, s), 4.69-4.51 (2H? m), 3.48-3.36 (1H, m)? 2.81-2.51 (2H, m), 2.34-2.19 (2H, m), 1·90-1·54 (4H, m),1·41 (9H, s);分析 C22H29N306 · H20: C, 58·79; H,6·92; N,9·35。實測値:C,59.10; H, 6.57; N,9.25; MS (ES +) 454 (M+ +Na,87%),432 (M+ +1,100)。 (15,95)9-苄醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611- 名°并並[1,2-3][1,2]-二氮雜笨-1-碳酸第三-丁§旨(2116)3亨 醯氣(1·61克,11.47毫莫耳)於CH2C12(15毫升)的溶液,逐 滴加至(13,95)9-胺基-6,10-二酮基-1,2,3,4,7,8,9,1〇-八氩· όΗ-嗒α井並[l,2-a][l,2]二氮雜苯-1·羰酸第三-丁酯(GB 2,128,984; 3·1 克,10.43毫莫耳),無水CH2C12(20毫升)及 二異丙基乙胺(4.54¾升’ 26.06¾矣耳)之禮掉冰冷混合物 中3混合物保持在冷處下1小時,再置室溫下0.5小時。混 合物以CH2C12稀釋,以鹽水洗二次,乾燥(iMgS〇4)再濃缩 。殘留物以快速層析純化(0-5°/。甲酵於(:112(:12中)可生成 211e (4·0克,96%)的無色豉璃狀:mp 74-76X: ; [a]D30-75.0e (c 0·12, ChClJ。 IR (KBr) 3350, 2979, 2938, 1736, 1677, 1662, 1536, 1422, 1276, 1250, 1155; !Η NMR (CDC13) &amp; 8.72 (2H, m), 7.53-7.40 (3H, m), 7.07 (1H, d, J=7.2), 5.30 (1H, dd, J=3.0, 5.8), 5.12 (1H, m), 4.66 (1H, m), 3.51 (1H, m), 2.90 (2H, m), 2.38 (1H, dd, J 13.2, 6.8), 2.25 (1H, m), 1.9 (2H, m), 1·70 (1H, m)。分析 C21H27N305 · 〇·5Η20之計算値:C,61.45; -362· 本纸伕尺度逍用中国国家標孪(CNS ) A4規格(210X297公澄) ' (請先聞讀背面之注意事項再填寫木頁) 訂 .4. 1235157 A7 B7 Μ濟部中央橾孪局貝工消费合作社印装 五、發明説明(360) Η,6·88; N,10.24。實測値:C, 61·69; H,6 71; Ν, ι〇 ι8 : ㈦^”身二銅基冬⑼-…基甲氧基’羰胺某)- 酸第三·丁酯(211f),以類似211e方式製備,除了使甴…箒 基甲基氣曱趋旨§代替字睦氣’可生成白色玻璃狀固趑211f (2.14兄 ’ 89%):mp 190-192 C;[戌]D25-8l.5。(c 0,1,CH’CIJ 3 IR (ΚΒι·) 3335, 2977, 1731, 1678, 1450, 1421, 1246, 1 156, 742; [H NMR (CDC13) &amp; 7.60 (2H, m), 7.57 (2H, m), 7.50^ 7.26 (4H, m), 5.60 (1H, d, J=7.8), 5.28 (1H, m), 4.67 (2H, m), 4.38 (2H, m), 4.23 (1H, m), 3.59-3.41 (1H, m), 2.92-2.65 (2H, m), 2.41-2.21 (2H, m), 1.95-1.58 (4H, m), 1.47 (9H, s) * MS (ES' m/z) 520 (ΝΓ+ 1,97%),179 (100%” (1S,9S) 6,10-二銅基-9-甲基續睡胺基-1,2,3,4,7,8,9,10-八氫 -611-”荅α井並[l,2-a][l,2]二氮雜革-1·叛酸(212b),依化合物 212e之相同方法合成(635毫克,85%.),呈無色粉末:mp 209-12°C ; [a]D24-132 (c 0.12, MeOH); IR (KBr) 3308, 2940, 1717, 1707, 1699, 1619, 1469, 1456, 1442, 1417, 1391, 1348, 1339, 1330, 1310, 1271, 1247, 1222, 1175, 1 152, 1133, 993, 976; lR NMR (CD3OD) &amp; 5.35 (1H, m), 4.58-4.48 (1H, m), 4.46-4.36 (1H, m), 3.60-3.42 (1H, m), 3.01-2.87 (1H, m), 2.95 (3H, s), 2.55-2.39 (1H, m), 2.32-2.20 (2H, m), 2.09-1.89 (2H, m), 1.78-1.62 (2H, m);分析計算値:C, 41.37; Η,5·37;Ν, 13.16;S, 10.04。實測値:C,41.59;H, 5·32;Ν, l2·57; S, 9·76; MS (ES -)。ChHbNsC^S (ΜΗ+)之確實質量估 363· 本纸伕尺度通用中國國家標孪(CNS Μ4说格(210Χ297公釐} (請先父讀背:&amp;之:;·χ意事項一本頁) 訂Printed by the Central Standards Bureau of the Ministry of Economic Affairs and Consumer Cooperatives, printed 3L 1235157 M. The Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, printed by A7 B7. V. Description of the Invention (358) Propylacetate (884 mg, 6.84 mmol) and CH2C12 ( 20 ml) of the 3 mixture in the stool mixture was kept for 1 hour and then diluted with EtOAc, washed with NaHC03 solution and then with Mann water, dried (MgS04) and concentrated. The product was purified by chiral chromatography ( 0.5-8% MeOH / CHflj can produce 211c (S04 mg, 71%) colorless powder: mp 162-3eC; [c] D23-109 (c 1.03, CH2Ci2); IR (KBr) 3358, 2974, 1733, 1693, 1668, 1528. 1462, 1431, 1406, 1371, 1278, 1271, 1250, 1233, 1217, 1 154 · 1124; &amp; lH NMR (CDC13) d 6.32 (1H, d), 5.29-5.25 (1H, m) , 4.98- 4.85 (1H, m), 4.68-4.58 (1H, m), 3.55-3.39 (1H, m), 2.91-2.66 (2H, m), 2.39-2.18 (2H, m), 2.03 (3H, s), 1.88-1.64 (4H7 m), 1.47 (9H, s); analysis of the calculation of C16H25N305:,: C, 56.62; H, 7.43; N, 12.38, measured 値: C, 56 · 62; Η , 7.43; N, 12.36; MS (+ FAB) 340 (M + + 1,40%), 284 (100). (IS, 9S) 9- (fluorenyloxycarbonylamino)- 6,10-dione · l, 2,3,4,7,8,9,10-octahydro-6H-ring benzo [l, 2 · a] [l, 2] diazapine-l · Tertiary-butyl carboxylic acid (21d) 3 g of formic acid (1.07 g) was added dropwise to (IS, 9S) 9-amino-6,10-diketo-1,2,3,4, 7,8,9,10-octazine-611- "well A0 and [1,2-3] [1,2] — Lantrazol-1-enedicarboxylic acid third-butyl ester (GB 2,128,984; 1.55 G, 5.21 mmoles), NaHC03 (0.66 g, 7.82 mmoles), dichloromethane (32 mL) and water (8 mL) in an ice-cold mixture. The mixture was kept at 5 eC. 15 minutes and 2 hours at room temperature. The mixture was diluted with EtOAc (10 mL) and washed twice with a lean NaHC03 solution, dried (MgS04) and concentrated. The oily residue was purified by flash chromatography to give 211d (1.98 g, 88%) as a colorless form: [Pan] 024 · 56.4 (c 1.0, CH2Cl2); IR (thin film) 3325, 2979, 2946, 1728, 1677, c -361-GG Home Rolling (CNS) A4 Specification (2 丨 0X297 mm) (Please read the notes of t &amp; before filling out this page) Order Φ Central Standards Bureau of the Ministry of Economic Affairs Printed by Beigong Consumer Cooperative 1235157 Λ; Β7 V. Invention Description (Lake) 1528, 1456, 1422, 1370, 1340, 1272, 1245, 1156, 1122, 1056, 916, 734, 699; XH NMR (CDC13) &amp; 7.29 (5H, m), 5.8l 10.72 (1H, m), 5.26-5.20 (1H, m), 5.05 (2H, s), 4.69-4.51 (2H? M), 3.48-3.36 (1H, m )? 2.81-2.51 (2H, m), 2.34-2.19 (2H, m), 1.90-1 · 54 (4H, m), 1.41 (9H, s); Analysis C22H29N306 · H20: C, 58 · 79; H, 6.92; N, 9.35. Found 値: C, 59.10; H, 6.57; N, 9.25; MS (ES +) 454 (M + + Na, 87%), 432 (M + +1, 100). (15,95) 9-benzylamido-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-611-name 3] [1,2] -Diazaben-1-carbonate tertiary-butadiene carbonate (2116) 3 hen gas (1.61 g, 11.47 mmol) in CH2C12 (15 ml) Dropwise to (13,95) 9-amino-6,10-diketo-1,2,3,4,7,8,9,10-octa-argon 2-a] [l, 2] Diazabenzene-1 · Carbonate tert-butyl ester (GB 2,128,984; 3.1 grams, 10.43 mmol), anhydrous CH2C12 (20 ml) and diisopropyl Ethylamine (4.54 ¾ '26.06 ¾ ears) was removed from the cold mixture. The 3 mixture was kept in the cold for 1 hour, and then left at room temperature for 0.5 hours. The mixture was diluted with CH2C12, washed twice with brine, dried (iMgS04) and concentrated. The residue was purified by flash chromatography (0-5 ° /. Formazan in (: 112 (: 12)) can produce 211e (4.0 g, 96%) as a colorless glassy: mp 74-76X:; [ a] D30-75.0e (c 0 · 12, ChClJ. IR (KBr) 3350, 2979, 2938, 1736, 1677, 1662, 1536, 1422, 1276, 1250, 1155;! Η NMR (CDC13) &amp; 8.72 ( 2H, m), 7.53-7.40 (3H, m), 7.07 (1H, d, J = 7.2), 5.30 (1H, dd, J = 3.0, 5.8), 5.12 (1H, m), 4.66 (1H, m ), 3.51 (1H, m), 2.90 (2H, m), 2.38 (1H, dd, J 13.2, 6.8), 2.25 (1H, m), 1.9 (2H, m), 1.70 (1H, m) 。Analyze the calculation of C21H27N305 · 〇 · 5Η20 値: C, 61.45; -362 · The standard of this paper is Chinese National Standard (CNS) A4 specification (210X297 Gongcheng) '(Please read the precautions on the back before filling in Wood page) ed. 4. 1235157 A7 B7 Μ Printed by the Shell Department Consumer Cooperative of the Central Ministry of Economic Affairs of the People's Republic of China 5. Description of the invention (360) Η, 6.88; N, 10.24. Measured 値: C, 61 · 69; H , 6 71; Ν, ι〇ι8: ㈦ ^ ^ double copper based winter stilbene-... methoxy carbonyl 'carbonyl amine--acid third butyl ester (211f), prepared in a manner similar to 211e, except that … Methylmethyl radical The word “Muqi” can produce white glassy solid 211f (2.14 '89%): mp 190-192 C; [戌] D25-8l. 5. (c 0,1, CH'CIJ 3 IR (ΚΒι ·) 3335, 2977, 1731, 1678, 1450, 1421, 1246, 1 156, 742; [H NMR (CDC13) &amp; 7.60 (2H, m), 7.57 (2H, m), 7.50 ^ 7.26 (4H, m), 5.60 (1H, d, J = 7.8), 5.28 (1H, m), 4.67 (2H, m), 4.38 (2H, m), 4.23 (1H, m), 3.59-3.41 (1H, m), 2.92- 2.65 (2H, m), 2.41-2.21 (2H, m), 1.95-1.58 (4H, m), 1.47 (9H, s) * MS (ES 'm / z) 520 (NΓ + 1, 97%), 179 (100% "(1S, 9S) 6,10-dicopper-9-methyldiaminoamine-1,2,3,4,7,8,9,10-octahydro-611-" 荅Alpha wells [1,2-a] [l, 2] diazepine-1 · metanoic acid (212b) were synthesized in the same way as compound 212e (635 mg, 85%.). It was colorless powder: mp 209 -12 ° C; [a] D24-132 (c 0.12, MeOH); IR (KBr) 3308, 2940, 1717, 1707, 1699, 1619, 1469, 1456, 1442, 1417, 1391, 1348, 1339, 1330, 1310, 1271, 1247, 1222, 1175, 1 152, 1133, 993, 976; lR NMR (CD3OD) &amp; 5.35 (1H, m), 4.58-4.48 (1H, m), 4.46-4.36 (1H, m) , 3.60-3.42 (1H, m), 3.01-2.87 (1H, m), 2.95 (3H, s), 2.55-2.39 (1H, m), 2.32-2.20 (2H, m), 2.09-1.89 (2H, m), 1.78-1.62 (2H, m); Analytical calculation 値: C, 41.37; Η, 5.37; Ν, 13.16; S, 10.04. Found 値: C, 41.59; H, 5.32; N, 12 · 57; S, 9.76; MS (ES-). ChHbNsC ^ S (ΜΗ +) 's exact quality estimate 363 · This paper's standard is common Chinese national standard (CNS Μ4 grid (210 × 297mm)) (Please read it from your father: &amp; of :; · χ Italian matter) Page) order

1235157 A7 B7 ' 五、發明説明(361) 計値:320.0916。實測値:320.0943。 (诗先53讀背面之注意事項再 (IS,9S)9-乙醯胺基-6,10-二酮基-1,2,3,4,7,8,9,1〇-八氫-611-嗒啩並[l,2-a][l,2]二氮雜苯-1-羧酸(212〇ί製備自211e, 如212e之相同方法呈白色破璃狀固體(595毫克,77%):mp&gt; 250’C ; ]d24-153 (c 0.10, MeOH); IR (KBr) 3280, 2942, 1742, 1697, 1675, 1650, 1616, 1548, 1470, 1443, 128K 1249, 1202, 1 187, 1 171; 1H NMR (CD3OD) &amp; 5.35-5.31 (’1H,m), 4.81-4.71 (1H? m), 4.61-4.46 (1H, m), 3.59-3.44 (2H, m), 3.Π-2.94 (1H, m), 2.58-2.39 (1H, m), 2.36-2.19 (2H, m), 2.11-1.83 (3H,m),1.99 (3H, s), 1.78-1.56 (2H,m);分 析 C12H17N3〇5: C, 50.88; H,6·05; N, 14.83。實測値:C,50.82; Η, 6·02; N, 14.58; MS (ES -) 282 (M-l, 100%):C12H18N305 (MH+) 之確實質量估計値:284.1246。實測値:284.1258。 (IS, 9S)9-t 氧羰基胺基-6,l(^二酮基-l,2,3,4,7,8,9,10-八氫-6H-嗒畊並[l,2-a][l,2]二氮雜萆-レ羧酸(212d)製備自211d, 利用如化合物212e之相同方法呈無色晶狀(170毫克, 97%):mp 60-100eC; [^]D22-l〇3 (c 0.10, MeOH); IR (KBr) 3341, 2947, 1728, 1675, 1531,1456, 1422, 1339, 1272, 1248, 1221, 1 174, 1 122, 1056, 982, 699; lH NMR (CDC13) &amp; 7.35 (5H, s), 經濟部中央標窣局员工消资合作社印製 5.65 (1H, d), 5.48-5.40 (1H, m), 5.10 (2H, s), 4.76-4.57 (2H, m), 3.49-3.30 (2H, m), 2.92-2.59 (2H, m), 2.40-2.27 (2H, m), 1.97-1.67 (4H,m); MS (ES -) 374 (Μ ·1, 100%)。 C1SH22N306 (MH+)之確實質量估計値:376.1509。實測値:376.1483, C18H2lN306Na (MNa+)之確實質量估計値:398.1328,實測値 -364- 本纸乐尺度通用中S國家標準(CNS ) A4規格(2丨0X297公釐) 1235157 經濟部中夬標準局貝工消費合作社印¾ Λ 7 ____Β7___五、發明説明(啦) :398.13 15 -(15,95)9-苄醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611- 嗒畊並[l,2-a][l,2]二氮雜箪小幾酸piZe)THF (20毫升)加 至第三-丁酯211e之冰冷攬拌溶液中(4·15克,10.34毫莫耳) 於無水CHfl2 (20毫升)3混合物保留冷處歷ι·5小時,再於 £溫下2.5小時’之後濃縮。TFA經由殘留物CH2C12\乙鞋及 乙醚溶液之重覆濃縮而移去。殘留物以醚最終研磨而生成 2126,3.05克(85%)的白色破璃狀固體:111?118-126。(:;[泛]〇2七 70.5° (c 0.1,CH2C12)。 IR (KBr) 336 1,2943, 1737, 1659, 1537, 1426, 1220, 1174; 1Η NMR (CDC13) &amp;7.80 (2H, m), 7.54-7.33 (4H, m)? 8.83 (brs), 5.44 (1H, m), 5.26o.l3 (1H, m), 4.66 (1H, m), 3.59-3.41 (1H, m), 2.97, 2.76 (2H, 2m.),2·36 (2H, m), 1.98 (2H,m), 1.75 (2H, m)。MS (ES·,m/z) 344 (M _ 1, 100%)。 (IS, 9S)6,10-二酮基-9(苐-9-基甲氧羰基胺基)-1,2,3,4,7,8,9,10-八氣-611-*答呼並[1,2-3][1,2]-二氣雜革-1-幾 酸(212f),製備自211f,以如212e之相同方法得96%產率 :mp 120-126°C; [^]d25-72.5° (c 0.1, CH2C12) - IR (KBr) 3406, 2950, 1725, 1670, 1526, 1449, 1421, 1272, 1248, 1223, 1175, 761, 741; lH NMR (CDC13) &amp; 7.76 (2H, m), 7.62-7.26 (4H, m), 6.07, 5.76 (2H, brs, d, d, 1=2.9), 5.46, 5.36 (1H, 2m), 4.79· 4.54 (2H, m), 4.77 (2H, m), 4.21 (1H, m), 3.41 (1H, m), 2.89 (1H,m),2.69 (1H,m),2·35 (2H, m), 1·98, 1.73 (4H, 2m)。 MS (ES·,m/z) 462 (M+ - 1,50%), 240 (100%)。 • 365 · (苟先聞讀背面之注意事項 II裝— 一 本頁 訂1235157 A7 B7 'V. Description of the Invention (361) Count: 320.0916. Found 値: 320.0943. (Notes on the back of 53 poems, then (IS, 9S) 9-acetamido-6,10-diketo-1,2,3,4,7,8,9,10-octahydro- 611-Da [1,2-a] [l, 2] diazabenzene-1-carboxylic acid (212〇ί prepared from 211e, the same method as 212e was a white glass-like solid (595 mg, 77 %): mp &gt;250'C;] d24-153 (c 0.10, MeOH); IR (KBr) 3280, 2942, 1742, 1697, 1675, 1650, 1616, 1548, 1470, 1443, 128K 1249, 1202, 1 187, 1 171; 1H NMR (CD3OD) &amp; 5.35-5.31 ('1H, m), 4.81-4.71 (1H? M), 4.61-4.46 (1H, m), 3.59-3.44 (2H, m), 3 .Π-2.94 (1H, m), 2.58-2.39 (1H, m), 2.36-2.19 (2H, m), 2.11-1.83 (3H, m), 1.99 (3H, s), 1.78-1.56 (2H, m); Analysis C12H17N305: C, 50.88; H, 6.05; N, 14.83. Found 値: C, 50.82; Η, 6.02; N, 14.58; MS (ES-) 282 (Ml, 100% ): The exact mass estimate of C12H18N305 (MH +) 値: 284.1246. Found 28: 284.1258. (IS, 9S) 9-t oxycarbonylamino-6, l (^ diketonyl-1,2,3,4,7 , 8,9,10-octahydro-6H-da-phen [l, 2-a] [l, 2] diazapyrene-carboxylic acid (212d) was prepared from 211d using the same method as compound 212e. Colorless crystal Shape (170 mg, 97%): mp 60-100eC; [^] D22-103 (c 0.10, MeOH); IR (KBr) 3341, 2947, 1728, 1675, 1531, 1456, 1422, 1339, 1272 , 1248, 1221. 5.48-5.40 (1H, m), 5.10 (2H, s), 4.76-4.57 (2H, m), 3.49-3.30 (2H, m), 2.92-2.59 (2H, m), 2.40-2.27 (2H, m ), 1.97-1.67 (4H, m); MS (ES-) 374 (M · 1, 100%). C1SH22N306 (MH +) exact mass estimate 质量: 376.1509. Measured 値: 376.1483, C18H2lN306Na (MNa +) actual mass estimate 値: 398.1328, Measured 値 -364- The standard of this paper music standard is the National Standard S (CNS) A4 (2 丨 0X297 mm) 1235157 Ministry of Economic Affairs Printed by Shelley Consumer Cooperative ¾ Λ 7 ____ Β7 ___ V. Description of the Invention (La): 398.13 15-(15,95) 9-Benzylamido-6,10-diketo-1,2,3,4,7 , 8,9,10-Octahydro-611-Da-Chen [l, 2-a] [l, 2] diazepine picoacid piZe) THF (20 ml) was added to the tert-butyl ester 211e The solution was mixed in ice (4 · 15 g, 10.34 mmol) in anhydrous CHfl2 (20 ml) and the mixture was kept in the cold place for 5 hours, and then concentrated at 2.5 hours' temperature. TFA was removed by repeated concentration of the residue CH2C12 \ B shoes and ether solution. The residue was finally triturated with ether to give 2126, 3.05 g (85%) of a white broken glassy solid: 111? 118-126. (:; [PAN] 〇2 七 70.5 ° (c 0.1, CH2C12). IR (KBr) 336 1, 2943, 1737, 1659, 1537, 1426, 1220, 1174; 1Η NMR (CDC13) &amp; 7.80 (2H, m), 7.54-7.33 (4H, m)? 8.83 (brs), 5.44 (1H, m), 5.26o. l3 (1H, m), 4.66 (1H, m), 3.59-3.41 (1H, m), 2.97, 2.76 (2H, 2m.), 2.36 (2H, m), 1.98 (2H, m), 1.75 (2H, m). MS (ES ·, m / z) 344 (M _ 1, 100% ). (IS, 9S) 6,10-diketo-9 (fluoren-9-ylmethoxycarbonylamino) -1,2,3,4,7,8,9,10-octagas-611- * Answer [1,2-3] [1,2] -Digas hetero leather-1-chinic acid (212f), prepared from 211f, 96% yield in the same way as 212e: mp 120-126 ° C; [^] d25-72.5 ° (c 0.1, CH2C12)-IR (KBr) 3406, 2950, 1725, 1670, 1526, 1449, 1421, 1272, 1248, 1223, 1175, 761, 741; lH NMR ( CDC13) &amp; 7.76 (2H, m), 7.62-7.26 (4H, m), 6.07, 5.76 (2H, brs, d, d, 1 = 2.9), 5.46, 5.36 (1H, 2m), 4.79 · 4.54 ( 2H, m), 4.77 (2H, m), 4.21 (1H, m), 3.41 (1H, m), 2.89 (1H, m), 2.69 (1H, m), 2.35 (2H, m), 1 · 98, 1.73 (4H, 2m). MS (ES ·, m / z) 462 (M +-1,50%), 240 (100%). • 365 · (Go first read the back Note II Pack - a set of this page

本纸法尺度通用中S國家標孪(CNS &gt; Α4規格(210Χ297公釐) 1235157 Λ7 B7 五、發明説明( R1-Standards in the paper method are common in the national S standard (CNS &gt; A4 size (210 × 297 mm) 1235157 Λ7 B7 V. Description of the invention (R1-

(213) (c) R1 = MeCO (e) R1 = PhCO(213) (c) R1 = MeCO (e) R1 = PhCO

(214) (c) R1 = MeCO 1(214) (c) R1 = MeCO 1

PhCO (ey R- [2RS, 3S(1S,9S)]N-(2-芊氧基-5-酮基四氫呋喃-3-基)-9-(乙 醢胺基)-6,10-二酮基-1,2,3,47,8,9,10-八氫-611-嗒呼並[1,2-a][l,2]二氮雜箪-1-羧醯胺(213c),合成自212c,以如化合 物213e之相同方法可生成非對映立體異構物之混合(193毫 克,36%)呈無色晶體:IR (KBr) 3272, 1799, 1701, 1682, 1650, 1555, 1424, 1412, 1278, 1258, 1221, 1122, 937; lU NMR (CDC13) &amp; 7.41-7.28 (5H, m), 6.52 (0.5H, d), 6.38 (0.5H, d), 經濟部中央樣绛扃負工消资合作社印装 6.22 (0.5H, d), 5.57 (0.5H, d), 5.36 (0.5H, s), 5.10-5.05 (1H, m)·, 5.00-4.45 (5.5H, m), 3.19-2.84 (3H, m), 2.72-2.56 (1H, m), 2.51-2.25 (2H, m), 2.02 (3H, s), 1.98-1.70 (3H, m), 1.66-1.56 (3H, m);分析 C23H2SN407:C, 58·47; Η, 5·97; N, 11.86、實測 値:(:231128]^407之計算値:C,58·47; Η, 5·97; N, 11·86。實測值: C, 58·37; Η,6·09; Ν, 11·47· MS(ES -) 471 (M-l,100%)。 C2i3H29N407(MH+)之精確估計貪量:473.2036 ;實测値: 473.2012。C23H2SN407Na (Mna+)之精確估計質量:495.1856 ;實測値:495.1853。 [IS, 9S(2RS,3S)]9-苄醢胺基-6,10-二酮基-1,2,3,4,7,S,9,10· 366 度適用中S国家標孪(CNS)A4%^( 210X297^ 1235157 A7 B7 超濟部中夬禕率局貝工消費合作乜印製 五·、發明說明(跑) 八氫氧基-5-酌基四氫吱喃-3-基)-6H-塔嗜i [ι,2-4[1,2]二氮雜箪-1-羧醯胺(2136)。氫化三丁錫(2.2毫升, 8.18毫莫耳)逐滴加至酸212e (1.95克,5:6毫莫耳),(3s, 2 RS)3-缔円氧談基按基-2-卞氧基-5-嗣基四夫脅(Chapman, Bioop· &amp; Med· Chem· Lett·,2,ρρ· 615-618 (1992); i.s〇克’ 6.16毫莫耳)及(Ph3P)2PdCl2(50毫克)於無水CH2C12(36毫升) 在無水氮及攪拌下之溶液中。5分鐘後,加入1-¾基苯並 三唑(1.51克,11·2毫莫耳,6.72毫莫耳),於冷郜後(冰 /Η2〇)再加乙基二甲胺基丙基磕化二亞胺鹽酸(1.29克,.6.72 毫莫專)3 5分鐘後,冷卻浴移去且混合物保持在室溫下4 小時,以EtOAc稀釋,以1Μ HC1,鹽水,NaHC〇3飽和水溶 液及鹽水洗滌,乾燥(MgS04)並濃縮。快速層析(矽膠,〇-90% EtOAc/CH2Cl2)可生成白色固體的產物,(2.34克, 78%):IR (KBr) 3499, 1792, 1658, 1536, 1421,1279, 1257, 1 123, 977, 699; 1H NMR (CDC13) &amp; 7·81 (2H, m), 7.54-7.34 (8H, m), 7.1, 6.97, 6.89, 6.48 (2H, m, d, J 7.7, d, J=7.5, d, J=7.6), 5.57, 5.28 (1H, d, J=5.2, s), 5.23-5.07 (2H, m), 4.93-4.42, 3.22-2.70, 2.51-2.26, 2.08-1.69, 1.22 (15Ht 5m)=分析 CzsHso^0? · 0·5Η2〇之計算値:C, 61.87; H, 5.75; N, 10.32。實 測値:C, 62.02; Η, 5·65; N, 10.25。 [3 5(15,95)]3-(9-乙醢胺基-6,10-三明基-1,2,3,4,7,8,9,10-八 氫-6H-嗒呼並[l,2-a][l,2]二氮雜箪-i-羧醢胺基)-4-嗣基丁 酸(214c),合成自213c,利用和自213e合成214e之相同方 法,生成無色晶體(140毫克,99%):mp 90-180O;I&gt;]D22-114 •367- 本紙ϋϊ通用中国國家標準(CNS ) A4規格(210X297公度) -- (請先閲讀背面之注意事項 4ΪPhCO (ey R- [2RS, 3S (1S, 9S)] N- (2-methoxy-5-ketotetrahydrofuran-3-yl) -9- (acetamido) -6,10-dione -1,2,3,47,8,9,10-octahydro-611-daphtho [1,2-a] [l, 2] diazepine-1-carboxamide (213c), Synthesized from 212c, the same method as compound 213e can produce a mixture of diastereoisomeric compounds (193 mg, 36%) as colorless crystals: IR (KBr) 3272, 1799, 1701, 1682, 1650, 1555, 1424 , 1412, 1278, 1258, 1221, 1122, 937; lU NMR (CDC13) &amp; 7.41-7.28 (5H, m), 6.52 (0.5H, d), 6.38 (0.5H, d), Central Ministry of Economic Affairs扃 Non-industrial consumer cooperatives printed 6.22 (0.5H, d), 5.57 (0.5H, d), 5.36 (0.5H, s), 5.10-5.05 (1H, m), 5.00-4.45 (5.5H, m ), 3.19-2.84 (3H, m), 2.72-2.56 (1H, m), 2.51-2.25 (2H, m), 2.02 (3H, s), 1.98-1.70 (3H, m), 1.66-1.56 (3H , m); analysis C23H2SN407: C, 58 · 47; Η, 5.97; N, 11.86, measured 値: (: 231128) ^ 407 calculation 値: C, 58 · 47; Η, 5.97; N, 11.86. Measured value: C, 58 · 37; Η, 6.09; Ν, 11.47 · MS (ES-) 471 (Ml, 100%). Accurate estimate of the amount of C2i3H29N407 (MH +): 473.2036; real Test 値: 473.2012. Accurate estimated mass of C23H2SN407Na (Mna +): 495.1856; Measured 値: 495.1853. [IS, 9S (2RS, 3S)] 9-benzylamido-6,10-diketo-1,2, 3,4,7, S, 9,10 · 366 degrees Applicable to China S National Standards (CNS) A4% ^ (210X297 ^ 1235157 A7 B7 Superconstruction Ministry of China Ministry of Economic Affairs Bureau Shellfish Consumer Cooperative Cooperative Printing 5 、、 Description of the invention (running) octahydrooxy-5-cotetrahydrocran-3-yl) -6H-taffin i [ι, 2-4 [1,2] diazepine-1-carboxamide (2136). Tributyltin hydride (2.2 ml, 8.18 mmol) was added dropwise to the acid 212e (1.95 g, 5: 6 mmol), (3s, 2 RS) 3-sodium oxalanthine -2-Methoxy-5-fluorenyltetrahydrofuran (Chapman, Bioop · &amp; Med · Chem · Let ·, 2, ρ ·· 615-618 (1992); is 0 g '6.16 mmol) and ( Ph3P) 2PdCl2 (50 mg) in anhydrous CH2C12 (36 ml) in a solution of anhydrous nitrogen with stirring. After 5 minutes, 1-¾ benzotriazole (1.51 g, 11.2 mmol, 6.72 mmol) was added, and ethyl dimethylaminopropyl was added after cold simmering (ice / 冰 20). After 5 minutes of tritiated diimine hydrochloride (1.29 g, .6.72 mmol), the cooling bath was removed and the mixture was kept at room temperature for 4 hours, diluted with EtOAc, 1M HC1, brine, saturated aqueous NaHC03 And brine, dried (MgSO4) and concentrated. Flash chromatography (silica gel, 0-90% EtOAc / CH2Cl2) gave the product as a white solid, (2.34 g, 78%): IR (KBr) 3499, 1792, 1658, 1536, 1421, 1279, 1257, 1 123, 977, 699; 1H NMR (CDC13) & 7.81 (2H, m), 7.54-7.34 (8H, m), 7.1, 6.97, 6.89, 6.48 (2H, m, d, J 7.7, d, J = 7.5, d, J = 7.6), 5.57, 5.28 (1H, d, J = 5.2, s), 5.23-5.07 (2H, m), 4.93-4.42, 3.22-2.70, 2.51-2.26, 2.08-1.69, 1.22 (15Ht 5m) = Analytical calculation of CzsHso ^ 0? 0.5? 20: C, 61.87; H, 5.75; N, 10.32. Measured 値: C, 62.02; Η, 5.65; N, 10.25. [3 5 (15,95)] 3- (9-Ethylamido-6,10-tribenzyl-1,2,3,4,7,8,9,10-octahydro-6H-daparin [l, 2-a] [l, 2] diazepine-i-carboxyamido) -4-fluorenylbutyric acid (214c), synthesized from 213c, produced in the same manner as 214e from 213e, yielded Colorless crystals (140 mg, 99%): mp 90-180O; I &gt;] D22-114 • 367- This paper is a common Chinese National Standard (CNS) A4 specification (210X297 degree)-(Please read the precautions on the back first 4Ϊ

Order

1235157 Λ7 B7 經濟部中央標準局員工消费合作杜印¾ 五、發明説明(365) (c 0.10, MeOH); IR (ΚΒι*) 3334, 3070, 2946, 1787, 1658, 1543, 1422, 1277, 1258; 1H NMR (d6-DMSO) &amp; 8.66 (1H? m), 8.18 (1H, d), 6.76 (1H, s), 5.08 (1H, m), 4.68 (1H, m), 4.30 (1H, m), 2.92-2.70 (2H, m), 2.27-2.06 (3H, m)? 1.95-1.72 (4H, m), 1.85 (3H, s), 1.58 (2H, m) : MS (ES -) 381 (M-l, 100%); C16H,3N407 (MH+)之確實質量估計値:383.1567。實測値 :383.1548 。 [3S(1S,9S)] 3-(9-笮醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒畊並H,2-a][l,2]二氮雜箪-1-羧醯胺基)-4-酮基丁 酸(214e)。213e (2.29克,4.28 毫莫耳),10% Pd/c (1.8 克)及 MeOH (160毫升)之混合物’在H2及大氣壓力下搜拌6·3小 時。經過濾及濃缩後,以新鲜催化劑重覆氫化作用(1.8克) 歷5小時β於過遽及濃縮後’殘留物以二乙謎研磨’過遽 並以乙醚充份洗滌可生成214e,呈白色固體(1.67克,88%) mP 143-147O;ha]D23-125o(c0.2,CH3〇H)3IR(KBr) 3391, 1657, 1651, 1538, 1421,1280, 1258;咕 NMR (CD3OD) &amp; 7.90 (2H, m), 7.63-7.46 (3H, m), 5.25 (1H, m), 5.08-4.85 (lH, m), 4.68-4.53 (2H, m), 4.33-4.24 (1H, m), 3.62-3.44, 3.22-3.11, 2.75-2.21, 2.15-1.92, 1.73-1.66 (1 1H, 5m) ^ 分析 C21H24N407. H2〇之計算値:C, 54.54; Η, 5·67; N, 12.1 卜實 測値:C, 54·48; H, 5.63; N, 11.92 3 368- 本纸铁尺度適用中國国家標隼(CNS)A4規格(2i〇x297公爱 (請先閱讀背云之注意事項1235157 Λ7 B7 Consumption Cooperation between Employees of the Central Standards Bureau of the Ministry of Economic Affairs Ⅴ. Description of Invention (365) (c 0.10, MeOH); IR (ΚΒι *) 3334, 3070, 2946, 1787, 1658, 1543, 1422, 1277, 1258 ; 1H NMR (d6-DMSO) &amp; 8.66 (1H? M), 8.18 (1H, d), 6.76 (1H, s), 5.08 (1H, m), 4.68 (1H, m), 4.30 (1H, m ), 2.92-2.70 (2H, m), 2.27-2.06 (3H, m)? 1.95-1.72 (4H, m), 1.85 (3H, s), 1.58 (2H, m): MS (ES-) 381 ( Ml, 100%); C16H, 3N407 (MH +) 's exact mass estimate: 383.1567. Found 値: 383.1548. [3S (1S, 9S)] 3- (9-fluorenylamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-6H-da-mer H, 2-a] [1,2] diazepine-1-carboxamido) -4-ketobutanoic acid (214e). A mixture of 213e (2.29 g, 4.28 mmol), 10% Pd / c (1.8 g) and MeOH (160 ml) was searched for 6.3 hours under H2 and atmospheric pressure. After filtration and concentration, the hydrogenation was repeated with fresh catalyst (1.8 g). After 5 hours β was passed through the concentration and concentration, and the 'residue was triturated with dioxin, and washed with ether to produce 214e. White solid (1.67 g, 88%) mP 143-147O; ha] D23-125o (c0.2, CH3〇H) 3IR (KBr) 3391, 1657, 1651, 1538, 1421, 1280, 1258; Gore NMR (CD3OD ) &amp; 7.90 (2H, m), 7.63-7.46 (3H, m), 5.25 (1H, m), 5.08-4.85 (lH, m), 4.68-4.53 (2H, m), 4.33-4.24 (1H, m), 3.62-3.44, 3.22-3.11, 2.75-2.21, 2.15-1.92, 1.73-1.66 (1 1H, 5m) ^ Analyze the calculation of C21H24N407. H2〇 値: C, 54.54; Η, 5.67; N, 12.1 Measurements: C, 54 · 48; H, 5.63; N, 11.92 3 368- The iron scale of this paper is applicable to the Chinese National Standard (CNS) A4 specification (2i × x297 public love (please read the precautions of back cloud first)

Order

1235157 Λ / B7 五、發明説明( 366) 〇1235157 Λ / B7 V. Description of the invention (366)

(請先笑讀背云之注意事項 X二”&lt; ) ¾¾¾ \/ %/ ) c d e(Please read the notes on back cloud first with laughter X &lt;) ¾¾¾ \ /% /) c d e

MeCO (217)MeCO (217)

PhCH2OC〇PhCH2OC〇

PhCO Μ濟部中央揉準局員工消费合作·社印装PhCO Μ Consumers' cooperation with the Central Government Bureau of the Ministry of Economic Affairs · Printing

[3S,4RS(1 S,9S)]3-[9-乙酿胺基-6,10-二明基-1,2,3,4,7,8,9,10-八氫-6仏嗒啩並[1,24][1,2]二氮雜苯-1-羧 睡胺基)-5-(2,6-二氣卞睡氧基)-4-經基戊酸第三-丁薛(215 c) ,合成自214c,以如化合物215e之相同方法,可生成养對 映立鳢異構之混合,呈白色玻璃狀固體(398毫克,84%) IR (KBr) 3338, 2977, 1738, 1658, 1562, 1541, 1433, 1368, 1277, 1150; lU NMR (CDC13) &amp; 7.36-7.32 (3H, m), 6.91 (1H, d), 6.30 (1H, d), 5.15-5.09 (1H, m), 5.01-4,88 (1H, m), 4.61-4.44 (2H, m), 4.37-4.08 (3H, m), 3.32-3.18 (1H, m), 3.04-2.89 (1H, -369- 本纸ft尺度適用中國国家標孪(CNS ) A4規格(210:&lt;297公爱1 一 經濟部中央標_局員工消費合作杜印¾ 1235157 A7 B7 五、發明説明(367) m), 2.82-2.51 (4H? m), 2.39-2.29 (1H, m), 2.08-1.64 (4H, m), 2.02 (3H,s),分析 C23H34N4Cl2〇9之計弄值:C,52.26; H, 5.64; N,8.7h 實測値:C,52.44; Η,5·87;Ν,έ·16。 MS (ES-) 645/3/1 (M-l, 26%), 189 (81), 134 (100) 〇 C2SR36N,C120^^ (MNa_)之確f質量計算値:643.1938 ;實測値:643.1924 3 (MNa+)之確實質量估計値:665.1757。實測 値:665.1756。 '[3S, 4RS (1 S, 9S)] 3- [9-Ethylamine-6,10-dibenzyl-1,2,3,4,7,8,9,10-octahydro-6 Pyrido [1,24] [1,2] diazepine-1-carboxamino) -5- (2,6-digaspyridyloxy) -4-trivalerate Xue (215 c), synthesized from 214c, can produce enantiomeric enantiomeric mixtures in the same way as compound 215e, as a white glassy solid (398 mg, 84%) IR (KBr) 3338, 2977, 1738, 1658, 1562, 1541, 1433, 1368, 1277, 1150; lU NMR (CDC13) &amp; 7.36-7.32 (3H, m), 6.91 (1H, d), 6.30 (1H, d), 5.15-5.09 ( 1H, m), 5.01-4,88 (1H, m), 4.61-4.44 (2H, m), 4.37-4.08 (3H, m), 3.32-3.18 (1H, m), 3.04-2.89 (1H,-- 369- The paper ft scale is applicable to the Chinese National Standard (CNS) A4 specification (210: &lt; 297 Public Love 1 Central Standard of the Ministry of Economic Affairs _ Bureau employee consumption cooperation Du Yin ¾ 1235157 A7 B7 V. Description of the invention (367) m) , 2.82-2.51 (4H? M), 2.39-2.29 (1H, m), 2.08-1.64 (4H, m), 2.02 (3H, s), analysis and calculation of C23H34N4Cl209: C, 52.26; H, 5.64; N, 8.7h Measured 値: C, 52.44; Η, 5.87; Ν, · 16. MS (ES-) 645/3/1 (Ml, 26%), 189 (81) , 134 (100) 〇 C2SR36N, C120 ^^ (MNa_), f mass calculation 値: 643.1938; measured 値: 643.1924 3 (MNa +), true mass estimate 値: 665.1757. Measured 値: 665.1756. '

[3S,4RS(1S,9S)] 3-(9-芊氧羰基胺基·6,10-:,-1,2,3,4,7,8,9,10-八氫-611-嗒畊並[1,24][1,2]二氮雜箪-1-幾 醢胺基)-5-(2,6-二氯苄氧基)-4-羥基戊酸第三-丁酯(2 1 5d), 合成自214d,以如化合物215e之相同方法可生成非對玦立 體異構之混合物(657毫克,70%)呈玻璃狀白色固體:IR (KBr) 3420, 3361, 2975, 2931, 1716, 1658, 1529, 1434, 1367, 1348, 1250, 1 157, 1083, 1055; LH NMR (CDC13) &amp; 7.32 (8H, m), 7.14 (1H, d), 5.81 (1H, d), 5.15 (1H, m), 5.07 (2H, s), 4.74-4.65 (1H, m)? 4.58-4.22 (4H, m), 4.15-4.06 (1H, m), 3.72 (1H, m), 3.32-3.21 (1H, m), 3.04-2.94 (1H, m), 2.69-2.52 (3H, m), 2·33·2·27 (1H,m), 1.95-1.59 (4H, m),1·28 (9H,s);分析 C34H40N4Cl2O10. 0·5Η2Ο之計算値:C, 54.70; H,5·54; N, 7·50 。實測値:C,54·98; H,5.59; N,7·24。MS (ES -) 737/5/3 (Μ-ΐ, 22%), 193/1/89 (100) 。 C34H41N*4Cl2O10(M!T)之確 實質量 估計値 735.2120。實測値:735.2181。 [3S, 4RS (1S,9S)]3-(9·芊醢胺基-6,10-二酮基· 1,2,3,4,7,8,9,10-八氫-611-嗒呻並[1,2-3][1,2]二氮雜苯-1-幾 •370· 本纸杀尺度逯用中gg家標率(CNS )A4^格(2丨0·Χ297公釐) (請先閲讀背面之注意事項本頁)[3S, 4RS (1S, 9S)] 3- (9-fluorenyloxycarbonylamino · 6,10-:,-1,2,3,4,7,8,9,10-octahydro-611-Da Geng [1,24] [1,2] Diazapyridine-1-chitamino) -5- (2,6-dichlorobenzyloxy) -4-hydroxypentanoic acid tert-butyl ester ( 2 1 5d), synthesized from 214d, in the same way as compound 215e, can produce a mixture of non-paraisomeric stereoisomers (657 mg, 70%) as a glassy white solid: IR (KBr) 3420, 3361, 2975, 2931 , 1716, 1658, 1529, 1434, 1367, 1348, 1250, 1 157, 1083, 1055; LH NMR (CDC13) &amp; 7.32 (8H, m), 7.14 (1H, d), 5.81 (1H, d), 5.15 (1H, m), 5.07 (2H, s), 4.74-4.65 (1H, m)? 4.58-4.22 (4H, m), 4.15-4.06 (1H, m), 3.72 (1H, m), 3.32- 3.21 (1H, m), 3.04-2.94 (1H, m), 2.69-2.52 (3H, m), 2.33 · 2 · 27 (1H, m), 1.95-1.59 (4H, m), 1.28 (9H, s); Analyze the calculation of C34H40N4Cl2O10. 5Η2O: C, 54.70; H, 5.54; N, 7.50. Found 値: C, 54 · 98; H, 5.59; N, 7.24. MS (ES-) 737/5/3 (M-ΐ, 22%), 193/1/89 (100). The true mass of C34H41N * 4Cl2O10 (M! T) is estimated to be 735.2120. Found 値: 735.2181. [3S, 4RS (1S, 9S)] 3- (9 · Amino-6,10-diketo · 1,2,3,4,7,8,9,10-octahydro-611-Da Pyrene [1,2-3] [1,2] Diazabenzene-1-Ji • 370 · This paper has a standard of gg family standard (CNS) A4 ^ grid (2 丨 0 · × 297 mm) ( (Please read the caution page on the back first)

1235157 Λ7 Β7 經濟部中央標準局員工消费合作社印¾ 五、發明说明(挪) ϋ腔)-5-(2,6-二氯;氧基)-4-經基戊酸第三-丁 i旨(215 e),氫 化三丁錫(4.6毫升,· 11.4毫莫耳)逐滴加至(3S,4RS)(N-烯丙 氧羰基)-3-胺基-5-(2,6-二氯芊醯氧基)-4-羥~基戊酸第三-丁 薛(以類似 Revesz et al·,Tetrahedron· Lett·,35, pp. 9693-9696 (1994)的方法製備(2.64克;5.7毫莫耳)(?113?)2?(1(:12 (50毫克),CH2C12 (100毫升)及DMF (20毫升)在室溫下之攪 捽混合物中。混合物再攪掉10分鐘,之後加入1-羥基苯並 三唑(1.54克,11.4毫莫耳混合物冷卻至(TC,再加入乙 基二甲胺基丙基羰化二亞胺i酸(1.31克:6.84毫莫耳)。 混合物保持在此溫度下15分鐘,再於室溫下1 7小時。混合 物以EtOAc (300毫升)稀釋,以1M HC1 (2 X 100毫升),飽 和的NaHC03水溶液(3 X 1〇〇毫升)及鹽水(2 X 100毫升)洗滌 ,乾燥(MgS04)及濃縮。殘留物以快速層析纯化(2〇% (MeOH/CH2Cl2))可生成3.24克(81%)的215e,爲玻璃狀固體: mp 106-110·。; IR (KBr) 3354, 1737, 1659,1531,1433, 1276, 1150;咕 NMR (CDC13) &amp; 7·80 (2Η,dd,J=7.9及 1.5),7.75-7.26 (6H, m), 7.14-6.76 (2H, m), 5.30-5.02 (2H, m), 4.63-4.11 (5H, m), 3.44-3.26 (2H, m), 3.10-2.30 (5H, m), 2.10-1.60 (5H, m),1·44 (9H, s);分析 C33H3SCl2N4〇9 · 〇·75Η20之計算値:C, 55.12; Η, 5·54; N, 7.79; Cl, 9·86 e f 測値:C, 55.04; Η, 5·34; Ν, 7·80; Cl, 10.24。MS (ES +) 709/7/5 (Μ +1),378 (59),324 (64),322 (100)。 [35(13,93)]3-(9-乙醯胺基-6,1〇-二酮基-1,2,3,4,7,8,9,10-八 氫-6Η-嗒畊並[l,2-a][l,2]二氮雜箪致醢胺基)-5《2,6-二 .371 - (請先聞讀背面之注意事項本頁) --裝 ,ν-口1235157 Λ7 Β7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Ⅴ 5. Description of the Invention (Norwegian) Lumen) -5- (2,6-dichloro; oxy) -4-Thrylvaleric acid (215e), tributyltin hydride (4.6 ml, · 11.4 mmol) was added dropwise to (3S, 4RS) (N-allyloxycarbonyl) -3-amino-5- (2,6-di Chlorofluorenyl) -4-hydroxy ~ valeric acid tertiary-butyric acid (prepared by a method similar to Revesz et al ·, Tetrahedron · Let ·, 35, pp. 9693-9696 (1994) (2.64 g; 5.7 Millimoles) (? 113?) 2? (1 (: 12 (50 mg), CH2C12 (100 ml) and DMF (20 ml) in a stirred mixture at room temperature. The mixture was stirred for another 10 minutes, after which Add 1-hydroxybenzotriazole (1.54 g, 11.4 mmol of the mixture and cool to (TC, add ethyldimethylaminopropylcarbonyldiimide i acid (1.31 g: 6.84 mmol)). Mixture Keep at this temperature for 15 minutes and at room temperature for 17 hours. The mixture was diluted with EtOAc (300 mL), 1M HC1 (2 X 100 mL), saturated aqueous NaHC03 (3 X 100 mL) and brine (2 X 100 ml) washed and dried (Mg S04) and concentrated. The residue was purified by flash chromatography (20% (MeOH / CH2Cl2)) to yield 3.24 g (81%) of 215e as a glassy solid: mp 106-110 ·; IR (KBr) 3354 , 1737, 1659, 1531, 1433, 1276, 1150; NMR (CDC13) &amp; 7.80 (2 (, dd, J = 7.9 and 1.5), 7.75-7.26 (6H, m), 7.14-6.76 (2H, m), 5.30-5.02 (2H, m), 4.63-4.11 (5H, m), 3.44-3.26 (2H, m), 3.10-2.30 (5H, m), 2.10-1.60 (5H, m), 1 · 44 (9H, s); Analyze the calculation of C33H3SCl2N4 0 · 75 · 20Η: C, 55.12; Η, 5.54; N, 7.79; Cl, 9.86 ef Test: C, 55.04; Η, 5 · 34; Ν, 7.80; Cl, 10.24. MS (ES +) 709/7/5 (Μ +1), 378 (59), 324 (64), 322 (100). [35 (13,93) ] 3- (9-Ethylamido-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-6 嗒 -dacrogen [l, 2-a ] [l, 2] Diazepine-induced amido group) -5 《2,6-Di.371-(Please read the precautions on the back page first) --install, ν- 口

本纸張尺度適用中國國家樣孪(〇知)八4現格(210&gt;&lt;297公釐) 1235157 A7 B7 五、發明説明(369 ) 氯芊醢氧基)·4-酮基戊酸第三-丁酯(216c),以化合物216e 之相同方法合成自215c。呈玻璃狀白色固體(300亳克, 83%):mp 80-125^ ; [a ]D23-89.1 (c 1.08, C^Cl^; lR (KBr) 3356, 2979, 2935, 1740, 1659, 1532, 1434, 1369, 1276, 1260, 1151; lH NMR (CDC13) &amp; 7.39-7.32 (3H, m), 7.13 (1H, d), 6.34 (1H, d), 5.22-5.17 (1H, m), 5.11 (1H, d), 5.04 (1H, d), 4.99-4.88 (2H, m), 4.64-4.52 (1H, m), 3.29-3.11 (1H, m), 3.05- 2.67 (4H, m), 2.39-2.29 (1H, m), 2.02 (3H, s), 1.98-1.75 (4H, m), 1.46 (9H, s);分析 C2S034N4C1209之計算値:C, 52.42; H, 5.34; N, 8.73 ^ 實測値:C, 52·53; H,5·70; N, 7.85,MS· (ES -) 643/41/39 (M-l, 100%)。C23H35N4Cl2〇9 (MH+)之確實 質量估計値:641.1781。實測値:641.1735。 分析 C28H34N4Cl2〇9Na (Mna+)之計算値:663.1601。實測値 :663.1542 。 .[3S(1S,9S)] 3-(9-芊氧羰胺基-6,10-二酮基·l,2,3,4,7,8,9,10-八.氫-6H-嗒畊並[l,2-a][l,2]二氮雜萆-l-羧醢胺基)-5-(2,6-二氣芊醯氧基)-4-酮基戊酸第三·丁酯(216d),以如化合物 216e之相同方法合成自215d,可生成216d呈白色玻璃狀固 體(688毫克 ’ 68%); mp 90_170eC ;[泛]D25-83.4 (c 1.01, CH2C13); IR (ΚΒγ) 3338, 2933, 1736, 1670, 1525, 1433, 1417, 1368, 1258, 1 151, 1056, 1031; lE NMR (CDC13) &amp; 7.33 (8H, m), 7.18 (1H, d), 5.65 (1H, d), 5.19 (1H, m), 5.09 (2H, s), 4.98-4.86 (1H, m), 4.82-4.49 (2H, d), 3.30-3.07 (1H, m), 3.05- 2.59 (4H, m), 2.42-2.27 (1H, m), 2.18-1.59 (5H, m), 1.42 -372- 本纸伕尺度適用中g國家標準(CNS ) A4規格(2丨0X297公釐) (請先闵讀背云之洼意事項寫大·頁 ——裝 大-This paper size is applicable to the Chinese national sample (zero known) 8 (4) (210 &gt; &lt; 297 mm) 1235157 A7 B7 V. Description of the invention (369) Chloroethoxy) 4-ketovalerate Tri-butyl ester (216c) was synthesized from 215c in the same manner as compound 216e. Glassy white solid (300 g, 83%): mp 80-125 ^; [a] D23-89.1 (c 1.08, C ^ Cl ^; lR (KBr) 3356, 2979, 2935, 1740, 1659, 1532 , 1434, 1369, 1276, 1260, 1151; lH NMR (CDC13) &amp; 7.39-7.32 (3H, m), 7.13 (1H, d), 6.34 (1H, d), 5.22-5.17 (1H, m), 5.11 (1H, d), 5.04 (1H, d), 4.99-4.88 (2H, m), 4.64-4.52 (1H, m), 3.29-3.11 (1H, m), 3.05- 2.67 (4H, m), 2.39-2.29 (1H, m), 2.02 (3H, s), 1.98-1.75 (4H, m), 1.46 (9H, s); Analysis of the calculation of C2S034N4C1209 値: C, 52.42; H, 5.34; N, 8.73 ^ Measured 値: C, 52 · 53; H, 5.70; N, 7.85, MS · (ES-) 643/41/39 (Ml, 100%). C23H35N4Cl2 09 (MH +) true mass estimate 値: 641.1781 Measured 値: 641.1735. Calculated for analysis of C28H34N4Cl2ONa (Mna +) 66: 663.1601. Measured 値: 663.1542.. [3S (1S, 9S)] 3- (9-fluorenoxycarbonylamino-6,10-dione -L, 2,3,4,7,8,9,10-octa.Hydroxy-6H-dacrogen [l, 2-a] [l, 2] diazepine-l-carboxyamido ) -5- (2,6-dioxofluorenyloxy) -4-ketovaleric acid tert-butyl ester (216d), synthesized from 215d in the same manner as compound 216e, yielding 216d White glassy solid (688 mg '68%); mp 90_170eC; [pan] D25-83.4 (c 1.01, CH2C13); IR (ΚΒγ) 3338, 2933, 1736, 1670, 1525, 1433, 1417, 1368, 1258 , 1 151, 1056, 1031; lE NMR (CDC13) &amp; 7.33 (8H, m), 7.18 (1H, d), 5.65 (1H, d), 5.19 (1H, m), 5.09 (2H, s), 4.98-4.86 (1H, m), 4.82-4.49 (2H, d), 3.30-3.07 (1H, m), 3.05- 2.59 (4H, m), 2.42-2.27 (1H, m), 2.18-1.59 (5H , m), 1.42 -372- This paper's standard is applicable to China National Standard (CNS) A4 specification (2 丨 0X297 mm) (please read the meaning of the back of the cloud to write a large page—install large-

經濟部中央標準局員工消费合作杜印«. 1235157 Λ7 . _____B7^___ 五、發明这明(37D) (9H, s); MS (ES-) 737/5/3 (M? 13%), 185 (l〇〇) 3 [3$(15,95)]3-(9-笮醯胺基-6,10-二酮基-1,2,3,4,7;8,9,10-八 氫·6Η-塔啩並[l,2-a][l,2]二氮雜箪-1-羧醯艋基)-5-(2,6-二 氯芊氧基)-4-酮基戊酸第三-丁酯(2l6e)。Dess-Martin試 劑(3.82克:9.0毫莫耳)加至醇215e (3.17克;4.5毫莫耳)於 CH2C12(100毫升)之攪摔溶液中。混合物攪摔1小時,以 Et〇Ac (300毫升)稀釋,再以1:1飽和的Na2S2〇3及绝和的 NaHC〇3 (100毫升)混合物洗滌及以鹽水洗滌(1〇〇毫升)3混 合物乾燥(MgS04)再濃縮。殘_留物以快速層析純化,可生 成2.2克(70%)的2166,呈無色固體:1^ 102-107\:;[“]1:)32- .¾濟部中夬樣率局負工消費合作红印¾ (请先閱讀背云之注意事項再填努·&lt;二只) 82·5 (c 0.1, CH2Cl2); IR (KBr) 3374, 2937, 1739, 1661,1525, 1433, 1275, 1260, 1 152; lR NMR (CDC13) &amp; 7.85-7.78 (2H, m), 7.57-7.32 (6H, m), 7.09 (1H, d, J=7.9), 7.01 (1H, d, J 7.3), 5.25-5.16 (1H, m), 5.16-5.05 (1H, m), 5.15 (1H, d), 5.03 (1H, d), 4.99-4.90 (1H, m), 4.68-4.54 (1H, m), 3.31-3.17 (1H, m), 3.17-2.72 (4H, m), 2.45-2.35 (1H, m), 2.30-1.66 (5H, m), 1.44 (9H, s);分析 C33H36CI2N4O9· 0·5Η2Ο之計算値.C, 55.62,H, 5·23; N,7.86; Cl,9·95。實測値:C, 55.79; H,5·15; N, 7·80; Cl, 9.81 ^ MS (ES +) 729/7/5 (Μ + Na), 707/5/3 (Μ + 1), 163 (100%)。 [3S (IS, 9S)】 3-(9-乙睦胺基-6,10-’二嗣基-1,2,3,4,7,8,9,10-八 氫-6士嗒_並[1,2-3][1,2]二氮雜苯-卜羧醢胺基)-5-(2,6-二 氣芊醢氧基)-4-酮基戊酸(217c),如化合物217e之相同方法 合成自216c,呈玻璃狀白色固體U66毫克,66%):mP 85- •373· 本垓乐尺度適用tgg家標孪(CNS M4現格(210X297公釐) 經濟部中央樣準局負工消资合作社印¾ 1235157 五、發明説明(371) 175°C;[泛]D25-156 (c 0.13, Me〇H); IR (KBr) 3373, 2929, 1742, 1659, 1562, 1533, 1433, 1412, 1274, 1266, 1223, 1 197, 1 145, 1138; lH NMR (CD3OD) &amp; 7.38 (3H, s), 5.14-5.03 (1H, m), 4.49-4.32 (2H, m), 3.50-3.27 (1H, m), 3.11-2.92 (1H, m), 2.84-2.62 (2H, m), 2.46-2.11 (2H, m), 2.05-1.46 (5H, m), 1.92 (3H,s);分析 C24H26N4C1209 · H20:C,47.77; H,4.68; N, 9·29 。實測値:C,47·75; N,4·59; N,9.07。MS (ES +) 627/5/3 (M+K,21%), 611/9/7 (M+Na,87),5 89/7/5 (M+ +1,71),266 (100); C24H27N4CI2O9 (MH+)之確賞質量估計値:585.1155。 實測値:585.1 134。 [3S (IS, 9S)]3-(9-笮氧羰基胺基-6,10-二酮基· 1,2,3,4,7,8,9,10-八氫-611-嗒呼並[1,24][1,2]二氮雜箪-1-羧 醯胺基)-5-(2,6-二氯苄醢氧基)-4-酮基戊酸(21 7d),以如化 合物217e之相同方法合成自216d,可生成217d呈白色玻璃 狀固體(310毫克,96%):mp85-110°C;k]D24-85.9 (c 0.13,Du Yin, employee consumption cooperation of the Central Bureau of Standards of the Ministry of Economic Affairs «. 1235157 Λ7. _____ B7 ^ ___ V. Invention (37D) (9H, s); MS (ES-) 737/5/3 (M? 13%), 185 (100) 3 [3 $ (15,95)] 3- (9-fluorenylamino-6,10-diketo-1,2,3,4,7; 8,9,10-octa Hydrogen · 6Η-pyrido [l, 2-a] [l, 2] diazapyridine-1-carboxyfluorenyl) -5- (2,6-dichlorofluorenyloxy) -4-one Tertiary-butyl valerate (2116e). Dess-Martin reagent (3.82 g: 9.0 mmol) was added to a stirred solution of alcohol 215e (3.17 g; 4.5 mmol) in CH2C12 (100 ml). The mixture was stirred for 1 hour, diluted with EtOAc (300 mL), washed with a mixture of 1: 1 saturated Na2S203 and absolute NaHC03 (100 mL) and washed with brine (100 mL) .3 The mixture was dried (MgS04) and concentrated. Residues were purified by flash chromatography, which produced 2.2 g (70%) of 2166 as a colorless solid: 1 ^ 102-107 \ :; ["] 1:) 32-. Red seal for work-consumption cooperation ¾ (Please read the precautions for Beyond Cloud and fill in the two) 82.5 (c 0.1, CH2Cl2); IR (KBr) 3374, 2937, 1739, 1661, 1525, 1433 , 1275, 1260, 1 152; lR NMR (CDC13) &amp; 7.85-7.78 (2H, m), 7.57-7.32 (6H, m), 7.09 (1H, d, J = 7.9), 7.01 (1H, d, J 7.3), 5.25-5.16 (1H, m), 5.16-5.05 (1H, m), 5.15 (1H, d), 5.03 (1H, d), 4.99-4.90 (1H, m), 4.68-4.54 (1H , m), 3.31-3.17 (1H, m), 3.17-2.72 (4H, m), 2.45-2.35 (1H, m), 2.30-1.66 (5H, m), 1.44 (9H, s); analysis C33H36CI2N4O9 · Calculation of 0.5 · 20Η. C, 55.62, H, 5.23; N, 7.86; Cl, 9.95. Found: C, 55.79; H, 5.15; N, 7.80; Cl, 9.81 ^ MS (ES +) 729/7/5 (Μ + Na), 707/5/3 (Μ + 1), 163 (100%). [3S (IS, 9S)] 3- (9-ethylamino -6,10-'difluorenyl-1,2,3,4,7,8,9,10-octahydro-6 stilbene [1,2-3] [1,2] diazabenzene -Carboxamido) -5- (2,6-dioxofluorenyloxy) -4-ketopentanoic acid (2 17c), synthesized from 216c in the same way as compound 217e, as a glassy white solid U66 mg, 66%): mP 85- • 373 · This scale is applicable to the tgg family standard (CNS M4 is present (210X297 mm) Printed by the Central Bureau of Standards, Ministry of Economic Affairs, Consumer Goods Cooperatives ¾ 1235157 V. Description of Invention (371) 175 ° C; [Pan] D25-156 (c 0.13, Me〇H); IR (KBr) 3373, 2929, 1742, 1659, 1562, 1533, 1433, 1412, 1274, 1266, 1223, 1 197, 1 145, 1138; lH NMR (CD3OD) &amp; 7.38 (3H, s), 5.14-5.03 (1H, m), 4.49-4.32 (2H, m), 3.50-3.27 (1H, m), 3.11-2.92 (1H, m), 2.84-2.62 (2H, m), 2.46-2.11 (2H, m), 2.05-1.46 (5H, m) , 1.92 (3H, s); analysis C24H26N4C1209 · H20: C, 47.77; H, 4.68; N, 9 · 29. Found 値: C, 47.75; N, 4.59; N, 9.07. MS (ES +) 627/5/3 (M + K, 21%), 611/9/7 (M + Na, 87), 5 89/7/5 (M + +1, 71), 266 (100) ; C24H27N4CI2O9 (MH +) confirmed quality estimate: 585.1155. Found 値: 585.1 134. [3S (IS, 9S)] 3- (9-fluorenyloxycarbonylamino-6,10-diketo · 1,2,3,4,7,8,9,10-octahydro-611-dahu And [1,24] [1,2] diazepine-1-carboxamido) -5- (2,6-dichlorobenzyloxy) -4-ketovaleric acid (21 7d), Synthesized from 216d in the same way as compound 217e, a white glassy solid (310 mg, 96%) can be produced: mp85-110 ° C; k] D24-85.9 (c 0.13,

MeOH); IR (KBr) 3351, 2945, 1738, 1669, 1524, 1433, 1258, 1 147, 1057; ιΚ NMR (CD3〇D) &amp; 7.56 (4Η, m), 7.45 (5H, m), 5.32 (2H, m), 5.20 (2H, s), 4.76-4.48 (3H, m), 3.65-3.38 (3H, m), 3.27-3.09 (2H, m), 3.03-2.89 (2H, m), 2.65-2.24 (3H, m), 2.19-1.62 (5H, m); MS (ES -) 679/7/5 (M-l, 100%): C30H31N4Cl2O10(MH+)之確實質量·估計値:677.1417。實測値 :677.1430。 [3S (IS, 9S)]3-(9-芊醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-611-嗒_並[1,24][1,2]二氮雜箪」-羧醯胺基)-5-(2,6-二 -374 - 本紙乐尺度通用中國國家標率(CNS ) A4坑格(210X297公釐) &quot;MeOH); IR (KBr) 3351, 2945, 1738, 1669, 1524, 1433, 1258, 1 147, 1057; ικ NMR (CD3〇D) &amp; 7.56 (4Η, m), 7.45 (5H, m), 5.32 (2H, m), 5.20 (2H, s), 4.76-4.48 (3H, m), 3.65-3.38 (3H, m), 3.27-3.09 (2H, m), 3.03-2.89 (2H, m), 2.65 -2.24 (3H, m), 2.19-1.62 (5H, m); MS (ES-) 679/7/5 (Ml, 100%): Exact mass of C30H31N4Cl2O10 (MH +) · Estimated 値: 677.1417. Found 値: 677.1430. [3S (IS, 9S)] 3- (9-fluorenylamino-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-611-da [1,24] [1,2] Diazapyridine "-Carboxylamido) -5- (2,6-Di-374-Chinese standard for paper scale (CNS) A4 (210X297) (B)) &quot;

1235157 A7 ____B7 · 一__ 五、發明説明(372) 氯苄醯氧基)-4-嗣戊酸(217e),TFA (25毫补)逐滴加至薛 216e(2.11克,3.0毫莫耳)之冰冷揽摔溶液中5混合物在〇 °C下攪拌20分鐘,再於室溫下1小時β混合物/蒸發至乾, .再以乙鲢共蒸發三次。加入無水乙瞇(50毫升)並過濾可得 1·9克(98%)的 217e,呈無色固體:mp 126-130°C;[泛]d30-122.0 (c 0.1, MeOH); IR (KBr) 3322, 1740, 1658, 1651, 1532, 1433, 1277, 1150; lE NMR (D6-DMSO) &amp; 8.87 (1H, d, J=7.4), 8.61 (1H, d, J=7.8), 7.92-7.86 (2H, m), 7.65-7.43 (6H, m), 5.25-5.12 (3H, m), 4.94-4.60 (2H, m), 4.44-4.22 (1H, m), 3.43-3.10 (1H, m), 3.00-2.52 (3H, m), 2.45-2.10 (3H, m), 2.10-1.75 (2H, m), 1.75-1.50 (2H,m);分析 C29H2SC12N409 · 1H20之計算値:C, 52·34; H,4·54; N,8.42; Cl, 10.66。實測値:C,52.02; H,4.36; N, 8.12; Cl,10.36。MS (ES -) 649/7/5 (M - 1), 411 (100%)。 (請先閱讀背VS7之ii意事項再填寫本頁) 經濟部中央標率局员工消費合作社印511235157 A7 ____B7 · One __ V. Description of the Invention (372) Chlorobenzyloxy) -4-pentanoic acid (217e), TFA (25 milligrams) was added dropwise to Xue 216e (2.11 grams, 3.0 millimoles The 5 mixture in the ice-cold solution was stirred at 0 ° C for 20 minutes, and then the β mixture / evaporated to dryness at room temperature for 1 hour, and then co-evaporated three times with acetamidine. Anhydrous acetamidine (50 ml) was added and filtered to obtain 1.9 g (98%) of 217e as a colorless solid: mp 126-130 ° C; [pan] d30-122.0 (c 0.1, MeOH); IR (KBr ) 3322, 1740, 1658, 1651, 1532, 1433, 1277, 1150; lE NMR (D6-DMSO) &amp; 8.87 (1H, d, J = 7.4), 8.61 (1H, d, J = 7.8), 7.92- 7.86 (2H, m), 7.65-7.43 (6H, m), 5.25-5.12 (3H, m), 4.94-4.60 (2H, m), 4.44-4.22 (1H, m), 3.43-3.10 (1H, m ), 3.00-2.52 (3H, m), 2.45-2.10 (3H, m), 2.10-1.75 (2H, m), 1.75-1.50 (2H, m); analyze the calculation of C29H2SC12N409 · 1H2020: C, 52 · 34; H, 4.54; N, 8.42; Cl, 10.66. Found 値: C, 52.02; H, 4.36; N, 8.12; Cl, 10.36. MS (ES-) 649/7/5 (M-1), 411 (100%). (Please read the meaning of VS7 and then fill out this page) 51

•375· 本纸伕尺度適用中国国家揉孪(CNS ) A4現格(210X297公楚) 1235157 Β7 經濟部中央榡準局負工消费合作社印製 五 '發明説明(373) [3S· 4RS (IS, 9S)]4-[5-(2,6-二氯苯基 y号唑·2·基卜3-(61〇-二 調基·、甲基續龜胺基,8,9,10-八氫· &amp;][1,2]二氮雜革-1-羧醯胺基)冰幾基丁酸第三_丁旨§(21肋) ’以類似化合物215e之方法製備自酸212{)及99,可生成非 釘玦三鱧異構混合物(865亳克,80%)呈無色固鳢:IR (KBr) j298, 2974,1723,1659,1544,1518,1430, 1394,1370,1328, 127j, 1256, 1 156, 1134; lH NMR (CDC13) &amp; 7.45-7.28 (4H, m),7.26-7.15 (2H, m), 5·26·5·1〇 (2H, m), 4.80-4.67 (1H, m), 4.59-4.42 (2H, m), 3.32-3.17 (1H, m), 2.96 (3H, 2xs), 2.93-2.79 (1H, m), 2.71-2.53 (4H, m), 2.38-2.28 (1H, m), 2.07-1.81 (4H,m);分析 C28H35N5C1209S · 0.5H2O之計算値:C, 48.21; H, 5·20; N,10.03。實測値:C, 48.35; H,5·26; N,9.48。MS (ES +) 714/2/0 (M + Na, 25%), 692/90/88 (M+ + 1, 51), 636/4/2 (3 8),246 (100) a C28H36N5C1209S (MH+)之確實質量估計値 :688.1611。實測値:688.1615。 [3S (IS, 9S)]4-[5-(2,6-二氣苯基)-呤唑-2·基】-3-(6,10-二酮基 -9-曱基磺醯胺基-l,2,3,4,7,8,9,10-八氫-6H·嗒啩並[l,2-a][l,2】二氮雜箪-1-羧醢胺基)·4·酮基丁酸第三-丁裔(219b) ,以類似化合物216e之方法製備自212b,呈摻白色粉未 (675毫克,81%):mp 100-20(TC; [a]D24-84.9 (c 1·01, CHP1# IR (KBr) 3336, 2978, 2936, 1719, 1674, 1510, 1433, 1421, 1369, 1329, 1274, 1257, 1155, 991, 789; ^ NMR (CDCi3) ^ 7.47-7.38 (4H, m),7·24 (1H, d), 5·61·5·53 (1H, m), 5.48 (1衫, d),5·38〇·30 (1H, m),4·67-4·45 (2H, m),3.48-3.18 (2H,m),• 375 · The standard of this paper is applicable to China's National Standards (CNS) A4 (210X297), 1235157 Β7 Printed by the Ministry of Economic Affairs of the Central Bureau of Standards of the People's Republic of China on the Printing of Five 'Inventions (373) [3S · 4RS (IS , 9S)] 4- [5- (2,6-dichlorophenylyzazole · 2 · kib 3- (61〇-diamidin ·, methyl diamylamine, 8,9,10- Octahydro &amp;] [1,2] diaza leather-1-carboxamido) ice-chityl butyric acid third_butt § (21 ribs) 'Prepared from acid 212 in a similar manner to compound 215e { ) And 99, which can form non-nailed trisomers (865 g, 80%) as colorless solids: IR (KBr) j298, 2974, 1723, 1659, 1544, 1518, 1430, 1394, 1370, 1328 , 127j, 1256, 1 156, 1134; lH NMR (CDC13) &amp; 7.45-7.28 (4H, m), 7.26-7.15 (2H, m), 5.26 · 5 · 1〇 (2H, m), 4.80 -4.67 (1H, m), 4.59-4.42 (2H, m), 3.32-3.17 (1H, m), 2.96 (3H, 2xs), 2.93-2.79 (1H, m), 2.71-2.53 (4H, m) , 2.38-2.28 (1H, m), 2.07-1.81 (4H, m); Analysis of the calculation of C28H35N5C1209S · 0.5H2O 値: C, 48.21; H, 5.20; N, 10.03. Found 値: C, 48.35; H, 5.26; N, 9.48. MS (ES +) 714/2/0 (M + Na, 25%), 692/90/88 (M + + 1, 51), 636/4/2 (3 8), 246 (100) a C28H36N5C1209S (MH + The true quality estimate 値: 688.1611. Found 値: 688.1615. [3S (IS, 9S)] 4- [5- (2,6-Difluorophenyl) -pyrazole-2 · yl] -3- (6,10-diketo-9-fluorenylsulfonamide -L, 2,3,4,7,8,9,10-octahydro-6H · dapyrido [l, 2-a] [l, 2] diazapyridine-1-carboxamido) · 4 · Ketobutyric acid third-butyric (219b), prepared from 212b in a similar manner to compound 216e, with white powder (675 mg, 81%): mp 100-20 (TC; [a] D24 -84.9 (c 1.01, CHP1 # IR (KBr) 3336, 2978, 2936, 1719, 1674, 1510, 1433, 1421, 1369, 1329, 1274, 1257, 1155, 991, 789; ^ NMR (CDCi3) ^ 7.47-7.38 (4H, m), 7.24 (1H, d), 5.61 · 5.53 (1H, m), 5.48 (1 shirt, d), 5.38〇30 (1H, m) , 4.67-4 · 45 (2H, m), 3.48-3.18 (2H, m),

(請先閲讀背面之注意事項再填寫本頁) 0 「填寫太 訂'(Please read the notes on the back before filling out this page) 0 "Fill in too much '

本纸伕尺度適用中国国家標李(CNS ) A4現格(210X297公釐) 1235157 A/ B7 五、發明説明(374) 3.04-2.90 (2H, m)? 2.97 (3H, s), 2.69-2.54 (1H, m), 2.42-2.32 (1H, m), 2.22-2.15 (1H, m), 2.07-1.93 (3H? m), 1.71-1.65 (2H, m), 1.38 (9H, s);分析 C28H33N3C12〇9S之計算値:C, 48.98; H, 4.84; N,1〇·2〇; S, 4·67。實測値:C,48.73; H,4.95; N,9·65; S, 4.54 ^ MS (ES +) 692/90/88 (M++ 1, 100%), 636/4/2 (71)-C2«H34N5C1209S (MH勹之確實質量估計値:686.1454。實測値: 686.1474。 [35(15,95)]4-[5-(2,6-二氯苯基)呤唑-2-基]-3-(6,10-二酮基-9-甲基磺醯基胺基-1,2,3,4,7,_8,9,10-八氫-61嗒畊並[1,2-a】[l,2]二氮雜箪-1-羧醯胺基)-4-酮基丁酸(220b),以類似化 合物217e之方式製備自219b,呈淺乳色粉末(396毫克, 870/〇):mp 100-20CTC ; [a ]D27-129 (c 0.12, MeOH); IR (KBr) 33 10, 3153, 1713, 1667, 1557, 1510, 1432, 1421, 1329, 1273, 1258, 1221, 1193, 1153, 1 134, 992, 789; lH NMR (d6 DMSO) 5?濟部中央揉準局貝工消费合作社印装The scale of this paper is applicable to Chinese national standard (CNS) A4 (210X297 mm) 1235157 A / B7 V. Description of the invention (374) 3.04-2.90 (2H, m)? 2.97 (3H, s), 2.69-2.54 (1H, m), 2.42-2.32 (1H, m), 2.22-2.15 (1H, m), 2.07-1.93 (3H? M), 1.71-1.65 (2H, m), 1.38 (9H, s); analysis Calculation of C28H33N3C12〇9S: C, 48.98; H, 4.84; N, 10.2; S, 4.67. Found: C, 48.73; H, 4.95; N, 9.65; S, 4.54 ^ MS (ES +) 692/90/88 (M ++ 1, 100%), 636/4/2 (71) -C2 « H34N5C1209S (MH's exact mass estimate: 686.1454. Found: 686.1474. [35 (15,95)] 4- [5- (2,6-dichlorophenyl) pyrazol-2-yl] -3- (6,10-diketo-9-methylsulfonamido-1,2,3,4,7, -8,9,10-octahydro-61 1,2] diazapyridine-1-carboxamido) -4-ketobutyric acid (220b), prepared from 219b in a similar manner to compound 217e, as a light cream powder (396 mg, 870 / 〇) : mp 100-20CTC; [a] D27-129 (c 0.12, MeOH); IR (KBr) 33 10, 3153, 1713, 1667, 1557, 1510, 1432, 1421, 1329, 1273, 1258, 1221, 1193, 1153, 1 134, 992, 789; lH NMR (d6 DMSO)

(請先閱讀背®之注意事項再本頁W &amp; 7.88 (1H, s), 7.81-7.60 (4H, m), 5.49-5.28 (1H, m), 5.24-5.14 (1H, m), 4·46-4·22 (2H, m),3·30-3·03 (2H, m), 2.97-2.76 (3H, m), 2.96 (3Ht s), 2.46-2.24 (1H, m), 2.16-2.05 (1H, m), 2.03-1.78 (3H, m), 1.68-1.46 (2H, m) ; MS (ES-) 632/30/28 (M -1,68%), 149/7/5 (100)。C24H26N5C12〇9S (MH勹之確實質 量估計値:630·0828。實測値:630.0852。 •377- 本纸伕尺度通用中gl家標车(CNS ) A4規格(2I0X297公釐) 1235157 AT B7 五、發明説明(375 )(Please read the Precautions of Back® before this page W &amp; 7.88 (1H, s), 7.81-7.60 (4H, m), 5.49-5.28 (1H, m), 5.24-5.14 (1H, m), 4 46-4 · 22 (2H, m), 3.30-3 · 03 (2H, m), 2.97-2.76 (3H, m), 2.96 (3Ht s), 2.46-2.24 (1H, m), 2.16 -2.05 (1H, m), 2.03-1.78 (3H, m), 1.68-1.46 (2H, m); MS (ES-) 632/30/28 (M -1, 68%), 149/7/5 (100). C24H26N5C12〇9S (MH's exact mass estimate: 630 · 0828. Measured: 630.0852. • 377- This paper is a universal medium-sized domestic standard car (CNS) A4 (2I0X297 mm) 1235157 AT B7 V. Description of the Invention (375)

00

223e Rx = phc〇 (請元閔讀背νβ之注意事項223e Rx = phc〇

•尽頁) 訂 [35,4115(15,93)]4-(5,7-二氣苯並”号唑-2-基)-3-(6,10-二嗣基 -9-甲基磺醯基胺基-1,2,3,4,7,8,9,10-八氫-611-,答喑並[1,2-a][l,2]二氮雜箪-1-羧醢胺基)-4-羥基丁酸第三-丁酯(221b) ,以類似化合物215e之相同方法,製備自酸212b及13S, 4RS) N-(烯丙氧羰基)-3-胺.基-4-羥基-4-(5,7-二氣苯並呤唑· 2-基)丁酸第三-丁酯(204),可生k非對映立鳢異構物之混 合物(460毫克,70°/。)呈玻璃狀:IR (film) 3325, 1725, 1664, 1453, 1399, 1373, 1327, 1274, 1256, 1 155; lU NMR (CDC13) &amp; 7.57 (1H, m), 7.36 (2Hr m), 6.06 (1H, t), 5.29 (2H, m), 4.79 -378- 本紙伕尺度適用中§國家揉窣(〇^)戍4規格(210父297公釐&gt;• End page) Order [35,4115 (15,93)] 4- (5,7-Digas benzo "oxazol-2-yl) -3- (6,10-diamidino-9-methyl Sulfonylamino-1,2,3,4,7,8,9,10-octahydro-611-, pyrido [1,2-a] [l, 2] diazepine-1- Carboxamidine) tert-butyl 3-hydroxybutyrate (221b), prepared in the same manner as compound 215e, from acids 212b and 13S, 4RS) N- (allyloxycarbonyl) -3-amine. 4-Hydroxy-4-hydroxy-4- (5,7-digas benzoxazol. 2-yl) butyric acid tertiary-butyl ester (204), a mixture of diastereoisomeric fluorene isomers (460 Mg, 70 ° /.) Glassy: IR (film) 3325, 1725, 1664, 1453, 1399, 1373, 1327, 1274, 1256, 1 155; lU NMR (CDC13) & 7.57 (1H, m), 7.36 (2Hr m), 6.06 (1H, t), 5.29 (2H, m), 4.79 -378- The size of this paper is applicable. § Country (窣 ^) 戍 4 specifications (210 father 297 mm &gt;

經濟部中夬樣準局負工消費合作社印«. 1235157 A7 B7 經濟部中央標挛局負工消费合作社印¾ 五、發明説明(376) (1H,m),4.47 (1H,m),3.2j (1H,m),2.97及 2.94 (3H combined, 2 x s), 2.9-2.4 (4H, m), 2.30 (1H, m), 1.96 (4H, m), 1,41 &amp;1.37(9Hcombined,2xs)aMSES,Da/e 660 (M-l)· Cl33 100%,662 (M - 1)· Cl37。 (3S,4RS (IS, 9S)]3-(9-芊醯胺基-6,10-二嗣基. 1,2,3,4,7,8,9,10-八氫-611-嗒畊並[1,2-3几1,2]二氮雜箪-1-敌 §S胺基)-4-(5,7-二氣私並0亏也-2·基)-4 _短基丁酸第三-丁薛 (221e),以類似化合物215e所用之方法,製備自酸(2i2e)及 (3S, 4RS)N-(烯丙氧談基)-3-胺基-4-經基-4-(5,7-二氯笨並今 唑-2-基)丁酸第三-丁酯(204),可生成非對峡立體異構物之 混合(613毫克,87%)呈玻璃狀:IR (film) 3328, 1729, 1660, 1534, 1454, 1422, 1399, 1276, 1254, 1155; lU NMR (CDC13) &amp; 7.80 (2H, d), 7.60-7.35 (5H, m), 7.05 (2H, m), 5.13 (3H, m), 4.74 (1H, m), 4.51 (1H, m), 3.25 (1H, m), 3.1-2.6 (5H, m), 2·33 (1H,m), 2.1-1.5 (5H, m), 1·43及 1.41 (9H combined, 2 x s)。 MS ES+ Da/e 688 (M + 1)+ Cl35 55%, 690 (M + 1)+ Cl37 35%, 328 100%。 [3S (IS, 9S)]4-(5,7-二氣苯並哼唑-2·基)·3-(6,10-二鲷基-9-甲基磺基胺基-1,2,3,4,7,8,9,10-八氩-611-嗒啩並[1,2-3][1,2】 二氮雜箪-1-羧琏胺基)-4-酮基丁酸第三-丁酯(222b),以類 似化合物216e之方法製備自221b'呈無色玻璃(371毫克, 86%): ]d26-81.0 (c 0.1, CH2C12): IR (ΚΒγ) 3324, 2979, 2936, 1726, 1664, 1394, 1370, 1328, 1 155, 991; lH NMR (CDC13) &amp; 7.78 (1H, d), 7.57 (2H, m), 5.87 (1H, d), 5.69 (1H, m), 5.47 • 379- 本纸佚尺度通用中§國家標準(CNS ) Α4規格(210Χ297公釐) (請先聞讀背面之注意事項 —κι^— 本頁 訂Printed by the Consumer Procurement Cooperative of the Central Provincial Bureau of the Ministry of Economic Affairs «. 1235157 A7 B7 Printed by the Procurement Consumer Cooperative of the Central Standard Administration of the Ministry of Economy j (1H, m), 2.97 and 2.94 (3H combined, 2 xs), 2.9-2.4 (4H, m), 2.30 (1H, m), 1.96 (4H, m), 1,41 &amp; 1.37 (9Hcombined, 2xs) aMSES, Da / e 660 (Ml) · Cl33 100%, 662 (M-1) · Cl37. (3S, 4RS (IS, 9S)) 3- (9-fluorenylamino-6,10-difluorenyl.1,2,3,4,7,8,9,10-octahydro-611-Da Geng Ben [1,2-3,1,2] Diazapyridine-1-ene §S Amine) -4- (5,7-Digas, and O 2 -yl) -4 _short Butyric acid tert-butyric acid (221e), prepared in a manner similar to that used for compound 215e, from acids (2i2e) and (3S, 4RS) N- (allyloxyalkyl) -3-amino group-4 3- (5-, 7-dichlorobenzimidazol-2-yl) butyric acid tertiary-butyl ester (204), which can produce a mixture of non-parastereoisomers (613 mg, 87%) Glassy: IR (film) 3328, 1729, 1660, 1534, 1454, 1422, 1399, 1276, 1254, 1155; lU NMR (CDC13) &amp; 7.80 (2H, d), 7.60-7.35 (5H, m), 7.05 (2H, m), 5.13 (3H, m), 4.74 (1H, m), 4.51 (1H, m), 3.25 (1H, m), 3.1-2.6 (5H, m), 2.33 (1H, m), 2.1-1.5 (5H, m), 1.43 and 1.41 (9H combined, 2 xs). MS ES + Da / e 688 (M + 1) + Cl35 55%, 690 (M + 1) + Cl37 35 %, 328 100%. [3S (IS, 9S)] 4- (5,7-Digas Benzozol-2 · yl) · 3- (6,10-Dibenzyl-9-methylsulfo Amino-1,2,3,4,7,8,9,10-O-argon-611-dapyrido [1,2-3] [1,2] diazapyridine-1-carboxamido -4-ketobutyric acid tert-butyl ester (222b), prepared in a similar manner to compound 216e from 221b 'as a colorless glass (371 mg, 86%):] d26-81.0 (c 0.1, CH2C12): IR ( ΚΒγ) 3324, 2979, 2936, 1726, 1664, 1394, 1370, 1328, 1 155, 991; lH NMR (CDC13) &amp; 7.78 (1H, d), 7.57 (2H, m), 5.87 (1H, d) , 5.69 (1H, m), 5.47 • 379- The standard of this paper is universal § National Standard (CNS) A4 specification (210 × 297 mm) (Please read the precautions on the back first—κι ^ — This page order

1235157 Λ: B7 五、發明説明,(377) (1H,m),4.55 (2H,m),3·24 (2H,m),3·0 (5H,m + s),2·59 (1H,m),2·39 (1H,m),2.2-1.7 (4H,m),1.65,(1H,m),1·40 (9H, s) 〇 / [35(15,93)]3-(9-芊醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氩_6H-”答畊並[i,2-a][l,2]二氮雜箪-1-羧醯胺基)-4-(5,7-二 氣笨並,号唑·2-基)-4-酮丁酸第三·丁酯(222e),以類似化合 物2 16e之相同方法製備自221e,可生成無色玻璃(480毫克 ,84%): [a ]d25-86.4〇 (c 0.1 CH2C12); IR (KBr) 3337, 2978, 2938, 1728, 1657, 1534, 1456, 1422, 1395, 1370, 1277, 1250, 1154; lH NMR (CDC13) &amp; 7.80 (3H, m), 7.50 (4H, m), 7.20 (1H, d), 7.02 (1H, d), 5.60 (1H, m), 5.28 (1H, m), 5.15 (1H, m)? 4.11 (1H, m), 3.34 (2H, m), 2.96 (3H, m), 2.40 (1H, m), 2.20 (1H, m), 1.92 (2H, m), 1.67 (2H, m), 1.38 (9H, s) ^ MS ES· Da/e 684 (M - I)· Cl35 47%,686 (M - 1)· Cl37 32% : [35(15,95)]4-(5,7-二氣苯並呤唑-2-基)-3-(6,10-二飼基-9-甲基磺醢胺基-1,2,3,4,7,8,9,10-八氫-6H-嗒啩並[l,2-a][l,2] 二氮雜苯-1-羧醢胺基)-4-酮基丁酸(223b),以類似化合物 217e之方法製備自222b,可得摻白色固體(257毫克,78%): [a ]D2M〇5.7° (c 0.1,CHflJ; IR (KB〇 3321,1723, 1663, 經濟部中央橾準局員工消费合作社印製 1407, 1325, 1151, 992; lH NMR (D6-DMSO) &amp; 8.96 (1H, d), 8.18 (1H, d), 7.96 (1H, d), 5.50 (1H, m), 5.15 (1H, m), 4.30 (2H, m), 3.06 (2H, m), 2.87 (5H, m + s), 2.29 (1H, m), 1.99 (4H, m), 1.56 (2H,m) 3 [35(13 95)]3-(9-+驢胺基-6,10-二嗣基-1,2,。,4,7,8,9,10-八 -380 · 本紙ft尺产速用中標李(CNS ) 規格(210X 297公釐) 1235157 A7 B7 五、發明説明(378) 氫_611-嗒啩並[1,2_3][1,2]二氮雜箪-1-羧醢胺基)-4-(5,7-二 氣苯並呤唑-2-基)-4-酮基丁酸(223e),以類似化合物217e 所用方法,製備自222e,可生成淺乳色gf鳢(311毫克, 78%):mp 167-180eC ; [a ]D23-88.6° (c 0.1 C^Cl^; IR (KBr) 3331, 1724, 1658, 1534, 1458, 1421,1279, 1256, 991;咕 NMR (CDC13) &amp; 7.77 (4H, m), 7.4 (5H, m), 5.57 (1H, bs), 5.33 (1H, bs), 5.47 (1H, q), 4.56 (1H, bd), 3.60 (2H, m), 3.20 (3H, m), 2.76 (1H, m), 2.36 (1H, dd), 2.0 (3H, m), 1.66 (1H, m)。 MS ES Da/e 628 (M - 1)· έΐ35 7%,630 (M - 1)· Cl37 2·3%, 584 100%。1235157 Λ: B7 V. Description of the invention, (377) (1H, m), 4.55 (2H, m), 3.24 (2H, m), 3.0 (5H, m + s), 2.59 (1H , M), 2.39 (1H, m), 2.2-1.7 (4H, m), 1.65, (1H, m), 1.40 (9H, s) 〇 / [35 (15,93)] 3- (9-fluorenylamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octaargon-6H- ", and [i, 2-a] [l , 2] Diazapyridine-1-carboxamido) -4- (5,7-diazidobenzoyl, oxazolyl-2-yl) -4-ketobutyric acid tert-butyl ester (222e), Prepared from 221e in the same way as compound 2 16e, it can produce colorless glass (480 mg, 84%): [a] d25-86.4〇 (c 0.1 CH2C12); IR (KBr) 3337, 2978, 2938, 1728, 1657 , 1534, 1456, 1422, 1395, 1370, 1277, 1250, 1154; lH NMR (CDC13) &amp; 7.80 (3H, m), 7.50 (4H, m), 7.20 (1H, d), 7.02 (1H, d ), 5.60 (1H, m), 5.28 (1H, m), 5.15 (1H, m)? 4.11 (1H, m), 3.34 (2H, m), 2.96 (3H, m), 2.40 (1H, m) , 2.20 (1H, m), 1.92 (2H, m), 1.67 (2H, m), 1.38 (9H, s) ^ MS ES · Da / e 684 (M-I) · Cl35 47%, 686 (M- 1) · Cl37 32%: [35 (15,95)] 4- (5,7-digas benzoxazol-2-yl) -3- (6,10-diaphthyl-9-formaldehyde Sulfonamido-1,2,3,4,7,8,9,10-octahydro-6H-dapyrido [l, 2-a] [l, 2] diazabenzene-1-carboxamidine Amine) -4-ketobutyric acid (223b), prepared from 222b in a similar manner to compound 217e, can be obtained with a white solid (257 mg, 78%): [a] D2M 05.7 ° (c 0.1, CHflJ; IR (KB〇3321, 1723, 1663, printed by the Consumers' Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs 1407, 1325, 1151, 992; lH NMR (D6-DMSO) &amp; 8.96 (1H, d), 8.18 (1H, d ), 7.96 (1H, d), 5.50 (1H, m), 5.15 (1H, m), 4.30 (2H, m), 3.06 (2H, m), 2.87 (5H, m + s), 2.29 (1H, m), 1.99 (4H, m), 1.56 (2H, m) 3 [35 (13 95)] 3- (9- + donylamino-6,10-diamidino-1,2 ,. , 4,7,8,9,10-Eight-380 · The winning bid (CNS) for this paper ft ruler production specification (210X 297 mm) 1235157 A7 B7 V. Description of the invention (378) Hydrogen_611- [1,2_3] [1,2] Diazapyridine-1-carboxamido) -4- (5,7-digasbenzoxazol-2-yl) -4-ketobutanoic acid (223e ), Similar to the method used for compound 217e, prepared from 222e, can produce light cream gf 鳢 (311 mg, 78%): mp 167-180eC; [a] D23-88.6 ° (c 0.1 C ^ Cl ^; IR ( KBr) 3331, 1724, 1658, 1534, 1458, 1421, 1279, 1256, 991; Go NMR (CDC13) &amp; 7.77 (4H, m), 7.4 (5H, m), 5.57 (1H, bs), 5.33 ( 1H, bs), 5.47 (1H, q), 4.56 (1H, bd), 3.60 (2H, m), 3.20 (3H, m), 2.76 (1H, m), 2.36 (1H, dd), 2.0 (3H , m), 1.66 (1H, m). MS ES Da / e 628 (M-1) · 35 7%, 630 (M-1) · Cl37 2.3%, 584 100%.

224e = PhCO/ X = S 226e = PhCO, X = S 225e Ri = PhCO,X = O 227e ~ PhCO, X = 0 經濟部中央揉準局貝工消资合作社印装 [35(15,95)3-(9-苄醢胺基-6,10-二辆基-1,2,3,4,7,8,9,10-八 氫-6H-嗒啩並[l,2-a][l,2]-二氮雜箪-1-羧琏胺基)-5-(2-氣苯 基)甲碇基-4-酮基戊酸第三-丁鹺(224e)。1·羥基苯並三吱 (0.23克,1.71毫莫耳)及乙基二甲胺基丙基凌化二亞胺鹽 酸加至酸212e (0.295克,0·853毫莫耳)於THF (5毫升)之擭 拌溶液中3 5分鐘後加水(〇·5毫升)’再7分鐘後’加入(3S) -381 - 度適用中国國家標李(CNS ) Α4規格(210X297公沒) ~&quot; 1235157 Λ 7 _ __Β7 五、發明説明(379)224e = PhCO / X = S 226e = PhCO, X = S 225e Ri = PhCO, X = O 227e ~ PhCO, X = 0 Printed by the Central Government Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives [35 (15,95) 3 -(9-benzylamidinyl-6,10-dicyryl-1,2,3,4,7,8,9,10-octahydro-6H-daparo [l, 2-a] [l , 2] -Diazapyridine-1-carboxamido) -5- (2-Gaphenyl) methylamidino-4-ketovaleric acid tert-butyridine (224e). 1. · Hydroxybenzotris (0.23 g, 1.71 mmol) and ethyl dimethylaminopropyl Lingimide hydrochloride were added to the acid 212e (0.295 g, 0.853 mmol) in THF (5 3) After adding water (0.5 ml) to the stir-fry solution for 3 to 5 minutes, add (3S) -381-degrees to the Chinese national standard (CNS) Α4 specification (210X297 public) ~ &quot; 1235157 Λ 7 _ __Β7 V. Description of the invention (379)

3-缔丙氧羰基铵基ο-(2-氯-苯基)曱硫基-4-酮戊酸第三丁 il (123, 0.478 克,1.02 毫莫耳)及(PPh3)2PdCl2(20 毫克)於丁 HF (2毫升)之溶液。再以20分鐘逐滴加入氫化-三丁錫(0.65毫 升,2.33毫莫耳混合物保持4.5小時,再以EtOAc稀釋, 以1M HC1,碧水,NaHC03飽和水溶液再以鹽水洗綠。昆 合物乾澡(MgS04)及濃縮。殘留物以己烷研磨數次,其再 傾析及丟棄,再以快速層析純化(1CM00% Et〇Ac/CH2Cl2) 可生成〇·2克(35。/〇)的白色玻璃狀固體mp 70-72°C; [c]D26-S2.5° (c 0,02, CH2Cl2)。 IR (KBr) 3404, 1726, 1660, 1 534, 1524, 1422, 1277, 1254, 1 154; lK NMR (CDC13) &amp; 7.83-7.78 (2H, m), 7.7, 7.75-7.32, 7.26-7.20 (7H, 3m), 7.12 (1H, d, J=8.2), 7.01 (1H, d, J=7.3), 5.23-5.08 (2H, m), 5.03-4.94 (1H, m), 4.62 (1H, dt, J=14.5), 3.78 (2H, m), 3.38-3.29 (1H, m), 3.26 (2H, s), 3.06-2.82 (4H, m), 2.71 (1H, dd, J=17.2, 4.5), 2.39 (1H, dd, J=13.2, 6.5), 2.15-1.83, 1.73-1.63 (5H, m), 1.45 (9H,s)。分析 c33H39ClN407Si 計算値:C, 59.05; H,5·86; N, 8.35。實測値:59·00; H, 5.80; N,7.92。 -¾濟部中央樣準局負工消費合作社印¾ [3RS, (IS, 9S)]3-(9-苄醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺基)-5-(2-氣 苯基甲氧基)-4-酮基戊酸第三-丁酯(225e),利用類似化合 物224e之方法,製備自酸212e及·(3S)N-(烯丙氧羰基)-3·胺 基-5-(2-氣苯基甲氧基)·4-酮基戊酸第三-丁酯(201),可生 成 40毫克(23%)的玻璃狀固體:¾ NMR (CDC13) &amp; 7,83-7.73 (2H, m), 7.67-7.10 (9H, m), 5.23-5.09 (2H, m), 4.59 (1H, m), • 382· 本纸ft尺度通用中g國家標準(CNS ) Μ規格(2丨OX297公釐) 1235157 Λ7 B7 經濟部中央標率局員工消费合作社印製 五、發明説明(380)4.45-4.22 (2H? m)? 3.7-3,19, 3.08-2.72, 2.71-2.47, 2.05-1.85, 1·72-1·61, 1.45-1.26 (20H,6m)。 [35(15,95)]3-(9-芊醢胺基-6,10-二酮基-1,2,3,4,7,8,9,1〇-八 氫_6H-嗒畊並[l,2-a][l,2]二氮雜箪-1-羧睦胺基)-5·(2·氯苯 基)甲硫基-4-嗣基戊酸(226e),以類似化合物21 &amp;之方法, 製備自224e,可生成0.22克(81%)摻白色固體:mp 95-10CTC; [a ]D23-95.6C (c 0.2, CH2Cl2)。 IR (KBr) 3393, 1720, 1658, 1529, 1422, 1279; lU NMR (D6-DMSO) &amp; 8.80 (1H, d, J=7.5), 7.89 (2H, m), 7.7 (1H, d, J=7.7), 7.56-7.28 (7H, m)? 5.10 (1H, m), 4.87-4.73 (2H? m), 4.39 (1H, m), 3.77 (2H, m), 3.44, 3.35 (2H,+H20, 2m), 2.97-2.56, 2.2, 1.92, 1.61 (11H, 4m):分析 C29H31C1N407S 0·5Η2Ο之計算値:C,55·02; H,5·10; N,8.85, 實測値:C, 55.00; H, 5.09; N, 8.71。 [3RS,(IS, 9S)]3·字醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氨-6Η·^ α井並[l,2-a][l,2]二亂雜卓-1-竣胺基)-5-(2-乳表 基甲氧基)-4-酮基戊酸(227e),以類似2l7e化合物之方法, 製備自225e,產物以快速層析進一步純化(0_5% MeOH/CH2Cl2)可生成19毫克(81%)的玻璃狀固體:¾ NMR (CDCI3) &amp; 7.79 (2H, m), 7.66-7.18 (9H, m), 5.30-5.10 (2H, m), 4.85 (1H, m), 4.65 (2H, m), 4.53 (1H, m), 4.28 (2H, m), 3.28, 3.01, 2.72, 2·33, 1.94, 1·60 (11H, in)。MS (ES·, m/z) 597 (M+ -1,100%)。 -383- 本纸伕尺度適用中g國家樣準(CNS )六4说格U10X297公釐) (請先¾ 讀背面之Ϊ事項再 111^ 本瓦) •装 訂3-Allyloxycarbonylammonium ο- (2-chloro-phenyl) fluorenylthio-4-ketovalerate tert-butyl il (123, 0.478 g, 1.02 mmol) and (PPh3) 2PdCl2 (20 mg ) In Ding HF (2 ml). Hydrogen-tributyltin (0.65 ml, 2.33 mmol) was added dropwise over 20 minutes and kept for 4.5 hours, then diluted with EtOAc, washed with 1M HC1, clear water, NaHC03 saturated aqueous solution, and then washed with saline. (MgS04) and concentrated. The residue was triturated with hexane several times, it was decanted and discarded, and then purified by flash chromatography (1CM00% Et〇Ac / CH2Cl2) to produce 0.2 g (35%). White glassy solid mp 70-72 ° C; [c] D26-S2.5 ° (c 0,02, CH2Cl2). IR (KBr) 3404, 1726, 1660, 1 534, 1524, 1422, 1277, 1254, 1 154; lK NMR (CDC13) &amp; 7.83-7.78 (2H, m), 7.7, 7.75-7.32, 7.26-7.20 (7H, 3m), 7.12 (1H, d, J = 8.2), 7.01 (1H, d , J = 7.3), 5.23-5.08 (2H, m), 5.03-4.94 (1H, m), 4.62 (1H, dt, J = 14.5), 3.78 (2H, m), 3.38-3.29 (1H, m) , 3.26 (2H, s), 3.06-2.82 (4H, m), 2.71 (1H, dd, J = 17.2, 4.5), 2.39 (1H, dd, J = 13.2, 6.5), 2.15-1.83, 1.73-1.63 (5H, m), 1.45 (9H, s). Analysis of c33H39ClN407Si Calculated 値: C, 59.05; H, 5.86; N, 8.35. Measured 値: 59.0; H, 5.80; N, 7.92. Printed by the Central Procurement Bureau of the Ministry of Work and Consumer Cooperatives ¾ [ 3RS, (IS, 9S)] 3- (9-benzylamido-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6H-daparin [l, 2-a] [l, 2] Diazapyridine-1-carboxamido) -5- (2-Gasphenylmethoxy) -4-ketovaleric acid tert-butyl ester ( 225e), using a method similar to compound 224e, prepared from acid 212e and · (3S) N- (allyloxycarbonyl) -3 · amino-5- (2-aminophenylmethoxy) · 4-keto Tertiary-butyl valerate (201), yielding 40 mg (23%) of a glassy solid: ¾ NMR (CDC13) &amp; 7,83-7.73 (2H, m), 7.67-7.10 (9H, m) , 5.23-5.09 (2H, m), 4.59 (1H, m), • 382 · This paper has a ft standard common Chinese national standard (CNS) M specification (2 丨 OX297 mm) 1235157 Λ7 B7 Central Standards Bureau of the Ministry of Economic Affairs Printed by employee consumer cooperatives V. Description of invention (380) 4.45-4.22 (2H? M)? 3.7-3, 19, 3.08-2.72, 2.71-2.47, 2.05-1.85, 1.72-1 · 61, 1.45-1.26 (20H, 6m). [35 (15,95)] 3- (9-Amido-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6H-Dagen And [l, 2-a] [l, 2] diazafluoren-1-carboxylamino) -5 · (2 · chlorophenyl) methylthio-4-fluorenylpentanoic acid (226e), A method similar to compound 21, prepared from 224e, yields 0.22 g (81%) of a white solid: mp 95-10CTC; [a] D23-95.6C (c 0.2, CH2Cl2). IR (KBr) 3393, 1720, 1658, 1529, 1422, 1279; lU NMR (D6-DMSO) &amp; 8.80 (1H, d, J = 7.5), 7.89 (2H, m), 7.7 (1H, d, J = 7.7), 7.56-7.28 (7H, m)? 5.10 (1H, m), 4.87-4.73 (2H? M), 4.39 (1H, m), 3.77 (2H, m), 3.44, 3.35 (2H, + H20, 2m), 2.97-2.56, 2.2, 1.92, 1.61 (11H, 4m): Analysis of the calculation of C29H31C1N407S 0 · 5Η2〇Ο: C, 55 · 02; H, 5.10; N, 8.85, Measured 値: C, 55.00; H, 5.09; N, 8.71. [3RS, (IS, 9S)] 3 · Amino-6,10-diketo-1,2,3,4,7,8,9,10-octaamine-6Η · ^ α well and [ l, 2-a] [l, 2] Dioxazi-1-octylamino) -5- (2-lactoepoxymethoxy) -4-ketovaleric acid (227e), similar to the compound 217e This method was prepared from 225e. The product was further purified by flash chromatography (0_5% MeOH / CH2Cl2) to yield 19 mg (81%) of a glassy solid: ¾ NMR (CDCI3) &amp; 7.79 (2H, m), 7.66- 7.18 (9H, m), 5.30-5.10 (2H, m), 4.85 (1H, m), 4.65 (2H, m), 4.53 (1H, m), 4.28 (2H, m), 3.28, 3.01, 2.72, 2.33, 1.94, 1.60 (11H, in). MS (ES ·, m / z) 597 (M + -1, 100%). -383- The standard of this paper is applicable to Chinese National Standards (CNS) 6 and 4 grid U10X297 mm) (please read the items on the back and then 111 ^ this tile) • Binding

1235157 A7 B7 五、發明説明(381 ) 01235157 A7 B7 V. Description of the invention (381) 0

(請先緊讀背云之注意事項 J— 訂 [3RS, 4RS (IS, 9S)]3-(9-芊醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611-嗒啩並[1,24][1,2]二氮雜萆-1-敌 醢胺基)-5-氟-4-氧戊酸第三-丁酯(228e)。卜羥基苯並三吱 (0.23克,1.68毫莫耳)繼以乙基二甲胺基丙基凌化二至胺 g酸(0.21克,1.09毫莫耳)加至·酸212e (0.29克,0.84毫莫 耳)於CH2C12(3毫升)在室溫下之攪摔溶液中。混合物保持 10分鐘,再加入(3RS, 4RS) 3-胺基〇-氟-4-羥基戊酸第三-丁 g旨(Revesz, L. et al. Tetrahedron Lett., 52, pp. 9693-9696 -384- 本纸伕尺度適用中g國家標辛(CNS ) Α4規格(210Χ297公釐)(Please read the precautions for Back Cloud J—Order [3RS, 4RS (IS, 9S)] 3- (9-fluorenyl-6,10-diketo-1,2,3,4,7 , 8,9,10-octahydro-611-dapyrido [1,24] [1,2] diazapyridine-1-eneamido) -5-fluoro-4-oxopentanoate Butyl ester (228e). Hydroxybenzotris (0.23 g, 1.68 mmol) followed by ethyl dimethylaminopropyl phosphonium amine acid (0.21 g, 1.09 mmol) was added to · Acid 212e (0.29 g, 0.84 mmol) in a solution of CH2C12 (3 ml) at room temperature. The mixture was held for 10 minutes, and then (3RS, 4RS) 3-aminoo-fluoro-4-hydroxy Tertiary valeric acid (Revesz, L. et al. Tetrahedron Lett., 52, pp. 9693-9696 -384- The standard of this paper is applicable to the national standard Xin (CNS) A4 specification (210 × 297 mm)

經涛部中央標率局员工消费合作社印製 1235157 A7 B7 經濟部中夬標準局員工消费合作杜印¾ 五、發明説明(382) (1994); 0.29克,1·40毫莫耳)於 CH2C12(3毫升),繼以 4-二 甲胺基吡啶(1〇毫克)。溶液攪摔17小時,以EtOAc稀釋, 以1M HC1,鹽水,飽和的NaHC03水溶液及再次的鹽水洗 滌,乾燥(MgS04)並濃縮。殘留物以快速層析純化(50-100% EtoAc/CH2Cl2 及 5% MeOH/EtoAc)可生成 0.25 克(56%) 白色玻璃狀固體(KBr) 3343, 1726, 1658, 1536, 1426, 1279, 1257, 1 157; LH NMR (CDC13) &amp; 7.84-7.79 (2H, m), 7.57-7.40 (3H, m), 7.05-6.92, 6.73 (2H, 2m), 5.17-5.04 (2H, m), 4.56, 4.35-4.21, 4.04 (5H, 3m), 3.36, 3.09^2.34, 2.00 (11H,3m), 1.46 (9H,s)。分析 C26H35FN407· 0·5Η2Ο之計算 値:C,57·45; H,6.65; N,10.31。實測値:C,57.64; H,6.56; N, 10.15。 [3RS, 4RS(1S, 9S)]3-(9-T 醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611-嗒啩並[1,24][1,2]二氮雜箪-1-羧 醯胺基)-5-氟-4-氧戊酸第三-丁酯(229e)以類似2l6e化合物 之方法製備自228c。經快速層析純化(30-50% Et〇Ac/CH2Cl2)可得白色玻璃狀固體之產物(0.194克, 89%):IR (KBr) 3376, 1728, 1659, 1529, 1424, 1279, 1256, 1156。 [3RS, (IS, 9S)]3-(9-苄醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6Η-嗒啩並[l,2-a][l,2]二氮·雜箪-1-羧醯胺基)-5-氟-4-酮戊酸(23〇e),以類似化合物21:7e之方法製備自229e,生 成 23 0e 呈白色玻璃狀固體(1 〇〇〇/0) mp 105-125°C; [a]D23-91.4 。(c 0.72, CH3〇H)。 IR (KBr) 3336, 1789, 1737, 1659, 1535, -385- (诗先閱讀背δ之注意事3填寫本\貝 耸 訂Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs of the People's Republic of China. 1235157 A7 B7 Du Yin of the China National Standards Bureau of the Ministry of Economic Affairs. (3 ml) followed by 4-dimethylaminopyridine (10 mg). The solution was stirred for 17 hours, diluted with EtOAc, washed with 1M HC1, brine, saturated aqueous NaHC03 solution and brine again, dried (MgS04) and concentrated. The residue was purified by flash chromatography (50-100% EtoAc / CH2Cl2 and 5% MeOH / EtoAc) to yield 0.25 g (56%) of a white glassy solid (KBr) 3343, 1726, 1658, 1536, 1426, 1279, 1257 , 1 157; LH NMR (CDC13) &amp; 7.84-7.79 (2H, m), 7.57-7.40 (3H, m), 7.05-6.92, 6.73 (2H, 2m), 5.17-5.04 (2H, m), 4.56 , 4.35-4.21, 4.04 (5H, 3m), 3.36, 3.09 ^ 2.34, 2.00 (11H, 3m), 1.46 (9H, s). Analyze the calculation of C26H35FN407 · 0.5 · 20. 値: C, 57 · 45; H, 6.65; N, 10.31. Found 値: C, 57.64; H, 6.56; N, 10.15. [3RS, 4RS (1S, 9S)] 3- (9-T amido-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-611-da Pyrene [1,24] [1,2] diazapyridine-1-carboxamido) -5-fluoro-4-oxopentanoic acid third-butyl ester (229e) was prepared from a compound similar to 2116e 228c. Purified by flash chromatography (30-50% EtOAc / CH2Cl2) to obtain the product as a white glassy solid (0.194 g, 89%): IR (KBr) 3376, 1728, 1659, 1529, 1424, 1279, 1256, 1156. [3RS, (IS, 9S)] 3- (9-benzylideneamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-6Η-da 啩And [1,2-a] [l, 2] diaza · heterofluorene-1-carboxamido) -5-fluoro-4-ketopentanoic acid (23〇e), similar to the method of compound 21: 7e Prepared from 229e, yielding 23 0e as a white glassy solid (1000/0) mp 105-125 ° C; [a] D23-91.4. (C 0.72, CH3OH). IR (KBr) 3336, 1789, 1737, 1659, 1535, -385- (Read the notes of δ before reading the poem 3Fill in this book

本紙法尺度通用中g國家標準(CNS ) Α·4%格(210X 297公釐) 1235157 A7 B7 五、發明说明() 1426, 1279, 1258, 1186; lE NMR (GD3〇D) &amp; 7.71-7.68 (2H, m)? 7.37-7.23 (3H? m), 5.02, 4.88-4.63, 4.37-4.0 (6H, 3m), 3.30, 2.97, 2.68-2.60, 2.37-1.54 (11H, 4m)。 MS (ES·,m/z) 475 (M+ - 1,1〇〇0/〇)。 O n ρΛThe national standard (CNS) of this paper method is in general. A · 4% grid (210X 297 mm) 1235157 A7 B7 V. Description of the invention () 1426, 1279, 1258, 1186; 1E NMR (GD3〇D) &amp; 7.71- 7.68 (2H, m)? 7.37-7.23 (3H? M), 5.02, 4.88-4.63, 4.37-4.0 (6H, 3m), 3.30, 2.97, 2.68-2.60, 2.37-1.54 (11H, 4m). MS (ES., M / z) 475 (M + -1, 1000 / 〇). O n ρΛ

經濟部中夬櫺隼局員工消費合作·杜印裝 [3S (1S,9S)] 9-(芊醯胺基)-3-[6,10-二酮基-l,2,3,4,7,8,9,10- 八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-l-羧醯胺基]-3-氰基 丙酸甲酯(23 le)。N-苐基甲氧基-羰基-3-胺基-3-氰基丙酸 甲酯(EP0547699A1,3 85毫克,1.1毫莫耳)以17毫升二乙胺 處理3經室溫下撥摔1 · 5小時後,溶液濃縮a殘留物在碎 膠上層析(3%甲醇於CH2C12)並生成自由態胺,呈淺黃色油 狀。對此油及羥基苯並三唑(297毫克,2· 19毫莫耳)於DMF (5毫升)之溶液中,在(TC下加入乙基二甲胺基丙基碳化二 亞胺(232毫克,1.21毫莫耳,1.1當量)再加(is, 9S)9-(字龜 胺基 H6,10-二酮基-1,2,3,4,7,8,9'10-八氫-611-嗒《井並[1,2- a][l,2]二氮雜箪-I-羧酸(212e)。在(TC下攪拌5分鐘,再於 室溫下攪拌一夜,混合物以CHfl2稀釋(50毫升)且生成的 溶液相繼以.1M HC1 (2 X 30毫升),H2〇 (30毫升),10% -386 各紙朵尺度適用中1!国家標孪(€%)六4規格(2丨0\ 297公釐) 1235157 Λ7 B7 ,五、發明説明(384)Consumption Cooperation of Employees of Zhongli Bureau of the Ministry of Economic Affairs · Du Yinzhuang [3S (1S, 9S)] 9- (fluorenylamino) -3- [6,10-diketo-l, 2,3,4, 7,8,9,10-Octahydro-6H-dalopano [l, 2-a] [l, 2] diaza-l-carboxamido] -3-cyanopropanoic acid methyl ester ( 23 le). N-fluorenylmethoxy-carbonyl-3-amino-3-cyanopropanoic acid methyl ester (EP0547699A1, 3 85 mg, 1.1 mmol) treated with 17 ml of diethylamine 3 at room temperature 1 · After 5 hours, the solution was concentrated and the residue was chromatographed on crushed gel (3% methanol in CH2C12) and a free-state amine was formed as a pale yellow oil. To this oil and hydroxybenzotriazole (297 mg, 2.19 mmol) in a solution of DMF (5 ml), ethyl dimethylaminopropylcarbodiimide (232 mg , 1.21 millimoles, 1.1 equivalents) plus (is, 9S) 9- (Word turtle amino H6,10-diketo-1,2,3,4,7,8,9'10-octahydro- 611-Da "Jing [1,2-a] [l, 2] diazepine-I-carboxylic acid (212e). Stir for 5 minutes at (TC, and then overnight at room temperature, the mixture was mixed with CHfl2 Diluted (50 ml) and the resulting solution was successively .1M HC1 (2 X 30 ml), H2 0 (30 ml), 10% -386 each paper flower scale is applicable to 1! National standard (€%) 6 4 specifications ( 2 丨 0 \ 297 mm) 1235157 Λ7 B7, V. Description of the invention (384)

NaHC03 (2 X 30毫升)及飽和的N丑Q水溶液洗滌,乾燥 (MgS04)並濃縮3以快速層析在碎膠上純化(3%甲醇於 CH2C12)可生成化合物231e (404毫克’ 83%)呈固體:[a]D20_ 121° (c 0.14, CH2Cl2); !H NMR (CDC13) &amp; 7.40-7.83 (5H, m) 7.38 (1H,d), 6·96 (1H,d), 5.27-5.07 (2H, m),4.66-4.50 (ih m),3.79 (3H,s),3·23-2·73 (6H,m), 2.47-2.33 (1H,m),2 15_ 1.82 (4H,in);分析(^22^25^5〇6之 *十异 ^ C,58.0; H,5 53. n 15.38。實測値:C,57.6; H,5·6; N,15.0。 [3S (1S,9S)] 9-(芊醯胺基)-3-[6,10-二酮基-l,2,3,4,7,8,9,l(^ 經濟部中央標準局貝工消費合作杜印裝 八氫·6H-嗒啩並[l,2-a][l,2]二氮雜箪-l-幾醯胺基l·3_氛基 丙酸(232e)。甲酯23le(4〇0毫克,0.88毫莫耳)於甲醇(3〇亳 升)及水(30毫升)之溶液,在0&quot;C下冷卻再以二異兩基乙胺 處理。溶液在〇eC下擾拌10分鐘,再於室溫下一夜3實質 的混合物▲縮且所仔的固體在碎膠上層析(5%甲醇/1%甲 酸於CH2C12)可生成自甴態酸232e (170毫克,44%)呈白色 固·體:mp 155°C (dec); 〇 ]d20-117。(c 0.1,Me〇H); IR (KBr) 3343, 3061,2955, 1733, 1656, 1577, 1533, 1490, 1421,1342, 1279, 1256, 1222, 1185, 708; lH NMR (D4-Me〇H) &amp; 7.88-7.28 (5H, m), 5.20-5.03 (1H, m), 4.98-4.84 (2H, m), 4.75-4.53 (1H, m), 4.51-4.34 (1H, m), 3.45-3.22 (1H, m), 3.14-2.94 (1H, m), 3.14-2.94 (1H? m), 2.88-2.61 (2H, m), 2.53-1.50 (8H, m); 分析 C21H23N506· 1·5Η20之計算値:c,53·84; Η, 5·59; N, 14.95; 0, 25·61。實測値:C, 54·3; H, 5.4; N, 14.3。 •387- 本紙伕尺度通用中國國家標率(CNS ) A4堤格(210犬297公变) 1235157 Λ7 B7 五、發明説明(385) 0Washed with NaHC03 (2 X 30 ml) and saturated aqueous N-Q solution, dried (MgS04) and concentrated 3 and purified by flash chromatography on a crushed gel (3% methanol in CH2C12) to give compound 231e (404 mg '83%) Solid: [a] D20_ 121 ° (c 0.14, CH2Cl2);! H NMR (CDC13) & 7.40-7.83 (5H, m) 7.38 (1H, d), 6.96 (1H, d), 5.27- 5.07 (2H, m), 4.66-4.50 (ih m), 3.79 (3H, s), 3.23-2 · 73 (6H, m), 2.47-2.33 (1H, m), 2 15_ 1.82 (4H, in); analysis (^ 22 ^ 25 ^ 5〇6 of * ten different ^ C, 58.0; H, 5 53. n 15.38. Found 値: C, 57.6; H, 5.6; N, 15.0. [3S ( 1S, 9S)] 9- (fluorenylamino) -3- [6,10-diketo-l, 2,3,4,7,8,9, l (^ Shellfish Consumption of Central Standards Bureau, Ministry of Economic Affairs Cooperative printing of octahydro · 6H-da- [1,2-a] [l, 2] diazepine-l-epiaminoamino l · 3-aminopropionic acid (232e). Methyl ester 23le (400 mg, 0.88 mmol) in methanol (30 liters) and water (30 ml), cooled at 0 ° C and then treated with diisopropylethylamine. The solution was perturbed at 0eC. Mix for 10 minutes, and then at room temperature overnight, 3 substantial mixtures ▲ shrink and the solids in the crushed gel Chromatography (5% methanol / 1% formic acid in CH2C12) can produce 232e (170 mg, 44%) of hydration acid as a white solid. Mp 155 ° C (dec); 〇] d20-117. (C 0.1 , Me〇H); IR (KBr) 3343, 3061, 2955, 1733, 1656, 1577, 1533, 1490, 1421, 1342, 1279, 1256, 1222, 1185, 708; lH NMR (D4-Me〇H) &amp; 7.88-7.28 (5H, m), 5.20-5.03 (1H, m), 4.98-4.84 (2H, m), 4.75-4.53 (1H, m), 4.51-4.34 (1H, m), 3.45-3.22 ( 1H, m), 3.14-2.94 (1H, m), 3.14-2.94 (1H? M), 2.88-2.61 (2H, m), 2.53-1.50 (8H, m); Analyze the calculation of C21H23N506 · 1.5 · 20 : C, 53 · 84; Η, 5.59; N, 14.95; 0, 25 · 61. Found 値: C, 54.3; H, 5.4; N, 14.3. • 387- The standard of this paper is the Chinese National Standard (CNS) A4 Tige (210 dogs and 297 male transformers) 1235157 Λ7 B7 V. Description of the invention (385) 0

0 人 Η COrN8u ΝΗ2 Η0 people Η COrN8u ΝΗ2 Η

H COrNBuH COrNBu

233β R233β R

234e R C〇2-/-Bu*234e R C〇2-/-Bu *

236e R 237eR= 0236e R 237eR = 0

co2hco2h

23SeR co2h (請先閱讀背面之注意事項再填^:本頁) 裝·23SeR co2h (Please read the notes on the back before filling ^: this page)

經濟部中夬櫺隼局員工消费合作杜印裳Du Yinshang, Consumer Cooperation of Employees of Zhongli Bureau, Ministry of Economic Affairs

238eR238eR

[4S,(IS, 9S)] 4-(9-(芊醢胺基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6H-嗒啡並[l,2-a][l,2]二氮·雜革-1-羧醯胺基]-5-酮基 戊酸第三-丁酯半卡巴腙(233e)。(IS, 9S)6,10-二酮基-1,2,3,4,7,8,9,10-八氫-9-(芊氧胺基)-6&amp;-嗒啩並[1,24][1,2]二 氮雜箪-1-羧酸(212e)(345毫克,1.0毫莫耳),(4S)N-(烯丙 -388- 本紙伕尺度逑用中國国家標隼(CNS ) A4%格(210X 297公釐) 1235157 A; B7 五、發明説明(386) 氧裝基)_4-胺基-5·萌基戊酸第三·丁酯半卡巴腙(208a)(361 笔克,1·1毫莫耳,1.1當量)及(Ph3P)2PdCl2 (20毫克)於 CH2C12(5毫升)的溶液,以n-Bu3SnH(0.621毫升,2.3毫莫 耳’ 2.1當量)逐滴處理。生成的橘棕色溶液在25τ下攪拌 10分鐘,再加入I-羥基苯並三唑(297毫克,2.2毫莫耳,2 當量)。混合物冷卻至0°C再加乙基二甲胺基丙基碳化二亞 胺(253毫克,1.3毫莫耳,1.2當量)。在CTC下攪拌10分鐘後 於室溫下一夜,混合物以EtOAc (50毫升)稀釋,生成的溶 液相繼以1M HC1 (3 X 25毫升),1〇% NaHC〇3 (3 X 25毫升) 及鲍和的NaCl水溶液洗滌,乾燥(MgS04)再濃縮。於矽膠 上快速層析(2-10%甲醇於(:112(:12)可生成化合物23 3€(280毫 克,49%)爲褐色固體:[泛]〇20-95 (c 0.09, MeOH); IR (KBr) 3477, 3333, 2968, 2932, 1633, 1580, 1535, 1423, 1378, 1335, 1259, 1 156, 1085, 709; lK NMR (CDC13) &amp; 9.32 (1H, s), 7.83- 7.39 (6H, m), 7.11-7.09 (1H, m), 6.30-5.30 (2H, brs), 5.17-5.05 (2H, m), 4.62-4.38 (2H, m), 3.30-3.15 (1H, m), 3.13-2.65 (2H, m), 2.46-2.19 (3H, m), 2.15-1.54 (8H, m), 1.42 (9H, s) ^ [411,(13,95)]4-[9-(苄醯胺基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6H-嗒畊並[l,2-a][l,2]二氮雜箪小羧醯胺基]-5-酮基 戍酸第三-丁酯半卡巴腙(236e),以類似233e之方法利用 (4R)N-烯丙氧羰基·4·胺基酮基二戊酸第三-丁酯半卡巴腙 (208b,435毫克,1.33毫莫耳)可製成呈泡沫狀之產物(542 毫克,71%):〇 ]D20-99° (c 0.19, CHC13); IR (KBr) 3473, 333 1, 3065, 2932, 2872, 1660, 1580, 1533, 1488, 1423, 1370, -389· 本纸伕尺度適用中國國家標隼(CNS ) Α4逯格(210Χ 297公釐) (請先閎讀背面之注意事13^填寫本一貝)[4S, (IS, 9S)] 4- (9- (fluorenylamino) -6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6H- Daphno [l, 2-a] [l, 2] diaza · heteroderma-1-carboxamido] -5-ketovalerate tert-butyl hemicarbazone (233e). (IS, 9S) 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-9- (fluorenylamino) -6 &amp; -dapyrono [1,24] [ 1,2] Diazapyridine-1-carboxylic acid (212e) (345 mg, 1.0 millimolar), (4S) N- (allyl-388-) paper standard (Chinese national standard (CNS) A4) % Grid (210X 297 mm) 1235157 A; B7 V. Description of the invention (386) Oxygen group) _4-Amino-5 · Mengylvaleric acid Third · Butyl hemicarbazone (208a) (361 pen grams, A solution of 1.1 mmoles (1.1 equivalents) and (Ph3P) 2PdCl2 (20 mg) in CH2C12 (5 mL) was treated dropwise with n-Bu3SnH (0.621 mL, 2.3 mmoles' 2.1 equivalents). The resulting The orange-brown solution was stirred at 25τ for 10 minutes, and then I-hydroxybenzotriazole (297 mg, 2.2 mmol, 2 equivalents) was added. The mixture was cooled to 0 ° C and then ethyldimethylaminopropylcarbodicarbide was added. Imine (253 mg, 1.3 mmol, 1.2 equiv). Stir for 10 minutes at CTC Then at room temperature overnight, the mixture was diluted with EtOAc (50 mL), and the resulting solution was washed successively with 1M HC1 (3 X 25 mL), 10% NaHC〇3 (3 X 25 mL) and an aqueous NaCl solution. Dry (MgS04) and concentrate. Flash chromatography on silica gel (2-10% methanol in (: 112 (: 12) can produce compound 23 3 € (280 mg, 49%) as a brown solid: [PAN] 〇20- 95 (c 0.09, MeOH); IR (KBr) 3477, 3333, 2968, 2932, 1633, 1580, 1535, 1423, 1378, 1335, 1259, 1 156, 1085, 709; lK NMR (CDC13) &amp; 9.32 ( 1H, s), 7.83- 7.39 (6H, m), 7.11-7.09 (1H, m), 6.30-5.30 (2H, brs), 5.17-5.05 (2H, m), 4.62-4.38 (2H, m), 3.30-3.15 (1H, m), 3.13-2.65 (2H, m), 2.46-2.19 (3H, m), 2.15-1.54 (8H, m), 1.42 (9H, s) ^ [411, (13,95 )] 4- [9- (benzylamido) -6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-6H-thalco [l, 2 -a] [l, 2] Diazapyridinocarboxamido] -5-ketoacetic acid tert-butyl hemicarbazone (236e), using (4R) N-allyl in a similar manner to 233e Oxycarbonyl · 4 · aminoketodivaleric acid third-butyl hemicarbazone (208b, 435 mg, 1.33 mmol) ) Can be made into a foamy product (542 mg, 71%): 〇] D20-99 ° (c 0.19, CHC13); IR (KBr) 3473, 333 1, 3065, 2932, 2872, 1660, 1580, 1533 , 1488, 1423, 1370, -389 · The size of this paper is applicable to China National Standards (CNS) Α4 grid (210 × 297 mm) (Please read the notes on the back 13 ^ Fill in this note)

*1T* 1T

經濟部中央櫺隼局員工消費合作社印5L 1235157 Λ 7 Β7____ 五、發明説明(387) ^ 1337, 1278, 1254, 1224, 1 155, 1080、,1024, 983, 925, 877, 846, 801, 770, 705; lK NMR (CDC13) &amp; 9.42 (1H, s), 7.81 (2H, d), 7.51-7.40 (4H,m)? 7.06 (1H, d),6.50-5.50 (2H,寬 s),5.25-5.00 (2H, m), 4.60-4.45 (2H, m), 3.15-2.85 (2H, m), 2.75-2.35 (1H, m), 2.30-1.23 (1 1H, m), 1.42 (9H, s) ^ [4S,(IS, 9S)] 4-[9-(苄醯胺基)-6,lC^二酮基-l,2,3,4,7,8,9,10-八氫-6H-β答tt并並[l,2-a][l,2]二氮雜革-l-幾睦胺基]-5-網戊 酸第三-丁酯(234e)e半卡巴腙233e(390毫克,0.68毫莫耳) 於甲醇之溶液(1〇毫升)冷卻至,再以38%曱醛(2毫升)及 1M HC1 (2毫升)之水溶液處理3反應混合物再於室溫下攪 拌一夜。溶液濃縮以除去甲醇3非溶液以EtoAc萃取(30毫 升)。有機溶液相繼以10% NaHC03 (30毫升)及飽和的NaCl 水溶液洗條,乾燥·(MgS04)並濃縮。在碎膠上快速屢析纯 化(2-5%甲醇於CH2Cl2)可生成234e (179毫克,51%)呈白色 泡沫狀:〇 ]D20-l〇l。(c 〇·064, Me〇H); IR (KBr) 3346, 2976, 2934, 1730, 1657, 1535, 1456, 1425, 1278, 1255, 1 156, 708; 屯 NMR (CDC13) &amp;9·56 (1Η,s),7.88-7.38 (5Η,m),7.01 及 經濟部中夬標準局員工消費合作社印¾ 6.92 (2H, 2d), 5.27-5.08 (2H, m), 4.69-4.46 (1H, m), 3.50-3.27 (2H, m), 3.15-2.73 (2H, m), 2.46-1.83 (l〇H, m), 1.45 (9H,s)。 [4反,(15,95)]4-[9-(笮醯胺基)-6,丨0-二酮基-1,2,3,4,7,8,9,10-八氫井並[l,2-a][l,2]二氮雜革-l-幾驢胺基]·5·酮基 戊酸第三-丁酯(237e),以類似234e之方法製備自236e,可 生成白色泡末狀(390¾克’ 85%):[叫D'u3。(c 0.242, •390- 本紙伕尺度適用中國國家標準(CNS ) A4現格(2丨0X297公釐) 經濟部中夬標準局員工消费合作社印¾ 1235157 A7 . _ B7__ 五、發明説明(388) CHC13); IR (KBr) 3352, 3065, 2974,、1729, 1657, 1536, 1489, 1454, 1423, 1369, 1338, 1278, 1255, 1223, 1 156, 1078, 1026, 981, 846, 709 。 [4S,(IS, 9S)] 4-[9-(苄醯胺基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6Η-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺基]-5-酮戊 酸(235e)。第三-丁酯234e (179毫克,0.35毫莫耳)於無水 CH2C12(3毫升)之溶液冷卻至0Ό,再以三氟醋§ί(2毫升)處 理。生成的溶液在〇°C下攪拌30分鐘,再於室溫下2小時。 溶液濃縮,殘留物以無水CH^C12(5毫升)吸收,混合物再 以濃縮。此過程以更多的CH2C12 (5毫升)再次重覆。所得Printed by the Consumer Affairs Cooperative of the Central Government Bureau of the Ministry of Economic Affairs 5L 1235157 Λ 7 Β7 ____ V. Description of the Invention (387) ^ 1337, 1278, 1254, 1224, 1 155, 1080, 1024, 983, 925, 877, 846, 801, 770 , 705; lK NMR (CDC13) &amp; 9.42 (1H, s), 7.81 (2H, d), 7.51-7.40 (4H, m)? 7.06 (1H, d), 6.50-5.50 (2H, width s), 5.25-5.00 (2H, m), 4.60-4.45 (2H, m), 3.15-2.85 (2H, m), 2.75-2.35 (1H, m), 2.30-1.23 (1 1H, m), 1.42 (9H, s) ^ [4S, (IS, 9S)] 4- [9- (benzylamido) -6,1C ^ diketo-l, 2,3,4,7,8,9,10-octahydro -6H-β and benzo [l, 2-a] [l, 2] diazepine-l-kidamine] -5-trivalerate tert-butyl ester (234e) e hemi-carbabazone 233e (390 mg, 0.68 mmol) was cooled to a solution of methanol (10 ml), and then treated with 38% formaldehyde (2 ml) and 1M HC1 (2 ml) in water. 3 The reaction mixture was then allowed to stand at room temperature. Stir overnight. The solution was concentrated to remove methanol and the non-solution was extracted with EtoAc (30 mL). The organic solution was washed successively with 10% NaHC03 (30 ml) and a saturated aqueous NaCl solution, dried (MgS04) and concentrated. Rapid repeated analysis and purification on crushed gel (2-5% methanol in CH2Cl2) can produce 234e (179 mg, 51%) as a white foam: 〇] D20-101. (C 〇.064, Me〇H); IR (KBr) 3346, 2976, 2934, 1730, 1657, 1535, 1456, 1425, 1278, 1255, 1 156, 708; Tun NMR (CDC13) &amp; 9.56 (1Η, s), 7.88-7.38 (5Η, m), 7.01 and printed by the Consumers' Cooperative of the China Standards Bureau of the Ministry of Economic Affairs ¾ 6.92 (2H, 2d), 5.27-5.08 (2H, m), 4.69-4.46 (1H, m), 3.50-3.27 (2H, m), 3.15-2.73 (2H, m), 2.46-1.83 (10H, m), 1.45 (9H, s). [4trans, (15,95)] 4- [9- (fluorenylamino) -6, 丨 0-diketo-1,2,3,4,7,8,9,10-octahydrowell And [l, 2-a] [l, 2] diaza-l-chitylamino] ·· ketovaleric acid third-butyl ester (237e), prepared from 236e in a similar manner to 234e, Can produce a white bubble-like shape (390¾g '85%): [called D'u3. (C 0.242, • 390- This paper's standard is applicable to the Chinese National Standard (CNS) A4 (2 丨 0X297 mm)) Printed by the Consumers' Cooperative of the China Standards Bureau of the Ministry of Economic Affairs 1235157 A7. _ B7__ V. Description of the invention (388) CHC13); IR (KBr) 3352, 3065, 2974, 1729, 1657, 1536, 1489, 1454, 1423, 1369, 1338, 1278, 1255, 1223, 1 156, 1078, 1026, 981, 846, 709. [4S, (IS, 9S)] 4- [9- (Benzylamido) -6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6Η- Da [l, 2-a] [l, 2] diazepine-1-carboxyamido] -5-ketovaleric acid (235e). A solution of tertiary-butyl ester 234e (179 mg, 0.35 mmol) in anhydrous CH2C12 (3 ml) was cooled to 0 ° C, and then treated with trifluoroacetate (2 ml). The resulting solution was stirred at 0 ° C for 30 minutes and then at room temperature for 2 hours. The solution was concentrated, the residue was taken up in anhydrous CH ^ C12 (5 ml), and the mixture was concentrated again. This process was repeated again with more CH2C12 (5 ml). Income

殘留物於二乙醚中結晶。沈澱物收集及於矽膠管柱上純化 (5%甲醇於CH2C12),可生成化合物235e呈白色固體(111毫 克,70%):mp 142。(:(dec); [or ]D20-85.5 (c 0.062, Me〇H); IR (KBr) 3409, 3075, 2952, 1651,1541,1424, 1280, 1198, 1136, 717; lK NMR (D6-DMS0) &amp; 9.40 (1H, s), 8.62 (2H, m)? 7.96· 7.38 (5H, m), 5.19 -5.02 (1H, m), 4.98-4.79 (1H, m), 4.48-4.19 (1H, m), 3.51-3.11 (2H, m), 3.04-2.90 (2H, m), 2.38-1.46 (10H,m)。 [4R,(IS, 9S)] 4-〇(苄醯胺基)-6,l(^二酮基-l,2,3,4,7,8,9,l(^ 八氫-6H-,答畊並[l,2-a][l,2]二氮雜革-l-羧醢胺基]-5-酮基 戊酸(23 8e),以類似235e方法製褚自237e,可生成褐色泡 沫狀(190毫克,60%): [a]D20-78 (c 0.145, MeOH); IR (KBr) 3400, 3070, 2955, 2925, 2855, 1653, 1576, 1541, 1490, 1445, 1427, 1342, 1280, 1258, 1205, 1 189, 1 137, 1075, 1023, 983, -391 - 本纸伕尺度通用中国國家標孳(CNS ) Α4見格(210Χ 297公釐) ' ~^ (請先閱讀背δ之注意事項再填寫本f )The residue was crystallized from diethyl ether. The precipitate was collected and purified on a silica gel column (5% methanol in CH2C12) to give compound 235e as a white solid (111 mg, 70%): mp 142. (: (Dec); [or] D20-85.5 (c 0.062, Me〇H); IR (KBr) 3409, 3075, 2952, 1651, 1541, 1424, 1280, 1198, 1136, 717; 1K NMR (D6- DMS0) &amp; 9.40 (1H, s), 8.62 (2H, m)? 7.96 · 7.38 (5H, m), 5.19 -5.02 (1H, m), 4.98-4.79 (1H, m), 4.48-4.19 (1H , m), 3.51-3.11 (2H, m), 3.04-2.90 (2H, m), 2.38-1.46 (10H, m). [4R, (IS, 9S)] 4-〇 (benzylamino)- 6, l (^ diketo-l, 2,3,4,7,8,9, l (^ octahydro-6H-, benzophenone [l, 2-a] [l, 2] diaza G-l-carboxamido] -5-ketovaleric acid (23 8e), prepared from 237e in a similar manner to 235e, can form a brown foam (190 mg, 60%): [a] D20-78 ( c 0.145, MeOH); IR (KBr) 3400, 3070, 2955, 2925, 2855, 1653, 1576, 1541, 1490, 1445, 1427, 1342, 1280, 1258, 1205, 1 189, 1 137, 1075, 1023, 983, -391-The standard of this paper is the Chinese National Standard (CNS) Α4, see the standard (210 × 297 mm) '~ ^ (Please read the notes of δ before filling in this f)

1235157 A7 B7 五 、發明说明( 389、 930, 878, 843, 801, 777, 722; NMR (D6-DMSO) &amp; 9.40 (1H, s), 8.72-8.60 (2H, m), 7.89 (2H, d), 7.56-7.44 (3H, m), 5 17 (1H, m), 4.90-4.83 (1H, m), 4.46-4.36 (1H, m), 4.20-4.15 (1H, m), 3.40-3.30 (1H, m), 2.98-2.90 (2H, m), 2.50-1.60 (10H, m) 3 λΡ H °cr^〇i.Bu (243)1235157 A7 B7 V. Description of the invention (389, 930, 878, 843, 801, 777, 722; NMR (D6-DMSO) &amp; 9.40 (1H, s), 8.72-8.60 (2H, m), 7.89 (2H, d), 7.56-7.44 (3H, m), 5 17 (1H, m), 4.90-4.83 (1H, m), 4.46-4.36 (1H, m), 4.20-4.15 (1H, m), 3.40-3.30 (1H, m), 2.98-2.90 (2H, m), 2.50-1.60 (10H, m) 3 λΡ H ° cr ^ 〇i.Bu (243)

H (246) 經濟部中夬樣箪局員工消费合作杜印裝H (246) Consumption cooperation among employees of the China Bureau of Economic Affairs of the Ministry of Economic Affairs

(請先閱讀背&amp;之注意事項异填寫本f ) (IS, 9S) 9-苄醢胺基-八氫-10-酮基-6H-嗒呼並[1,24][1,2]二 氮雜箪-1-羧酸第三-丁酯(243),製備自(1S,9S) 9-胺基-八 氫-10-酮基-6H_嗒啩並[l,2-a][l,2]二氮雜箪-1-羧酸第三-丁 黯 (Attwood, et al., J. Chem Soc·,Perkin 1,pp· 1011-19 (1986))以211e所述之方法,可生·成2.03克(86%)無色泡沫狀 物:[從]d2)-15.9。(c 0.5, CH2C12); IR (KBr) 3400, 2976, 2937, 1740, 1644, 1537, 1448, 1425, 1367, 1154; 1Η NMR (CDC13) &amp; 7.88-7.82 (2H, m), 7.60-7.38 (4H, m), 5.48 (1H, m), 4.98 -392- 本錄尺度賴&quot;s家鮮(CNS)从祕(21QX 297公策 經涛部中央樣隼局員工消费合作社印製 1235157 Λ 7 Β7 五、發明説明(39°) (1Η, m), 3.45 (1H? m), 3.22-2.96 (2H, m)? 2.64 (1H, m), 2.43-2.27 (2H, m), 1.95 (2H, m), 1.82-1.36 (4H, m), 1.50 (9H, s); C2lH29N304 · 〇·25Η20之確實質量估計値:C, 64.35; H,7.59; N,10.72。實測値:C,64.57; H,7·43; N,10.62。MS (ES +, m/z) 388 (100%,M+ + 1)。 (IS, 9S) 9-芊醯胺基-八氫-10-酮基-6H-嗒畊並[1,24][1,2]二 氮雜箪-羧酸(244),以212e之方法製備自(1S,9S) 9-芊醯 胺基-八氫-10-酮基-6H-嗒畊並[l,2-a][l,2]二氮雜箪-1·羧酸 第三-丁酯(243),可生成1.52克(89%)白色粉末:mp· 166-169 eC(dec); [a ]D25-56.40 (c 0.5, CH3OH); IR (KB〇 3361,2963, 2851, 1737, 1663, 1620, 1534, 1 195, 1 179; lH NMR (D6- DMSO) &amp; 12.93 (1H, brs), 8.44 (1H, d, J=8.4), 7.93 (2H, m), 7.54 (3H, m)5.46 (1H, m), 4.87 (1H, m), 3.12 (2H, m), 2.64 (1H,m), 2·27 (1H,m),1.98-1.68 (7H,m),1.40 (1H, m);分析 C17H2lN304.0.25H2O^1f % O. :C, 60.79; H, 6.45; N, 12.51 - 實測値:C, 61.07; H, 6.35; N, 12.55。MS (ES+,m/z) 332 (58%, 1VT + 1), 211 (100)。 [3S,2RS (1S,9S)]N-(2-苄氧基-5-酮基四氫呋喃-3-基)-9-苄 醢胺基-八氫-10-酮基-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧 醯胺(245) ’以213e所述方法製備自(IS, 9S) 9-芊醯胺基-八 氫-10-酮基-6H-嗒畊並[l,2-ani,i]二氮雜箪-1-羧酸(244), 可生成601毫克(76%)的無色泡沫狀:IR (KBr) 3401,2945, 1794, 1685, 1638, 1521, 1451, H20; lH NMR (CDC13) &amp; 7.87- 7·77 (2H, m), 7.57-7.14 (10H, m), 5·59-5·47 (2H, m), 4·97- -393 - 本尺度通用中国國家標隼(CNS ) A4規格(21^297公慶) (請先聞讀背面之注意事項再填寫本f ) 訂(Please read the notes on the back &amp; first fill in this f) (IS, 9S) 9-benzylamido-octahydro-10-keto-6H-daphno [1,24] [1,2] Diazapyridine-1-carboxylic acid tertiary-butyl ester (243), prepared from (1S, 9S) 9-amino-octahydro-10-keto-6H_dapyrido [l, 2-a] [1,2] Diazapyridine-1-carboxylic acid tertiary-butanone (Attwood, et al., J. Chem Soc ·, Perkin 1, pp · 1011-19 (1986)) method described in 211e , Can be produced into 2.03 g (86%) colorless foam: [from] d2) -15.9. (C 0.5, CH2C12); IR (KBr) 3400, 2976, 2937, 1740, 1644, 1537, 1448, 1425, 1367, 1154; 1Η NMR (CDC13) &amp; 7.88-7.82 (2H, m), 7.60-7.38 (4H, m), 5.48 (1H, m), 4.98 -392- The size of this record is based on "Changxian (CNS) Congmi" (21QX 297). Printed by the Consumer Sample Cooperative of the Central Provincial Bureau of Economic Development, Ministry of Economic Affairs, 1235157 Λ 7 Β7 V. Description of the invention (39 °) (1Η, m), 3.45 (1H? M), 3.22-2.96 (2H, m)? 2.64 (1H, m), 2.43-2.27 (2H, m), 1.95 ( 2H, m), 1.82-1.36 (4H, m), 1.50 (9H, s); C2lH29N304 · 0.25 · 20Essential mass estimate: C, 64.35; H, 7.59; N, 10.72. Measured: C, 64.57 H, 7.43; N, 10.62. MS (ES +, m / z) 388 (100%, M + 1). (IS, 9S) 9-amido-octahydro-10-keto- 6H-Da-Phen [1,24] [1,2] diazafluorene-carboxylic acid (244) was prepared from (1S, 9S) 9-fluorenylamino-octahydro-10-one by 212e method -6H-da-phen [l, 2-a] [l, 2] diazepine-1 · carboxylic acid tert-butyl ester (243), which can produce 1.52 g (89%) of white powder: mp · 166-169 eC (dec); [a] D25-56.40 (c 0.5, CH3OH); IR (KB〇3361, 2963, 2851, 1737, 1663, 1620, 1534, 1 195, 1 179; lH NMR (D6- DMSO) &amp; 12.93 (1H, brs), 8.44 (1H, d, J = 8.4), 7.93 (2H, m), 7.54 (3H, m) 5.46 ( 1H, m), 4.87 (1H, m), 3.12 (2H, m), 2.64 (1H, m), 2.27 (1H, m), 1.98-1.68 (7H, m), 1.40 (1H, m) ; Analyze C17H2lN304.0.25H2O ^ 1f% O.: C, 60.79; H, 6.45; N, 12.51-Found: C, 61.07; H, 6.35; N, 12.55. MS (ES +, m / z) 332 (58%, 1VT + 1), 211 (100). [3S, 2RS (1S, 9S)] N- (2-benzyloxy-5-ketotetrahydrofuran-3-yl) -9-benzylamido-octahydro-10-keto-6H-dapyridine [l, 2-a] [l, 2] Diazapyridine-1-carboxamide (245) 'was prepared from (IS, 9S) 9-fluorenylamino-octahydro-10- by the method described in 213e. Keto-6H-dacrogen [l, 2-ani, i] diazepine-1-carboxylic acid (244), yielding 601 mg (76%) of a colorless foam: IR (KBr) 3401, 2945 , 1794, 1685, 1638, 1521, 1451, H20; lH NMR (CDC13) &amp; 7.87- 7.77 (2H, m), 7.57-7.14 (10H, m), 5.59-5 · 47 (2H, m), 4.97- -393-This standard is in accordance with the Chinese National Standard (CNS) A4 specification (21 ^ 297 public holidays) (Please read the precautions on the back before filling in this f) Order

經濟部中央櫺準局員工消费合作社印裝 1235157 Λ 7 _Β7_____ 五、發明説明(391 ) . 4·32 (4H,m),3.27-1.35 (14H,m);分析 C2SH32N406 · 〇.5H2〇之 計算値:C,63.50; H,6.28; N,10.58。實測値:C,63·48; H, 6·14; N,10.52。MS (ES +,m/z) 521 (100%,M+ + 1) 3 [3S (1S,9S)] 3-(9-芊醯胺基-八氫-10-酮基-6H-嗒啩並[1,2-a][l,2]二氮雜箪-1-羧醯胺-4-酮基丁酸(246),以2Ue所述 方法製備自[3S,2RS (IS, 9S)]N-(2-芊氧基-5·酮基四氫呋喃 •3-基)-9·^ δδ 腔基-八氮-10-8¾ 基-6H-*答啡並[1,2-a][l,2] — 氮雜箪-1-羧醯胺(245),可生成396毫克(84%)白色粉末:mp. 110-115Ό ; [a ]d26-126.3 ° (c 0.2, CH3OH); IR (KBr) 3345, 2943, 1787? 1730, 1635, 1578, 1528, 1488, 1450, 1429; lH NMR (CD3OD) &amp; 7.88 (2H, m), 7.48 (3H, m), 5.55 (1H? m), 4.91 (1H, m), 4.56 (1H, m), 4.29 (1H, m), 3.41-3.05 (3H, m), 2.76-2.41 (3H, m)? 2.28-2.01 (3H, m), 1.86-1.65 (4H, m), 1.36 (1H,m);分析 C2lH26N406. 1.25H20之計算値:C, 55.68; H, 6·34; N,12.37。實測値:C,55.68; H,6· 14; N,12· 16。MS (ES-, m/z) 429 (100%,M+ - 1) 〇 -394 - 本纸乐尺度適用中國國家標準(CNS ) A4^i厂(2urx 297公) (請先閱讀背面之注意事項-41填寫本頁)Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 1235157 Λ 7 _Β7 _____ V. Description of the Invention (391). 4 · 32 (4H, m), 3.27-1.35 (14H, m); Analysis of the calculation of C2SH32N406 · 0.5H2〇 Tritium: C, 63.50; H, 6.28; N, 10.58. Found 値: C, 63 · 48; H, 6.14; N, 10.52. MS (ES +, m / z) 521 (100%, M + + 1) 3 [3S (1S, 9S)] 3- (9-fluorenylamino-octahydro-10-keto-6H-dapyron [1,2-a] [1,2] diazepine-1-carboxamidin-4-one-butyric acid (246), prepared from [3S, 2RS (IS, 9S)] by the method described in 2Ue N- (2-Methoxy-5 · ketotetrahydrofuran • 3-yl) -9 · ^ δδ Cavityl-octazine-10-8¾yl-6H- * Anorphino [1,2-a] [l , 2] — Azapyridine-1-carboxamide (245), which can produce 396 mg (84%) of white powder: mp. 110-115Ό; [a] d26-126.3 ° (c 0.2, CH3OH); IR ( KBr) 3345, 2943, 1787? 1730, 1635, 1578, 1528, 1488, 1450, 1429; lH NMR (CD3OD) &amp; 7.88 (2H, m), 7.48 (3H, m), 5.55 (1H? M), 4.91 (1H, m), 4.56 (1H, m), 4.29 (1H, m), 3.41-3.05 (3H, m), 2.76-2.41 (3H, m)? 2.28-2.01 (3H, m), 1.86- 1.65 (4H, m), 1.36 (1H, m); Analysis of the calculation of C21H26N406. 1.25H20: C, 55.68; H, 6.34; N, 12.37. Found: C, 55.68; H, 6.14; N, 12.16. MS (ES-, m / z) 429 (100%, M +-1) 〇-394-This paper scale is applicable to China National Standard (CNS) A4 ^ i factory (2urx 297 male) (please First read the notes on the back-41 )

1235157 A7 B7 五、發明説明(392)1235157 A7 B7 V. Description of the Invention (392)

++

經漭部中夬糅隼局員工消费合作社印^ [(3S (2R,5S)]-4-甲氧基苯基5-二氫 _3,6-二甲氧基· 2-(1-甲基乙基)吡畊基)]丁酸2,6-二-第三-丁酯(247) 3正丁 基錢(1.6M於己烷)(22.3毫升,35··7毫莫耳)逐滴加至(2RH-)-2’5- —風-3,6-一甲乳基-2-(1-甲基乙基)叶[:11井(5.8毫升,6.0 克,32.4毫莫耳)於THF (250毫升)冷卻至-75X之溶液中歷 20分鐘,加入之速率使溫度可保持在-721以下。反應混 -395- 本紙尺/人遇用中§國冬標洋(CNS ) 格(210 X 297公凌) 1235157 經濟部令夬標準局員工消费合作社印裝 A1 B7 五、發明説明(393) 合物在-75X:下攪拌1小時,再以30分鐘加入4-甲氧基苯基-2-丁 缔酸,2,6-二·第三-丁醋(Suzuck et al· Liebigs Ann. Chem· ρρ· 5 卜61 (1992))(9.9克,32·5 毫莫耳)於 THF (60毫升) 之溶液’且於加入期間溫度保持在-7 2 C以下a反應混合 物在-75X:下保持1.5小時,在-75X下加入冰醋酸(6毫升)於 THF (25毫升)之溶液,且溶液加溫至室溫3溶液倒入10% NH4C1 (300毫升)再以二乙醚萃取(3 X 250毫升)。混合的有 機相以鹽水洗(2 X 200毫升),於Na2S04上乾燥並於減蜃下 蒸發至乾。殘留的油以矽膠快逯層析純化(20%庚烷於 CH2Cl2:&gt;可生成標題化合物爲淺黃色油狀(13.5克,85%): [α] D20-64。( c 0.22, MeOH); IR (KBr) 2962, 2873, 2840, 1757, 1697, 1593, 1460, 1433, 1366, 1306, 1269, 1236, 1 187, 1 157, 1 126, 1063, 1038, 101 1, 970, 924, 892, 867, 846, 831, 797, 773, 754; ιΕ NMR (CDC13) &amp; 6.85 (2Η, s), 4.21 (1H, t, J=3.5), 3.98 (1H, t, J=3.5), 3.79 (3H, s), 3.71 (3H, s), 3.69 (3H, s), 3.15 (1H, dd, J 17.8, 7.9), 2.86-2.81 (1H, m), 2.58 (1H, dd, J=17.8, 5.9), 2.28-2.19 (1H, m), 1.33 (18H, s), l.〇2 (3H, d, J=6.8), 0.70 (6H, dd, J=13, 6.8)-Printed by the Consumer Affairs Cooperative of the Ministry of Economic Affairs of the People's Republic of China ^ [(3S (2R, 5S)]-4-methoxyphenyl 5-dihydro_3,6-dimethoxy · 2- (1-methyl Ethyl) Pyryl)] Butyric acid 2,6-di-tertiary-butyl ester (247) 3 n-Butyl (1.6M in hexane) (22.3 ml, 35 · 7 mmol) Add dropwise to (2RH-)-2'5- —Wind-3,6-monomethyllactyl-2- (1-methylethyl) leaf [: 11 wells (5.8 ml, 6.0 g, 32.4 mmol) ) In a solution of THF (250 ml) cooled to -75X for 20 minutes at a rate that keeps the temperature below -721 Reaction Mix -395- This paper ruler / person is in use § National Winter Standard Ocean (CNS) grid (210 X 297 liters) 1235157 Order of the Ministry of Economic Affairs Standards Bureau Employees' Cooperative Printed A1 B7 V. Description of Invention (393) The mixture was stirred at -75X: for 1 hour, and then 4-methoxyphenyl-2-butanoic acid, 2,6-di · tertiary-butyric acid (Suzuck et al. Liebigs Ann. Chem. ρρ · 5 61 61 (1992)) (9.9 g, 32.5 mmol) in THF (60 ml) and the temperature was kept below -7 2 C during the addition. The reaction mixture was kept at -75X: For 1.5 hours, add a solution of glacial acetic acid (6 mL) in THF (25 mL) at -75X, and warm the solution to room temperature. 3 Pour the solution into 10% NH4C1 (300 mL) and extract with diethyl ether (3 X 250 Ml). The combined organic phases were washed with brine (2 X 200 ml), dried over Na2S04 and evaporated to dryness under reduced pressure. The remaining oil was purified by silica gel flash chromatography (20% heptane in CH2Cl2: >> to give the title compound as a pale yellow oil (13.5 g, 85%): [α] D20-64. (C 0.22, MeOH) ; IR (KBr) 2962, 2873, 2840, 1757, 1697, 1593, 1460, 1433, 1366, 1306, 1269, 1236, 1 187, 1 157, 1 126, 1063, 1038, 101 1, 970, 924, 892 , 867, 846, 831, 797, 773, 754; ιΕ NMR (CDC13) &amp; 6.85 (2Η, s), 4.21 (1H, t, J = 3.5), 3.98 (1H, t, J = 3.5), 3.79 (3H, s), 3.71 (3H, s), 3.69 (3H, s), 3.15 (1H, dd, J 17.8, 7.9), 2.86-2.81 (1H, m), 2.58 (1H, dd, J = 17.8 , 5.9), 2.28-2.19 (1H, m), 1.33 (18H, s), 1.02 (3H, d, J = 6.8), 0.70 (6H, dd, J = 13, 6.8)-

(2S,3S) 1-甲基-3·甲基縠胺酸5-[2,6-二-第三-丁基-4-甲氧 基苯基]酯(248)。[3S (2R,5S)]-2,6-二-第三-丁基-4-甲氧基 苯基-3-[5-(2,5-二氫-3,6-二曱氧墓-2-(1-甲基乙基)吡井基.)] 丁酸酯(247)(22.4克,45.8毫莫耳)於乙腈(300毫升)及〇·25 NHC1 (366毫升,2當量)在氮大氣及室溫下攪拌4天。乙腈 在減壓下蒸發並加二乙瞇(250毫升)至水相中。水相之PH -396 - 本纸伕尺度通用中國國家標隼(CNS ) A4堤格(210x 297公;$ &gt; (請先聞讀背面之泾意事項再填寫太頁) 士衣 *^τ 1235157 A7 B7 五、發明説明(394) · 値以濃氨水(32%)調至pH 8-9,再、分相。水相以二乙醚萃 取(2 X 250毫升)。混合的有機相於Na2S04上乾燥並於減壓 下蒸發至乾。殘留的油以快速層析純化,於矽膠(2%甲諄 於CH2C12)上可生成所需產物,呈淺黃色油(8.2克,45%): 〔α ]D20 + 20。(c 0.26, MeOH]; IR (ΚΒι〇 3394, 3332, 3000, 2962, 2915, 2877, 2838, 1738, 1697, 1593, 1453, 1430, 1419, 1398, 1367, 1304, 1273, 1251, 1221, 1203, 1 183, 1126, 1063, 1025, 996, 932, 891,866, 847, 800, 772, 745;咕 NMR (CDC13) &amp; 6.85 (2H, s), 3.79 (3H, s), 3.74 (3H, s), 3.72-3.69 (1H, m)? 3.05-2.85 (1H? m)? 2.67-2.50 (2H, m), 1.32 (18H, s), 0.93 (3H, d,J=7);分析 C22H35N05i 計算値:C,67.15; H, 8.96; N, 3.56 3 實測値:C,67.20; H,9.20; N,3.70。 (2S,9S) 3-甲基穀胺酸5-[2,6-二-第三-丁基-4-甲氧基苯基酯 (249)。(2S,3S) 3-甲基穀胺酸5-[2,6-二-第三-丁基-4-甲氧 基笨基]酯(248)(8.0克,20.3毫莫耳)於5NHC1 (200毫升)的 溶液,迴流加熱2小時。反應ί昆合物在減譽下蒸發至乾。 殘留物溶於環己烷(X 4)並蒸發至乾(X 4),可得白色固體 (7.9克,93%):mp 230°C ;[沈]D20+22。 (c 0.27, MeOH); IR (KBr) 3423, 2964, 1755, 1593, 1514, 1456, 1421, 1371,1303, 1259, 1201,1 179, 1 138, 1 106, 1060, 966, 926, 861,790, 710; 1H NMR (MeOD) &amp; 6.76 (2H, s), 4.02 (1H, d, J=3.7), 3.67 (3H, s), 3.05-2.85 (1H, m), 2.80-2.55 (2H, m), 1.22 (18H, s), 1.09 (3H, d, J=6.3); l3C NMR (MeOD) &amp; 174.5, 171.4, 158.6, 145.2, 143.1, 1 13.2, 58.3, 56.3, 39·8, 36.9, 32.5, 16.6;分析 -397- 本纸乐尺度通用中S國家標導(CNS )以堤格(210X297公釐) 請 先 Κ1 讀 背 面 意 事(2S, 3S) 1-methyl-3.methylpyramic acid 5- [2,6-di-tertiary-butyl-4-methoxyphenyl] ester (248). [3S (2R, 5S)]-2,6-di-third-butyl-4-methoxyphenyl-3- [5- (2,5-dihydro-3,6-dioxan -2- (1-methylethyl) pyryl.)] Butyrate (247) (22.4 g, 45.8 mmol) in acetonitrile (300 ml) and 0.25 NHC1 (366 ml, 2 equivalents) Stir under nitrogen atmosphere and room temperature for 4 days. Acetonitrile was evaporated under reduced pressure and diacetamidine (250 ml) was added to the aqueous phase. PH of PHASE PHASE -396-This paper is a common Chinese national standard (CNS) A4 scale (210x 297g; $ &gt; (Please read the notice on the back before filling out the page)) Shiyi * ^ τ 1235157 A7 B7 V. Description of the invention (394) 値 Adjust the pH to 8-9 with concentrated ammonia (32%), and then separate the phases. The aqueous phase is extracted with diethyl ether (2 X 250 ml). The mixed organic phase is in Na2S04 It was dried over dry and evaporated to dryness under reduced pressure. The remaining oil was purified by flash chromatography. The desired product was formed on silica gel (2% formamidine in CH2C12) as a pale yellow oil (8.2 g, 45%): [ α] D20 + 20. (c 0.26, MeOH]; IR (ΚΒι〇3394, 3332, 3000, 2962, 2915, 2877, 2838, 1738, 1697, 1593, 1453, 1430, 1419, 1398, 1367, 1304, 1273 , 1251, 1221, 1203, 1 183, 1126, 1063, 1025, 996, 932, 891, 866, 847, 800, 772, 745; Go NMR (CDC13) &amp; 6.85 (2H, s), 3.79 (3H, s), 3.74 (3H, s), 3.72-3.69 (1H, m)? 3.05-2.85 (1H? m)? 2.67-2.50 (2H, m), 1.32 (18H, s), 0.93 (3H, d, J = 7); Analysis C22H35N05i Calculate 値: C, 67.15; H, 8.96; N, 3.56 3 Measured 値: C, 67.20; H, 9.20; N, 3.70. (2S 9S) 3-methylglutamine 5- [2,6-di-tertiary-butyl-4-methoxyphenyl ester (249). (2S, 3S) 3-methylglutamine 5- [2,6-Di-tertiary-butyl-4-methoxybenzyl] ester (248) (8.0 g, 20.3 mmol) in 5NHC1 (200 ml), heated at reflux for 2 hours. Reaction The compound was evaporated to dryness under reduced reputation. The residue was dissolved in cyclohexane (X 4) and evaporated to dryness (X 4) to obtain a white solid (7.9 g, 93%): mp 230 ° C; [沈] D20 + 22. (C 0.27, MeOH); IR (KBr) 3423, 2964, 1755, 1593, 1514, 1456, 1421, 1371, 1303, 1259, 1201, 1 179, 1 138, 1 106, 1060, 966 , 926, 861, 790, 710; 1H NMR (MeOD) &amp; 6.76 (2H, s), 4.02 (1H, d, J = 3.7), 3.67 (3H, s), 3.05-2.85 (1H, m), 2.80-2.55 (2H, m), 1.22 (18H, s), 1.09 (3H, d, J = 6.3); l3C NMR (MeOD) &amp; 174.5, 171.4, 158.6, 145.2, 143.1, 1 13.2, 58.3, 56.3 , 39 · 8, 36.9, 32.5, 16.6; Analyze-397- This paper has a common Chinese national standard (CNS) with Tigger (210X297 mm)

經濟部中夬橾準局員工消費合作社印装 1235157 A7 B7______ 五、發明説明(395) _ C21H34ClN05t 計算値:C,60,64; Η,、8·24; Ν,3·37。實測値:C, 60.80; Η, 8.40; N,3.40 ° (2S,3S) 3-甲基-2-酞醯亞胺基-1,5·戊烷二酸5·[2,6-二·第三-丁基-4·甲氧基苯基]酯(250),二異丙基乙胺(4.1毫升,3.04 克,23.5毫莫耳,1.25當量)及献纤兄’ 2°.6¾莫耳’ 1.25當量)加至(2S,3S) 3-曱基穀胺酸-5-[2,6-二-第三-丁基-4-曱氧基苯基丁酯(249)(7.8克,18.6毫莫耳)於甲苯(300毫 升)之溶液中,生成的混合物迴流加熱3小時。於冷卻至室 溫後,反應混合物蒸發至乾,生成的油以矽膠上快速層析 純化(2%甲醇於CH2C12)可生成所需之產物,呈白色泡沫狀 (8.35 克,87%): [a]D20-2(T(C 1.04, Me〇H);IR(KBr) 3480, 2968, 2880, 1753, 1721,1594, 1462, 1422, 13 88, 1303, 1263, 1216, 1 183, 1 148, 1062, 1003, 933, 899, 755, 723; lK NMR (CDC13) &amp; 7.92-7.87 (2H, m),7.78·7.73 (2H, m), 6.84 (2H, s), 4.95 (1H,d), 3.78 (3H, s),3.30-3.05 (2H,m),2.85-2.65 (1H, m), 1·30 (18H,s),1.13 (3H,d)。 (請先Μ讀背面之注意事項再填寫本頁) 訂 經濟部中夬嘌隼局員工消费合作杜印裝 -398· 本纸ft又度遺用中SI家標隼(CNS ) A4現格(210: 297公;) 1235157 A7 B7五、發明説明(396)Printed by the Consumers' Cooperatives of the China Prospective Bureau of the Ministry of Economic Affairs 1235157 A7 B7______ V. Description of the invention (395) _ C21H34ClN05t Calculation 値: C, 60, 64; Η, 8, 24; Ν, 3.37. Measured fluorene: C, 60.80; hydrazone, 8.40; N, 3.40 ° (2S, 3S) 3-methyl-2-phthalimidoimino-1,5 · pentanedicarboxylic acid 5 · [2,6-di · Tertiary-butyl-4 · methoxyphenyl] ester (250), diisopropylethylamine (4.1 ml, 3.04 g, 23.5 mmol, 1.25 equiv), and Xianxian '2 °. 6¾ Ear '1.25 equivalents) was added to (2S, 3S) 3-fluorenylglutamate-5- [2,6-di-tertiary-butyl-4-fluorenoxyphenylbutyl (249) (7.8 g (18.6 mmol) in toluene (300 ml), and the resulting mixture was heated at reflux for 3 hours. After cooling to room temperature, the reaction mixture was evaporated to dryness. The resulting oil was purified by flash chromatography on silica gel (2% methanol in CH2C12) to yield the desired product as a white foam (8.35 g, 87%): [ a) D20-2 (T (C 1.04, Me〇H); IR (KBr) 3480, 2968, 2880, 1753, 1721, 1594, 1462, 1422, 13 88, 1303, 1263, 1216, 1 183, 1 148 , 1062, 1003, 933, 899, 755, 723; lK NMR (CDC13) &amp; 7.92-7.87 (2H, m), 7.78 · 7.73 (2H, m), 6.84 (2H, s), 4.95 (1H, d ), 3.78 (3H, s), 3.30-3.05 (2H, m), 2.85-2.65 (1H, m), 1.30 (18H, s), 1.13 (3H, d). (Please read the first Note: Please fill in this page again.) Order the consumer cooperation between the Ministry of Economic Affairs and the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China. Du-print pack-398 · This paper ft has been re-used in the Chinese standard of SI house (CNS) A4 (210: 297); 1235157 A7 B7 V. Description of Invention (396)

(250) (251)(250) (251)

(252) 經濟部中央標隼局負工消費合作社印¾(252) Seal of Consumers' Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs ¾

(257) (256) -399- (請先閱讀背面之洼意事項再填寫本頁)(257) (256) -399- (Please read the intent on the back before filling this page)

本紙張尺度適用中国國家標皁(CNS ) A4規格(210X297公釐) 1235157 Λ7 ______^Β7_ · 五、發明説明(撕) 1-(2,6·二-第三-丁基-4-甲氧基)-苯、基〇-(1-芊氧羰基-3-第三 •丁氧羰基-六氫嗒啡-2-基)-3-甲基-4-酞醯亞胺基戊烷-丨,% 二酸酯(251)。胺基酸(250)(1.2克,2.35毫莫耳)於無水二乙 醚(10毫升)之溶液以五氣化磷(0.52克,2.5毫莫耳)在室溫· 下處理2小時。混合物濃縮並以甲苯處理數次及再次蒸發 至乾。生成的醯基氣溶於無水THF(5毫升)及CH2C12(5毫 升)中並冷卻至0°C。加第三-丁基-1-(芊氧羰基 &gt; 六氫嗒 畊-羧酸酯(0.753克,2·35毫莫耳,1當量)及N-乙基嗎福啉 (3毫升)至溶液中。反應混合物在CTC下授拌30分鐘再於室 溫下一夜。混合物蒸發且生成之殘留物以CH2C12 (30毫升) 吸收。溶液以1M HC1,水,10% NaHC03洗滌,乾燥 (MgS04)並蒸發3生成的白色泡·沫物於麥膠上純化(0-2%甲 醇於CH2C12)可生成所需之化合物251,呈淺黃色玻璃狀固 體(740毫克,39%) : |&gt;]D20 -22 (c 0.42, MeOH); IR (KBr) 3441, 2966, 1725, 1693, 1386, 1255, 1221,1 186, 1 154, 1 123, 1063, 724; lU NMR (CDC13) ά 7.94-7.89 (4H, m), 7.56-7.28 (5H, 經濟部中夬標隼局員工消资合作·杜印¾ m),6.84 (2H,2s), 5.29-5.20 (2H,AB),4·91-4·81 (1H,m), 4.05-3.88 (1H, m), 3.78 (3H, s), 3.75-3.80 (1H, m), 3.28-2.95 (2H, m), 2.23-1.51 (6H, m), 1.45 (9H, s), 1.31 (9H, s), 1.28 (9H, s), 1.27 (3H, d) 〇 (IS, 8S,9S) 6,10-二酮基-8-甲基-1,2,3,4,7,8,9.10-八氫-9-酞 醯亞胺基-6H-嗒畊並[l,2-a][l,2]二氮雜苯-卜羧酸第三·丁酯 (254)。經保護的酸(251)(715毫克,0.893毫莫耳)於乙腈之 溶液以硝酸铯(IV)銨(1.8克,3.3毫莫耳,3.7當量)於水在 -400 - 本纸伕尺度適用中国國家標隼(CNS) A4堤格(210X2W公釐) 1235157 Λ 7 ________Β7___ 五、發明說明(398 ) 玄溫下處理4小時3加入甘露醇(6〇〇毫克,3.3毫莫耳,3.7 當量)且混合物攪拌1小時。加二乙醚(5〇毫升)及水(30毫升) 至混合物中。經傾析後,水相以二乙醚萃取(4 X 50毫升) 。混合的有機相以水洗,乾燥(MgS04)並濃縮。在矽膠上 層析(10%甲醇於CH2C12)可生成5-(1-芊氧羰基-3-第三-丁氧 羰基-六氫嗒併-2-基)羰基-3-甲基-4-酞醯亞胺基戊酸 (252)(360毫克,64%) : [〇]D20 -49.2。(c 0.118, MeOH)。此 產物可使用勿需再純化(360毫克,0.609毫莫耳),並於曱 醇中氫化(3 0毫升),利用1〇。/0 Pd/C (36毫克)歷3小時。反應 混合物過濾,且生成的溶液濃縮以生成胺(253)呈泡沫狀 (270毫克,96%)[dD20 -56.1。(c0.18,MeOH)。胺(253)溶 經濟部中夬糅率局員工消费合作社印製 於無水THF(10毫升)中再加五氯化磷(3〇5毫克,1.47毫莫 &quot;&quot;τ ’ 2.5‘里)3 )¾合物再冷卻至-5C並於氣下加入乙基 嗎福啉。反應混合物在室溫下攪拌一夜。混合物濃縮且殘 留物以CH2C12(20毫升),冷水(20毫升),1MHC1(20毫升) 吸收。於傾析後,水相再以(:^12&lt;:12萃取(2 X 20毫升)。混 合的有機相以10% NaHC〇3及水洗滌,乾燥(MgS〇4)再濃縮 。生成的油以矽膠純化(1%甲醇/CH2C12)可生成二環化合 物(252)呈固體(65毫克,25%) : [a]D20 -77。,0.208, MeOH); IR (KBr) 3471,3434, 2975, 2928, 1767, 1723, 1443, 1389, 1284, 1243, 1 15 1,1 1 12, 720;咕 NkR (CDC13) d 7.94-7.69 (4H, m), 5.34-5.27 (1H, m), 4.89-4.66 (2H, m), 3.94-3.64 (2H, m), 3.02-2.84 (1H, m), 2.34-2.19 (2H, m), 1.94-1.61 (3H, m), 1.47 (9H,s), 1·14 (3H, d);分析 C23H27N306之計算値:C, -401 - 經濟部中夬標窣局員工消費合作杜印«. 1235157 A7 B7 _____ 五、發明説明(399 ) 62·57; Η,6·17; N,9.52。實測値:C,、62.60; Η,6·40; N,9.10。 (IS, 8S,9S)弟二-丁基-9-爷臨胺基-6,10 - —明基-8-甲基-1,2,3,4,7,8,9,10-八氫-611-嗒畊並[1,24][1,2]二氮雜箪-1-羧 酸酯(255)。二環化合物(254)(70毫克,〇·16毫莫耳)於乙醇 之溶液以水合肼(0.02毫升,4毫莫耳,2.5當量)處理。經 室溫下攪拌5小時後,混合物濃縮且生成的殘留物以’甲苯 吸收再蒸發。殘留物以2M醋酸(2毫升)處理16小時。生成 的沈澱物過濾並以2M醋酸(10毫升)洗滌3濾液以固體 NaHC03鹼化,再以EtOAc萃 &lt;。有機溶液以水洗,乾燥 (MgS04)並濃縮。以快速層析在矽膠上純化(2%甲醇 /CH2C12)可生成自由態胺呈泡沫(50毫克,100%)。胺(50毫 克,〇·16毫莫耳)溶於二,号烷(1毫升)及水(0.25毫升)中,再 以NaHC03 (0.034克,0.04毫莫耳)繼以苄醯氯(0.047毫升, 〇·40毫莫耳,2.8當量)處理。混合物在室溫下攪拌一夜, 再以EtOAc稀釋(15毫升)。有機溶液以10% NaHC03及飽和 的NaCl水溶液洗滌,乾燥(MgS04)再濃縮3在矽膠上快逯 層析純化(2%甲醇/CH2C12)可得芊醯胺255呈泡沫狀(67毫克 ,100%) : lK NMR (CDC13) (ί 7.89-7.39 (5Η, m), 6.79 (1H, d), 5.32-5.20 (1H, m), 4.98-4.82 (1H, m), 4.75-4.64 (1H, m), 3.84-3.65 (1H, m), 3.09-2.89 (1H, m), 2.45-2.18 (2H, m), 2.00-1.61 (4H, m), 1.48 (9H, s), 1.28 (3H, d) ^ (3S)(1S, 8S,9S) 3-(9-芊醯胺基-6,10-二酮基-8-甲基-1,2,3,4, 7,8,9,10-八氫-6^1-嗒畊並[1,24][1,2]二氮雜苯-1-羧醯胺基)-4-酮基丁酸(257)。第三-丁酯255 (67毫克,0.16毫莫耳)於 -402 - (請先閱讀背Ιδ之注意事項再填寫本頁)This paper size applies to China National Standard Soap (CNS) A4 specification (210X297 mm) 1235157 Λ7 ______ ^ Β7_ · V. Description of the invention (tearing) 1- (2,6 · Di-tertiary-butyl-4-methoxy -), Benzene, 0- (1-fluorenyloxycarbonyl-3-tert-butoxycarbonyl-hexahydropyridin-2-yl) -3-methyl-4-phthalimidoiminopentane- 丨,% Diacid (251). A solution of amino acid (250) (1.2 g, 2.35 mmol) in anhydrous diethyl ether (10 ml) was treated with phosphorus pentagas (0.52 g, 2.5 mmol) at room temperature for 2 hours. The mixture was concentrated and treated several times with toluene and evaporated again to dryness. The generated amidine gas was dissolved in anhydrous THF (5 ml) and CH2C12 (5 ml) and cooled to 0 ° C. Add tertiary-butyl-1- (fluorenyloxycarbonyl) hexahydro-phenyl-carboxylate (0.753 g, 2.35 mmol, 1 equivalent) and N-ethylmorpholine (3 ml) to In solution. The reaction mixture was stirred under CTC for 30 minutes and then overnight at room temperature. The mixture was evaporated and the resulting residue was taken up in CH2C12 (30 ml). The solution was washed with 1M HC1, water, 10% NaHC03, and dried (MgS04) And the white foam and foam produced by evaporation 3 were purified on gluten (0-2% methanol in CH2C12) to produce the required compound 251 as a pale yellow glassy solid (740 mg, 39%): | &gt;] D20 -22 (c 0.42, MeOH); IR (KBr) 3441, 2966, 1725, 1693, 1386, 1255, 1221, 1 186, 1 154, 1 123, 1063, 724; lU NMR (CDC13) ά 7.94-7.89 (4H, m), 7.56-7.28 (5H, Consumers' Cooperation and Du Yin of the Ministry of Economic Affairs, China Standards Bureau · Du Yin ¾ m), 6.84 (2H, 2s), 5.29-5.20 (2H, AB), 4.91- 4.81 (1H, m), 4.05-3.88 (1H, m), 3.78 (3H, s), 3.75-3.80 (1H, m), 3.28-2.95 (2H, m), 2.23-1.51 (6H, m ), 1.45 (9H, s), 1.31 (9H, s), 1.28 (9H, s), 1.27 (3H, d) 〇 (IS, 8S, 9S) 6,10-diketo-8-methyl- 1,2,3,4,7,8,9.10-octahydro-9-醯 imino-6H-dacro [1,2-a] [l, 2] diazabenzene-tricarboxylic acid tert-butyl ester (254). Protected acid (251) (715 mg, 0.893 millimolar) in acetonitrile solution with ammonium cesium (IV) nitrate (1.8 g, 3.3 millimolar, 3.7 equivalents) in water at -400-this paper is compliant with China National Standard (CNS) A4 210X2W mm) 1235157 Λ 7 ________ Β7 ___ V. Description of the invention (398) Treatment at xuan temperature for 4 hours 3 Add mannitol (600 mg, 3.3 mmol, 3.7 equivalents) and stir the mixture for 1 hour. Add diethyl ether (5 0 ml) and water (30 ml) into the mixture. After decantation, the aqueous phase was extracted with diethyl ether (4 X 50 ml). The combined organic phases were washed with water, dried (MgS04) and concentrated. Chromatography on silica gel (10% methanol in CH2C12) can generate 5- (1-fluorenyloxycarbonyl-3-tertiary-butoxycarbonyl-hexahydropyrido-2-yl) carbonyl-3-methyl-4-phthalimidoimine Valeric acid (252) (360 mg, 64%): [0] D20-49.2. (C 0.118, MeOH). This product was used without further purification (360 mg, 0.609 mmol) and hydrogenated in methanol (30 ml) using 10%. / 0 Pd / C (36 mg) over 3 hours. The reaction mixture was filtered and the resulting solution was concentrated to give amine (253) as a foam (270 mg, 96%) [dD20-56.1. (C0.18, MeOH). Amine (253) dissolved by the Consumers ’Cooperative of the Ministry of Economic Affairs, printed in anhydrous THF (10 ml) and added with phosphorus pentachloride (305 mg, 1.47 mmol &quot; &quot; &quot; τ '2.5') 3) The compound was cooled to -5C and ethylmorpholine was added under gas. The reaction mixture was stirred at room temperature overnight. The mixture was concentrated and the residue was taken up in CH2C12 (20 ml), cold water (20 ml), 1MHC1 (20 ml). After decantation, the aqueous phase was extracted again with (: ^ 12 &lt;: 12 (2 X 20 ml). The mixed organic phases were washed with 10% NaHC03 and water, dried (MgS04) and concentrated. The resulting oil Purification with silica gel (1% methanol / CH2C12) can produce bicyclic compound (252) as a solid (65 mg, 25%): [a] D20 -77., 0.208, MeOH); IR (KBr) 3471, 3434, 2975 , 2928, 1767, 1723, 1443, 1389, 1284, 1243, 1 15 1, 1 1 12, 720; Go NkR (CDC13) d 7.94-7.69 (4H, m), 5.34-5.27 (1H, m), 4.89 -4.66 (2H, m), 3.94-3.64 (2H, m), 3.02-2.84 (1H, m), 2.34-2.19 (2H, m), 1.94-1.61 (3H, m), 1.47 (9H, s) , 1 · 14 (3H, d); Analyze the calculation of C23H27N306C: C, -401-Consumption cooperation between employees of the Ministry of Economic Affairs and the Bureau of Standards, Du Yin «. 1235157 A7 B7 _____ V. Description of the invention (399) 62 · 57; No, 6.17; N, 9.52. Found 値: C, 62.60; Η, 6.40; N, 9.10. (IS, 8S, 9S) di-butyl-9-epi-amino-6,10--benzyl-8-methyl-1,2,3,4,7,8,9,10-octahydro -611-Dageno [1,24] [1,2] diazafluorene-1-carboxylic acid ester (255). A solution of the bicyclic compound (254) (70 mg, 0.16 mmol) in ethanol was treated with hydrazine hydrate (0.02 ml, 4 mmol, 2.5 equivalents). After stirring at room temperature for 5 hours, the mixture was concentrated and the resulting residue was taken up in &apos; toluene and evaporated. The residue was treated with 2M acetic acid (2 ml) for 16 hours. The resulting precipitate was filtered and washed with 2M acetic acid (10 ml). The 3 filtrate was basified with solid NaHC03 and extracted with EtOAc. The organic solution was washed with water, dried (MgS04) and concentrated. Purification by flash chromatography on silica gel (2% methanol / CH2C12) gave a free amine as a foam (50 mg, 100%). Amine (50 mg, 0.16 mmol) was dissolved in dioxane (1 ml) and water (0.25 ml), followed by NaHC03 (0.034 g, 0.04 mmol) followed by benzamidine chloride (0.047 ml). , 0.40 mol, 2.8 equivalents). The mixture was stirred at room temperature overnight and then diluted with EtOAc (15 mL). The organic solution was washed with 10% NaHC03 and a saturated NaCl aqueous solution, dried (MgS04), and concentrated. 3 Purified by silica gel flash chromatography (2% methanol / CH2C12) to obtain amidine 255 as a foam (67 mg, 100%). ): lK NMR (CDC13) (ί 7.89-7.39 (5Η, m), 6.79 (1H, d), 5.32-5.20 (1H, m), 4.98-4.82 (1H, m), 4.75-4.64 (1H, m ), 3.84-3.65 (1H, m), 3.09-2.89 (1H, m), 2.45-2.18 (2H, m), 2.00-1.61 (4H, m), 1.48 (9H, s), 1.28 (3H, d ) ^ (3S) (1S, 8S, 9S) 3- (9-fluorenylamino-6,10-diketo-8-methyl-1,2,3,4, 7,8,9,10 -Octahydro-6 ^ 1-da-phen [1,24] [1,2] diazabenzene-1-carboxamido) -4-ketobutanoic acid (257). Tertiary-butyl ester 255 (67 mg, 0.16 mmol) at -402-(Please read the precautions for Ιδ before filling this page)

^ ^ Γ ΓΧ5; ) ( 710 ν ?07/Λ4ί5· \ 1235157 A7 _ _________ B7_____ 五、發明説明(400) CHfl2之溶液,在〇ec下以三氟醋、酸處理(1毫升p生成的 么液在0 C下擾拌15分鐘,再於室溫下1小時。溶液濃縮, 殘留物以無水(:112(:12吸收(2 X 2毫升),且混合物再次濃縮 (x2)。殘留物自二乙醚中結晶。沈澱物過濾可生成255之 自由態酸,呈灰色固體(40毫克,70%)。酸(40毫克,0.11 毫莫耳),N-烯丙氧羰基-4-胺基-5-芊氧基-2-酮基四氩呋喃 (Chapman, Bioorg· &amp; Med. Chem. Lett.· 2, pp. 615-18 (1992) ;39毫,0.13毫莫耳,1.2當量)及(Ph3P)2PdCl2(3毫克)於無 水CH2C12 (1毫升)及無水DMF /〇.2毫升)混合物中之溶液, 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 以n-Bu3SnH(0.089毫升,〇·33毫莫耳,3當量)逐滴處理。 生成的溶液在25°C下攪拌10分鐘,再加卜羥基苯並二唑(36 毫克,0.266毫莫耳,2.4當量)^混合物冷卻至0°C,再加 乙基二甲胺基丙基碳化二亞胺(31毫克,0.16毫莫耳,1.5當 量)。在0Ό下攪拌10分鐘,再於室溫下一夜,混合物以 EtOAc稀釋(20毫升)且生成的溶液相繼以iM HC1 (2 X 5毫升) ,10% NaHC03 (2 X 5毫升)及飽和的NaCl水溶液(5毫升)洗 滌,乾燥(MgS04)並濃縮。在矽膠上快速層析(2%甲醇 /CH2C12)可生成非對映立體異構(256)之混合,呈灰色固鳢 (50毫克,82%)。此產物(256)可使用勿需再純化(50毫克, 0.091毫莫耳)並於甲醇中(5毫升)以10% Pd/C (30毫克)氫化 24小時。反應混合物過濾且生成的溶液再濃縮-於矽膠上 快速層析(2-20%甲醇/CH2C12)可生成化合物257 (9毫克, 21%)呈白色固體·· 4 NMR (D4-MeOH) β 7·88-7·29 (5H,m), 5.18-4.99 (1H, m), 4.59-4.35 (3H, m), 4.26-4.11 (1H, m), -403- 本纸乐尺度適用中國國家標李(CNS ) A4規格(2丨0X297公廣1 ~&quot; 1235157 A7 B7 五、發明説明(401)3.65-3.41 (2H, m), 3.18-2.91 (1H, nr), 2.62-1.47 (8H, m), 1.29-1.00 (3H,2d)(縮醛及半縮醛之混合物)。MS (ES -) 457^ ^ Γ Γχ5;) (710 ν? 07 / Λ4ί5 · \ 1235157 A7 _ _________ B7_____ V. Description of the invention (400) The solution of CHfl2 was treated with trifluoroacetic acid and acid (1 ml of p Stir for 15 minutes at 0 C, and then for 1 hour at room temperature. The solution was concentrated, and the residue was taken up in anhydrous (: 112 (: 12 (2 X 2 ml), and the mixture was concentrated again (x2). Crystallized from ether. Filtration of the precipitate yielded 255 free-state acid as a gray solid (40 mg, 70%). Acid (40 mg, 0.11 mmol), N-allyloxycarbonyl-4-amino-5 -Methoxy-2-ketotetrahydrofuran (Chapman, Bioorg &amp; Med. Chem. Lett. · 2, pp. 615-18 (1992); 39 mmol, 0.13 mmol, 1.2 equivalents) and ( Ph3P) 2PdCl2 (3 mg) in a mixture of anhydrous CH2C12 (1 ml) and anhydrous DMF / 0.2 ml), printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) ) Treated dropwise with n-Bu3SnH (0.089 ml, 0.33 mmol, 3 eq.) The resulting solution was stirred at 25 ° C for 10 minutes, and then added with hydroxybenzodione (36 mg, 0.266 mmol, 2.4 equivalents) ^ The mixture was cooled to 0 ° C, and ethyldimethylaminopropylcarbodiimide (31 mg, 0.16 mmol, 1.5 equivalents) was added. At 0 ° C Stir for 10 minutes, and then overnight at room temperature. The mixture was diluted with EtOAc (20 mL) and the resulting solution was successively iM HC1 (2 X 5 mL), 10% NaHC03 (2 X 5 mL) and saturated aqueous NaCl solution (5 Ml) was washed, dried (MgS04) and concentrated. Flash chromatography on silica gel (2% methanol / CH2C12) can produce a mixture of diastereoisomeric (256), a gray solid (50 mg, 82%). This product (256) was used without further purification (50 mg, 0.091 mmol) and hydrogenated in methanol (5 ml) at 10% Pd / C (30 mg) for 24 hours. The reaction mixture was filtered and the resulting solution was re- Concentration-flash chromatography on silica gel (2-20% methanol / CH2C12) yields compound 257 (9 mg, 21%) as a white solid. · 4 NMR (D4-MeOH) β 7 · 88-7 · 29 (5H , M), 5.18-4.99 (1H, m), 4.59-4.35 (3H, m), 4.26-4.11 (1H, m), -403- This paper scale is applicable to China National Standard (CNS) A4 specifications (2丨 0X29 7 Gong Guang 1 ~ &quot; 1235157 A7 B7 V. Description of the invention (401) 3.65-3.41 (2H, m), 3.18-2.91 (1H, nr), 2.62-1.47 (8H, m), 1.29-1.00 (3H, 2d) (mixture of acetals and hemiacetals). MS (ES-) 457

PhCONHNH2 (258)PhCONHNH2 (258)

PhCO-N^H Η (259)PhCO-N ^ H Η (259)

(請先閱讀背面之注意事項具填寫本f ) 訂 Μ濟部中夬標準局員工消费合作社印¾ Ο(Please read the note on the back to fill in this f) Order the seal of the Consumer Consumption Cooperative of the China Standards Bureau of the Ministry of Economic Affairs ¾ 〇

-404- 本紙浪尺度適用tg國家標孪(CNS ) A4規格(210X29?公釐) 1235157 A7 ___B7 ____ 五、發明説明(402) 3 · (N、辛酿基膀基)丙酸辛g旨(259)3丙烯酸+醋(1.13¾升, 7·34毫莫耳)加至苄醯胼(285)(1.0克,7·34毫莫耳)於異丙醇 (28毫升)之攪拌懸液中3混合物迴流20小時,冷卻至室溫 再濃縮3殘留物以快速層析純化(20% Et〇Ac/CH2Cl2)可生 成259 (1.098克,50%)呈油狀,於靜置後可結晶:mp 65X: IR (KBr) 3283, 1723, 1644, 1316, 1201, 1 156; lU NMR (CDCi3) ά 8.32-8.18 (1H, m), 7.81-7.70 (2H? m), 7.57-7.23 (8H, m), 5.36-4.92 (1H, brm), 5.11 (2H, s), 3.26 (2H, t, J = 6.5), 2.59 (2H, t, J = 6.5); 13C NMR (CDC13) ^ 172.12, 經濟部中夬樣隼局員工消費合作社印¾ 167.27, 135.65, 132.54, 131.66, 128.45, 128.10, 128.06, 126.84, 66.31, 47.33, 33.31;分析 Cl7H13N203之計算値:C 68.44; H,6.08; N, 9.39。實測値:C, 68.42; H, 6.10; N, 9.38。 MS (ES +) 321 (M + Na, 38%), 299 (M+ + 1,100) 3 (3S) 2·(Ν、芊醢基-N-(2-芊氧基羰基乙基)肼基羰基)六氩嗒 啡-1,3-二羧酸1-苄基3-第三-丁酯(260)。六氫嗒畊-1,3-二幾 酸(3S)-1-芊基 3-第三-丁酯(Hassall et al· J. Chem· Soc· Perjon i,p· 1451-1454 (1979))(925.3毫克,2.89毫莫耳)及二異丙 基乙胺(0.70毫升,4.0毫莫耳)於1.93%光氣(17.96毫升, 34.7毫莫耳)之甲苯溶液,在室溫下攪拌45分鐘,再濃縮留 下黃色固體。在此固體中加入甲苯(18毫升),醯胼 (259)(861.6毫克,2.89毫莫耳)及二異丙基乙胺(〇·7〇毫升, 4.0毫莫耳)。混合物在室溫下攪拌2· 75小時,再濃縮。生 成的殘留物以EtOAc吸收,以1M HC1,鹽水洗滌,再乾燥 (MgS〇4),過濾及濃縮可生成2.15克粗製物質。快速層析 -405- 本紙張尺度適用中g國家標率(CNS ) A4規格(2丨0X 297公慶) 一 '^&quot; 1235157 經濟部中夬標隼局負工消费合作社印装 A 7 B7_五、發明説明(4〇3) (40% EtOAc於己烷)可生成1·65克(、89%)標題化合物,呈白 色泡末狀♦· mp· 40°C ;[泛]〇24 *55.78 (c 0.40,CH2Cl2); IR (KBr) 3436, 2930, 1733, 1689, 1455, 1412, 1367, 1258, 1 156, 697; NMR (CDC13) ά 8.54-8.23 (0.5H, m), 7.97-7.09 (15.5H), 5.16-4.80 (4H, m), 4.66-4.32 (1H, m), 4.24-3.55 (3.3H, m), 3.50-3.26 (0.4H, m), 3.19-2.49 (2.3H, m), 2.11-1.43 (6H, m), 1.32-1.05 (7H,m);分析 C35H40N4O8.0.5H2〇之 計算値:C,64.31; H,6.32; N,8.57。實測値:C,64.18; H, 6.27; N,8.56。MS (ES +) 662 (M + Na,84%), 645 (M+ + 1, 100),384 (77) 〇 (6S)-3 - (Ν’ -爷酷基-N-(6 -第三-丁氧談基穴氫卷〃井-1-装基)縣 基)丙酸(261)。260 (1· 59克,2.47毫莫耳)於MeOH (142毫升) 之溶液,以10%?〇1/(:(230.0毫克)處理,再於112大氣下攪 拌1.5小時。混合物過濾,且溶劑蒸發生成1·〇4克(100%)白 色泡沫。此可用於下一步驟勿需再純化:mP &lt;4〇1;[從]D26 + 1.6。(c 0.26, CH2C12); IR (KBr) 3422, 2977, 2986, 1728, 1677, 1486, 1445, 1396, 1369, 1309, 1228, 1 155, 916, 716; [H NMR (CDCI3) ^ 10.0-9.7 (1H, brm), 7.86 (2H, d, J = 7.5), 7.62-7.38 (3H, m), 7.3-5.6 (2H, brm), 4.57 (1H, brd, J = 4.0), 4.05-3.77 (2H, m), 3.00-2.82 (1H, m), 2.80-2.43 (3H, m), 2.20-2.03 (1H, m), 2.00-1.47 (1H, m), 1.62-1.14 (11H, m); l3C NMR (CDCI3) S 175.00, 171.17, 167.62, 160.68, 132.39, 13 1.77, 128.67, 127.38, 82.27, 54.38, 48.04, 46.35, 33.62, 28.02, 25.68, 21.61 - MS (ES +) 443 (M + Na, 68%), 421 (M&quot; -406- 本紙伕尺度適用中國a家標隼(CNS)M说格(210X 297公4 ) (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 1235157 A7 — B7 五、發明説明(404) + 1),1〇〇),365 (50),131 (61” —— (45)7-苯甲醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6只-嗒啡並[1,24][1,2,4]三氮雜箪-4-羧酸第三丁酯(262)。對胺 基酸261 (1.012克,2.41毫莫耳)於無水THF (26毫升)之溶液 ,在0°C下加入N-乙基嗎福啉(597微升,4.69毫莫耳)再加 PC15 (65 1.3毫克,3.12毫莫耳)。反應在(TC下攪摔2小時, 再加溫至室溫並再攪拌15.5小時。混合物濃縮,生成的殘 留物以EtOAc吸收,以1M HC1,飽和的NaHC03,鹽水洗 二次,再乾燥(MgS04),過&amp;並濃縮。快逯層析(20% EtOAc/ CH2Cl2)可得727.3毫克(75%)標題化合物,呈白色 泡沫:〇]D26 +51.0。(c 〇·20, CH2C12); IR (KBr) 3436, 2979, 1733, 1670, 1483, 1437, 1420, 1299, 1243, 1 156; lHNMR (CDC13) ά 8.70 (1H, s), 7.78 (2H, d, J = 7.0), 7.57-7.32 (3H, m), 5.08 (1H, dd, J = 2.5, 5.5), 4.59-4.43 (1H, m), 4.08-3.69 (3H, m), 3.07-2.84 (1H, m), 2.57-2.35 (1H, m), 2.34-2.14 (1H, m), 2.07-1.43 (3H, m), 1.48 (9H, s); 13C NMR (CDC13) d 172.41, 169.04, 166.35, 158.35, 132.24, 132.03, 128.61, 127.3 1, 82.77, 55.41, 54.07, 41.57, 32.21, 28.04, 24.97, 20.37; 分析C2〇H26N4〇5之計算値:C, 59·69; H, 6.51; N,13.92。實測 値:C,59·53; Η, 6·53; N, 13.84。MS (ES +) 425 (Μ + Na, 71%), 403 (M+ + 1,100),145 ⑷)。 (45)-7-苯甲醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6^1-喀啩並[l,2-a] [1,2,4]三氮雜箪-4-羧酸(263)。醋262 (720.0毫 克,1.80毫莫耳)於i:1 CH2C12&amp;TFA (150毫升)混合物中之 -407- 本纸诙尺度適用中ϋΙΙ家標率(CNS ) A4現格(2H)X297公慶) --- (請先閣讀背面之注意事項再填寫本頁)-404- This paper applies the tg national standard (CNS) A4 specification (210X29? Mm) 1235157 A7 ___B7 ____ V. Description of the invention (402) 3 · (N, Octyl base) Propionate (g ) 3 Acrylic acid + vinegar (1.13¾ liters, 7.34 mmoles) was added to a stirred suspension of benzamidine (285) (1.0 g, 7.34 mmoles) in isopropanol (28 ml) 3 The mixture was refluxed for 20 hours, cooled to room temperature, and concentrated. The residue was purified by flash chromatography (20% EtOAc / CH2Cl2) to give 259 (1.098 g, 50%) as an oil, which crystallized after standing: mp 65X: IR (KBr) 3283, 1723, 1644, 1316, 1201, 1 156; lU NMR (CDCi3) ά 8.32-8.18 (1H, m), 7.81-7.70 (2H? M), 7.57-7.23 (8H, m ), 5.36-4.92 (1H, brm), 5.11 (2H, s), 3.26 (2H, t, J = 6.5), 2.59 (2H, t, J = 6.5); 13C NMR (CDC13) ^ 172.12, Ministry of Economic Affairs Printed by the Consumers' Cooperatives of the China Provincial Sample Bureau 167.27, 135.65, 132.54, 131.66, 128.45, 128.10, 128.06, 126.84, 66.31, 47.33, 33.31; Analysis of calculation of Cl7H13N203: C 68.44; H, 6.08; N, 9.39. Found 値: C, 68.42; H, 6.10; N, 9.38. MS (ES +) 321 (M + Na, 38%), 299 (M + + 1,100) 3 (3S) 2 · (N, fluorenyl-N- (2-methoxyoxyethylethyl) hydrazine (Carbonyl) hexadacorphine-1,3-dicarboxylic acid 1-benzyl 3-third-butyl ester (260). Hexahydrophenyl-1,3-dicicarboxylic acid (3S) -1-fluorenyl 3-tert-butyl ester (Hassall et al. J. Chem. Soc. Perjon i, p. 1451-1454 (1979)) (925.3 mg, 2.89 mmol) and a solution of diisopropylethylamine (0.70 ml, 4.0 mmol) in 1.93% phosgene (17.96 ml, 34.7 mmol) in toluene and stirred at room temperature for 45 minutes , And concentrated to leave a yellow solid. To this solid were added toluene (18 ml), osmium (259) (861.6 mg, 2.89 mmol) and diisopropylethylamine (0.70 ml, 4.0 mmol). The mixture was stirred at room temperature for 2.75 hours and then concentrated. The resulting residue was taken up in EtOAc, washed with 1M HC1, brine, and dried (MgSO), filtered and concentrated to give 2.15 g of crude material. Quick Chromatography-405- This paper standard is applicable to China National Standards (CNS) A4 specifications (2 丨 0X 297 public holidays) 1 '^ &quot; 1235157 Printed by the Ministry of Economic Affairs, China Standards Bureau, Off-line Consumer Cooperatives A 7 B7 _V. Description of the invention (403) (40% EtOAc in hexane) can produce 1.65 g (, 89%) of the title compound, which is white foamy ♦ · mp · 40 ° C; [PAN] 〇24 * 55.78 (c 0.40, CH2Cl2); IR (KBr) 3436, 2930, 1733, 1689, 1455, 1412, 1367, 1258, 1 156, 697; NMR (CDC13) ά 8.54-8.23 (0.5H, m), 7.97 -7.09 (15.5H), 5.16-4.80 (4H, m), 4.66-4.32 (1H, m), 4.24-3.55 (3.3H, m), 3.50-3.26 (0.4H, m), 3.19-2.49 (2.3 H, m), 2.11-1.43 (6H, m), 1.32-1.05 (7H, m); analysis of the calculation of C35H40N4O8.0.5H20: C, 64.31; H, 6.32; N, 8.57. Found 値: C, 64.18; H, 6.27; N, 8.56. MS (ES +) 662 (M + Na, 84%), 645 (M + + 1, 100), 384 (77) 〇 (6S) -3-(N '-Yekuji-N- (6 -Third -Butoxy talks on the base point hydrogen curling 〃Sakai-1-loading base) prefecture base) propionic acid (261). A solution of 260 (1.59 g, 2.47 mmol) in MeOH (142 ml) was treated with 10% 100 / (: (230.0 mg), and then stirred for 1.5 hours under 112 atmosphere. The mixture was filtered and the solvent Evaporation yielded 1.04 g (100%) of a white foam. This was used in the next step without further purification: mP &lt;4〇1; [from] D26 + 1.6. (C 0.26, CH2C12); IR (KBr) 3422, 2977, 2986, 1728, 1677, 1486, 1445, 1396, 1369, 1309, 1228, 1 155, 916, 716; [H NMR (CDCI3) ^ 10.0-9.7 (1H, brm), 7.86 (2H, d , J = 7.5), 7.62-7.38 (3H, m), 7.3-5.6 (2H, brm), 4.57 (1H, brd, J = 4.0), 4.05-3.77 (2H, m), 3.00-2.82 (1H, m), 2.80-2.43 (3H, m), 2.20-2.03 (1H, m), 2.00-1.47 (1H, m), 1.62-1.14 (11H, m); l3C NMR (CDCI3) S 175.00, 171.17, 167.62 , 160.68, 132.39, 13 1.77, 128.67, 127.38, 82.27, 54.38, 48.04, 46.35, 33.62, 28.02, 25.68, 21.61-MS (ES +) 443 (M + Na, 68%), 421 (M &quot; -406- The size of this paper is applicable to the Chinese standard of a family house (CNS) M (210X 297 male 4) (Please read the notes on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1235157 A7 — B7 V. Description of the invention (404) + 1), 100), 365 (50), 131 (61 "—— (45) 7-benzylamido-6,10-diketo- 1,2,3,4,7,8,9,10-octahydro-6-daphno [1,24] [1,2,4] triazafluorene-4-carboxylic acid tert-butyl ester (262). A solution of p-amino acid 261 (1.012 g, 2.41 mmol) in anhydrous THF (26 ml) was added N-ethylmorpholine (597 μl, 4.69 mmol) at 0 ° C. PC15 (65 1.3 mg, 3.12 mmol) was added. The reaction was stirred at (TC for 2 hours, then warmed to room temperature and stirred for another 15.5 hours. The mixture was concentrated and the resulting residue was taken up in EtOAc, washed twice with 1M HC1, saturated NaHC03, brine, dried (MgS04), &amp; and concentrated. Flash chromatography (20% EtOAc / CH2Cl2) gave 727.3 mg (75%) of the title compound as a white foam: 0] D26 + 51.0. (C 〇 · 20, CH2C12); IR (KBr) 3436, 2979, 1733, 1670, 1483, 1437, 1420, 1299, 1243, 1 156; lHNMR (CDC13) ά 8.70 (1H, s), 7.78 (2H, d, J = 7.0), 7.57-7.32 (3H, m), 5.08 (1H, dd, J = 2.5, 5.5), 4.59-4.43 (1H, m), 4.08-3.69 (3H, m), 3.07-2.84 (1H, m), 2.57-2.35 (1H, m), 2.34-2.14 (1H, m), 2.07-1.43 (3H, m), 1.48 (9H, s); 13C NMR (CDC13) d 172.41, 169.04, 166.35, 158.35, 132.24, 132.03, 128.61, 127.3 1, 82.77, 55.41, 54.07, 41.57, 32.21, 28.04, 24.97, 20.37; Analysis of the calculation of C20H26N40.5: C, 59 · 69; H, 6.51; N , 13.92. Measured 値: C, 59.53; Η, 6.53; N, 13.84. MS (ES +) 425 (M + Na, 71%), 403 (M + + 1,100), 145 °). (45) -7-benzylamido-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-6 ^ 1-carbo [l, 2 -a] [1,2,4] triazafluorene-4-carboxylic acid (263). Vinegar 262 (720.0 mg, 1.80 mmol) in i: 1 CH2C12 &amp; TFA (150 ml) mixture of -407- this paper 诙 standard applicable ϋ Ι house standard rate (CNS) A4 format (2H) X297 public holiday ) --- (Please read the precautions on the back before filling out this page)

經濟部中夬櫺準局員工消費合作杜印製 1235157 Λ7 B7 五、發明説明(405 ) 溶液,在無水大氣下攪摔1.3小時、。溶液再於眞空下減量 ,以Et201收並再次減量。此過程重覆六次以生成粗製產 物,爲摻白色固體。產物以快速層析純化(5% MeOH/ CH2C12)可生成520.0毫克(83%)標題化合物,呈白色泡沫·· 〇]D25 +59.5。(c 1.82, CH2C12); IR (KBr) 3435, 3266, 2956, 1732, 1664, 1524, 1486, 1440, 1302; lH NMR (CDC13) 9.13 (1H, s), 7.77 (2H, d, J = 7.5), 7.57-7.32 (3H, m), 5.27· 5.16 (1H, m), 4.62-4.43 (1H, m), 4.09-2.70 (3ΗΫ m), 3.14-2.89 (1H, m), 2.59-2.43 (1H, m), 2.38-2,20 (1H, m), 2.14-1.89 (1H, m), 1.82-L59 (2H, m); l3C NMR (CDC13) ^ 173.65, 1 72.28, 166.44, 158.42, 132.44, 13 1.3 1, 128.61, 127.39, 54.83, 54.01, 42.11, 31.79, 24.42, 20.29; MS (ES -) 345 (M - H+, 100%), 161 (45)。 [21^,33(43)]1&gt;1-(2-芊氧基〇-酮基四氫呋喃-3-基)-6,10-二酮 基-1,2,3,4,7,8,9,10-八氫-6H-嗒啩並[l,2-a][l,2,4]三氮雜箪-4-羧醯胺(264)。對酸263 (300.0毫克,〇·87毫莫耳)及 (2RS,3S)-3-缔丙氧裝基胺基-2-苄氧基-5-明基四氫咬喘 (Chapman, Bioorg. &amp; Med. Chem. Lett. 2· pp. 615-18 (1992)) (277.6毫克,〇·95毫莫耳)於無水CH2C12 (2.5毫升)及無水 DMF (2.5毫升)在rt下之溶液加入雙(三苯膦)鈀化氯(13·0毫 克),再加三-正-丁基錫化氫(466.0微升,1.73毫莫耳)。反 應搜拌5分鐘,再加1-經基笨並三吐(234.1毫克,I·73毫莫 耳)且混合物冷卻至0Χ:,再加·Ν(3-二甲胺基丙基)-3-乙基 琰化二亞胺鹽酸(204.5毫克,1.04毫莫耳)。令混合物加溫 -408· 本紙&amp;尺度適用中國國家櫺搫(CNS ) Μ現格(210X 297公鉻) (請先聞讀背©之洼意事項再填寫本I )Consumption cooperation by employees of the China Prospective Bureau of the Ministry of Economic Affairs, produced by Du Yin 1235157 Λ7 B7 V. Description of the invention (405) Solution, stirred for 1.3 hours in an anhydrous atmosphere. The solution was reduced again under vacuum, and the solution was reduced with Et201 and reduced again. This process was repeated six times to produce the crude product as a white solid. The product was purified by flash chromatography (5% MeOH / CH2C12) to yield 520.0 mg (83%) of the title compound as a white foam ...] D25 +59.5. (C 1.82, CH2C12); IR (KBr) 3435, 3266, 2956, 1732, 1664, 1524, 1486, 1440, 1302; lH NMR (CDC13) 9.13 (1H, s), 7.77 (2H, d, J = 7.5 ), 7.57-7.32 (3H, m), 5.27 · 5.16 (1H, m), 4.62-4.43 (1H, m), 4.09-2.70 (3ΗΫ m), 3.14-2.89 (1H, m), 2.59-2.43 ( 1H, m), 2.38-2,20 (1H, m), 2.14-1.89 (1H, m), 1.82-L59 (2H, m); l3C NMR (CDC13) ^ 173.65, 1 72.28, 166.44, 158.42, 132.44 , 13 1.3 1, 128.61, 127.39, 54.83, 54.01, 42.11, 31.79, 24.42, 20.29; MS (ES-) 345 (M-H +, 100%), 161 (45). [21 ^, 33 (43)] 1> 1- (2-methoxyoxy-ketotetrahydrofuran-3-yl) -6,10-diketo-1,2,3,4,7,8, 9,10-octahydro-6H-dapyrido [l, 2-a] [l, 2,4] triazapyridin-4-carboxamide (264). To acid 263 (300.0 mg, 0.87 mmol) and (2RS, 3S) -3-alanoxyamino-2-benzyloxy-5-benzyltetrahydrobitan (Chapman, Bioorg. & Amp Med. Chem. Lett. 2. pp. 615-18 (1992)) (277.6 mg, 0.95 mmol) in anhydrous CH2C12 (2.5 ml) and anhydrous DMF (2.5 ml) at rt. (Triphenylphosphine) palladium chloride (13.0 mg), followed by tri-n-butyltinhydrogen (466.0 µl, 1.73 mmol). The reaction was stirred for 5 minutes, followed by adding 1-benzylbenzene and three vomiting (234.1 mg, 1.73 mmol) and cooling the mixture to 0 × :, then adding · N (3-dimethylaminopropyl) -3 -Ethylphosphonium diimide hydrochloride (204.5 mg, 1.04 mmol). Warm up the mixture -408 · This paper &amp; dimensions are applicable to the Chinese National Cricket (CNS) Μ current grid (210X 297 male chromium) (please read the meaning of the © before filling in this I)

經濟部中央標李局員工消費合作社印¾ 1235157 A7 B7 ' 五、發明説明(406) 至rt,再攪拌16.5小時。混合物以EtOAc稀釋,以1M NaHS03,飽和的NaHC03 (x2),H20再來是鹽水洗滌。有 機層乾燥(MgS04),過濾及濃縮。殘留物以快速層析純化 (5%MeOH/CH2Cl2)可生成358.3毫克(77%)標題化合物,呈 白色固體:IR (KB〇 3435, 1791,1665, 1526, 1421,1285; β NMR (CDC13) d 8.76 及 8.49 (1Η,2 X s),7.92-7.73 (2Η,m), 7.62-7.24 (8.5H,m),6.86 (0·5Η,d,J = 8.0),5.53 及 5·33 (1H, d, J = 5.5, s), 4.95-4.34 (5H, m), 4.04-3.54 (3H, m), 3.03-2.64 (2H, m), 2.49-2.14 (2H, m), 2.11-1.46 (4H, m); MS (ES +) 558 (M + Na, 100%), 536 (M+ + 1, 78),404 (58) 〇 [3S(4S)]3-(7_ 苯甲醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫 答味並[l,2-a][l,2,4]三氮雜革-4-羧醯胺基)-4-酮基丁酸 (265)。264 (350.0毫克,0.65毫莫耳),10% Pd/C (350毫克) 及甲醇(36亳升)的混合物在h2大氣下攪拌6.5小時。混合物 過遽且溶劑蒸發3加入Et20並再次移去溶劑〇此過程重覆 四次以移去283毫克(97%)標題化合物,呈白色晶狀固體: mp上去羧酸鹽14〇。(:;[泛]D26 +33.5。(c 0.18, MeOH); IR (KBr) 3428, 1663, 1528, 1487, 1437, 1288; LH NMR (D6-DMSO) d 10.56 (1H, S), 8.71-8.57 (1H, m), 7.88-7.81 (2H, m), 7.65· 7.46 (3H, m), 4.97-4.85 (1H, m), 4.38-4.0 (3H, m), 3.88-3.52 (3H, m), 2.91-2.71 (2H, m), 2.50-2.38 (1H, m), 2.35-2.21 (1H, m), 2.10-1.94 (1H, m), 1.93-1.49 (3H, m); 13C NMR (D6- DMSO) δ 173.66, 172.49, 169.97, 169.89, 164.96, 157.62, 132.35, 131,85, 128.39, 127.32, 53.81, 52.69, 40.90, 33.17, ______-409-_ 太祕这旧办si兩方逢:·达(ΓΝ;ς、故^v,Q7八饬、 (請先閱讀背vB之注意事項再填寫本I )Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1235157 A7 B7' V. Description of the invention (406) to rt, stirring for another 16.5 hours. The mixture was diluted with EtOAc and washed with 1M NaHS03, saturated NaHC03 (x2), H20 and then brine. The organic layer was dried (MgS04), filtered and concentrated. Purification of the residue by flash chromatography (5% MeOH / CH2Cl2) yielded 358.3 mg (77%) of the title compound as a white solid: IR (KB〇3435, 1791, 1665, 1526, 1421, 1285; β NMR (CDC13) d 8.76 and 8.49 (1Η, 2 X s), 7.92-7.73 (2Η, m), 7.62-7.24 (8.5H, m), 6.86 (0 · 5Η, d, J = 8.0), 5.53 and 5.33 ( 1H, d, J = 5.5, s), 4.95-4.34 (5H, m), 4.04-3.54 (3H, m), 3.03-2.64 (2H, m), 2.49-2.14 (2H, m), 2.11-1.46 (4H, m); MS (ES +) 558 (M + Na, 100%), 536 (M + + 1, 78), 404 (58) 〇 [3S (4S)] 3- (7-benzylamine -6,10-diketo-1,2,3,4,7,8,9,10-octahydrodiamine and [l, 2-a] [l, 2,4] triazale-4 -Carboxamido) -4-ketobutyric acid (265). A mixture of 264 (350.0 mg, 0.65 mmol), 10% Pd / C (350 mg) and methanol (36 liters) in h2 atmosphere Stir for 6.5 hours. The mixture was evaporated and the solvent was evaporated. 3 Et20 was added and the solvent was removed again. This process was repeated four times to remove 283 mg (97%) of the title compound as a white crystalline solid: mp off the carboxylate salt. 14 . (:; [PAN] D26 +33.5. (C 0.18, MeOH); IR (KBr) 3428, 16 63, 1528, 1487, 1437, 1288; LH NMR (D6-DMSO) d 10.56 (1H, S), 8.71-8.57 (1H, m), 7.88-7.81 (2H, m), 7.65 · 7.46 (3H, m ), 4.97-4.85 (1H, m), 4.38-4.0 (3H, m), 3.88-3.52 (3H, m), 2.91-2.71 (2H, m), 2.50-2.38 (1H, m), 2.35-2.21 (1H, m), 2.10-1.94 (1H, m), 1.93-1.49 (3H, m); 13C NMR (D6- DMSO) δ 173.66, 172.49, 169.97, 169.89, 164.96, 157.62, 132.35, 131,85, 128.39, 127.32, 53.81, 52.69, 40.90, 33.17, ______- 409-_ Tai Mi This old office si meets on both sides: · Da (ΓΝ; ς, therefore ^ v, Q7 饬, (Please read the note of vB first Matters refill this I)

1235157 A7 B7 五、發明説明(407 ) 31.60, 24.40, 24.13, 19.24; MS (ES -)1235157 A7 B7 V. Description of the invention (407) 31.60, 24.40, 24.13, 19.24; MS (ES-)

^NHZ Η^ NHZ Η

1) TFA1) TFA

ΝΗΖ Phth-N^^^H Η (266) 1) PCI5 2) ZN^ΝΗZ Phth-N ^^^ H Η (266) 1) PCI5 2) ZN ^

經濟部中夬榡準局員工消費合作社印it (2S) 3-芊氧羰基胺基-2-酞醯亞胺基丙酸(266)。(2S) 3·芊氧 羰基胺基-2-第三-丁氧羰基胺基丙酸二環己基胺鹽(3克, 5.8毫莫耳)於二氣甲烷(200毫升)之溶液,以1M HC1溶液洗 四次,乾燥(MgS04)再濃縮。生成的油再溶於無水二氣甲 烷(33毫升),冷卻至〇eC並以三氟醋酸處理(3 5毫升),此溶 液在(TC下攪拌1.5小時再蒸發至乾。加二氣甲烷(50毫升: 至殘留物再於眞空下移去。此過程重覆六次以生成白色固 體。白色固體懸浮在甲苯中(50½升),以粉末酞酐(94〇毫 克,6 · 3 5毫莫耳)處理並再迴流18小時。生成的溶液農縮生 成油’其以快逯層析純化(2-10%甲醇/二氣曱燒)可生成266 ,2.01 克(94%)呈白色粉末:ir (KBr) 3600-2500br,1776 1714, -410 - 本紙乐尺度通用中S國家標孪(CNS ) A4規格(210 X29*7公釐) 1235157 Λ7 B7 五、發明説明(408 ) 1530, 1469, 1455, 1392, 1263, 1 13 1, 722; NMR (CDC13) d 7.83 (2H, m), 7.72 (2H, m), 7.29 (5H, m), 5.41 (1H, m), 5.03 (2H,s), 3·90 (2H,m); MS (ES 367 (M - 1)。 [3S (2S) 1-芊氧羰基-2-(3-;氧羰基胺基酞醯亞胺基丙鏟 基)〃答^并-3-敌故第二-丁醋(267)。酸266 (1.32克,3.58毫莫 斗)於無水乙鲢(3 7毫升)之懸浮液,以五氯化磷(1〇4克, 毫莫耳)處理,再於室溫下攪掉2小時。溶液過濾以移去未 反應之五氯化锋’再蒸發至乾。殘留物以無水曱笨(25毫 升)處理再蒸發。此過程重覆數次。生成的油溶於無水二 氯甲烷(25毫升),冷卻至〇eC再以(3S) 1-苄氧羰基嗒畊-3-致酸第三-丁酯(1.15克,3.58毫莫耳)於無水二氣甲坑(2毫 升)繼以5%碳酸氫鈉水溶液(25毫升)處理。;·昆合物在室溫 下快速攪摔20小時,再以乙酸乙酯(1〇〇毫升)稀釋,並以 1M HCI酸化至pH 2。有機相以稀HC1溶液再以鹽水洗,乾 燥(MgS〇4)並農縮。生成的油以快速層析純化(2-20%乙酸 乙酯/二氣甲烷,再以10-20%甲醇/二氣甲烷)可生成(267) W 經濟部中夬標隼局員工消費合作杜印裝 f,1·25克(52%)呈白色粉末:IR (KBr) 3367, 2955, 1722, 1517, 1455, 1387, 1369, 1251, 1 153, 721; lH^NMR (CDC13)Employees' Cooperatives of the China Economic and Trade Standards Bureau of the Ministry of Economic Affairs (it) (2S) 3-Aminooxycarbonylamino-2-phthalimidoimidopropionic acid (266). (2S) a solution of 3 · fluorenyloxycarbonylamino-2-tertiary-butoxycarbonylaminopropionic acid dicyclohexylamine salt (3 g, 5.8 mmol) in digas methane (200 ml), at 1 M The HC1 solution was washed four times, dried (MgS04) and concentrated. The resulting oil was redissolved in anhydrous methane (33 ml), cooled to 0eC and treated with trifluoroacetic acid (35 ml). This solution was stirred at (TC for 1.5 hours and evaporated to dryness. Add methane ( 50 ml: Remove the residue under empty air. Repeat this process six times to produce a white solid. The white solid is suspended in toluene (50½ liters) and powdered phthalic anhydride (94 mg, 6.35 mmol) (Ear)) treated and refluxed for another 18 hours. The resulting solution was agriculturally contracted to form an oil, which was purified by flash chromatography (2-10% methanol / digassing) to yield 266, 2.01 g (94%) as a white powder: ir (KBr) 3600-2500br, 1776 1714, -410-This paper music standard is commonly used in the Chinese National Standard (CNS) A4 specification (210 X29 * 7 mm) 1235157 Λ7 B7 V. Description of the invention (408) 1530, 1469, 1455, 1392, 1263, 1 13 1, 722; NMR (CDC13) d 7.83 (2H, m), 7.72 (2H, m), 7.29 (5H, m), 5.41 (1H, m), 5.03 (2H, s ), 3.90 (2H, m); MS (ES 367 (M-1). [3S (2S) 1-fluorenyloxycarbonyl-2- (3-; oxocarbonylaminophthalimidoimidopropylidene) ) Answer ^ and -3- enemies second-butyric acid (267). Acid 266 (1.32 g, 3.58 millimoles) in anhydrous acetamidine (37 mL), treated with phosphorus pentachloride (104 g, millimoles), and stirred at room temperature for 2 hours. The solution was filtered to remove The unreacted pentachloride was evaporated to dryness. The residue was treated with anhydrous benzene (25 ml) and evaporated. This process was repeated several times. The resulting oil was dissolved in anhydrous dichloromethane (25 ml) and cooled to 〇eC and (3S) 1-benzyloxycarbonyl dagen-3-acid tert-butyl ester (1.15 g, 3.58 mmol) in anhydrous digas methyl pit (2 ml) followed by 5% sodium bicarbonate Aqueous solution (25 ml) was treated; • The kun compound was quickly stirred at room temperature for 20 hours, then diluted with ethyl acetate (100 ml), and acidified to pH 2 with 1M HCI. The organic phase was diluted with HC1 solution It was washed with brine, dried (MgS04), and shrunk. The resulting oil was purified by flash chromatography (2-20% ethyl acetate / digas methane, and then 10-20% methanol / digas methane). (267) W Consumption cooperation with employees of the China Bureau of Standards and Technology, Ministry of Economic Affairs, Du printed f, 1.25 grams (52%) was white powder: IR (KBr) 3367, 2955, 1722, 1517, 1455, 1387, 1369, 1251 , 1 1 53, 721; lH ^ NMR (CDC13)

7.81 (2H, m), 7.74 (2H, m), 7.63 (1H, brs)? 7.31 (i〇H, m), 5.46-4.76 (5H, m), 4.07-3.54 (4H, m), 2.4 (1H, m)7 2.0-1.6 (3H, m),1.40 (9H, s); MS (ES+),671 (M + 1),693 (M + Na)。 (15,95)1,2,3,4,7,8,9,10-八氫-10-酮基-9-酞醯亞胺-61*1-嗒畊 並[l,2-a][l,2,4]三氮雜苯小羧酸第三-丁 §旨(268)。酯267 (50毫克·,0.074亳莫耳)於甲醇(15毫升)之溶液以10% Pd/C 411- 本紙ife尺度適用中國國家標隼(CNS ) A4現格(2l〇X ^97公釐) 1235157 A7 B7 五、發明説明(409 ) (50毫克)處理再於室溫及大氣屢力下氫化24小時。混合物 充份抽空以移去氫,再以37%甲醛水溶液處理(18毫克, 0.22毫莫耳)並在氮下攪拌2小時。混合物過濾,蒸至乾工 產物以快速層析純化(4-100%乙酸乙酯/二氯甲烷)以生成 268 14.5 毫克(48%)呈汍狀:W NMR (CDC13) d 7·85 (2H,位), 7·71 (2H,m),5·78 (1H,dd,J = 10, 5),4·99 (1H,dd,J = 6丄 1.5), 4.07 (1H, d, J = 10.6), 3.49 (1H, dd, J = 14, 5), 3.39 (lH, d, J = 10.3),3.24 (1H,dd, J = 14, 10.2),3·17 (2H, m),2.39 (1H, m),1.84-1.46 (3H),1.51 (9H, s); MS (ES+), 415 (M + 43 7 (M + Na)。 化合物280-283以類似製備226e之方法製備自212b 3化合 物284-227以類似製備217e之方法製備。 經濟部中央樣準局負工消費合作社印製 -412- 本紙乐尺度適用申国国家標李(CNS ) A4現格(210x 297公釐) 1235157 A7 B7 五、發明説明(410 ) Ο R5, 、N Η7.81 (2H, m), 7.74 (2H, m), 7.63 (1H, brs)? 7.31 (i〇H, m), 5.46-4.76 (5H, m), 4.07-3.54 (4H, m), 2.4 ( 1H, m) 7 2.0-1.6 (3H, m), 1.40 (9H, s); MS (ES +), 671 (M + 1), 693 (M + Na). (15,95) 1,2,3,4,7,8,9,10-octahydro-10-keto-9-phthaloimine-61 * 1-dioxo [l, 2-a] [1,2,4] Triazabenzene tricarboxylic acid tertiary-butane § (268). Ester 267 (50 mg ·, 0.074 mol) in methanol (15 ml) solution at 10% Pd / C 411- this paper ife scale applies Chinese National Standard (CNS) A4 (2l0X ^ 97mm) ) 1235157 A7 B7 V. Description of the invention (409) (50 mg) Treatment and hydrogenation at room temperature and repeated atmospheric pressure for 24 hours. The mixture was fully evacuated to remove hydrogen, and then treated with a 37% aqueous formaldehyde solution (18 mg, 0.22 mmol) and stirred under nitrogen for 2 hours. The mixture was filtered and evaporated to dry product and purified by flash chromatography (4-100% ethyl acetate / dichloromethane) to yield 268 14.5 mg (48%) as a mash: W NMR (CDC13) d 7.85 (2H Bit), 7.71 (2H, m), 5.78 (1H, dd, J = 10, 5), 4.99 (1H, dd, J = 6 丄 1.5), 4.07 (1H, d, J = 10.6), 3.49 (1H, dd, J = 14, 5), 3.39 (lH, d, J = 10.3), 3.24 (1H, dd, J = 14, 10.2), 3.17 (2H, m), 2.39 (1H, m), 1.84-1.46 (3H), 1.51 (9H, s); MS (ES +), 415 (M + 43 7 (M + Na). Compounds 280-283 were prepared in a similar manner to 226e 212b 3 compound 284-227 was prepared in a similar manner to 217e. Printed by the Central Consumer Bureau of the Ministry of Economic Affairs and the Consumer Cooperatives -412- This paper scale is applicable to the national standard Li (CNS) A4 (210x 297 mm) 1235157 A7 B7 V. Description of the invention (410) 〇 R5, N N Η

280-287280-287

化合物 ACompound A

R 280 281 282 283 〇r^〇r^ % 請 先 閱 η 背 ιέ 之 注 意 _ 填 ! I装 訂 284 、。分 285 經濟部中央標华局員工消費合作社印裝 286 287R 280 281 282 283 〇r ^ 〇r ^% Please read η Note on the back first_fill! I Binding 284 ,. Sub-285 Printed by the Consumer Standards Cooperative of the Central Standardization Bureau of the Ministry of Economic Affairs 286 287

-413- 1235157 Λ7 B7 五、發明説明(411 )-413- 1235157 Λ7 B7 V. Description of the invention (411)

H2N-ORH2N-OR

00

a Ra R

b R 經濟部中夬標率局貝工消費合作社印装 (3S) 3-烯丙氧羰基胺基-4-酮基丁酸第三、丁酷 〇-(2,6-二氯 苯基甲基)肟(306a),以類似208a之方法絮岛. 椅’除了使用2,6-二氣苯基甲氧基胺(以類似306b之方法製備)替 巴胼生成870毫克(定量)呈澄清的油。 代半卡 (3S) 3-缔丙氧幾基胺基-4-明基丁龄笑_ 吸节二,丁酯0-(2-(苯基) 乙基)妨(3〇6b),以類似208a之步驟釗供 ^ 殊1備,除了使用2-(苯基) 乙氧基胺(US 5 346 911)替代半卡p &gt; 、 卜匕胼生成395毫克(定芰) 的澄清油狀。 -414- 本纸伕尺度適用中国國家標隼(CNS ) A4規格(210x297公Ρ 1235157 經濟部中夬標隼局員工消費合作社印製 Λ7 ___— —_B7____ 五、發明説明(412 ) [3S(1S,9S) 3-(9-;醯胺基-6,10-二酮基-1,2,3,4,7,8,9.10-八氫 -6H-嗒畊並[i,2-a][i,2]二氮雜萆-1-羧醯胺基)-胺基]-4-酮基 丁酸第三-丁酯,0-(2,6-二氣苯基甲基)肪(307a)以類似 233e之步驟製備,除了以306a替代207a,可生成23毫克 (23%)的307a,呈白色固體〇 [3 5(15,93)3-(9-芊醯胺基-6,10_二酮基-1,2,3,4,7,8,9,10-八氫 -611-嗒畊並[1,24][1,2]二氮雜箪-1-羧醯胺基)-胺基]-4-酮基 丁酸第三·丁酯,0-(2-(苯基)乙基)沾(307b)以類似233e之 步驟製備,除了以306b替代207a,生成43毫克(48%)的307b ,呈白色固體。 [3S(1S,9S) 3-(9-苄醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫 -6H-嗒啡並[l,2-a][l,2]二氮雜箪-1-羧醯胺基)-胺基]-4-酮基 丁酸,0-(2,6-二氣苯基甲基)肟(308a),以類似由234e製備 235e之方法製備自307a,可生成15.2毫克(74%)白色固體: lH NMR (CD3OD) ά 0.9 (m), 1.3 (s), 1.7 (m), 1.8 (m)? 2.0 (m&gt;, 2.1-2.2 (m), 2.3 (dd), 2.4-2.5 (m), 2.6 (m), 2.7-2.8 (m), 3.1 (m), 3.3 (m), 3.4-3.5 (m), 4.5 (m), 4.9 (m), 5.1 (m)? 5.3 (d), 5.4 (s), 6.8 (d), 7.2-7.5 (m), 7.8 (dd), 8.4 (dd) 〇 [3S(1S,9S) 3-(9-芊醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫 -6H-嗒呻並[l,2-a][l,2]二氮雜箪-卜羧醯胺基)-胺基]-4-酮基 丁酸,0-(2-(苯基)乙基)肟(308b),以類似23扑製備235e之 方法製備自307b,可生成25·2毫克(68%)的白色固鱧·· NMR (CD3OD) δ 1.2 (m), 1.6-1.7 (m), 2.0-2.1 (m), 2.2 (m), 2.3 (m), 2.5 (m), 2.6-2.7 (dd), 2.9 (t), 3.0 (t), 3.1 (m), 3.3-3.5 -415 - 本紙伕尺度適用中国國家標车(CNS ) A4現格(210X 297公釐) 1235157 A7 B7 五、發明説明(413 (m), 4.2 (t), 4.25 (m), 4.5 (m), 5.2 ('t), 5.3 (t), 6.7 (d), 7.1-7.2 (m), 7.35 (dd), 7.4 (m), 7.5 (m), 7.8 (dd), 8.3 (dd) ^b R Printed by (3S) 3-allyloxycarbonylamino-4-ketobutanoic acid in the Biaoconsumer Cooperative of the Ministry of Economic Affairs of the Ministry of Economic Affairs. ) Oxime (306a), similar to 208a, Sushima. The chair 'except for the use of 2,6-digas phenylmethoxyamine (prepared in a similar way to 306b) to produce 870 mg (quantitative) tibazone was clarified Of oil. Generation of half card (3S) 3-alanoxypropylamino-4-benzyl butyl succinyl _ sucker two, butyl ester 0- (2- (phenyl) ethyl) oxo (306b), similar to Step 208a is a special preparation, except that 2- (phenyl) ethoxyamine (US 5 346 911) is used in place of the half card p &gt;, which yields 395 mg (fixed tin) of a clear oil. -414- The size of this paper is applicable to China National Standard (CNS) A4 (210x297 G 1235157 Printed by the Consumers' Cooperatives of the China National Standards Bureau of the Ministry of Economic Affairs Λ7 ___ — —_B7 ____ V. Description of the invention (412) [3S (1S , 9S) 3- (9-; amido-6,10-diketonyl-1,2,3,4,7,8,9.10-octahydro-6H-da-pene [i, 2-a] [i, 2] Diazapyridine-1-carboxamidoamino) -amino] -4-ketobutyric acid third-butyl ester, 0- (2,6-difluorophenylmethyl) fat ( 307a) was prepared in a similar procedure to 233e, except that 207a was replaced with 306a, which yielded 23 mg (23%) of 307a as a white solid. [3 5 (15,93) 3- (9-fluorenylamino-6, 10_diketo-1,2,3,4,7,8,9,10-octahydro-611-dapono [1,24] [1,2] diazapine-1-carboxamide ) -Amino] -4-ketobutyric acid tert-butyl ester, 0- (2- (phenyl) ethyl) zine (307b) was prepared in a similar manner to 233e, except that 207a was replaced by 306b, yielding 43 Mg (48%) of 307b as a white solid. [3S (1S, 9S) 3- (9-benzylamido-6,10-diketonyl-1,2,3,4,7,8,9 , 10-octahydro-6H-daphno [l, 2-a] [l, 2] diazepine-1-carboxamido) -amino] -4-ketobutanoic acid, 0- ( 2,6-two gas Phenylmethyl) oxime (308a), prepared from 307a in a similar way to 235e from 234e, yields 15.2 mg (74%) of a white solid: lH NMR (CD3OD) ά 0.9 (m), 1.3 (s), 1.7 (m), 1.8 (m)? 2.0 (m &gt;, 2.1-2.2 (m), 2.3 (dd), 2.4-2.5 (m), 2.6 (m), 2.7-2.8 (m), 3.1 (m), 3.3 (m), 3.4-3.5 (m), 4.5 (m), 4.9 (m), 5.1 (m)? 5.3 (d), 5.4 (s), 6.8 (d), 7.2-7.5 (m), 7.8 (dd), 8.4 (dd) 〇 [3S (1S, 9S) 3- (9-fluorenylamino-6,10-diketo-1,2,3,4,7,8,9,10- Octahydro-6H-dalopano [l, 2-a] [l, 2] diazapyridine-carboxamido) -amino] -4-ketobutanoic acid, 0- (2- (benzene (Ethyl) ethyl) oxime (308b), prepared from 307b in a similar manner to that of 235e from 23 puff, yields 25.2 mg (68%) of white solids. · NMR (CD3OD) δ 1.2 (m), 1.6- 1.7 (m), 2.0-2.1 (m), 2.2 (m), 2.3 (m), 2.5 (m), 2.6-2.7 (dd), 2.9 (t), 3.0 (t), 3.1 (m), 3.3 -3.5 -415-The size of this paper is applicable to Chinese National Standard Car (CNS) A4 (210X 297mm) 1235157 A7 B7 V. Description of the invention (413 (m), 4.2 (t), 4.25 (m), 4.5 ( m), 5.2 ('t), 5.3 (t), 6.7 (d), 7.1-7.2 (m), 7.35 (dd), 7.4 (m), 7.5 (m), 7.8 (dd), 8.3 (dd) ^

O OO O

OO

H OR (請先%讀背面之注意填寫本瓦) 裝 訂 經濟部中央標準局員工消費合作社印¾ (304a) R=CH3 [3S(1S,9S) 3-(9-苄醯胺基-6,10-二'_基-1,2,3,4,7,8,9,10-八氫 -6H-嗒畊並[l,2-a】[l,2]二氮雜箪-1-羧醯胺基)-胺基]-4-酮基 丁酸第三-丁酯(302)。 A步驟:301以類似605a (A步驟)之步驟製備,除了使用 -416- 本紙伕尺度適用中國國家標李(CNS )以礼格(2I0X 297公釐) 1235157 Λ7 B7 五、發明説明(414) 替代6〇3以,可生成54Q毫克(、34%)白色固體^ B步驟。〇2。〇1 ()0.7¾克;〇 〇91毫莫耳)於2 8毫升他⑽/ MOAc⑽甲遂水落液(5:1:1)之溶液在n下授摔$ 5小時, 反應再於眞空下滚縮至〇·7亳升1留物溶於3毫升CH3CN 中,再濃縮至0.7毫升(3x),溶於曱笨中並;農縮至〇7毫升( 眞2下2X),再濃縮至乾1析(快速,Sl〇2, 5%異丙醇 /CH2C12)可生成 j〇2 (4).5¾ 克 ’ 78%)呈白色固體:iH NMR (DMS〇.d6) ^ 1.0-1.15 (m, 2H), 1.4 (s? 9H), 1.65 (m, 2H), 1.9-2.1 (m, 2H), 2.15^2.4 (m, 3H)? 2.55 (m, 1H), 2.7-3.0 (m, 2H), 4.3-4.6 (m, 2H), 4.9 (m, 1H), 5.2 (m, 1H), 7.4-7.6 (m, 2H), 7·8-8·0 (m,2H),8.6 (m,1H),8.8 (m,1H),9·4 (s,1H)。 [1S,9S (2RS,)S)] 9-苄 gg 胺基 _6,l〇-二嗣基 _1,2,3,4,7,8,9,l0- 八氫-N-(2-甲氧基-5-酮基-四氫吱喃_3·基)_6H_嗒tr井並[1,2-a][l,2]二氮雜箪-1-羧酸胺(3〇4a) 3 經濟部中央標準局員工消费合作社印¾ A步驟:302 (90毫克;0.18毫莫耳)於i〇毫升Me〇H之溶液 ’以二甲基原甲酸酯(1毫升)及對位-曱笨續酸-水合物(5毫 克,0.026毫莫耳)處理,且反應再攪拌2〇小時。反應以3毫 升飽和的NaHC〇3水溶液處理,再於眞空下濃縮。殘留以 EtOAc吸收,並以稀的NaHC03水溶液洗滌,於MgS〇4上乾 燥再眞空濃縮生成80毫克的303a。 B步驟:303a溶於2毫升TFA中,再於室溫下擾掉15分鐘3 反應溶於CHzCl2中並眞空濃縮(3χ)。層析(快速,si〇,,”/〇 至3% MeOH/CH2Cl2生成43毫克(64%)的304a,呈白色固鱧 :lH NMR (CDC13) d 1.55-1.8 (m, 2H), 1.9-2.15 (m, 4H), -417- 1235157 A7 B7 五、發明説明(415) 2.25-2.5 (m,2H),2.7-3.3 (m,4H),Ϊ.45, 3.6 (s,s,3H), 4.4, 4.75 (2m, 1H), 4.6 (m, 1H), 4.95, 5.4 (t, d? 1H), 5.1-5.2 (m, 1H), 6.45, 7.05 (2d, 1H), 6.95 (m, 1H), 7.45 (m, 2H), 7.5 (m? 1H),7.85 (m,2H)。 實例11 化合物 214e,404-413,415-445,446-468,470-491,及 493-499依實例11及表7所述地合成。 請 先 閱 讀 背 之 意 % 再 填 寫 本 買 經濟部中夬標隼局員工消f合作杜印裝 -418- 本帙乐尺度適用中S3家標導(CNS )六4汉格(210X 297公釐) 1235157 A7 B7 五、發明説明(416) 經濟部中夬標準局員工消費合作社印製H OR (Please read the note on the reverse side first and fill in the tile) Binding of the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 10-di'_yl-1,2,3,4,7,8,9,10-octahydro-6H-da-peng [l, 2-a] [l, 2] diazapyridine-1- Carboxamido) -amino] -4-ketobutyric acid tert-butyl ester (302). Step A: 301 is prepared in a similar step to 605a (Step A), except that -416- paper scale is applicable to Chinese national standard plums (CNS) with a courtesy (2I0X 297 mm) 1235157 Λ7 B7 V. Description of the invention (414) Instead of 603, 54Q mg (, 34%) of a white solid ^ B step can be generated. 〇2. 〇1 () 0.7¾g; 〇91mmol) in 28 ml of a solution of tartar / MOAc (5: 1: 1) solution for 5 hours under n, and the reaction was carried out under the air Rolled to 0.7 ml 1 retentate dissolved in 3 ml of CH3CN, and then concentrated to 0.7 ml (3x), dissolved in glutinous rice; reduced to 07 ml (2 x 2X), and concentrated to Dry analysis (fast, S02, 5% isopropanol / CH2C12) yields j02 (4). 5¾ g '78%) as a white solid: iH NMR (DMS〇.d6) ^ 1.0-1.15 ( m, 2H), 1.4 (s? 9H), 1.65 (m, 2H), 1.9-2.1 (m, 2H), 2.15 ^ 2.4 (m, 3H)? 2.55 (m, 1H), 2.7-3.0 (m, 2H), 4.3-4.6 (m, 2H), 4.9 (m, 1H), 5.2 (m, 1H), 7.4-7.6 (m, 2H), 7 · 8-8 · 0 (m, 2H), 8.6 ( m, 1H), 8.8 (m, 1H), 9.4 (s, 1H). [1S, 9S (2RS,) S)] 9-benzylgg amino-6,10-diamidino_1,2,3,4,7,8,9,10-octahydro-N- (2 -Methoxy-5-keto-tetrahydrocranyl-3-yl) _6H_datr and [1,2-a] [l, 2] diazafluorene-1-carboxylic acid amine (3〇 4a) 3 Printed by the Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs A Step: 302 (90 mg; 0.18 mmol) in 10 ml of MeOH solution of dimethyl orthoformate (1 ml) and The meta-ammonium benzyl acid-hydrate (5 mg, 0.026 mmol) was treated and the reaction was stirred for another 20 hours. The reaction was treated with 3 ml of a saturated NaHC03 aqueous solution and concentrated under vacuum. The residue was taken up in EtOAc and washed with dilute aqueous NaHC03 solution, dried over MgS04 and concentrated in vacuo to give 80 mg of 303a. Step B: 303a was dissolved in 2 ml of TFA, and then stirred at room temperature for 15 minutes. 3 The reaction was dissolved in CHzCl2 and concentrated in vacuo (3χ). Chromatography (Rapid, SiO ,, "/ 0 to 3% MeOH / CH2Cl2 yielded 43 mg (64%) of 304a as a white solid: 1H NMR (CDC13) d 1.55-1.8 (m, 2H), 1.9- 2.15 (m, 4H), -417- 1235157 A7 B7 V. Description of the invention (415) 2.25-2.5 (m, 2H), 2.7-3.3 (m, 4H), Ϊ.45, 3.6 (s, s, 3H) , 4.4, 4.75 (2m, 1H), 4.6 (m, 1H), 4.95, 5.4 (t, d? 1H), 5.1-5.2 (m, 1H), 6.45, 7.05 (2d, 1H), 6.95 (m, 1H), 7.45 (m, 2H), 7.5 (m? 1H), 7.85 (m, 2H). Example 11 Compounds 214e, 404-413, 415-445, 446-468, 470-491, and 493-499 Example 11 and Table 7. Synthesize as described in Table 7. Please read the meaning of “%” before you fill in the “Ministry of Economic Affairs and Standards Bureau of the People ’s Republic of China” employee cooperation cooperation printed-418- This standard is applicable to S3 domestic standards (CNS ) Six 4 hans (210X 297 mm) 1235157 A7 B7 V. Description of invention (416) Printed by the Consumers' Cooperative of China Standards Bureau of the Ministry of Economic Affairs

0 -419- 本紙法尺度適用中g國家標车(CNS ) A4呒格(210 X 297公釐) (辞先另讀背云之注意事項再填寫本頁) 士衣- 訂 1235157 A7 B7 --- - -_______ -- -- - ^ - - . - _ 五、發明説明(417) A步驟。合成401。TentaGel S®、NH2樹脂(0.16毫莫耳/克 ,10.0克)置於有篩孔之玻璃漏斗内,並以DMF(3x 50毫 升),10% (v/v) DIEA 於 DMF (2 X 50 毫升)及最後的 DMF (4 X 50毫升)洗滌。加充份的DMF至樹脂,再加400 (1·42克, 2·4毫莫耳,製備自(3S)-3-(苇基甲氧羰基)-4-酮基丁酸第三 -丁酿,依據 Α·Μ· Murphy et. al· J. Am. Chem. Soc·,114, 3 156-3157 (1992)),1-羥基苯並三唑-水合物(ΗΟΒΤ·Η2〇: 0.367克,2·4毫莫耳),0-笨並三唑-1-基-N,N,N,Nf·四甲基 鑌六氟磷酸(HBTU; 0.91克,2.4毫莫耳)及DIEA(0.55毫升 ,3.2毫莫耳)可得淤漿。反應混合物在rt下攪動一夜,利 用腕臂式震盪槽。樹脂在有孔玻璃漏斗上以吸空過瀘法分 離,再以DMF (3 X 50毫升)洗滌。未反應的胺基再加蓋, 係將樹脂與20% (v/v) Ac20/DMF (2 X 25毫升)直接在漏斗中 反應(10分/洗滌)。樹脂以DMF (3 X 50毫升)及CH2C12 (3 X 5〇毫升)洗滌,再於眞空下乾燥一夜以生成401 (11.0克, 定量產率)3 經濟部中央標準局員工消費合作社印变 f請先閱讀背面之;i.意事¾再填寫本頁)0 -419- Chinese standard car (CNS) A4 grid (210 X 297 mm) applicable to the standard of this paper (remember to read the precautions of back cloud before filling out this page) Shiyi-Order 1235157 A7 B7- ---_______---^--.-_ 5. Description of the invention (417) Step A. Synthesis 401. TentaGel S®, NH2 resin (0.16 mmol / g, 10.0 g) was placed in a glass funnel with sieve holes, and DMF (3 x 50 ml), 10% (v / v) DIEA in DMF (2 X 50 Ml) and finally DMF (4 x 50 ml). Add sufficient DMF to the resin, then add 400 (1.42 g, 2.4 mmol, prepared from (3S) -3- (retylmethoxycarbonyl) -4-ketobutanoic acid tert-butyl According to A.M. Murphy et. Al. J. Am. Chem. Soc., 114, 3 156-3157 (1992)), 1-hydroxybenzotriazole-hydrate (唑 ΟΒΤ · Η20: 0.367 g , 2.4 mmoles), 0-benzyltriazol-1-yl-N, N, N, Nf · tetramethylphosphonium hexafluorophosphate (HBTU; 0.91 g, 2.4 mmoles) and DIEA (0.55 Ml, 3.2 mmol) to obtain a slurry. The reaction mixture was stirred at rt overnight using a wrist-arm shaker. The resin was separated on a perforated glass funnel by vacuum suction and washed with DMF (3 X 50 ml). Unreacted amines were capped and the resin was reacted directly with a 20% (v / v) Ac20 / DMF (2 X 25 ml) in the funnel (10 min / wash). The resin was washed with DMF (3 X 50 ml) and CH2C12 (3 X 50 ml), and then dried overnight in the air to produce 401 (11.0 g, quantitative yield). (Please read the back; i. What you want ¾ before filling out this page)

B步驟。合成402。樹脂401 (6.0克,0.16毫莫耳/克,0.96 毫莫耳)於有孔玻璃漏斗中以DMF (3 X 25毫升)洗滌而泡脹 。Fmoc保護基再以25% (v/v)六氫吡啶/DMF (25毫升)10分 鐘(間歇攪拌)及新鲜的六氫吡啶試劑(25毫升)20分鐘解析 3樹脂再以DMF (3 X 25毫升)及k-甲基吡咯啶酮(2 X 25毫 升)洗滌。樹脂轉移至100毫升燒瓶後,N-甲基吡咯啶酮加 入以得淤漿,再加212f (0.725克,1.57毫莫耳),Η〇ΒΤ·Η,〇 (〇·25克,1·6毫莫耳),HBTU(0.61 克,1.6毫莫耳)及 dIEA -420- 本纸伕尺度適用中II國家標孪TcNS ) A4堤格(210 X 297公变Ί ' 1235157 經濟部中夬標準局員工消费合作社印製 A7 . _ B7___ 五、發明説明(418) (0.84毫升,4.8毫莫耳)3反應混合物在rt下攪動一夜,利 闱腕臂震盪槽3樹脂處理及以20% (v/v) Ac2〇/DMF如40 1中 所述般加蓋,可生成402 (6.21克,定量產率)。 C步驟3合成403。此化合物製備自樹脂402 (0.24克, 0.038 毫莫耳),利用 Advanced ChemTech 3 96 Multiple Peptide 合成儀。自動化之循環包括以DMF (3 x 1毫升)洗滌樹脂, 以25%(v/v)六氫吡啶/DMF(1毫升)去保護3分鐘,再以新 鲜試劑(1毫升)歷10分鐘以生成樹脂403。樹脂以DMF (3 X 1毫升)及N-甲基说洛咬酮(3 X 1毫升)洗條a D步驟。方法 1。[3S(lS,9S)]-3-(6,10-二酮基-1,2,3,4,7,8,9, 10-八氫-9七塞吩-3-曱羰基胺基)-6H-嗒啩並[l,2-a][l,2]二氮 雜箪-1-羧醯胺基)-4-酮丁酸(409)。樹脂403以0.4M,塞吩-3-甲酸及0·4Μ HOBT於N-甲基吡咯啶酮(1毫升),〇·4Μ HBTU 於N-甲基吡咯啶酮(0.5毫升)及1.6M DIE A於N-甲基吡咯啶 酮(0.35毫升)之溶液醯化,且反應在rt下震盪2小時3醯化 步驟重覆。最後,樹脂以DMF (3 X 1毫升),CH2C12 (3 X 1 毫升)洗滌,再於眞空下乾燥。醛自樹脂中解離,並以95% TFA/5% H20 (v/v,1.5毫升)在rt下處理30分鐘而整鳢地去 保護。於以解離試劑(1毫升)洗滌樹脂後,混合的;慮液加 至冷的1:1 Et20:戊淀(12毫升)中,且生成的沈殿物以離心 及傾析法分離。生成的團▲再溶於10% CH3CN/9〇% H2O/0.1% TFA (15毫升)中並冷凍乾燥以得粗製的409,呈 白色粉末3化合物以半製備式HPLC純化,利用 MicrosorbTM C18管柱(5微米,21·4 X 250毫升),以線受 -421 - 本纸乐尺度逑用中國1]家標李(CNS ) A4現格(210X 297公潑) ' &quot; (請先y讀背面之洼意事項再填寫.fr貝) 1235157 A7 B7 五、發明説明(419) CH3CN梯度(5%-45%)溶離,内含有0.1%TFA(v/v)歷45分鐘 ,於12毫升/分3匯集含有欲求產物之流份,並冷凍乾燥 生成 409 (10.8毫克,63%)。 D步驟。方法1A。合成41 8。依類似方法1之步驟,樹脂 403 ’以4-(1-卓基甲氧》幾基胺基)尽曱化並重覆,Fmoc 基如C步驟般移去,自由態胺以20% (v/v) Ac20於DMF (1毫 井)及1.6M DIEA於N-甲基吡咯啶酮(0.35毫升)在rt下乙醯化 2小時。重覆此乙醯化步驟。醛自樹脂中解離可生成41 8 (3.2毫克)。 D步驟。方法1B。合成447。依循如方法1A之步驟。樹 脂403以0.4M 4-(1-苐基甲氧羰基胺基)苯甲酸醯化3醯化 步驟重覆一次。Fmoc基如上般移去,且自甴態胺與1M甲 烷磺醯氣於CH2C12 (0.5毫升)及1M吡啶於CH2C12 (0.60毫升) 在rt下反應4小時。醛自樹脂上解離可生成447 (10.0毫克)。 D步驟3方法2,合成214e。依循如方法1之類似步驟, 樹脂403以0.5M芊醯氣於N-甲基说咯啶酮(1毫升)及1.6M DIEA於N-甲基说洛淀銅(0.35毫升)中,以rtSS化2小時3縫 化步驟重覆。醛自樹脂中解離可生成214e (5.1毫克,30%)。 經濟部中夬標率局員工消费合作钍印¾ (請先閲讀背面之注意事項再填寫本頁) D步驟。方法3。合成427。依循類似方法1之步驟,樹脂 403與1.0M笨磺醯氣於CH2C12 (0.5毫升)及1M吡啶於CH2C12 (0.60毫升)在rt下反應4小時。反應重覆。醛自樹脂中解離 可生成427 (7.2毫克,40%) ^B step. Synthesis 402. Resin 401 (6.0 g, 0.16 mmol / g, 0.96 mmol) was washed in a perforated glass funnel with DMF (3 x 25 ml) and swelled. The Fmoc protecting group was then resolved with 25% (v / v) hexahydropyridine / DMF (25 ml) for 10 minutes (intermittent stirring) and fresh hexahydropyridine reagent (25 ml) for 20 minutes. 3 resins were then resolved with DMF (3 X 25 Ml) and k-methylpyrrolidone (2 x 25 ml). After the resin was transferred to a 100 ml flask, N-methylpyrrolidone was added to obtain a slurry, and 212f (0.725 g, 1.57 mmol), 〇〇ΒΤ · Η, 〇 (〇.25 g, 1.6 Millimoles), HBTU (0.61 grams, 1.6 millimoles) and dIEA -420- The standard of this paper is applicable to the national standard TcNS of China II) A4 Tiege (210 X 297 Public Transformer Ί 1235157 Ministry of Economic Affairs, China Standards Bureau Printed by employee consumer cooperative A7. _ B7___ V. Description of the invention (418) (0.84 ml, 4.8 millimoles) 3 The reaction mixture was stirred overnight at rt, and the wrist arm oscillating tank 3 was treated with resin and 20% (v / v) Ac2O / DMF was capped as described in 401 to produce 402 (6.21 g, quantitative yield). C Step 3 Synthesis of 403. This compound was prepared from resin 402 (0.24 g, 0.038 mmol). , Using Advanced ChemTech 3 96 Multiple Peptide Synthesizer. The automated cycle includes washing the resin with DMF (3 x 1 ml), deprotecting with 25% (v / v) hexahydropyridine / DMF (1 ml) for 3 minutes, and then Fresh reagent (1 ml) over 10 minutes to produce resin 403. Resin was washed with DMF (3 X 1 ml) and N-methyl siloxone (3 X 1 ml). A D Method 1. [3S (lS, 9S)]-3- (6,10-diketo-1,2,3,4,7,8,9, 10-octahydro-9 heptathione-3 -Fluorenylcarbonylamino) -6H-da [[1,2-a] [1,2] diazafluoren-1-carboxamido) -4-ketobutanoic acid (409). Resin 403 with 0.4M, Sephen-3-carboxylic acid and 0.4M HOBT in N-methylpyrrolidone (1ml), 0.4M HBTU in N-methylpyrrolidone (0.5ml) and 1.6M DIE A was tritiated with a solution of N-methylpyrrolidone (0.35 ml), and the reaction was shaken at rt for 2 hours. The tritiated step was repeated. Finally, the resin was washed with DMF (3 X 1 mL), CH2C12 (3 X 1 mL), and dried under air. The aldehyde was dissociated from the resin and treated neatly with 95% TFA / 5% H20 (v / v, 1.5 ml) at rt for 30 minutes. After washing the resin with a dissociation reagent (1 ml), the mixed solution was added to cold 1: 1 Et20: pentamidine (12 ml), and the resulting precipitate was separated by centrifugation and decantation. The resulting pellet was re-dissolved in 10% CH3CN / 90% H2O / 0.1% TFA (15 ml) and freeze-dried to obtain crude 409 as a white powder. The 3 compound was purified by semi-preparative HPLC using a MicrosorbTM C18 column (5 micron, 21.4 X 250 ml), with a line receiving -421-This paper music scale uses China 1] House standard Li (CNS) A4 (210X 297 male splash) '&quot; (Please read first Fill in the matters on the back.fr) 1235157 A7 B7 V. Description of the invention (419) CH3CN gradient (5% -45%) dissolves, containing 0.1% TFA (v / v) for 45 minutes, at 12 ml / Fractions containing the desired product were pooled in 3 and freeze-dried to yield 409 (10.8 mg, 63%). Step D. Method 1A. Synthesis 41 8. According to the similar method, the resin 403 ′ is completely transformed with 4- (1-trimethylmethoxy group) and the amino group is repeated. The Fmoc group is removed as in step C, and the free amine is 20% (v / v) Ac20 was acetylated in DMF (1 milliwell) and 1.6M DIEA in N-methylpyrrolidone (0.35 ml) at rt for 2 hours. Repeat this ethylation step. Dissociation of the aldehyde from the resin yields 41 8 (3.2 mg). Step D. Method 1B. Synthesis 447. Follow steps as in Method 1A. Resin 403 was repeatedly triturated with 0.4M 4- (1-fluorenylmethoxycarbonylamino) benzoic acid. The Fmoc group was removed as above, and the autofluorinated amine was reacted with 1M methanesulfonium in CH2C12 (0.5 ml) and 1M pyridine in CH2C12 (0.60 ml) at rt for 4 hours. Dissociation of the aldehyde from the resin produces 447 (10.0 mg). D Step 3 Method 2 to synthesize 214e. Following a similar procedure as Method 1, Resin 403 was 0.5M tritium in N-methyl said pyridone (1 ml) and 1.6M DIEA in N-methyl said Luodian copper (0.35 ml) with rtSS Repeat for 2 hours and 3 stitches. Dissociation of the aldehyde from the resin produces 214e (5.1 mg, 30%). Seal of Consumer Co-operation of the Bureau of Standards of the Ministry of Economic Affairs ¾ (Please read the notes on the back before filling this page) Step D. Method 3. Synthesis 427. Following a similar procedure to Method 1, resin 403 and 1.0M benzenesulfonium were reacted in CH2C12 (0.5 ml) and 1M pyridine in CH2C12 (0.60 ml) at rt for 4 hours. The response was repeated. Dissociation of aldehyde from resin yields 427 (7.2 mg, 40%) ^

D步驟。方法4。合成420 3依循類似方法1之歩驟,樹脂 403與0.5M甲基異氰酸酯於N-甲基吡咯啶酮(1毫升)及1.6M _ - 422 - 本纸乐尺度通用中國國家標孪(CNS ) Μ現格(210:&lt; 297公釐) 1235157 Λ7 B7 五、發明説明(420) 請 先 35 讀 背 之 注Step D. Method 4. Synthesis 420 3 Follow the steps of similar method 1, resin 403 and 0.5M methyl isocyanate in N-methylpyrrolidone (1 ml) and 1.6M _-422-This paper is a common Chinese national standard (CNS) Μ current grid (210: &lt; 297 mm) 1235157 Λ7 B7 V. Description of the invention (420) Please read the note after 35

填 窝 ¥ DIEA於N-甲基吡咯啶酮(0.35毫升)反應,Μ下2小時。反應 重覆,醛自樹脂中解離可生成420 (8.3毫克,55°/〇) 3 D步驟。方法5。合成445。依循方法1之類似步驟,樹脂 403以0.27M咪唑-2-甲酸(1毫升)於2:1 DMF:H2〇(有1當量 DIEA)及1M 1-(3-二甲胺基丙基)-3-乙基碳化二亞胺鹽酸 (EDC)於2:1 N-甲基吡咯啶酮/Η2〇(〇·35毫升)於rt下3小時而 醯化。醛自樹脂中解離可生成445 (9.5毫克)3 分析HPLC方法: (1) Waters DeltaPak C18, 300A (5微米,3.9 X 150毫米)。 直線CH3CN梯度(5°/。-45%)含有0.1% TFA (v/v)於1毫升/分下 歷14分鐘。 . (2) Waters DeltaPak C18, 300A (5微米,3·9 X 150毫米)。 直線CH3CN梯度(0%-25°/〇)含有0· 1% TFA (v/v)於1毫升/分下 歷14分鐘β (3) Waters DeltaPak C18, 300Α (5微米,3·9 X 150毫米)。 等密度溶離,以0.1%TFA/水(ν/ν)在1毫升/分下。 (4) Waters DeltaPak C18, 300Α (5微米,3·9 X 150毫米)。 直線CH3CN梯度(〇%-30。/〇)含有0· 1% TFA (Wv)於1毫升/分下 歷14分鐘。Fill in ¥ DIEA in N-methylpyrrolidone (0.35 ml) for 2 hours. The reaction was repeated and the aldehyde was dissociated from the resin to give 420 (8.3 mg, 55 ° / 〇) 3 D step. Method 5. Synthesis 445. Following a similar procedure to Method 1, resin 403 was 0.27M imidazole-2-carboxylic acid (1 ml) in 2: 1 DMF: H20 (with 1 equivalent of DIEA) and 1M 1- (3-dimethylaminopropyl)- 3-ethylcarbodiimide hydrochloride (EDC) was tritiated at 2: 1 N-methylpyrrolidone / H2O (0.35 mL) at rt for 3 hours. Dissociation of the aldehyde from the resin produces 445 (9.5 mg) 3 Analytical HPLC method: (1) Waters DeltaPak C18, 300A (5 microns, 3.9 x 150 mm). The linear CH3CN gradient (5 ° / -45%) contains 0.1% TFA (v / v) at 1 ml / min for 14 minutes. (2) Waters DeltaPak C18, 300A (5 microns, 3.9 x 150 mm). Linear CH3CN gradient (0% -25 ° / 〇) containing 0.1% TFA (v / v) for 14 minutes at 1 ml / min β (3) Waters DeltaPak C18, 300Α (5 microns, 3. 9 X 150 Mm). Dissolve at equal density and 0.1% TFA / water (v / v) at 1 ml / min. (4) Waters DeltaPak C18, 300Α (5 microns, 3.9 x 150 mm). A straight CH3CN gradient (0% -30% / 0) containing 0.1% TFA (Wv) at 1 ml / min for 14 minutes.

經濟部中夬檫隼局員工消費合作社印5L (5) Waters DeltaPak C18, 300A (5微米,3·9 X 150毫米)3 直線CH3CN梯度(〇%-35%)含有0」% TFA (v/v)以1毫升/分歷 14分鐘。 •423- 本纸乐尺度適用中国國家標挛(CNS ) A4現格(210X 297公麋) 12351575L (5) Waters DeltaPak C18, 300A (5 micrometers, 3.9 x 150 mm) printed by the China Consumer Affairs Bureau of the Ministry of Economic Affairs. 3 Linear CH3CN gradient (0% -35%) contains 0 ″% TFA (v / v) 14 minutes at 1 ml / min. • 423- The paper scale is applicable to the Chinese National Standard (CNS) A4 standard (210X 297 male elk) 1235157

AA

7 B 42 /^\ 明説 明發, 經濟部令央標隼局員工消费合作杜印¾ ΓΨ &lt;(&amp;牧 csj CM CNJ + cn X 2 έ in &lt;J\ in to Η CC CU IT CvJ 一 dQ 〜① VO (NJ oiP KD $ KO VO rH —afi CO -c\i σ\ 00 Σ in π rr 00 - 00 to 卜 卜 t4 s 卜 〇 Z CM re r-l &lt;N 〇 卜 〇 z VD C\J X CNi CN CJ CO 〇 2 VD CM X CNJ CN U 赛 5 δχ °&lt;&gt;° 。汐。 °s 。化 母: 5 re °&lt;&gt;° 、:s &lt;u *^r tH CN Ο in o -424- 本纸伕尺度適用中g國家標李(CNS ) Α·4堤格(210X 297公釐) (請先閱讀背&amp;之注意容^一:填寫本一貝 •装 訂 1235157 μ Β7 五、發明説明(422) 經濟部中夬樣牮局員工消费合作社印袈 CN CNJ CM eg + cn re s 1 r· LD cn U〇 a\ L〇 · Η a: U j CLi re 1-4 cfP VO rH 一 df&gt; 〇 ^ σ\ r-H Op CO 〇 (Ti a\ r-H dP 00 ,r-H G\ rH f-H 2: 2 σι 00 CO 卜 rH &lt;Tk ^r r-l L〇 a\ iT&gt; L〇 o CM L〇 X 卜 Ο 2 r—1 Ο m CN rH CN U 2: vo CN re tO CNJ CJ 卜 〇 2 CM X «r&gt; CVJ CJ ; o &lt;r 2 CD CN CNJ CJ 5 = °&lt;&gt;0 。發 δ re °^° 。纪 Srn o=^J&gt;=o 。挖 δ = if 趣。 \ VD 〇 卜 〇 03 〇 σ\ ο 42. (請先閱讀背面之注意事項再填寫本頁) 訂 本纸乐尺度適用中g國家標洋(CNS Μ4堤格(210X29?公釐) 1235157 Λ7 B7 五、發明説明( 423 ) 經濟部中央標準局員工消费合作社印製7 B 42 / ^ \ Explanatory note issued by the Ministry of Economic Affairs, the Central Bureau of Standards and Technology for the consumption cooperation of employees Du Yin ¾ Ψ &lt; (&amp; 牧 csj CM CNJ + cn X 2 in in &lt; J \ in to Η CC CU IT CvJ 1 dQ ~ ① VO (NJ oiP KD $ KO VO rH —afi CO -c \ i σ \ 00 Σ in π rr 00-00 to 卜卜 t4 s 卜 〇Z CM re rl &lt; N 〇〇〇〇VD C \ JX CNi CN CJ CO 〇2 VD CM X CNJ CN U Race 5 δχ ° &lt; &gt; °. Tide. ° s. Chemical mother: 5 re ° &lt; &gt; °,: s &lt; u * ^ r tH CN Ο in o -424- The standard of this paper is applicable to the national standard of Chinese g (CNS) Α · 4 Tiege (210X 297 mm) (Please read the back &amp; note the contents first): Fill in this book Order 1235157 μ Β7 V. Description of the invention (422) Employees' Cooperatives of the National Bureau of Samples of the Ministry of Economic Affairs, CN CN CM eg + cn re s 1 r · LD cn U〇a \ L〇 · Η a: U j CLi re 1-4 cfP VO rH-df &gt; 〇 ^ σ \ rH Op CO 〇 (Ti a \ rH dP 00, rH G \ rH fH 2: 2 σι 00 CO bu rH &lt; Tk ^ r rl L〇a \ iT &gt; L〇o CM L〇X BU 0 2 r—1 〇 m CN rH CN U 2: vo CN re tO CNJ CJ BU 02 CM X «r &gt; CVJ CJ; o &lt; r 2 CD CN CNJ CJ 5 = ° &lt; &gt; 0. Send δ re ° ^ °. Ji Srn o = ^ J &gt; = o. Dig δ = if interesting. \ VD 〇 卜 〇03 〇σ \ ο 42. (Please read the precautions on the back before filling in this page) The size of the paper is applicable to the national standard of the country (CNS Μ4 Tiege (210X29? Mm) 1235157 Λ7 B7 V. Description of the invention (423) Central Ministry of Economic Affairs Printed by Standards Bureau Consumer Cooperatives

請 先 %Ά 讀 背 面 之 》·士 ί t· I ^ t 訂 餐 -426- 本紙伕尺度適用中国國家標隼(CNS ) A4現格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(424 ) 經濟部中夬標隼局員工消費合作社印¾Please read the book "Shi Shi" t I I ^ t Ordering -426- The standard of this paper is applicable to Chinese national standard (CNS) A4 (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (424 ) Printed by the Consumers' Cooperatives of the Ministry of Economic Affairs, China Standards Bureau

γΗ rH rH + cn 2: X + X 00 σ\ 卜 in cn in Η CC α. re rH 一 afi CO 5 tn ^ 卜 t—ί 一 dP κο α rH L〇 tn 00 3: X KO rr 00 CO **3* 〇〇 . 00 卜 Γ0 tn ro L〇 Ct4 X a\ 〇 2 -^r C\J X CNJ CNJ CJ 卜 Ο 2 rH U cn CN a: r-H CM 〇 o t-H o o ΓΊ X &lt;r CM U: i -r σ x 。化 。校。 。妇 δχ 〇=&lt;~&gt;=〇 s= 〇==&lt;7&gt;=〇 %r、 -o o— in rH VO rH r- rH -427- (請先聞讀背®之洼意事項再填寫本頁)γΗ rH rH + cn 2: X + X 00 σ \ bu in cn in Η CC α. re rH afi CO 5 tn ^ b t—ί dP κο α rH L〇tn 00 3: X KO rr 00 CO * * 3 * 〇〇. 00 Γ0 tn ro L〇Ct4 X a \ 〇2-^ r C \ JX CNJ CNJ CJ 〇 2 rH U cn CN a: rH CM 〇o tH oo ΓΊ X &lt; r CM U : I -r σ x. Into. school. . Women δχ 〇 = &lt; ~ &gt; = 〇s = 〇 == &lt; 7 &gt; = 〇% r, -oo— in rH VO rH r- rH -427- (Fill in this page)

本纸悵尺度適用中S國家標达(CNS ) A4現格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(425 ) + &lt;H+W)ss sun 66ΓΟ 86ΓΟThe standard of this paper is applicable to Chinese National Standards (CNS) A4 (210X 297mm) 1235157 Λ7 B7 V. Description of the invention (425) + &lt; H + W) ss sun 66ΓΟ 86ΓΟ

Φ iHuldH (JPCD6Ξ ε6·ς S6 5 ς3·ς 2:2: 〇ς· ι〇ς 8Ξ6ε 6ε·卜 6rn 80LON 卜CNlHrnCNo 80SSH9I3 stnNroCSIH9Io 經濟部中夬糅隼局員工消费合作社印^Φ iHuldH (JPCD6Ξ ε6 · ς S6 5 ς3 · ς 2: 2: 〇ς · ι〇ς 8Ξ6ε 6ε · bu 6rn 80LON bu CNlHrnCNo 80SSH9I3 stnNroCSIH9Io Printed by the Consumer Affairs Cooperative of the China Economic Development Bureau of the Ministry of Economic Affairs ^

&gt;。 NH&gt;. NH

Ο =¾¾ ocvl^r -428-Ο = ¾¾ ocvl ^ r -428-

本纸ft尺度適用中國國家標隼(CNS M4現格(210 X 297公釐) 1235157The ft scale of this paper applies to the Chinese national standard (CNS M4 is now (210 X 297 mm) 1235157

五、發明説明( 426 ) 經濟部中央糅隼局員工消費合作社印^V. Description of Invention (426) Printed by the Consumers' Cooperative of the Central Government Bureau of the Ministry of Economic Affairs ^

cn 1-H rH r-H Ξ* X + X CO ro 卜 卜 o CD o t〇 Η CC g令 α. 3C CM 〜 dP 2 -卜 t-H 一 c?p s &quot; VD rH 一 d〇 〜 c〇 s ^ L〇 rH 一 o CN ^ S Σ VD CN m £T^ - kO 卜 CNi 0Ί &lt;Tk 卜 CM as U4 X CO CO 〇 Z CNJ 2: vo rH U r- O VO Z CO CVJ r r-i C\J o cn 卜 o uO 2 L〇 CN -r o CNJ . 〇 CO O L〇 2 cn CN 5 1—» u 赛 s = 0¾ 〇.«Λ^〇 i = 〇=H=° 5 = °&lt;&gt;0 。逆 δ = 0=^=0 。&amp;! °v tH CN4 OJ CVJ cn OJ ry CMcn 1-H rH rH Ξ * X + X CO ro bu o CD ot〇Η CC g order α. 3C CM ~ dP 2-Bu tH-c? ps &quot; VD rH-d〇 ~ c〇s ^ L 〇rH 1 o CN ^ S Σ VD CN m £ T ^-kO bu CNi 0Ί &lt; Tk bu CM as U4 X CO CO 〇Z CNJ 2: vo rH U r- O VO Z CO CVJ r ri C \ J o cn ooO 2 L〇CN-ro CNJ. 〇CO OL〇2 cn CN 5 1— »u Race s = 0¾ 〇.« Λ ^ 〇i = 〇 = H = ° 5 = ° &lt; &gt; 0. Inverse δ = 0 = ^ = 0. &amp;! ° v tH CN4 OJ CVJ cn OJ ry CM

II

I 1· % Έ 訂 -429- 1235157 A7 B7 五、發明説明(427) 經濟部中夬標準局員工消f合作社印^I 1 ·% Έ Order -429- 1235157 A7 B7 V. Description of the invention (427) Employees of the China Standards Bureau of the Ministry of Economic Affairs will print the cooperative seal ^

rH cvj cn + cn X Σ § f-» t—&lt; UO r-H L〇 rH 00 s 〇4 X r-H dP CS4 u 00 rH '—dP CO O CTi 00 cfP ^ CO ε ^ 卜 s Σ rH vr&gt; o t-H in o in · o L〇 O in o 00 CT4 Σ 00 〇 ^3* CVJ 2: iD CN U 卜 〇 π 2: 〇 ro X rH CnJ 〇 CO CO o &quot;«T 2 &lt;N X o cvj ; U s δχ 。&amp;t \ re 〇工 〇=〇=〇 o〇。。 °b' S x 0=^° o^^o° °6° m C4 VO 04 r- &lt;N (#.先閨讀背云之注意事項再填寫本一貝) -430- 本紙張尺度適用中國國家標準(CNS ) A4現格(210X 297公釐)rH cvj cn + cn X Σ § f- »t— &lt; UO rH L〇rH 00 s 〇 4 X rH dP CS4 u 00 rH '-dP CO O CTi 00 cfP ^ CO ε ^ s Σ rH vr &gt; o tH in o in · o L〇O in o 00 CT4 Σ 00 〇 ^ 3 * CVJ 2: iD CN U buπ 2: 〇ro X rH CnJ 〇CO CO o &quot; «T 2 &lt; NX o cvj ; U s δχ. &amp; t \ re 〇 工 〇 = 〇 = 〇 o〇. . ° b 'S x 0 = ^ ° o ^^ o ° ° 6 ° m C4 VO 04 r- &lt; N (# .Please read the precautions for the back of the girl before filling in this one) -430- This paper size applies Chinese National Standard (CNS) A4 is now available (210X 297 mm)

1235157 A7 B7 五、發明説明(428 ) 經濟部中央標搫局員工消费合作社印製 cn • &lt; t-H rH + cn X CO rH n CNJ 〇 iT&gt; o VD &lt;r e- cc a. 一 dP ^ -m m 一 &lt;^P 2 - 一 όΡ s - L〇 CNJ 一 cfP VD ^ VD 、i 卜 卜 Γ0· o m o L〇 rH o L〇 VO 々 C7N tO Cu cn 00 〇 in z m CN X VD r-l 〇 VO 〇 Z o CN X rH o CD 〇 L〇 2: 卜 CNJ X Γ0 CNJ υ 卜 〇 in 2 L〇 CvJ X i-H CN u -r· δ e 〇=〇=〇 。^。 V- ac0 。··厂 3: O X 0=Q=0 rw2X °Cr; X o X 〇=&lt;&gt;=〇 。校。 ZI 1¾ O' W ox 0&lt;^=0 。莩 % ω 04 Oi CVJ o cn r-4 m -431 - 本纸浃尺度適用中國國家標李(CNS ) Μ現格(210X297公釐)1235157 A7 B7 V. Description of the invention (428) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs cn • &lt; tH rH + cn X CO rH n CNJ 〇iT &gt; o VD &lt; r e- cc a. One dP ^ -mm a &lt; ^ P 2-ath s s-L〇CNJ-cfP VD ^ VD, i Γ0 · omo L〇rH o L〇VO 々C7N tO Cu cn 00 〇in zm CN X VD rl 〇VO 〇Z o CN X rH o CD 〇L〇2: BU CNJ X Γ0 CNJ υ Bu 〇in 2 L〇CvJ X iH CN u -r · δ e 〇 = 〇 = 〇. ^. V- ac0. · Plant 3: O X 0 = Q = 0 rw2X ° Cr; X o X 〇 = &lt; &gt; = 〇. school. ZI 1¾ O 'W ox 0 &lt; ^ = 0.莩% ω 04 Oi CVJ o cn r-4 m -431-The size of this paper is applicable to Chinese National Standard Plum (CNS) Μ Appearance (210X297 mm)

1235157 A 7 B7 五、發明説明(429 ) 經濟部中夬標李局員工消f合作社印裝 rH rH rH + cn 工 S + X VO CO 00 σ» L〇 00 σν CC 〇4 X r-H 一 s &quot; L〇 rH aP 卜 卜 O &lt;Ti r—H r-H r-H 一 σΡ 5 - rH 一 ciP ,〇 S η ^ L〇 s 2 v«o L〇 00 rH L〇 * 卜 σ\ 卜 00 o uO 0&quot;) C7k 々 U4 X 卜 〇 卜 2 cn CM rc *-( CNJ o r- 〇 L〇 2 r· CNJ n: CN CJ S Ζ S c\i CNJ υ_· r- 〇 lD 2 m 04 X CN CJ 5 x 0=V=0 % 工zzz §x 0=^° 。逆 5工 〇=〇=〇 。逆 1¾ §x °&lt;&gt;〇 oi °o° ^3 CM m cn rT m in rn 先 讀 背 Sr 之 I事羞 i 填 寫 本 Έ 訂 -432- 本紙乐尺度適用中gg家標李(CNS ) A4規格(210 X297公釐) 1235157 A7B7 五、發明説明( 430 ) 經濟部t央標孪局員工消费合作社印裝 4μ ^ r-H r-H i—l t-H + (η X x X VO &lt;y\ &lt;NJ L〇 VO (Ti VD σ\ Η α: &gt;—ί Οι 2: d〇 〇 s CN w 00 t〇 cfP 00 &lt;23 r- &lt;Jk CVJ rH rH 〜 dP s - &lt;r lD 〜 &lt;5P CO 3: Σ 〇 L〇 u〇 a\ CNi lD uO CNJ L〇 o - L〇 L〇 c\ o L〇 in σ\ 々 txu Σ 卜 〇 in 2 L〇 CN &quot;ζΓ CM CJ CO o in 2: 卜 CN X L〇 cvj u 卜 芝 CM X CNJ CJ r· 〇 tr&gt; 2 L〇 CN X 04 CJ 赛 O I °§ O X SP 0eCC° &gt; δχ °^° 。&amp;! \ X O X 〇={ )=0 °o° °U&gt; VO m Γ η CD cn c\ cn rr (請先3讀背云之注意事項再填寫本頁) &gt;水 訂 •433 - 本纸伕尺度適用中SS家標李(CNS〉以垅格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(431 ) 經濟部中夬標生·局員工消费合作枉印¾1235157 A 7 B7 V. Description of the invention (429) Employees of the Li Bureau of the Ministry of Economic Affairs of the People's Republic of China will print fH cooperatives rH rH rH + cn S + X VO CO 00 σ »L〇00 σν CC 〇4 X rH as s & quot L〇rH aP OB O &lt; Ti r—H rH rH-σP 5-rH-ciP, 〇S η ^ L〇s 2 v «o L〇00 rH L〇 * σ \ 卜 00 o uO 0 &quot;) C7k 々U4 X 卜 〇 卜 2 cn CM rc *-(CNJ o r- 〇L〇2 r · CNJ n: CN CJ S ZZ S c \ i CNJ υ_ · r- 〇lD 2 m 04 X CN CJ 5 x 0 = V = 0% work zzz §x 0 = ^ °. Reverse 5 work 〇 = 〇 = 〇. Reverse 1¾ §x ° &lt; &gt; 〇oi ° o ° ^ 3 CM m cn rT m in rn first Read the back of Sr and fill in this book. Bookmark -432- This paper scale is applicable to the standard gg family standard (CNS) A4 (210 X297 mm) 1235157 A7B7 5. Description of the invention (430) Ministry of Economic Affairs t Central Standard Twin Bureau employee consumer cooperatives printed 4μ ^ rH rH i—l tH + (η X x X VO &lt; y \ &lt; NJ L〇VO (Ti VD σ \ Η α: &gt; -— Ο 2 2: d〇〇s CN w 00 t〇cfP 00 &lt; 23 r- &lt; Jk CVJ rH rH to dP s-&lt; r lD to &lt; 5P CO 3: Σ 〇L〇u〇a \ CNi lD uO CNJ L〇o-L〇L〇c \ o L〇in σ \ 々txu Σ 〇〇 2 2 〇CN &quot; ζΓ CM CJ CO o in 2: CN CN XL〇cvj u 芝芝 CM X CNJ CJ r · 〇tr &gt; 2 L〇CN X 04 CJ Race OI ° § OX SP 0eCC ° &gt; δχ ° ^ °. &! \ XOX 〇 = () = 0 ° o ° ° U &gt; VO m Γ η CD cn c \ cn rr (please read the precautions of Back Cloud 3 before filling out this page) &gt; Shui Ding • 433-The SS family standard is applicable to the paper size (CNS) with a grid (210X 297 mm) 1235157 Λ7 B7 V. Description of Invention (431) Seal of Consumption Cooperation between Standards and Bureau of Ministry of Economic Affairs ¾

&lt;(ci 枚 rH rH rH + CO X Σ i 〇 r-H iH 00 m u〇 卜 o uO cC Οι rr a? cfP S - cn 一 όΡ Λ CO q π VD CfP O 00 r-H 0Λ 〇 3: Σ CN ID σ\ o in 0D L〇 · 卜 cn L〇 tn U5 o ID Cu Σ 卜 s 2: r- CM 5 &lt;N u 卜 〇 m 2 r-4 Γ0 X 卜 CM 〇 CNJ cn 卜 〇 z CN CNJ X rH CNJ U δ x O X 0=w=° Sx 0=v=° —— yr °&lt;!c°5~ 。為 °o°° z- / °cc° ο r~4 CVJ -434- (請先».讀背¾之注意事項再填寫本頁)&lt; (ci rH rH rH + CO X Σ i 〇rH iH 00 mu 〇 oO cC 〇ι rr a? cfP S-cn 一 όΡ Λ CO q π VD CfP O 00 rH 0Λ 〇3: Σ CN ID σ \ o in 0D L〇 · bu cn L〇tn U5 o ID Cu Σ bu s 2: r- CM 5 &lt; N u bu m 2 r-4 Γ0 X bu CM cn CN cn bu oz CN CNJ X rH CNJ U δ x OX 0 = w = ° Sx 0 = v = ° —— yr ° &lt;! C ° 5 ~. It is ° o °° z- / ° cc ° ο r ~ 4 CVJ -434- (Please first ». Read the notes before filling in this page)

本紙&amp;尺度通用中a國家標洋(CNS ) A4現格(210X 297公釐) 1235157 A7 B7 五、發明説明( 432 ) 經濟部中央標隼局負工消費合作社印¾ rH rH L〇 + κη X 卜 Γ0 If) o rH m L〇 cn Η CC α. X t—1 dP CNJ 〇〇 rH Γ0 rH £ ^ cfp &lt;J\ r-4 一 op 00 Pi ^ lD 3: Σ tn in ro tn m · m r-&lt; m rH m u* X GO 〇 •z CO 04 a: 卜 CNi o 卜 〇 2 CNJ ·—1 o CN CM X t—4 CN u 〇 vo Z CN] CNJ s rH 〇 ox °^t。 °〇:- δ x 〇=w=〇 。逆 〇=Q^ O X 〇=c^° 。逆 °u n XT in -435- 本纸乐尺度通用中S國家標準(CNS M4現格(210 X 297公釐) 請 S a 云 之 意 % %4 寫 太 頁The paper &amp; standard is a national standard (CNS) A4 (210X 297 mm) 1235157 A7 B7 5. Description of the invention (432) Printed by the Consumers ’Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs ¾ rH rH L〇 + κη X Γ0 If) o rH m L〇cn Η CC α. X t—1 dP CNJ 〇〇rH Γ0 rH £ ^ cfp &lt; J \ r-4 -op 00 Pi ^ lD 3: Σ tn in ro tn m · M r- &lt; m rH mu * X GO 〇 • z CO 04 a: BU CNi o BU 02 CNJ · -1 o CN CM X t-4 CN u 〇vo Z CN] CNJ s rH 〇ox ° ^ t. ° 〇:-δ x 〇 = w = 〇. Inverse 〇 = Q ^ O X 〇 = c ^ °. Inverse ° u n XT in -435- This paper is a universal standard of Chinese standard S (CNS M4 is now (210 X 297 mm) Please Saa Yunyi%% 4 Write too page

A 訂 1235157 Λ7 B7 五、發明説明( 2 &lt;Order A 1235157 Λ7 B7 V. Description of the invention (2 &lt;

{H+w》 SH εςπ 8ες 9Itn 請 先 33 讀 背(H + w) SH εςπ 8ες 9Itn Please read it first 33

φ JLHCJldH S6Ξ 00·ς %86 {Ι)3ε·9 dp86Ξ 9ε·9 3:2 ςς·Γ-ες ες·ςΐιο s 卜 09Nosi.o 80ςΝ62Η{7ΰ 經濟部t央榡準局員工消费合作社印¾φ JLHCJldH S6Ξ 00 · ς% 86 {Ι) 3ε · 9 dp86Ξ 9ε · 9 3: 2 ςς · Γ-ες ες · ςΐιο s 09Nosi.o 80ςN62Η {7ΰ Ministry of Economic Affairs t Central Bureau of Associate Bureau Consumer Consumption Cooperative ¾

ΚηKn

}ΛΖ/ ;i 意} ΛZ /; i means

^4α^ -436- 本紙伕尺度適用中S國家橾革(CNS ) A4規格(210X 297公慶7 1235157 A7 B7 五、發明説明( 經濟部中夬標华局員工消费合作社印制各^ 4α ^ -436- The standard of this paper is applicable to the Chinese National Leather (CNS) A4 specification (210X 297 Public Holiday 7 1235157 A7 B7) V. Description of the invention

r-H &lt; rH CN + cn X 2: + X r-4 r—&lt; m CNJ o in ID 卜 e- cc Οι re &lt;—4 CW3 a 00 αο σ\ cn rH rH 一 cfP 2 - rH 一 dP 〜 00 g ^ -00 Σ rH L〇 o f-» u〇 o iD rH o L〇 卜 卜 U4 Σ CO 〇 2 VO CN 3: t〇 CM O CO 〇 tn 2 卜 CM X CN U CO 〇 2 K〇 CN X CNJ CNJ U 赛 4a 5 x °^° °κ. M3 O X 〇=〇=〇 。逆 °^-i -r δ x 〇ν=° 。逆 °s。、 σ\ 〇 lO ιΗ LO -437- 本纸&amp;尺度適用中S國家標革(CNS ) A4現格(210 X 297公釐) (請先閱讀背S之注意事項再填寫本頁) 訂 鑷 1235157 A7 B7 五、發明説明(435 經濟部中央櫺隼局員工消費合作社印¾ CN CN CNJ &lt;NJ + cn ϊ 〇*) rH o L〇 VO &lt;J\ ^ · Η cC Η-ί 〇4 3: r—4 一&quot;df&gt; 〜① 卜 i-H dP rH 00 rH OS r-H pH CNJ 一 c〇 CD z ^ VD CtP ^ s σ\ 3: 2 r- &lt;3* r- cD - o o m L〇 σ\ CO CO 卜 tu S CD σ z VO CNJ X CNJ CNJ U CO r- 〇 2 CM rc n CNi U Γ' 〇 in z m CNJ CNJ 〇 卜 Ο Ζ rH Ο ΓΟ CM 3: f~i CN u 赛 •^α ix o=Q=o r^l 。〇。。 Λ^ζχ * 。公 o— O X 0=^° 。逆 °% O I 0=^° 。莩 s δχ 〇=v=〇 。莩 5 CVJ IT) cn m m 勺· in in -438 - 本纸乐尺度適用中S國家標準(CNS ) A4見格(2丨0 X 297公笼) (請先閱讀背面之注意事項再填寫本I) 装 訂 1235157 A7 B7 五、發明説明(436 經濟部中央糅辛局員工消費合作杜印衮rH &lt; rH CN + cn X 2: + X r-4 r— &lt; m CNJ o in ID e- cc 〇ι re &lt; —4 CW3 a 00 αο σ \ cn rH rH-cfP 2-rH-dP ~ 00 g ^ -00 Σ rH L〇o f- »u〇o iD rH o L〇Bu U4 Σ CO 〇2 VO CN 3: t〇CM O CO 〇tn 2 Bu CM X CN U CO 〇2 K 〇CN X CNJ CNJ U Sai 4a 5 x ° ^ ° ° κ. M3 OX 〇 = 〇 = 〇. Inverse ° ^ -i -r δ x 〇ν = °. Inverse ° s. 、 Σ \ 〇lO ιΗ LO -437- Paper &amp; Standards Applicable in China National Standard Leather (CNS) A4 (210 X 297 mm) (Please read the precautions on the back before filling this page) Order tweezers 1235157 A7 B7 V. Description of the invention (printed by the Consumer Cooperative of the Central Government Bureau of the Ministry of Economic Affairs 435 CN CN CNJ &lt; NJ + cn ϊ 〇 *) rH o L〇VO &lt; J \ ^ · Η cC Η-ί 〇4 3: r—4 a &quot; df &gt; ~ ① i iH dP rH 00 rH OS rH pH CNJ a c〇CD z ^ VD CtP ^ s σ \ 3: 2 r- &lt; 3 * r- cD-oom L〇 σ \ CO CO tu tu CD S σ z VO CNJ X CNJ CNJ U CO r- 〇2 CM rc n CNi U Γ '〇in zm CNJ CNJ 〇 Ο 〇 r 0 Γ Ο CM 3: f ~ i CN u ^ α ix o = Q = or ^ l. 〇. . Λ ^ ζχ *. Common o— O X 0 = ^ °. Inverse °% O I 0 = ^ °.莩 s δχ 〇 = v = 〇.莩 5 CVJ IT) cn mm spoon · in in -438-This paper music standard is applicable to China National Standard (CNS) A4 (2 丨 0 X 297 male cage) (Please read the precautions on the back before filling in this I ) Binding 1235157 A7 B7 V. Description of the invention

&lt;(&amp;收 rH r-H + (Π X 2 + S 2 cn ί c〇 S ^ I n X 〇 X ^ f-H «-Η CO CC 〇4 re 一 dP 〇〇 ® L〇 ID P-H &lt;JP CNJ CD 々 CTk o »-H rH ^ cfP S -00 S Σ L〇 o VO VO L〇 * o 00 L〇 O 00 π Cjli Σ CD o rr z c\i re rH CN4 CJ o «-Η o 2 o CNJ X 00 CNJ CJ 卜 Ο 2 CM CS4 OJ &lt;N X rH 〇 赛 δ x °^t° 硬. ox 。=〇:。 o=^ o Q〇p o X o工 〇==&lt;&gt;=〇 %ι LL LL m nr 卜 to GO ID •439- 本紙&amp;尺度適用中g國家揉莩(CNS M4現格(210X 297公釐) 請先閱 讀背 Γ&amp; 之 注意 畜 %再I填寫 本 頁 訂 1235157 Λ7B7 五、發明説明(437 經濟部中夬樣箪局員工消f合作社印製&lt; (&amp; rH rH + (Π X 2 + S 2 cn ί c〇S ^ I n X 〇X ^ fH «-Η CO CC 〇4 re-dP 〇〇® L〇ID PH &lt; JP CNJ CD 々CTk o »-H rH ^ cfP S -00 S Σ L〇o VO VO L〇 * o 00 L〇O 00 π Cjli Σ CD o rr zc \ i re rH CN4 CJ o« -Η o 2 o CNJ X 00 CNJ CJ BU 02 2 CM CS4 OJ &lt; NX rH 〇 Race δ x ° ^ t ° Hard. Ox. = 〇:. O = ^ o Q〇po X 工 〇 == &lt; &gt; = 〇% ι LL LL m nr GO to GO ID • 439- This paper &amp; standard is applicable in g countries (CNS M4 is now standard (210X 297mm) Please read the back of Γ &amp; 's attention to the animal and then fill in this page to order 1235157 Λ7B7 V. Description of the invention

fH rH f-H cn s cn 00 σ\ VD m CN in cn m K〇 ε- α: 〇 &lt;k »—4 Οι re f-H r-i 00 »—4 〇&quot;\ o t-H rH 一 σΡ 2 -VD rH ciP rH 03 * 卜 s X CO 00 KD (Ti ir&gt;- CNJ C\J L〇 CNJ VD L·* 卜 〇 s 〇 CM CN X pH CM 〇 cn c\ 〇 2 CVJ X CN C\j u 卜 o 2 CS4 m CN X rH C\J U 赛 屮α δ x 〇=w=〇 °&amp;° zx °k 5 x o-Q=° 〇Qt° ZX Mt° d:。 工 5 x =。 。逆 4&gt; 4α a\ o VO rH KO -440- 本紙乐尺度適用tS國家標耷(CNS ) Α4堤格(210X 297公笼) . ,玎 負Μ (請先閲讀背面之注意事項再填寫本頁) 1235157 A7 B7 五、發明説明(439 ) 經濟部中夬標隼局員工消费合作社印¾fH rH fH cn s cn 00 σ \ VD m CN in cn m K〇ε- α: 〇 &lt; k »—4 〇re re fH ri 00» —4 〇 &quot; \ o tH rH -σP 2 -VD rH ciP rH 03 * BU X X CO 00 KD (Ti ir &gt;-CNJ C \ JL〇CNJ VD L · * BU 〇s 〇CM CN X pH CM 〇cn c \ 〇2 CVJ X CN C \ ju BU 2 CS4 m CN X rH C \ JU Sai 屮 α δ x 〇 = w = 〇 ° &amp; ° zx ° k 5 x oQ = ° 〇Qt ° ZX Mt ° d:. 5 x =.. Inverse 4 &gt; 4α a \ o VO rH KO -440- This paper scale is applicable to tS national standard (CNS) Α4 Tiege (210X 297 male cage). 玎 玎 (Please read the notes on the back before filling this page) 1235157 A7 B7 V. Invention Note (439) Printed by the Consumers' Cooperatives of the Ministry of Economic Affairs, China Standards Bureau

-442- 本紙張尺度適用中g a家標车(CNS ) A4現格(210 X 297公潑) (請先閱讀背面之注意事項再填寫本頁) 訂 1235157 A7 B7 五、發明説明(440 經濟部中央標準局員工消費合作社印!^-442- This paper size is applicable to Chinese standard car (CNS) A4 (210 X 297). (Please read the precautions on the back before filling this page.) Order 1235157 A7 B7 V. Description of the invention (440 Ministry of Economic Affairs Printed by the Central Bureau of Standards Consumer Cooperatives! ^

請 先 閣 讀 背 面 Ϊ %Please read it on the back.%

II 填 寫 立 i 訂 -443- 本纸張尺度適用申国國家標李(CNS ) A4現格(210X297公釐) 1235157 A7 B7 五、發明説明(441 經濟部中夬標準局員工消资合作社印¾ r-H f-H + cn X s 1 卜 VD &quot;ro 〇 tn r-H CO 00 Ou X t-H cN〇 § - rH dP in S K〇 ^ 卜 r-H 一 dP S -卜 s X 卜 cr r-&lt; 卜 CNl Ο to (Ti ◦ CO tx4 X s m &lt;\j 山 CM CVJ O c\ o Z CN 3: Γ0 CN 〇 CO 〇 2 vo CNi X cn CN ; 〇 赛 5 x 。=&lt;^。 \ 5x 。〇4 °Κ&lt;δ Q' °^° δι 〇=^° 。校。 CVJ 卜 n 卜 rr -444- 本紙乐尺度適用中国國家標準(〇&gt;^)六4垅格(210/ 297公釐) (請先K讀背面之注意事項再填寫本一貝) 1235157 A7 B7 五、發明説明( 442 ) 經濟部中夬標準局員X消贫合作社印¾ f-H »-H r-H + CO S* S + 2 rH ιΤ) 0D 00 tn 卜 00 r-H ΚΩ tn Η cc CJ令 v-5 Οι 5C rH ^ -ON rH dP ^ % CNJ W L〇 «-Η ciP ^ ' S X &lt;Jk m 00 r· - ^r 卜 rr 00 L〇 cn in uO C^i 卜 〇 in Z L〇 CNJ re Γ0 eg U CO 〇 § CVJ X CM CNJ u 〇 uO 2 m cn X VO OJ ·· U 5 O X °^r° 。贤 δχ 〇=&lt;^&gt;=〇 。逆 Ο 工 X O X °^° 。&amp;。 2X Hb 吞 i〇 r* VO 卜 卜 卜 -445- 本纸乐尺度適用中国國家標李(CNS )六“見格(210X297公釐) (請先閣讀背面之注意事項再填寫本頁)II Fill in the form of I-443- This paper size applies to the national standard of China (CNS) A4 (210X297 mm) 1235157 A7 B7 V. Description of the invention (441 Printed by the China Consumer Standards Cooperative Standards Bureau of the Ministry of Economic Affairs ¾ rH fH + cn X s 1 BU VD &quot; ro 〇tn rH CO 00 Ou X tH cN〇§-rH dP in SK〇 ^ BU rH-dP S-BU s X BU cr r- &lt; BU CNl 〇 to ( Ti ◦ CO tx4 X sm &lt; \ j 山 CM CVJ O c \ o Z CN 3: Γ0 CN 〇CO 〇2 vo CNi X cn CN; 〇 赛 5 x. = &^; \. 5x .〇4 ° Κ & lt δ Q '° ^ ° δι 〇 = ^ °. School. CVJ n rr rr -444- This paper music scale is applicable to the Chinese national standard (〇 &gt; ^) six 4 grids (210/297 mm) (please first (Please read the notes on the back of the K and fill in this one) 1235157 A7 B7 V. Description of the invention (442) Member of the China Standards Bureau of the Ministry of Economic Affairs X Poverty Alleviation Cooperative Society ¾ fH »-H rH + CO S * S + 2 rH ιΤ) 0D 00 tn bu 00 rH ΚΩ tn Η cc CJ order v-5 Ο 5C rH ^ -ON rH dP ^% CNJ WL〇 «-Η ciP ^ 'SX &lt; Jk m 00 r ·-^ r bl rr 00 L〇cn in uO C ^ i 卜 〇in ZL〇CNJ re Γ0 eg U CO 〇§ CVJ X CM CNJ u 〇uO 2 m cn X VO OJ ·· U 5 OX ° ^ r °. Δδχ 〇 = &lt; ^ &gt; = 〇. Inverse 0 XOX ° ^ °. &Amp;. 2X Hb swallow i 〇r * VO 卜卜卜 -445- This paper music scale is applicable to the Chinese National Standard Li (CNS) VI "See box (210X297 mm) (Please read the precautions on the back before filling this page)

1235157 A7 B7 五、發明説明(443 經濟部中夬標华局員工消费合作杜印¾ 4μ ^ γ—1 rH &lt; r—4 + CO X Σ 1 Γ0 c\i L〇 00 L〇 卜 cn cn in in ο Φ Ι-Η 〇4 32 r-H 一 dP _ 〇〇 L〇 r—f 一 CfP S - uO 一 cfP 00 , q ^ L〇 3: Σ ΓΟ tD r&gt; CN in 5 - r- m in CO L〇 ID Cu cn &lt;ji 〇 L〇 芝 CNJ X rH CM U 00 〇 2 VD CVJ rr CN4 CN U a\ 〇 VD 2 o m X uD CN CJ 赛 δχ °=&lt;i&gt;〇 。麥 \ δ x o=w=。 。纪 。夸· ο X •gi 〇=〇=〇 。逆 。各 o ο A工工A X X 豸 ^3 ω ο σ\ 卜 ο 00 -446- 本紙張尺度適用中ϋ国家標孪(CNS ) A4現格(2丨0X2W公釐) (請先聞讀背面之注意事項再填寫本頁) 1235157 經濟部中央標準局員工消費合作社印裝1235157 A7 B7 V. Description of the Invention (443 Employee Consumption Cooperation of the Ministry of Economic Affairs, China Standards Bureau, Du Yin ¾ 4μ ^ γ-1 rH &lt; r-4 + CO X Σ 1 Γ0 c \ i L〇00 L〇 卜 cn cn in in ο Φ Ι-Η 〇4 32 rH-dP _ 〇〇L〇r-f-CfP S-uO-cfP 00, q ^ L〇3: Σ ΓΟ tD r &gt; CN in 5-r- m in CO L〇ID Cu cn &lt; ji 〇L〇 芝 CNJ X rH CM U 00 〇2 VD CVJ rr CN4 CN U a \ 〇VD 2 om X uD CN CJ Race δχ ° = &lt; i &gt; 〇. 麦 \ δ xo = w =.. Ji. QU · ο X • gi 〇 = 〇 = 〇. Inverse. Each o ο A 工 工 AXX 豸 ^ 3 ω ο σ \ Bu ο 00 -446- This paper standard applies to the national standard of China and China. (CNS) A4 is now available (2 丨 0X2W mm) (Please read the precautions on the back before filling out this page) 1235157 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

A B7 五、發明説明( 444 )A B7 V. Description of Invention (444)

請 δ 讀 背 面 之 注 t事j t 填 寫 太 i 訂 本纸伕尺度適用中S國家標萃(CNS ) A4現格(210 X 297公釐) 1235157 A7 B7 五、發明説明(445 經濟部中夬糅準局員工消费合作社印裝 CN 、 rH CN 、 、 rH CNJ rH + cn Ξ S + rH ro L〇 VO 卜 m 々 σ\ 卜 ID CC ο Φ cu X f-H 一 ciP CO g ao … 卜 r-H cfP g - Γ' dP cn co G\ 〇 r-I 3: X ιΠ ιΤ) σ\ CNJ in ro u〇· in f—1 m 〇 VO 卜 卜 in Ud CO s 2; rH ΓΟ X lD C\i CJ GO 〇 m •z a\ CN re CN a 00 〇 tD 2 r-( m re CM ••CJ 寒 440 如- 5 X °^Jr° 。淨。: zx °i^ 5x 〇=&lt;&gt;=〇 。逆 o=s a O X 0=w=° 。承 脅 3 QO m 03 VO ωΔ Please read the note on the back, jt, fill in too, the size of the paper, the size of the national standard (CNS) A4 is applicable (210 X 297 mm), 1235157 A7 B7 5. Description of the invention (445 Ministry of Economic Affairs) Printed CN, rH CN,, rH CNJ rH + cn Ξ S + rH ro L〇VO mm 々σ \ ID ID CC ο Φ cu X fH a ciP CO g ao… rH cfP g- Γ 'dP cn co G \ 〇rI 3: X ιΠ ιΤ) σ \ CNJ in ro u〇 · in f—1 m 〇VO in Ud CO s 2; rH Γ〇 X lD C \ i CJ GO 〇m • za \ CN re CN a 00 〇tD 2 r- (m re CM •• CJ Han 440 such as-5 X ° ^ Jr ° .Net .: zx ° i ^ 5x 〇 = &lt; &gt; = 〇. Inverse o = sa OX 0 = w = °. Threaten 3 QO m 03 VO ω

A 訂 -448- 本紙浪尺度適用中gg家標牮(CNS ) A4堤格(210X 297公釐) 1235157 A7 B7 五、發明説明(446) 經濟部中夬標準局員工消費合作社印裝 CN 、 1-H CNJ 、 r-H CT r-K CNJ r-H + cn 3: 卜 LO Lf) rH rH cn L〇 CO 卜 rH uD CO fX3 · 2 .〇 + s ^ a: 〇4 X rH rH 一 cfP ^ -CO 一 dP s S L〇 r-H GiP 〜 03 * ^ C\ &lt;N .Γ- X 00 L〇 m L〇 in in -cn CN L〇 CN L〇 KD rH ID o L〇 卜 rH m Ud X CO Ο L〇 2 cn m X VO CM o 00 s 2 «-Η n re ID CNJ CJ CO 〇 VD 2 CD CNJ X m CM U c\ 〇 lD Z 卜 CN cn CN U 赛 屮Q δ x 0=&lt;w^=0 % A X 5x °=c^=〇 。逆 °Λ X 5 x o=&lt;^ v=o 。逆 〇=&lt;zx δχ °=&lt;w^。 zx 〇=&lt; o -«r r* GO GO 00 -cr ω o σ\ 449Order A-448- The standard of this paper is applicable to the standard of gg family standard (CNS) A4 Tige (210X 297 mm) 1235157 A7 B7 V. Description of the invention (446) CNPC Standards Bureau employee consumer cooperative printed CN, 1 -H CNJ, rH CT rK CNJ rH + cn 3: BU LO Lf) rH rH cn L〇CO BU rH uD CO fX3 · 2.. + S ^ a: 〇4 X rH rH-cfP ^ -CO-dP s SL〇rH GiP 〜 03 * ^ C \ &lt; N .Γ- X 00 L〇m L〇in in -cn CN L〇CN L〇KD rH ID o L〇 卜 rH m Ud X CO 〇 L〇2 cn m X VO CM o 00 s 2 «-Η n re ID CNJ CJ CO 〇VD 2 CD CNJ X m CM U c \ 〇lD Z Bu CN cn CN U Sai QQ δ x 0 = &lt; w ^ = 0% AX 5x ° = c ^ = 〇. Inverse ° Λ X 5 x o = &lt; ^ v = o. Inverse 〇 = &lt; zx δχ ° = &lt; w ^. zx 〇 = &lt; o-«r r * GO GO 00 -cr ω o σ \ 449

木纸伕尺度適用中S國家標孳(CNS M4現格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(447) 經濟部中央標準局貝工消费合作社印製 rH rH CN + CO X Σ g m lD vo L〇 CTi m cn 々 CN r-H r* Η a: u令 cu 2: rH cP r-4 r—♦ 一 CtP CD CO rH _ CD 2: S vo L〇 vo L〇 VO -々 · CNJ ON rr σ\ 〇 r- Ou X &lt;Tk 〇 Z CO CM 3: CO CSi (J 00 〇 2 CZ4 iT) oa X Csi CN U r- 〇 § CN X cn CN. U 赛 o X 〇=w=〇 °&amp;° 〇=b δ x 〇=^=。 Q^〇x °\JT〇 p x° O X ο==^Γ&gt;=ο 。按。 ZJZ \ λ3 rH &lt;J\ mThe standard of wood paper is applicable to the national standard of China S (CNS M4 is now (210X 297 mm) 1235157 Λ7 B7 V. Description of the invention (447) Printed by the Central Bureau of Standards of the Ministry of Economics, printed by the Bayer Consumer Cooperative, rH rH CN + CO X Σ gm lD vo L〇CTi m cn 々CN rH r * Η a: u command cu 2: rH cP r-4 r — ♦ CtP CD CO rH _ CD 2: S vo L〇vo L〇VO -々 CNJ ON rr σ \ 〇r- Ou X &lt; Tk 〇Z CO CM 3: CO CSi (J 00 〇2 CZ4 iT) oa X Csi CN U r- 〇 CN X cn CN. U Race o X 〇 = w = 〇 ° &amp; ° 〇 = b δ x 〇 = ^ =. Q ^ 〇x ° \ JT〇px ° OX ο == ^ Γ &gt; = ο. Press. ZJZ \ λ3 rH &lt; J \ m

請 讀 背 气· I 再 填 寫 太I 裝 訂 -450- 本紙ft尺度適用tg國家標萃icNS ) A4規格(210X297公) 1235157Please read Back Gas I and fill in too I binding -450- This paper ft size is suitable for tg national standard extraction icNS) A4 size (210X297 male) 1235157

7 7 A B 明説 明發 五 經濟部中夬樣李局員工消費合作社印^ C\i CN f-H t—i + cn 2: Σ 1 σ\ α\ L〇 卜 L〇 r- L〇 σν o L〇 r-H Lf&gt; α: ^ &lt;-〇4 re «-Η 一 dP -S CNJ U 卜 r-H ofP CTk «—4 一 a〇 _ CD S ^ C7i r-H OP - _ CO Ξ ^ 卜 3: X CO 々 00 vT) 々 卜 · rr 卜 CN a\ CD 0 L〇 σ\ GO σ\ U4 r* 〇 Z VO CVJ X OvJ CNi u 0D 〇 之 VO CN re CVi CNJ U CO 0 Z ί-Η CJ L〇 C\J X CN. CN' 〇 αο Ο 守 2 ( Ο m CN 3: f-H CV] u 5 X 〇=w=〇 °&amp;° zx 3 0 X Q=^ &gt;=〇 。校。 ZX 〇==&lt; 0 . b 〇 X 〇=〇=〇 p X 0 X =。 。往。 0 X m σ\ &lt;T U3 C\ 卜 σ\ αο σ\ -451 - 本紙乐尺度適用中國國家標萃(CNS ) A4規格(2丨0X297公釐) I In ..........1--: - -- - 士5&quot;1-- -- - I: -I Hi ------------ 丁 、T (請先閲讀背云之注意再填寫本頁) 1235157 Λ7B7 五、發明説明( 449 ) 經濟部中央標進局員工消費合作社印ίι «-Η + cn X c\] LO LT) CC rH 〇1 X cfP 卜 CO 〇4 m rH 卜 L〇 o L〇 in CO 〇 C^l XT 2 〇 Γ0 i 04 u O X °=^=° /—\^工 〇 Z.2: 〇Q \^Tx 0=ζ M) b &lt;J\ a\ rr -452- 本纸&amp;尺度適用中ag家標莩(CNS &gt; Α4規格(210 X 297公釐) 12351577 7 AB states that it is printed by the Consumers' Cooperative of the Li Bureau in the Ministry of Economic Affairs ^ C \ i CN fH t—i + cn 2: Σ 1 σ \ α \ L〇 卜 L〇r- L〇σν o L〇 rH Lf &gt; α: ^ &lt; -〇4 re «-Η one dP -S CNJ U r rH ofP CTk« —4 one a〇_ CD S ^ C7i rH OP-_ CO Ξ ^ 3 3: X CO 々00 vT) 々 · rr CN CN a \ CD 0 L〇σ \ GO σ \ U4 r * 〇Z VO CVJ X OvJ CNi u 0D VO CN re CVi CNJ U CO 0 Z ί-Η CJ L〇C \ JX CN. CN '〇αο Ο Shou 2 (Ο m CN 3: fH CV] u 5 X 〇 = w = 〇 ° & ° zx 3 0 XQ = ^ &gt; = 〇. Calibration. ZX 〇 == &lt; 0. B 〇X 〇 = 〇 = 〇p X 0 X =... 0 X m σ \ &lt; T U3 C \ \ σ \ αο σ \ -451-This paper scale is applicable to China National Standards Extraction (CNS) A4 specification (2 丨 0X297mm) I In .......... 1--:---士 5 &quot; 1----I: -I Hi ------- ----- Ding, T (Please read the note of Back Cloud before filling out this page) 1235157 Λ7B7 V. Description of the invention (449) Printed by the Employees' Cooperatives of the Central Standardization Bureau of the Ministry of Economic Affairs «-Η + cn X c \] LO LT) CC rH 〇1 X cfP CO CO 〇4 m rH LLo 〇o L〇in CO 〇C ^ l XT 2 〇Γ0 i 04 u OX ° = ^ = ° / — \ ^ 工 〇Z.2: 〇Q \ ^ Tx 0 = ζ M) b &lt; J \ a \ rr -452- Paper &amp; standard applicable ag house standard 莩 (CNS &gt; Α4 size (210 X 297 mm) 1235157

五、發明説明(伽) 實例1: 化合物605a-j,605m-q,605 s,605t及605v如下述地合成 boc-n^y&quot;ohV. Description of the Invention (Gamma) Example 1: Compounds 605a-j, 605m-q, 605s, 605t and 605v were synthesized as follows: boc-n ^ y &quot; oh

Η Ο BOC—ΝΗ Ο BOC—Ν

步驟DStep D

化合物编號 r2 r5 605a/103 Η ch3 600b Η CH2Ph 600c ch3 CH2Ph (請先%讀背5之注意9弄填寫本I ) 装Compound No. r2 r5 605a / 103 Η ch3 600b Η CH2Ph 600c ch3 CH2Ph (please read the note of 5 and fill in this I first)

•1T 气 經濟部中央標準局負工消费合作社印裝 (3S)-2-嗣基-3-第三-丁氧疑基胺基-2,3,4,5-四氫-1^1-1,5-苯 並二氮雜萆-卜醋酸甲酯(600a/l〇3」3 A步驟。(2S)-2-第三-丁氧羰基胺基-3-(2-硝基苯基-胺基)-丙酸。(2S)-2-第三-丁氧羰基胺基-3-胺基丙酸(10克,49毫 莫耳),2-氟硝基苯(5·7毫升,54毫莫耳),及NaHC03 (8.25 克,98毫莫耳)加至130¾升DMF,並在80°C下加熱至18小 453- 本纸伕尺度適用中国國家標革(CNS ) A4現格(2丨0&gt;&lt; 297公釐) 1235157 Λ7 37 五、發明説明(451 ) 閱 讀 背 面 之 注 意 %• 1T Printed by the Central Standards Bureau of the Ministry of Gas and Energy, Consumer Cooperatives (3S) -2-fluorenyl-3-third-butoxyalkylamino-2,3,4,5-tetrahydro-1 ^ 1- 1,5-Benzodiazepine-Methyl Acetate (600a / 103 "3 A step. (2S) -2-Third-butoxycarbonylamino-3- (2-nitrophenyl -Amino) -propionic acid. (2S) -2-Third-butoxycarbonylamino-3-aminopropionic acid (10 g, 49 mmol), 2-fluoronitrobenzene (5.7 ml , 54 millimoles), and NaHC03 (8.25 grams, 98 millimoles) were added to 130¾ liters of DMF, and heated to 18 hours at 80 ° C. 453- This paper is sized for China National Standard Leather (CNS) A4. Case (2 丨 0 &gt; &lt; 297 mm) 1235157 Λ7 37 V. Description of the invention (451) Attention of reading the back%

時。反應眞2下蒸發以生成粘稠、的橘色殘留物,其溶於 300毫升H20中再以Et2〇萃取(3 X 15〇毫升)3水溶液以1〇0/〇 • NaHS〇4酸化至pH 5,並以Et〇Ac萃取(3 X 250毫升)3混合 的萃取物在無水Na2S〇4上乾燥,過濾,並蒸發生成12 64 克(83%)標題化合物,呈橘色無晶形固體:咕NMR (CD3〇D) 5 8.15-8.10 (iH,d),7_54-7·48 (lH,t),7.13-7.08 (1H, d), 6.73-6.65 (1H, t), 4.45^4.35 (1H, m), 3.9-3.8 (1H, dd), 3.65-3.55 (1H, dd)? 1.45 (9H, s) ^ ^ 3 (2S)·2·第三-丁氧羰基胺基-3-(2-胺基苯基胺基)-丙 酸。(2S)-2-第三-丁氧羰基胺基-3气2-硝基笨基胺基)丙酸 (12.65克,40.5毫莫耳)及〇·5克1〇% Pd/C於100毫升MeOH之 混合物,在1大氣之氫氣下攪拌4小時。溶液經甴Celite 545過濾,且濾液眞空下蒸發生成11.95克標題化合物,呈 定量產率爲暗棕色固體,即可使用勿需再純化··〖H NMR (CD3OD) ά 6.75-6.70 (3H,m), 6.65-6.58 (1H, m), 4.35-4.3 (1H, m), 3.6-3.38 (2H, m), 1.45 (9H, s) ^ 經濟部中央糅準局員工消費合作社印^ C步驟。(3S)-2-酮基-3-第三·丁氧談·基胺基-1,3,4,5-四氫-1H-1,5-笨並二氮雜萆。1-(3-二甲胺基丙基)-3-乙基硖化二 亞胺鹽酸(8.54克,44.5毫莫耳)加至(2S)-2-第三-丁氧羰基 胺基-3-(2-胺基苯胺基)丙酸(11.95克,40.5毫莫耳)於100毫 升DMF之冷卻(〇汜)溶液,並攪拌18小時。反應倒入700毫 升EtOAc中,再以毫升H20洗4次。有機層在無水 Na2S04上乾燥,過濾,並蒸發生成棕色固體’其以快速層 析純化,並以3:7 EtOAc/己坑溶離生成8克(71%)標題化合 -454- 本紙伕尺度適用中g國家標導(CNS) A4規格(2i〇x 297公瘦&gt; 經濟部中央標準局員工消资合作杜印製 1235157 A7 B7 _ 五、發明説明( 452 ) 物:NMR (CD3〇D) d 7.78 (1R,s), 7.02-6.95 (1H,m), 6.88- 6.82 (1H? m), 6.82-6.78 (1H, m), 6.75-6.70 (1H, m)? 5.8-5.7 (1H, d), 4.55-4.45 (1H? m)? 3.95 (1H, s), 3.9-3.82 (1H, m)? 3.48-3.40 (lH?m), 1.45 (9H,s) 3 D步驟。(3S)-2-酮基-3-第三-丁氧羰基胺基-2,3,4,5-四氫-lH-l,5-苯並二氮雜箪-l-醋酸曱酯(600a/103)3l·0M雙(三曱 基矽烷基)醯胺鋰(3.4毫升,3.4毫莫耳)於THF之溶液,逐 滴加至(3 5)-2-酮基-3-第三丁氧羰基胺基-2,3,4,5-四氫-111-1.5-苯並二氮雜箪(0.94克,3.38毫莫耳)於20毫升無水THF 之-78X:溶液,並攪掉30分鐘3將溴乙酸甲酯(0.44毫升,4 毫莫耳)逐滴加至反應混合物中,再加溫至RT。反應以100 毫升EtOAc稀釋,再以0.3N KHS〇4 (50毫升),H,〇(2 X 50 毫升)及鹽水洗滌。混合的有機層在無水Na2S〇4上乾燥, 過濾,並蒸發生成膠狀物,再以快速層析純化,以3:7 Et〇Ac/己燒溶離生成0·98克(83%)標題化合物,呈白色固體 3 lH NMR (CD3C1) ci 7.15-7.07 (2Η, m), 6.98-6.94 (1H, m), 6.88- 6.84 (1H, d), 5.62-5.55 (1H, d), 4.71-4.65 (1H, d), 4.65-4.6 (1H,m), 4.33-4.27 (1H,d),3.96-3.90 (1H, m), 3.78 (3H, s),3.44-3.37 (1H,m),1.4 (9H,s)。 (3S)-2-酮基-3-第三-丁氧羰基胺基-2,3,4,5-四氫-1H-1,5-苳 並二雜革-1-醋酸+ S旨(600b) 3以類似600 a/103 (D步踩)么 製法,除了使用溴醋酸芊醋替代溴醋酸甲酯之外,可生成 600b之定量產率。 (35)-2-酮基-3-第三-丁氧羰胺基-2,3,4,5-四氫-7,9-二甲基一 -455 - 本纸疚尺度適用中3國家標达(CNS ) A4規格(210X297公釐) (請先聞讀背面之注意事填寫本頁) 裝 訂 1235157 Λ7 ___________Β7 五、發明説明(始3) 1仏1,5-笨並二氮雜箪-1_醋酸芊酯(6〇〇(:)3 (2S)-2-第三-丁氧羰基胺基-3-(2-硝基-3,5-二甲基 苯胺基)-丙酸。以類似製備60(^/103之方法(八步驟),除了 使用2·氟-4,6-二曱基-硝基苯替代2-氟硝基笨可生成欲求化 合物,產率93% 3 妙崞&quot;3 (2S)-2-第三-丁氧羰基胺基-3-(2-胺基-3,5-二甲基 苯基胺基)-丙酸。(2S)-2-第三丁氧羰基胺基-3-(2-硝基〇,5-二甲基苯基胺基)丙酸,轉化成標題化合物,呈定量產率 ,如600a/103之製法(B步驟 Q步驟3 2-酮基第三-丁氧羰基胺基-2,3,4,5-四氫· 7.9- 二甲基-111-1,5-苯並二氮雜箪。(25)-2-第三-丁氧幾基 腔基-3-(2-胺基-3,5-二甲基苯基胺基)·丙酸(763毫克,2.36 毫莫耳)及N-甲基嗎福啉(483毫克,4.78毫莫耳)於60亳升 無水THF之0X:溶液,以異丁基氣甲酸酯逐滴處理(3 52毫克 ,2.5毫莫耳)。反應在〇°C下攪拌2小時,於RT下1小時並 倒入Et〇Ac。混合物以5%NaHS047]c溶液,NaHC〇3i&amp;和水 溶液,及NaCl飽和水溶液洗滌,在NaS04i乾澡並眞空下 濃縮。層析(快速,Si02,10%至 25%至 50%EtOAc/CH2Cl2) 可生成490毫克(68%)欲求產物。 經濟部中夬標隼局員工消资合作社印¾ D步驟。(3S)-2-酮基-3-第三-丁氧羰基胺基-2,3,4,5-四氫- 7.9- 二甲基-lH-l,5-苯並二氮雜箪-l-醋酸芊酯(600c)。(2S)-2-第三-丁氧羰基胺基·3-(2-胺基-3,5-二甲基苯基-胺基)丙 酸,以類似60〇b之製法轉化成600c,75%。 -456- 本紙&amp;尺·( cns7a4— (2lGx 297公廢) 1235157 Λ7 B7 五、發明説明(454Time. Evaporate at reaction 2 to give a viscous, orange residue, which is dissolved in 300 ml of H20 and extracted with Et20 (3 x 150 ml). The 3 aqueous solution is acidified to pH with 100 / 〇 • NaHS〇4 5, and extracted with EtoAc (3 X 250 ml) 3 The mixed extract was dried over anhydrous Na2SO4, filtered, and evaporated to give 12 64 g (83%) of the title compound as an orange amorphous solid: Goo NMR (CD3〇D) 5 8.15-8.10 (iH, d), 7_54-7 · 48 (lH, t), 7.13-7.08 (1H, d), 6.73-6.65 (1H, t), 4.45 ^ 4.35 (1H , m), 3.9-3.8 (1H, dd), 3.65-3.55 (1H, dd)? 1.45 (9H, s) ^ ^ 3 (2S) · 2 · tertiary-butoxycarbonylamino-3- (2 -Aminophenylamino) -propionic acid. (2S) -2-Third-butoxycarbonylamino-3a-2-nitrobenzylamino) propionic acid (12.65 g, 40.5 mmol) and 0.5 g 10% Pd / C at 100 A mixture of ml of MeOH was stirred under 1 atmosphere of hydrogen for 4 hours. The solution was filtered through Celite 545, and the filtrate was evaporated under the air to produce 11.95 g of the title compound in a quantitative yield as a dark brown solid, which was ready for use without further purification. H NMR (CD3OD) ά 6.75-6.70 (3H, m), 6.65-6.58 (1H, m), 4.35-4.3 (1H, m), 3.6-3.38 (2H, m), 1.45 (9H, s) ^ Printed by the Consumers' Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs ^ Step C . (3S) -2-keto-3-tertiary-butoxytanylamino-1,3,4,5-tetrahydro-1H-1,5-benzodiazepine. 1- (3-Dimethylaminopropyl) -3-ethylphosphonium diimide hydrochloride (8.54 g, 44.5 mmol) was added to (2S) -2-third-butoxycarbonylamino-3 -(2-Aminoaniline) propionic acid (11.95 g, 40.5 mmol) in 100 ml of a cooled (0 汜) solution of DMF and stirred for 18 hours. The reaction was poured into 700 mL of EtOAc and washed 4 times with ml of H20. The organic layer was dried over anhydrous Na2S04, filtered, and evaporated to give a brown solid, which was purified by flash chromatography and dissociated with 3: 7 EtOAc / hexane to yield 8 g (71%) of the title compound -454- This paper is suitable for standard scale g National Standards (CNS) A4 specification (2i0x 297 male thin)> Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, printed 1235157 A7 B7 _ V. Description of the invention (452) Object: NMR (CD3〇D) d 7.78 (1R, s), 7.02-6.95 (1H, m), 6.88- 6.82 (1H? M), 6.82-6.78 (1H, m), 6.75-6.70 (1H, m)? 5.8-5.7 (1H, d ), 4.55-4.45 (1H? M)? 3.95 (1H, s), 3.9-3.82 (1H, m)? 3.48-3.40 (lH? M), 1.45 (9H, s) 3 D step. (3S)- 2-keto-3-tertiary-butoxycarbonylamino-2,3,4,5-tetrahydro-lH-1,5-benzodiazepine-l-acetic acid acetate (600a / 103) A solution of 3 l · 0M lithium bis (trimethylsilyl) phosphonium amine (3.4 ml, 3.4 mmol) in THF was added dropwise to (3 5) -2-keto-3-tert-butoxycarbonylamine -2,3,4,5-tetrahydro-111-1.5-benzodiazepine (0.94 g, 3.38 mmol) in 20 ml of anhydrous THF-78X: solution, and stirred for 30 minutes Methyl bromoacetate (0.44 ml, 4 mmol) ) Was added dropwise to the reaction mixture, and then warmed to RT. The reaction was diluted with 100 mL of EtOAc, and then washed with 0.3N KHS04 (50 mL), H, 0 (2 X 50 mL) and brine. Mixed organic The layer was dried over anhydrous Na2SO4, filtered, and evaporated to give a gum, which was purified by flash chromatography and dissolved at 3: 7 EtoAc / hexane to give 0.98 g (83%) of the title compound as a white color. 3 lH NMR (CD3C1) ci 7.15-7.07 (2Η, m), 6.98-6.94 (1H, m), 6.88- 6.84 (1H, d), 5.62-5.55 (1H, d), 4.71-4.65 (1H, d), 4.65-4.6 (1H, m), 4.33-4.27 (1H, d), 3.96-3.90 (1H, m), 3.78 (3H, s), 3.44-3.37 (1H, m), 1.4 (9H, s). (3S) -2-keto-3-tert-butoxycarbonylamino-2,3,4,5-tetrahydro-1H-1,5-pyridobiazale-1-acetic acid + The purpose of S (600b) 3 is similar to 600 a / 103 (D step), except that it uses methyl bromoacetate instead of methyl bromoacetate to produce a quantitative yield of 600b. (35) -2-keto-3-tertiary-butoxycarbonylamino-2,3,4,5-tetrahydro-7,9-dimethyl--455 Standard (CNS) A4 specification (210X297 mm) (Please read the notes on the back and fill in this page first) Binding 1235157 Λ7 ___________ Β7 V. Description of the invention (Beginning 3) 1 仏 1,5-benzodiazine- 1-acetic acid acetate (600 (:) 3 (2S) -2-third-butoxycarbonylamino-3- (2-nitro-3,5-dimethylaniline) -propionic acid. A similar method to prepare 60 (^ / 103 (eight steps), except that the use of 2-fluoro-4,6-diamidino-nitrobenzene instead of 2-fluoronitrobenzine can produce the desired compound, yield 93%. 3 Miao崞 &quot; 3 (2S) -2-Third-butoxycarbonylamino-3- (2-amino-3,5-dimethylphenylamino) -propionic acid. (2S) -2-section Tributoxycarbonylamino-3- (2-nitro0,5-dimethylphenylamino) propanoic acid is converted to the title compound in a quantitative yield, such as the method for preparation of 600a / 103 (B step Q Step 3 2-keto third-butoxycarbonylamino-2,3,4,5-tetrahydro · 7.9-dimethyl-111-1,5-benzodiazepine. (25) -2 -Third-butoxycalyl-3- (2-amino-3,5-dimethylphenylamino) · propyl (763 mg, 2.36 mmol) and N-methylmorpholine (483 mg, 4.78 mmol) in 60 liters of anhydrous THF in 0X: solution, treated dropwise with isobutyl aquamate (3 52 mg, 2.5 mmol). The reaction was stirred for 2 hours at 0 ° C, 1 hour at RT and poured into EtoAc. The mixture was saturated with 5% NaHS047] c solution, NaHC03i &amp; and aqueous solution, and NaCl. Wash with aqueous solution, dry in NaS04i and concentrate under air. Chromatography (quick, SiO2, 10% to 25% to 50% EtOAc / CH2Cl2) can produce 490 mg (68%) of the desired product. Employees of the Ministry of Economic Affairs Consumers' cooperatives print ¾ step D. (3S) -2-keto-3-third-butoxycarbonylamino-2,3,4,5-tetrahydro-7.9-dimethyl-lH-l, 5 -Benzodiazepine-l-fluorenyl acetate (600c). (2S) -2-Third-butoxycarbonylamino · 3- (2-amino-3,5-dimethylphenyl- Amino) propionic acid is converted into 600c, 75% by a method similar to 60b. -456- Paper &amp; ruler (cns7a4— (2lGx 297 public waste) 1235157 Λ7 B7 V. Description of the invention (454

步骤 A* HC1 丄&gt; 步隸B. PhCQoH 步驟 C. R3X 600Step A * HC1 丄 &gt; Step B. PhCQoH Step C. R3X 600

步驟DStep D

經濟部中央標準局員工消免合作社印裝 (3S)-2-酮基-3-苄醯胺基-5-(3-苯基丙醢基)-2,3,4,5-四氫-1H- 1,5-笨並二氮雜箪-1-醋酸甲酯(602a)。 〆 4步樣3無水HC1泡騰至(3S)-2-酮基-3-第三-丁氧幾姜胺某 2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-卜醋酸甲酯(6〇〇a/i〇3 , 4.〇克,11.4毫莫耳)於20毫升(:^12(:12中歷20分鐘,再於{1丁 下攪拌1小時。反應蒸發生成(3S)-2-酮基-3-胺基-2,3,4,5-四 氩-1H-1,5-苯並二氮雜萆-1-醋酸甲酯鹽酸,呈白色固體3 杜骤。白色固體溶於70毫升DMF中再加苯甲酸(1.5克, 12.3毫莫耳)。反應於冰/h2〇中冷卻,再以1-(3-二甲胺基 丙基)-3-乙基碳化二亞胺鹽酸(2.4克,12.5毫莫耳)1-羥基 苯並三唑(1.7克,12.6毫莫耳)及二異丙基乙胺(3·0克,23· 毫莫耳)處理。反應在RT及氮大氣下攪拌18小時,再倒入 H20中。水性混合物以EtOAc萃取(2x)。混合的有機層以飽 2 (請先閣讀背面之注意事項再填寫本一貝)Employees of the Central Bureau of Standards of the Ministry of Economic Affairs exempted the printing of (3S) -2-keto-3-benzylamido-5- (3-phenylpropanyl) -2,3,4,5-tetrahydro- 1H- 1,5-Benzodiazepine-1-acetic acid methyl ester (602a). 〆4 step sample 3 anhydrous HC1 effervescent to (3S) -2-keto-3-tertiary-butoxychicamamine some 2,3,4,5-tetrahydro-1H-1,5-benzodi Aza-p-methyl acetate (600a / io3, 4.0g, 11.4mmol) in 20ml (: ^ 12 (: 12 for 20 minutes, then stirred under {1 丁丁) 1 hour. The reaction was evaporated to form (3S) -2-keto-3-amino-2,3,4,5-tetraargine-1H-1,5-benzodiazepine-1-acetic acid methyl ester hydrochloride. A white solid was added in 3 steps. The white solid was dissolved in 70 ml of DMF and benzoic acid (1.5 g, 12.3 mmol) was added. The reaction was cooled in ice / h2O, and then 1- (3-dimethylamine group was added. Propyl) -3-ethylcarbodiimide hydrochloride (2.4 g, 12.5 mmol) 1-hydroxybenzotriazole (1.7 g, 12.6 mmol) and diisopropylethylamine (3.0 g , 23 · mmol). The reaction was stirred at RT and nitrogen atmosphere for 18 hours, and then poured into H20. The aqueous mixture was extracted with EtOAc (2x). The mixed organic layer was saturated with 2 (please read the note on the back first) (Fill in this question and fill in this one)

-457- 本紙杀尺度通用中國國家標李(CNS ) A4規格(210X 297公釐) 1235157 經濟部中央樣準局員工消资合作社印裳 Β; 五、發明説明(455) 和的0.5N NaHS04,H20,飽和的^NaHC03水溶液,h9〇及 鲍和的NaCl水溶液洗滌,於1^1§3〇4上乾燥再於眞空下滚縮 。層析(快速,Si〇2,10%至30% Et〇Ac/CH2Cl2)可生成3.4 克(85%)的(35)-2-二酮基-3-(芊胺基)-2,3,4,5-四氫-1幵-1,5-笨 並二氮雜箪-1-醋酸甲酯,呈白色固體。 C步驟。A方法。(3S)-2-酌基-3-苄醯胺基-5-(3-笨基丙醯基) -2,3,4,5-四氫-111-1,5-苯並二氬雜萆-1-醋酸甲酯(6〇24。 (3S)-2-酮基-3-(芊醯胺基)-2,3,4,5-四氫-1H-1,5-笨並二氮韓 箪-1-醋酸甲酯(200毫克,0.57毫莫耳)於CH2C12(10毫升)之 溶液,以三乙胺(119毫克,1.13毫莫耳)及3-苯基丙醯氣 (1M毫克,0.68毫耳)處理。反應在RT下攪拌30分,再以 CH2C12稀釋。溶液以10%HC1水溶液,飽和的NaHC〇3水溶 液,NaCl飽和水溶液洗滌,於Na2S04上乾燥並於眞空下濃 縮以生成24〇毫克(87%)的602a呈白色泡沫。 gJ:驟3 I方法3 (3S)-2-酮基-3-苄醯胺基-5-乙醯乙醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜革-1-醋酸宇g旨(6〇2g) 3 (3S)-2-酮基-3-(芊醯胺基)-2,3,4,5-四氫-1H-1,5-苯並二氮雜 箪-1-醋酸苄薛(600b)(465毫克,1.10毫莫耳)於CH2C12(5毫 升)之(TC溶液,以乙醯乙酸於i毫升ch2ci2處理,再緩緩 加入1-(3·二甲胺基丙基乙基碳化二亞胺鹽酸(431毫克 ,2.2毫莫耳)於2毫升CH2C12,於\大氣下。15分鐘後反應 倒入EtOAc中,以飽和的5〇/〇 NaHS〇4水溶液洗滌,於 NajO4上乾燥並眞空濃縮。層析(快逯,si〇2,〇%至ι〇〇/〇 至25% MeOH/CH2Cl2)可生成580毫克(3S)-2-酮基-3-(芊醯胺 -—__ - 458 - 本μ尺度逆用㈣g家標^Τ^Γπ10χ 297:^--^一~^ (碕先閔讀背面之:i!i意事填寫本頁} li衣 -訂 1235157 B7 五、發明説明(456 ) 基)-5 -乙酷乙酷基-2,3,4,5-四氫-1H-1,5-笨並二氮雜笨-卜醋 酸芊酯,呈白色固體β C步驟。C方法。(3S)-2-酮基-3-苄醯胺基-5·甲氧羰基. 2,3,4,5-四氯-1H-1,5-本並一亂雜箪醋酸辛g旨(6〇2j)。 (3 3)-2-酮基-3-(芊醯胺基)-2,3,4,5-四氫-1^[-1,5_苯龙二氮雜 苯-1-醋酸辛黯(6001))(461愛兄,1.07¾莫耳)於thf (5毫升) 及飽和NaHC〇3 (2.5毫升)之劇烈攪拌的οχ:液/以氯甲酸 甲酯(151毫克,1·6毫莫耳)之THF溶液(〇25毫升)處理,且 反應在RT下攪拌45分鐘。反應倒入CH2Cl2t,再以水洗 ,於Na2S〇4上乾燥並眞空濃縮3層析(快速,SiO,,0%至 10% MeOH/CH2Cl2)可生成525毫克的602j,呈白色固鳢。 步驟C。D方法。(3S)-2-銅基-3-芊醯胺基-5_芊胺羰基-2,3,4,5·四氮-1 Η-1,5-表並一亂雜卓-1-醋酸曱g旨(602p)。 602a/103 (400毫克/1.1毫莫耳)及苄基異氰酸酯(166毫克, 1.2毫莫耳)於1〇毫升CH2C12&amp; 10毫升DMF之溶液,在8(TC 下加熱3天。反應冷卻至RT再倒入H20中並以EtOAc萃取 (2x)。混合的有機層以H20洗(4x),再以飽和的NaCl洗,於 1^504上乾燥並於眞空下濃縮3層析(快速,Si02,50%至 80% EtOAc/己烷)可生成440毫克(80%) 602p,呈白色固體。 經濟部中央標準局員工消费合作社印製 C步驟。E方法3 (3S)-2-酮基-3-芊胺基-5-(3-苯基丙醯基)-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-1-醋酸甲酯(602v)。(3S) 2-酮基-3-胺基-5-(3-苯基丙醯基-2,3;4,5-四氫-1^1-1,5-苯並 二氮雜箪-1-醋酸甲酯鹽酸(560毫克,1.34毫莫耳),苄醛 (146毫克,1.34毫莫耳)及醋酸鈉(220毫克,2.68毫莫耳)於 _ · 459 -_ 本纸伕尺度適用中國國家標il CNS &gt; A4堤格(210 X 297公潑)~ ^ 經濟部中夬櫺準局員工消費合作社印裝 1235157 A 7 _B7____ 五、發明説明(457 ) 曱醇(20毫升)之溶液,以4A篩(2克、)及NaCNBH3 (168毫克, 2.68毫莫耳)處理3反應攪拌2.5小時,以10%HC1水溶液酸 化至pH 2,再以Et20洗條(2x75毫升)°有機層眞空;農縮可 生成油。層析(快速,Si02,〇至35% Et〇Ac/CH2Cl2)可生成 250毫克(40%) 602v,呈澄清油3 步驟D。A方法。(3S)-2-酮基芊醯胺基〇·(3-苯基丙醯基 )-2,3,4,5-四氫-1仏1,5-苯並二氮雜革-1-醋酸(603&amp;)。(35)-2-酮基-3-芊醯胺基〇-(3-苯基丙醯基)-2,3,4,5-四氫-1沁1,5-苯 並二氮雜箪-1-醋酸甲酯(602a); 1.25克,2·57毫莫耳)溶於 11毫升1^?,乂6〇^[及1120(5:5:1)中,再以1^01^112〇(42毫 克,0.62毫莫耳)處理並於RT下攪拌64小時。反應於眞空 下濃縮,以Η20稀釋並以IN HCi水溶液酸化以生成230毫 克的603a,呈白色固體。 步驟B方法,(3S) 2-酮基-3-芊醯胺基〇-乙醯基-2,3,4,5-四氫-1H-1,5-笨並二氮雜苯·ι_醋酸(603d)。(3S)-2-_l-3-( 苄Si胺基)-5 -乙酿基-2,3,4,5-四氛-1 Η-1,5-苯並二氮華箪-卜 乙酸芊酯(602d ; 510毫克,1.08毫莫耳)及5% Pd/C (250毫 兄)於Me OH (10¾升)之混合物在h2 (1大氣壓下)擾棹〇5小 時。反應過;慮且眞空濃縮可生成410毫克的603d,呈白色 固體3 表8化合物如表9所述地製備,利用實例12之方法。 -460- 本紙伕尺度適用中國國家標率(CNS &gt; A4堤格(210X 297公釐) (請先閱讀背&amp;之注意事填寫本頁 訂 1235157-457- The standard for this paper is General Chinese National Standard Li (CNS) A4 (210X 297 mm) 1235157 Yin Sang, Co-operative Cooperative of Employees of the Central Procurement Bureau of the Ministry of Economic Affairs; 5. Description of Invention (455) and 0.5N NaHS04, H20, saturated aqueous NaHC03 solution, h90 and aqueous NaCl solution were washed, dried over 1 ^ 1 §304 and then rolled under air. Chromatography (fast, Si02, 10% to 30% Et〇Ac / CH2Cl2) yielded 3.4 g (85%) of (35) -2-diketo-3- (fluorenylamino) -2,3 , 4,5-tetrahydro-1,1,5-benzodiazepine-1-acetic acid methyl ester as a white solid. Step C. A method. (3S) -2-Iki-3-benzylamidinyl-5- (3-benzylpropanyl) -2,3,4,5-tetrahydro-111-1,5-benzodiazepine Pyrene-1-acetate methyl ester (602). (3S) -2-keto-3- (fluorenylamino) -2,3,4,5-tetrahydro-1H-1,5-benzyl A solution of N-Hexane-1-methyl acetate (200 mg, 0.57 mmol) in CH2C12 (10 ml), triethylamine (119 mg, 1.13 mmol) and 3-phenylpropanine (1M Mg, 0.68 milli-ears). The reaction was stirred at RT for 30 minutes, and then diluted with CH2C12. The solution was washed with 10% HC1 aqueous solution, saturated NaHC03 aqueous solution, NaCl saturated aqueous solution, dried over Na2S04 and concentrated under vacuum. 24.0 mg (87%) of 602a was produced as a white foam. GJ: Step 3 I Method 3 (3S) -2-keto-3-benzylamido-5-ethylamidineethyl-2,3,4 , 5-tetrahydro-1H-1,5-benzodiazepine-1-acetic acid (60.2 g) 3 (3S) -2-keto-3- (fluorenamino) -2 , 3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-acetic acid benzyl (600b) (465 mg, 1.10 mmol) in CH2C12 (5 ml) (TC solution , Treated with acetic acid in 1 ml of ch2ci2, and then slowly added 1- (3 · dimethylaminopropylethyl carbonization Diimine hydrochloride (431 mg, 2.2 mmol) in 2 ml of CH2C12 under atmospheric air. After 15 minutes, the reaction was poured into EtOAc, washed with a saturated 50 / 〇NaHS〇4 aqueous solution, dried over NajO4 and Concentrated in the air. Chromatography (quick beating, SiO2, 0% to 〇00 / 〇 to 25% MeOH / CH2Cl2) can produce 580 mg (3S) -2-keto-3- (fluorenamine -___ -458-μg house mark ^ Τ ^ Γπ10χ 297: ^-^ 一 ~ ^ (碕 Xian Min read the back: i! I intended to fill in this page} li clothes-order 1235157 B7 V. Invention Explanation (456) group) -5-Ethyl 2-3,4,5-tetrahydro-1H-1,5-benzodiazabenzyl-butyrate acetate, white solid β C step Method C. (3S) -2-keto-3-benzylamido-5 · methoxycarbonyl. 2,3,4,5-tetrachloro-1H-1,5-naphthoacetic acid Symptoms (6〇2j). (3 3) -2-keto-3- (fluorenamino) -2,3,4,5-tetrahydro-1 ^ [-1,5_benzoyl Azabenzene-1-acetic acid octane (6001)) (461 Love Brother, 1.07¾ mol) in thf (5 ml) and saturated NaHC03 (2.5 ml) vigorously stirred οχ: liquid / methyl chloroformate Ester (151 mg, 1.6 mmol) in THF (0 25 Ml), and the reaction was stirred at RT for 45 minutes. The reaction was poured into CH2Cl2t, washed with water, dried over Na2SO4, and concentrated by air chromatography (fast, SiO, 0% to 10% MeOH / CH2Cl2) to produce 525 mg of 602j, which was a white solid. Step C. D method. (3S) -2-copperyl-3-fluorenylamino-5-fluorenylaminocarbonyl-2,3,4,5 · tetrazine-1 fluorene-1,5-epoxy曱 g purpose (602p). A solution of 602a / 103 (400 mg / 1.1 mmol) and benzyl isocyanate (166 mg, 1.2 mmol) in 10 ml of CH2C12 & 10 ml of DMF, heated at 8 ° C for 3 days. The reaction was cooled to RT It was then poured into H20 and extracted with EtOAc (2x). The combined organic layers were washed with H20 (4x), then with saturated NaCl, dried over 1 ^ 504 and concentrated under vacuum. Chromatography (Rapid, SiO2, 50% to 80% EtOAc / hexane) can produce 440 mg (80%) of 602p as a white solid. Step C, printed by the Consumer Cooperative of the Central Standards Bureau, Ministry of Economic Affairs, Method 3 (3S) -2-keto-3 -Methylamino-5- (3-phenylpropylamido) -2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-acetic acid methyl ester (602v). (3S) 2-keto-3-amino-5- (3-phenylpropanyl-2,3; 4,5-tetrahydro-1 ^ 1-1,5-benzodiazepine- 1-methyl acetate hydrochloride (560 mg, 1.34 mmol), benzaldehyde (146 mg, 1.34 mmol) and sodium acetate (220 mg, 2.68 mmol) are used in _ · 459 -_ This paper is applicable to the standard China National Standard CNS &gt; A4 Tiege (210 X 297 male splashes) ~ ^ Printed by the Consumers' Cooperative of the China Prospective Bureau of the Ministry of Economic Affairs 1235157 A 7 _B7____ V. Description of the invention (457) A solution of methanol (20 ml), treated with a 4A sieve (2 g,) and NaCNBH3 (168 mg, 2.68 mmol). The reaction was stirred for 2.5 hours, and acidified to pH with a 10% HC1 aqueous solution. 2. Wash the strip with Et20 (2x75 ml) ° and empty the organic layer; the agricultural shrinkage can generate oil. Chromatography (quick, SiO2, 0 to 35% Et〇Ac / CH2Cl2) can produce 250 mg (40%) 602v, showing Clear oil 3 Step D. Method A. (3S) -2-ketoamidoamino · (3-phenylpropylamido) -2,3,4,5-tetrahydro-1 仏 1,5- Benzodiazepine-1-acetic acid (603 &). (35) -2-keto-3-amidoamino group 0- (3-phenylpropylamido) -2,3,4,5- Tetrahydro-1 Qin 1,5-Benzodiazepine-1-acetic acid methyl ester (602a); 1.25 g, 2.57 mmoles are dissolved in 11 ml of 1 ^ ?, 乂 6〇 ^ [and 1120 (5: 5: 1), and then treated with 1 ^ 01 ^ 112 (42 mg, 0.62 mmol) and stirred at RT for 64 hours. The reaction was concentrated under vacuum, diluted with pH 20 and acidified with IN HCi aqueous solution. To produce 230 mg of 603a as a white solid. Step B method, (3S) 2-keto-3-amidinoamino-ethyl-2,3,4,5-tetrahydro-1H-1, 5-benzodiazepine · ι_ Acid (603d). (3S) -2-_l-3- (benzylSiamino) -5 -ethynyl-2,3,4,5-tetramethane-1 fluorene-1,5-benzodiazepine fluorene-acetic acid A mixture of methyl ester (602d; 510 mg, 1.08 mmol) and 5% Pd / C (250 mmol) in Me OH (10¾ liters) was disturbed at h2 (at 1 atmosphere) for 0.5 hours. It has been reacted; and it can be concentrated in the air to produce 410 mg of 603d as a white solid. 3 The compound of Table 8 was prepared as described in Table 9, using the method of Example 12. -460- The standard of this paper is applicable to China's national standard (CNS &gt; A4 Tiege (210X 297mm)) (Please read the notes on the back and fill in this page. Order 1235157

7 7 A B 五、發明説明( 458 ) 表8 經濟部中央樣隼局員工消费合作·社印¾ 化合物編號 R2 R3 r4 % 602b H PhCH2C(0) PhC(O) CH2Ph 602c H PhC(O) PhC(O) CH2Ph 602d H CH3C(0) PhC(O) , CH2Ph 602e H ch3〇ch2c(o) PhC(O) CH2Ph 602f H (CH3)2CHCH2C(0) PhC(0) CH2Ph 602g H CH3C(0)CH2C(0) PhC(0) CH2Ph 602h H CH30C(0)C(0) PhC(0) CH2Ph 602i H ch3c(〇)c(o) PhC(0) CH2Ph 602j H ch3〇c(o) PhC(O) CH2Ph 602k H CH3C(0) Boc CH2Ph 6021 CH3 CH3C(0) Boc ·· CH2Ph 602m H CH3S(02) PhC(0) ch3 602p H PhCH2NHC(0) PhC(0) ch3 602q H ^^000 PhC(0) CH2Ph 602r H PhCH2CH2C(0) PhCH2CH2C(0) CH2Ph 602s H 4·吡啶基CH2C(0) PhC(O) CH2Ph -461 - 本紙乐尺度適用中国國家標洋(CNS ) A4现格(2IOX 297公釐) 1235157 五、發明説明( 459 ) 表9 經濟部中夬標準局員工消費合作社印製 编號 起始物 R3X c步驟 方法/ (%產率) D步驟 方法/ (%產車) 603b 600b PhCH2C(0)Cl A (98) Β (89) 603c 600b PhC(0)Cl A (quant.) Β (quant·) 603d 600b CH3C(0)C1 A (quant.) Β (quant·) 603e 600b ch3〇ch2c(〇)ci A (59) Β (quant.) 603f 600b (CH3)2CHCH2C(0)C1 A (88) Β (95) 603g 600b CH3C(0)CH2C02H B (quant.) Β (quant.) 603h 600b CH30C(0)C(0)C1 A (96) Β (quant.) 603i 600b CH3C(0)C02H B (87) Β (94) 603j 600b CH30C(0)C1 C (quant·) 3 (quant.) 603k 600b CH3C(0)C1 A,僅步琢C (quant.) 未操作 6031 600c CH3C(0)C1 A,僅步黎C (quant.) 未操作 603m S00a/103 CH3S03C1, 以NEt3&lt;代?比症, 而以THF取代CH2C12 A (76) A (92) 603p 600a/103 PhCH2C=N=0 D (80) A (86) 603q 600b ^^οοοα C (83) B 〇71) 603r 600a/103 PhCH2CH2C(0)Cl A 603s 600b ‘吡啶基ch2co2h B (90) B (98) (請先閲讀背5之^意畜1^再填寫_5貝) -462- 本紙ft尺度適用中3國家標挛(CNS ) Α4規格(210X29?公釐) 1235157 A7 __B7 五、發明説明(460)7 7 AB V. Description of Invention (458) Table 8 Consumption Cooperation of the Central Sample Industry Bureau of the Ministry of Economic Affairs · Social Printing ¾ Compound No. R2 R3 r4% 602b H PhCH2C (0) PhC (O) CH2Ph 602c H PhC (O) PhC ( O) CH2Ph 602d H CH3C (0) PhC (O), CH2Ph 602e H ch3〇ch2c (o) PhC (O) CH2Ph 602f H (CH3) 2CHCH2C (0) PhC (0) CH2Ph 602g H CH3C (0) CH2C ( 0) PhC (0) CH2Ph 602h H CH30C (0) C (0) PhC (0) CH2Ph 602i H ch3c (〇) c (o) PhC (0) CH2Ph 602j H ch3〇c (o) PhC (O) CH2Ph 602k H CH3C (0) Boc CH2Ph 6021 CH3 CH3C (0) Boc ·· CH2Ph 602m H CH3S (02) PhC (0) ch3 602p H PhCH2NHC (0) PhC (0) ch3 602q H ^ 000 PhC (0) CH2Ph 602r H PhCH2CH2C (0) PhCH2CH2C (0) CH2Ph 602s H 4 · Pyridyl CH2C (0) PhC (O) CH2Ph -461-This paper scale is applicable to Chinese National Standard Ocean (CNS) A4 (2IOX 297 mm) 1235157 V. Description of the invention (459) Table 9 Printed serial number starting material R3X by the Consumer Cooperatives of the China Standards Bureau of the Ministry of Economics c Step method / (% yield) D step method / (% production car) 603b 600b PhCH2C (0) Cl A (98) Β (89) 603c 600b PhC (0) Cl A (quant.) Β (quant.) 603d 600b CH3 C (0) C1 A (quant.) Β (quant ·) 603e 600b ch3〇ch2c (〇) ci A (59) Β (quant.) 603f 600b (CH3) 2CHCH2C (0) C1 A (88) Β (95 ) 603g 600b CH3C (0) CH2C02H B (quant.) Β (quant.) 603h 600b CH30C (0) C (0) C1 A (96) Β (quant.) 603i 600b CH3C (0) C02H B (87) Β (94) 603j 600b CH30C (0) C1 C (quant.) 3 (quant.) 603k 600b CH3C (0) C1 A, only step C (quant.) Not operated 6031 600c CH3C (0) C1 A, step only Li C (quant.) Did not operate 603m S00a / 103 CH3S03C1, replaced NE2 with <3, and replaced CH2C12 A (76) A (92) 603p 600a / 103 PhCH2C = N = 0 D (80) A ( 86) 603q 600b ^^ οοοαα C (83) B 〇71) 603r 600a / 103 PhCH2CH2C (0) Cl A 603s 600b 'pyridyl ch2co2h B (90) B (98) (please read the 5 of the first 5) ^ Fill in _5 shells) -462- The paper ft scale is applicable to 3 national standard (CNS) A4 specifications (210X29? Mm) 1235157 A7 __B7 V. Description of the invention (460)

602602

1) 步驟 C. R3X 2) 步驟人 HC11) Step C. R3X 2) Step human HC1

3) 步驟 C. R4X3) Step C. R4X

Ο',、ΟΗ 603Ο ', ΟΗ 603

步驟D R4-N Η 表10化合物如表11所述地製備,利用實例12方法3 表10 經濟部_夬標隼局員工消費合作社印製 化合物编號 R2 R3 r4 % 602η Η CH3C(0) 伸莕基-2-C(0) CH2Ph 602〇 ch3 CH3C(0) PhC(O) CH2Ph 6021 Η 3-CH3PhCH2C(0) PhC(O) CH2Ph 602u Η CH3C(0) Fmoc CH2Ph 602v Η PhCH2CH2CO PhCH2 ch3 -463- 本紙ft尺度通用中國國家標孪( CNS ) Α4規格(210X29?公釐) 1235157 A 7 B7 五、發明説明(461) 表1 1 编號 起始物 1&gt;步驟C. R3x方法 (°/。1 率) 3)步驟C R4X方法 (%產率) 步驟D 方法 (%產率) 603η 602k CH3C(0)C1 A (quant.) 伸莕基- 2-C(0)Cl A (70) B(quant.) 603〇 6021 CH3C(0)C1 . A (quant·) PhC(0)Cl A (73) B(quant.) 603t 602k 3- CH3PhCH2C(0)Cl A (quant.) PhC(0)Cl A (93) :B (95) 603u 602k CH3C(0)C1 A (quant.) Fmoc-Cl C (82) C (98) 603v 600a/103 PhCH2CH2C(0)Cl A PhCHO E(40) A (95) (請先聞讀背¾之注意事項再填寫本一貝) 訂 經濟部中夬標準局負工消费合作社印製Step D R4-N Η Table 10 compounds were prepared as described in Table 11, using Example 12 Method 3 Table 10 Compound No. R2 R3 r4% 602η Η printed by the Ministry of Economic Affairs and Standards Bureau Consumer Cooperatives Η CH3C (0) Extend Fluorenyl-2-C (0) CH2Ph 602〇ch3 CH3C (0) PhC (O) CH2Ph 6021 Η 3-CH3PhCH2C (0) PhC (O) CH2Ph 602u Η CH3C (0) Fmoc CH2Ph 602v Η PhCH2CH2CO PhCH2 ch3 -463 -The paper ft scale is in accordance with the Chinese National Standard (CNS) A4 specification (210X29? Mm) 1235157 A 7 B7 V. Description of the invention (461) Table 1 1 Numbering starter 1 &gt; Step C. R3x method (° /. 1 rate) 3) Step C R4X method (% yield) Step D method (% yield) 603η 602k CH3C (0) C1 A (quant.) Dendronyl-2-C (0) Cl A (70) B (quant.) 603〇6021 CH3C (0) C1. A (quant ·) PhC (0) Cl A (73) B (quant.) 603t 602k 3- CH3PhCH2C (0) Cl A (quant.) PhC (0) Cl A (93): B (95) 603u 602k CH3C (0) C1 A (quant.) Fmoc-Cl C (82) C (98) 603v 600a / 103 PhCH2CH2C (0) Cl A PhCHO E (40) A ( 95) (Please read the precautions before filling in this one) Order printed by the Offshore Consumer Cooperative of the China Standards Bureau of the Ministry of Economic Affairs

步驟BStep B

464 衣纸乐尺度通用中S国家標莩(CNS〉A4規格(210X 297公釐) 1235157464 Paper and paper music scale universal Chinese S national standard (CNS> A4 size (210X 297 mm) 1235157

7 7 A B 經濟部令夬標隼局員工消費合作社印製 五、發明説明(你2) 表12化合物如下述方法製備。 表12 化合物编號 R2 R3 R4 605a H PhCH2CH2C(〇) PhC(O) 605b H PhCH2C(〇) PhC(O) 605c H PhC(O) PhC(O) 605d H CH3C(0) PhC(O) 60Se H ch3〇ch2c(〇) PhC(0) 605f H (CH3)2CHCH2C(0) PhC(0) 605g H ch3c(〇)ch2c(o) PhC(0) 605h H CH30C(0)C(0) PhC(O) 605i H ch3c(〇)c(〇) PhC(0) 605j H CH30C(0) PhC(O) 605m H CH3S03 PhC(0). 605n H CH3C(0) 莕基-2-C(0) 605〇 ch3 CH3C(0) PhC(O) 605p H PhCH2NHC(0) PhC(0) 605q H ^^000 PhC(O) 605s H 4- pyridylCH^C(0) PhC(0) 605t H 3-CH3PhCH2C(〇) PhC(O) 605v H PhCH2CH2C(0) PhCH2 (35)-3-[(35)-2-酮基-3-辛酷胺基-5-(3-苯基丙酷基)-2,3,4,5- (請先聞讀背*之泾意事項再填寫本頁 •νά •f -465- 本紙伕尺度適用中國國家標洋(CNS ) Α4;^格(210X 297公釐) 1235157 A7 ______B7_^_____ 五、發明説明(463 ) 四氫-1H-1,5-笨並二氮雜苯-1-乙醯胺基]-4-酮基-丁酸(605a) 3 A步驟。(3S)-3-(l-苐基甲氧羰基胺基)-4-酮基丁酸第三丁 酯半卡巴腙(2 10毫克。0.45莫耳,以類似芊氧羰基同系物 之 Graybill et al.,Int. J. Protein Res·,44, pp. 173-82 (1994) 所述方式)溶於10毫升DMF及2毫升二乙胺中,再攪拌2小 時。反應於眞空下濃縮生成(3S)-3-胺基-4-酮丁声第三-丁 酯半卡巴腙。上述殘留物及603a (200毫克,0.42毫莫耳)於 5毫升DMF及5毫升CH2Cl2iO’C溶液,以1-羥基苯並三唑 (57毫克,0.42毫莫耳)及1-(3-二甲胺基丙基)-3-乙基碳化二 亞胺鹽酸(98毫克,0.51毫莫耳)處理。反應在RT下攪拌18 小時,倒入EtOAc (75毫升)再以0.3N KHS04水溶液, NaHC03飽和水溶液及NaCl飽和水溶液洗滌,於NaS04上乾 燥及真空濃縮。層析(快速,Si02,0%-4% Me〇H/0/l% NH40H/CH2C12)生成 240毫克(83%)的 604a。7 7 A B Printed by the Order of the Ministry of Economic Affairs, the Consumer Cooperatives of the Bureau. 5. Description of the invention (you 2) The compounds in Table 12 were prepared as follows. Table 12 Compound numbers R2 R3 R4 605a H PhCH2CH2C (〇) PhC (O) 605b H PhCH2C (〇) PhC (O) 605c H PhC (O) PhC (O) 605d H CH3C (0) PhC (O) 60Se H ch3〇ch2c (〇) PhC (0) 605f H (CH3) 2CHCH2C (0) PhC (0) 605g H ch3c (〇) ch2c (o) PhC (0) 605h H CH30C (0) C (0) PhC (O ) 605i H ch3c (〇) c (〇) PhC (0) 605j H CH30C (0) PhC (O) 605m H CH3S03 PhC (0). 605n H CH3C (0) Amidino-2-C (0) 605. ch3 CH3C (0) PhC (O) 605p H PhCH2NHC (0) PhC (0) 605q H ^^ 000 PhC (O) 605s H 4- pyridylCH ^ C (0) PhC (0) 605t H 3-CH3PhCH2C (〇) PhC (O) 605v H PhCH2CH2C (0) PhCH2 (35) -3-[(35) -2-keto-3-octylamido-5- (3-phenylpropoxy) -2,3, 4,5- (Please read the meanings of the back * before filling out this page • νά • f -465- The standard of this paper is applicable to China National Standards (CNS) Α4; ^ (210X 297 mm) 1235157 A7 ______B7_ ^ _____ V. Description of the invention (463) Tetrahydro-1H-1,5-benzodiazepine-1-acetamido] -4-keto-butanoic acid (605a) 3A step. (3S) -3- (l-fluorenylmethoxycarbonylamino) -4-ketobutyric acid tert-butyl hemicarbazone (2 10 mg. 0.45 Mol, dissolved in 10 ml of DMF and 2 ml of diethylamine in the manner described by Graybill et al., Int. J. Protein Res., 44, pp. 173-82 (1994) similar to the oxocarbonyl homologue , And stirred for another 2 hours. The reaction was concentrated in the air to form (3S) -3-amino-4-one butanone tert-butyl ester hemicarbazone. The above residue and 603a (200 mg, 0.42 mmol) were 5 ml of DMF and 5 ml of CH2Cl2iO'C solution with 1-hydroxybenzotriazole (57 mg, 0.42 mmol) and 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide Treatment with hydrochloric acid (98 mg, 0.51 mmol). The reaction was stirred at RT for 18 hours, poured into EtOAc (75 mL), and washed with 0.3N aqueous KHS04 solution, saturated NaHC03 aqueous solution and saturated NaCl aqueous solution, dried over NaS04 and concentrated in vacuo. Chromatography (Si02, 0% -4% MeOH / 0/1% NH40H / CH2C12) yielded 240 mg (83%) of 604a.

經濟部中央樣準局員工消費合作社印X (請先聞讀背云之注意事項再填寫本\貝) B步驟。604a與10毫升33% TFA/H20攪摔4小時,再於眞空 中濃縮。殘留物溶於7毫升MeOH/醋酸/37%甲醛水溶液 (5:1:1)中,並攪拌18小時。層析(逆相C1 8,4.4毫米ID X 25 公分,15%至 70% CH3CN/0.1% TFA/H20)可生成 32毫克 (16%)的605a呈白色固體:iH NMR (CD3OD,呈半縮醛非對 块立體異構型式)d 7·85-7·78 (2H,d),7.5-7.32 (6H,m), 7.32-7.28 (1H, m), 7.18-6.98 (5H, m), 4.92^4.85 (2H, m), 4.5-4.32 (2H, m), 4.31-4.20 (2H, m), 3.7-3.6 (1H, m), 2.90-2.75 (2H, m), 2.65-2.5 (1H, m), 2.48-2.25 (3H, m) 〇 以下化合物以相似方法製備: ____ -466- 本紙ft尺度適用中國國家標车(CNS ) A4現格(210&gt;&lt; 297公慶) ' --- 1235157 Λ7 B7 五、發明説明( 464 ) (35)-3-[(33)-2-酮基-3-苄醯胺基-5-苯基乙醯基-2,3,4,5-四氩 -111-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁酸(60513)。 .148 毫克(33%)呈白色固體·· 4 NMR (CD3〇D) β 7.9-6.9 (m, 16H), 4.9 (s, 2H), 4.5 (m, 1H), 4.4 (m, 2H), 3.75 (s, 1H), 3.6 (dd, 1H), 3.45 (dd, 1H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (35)-3-[(33)-2-酮基-3-苄醯胺基-5-芊醯基-2,3,4,5-四氫-111-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁酸(605c)。3 19毫 克(56%)呈白色固體:4 NMR (CD3OD) β 7·9-6·9 (m,16H), 5.1 (m,1Η),4.9 (dd,1Η),4·7 (m,1Η),4.6 (dd,1Η),4.4 (m, 2H), 4.05 (m, 1H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (3 5)-3-[(3 3)-2-酮基-3-苄醯胺基-5-乙醯基-2,3,4,5-四氫-1士 1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁酸(605d)。190毫 克(38%)呈白色固體:[H NMR (CD3OD) β 1.9 (d,H), 2.4 (m, 1H)? 2.65 (m, 1H), 3.7 (m, 1H), 4.25 (m, 1H)? 4.45 (m, 2H), 4.8-5.05 (m, 3H), 7.3-7.7 (m, 7H), 7.9 (d, 2H) ^ (35)-〕-[(〇5)-2-網基-3-爷酷胺基-5-甲氧基乙酿基-2,3,4,5-四 氫-1H-1,5-苯並二氮雜箪-卜乙醯胺基]4-酮基-丁酸(605e)。 250毫克(78%) : NMR (CD3OD) β 1.87 (bs), 1.95 (s,2H), 經濟部中夬橾準局員工消费合作社印¾ 2.1 (bs), 2.4 (m, 2H), 2.65 (m, 2H), 3.59 (bs), 3.75 (bs), 3.87 (bs), 4.19 (m), 4.37 (m), 4.50-4.78 (bm), 4.92 (m), 5.27 (bs), 7.41-7.58 (m,7H),及 7.87 ppm (d,2H)。 (3S)-3-[(3S)-2·酮基-3-苄醯胺基-5-(3-甲基 丁醯基)-2,3,4,5- 四乱-1Η-1,5·苯·並一亂雜革-1-乙酿胺基]4-酌基-丁酸(605 f) 。210.5 毫克(46%)呈白色固體:lH NMR (CD3〇D) d 7.9- —____ - 467 - i尺度適用ta國家標ϋ ( CNS ) ( 2ι〇 χ2π公变) &quot; - ~ 1235157 經濟部中央標準局員工消贤合作社印製 Λ7 B7 五、發明説明(46δ ) 7.4 (m,9H),5.1 (m,1H),4.9 (m,1H), 4.6 (dd,1H),4.4 (m, 2H), 4.1 (d, 1H), 3.8 (m, 1H), 3.5 (q, 1H), 2.7 (m, 1H), 2.5 (m, 1H), 2.0 (m, 3H), 1.2 (t, 1H), 0.9 (d, 3H), 0.S (d, 3H) ^ (3 3)-3-[(33)-2-酮基-3-芊醯胺基-5-乙醯乙醯基-2,3,4,5-四氫 -1H_1,5-苯並二氮雜箪-l-乙醯胺基]4-酮基·丁酸(605g)。81 毫克(19%)白色固體:NMR (CD3〇D) β 7·9-7·3 (m,11H), 4.9^4.8 (m, 2H), 4.6-4.4 (m, 3H), 4.3 (m, 1H), 3.75 (q, 1H), 3.55 (d, 1H), 2.7 (m, 1H), 2.5 (m, 1H), 2.05 (s, 3H) ^ (jS)-3-[(3S)-2-嗣基S莲胺基-5-甲基草酿基-2,3,4,5-四氫 -1士1,5-苯並二氮雜箪-1-乙醯胺基]4_酮基-丁酸(60511)。 227毫克(54%)呈白色固體:iH NMR (CD3OD) d 2.5 (m, 1H),2.7 (m,1H),3.55 (s,3H),3.8-4.0 (m,2H),4.4 (m,1H), 4.6-4.8 (m, 2H), 4.95 (d, 1H), 5.1 (m, 1H), 7.3-7.7 (m, 7H), 7.9 (d, 2H), 8.6 (d, 1H) 〇 (3S)-3-[(3S)-2-酮基-3-芊醯胺基-5-乙醯羰基-2,3,4,5-四氫-lH-l,5-笨並二氮雜箪-l-乙醯胺基]4-酮基-丁酸(605i)。150 毫克(37%),白色固體:iH NMR (CD3〇D) d 7.9-7.3 (m, 12H), 5.1 (m, 1H), 4.65 (t, 1H), 4.55 (dd, 1H), 4.35 (m, 1H), 4.1 (d, 1H), 3.9 (q, 1H), 3.45 (q, 1H), 2.7 (m, 1H), 2.5 (m, 1H),2.25 (s,3H)。 (3S)-3-[(3S)-2-酮基-3-芊醯胺基-5-甲氧羰基-2,3,4,5-四氫-1 Η -1,5 -表並一亂雜卓-1 -乙酷胺基]4-嗣基-丁酸(605j)。234 毫克(44%)呈白色固體:iHNMR(CD3〇D) d 7.9-7.4 (m, 12H), 5.0 (m, 1H), 4.8-4.5 (m, 3H), 4.4 (m, 1H), 4.3 (t, 1H), -468- 本纸伕尺度適用中国國家標準(CNS ) A4規格(2丨0X 297公犛) (讀先閱讀背云之^意事項再填寫本頁)Employees 'Cooperative Cooperatives' Seal X of the Central Procurement Bureau of the Ministry of Economic Affairs (please read and read the precautions of the back of the cloud before filling in this \) Step B. 604a was stirred with 10 ml of 33% TFA / H20 for 4 hours, and then concentrated in the air. The residue was dissolved in 7 ml of MeOH / acetic acid / 37% aqueous formaldehyde (5: 1: 1) and stirred for 18 hours. Chromatography (reverse phase C1 8, 4.4 mm ID X 25 cm, 15% to 70% CH3CN / 0.1% TFA / H20) yields 32 mg (16%) of 605a as a white solid: iH NMR (CD3OD, half shrinkage Non-stereoisomeric form of aldehyde) d 7 · 85-7 · 78 (2H, d), 7.5-7.32 (6H, m), 7.32-7.28 (1H, m), 7.18-6.98 (5H, m), 4.92 ^ 4.85 (2H, m), 4.5-4.32 (2H, m), 4.31-4.20 (2H, m), 3.7-3.6 (1H, m), 2.90-2.75 (2H, m), 2.65-2.5 (1H , m), 2.48-2.25 (3H, m) 〇 The following compounds were prepared in a similar manner: ____ -466- This paper ft scale is applicable to China National Standard Car (CNS) A4 (210 &gt; &lt; 297 public celebration) '- -1235157 Λ7 B7 V. Description of the invention (464) (35) -3-[(33) -2-keto-3-benzylamido-5-phenylethylfluorenyl-2,3,4,5- Tetragon-111-1,5-benzodiazepine-1-acetamido] 4-keto-butanoic acid (60513). .148 mg (33%) as a white solid · 4 NMR (CD3〇D) β 7.9-6.9 (m, 16H), 4.9 (s, 2H), 4.5 (m, 1H), 4.4 (m, 2H), 3.75 (s, 1H), 3.6 (dd, 1H), 3.45 (dd, 1H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (35) -3-[(33) -2-one -3-benzylamidinyl-5-fluorenyl-2,3,4,5-tetrahydro-111-1,5-benzodiazepine-1-ethylamidino] 4-keto- Butyric acid (605c). 3 19 mg (56%) as a white solid: 4 NMR (CD3OD) β 7 · 9-6 · 9 (m, 16H), 5.1 (m, 1Η), 4.9 (dd, 1Η), 4 · 7 (m, 1Η), 4.6 (dd, 1Η), 4.4 (m, 2H), 4.05 (m, 1H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (3 5) -3-[(3 3) -2-keto-3-benzylamidinyl-5-ethenyl-2,3,4,5-tetrahydro-1,1,5-benzodiazepine-1-ethenylamino] 4-keto-butanoic acid (605d). 190 mg (38%) as a white solid: [H NMR (CD3OD) β 1.9 (d, H), 2.4 (m, 1H)? 2.65 (m, 1H), 3.7 (m, 1H), 4.25 (m, 1H )? 4.45 (m, 2H), 4.8-5.05 (m, 3H), 7.3-7.7 (m, 7H), 7.9 (d, 2H) ^ (35)-]-[(〇5) -2-Netbase -3-Cycloamino-5-methoxyethynyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-buethamidinyl] 4-one -Butyric acid (605e). 250 mg (78%): NMR (CD3OD) β 1.87 (bs), 1.95 (s, 2H), printed by the Consumers' Cooperatives of the China Prospective Bureau, Ministry of Economic Affairs 2.1 (bs), 2.4 (m, 2H), 2.65 ( m, 2H), 3.59 (bs), 3.75 (bs), 3.87 (bs), 4.19 (m), 4.37 (m), 4.50-4.78 (bm), 4.92 (m), 5.27 (bs), 7.41-7.58 (m, 7H), and 7.87 ppm (d, 2H). (3S) -3-[(3S) -2 · Keto-3-benzylamidinyl-5- (3-methylbutylamidino) -2,3,4,5- Tetrazol-1Η-1,5 · Benzene-Isotriazol-1-Ethylamino] 4-acetyl-butanoic acid (605 f). 210.5 mg (46%) as a white solid: lH NMR (CD3〇D) d 7.9- —____-467-Applicable to national standard CN (CNS) (2ι〇χ2π variable) on i scale &quot;-~ 1235157 Central Ministry of Economic Affairs Printed by the staff of the Bureau of Standards, Xiaoxian Cooperative Λ7 B7 V. Description of the invention (46δ) 7.4 (m, 9H), 5.1 (m, 1H), 4.9 (m, 1H), 4.6 (dd, 1H), 4.4 (m, 2H ), 4.1 (d, 1H), 3.8 (m, 1H), 3.5 (q, 1H), 2.7 (m, 1H), 2.5 (m, 1H), 2.0 (m, 3H), 1.2 (t, 1H) , 0.9 (d, 3H), 0.S (d, 3H) ^ (3 3) -3-[(33) -2-keto-3-amido-5-acetamidoethenyl-2 , 3,4,5-tetrahydro-1H-1,5-benzodiazepine-l-acetamido] 4-keto · butanoic acid (605 g). 81 mg (19%) white solid: NMR (CD3〇D) β 7 · 9-7 · 3 (m, 11H), 4.9 ^ 4.8 (m, 2H), 4.6-4.4 (m, 3H), 4.3 (m , 1H), 3.75 (q, 1H), 3.55 (d, 1H), 2.7 (m, 1H), 2.5 (m, 1H), 2.05 (s, 3H) ^ (jS) -3-[(3S)- 2-fluorenylS-Linylamino-5-methylsuccinyl-2,3,4,5-tetrahydro-1 ± 1,5-benzodiazepine-1-ethylfluorenyl] 4_ Keto-butyric acid (60511). 227 mg (54%) as a white solid: iH NMR (CD3OD) d 2.5 (m, 1H), 2.7 (m, 1H), 3.55 (s, 3H), 3.8-4.0 (m, 2H), 4.4 (m, 1H), 4.6-4.8 (m, 2H), 4.95 (d, 1H), 5.1 (m, 1H), 7.3-7.7 (m, 7H), 7.9 (d, 2H), 8.6 (d, 1H) 〇 ( 3S) -3-[(3S) -2-keto-3-amidino-5-acetamidocarbonyl-2,3,4,5-tetrahydro-lH-1,5-benzodiazepine Amidine-l-acetamido] 4-keto-butanoic acid (605i). 150 mg (37%), white solid: iH NMR (CD3〇D) d 7.9-7.3 (m, 12H), 5.1 (m, 1H), 4.65 (t, 1H), 4.55 (dd, 1H), 4.35 ( m, 1H), 4.1 (d, 1H), 3.9 (q, 1H), 3.45 (q, 1H), 2.7 (m, 1H), 2.5 (m, 1H), 2.25 (s, 3H). (3S) -3-[(3S) -2-keto-3-amidino-5-methoxycarbonyl-2,3,4,5-tetrahydro-1 fluorene -1,5- Lanzaza-1 -ethoxyamido] 4-fluorenyl-butyric acid (605j). 234 mg (44%) as a white solid: iHNMR (CD3〇D) d 7.9-7.4 (m, 12H), 5.0 (m, 1H), 4.8-4.5 (m, 3H), 4.4 (m, 1H), 4.3 (t, 1H), -468- The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (2 丨 0X 297 cm) (Read the meanings of the back of the cloud before filling in this page)

.1T 1235157 Λ7 B7 五、發明説明(466 ) 3.9-3.75 (m, 2H), 3.6 (s, 3H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (3S)-3-[(3S)_2-酮基-3-苄醯胺基-5-甲烷磺醯基-2,3,4,5-四氫 -1H-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁酸(605m)。 64.5毫克(34%)呈白色固體:4 NMR (DMS〇-d6,呈半縮醛 之非對映異構型式&amp;醛之開放型式)^9.48(0.2氏5),8.85-8.72 (1H, m), 8.65-8.60 (0.8 H, d), 8.30-8.26 (0.2 H, d), 7.95-7.88 (2H,d), 7.6-7.45 (6H, m), 7.44-7.38 (1H, m), 5.78-5.75 (0.2H, d), 5.48 (0.6H, s), 4.85-4.70 (2H, m), 4.62-4.54 (1H, d), 4.50-4.40 (2H, m), 4.25-4.14 (1H, m), 3.9-3.85 (1H, m), 3·16 (3H,s),3.05-2.3 (2, m)。 (jS)-3-[(jS)-2-銅基-3 -卞驢胺基-5-(各-2-談基)-2,3,4,5 -四氣 -1H-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁酸(605η)。 103 毫克(17%)呈白色固體·· 4 NMR (CD3OD) θ 1·9 (s,3Η), 2.5 (m, 1H), 2.65 (m, 1H), 3.75 (m, 1H), 4.3 (m, 1H), 4.5-4.7 (m,3H),4.85-5.1 (m,2H), 7.3-7.65 (m,6H),7.85-8.05 (m, 4H),8.45 (s,1H)。 (3 5)-3-[(3 3)-2-酮基-3-;醯胺基-5-乙醯基-2,3,4,5-四氫-7,9-二甲基-1H-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁酸 (605〇)。42毫克(12%)呈白色固體:β NMR (CD3OD,呈半 經濟部中夬標準局員工消費合作社印裝 (請先y讀背云之.么意事項再填寫本f ) 縮醛之非對玦立體異構型)d 7.85-7.74 (2H,m), 7·5-7·44 (1Η, m), 7.43-7.35 (4H? m), 5.6-5.05 (2H, m), 4.82-4.42 (2H, m), 4.40-3.95 (2H, m), 3.6-3.5 (1H, m), 2.7-2.38 (2H, m), 2·32 (3H,s), 2.27 (3H,s), 1.92 (3H,s)。 (3S)-3-[(3S)-2-酮基-3-芊醯胺基-5-芊基胺基羰基-2,3,4,5-四 -469 - 本纸伕尺度適用中g國家標李(CNS ) Μ堤格(210X 297公釐) 1235157 _____ · B7_ 五、發明説明(467 ) 氫-1H-1,5 -革·並一亂雜革-1·乙酷胺基]4-銅基-丁酸(605p) 3 165 毫克(37%)呈白色固體:iH NMR (CD3〇D) Θ 2.45 (m, 1H),2·7 (m,1H),3.8 (m,1H),4.15-4.5 (m,4H),4.5-4.75 (m, 2H), 4.8-5.0 (m, 2H), 7.1-7.7 (m? 12H), 7.9 (d, 2H) ^ (3S)-3-[(3S)_2-酮基-3-字醯胺基-5-[(3R,S) 3-四氫呋喃基曱 氧碳基]-2,3,4,5-四氫-1 Η-1,5-苯並二氮雜苯-1-乙醯胺基]4-酮基-丁酸(605q)。210毫克(66%) 4 NMR (CD3OD) 0' 1.95 (s,2H),2.4 (m,2H),2.65 (m,2H),3.29 (s,3H),3·78 (m), 3.87 (bs), 4.0 (d, 1H), 4.32 (m), 4.50-4.15 (m), 4.95 (m)? 5.27 (bs),7.45-7.65 (m,7H),及 7.89 ppm (d,2H)。 (3S)-3-[(3S)-2-酮基-3-苄醯胺基-5-(4-吡啶基乙醢基)· 2.3.4.5- 四氫-1H-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基-丁 酸(605s)。128 毫克(19%)白色固體·· iH NMR (CD3〇D) β 8.5- 7.4(m,13H),5.0(m,lH),4.7(m,lH),4.5(m,2H),4.45-4.4 (m, 3H), 3.8-3.7 (m, 2H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (3S)-3-[(3S)-2-i3 基Ss 胺基-5-(3-甲基苯基乙蹈基)· 2.3.4.5- 四氫-1H-1,5-苯並二I雜箪-1-乙醯胺基】4-酮基-丁 酸(605t)。132毫克(24%)呈白色固體:iH NMR (CD3〇D) d 經濟部中央櫺準局員工消費合作.杜印^ 7.8-6.7 (m, 13H), 4.9 (t, 1H), 4.75 (dd, 1H), 4.2 (dd, 1H), 4.1 (m, 2H), 3.8 (dd? 1H), 3.6 (q, 1H), 3.45 (dd, 1H), 3.3 (dd, 1H), 2.6 (m,1H), 2·3 (m,1H),2.15 (s,3H)。 (3S)-3-[(3S)-2-酮基-3-芊醯胺基-5-(3-苯基丙醯基)-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-1-乙醯胺基]4-酮基·丁酸三氟 醋酸(605v)。88毫克(28%)呈白色固體:[Η NMR (CD3〇D) -470- 衣紙乐尺度適用中g國家標孪(CNS) A4規格(210Χ:9·;公釐) ' 1235157 Λ7 __B7_ 五、發明説明(468 ) δ 7.63-7.51 (2Η, m), 7.5-7.35 (7H,'m), 7.25-7.10 (3H, m), 7.1-7.02 (2H, m), 5.04-4.96 (1H, m), 4.75-4.57 (2H, m), 4.38-4.26 (2H, m), 4.24-4.12 (2H, m), 4.10-4.02 (1H, d), 4.88-4.80 (1H, m), 2.90-2.80 (2H, m), 2.78-2.63 (1H, m), 2.55-2.35 (2H, m),2.34-2.22 (1H,m)。.1T 1235157 Λ7 B7 V. Description of the invention (466) 3.9-3.75 (m, 2H), 3.6 (s, 3H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (3S) -3-[( 3S) _2-keto-3-benzylamidinyl-5-methanesulfonyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-ethylfluorenamine Group] 4-keto-butyric acid (605m). 64.5 mg (34%) as a white solid: 4 NMR (DMS 0-d6, diastereomeric form of hemiacetal & open form of aldehyde) ^ 9.48 (0.2 ° 5), 8.85-8.72 (1H, m), 8.65-8.60 (0.8 H, d), 8.30-8.26 (0.2 H, d), 7.95-7.88 (2H, d), 7.6-7.45 (6H, m), 7.44-7.38 (1H, m), 5.78-5.75 (0.2H, d), 5.48 (0.6H, s), 4.85-4.70 (2H, m), 4.62-4.54 (1H, d), 4.50-4.40 (2H, m), 4.25-4.14 (1H , m), 3.9-3.85 (1H, m), 3.16 (3H, s), 3.05-2.3 (2, m). (jS) -3-[(jS) -2-copperyl-3 -codonylamino-5- (each-2-yl) -2,3,4,5 -tetraki-1H-1,5 -Benzodiazepine-1-acetamido] 4-keto-butanoic acid (605n). 103 mg (17%) as a white solid · 4 NMR (CD3OD) θ 1 · 9 (s, 3Η), 2.5 (m, 1H), 2.65 (m, 1H), 3.75 (m, 1H), 4.3 (m , 1H), 4.5-4.7 (m, 3H), 4.85-5.1 (m, 2H), 7.3-7.65 (m, 6H), 7.85-8.05 (m, 4H), 8.45 (s, 1H). (3 5) -3-[(3 3) -2-keto-3-; fluorenyl-5-ethylfluorenyl-2,3,4,5-tetrahydro-7,9-dimethyl- 1H-1,5-benzodiazepine-1-acetamido] 4-keto-butanoic acid (605o). 42 mg (12%) as a white solid: β NMR (CD3OD, printed by the Consumers' Cooperative of the China Standards Bureau of the Ministry of Semi-Economy (please read yinyunzhi first and then fill in this f).玦 Stereoisomeric form) d 7.85-7.74 (2H, m), 7 · 5-7 · 44 (1Η, m), 7.43-7.35 (4H? M), 5.6-5.05 (2H, m), 4.82-4.42 (2H, m), 4.40-3.95 (2H, m), 3.6-3.5 (1H, m), 2.7-2.38 (2H, m), 2.32 (3H, s), 2.27 (3H, s), 1.92 (3H, s). (3S) -3-[(3S) -2-keto-3-amidino-5-amidoaminocarbonyl-2,3,4,5-tetra-469-this paper is suitable for medium g National Standard Li (CNS) M Tige (210X 297 mm) 1235157 _____ · B7_ V. Description of the invention (467) Hydrogen-1H-1, 5-leather and miscellaneous leather-1 · ethoxyamido] 4 -Copper-butyric acid (605p) 3 165 mg (37%) as a white solid: iH NMR (CD3OD) Θ 2.45 (m, 1H), 2.7 (m, 1H), 3.8 (m, 1H) , 4.15-4.5 (m, 4H), 4.5-4.75 (m, 2H), 4.8-5.0 (m, 2H), 7.1-7.7 (m? 12H), 7.9 (d, 2H) ^ (3S) -3- [(3S) _2-keto-3-wordamidoamino-5-[(3R, S) 3-tetrahydrofuranyloxocarbonyl] -2,3,4,5-tetrahydro-1 fluorene-1, 5-Benzodiazepine-1-acetamido] 4-keto-butanoic acid (605q). 210 mg (66%) 4 NMR (CD3OD) 0 '1.95 (s, 2H), 2.4 (m, 2H), 2.65 (m, 2H), 3.29 (s, 3H), 3.78 (m), 3.87 ( bs), 4.0 (d, 1H), 4.32 (m), 4.50-4.15 (m), 4.95 (m)? 5.27 (bs), 7.45-7.65 (m, 7H), and 7.89 ppm (d, 2H). (3S) -3-[(3S) -2-keto-3-benzylamidinyl-5- (4-pyridylethylfluorenyl) 2.3.4.5-tetrahydro-1H-1,5-benzo Diazapyridine-1-acetamido] 4-keto-butanoic acid (605s). 128 mg (19%) white solid. IH NMR (CD3OD) β 8.5- 7.4 (m, 13H), 5.0 (m, 1H), 4.7 (m, 1H), 4.5 (m, 2H), 4.45- 4.4 (m, 3H), 3.8-3.7 (m, 2H), 2.7 (m, 1H), 2.5 (m, 1H) ^ (3S) -3-[(3S) -2-i3 group Ss amino-5 -(3-methylphenylethenyl) · 2.3.4.5-tetrahydro-1H-1,5-benzobisI heteropyridine-1-acetamido] 4-keto-butanoic acid (605t) . 132 mg (24%) as a white solid: iH NMR (CD3〇D) d Consumption cooperation among employees of the Central Bureau of Standards, Ministry of Economic Affairs. Du Yin ^ 7.8-6.7 (m, 13H), 4.9 (t, 1H), 4.75 (dd , 1H), 4.2 (dd, 1H), 4.1 (m, 2H), 3.8 (dd? 1H), 3.6 (q, 1H), 3.45 (dd, 1H), 3.3 (dd, 1H), 2.6 (m, 1H), 2.3 (m, 1H), 2.15 (s, 3H). (3S) -3-[(3S) -2-keto-3-amidino-5- (3-phenylpropanyl) -2,3,4,5-tetrahydro-1H-1, 5-Benzodiazepine-1-acetamido] 4-keto · butanoic acid trifluoroacetic acid (605v). 88 mg (28%) as a white solid: [Η NMR (CD3〇D) -470- Applicable to paper and paper scales in China National Standards (CNS) A4 specifications (210 ×: 9 ·; mm) '1235157 Λ7 __B7_ 5 Description of the invention (468) δ 7.63-7.51 (2Η, m), 7.5-7.35 (7H, 'm), 7.25-7.10 (3H, m), 7.1-7.02 (2H, m), 5.04-4.96 (1H, m), 4.75-4.57 (2H, m), 4.38-4.26 (2H, m), 4.24-4.12 (2H, m), 4.10-4.02 (1H, d), 4.88-4.80 (1H, m), 2.90- 2.80 (2H, m), 2.78-2.63 (1H, m), 2.55-2.35 (2H, m), 2.34-2.22 (1H, m).

Re 步骤B. R2Re Step B. R2

請 先 讀 背 云 之 Ϊ % 再 填 寫 本 Έ 步驟C. 經濟部中夬樣率局員工消费合作社印製 表13化合物述於下Please read Ϊ% of the cloud first and then complete this 本 Step C. Printed by the Employees' Cooperative of the Sample Rate Bureau in the Ministry of Economic Affairs Table 13 Compounds are described below

609 -471 - 本纸張尺度適用中國國家標洋(CNS ) A4堤格(210X297公釐 1235157 A7 B7 經濟部中央標準局員工消费合作社印^ 五、發明説明(469 表13 # r2 R3 r4 r6 Rt 609a Η PhCH2CH2C(0) PhCH2CH2C(0) Cl Cl 609b Η CH3C(0) phcro) Cl Cl (3S)-3-[(3S)-2-酮基-3-(3-笨基丙醢胺基)-5-(3-苯基两酿基l· 2,3,4,5-四氫-1H-1,5-苯並二氮雜苯-卜乙醯胺基J-4-(5,7·二 氣苯並哼唑-2-基)-4-酮基-丁酸(609a)。 A步驟。204 (223毫克,〇.5毫荚耳)及603r (300毫克,〇·36 毫莫耳)於4毫升DMF及4毫升CH2C12之溶液’以 (Ph3P)2PdCl2(10毫克),卜羥基苯並三唑(135毫克,1·〇毫 莫耳)及1-(3-二甲胺基丙基)-3-乙基碳化二亞胺鹽酸(115毫 克,0.6毫莫耳)處理。逐滴加氫化三正丁錫(219毫克’ 0.75毫莫耳)至反應中並攪拌18小時。反應倒入EtOAc中並 以10% NaHSOyjc溶液,NaHC03飽和水溶液及NaCl鲍和水 溶液洗涤,於Na2S04上乾燥並眞空濃縮。層析(快速, Si〇2,0%至50% EtOAc/己烷)可生成360毫克(86%)的607a呈 泡末狀3 B步驟3 607a (360毫克)於5毫升CH2C12之溶液,逐滴加至 1,1,1-三乙醯基-1,1-二氫-1,2-苯並二酮基-3(1H)-酮(362毫克 ,0.85毫莫耳)於20毫升&lt;:112(:12之懸浮液中3反應攪拌4.5 小時,以(:112(:12稀釋再以1:1飽和的NaHC03水溶液 /Na2S2〇3绝和水溶液混合物,飽和的NaHC0;3水溶液(2x)及 飽和的NaCl水溶液洗滌,於Na2S04上乾燥並眞空濃缩。層 析(快速,Si〇2,20% EtOAc/CH2Cl2)可生成 340毫克(95%) -472- 本纸掁尺度適用中311家標李(CNS ) A4規格(210X 297公釐) ----------克〆-- (請先閎請背面之/X意事項寫本頁) 訂 d 1235157 Λ7 ___B7 五、發明説明(470 ) 綱 608a。 、 c步躁,608a (300毫克,0.36毫莫耳)溶於25毫升25% TFA/ (^2(:12中,再於RT下攪拌5小時並眞空濃縮。層析(快速, Si02,〇-5%MeOH/CH2Cl2)可生成 118毫克(42%)的 609a,呈 白色固體··iHNMR(CD3〇D)¢y7·62-6·65(16H,m),4·85- 4.7 (1H, m), 4.68-4.42 (2H, m), 4.40-4.15 (2H, m), 3.48-3.28 (1H, m)? 3.0-2.9 (1H, m), 2.9-2.6 (4H, m), 2.55-2.18 (3H, m), 2.16-1.96 (2H,m)。 (3S)-3-[(3S)-2-酮基-3-;醯胺基-5-乙醯基.2,3,4,5-四氫-1H- 1,5 -本並一氣雜卓-1 -乙輕胺基]-4-(5,7-二氣苯並4咬-2 -基 )-4-酮基-丁酸(609b),製備自603d,以類似609a之方法可 生成287毫克(43。/〇整體產率)呈白色固體:lHNMR(DMSC^ d6) ό' 1·6 (s,3H),2.7-3.1 (m,2H),3·45 (m,1H), 4.4 (t,1H), 4.7 (m, 2H), 4.95 (m, 1H), 5.2, 5.4 (2s, 1H), 7.2-7.65 (m, 8H), 7.9 (d, 2H), 8.8 (t, 1H), 8.9, 9.1 (2s, 1H), 12.6 (br, 1H) ^ 經濟部中央糅準局員工消费合作杜印製609 -471-This paper size is applicable to China National Standard Ocean (CNS) A4 Tige (210X297 mm 1235157 A7 B7 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ^ V. Description of the invention (469 Table 13 # r2 R3 r4 r6 Rt 609a Η PhCH2CH2C (0) PhCH2CH2C (0) Cl Cl 609b Η CH3C (0) phcro) Cl Cl (3S) -3-[(3S) -2-keto-3- (3-benzylpropylamido) -5- (3-phenylammonyl 1,2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-buethamidinyl J-4- (5,7 • Digas benzohumazol-2-yl) -4-one-butyric acid (609a). Step A. 204 (223 mg, 0.5 mmol) and 603r (300 mg, 0.36 mmol) (Ear) in a solution of 4 ml of DMF and 4 ml of CH2C12 'with (Ph3P) 2PdCl2 (10 mg), hydroxybenzotriazole (135 mg, 1.0 mmol) and 1- (3-dimethylamino Treatment with propyl) -3-ethylcarbodiimide hydrochloride (115 mg, 0.6 mmol). Tri-n-butyltin hydride (219 mg '0.75 mmol) was added dropwise to the reaction and stirred for 18 hours. Reaction Pour into EtOAc and wash with 10% NaHSOyjc solution, saturated aqueous NaHC03 solution and NaCl abalone and aqueous solution, dry over Na2S04 and concentrate in air. Chromatography (quick, SiO2, 0% to 50% EtOAc / hexanes) yields 360 mg (86%) of 607a as a bubble 3 B Step 3 607a (360 mg) in 5 ml of CH2C12 solution, Add dropwise 1,1,1-triethylfluorenyl-1,1-dihydro-1,2-benzodiketo-3 (1H) -one (362 mg, 0.85 mmol) to 20 ml &lt;: 112 (: 12 in suspension of 3 was stirred for 4.5 hours, diluted with (: 112 (: 12 and then saturated with 1: 1 saturated NaHC03 aqueous solution / Na2S203 solution, saturated NaHC0; 3 aqueous solution ( 2x) and saturated NaCl aqueous solution, dried over Na2S04 and concentrated in vacuo. Chromatography (fast, SiO2, 20% EtOAc / CH2Cl2) can produce 340 mg (95%) -472- This paper is suitable for standard scale 311 Standard Li (CNS) A4 specifications (210X 297mm) ---------- grams-(please write down the / X notices on the back page first) Order d 1235157 Λ7 ___B7 5 Description of the invention (470) class 608a. C Step irritability, 608a (300 mg, 0.36 mmol) is dissolved in 25 ml of 25% TFA / (^ 2 (: 12), and then stirred at RT for 5 hours and left to concentrate . Chromatography (quick, SiO2, 0-5% MeOH / CH2Cl2) yielded 118 mg (42%) of 609a as a white solid. · IHNMR (CD3〇D), y7 · 62-6 · 65 (16H, m) , 4.85- 4.7 (1H, m), 4.68-4.42 (2H, m), 4.40-4.15 (2H, m), 3.48-3.28 (1H, m)? 3.0-2.9 (1H, m), 2.9- 2.6 (4H, m), 2.55-2.18 (3H, m), 2.16-1.96 (2H, m). (3S) -3-[(3S) -2-keto-3-; fluorenyl-5-ethylfluorenyl. 2,3,4,5-tetrahydro-1H-1,5 -benzyl Benzene-1 -ethylaminyl] -4- (5,7-digas benzo4-bitan-2-yl) -4-keto-butanoic acid (609b), prepared from 603d, can be prepared in a similar manner to 609a 287 mg (43% overall yield) was obtained as a white solid: 1HNMR (DMSC ^ d6), 1.6 (s, 3H), 2.7-3.1 (m, 2H), 3.45 (m, 1H) , 4.4 (t, 1H), 4.7 (m, 2H), 4.95 (m, 1H), 5.2, 5.4 (2s, 1H), 7.2-7.65 (m, 8H), 7.9 (d, 2H), 8.8 (t , 1H), 8.9, 9.1 (2s, 1H), 12.6 (br, 1H)

•473- 衣紙伕尺度適用中11國家標隼(CNS ) Μ堤格(210x 297公慶) 1235157 A7 37 五、發明説明(471 )• 473- The paper and paper scale is applicable to the 11 national standards (CNS) Μ Tig (210x 297 public holidays) 1235157 A7 37 V. Description of the invention (471)

611611

步驟BStep B

612 經濟部中夬標隼局wac工消费合作社印¾ (3S)-3-[(3S)-2-酮基-3-芊醯胺基-5-甲烷磺醯基_2,3,4,5-四氫 -111-1,5-苯並二氮雜箪-1-乙醯胺基]-5-(2,6-二氣芊醯氧基)-4-酮基-戊酸(612),以類似607a之方法(僅A及C步驟)利用 603111 (150毫克,0.36毫莫耳)替代6031:,及(35)-3-(缔丙氧 羰基胺基)-4-酮基-5-(2,6-二氣芊醯氧基)戊酸第三-丁酯 (110; 160毫克,0.36毫莫耳,WO 93/16710)替代 606a,可 生成 612 (56%)呈白色固體·· [H'NMR (CDC13) d 7.85-7.10 (12H, m), 5.4-4.65 (4H, m), 4.6-4.15 (4H, m)7 3.10-2.72 (5H, s &amp; m)。 -474- 本紙呆尺度逋用中國國家標隼(CNS ) A4規格(2丨0X 297公釐) 1235157 經濟部令夬樣準局員工消f合作杜印製 A7 B7 五、發明説明(472) 實例13 ' 化合物619-635依據實例13及表14所述合成。612 Printed by the Wac Industrial and Consumer Cooperatives, China Standards Bureau, Ministry of Economic Affairs (3S) -3-[(3S) -2-keto-3-amido-5-methanesulfonyl_2,3,4, 5-tetrahydro-111-1,5-benzodiazepine-1-ethenylamino] -5- (2,6-difluorofluorenyloxy) -4-one-pentanoic acid (612 ), Using a method similar to 607a (steps A and C only) using 603111 (150 mg, 0.36 mmol) instead of 6031 :, and (35) -3- (alanoxycarbonylamino) -4-one- Tertiary-butyl 5- (2,6-difluoroalkoxy) valerate (110; 160 mg, 0.36 mmol, WO 93/16710) instead of 606a, yielding 612 (56%) as a white solid [H'NMR (CDC13) d 7.85-7.10 (12H, m), 5.4-4.65 (4H, m), 4.6-4.15 (4H, m) 7 3.10-2.72 (5H, s &amp; m). -474- The paper size is in Chinese National Standard (CNS) A4 (2 丨 0X 297 mm) 1235157 The Ministry of Economic Affairs ordered the staff of the Prospective Bureau to cooperate and print A7 B7. V. Description of Invention (472) Example 13 'Compounds 619-635 were synthesized as described in Example 13 and Table 14.

-475- 衣纸乐尺度適用中S國家標準(CNS ) A4現格(210X 297公釐) 1235157 Λ7 _B7_ 五、發明説明(473) 619-635之合成。 、 A步骤。614之合成3 TentaGel S® 1^%樹脂(0.16毫莫耳/ 克,10.0克)置於多孔1之玻璃漏斗中,並以二甲替甲酿胺 (3 X 50毫升),10% (v/v)二異丙基乙胺(DIEA)於二曱替甲 醯胺(2 X 50毫升)及最後的二甲替甲醯胺(4 X 50毫升)洗滌 3加充份量的二甲替甲醯胺至樹脂中,以得於漿,再加 400 (1·42克,2·4毫莫耳,製備自(3S)-3-(苐基曱氧羰基)-4-酮丁 酸第三-丁酯,依 A.M. Murphy et al. J. Am. Chem. Soc.. 1 14, 3 156-3157 (1992)製備),1-羥基苯並三唑水合物 (H〇BT、H20: 0.367 克,2.4 毫莫耳)〇-苯並三唾-n,n,N,N,-四甲基鑌六氟磷酸鹽(HBTU ; 0.91克,2.4毫莫耳)及DIEA (0.55毫升,3·2毫莫耳)。反應混合物在室溫下利用腕臂震 盪器攪動一夜。樹脂在多孔玻璃漏斗上經吸空過遽分離, 再以二曱替曱醯胺洗滌(3 X 50毫升)。未反應的胺基再加 蓋,即樹脂與20% (v/v)醋肝/二甲替甲酿胺(2X25毫升)在 漏斗中且接反應(10分鐘/洗務)。樹脂以二甲替曱酷胺(3 X 50毫升)及二氣甲烷(3 X 50毫升)洗滌,再於眞空下乾燥一 夜生成614(11.0克,定量產率)β Μ濟部t央標绛局員工消资合作社印装 (詩先閎讀背面之注意事項再填寫本頁} Β步樣3 616之合成。樹脂614(3.0克,0.16毫莫耳/克, 0.48毫莫耳)於多孔玻璃漏斗中以二甲替曱醯胺(3父15毫 升)洗滌而泡脹。Fmoc保護基再以25% (v/v)六氫吡咬/二曱 替甲酷胺(15毫升)解離1〇分鐘(間歇攪拌),再以新鮮的六 氫毗哫試劑20分鐘。樹脂再以二甲替甲醯胺(3 χι5毫升) 及Ν-甲基吡咯啶酮(2 X 15毫升)洗滌3樹脂轉移至1〇〇毫升 -476- 適用國家標辛(CNS ) Α4現格(210Χ297公沒) —---- 1235157 Α7 Β7 五、發明説明(474 ) 燒瓶後’加N-甲基吡咯啶酮以得於漿,再加6〇3u (〇 736克 ,0.72毫莫耳)Η0ΒΤ·Η20 (0.112克,0·73毫莫耳),HBTU (0.27克,0.73毫莫耳)及〇圧八(0.26毫升,1.5毫莫耳)。反 應混合物在室溫下利用腕臂震盪器攪動一夜。樹脂以20% (ν/ν)醋酐於二甲替甲醯胺中之操作及加蓋,如614所述地 進行以生成616(3.13克,定量產率)。 C步驟。617之合成。此化合物製備自616 (0.24克,0.038 毫莫耳),利用 Advanced ChemTech 396 Multiple Peptide合 成儀進行。自動化循環包括有以二甲替甲醯胺(3 XI毫升) 洗滌樹脂,以25% (ν/ν)六氫吡啶/二曱替甲醯胺(1毫升)去 保護3分鐘,再以新鮮試劑(1毫升)歷1 〇分鐘以生成樹脂61 7 。樹脂以二曱替甲鏟胺(3 X 1毫升)及Ν-曱基吡咯啶酮(3 X 1毫升)洗滌。 經濟部中央標隼局員工消资合作社印製 D步躁。方法1。(624)。樹脂617以0.4Μ,塞吩-3-幾酸及 0.4ΜΗΟΒΤ於Ν-曱基吡咯啶酮(1毫升)溶液,0.4MHBTU於 1^-甲基批洛症_(〇.5毫升)及1.61^1〇1£八於&gt;^-甲基0比冬症嗣 (0.35毫升)溶液醯化,且反應在室溫下攪拌2小時。醢化步 驟重覆°最後,樹脂以二甲替甲醯胺(3 XI毫升),二氣甲 烷(3 XI毫升)洗滌,再於眞空中乾燥。醛自樹脂中解離, 再以95% TFA/5% Η20 (ν/ν,1.5毫升)在室溫下整體處理3〇 分鐘而去保護之。樹脂以解離試劑(1毫升)洗滌後,混合 的濾液加至冷的1:1乙醚:戊烷(12毫升)中(生成的沈;殿物 離心及傾析分離之β生成的團塊溶於10%乙腈/90% Η2〇/ 0.1 % TFA (15毫升)中,再冷凍乾燥以得粗製的624,呈白 -477- 本纸乐尺度適用中國國家標準(CNS ) Μ現格(2丨0X 297公釐) ' ^ 1235157 A7 ________Β7_:__ 五、發明説明(475 ) 色粉末。化合物以半製備式Rp_HPLC純化,利用Rainin MicnDS〇rbTM ci8管柱(5微米,21·4 X 250毫米),並以線性 乙猜梯度溶離(5%-45%)含有0.1%TFA(v/v)歷45分鐘,12 愛升/分。含有欲求產物之流份匯集再冷凍乾燥可生成624 (1〇.〇毫克,54%)。 D步驟。1A之方法。合成627。依循方法1之相似步驟, 樹脂01 7以4-(1-苇基甲氧羰基胺基)苯甲酸醯化並重覆之^ Fmoc基如C步骤所述地移去,且自甴態胺以2〇。/0 (v/v)乙奸 於二甲替甲醯胺(1毫升)及L6M DIEA於N-甲基吡咯唉酮 (0. j5愛升)在I溫下酿化2小時3重覆乙酿化步緣3遂自街 脂中解離可生成627 (4.2毫克,20%)。 D步驳。方法2。合成632。依循方法1之相似步黎,樹脂 617以0.5]^肉桂醯基氣於义甲基吡咯啶酮(1毫升)及1.61^ DIEA於N-甲基吡咯啶酮(0·35毫升)在室溫下醯化2小時。 酷化步隸重覆3醛自樹脂中解離可生成632 (1 1丨毫克, 58%) ^-475- The size of the paper and paper music scale is applicable to the Chinese National Standard (CNS) A4 (210X 297 mm) 1235157 Λ7 _B7_ V. Synthesis of Invention Note (473) 619-635. Step A. Synthesis of 614 3 TentaGel S® 1 ^% resin (0.16 mmol / g, 10.0 g) was placed in a glass funnel of porous 1, and dimethylformamide (3 X 50 ml), 10% (v / v) Diisopropylethylamine (DIEA) was washed with dimethylformamide (2 X 50 ml) and the last dimethylformamide (4 X 50 ml) 3 plus a sufficient amount of dimethylformamide Add amidine to the resin to obtain the pulp, add 400 (1.42 g, 2.4 mmol, prepared from (3S) -3- (fluorenylfluorenyloxycarbonyl) -4-ketobutyrate third -Butyl ester, prepared according to AM Murphy et al. J. Am. Chem. Soc. 1 14, 3 156-3157 (1992)), 1-hydroxybenzotriazole hydrate (HOBT, H20: 0.367 g , 2.4 millimolar) o-benzotrisial-n, n, N, N, -tetramethylphosphonium hexafluorophosphate (HBTU; 0.91 g, 2.4 millimolar) and DIEA (0.55 ml, 3.2 Mol). The reaction mixture was stirred overnight at room temperature using a wrist-arm shaker. The resin was separated by suction on a porous glass funnel and washed with diamidine (3 x 50 ml). Unreacted amines were capped, ie, the resin was reacted with 20% (v / v) hepatic acetate / dimethylformamide (2X25 ml) in the funnel and allowed to react (10 minutes / washing). The resin was washed with dimethyltetramidine (3 X 50 ml) and digas methane (3 X 50 ml), and then dried overnight in the air to produce 614 (11.0 g, quantitative yield) β Μ 部 部 central standard Printed by the Bureau of Consumer Affairs Cooperatives (Read the notes on the back of the poem before filling out this page) Β Step 3 616 Synthesis. Resin 614 (3.0 g, 0.16 mmol / g, 0.48 mmol) is porous The glass funnel was washed with dimethylformamide (15ml for 3 fathers) and swelled. The Fmoc protecting group was dissociated with 25% (v / v) hexahydropyridine / dimethylformamide (15ml). 〇 minutes (intermittent stirring), and then fresh hexahydropyridine reagent for 20 minutes. The resin was washed with dimethylformamide (3 x 5 ml) and N-methylpyrrolidone (2 x 15 ml). Transfer to 100ml-476- Applicable national standard Xin (CNS) A4 is now available (210 × 297 publicly available) —---- 1235157 Α7 B7 V. Description of the invention (474) N-methylpyrrolidone is added after the flask In order to obtain the pulp, add 〇3u (〇736 grams, 0.72 millimoles) Η0BT · Η20 (0.112 grams, 0.73 millimoles), HBTU (0.27 grams, 0.73 millimoles) and 〇 圧 八 ( 0 .26 ml, 1.5 mmol). The reaction mixture was stirred overnight with a wrist-arm shaker at room temperature. The resin was manipulated and capped with 20% (ν / ν) acetic anhydride in dimethylformamide, as 614 was performed as described to produce 616 (3.13 g, quantitative yield). Step C. Synthesis of 617. This compound was prepared from 616 (0.24 g, 0.038 mmol) using an Advanced ChemTech 396 Multiple Peptide Synthesizer. The automated cycle included washing the resin with dimethylformamide (3 XI ml), deprotection with 25% (ν / ν) hexahydropyridine / dimethotamine (1 ml), and fresh reagents (1 ml) over 10 minutes to produce Resin 61 7. The resin was washed with Dimethoamine (3 X 1 ml) and N-methylpyrrolidone (3 X 1 ml). Central Bureau of Standards, Ministry of Economic Affairs Employees' cooperatives printed D-step irritability. Method 1. (624). Resin 617 was 0.4M, cefin-3-guinic acid and 0.4MΗBBT in N-fluorenylpyrrolidone (1ml) solution, 0.4MHBTU in 1 ^ -methyl-Pycnogenol _ (0.5 ml) and 1.61 ^ 10 ^ ^ ^ -methyl 0 Bidong disease 嗣 (0.35 ml) solution, and It should be stirred at room temperature for 2 hours. Repeat the hydration step. Finally, the resin was washed with dimethylformamidine (3 XI ml), digas methane (3 XI ml), and then dried in the air. The aldehyde was removed from the resin. It was dissociated in medium, and then treated with 95% TFA / 5% Η20 (ν / ν, 1.5 ml) as a whole for 30 minutes at room temperature to deprotect it. After the resin was washed with a dissociation reagent (1 ml), the mixed filtrate was added to cold 1: 1 ether: pentane (12 ml) (the resulting precipitate; the pellet formed by centrifugation and decantation of the β-soluble pellet was dissolved 10% acetonitrile / 90% Η20 / 0.1% TFA (15 ml), and then freeze-dried to obtain the crude 624, which is white -477- The paper scale is applicable to the Chinese National Standard (CNS) Μ Appearance (2 丨 0X 297 mm) '^ 1235157 A7 ________ Β7 _: __ 5. Description of the invention (475) color powder. The compound was purified by semi-preparative Rp_HPLC using a Rainin MicnDS〇rbTM ci8 column (5 microns, 21.4 x 250 mm), and Dissolve in a linear gradient (5% -45%) containing 0.1% TFA (v / v) for 45 minutes, 12 liters / min. Fractions containing the desired product are pooled and freeze-dried to produce 624 (10.0. Mg, 54%). Step D. Method 1A. Synthesis 627. Following a similar procedure to Method 1, the resin 01 7 was tritiated with 4- (1-retylmethoxycarbonylamino) benzoic acid and repeated ^ Fmoc group. Removed as described in step C, and the ammonium amine is acetic acid at 20.0 / v (v / v) in dimethylformamide (1 ml) and L6M DIEA in N-methylpyrrolidone (0. j5 Aisheng) Brew for 2 hours at 1 ° C. 3 Repeated B fermentation steps. 3 Dissociate from street fat to produce 627 (4.2 mg, 20%). Step D. Method 2. Synthesis 632 Following the similar steps of Method 1, resin 617 was treated with 0.5% of cinnamonyl radicals in sense methylpyrrolidone (1 ml) and 1.61 ^ DIEA in N-methylpyrrolidone (0.35 ml) in the room. It was decanted for 2 hours at room temperature. Cooling step repeats the dissociation of 3 aldehydes from the resin to produce 632 (1 1 丨 mg, 58%) ^

經濟部中央櫺準局員工消費合作杜印$L D步骤。方;云3。合成629。依循方法1之類似步驟,樹脂 617與1.0Μ苯磺醯氣於二氣甲烷(〇 5毫升)及丨“吡啶於二氯 甲烷(0.60毫升)中於室溫下反應4小時β反應重覆。醛自樹 脂解離可生成629 (4.7毫克,24%)。 分析HPLC方法 ' (1) Waters DeltaPak C18 , 300Α (5微米,3·9 X 15〇毫米)。 線性乙腈梯度(5%-450/〇)含有0.1% 丁FA卜/4歷14分鐘,於i 毫升/分下。 _____ - 478 - 本纸&amp;尺度通用中§國冬標李(CNS ) A4現格(210 X 297公签〉 1235157 A7 B7 五、發明說明(476 ) 經濟部中夬樣隼局員工消费合作社印製Steps of $ L D step for consumer cooperation of the Central Government Bureau of the Ministry of Economic Affairs. Party; cloud 3. Synthesis 629. Following a similar procedure to method 1, resin 617 and 1.0 M benzenesulfonium gas were reacted in digas methane (05 ml) and "pyridine in dichloromethane (0.60 ml) at room temperature for 4 hours and the β reaction was repeated. The aldehyde dissociates from the resin to yield 629 (4.7 mg, 24%). Analytical HPLC method '(1) Waters DeltaPak C18, 300A (5 microns, 3.9 x 150 mm). Linear acetonitrile gradient (5% -450 / 〇 ) Contains 0.1% DFA / 4 calendars for 14 minutes at i ml / min. _____-478-Paper &amp; Standard General § National Winter Standard Li (CNS) A4 (210 X 297 notarized) 1235157 A7 B7 V. Description of Invention (476) Printed by the Consumers' Cooperatives of the Ministry of Economic Affairs

f-j rH CN + cn X CN cn L〇 CN cn m , + (T3 m 之 in + L〇 e- cC ^令 Οι rH dP rH CO ON rH rH ^ CO ^r CTi 蠢 o rH i-H ao 卜 CO in ' σ\ rH r-» 3: S ro L〇 cn lD cn - in «-Η m m L〇 o Γ0 in 0. 卜 〇 L〇 Z L〇 Csi 2: 卜 CN U L〇 2 in CM X 卜 CVJ U 卜 〇 2 CNJ X 00 CNJ 〇 。势。 % 〇\^° T yo °rz^ T zx 。々。 (ff T Z工 /V c\ tH VX) O CV4 VD τΗ CM VO (請先間讀背面之洼意事項弄填寫本頁) -479- 本纸法尺度適用tgil家標皁(CNS )八以見格(210·Χ 297公釐) 1235157 A7 B7 五、發明説明(477 ) 經濟部t夬標隼局員工消费合作社印製fj rH CN + cn X CN cn L〇CN cn m, + (T3 m in + L〇e- cC ^ 令 Οι rH dP rH CO ON rH rH ^ CO ^ r CTi oo rH iH ao BU CO in ' σ \ rH r- »3: S ro L〇cn lD cn-in« -Η mm L〇o Γ0 in 0. BU〇L〇ZL〇Csi 2: BU CN UL〇2 in CM X BU CVJ U BU 〇 2 CNJ X 00 CNJ 〇. Potential.% 〇 \ ^ ° T yo ° rz ^ T zx .々. (Ff TZ 工 / V c \ tH VX) O CV4 VD τΗ CM VO (Please read the meaning of the back side first Please fill in this page) -479- This paper method is applicable to tgil house standard soap (CNS) Yakisumi (210 · X 297 mm) 1235157 A7 B7 V. Description of invention (477) Ministry of Economic Affairs t 夬 Standards Bureau Printed by Employee Consumer Cooperative

rH t-H + cn re + 〇3 σν + m S T 2 Γ ΟΟ Η CC Η-1 〇4 X t-H dP CTk GO t-H o i~4 f-H 一 &lt;ίΡ 〇〇 ^ • 〇 iD rH rH dP ^ CO -00 3: X in in r—4 VD rH 卜 r-H m VD 00 ΕΧ4 X CD 〇 z VO CN rc CD CVJ u o t—i 〇 2 &lt;N4 Γ0 X (Ti r&gt; CJ cn 卜 〇 &lt;NJ CNi 5: CN CN CJ 赛 。々。 4¾ 。\ 。々。 5x 。乂。 2J CVi VD m CM VD eg VO 48 本纸伕尺度適用中國國家標李(CNS ) A4蚬格(210X 297公釐) (請先閱讀背面之注意事項再填寫本I) ly 1235157 A7 B7 五、發明説明(478 經濟部中央標隼局員工消費合作社印装rH tH + cn re + 〇3 σν + m ST 2 Γ ΟΟ Η CC Η-1 〇4 X tH dP CTk GO tH oi ~ 4 fH-&lt; ίΡ 〇〇 ^ • 〇iD rH rH dP ^ CO -00 3 : X in in r—4 VD rH and rH m VD 00 Ε × 4 X CD 〇z VO CN rc CD CVJ uot—i 〇2 &lt; N4 Γ0 X (Ti r &gt; CJ cn 卜 〇 &lt; NJ CNi 5: CN CN CJ competition. 々. 4¾. \. 々. 5x. 乂. 2J CVi VD m CM VD eg VO 48 The size of this paper is applicable to Chinese national standard (CNS) A4 grid (210X 297 mm) (please read the back first) For the matters needing attention, fill in this I) ly 1235157 A7 B7 V. Description of the invention (478 Printed by the Staff Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs

^ * rH 1-t + cn £ S + X ι-ί vn tH r-i in CO CO m 〇4 3: 一 dP S笤 卜 f—&lt; dP ^ 00 卜 一 dfi ^ &quot; * 卜 3: 2: in to tn r-H vn f-l m. o rH un cn L〇 卜 CO m (X4 X cn 卜 芝 CNJ K cn CN o CO 〇 ^3* z VO CM as to C\J o CO s 2; 卜 CN X VD C\J .u Sx 〇KwC °v X 5x °^工。 。芬 ^ 〇=T 0 1 5x Φ m 2 U) CM vo r- &lt;N (請先3讀背¾之:!意事一^填寫.尽頁 if 訂 齜 -481 - 本紙伕尺度適用中國國家標李(CNS )六4堤格(210X297公釐) 1235157 Λ7 B7 五、發明説明( 479 ) 經濟部中央標進局員工消资合作社印製^ * rH 1-t + cn £ S + X ι-ί vn tH ri in CO CO m 〇 4 3: a dP S 笤 f— &lt; dP ^ 00 bu dfi ^ &quot; * bu 3: 2: in to tn rH vn fl m. o rH un cn L〇 卜 CO m (X4 X cn Buzhi CNJ K cn CN o CO 〇 ^ 3 * z VO CM as to C \ J o CO s 2; bu CN X VD C \ J .u Sx 〇KwC ° v X 5x ° ^. .Fen ^ 〇 = T 0 1 5x Φ m 2 U) CM vo r- &lt; N ^ Fill in. End of page if Bookmark -481-The size of this paper is applicable to Chinese National Standard Li (CNS) 64 4 Teg (210X297 mm) 1235157 Λ7 B7 V. Description of Invention (479) The Ministry of Economic Affairs Central Standardization Bureau staff consumption Printed by a cooperative

(請先聞讀背面之/X意事項再填寫本頁)(Please read the / X notice on the back before filling this page)

本紙浪尺度適用中S國家標李(CNS ) .\4蚬格(210X 297公釐) 1235157 Λ7 B7 經濟部中夬樣準局貝工消费合作社印*. 五、發明説明(480 ) CM CN CM rH 4- m re Σ 1 卜 〇 L〇 f—( i-H in rH cn σι o L〇 cC 〇4 X η rH dP a\ 〇〇 cTi σ\ ο r-H rH ««—«» dP 00 CO sr &lt;Jk rH rH rH 一 c^P 卜 00 'sO r-H cP &lt;n cd O (Ti o 1 CSJ ID VJD 〇 L〇 1—4 ir&gt; · 〇 rH 0Ί 卜 〇 as 00 o in CM 2 卜 o 2; VD CVJ X VO CM u CO 〇 Z VO CNJ 5: in Csi 〇 σ\ Ο § CN X CM CNJ CJ CO 〇 2 *^r CN4 2: tD CSJ U 5 x 〇*&lt;7&gt;=〇 b δ x °XL° ^ °=&lt;〇 b 5x 〇=&lt;&gt;=〇 工 O 5 X 〇=&lt;7)=〇 &lt;N &lt;n VO n n vo n VO m cn VD -483- 請 讀 背 ώ 之 意 事 4 % 本 1 訂 本紙伕尺度適用中國國家標李(CNS ) Α4現格(210Χ297公釐) 1235157 A7 B7The scale of this paper is applicable to Chinese National Standards (CNS). \ 4 蚬 Grid (210X 297mm) 1235157 Λ7 B7 Printed by the Shellfish Consumer Cooperative of the China Prototype Bureau of the Ministry of Economic Affairs *. 5. Description of the Invention (480) CM CN CM rH 4- m re Σ 1 BU〇L〇f— (iH in rH cn σι o L〇cC 〇4 X η rH dP a \ 〇〇cTi σ \ ο rH rH «« — «» dP 00 CO sr &lt; Jk rH rH rH-c ^ P bu 00 'sO rH cP &lt; n cd O (Ti o 1 CSJ ID VJD 〇L〇1-4—ir &gt; · 〇rH 0Ί 〇as 00 o in CM 2 or o 2; VD CVJ X VO CM u CO 〇Z VO CNJ 5: in Csi 〇σ \ Ο § CN X CM CNJ CJ CO 〇2 * ^ r CN4 2: tD CSJ U 5 x 〇 * &lt; 7 &gt; = 〇b δ x ° XL ° ^ ° = &lt; 〇b 5x 〇 = &lt; &gt; = 〇 工 O 5 X 〇 = &lt; 7) = 〇 &lt; N &lt; n VO nn vo n VO m cn VD -483- Please read Meaning of back-sale 4% of this 1 book size is applicable to Chinese national standard (CNS) Α4 standard (210 × 297 mm) 1235157 A7 B7

五、發明説明(481 ) 實例14、 化合物 1605a-j,1605m,1605n,1605p,1605t 及 1605v 如 下述地合成aV. Description of the invention (481) Example 14, Compounds 1605a-j, 1605m, 1605n, 1605p, 1605t and 1605v are synthesized as follows

步驟B (請先閱讀背面之注意事填寫本頁) &quot;αStep B (Please read the notes on the back and fill in this page) &quot; α

步驟E_Step E_

步驟CStep C

步驟D 〇 經濟部中央標準局員工消費合作社印製 (3S) N-(2-網基-ο -第二-丁 乳談基胺基-2,3,4,5-®^-1Η-^®^ 並[3,4-1^[1,4-二氮雜箪(1600)。 · Α步驟。(2S) 2-第三-丁氧羰基胺基-3-(3-硝基吡啶-2-基胺 基)丙酸,以類似600a/103合成之2-第三-丁氧羰基胺基-3· (2-硝基苯基·胺基)丙酸A步驟方法製備,除了使用3-氯-3-硝基扯咬替代2-氟靖基苯,可生成4.05克(64%)黃色固體。 • 484 - 本紙乐尺度適用中國國家標李(CNSM4况格(210X297公釐) 1235157 A7 B7 五、發明说明(招2) B步骤,(2S) 2-第三-丁氧幾基胺基-3-(3-胺基σ比症-2-基胺 基)丙酸,以類似600a/103合成之(2S) 2-第三-丁氧羰基胺 基-3-(2-胺基苯基胺基)丙酸之3步驟製備,可生成3·68克( 定量)的暗色固體3 C步骤。(2S) 2-第三-丁乳碳基胺基-3-(3-胺基a比症-2-基胺 基)丙酸甲酯3 (2S)2·第三-丁氧羰基胺基-3-(3-胺基吡啶-2-基胺基)丙酸(360毫克,I·21毫莫耳)及Me〇H(59毫克,1·82 毫莫耳)於無水CH2C12 (20毫升)之溶液,以4-二甲接基1^匕 啶(DMAP,163毫克,1.33毫莫耳)及1-(3-二甲胺基兩基)-3· 乙基碳化二亞胺鹽酸(280毫克,1.45毫莫耳)處理。反應攪 拌18小時,以EtOAc (150毫升)稀釋,以水(2χ),绝和的 NaHC〇3及飽和的NaCl水溶液洗滌,於Na2S04上乾燥並眞 空濃縮3層析(快速,Si〇2,0至5% MeOH/CH2Cl2)可生成 250毫克(67%)標題化合物呈淺褐色固體。 經濟部中夬標準局員工消费合作.杜印¾ D步驟3 (3S) N-(2-酮基-3-第三-丁氧羧基胺基-2,3,4,5-四氫 JE. [-),4-b][ 1,4-一 亂雜革(1600) 3 (2S) 2-第二-丁氧 羰基胺基-3-(3-胺基吡啶-2-基胺基)丙酸甲酯(70毫克, 0.225莫耳)及25%甲氧化鈉/MeOH (130微升,0.56毫莫耳) 於無水MeOH(4毫升)之溶液加熱至6〇eCl6小時。反應在眞 空下濃缩,殘留物溶於2毫升H2〇中再以EtOAc萃取(3x)。 混合的萃取物在Na2S04上乾燥^眞空濃縮3層析(快迷, Si〇2,0至 3%MeOH/CH2Cl2)可生成 7.5 毫克(3%)的 1600,呈 淺褐色固體31HNMR(CD3OD)(ί7.96-7·92(lH,d),7·75-7.65 (1H, br. s), 7.14-7.08 (1H, d), 6.73-6.65 (lH, m), 5.83- ______ - 485 - ( CNS ) ( 2i0x 297/^¾ ) ' 1235157 A 7 B7 五、發明説明(明3) D.7D (1H, br. S), 5.40.25 (1H, br. s), 4.6-4.5 (lH,m), 3.95, 3·84 (1H,m),3·55、3.48 (1H,m), 1·4 (9H, s)。 E步躁。1601製備自1600,依循600a/103製備之D步樣方法Step D 〇 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (3S) N- (2-net-based-ο-Second-butyranylamino-2,3,4,5-® ^ -1Η- ^ ® ^ and [3,4-1 ^ [1,4-diazapyrene (1600). Step A. (2S) 2-third-butoxycarbonylamino-3- (3-nitropyridine- 2-Aminoamino) propanoic acid, similar to the 2-third-butoxycarbonylamino-3 · (2-nitrophenyl · amino) propanoic acid A method similar to 600a / 103 synthesis, except that 3 -Chloro-3-nitro bite replaces 2-fluoroazylbenzene, which can produce 4.05 g (64%) of yellow solid. • 484-The paper scale is suitable for Chinese national standard plums (CNSM4 condition (210X297 mm) 1235157 A7 B7 V. Description of the Invention (Trick 2) Step B, (2S) 2-Third-butoxyepiamino-3- (3-aminosigma ratio-2-ylamino) propionic acid, similar to 600a / 103 Synthesis of (2S) 2-third-butoxycarbonylamino-3- (2-aminophenylamino) propanoic acid in 3 steps, which can produce 3.68 g (quantitative) of dark solid 3 C Steps. (2S) 2-Third-butyrocarbamoylamino-3- (3-aminoa ratio-2-ylamino) propionic acid methyl ester 3 (2S) 2 · Third-butoxycarbonyl Amino-3- (3-aminopyridin-2-ylamino A solution of propionic acid (360 mg, I · 21 mmol) and MeOH (59 mg, 1.82 mmol) in anhydrous CH2C12 (20 ml), with 4-dimethyl linker 1 ^ pyridine ( DMAP, 163 mg, 1.33 mmoles) and 1- (3-dimethylaminodiyl) -3 · ethylcarbodiimide hydrochloride (280 mg, 1.45 mmoles). The reaction was stirred for 18 hours to Diluted with EtOAc (150 mL), washed with water (2x), absolute NaHC03 and saturated aqueous NaCl solution, dried over Na2S04 and concentrated in vacuo. 3 Chromatography (Rapid, SiO2, 0 to 5% MeOH / CH2Cl2 ) Can produce 250 mg (67%) of the title compound as a light brown solid. Consumers' cooperation with the China Bureau of Standards, Ministry of Economic Affairs, Du Yin ¾ D Step 3 (3S) N- (2-keto-3-third-butoxy Carboxylamino-2,3,4,5-tetrahydro JE. [-), 4-b] [1,4-Anodic leather (1600) 3 (2S) 2-Second-butoxycarbonylamino Methyl 3- (3-aminopyridin-2-ylamino) propanoate (70 mg, 0.225 mol) and 25% sodium methoxide / MeOH (130 μl, 0.56 mmol) in anhydrous MeOH ( 4 ml) of the solution was heated to 60eCl for 6 hours. The reaction was concentrated under vacuum and the residue was dissolved in 2 ml of H2O and then Et OAc extraction (3x). The combined extracts were dried over Na2S04 and concentrated in vacuo. 3 Chromatography (Foam, SiO2, 0 to 3% MeOH / CH2Cl2) yielded 7.5 mg (3%) of 1600 as a light brown 31HNMR (CD3OD) (7.99-7.92 (lH, d), 7.75-7.65 (1H, br.s), 7.14-7.08 (1H, d), 6.73-6.65 (lH, m), 5.83- ______-485-(CNS) (2i0x 297 / ^ ¾) '1235157 A 7 B7 V. Description of the invention (Ming 3) D.7D (1H, br. S), 5.40.25 (1H, br. S) , 4.6-4.5 (lH, m), 3.95, 3.84 (1H, m), 3.55, 3.48 (1H, m), 1.4 (9H, s). E step irritability. 1601 was prepared from 1600, followed by step D method of 600a / 103

步驟DStep D

經濟部中央樣隼局員工消f合作社印製 160j之σ成160〇製備自1601,依循自6〇〇合成603之方法Printed by the staff of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs, Cooperative Society, 160j, 160, 160, prepared from 1601, followed by 603 synthesis from 600

步驟AStep A

NH2NH2

486- 表纸乐尺度適用中国國參標李(〇\5)焱4現格(210&gt;&lt; 297&gt;公凝 1235157 Λ7 37 五、發明説明( 484 ) 1605之合成。1605製備自1603,依由603製備605之方法。 表15 1605 Rs r4 a PhCH2CH2C〇 PhCO b PhCH2CO PhCO c PhCO PhCO d CH3C0 PhCO e CH3OCH2CO PhCO f (ch3)2chch2c〇 PhCO g ch3coch2co PhCO h CH30COCO PhCO i CH3COCO PhCO j CH.OCO PhCO m CH3S03 PhCO n CH3C0 奈基-2-CO P PhCH2NHC0 PhCO t 3-CH3PhCH2CO PhCO V PhCH2CH2CO PhCH2 實例15 M濟部中夬標準局員工消资合作社印製 -裝丨 (請先聞讀背面之^意事1_^寫本一貝 化合物1610-1621製備自1600,以由600a/l 03及600b製備化 合物619-63 5所用之類似方法。 -487- 本纸乐尺度通用中國國家標李(CNS ) Μ現格(210X 297公釐〉 1235157 經濟部令夬標準局員工消費合作杜印¾486- The paper scale is applicable to the Chinese national ginseng standard plum (〇 \ 5) 焱 4 (210 &gt; &lt; 297 &gt; Gongning 1235157 Λ7 37 V. Synthesis of the invention (484) 1605. 1605 was prepared from 1603, according to Method for preparing 605 from 603. Table 15 1605 Rs r4 a PhCH2CH2C0PhCO b PhCH2CO PhCO c PhCO PhCO d CH3C0 PhCO e CH3OCH2CO PhCO f (ch3) 2chch2c0PhCO g ch3coch2co PhCO h CH30COCO PhCO i CH3COCO PhCO j CHO. CH3S03 PhCO n CH3C0 Nyki-2-CO P PhCH2NHC0 PhCO t 3-CH3PhCH2CO PhCO V PhCH2CH2CO PhCH2 Example 15 Printed by the Consumers' Cooperatives of the Ministry of Economic Affairs of the China Standards Administration Bureau-(Please read the ^ 意 事 1_ on the back first ^ Written compound 1610-1621 was prepared from 1600, similar to the method used to prepare compounds 619-63 5 from 600a / 103 and 600b. -487- This paper has a common Chinese national standard (CNS). 210X 297 mm> 1235157 Orders from the Ministry of Economic Affairs, Standards Bureau, Consumer Cooperation Du Yin ¾

本紙&amp;尺度適用中S國家標準(CNS ) A4規格(2丨0X297公釐) 1235157 Λ7 B7 五、發明説明( 486 )其中於化合物1610-1621, a R3 = CH3C(0)-b R3 = CH3〇CH2C(〇)-: 1610The paper &amp; standard is applicable to China National Standard (CNS) A4 specification (2 丨 0X297 mm) 1235157 Λ7 B7 V. Description of the invention (486) Among the compounds 1610-1612, a R3 = CH3C (0) -b R3 = CH3 〇CH2C (〇)-: 1610

16111611

16121612

16131613

16141614

16151615

16161616

1617 經濟部中央標準局員工消費合作杜印¾1617 Employees' Cooperation of Central Standards Bureau, Ministry of Economic Affairs Du Yin ¾

161S 1619 1620161S 1619 1620

CH3 OCH3 O

〇V o〇V o

CH, -489 本紙伕尺度適用中國國家標李(CNS M4地格(2[0X 297公釐) 1235157 A7 B7 五、發明.説明( 487 ) 、。又 請 先 實例16 · 化合物含有骨架(ell),(yl),(y2),(z)及(el:2)可如下述 地合成3 骨架之合成,其中RiS(ell)且Y2*=0。CH, -489 The standard of this paper is applicable to Chinese national standard plum (CNS M4 grid (2 [0X 297 mm) 1235157 A7 B7 V. Invention. Explanation (487)). Please also refer to Example 16 · Compound contains skeleton (ell) , (Yl), (y2), (z), and (el: 2) can be synthesized as follows: RiS (ell) and Y2 * = 0.

NH—NH 讀 背 之 意 事NH—NH Reading Meaning

寫 頁 C〇2〇H2PhWrite page C〇2〇H2Ph

OO

BoclBocl

經濟部中夬櫺隼局員工消资合作社印¾Printed by the Consumer Affairs Cooperative of Zhongli Bureau of the Ministry of Economic Affairs ¾

OO

O 269 490- 本紙法尺度通用中a國家標洋(CNS ) A4現格(210X 297公釐) 1235157 A7 B7 經濟部中夬標準局員工消费合作社印¾ 五、發明説明(488 ) 骨架Ri之合成,其中1^是(71)且丫2是=〇。O 269 490- The standard of this paper is universal Chinese national standard (CNS) A4 is present (210X 297 mm) 1235157 A7 B7 Printed by the Consumers' Cooperatives of China Standards Bureau of the Ministry of Economic Affairs Ⅴ 5. Description of invention (488) Synthesis of skeleton Ri Where 1 ^ is (71) and y2 is = 〇.

270 (請先閱讀背面之注意事項再填寫本f ) -491 - 本纸&amp;尺度通用中國國家標李(CNS ) Μ現格(2l〇X:97公釐) 1235157 A7 B7 五、發明説明( 489 ) 骨架I之合成,其中Ri*(y2)且¥2是仏且乂7是〇270 (Please read the notes on the back before filling in this f) -491-This paper &amp; standard common Chinese national standard plum (CNS) M is present (210X: 97 mm) 1235157 A7 B7 V. Description of the invention ( 489) Synthesis of skeleton I, where Ri * (y2) and ¥ 2 are 仏 and 乂 7 is 〇

Boc SN ΗBoc SN Η

Η ΟΗ Ο

經濟部令夬標準局員工消贫合作杜印製Poverty alleviation cooperation for employees of the Ministry of Economic Affairs

TFA ΟTFA Ο

-492 本纸張尺度適用中S國家標达(CNS ) Α4堤格(210X29?公釐) 1235157 A7 B7 五、發明説明( 490 )-492 The standard of this paper is applicable to China National Standards (CNS) Α4 tier grid (210X29? Mm) 1235157 A7 B7 V. Description of the invention (490)

骨架I之合成,其中Ri是(y2)且其、中丫2是=0且X7是NHSynthesis of skeleton I, where Ri is (y2) and its, y2 is = 0 and X7 is NH

+ Η+ Η

TFA ΟTFA Ο

(請先閱讀背面之-;1意事項\^%寫本頁) -裝· 訂 經濟部中夬標隼局員工消費合作社印製 -493- 本紙法尺度適用中g國家標準(CNS ) Α4規格(210X 297公釐) 1235157 A7 B7 五、發明説明(491(Please read the-on the back of the first; 1 note \ ^% write this page)-Binding and ordering Printed by the Employees' Cooperatives of the China Standards Bureau of the Ministry of Economic Affairs -493- The national standard (CNS) Α4 specification of this paper method applies (210X 297 mm) 1235157 A7 B7 V. Description of the invention (491

骨架Ri之合成,其中1^是以2)且Y2*H2iX7*NHSynthesis of skeleton Ri, where 1 ^ is 2) and Y2 * H2iX7 * NH

CbzHl·^ o,、cCbzHl · ^ o, c

(請先閱讀背面之注意事項再填芎本頁 裝 訂 it 經濟部中夬樣準局員工消费合作社印¾ -494- 本纸法尺度適硐中S國家標车(CNS ) A4現格(2丨0X2W公釐) 1235157 Λ7 B7 五、發明説明(492 ) 骨架Ri之合成,其中心是卜)且其中丫2是〇(Please read the precautions on the back before filling in this page. It is bound by it. It is printed by the Employees' Cooperatives of the Prospective Bureau of the Ministry of Economic Affairs ¾ -494- This paper method is suitable for the National Standard Vehicle (CNS) A4 (2 丨0X2W mm) 1235157 Λ7 B7 V. Description of the invention (492) The synthesis of the skeleton Ri, the center of which is Bu), and γ 2 is 〇

PhCH2〇2〇^^ 1) PC15PhCH2〇2〇 ^^ 1) PC15

hA、nJhA, nJ

Boc 2) NaHC〇3 X = NHCbz X = OCH2PhBoc 2) NaHC〇3 X = NHCbz X = OCH2Ph

PhCH2〇2CPhCH2〇2C

267267

H2, Pd/CH2, Pd / C

ococ

OO

1) NH2NH2 經濟部中央樣準局員工消費合作社印袈 0 o1) NH2NH2 Consumer Cooperatives' Seal of the Central Sample Bureau of the Ministry of Economic Affairs 0 o

1) TFA 2) COCl21) TFA 2) COCl2

274 275 X7 = NH X7 = 〇 -495 本纸乐尺度適用中國國家標李(CNS ) Λ4規格(210 X 297公釐) 1235157 A7 B7 五、發明説明(493 ) 骨架Ri之合成,其中1^是021)且¥2是=〇 ,C〇2CH2Ph ^^C〇2CH2Ph /274 275 X7 = NH X7 = 〇-495 This paper scale is applicable to Chinese National Standard Plum (CNS) Λ4 specification (210 X 297 mm) 1235157 A7 B7 V. Description of the invention (493) Synthesis of skeleton Ri, where 1 ^ is 021) and ¥ 2 is = 〇, C〇2CH2Ph ^^ C〇2CH2Ph /

t-BuONH2__- t-BuO-NH 276t-BuONH2 __- t-BuO-NH 276

CbzCbz

COCl2COCl2

276276

M濟部中夬標李局員工消费合作杜印¾M Ministry of Economic Affairs wins bid for Li Bureau employee consumption cooperation

1〉 H2, Pd/C 2) PC15 01> H2, Pd / C 2) PC15 0

277 -496- 本纸伕尺度通用中國國家標李(CNS M4堤格(210X297公釐) 1235157 A7 B7 五、發明説明(494) 實例17、277 -496- The standard of this paper is Chinese national standard plum (CNS M4 dyke (210X297 mm) 1235157 A7 B7 V. Description of the invention (494) Example 17,

化合物2001,2002,2100a-e及2201之製備如下述 Ο ^Compounds 2001, 2002, 2100a-e and 2201 were prepared as follows.

ΟΟ

2002 Ο2002 Ο

Η 2001 經濟部中夬橾準局員工消费合作杜印¾ (1S,9S) 9-芊醢基甲醯胺基-6,10-二酮基-1,2,3,4,7,8,9,1心八 氫-6H“答哜並[l,2-a][l,2]二氮雜苯-1-羧酸(2000)。對9一胺 1 基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611-嗒畊並[1,24][1’^ 二氮雜箪-1-羧酸第三-丁酯(〇3 2,128,984;340毫克,1·1) 毫莫耳)於CH2C12之溶液中,加入芊縫基甲酸(260毫克 1.7毫莫耳),HOBT(230毫克,1.7毫莫耳)及EDC(34〇毫兄 ,1.7毫莫耳)β生成的混合物在環境溫度下撥拌16小時, 倒入IN HC1中再以CH2C12萃取。有機萃取物進一步以跑和 的NaHC03洗滌,於MgS〇4上乾燥並濃縮生成1999,呈戔 黃色固體。固體溶於CH2C12 (25毫升)及TFA (25毫升)中並 -497 本紙乐尺度適用中國國家標李(CNS ) A4况格(210x 297公釐) 1235157 A7 ___B7_____ 五、發明説明( 495 ) 攪拌一夜,再眞空濃縮生成560毫、克的2000,呈油狀3 [1S,9S(2RS,3S)] 9-苄醯基甲醯胺基-6,10-二酮基-1,2,3,4,7』, 9,10-八氫-N-(2(R,S)-芊氧基-5-酮四氩啥喊基答3井 並[l,2-a][l,2]-二氮雜箪-1_幾醯胺(2001),合成自2〇〇〇,以 類似化合物213e之方法可生成410毫克(63%)的200丨,呈白 色固體;4 NMR (CDC13;非對映立體異構物之混合物)〇' 8·25 (1H,d),8.23 (1H, d), 7.78 (1H,dd),7·65 (1H,bm),7.50 (2H, m), 7.40-7.25 (4H, m), 6.55 (1H? d), 5.57 (1H, d)? 5.10 (1H,t),5.05-4.95 (2H,m),4.90 (1H,d),4.80 (1H, d),4.72 (1H,bm),4·65 (1H, m),4,55 (1H,m), 4,45 (1H, t),3.25 (1H, m),3.15 (1H,m),3·00 (2H,bm),2.90 (1H,dd),2.70 (1H,m), 2·47 (1H,dd),2.45 (1H,m),2·35 (1H,m),2.00-1.75 (4H,m), 1.60 (1H, bm) ° 經濟部中央標準局員工消費合作社印裝 (請先聞讀背面之淦意事項再填寫本一貝) [3S(1S,9S)] 3-(9-苄醯基甲醯胺基-6,10-二酮基·1,2,3,4,7,8,9, 10-八氫-6Η-嗒啩並[l,2-a][l,2]-二氮雜箪-1-羧藴胺基酮 基丁酸(2002)。化合物2001 (58.6毫克,0.10毫莫耳)以5毫 升TFA/MeCN/水(1:2:3)處理,並在室溫下攪拌6.5小時。反 應以乙酸萃取。水層以利用MeCN共沸移去水方式濃縮。 產物懸浮於CH2C12,於眞空下濃縮並以乙醚沈澱可生成 46.8毫克(99%)的 2002,呈白色固體:lH NMR (CD3OD) d 9·05 (0.25H,d),8·15 (1H,d),7.68 (1H,t),7.64 (0.25H,d), 7.55 (3H, t), 7.35 (0.5H, m), 5.22 (1H, t), 4.90 (1H, m)? 4.58 (1H, dd), 4.50 (1H, m), 4.28 (1H, bm), 3.45 (1H, m), 3.10 (1H, bt), 2.68 (1H, ddd), 2.60-2.45 (2H, m), 2.30 (1H, dd), 2.15- -498- 本紙ft尺度通用中1]國家標隼(CNS ) A4現格(210X 29Y公釐) &quot;&quot; 1235157 A7 B7 五、發明説明(496 ) 2·05 (2H,m),1·90 (2H,bm),1.68 (1、H,bm)。 〇Η 2001 Consumption Cooperation between Employees of China and the Central Bureau of the Ministry of Economic Affairs Du Yin ¾ (1S, 9S) 9-Aminomethylamido-6,10-diketo-1,2,3,4,7,8, 9,1 octahydro-6H "Anhydro [1,2-a] [l, 2] diazabenzene-1-carboxylic acid (2000). P-9 monoamine 1-yl-6,10-dione -1,2,3,4,7,8,9,10-octahydro-611-dalopano [1,24] [1 '^ diazapyridine-1-carboxylic acid tert-butyl ester ( 〇3 2,128,984; 340 mg, 1.1) mol) in a solution of CH2C12, adding quilted formic acid (260 mg 1.7 mol), HOBT (230 mg, 1.7 mol) and EDC ( (34 mM, 1.7 mM)) The mixture generated by β was stirred at ambient temperature for 16 hours, poured into IN HC1 and extracted with CH2C12. The organic extract was further washed with NaHC03 and dried on MgS04. And concentrated to form 1999, a ochre yellow solid. The solid is dissolved in CH2C12 (25 ml) and TFA (25 ml) and -497. This paper scale is suitable for Chinese national standard plum (CNS) A4 (210x 297 mm) 1235157 A7 ___B7_____ 5. Description of the invention (495) Stir overnight and concentrate in the air to produce 560 milligrams and 2000 grams, which is oily 3 [1S, 9S (2RS, 3 S)] 9-benzylfluorenylmethaneamido-6,10-diketonyl-1,2,3,4,7 ′, 9,10-octahydro-N- (2 (R, S) -fluorene Oxy-5-ketone tetra-argon sulfanyl group 3 wells and [l, 2-a] [l, 2] -diazapyridine-1_chipinamine (2001), synthesized from 2000, to A method similar to compound 213e can yield 410 mg (63%) of 200 丨 as a white solid; 4 NMR (CDC13; a mixture of diastereoisomeric forms) 0 '25 (1H, d), 8.23 (1H , d), 7.78 (1H, dd), 7.65 (1H, bm), 7.50 (2H, m), 7.40-7.25 (4H, m), 6.55 (1H? d), 5.57 (1H, d)? 5.10 (1H, t), 5.05-4.95 (2H, m), 4.90 (1H, d), 4.80 (1H, d), 4.72 (1H, bm), 4.65 (1H, m), 4,55 ( 1H, m), 4,45 (1H, t), 3.25 (1H, m), 3.15 (1H, m), 3.00 (2H, bm), 2.90 (1H, dd), 2.70 (1H, m) , 2.47 (1H, dd), 2.45 (1H, m), 2.35 (1H, m), 2.0-1.75 (4H, m), 1.60 (1H, bm) ° Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Printed (please read the notes on the back before filling in this one) [3S (1S, 9S)] 3- (9-benzylmethylformamidine-6,10-diketo · 1,2 , 3,4,7,8,9, 10-octahydro-6Η-da-benzo [l, 2-a] [l, 2]- Diazapyridine-1-carboxylaminoketobutyric acid (2002). Compound 2001 (58.6 mg, 0.10 mmol) was treated with 5 mL of TFA / MeCN / water (1: 2: 3) and stirred at room temperature for 6.5 hours. The reaction was extracted with acetic acid. The aqueous layer was concentrated by removing water by azeotropic distillation with MeCN. The product was suspended in CH2C12, concentrated under a vacant space and precipitated with ether to give 46.8 mg (99%) of 2002 as a white solid: lH NMR (CD3OD) d 9 · 05 (0.25H, d), 8 · 15 (1H, d), 7.68 (1H, t), 7.64 (0.25H, d), 7.55 (3H, t), 7.35 (0.5H, m), 5.22 (1H, t), 4.90 (1H, m)? 4.58 (1H , dd), 4.50 (1H, m), 4.28 (1H, bm), 3.45 (1H, m), 3.10 (1H, bt), 2.68 (1H, ddd), 2.60-2.45 (2H, m), 2.30 ( 1H, dd), 2.15- -498- This paper is commonly used in ft scale 1] National standard (CNS) A4 is now (210X 29Y mm) &quot; &quot; 1235157 A7 B7 V. Description of the invention (496) 2 · 05 ( 2H, m), 1.90 (2H, bm), 1.68 (1, H, bm). 〇

(請先閱讀背一 8之浼意事項再填寫.尽一貝) 214c 2100a R1 2100b R1 [1S,9S(2RS,3S)] 9-芊醯胺基-6,l〇-二酮基-1,2,3,4,7,8,9,10-—- 經濟部中央樣準局員工消f合作杜印¾ 八氫-N-(2-異丙氧基-5-酮基-四氫-呋喃-3-基)-6H-嗒畊並 [l,2-a][l,2]二氮雜苯-1-羧醯胺(2100a)。214e (101毫克, 0.23毫莫耳)於異丙醇(1〇毫升)之溶液,在室溫下以催化剤 量之對位-甲苯磺酸(10毫克)攪拌。75分鐘後,反應昆合物 倒入飽和的NaHC03中再以CH2C12萃取。混合的萃取物於 Na2S〇4上乾燥並濃縮。快速層析(Si02,CH2C12至EtOAc) 可生成56毫克(51%)的2100a,呈白色固體: (CDC13;非對玦立體異構物之混合)(^7.9-7.8(2反111),7&gt; 7.5 (1H,m),7.5-7.4 (2H,m),7·1 (〇·5Η,d),6.9 (0.5H,d),6.4 (0.5H,d),5·6 (0·5Η,d),5.3 (0.5H,s),5.2-5.1 (1H,m),4.95 (0.5H,m),4.75-4.5 (1.5H,m),4.35 (0·5Η,t),4·1 (〇·5Η,m), -499 - _ 一 本纸伕尺度遴用中國國家標隼(CNS ) A4現格(210X 297公釐) 1235157 經濟部中央堞毕局貝工消费合作社印¾ A 7 B7 五、發明説明(497 ) 3.98 (0.5H, m), 3.3-2.75 (4H, m), 2,5-2.4 (2H,m), 2.25 (1H, m), 2.1-1.9 (3H,m),1.75-1.55 (2H,m)。 [3S(1S,9S)] 3-(9-芊醯基曱醯胺基-6,10-二銅基-1,2’3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]-二氮雜苯-1-羧醯胺基)-4,‘ 二乙氧基-丁酸乙酯(2100b)。214e (16毫克’ 0.036愛莫耳) 於乙醇(2毫升)之溶液在室溫下以催化劑量之對位-甲苯讀 酸(2毫克)處理。5天後,反應混合物倒入飽和的NaHC〇3中 再以CH2C12萃取。混合的萃取物於Na2S〇4上乾燥並濃縮。 快速層析(Si02,CH2Cl2:EtOA0 95:5 v/v)可生成 16毫克(81%) 的 2100b,呈白色固體:NMR (CDC13) d 7.85-7.74 (2H,m), 7.55-7.38 (3H,m), 7.04-6.95 (lH,d), 6.61-6.48 (lH,d), 5.15- 5.08 (lH,m),4.63-4.53 (lH,m),4.52-4.45 (lH,m),4.42-4.35 (lH,m),4.15-4.05 (2H,m),3.74-3.60 (2H,m),3.57-3.42 (2H,m), 3.39-3.28 (lH,m),3.03-2.93 (lH,m),2.92-2.82 (lH,m), 2.65-2.52 (2H,m), 2.42-2.25 (lH,m), 2.20-1.88 (4H,m), 1.76-1.50 (2H,m), 1·35·1·10 (9H,m)。 [3 3(15,93)]3-(9-芊醯甲醯胺基-6,10-二酮基.1,2,3,4,8,9,10-八氫-6H-嗒哜並[l,2-a][l,2]-二氮雜革-1-羧醯胺基)-4,4-二 甲氧基-丁酸甲醋(2100c)。214e (165毫克,〇·37毫莫耳)於 甲醇(5毫升)之溶液在室溫下與催化劑量的對位-曱笨磺酸 (17.5毫升)共攪拌。4天後,反‘混合物以EtOAc稀釋,再 以10% NaHC03 (3x)及鹽水洗滌3混合的萃取物於Na2S04 上乾燥並濃縮。快速層析/Si02,EtOAc)可生成127毫克 (68%)的 2100c,呈白色固體:iH NMR (CDC13) Θ 7.S2 (2H, _ _^500- 本纸乐尺度適用中g國家標李(CNS ) A4規格(2丨Οχ 297公釐) 一 ---------- (請先閱讀背面之注意事寫本頁) 訂 1235157 A i B7 五、發明説明(498 ) d), 7.55-7.50 (1H, m), 7.47-7.43 (2H; m), 7.02 (1H, d), 6.53 (1H, d), 5.20〇.10 (1H, m), 4.56-4.50 (1H? m), 4.45-4.50 (1H, each, two m), 3.69 (3H, s), 3.41 (3H, s), 3.43 (3H? s), 3.35· 3.25 (1H, m), 3.06-2.98 (1H, m), 2.94-2.83 (1H, m), 2.65-2.53 (2H, m), 2.35-2.32 (1H, m), 2.15-2.07 (lH?m), 2.00-1.89 (3H, m), 1.75-1.56 (2H, m)- [3S(1S,9S)] 3-(9-;醯基曱醯胺基-6,10-二酮基-1,2,3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]-二氮雜苯-1-羧醯胺基)-4,4-二異丙氧基-丁酸異丙酯(2100d)。2 14e (53毫克,0.12毫莫 耳)於異丙醇(5毫升)之溶液,在5CTC下與催化劑量的對位-甲笨磺酸(5毫克)共攪拌。3天後,反應浥合物倒入鉋和的 NaHC〇3中再以CH2C12萃取。混合的萃取物於Na2S〇4上乾 燥及濃縮,快速層析(Si〇2,CH2Cl2:Et〇Ac (4:1至1:1 v/v) 可生成49毫克(68%)的2100d,呈白色固鳢:4 NMR (CDC13) ^ 7.85 (2H, d), 7.50-7.43 (1H, m), 7.41-7.35 (2H, M濟部中夬嘌ri局員二消資合作.社印裝 (請气$讀背云之·λΐ意事項再填寫大二貝) m), 7.02 (1H, d), 6.47 (1H, d), 5.13O.07 (1H, m), 5.00-4.9 (1H, m), 4.61-4.55 (2H, m), 4.37^4.30 (1H, m), 3.80-3.70 (1H, m), 3.90-3.80 (1H, m), 3.42-3.35 (1H, m), 3.03-2.93 (1H, m), 2.91-2.81 (1H, m), 2.62-2.50 (2H, m), 2.38-2.33 (1H, m), 2.12-2.06 (lH,m), 1.97-1.81 (3H, m), 1.70-1.60 (2H, m), 1.28-1.05 (18H,m)。 〇(Please read the notes on the back of the first 8 and fill it out. Exhaust) 214c 2100a R1 2100b R1 [1S, 9S (2RS, 3S)] 9-Amine-6, 10-Diketo-1 , 2,3,4,7,8,9,10 -—- The staff of the Central Procurement Bureau of the Ministry of Economic Affairs cooperated with Du Yin ¾ octahydro-N- (2-isopropoxy-5-one-tetrahydro -Furan-3-yl) -6H-dalop [1,2-a] [l, 2] diazabenzene-1-carboxamide (2100a). A solution of 214e (101 mg, 0.23 mmol) in isopropanol (10 ml) was stirred at room temperature with a catalytic amount of para-toluenesulfonic acid (10 mg). After 75 minutes, the reaction mixture was poured into saturated NaHC03 and extracted with CH2C12. The combined extracts were dried over Na2SO4 and concentrated. Flash chromatography (Si02, CH2C12 to EtOAc) yielded 56 mg (51%) of 2100a as a white solid: (CDC13; a mixture of non-isomeric stereoisomers) (^ 7.9-7.8 (2 trans 111), 7 &gt; 7.5 (1H, m), 7.5-7.4 (2H, m), 7.1 (〇 · 5Η, d), 6.9 (0.5H, d), 6.4 (0.5H, d), 5.6 (0 · 5Η, d), 5.3 (0.5H, s), 5.2-5.1 (1H, m), 4.95 (0.5H, m), 4.75-4.5 (1.5H, m), 4.35 (0.5 ·, t), 4 · 1 (〇 · 5Η, m), -499-_ A paper size is selected from Chinese National Standard (CNS) A4 (210X 297 mm) 1235157 Printed by the Bayong Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs ¾ A 7 B7 V. Description of the invention (497) 3.98 (0.5H, m), 3.3-2.75 (4H, m), 2,5-2.4 (2H, m), 2.25 (1H, m), 2.1-1.9 (3H , M), 1.75-1.55 (2H, m). [3S (1S, 9S)] 3- (9-fluorenylamido-6,10-dicopperyl-1,2'3,4, 7,8,9, 10-octahydro-6H-dapyrolo [l, 2-a] [l, 2] -diazabenzene-1-carboxamido) -4, 'diethoxy- Ethyl butyrate (2100b). 214e (16 mg '0.036 Emole) in ethanol (2 ml) at room temperature in catalytic amount of para-toluene acid (2 mg Treatment. After 5 days, the reaction mixture was poured into saturated NaHC03 and extracted with CH2C12. The combined extracts were dried over Na2SO4 and concentrated. Flash chromatography (Si02, CH2Cl2: EtOA0 95: 5 v / v) Generates 16 mg (81%) of 2100b as a white solid: NMR (CDC13) d 7.85-7.74 (2H, m), 7.55-7.38 (3H, m), 7.04-6.95 (lH, d), 6.61-6.48 (lH, d), 5.15- 5.08 (lH, m), 4.63-4.53 (lH, m), 4.52-4.45 (lH, m), 4.42-4.35 (lH, m), 4.15-4.05 (2H, m) , 3.74-3.60 (2H, m), 3.57-3.42 (2H, m), 3.39-3.28 (lH, m), 3.03-2.93 (lH, m), 2.92-2.82 (lH, m), 2.65-2.52 ( 2H, m), 2.42-2.25 (lH, m), 2.20-1.88 (4H, m), 1.76-1.50 (2H, m), 1.35 · 1 · 10 (9H, m). [3 3 (15,93)] 3- (9-Aminomethylamido-6,10-diketonyl.1,2,3,4,8,9,10-octahydro-6H-Da And [l, 2-a] [l, 2] -diaza leather-1-carboxamido) -4,4-dimethoxy-butyric acid methyl ester (2100c). A solution of 214e (165 mg, 0.37 mmol) in methanol (5 ml) was co-stirred with a catalyst amount of para-ammonium sulfonic acid (17.5 ml) at room temperature. After 4 days, the reaction mixture was diluted with EtOAc and washed with 10% NaHC03 (3x) and brine. The combined extracts were dried over Na2S04 and concentrated. Flash chromatography / Si02, EtOAc) can produce 127 mg (68%) of 2100c as a white solid: iH NMR (CDC13) Θ 7.S2 (2H, _ _ ^ 500- this paper scale is suitable for national g standard plums (CNS) A4 specification (2 丨 〇χ 297 mm) I ---------- (Please read the note on the back to write this page) Order 1235157 A i B7 V. Description of the invention (498) d) , 7.55-7.50 (1H, m), 7.47-7.43 (2H; m), 7.02 (1H, d), 6.53 (1H, d), 5.20〇.10 (1H, m), 4.56-4.50 (1H? M ), 4.45-4.50 (1H, each, two m), 3.69 (3H, s), 3.41 (3H, s), 3.43 (3H? S), 3.35 · 3.25 (1H, m), 3.06-2.98 (1H, m), 2.94-2.83 (1H, m), 2.65-2.53 (2H, m), 2.35-2.32 (1H, m), 2.15-2.07 (lH? m), 2.00-1.89 (3H, m), 1.75- 1.56 (2H, m)-[3S (1S, 9S)] 3- (9-; fluorenylamido-6,10-diketo-1,2,3,4,7,8,9, 10-octahydro-6H-dapyrido [l, 2-a] [l, 2] -diazabenzene-1-carboxamido) -4,4-diisopropoxy-butyric acid isopropyl Ester (2100d). 2 A solution of 14e (53 mg, 0.12 mmol) in isopropanol (5 ml) was co-stirred with a catalyst amount of para-toluenesulfonic acid (5 mg) at 5 CTC. After 3 days, the reaction mixture was poured into NaHC03 and extracted with CH2C12. The combined extracts were dried and concentrated on Na2SO4, and flash chromatography (Si02, CH2Cl2: EtOAc (4: 1 to 1: 1 v / v) yielded 49 mg (68%) of 2100d. White solid: 4 NMR (CDC13) ^ 7.85 (2H, d), 7.50-7.43 (1H, m), 7.41-7.35 (2H, M, Ministry of Economic Affairs, China Purchasing Bureau. Read the second question of the lambda in mind and fill in sophomore) m), 7.02 (1H, d), 6.47 (1H, d), 5.13O.07 (1H, m), 5.00-4.9 (1H, m ), 4.61-4.55 (2H, m), 4.37 ^ 4.30 (1H, m), 3.80-3.70 (1H, m), 3.90-3.80 (1H, m), 3.42-3.35 (1H, m), 3.03-2.93 (1H, m), 2.91-2.81 (1H, m), 2.62-2.50 (2H, m), 2.38-2.33 (1H, m), 2.12-2.06 (lH, m), 1.97-1.81 (3H, m) , 1.70-1.60 (2H, m), 1.28-1.05 (18H, m).

本纸ft尺度適用ta國家#挛(CNS ) Α4規咯(210X297公蝥) 1235157 A7 B7 五、發明説明(499 ) [15,95(2艮5,35)]9-苄醯胺基-6,10-二酮基-1,2,3,4,7,3,9,10· 八氫-N-(2-乙氧基-5-酮基-四氫-呋喃-3-基)-6H-嗒呼並[1,2-a][l,2]-二氮雜革-1-羧醢胺(2100e),合成自302,經甴合成 3 04a之方法,可生成2100e,除了使用乙醇及三乙基原曱 酸酯替代甲醇及三甲基原甲酸酯之外。層析(Si〇2,5%乙 醇/CH2C12)可生成92毫克(68%)的白色固鳢:lH NMR (CDC13;非對映體之混合物)c? 7.90-7.80 (2H,m),7.60-7.50 (1H, m), 7.50-7.40 (2H, m), 7.30 (0.5H, d), 7.00 (0.5H? d), 6.50 (0.5H, d), 5.50 (0.5H, d), 5.20-5.10 (1.5H, m), 4.95 (0.5H, m), 4.75-4.65 (0.5H, m), 4.65-4.50 (1H, m), 4.38 (0.05H, t), 4.00-3.90 (0.5H, m), 3.85-3.75 (0.5H, m), 3.75-3.65 (0.5H, m), 3.65-3.55 (0.5H, m), 3.30-2.70 (4H, m), 2.50-2.35 (2H, m), 2.30 (1H, d), 2.15-1.90 (3H, m), 1.80-1.60 (2H, m),1.25-1.20 (3H,two t)。 Λ πThe paper ft scale is applicable to the ta country # 挛 (CNS) A4 gauge (210X297 male) 1235157 A7 B7 V. Description of the invention (499) [15,95 (2,5,35)] , 10-diketo-1,2,3,4,7,3,9,10 · octahydro-N- (2-ethoxy-5-keto-tetrahydro-furan-3-yl)- 6H-Dahu [1,2-a] [l, 2] -diaza leather-1-carboxamide (2100e), synthesized from 302, and by the method of 3 04a, 2100e can be produced, except for using Ethanol and triethyl orthoacetate replace methanol and trimethyl orthoformate. Chromatography (Si02, 5% ethanol / CH2C12) yielded 92 mg (68%) of a white solid: lH NMR (CDC13; diastereomeric mixture) c? 7.90-7.80 (2H, m), 7.60 -7.50 (1H, m), 7.50-7.40 (2H, m), 7.30 (0.5H, d), 7.00 (0.5H? D), 6.50 (0.5H, d), 5.50 (0.5H, d), 5.20 -5.10 (1.5H, m), 4.95 (0.5H, m), 4.75-4.65 (0.5H, m), 4.65-4.50 (1H, m), 4.38 (0.05H, t), 4.00-3.90 (0.5H , m), 3.85-3.75 (0.5H, m), 3.75-3.65 (0.5H, m), 3.65-3.55 (0.5H, m), 3.30-2.70 (4H, m), 2.50-2.35 (2H, m ), 2.30 (1H, d), 2.15-1.90 (3H, m), 1.80-1.60 (2H, m), 1.25-1.20 (3H, two t). Λ π

(3S)-3-[(3S)-2-酮基-3-(1-莕甲醯基)胺基-5-甲氧基乙醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-1-乙醯胺基卜4-嗣基丁 酸(2201)合成自600b,利用合成自605b之方法可生成2201 ·· lH NMR (CDC13) Θ 8.30-8.22 (lH,m),8.05-7.98 (1H,d), -502- 本紙杀尺度通用中as家漂李(CNS ) Α4規格(210X297公釐)(3S) -3-[(3S) -2-keto-3- (1-fluorenylmethylfluorenyl) amino-5-methoxyethylfluorenyl-2,3,4,5-tetrahydro-1H -1,5-Benzodiazepine-1-acetamidinyl 4-pyridylbutyric acid (2201) is synthesized from 600b, and 2201 ·· lH NMR (CDC13) Θ 8.30 can be generated by the method synthesized from 605b -8.22 (lH, m), 8.05-7.98 (1H, d), -502- This paper is generally used in standard papers, such as Jiashui Li (CNS) Α4 (210X297 mm)

I 請 先 if 背 面I please if the back

寫 太 fWrite too f

Μ濟部.7央樣隼局_員二消费合作杜印XM 部 部 .7central sample bureau _ member two consumer cooperation Du Yinx

VT7 1235157 Λ7 B7 、發明説明(5〇〇) 7.96-7.83 (lH,m), 7.77-7.68 (lH,m);'7.67.7.40 (7H,m). 5.12-5.02 (lH,m), 4.98-4.41 (5H,m), 4.38-4.24 (lH,m), 4.07-4.00 (lH,d), 3.92-3.80 (2H,m), 3.32 (3H,s), 2.75-2.60 (lH,m), 2.58-2.35 (lH,m)。 實例1 8 吾等利用此中所述之方法得到本發明所選定化合物的以 下數據(表16,見實例7;表17及18,見實例1-4)。本發明 化合物之結構及製備述於實例28-3 1中。 _表16前藥於LPS受挑戰老鼠中效力之比較·· 產製之抑 制作用。示出以本發明化合物處理後IL-1 產製之抑制百 分率,爲LPS挑戰後之時間函數關係表示在相對時間 下無數値得到)。 (請先%讀背云之达意事項4填寫太一貝 經濟部令夬標达局員二消资合作社印製 化合物 -2h -lh 〇h 213f (-4) - 8 - 213h 9 - 53 - 213i (-11) • 62 - 213k 0 - 63 讀 2131 (-18) - 80 嫌 213m 26 一 42 • 213o 4 - 8 - 213p 21 - 29 - 213q 17 • 91 - 213r 59 - 37 - 213x 0 - 78 B 1 - 1 213y 29 - . 50 i 销 I 214e 39 - 70 75 I 43 44 48 11 ί - - • 47 ί 214k 12 - 31 爾 i 2141 0 一 54 - 214m 0 - 17 - 214w 11 - 91 i 2641 0 - 23 - 404 - - - 56 55 鱗 6 — ί 1 503 - 本纸伕尺度適用令ϋ國家標李(CNS ) Λ4現格(2!0x:!97公;$ ) 1235157 A7 __ 五、發明説明(501 ) 經濟部中夬橾準局員工消贫合作杜印¾ 化合物 -2h -lh Oh 412 0 - 、0 - 11 - 37 - 418 - - • S4 25 - 52 - 434 0 - S3 80 450 0 - 35 - 452 • 一 - 70 28 - 89 - 456 • - - 5S 41 - 69 - 470 0 - 36 - 471 0 餐 34 箱 475 0 - 15 • 481 27 - 0 - 486 19 - 15 - 487 17 - 20 - 528 25 - 67 - 550f 0 - 50 - 550h 55 - 73 - SSOi (-10) - 23 - 5S0k 36 - 34 一 5501 9 - 38 • 550m 45 - 52 - 550a 19 - 65 • 550〇 19 - 64 - 550p 30 - SO 轉 655 0 - 68 - 656 31 - 16 1 662 41 - 75 - 668 - 一 - 53 695a 49 - 78 - 1015 15 - 28 - 2001 64 62 58 55 2001a 10 • 16 2002 5 - 87 « 2100h 34 麵 32 — · 2100i 19 - 74 - i 2100j 48 41 0 33 ,: 2100k 30 50 32 72 21001 52 - 28 - 1 2100m 40 - 42 2100n 21 9 64 73 ; 2100o 31 44 68 64 (請先閉讀背5之-;±意事項耳填寫本\貝 裝 訂 4 -504- 本紙法尺度適用中§國家標隼(CNS ) Λ4現洛(210 X 297公釐) 1235157 Λ7 Β7 五、發明説明(502 ) 表17利用實例1-4所述方法所得的、本發明選定化合物之數 據3 經濟部令夬橾隼局員二消费合作杜印¾ 化合物 UV- 可見光 Ki (nM) Cell PBMC avg· IC50 (nM) 人類 全 IC50 (nM) 老鼠清除 率,i.v. 毫升/分/公斤 大鼠清除 率,i.v· · 毫升/分/公斤 213f 3000 213g 2200 轉 213h 1500 213i 1100 213j 213k 2000 2131 2000 ! 213m 2500 213o 5000 3300 j 213p &lt;300 1 1 213q &lt;300 1 I : 213r &lt;300 1 1 1 213v 0.5 1,100 1100 41 23 ! 213x 4500 2500 1 j 213y 930 | 214j 4.2 2500 6000 214k 0.2 500 580 22 , 2141 6 1900 1100 12彳丨 214m 1.5 530 2200 33.4 214w 0,6 620 370 15 246b 30000 &gt;30000 87 I t 2641 3000 265a 2600 25000 1 1 1 265c 1100 4500 ! 32 26Sd 500 1500 ί 35 265f 1200 ! 24 280b I 13000 ! i 280c j 10000 1 ; 86 280d 25000 1 283b 1750 41 283c 4000 ! ! 50 I * -505- 本纸法尺度通用中國国家標达(CNS &gt; A4現格(210X 297公釐) (請先閨讀背云之..V!意事Vf再填寫本一貝 裝 1235157 _B7 五、發明説明(503 ) M濟部中夬tvi局員二消贫合作让印¾ 化合物 UV-可見光 Ki (nM) Cell PBMC avg. IC50 (nM) 人類 全血'' IC50 (nM) 老鼠清除 率,i.v· 毫升/分/公片 大鼠清涂. 率,i.v· |嚎升/分/公斤 283d &gt;8000 10000 | 308c 3000 1 1 ί 308d 3000 -1 500 25 1800 1800 I j 501 2.5 1800 1600 1 1 r 505c 1500 505d &gt;20000 - 505f 550 510a 65 200 267 510d 2300 &gt;20000 - 511c 730 &gt;20000 78 40 528 2200 5S0f 1100 550h 1800 550i 1400 550k 3000 5501 750 550m 2000 ; I S50n &lt;300 1 550〇 450 3000 t ! 5S0p 2900 1 550q 700 1 640 155 2250 3900 ; 642 35 8000 2900 ; 645 150 1 650 550 4000 1 1 653 30 2300 -6000 , ί 655 i I 656 0·6 2100 1600 ; ! 2.9 662 0·5 1800 800 i 2·75 668 9 5200 3700 29 i 669 14 10000 670 4500 i 1 671 5 2000 2500 I 33.2 677 1 ! 1 610 i ; 678 5 2700 2200 680 -506- 本饫&amp;尺度通用tS國家標隼(CNS ) A4汊洛(21〇 ’,&lt;297公釐) (請先閣讀背云之注意事項再填寫本頁)VT7 1235157 Λ7 B7, description of the invention (500) 7.96-7.83 (lH, m), 7.77-7.68 (lH, m); '7.67.7.40 (7H, m). 5.12-5.02 (lH, m), 4.98 -4.41 (5H, m), 4.38-4.24 (lH, m), 4.07-4.00 (lH, d), 3.92-3.80 (2H, m), 3.32 (3H, s), 2.75-2.60 (lH, m) , 2.58-2.35 (lH, m). Example 18 We used the method described here to obtain the following data for selected compounds of the present invention (Table 16, see Example 7; Tables 17 and 18, see Examples 1-4). The structure and preparation of the compounds of the present invention are described in Example 28-31. _Table 16 Comparison of potency of prodrugs in LPS challenged mice ... The percentage of inhibition of IL-1 production after treatment with the compounds of the present invention is shown as a function of time after LPS challenge, expressed in countless times at relative time). (Please read the following items of Yunyi ’s intentions 4) Fill in the order printed by Taiyibei Ministry of Economic Affairs, the member of the Bureau of Consumers and Consumers Cooperatives, 2h -lh 〇h 213f (-4)-8-213h 9-53-213i (- 11) • 62-213k 0-63 read 2131 (-18)-80 213m 26-42 • 213o 4-8-213p 21-29-213q 17 • 91-213r 59-37-213x 0-78 B 1- 1 213y 29-. 50 i pin I 214e 39-70 75 I 43 44 48 11 ί--• 47 ί 214k 12-31 i 2141 0-54-214m 0-17-214w 11-91 i 2641 0-23 -404---56 55 Scale 6 — ί 1 503-The standard of this paper is applicable to the national standard plum (CNS) Λ4 (2! 0x:! 97); $) 1235157 A7 __ 5. Description of the invention (501 ) Poverty Alleviation Cooperation among Employees of the China Prospective Bureau of the Ministry of Economic Affairs Du Yin ¾ Compound-2h -lh Oh 412 0-, 0-11-37-418--• S4 25-52-434 0-S3 80 450 0-35- 452 • Mon-70 28-89-456 •--5S 41-69-470 0-36-471 0 Meals 34 Boxes 475 0-15 • 481 27-0-486 19-15-487 17-20-528 25 -67-550f 0-50-550h 55-73-SSOi (-10)-23-5S0k 36-34-5501 9-38 • 550m 45-52-550a 19-65 • 550〇19-64-550p 30-SO 655 0-68-656 31-16 1 662 41 -75-668-Mon-53 695a 49-78-1015 15-28-2001 64 62 58 55 2001a 10 • 16 2002 5-87 «2100h 34 side 32 — · 2100i 19-74-i 2100j 48 41 0 33, : 2100k 30 50 32 72 21001 52-28-1 2100m 40-42 2100n 21 9 64 73; 2100o 31 44 68 64 (Please close the back 5 of the-; ± Notes ear fill in this book \ Paper binding 4 -504- In the application of this paper, the national standard (CNS) Λ4 is now (210 X 297 mm) 1235157 Λ7 B7 V. Description of the invention (502) Table 17 The selected compounds of the present invention obtained by the method described in Example 1-4 Data 3 Order of the Ministry of Economic Affairs of the People's Republic of China 2. Consumption Cooperation Du Yin ¾ Compound UV-Visible Ki (nM) Cell PBMC avg · IC50 (nM) Human total IC50 (nM) rat clearance rate, iv ml / min / kg rat clearance Rate, iv · · ml / min / kg 213f 3000 213g 2200 rpm 213h 1500 213i 1100 213j 213k 2000 213 1 2000! 213m 2500 213o 5000 3300 j 213p &lt; 300 1 1 213q &lt; 300 1 I: 213r &lt; 300 1 1 1 213v 0.5 1,100 1100 41 23! 213x 4500 2500 1 j 213y 930 | 214j 4.2 2500 6000 214k 0.2 500 580 22, 2141 6 1900 1100 12 彳 214m 1.5 530 2200 33.4 214w 0,6 620 370 15 246b 30000 &gt; 30000 87 I t 2641 3000 265a 2600 25000 1 1 1 265c 1100 4500! 32 26Sd 500 1500 ί 35 265f 1200! 24 280b I 13000! I 280c j 10000 1; 86 280d 25000 1 283b 1750 41 283c 4000!! 50 I * -505- This paper method is commonly used in China National Standards (CNS &gt; A4 is now available (210X 297) (%) (Please read the back of the cloud .. V! Meaning Vf and then fill out this package 1235157 _B7 V. Invention Description (503) M Ministry of Economic Affairs of the Ministry of Economic Affairs of Tvi Bureau two poverty alleviation cooperation let India ¾ compound UV-visible light Ki (nM) Cell PBMC avg. IC50 (nM) human whole blood '' IC50 (nM) rat clearance, iv · ml / min / mice rat smear. Rate, iv · | liter / min / kg 283d &gt; 8000 10000 | 308c 3000 1 1 ί 308d 3000 -1 500 25 1800 1800 I j 501 2.5 1800 1600 1 1 r 505c 1500 505d &gt; 20000-505f 550 510a 65 200 267 510d 2300 &gt; 20000-511c 730 &gt; 20000 78 40 528 2200 5S0f 1100 550h 1800 550i 1400 550k 3000 5501 750 550m 2000; I S50n &lt; 300 1 550〇450 3000 t! 5S0p 2900 1 550q 700 1 640 155 2250 3900; 642 35 8000 2900; 645 150 1 650 550 4000 1 1 653 30 2300 -6000, ί 655 i I 656 0 · 6 2100 1600;! 2.9 662 0 · 5 1800 800 i 2 · 75 668 9 5200 3700 29 i 669 14 10000 670 4500 i 1 671 5 2000 2500 I 33.2 677 1! 1 610 i; 678 5 2700 2200 680 -506 -The standard & standard tS national standard (CNS) A4 Luo (21〇 ', &lt; 297 mm) (please read the precautions of Beyond Cloud before filling this page)

1235157 Λ7 B71235157 Λ7 B7

J • rf 明 説明 發 經濟部中夬標率局員工消费合作社印^ 化合物 UV-可見光 Ki (nM) Cell PBMC avg. IC50 (nM) 人類 全血 IC50 (nM) 老鼠清除 率,i.v· 毫升/分/公斥 大鼠清除: 率,i.v· _毫升/分/公巧 681 9 3000 5000 1 | 682 1300 683 400 &gt;20000 &gt;20000 i 684 15 5000 2800 1 I 686 4 4000 9000 j 688a 3000 688b 1300 - 689a 0.8 910 2500 689b 2.2 600 2000 690a 1600 690b i 691a 2.1 2900 1200 9,9 691b 11.5 1,900 1400 692a 692b 1800 693 694 3 2600 2100 I I 695a 1 • 695b 695c 2500 ( 696 4.5 2000 2900 13 ; 700 275 I 701 90 702 45 &gt;5000 20000 703 5 1400 20000 704 30 2600 9800 705 5 2300 3200 706 S 2400 5800 707 180 708 140 1 | 709 10 2100 14000 i : 710 110 t : 711 175 910 10 3400 3800 ; 911 9 3500 1900 912 10 4200 3800 ΐ 913 4.5 2400 7000 ! 丨I -507- 本纸伕尺度適用中US家標隼(CNS ) A4蚬咯(2丨OX 297公簦) (請^父讀背\-5上意事項再填寫本頁 •裝 訂 1235157 Α7 S7 五、發明説明(505 超濟部中央樣达局員工消f合作社印¾ 化合物 UV- 可見光 Ki (nM) Cell PBMC avg. ICSO (nM) 人類 全血、 IC50 (dM) 老鼠清除 率,i.v. 丨毫升/分/公片 大鼠清除 率,i.v. _毫升/分/公斤 914 5.2 2600 2800 I 915 11.5 &gt;8000 1900 918 7 1150 919 4 2000 4300 920 16 2100 3000 921 8.5 1800 3000 1018 170 4000 5500 -9.1 1052 100 2500 16 1053 27 2000 &gt;20000 34 1056 170 • 17 1075 120 5000 5500 14.5 1095 360 6000 28 1105 250 3500 3000 1106 75 4000 1700 1107 65 1108 22 1400 2600 1109 80 1110 45 ; 1111 18 6050 4400 1112 3.5 1800 2300 1113 290 1114 125 ! 1 1115 250 i 1116 215 i J 1117 35 1700 1300 1 i 1118 380 ; 1119 515 1 1120 95 i 1121 170 i i 1122 400 I : 1123 30 2,400 4500 1 * 1124 270 i ; r 1125 55 2300 9000 2001a 3000 • * 2100f 1 f ; 2100g ι ; -. I ; 2100h 2000 i -508 -J • rf Stated by the Ministry of Economic Affairs, Bureau of Labor Standards, Consumer Consumption Cooperatives ^ Compound UV-Visible Ki (nM) Cell PBMC avg. IC50 (nM) Human Whole Blood IC50 (nM) Rat Clearance, iv · ml / min / Public rat clearance: rate, iv · _ml / min / gong 681 9 3000 5000 1 | 682 1300 683 400 &gt; 20000 &gt; 20000 i 684 15 5000 2800 1 I 686 4 4000 9000 j 688a 3000 688b 1300 -689a 0.8 910 2500 689b 2.2 600 2000 690a 1600a 690a i 691a 2.1 2900 1200 9,9 691b 11.5 1,900 1400 692a 692b 1800 693 694 3 2600 2100 II 695a 1 • 695b 695c 2500 (696 4.5 2000 2900 13; 700 275 I 701 90 702 45 &gt; 5000 20000 703 5 1400 20000 704 30 2600 9800 705 5 2300 3200 706 S 2400 5800 707 180 708 140 1 | 709 10 2100 14000 i: 710 110 t: 711 175 910 10 3400 3800; 911 9 3500 1900 912 10 4200 3800 ΐ 913 4.5 2400 7000! 丨 I -507- The standard of this paper is applicable to the Chinese house standard (CNS) A4 蚬 (2 丨 OX 297簦) (please read ^ Parent's reading \ -5 the above matters and fill in this page again. • Binding 1235157 Α7 S7 V. Description of the invention (505 Employees of the Central Samples Bureau of the Ministry of Economic Affairs, printed by the cooperative) ¾ Compound UV- Visible light Ki (nM) Cell PBMC avg. ICSO (nM) human whole blood, IC50 (dM) mouse clearance, iv 丨 ml / min / male clearance, iv _ml / min / kg 914 5.2 2600 2800 I 915 11.5 &gt; 8000 1900 918 7 1150 919 4 2000 4300 920 16 2100 3000 921 8.5 1800 3000 1018 170 4000 5500 -9.1 1052 100 2500 16 1053 27 2000 &gt; 20000 34 1056 170 • 17 1075 120 5000 5500 14.5 1095 360 6000 28 1105 250 3500 3000 1106 75 4000 1700 1107 65 1108 22 1400 2600 1109 80 1110 45; 1111 18 6050 4400 1112 3.5 1800 2300 1113 290 1114 125! 1 1115 250 i 1116 215 i J 1117 35 1700 1300 1 i 1118 380; 1119 515 1 1120 95 i 1121 170 ii 1122 400 I: 1123 30 2,400 4500 1 * 1124 270 i; r 1125 55 2300 9000 2001a 3000 • * 2100f 1 f; 2100g ι;-. I; 2100h 2000 i -508-

請元.¾ 讀 背 ί 事 項 具 填 寫 s. I 本紙法尺度通用中国國家標隼(CNS )六4圪格(210X297公釐) 1235157 A7 B7 五、發明説明(5〇6) 化合物 UV-可見光 Ki (nM) Cell PBMC avg. ICSO (nM) 人類' 全血 IC50 (nM) 老鼠清除 率,i.v. 毫升/分/公斤 大鼠清除 率,i.v· 毫升/分/公斤 2100i 2100j 30000 12000 t 21001c 520 4000 600 21001 750 2200 2100m r 2100η 670 770 4000 - 2100ο 670 1150 1500 % 讀 背 之 ;·主 意 富 ψ_ i t 吾等利用此中所述方法(見實例1 -4)得到以下本發明選定 化合物之數據(表18)。本發明化合物之結構及製備示於實 例 2 8 - 3 1 3 表18 化合物 螢光分析 kinact m*1 s&quot;1 Ceil PBMC avg. IC50 (nM) 人類 全企 ICSO (nM) 老鼠清 除率, i.v. 毫升/分/公斤 大鼠清 除率, i.v. 毫升/分/公斤 286 370000 300 1600 119 505 b 190000 1500 2100 161 196 505 e 420000 9000 1000 實例1 9 M濟部中夬標这局員工消费合作社印¾ 充作抗炎劑之效力洽體内急性分析法 於表19之結果顯示,412f,412d及696a於利用乙醇/PEG/ 水,-環糊精,labrosol/水或cremophor/水充作溶媒口服 後可在LPS-挑戰之老鼠中抑制IL-1 之產製。化合物於施 以LPS之時給藥。策略述於實例7。 表19於LPS-挑戰老鼠中IL-1/?產製之抑制率(%)。 -509 - 經濟部中央糅準局員工消费合作社印製 1235157 A7 ________BT^ 五、發明説明(5〇7) 化合物 10毫元/公斤 劑量 25毫克/公斤 劑臺、 50毫克/公斤 劑量 412f 17% 25% 32% _ 412e 5% 17% — 61% 696a 0 45% 52% 實例20 童_鼠角又菜膠腹膜疹士: 老鼠以10毫角又菜膠(carrageenan)於〇· 5毫升食鹽水經腹 膜内(IP)注射而誘生發炎(Griswold et al.,Inflammation. 13, ρρ· 727-739 (1989))。等物於乙醇 /peg/水,環翔精, labrosol/水或cremophor/水溶媒中再經口灌食投藥。投予角 又菜膠4小時後犧牲老鼠,再以2毫升含有5單位/毫升肝素 之食鹽水IP注射3於腹部緩和按摩後切一小切口,收集内 容物再i己錄體積樣品保持在冰上直到離心(1 3 0 X g , 8分 鐘,4eC )以移去細胞物質,且生成的上清液貯於-2〇,C下a 以ELISA決定腹水中之IL-10水平。 表20之結果顯示前藥412f可於角又菜膠挑戰之老鼠於口 服藥物後抑制IL-1 產製。化合物214e當以50毫克/公斤口 服時不會抑制IL-1/?產製3 (If元$讀背面之·:5一意事Vf玉:填寫衣頁)Please Yuan. ¾ Read the matter and fill in the s. I The paper scale is in accordance with the Chinese National Standards (CNS) six 4 squares (210X297 mm) 1235157 A7 B7 5. Description of the invention (5 06) Compound UV-visible light (nM) Cell PBMC avg. ICSO (nM) Human's whole blood IC50 (nM) rat clearance, iv ml / min / kg rat clearance, iv · ml / min / kg 2100i 2100j 30000 12000 t 21001c 520 4000 600 21001 750 2200 2100m r 2100η 670 770 4000-2100ο 670 1150 1500% Read back; · idea rich ψ_ it We use the method described here (see Examples 1-4) to obtain the following data for selected compounds of the present invention (Table 18 ). The structure and preparation of the compound of the present invention are shown in Example 2 8-3 1 3 Table 18 Fluorescent analysis of compounds kinact m * 1 s &quot; 1 Ceil PBMC avg. IC50 (nM) Human-wide ICSO (nM) rat clearance, iv ml Rat clearance rate per minute / kg, iv ml / min / kg 286 370000 300 1600 119 505 b 190000 1500 2100 161 196 505 e 420000 9000 1000 The efficacy of the anti-inflammatory agents in the in vivo acute analysis method shown in Table 19 shows that 412f, 412d, and 696a can be used after oral administration using ethanol / PEG / water, -cyclodextrin, labrosol / water or cremophor / water as a vehicle. LPS-Challenge Inhibition of IL-1 Production in Mice. The compound is administered at the time of LPS administration. The strategy is described in Example 7. Table 19 Inhibition rate (%) of IL-1 /? Production system in LPS-challenge mice. -509-Printed by the Consumer Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs 1235157 A7 ________ BT ^ V. Description of the Invention (507) Compound 10 milligram / kg dose 25 mg / kg dose table, 50 mg / kg dose 412f 17% 25 % 32% _ 412e 5% 17% — 61% 696a 0 45% 52% Example 20 Child _ rat horn and vegetable glue peritoneal rash: rats take 10 millihorn and carrageenan in 0.5 ml of saline solution Intraperitoneal (IP) injection induces inflammation (Griswold et al., Inflammation. 13, ρρ · 727-739 (1989)). Equal in ethanol / peg / water, cyclophosphine, labrosol / water or cremophor / water solvent and then orally administered. The rats were sacrificed 4 hours after the administration of carrageenan, and then 2ml of saline IP containing 5 units / ml of heparin was injected into the abdomen, and a small incision was made after gentle massage on the abdomen. The contents were collected and the recorded volume was kept on ice The cells were removed by centrifugation (130 × g, 8 minutes, 4eC) to remove the cellular material, and the resulting supernatant was stored at -20. C was determined by ELISA to determine the level of IL-10 in ascites. The results in Table 20 show that the prodrug 412f can inhibit IL-1 production in mice challenged by carrageenan after oral administration. Compound 214e does not inhibit IL-1 / production system when taken orally at 50 mg / kg 3 (If $$ read on the back of the ·: 5 Yiyi Shi Vf Jade: fill in the clothing page)

表20 412f及412d於施以角又菜膠挑戰老鼠中對IL-1/5產製 之抑制率(%)。 劑量 (毫克/公斤) 化合物412f 化合物412d 1 3 0% 0 10 54% 3 2% 25 49% [ 3 1% 50 73% 3 6% 100 75% 53% -510- 本纸乐尺度適用中S國家標率(CNS ) Λ4現洛(2丨0X29?公,¾ ) 1235157 Λ7 _B7__ 五、發明説明(508) 實例2 1 '、 II型膠原蛋白-謗導之關節炎 於公的DBA/1J老鼠中發音II型膠原蛋白謗生之關節炎, 如 Wooley and Geiger (Wooley, P.H., Methods in Enzvmology, 162, pp· 361-373 (1988)及 Geiger, T.,Clinical and Experimental Rheumatology, 11,pp. 3 15-522 (1 993))所述 3 小雞胸骨II型膠原蛋白(4毫克/公斤於10 mM醋酸)以等鳢 積的FreuncTs完全濾劑(FCA)乳化,係在二個10毫升玻璃注 射器及16號雙轂針間重覆抽逆(400)而成。老鼠於21天後在 尾基部之對·側邊處皮内注入膠原白乳劑(50微升:100微 升(11/老鼠)而使免疫之。藥物經口灌食每天二次約距7小 時3所使用之溶媒包括乙醇/DEG/水,-環翔精, labrosol/水或cremophor/水。在CII追加免疫接種2小時内開 始藥物之治療。在二個前腳記錄發炎情況,按逐漸薮重度 記1至4,並累記記分得最終記分。 於圖12,13及14之結果顯示,前藥412f,412d及696a可 於口服至老鼠後抑制由膠原蛋白-誘生之關節炎發炎。化 合物214e當口灌食一天一次時(50毫克/公斤)並不會抑制發 炎3 M濟部中央捃準局員工消费合作杜印裂 (請先閨讀背云之;±意事項再填寫大二貝) 實例22 活體内生物利用率之決定 藥物於乙醇/DEG/水,環糊精,labrosol/水或cremophor/ 水中口服投予(10-100毫克/公斤)至大鼠(10毫升/公斤)。於 給藥後0.25,0.50,1,1.5,2,3,4,6及8小時後自頸動 -511 - 本紙伕尺度適用中g國家標洋(CNS ) A4堤格(210 X297公簦) 1235157 Λ7 B7 經濟部中央樣導局員工消费合作社印¾ 五、發明説明(509 ) 哌中抽血,離去血漿再貯於-7CTC、、直到分析。利用酵素分 析決定兹濃度3利用RStrip (MicroMath Software,UT)經非 線性回歸進行數據之藥物動力分析3可如下決定藥物之生 物利用率値:(前藥口服後之藥物AUC/藥物i.v·給藥後之藥 物 AUC)x(i.v·劑量/ρ·〇·劑量)χίοο%, 表21之結果頭示前藥412f,412d及696a當σ服時可得藥 物顯著的血中水平且有良好的藥物利用率3當口服時並未 測及2 14e之血中水平。 表2 1 -H2f ’ 412d,696a及214e之大鼠中之口服生物利用率3 化合物 劑量 (毫克/公斤) Cmax (微克/毫升) 藥物 利用率(%) 4l2f 25 2.4 32 4l2d 25 2.6 35 696a 50 1.2 Γο 214e 45 0.2 0.9% 實例23Table 20 Inhibition rates (%) of IL-1 / 5 production in mice challenged with carrageenan by 412f and 412d. Dose (mg / kg) Compound 412f Compound 412d 1 3 0% 0 10 54% 3 2% 25 49% [3 1% 50 73% 3 6% 100 75% 53% -510- The paper scale is applicable to S countries Standard rate (CNS) Λ4 now Luo (2 丨 0X29? Male, ¾) 1235157 Λ7 _B7__ V. Description of the invention (508) Example 2 1 ', Type II collagen-slandering arthritis in male DBA / 1J mice Collagen type II is pronounced against arthritis, such as Wooley and Geiger (Wooley, PH, Methods in Enzvmology, 162, pp. 361-373 (1988) and Geiger, T., Clinical and Experimental Rheumatology, 11, pp. 3 15-522 (1 993)) The 3 chicken sternal type II collagen (4 mg / kg in 10 mM acetic acid) was emulsified with an equal volume of FreuncTs complete filter (FCA) and was tied to two 10 ml glass syringes And the number 16 double-bobbin needle drawn repeatedly (400). After 21 days, mice were immunized with collagen white emulsion (50 microliters: 100 microliters (11 / rat)) intradermally at the opposite and lateral sides of the tail base. The drug was orally administered twice daily for about 7 hours. 3 The solvents used include ethanol / DEG / water, -Cyclopline, labrosol / water or cremophor / water. Drug treatment will be started within 2 hours of CII additional immunization. Record the inflammation on the two forefoot, and gradually increase the severity. Record 1 to 4 and accumulate the scores to get the final score. The results shown in Figures 12, 13 and 14 show that the prodrugs 412f, 412d and 696a can inhibit inflammation induced by collagen-induced arthritis after oral administration to mice. Compound 214e does not inhibit inflammation when administered orally once a day (50 mg / kg) Example 22: Determination of bioavailability in vivo Drugs were administered orally (10-100 mg / kg) to rats (10 ml / kg) in ethanol / DEG / water, cyclodextrin, labrosol / water or cremophor / water. Movement from the neck after 0.25, 0.50, 1, 1.5, 2, 3, 4, 6 and 8 hours after administration -511-The standard of this paper is applicable to the national standard of China (CNS) A4 Tige (210 X297) 7 1235157 Λ7 B7 Printed by the Consumer Cooperative of the Central Bureau of Sample Guidance of the Ministry of Economic Affairs Ⅴ 5. Description of the invention (509) Plasma was removed and stored at -7CTC until analysis. Enzyme analysis was used to determine the concentration. 3 RStrip (MicroMath Software, UT) was used for pharmacokinetic analysis of the data through nonlinear regression. 3 The bioavailability of the drug can be determined as follows: ( Prodrug AUC / drug iv · drug AUC) x (iv · dose / ρ · 〇 · dose) × ίοο%, the results in Table 21 show the prodrugs 412f, 412d, and 696a when σ is administered Significant blood levels of the drug are available and good drug utilization rates 3 Blood levels of 2 14e were not measured when taken orally. Table 2 1 -H2f '412d, 696a, and 214e rats oral bioavailability 3 Compound dosage (mg / kg) Cmax (μg / ml) Drug utilization (%) 4l2f 25 2.4 32 4l2d 25 2.6 35 696a 50 1.2 Γο 214e 45 0.2 0.9% Example 23

ICE解離及活化pro-IGIF ICE及ICE同系物表現質體 0.6 kb编碼全長鼠 pro-IGIF之 cDNA(H.Okamuraetal., Nature, 3 78, ρ· 88 (199 5)連接至哺乳動物表現載體pCDLSR α (Y. Takebe et al., Mol. Cell Biol·,8, p. 466 (1988)) ^ 一般而言,編碼活性ICE (上£ )或三個ICE-相關酵素TX ,CPP32,及CMH-1,於pCDLSR泛表現載體之質體(3微克) ,(C. Faucheu et al·,EMBO, 14, p. 1914 (1995); Υ· Gu et al., EMBO, 14, p. 1923 (1995); J· A. Lippke et al.,J. Biol. Chem.· __ -512- 衣紙&amp;尺度適用申国国家標李(CNS ) A』規格(2I0 a 公釐) (請先%讀背云之注意事項弄填寫本一貝)ICE dissociates and activates pro-IGIF ICE and ICE homologues express plastids 0.6 kb encoding a full-length mouse pro-IGIF cDNA (H. Okamuraetal., Nature, 3 78, ρ 88 (199 5) linked to a mammalian expression vector pCDLSR α (Y. Takebe et al., Mol. Cell Biol., 8, p. 466 (1988)) ^ In general, it encodes active ICE (above £) or three ICE-related enzymes TX, CPP32, and CMH -1, plastids in the pCDLSR pan-expression vector (3 micrograms), (C. Faucheu et al., EMBO, 14, p. 1914 (1995); Υ Gu et al., EMBO, 14, p. 1923 ( 1995); J. A. Lippke et al., J. Biol. Chem. · __ -512- Paper &amp; Standards Applicable to Shen Guo National Standard Li (CNS) A 'Specifications (2I0 a mm) (Please first% (Read the note of back cloud and fill in this book)

Λ7 1235157· 37 五、發明説明(510 ) (诗先閱請背5之·.V!意事項再填寫太f ) 271,p. 1825 (1996))利用 DEAE-右、旋糖方法(Y. Gu. et al., EMBO J., 14, p. 1923 (1995))轉感至35毫米盤中之Cos細胞 次於融合狀之單層中。24小時後,細胞溶解,溶胞產物接 受SDS-PAGE及免疫吸潰,利用與IGIF具特異性之抗血清 進行(H· Okamura et al·,Nature, 378,ρ· 88 (1995)。 使用聚合酶鏈反應在鼠pro-IGIF cDNA之罗及Γ端引入 Ndel位置,禾J 用以下引子:GGAATTCCATATGGCTGCCAT GTCAGAAGAC (向前)及GGTTAACCATATGCTAACTTTGATG TAAGTTAGTGAG (逆向)。生成的Ndel片段在Ndel位置處 連接至大腸样菌表現載鳢pET-15B (Novagen)以生成質體, 經濟部中央樣皋局員工消费合作杜印¾ 其可指令213胺基酸系肽之合成,此肽包括有2卜殘基之肽 (MGSSHHHHHHSSGLVPRGSHM,其中 LVPRGS代表一個凝 血酶解離位置)在架構上融合至pro-IGIF在AU2之N-宋端, 可甴質^tDNA定序及表現蛋白質之N-末端定序證實。攜 有質體之大腸桿菌株BL21 (DE3)以0.8 mM異丙基-1-硫-/3 -D-半乳糖吡喃糖荅在37sc下誘導1.5小時,回收,以微量 &quot;ru 化作用(Microfluidic,Watertown,MA)於緩衝溶液 A (20 mM臂酸納,pH 7.0,300 mM Nal,2 mM二硫異未弱蕩酵 ,1〇%甘油,1 mM苯基曱基磺醢基氟,及2.5微克/毫升亮肽 素)中溶解3溶胞產物在100,000 X g下離心30分鐘使澄清 化3再自上清液中經Ni-NTA-瓊脂糖(Qiagen)層析缒化出 (HlS) 加篩之pro-IGIF蛋白質,條件如廠商所建議的3 解離反應 内的解離反應(3〇微升)含有2微克經純化的pro-IGIF ---·— —___ -513- ’氏成瓦度_? 11國家縣(CNS ) AUt洛(:10χ:97公疫) 1235157 A7 B7 五、發明説明(511) ,及各種濃度的經纯化蛋白酶,於含有20 mM Hepes,pH 7.2,0· 1 % Triton X,100,2 mM DTT,1 mM PMSF反 2.5微 克/毫升亮肽素之緩衝溶液中,並在37aC下培育1小時。爲 一 granzyme B解離之條件如前述(γ· Gu et ai·,J. Biol· Chem., 2.71,p. 10816 (1996))。解離產物以 16% 凝膠上之 SDS-PAGE 及考馬斯藍染色分析,並接受N-末端胺基酸定序,利闲 ABI自動化肽定序儀,條件則如廠商所建議的。 ICE解離IGIF之動力皋穸數 如下決定ICE解離IGIF之動力學變數(kcat/KM,,及 kcat)。將標記有35S-甲硫胺酸之pro-IGIF (3000 cpm,甴試 管内纖網血球溶胞系統(Promega)及pro-IGIF cDNA於pSP73 載體爲模板)在60微升含有0.1至1 riM重組體ICE及190 nM 至12 //Μ未標記之pro-IGIF之反應混合物中,以371培育8· 10分鐘。以SDS-PAGE及Phosphholmager分析決定解難產物 之濃度3將速率對濃度數據與Michaelis-Menten平衝式利 用程式Enzifitter (Biosoft)行非線性回歸配合而估計出動力 學變數。 IFN- r誘導分析 經濟部t夬樣準局員工消肾合作社印¾ (請先viflt背云之;±意事項异填芎本頁) 於 96孔洞盤内之 A.E7 Thl 細胞(H. Quill and R. H· Schwartz, J- Immunol.. 138, p. 3704 (1987))(1.3 x 10)細胞於 0.1 5 毫升 添加有10% FBS,50μΜ 2-巯基乙醇及50單位/毫升IL-2之 Click’s培養基中)以IGIF處理18-20小時,且培養物上清液 分析 INF- r (利用 ELISA (Endogen,Cambridge, MA)) 3 __ -514- 本紙伕尺度逋用中国國家標孪(CNS ) :U現格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(512) 實例24、、 於Cos細胞内ICE對pro-IGIF之慮理修毹Λ7 1235157 · 37 V. Description of the invention (510) (Read the poem first, please recite the 5th. V! Italian matter, and then fill in too f) 271, p. 1825 (1996)) using the DEAE-right, caramel method (Y. Gu. Et al., EMBO J., 14, p. 1923 (1995)) transduced Cos cells in a 35 mm disc to a confluent monolayer. After 24 hours, the cells were lysed, and the lysates were subjected to SDS-PAGE and immunosucking, using antiserum specific to IGIF (H. Okamura et al., Nature, 378, ρ 88 (1995). Using polymerization The enzymatic chain reaction introduced Ndel positions at the ends and ends of the mouse pro-IGIF cDNA. He used the following primers: GGAATTCCATATGGCTGCCAT GTCAGAAGAC (forward) and GGTTAACCATATGCTAACTTTGATG TAAGTTAGTGAG (reverse). The resulting Ndel fragment was linked to the coliform at the Ndel position The expression contains pET-15B (Novagen) to generate plastids. The staff of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs has cooperated with Du Yin. It can instruct the synthesis of 213 amino acid peptides. This peptide includes a peptide with 2 residues (MGSSHHHHHHSSGLVLVPRGSHM). (Where LVPRGS represents a thrombin dissociation site) is fused structurally to the N-song end of AU2 in pro-IGIF, which can be confirmed by tDNA sequencing and N-terminal sequencing of expressed proteins. Large intestine with plastids Strain BL21 (DE3) was induced with 0.8 mM isopropyl-1-thio- / 3-D-galactopyranoside at 37sc for 1.5 hours, recovered, and recovered in trace amounts ("Microfluidic, Watertown, MA ) In buffer solution A (20 Soluble in mM sodium bramate, pH 7.0, 300 mM Nal, 2 mM dithioisobutyridine, 10% glycerol, 1 mM phenylsulfonylsulfonyl fluoride, and 2.5 μg / ml leupeptin) 3 The lysate was centrifuged at 100,000 X g for 30 minutes to clarify 3, and then the Ni-NTA-sepharose (Qiagen) chromatography was used to clarify (H1S) and sieved pro-IGIF protein from the supernatant under conditions such as the manufacturer The proposed dissociation reaction within 3 dissociation reactions (30 microliters) contains 2 micrograms of purified pro-IGIF --- ·-—___ -513- '' s Chengwadu__ 11 National Counties (CNS) AUt Luo (Public plague of 10x: 97) 1235157 A7 B7 V. Description of the invention (511) and purified proteases in various concentrations, containing 20 mM Hepes, pH 7.2, 0.1% Triton X, 100, 2 mM DTT, 1 mM PMSF was reversed to 2.5 μg / ml Leupeptin in a buffer solution and incubated at 37 aC for 1 hour. The conditions for dissociation of granzyme B were as described previously (γ · Gu et ai ·, J. Biol · Chem., 2.71, p 10816 (1996)). The dissociated products were analyzed by SDS-PAGE and Coomassie blue staining on a 16% gel, and subjected to N-terminal amino acid sequencing. The ABI automated peptide sequencer was used under the conditions recommended by the manufacturer. Dynamics of ICE dissociation of IGIF The dynamic variables (kcat / KM, and kcat) of ICE dissociation of IGIF are determined as follows. Pro-IGIF labeled with 35S-methionine (3000 cpm, in vitro endoplasmic reticulocyte hemolysing system (Promega) and pro-IGIF cDNA in pSP73 vector as template) in 60 μl containing 0.1 to 1 riM recombinant Incubate with ICE and 190 nM to 12 // M unlabeled pro-IGIF in a reaction mixture at 371 for 8.10 minutes. SDS-PAGE and Phosphholmager analysis were used to determine the concentration of the problem-solving product. 3 The velocity versus concentration data was combined with the Michaelis-Menten flat- punch method using nonlinear regression with the program Enzifitter (Biosoft) to estimate dynamic variables. Induced by IFN-r analysis of A.E7 Thl cells (H. Quill) in a 96-well plate by the Kidney Cooperative Society of the Ministry of Economic Affairs of the United States of America and R. Schwartz, J- Immunol .. 138, p. 3704 (1987)) (1.3 x 10) cells in 0.1 5 ml with 10% FBS, 50 μM 2-mercaptoethanol and 50 units / ml IL-2 Click's medium) was treated with IGIF for 18-20 hours, and the culture supernatant was analyzed for INF-r (using ELISA (Endogen, Cambridge, MA)) 3 __ -514- This paper is in Chinese standard (CNS) ): U present (210X 297 mm) 1235157 Λ7 B7 V. Description of the invention (512) Example 24. ICE's consideration of pro-IGIF in Cos cells

ί請先閔讀背云之&gt;±意事項具填寫本一貝W 如實例23般,Cos細胞以各種表現質體之組合轉感。經 轉感之Cos細胞(3·5 X 105細胞於35毫米之孤内)以!毫升無 甲硫胺酸之DMEM,含有2.5%正常DMEM,1%經透析之胚 牛血清及300微居里/毫升35S-曱硫胺酸(33S-Express Protein Labeling-Mix, New England Nuclear)標記 7小時 ο 溶孢產物( 製備於 20 mM Hepes,pH 7·2,150 mM Naa,0.1% Tritox \,100,51111\4&gt;1-乙基馬來醯亞胺,11111^?^^?,2.5微克/ 毫升亮肽素)或調適培養基,以抗-IGIF抗體免疫沈衮,其 可確認IGIF的前骚體及成熟型式(H· Okamura et al.,Nature, 3 78, ρ· 88 (1995))。以SDS-PAGE (聚丙烯醯胺凝膠電泳)及 螢光照相(圖2 A)分析免疫沈澱之蛋白質。Please read Min Yun's notes below and fill in this note. As in Example 23, Cos cells are transfected with various combinations of plastids. Transduced Cos cells (3.5 x 105 cells in a 35 mm orphan) Ml of methionine-free DMEM, containing 2.5% normal DMEM, 1% dialyzed embryonic bovine serum, and 300 microcurie / ml 35S-Expression Labeling-Mix, New England Nuclear 7 hours ο lysosomal product (prepared in 20 mM Hepes, pH 7.2, 150 mM Naa, 0.1% Tritox \, 100, 51111 \ 4 &gt; 1-ethylmaleimide, 11111 ^? ^^ ?, 2.5 μg / ml leucopeptin) or an adaptation medium that is immunoprecipitated with anti-IGIF antibodies, which can confirm the precursor and mature form of IGIF (H. Okamura et al., Nature, 3 78, ρ 88 (1995 )). Immunoprecipitated proteins were analyzed by SDS-PAGE (polyacrylamide gel electrophoresis) and fluorescence photography (Figure 2A).

經濟部中夬標.举局員工消费合作杜印5L 吾等在溶胞產物及經轉感細胞之調適培養基中測及IFN-r誘導活性(圖2B) 3轉感的Cos細胞(3.5 X 1〇〕細跑於35毫米 皿中)生長在1毫升培養基中歷18小時。培養基回收並以 1:10最終稀釋應用於IFN- r誘導分析中(實例23) 3來自相同 轉感作用之Cos細孢團塊溶解於100微升20 mM Hepes,pH 7.0中,係冷;東-解;東達3次3溶胞產物以上述般離心而發 明之,並以1:10稀釋倍數應用於分析中, 實例25~ IGIF是ICE之生理受質 野生型(ICE+/+)及ICE-Λ老鼠给予熱滅活的P. acnes,且 於備妥後7天自老鼠中分離出Kupffer細胞,並挑戰地施以1 -515- _ 本紙伕尺度適用中國國家標窣(CNS ) A4規格(210X297公釐) 1235157 A' B/ 五、發明説明(513) 微克/毫升LPS歷3小時。以ELISA、偵測出調適培養基中之 IGIF 量。 野生型或缺乏ICE的老鼠腹膜内注入經熱殺死之p. acnes ,4口所述(H· Okamura et al.,Infection and Immunity, 63,p· 3966 (1955)) 3 7天後備妥 KupfferM 胞,依據 Tsutsui et al. (H. Tsutsui et al., Hepato-Gastroenterol.,39,p. 553 (1992)) 洽了使用nycodenz梯度替代metrizamide。於各實驗,匯集 2-3隻動物之Kupffer細胞並培養在添加有10%胚牛血清及1 微克/毫升LPS之RPMI 1640中溶胞產物及調適培養基3小時 後備妥。 來自野生型及ICE-1-老鼠之Kupffer細胞,代謝性標以 35S-甲硫胺酸,如Cos細胞一般(如實例24所述)除了使用無 曱硫胺酸之RPMI 1640以替代DMEM。在溶胞產物及調適 培養基中進行IGIF免疫沈澱實驗,免疫沈澱物以SDS-PAGE及螢光照相分析,如實例23所述。見圖3。 實例26 洽體内IFN- r產製之謗導 經涛部中夬榡隼局員工消费合作社印裝 (請先閱請背云之注意事項再填寫本I) 將LPS與0.5%羧甲基纖維素於PBS,pH 7.4混合,以10毫 克/公斤劑量體積經由腹膜内注射(30毫克/公斤LPS)投予至 老氛3每3小時採血光24小時,取自三個一组之ICE-缺失 的或野生型老鼠。以ELISA決定血清中INF-r水平 (Eadogen) ° 實例27 ICIF及INF- r抑制分析 -516- 本纸伕尺度適用中§國家標洋(CNS ) A4規格(210X29?公帑} 1235157The Ministry of Economic Affairs of the People's Republic of China. The staff of the Bureau of Consumer Cooperation Du Yin 5L We measured the IFN-r induction activity in the lysate and the adapted medium of transfected cells (Figure 2B) 3 Transduced Cos cells (3.5 X 1 (0) Sprint in 35 mm dish) and grow in 1 ml of medium for 18 hours. The culture medium was recovered and applied to the IFN-r induction analysis at a final dilution of 1:10 (Example 23). 3 Cos microspore masses from the same transduction effect were dissolved in 100 microliters of 20 mM Hepes, pH 7.0, and cold; -Solution; Dongda 3 times lysate was invented by centrifugation as described above, and applied to the analysis at a dilution factor of 1:10. Examples 25 ~ IGIF is the physiological type of wild type (ICE + / +) and ICE of ICE -Λ mice were given heat-inactivated P. acnes, and Kupffer cells were isolated from the mice 7 days after preparation and challenged with 1 -515- _ This paper is compliant with China National Standard (CNS) A4 (210X297 mm) 1235157 A 'B / V. Description of the invention (513) Micrograms / ml LPS over 3 hours. The amount of IGIF in the adjustment medium was detected by ELISA. Wild-type or ICE-deficient mice are injected intraperitoneally with heat-killed p. Acnes, as described in 4 (H. Okamura et al., Infection and Immunity, 63, p. 3966 (1955)). 3 KupfferM is ready after 7 days According to Tsutsui et al. (H. Tsutsui et al., Hepato-Gastroenterol., 39, p. 553 (1992)), the use of nycodenz gradient instead of metrizamide was agreed. In each experiment, Kupffer cells of 2-3 animals were pooled and cultured in RPMI 1640 supplemented with 10% embryonic bovine serum and 1 μg / ml LPS and conditioned medium for 3 hours before preparation. Kupffer cells from wild-type and ICE-1-rats were labeled metabolically with 35S-methionine, as Cos cells (as described in Example 24), except that RPMI 1640 without pyridine was used instead of DMEM. An IGIF immunoprecipitation experiment was performed on the lysate and the adapted medium. The immunoprecipitate was analyzed by SDS-PAGE and fluorescence photography, as described in Example 23. See Figure 3. Example 26: In vivo production of IFN-r produced by the Ministry of Economic Affairs of the China Bureau of Labor and Consumer Cooperatives, printed (please read the precautions of the cloud before filling in this I). LPS and 0.5% carboxymethyl fiber It was mixed in PBS, pH 7.4, and administered to Lao Xia via intraperitoneal injection (30 mg / kg LPS) at a dose volume of 10 mg / kg. The blood was collected every 3 hours for 24 hours. Or wild type mouse. Determine INF-r level in serum by ELISA (Eadogen) ° Example 27 ICIF and INF-r inhibition analysis -516- The standard of this paper is applicable § National Standard Ocean (CNS) A4 specification (210X29? Public) 1235157

7 7 A B 五、發明説明(514) 於此中所述之ICE抑制分析中偵、測ICE抑制劑對IGIF處理 修鈽之抑制作用(見實例1及表22)。 人類PBMC分析 人類金液黃層.知胞得自供金者,並於LeukoPrep管中内離 心分雜出周邊企液單核細胞(PBMC)(Becton-Dick:inson, Lincoln Park, NJ)。PBMC (加至(3 X 106/孔洞)24孔洞之 Corning組織培養盤中,經37&quot;C下培育1小時後,以緩和沖 洗移去未粘附之細胞。已粘附的單核細胞以LPS (1微克/毫 升)在有或無ICE抑制劑下於2毫升RPMI-1640-10% FBS中刺 激。經37°C下16-18小時培育後,以ELISA定量培養物上清 液中之IGIF及IFN-厂。 例如,吾等利用此中所述之方法可得本發明化合物412 的下列數據3化合物412之結構示於下。 表22 化合物 UV-可見光 Κ{ (πΜ) 細胞PBMC 平均IC50 (niM) 412 1.3 580 實例28 經濟部中夬樣準局員工消费合作社印裝 (請先3讀背*之注意事項弄填芎太頁) 本發明化合物可以各種方法製備。以下說明一個較佳的 方法: -517- 本纸裱尺度適用令S國家標準(CNS ) A4現格(210 X 297公痊) 1235157 AT B7 五、發明説明(515 )7 7 A B V. Description of the invention (514) In the ICE inhibition analysis described herein, the inhibitory effect of ICE inhibitors on the repair of IGIF treatment is measured (see Example 1 and Table 22). Analysis of human PBMCs. The yellow layer of human gold solution. Known cells were obtained from donors, and peripherally separated into peripheral enterprise fluid mononuclear cells (PBMCs) in LeukoPrep tubes (Becton-Dick: inson, Lincoln Park, NJ). PBMC (Add to (3 X 106 / holes) 24 holes of Corning tissue culture plate, and incubate at 37 &quot; C for 1 hour, then remove the non-adherent cells by gentle washing. The adhered monocytes are treated with LPS (1 μg / ml) was stimulated in 2 ml RPMI-1640-10% FBS with or without ICE inhibitor. After incubation at 37 ° C for 16-18 hours, IGIF in the culture supernatant was quantified by ELISA For example, we can use the method described here to obtain the following data for compound 412 of the present invention. 3 The structure of compound 412 is shown below. Table 22 Compound UV-visible light K {(πΜ) Cell PBMC average IC50 ( niM) 412 1.3 580 Example 28 Printed by the Consumers' Cooperatives of the Ministry of Economic Affairs of the Ministry of Economic Affairs (please read the notes on the back 3 * to fill out the page) The compound of the present invention can be prepared by various methods. The following describes a preferred method : -517- Applicable scale of this paper is the order of National Standard (CNS) A4 (210 X 297 healed) 1235157 AT B7 V. Description of Invention (515)

對 A (1.1 當量)於 CH2C12 (或 DMF,或 CH2C12:DMF (1:1)) 之溶液中加入三苯膦(0-0.5當量),親核性清除劑(2〇〇當量) 反肆(三苯膦)化鈀(〇)(〇.05-0.1當量),於惰性大氣(氮或氬) 之環境溫度下。10分鐘後,上述反應混合物視所需地濃縮 ,再加入酸 A-Ι或 A-Ι工於 CH2C12 (或 DMF或 CH2C12:DMF (1:1)) 之漆液,再加入ΗΟΒΤ(1.1當量)及EDC (丨·1當量)。生成的 反應混合物令其在環境溫度下攪拌1至48小時,以生成偶 合產物C-I或C-n 3 經濟部中夬樣率局員工消f合作社印災 (請先¾.讀背云之注意事項再填寫本\貝) 於上述過程中可使用各種親核性清除劑:Merzouk and Guibe,Tetrahedron Letters,33, pp. 477-480 (1992); Guibe and Balavoine, Journal of Organic Chemistry, 52, pp. 4984-4993 (1987))。可使用的較佳的親核性清除劑包括:雙曱 酮,嗎福啉,三甲基矽烷基二甲胺及二甲基巴比妥酸。較 佳的親核性清除劑爲三甲基矽烷基二甲胺(2〇當量)及二曱 基巴比妥酸(5〇0當量)。當親核性清除劑是三甲基矽烷基 二甲胺時,上述反應混合物必需是濃縮,再加入A -1或A -11 3 ^_ -518· 度適用令國國家標準(CNS ) Λ4^格(:ι〇 ,&lt;:9·公;^ &quot; 1235157 Λ: Β7 五、發明説明(516) 本發明其他化合物可如下流程所述,甴水解由^^及c-n 代衣之化合物成甴H-I及H-II代表之化合物而製備:To a solution of A (1.1 equivalents) in CH2C12 (or DMF, or CH2C12: DMF (1: 1)) was added triphenylphosphine (0-0.5 equivalents), and a nucleophilic scavenger (200 equivalents). Triphenylphosphine) palladium (0) (0.05-0.1 equivalents) at an ambient temperature of an inert atmosphere (nitrogen or argon). After 10 minutes, the above reaction mixture was concentrated as needed, and then a paint solution of acid A-1 or A-1 in CH2C12 (or DMF or CH2C12: DMF (1: 1)) was added, followed by Η〇ΒΤ (1.1 equivalents) And EDC (丨 · 1 equivalent). The resulting reaction mixture is allowed to stir at ambient temperature for 1 to 48 hours to produce the coupling product CI or Cn. 3 The staff of the sample rate bureau in the Ministry of Economic Affairs and the cooperative society printed the disaster (please read the precautions for back cloud before filling in Ben \ Bei) Various nucleophilic scavengers can be used in the above process: Merzouk and Guibe, Tetrahedron Letters, 33, pp. 477-480 (1992); Guibe and Balavoine, Journal of Organic Chemistry, 52, pp. 4984- 4993 (1987)). Preferred nucleophilic scavengers that can be used include: bisone, morpholine, trimethylsilyldimethylamine and dimethylbarbituric acid. The better nucleophilic scavengers are trimethylsilyldimethylamine (20 equivalents) and dimethylbarbituric acid (500 equivalents). When the nucleophilic scavenger is trimethylsilyldimethylamine, the above reaction mixture must be concentrated, and then add A -1 or A -11 3 ^ _ -518 · Degree Applicable National Standard (CNS) Λ4 ^格 (: ι〇, &lt;: 9 · 公; ^ &quot; 1235157 Λ: Β7 V. Description of the invention (516) Other compounds of the present invention can be described in the following scheme. HI and H-II compounds:

(請先聞讀背云之注意事項再填寫本一貝)(Please read the precautions of Beiyun before filling in this one)

經濟部.〒央樣孪局員工消费合作.社印SL 水解可在各種條件下進行,只要絛件中包括有酸及H20。 可使用的酸包括對位-甲笨磺酸,甲烷磺酸,硫酸,過氯 酸,三氟乙酸,及氫氣酸3如,三氟乙酸(卜90%按重計) 或氫氣酸(〇.1-30°/。按重計)於(:1130^/1120(卜90%112〇按重計) ,於0-5(TC間,可利用。 實例29 化合物 213f,213g,213h,213i,213j,213k,213卜 213m,214f,214g,214h,214i,214j,214k,2141,214m ,550f,550g,550h,550i,550j,550k,5501 及 550m可如 下製備。 -519- 本纸法尺度適用中國國家標準(CNS〉六心見洛(2丨〇'&lt;297公笼 1235157 AT B7 五、發明説明(517)The Ministry of Economic Affairs, the Central Government Bureau, and the Consumer Co-operation of the Bureau. The SL hydrolysis can be performed under various conditions, as long as the files include acid and H20. Acids that can be used include para-methanesulfonic acid, methanesulfonic acid, sulfuric acid, perchloric acid, trifluoroacetic acid, and hydrogen acid 3 such as trifluoroacetic acid (90% by weight) or hydrogen acid (0.01%). 1-30 ° /. By weight) at (: 1130 ^ / 1120 (90% by 112% by weight), between 0-5 (TC, available). Example 29 Compound 213f, 213g, 213h, 213i, 213j, 213k, 213, 213m, 214f, 214g, 214h, 214i, 214j, 214k, 2141, 214m, 550f, 550g, 550h, 550i, 550j, 550k, 5501, and 550m can be prepared as follows. -519- Size of paper method Applicable to Chinese National Standards (CNS) Liu Xin Jian Luo (2 丨 〇 '<297 male cage 1235157 AT B7 V. Description of the invention (517)

550f-m, R1 = Et550f-m, R1 = Et

(碕元翊讀背云之;V〗意事項再填寫本I ) 經濟部中夬櫺準局員工消费合作社印製 [15,95(21^,35)]9-[(4-二曱胺基芊醯基)胺基]-6,10-二嗣基- 唼畊並[l,2-a][l,2]二氮雜箪-1-羧醯胺(213f),合成自212f ,利用自212e製備213e之方法可生成504毫克的213f,呈黃 色固體,1H NMR (CD3OD) d 1·10 (br· m, 0.25H),1.30 (br· m, 2H), 1.50 (br. m, 1H), 1.65 (br. m, 1.5H), 1.80 (br. m, 0.25H),1.90 (br· m,0.25H),1.95 (br. m,0.5H),2.05 (br. m, 0.25H), 2.15 (m, 1H), 2.3 (m, 1H), 2.5 (br. m, 1H), 2.6 (dd, 1H),2.8 (m,1H),3.1 (bi*. s, 3H),3.15 (br· m,1H), 3.32 (br. s, -520- 本紙乐尺度適用中國國家標隼(CNS ) A4現格(210X 297公釐) 1235157 A7 B7 五、發明説明(518) 3H),3.5 (m,1H),4.5 (br. m,1H),4'、62 (d,0.25H),4.72 (m, 3H), 4.95 (m, 1H), 5.1 (br. t, 0.25H), 5.15 (br. t, 0.75H), 5.7 (d, iH), 6.75 (d, 2H), 7.35 (br. s, 5H), 7.75 (d, 2H) ^ [lS,9S(2RS,3S)】9-[(3-二曱胺基芊醯基)胺基]-6,10-二酮基· 1,2,3,4,7,8,9,10-八氫-N-(2-芊氧基-5-酮四氫呋喃-3-基)-6H-,答啡並[l,2-a】[l,2]二氮雜箪-1-羧醯胺(213g),合成自212g ,利用自212e製備213e之方法可生成400毫克的213g,4 NMR (CD3OD) ά 1.5 (br. m, 1H), 1.65 (br. m, 2H), 1.70 (br. m,0.25H),1.90 (br. m, 1H), 1.95 (br. m,1H),2.05 (br. m, 0.25H),2.10 (m,1H),2.3 (m,1H),2.5 (m,2H),2.59 (d· 1H), 2.6 (d,1H), 2.78 (d,1H), 2·8 (d,1H),2.93 (br· s,4H)· 3.05 (br. m, 1H), 3.15 (br. m, 0.25H), 3.3 (br. s, 3H), 3.5 (m, 2H)? 4.5 (br. m,2H),4.65 (d,1H), 4.7 (br· m,2H),4.95 (br. m, 1H),5.15 (br· t,0.25H),5.2 (br· t,0.75H),5.2 (d,1H),6.95 (d,1H), 7.15 (d, 1H), 7.25 (br· s,1H), 7.3 (br. t,2H),7.45 (br: s,6H)。 [lS,9S(2RS,3S)]9-[(3-氣-4-胺基芊醯基)胺基]-6,10-二酮基- &gt;2济部,〒夬嘌31局員二消費合作杜印^ 1,2,〕,4,7,8,9,10-八鼠-1^-(2-卞乳基-5-銅四鼠吃喃-»)-基)-61·!-落啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺(213h),合成自212h ,利用自212e製備213e之方法可生成296毫克的213h,4 NMR (CDC13) 0' 1.55-1.68 (m, 1H·),1.7-2.05 (m,3H), 2.3-2.5 (m, 2H), 2.65-2.8 (m, 1H), 2.85-2.93 (m, 1H), 2.95-3.25 (m, 3H), 4.44-4.65 (m, 2H), 4.68-4.82 (m, 1H), 4.9^4.95 (d. 1H), 5.05-5.18 (m, 2H), 5.28 (s, 0.5H), 5.55-5.58 (d, 0.5H), 6.52- -521 - 本纸杀尺度適用中国國家標洋(CNS ) A4%格(UlOx 公慶)~ 1235157 __B7_ 五、發明説明(519) 6.58 (d, 0.5H), 6.7-6.76 (m? 2H), 6.82-6.85 (d, 0.5H), 7.3-7.4 (m, 5H),7.52-7.58 (m,1H), 7.75 (s,0.5H), 7.8 (s,0.5H)。 [lS,9S(2RS,3S)]9-[(4-曱氧基芊醯基)胺基卜6,10-二酮基-1,2,3,4,7,8,9,10-八氫-义(2-芊氧基-5-酮四氩呋喃-3-基)-6^1-嗒啡並[l,2-a][l,2]二氮雜箪-1-羧醯胺(213i),合成自212i, 利用甴212e製備213e之方法可生成1.1克的213i,4 NMR (CDCi3) δ 1.55-2.05 (m, 6H), 2.26-2.5 (m, 2H), 2.68-2.82 (m, 1H), 2.85-2.92 (m, 1H)? 2.95-.325 (m, 2H), 3.82 (s? 1.5H), 3.85 (s, 1.5H), 4.4-4.65 (m, 2H), 4.7-4.78 (m, 1H), 4.83-4.95 (m, 1H), 5.05-5.23 (m, 1H), 5.28 (s, 0.5H)? 5.55-5.58 (d? 0.5H), 6.6-6.65 (m? 1H), 6.8-6.84 (m, 1H), 6.9-6.95 (m? 3H), 7.3-7.45 (m, 4H), 7.78-7.85 (m, 2H) ^ [13,95(2115,35)]9-[(3,5-二氣笮醯基)胺基]-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-N-(2-芊氧基-5-酮四氫呋喃-3-基)-6H-嗒畊並[l,2-a][l,2]二氮雜箪-1·羧醯胺(213j),合成自212j, 利用由212e製備213e之方法,可生成367毫克的213j,W NMR (CDC13) ^ 1.55-2.05 (m, 12H), 2.25 (d, 1H), 2.35 (m,(碕 元 翊 read the back of the cloud; V 〖I want to fill in this matter again I) Printed by the Consumers' Cooperatives of the China Prospective Bureau of the Ministry of Economic Affairs [15,95 (21 ^, 35)] 9-[(4-Diamine Amidino) amino] -6,10-diamidino-pyrene [l, 2-a] [l, 2] diazapyridine-1-carboxamide (213f), synthesized from 212f, The method of preparing 213e from 212e can generate 504 mg of 213f as a yellow solid, 1H NMR (CD3OD) d 1.10 (br · m, 0.25H), 1.30 (br · m, 2H), 1.50 (br. M , 1H), 1.65 (br. M, 1.5H), 1.80 (br. M, 0.25H), 1.90 (br · m, 0.25H), 1.95 (br. M, 0.5H), 2.05 (br. M, 0.25H), 2.15 (m, 1H), 2.3 (m, 1H), 2.5 (br. M, 1H), 2.6 (dd, 1H), 2.8 (m, 1H), 3.1 (bi *. S, 3H) , 3.15 (br · m, 1H), 3.32 (br. S, -520- This paper music scale is applicable to the Chinese national standard (CNS) A4 now (210X 297 mm) 1235157 A7 B7 V. Description of the invention (518) 3H ), 3.5 (m, 1H), 4.5 (br. M, 1H), 4 ', 62 (d, 0.25H), 4.72 (m, 3H), 4.95 (m, 1H), 5.1 (br. T, 0.25 H), 5.15 (br. T, 0.75H), 5.7 (d, iH), 6.75 (d, 2H), 7.35 (br. S, 5H), 7.75 (d, 2H) ^ [lS, 9S (2RS, 3S)] 9-[(3- 二 曱Amidino) amino] -6,10-diketo · 1,2,3,4,7,8,9,10-octahydro-N- (2-fluorenyl-5-one tetrahydrofuran- 3-yl) -6H-, pyracino [l, 2-a] [l, 2] diazapyridine-1-carboxamide (213g), synthesized from 212g, can be produced by the method of preparing 213e from 212e 400 mg of 213g, 4 NMR (CD3OD), 1.5 (br. M, 1H), 1.65 (br. M, 2H), 1.70 (br. M, 0.25H), 1.90 (br. M, 1H), 1.95 ( br. m, 1H), 2.05 (br. m, 0.25H), 2.10 (m, 1H), 2.3 (m, 1H), 2.5 (m, 2H), 2.59 (d · 1H), 2.6 (d, 1H) ), 2.78 (d, 1H), 2.8 (d, 1H), 2.93 (br · s, 4H) · 3.05 (br. M, 1H), 3.15 (br. M, 0.25H), 3.3 (br. s, 3H), 3.5 (m, 2H)? 4.5 (br. m, 2H), 4.65 (d, 1H), 4.7 (br · m, 2H), 4.95 (br. m, 1H), 5.15 (br · t, 0.25H), 5.2 (br · t, 0.75H), 5.2 (d, 1H), 6.95 (d, 1H), 7.15 (d, 1H), 7.25 (br · s, 1H), 7.3 (br. t, 2H), 7.45 (br: s, 6H). [1S, 9S (2RS, 3S)] 9-[(3-Ga-4-Aminoamido) amino] -6,10-diketo- &gt; 2 Ministry of Economy, Purine 31 Consumption Cooperation Du Yin ^ 1,2,3,4,7,8,9,10-eight rats-1 ^-(2- 卞 lactyl-5-copper four rats eat ran-»)-based) -61 · ! -Larcono [l, 2-a] [l, 2] diazepine-1-carboxamide (213h), synthesized from 212h, using the method of preparing 213e from 212e can generate 296 mg of 213h, 4 NMR (CDC13) 0 '1.55-1.68 (m, 1H ·), 1.7-2.05 (m, 3H), 2.3-2.5 (m, 2H), 2.65-2.8 (m, 1H), 2.85-2.93 (m, 1H ), 2.95-3.25 (m, 3H), 4.44-4.65 (m, 2H), 4.68-4.82 (m, 1H), 4.9 ^ 4.95 (d. 1H), 5.05-5.18 (m, 2H), 5.28 (s , 0.5H), 5.55-5.58 (d, 0.5H), 6.52- -521-This paper is applicable to Chinese National Standard Ocean (CNS) A4% grid (UlOx public holiday) ~ 1235157 __B7_ V. Description of the invention (519) 6.58 (d, 0.5H), 6.7-6.76 (m? 2H), 6.82-6.85 (d, 0.5H), 7.3-7.4 (m, 5H), 7.52-7.58 (m, 1H), 7.75 (s, 0.5 H), 7.8 (s, 0.5H). [1S, 9S (2RS, 3S)] 9-[(4-Methoxyfluorenyl) amino group 6,10-diketo-1,2,3,4,7,8,9,10- Octahydro-sense (2-fluorenyl-5-one tetraargylfuran-3-yl) -6 ^ 1-daphno [l, 2-a] [l, 2] diazafluorene-1-carboxyl Phenamine (213i), synthesized from 212i, and the method of preparing 213e using polonium 212e can generate 1.1 g of 213i, 4 NMR (CDCi3) δ 1.55-2.05 (m, 6H), 2.26-2.5 (m, 2H), 2.68- 2.82 (m, 1H), 2.85-2.92 (m, 1H)? 2.95-.325 (m, 2H), 3.82 (s? 1.5H), 3.85 (s, 1.5H), 4.4-4.65 (m, 2H) , 4.7-4.78 (m, 1H), 4.83-4.95 (m, 1H), 5.05-5.23 (m, 1H), 5.28 (s, 0.5H)? 5.55-5.58 (d? 0.5H), 6.6-6.65 ( m? 1H), 6.8-6.84 (m, 1H), 6.9-6.95 (m? 3H), 7.3-7.45 (m, 4H), 7.78-7.85 (m, 2H) ^ [13,95 (2115,35) ] 9-[(3,5-Diaziridinyl) amino] -6,10-diketo-1,2,3,4,7,8,9,10-octahydro-N- (2 -Methoxy-5-onetetrahydrofuran-3-yl) -6H-da- [1,2-a] [l, 2] diazepine-1 · carboxamide (213j), synthesized from 212j, Using the method of preparing 213e from 212e, 367 mg of 213j, W NMR (CDC13) ^ 1.55-2.05 (m, 12H), 2.25 (d, 1H), 2.35 (m,

經濟部中夬標準局員工消贤合作社印X 1H), 2.48 (m, 2H), 2.75 (m, 2H), 2.9 (m, 1H), 2.95-3.25 (m, 5H), 4.45 (t, IH), 4.5-4.6 (m, 4H), 4.7 (m, 1H), 4.75 (d, 1H), 4.88 (m, 1H), 5.05 (m, 2H), 5.15 (q, IH), 5.3 (s, 1H), 5.58 (d. 1H), 6.5 (d, 1H), 6.9 (d, iH), 7.05 (d, IH), 7.25-7.3 5 (m, 5H), 7.6 (s, 2H), 7.7 (s, 2H) ^ [15,95(2115,35)】9-[(3,5-二氣-4-羥基芊醯基)胺基卜6,10-二酮 基-1,2,3,4,7,8,9,10-八氫-:^-(2-芊氧基-5-酮基四氫呋嘀-3-基) ___-522-_ 本纸汝尺度適用中國國家標孪(CNS ) A4規洛(2丨0X297公釐) 1235157 Λ 7 _Β7___ 五、發明説明(520 ) -6H-喀畊並[l,2-a][l,2]二氮雜箪-1一羧醯胺(213k),合成自 212k,利用自212e製備213e之方法可生成593毫克的213k, lH NMR (CD3OD) ά 1.5 (m, 1Η), 1.6-1.7 (m, 2H), 1.75-1.95 (m, 4H), 2.15 (m, 2H), 2.3 (m, 1H), 2.6 (m, 1H), 2.7 (m, iH), 3.05 (m, 2H), 3.15 (m, 1H), 3.5 (m, 2H), 4.45 (m? 2H)? 4.65 (d, 1H), 4.7 (m, 1H), 4.95 (m, 1H), 5.15 (m, 1H)? 5.4 (s? 1H), 5.7 (d, 1H), 7.3 (m, 5H), 7.85 (s, 2H) ^ [lS,9S(2RS,3S)]9-[(3-氣-4-乙醯胺基;醯基)胺基]·6,10-二 酮基-1,2,3,4,7,8,9,10-八氫-;^(2-笮氧基〇-酮四氫呋嘹-3-基) -6Η-咨畊並[l,2-a][l,2]二氮雜箪-1-羧醯胺(2131),合成自 2121,利用自212e製備213e之方法,可生成133毫克的2131 ^ lH NMR (CDCI3) δ 1.55-1.7 (m, 1H), 1.75-2.05 (m, 3H), 經濟部中夬標準局員工消贤合作社印裳 (請先聞讀背面之泾意事^再填寫本頁) 2.25 (s, 1.5 H), 2.27 (s, 1.5H), 2.3-2.48 (m? 2H)? 2.7-2.83 (m, 1H), 2.85^2.94 (dd, 1H), 2.95-3.25 (m, 2H), 4.42-4.65 (m, 2H), 4.68-4.85 (m, 1H), 4.88-4.95 (m, 1H), 5.05-5.18 (m, 2H), 5.32 (s, 0.5H), 5.55-5.6 (d, 0.5H), 6.48^6.55 (d, 1H), 6.88-6.92 (d, 1H), 7.0-7.04 (d, 0.5H), 7.15-7.2 (d, 0.5H), 7.3-7.4 (m, 4H), 7.64-7.78 (m, 2H), 7.88^7.94 (m, 1H), 8.45-8.56 (m7 1H) ^ [15,95(2尺5,3 5)]9-[(3,5-二氣-4-甲氧基芊醯基)胺基]-6,10-二 酮基-1,2,3,4,7,8,9,10-八氫-;^-(2-芊氧基-5-酮四氫呋嘀-3-基) -6H-,答畊並[l,2-a】[l,2]二氮雜箪-卜羧醯胺(213m),合成自 212m,利用甴212e製備213e之方法,可生成991毫克的 213m,lHNMR(CDCl3)d 1.5-2.15 (m,5H),2.2-2.55 (m, 3H),2.6-3.3 (m,4H),3.95 (2s,3H),4.45-4.7 (m,2H),4.7- -523 - 本纸伕尺度適用中國国家標草(CNS ) A4規格(210X 297公釐) 1235157 Λ7 B7 一 五、發明説明(521 ) , 4.85 (m, 1H), 4.85-4.95 (mt 1H), 5.05-5.25 (m? 1H), 5.3 (s, 0.5H), 5.6 (d, 〇.5H), 6.55 (d, 0.5H), 6.85 (d, 0.5H)? 7.0 (d? 0.5H), 7.25-7.6 (m, 5.5H), 7.75 (s, 1H), 7.85 (s? 1H) [lS,9S(2RS,3S)]9-[(4-二甲胺基芊链基)胺基 l·6,10·一酮基- 1,2,3,4,7,8,9,1〇-八氫-讨-(2-乙氧基-5-酮四氫呋喃-3-基)-6«^ 咨畊並[l,2-a][l,2】二氮雜箪-1-羧醯胺(550f),合成自212f ,利用甴212e製備213e之方法,可生成420毫克的’玉Printed by Xiaoxian Cooperative of Employees of Zhongli Standards Bureau, Ministry of Economic Affairs X 1H), 2.48 (m, 2H), 2.75 (m, 2H), 2.9 (m, 1H), 2.95-3.25 (m, 5H), 4.45 (t, IH ), 4.5-4.6 (m, 4H), 4.7 (m, 1H), 4.75 (d, 1H), 4.88 (m, 1H), 5.05 (m, 2H), 5.15 (q, IH), 5.3 (s, 1H), 5.58 (d. 1H), 6.5 (d, 1H), 6.9 (d, iH), 7.05 (d, IH), 7.25-7.3 5 (m, 5H), 7.6 (s, 2H), 7.7 ( s, 2H) ^ [15,95 (2115,35)] 9-[(3,5-Digas-4-hydroxyfluorenyl) amino group 6,10-diketo-1,2,3, 4,7,8,9,10-octahydro-: ^-(2-fluorenyl-5-ketotetrahydrofuran-3-yl) ___- 522-_ This paper is applicable to Chinese national standards (CNS) A4 gauge (2 丨 0X297 mm) 1235157 Λ 7 _Β7 ___ V. Description of the invention (520) -6H-Ka Teng and [l, 2-a] [l, 2] diazapine-1-carboxyl Amidine (213k), synthesized from 212k, and using the method of preparing 213e from 212e, 593 mg of 213k can be generated, lH NMR (CD3OD), 1.5 (m, 1Η), 1.6-1.7 (m, 2H), 1.75-1.95 ( m, 4H), 2.15 (m, 2H), 2.3 (m, 1H), 2.6 (m, 1H), 2.7 (m, iH), 3.05 (m, 2H), 3.15 (m, 1H), 3.5 (m , 2H), 4.45 (m? 2H)? 4.65 (d, 1H), 4.7 (m, 1H), 4.95 (m, 1H), 5.15 (m, 1H)? 5.4 (s? 1H ), 5.7 (d, 1H), 7.3 (m, 5H), 7.85 (s, 2H) ^ [lS, 9S (2RS, 3S)] 9-[(3-Ga-4-ethylamidino; fluorenyl ) Amino], 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-; (2- (2-oxooxy-one-tetrahydrofuran-3-) Base) -6Η- [2,2-a] [l, 2] diazapyridine-1-carboxamide (2131), synthesized from 2121, and produced from 212e by 212e, yielding 133 mg 2131 ^ lH NMR (CDCI3) δ 1.55-1.7 (m, 1H), 1.75-2.05 (m, 3H), Yin Chang, an employee of the China Standards Bureau, Ministry of Economic Affairs, Xiaoxian Cooperative (please read the intention on the back ^ Fill out this page again) 2.25 (s, 1.5 H), 2.27 (s, 1.5H), 2.3-2.48 (m? 2H)? 2.7-2.83 (m, 1H), 2.85 ^ 2.94 (dd, 1H), 2.95- 3.25 (m, 2H), 4.42-4.65 (m, 2H), 4.68-4.85 (m, 1H), 4.88-4.95 (m, 1H), 5.05-5.18 (m, 2H), 5.32 (s, 0.5H) , 5.55-5.6 (d, 0.5H), 6.48 ^ 6.55 (d, 1H), 6.88-6.92 (d, 1H), 7.0-7.04 (d, 0.5H), 7.15-7.2 (d, 0.5H), 7.3 -7.4 (m, 4H), 7.64-7.78 (m, 2H), 7.88 ^ 7.94 (m, 1H), 8.45-8.56 (m7 1H) ^ [15,95 (2 feet 5,3 5)] 9- [ (3,5-Digas-4-methoxyfluorenyl) amino] -6,10-diketo-1,2,3,4,7,8,9,10-octahydro-; -(2-Methoxy-5 -Ketotetrahydrofuran-3-yl) -6H-, which is [1,2-a] [l, 2] diazapyrene-carboxamide (213m), synthesized from 212m, using 甴 212e The method for preparing 213e can produce 991 mg of 213m, lHNMR (CDCl3) d 1.5-2.15 (m, 5H), 2.2-2.55 (m, 3H), 2.6-3.3 (m, 4H), 3.95 (2s, 3H) , 4.45-4.7 (m, 2H), 4.7- -523-The standard of this paper is applicable to Chinese National Standard Grass (CNS) A4 specification (210X 297 mm) 1235157 Λ7 B7 15. Description of the invention (521), 4.85 (m , 1H), 4.85-4.95 (mt 1H), 5.05-5.25 (m? 1H), 5.3 (s, 0.5H), 5.6 (d, 0.5H), 6.55 (d, 0.5H), 6.85 (d, 0.5H)? 7.0 (d? 0.5H), 7.25-7.6 (m, 5.5H), 7.75 (s, 1H), 7.85 (s? 1H) [lS, 9S (2RS, 3S)] 9-[(4 -Dimethylamino fluorenyl chain) amine 1 · 6,10 · monoketo-1,2,3,4,7,8,9,10-octahydro- Discussion- (2-ethoxy- 5-ketotetrahydrofuran-3-yl) -6 «^ Geng [1,2-a] [l, 2] Diazapyridine-1-carboxamidine (550f), synthesized from 212f, prepared using 甴 212e 213e method can produce 420 mg of 'jade

摻白色固體,lH NMR (CDC13) d 1.2-1.25 (br· t,3H),U (m,1H),1.55 (br. m,1H),1.88-2.02 (br. m,4H),2·: (d,1H)’ 2.35 (m,1H),2·45 (m,1H),2.55-2.75 (m,3H),3.0 (s,6H), 3.25 (m,1H),3·55 (m,1H),3.65 (m,1H),3.75 (m,1H),3.9 (m,1H),4·3 (t,1H),4.55 (m,2H),4.68 (bf· m,1H),3.9 (m, 1H),4.3 (t,1H),4.55 (m,2H),4.68 (br· m,1H),4.95 (br. m, 1H), 5.1 (br. m, 2H), 5.45 (d, 1H), 6.5 (m, 2H), 7.7 (m, 2H) ^ [15,95(2115,3 5)]9-[(3-氣-4-胺基芊醯基)胺基]-6,10-二酮基- 1,2,3,4,7,8,9,10-八氫_:^-(2-乙氧基-5-酮基四氫呋喃-3-基)- 6Η-»答呼並[l,2-a][l,2]二氮雜箪-1-羧醯胺(550h),合成自 212h,利用由212e製備213e之方法,可生成195毫克的550h ,呈白色固體,1H NMR (DMSO-d0) d 1.1-1.18 (2t,3H), 經濟部中夬嘌这局員二消费合作社印♦各 1.6-1.7 (m, 2H), 1.88-2.05 (m, 2H), 2.1-2.5 (m, 3H), 2.48-2·56 (m,1H),2.75-2.8 (m, 0.75H),2.88-3.08 (m, 1.25H), 3.25-3.4 (m, 1H), 3.55-3.8 (m, 2H), 4.35-4.45 (m, 1H), 4.55-4.62 (m, 1H), 4.8-4.88 (m, 1H), 4.98-5.03 (m? 0.25H), 5.1-5.13 (m, 0.75H), 5.33 (s, 0.25H), 5.58-5.6 (d, 0.75H), 5.9-6.0 本饫ff、尺度通用中a國家標李(CNS〉A4規格(210X297公釐) -524- _ 1235157 Λ7 _B7_ 五、發明説明(S22) (br. s, 2H), 6.8-6.85 (d, 1H), 7.58-7,62 (d, 1H), 7.82 (s, 1H), 8.22^8.28 (d7 1H), 8.48-8.52 (d, 0.75H), 8.72^8.76 (d, 0.25H) ^ [15,95(2尺5,35)]9-[(4-甲氧基芊醯基)胺基]-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-1^(2-乙氧基-5-酮基四氫呋喃-3-基)-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺(550ι),合成自 212i,利用甴212e製備213e之方法可生成315毫克的550i, lH NMR (CDC13) δ 1.18-1.28 (2t? 3Η), 1.6-1.75 (τη, 1.5Η), 1.9-2.1 (m, 3.5Η), 2.22-2.3 (d, 0.5H), 2.38-2.47(m, 1.5H), 2.7- 2.8 (m, 0.5H), 2.8-2.93 (m, 1H), 2.94-3.15 (m, 1.5H), 3.15-3.28 (m, 1H), 3.55-3.62 (q, 0.5H), 3.62-3.73 (q, 0.5H), 3.780.88 (q, 0.5H), 3.88 (s, 3H), 3.9-3.95 (q, 0.5H), 4.33-4.4 (m, 0.5H), 4.5-4.55 (m, 1H), 4.68-4.76 (m, 0.5H), 4.9-4.95 (m, 0.5H), 5.10.2 (m7 1.5H), 5.18 (s, 0.5H), 5.48-5.52 (d, 0.5H), 6.48-6.55 (d, 0.5H), 6.85-6.9 (m, 1H), 6.9-6.95 (m, 2H), 7.34-7.38 (d, 0.5H), 7.78-7.85 (m, 2H) ^ 經濟部中夬標準局員工消費合作社印裏 (請元$請背云之:·/-£意事項再填Trr本I ) [15,95(21^,3 5)]9-[(3,5-二氣-4-羥基芊醯基)胺基卜6,10-二酮 基-1,2,3,4,7,8,9,10-八氮-N-(2-乙乳基-5-嗣四鼠*7夫喃-3 -基)-6H-,答啡並[l,2-a][l,2]二氮雜箪-1-羧醯胺(550k),合成自 212k,利用由212e製備213e之方法可生成174毫克的550k, 呈白色固體,lH NMR (DMSO-d6) J 1.15 (2t,3H),1.6-1.75 (m, 2H), 1.9-2.05 (m, 2H), 2.1-2.4 (m, 5H), 2.5-2.55 (m, 1H)? 2.7- 2.8 (m, 0.5H), 2.85-3.0 (m, 1H)? 3.0-3.1 (m, 0.5H), 3.55-3.7 (m, 1H), 3.7-3.8 (m, IH), 4.2 (t, 0.5H), 4.35-4.45 (m? 0.5H), 4.55-4.65 (m, 0.5H), 4.8-4.9 (m, 0.5H), 5.05 (t, 0.5H), -525 - 本纸乐尺度適用中國国家標隼(CNS ) A4規格(210:&lt;1公罨) 1235157 AT B7 五、發明説明(523 ) 5.15 (t,0·5Η),5.35 (s,0·5Η),5.6 (d、,、0.5H),7.95 (s,2H),8·5 (d,0·5Η),8·65 (d,1Η),8.75 (d,0.5Η),10.9 (br·· s,1Η)。 [lS,9S(2RS,3S)]9-[(3-氣-4-乙醯胺基芊醯基)腔基卜(^二 嗣基-1,2,3,4,7,8,9,10-八氫-1^-(2-乙乳基-5-網四氫咳續-3-基) -6H-嗒呼並[l,2-a][l,2]二氮雜苯-1-羧醯胺(5501),合成自 2U1,利用甴2lZe製備2ne之方法,可生成m学克的55〇1 ,lH NMR (CDC13) β 1·2,1·28 (2t, 3H),1.6-1.72 (m,1.5H), 1.88-2.15 (m, 3.5H), 2.22-2.28 (m, 0.5H), 2.28 (s, 3H). 2.38-2.48 (m, 1.5H), 2.66-2.92 (m, 1.5H), 2.95-3.14 (m, 1.5H), 3.2- 3.34 (m, 1H), 3.56-3.63 (q, 0.5H), 3.63-3.72 (q, 0.5H), 3.8- 3.85 (q, 0.5H), 3.9-3.95 (q, 0.5H), 4.32-4.38 (m, 0.5H), 經濟部中夬標準局貝工消费合作社印¾ {持.之閨讀背云之-;1意事項昇填寫本買) 4.5- 4.62 (m, 1H), 4.68-4.75 (m, 0.5H), 4.88-4.92 (m, 0.5H), 5.08ο.2 (m, 1.5H), 5.18 (s, 0.5H), 5.46^5.5 (d, 0.5H), 6.5-6.55 (d, 0.5H), 6.98-7.05 (m, 1H), 7.42-7.48 (d, 0.5H), 7.63-7.78 (m, 2.5H), 7.9-7.94 (d, 0.5H), 8.44-8.52 (m, 1H) ^ [15,95(2反5,35)]9-[(3,5-二氣-4-曱氧基芊醯基)胺基]-6,10-二 酮基-1,2,3,4,7,8,9,10-八氫-&gt;1-(2-乙氧基-5-酮基四氫吱喃-3-基)-6H-嗒畊並[l,2-aHl,2]二氮雜箪-1-羧醯胺(550m),合成 自212m,利用甴212e製備213e之方法可生成301毫克的 550m,呈白色固體,NMR (CDC13) β 1.2-1.35 (2t,3H), 1.5- 1.8 (m, 2H), 1.9-2.15 (5H), 2.25 (d, 0.5H), 2.4-2.5 (m, 2H), 2.65-2.8 (m, 0.5H), 2.8-3.0 (m, 0.5H), 3.0-3.2 (m, 1H), 3.2- 3.35 (m, 0.5H), 3.55-3.65 (m, 0.5H), 3.65-3.75 (m, 0.5H), 3.8- 3.9 (m, 0.5H), 3.9-4.0 (m, 0.5H), 4.4-4.45 (m, 0.5H), -526 - 本紙泫尺度逑用中國國家標準(CNS M4現格(210X297公签) 1235157 A7 _B7_ 五、發明説明(524 ) 4.55-4.65 (m, 0.5H), 4.7-4.8 (m. 0.5Ή), 4.85-4.95 (m, 0.5H), 5.05- 5.2 (m, 0.5H), 5.2 (s, 〇.5H)? 5.5 (d, 0.5H), 6.5 (d? 0.5H), 6.9 (d,0.5H), 6.95 (d, 0.5H),7.35 (d,0.5H),7.75 (s,1H), 7.85 (s,1H)。 [3 5(15,95)]3-(9-(3,5-二氣芊醯基)胺基]-6,10-二酮基-1,2,3,4, 7,8,9,10-八氫-611-嗒畊並[1,24][1,2]二氮雜箪-1-羧醯胺基)-4-酮乙酸(214j),合成自213j,利用甴2001製備2002之方法 ,可生成62毫克的214j,呈白色固體,lH NMR (CD3〇D) ό' 0.9 (t,1H),1·3 (br· s,1H),1.7 (br. m,1H),1.9 (br. m, 1H), 2.1 (br. s, 1H), 2.25 (q, 1H)? 2.35 (m, 1H), 2.48 (m, 2H), 2.65 (t, 1H), 3.15 (br. t,1H),3.5 (br· m,1H),4.3 (br· s, 1H),4.55 (m, 2H), 4.95 (t, 1H), 5.25 (br. s, 1H), 7.6 (br. s, 1H)? 7.85 (br. s, 1H)。 [3 5(15,95)]3-(9-(3,5-二氣-4-羥基苄醯基)胺基]-6,10-二酮-1,2,3,4,7,8,9,10-八氫-611-嗒啩並[1,24][1,2]二氮雜箪-1-羧 SI胺基)-4-酮丁酸(214k),合成自213k,利用甴2001製備 2002之方法,可生成80毫克的214k,呈白色固鳢,4 NMR (CD3OD) ά 1.6-1.7 (m, 1H), 1.8-2.0 (m, 2H), 2.0-2.1 (m, 2H), 2.15-2.25 (m, 1H), 2.3-2.4 (m, 1H), 2.4-2.55 (m? 2H)?Doped with white solid, lH NMR (CDC13) d 1.2-1.25 (br · t, 3H), U (m, 1H), 1.55 (br. M, 1H), 1.88-2.02 (br. M, 4H), 2 · : (d, 1H) '2.35 (m, 1H), 2.45 (m, 1H), 2.55-2.75 (m, 3H), 3.0 (s, 6H), 3.25 (m, 1H), 3.55 ( m, 1H), 3.65 (m, 1H), 3.75 (m, 1H), 3.9 (m, 1H), 4.3 (t, 1H), 4.55 (m, 2H), 4.68 (bf · m, 1H) , 3.9 (m, 1H), 4.3 (t, 1H), 4.55 (m, 2H), 4.68 (br · m, 1H), 4.95 (br. M, 1H), 5.1 (br. M, 2H), 5.45 (d, 1H), 6.5 (m, 2H), 7.7 (m, 2H) ^ [15,95 (2115,3 5)] 9-[(3-Ga-4-aminofluorenyl) amino] -6,10-diketo-1,2,3,4,7,8,9,10-octahydro _: ^-(2-ethoxy-5-ketotetrahydrofuran-3-yl) -6 -»Answer [l, 2-a] [l, 2] diazepine-1-carboxamide (550h), synthesized from 212h, using the method of preparing 213e from 212e, can produce 195 mg of 550h, It was a white solid, 1H NMR (DMSO-d0) d 1.1-1.18 (2t, 3H), printed by the second consumer cooperative of the bureau of the Ministry of Economic Affairs. 1.6-1.7 (m, 2H), 1.88-2.05 (m, 2H) ), 2.1-2.5 (m, 3H), 2.48-2 · 56 (m, 1H), 2.75-2.8 (m, 0.75H), 2.88-3.08 (m, 1.25H), 3.25-3.4 (m, 1H), 3.55-3.8 (m, 2H), 4.35-4.45 (m, 1H), 4.55-4.62 (m, 1H), 4.8-4.88 (m, 1H ), 4.98-5.03 (m? 0.25H), 5.1-5.13 (m, 0.75H), 5.33 (s, 0.25H), 5.58-5.6 (d, 0.75H), 5.9-6.0 a National standard (CNS> A4 specification (210X297 mm) -524- _ 1235157 Λ7 _B7_ V. Description of the invention (S22) (br. s, 2H), 6.8-6.85 (d, 1H), 7.58-7, 62 (d, 1H), 7.82 (s, 1H), 8.22 ^ 8.28 (d7 1H), 8.48-8.52 (d, 0.75H), 8.72 ^ 8.76 (d, 0.25H) ^ [15,95 (2 feet 5, 35)] 9-[(4-methoxyfluorenyl) amino] -6,10-diketo-1,2,3,4,7,8,9,10-octahydro-1 ^ ( 2-Ethoxy-5-ketotetrahydrofuran-3-yl) -6H-dapyrido [l, 2-a] [l, 2] diazapine-1-carboxamide (550m), synthesized from 212i, the method of preparing 213e with 甴 212e can generate 315 mg of 550i, lH NMR (CDC13) δ 1.18-1.28 (2t? 3Η), 1.6-1.75 (τη, 1.5Η), 1.9-2.1 (m, 3.5Η) , 2.22-2.3 (d, 0.5H), 2.38-2.47 (m, 1.5H), 2.7- 2.8 (m, 0.5H), 2.8-2.93 (m, 1H), 2.94-3.15 (m, 1.5H), 3.15-3.28 (m, 1H), 3.55-3.62 (q, 0.5H), 3.62-3.73 (q, 0.5H), 3.780.88 (q, 0.5H), 3.88 (s, 3H), 3.9-3.95 (q, 0.5H), 4.33-4.4 (m, 0.5H), 4.5-4.55 (m, 1H), 4.68-4.76 (m, 0.5H), 4.9-4.95 (m , 0.5H), 5.10.2 (m7 1.5H), 5.18 (s, 0.5H), 5.48-5.52 (d, 0.5H), 6.48-6.55 (d, 0.5H), 6.85-6.9 (m, 1H) , 6.9-6.95 (m, 2H), 7.34-7.38 (d, 0.5H), 7.78-7.85 (m, 2H) ^ Industry Consumer Cooperative Cooperative, Zhongli Standards Bureau, Ministry of Economic Affairs /-£ Please fill in the trr item I) [15,95 (21 ^, 3 5)] 9-[(3,5-Digas-4-hydroxyfluorenyl) amino group 6,10-dione N- (1,2,3,4,7,8,9,10-octaazepine-N- (2-ethyllactyl-5-carboxamidine * 7-furan-3 -yl) -6H- And [l, 2-a] [l, 2] diazepine-1-carboxamide (550k), synthesized from 212k, using the method of preparing 213e from 212e to produce 174 mg of 550k, as a white solid, lH NMR (DMSO-d6) J 1.15 (2t, 3H), 1.6-1.75 (m, 2H), 1.9-2.05 (m, 2H), 2.1-2.4 (m, 5H), 2.5-2.55 (m, 1H)? 2.7- 2.8 (m, 0.5H), 2.85-3.0 (m, 1H)? 3.0-3.1 (m, 0.5H), 3.55-3.7 (m, 1H), 3.7-3.8 (m, IH), 4.2 (t , 0.5H), 4.35-4.45 (m? 0.5H), 4.55-4.65 (m, 0.5H), 4.8-4.9 (m, 0.5H), 5.05 (t, 0.5H), -525-Paper scale In use National Standards (CNS) A4 specifications (210: &lt; 1 cm) 1235157 AT B7 V. Description of the invention (523) 5.15 (t, 0.5mm), 5.35 (s, 0.5mm), 5.6 (d, , 0.5H), 7.95 (s, 2H), 8.5 (d, 0.50), 8.65 (d, 1Η), 8.75 (d, 0.5Η), 10.9 (br ·· s, 1Η) . [1S, 9S (2RS, 3S)] 9-[(3-Ga-4-Ethylamidofluorenyl) calyl (^ Diamido-1,2,3,4,7,8,9 , 10-octahydro-1 ^-(2-ethyllactyl-5-nettetrahydroketra-3-yl) -6H-daphtho [l, 2-a] [l, 2] diazabenzene -1-Carboxamidamine (5501), synthesized from 2U1, and 2ne using osmium 2lZe, can produce 55 g of m gram, 1H NMR (CDC13) β 1.2, 1.28 (2t, 3H) , 1.6-1.72 (m, 1.5H), 1.88-2.15 (m, 3.5H), 2.22-2.28 (m, 0.5H), 2.28 (s, 3H). 2.38-2.48 (m, 1.5H), 2.66- 2.92 (m, 1.5H), 2.95-3.14 (m, 1.5H), 3.2- 3.34 (m, 1H), 3.56-3.63 (q, 0.5H), 3.63-3.72 (q, 0.5H), 3.8- 3.85 (q, 0.5H), 3.9-3.95 (q, 0.5H), 4.32-4.38 (m, 0.5H), printed by the Shellfish Consumer Cooperative of the China Standards Bureau of the Ministry of Economic Affairs ¾ {hold. Please fill in this item if you want to buy 1) 4.5- 4.62 (m, 1H), 4.68-4.75 (m, 0.5H), 4.88-4.92 (m, 0.5H), 5.08ο.2 (m, 1.5H), 5.18 ( s, 0.5H), 5.46 ^ 5.5 (d, 0.5H), 6.5-6.55 (d, 0.5H), 6.98-7.05 (m, 1H), 7.42-7.48 (d, 0.5H), 7.63-7.78 (m , 2.5H), 7.9-7.94 (d, 0.5H), 8.44-8.52 (m, 1H) ^ [15,95 (2 reverse 5,35)] 9-[(3,5- 二 气 -4- 曱Oxyfluorenyl) amino] -6 10-diketo-1,2,3,4,7,8,9,10-octahydro- &gt; 1- (2-ethoxy-5-ketotetrahydrocran-3-yl)- 6H-Da Geng and [l, 2-aHl, 2] diazapyrene-1-carboxamide (550m), synthesized from 212m, the method of preparing 213e using 甴 212e can produce 301 mg of 550m, as a white solid NMR (CDC13) β 1.2-1.35 (2t, 3H), 1.5- 1.8 (m, 2H), 1.9-2.15 (5H), 2.25 (d, 0.5H), 2.4-2.5 (m, 2H), 2.65-2.8 (m, 0.5H), 2.8-3.0 (m, 0.5H), 3.0-3.2 (m, 1H), 3.2- 3.35 (m, 0.5H), 3.55-3.65 (m, 0.5H), 3.65-3.75 ( m, 0.5H), 3.8- 3.9 (m, 0.5H), 3.9-4.0 (m, 0.5H), 4.4-4.45 (m, 0.5H), -526-Chinese paper standard (CNS M4) Present (210X297) 1235157 A7 _B7_ V. Description of the invention (524) 4.55-4.65 (m, 0.5H), 4.7-4.8 (m. 0.5Ή), 4.85-4.95 (m, 0.5H), 5.05- 5.2 (m, 0.5H), 5.2 (s, 0.5H)? 5.5 (d, 0.5H), 6.5 (d? 0.5H), 6.9 (d, 0.5H), 6.95 (d, 0.5H), 7.35 ( d, 0.5H), 7.75 (s, 1H), 7.85 (s, 1H). [3 5 (15,95)] 3- (9- (3,5-Diaziridinyl) amino] -6,10-diketo-1,2,3,4, 7,8,9 , 10-Octahydro-611-Da-Chen [1,24] [1,2] Diazapyridine-1-carboxamido) -4-ketoacetic acid (214j), synthesized from 213j, prepared using pyrene 2001 The method of 2002 can produce 62 mg of 214j as a white solid, lH NMR (CD3〇D), 0.9 (t, 1H), 1.3 (br · s, 1H), 1.7 (br. M, 1H) , 1.9 (br. M, 1H), 2.1 (br. S, 1H), 2.25 (q, 1H)? 2.35 (m, 1H), 2.48 (m, 2H), 2.65 (t, 1H), 3.15 (br t, 1H), 3.5 (br · m, 1H), 4.3 (br · s, 1H), 4.55 (m, 2H), 4.95 (t, 1H), 5.25 (br. s, 1H), 7.6 (br s, 1H)? 7.85 (br. s, 1H). [3 5 (15,95)] 3- (9- (3,5-Digas-4-hydroxybenzylfluorenyl) amino] -6,10-dione-1,2,3,4,7, 8,9,10-octahydro-611-dapyrido [1,24] [1,2] diazapyridine-1-carboxySIamino) -4-ketobutanoic acid (214k), synthesized from 213k, Using the method of 甴 2001 to prepare 2002, 80 mg of 214k can be generated, which is a white solid, 4 NMR (CD3OD), 1.6-1.7 (m, 1H), 1.8-2.0 (m, 2H), 2.0-2.1 (m, 2H), 2.15-2.25 (m, 1H), 2.3-2.4 (m, 1H), 2.4-2.55 (m? 2H)?

經濟部,〒夬櫺这局員二消f合作杜印X 2.6- 2.75 (m, iH), 3.05-3.2 (m, 1H), 3.4-3.6 (m? 2H), 4.2^4.3 (m, IH), 4.45-4.6 (m, iH), 4.8-5.0 (m, 1H), 5.1-5.2 (m, 1H), 7.85 (s,2H)。 [3S(lS,9S)】3-(9-(3-氣-4-乙醯胺基芊醯基)胺基卜6,10-二酮-1,2,3,4,7,8,9,10-八氫-61^嗒啩並[1,24几1,2]二氮雜箪-1-羧 -527 - 本纸*尺度適用中國國家標隼(CNS ) A4堤洛(210 X297公瘦) 1235157 經涛部t夬襟革局負工消费合作杜印¾ B7 五、發明説明(525 ) · 醯胺基)-4-酮基丁酸(214〖),合成舍2131,利用由2001製備 2002之方法,可生成91毫克的214丨,呈白色固體,1H NMR (DMSO-d6) S 1.65 (br. m, 6H), 1.9 (br. m, 6H), 2.15 (s, 3H), 2.3 (m, 3H), 2.6-2.85 (m, 3H), 2.9 (m, 2H), 3.0 (m, 1H);4.15 (br. q, 1H), 4.4 (m, 3H), 5.0 (m, 1H), 5.15 (m, 1H), 5.45 (s5 1H), 7.8 (d, 2H), 7.95 (d, 1H), 8.05 (s, 1H&gt;, 8.65 (m, 2H), 9·65 (s, 1H” [3S(lS,9S)]3-(9-(3,5·二氯-芊盛·基)胺基]·6,1〇-二酮基·ι,2,3, 4,7,8,9,10-八氫-6仏嗒啩並[1,24][1,2]二氮雜箪-1-羧睦胺基) -4-酮基丁酸(214m),合成自213m,利用甴2001製備2002之 方法,可生成105毫克的214m,呈白色固體,β NMR (CD3〇D) δ 1.6-1.75 (m, IH), 1.85-1.95 (m, iH), 2.0-2.1 (m, 2H), 2.15-2.25 (m, 1H), 2.3-2.4 (m, 1H), 2.45-2.55 (m, 2H), 2.65-2.75 (m, 1H), 3.4-3.55 (m, 2H), 3.95 (s, 3H), 4.2-4.3 (m, 1H), 4.45-4.6 (m, 1H), 4.9〇.0 (m&gt; 1H), 5.15-5.2 (m, 1H), 7.9 (s, 2H) a 化合物308c及308d如下製備3The Ministry of Economic Affairs, the Bureau of the Ministry of Economic Cooperation and Cooperation Du Yin X 2.6- 2.75 (m, iH), 3.05-3.2 (m, 1H), 3.4-3.6 (m? 2H), 4.2 ^ 4.3 (m, IH) , 4.45-4.6 (m, iH), 4.8-5.0 (m, 1H), 5.1-5.2 (m, 1H), 7.85 (s, 2H). [3S (1S, 9S)] 3- (9- (3-Ga-4-ethylamidoamidinyl) amino group 6,10-dione-1,2,3,4,7,8, 9,10-octahydro-61 ^ Da [1,24,1,2,2] diazepine-1-carboxyl-527-The paper * size is applicable to China National Standard (CNS) A4 Tillow (210 X297 Public thin) 1235157 Ministry of Economic Affairs, Ministry of Economics and Trade, Co-operation and Consumption Cooperation, Du Yin ¾ B7 V. Description of the invention (525) · Amido) -4-ketobutyric acid (214 〖), synthetic house 2131, using The method of 2001 and 2002 can produce 91 mg of 214 丨 as a white solid. 1H NMR (DMSO-d6) S 1.65 (br. M, 6H), 1.9 (br. M, 6H), 2.15 (s, 3H) , 2.3 (m, 3H), 2.6-2.85 (m, 3H), 2.9 (m, 2H), 3.0 (m, 1H); 4.15 (br. Q, 1H), 4.4 (m, 3H), 5.0 (m , 1H), 5.15 (m, 1H), 5.45 (s5 1H), 7.8 (d, 2H), 7.95 (d, 1H), 8.05 (s, 1H &gt;, 8.65 (m, 2H), 9.65 (s , 1H "[3S (lS, 9S)] 3- (9- (3,5 · Dichloro-fluorene · yl) amino] · 6,10-diketo · ι, 2,3, 4, 7,8,9,10-octahydro-6-da- [1,24] [1,2] diazepine-1-carboxamido) -4-ketobutanoic acid (214m), synthesis From 213m, using the method of 甴 2001 to prepare 2002, 105mg of 214m can be generated. White solid, β NMR (CD3〇D) δ 1.6-1.75 (m, IH), 1.85-1.95 (m, iH), 2.0-2.1 (m, 2H), 2.15-2.25 (m, 1H), 2.3-2.4 (m, 1H), 2.45-2.55 (m, 2H), 2.65-2.75 (m, 1H), 3.4-3.55 (m, 2H), 3.95 (s, 3H), 4.2-4.3 (m, 1H), 4.45 -4.6 (m, 1H), 4.90.0 (m &gt; 1H), 5.15-5.2 (m, 1H), 7.9 (s, 2H) a Compounds 308c and 308d were prepared as follows 3

OO

_ - 528 - 本紙張尺度遴用中国S家標隼(CNS ) Λ4現格29了公Try 1235157 Λ7 B7 五、發明説明( 526 ) 會 [3S(lS,9S)]3-(9-(4-甲氧基节縫基)胺基]-6,10-二 ’ -1,2,3,4,7, 8,9,1〇-八氫-6Η-嗒啩並[l,2-a】[l,2]二氮雜革-1-致趋胺基)· 胺基]-4-酮基乙酸,〇-曱基肪(3〇8c),合成自212e,利用甴 212e製備308b之方法,可生成266毫克的308c ’ lH NMR (CDC13) 6 1.6-1.7 (m, 1H), 1.88-1.98 (m, 3H), 2.02-2.15 (m. 1H), 2.3-2.4 (m, 1H), 2.65-2.95 (m, 3H), 3.04-3.09 (m? 1H)? 3.12-3.25 (m, 1H), 3.84 (s, 3H), 3.86 (s, 3H), 4.5-4.58 (m, 1H), 4.88-4.95 (m, 1H), 5.1-5.25 (m, 2H), 6.86-6.9 (d? 2H), 7.15-7.25 (m, 2H),7.36-7.4 (m,1H), 7.75-7.8 (d,2H)。 [3 3(15,95)]3-(9-(4-甲氧基;醢基)胺基]-6,10-二酮-1,2,3,4,7, 8,9,10-八氫-6只-&lt;7答*井並[1,2-汪][1,2]二氮雜輩-1-幾縫腔基)-胺基]-4-酮基丁酸l〇-笮基肟(3〇〇d),合成自212e,利用甴 212e製備 308b之方法,可生成 308d,β NMR (CDC13) c? 1.55-1.65 (m, 1H), 1.8-2.1 (m, 4H), 2.3-2.4 (m, 1H), 2.65-2.88 (m, 3H)? 2.9-3.3 (m, 3H), 4.5-4.58 (m, 1H), 4.88-4.95 (m, 1H), 5.05 (s, 2H), 5.10.2 (m, 1H), 6.82-6.95 (m? 2H), 7.02-7.15 (m, 2H), 7.28 (m, 5H), 7.45 (m, 1H), 7.72 (d, 2H) 3 化合物 2100f,2100g,2100h,2100i 及 2100j如下述地製 備3 (請先閣讀背云之;^意事\^續寫犬二貝) 裝· 訂 經濟部中夬糅準局員工消费合作社印¾ -529- 本纸杲尺度逍用中國国家樣绛(CNS M4規格(2〖0 X 297公釐) 1235157 A7 β 了 五、發明説明(527 )_-528-The Chinese paper standard (CNS) 遴 4 is selected for this paper. Try 1235157 Λ7 B7 V. Description of the invention (526) [3S (lS, 9S)] 3- (9- (4 -Methoxy nodoxy) amino] -6,10-di'-1,2,3,4,7,8,9,10-octahydro-6'-dapyrido [l, 2-a ] [1,2] Diaza leather-1-induced amine-forming amino group) · Amino] -4-ketoacetic acid, 0-fluorenyl fatty acid (308c), synthesized from 212e, and 308b was prepared using 甴 212e Method, 266 mg of 308c'lH NMR (CDC13) 6 1.6-1.7 (m, 1H), 1.88-1.98 (m, 3H), 2.02-2.15 (m. 1H), 2.3-2.4 (m, 1H) , 2.65-2.95 (m, 3H), 3.04-3.09 (m? 1H)? 3.12-3.25 (m, 1H), 3.84 (s, 3H), 3.86 (s, 3H), 4.5-4.58 (m, 1H) , 4.88-4.95 (m, 1H), 5.1-5.25 (m, 2H), 6.86-6.9 (d? 2H), 7.15-7.25 (m, 2H), 7.36-7.4 (m, 1H), 7.75-7.8 ( d, 2H). [3 3 (15,95)] 3- (9- (4-methoxy; fluorenyl) amino] -6,10-dione-1,2,3,4,7,8,9,10 -Octahydro-6- &lt; 7A * Jing [1,2-wang] [1,2] diazepine-1-cavity) -amino] -4-ketobutanoic acid l 〇-fluorenyl oxime (300d), synthesized from 212e, using 212e to prepare 308b, can generate 308d, β NMR (CDC13) c? 1.55-1.65 (m, 1H), 1.8-2.1 (m, 4H), 2.3-2.4 (m, 1H), 2.65-2.88 (m, 3H)? 2.9-3.3 (m, 3H), 4.5-4.58 (m, 1H), 4.88-4.95 (m, 1H), 5.05 ( s, 2H), 5.10.2 (m, 1H), 6.82-6.95 (m? 2H), 7.02-7.15 (m, 2H), 7.28 (m, 5H), 7.45 (m, 1H), 7.72 (d, 2H) 3 Compounds 2100f, 2100g, 2100h, 2100i, and 2100j are prepared as follows 3 (Please read back the cloud first; ^ 意 事 \ ^ Continue to write a dog two shells) Binding and ordering by the Ministry of Economic Affairs, Associate Bureau staff Cooperative cooperative seal ¾ -529- The standard of this paper is free to use the national sample of China (CNS M4 specification (2 〖0 X 297mm) 1235157 A7 β V. Description of invention (527)

:您濟部申夬樣绛局員工消费合作社印裳 (3S,2RS) 3-烯丙氧羰基胺基-2-(4-氣芊基)氧基-5-酮四氫呋 痛(2101a),合成自晞丙氧談胺基-点**弟二-丁基天冬胺酸 酯,利用 Chapman之方法 rBioorg. &amp; Med. Chem. Lett,, 2, pp. 615-618 (1992))製備(3S,2RS) 3-烯两氧羰基胺基-2-辛氧基-5-酮基四氩呋喃,利用4-氣芊醇替代芊醇,可生成I·84兄 的2101a,呈晶狀固體。 [1S,9S(2RS,3S)] 9-苄醯胺基-6,10-二酮基-l,2,3,4,7,8,9,l〇- 八氩-N-(2-(4·氯芊基)氧-5-酮基四氫呋喃-3-基〃井並 [l,2-a][l,2]二氮雜箪-1-¾醯胺(2100f),合成自212e’利用: Yin Chang (3S, 2RS), 3-allyloxycarbonylamino-2- (4-pyridyl) oxy-5-one tetrahydrofuran (2101a) , Synthesized from 晞 -Propoxy-amino-diodo-di-butylaspartate, using the method of Chapman rBioorg. &Amp; Med. Chem. Lett ,, 2, pp. 615-618 (1992)) Preparation of (3S, 2RS) 3-ene dioxocarbonylamino-2-octyloxy-5-ketotetrahydrofuran, and the use of 4-peranyl alcohol instead of fluorenyl alcohol can generate 2 · 101a of I · 84, which is crystal Like solid. [1S, 9S (2RS, 3S)] 9-benzylamido-6,10-diketonyl-1,2,3,4,7,8,9,10- octa-argon-N- (2- (4. Chlorofluorenyl) oxy-5-ketotetrahydrofuran-3-ylfluorene and [l, 2-a] [l, 2] diazafluorene-1-¾fluorenamine (2100f), synthesized from 212e 'use

本纸杀尺度通用中國国家標孳(CNS )以堤格(2丨0X2W公釐) 1235157 Λ7 B7 五、發明説明(S2S) 由212e製備213e之方法,可生成38、〇毫克的2100f,〖HNMR (CDCI3) ^ 1.8-2.0 (m, 10H), 2.30 (d&gt; 1H)^ 2.31-2.5 (m, 3H), 2.7-2.9 (m,3H), 3.05 (m, 2H),3.1.3 2 (瓜,々Η), 4·45 (q,1H), 4.5-4.6 (m,3H),4·7 (d,2H),4.85 (d,iH),4·9 (t,1H),5:2 (t, 1H), 5.15 (m, 2H), 5.25 (s, 1H), 5.55 (d, iH), 6.5 (d, 1H), 6.9 (d, 1H), 6.95 (d, 1H), 7.25 (m, 3H), 7.35 (t, 2H), 7.45 (m, 2H), 7·55 (1H), 7.8 (m, 3H)。 (3S,2RS) 3-缔丙氧羰基胺基-2:對側-異丙氧基-5-酮四氫呋 喃(2101b),合成自(3S,2RS) 3-烯丙氡羰基胺基芊氡基-5-酮基四氩呋喃,利用自214e製備2100d之方法,並以 H2S04替代pTSA,可生成2101b。 [13,95(2113,33)】9-笮醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-N-(2-對側-異丙氧基酮基四氫呋喃-3-基)-6H-嗒啩 並[l,2-ani,2]二氮雜箪-1-羧醯胺(2100g),合成自212e,利 用甴212e製備213e之方法,可生成31毫克的2l〇〇g,4 NMR (CDCI3) S 1.19 (d), 1.94 (br s), 2.00-2.12 (m), 2.24 (d), 經濟部中夬橾淇局員工消费合作杜印製 2.42 (dd), 2.71-2.83 (m), 3.02 (dd), 3.12-3.27 (overlapping m), 3.93 (m), 4.32-4.37 (m,), 4.52-4.63 (m), 4.90-4.95 (m), 5.12-5.20 (m), 5.28 (s), 6.93 (d), 7.10 (d), 7.41-7.50 (m), 7.51-7.58 (m), 7.84 (d)-The standard for this paper is the Chinese National Standard (CNS). Tigger (2 丨 0X2W mm) 1235157 Λ7 B7 V. Description of the invention (S2S) The method for preparing 213e from 212e can generate 2100f at 38 and 0 mg. (CDCI3) ^ 1.8-2.0 (m, 10H), 2.30 (d &gt; 1H) ^ 2.31-2.5 (m, 3H), 2.7-2.9 (m, 3H), 3.05 (m, 2H), 3.1.3 2 ( Melon, 々Η), 4.45 (q, 1H), 4.5-4.6 (m, 3H), 4.7 (d, 2H), 4.85 (d, iH), 4.9 (t, 1H), 5 : 2 (t, 1H), 5.15 (m, 2H), 5.25 (s, 1H), 5.55 (d, iH), 6.5 (d, 1H), 6.9 (d, 1H), 6.95 (d, 1H), 7.25 (m, 3H), 7.35 (t, 2H), 7.45 (m, 2H), 7.55 (1H), 7.8 (m, 3H). (3S, 2RS) 3-Allyloxycarbonylamino-2: contra-isopropoxy-5-one tetrahydrofuran (2101b), synthesized from (3S, 2RS) 3-allylfluorenylcarbonylaminofluorenyl -5-ketotetrahydrofuran, using the method of preparing 2100d from 214e, and replacing pTSA with H2S04 can generate 2101b. [13,95 (2113,33)] 9-fluorenylamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-N- (2-pair Pendant-isopropoxyketotetrahydrofuran-3-yl) -6H-dapyrido [l, 2-ani, 2] diazapyridine-1-carboxamidine (2100g), synthesized from 212e, using 甴 212e The method for preparing 213e can generate 31 mg of 2 lOOg, 4 NMR (CDCI3) S 1.19 (d), 1.94 (br s), 2.00-2.12 (m), 2.24 (d), in the Ministry of Economic Affairs Bureau Consumer Consumption Du printed 2.42 (dd), 2.71-2.83 (m), 3.02 (dd), 3.12-3.27 (overlapping m), 3.93 (m), 4.32-4.37 (m,), 4.52-4.63 (m ), 4.90-4.95 (m), 5.12-5.20 (m), 5.28 (s), 6.93 (d), 7.10 (d), 7.41-7.50 (m), 7.51-7.58 (m), 7.84 (d)-

OO

(討先¥讀背云之-;1意事項4填寫本一貝) 214e -531 本紙法尺度通用中3國家標李(CNS &gt; AKt格(210 Λ 297公慶) 1235157 Λ7 B7 五、發明説明(529 ) [1S,9S(2RS,3RS)] 9-苄醯胺基-6,10:二酮基-i,2,3,4,7,8,9,1〇-八氫-N-(2-乙醯氧基-5-酮基四氫咬喃-3-基)-6Η^荅哜並[1,2-a][l,2]二氮雜革-1-羧醯胺(2100h),214e(287 毫克,0·65 毫 莫耳)於吡啶(5毫升)之溶液,以Ac20處理(0.4毫升,3.62毫 莫耳)。6小時後,反應混合物倒入5% NaHSOj中並以 EtOAc萃取3次。混合的有機物以鹽水洗滌,於Na2S04上 乾躁,並眞空濃縮3層析(Si02,EtOAc)可生成,19毫克 的2100h,lH NMR (CDC13, 4種非對映立體異構物之混合) ά 1.80-2.05 (m), 2.12 (s), 2.13 (s), 2.19 (s), 2.22 (d), 2.67-2.75 (m), 2.80-2.95 (m), 3.00-3.20 (m), 3.21-3.33 (m), 3.50-3.95 (4個分別的多峰),4.19 (m), 4·55 (m), 4.57-4.65 (m),4.69 (m), 4.85-4.95 (m), 5.04 (m), 5.10 (s), 5.10-5.22 (m), 6.46 (d)? 6.03 (s), 6.50 (d), 6.58 (d), 6.75 (d), 6.95-7.05 (m), 7.22 (m), 7.30 (m), 7.71 (d), 7.75-7.83 (m) « O 2100b(Discuss ¥ -read the back-of-the-cloud;-1 note 4 fill in the present one) 214e -531 paper standard universal 3 national standard plum (CNS &gt; AKt grid (210 Λ 297 public celebration) 1235157 Λ7 B7 V. Invention Explanation (529) [1S, 9S (2RS, 3RS)] 9-benzylamido-6,10: diketo-i, 2,3,4,7,8,9,10-octahydro-N -(2-Ethyloxy-5-ketotetrahydro-3-anyl) -6pyridine [1,2-a] [l, 2] diazepine-1-carboxamidine (2100h), a solution of 214e (287 mg, 0.65 mmol) in pyridine (5 ml), treated with Ac20 (0.4 ml, 3.62 mmol). After 6 hours, the reaction mixture was poured into 5% NaHSOj It was extracted 3 times with EtOAc. The combined organics were washed with brine, dried over Na2S04, and concentrated under reduced pressure. 3 Chromatography (Si02, EtOAc) yielded 19 mg of 2100 h. Mixture of isomers) ά 1.80-2.05 (m), 2.12 (s), 2.13 (s), 2.19 (s), 2.22 (d), 2.67-2.75 (m), 2.80-2.95 (m), 3.00- 3.20 (m), 3.21-3.33 (m), 3.50-3.95 (4 separate multimodal), 4.19 (m), 4.55 (m), 4.57-4.65 (m), 4.69 (m), 4.85- 4.95 (m), 5.04 (m), 5.10 (s), 5.10-5.22 (m), 6. 46 (d)? 6.03 (s), 6.50 (d), 6.58 (d), 6.75 (d), 6.95-7.05 (m), 7.22 (m), 7.30 (m), 7.71 (d), 7.75-7.83 (m) «O 2100b

M^部也-夫樣达局員二消资合作社印装 [3S(lS,9S)]3-(9-芊醯胺基-6,10-二酮基-1,2,3,4,7,8,9,1〇-八 氫-6H-嗒畊並[l,2-a][l,2]二氮雜箪-卜羧醯胺基l·4·銅基丁 酸乙酯(2l00i)。2100b(1.5 克,2.7毫莫耳)於 CH3CN(l〇毫 升)之溶液中,於環境溫度下加入IE HC1。6小時後,加入 固體NaHC03,且產物以EtOAc萃取,於MgS〇4上乾澡並眞 -532- 1235157 A 7 B7 五、發明説明(530 ) 空濃縮。層析(Si02,30-100% CHiCl2/EtOAc)可生成 123 毫 克的 2100i,β NMR (CDC13) d 1·25 (t,3H), 1·6-1·8 (m,1H) ι·9·2.2 (m, 5H), 2.4-2.5 (m, 1H), 2.75-2.9 (m, 2H), 3.0^3^ ^ 2H), 3.2-3.25 (m, 1H), 4.05-4.2 (m, 1H), 4.5-4.7 (m, 1H)? 5 u 5.25 (m, 1H), 7.0-7.2 (m, 2H), 7.4-7.45 (m, 2H), 7.5 (t, 7·8 (t, 2H), 9.5 (s, 1H)。M ^ 部 也 -Fuchanda Bureau member Erxiao Cooperative Co., Ltd. [3S (lS, 9S)] 3- (9-fluorenylamino-6,10-diketonyl-1,2,3,4,7 Ethyl, 8,9,10-octahydro-6H-da-co- [1,2-a] [l, 2] diazepine-p-carboxamido 1.4-copper ethyl butyrate (2l00i ). 2100b (1.5 g, 2.7 mmol) in a solution of CH3CN (10 ml) was added IE HC1 at ambient temperature. After 6 hours, solid NaHC03 was added, and the product was extracted with EtOAc on MgS04. Dry bath and 眞 -532-1235157 A 7 B7 V. Description of the invention (530) Concentrated in air. Chromatography (Si02, 30-100% CHiCl2 / EtOAc) can produce 123 mg of 2100i, β NMR (CDC13) d 1 · 25 (t, 3H), 1.6-1.8 (m, 1H) 2.9 · 2.2 (m, 5H), 2.4-2.5 (m, 1H), 2.75-2.9 (m, 2H), 3.0 ^ 3 ^ ^ 2H), 3.2-3.25 (m, 1H), 4.05-4.2 (m, 1H), 4.5-4.7 (m, 1H)? 5 u 5.25 (m, 1H), 7.0-7.2 (m, 2H), 7.4-7.45 (m, 2H), 7.5 (t, 7 · 8 (t, 2H), 9.5 (s, 1H).

OO

-裝 [3S(lS,9S)]3-(9-苄醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10、八 氫-6H-喀啩並[l,2-a][l.,2】二氮雜箪-1-羧醯胺基)-4-乙墙氣 •基-3-丁烯酸乙酯(2100j),合成自2100i,利用甴2Ue製傍 2100h之方法,可生成347毫克的2100j,W NMR (CDCl3) ό' 1.3 (t,3H),1.6-1.8 (m,2H), 1.9-2.25 (m,4H),2·25 (s,3H), 2.3-2.45 (m,1H), 2.8-3.0 (m, 1H),3.0-3.25 (m,2H),3.4-3.45 (m, 2H), 4.1-4.2 (m, 2H), 4.55-4.7 (m, 1H), 5.1-5.25 (m? 1H), 6.8 (s, IH), 7.0-7.1 (m, 2H), 7.5 (tvlH), 7.8 (t, 2H), 9.5 (s, 1H)。 化合物500及501述於表23。這些化合物以製備化合物 404-449之相似方法製備(見實例11)。 -533- 本纸&amp;尺度適用中S园家標準(CNS ) A4規格(2丨0:&lt;297公釐) 訂 M濟部中央螓準局員工消费合作社印¾ 1235157 五、發明説明(-Equipped with [3S (lS, 9S)] 3- (9-benzylideneamino-6,10-diketonyl-1,2,3,4,7,8,9,10, octahydro-6H-Ka Pyrene [l, 2-a] [l., 2] Diazapyridine-1-carboxamido) -4-ethylwall gas • yl-3-butenoate ethyl ester (2100j), synthesized from 2100i Using 甴 2Ue to produce 2100h, 347 mg of 2100j, W NMR (CDCl3), 1.3 (t, 3H), 1.6-1.8 (m, 2H), 1.9-2.25 (m, 4H), 2 · 25 (s, 3H), 2.3-2.45 (m, 1H), 2.8-3.0 (m, 1H), 3.0-3.25 (m, 2H), 3.4-3.45 (m, 2H), 4.1-4.2 (m, 2H), 4.55-4.7 (m, 1H), 5.1-5.25 (m? 1H), 6.8 (s, IH), 7.0-7.1 (m, 2H), 7.5 (tvlH), 7.8 (t, 2H), 9.5 (s, 1H). Compounds 500 and 501 are described in Table 23. These compounds were prepared in a similar manner to compounds 404-449 (see Example 11). -533- The paper &amp; standard is applicable to the Chinese Garden Standard (CNS) A4 specification (2 丨 0: &lt; 297 mm). Ordered by the Ministry of Economic Affairs, Central Procurement Bureau, Staff Consumer Cooperatives Co., Ltd. 1235157 V. Description of the invention (

+ {Ηέ SS+ {Ηέ SS

5铁) ^&lt;ki&gt;l DldH 3:2 cus 經濟部中夬標準局員工消费合作杜印¾(5 iron) ^ &lt; ki &gt; l DldH 3: 2 cus Consumption cooperation between employees of China Standards Bureau, Ministry of Economic Affairs

本纸永尺度通用中國國家標準(CNS ) A4規咯(210x 297公釐) 1235157This paper is a permanent Chinese Standard (CNS) A4 standard (210x 297 mm). 1235157

五、發明説明( 532 ) 下述的化合物(213m&lt; 213n,21、3〇,213p,213 213s,213t,213u,213v,213w,213x5. 214w;-合物213b-f之類似方法製備3 化合物 419,415,450,456,475,404 · 486 · ,408及418也可如下述地製備, :· 2 1 3 r · ,乂製诗化 437 ^ 417 ΟV. Description of the invention (532) The following compound (213m &lt; 213n, 21, 30, 213p, 213 213s, 213t, 213u, 213v, 213w, 213x5. 214w;-Compound 213b-f is prepared in a similar manner to 3 compounds 419, 415, 450, 456, 475, 404, 486, 408, and 418 can also be prepared as follows: 2 1 3 r

YY\ 213r^x . 214w, 404, 408, 415, R1 ΟYY \ 213r ^ x. 214w, 404, 408, 415, R1 Ο

Μ濟神r中夬¾洋局員二消贫合作..5ί印製 417, 418, 419, 450, 456, 475, 486, 487 化合物 R1 213ιη^ 419 MeOC(O)- 213η, 415 CO1 535 - 本汔头尺度適用中國国家標準(CNS ) Α4現格(210X29 —公釐) S濟部中夫噤达局員二消费合作枉印製 1235157 Λ7 B7 五、發明説明(533 ) 213〇, 450 0 HN M· Ϊ 213ρ, 456 213q, 475 213r, 404 Μ· Ο 213s, 486 Η 213t, 487 Η 213u, 417 ΟΜβ (請先閱讀背面之)±意事項再填寫本頁) -裝 訂 1· -536 · 衣钱&amp;尺度適用_国國家標隼(CNS ) A·;現咯(:10χ2π公沒) 1235157Members of the Chinese Ministry of Foreign Affairs, China and the Western Bureau of the Second Anti-Poverty Cooperation: 5 ί printed 417, 418, 419, 450, 456, 475, 486, 487 Compound R1 213ιη ^ 419 MeOC (O)-213η, 415 CO1 535-this The size of the mark is applicable to the Chinese National Standard (CNS). A4 is present (210X29—mm). S Member of the Ministry of Economic Affairs and China ’s Tuda Bureau. 2 Consumption cooperation print. 1235157 Λ7 B7. 5. Description of the invention (533) 213〇, 450 0 HN M Ϊ 213ρ, 456 213q, 475 213r, 404 Μ · Ο 213s, 486 Η 213t, 487 Η 213u, 417 ΟΜβ (please read the first page on the back) ± Issue before filling in this page)-Binding 1 · -536 · Money &amp; Scale Applicable_National Standards (CNS) A ·; Now (: 10χ2π 公 没) 1235157

五、發明説明(534 ) .¾濟部中夬樣隼局員工消費合作社印裳 213v, 408 213w, 214w 1^ 213x, 418 h,anj〇t^ Η [1S,9S(2RS,3S)] Ν-(2·;氧基-5,基四氫吱 % 〇 ’ 氮 όΗ-二酮-9-(3,4-甲二氧基苄醯胺基)-U2,3,4,7,8,9,l〇 ; 嗒哜並[l,2-a][l,2]二氮雜苯-卜羧醢胺(2Πϋ),呈$ \ 體異構物之混合物被分離(同側:對側異構物比例6·4V. Description of the invention (534). ¾ Yinshang 213v, 408 213w, 214w 1 ^ 213x, 418 h, anj〇t ^ 员工 [1S, 9S (2RS, 3S)] Ν -(2 ·; oxy-5, yltetrahydro-squeeze% 〇 ′ nitrogen Η-diketone-9- (3,4-methoxydioxybenzylamino) -U2,3,4,7,8, 9, l〇; Tara [l, 2-a] [l, 2] diazabenzene-carboxamidine (2Πϋ), a mixture of isomers is separated (ipsilateral: contralateral Isomer ratio 6.4

克,82%)呈白色固趑:mp· 206-UTC ; IR (KBr) 3288, 1787, 1680, 1657, 1651,1619, 1548, 1440, 1256, 1 135; lHNMR (D6-DMSO) δ 8.75 (0.4H, d), 8.55 (0.6H, d), 8.45¾. 8.43 (1H, 2 x d),7.50 (1H,d), 7.42 (1H,s),7.40·7·27 (5H, m),7.01 (1H, d), 6.11 (2H, s), 5.67 (0.6H, d), 5.43 (0.4H, s), 5.10〇.00 (1H, m), 4.90-4.59 (3.5H, m), 4.45-4.25 (1.5H, m), 3.47^3.20 (1H, m), 3.20-2.70 (2H, m), 2.65-2.35 (1H, m), 2.35-2.00 (3H, m), 2.00-1.75 (2H,m),1·65]·40 (2H, m) 3 分析 C29H3〇N4〇9之計 -537- 本纸块尺度適用中国國家標洋(CNS ) .Λ4^格(公帑) 一 — 1235157 經濟部令夬¾準局員工消费合作杜印¾ Λ7 五、發明説明(535 ) 算値:C,60.20; H,5.23; N,9.68。實測値:C,60·08; H,5.32; N,9.50。MS (ES+) 580 (M+ + 2, 35%),579 (M+ +1,1〇〇),404 (5),367 (5),236 (7),1〇7 (5” [lS,9S(2RS,3S)]9-[(3-乙醯胺基)芊醯胺基]-Ν·(2-芊氧基〇-酌基四氫 矢喊-3-基)-6,10-二 S3 基.l,2,3,4,7,8,9,10-八氫-6H-咩畊並[l,2·a][l,2]二氮雜箪-l-羧醯胺(213o),對_側-異構物 呈白色泡沫固體(〇·73 克,69%) : mp. 135-4(TC; |&gt;】D2i -37·35 (c 0.1, CH2Ci2); IR (KBr) 3452, 3310, 1790, 1664, 1659, 1650, 1549, 1425, 1258, 1 121; LH NMR (D6-DMSO) ά 10.H (1H, s), 8.77 (1H, d), 8.57 (1H, d), 8.01 (1H, s), 7.76 (1H, d), 7.55 (1H, d), 7.45-7.25 (6H, m), 5.43 (1H, s)? 5.08-5.00 (1H, m), 4.95-4.73 (1H,m), 4.76及 4.68 (2H,dd),3.40-3.20 (1H,m), 3.09 (1H, dd), 3.02-2.75 (1H, m), 2.45-2.06 (4H, m), 2.06 (3H, s), 2.00-1.75 (2H, m), 1.70-1.40 (2H, m)。分析 C30H33N5Os· 0.75H2O之計算値:C,59.54; Η, 5·75; N, 11.57。實測値:C, 59.40; H, 5.62; N, il.50 ^ MS (ES + ) 593 (M+ + 2, 33%), 592 (NT + 1,100), 574 (7),487 (7), 475 (6),385 (9),373 (26), 318 (14), 296 (11), 266 (10), 221 (22)。 [1S,9S(2RS,3S)1 Ν-(2·芊氧基-5-酮基四氫吱喃-3-基)-6,10-二酮基-9-(4-羥基竽醯基)胺基-1,2,3,4,7,8,9,10-八氫-6!·!-^ 畊並[l,2-a】[l,2】二氮雜箪-1-羧醯胺(213p),呈泡沫狀被分 離(1·2 克,77%) ·· 〇]D20 -115。(c 0.20, CH2C12); IR (KBr) 3368, 2946, 1794, 1654, 1609, 1540, 1505, 1421, 1277, 1 175, 1 1 19, 980; 1H NMR (D6-DMSO) δ 10.1 (1H, s), 8.80 (0.5H, - 538 - 本纸伕尺度適用肀国國家標隼(CNS ) A4堤略(2丨OX 297公釐) — (請先閱讀背©之注意事項再凑寫本頁) ,裝 -'δ 1235157 A7 _B7_ 五、發明説明(S36) 經漭部中央嘌在局員工消费合作社印裝 (請先閱讀背面之注意事項再填寫本f ) d? J = 6.6), 8.60 (0.5H, d, J = 7.2), 8^.40-8.36 (1H, 2d). 7.82 (2H, d, J = 8.0), 7.41 (5H, bs), 6.86 (2H, d, J 8.6), 5.72 (0.5H, d, J = 5.0), 5.49 (0.5H, bs), 5.13-5.07 (1H? m), 4.95-4.65 (2.5H, m), 4.49-4.38 (2.5H, m)? 3.49-3.30 (2H, m), 3.21, 2.79 (2H,m),2.40-1.41 (7H,m)。MS (ES+) 55卜 [1S,9S(2RS,3S)] N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6,10-二酮基·9-(4 哚-2-甲醯胺基)-1,2,3,4,7,8,9,10-八氫-61*1^答呤 並[l,2-a][l,2]二氮雜箪·1-羧醯胺(213q),呈白色玻璃狀固 體被分離(80%) : mp. 145-149Ό ; [α]Ό23 〇6.03 (c 0.05, CH2C12); IR (KBr) 3399-3319, 1791, 1657, 1543, 1420, 1253, 1119; lH NMR (CDCI3) ά 9.54 (1H, s), 7.65 (1H, d, J = 7.9), 7.51 (1H,d,J = 6.9),7·44-7·25 (7H,m),7.18-7.06 (3H,m), 5.30-5.20 (IH,m),5,27 (1H,s),4.84 (1H,m),4·79 (1H,d,J =il.4)? 4.56 (1H, d, J = 11.3), 4.47 (2H, m), 3.28 (1H, m), 3.10-2.97 (2H, m), 2.71 (IH, m), 2.47-2.37 (1H, m), 2.26 (1H, d, J = 17.9), 2·09 (1H,m),1.83, 1.70, 1.51 (4H· 3m)。 [1S,9S(2RS,3S)] N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6,10-二酮基·1,2,3,4,7,8,9,10-八氫-9-(2-甲苯甲醯胺基)-6^!-嗒呼 並[l,2-a][l,2]二氮雜苯小羧醯胺(213r),呈非對映立體異 構型式之混合物被分離(同側:對側異構物比例5 5 : 4 5 ), 呈白色泡沫狀固體(1.46 克,89%) : mp. 106-1CTC; IR (KBr) 3306, 2947, 1791,1659, 1650, &quot;35, 1421,1256, U22; 4 NMR(D6-DMSO)(y8.76(0·45H,d),8·:56(0.55H,d),8.49及 8.47 (1H, 2 x d), 7.41-7.19 (9H, m), 5.67 (0.55H, d), 5.43 -539- 本呔朵尺度通用中SS家標隼(CNS ) A4纥洛(2丨〇乂巧7公笼&gt; 1235157 Λ7 _B7____ 五、發明説明(537 ) (0.45H, s), 5.11-5.02 (1H, m), 4.86-'4.55 (3.5H, m)? 4.45^4.25 (1.5H, m), 3.40-3.20 (1H, m), 3.20-2.70 (2H? m), 2.65-2.40 (1H, m), 2.34 (3H, s), 2.30-1.70 (5H, m), 1.65-1.40 (2H, m) ^ 分析 C29H32N407之計算値:C, 62·66; Η, 5·95; N,10.08 3 實 測値·· C,62.91; H,6.00; N,9.70,MS (ES + ) 550 (M+ + 2, 43%),549 (M+ + 1,100),374 (3),280 (4),279 (20),118 (5) 3 [1S,9S(2RS,3S)] N-(2-芊氧基-5-酮基四氫呋喃-3-基)_6,l〇-一嗣基-1,2,〕,4,7,8,9,10-八氣-9-(4-(笨基乙酿胺基)卞驢胺 基】-61^-»答*1井並[1,2-3][1,2】二氬雜笨-1-幾2產胺(2135),呈對 側-異構物型被分離,呈白色泡沫狀固體(0.64克,77%): mp. 137-4TC ; [a]D2{ -48.2° (c 0.05, CH3OH); IR (KBr) 3477, 3314, 1791, 1659, 1599, 1529, 1499? 1406, 1256, 1 122; lH NMR (D6-DMSO) ά 10.45 (1H, s), 8.76 (1H, d), 8.50 (1H, 經濟部中夬櫺.準局員工消費合作社印裝 (請先閱νί背云之注意事項再4寫本f ) d), 7.86 (2H, d), 7.69 (2H, d)t 7.41^7.20 (10H, m), 5.43 (1H, s),5.08-4.98 (1H,m), 4.90-4.73 (1H,m),4.76及 4.68 (2H,dd), 3.67 (2H, s), 3.40-3.20 (1H, m), 3.09 (1H? dd), 3.02-2.75 (1H, m), 2.39 (1H, dd), 2.30-2.00 (3H, m), 2.00-1.75 (2H, m), 1·70-1·40 (2H, m)。分析 C36H37N5O8.0.5H2O之計算値:C, 63·90; H,5·66; N,10.35。實測値:C,63.68; H,5·67; N,10.24 ,MS (ES+) 669 (M+ + 2, 40%),668 (M+ + 1,100),640 (12), 435 (18),425 (23),403 (33),328 (17),302,(32),274 (22), 197 (16), 138 (17) ^ [1S,9S(2RS,3S)] N-(2-^ 氧基-5-銅基四氫吃喘·3-基)-6,10-二嗣基-9-[4-(3-甲基丁烷-1-甲醯胺基)芊醯胺基卜ι,2,3,4,7, ___ -540- 本戒S尺度適用令g國家標隼(C.\S )焱4現格(21ΰχ 297公苍) 1235157 Λ7 B7 五、發明説明( 538 ) 請 先 閱 讀 背 面 之 注 意 事 項 再 填 % 太 Ά 8,9,10-八氫-61^,答呼並[1,24][1,2]、二氮雜箪-:1-羧醯按(213〇 ,呈白色泡沫狀固體(0.63克,80%) : mp. 159«C ; 〇]D】i -37.0° (c 0.05, CH3OH); IR (KBr) 3463, 3321, 1790, 1680, 1658, 1650, 1644, 1595, 1525, 1501, 1408, 125i? 1 1 13. 933; 1H NMR (D6-DMSO) ά 10.13 (1H, s), 8.76 (1H, d), 8.48 (1H, d), 7.85 (2H, d), 7.68 (2H, d), 7.40-7.25 (5H? m), 5.43 (1H, s), 5.08-4.95 (1H,m), 4·92·4·73 (1H,m),4.76及 4.68 (2H, dd), 3.40-3.20 (1H , m), 3.09 (1H, dd), 3.02-2.75 (1H, m), 2.39 (1H, dd), 2.35-2.00 (6H, m), 2.00-1.75 (2H, m), 1.70-1.40 (2H, m),0.93 (6H, d) 3 分析 C33H39N5O8-0.5H2O之計算値:C, 61.67; H,6.27; N,10.90。實測値·· C,61·49; H,6.24; N,10.86 。MS (ES+) 635 (M+ + 2, 39%),634 (M+ + 1,100),484 (10), 427 (9), 274 (18),268 (37),204 (19), 117 (13)。 [1S,9S(2RS,3S)] N-(2-;氧基-5-酮基四氫呋喃-3-基)-6,10-二酮基-l,2,3,4,7,8,9,10-八氫-9-(3,4,5-三甲氧基芊璲胺基)· 61+*并並[1,2-汪][1,2】二氮雜革-1-幾8產胺(21311),呈白色固 禮(81%): mp. 120-132〇C ; IR (KBr) 3361-3334, 1792, 1659, 1585, 1536, 1499, 1457, 1416, 1340, 1236, 1 126, 989; lH NMR (CDCi3) (ί 7.39-7.29 (6H, m), 7.12 (1H, s), 7.03 (1H, s), M濟部中夬樣準局員二消费合作杜印製 6.92, 6.83T 6.48 (approx 3H, 3d, J = 8.1, 7.5, 8.1), 5.57 (d, J =5.3), 5.27 (1H, s), 5.23-5.06, 4.91-4.71, 4.64-4.43, (6H, 3m), 3.92, 3.91, 3.89, 3.88 (9H, 4s), 3.32-2.70, 2.52-2.08, 1.91,1.63 (1H,4m)。 [1S,9S(2RS,3S)] N-(2-;氧基-5-酮基四氫呋喃-3-基)-6,10- -541 - 本纸伕尺度逆用中國3家標奂(CNS〉A4規格(2I0X 297公釐) M濟部中夬樣準局員二消费合作杜印¾ 1235157 Λ7 _B7__ 五、發明説明(539 ) 二酮基-9-(莕-1-甲醯胺基)-1,2,3,4,、7,8,9,10-八氫-611-冬啩並 [1,24][1,2】二氮雜箪-1-羧醯胺(213幻,呈白色固體(78%): mp. 121-7Ό ; IR (KBr) 3534-3331, 1791, 1659, 1528, 1420, 1256, 1122; lH NMR (CDC13) ό' 8.34-8.29 (1H, m), 7·98-7·87 (2H, m), 7.68-7.45 (4H, m), 7.34-7.24 (5H, m), 7.04 (d, J = 6.8), 6.78 (d, J = 7.8), 6.66 (d, J = 7.7), 6.48 (2H, d, J = 7.5)? 5.56 (d, J = 5.4), 5.15 (iH, s), 5.30-5.14, 5.0? 4.89 (d, J -il.2), 4.71-4.41 (6H), 3.18-2.80, 2.50-2.27, 2.08^1.60 (11H? 3m” [1S,9S(2RS,3S)] N-(2-;氧基-5-酮基四氫吱喃-3-基)-6,10-二酮基-9-(4-羥基-3,5-二曱基苄醯基)胺基·l,2,3,4,7,S,9,lC^ 八氫-6ί^咨啡並[l,2-aΠl,2]二氮雜箪-:l-羧醯胺(213w),呈 非對玦立體異構之混合物型式(65/35),呈白色固韹(0.9克 ,65%) : mp. 110-115’C (分解):IR (KBr) 3409, 2945, 1792, 1658, 1606, 1534, 1486, 1420, 1330, 1276, 1209, 1 122? 980, 960; lH NMR (CDCi3) ^ 7.66 (0.35H, d? J = 6.9), 7.46-7.20 (7H, m), 6.93 (0.35H, d, J = 7.7), 6.85 (0.65H, d, J = 7.6), 6.73 (0.65H, d, J = 7.6), 5.96 (0.35H, bs), 5.85 (0.65H. bs), 5.56 (0.65H, d, J = 5.2), 5.28 (0.35H, bs), 5.20-4.98 (2H, m), 4.96-4.40 (4H, m), 3.28-2.55 (3H, m), 2.53-2.32 (1H, m), 2.23 (6H, 2s), 2.03-1.40 (7H,m),MS (ESJ 577,(ES+) 579, [1S,9S(2RS,3S)] 9-[4-(乙醯胺基)芊醯胺基]-N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6幵-嗒啡並[l,2-a][l,2】二氮雜苯-1-羧醯胺(213x),呈無色粉未 -542- 本紙乐尺度通用t S國家標準(CNS M4現格(210 X :^7公釐) (請先閨讀背面之渣意事項再填寫本f -裝 訂 1235157 五、發明説明(540 ) (691毫克,86%) : mp. 150-7(TC : {w】D21 -10.1° (c 0.10, Me2CO); IR (KBr) 33 13, 1 791,1679, 1654, 1597, 1528, 1501, 1457, 1407, 1371, 13 15, 1255, 1 184. 1 122, 933; lH NMR (d6-DMSO) S 8.75 (1H, d), 8.47 (1H. d), 7.84 (2H, d), 7.66 (2H, d), 7.35 (5H, m), 5.43 (1H, s), 5.06〇.00 (1H, m), 4.90-4.64 (3H, m), 4.46-4.26 (2H,m), 3.16-2.86 (2H, m), 2.45·2.05 (5H, m), 2·07 (3H,s),2·〇〇-1·84 (2H,m)· 1.68-1.56 (2H,m);分析 C30H33N5O3.H2O之計算値·· C,59.11; H,5.79; N, 11.49 a 實 測値:C,59·38; H,5·66; N,11.31; M.S. (ES+) 614 (100%), 592 (M++1.66), [3S(1S,9S)] 3·[6,10-二酮基-9-(3,4-甲二氧基芊醯胺基)· 1,2,3,4,7,8,9,10-八氫-611-疼畊並[1,24】[1,2】二氮雜箪-卜羧 醯胺基】-4-酮基丁酸(415),以類鉍214e化合物之方法製備 ,可生成白色固體(297毫克,84%) : mp. 158-62’C; [a]D24 • 109.5。(c 0.1,CH3OH); IR (KB〇 3700-2500 (br),1 783, 1659, 1650, 1538, 1486, 1439, 1257, 1037; lH NMR (CD3OD) 7.48 (1H, dd), 7.35 (1H, d), 6.88 (1H, d), 6.03 (2H, s), 5.25-5.15 (1H, m), 5.02-4.90 (1H, m), 4.63-4.45 (2H, m), 4.30-4.20 (1H, m), 3.57-3.30 (1H, m), 3.20-3.05 (1H, m), 2.75-2.10 (5H, m), 2.10-1.60 (4H, m) ^ MS (ES-) 488 (M+, 25%), 487 (M+ -1,100),443 (8),387 (3),315 (5),150 (6),127 (5),113 (8)。 CnH25N409 (MH+)之精確質量計算値·· 489.1621。實測値 489.1648 。 [3S(1S,9S)】3-{9-[(3-乙醯胺基)芒醯胺基】-6,10-二酮基- -543 - 本纸乐尺度it用宁國國家標孪(CNS M4現格(2丨0X29了公$ ) 請 irk 背 'ΧΓ 意 事 寫 方、 買 經濟部中夬標隼局員工消资合作社印装 1235157 Λ 7 - _Β7 .___ 五、發明説明(541 ) - 1,2,3,4,7,8,9,1〇-八重-611-卷呼並[1、,2-21][1,2]二氣雜卓-1-致 醯胺基卜4-酮基丁酸(450),以類似化合物2Ue之方法製備 ,生成白色泡沫固體(378毫克,94%) : mp· 175-9X:; [a]D22 -91.7° (c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 33 19. 1659, 1590, 1553, 1427, 1260; lH NMR (CD3OD) ^ S.01 (1H? d), 7.74 (1H, dd), 7.58 (1H, d), 7.45^7.35 (1H, m), 5.25-5.15 (1H, m), 5.05-4.90 (1H, m), 4.60-4.45 (2H, m), 4.30-4.20 (1H, m), 3.55-3.3*0 (1H, m), 3.20-3.00 (1H, m), 2.75-2.20 (5H, m), 2.14 (3H, s),2·20-1·60 (4H)。分析 C23H27N508· 1·5Η20之計算値 ·· C,52.27; H,5.72; N,13·25。實測値 C,52·31; H,5.86; N, 12.85、MS (ES+) 501 (M+, 26%),500 (NT - 1, 100),328 (2), 149 (3), Π3 (3) 3 [3S(1S,9S)】 3-[4-(羥基芊醯基)胺基]-6,10-二酮基-1,2.3,4,7,8, 9,10-八氩-6H-嗒啩並[l,2-ani,2】二氮雜箪·1-羧醢胺基]-4-酮基丁酸(456),以類似化合物214e之方法製備,可生成白 色固體(0.73 克,72%) ·· mp· &gt;260eC ; 〇]D20 -66c (c 0.34,G, 82%) was white solid: mp · 206-UTC; IR (KBr) 3288, 1787, 1680, 1657, 1651, 1619, 1548, 1440, 1256, 1 135; lHNMR (D6-DMSO) δ 8.75 ( 0.4H, d), 8.55 (0.6H, d), 8.45¾. 8.43 (1H, 2 xd), 7.50 (1H, d), 7.42 (1H, s), 7.40 · 7 · 27 (5H, m), 7.01 (1H, d), 6.11 (2H, s), 5.67 (0.6H, d), 5.43 (0.4H, s), 5.10〇.00 (1H, m), 4.90-4.59 (3.5H, m), 4.45-4.25 (1.5H, m), 3.47 ^ 3.20 (1H, m), 3.20-2.70 (2H, m), 2.65-2.35 (1H, m), 2.35-2.00 (3H, m), 2.00-1.75 ( 2H, m), 1.65] · 40 (2H, m) 3 Analysis of C29H3ON4409-537- This paper block size is applicable to China National Standard Ocean (CNS). Λ4 ^ grid (common) 1 — 1235157 Order of the Ministry of Economic Affairs ¾ Consumption Cooperation among Employees of Associate Bureau Du Yin Λ7 V. Description of Invention (535) Calculation: C, 60.20; H, 5.23; N, 9.68. Found 値: C, 60 · 08; H, 5.32; N, 9.50. MS (ES +) 580 (M + + 2, 35%), 579 (M + +1, 100), 404 (5), 367 (5), 236 (7), 107 (5 ”[1S, 9S (2RS, 3S)] 9-[(3-Ethylamido) amido] -N · (2-methoxyoxy-O-tetrahydroazetidin-3-yl) -6,10-di S3 radical. 1,2,3,4,7,8,9,10-octahydro-6H-pyrene and [l, 2 · a] [l, 2] diazapyrene-l-carboxamide ( 213o), para-isomer as a white foam solid (0.73 g, 69%): mp. 135-4 (TC; | &gt;) D2i -37 · 35 (c 0.1, CH2Ci2); IR ( KBr) 3452, 3310, 1790, 1664, 1659, 1650, 1549, 1425, 1258, 1 121; LH NMR (D6-DMSO) ά 10.H (1H, s), 8.77 (1H, d), 8.57 (1H , d), 8.01 (1H, s), 7.76 (1H, d), 7.55 (1H, d), 7.45-7.25 (6H, m), 5.43 (1H, s)? 5.08-5.00 (1H, m), 4.95-4.73 (1H, m), 4.76 and 4.68 (2H, dd), 3.40-3.20 (1H, m), 3.09 (1H, dd), 3.02-2.75 (1H, m), 2.45-2.06 (4H, m ), 2.06 (3H, s), 2.00-1.75 (2H, m), 1.70-1.40 (2H, m). Analysis of the calculation of C30H33N5Os · 0.75H2O 値: C, 59.54; Η, 5.75; N, 11.57. Measured 値: C, 59.40; H, 5.62; N, il. 50 ^ MS (ES +) 593 (M + + 2, 33%), 592 (NT + 1, 100), 574 (7), 487 (7 ), 475 (6), 385 (9), 373 (26), 318 (14), 296 (11), 266 (10), 221 (22). [1S, 9S (2RS, 3S) 1 Ν- ( 2. · Ethoxy-5-ketotetrahydrocran-3-yl) -6,10-diketo-9- (4-hydroxyfluorenyl) amino-1,2,3,4,7 , 8,9,10-octahydro-6! ·!-^ Gong [1,2-a] [l, 2] Diazapyridine-1-carboxamide (213p) was isolated as a foam ( 1.2 g, 77%) D20-115. (C 0.20, CH2C12); IR (KBr) 3368, 2946, 1794, 1654, 1609, 1540, 1505, 1421, 1277, 1 175, 1 1 19, 980; 1H NMR (D6-DMSO) δ 10.1 (1H, s), 8.80 (0.5H,-538-The standard of this paper is applicable to the national standard of China (CNS) A4 (2 丨 OX 297 mm) — (Please read the precautions of the back © before writing this page) ), Installed-'δ 1235157 A7 _B7_ V. Description of the invention (S36) Printed by the Central Consumers Cooperative Bureau of the Ministry of Economic Affairs (Please read the notes on the back before filling in this f) d? J = 6.6), 8.60 ( 0.5H, d, J = 7.2), 8 ^ .40-8.36 (1H, 2d). 7.82 (2H, d, J = 8.0), 7.41 (5H, bs), 6.86 (2H, d, J 8.6), 5.72 (0.5H, d, J = 5.0), 5.49 (0.5H, bs), 5.13-5.07 (1H? M), 4.95-4.65 (2.5H, m), 4.49-4.38 (2.5H, m)? 3.49 -3.30 (2H, m), 3.21, 2.79 (2H, m), 2.40-1.41 (7H, m). MS (ES +) 55, [1S, 9S (2RS, 3S)] N- (2-methoxy-5-ketotetrahydrofuran-3-yl) -6,10-diketo · 9- (4 indole- 2-methylamido))-1,2,3,4,7,8,9,10-octahydro-61 * 1 ^ pyridino [l, 2-a] [l, 2] diazapine · 1-Carboxamide (213q), white glassy solid was isolated (80%): mp. 145-149Ό; [α] Ό23 〇6.03 (c 0.05, CH2C12); IR (KBr) 3399-3319, 1791 , 1657, 1543, 1420, 1253, 1119; lH NMR (CDCI3) ά 9.54 (1H, s), 7.65 (1H, d, J = 7.9), 7.51 (1H, d, J = 6.9), 7.44- 7.25 (7H, m), 7.18-7.06 (3H, m), 5.30-5.20 (IH, m), 5,27 (1H, s), 4.84 (1H, m), 4.79 (1H, d , J = il.4)? 4.56 (1H, d, J = 11.3), 4.47 (2H, m), 3.28 (1H, m), 3.10-2.97 (2H, m), 2.71 (IH, m), 2.47 -2.37 (1H, m), 2.26 (1H, d, J = 17.9), 2.09 (1H, m), 1.83, 1.70, 1.51 (4H · 3m). [1S, 9S (2RS, 3S)] N- (2-methoxy-5-ketotetrahydrofuran-3-yl) -6,10-diketo · 1,2,3,4,7,8, 9,10-octahydro-9- (2-toluidinemethylamino) -6 ^!-Daphtho [l, 2-a] [l, 2] diazepine small carboxamide (213r), The mixture in the diastereoisomeric form was separated (isotope: ratio of the opposite isomers 5 5: 4 5), as a white foamy solid (1.46 g, 89%): mp. 106-1CTC; IR ( KBr) 3306, 2947, 1791, 1659, 1650, &quot; 35, 1421, 1256, U22; 4 NMR (D6-DMSO) (y8.76 (0.45H, d), 8:56 (0.55H, d ), 8.49 and 8.47 (1H, 2 xd), 7.41-7.19 (9H, m), 5.67 (0.55H, d), 5.43 -539- This standard is commonly used in the SS family standard (CNS) A4 Luo Luo ( 2 丨 〇 乂 巧 7 公 笼> 1235157 Λ7 _B7____ V. Description of the invention (537) (0.45H, s), 5.11-5.02 (1H, m), 4.86-'4.55 (3.5H, m)? 4.45 ^ 4.25 (1.5H, m), 3.40-3.20 (1H, m), 3.20-2.70 (2H? M), 2.65-2.40 (1H, m), 2.34 (3H, s), 2.30-1.70 (5H, m), 1.65-1.40 (2H, m) ^ Analysis of the calculation of C29H32N407 C: C, 62 · 66; Η, 5.95; N, 10.08 3 Measured 値 · C, 62.91; H, 6.00; N, 9.70, MS (ES +) 550 (M + + 2, 43%), 549 (M + + 1,100), 374 (3), 280 (4), 279 (20), 118 (5) 3 [1S, 9S (2RS, 3S)] N- (2-fluorene oxygen Methyl-5-ketotetrahydrofuran-3-yl) -6,10-monofluorenyl-1,2,], 4,7,8,9,10-octagas-9- (4- (benzylethyl) Amine group] 卞 donkey amino group] -61 ^-»A * 1 and [1,2-3] [1,2] Diargin-1-guinea-2 produces amine (2135), which is contralateral-iso The structure was isolated as a white foamy solid (0.64 g, 77%): mp. 137-4TC; [a] D2 {-48.2 ° (c 0.05, CH3OH); IR (KBr) 3477, 3314, 1791, 1659, 1599, 1529, 1499? 1406, 1256, 1 122; lH NMR (D6-DMSO) ά 10.45 (1H, s), 8.76 (1H, d), 8.50 (1H, Ministry of Economic Affairs, China. Prospective staff Printed by Consumer Cooperatives (please read the precautions for νί back cloud before writing 4 f) d), 7.86 (2H, d), 7.69 (2H, d) t 7.41 ^ 7.20 (10H, m), 5.43 (1H, s ), 5.08-4.98 (1H, m), 4.90-4.73 (1H, m), 4.76 and 4.68 (2H, dd), 3.67 (2H, s), 3.40-3.20 (1H, m), 3.09 (1H? Dd ), 3.02-2.75 (1H, m), 2.39 (1H, dd), 2.30-2.00 (3H, m), 2.00-1.75 (2H, m), 1.70-1 · 40 (2H, m). Analyze the calculation of C36H37N5O8.0.5H2O 値: C, 63 · 90; H, 5.66; N, 10.35. Measured 値: C, 63.68; H, 5.67; N, 10.24, MS (ES +) 669 (M + + 2, 40%), 668 (M + + 1,100), 640 (12), 435 (18), 425 (23), 403 (33), 328 (17), 302, (32), 274 (22), 197 (16), 138 (17) ^ [1S, 9S (2RS, 3S)] N- (2 -^ Oxy-5-copper-based tetrahydrocyclopentadiene-3-yl) -6,10-diamidino-9- [4- (3-methylbutane-1-methylamido) pyridine Kibí, 2,3,4,7, ___ -540- This or S scale is applicable to the national standard 隼 (C. \ S) 焱 4 (21ΰχ 297 公 苍) 1235157 Λ7 B7 V. Description of the invention ( 538) Please read the notes on the back first and then fill in% Taiji 8,9,10-octahydro-61 ^, answer [1,24] [1,2], diazapyridine-: 1-carboxypyridine Press (213〇, white foamy solid (0.63 g, 80%): mp. 159 «C; 〇] D] i -37.0 ° (c 0.05, CH3OH); IR (KBr) 3463, 3321, 1790, 1680 , 1658, 1650, 1644, 1595, 1525, 1501, 1408, 125i? 1 1 13. 933; 1H NMR (D6-DMSO) ά 10.13 (1H, s), 8.76 (1H, d), 8.48 (1H, d ), 7.85 (2H, d), 7.68 (2H, d), 7.40-7.25 (5H? M), 5.43 (1H, s), 5.08-4.95 (1H, m), 4.92 · 4 · 73 (1H , M), 4.76 and 4.68 (2H, dd ), 3.40-3.20 (1H, m), 3.09 (1H, dd), 3.02-2.75 (1H, m), 2.39 (1H, dd), 2.35-2.00 (6H, m), 2.00-1.75 (2H, m ), 1.70-1.40 (2H, m), 0.93 (6H, d) 3 Analysis of the calculation of C33H39N5O8-0.5H2O 値: C, 61.67; H, 6.27; N, 10.90. Measured 値 ·· C, 61 · 49; H , 6.24; N, 10.86. MS (ES +) 635 (M + + 2, 39%), 634 (M + + 1,100), 484 (10), 427 (9), 274 (18), 268 (37), 204 (19), 117 (13). [1S, 9S (2RS, 3S)] N- (2-; oxy-5-ketotetrahydrofuran-3-yl) -6,10-diketo-l, 2,3,4,7,8, 9,10-octahydro-9- (3,4,5-trimethoxyfluorenylamino) · 61 + * and [1,2-wang] [1,2] diaza leather-1-gui 8 Amine production (21311), white solid gift (81%): mp. 120-132 ° C; IR (KBr) 3361-3334, 1792, 1659, 1585, 1536, 1499, 1457, 1416, 1340, 1236, 1 126, 989; lH NMR (CDCi3) (ί 7.39-7.29 (6H, m), 7.12 (1H, s), 7.03 (1H, s), M. Probationary Bureau of the Ministry of Economic Affairs of the People's Republic of China, second consumer cooperation printing 6.92 , 6.83T 6.48 (approx 3H, 3d, J = 8.1, 7.5, 8.1), 5.57 (d, J = 5.3), 5.27 (1H, s), 5.23-5.06, 4.91-4.71, 4.64-4.43, (6H, 3m), 3.92, 3.91, 3.89, 3.88 (9H, 4s), 3.32-2.70, 2.52-2.08, 1.91, 1.63 (1H, 4m). [1S, 9S (2RS, 3S)] N- (2-; oxygen Methyl-5-ketotetrahydrofuran-3-yl) -6,10- -541-This paper uses three Chinese standards (CNS> A4 size (2I0X 297 mm) for paper size inversion) Two consumer cooperation Du Yin ¾ 1235157 Λ7 _B7__ V. Description of the invention (539) Diketo-9- (fluoren-1-methylamido) -1, 2, 3, 4, 7, 7, 9, 10, 10- Octahydro-611-Winter Pyrene [1,24] [1,2 】 Diazapyridine-1-carboxamide (213 fluorene, white solid (78%): mp. 121-7 121; IR (KBr) 3534-3331, 1791, 1659, 1528, 1420, 1256, 1122; lH NMR (CDC13) ό '8.34-8.29 (1H, m), 7.98-7 · 87 (2H, m), 7.68-7.45 (4H, m), 7.34-7.24 (5H, m), 7.04 (d, J = 6.8), 6.78 (d, J = 7.8), 6.66 (d, J = 7.7), 6.48 (2H, d, J = 7.5)? 5.56 (d, J = 5.4), 5.15 (iH, s), 5.30-5.14, 5.0? 4.89 (d, J -il.2), 4.71-4.41 (6H), 3.18-2.80, 2.50-2.27, 2.08 ^ 1.60 (11H? 3m ”[1S, 9S (2RS, 3S)] N- (2-; oxy-5-ketotetrahydrocran-3-yl) -6,10-diketo-9- (4-hydroxy-3,5-difluorenylbenzyl) amine Yl l, 2,3,4,7, S, 9,1C ^ octahydro-6 and benzophenone [l, 2-aΠl, 2] diazepine-: l-carboxamide (213w), It is a mixture of non-epicyclic stereoisomers (65/35) and white solid (0.9 g, 65%): mp. 110-115'C (decomposition): IR (KBr) 3409, 2945, 1792, 1658 , 1606, 1534, 1486, 1420, 1330, 1276, 1209, 1 122? 980, 960; lH NMR (CDCi3) ^ 7.66 (0.35H, d? J = 6.9), 7.46-7.20 (7H, m), 6.93 (0.35H, d, J = 7.7), 6.85 (0.65H, d, J = 7.6), 6.73 (0.65H, d , J = 7.6), 5.96 (0.35H, bs), 5.85 (0.65H. Bs), 5.56 (0.65H, d, J = 5.2), 5.28 (0.35H, bs), 5.20-4.98 (2H, m) , 4.96-4.40 (4H, m), 3.28-2.55 (3H, m), 2.53-2.32 (1H, m), 2.23 (6H, 2s), 2.03-1.40 (7H, m), MS (ESJ 577, ( ES +) 579, [1S, 9S (2RS, 3S)] 9- [4- (Ethylamido) amido] -N- (2-Methoxy-5-ketotetrahydrofuran-3-yl) -6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6'-daphno [l, 2-a] [l, 2] diazabenzene -1-Carboxamide (213x), colorless powder-542- This paper is a universal t S national standard (CNS M4 is present (210 X: ^ 7 mm) (please read the scum on the back first) Fill out this f-binding 1235157 V. Description of the invention (540) (691 mg, 86%): mp. 150-7 (TC: {w] D21 -10.1 ° (c 0.10, Me2CO); IR (KBr) 33 13, 1 791, 1679, 1654, 1597, 1528, 1501, 1457, 1407, 1371, 13 15, 1255, 1 184. 1 122, 933; lH NMR (d6-DMSO) S 8.75 (1H, d), 8.47 (1H d), 7.84 (2H, d), 7.66 (2H, d), 7.35 (5H, m), 5.43 (1H, s), 5.06〇.00 (1H, m), 4.90-4.64 (3H, m) , 4.46-4.26 (2H, m), 3.16-2.86 (2H, m), 2.45 · 2.05 (5H , m), 2.07 (3H, s), 2.0- 1.84 (2H, m) 1.68-1.56 (2H, m); Analysis of the calculation of C30H33N5O3.H2O C C, 59.11; H , 5.79; N, 11.49 a Found 値: C, 59 · 38; H, 5.66; N, 11.31; MS (ES +) 614 (100%), 592 (M ++ 1.66), [3S (1S, 9S )] 3 [[6,10-Diketo-9- (3,4-methoxydioxyamido)] 1,2,3,4,7,8,9,10-octahydro-611 -Tong Geng and [1,24] [1,2] diazapyrene-carboxamido] -4-ketobutyric acid (415), which is prepared by a method of bismuth-like 214e compound, can produce a white solid ( 297 mg, 84%): mp. 158-62'C; [a] D24 • 109.5. (C 0.1, CH3OH); IR (KB〇3700-2500 (br), 1 783, 1659, 1650, 1538, 1486, 1439, 1257, 1037; 1H NMR (CD3OD) 7.48 (1H, dd), 7.35 (1H , d), 6.88 (1H, d), 6.03 (2H, s), 5.25-5.15 (1H, m), 5.02-4.90 (1H, m), 4.63-4.45 (2H, m), 4.30-4.20 (1H , m), 3.57-3.30 (1H, m), 3.20-3.05 (1H, m), 2.75-2.10 (5H, m), 2.10-1.60 (4H, m) ^ MS (ES-) 488 (M +, 25 %), 487 (M + -1, 100), 443 (8), 387 (3), 315 (5), 150 (6), 127 (5), 113 (8). Accurate mass calculation of CnH25N409 (MH +)値 ·· 489.1621. Measured 値 489.1648. [3S (1S, 9S)] 3- {9-[(3-Ethylamido) carboxamido] -6,10-diketo- -543-Paper Le scale it uses the Ningguo national standard (CNS M4 is now (2 丨 0X29).) Irk should write the name of the owner and buy the printed materials of the China Consumer Goods Cooperatives Bureau of the Ministry of Economic Affairs 1235157 Λ 7- _Β7 .___ V. Description of the invention (541)-1,2,3,4,7,8,9,1〇-Yaegei-611-Volume and [1,2,2-21] [1,2] Diqi Hetero-1-caproamido-4-ketobutyric acid (450) was prepared in a similar manner to compound 2Ue, yielding a white foamy solid (378 mg, 94%) : mp · 175-9X :; [a] D22 -91.7 ° (c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 33 19. 1659, 1590, 1553, 1427, 1260; lH NMR (CD3OD ) ^ S.01 (1H? D), 7.74 (1H, dd), 7.58 (1H, d), 7.45 ^ 7.35 (1H, m), 5.25-5.15 (1H, m), 5.05-4.90 (1H, m ), 4.60-4.45 (2H, m), 4.30-4.20 (1H, m), 3.55-3.3 * 0 (1H, m), 3.20-3.00 (1H, m), 2.75-2.20 (5H, m), 2.14 (3H, s), 2.20-1 · 60 (4H). Analyze the calculation of C23H27N508 · 1.5 · 20Η C, 52.27; H, 5.72; N, 13.25. Measured 値 C, 52 · 31; H, 5.86; N, 12.85, MS (ES +) 501 (M +, 26%), 500 (NT-1, 100), 328 (2), 149 (3), Π3 (3 ) 3 [3S (1S, 9S)] 3- [4- (hydroxyfluorenyl) amino] -6,10-diketo-1,2.3,4,7,8,9,10-octaargon- 6H-Da [1,2-ani, 2] diazepine · 1-carboxyamido] -4-ketobutanoic acid (456), prepared in a similar manner to compound 214e, can produce a white solid ( 0.73 g, 72%) ·· mp · &gt;260eC; 〇] D20 -66c (c 0.34,

MeOH); IR (KBr) 3401,2946, 1651,1584, 1506, 1426, 1277, 1257, 1177; lH NMR (D6^DMSO) S 10.2 (1H, very bs)r 9.17 (1H, bs), 8.65 (1H, s), 8.37 (1H, d, J 5.4), 7.81 (2H, d, J = 經濟部中夬橒隼局員工消費合作.杜印¾ 8.2), 6.87 (2H, d, J = 8.4), 5.24 (1H, m), 4.92-4.86 (1H. m), 4.41-4.32 (2H, m), 3.68-3.21 (3H, m), 3.12-2.79 (lH, m), 2.50-1.42 (7H, m)。MS (ES+) 459。 [3S(1S,9S) 3-[6,10-二酮基-9-(吲哚-2-甲醢胺基)-l,2,3,4,7,8, 9,10-八氫-6H-咚畊並[l,2-a][l,2]二氮雜箪-卜殘醢胺基]-4- -544 - 尺度適用中國國家標牟( CNS ) A4現格(210X 297公釐) _ 1235157 經濟部中夬櫺华局員工消费合作杜印災 Λ7 . B7 五、發明説明(542) 酮基丁酸(475),以類似化合物214e之方法製備,可生成白 色固體(79%) : mp· 150Ό (轉化)190-210°C ;[以]〇23 .97 5 : (c 0.1, CH3〇H); IR (KBr) 3319, 1658, 1650, 1549, 1421, 1256; lH NMR (CD3OD) δ 7.61 (1H, d, J = 8.0), 7.43 (1H, dt J = 8.1), 7.21 (2H, m), 7.05 (1H, m), 5.21 (1H, m), 5.07-4.77 (1H, m)? 4.54 (2H, m), 4.23 (1H, m), 3.46 (1H, m), 3.14 (1H? m), 2·66-1·71 (9H,m)。MS (ES' m/z), 482 (M、l, i〇〇〇/0) 3 [3S(1S,9S) 3-[6,10-二酮基-1,2,3,4,7,8,9,10-八氩-9-(2-甲苯 甲醯胺基)-6H-嗒哜並[l,2-a][l,2]二氮雜箪-1-羧醯铵基卜4· 酮基丁酸(404),以類似化合物214e之方法製備,可生成白 色固體(0.79克,86%) : mp· 156-9°C ; 〇]D25 -ΐΐ9·7: (c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 3387, 3309, 2956, 1785, 1659, 1650, 1535, 1422, 1278; lH NMR (CD3OD) ά 7.46-7.15 (4H? m), 5.25-5.15 (1H, m), 5.02-4.90 (1H, m), 4.58-4.45 (2H, m), 4.30-4.20 (1H, m),3.55-3.30 (1H,m),3.20-3.05 (1H,m), 2.80-2.20 (4H, m), 2.41 (3H, s), 2.20-1.60 (5H, m) 0 MS (ES^) 458 (M十,27%),457 (M+ - 1,100),413 (13),339 (8), 285 (5), 134 (6),127 (11)。C22H27N4〇7 (MH+)之精確質量計算値: 459.1880。實測値 459.1854。 [3S(1S,9S) 3-[6,10·二酮基-1,2,3,4,7,8,9,10-八氫-9-(4-(笨基 乙醯胺基)笮醯胺基]-6Η-嗒啡並[l,2-a】[l,2】二氮雜箪-u幾 醯胺基]-4-酮基丁酸(486),以類似化合物214e之方法製備 ,生成白色固禮(325 毫克,89%) : mp. 165-9’C ; [ ]〇22 -69.1° (c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 33 18, 1658, -545- 衣呔杀尺度通用中國國家標李(CNS &gt; A4規格(210X297公蝥) ~ (請先兒讀背©之·注意事項再填寫本一貝) 裝 訂 4 1235157 A/ B7 五、發明説明( 543 ) 1599, 1530, 1505, 1407, 1258; lH NMR (CD3OD) ά 7.85 (2H? d), 7.69 (2H, d), 7.38-7.20 (5H, m), 5.25-5.15 (1H, m), 5.05-4.90 (1H, m), 4.57-4.45 (2H, m), 4.30-4.20 (1H, m), 3.70 (2H? s), 3.55-3.30 (1H, m), 3.20-3.00 (1H, m), 2.75-1.60 (9H, m) ^ 分析 C29H31N508*1.5H20之計算値:C,57.61;,H,5.67; N, 11·58。實測値:C,57.81; H, 5.74; N,11.47。MS (ES+) 577 (M+,33%), 576 (M+ - 1,100),502 (2)。 [3S(1S,9S) 3-{6,10-二酮基-9-[4-(3-甲基丁-1-醯基胺基)芊鏟 胺基】-1,2,3,4,7,8,9,10-八氫-611-嗒啩並[1,24】[1,2]二氮雜箪 -1-羧醯胺基]-4-酮基丁酸(487),以類似化合物214e之方法 製備,可生成白色泡沫固體(335毫克,93°/〇) ·· mp· 176-80’C ;[α]Ό22 -88.0' (c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 3321, 2960, 1781, 1660, 1597, 1529, 1407, 1258, 1187; lH NMR (CD3OD) δ 7.86 (2H, d), 7.69 (2H, d), 5.25o.l5 (1H, 經濟部中夬樣孳局負工消資合作杜印¾ (請先閱讀背vB之注意事項再填寫本買) m), 5.05-4.90 (lH, m), 4.60-4.45 (2H, m), 4.30-4.20 (1H, m), 3.57-3.30 (1H, m), 3.20-3.00 (1H, m), 2.75-1.60 (12H, m), 1.00(6H,d)。分析 C26H33N503.H20之計算値:C,55.61;H, 6.28; N,12.45 3 實測値:C,56·00; H,6.37; N,12.15。MS (ES+) 543 (M+, 31%), 542 (M+ - 1, 100), 498 (2), 468 (3) 〇 [3S(1S,9S) 3-(6,10-二酮基-1,2,3,4,7,8,9,10-八氫-9-(3,4,5-三 甲氧基芊醢胺基)-6H^答啩並[Halt1,2】二氮雜革-1-羧醯胺 基]·4-酮基丁酸(417),以類似化合物214e之方法製備,可 生成白色固體(0.63克,92%) : mp· 145-155°C (約値,不鮮 明):[戌]D27 -114.6。(c 011,CH3〇H); IR (KBr) 3327, 1658, -546- 本纸伕尺度適用中國國家標隼(CNS ) Α4現格(2丨0x 297公瘦^ 1235157 A7 B7 五、發明説明( 544 ) 1586, 1548, 1501,1416, 1341,1238、,、1126; iHNMR(CD3〇D) ά 7.22 (2Η, s), 5.21 (1H, m), 5.00 (1H, m), 4.56, 4.49 (2H, 2m), 4.25 (1H, m), 3.88 (6H, s), 3.80 (3H, s), 3.55^3.43 (1H, m),3.12 (1H,m),2.71-1.70 (9H,m) 3 分析C24H30N4Oi0.2H;〇 之計算値:C,50.52; Η,6·01; N,9.82。實測値:&lt; 5〇 49; H, 6.05; N, 9.68 ^ MS (ES+, m/z 533 (M+ · 1, 100%) 〇 [3S(1S,9S) 3-[6,10-二 S3 基-9·(茶-1-甲酿基胺基2.3,4,7,8, 9,10-八氫答畊並[l,2-a][l,2]二氮雜箪小瘦醯按基卜4-酮基丁酸(408),以類似化合物214e之方法製備,可生成白 色固體(73%) : mp· 157-165X (不鮮明):〇 ]D27 -14〇 5。(c O.i, CH3〇H); IR (KBr) 3325, 1658, 1531, 1420, 1278? 1257; ιΗ NMR (CD3OD) β 8.33-8.28 (1Η, m), 8.01-7.78 (2Η, m), 7.71(lH,d,J = 6.0),7.59-7.52 (3H,m),5.27(lH,m),5.12- 5.03 (1Η, m), 4.55 (2H, m), 4.25 (1H, m), 3.64-3.43 (1H, m), 3.24-3.12 (1H,m),2·80·1.67 (9H, m)。分析C25H26N407.2H2〇 經濟部中央橾隼局員工消费合作杜印¾ {請先閱讀背云之-i意事項再填寫本頁) 之計算値:C, 56.60; Η, 5·70; N,10.56。實測値:C,56.70; H, 5.80; N,10.33。MS (ES+,m/z), 493 (M+ · 1,100%)。 [3S(1S,9S) 3-[6,10-二酮基-4-(羥基-3,5-二甲基芊醯基)胺基-l,2,3,4,7,8,9,10-八氫-6H^嗒呼並[l,2-a】Π,2】二氮雜苯-l-羧 醢胺基卜4-酮基丁酸(214w),如化合物214e之類似方法製 備,可生成210毫克(62%)的白色固體:mp. &gt;260 Ό : [以]D20 -93。(c 0·20, MeOH); IR (KBr) 3401,2948, 1651, 1604, 1559, I486, 1421, 1325, 1276, 1210; lH NMR (D6-DMSO) d 9.39 (1H, bs), 8.29 (1H, d, J = 5.9), 7.55 (2H, s), -547 - 本纸伕尺度通用中國國冢祿準(CNS ) A4堤咯(2i〇x297公釐) 1235157 A7 B7 五、發明説明(545 ) 6.64 (1H, d, J = 6.1), 5.79 (1H, s), 5:25-5.21 (1H, m), 1.90-1.82 (1H, m), 4.410.69 (2H, m), 3.47-3.20 (3H, m), 2.97-2.91 (1H, m), 2.23 (6H, s), 2.25-1.60 (7H, m)-MeOH); IR (KBr) 3401, 2946, 1651, 1584, 1506, 1426, 1277, 1257, 1177; lH NMR (D6 ^ DMSO) S 10.2 (1H, very bs) r 9.17 (1H, bs), 8.65 ( 1H, s), 8.37 (1H, d, J 5.4), 7.81 (2H, d, J = consumer cooperation between employees of China Economic and Trade Bureau, Ministry of Economic Affairs. Du Yin ¾ 8.2), 6.87 (2H, d, J = 8.4) , 5.24 (1H, m), 4.92-4.86 (1H. M), 4.41-4.32 (2H, m), 3.68-3.21 (3H, m), 3.12-2.79 (lH, m), 2.50-1.42 (7H, m). MS (ES +) 459. [3S (1S, 9S) 3- [6,10-diketo-9- (indole-2-carboxamido) -1,2,3,4,7,8,9,10-octahydro -6H-plow farming and [l, 2-a] [l, 2] diazapyrene-bu residue amine] -4- -544-scale applicable to Chinese National Standards (CNS) A4 (210X 297) (Mm) _ 1235157 Consumer cooperation between China and China Bureau of the Ministry of Economic Affairs, Du Yin disaster Λ7. B7 V. Description of the invention (542) Ketobutyric acid (475), prepared by a method similar to compound 214e, can produce a white solid (79 %): mp · 150Ό (transformation) 190-210 ° C; [to] 〇23 .97 5: (c 0.1, CH3〇H); IR (KBr) 3319, 1658, 1650, 1549, 1421, 1256; lH NMR (CD3OD) δ 7.61 (1H, d, J = 8.0), 7.43 (1H, dt J = 8.1), 7.21 (2H, m), 7.05 (1H, m), 5.21 (1H, m), 5.07-4.77 (1H, m)? 4.54 (2H, m), 4.23 (1H, m), 3.46 (1H, m), 3.14 (1H? M), 2.66-1 · 71 (9H, m). MS (ES 'm / z), 482 (M, 1, 1000/0) 3 [3S (1S, 9S) 3- [6,10-diketo-1,2,3,4,7 , 8,9,10-octa-argon-9- (2-toluidineamido) -6H-dapyrido [l, 2-a] [l, 2] diazapyridine-1-carboxamido 4. Ketobutyric acid (404), prepared by a method similar to compound 214e, can produce a white solid (0.79 g, 86%): mp · 156-9 ° C; 〇] D25-ΐΐ9 · 7: (c 0.1 , CH3OH); IR (KBr) 3700-2500 (br), 3387, 3309, 2956, 1785, 1659, 1650, 1535, 1422, 1278; lH NMR (CD3OD) ά 7.46-7.15 (4H? M), 5.25- 5.15 (1H, m), 5.02-4.90 (1H, m), 4.58-4.45 (2H, m), 4.30-4.20 (1H, m), 3.55-3.30 (1H, m), 3.20-3.05 (1H, m ), 2.80-2.20 (4H, m), 2.41 (3H, s), 2.20-1.60 (5H, m) 0 MS (ES ^) 458 (M ten, 27%), 457 (M +-1,100), 413 (13), 339 (8), 285 (5), 134 (6), 127 (11). Accurate mass calculation for C22H27N407 (MH +) 値: 459.1880. Found 値 459.1854. [3S (1S, 9S) 3- [6,10 · diketo-1,2,3,4,7,8,9,10-octahydro-9- (4- (benzylacetamido)) Amido] -6Η-daphne [l, 2-a] [l, 2] diazapyrene-u-chipinamino] -4-ketobutanoic acid (486), similar to that of compound 214e Prepared by the method to produce a white solid (325 mg, 89%): mp. 165-9'C; [] 〇22 -69.1 ° (c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 33 18 , 1658, -545- General standard of Chinese standard plums (CNS &gt; A4 size (210X297 gong)) ~ (please read the back of the ©© Notes before filling in this book) Binding 4 1235157 A / B7 V. Description of the invention (543) 1599, 1530, 1505, 1407, 1258; lH NMR (CD3OD) ά 7.85 (2H? D), 7.69 (2H, d), 7.38-7.20 (5H, m), 5.25-5.15 ( 1H, m), 5.05-4.90 (1H, m), 4.57-4.45 (2H, m), 4.30-4.20 (1H, m), 3.70 (2H? S), 3.55-3.30 (1H, m), 3.20- 3.00 (1H, m), 2.75-1.60 (9H, m) ^ Analyze the calculation of C29H31N508 * 1.5H20 値: C, 57.61 ;, H, 5.67; N, 11.58. Measured 値: C, 57.81; H, 5.74 N, 11.47. MS (ES +) 577 (M +, 33%), 576 (M +-1,100), 502 (2). [3S (1S, 9S) 3- {6,10-diketo- 9- [4- (3-methylbut-1-fluorenylamino) fluorenamine] -1,2,3,4,7,8,9,10-octahydro-611-da-benzo [ 1,24] [1,2] Diazapyridine-1-carboxamido] -4-ketobutanoic acid (487), prepared in a similar manner to compound 214e, can form a white foamy solid (335 mg, 93 ° / 〇) ·· mp · 176-80'C; [α] Ό22 -88.0 '(c 0.1, CH3OH); IR (KBr) 3700-2500 (br), 3321, 2960, 1781, 1660, 1597, 1529 , 1407, 1258, 1187; lH NMR (CD3OD) δ 7.86 (2H, d), 7.69 (2H, d), 5.25o.l5 (1H, Ministry of Economic Affairs, Bureau of Samples, Work and Consumption Cooperation Du Yin ¾ ( Please read the precautions of vB before filling in this purchase) m), 5.05-4.90 (lH, m), 4.60-4.45 (2H, m), 4.30-4.20 (1H, m), 3.57-3.30 (1H, m ), 3.20-3.00 (1H, m), 2.75-1.60 (12H, m), 1.00 (6H, d). Analyze the calculations for C26H33N503.H20: C, 55.61; H, 6.28; N, 12.45 3 Found: C, 56 · 00; H, 6.37; N, 12.15. MS (ES +) 543 (M +, 31%), 542 (M +-1, 100), 498 (2), 468 (3) 〇 [3S (1S, 9S) 3- (6,10-diketo-1 , 2,3,4,7,8,9,10-octahydro-9- (3,4,5-trimethoxyfluorenylamino) -6H ^ Aza [Halt1,2] diaza leather -1-Carboxamidinyl] · 4-ketobutyric acid (417), prepared in a similar manner to compound 214e, can produce a white solid (0.63 g, 92%): mp · 145-155 ° C (about 値, Not clear): [戌] D27 -114.6. (C 011, CH3〇H); IR (KBr) 3327, 1658, -546- The standard of this paper is applicable to China National Standard (CNS) A4 (2 丨 0x 297) Male thin ^ 1235157 A7 B7 V. Description of the invention (544) 1586, 1548, 1501, 1416, 1341, 1238,, 1126; iHNMR (CD3〇D) ά 7.22 (2Η, s), 5.21 (1H, m), 5.00 (1H, m), 4.56, 4.49 (2H, 2m), 4.25 (1H, m), 3.88 (6H, s), 3.80 (3H, s), 3.55 ^ 3.43 (1H, m), 3.12 (1H, m), 2.71-1.70 (9H, m) 3 analysis C24H30N4Oi0.2H; Calculated 値: C, 50.52; Η, 6.01; N, 9.82. Found 値: &lt;5〇49; H, 6.05; N , 9.68 ^ MS (ES +, m / z 533 (M + · 1, 100%) 〇 [3S (1S, 9S) 3- [6,10-bisS3 group-9 · (tea-1-methylaminoamino group 2.3,4,7,8, 9,10-octahydrogen and [l, 2-a] [l, 2] diazepine, small sloppy, prepared by the method similar to the compound 214e based on 4-keto 4-ketobutyric acid (408), can be Generated a white solid (73%): mp · 157-165X (unclear): 〇] D27 -14〇5. (C Oi, CH3〇H); IR (KBr) 3325, 1658, 1531, 1420, 1278? 1257; ιΗ NMR (CD3OD) β 8.33-8.28 (1Η, m), 8.01-7.78 (2Η, m), 7.71 (lH, d, J = 6.0), 7.59-7.52 (3H, m), 5.27 (lH, m) , 5.12-5.03 (1Η, m), 4.55 (2H, m), 4.25 (1H, m), 3.64-3.43 (1H, m), 3.24-3.12 (1H, m), 2.80 · 1.67 (9H, m). Analyze the calculation of C25H26N407.2H2〇 The consumption cooperation of the Central Government Bureau of the Ministry of Economic Affairs of the People's Republic of China Du Yin ¾ {Please read the back of the Yun-i matter before filling out this page) Calculation: C, 56.60; . Found 値: C, 56.70; H, 5.80; N, 10.33. MS (ES +, m / z), 493 (M + · 1,100%). [3S (1S, 9S) 3- [6,10-diketo-4- (hydroxy-3,5-dimethylfluorenyl) amino-1,2,3,4,7,8,9 , 10-Octahydro-6H ^ Daparo [l, 2-a] Π, 2] Diazabenzene-l-carboxamido 4-ketobutyric acid (214w), similar method as compound 214e Preparation, can produce 210 mg (62%) of a white solid: mp. &Gt; 260 Ό: [to] D20 -93. (C 0 · 20, MeOH); IR (KBr) 3401, 2948, 1651, 1604, 1559, I486, 1421, 1325, 1276, 1210; lH NMR (D6-DMSO) d 9.39 (1H, bs), 8.29 ( 1H, d, J = 5.9), 7.55 (2H, s), -547-The standard of this paper is the same as that of China National Standards (CNS) A4 (2i0x297 mm) 1235157 A7 B7 V. Description of the invention ( 545) 6.64 (1H, d, J = 6.1), 5.79 (1H, s), 5: 25-5.21 (1H, m), 1.90-1.82 (1H, m), 4.410.69 (2H, m), 3.47 -3.20 (3H, m), 2.97-2.91 (1H, m), 2.23 (6H, s), 2.25-1.60 (7H, m)-

OO

213y R= Bn - [1S,9S(2RS,3S)] N-(2-乙氧基-5-酮基四氫呋喃-3-基)-6,10^ 二酮基-9-(異喹啉-1-甲醯胺基)-1,2,3,4,7,8,9,10-八氩-6-H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺(550q),利用製備 213e之方法合成,可生成550q。 [1S,9S(2RS,3S)】 Ν·(2-芊氧基-5-酮基四氫呋喃-3·基)-6,10-二酮基-9-(異喹啉-1-甲醯胺基)-1,2,3,4,7,8,9,10-八氫-6-11-咨啡並[l,2-a][l,2]二氮雜箪-1-羧醯胺(213y),利同製備 213e之方法合成,可生成213y。 (請先閨讀背云之注意事項再填寫本I) Μ濟部中夬標.準局員工消贫合作社印¾213y R = Bn-[1S, 9S (2RS, 3S)] N- (2-ethoxy-5-ketotetrahydrofuran-3-yl) -6,10 ^ diketo-9- (isoquinoline- 1-formamidine) -1,2,3,4,7,8,9,10-octaargon-6-H-daparo [l, 2-a] [l, 2] diazapine -1-Carboxamide (550q), synthesized by the method of preparing 213e, can produce 550q. [1S, 9S (2RS, 3S)] Ν · (2-methoxy-5-ketotetrahydrofuran-3 · yl) -6,10-diketo-9- (isoquinoline-1-carboxamide) Radical) -1,2,3,4,7,8,9,10-octahydro-6-11-ependorphin [l, 2-a] [l, 2] diazapine-1-carboxamidine Amine (213y) can be synthesized by the same method as 213e to produce 213y. (Please read the precautions of Back Cloud before completing this I) The Ministry of Economic Affairs has won the bid.

v〇^€)、0〇 -548- 本纸伕尺度逋用中國國家標李(CNS ) A4規格(2丨OX 297公釐} 1235157 A7 ______B7 五、發明説明(546 ) [1S,9S(2S,jS)】 N,(2-苯乙氧基-5-嗣'、基四氮吃σ南-3-基),6,1〇_ 二酮基-9-(異喹啉q-甲醯胺基)-1,2,3,4,7,8,9,10·八氫 咨畊並[1,24】[1,2]二氮雜箪-1-羧醯胺,(412&amp;)利甩製備 550q之方法,利用513a-l可生成412a。 [1S,9S(2R,jS)] Ν-(2·表乙乳基-5-銅基四鼠咬1^ 基)·6,1〇· 二酮基-9-(異喹啉-1-甲醯基胺基)-1,2,3,4,7,8,9,10-八氩-6_ Η-嗒畊並[l,2-a】[l,2]二氮雜箪-1-羧醯胺,(412b)利用製備 550q之方法,以513a-2可生成412b。 [1S,9S(2S,3S)】 Ν·(2-環戊氧基-5-酮基四氫呋喃-3-基)-6,1〇, 二酮基-9-(異喹啉-1-甲醯胺基)-1,2,3,4,7,8,9,10-八氫-6-{^ 嗒啩並[l,2-a][l,2]二氮雜箪·卜羧醯胺,(412c)利用製備 550q之方法合成,利用513b-l可生成412c, [1S,9S(2R,3S)] N-(2-環戊氧基-5-酮基四氫呋喃-3-基)-6,1〇_ 二酮基-9-(異喹琳-1-甲醯基胺基)-1,2,3,4,7,8,9,10-八氣-6· 士嗒啡並[1,24][1,2]二氮雜箪-1-羧醯胺,(412(1)利用製備 550q之方法合成,利用513b-2可生成412d ·· 4 NMR (CDCl3) ά 9.5 (1Η, d), 8.9 (1H, d), 8.5 (1H? d), 7.9-7.8 (2H, m), 7.g, 7.65 (2H, m), 6.55 (1H, d), 5.55 (1H, d), 5.25-5.1 (2H, m), 4.75-4.65 (1H, m), 4.65-4.6 (1H, m), 4.4-4.3 (1H, m)? 3.25^ 經濟部中夬標率局員工消費合作社印裳 3.15 (lHt m), 3.15-3.05 (1H, m), 2.95-2.8(2H, m), 2.55-2.4 (2H,m), 2.15-1.5 (14H,m)。 [15,95(25,35)]1^-(2-乙氡基-5-酮基四氩吱喃-3-基)-6,1〇,二 酮基-9-(異喹啉-卜甲醯基胺基)-1,2,3,4,7,8,9,10-八氣-6,{^ 咨畊並[l,2-a][l,2]二氮雜箪-1-羧醢胺,(412e)利用製備 -549 - 本紙杀尺度適用中國國家標李(CNS ) A4現格(210X297公釐Ί ^ 1235157 A7 B7 五、發明説明(547 ) 550q之方法合成,利用5 13f-l可生、成412e 3 [1S,9S(2R,3S)] N-(2-乙氧基-5-酮基四氫呋喃-3-基)-6,10-二 酮基-9-(異喹啉-l-甲醯基胺基)-l,2,3,4,7,8,9,10-八氫-6-H-疼啩並[l,2-a][l,2]二氮雜箪小羧醯胺,(412f)利用、製備 550q之方法合成,利用513f-2可生成412f。 化合物410及412利用自6〇4製備605之方法製備3 〇v〇 ^ €), 0〇-548- Chinese paper standard (CNS) A4 specifications (2 丨 OX 297 mm) 1235157 A7 ______B7 V. Description of the invention (546) [1S, 9S (2S) ,, jS)] N, (2-phenethoxy-5-fluoren ', radical tetrazolium sigma-3-yl), 6,10-diketo-9- (isoquinoline q-formamidine Amine) -1,2,3,4,7,8,9,10 · Octahydrogen [1,24] [1,2] diazapine-1-carboxamide, (412 &amp;) The method of preparing 550q can be used to generate 412a by using 513a-1. [1S, 9S (2R, jS)] Ν- (2. Epilactyl-5-copper-based four rat bite 1 ^ group) · 6,1 〇 · Diketo-9- (isoquinoline-1-methylamidoamino) -1,2,3,4,7,8,9,10-octaargon-6_ 2-a] [l, 2] Diazapyridine-1-carboxamide, (412b) Using the method of preparing 550q, 412b can be generated with 513a-2. [1S, 9S (2S, 3S)] Ν · ( 2-cyclopentyloxy-5-ketotetrahydrofuran-3-yl) -6,10, diketo-9- (isoquinoline-1-carboxamido) -1,2,3,4, 7,8,9,10-octahydro-6-{^ ta [[1,2, a] [l, 2] diazepine · carboxamide, (412c) was synthesized by the method of preparing 550q, 513b-1 can be used to generate 412c, [1S, 9S (2R, 3S)] N- (2-cyclopentyloxy -5-ketotetrahydrofuran-3-yl) -6,10_diketo-9- (isoquinolin-1-methylamidoamino) -1,2,3,4,7,8,9 , 10-octagas-6 · daphta [1,24] [1,2] diazapyridine-1-carboxamide, (412 (1) was synthesized by the method of preparing 550q, and 513b-2 was used 412d · 4 NMR (CDCl3) 9.5 (1Η, d), 8.9 (1H, d), 8.5 (1H? D), 7.9-7.8 (2H, m), 7.g, 7.65 (2H, m) , 6.55 (1H, d), 5.55 (1H, d), 5.25-5.1 (2H, m), 4.75-4.65 (1H, m), 4.65-4.6 (1H, m), 4.4-4.3 (1H, m) ? 3.25 ^ Employees' Cooperatives of the China National Standards Bureau, Ministry of Economic Affairs, Yin Chang 3.15 (lHt m), 3.15-3.05 (1H, m), 2.95-2.8 (2H, m), 2.55-2.4 (2H, m), 2.15- 1.5 (14H, m). [15,95 (25,35)] 1 ^-(2-Ethyl-5-one-tetraargin-3-yl) -6,10, diketo- 9- (isoquinoline-bucarboxylamino) -1,2,3,4,7,8,9,10-octagas-6, {^ gong [1, 2-a] [l , 2] Diazapyridine-1-carboxamide, (412e) using the preparation of -549-This paper is suitable for Chinese national standard (CNS) A4 (210X297 mmΊ ^ 1235157 A7 B7) V. Description of the invention ( 547) 550q method, using 5 13f-1 to produce 412e 3 [1S, 9S (2R, 3S)] N- (2-ethoxy-5-ketotetrahydrofuran-3-yl) -6,10-diketo-9- (isoquinoline-l-methylamidoamino) -l, 2,3,4,7,8,9,10-octahydro-6-H-pyridine and [l, 2-a] [l, 2] diazapine small carboxamide, (412f ) Synthesis using the method of preparing 550q, using 513f-2 can generate 412f. Compounds 410 and 412 were prepared by the method of preparing 605 from 60.

410, 412 經濟部中夬糅达局員工消费合作社印裝410, 412 Printed by the Consumer Cooperatives of Zhongda Bureau of the Ministry of Economic Affairs

5022 化合物 R1 . 0 502γ, 410 502ζ, 412 CO5022 Compound R1. 0 502γ, 410 502ζ, 412 CO

[:SUS,9S)】3-[(6,1〇-二酮基十2,3 4,7,8,91〇-八氣_6士塔 亚[1,24][1,2]二氮雜箪-9-(噻吩_3_基-羰胺基卜卜羧醯胺 基]· 550 -[: SUS, 9S)] 3-[(6,10-diketodeca, 2,3 4,7,8,91〇-octagas-6 Staya [1,24] [1,2] di Azafluorene-9- (thiophene-3-yl-carboxamido-b-carboxamido) · 550-

1235157 M濟部.f史糅这局員二消资合作社印¾ A7_B7___五、發明説明(548 )4-§3基丁酸(410),以快速層析純化(5-25%甲醇於二氣甲燒) 可生成296毫克(94%)的無色固體:mp· 90-200&quot;C ; IR (KBr) 3338, 3096, 2950, 1787, 1726, 1657, 1546, 1420, 1279, 1258, 1 125, 1092, 984, 933; lH NMR (CD3OD) ά 8.41 (1H, d), 8.13 (IH, d), 7.54-7.41 (3H, m), 7.20 (1H, d), 5.19-5.11 (1H, m), 4.54-4.30 (1H, m), 3.27 (1H, m), 3.18-3.03 (1H, m)? 2.81-2.64 (2H, m), 2.56-1.59 (7H, m) 3 分析Cl9H22N407S.2.5H20之計算 値:C, 46.05; Η, 5·49; N, 11.3卜實測値·· C,46.36; H, 5.25; N, 11.10。MS (ES,449 (M - 1,80%),113 (100)。 Cl9H23N407S(MH+)之糈確質量計算値:451.1287。實測値 :451.1295 - [35(丨5,95)]3-[(6,10-二酮基-9-(異4啉-1-甲醯基胺基-胺基 )-1,2,3,4,7,8,9,10-八氫-6H-嗒哜並[l,2-a】[l,2]二氮雜箪-1-羧 醯胺基】-4·酮基丁酸(412),以類似化合物605之方法製備 ,可生成白色玻璃狀固體(69%) ·· mp· 138-141X:;[從]D23 -105.5。(c 0·5, CH2C12); IR (KB〇 3375, 1787, 1659, 1515, 1421, 1278, 1256; lH NMR (CDC13) ά 9.32 (1H, m), 8.79 (1H, m), 8.47 (iH, m), 7.86-7.64 (4H, m), 5.3 1, 5.18, 4.59, 4.37 (4 或 5H, ιη),3·55-2·76, 2.49-2.39, 2.05, 1.65 (11H,4m)。分析 &lt;:”只2#5〇7*1.5^12〇之計算値:(:,55.17;11,5.40;队13.40。 實測値·· C, 54.87; H,5·22; N,13.15。MS (ES' m/z) 494 (M+ -1, 100%) 0[3S(1S,9S)】 3-[(6,10-二酮基-1,2,3,4,7,8,9,10-八氫-9-(嚐吩-3-基)-6H-咨啩並[l,2-a][1,2】二氮雜箪-羰胺基)-卜羧醯胺基 -551 -^纸用中國國家揉革(CNS ) ‘以規格(210X297公笼) 一 (請先閣讀背δ之注意事項再填寫本f ) 裝 訂 4 1235157 Λ7 B7 ----------------- 五、發明説明( 549 ) 卜4-酮基丁酸第三-丁酯半卡巴腙、'(502y),利用甴603製備 604之方法合成,可生成淺乳色粉末:mp. 120-180 °C; 〇]D23 -109° (c 0.18, CH2C12); IR (KBr) 3478, 3327, 1670, 1582, 1543, 1421, 1279, 1257, 1 155; lH NMR (CDCi3, CD3OD) ά 8.04 (1H, m), 7.49 (1H, m), 7.38 (1H, m), 7.17 (1H, m), 5.170.01 (2H, m), 4.86 (1H, m)? 4.61-4.50 (1H? m), 3.45-3.29 (2H, m), 3.21-3.03 (1H, m), 2.79-2.54 (3H, m), 2.43-2.33 (1H, m), 2.11-1.66 (5H, m), i.44 (9H, s) ^ 分析 C24H33N707S-H20之計算値:C,49.56; Η, 6.07; N, 16.86; S, 5.5卜實測値:C,49.51; Η, 5·93; N, 16.31; S,5.17。MS (ES+) 586 (100%),564 (M+ + 1,1.59)。C24H34N707S (MH+)之精確 質量計算値:564.2240。實測値:564.2267。 [3S(1S,9S)] 3-[(6,10-二酮基-9-(異喹啉-1-曱醯胺基)-1,2,3,4, 7,8,9,10-八氫-611-嗒畊並[1,24][1,2]二氮雜箪-1-羧醯胺基卜 4-酮基丁酸第三-丁酯半卡巴腙(502z),以如化合物604所 述之相似方法製備,可生成淺黃色固體(90%):〇^.142_ 145Ό ; [a]D24 -136.5 ° (c 0.06, CH2C12); lH NMR (CDC13) d' 9.51-9.46 (1H, m), 9.11 (iH, s), 8.83 (1H, d, J = 7.8), 8.53 (1H, d, J = 5.5), 7.89-7.83 (2H? m), 7.77-7.65 (2H, m), 7.55 (iH, d, J = 7.2), 7.18 (1H, d, J = 2.7), 5.26-5.12 (2H, m), 4.87 (1H, m), 4.59 (1H, m), 3.25-3.12 (2H, m), 2.95-2.76 (2H, m), 2.59-2.38, 2.18-1.94, 1.70 (5H, 3m), 1.44 (9H, s) ^ -552- 本纸ft尺度適用中國國家標李(CNS M4規格(210x 297公笼i ,訂 4 經濟部申夬櫺隼局員工消費合作社印製 1 1235157 Λ7 B7 五、發明説明(55〇 ) 01235157 M Ministry of Economic Affairs. F Shi Yan, a member of the Bureau of Consumers' Cooperatives ¾ A7_B7___ V. Description of the invention (548) 4-§3 Butyric acid (410), purified by flash chromatography (5-25% methanol in two gases (Methane) can produce 296 mg (94%) of colorless solid: mp · 90-200 &quot;C; IR (KBr) 3338, 3096, 2950, 1787, 1726, 1657, 1546, 1420, 1279, 1258, 1 125, 1092, 984, 933; lH NMR (CD3OD) ά 8.41 (1H, d), 8.13 (IH, d), 7.54-7.41 (3H, m), 7.20 (1H, d), 5.19-5.11 (1H, m) , 4.54-4.30 (1H, m), 3.27 (1H, m), 3.18-3.03 (1H, m)? 2.81-2.64 (2H, m), 2.56-1.59 (7H, m) 3 Analysis of Cl9H22N407S.2.5H20 Calculate 値: C, 46.05; Η, 5.49; N, 11.3 Measured 値 · C, 46.36; H, 5.25; N, 11.10. MS (ES, 449 (M-1, 80%), 113 (100). Correct mass calculation of Cl9H23N407S (MH +): 451.1287. Found: 451.1295-[35 (丨 5, 95)] 3-[( 6,10-diketo-9- (iso4line-1-methylamidoamino-amino) -1,2,3,4,7,8,9,10-octahydro-6H-da [1,2-a] [1,2] diazepine-1-carboxamido] -4 · ketobutyric acid (412), prepared in a similar manner to compound 605, can produce a white glassy solid (69%) ·· mp · 138-141X :; [from] D23 -105.5. (C 0 · 5, CH2C12); IR (KB〇3375, 1787, 1659, 1515, 1421, 1278, 1256; lH NMR ( CDC13) ά 9.32 (1H, m), 8.79 (1H, m), 8.47 (iH, m), 7.86-7.64 (4H, m), 5.3 1, 5.18, 4.59, 4.37 (4 or 5H, ιη), 3 · 55-2 · 76, 2.49-2.39, 2.05, 1.65 (11H, 4m). Analysis &lt;: "Only 2 # 5〇7 * 1.5 ^ 12〇 calculations: (:, 55.17; 11, 5.40; team 13.40. Measured 値 ·· C, 54.87; H, 5.22; N, 13.15. MS (ES 'm / z) 494 (M + -1, 100%) 0 [3S (1S, 9S)] 3-[( 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-9- (tastephen-3-yl) -6H-benzopyrene [l, 2-a] [1,2] Diazafluorene-carbonylamino group) -carboxamido-551- ^ China Crushing leather (CNS) 'With specifications (210X297 male cage) One (please read the precautions of δ first and then fill out this f) Binding 4 1235157 Λ7 B7 ---------------- -V. Description of the invention (549) Alkyl 4-ketobutyrate tertiary-butyl hemicarbazone, '(502y), synthesized by the method of preparation 604 of 甴 603, can produce light cream powder: mp. 120-180 ° C; 〇] D23 -109 ° (c 0.18, CH2C12); IR (KBr) 3478, 3327, 1670, 1582, 1543, 1421, 1279, 1257, 1 155; lH NMR (CDCi3, CD3OD) ά 8.04 (1H , m), 7.49 (1H, m), 7.38 (1H, m), 7.17 (1H, m), 5.170.01 (2H, m), 4.86 (1H, m)? 4.61-4.50 (1H? m), 3.45-3.29 (2H, m), 3.21-3.03 (1H, m), 2.79-2.54 (3H, m), 2.43-2.33 (1H, m), 2.11-1.66 (5H, m), i.44 (9H , s) ^ Analyze the calculation of C24H33N707S-H20 値: C, 49.56; Η, 6.07; N, 16.86; S, 5.5 Measured 値: C, 49.51; Η, 5.93; N, 16.31; S, 5.17. MS (ES +) 586 (100%), 564 (M + + 1, 1.59). C24H34N707S (MH +) accurate mass calculationMH: 564.2240. Found 値: 564.2267. [3S (1S, 9S)] 3-[(6,10-diketo-9- (isoquinoline-1-amidino) -1,2,3,4,7,8,9,10 -Octahydro-611-Da-Chen [1,24] [1,2] diazapyridine-1-carboxamido-4-ketobutyric acid tert-butyl hemicarbazone (502z) to Prepared in a similar manner as described for compound 604, yielding a pale yellow solid (90%): 〇 ^ .142_ 145Ό; [a] D24 -136.5 ° (c 0.06, CH2C12); lH NMR (CDC13) d '9.51-9.46 (1H, m), 9.11 (iH, s), 8.83 (1H, d, J = 7.8), 8.53 (1H, d, J = 5.5), 7.89-7.83 (2H? M), 7.77-7.65 (2H, m), 7.55 (iH, d, J = 7.2), 7.18 (1H, d, J = 2.7), 5.26-5.12 (2H, m), 4.87 (1H, m), 4.59 (1H, m), 3.25- 3.12 (2H, m), 2.95-2.76 (2H, m), 2.59-2.38, 2.18-1.94, 1.70 (5H, 3m), 1.44 (9H, s) ^ -552- The paper ft scale is applicable to Chinese national standard (CNS M4 specifications (210x 297 male cage i, order 4 printed by the Consumers' Cooperative of the Shenyang Bureau of the Ministry of Economic Affairs 1 1235157 Λ7 B7 V. Description of the invention (55)) 0

經洚部中夬榡準局員工消费合作.杜印¾ 化合物 R4 R1 415a 415b 415c 214w-l 214w-2 CHj 214w-3 CH3 214w-4 CHa 214w-5 CH3 -553- 本纸伕尺度適用中S國家標李(CNS )六4現洛(2丨0 X297公釐) 1235157 AT B7 五、發明説明(551 ) 化合物 R4 ' R1 214w—6 ,〇0 214w-7 ρΌ 412g 412h ^0 (請先閱讀背云之泾意事項再填寫本f ) -裝 [13,93(25,35)]1^-(2-:^:氧基-5-嗣基四氫咬喊-3-基)-6,10-二 酮基-9-(甲二氧基;醢按基)-1,2,3,4,7,8,9,10-八氫-61^咨哜 : 並[1,24】[1,2]二氮雜箪-卜羧醯胺,(4153)利用製備55(^之 方法合成,生成415a。 [1S,9S(2RS,3S)] N-(2-乙氧基-5-酮基四氫呋喃-3-基)-6,10-二酮基-9-(甲二氧基芊醯胺基)-1,2,3,4,7,8,9,10-八氩-6^1-嗒 啡並[l,2-a][l,2]二氮雜苯-1-羧醯胺,(415b)利用製備550q 之方法合成可生成415b。 [1S,9S(2R,3S)] N-(2-^ 氧基-5-嗣基四氮 11 夫續-3-基)-6,10-二 酮基-9-(曱二氡基笮醯胺基)-1,2,3,4,7,8,9,10-八氫-6^1-咚呼 並[1,24】[1,2]二氮雜箪-1-羧醯胺,(415(:)利用製備55(^之 方法合成,生成415c。 [1S,9S(2RS,3S)] N-(2-芊氧基-5-酮基四氩呋喃-3-基)-6,10- _ - 554 - 本纸尺度通用中国國家標窣(CNS ) /U緹洛(210X2W公笼) 訂 經濟部中夬標.準局員二消f合作社印¾ 1235157 ______B7 __ 五、發明説明( 552) 二銅基-9-(3,5-二甲基,4 -經基芊疲、胺基)-1,2,3,4,7,8,9,10-八 氫-6H-嗒啩並[l,2-a][i,2]二氮雜蕈-卜羧醯胺,(214w-l)利 用製備5 5 Oq之方法合成,以生成214w-l 3 [1S,9S(2R,3S)】 Ν-(2·;氧基-5•酮基四氫呋喃-3-基)-6,10-二 酮基-9-(3,5-二曱基-4-羥基;醯胺基)-1,2,3,4,7,8,9,10-八氫 -6H-,答畊並[l,2-aHl,2]二氮雜苯-卜羧醯胺,(214W-2)利用 製備550q之方法合成可生成2i4w-2 3 [1S,9S(2S,3S)】 N-(2·芊氧基-5·酮基四氫呋喃小基)-610-二 S3 基-9-(3,5·二甲基-4-羥基;醢胺基)-1,2,3,4,7,8,9,10-八氫 -6Η-嗒啩並[l,2-aHl,2]二氮雜箪-1-羧醯胺,(214W-3)利用 製備550q之方法合成,可生成214w-3。 [1S,9S(2R,jS)] N-(2-笨乙乳基-5-銅基四氮咬喘-3-基)-6,10* 二酮基-9-(3,5-二甲基-4 -羥基笮醯胺基)-1,2,3,4,7,8,9,10-八 氫-6Η-»答啡並[l,2-a][l,2]二氮雜蕈-1-幾醯胺,(2i4w-4)利 用製備550q之方法合成,可生成214w-4。 [1S,9S(2S,3S)】 Ν·(2-笨乙氧基-5-酮基四氫吱喃-3-基)-6,10-二銅基-9-(3,5-二甲基-4-輕基芊δ备胺基)·ι,2,3,4,7,8,9,10-八 氮-6Η-4 σ井並[1,2-a][ 1,2]一 乳雜革.1-幾 s產胺,(214w-5)利 用製備550q之方法合成可生成214wo。Consumption cooperation between employees of the Ministry of Economic Affairs and the Central Bureau of Commerce. Du Yin ¾ Compound R4 R1 415a 415b 415c 214w-l 214w-2 CHj 214w-3 CH3 214w-4 CHa 214w-5 CH3 -553- The standard of this paper is applicable to S National standard plum (CNS) June 4 now Luo (2 丨 0 X297 mm) 1235157 AT B7 V. Description of the invention (551) Compound R4 'R1 214w-6, 0 0 214w-7 ρΌ 412g 412h ^ 0 (Please read first Please fill in this matter of the back of the cloud f) -Pack [13,93 (25,35)] 1 ^-(2-: ^: oxy-5-fluorenyltetrahydrobite-3-yl) -6 , 10-diketo-9- (methyldioxy; fluorenyl) -1,2,3,4,7,8,9,10-octahydro-61 ^ Resin: and [1,24] [1,2] Diazapyridine-carboxamide, (4153) was synthesized by the method of preparation 55 (^) to produce 415a. [1S, 9S (2RS, 3S)] N- (2-ethoxy-5 -Ketotetrahydrofuran-3-yl) -6,10-diketo-9- (methyldioxyamidoamino) -1,2,3,4,7,8,9,10-octaargon- 6 ^ 1-Daphno [l, 2-a] [l, 2] diazabenzene-1-carboxamide, (415b) can be synthesized by the method of preparing 550q to produce 415b. [1S, 9S (2R, 3S)] N- (2- ^ oxy-5-fluorenyltetrazine 11-fluorocontinyl-3-yl) -6,10-diketo-9- (fluorenedifluorene Sulfonylamino) -1,2,3,4,7,8,9,10-octahydro-6 ^ 1-pyrido [1,24] [1,2] diazafluorene-1- Carboxamidine, (415 (:) was synthesized by the method of Preparation 55 (^) to produce 415c. [1S, 9S (2RS, 3S)] N- (2-Methoxy-5-one tetrahydrofuran-3- Base) -6, 10- _-554-This paper is in accordance with the Chinese National Standard (CNS) / U Ti Luo (210X2W public cage). The bid is awarded by the Ministry of Economic Affairs. The Associate Bureau ’s second consumerism f cooperative print ¾ 1235157 ______B7 __ 5 、 Explanation of the invention (552) Dicopper-9- (3,5-dimethyl, 4-acryl, amine) -1,2,3,4,7,8,9,10-octahydro -6H-dapyrolo [l, 2-a] [i, 2] diazamycin-carboxamide, (214w-l) was synthesized by the method of preparing 5 5 Oq to generate 214w-l 3 [1S , 9S (2R, 3S)] Ν- (2 ·; oxy-5 • ketotetrahydrofuran-3-yl) -6,10-diketo-9- (3,5-difluorenyl-4-hydroxyl Fluorenylamino) -1,2,3,4,7,8,9,10-octahydro-6H-, and [1,2-aHl, 2] diazepine-p-carboxamide, (214W-2) 2i4w-2 3 can be synthesized by the method of preparing 550q [1S, 9S (2S, 3S)] N- (2 · fluorenyl-5 · ketotetrahydrofuran small group) -610-diS3 group -9- (3,5 · dimethyl-4 -Hydroxy; fluorenylamino) -1,2,3,4,7,8,9,10-octahydro-6'-dapyrido [l, 2-aHl, 2] diazapyridine-1-carboxyfluorene Amine, (214W-3) is synthesized by the method of preparing 550q, which can produce 214w-3. [1S, 9S (2R, jS)] N- (2-benzylethoxy-5-coppertetrazine-3-yl) -6,10 * diketo-9- (3,5-di Methyl-4 -hydroxyamido)) 1,2,3,4,7,8,9,10-octahydro-6Η- »aporphino [l, 2-a] [l, 2] di Azamus-1-chiamine, (2i4w-4) is synthesized by the method of preparing 550q, which can produce 214w-4. [1S, 9S (2S, 3S)] Ν · (2-benzylethoxy-5-ketotetrahydrocran-3-yl) -6,10-dicopper-9- (3,5-di Methyl-4-light fluorene δ δ amino group), ι, 2,3,4,7,8,9,10-octaazepine-6 fluorene-4 σ well [1,2-a] [1,2 ] -Miscellaneous leather. 1-A few s of amines, (214w-5) can be synthesized by the method of preparing 550q to produce 214wo.

經濟部中夬樣革局員工消費合作·社印5LEmployees' Cooperation of Zhongli Sample Leather Bureau, Ministry of Economic Affairs · Social Seal 5L

[1S,9S(2R,3S)] N-(2-環戍氧基-5-酮基四氫呋喃-3-基)-6,10-二酮-9-(3,5-二甲基-4-羥基苄醯胺基)-1,2,3,4,7,8,9,10-八氫 -6Η-^ β井並[1,2-a][ 1,2] — 亂雜 ¥ -1-¾ δδ 胺,(2 14w-6)利用 製備550q之方法合成,可生成214w-6。 [1S,9S(2S,3S)] N-(2-環戍氧基〇'酮基四氫呤喃-3-基)-6,10· -555 - 本纸法尺度通用中國國家樣隼(CNS ) Α4規格(210Χ297公笼〉 1235157 Λ7 _ _ B7__ 五、發明説明( 553 ) 二酮基-9-(3,5-二甲基-4-羥基笮醢、胺基)-1,2,3,4,7,8,9,10-八 氫-6H-嗒啡並[1,24][1,2】二氮雜箪-1-羧醯胺,(214〜-7)利 用製備550q之方法合成,可生成2Mw-7。 [1S,9S(2R,3S)] N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6;10·二 酮基-9-(異喹啉·1-甲醯胺基)-1,2,3,4,7,8,9,10-八氫-6只-嗒呼 並[l,2-a][l,2]二氮雜苯-卜羧醯胺,(4!2g)利用製備550q之 方法合成,可生成412g。 [1S,9S(2S,3S)】 N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6,10-二 酮基-9-(異峻淋-1-甲醯胺基)-1,2,3,4,7,8,9,10-八氫-6{^嗒吟 並[l,2-a][l,2]二氮雜箪-卜幾酿胺’(412h)利用製備550q之 方法合成,可生成412he 0[1S, 9S (2R, 3S)] N- (2-Cyclooxy-5-ketotetrahydrofuran-3-yl) -6,10-dione-9- (3,5-dimethyl-4 -Hydroxybenzylamino) -1,2,3,4,7,8,9,10-octahydro-6Η- ^ β well and [1,2-a] [1,2] — Chaos ¥- 1-¾ δδ amine, (2 14w-6) is synthesized by the method of preparing 550q, which can generate 214w-6. [1S, 9S (2S, 3S)] N- (2-Cyclooxyloxy'ketotetrahydrofuran-3-yl) -6,10 · -555-This paper method is commonly used in Chinese national samples ( CNS) A4 specification (210 × 297 male cage> 1235157 Λ7 _ _ B7__ V. Description of the invention (553) diketo-9- (3,5-dimethyl-4-hydroxyfluorene, amine group) -1, 2, 3,4,7,8,9,10-octahydro-6H-daphne [1,24] [1,2] diazapyridine-1-carboxamide, (214 ~ -7) Preparation 550q It can be synthesized by the method to produce 2Mw-7. [1S, 9S (2R, 3S)] N- (2-methoxy-5-ketotetrahydrofuran-3-yl) -6; 10 · diketo-9- (Isoquinoline · 1-methylamido) 1,2,3,4,7,8,9,10-octahydro-6 only-daphtho [l, 2-a] [l, 2] Diazabenzene-carboxamidine, (4! 2g) was synthesized by the method of preparing 550q, and 412g was produced. [1S, 9S (2S, 3S)] N- (2-Methoxy-5-ketotetrahydrofuran -3-yl) -6,10-diketo-9- (isojunyl-1-carboxamido) -1,2,3,4,7,8,9,10-octahydro-6 { ^ Dain and [l, 2-a] [l, 2] diazapyrene-buguisamine '(412h) is synthesized by the method of preparing 550q, which can generate 412he 0

415 0415 0

214w [3S(1S 9S)]3-(9-(4,5-甲二乳基+ 驢基)胺基-6,10-二嗣基-214w [3S (1S 9S)] 3- (9- (4,5-methyldilactyl + donyl) amino-6,10-difluorenyl-

經濟部令夬樣.華局員工消f合作社印5L 17 3 4 7 8 9,10-八氫-6]3-‘*井並[1,2-玨][1,2]二氣雜革-1-致 醯胺基)-4-酮基丁酸(415),以自.2001製備2002之方法合成 以生成415。 [35(13,95)】3-(9-(3,5-二氣-4-超基亨睡基)胺基-6,10-二銅基· 1 7 3 4 7 8 9 10-八氫σ井並[l,2-a][l,2]二氣雜車-1-致 醯胺基)-4-酮基丁酸(214W),以自2001製備2002之方法合 556-Order from the Ministry of Economic Affairs. Employees of the China Bureau of the People's Republic of China 5L 17 3 4 7 8 9,10-octahydro-6] 3-'* Jing [1,2- 玨] [1,2] -1-Aminomethylamino) -4-ketobutyric acid (415) was synthesized by the method of 2002 from 2002 to produce 415. [35 (13,95)] 3- (9- (3,5-Digas-4-superylhexyl) amino-6,10-dicopperyl · 1 7 3 4 7 8 9 10-eight Hydrogen σ wells [1,2-a] [l, 2] two-gas heterocycle-1-induced amido) -4-ketobutanoic acid (214W), 556-

1235157 A7 B7 五、發明説明( 554 ) 成,以生成214 w。1235157 A7 B7 5. The invention description (554) was completed to generate 214w.

2100k-o 經濟部中夬樣隼局員工消f合作社印袈 化合物 R 2100k 21001 χ〇-〇 2100m 、。&lt;〇 2100η V°T) 2100ο &gt;0Τ3 [15,95(2尺5,35)9-芊醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-N-(2-苯乙氧基-5-酮基四氫呋喃-3-基)-6H-畚畊並[1,2-a][l,2】二氮雜革-1-羧醯胺(2100k),以如化合物213e之類似 方法製備,以生成非對映立體異構物之混合物(75/25),呈-557- 本咆&amp;尺度通用中a國家標孳(CNS ) A4現格(210乂2了公釐) (請先聞讀背云之^意事1¾填寫本頁) 雄填 裝 訂 1235157 A? __B7_ 五、發明説明(555 ) 白色固禮(258毫克,83%) : mp. ΙΌΐΧ; •[立]/5 -96。(c 0.2, CH2C12); IR (KBr) 3328, 2935, 2978, 1732, 1669, 1603, 1483, 1450, 1414, 1237, 1155, 1082, 989, 755; lH NMR (CDC13) ά 7.84^7.80 (2H, m), 7.54-7.17 (8H, m), 7.06-6.99 (1H, m), 6.25 (1H, d, J = 7.9H), 5.41 (0.75H, d? J = 5.4H), 5.31 (0.25H? bs), 5.23^5.09 (1H, m), 4.93-4.87 (1H, m), 4.68^4.51 (2H, m), 4.40-4.33 (0.25H, m), 4.24-4.14 (0.75H, m), 3.95-3.70 (1H, m), 3.30-3.13 (1H, m), 3.14-2.78 (5H, m)? 2.47-2.21 (2H, m)? 2.05-1.50 (5H,m)。分析 C29H32N4O7.0.5H2〇之計算値·‘ C, 62·47; H,5·97; N,10.05。實測値·· C,62.17; H, 5.83; N,9·97 3 MS (ES+) 549。 [1S,9S(2RS,3S) 9-苯曱醯胺基-N-(2-環戊氧基-5-酮基-四氫 呋喃·3-基)-6,10·二酮基-1,2,3,4,7,8,9,10-八氫-611-,答呼並 [l,2-a][l,2]二氛雜卓-1-幾胺(21001)’以如213e之類似方 法製備,呈無色固體:mp· 172-8CTC ;[泛]D23 -91.53 (c 0.1, CH-2Ci2); IR (KBr) 3290, 1792, 1677, 1657, 1642, 1544, 1425, 1280, 1259, 1 124, 977; lR NMR (CDCi3) c? 7.80 (2H, m), 經濟部中央櫺準局員工消费合作杜印¾ (請先聞請背一 B之·./X意事項弄填寫本I ) 7.46 (3.5H, m), 7.00 (1H, d, J = 6.7), 6.48 (0.5H, d, J = 7·9)^ 5.55 (0.5H, d, J = 5.3), 5.19 (2H, s + m), 4.93 (0.5H, m), 4.62 (1.5H, m), 4.34 (1H, m), 4.18 (0.5H, m), 3.28-2.70 (4H, m), 2.49-2.29 (2H, m), 205-1.48 (15H,m)。 [1S,9S(2R,3S) 9·苯甲醯胺基-6,10-二酮基氺-〇(2-氫茚基氡 基)-5-酮基-四氫呋喃-3-基]-1,2,3,4,7,8,9,10-八氫-6{^各呼 並[1,24][1,2]二氮雜箪-1-羧醢胺(210〇111),依213€之類似方 -558 - ___ --------- _ 一 _____ — ______ ______ ^ 本纸抶尺度通用中g國家標隼(CNS ) A4垅格(210人297公釐) 1235157 A7 __ B7 五、發明説明(556 ) 法製備,(76%)呈無色固體,mp.、、〜14(TC,再溶化187-VC ; l&gt;]D23 -96.90 (c 0.11,CH2C12); IR (KBr) 3507, 3308, 3251, 1772, 1660, 1641, 1566, 1545, 1457, 1424, 1346, 1326, 1302, 1275, 1258, 1 136, 1085, 1018, 981; lH NMR (CDC13) ό 7.78 (2H, m), 7.53 (3H, m), 7.19 (4H, m), 6.91 (1H, d, J = 7.4), 6.27 (1H, d, J = 7.6), 5.66 (1H, d, J = 5.3), 5.10 (1H, m), 4.96 (1H, m), 4.75 (2H, m), 4·52 (1H, m), 3.08 (3H,m), 3.03-2.71 (5H, m), 2.48-2.31 (2H, m), 1.90-1.40 (4H, m), 1.22 (1H, m) 〇 [1S,9S(2S,3S) 9-芊醯胺基-N-(2-芊氧基〇-酮基四氫呋喃-3-基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611-嗒啩並[1,24][1,2】 二氮雜箪-1-羧醯胺(21〇〇n),依化合物213e之相似方法製 備,可生成白色玻璃狀固鳢(76%); mp. U2-5X: ; 〇 ]〇23 -62·0ο (c 0·1, CH2C12); IR (ΚΒγ) 3305, 1789, 1677, 1665, 1535, 1422, 1279, 1256, 11 19, 942, 700; lK NMR (CDCi3) ^ 7.84 (2H, s), 7.58^7.27 (9H, m), 6.99 (1H, d, J = 7.8), 5.23 (1H, s), 5.23-5.11 (1H, m), 4.89 (1H? m), 4.76 (1H, d, J = 11.3), 4.55 (1H, d, J = 1 1.4), 4.58-4.43 (2H, m), 3.30^2.96, 2.81-2.69, 2.46-2.37, 2Λ6Λ.66 (10H, 4m), 2.27 (1H, d, J =, M濟部肀夬樣皋局員Μ消费合作杜印裝 17.8)。分析 C28H30N4O7.0.5H2O 之計算値:C,61.87; H, 5.75. y N,10.32 3 實測値:c, 61.88; H,5·70; N,10.33 ° MS (ES' 取/之) 535 (M+ + 1,100%)。 - [1S,9S(2R,3S) 9-芊醯胺基-N-(2-辛氧基-5-酮基四氣啥淹 基)-6,10-二酮基,ι,2,3,4,7,8,9,1〇-八氫-6H-嗒畊並, 二氮雜箪,1-幾醯胺(2100〇)(含有約7%的(2S)),依化合物 -559- 本纸汝尺度通用中國國家標隼(CNS ) Α4現格(21〇&gt;&lt; 297公慶) 1235157 A7 B7 五、發明説明(557) 213e之類似方法製備,可生成白、、色玻璃狀固體(81%);mp 115-7’C ; 〇]D2l12l (c 〇 u,叫(:12); IR (KBr) 3326, 1792, 1659, 1535, 1421, 1278, 1257, 1 124, 978; lH NMR (CDC13) ά 7.82 (2H, m), 7.58-7.24 (8H, m), 6.90 (1H; d, J = 7·3), 6·49 (1H, d,J = 7 7),5 57 (lfi,山 J = 5.5), 5.11 (2H,m), 4.91 (IH, d,J = 11·4), 4 57 (1H,d,j = lhl),4·81-4.68 (1H, m), 4.65-4.54 (1H, m), 3.18-2.71, 2.52-2.30, 2.05-1.62 (1 1H? 3m)。分析C28H3〇N4〇7.〇.5H2〇之計算値·· C, 61.87; Η, 5·75; N, 10.32 3 實測値:c,61.70; H,5·71; N, 1〇·15。MS (ES+,m/z) 535 (M,十 1,94.3%), 557 (100%)。 Ο2100k-o Employees of the China Bureau of Economic Affairs, China Ministry of Economic Affairs, Cooperative Cooperative Association, Compound R 2100k 21001 χ〇-〇 2100m. &lt; 〇2100η V ° T) 2100ο &gt; 0Τ3 [15,95 (2 feet 5,35) 9-amido-6,10-diketo-1,2,3,4,7,8, 9,10-octahydro-N- (2-phenethoxy-5-ketotetrahydrofuran-3-yl) -6H-pyrene [1,2-a] [l, 2] diaza leather- 1-Carboxamide (2100k), prepared in a similar manner as compound 213e, to produce a mixture of diastereoisomeric compounds (75/25), which is -557- Bennol &amp; standard in general a national standard (CNS) A4 is now available (210 乂 2mm) (please read the meaning of the back of the cloud 1 ^ 1 to complete this page) Male bookbinding 1235157 A? __B7_ 5. Description of the invention (555) White solid gift (258 mg , 83%): mp. ΙΌΐΧ; • [立] / 5 -96. (C 0.2, CH2C12); IR (KBr) 3328, 2935, 2978, 1732, 1669, 1603, 1483, 1450, 1414, 1237, 1155, 1082, 989, 755; lH NMR (CDC13) ά 7.84 ^ 7.80 (2H , m), 7.54-7.17 (8H, m), 7.06-6.99 (1H, m), 6.25 (1H, d, J = 7.9H), 5.41 (0.75H, d? J = 5.4H), 5.31 (0.25 H? Bs), 5.23 ^ 5.09 (1H, m), 4.93-4.87 (1H, m), 4.68 ^ 4.51 (2H, m), 4.40-4.33 (0.25H, m), 4.24-4.14 (0.75H, m ), 3.95-3.70 (1H, m), 3.30-3.13 (1H, m), 3.14-2.78 (5H, m)? 2.47-2.21 (2H, m)? 2.05-1.50 (5H, m). Calculated for analysis of C29H32N4O7.0.5H2O 値 'C, 62 · 47; H, 5.97; N, 10.05. Found 値 · C, 62.17; H, 5.83; N, 9.97 3 MS (ES +) 549. [1S, 9S (2RS, 3S) 9-phenylamido-N- (2-cyclopentyloxy-5-one-tetrahydrofuran · 3-yl) -6,10 · diketo-1,2 , 3,4,7,8,9,10-octahydro-611-, answer to [l, 2-a] [l, 2] diazahetero-1-chitamine (21001) 'such as 213e Prepared by a similar method as a colorless solid: mp · 172-8CTC; [Pan] D23 -91.53 (c 0.1, CH-2Ci2); IR (KBr) 3290, 1792, 1677, 1657, 1642, 1544, 1425, 1280, 1259, 1 124, 977; lR NMR (CDCi3) c? 7.80 (2H, m), Du Yin, employee cooperation of the Central Bureau of Standards of the Ministry of Economic Affairs Book I) 7.46 (3.5H, m), 7.00 (1H, d, J = 6.7), 6.48 (0.5H, d, J = 7.9) ^ 5.55 (0.5H, d, J = 5.3), 5.19 ( 2H, s + m), 4.93 (0.5H, m), 4.62 (1.5H, m), 4.34 (1H, m), 4.18 (0.5H, m), 3.28-2.70 (4H, m), 2.49-2.29 (2H, m), 205-1.48 (15H, m). [1S, 9S (2R, 3S) 9 · Benzamidoamino-6,10-diketofluorene-〇 (2-hydroindenylfluorenyl) -5-keto-tetrahydrofuran-3-yl] -1 , 2,3,4,7,8,9,10-octahydro-6 {^ each ac [1,24] [1,2] diazepine-1-carboxamide (210〇111), Similar to 213 € -558-___ --------- _ 1 _____ — ______ ______ ^ This paper has a standard Chinese national standard (CNS) A4 grid (210 people 297 mm) 1235157 A7 __ B7 V. Description of the invention (556) method, (76%) was a colorless solid, mp., ~ 14 (TC, redissolved 187-VC; l &gt;) D23 -96.90 (c 0.11, CH2C12); IR (KBr) 3507, 3308, 3251, 1772, 1660, 1641, 1566, 1545, 1457, 1424, 1346, 1326, 1302, 1275, 1258, 1 136, 1085, 1018, 981; lH NMR (CDC13) ό 7.78 (2H, m), 7.53 (3H, m), 7.19 (4H, m), 6.91 (1H, d, J = 7.4), 6.27 (1H, d, J = 7.6), 5.66 (1H, d, J = 5.3), 5.10 (1H, m), 4.96 (1H, m), 4.75 (2H, m), 4.52 (1H, m), 3.08 (3H, m), 3.03-2.71 (5H, m), 2.48 -2.31 (2H, m), 1.90-1.40 (4H, m), 1.22 (1H, m) 〇 [1S, 9S (2S, 3S) 9-fluorenylamino-N- (2-fluorenyloxy)- Ketotetrahydrofuran-3-yl) -6,10- Diketo-1,2,3,4,7,8,9,10-octahydro-611-dapyrido [1,24] [1,2] diazapyridine-1-carboxamide (21 〇〇n), prepared according to a similar method of compound 213e, can produce a white glassy solid (76%); mp. U2-5X:; 〇] 〇23 -62 · 0ο (c 0 · 1, CH2C12); IR (ΚΒγ) 3305, 1789, 1677, 1665, 1535, 1422, 1279, 1256, 11 19, 942, 700; 1K NMR (CDCi3) ^ 7.84 (2H, s), 7.58 ^ 7.27 (9H, m), 6.99 ( 1H, d, J = 7.8), 5.23 (1H, s), 5.23-5.11 (1H, m), 4.89 (1H? M), 4.76 (1H, d, J = 11.3), 4.55 (1H, d, J = 1 1.4), 4.58-4.43 (2H, m), 3.30 ^ 2.96, 2.81-2.69, 2.46-2.37, 2Λ6Λ.66 (10H, 4m), 2.27 (1H, d, J =, M) Member of the Bureau, Consumer Cooperation, Du Yinzhuang 17.8). Analyze the calculation of C28H30N4O7.0.5H2O 値: C, 61.87; H, 5.75. Y N, 10.32 3 Measured 値: c, 61.88; H, 5.70; N, 10.33 ° MS (ES '//) 535 (M + + 1, 100%). -[1S, 9S (2R, 3S) 9-fluorenylamino-N- (2-octyloxy-5-ketotetrahydrocarbyl) -6,10-diketoyl, ι, 2, 3 , 4,7,8,9,10-octahydro-6H-da-porphyrin, diazapyrene, 1-epioxamine (2100) (containing about 7% (2S)), according to compound -559 -The standard of this paper is the Chinese National Standard (CNS) A4. (21〇 &gt; &lt; 297 public holiday) 1235157 A7 B7 V. Description of the invention (557) 213e. It can be produced by a similar method, which can produce white, stained glass. Solid (81%); mp 115-7'C; 〇] D2l12l (c 〇u, called (: 12); IR (KBr) 3326, 1792, 1659, 1535, 1421, 1278, 1257, 1 124, 978 ; lH NMR (CDC13) ά 7.82 (2H, m), 7.58-7.24 (8H, m), 6.90 (1H; d, J = 7.3), 6.49 (1H, d, J = 7 7), 5 57 (lfi, J = 5.5), 5.11 (2H, m), 4.91 (IH, d, J = 11.4), 4 57 (1H, d, j = lhl), 4 · 81-4.68 (1H , M), 4.65-4.54 (1H, m), 3.18-2.71, 2.52-2.30, 2.05-1.62 (1 1H? 3m). Analyze the calculation of C28H3〇N4.07.0.5H2〇 C · C, 61.87 Η, 5.75; N, 10.32 3 Measured 値: c, 61.70; H, 5.71; N, 10 · 15. MS (ES +, m / z) 535 (M, 10, 94.3%), 557 (100%) Ο

經濟部中央樣.準局員工消贫合作社印裝 [13,93(2尺3,35)9-(3-乙醯胺基)芊醯胺基-6,10-二酮基-义(2-乙氧基-5-酮基-四氫呋喃-3-基)-:1,2,3,4,7,8,9,10-八氫-611-,答 啡並n,2-aHl,2]二氮雜箪小羧醯胺(550η),依化合物213e 之類似方法製備,生成非對映立體異構物之混合(65/35), 呈褐色粉末(390毫克,28%);〇^.139-145°(:;[泛】〇23 -1043 (c 0.2, MeOH); IR (KBr) 3318, 2405, 2369, 1792, 1660, 1591, _一 :560- __ 本纸法尺度通用中国國家標隼(CNS ) A4現格(2丨0'&lt;2Q7公浚) 1235157 Λ7 _B7_ 五、發明説明(558) 1549, 1484, 1422, 1257, 1 1 17; XH NMR (D6-DMSO) ά 10.1 (1Η, s), 8.80 (0.65H, d, J =6.6), 8.58 (0.35H, d, J = 6.6), 8.59 (1H, d, J = 7.0), 8.06 (1H, bs), 7.83-7.79 (1H, m), 7.61-7.57 (1H, m), 7.47-7.39 (1H, m), 5.61 (0.35H, d? J = 5.0), 5.37 (0.65H, bs), 5.170.14 (0.35H, m), 5.08-5.06 (0.65H, m), 4.92-4.86 (1H, m), 4.67-4.61 (0.35H, m), 4.47-4.41 (0.65H, m), 4.28-4.11 (1H, 2m), 3.80-3.59 (2H, m), 3.23-2.75 (3H, m), 2.6卜 1.48 (7H, m), 2.10 (3H,s),1.25及 1.17 (3H,2t,J = 5.8) 。MS (ES” 528。Central sample of the Ministry of Economic Affairs. Printed by the Anti-Poverty Cooperative of the Associate Bureau [13,93 (2 feet 3,35) -Ethoxy-5-keto-tetrahydrofuran-3-yl)-: 1,2,3,4,7,8,9,10-octahydro-611-, pyrenol n, 2-aHl, 2 ] Diazapyridoxamine (550η), prepared in a similar manner to compound 213e, to form a mixture of diastereoisomeric compounds (65/35), as a brown powder (390 mg, 28%); .139-145 ° (:; [PAN] 〇23 -1043 (c 0.2, MeOH); IR (KBr) 3318, 2405, 2369, 1792, 1660, 1591, _One: 560- __ This paper method is common in China National Standards (CNS) A4 now available (2 丨 0 '&lt; 2Q7 public dredging) 1235157 Λ7 _B7_ V. Description of the invention (558) 1549, 1484, 1422, 1257, 1 1 17; XH NMR (D6-DMSO) ά 10.1 (1Η, s), 8.80 (0.65H, d, J = 6.6), 8.58 (0.35H, d, J = 6.6), 8.59 (1H, d, J = 7.0), 8.06 (1H, bs), 7.83 -7.79 (1H, m), 7.61-7.57 (1H, m), 7.47-7.39 (1H, m), 5.61 (0.35H, d? J = 5.0), 5.37 (0.65H, bs), 5.170.14 ( 0.35H, m), 5.08-5.06 (0.65H, m), 4.92-4.86 (1H, m), 4.67-4.61 (0.35H, m), 4.47-4.41 (0.65H, m), 4. 28-4.11 (1H, 2m), 3.80-3.59 (2H, m), 3.23-2.75 (3H, m), 2.6b 1.48 (7H, m), 2.10 (3H, s), 1.25 and 1.17 (3H, 2t , J = 5.8). MS (ES "528.

550〇550〇

經濟部夬標隼局員工消f合作社印SLStaff of the Ministry of Economic Affairs, Bureau of Standards, Consumers, Cooperatives, SL

[15,95(2115,35)6,10-二酮基-:^-(2-乙氧基-5-酮基四氩呋喃· 3-基)-9-(2-哬哚甲醢胺基)-1,2,3,4,7,8,9,10-八氫-611-嗒啩並 [l,2-a][l,2】二氮雜箪-1-羧醯胺(550〇),依化合物213e之相 似方法製備,可生成無色的固體(1·〇71克,80%);111?.155-7〇°C ; [α]Ό22 -75.8° (c 0.26, CH2C12); IR (KBr) 3314, 2941, 1791, 1658, 1545, 1420, 1341, 1312, 1252, 1 181, 11 18, 939, 749; lH NMR (CDCi3) 9.45 (0.5H, s), 9.34 (0.5H, s), 7.68- 7.62 (1H, m), 7.49-7.39 (2H, m), 7.33-7.26 (1H, m), 7.18-7.03 -561 - 本纸伕尺度適用中3國家標李(匸&gt;^)六4垅格(2丨0乂297公釐) 1235157 經濟部άτ:夭樣毕局員工消费合作·杜印¾[15,95 (2115,35) 6,10-diketo-: ^-(2-ethoxy-5-ketotetrahydrofuran · 3-yl) -9- (2-oxindolecarboxamide Radical) -1,2,3,4,7,8,9,10-octahydro-611-dapyrido [l, 2-a] [l, 2] diazapine-1-carboxamide ( 550), prepared according to the similar method of compound 213e, which can produce colorless solid (1.071 g, 80%); 111? .155-7 ° C; [α] Ό22 -75.8 ° (c 0.26, CH2C12 ); IR (KBr) 3314, 2941, 1791, 1658, 1545, 1420, 1341, 1312, 1252, 1 181, 11 18, 939, 749; lH NMR (CDCi3) 9.45 (0.5H, s), 9.34 (0.5 H, s), 7.68- 7.62 (1H, m), 7.49-7.39 (2H, m), 7.33-7.26 (1H, m), 7.18-7.03 -561-This paper's standard is applicable to 3 national standards (李&gt; ^) Six 4 squares (2 丨 0 乂 297 mm) 1235157 Ministry of Economic Affairs: 夭 Sample cooperation between employees of the Bureau · Du Yin ¾

AT B7 五、發明説明(559) (3H,m), 5.49 (0·5Η,d),5.30 (0.5H,’s),5.26-5.13 (1H,m), 4.90-4.83 (0.5H, m), 4.76-4.49 (1H, m), 4.42-4.35 (0.5H, m), 3.97-3.74 (1H, m), 3.72-3.53 (1H, m), 3.35^2.64 (4H, m), 2.50-2.37 (1H, m), 2.20-1.82 (5H, m), 1.69-1.50 (2H, m)', 1.30-1.19 (3H, m)。 0AT B7 V. Description of the invention (559) (3H, m), 5.49 (0.5Η, d), 5.30 (0.5H, 's), 5.26-5.13 (1H, m), 4.90-4.83 (0.5H, m ), 4.76-4.49 (1H, m), 4.42-4.35 (0.5H, m), 3.97-3.74 (1H, m), 3.72-3.53 (1H, m), 3.35 ^ 2.64 (4H, m), 2.50- 2.37 (1H, m), 2.20-1.82 (5H, m), 1.69-1.50 (2H, m) ', 1.30-1.19 (3H, m). 0

[15,95(2尺5,3 3)6,10-二嗣基-义(2-乙氧基-5-酮基四氫呋喃· 3-基)-9-(4-羥基芊醢基)胺基-1,2,3,4,7,8,9,10-八氩·6Η-嗒咩 並[l,2-a][l,2]二氮雜箪-1-羧醢胺(550ρ),依化合物213e之 類似方法製備,以生成非對映立體異構物之混合物,呈白 色泡沫(820毫克,47%):[泛]〇24 -75° (c 0.16, CH2C12); IR (KBr) 3401,2937, 1791,1657, 1609, 1539, 1505, 1423, 1277, 1177, Π18; lH NMR (CDCI3) ά 8.07-8.05 (1H, m), 7.67 (2H? d, J = 7.9), 7.38-7.29 (2H, m), 6.80 (2H, d, J = 8.5), 5.49 (0.5H, d, J = 4.6), 5.23 (0.5H, bs), 5.24-5.20 (1H, m), 5.12-5.08 (1H, m), 4.68-4.29 (2H, m), 3.92-3.45 (3H, m), 3.32-2.30 (2H,m), 2.80-1.56 (1 1H,m), 1.21 (3H,t,J = 7.0H)。 -562- 本纸乐尺度通甩中國a家標隼(CNS) 公瘦) (請先父讀背云之注意事項再填芎,5貝)[15,95 (2,5,3 3) 6,10-Difluorenyl-sense (2-ethoxy-5-ketotetrahydrofuran · 3-yl) -9- (4-hydroxyfluorenyl) amine -1,2,3,4,7,8,9,10-octaargon · 6Η-dapyrido [l, 2-a] [l, 2] diazapyridine-1-carboxamide (550ρ ), Prepared according to a similar method of compound 213e to produce a mixture of diastereoisomeric compounds as a white foam (820 mg, 47%): [ubiquitous] 〇24 -75 ° (c 0.16, CH2C12); IR ( KBr) 3401, 2937, 1791, 1657, 1609, 1539, 1505, 1423, 1277, 1177, Π18; lH NMR (CDCI3) ά 8.07-8.05 (1H, m), 7.67 (2H? D, J = 7.9), 7.38-7.29 (2H, m), 6.80 (2H, d, J = 8.5), 5.49 (0.5H, d, J = 4.6), 5.23 (0.5H, bs), 5.24-5.20 (1H, m), 5.12 -5.08 (1H, m), 4.68-4.29 (2H, m), 3.92-3.45 (3H, m), 3.32-2.30 (2H, m), 2.80-1.56 (1 1H, m), 1.21 (3H, t , J = 7.0H). -562- Chinese paper scales are sold through a Chinese family standard (CNS) (thin, please read the precautions of the back of your father before filling in, 5 shells)

1235157 AT Β7 五、發明説明(56〇) Ο Ο1235157 AT Β7 V. Description of the invention (56〇) Ο Ο

(請先閲讀背VB之注意事項再填寫本頁) 裝 經濟部中夬糅华局員工消費合作枉印裝(Please read the precautions of VB before filling out this page)

化合物 R 503a 504a 286 00 503b 504b Me Vo 505b 503c 504c 505c OPh 503d 504d 505d XT -563- 本.¾¾尺度通用中国國家標洋(CNS ) Μ汊洛(2[0:&lt;57公釐) 訂 4 1235157 Λ 7 Β7 五、發明説明(561 ) 503β 504e 505βCompound R 503a 504a 286 00 503b 504b Me Vo 505b 503c 504c 505c OPh 503d 504d 505d XT -563- Ben. ¾ ¾ standard China National Standard Ocean (CNS) Mello (2 [0: &lt; 57 mm) Order 4 1235157 Λ 7 Β7 V. Description of the invention (561) 503β 504e 505β

[35,411(15,93)3-(6,10-二酮基-9-甲烷磺醯基胺基-1,2,3,4,7, 8,9,10-八氫-6H-嗒哜並[l,2·a][l,2]二氮雜蕈-l-羧醯胺基)-4-羥基-5-(1-莕甲醯基氧基)戊酸第三-丁酯(503a),以(213e) 之方法,製備自212b及(3S,4R)(N-烯丙氡羰基)-3-胺基-4-羥 基〇-(1-莕甲醯基氧基)戊酸第三·丁酯,可生成533毫克 (81%)的摻白色泡沫:[a]D22-81.4e(c0.5,CH2Ci2);IR (KBr) 3342, 2976, 1719, 1664, 1328, 1278, 1246, 1 153, 1 137 。lH NMR (CDC13) β 8.86 (1H,d, J = 8.4),8·21 (1H,dd,J = 1.3, 7.3), 8.03 (1H, d, J = 8.1), 7.88 (1H, d, J = 8.6), 7.66-7.45 (3H, m), 7.23 (1H, d, J = 8.6), 5.96 (1H, d, J = 9.2), 5.30 (1H, m), 4.59-4.33 (5H, m), 4.24 (1H, m), 3.96 (1H, brd), 3.29 (1H, m), 2.95 (1H, m), 2.93 (3H, s), 2.69-2.50 (3H, m), 2.36 (1H, m), 1.96 (4H, m), 1.62 (1H,m), 1·41 (9H,s)。分析 C31H40N4Ol0S-0.25H2O之計算値·· C, 55·97; Η, 6·14; N,8.42 3 實測値:C,55·90; Η, 6.11; Ν,8.23 a M.S. (ES+) 683 (M+Na, 經濟部中夬標牵局負工消費合作社印¾ 100%), 661 (M+l,39),605 (78)。 [3S(1S,9S) 3-(6,10-二酮基-9-甲烷磺醢胺基-1,2,3,4,7,8,9,10· 八氫-6H-嗒啩並[l,2-a][l,2]二氮雜苯-1-羧醯胺基)·5-(1-莕 甲醯基氧基)-4-酮基戊酸第三-丁酯(504a) ’利用由21〜製 備216e之方法,合成自503a,可生成446毫兄(91%)的蜂巴 -564- 本紙佚尺度通用ta國家標準(CNS).A4蚬格(21〇八297公釐) 1235157 A 7 . _B7___ _ 五、發明説明(562) _ 泡沫:〇]D21 -111.6。(c 0.5, CH2、tl2); IR (KBr) 33 19, 2978, 2936, 1723, 1670, 1413, 1370, 1329, 1278, 1246, 1 153 ^ ιΗ NMR (CDC13) ά 8.87 (1H, d, J = 8.9), 8.29 (1H, d, J = 7.2); 8.06 (1H, d, J = 8.3), 7.90 (1H, d, J = 8.2), 7.66-7.48 (3H, m), 7.37 (1H, d, J = 8.1), 5.61 (1H, d, J = 9.0), 5.31 (1H, m), 5.22 (1H, AB, J = 16.9), 5.09 (1H, AB, J = 16.92), 4.99 (1H? m), 4.65-4.43 (2H, m), 3.28 (1H, m), 2.96 (3H, s), 2.86 (2H, m), 2.59 (1H, m), 2.38 (1H, dd, J = 6.8, 13.2), 2.21-1.70 (6Hy m), 1.45 (9H, s)。分析C3lH33N4Ol0S-0.25H2O之計算値·· C, 56.14; Η, 5·85; N,8.45。實測値:C,56.11; Η, 5·83; N, 8.29,M.S· (ES.) 657 (M-l,100%) 3 [3S(1S,9S) 3-(6,10-二酮基-9-甲烷磺醯基胺基-1,2,3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-卜羧醯胺基)-5-(1-莕甲醯基氧基)-4-酮基戊酸(286),以21 7之方法製備自504a ,可生成356毫克(93%)的白色粉末:mp· 120-123°C; [a]D23 -121。(c 0·194, CH2C12); IR (KBr) 3314, 2937, 1722, 1663, 1412, 1328, 1278, 1245, 1 195, 1132。lH NMR (d6-DMS〇)o' 12.63 (1H, brs), 8.94 (1H, d, J = 7.4), 8.78 (1H, d, J = 8.6),[35,411 (15,93) 3- (6,10-diketo-9-methanesulfonylamino-1,2,3,4,7, 8,9,10-octahydro-6H-da And [l, 2 · a] [l, 2] diazepine-l-carboxamido) -4-hydroxy-5- (1-methylformyloxy) valeric acid tert-butyl ester ( 503a), prepared by the method of (213e) from 212b and (3S, 4R) (N-allylfluorenylcarbonyl) -3-amino-4-hydroxy 0- (1-fluorenylmethyloxy) valeric acid Tertiary butyl ester, which can generate 533 mg (81%) of white foam: [a] D22-81.4e (c0.5, CH2Ci2); IR (KBr) 3342, 2976, 1719, 1664, 1328, 1278, 1246, 1 153, 1 137. lH NMR (CDC13) β 8.86 (1H, d, J = 8.4), 8.21 (1H, dd, J = 1.3, 7.3), 8.03 (1H, d, J = 8.1), 7.88 (1H, d, J = 8.6), 7.66-7.45 (3H, m), 7.23 (1H, d, J = 8.6), 5.96 (1H, d, J = 9.2), 5.30 (1H, m), 4.59-4.33 (5H, m) , 4.24 (1H, m), 3.96 (1H, brd), 3.29 (1H, m), 2.95 (1H, m), 2.93 (3H, s), 2.69-2.50 (3H, m), 2.36 (1H, m ), 1.96 (4H, m), 1.62 (1H, m), 1.41 (9H, s). Analysis of the calculation of C31H40N4O10S-0.25H2O ·· C, 55 · 97; Η, 6.14; N, 8.42 3 Found: C, 55 · 90; Η, 6.11; Ν, 8.23 a MS (ES +) 683 (M + Na, Printed by the Ministry of Economic Affairs of the Ministry of Economic Affairs and Consumer Affairs Cooperatives (100%), 661 (M + 1, 39), 605 (78). [3S (1S, 9S) 3- (6,10-diketo-9-methanesulfonamido-1,2,3,4,7,8,9,10 [l, 2-a] [l, 2] Diazabenzene-1-carboxamido) · 5- (1-fluorenylmethyloxy) -4-ketovaleric acid tert-butyl ester ( 504a) 'Using the method from 21 to 216e, synthesized from 503a, it can generate 446 milligrams (91%) of bee bark -564- National Standard (CNS) .A4 grid (2108) Mm) 1235157 A 7. _B7___ _ V. Description of the Invention (562) _ Foam: 〇] D21 -111.6. (C 0.5, CH2, t12); IR (KBr) 33 19, 2978, 2936, 1723, 1670, 1413, 1370, 1329, 1278, 1246, 1 153 ^ Η NMR (CDC13) ά 8.87 (1H, d, J = 8.9), 8.29 (1H, d, J = 7.2); 8.06 (1H, d, J = 8.3), 7.90 (1H, d, J = 8.2), 7.66-7.48 (3H, m), 7.37 (1H, d, J = 8.1), 5.61 (1H, d, J = 9.0), 5.31 (1H, m), 5.22 (1H, AB, J = 16.9), 5.09 (1H, AB, J = 16.92), 4.99 (1H ? m), 4.65-4.43 (2H, m), 3.28 (1H, m), 2.96 (3H, s), 2.86 (2H, m), 2.59 (1H, m), 2.38 (1H, dd, J = 6.8 , 13.2), 2.21-1.70 (6Hy m), 1.45 (9H, s). Analysis of the calculation of C3lH33N4O10S-0.25H2O 値 · C, 56.14; Η, 5.85; N, 8.45. Found 値: C, 56.11; Η, 5.83; N, 8.29, MS · (ES.) 657 (Ml, 100%) 3 [3S (1S, 9S) 3- (6,10-diketo-9 -Methanesulfonylamino-1,2,3,4,7,8,9, 10-octahydro-6H-dapyridine [l, 2-a] [l, 2] diazepine-Bu Carboxamido) -5- (1-methylformamyloxy) -4-ketovaleric acid (286), prepared from 504a by 217 method, can produce 356 mg (93%) of white powder: mp 120-123 ° C; [a] D23 -121. (C 0 · 194, CH2C12); IR (KBr) 3314, 2937, 1722, 1663, 1412, 1328, 1278, 1245, 1 195, 1132. lH NMR (d6-DMS〇) o '12.63 (1H, brs), 8.94 (1H, d, J = 7.4), 8.78 (1H, d, J = 8.6),

M濟部中夬糅準局員工消資合作社印X (請先閃讀背云之注意事項再填寫大二貝) 8.26 (2H, m), 8.11 (1H, d, J = 8.0), 7.77-7.62 (4H, m), 5.28 (2H,s),5.21 (1H,m),4·82 (1H,m), 4.44-4.29 (2H, m),3.31 (1H, m), 2.98 (3H, s), 2.98-2.86 (2H, m), 2.72 (iH, dd? J = 7.3, 16.9),2·40 (1H,m),2.24-1.84 (4H,m),1·69 (2H,m) 3 分 析 C27H30N4Ol0S-H2O 之計算値:C,52·25; H,5.20; N,9.03 3 實測値:C, 52.11; H,4.97; N,8.89。M.S· (ES + ) 601 (M-l, -565 - 本紙法尺度適用中國國家標隼(CNS ) AMt洛(210X 297公笼) &quot;' 1235157 A7 B7 五、發明説明(知) 100%” 、 請 53 讀 背 δ 之 注 意 % 填 寫 太 [3 5,4尺5(15,95)]3-[6,10-二酮基-1,2,3,4,7,8,9,10-八氫-6^1-嗒 呻並[l,2-a][l,2]二氮雜箪-9-(甲烷磺醯胺基)·1-羧醯胺基]-4-羥基-5-(5-曱基-3-笨基異噁唑基氧基)戍酸第三-丁酯 (503b),以類似213e化合物之方法合成,生成摻白色粉末 (671毫克,88%) : mp· 90-12CTC ; IR (KBr) 3345, 2977, 1727, 1664, 1532, 1450, 1423, 1369, 1323, 1310, 1276, 1257, 1154, i iOi, 990, 766; lH NMR (CDC13) ά 7.61-7.55 (2H, m). 7.51- 7.42 (3H, m), 6.86 (1H, d), 5.69 (1H, d), 5.21 (1H, m)? 4.64· 4.38 (2H, m), 4.15-4.05 (3H, m), 3.84 (1H, s), 3.31-3.14 (2H, m), 2.97-2.87 (1H, m), 2.94 (3H, s), 2.76 (3H? s), 2.64-2.48 (3H, m),2.39·2·29 (1H,m), 2.04-1.61 (5H,m)。分析 C3lH4lN50uS.H20之計算値:C,52.46;H,6.U;N,9.87;S, 4.52。實測値·· C,52·34; H,5·92; N,9.56; S,4.44 3 MS (ES—) 714 (47%), 692 (M+ + 1, 84), 636 (100)- Μ濟部中夬糅隼局員工消f合作社印裝M Printed by the Ministry of Economic Affairs of the China Prospective Bureau Consumers Cooperatives X (please read the precautions for the back cloud first and then fill in sophomore) 8.26 (2H, m), 8.11 (1H, d, J = 8.0), 7.77- 7.62 (4H, m), 5.28 (2H, s), 5.21 (1H, m), 4.82 (1H, m), 4.44-4.29 (2H, m), 3.31 (1H, m), 2.98 (3H, s), 2.98-2.86 (2H, m), 2.72 (iH, dd? J = 7.3, 16.9), 2.40 (1H, m), 2.24-1.84 (4H, m), 1.69 (2H, m ) 3 Analyze the calculation of C27H30N4O10S-H2O 値: C, 52 · 25; H, 5.20; N, 9.03 3 Measured 値: C, 52.11; H, 4.97; N, 8.89. MS · (ES +) 601 (Ml, -565-Chinese paper standard (CNS) AMt Luo (210X 297 male cage) is applicable to the standard of this paper) &quot; '1235157 A7 B7 V. Description of the invention (knowledge) 100% ", please 53 Attention% of reading δ Fill in too [3 5,4 feet 5 (15,95)] 3- [6,10-diketo-1,2,3,4,7,8,9,10-eight Hydrogen-6 ^ 1-dapyrido [l, 2-a] [l, 2] diazepine-9- (methanesulfonamido) · 1-carboxyamido] -4-hydroxy-5- (5-fluorenyl-3-benzyl isoxazolyloxy) phosphonium tert-butyl ester (503b) was synthesized in a similar manner to the compound 213e to give a white powder (671 mg, 88%): mp · 90-12CTC; IR (KBr) 3345, 2977, 1727, 1664, 1532, 1450, 1423, 1369, 1323, 1310, 1276, 1257, 1154, i iOi, 990, 766; lH NMR (CDC13) ά 7.61-7.55 (2H, m). 7.51- 7.42 (3H, m), 6.86 (1H, d), 5.69 (1H, d), 5.21 (1H, m)? 4.64 · 4.38 (2H, m), 4.15-4.05 (3H , m), 3.84 (1H, s), 3.31-3.14 (2H, m), 2.97-2.87 (1H, m), 2.94 (3H, s), 2.76 (3H? s), 2.64-2.48 (3H, m ), 2.39 · 2 · 29 (1H, m), 2.04-1.61 (5H, m). Analysis of the calculation of C3lH4lN50uS.H20 値: C, 52.46; H, 6.U; N, 9.87; S, 4.52 Measured 値 ·· C, 52 · 34; H, 5.92; N, 9.56; S, 4.44 3 MS (ES—) 714 (47%), 692 (M + + 1, 84), 636 (100)-Μ Employees of the Ministry of Economic Affairs of China

[3S(1S,9S) 3-[6,10-二酮基-9-(甲烷磺醯胺基)-l,2,3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1·羧醢胺基]-5-(5-甲基-3·苯基異噁唑基氧基)-4-酮基戊酸第三-丁酯(504b), 以類似化合物216b之方法合成,可生成無色粉末(601毫克 ,93%) ·· mp· 75-115X: ; 〇]D23 -104。(c 0.26, CH2C1:); IR (fCBr) 3324, 2977, 2935, 1730, 1670, 1525, 1452, 1422, 1369, 13 17, 1276, 1256, 1222, 1 155, 1 107, 990, 766; lH NMR (CDCl3) o' 7.68-7.61 (2H,m),7.47·7.38 (3H,m), 7.32-7.24 (iH, m), 5.56 (1H, d), 5.36-5.24 (1H, m), 5.04 (1H, d)? 4.88 -566- 本呔汝尺度適用中SS家標準(CNS ) A4現格(210 乂 57公釐) 1235157 Λ/ 五、發明説明(564) (1H, d), 4.86^4.77 (1H, m), 4.64-4.3P (2H? m), 3.32-3.17 (1H? m), 2.97-2.85 (1H, m), 2.93 (3H, s), 2.76 (3H, s), 2.80-2.71 (1H, m), 2.65-2.49 (1H, m), 2.41-2.30 (1H, m), 2.12-1.61 (6H? m),1.42 (9H, s)。分析CsiHwNjOnS.i^O之計算値:C,52.61; H,5·84; N,9.90; S,4.53 ^ 實測値:C,52.94; Η, 5·69; N,9·72; S,4·51,MS (ES+) 712 (31%),707 (100),690 (Μ,+ 1,41), 634 (55)- [3S(1S,9S) 3-[6,10-二酮基-9-甲烷磺醯胺基)-1,2,3,4,7,8,9, 10-八氫·6Η·嗒畊並[l,2-a][l,2]二氮雜箪-1-羧醢胺基]-5-(5-甲基-3-苯基異噁唑基氧基)-4-酮基戊酸(505b),以類似化 合物217之方法合成,可生成無色粉末(499毫克,96%): mp. 95-145°C ; [a]D22 -137° (c 0.12, MeOH); IR (KBr) 3323, 2936, 1732, 1665, 1529, 1452, 1421, 13 12? 1275, 1256, 1221, 1 183, 1 153, 1 135, 1 101, 990; NMR (CD3OD) δ 7.67-7.56 (2H, m), 7.49-7.38 (4H, m), 5.23-5.12 (1H, m), 5.02 (1H, d)? 4.79-4.73 (1H, m), 4.52-4.34 (3H, m), 3.48-3.25 (2H, m), 3.03-2.85 (2H, m), 2.94 (3H, s), 2.74 (3H, s), 2.79-2.66 (1H, m), 2.52-2.38 (1H, m), 2.29-2.14 (1H, m), 2.04-1.70 (4H, m) 。分析 C27H31N50uS‘H20之計算値·· C,49.77;H,5.18;N, 經濟部中央糅寒局員工消费合作社印¾ (請先閱讀背面之洼意事項再填寫本買) 10.75; S, 4.92。實測値:C,49.83; H,5.01; N,10.27; S,4.84 -MS (ES+) 746 (42%), 632 (M - 1, 100), 386 (60)-CyHnNsOnSCMH勹之精確質量計算値:634.18 19。實測 値:634.1807。 bSi4RS(lS,9S) 3-[6,10-二酮基-9-曱烷磺醯胺基)-1,2,3,4,7,8, -567- 本纸伕尺度適用中國國家糅隼(CNS ) 咯(公笼)_ &quot; 1235157[3S (1S, 9S) 3- [6,10-diketo-9- (methanesulfonamido) -1,2,3,4,7,8,9, 10-octahydro-6H- Pyrene [l, 2-a] [l, 2] diazapyrene-1 · carboxamido] -5- (5-methyl-3 · phenylisoxazolyloxy) -4-one Tertiary-butyl valerate (504b), synthesized in a manner similar to compound 216b, can produce a colorless powder (601 mg, 93%) .. mp. 75-115X :; 〇] D23-104. (C 0.26, CH2C1 :); IR (fCBr) 3324, 2977, 2935, 1730, 1670, 1525, 1452, 1422, 1369, 13 17, 1276, 1256, 1222, 1 155, 1 107, 990, 766; lH NMR (CDCl3) o '7.68-7.61 (2H, m), 7.47 · 7.38 (3H, m), 7.32-7.24 (iH, m), 5.56 (1H, d), 5.36-5.24 (1H, m), 5.04 (1H, d)? 4.88 -566- This standard is applicable to SS standards (CNS) A4 (210 乂 57 mm) 1235157 Λ / V. Description of the invention (564) (1H, d), 4.86 ^ 4.77 (1H, m), 4.64-4.3P (2H? M), 3.32-3.17 (1H? M), 2.97-2.85 (1H, m), 2.93 (3H, s), 2.76 (3H, s), 2.80 -2.71 (1H, m), 2.65-2.49 (1H, m), 2.41-2.30 (1H, m), 2.12-1.61 (6H? M), 1.42 (9H, s). Analyze the calculation of CsiHwNjOnS.i ^ O: C, 52.61; H, 5.84; N, 9.90; S, 4.53 ^ Measured: C, 52.94; Η, 5.69; N, 9.72; S, 4 51, MS (ES +) 712 (31%), 707 (100), 690 (M, +1, 41), 634 (55)-[3S (1S, 9S) 3- [6,10-diketo -9-methanesulfonamido) -1,2,3,4,7,8,9,10-octahydro · 6Η · dageno [l, 2-a] [l, 2] diazapine -1-Carboxamidinyl] -5- (5-methyl-3-phenylisoxazolyloxy) -4-ketopentanoic acid (505b), synthesized in a similar manner to compound 217, which can produce colorless Powder (499 mg, 96%): mp. 95-145 ° C; [a] D22 -137 ° (c 0.12, MeOH); IR (KBr) 3323, 2936, 1732, 1665, 1529, 1452, 1421, 13 12? 1275, 1256, 1221, 1 183, 1 153, 1 135, 1 101, 990; NMR (CD3OD) δ 7.67-7.56 (2H, m), 7.49-7.38 (4H, m), 5.23-5.12 (1H , m), 5.02 (1H, d)? 4.79-4.73 (1H, m), 4.52-4.34 (3H, m), 3.48-3.25 (2H, m), 3.03-2.85 (2H, m), 2.94 (3H , s), 2.74 (3H, s), 2.79-2.66 (1H, m), 2.52-2.38 (1H, m), 2.29-2.14 (1H, m), 2.04-1.70 (4H, m). Analysis of the calculation of C27H31N50uS ‘H20 C · C, 49.77; H, 5.18; N, printed by the Consumer Cooperatives of the Central Government Bureau of the Ministry of Economic Affairs ¾ (Please read the intent on the back before filling in this purchase) 10.75; S, 4.92. Measured: C, 49.83; H, 5.01; N, 10.27; S, 4.84 -MS (ES +) 746 (42%), 632 (M-1, 100), 386 (60) -CyHnNsOnSCMH (accurate mass calculation) : 634.18 19. Found 値: 634.1807. bSi4RS (1S, 9S) 3- [6,10-diketo-9-pyranesulfonamido) -1,2,3,4,7,8, -567- This paper is sized for China. (CNS) slightly (public cage) _ &quot; 1235157

AT B7 ---- ' 五、發明説明(565) _ 9,10-八氯-6H-^ *并並[l,2-a][l,2] — SL 雜本-1-¾¾接基]-4-羥基-5-(2-苯氧基芊醯氧基)戊酸第三-丁酯(5〇3c),以類似 化合物213e之方法合成,可生成無色固體(446毫克,84%) :IR (KBr) 3345, 2976, 2935, 1727, 1664, 1603, 1 535, 1483, 1451,1416, 1395, 1369, 1328, 1297, 1277, 1237, 1 155· 1135. 1076, 990; 755; NMR (CDCi3) ^ 7.98-7.89 (1H, m), 7.55- 7·45 (1H,m), 7·39-7·18 (3H,m),7.14-7.07 (1H,m),7.00-6.90 (3H,m),6·75 (1H, d), 5·57〇·50-(1Η,m),5.21-5.09 (1H,m), 4.64-4.42 (2H, m), 4.36-4.12 (3H, m), 3.95-3.87 (1H, m), 3.39-3.18 (1H, m), 3.00-2.82 (1H, m), 2.95 (3H, s), 2.69-2.48 (3H, m), 2.42-2.28 (1H,m), 2.07-1.62 (6H,m), 1.42 (9H,s)。 分析之計算値:C,54·99; Η, 6·15; N,7.77; S, 4.45 3 實測値:C,54·95; H,5·95; N,7·34; S,4.20。MS (ES + ) 725 (26%),720 (47), 703 (M+ + 1,34), 433 (100),403 (89) 3 經濟部中夬標孳局員工消斧合作社印裝 (請先聞讀背δ之注意事項再填寫本一貝) [33(15,95)3-[6,10-二酮基-9-甲烷磺醯基胺基)-1,2,3,4,7,8,9, 10-八氩-6H-嗒畊並[l,2-a][l,2]二氮雜箪-1-羧醯胺基]-4·酮 基〇-(2-苯氧基;醯氧基)戊酸第三-丁酯(504c),以類似化 合物216e之方法合成,可生成無色粉末:mp. 85-10CTC; [^]D22 -91.3° (c 0.52, CH2C12); IR (KBr) 332S, 2978, 2935, 1732, 1669, 1603, 1524, 1483, 1450, 1396, 1369, 1296? 1276, 1237, 1 155, 1 132, 1082, 989, 755; lH NMR (CDC13) δ 8.03- 7.98 (1H, m), 7.52-7.44 (1H, m), 7.37-7.07 (5H, m)7 7.01-6.92 (3H, m), 5.52 (1H, d), 5.28-5.20 (1H, m), 5.06-4.84 (3H, m), • 568 - 本纸乐尺度逑用中國g家標华(CNS ) AW.t格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(566 ) 4.64-4.39 (2H, m), 3.32-3.14 (1H, m'), 2.99-2.88 (1H, m), 2.94 (3H, s), 2.65-2.45 (2H, m), 2.39-2.29 (1H, m), 2.12-1.58 (6H, m), 1·40 (9H,s) 3 分析 CuHwNPnS之計算値:C,56.56; H, 5.75; N,8.00; S,4.58 ^ 實測値:C,56.37; H,5.84; N, 7.69; S, 4.37。MS (ES” 723 (30%),718 (100),701 (NT + 1,23),645 (59” · [3S(1S,9S) 3-[6,10-二酮基·9-甲烷磺醯基胺基)·1,2,3,4,7,8,9, 10-八氫·6Η-嗒啩並[l,2-a][l,2]二氮雜箪-1·羧醴胺基]-4-酮 基〇-(2-笨氧基芊醯氧基)戊酸(505c),以類似化合物21 7之 方法合成,可生成無色泡沫(252毫克,72%):1^.90-125 ; [^]D23 -1333 (c 0.11, MeOH); IR (KBr) 33 14, 2938, 1 792, 1734, 1663, 1604, 1535, 1483, 1448, 1415, 1250? 1 132, 756; lH NMR (d6-DMSO) ά 8.81-8.76 (1H, m), 7.92 (1H, d), 7.68- 7.54 (2H, m), 7.41-7.25 (3H, m), 7.16-6.91 (4H, m), 5.13-4.98 (2H, m), 4.72-4.63 (1H, m), 4.37-4.21 (2H, m), 2.92 (3H, s), 2.90-2.60 (3H, m), 2.35-2.26 (1H, m), 2.17^2.05 (2H, m), 1.99-1.08 (2H, m), 1.61-1.50 (1H, m)。分析 之計算値:C,53.29;H,5.09; N, 8.57; 經濟部中央標並局員工消f合作社印^ (請先聞讀背S之注意事項再填寫本頁) S,4.90,實測値:C,53.57;H,5.18;N,8.32:S,4.75。MS (ES + ) 643 (M - 1,100%” [3 5,4115(15,95)3-1;6,10-二酮基-9-甲烷磺醯基胺基)-1,2,3,4, 7,8,9,10-八氫-6H-嗒畊並[l,2-a][1,2】二氮雜箪-1-羧醯胺基ΙΑ-羥基 -5-(3-笨氧基芊醢氧基) 戍酸第三-丁酯 (5〇3d) , 以類 似化合物213e之方法合成,可生成無色固體(563毫克, -569- 本纸乐尺度適沔中S3家標隼(CNS ) A4迖格U10X 297公.$ ) 1235157 Λ7 B7 五、發明説明(567 ) 90%) : IR (KBr) 3349, 2978, 2935,1724, 1664, 1583, 1536,AT B7 ---- 'V. Description of the invention (565) _ 9,10-octachloro-6H- ^ * Bin [l, 2-a] [l, 2] — SL heteroben-1-¾¾ ] -4-Hydroxy-5- (2-phenoxyfluorenyloxy) tert-butyl valerate (503c), synthesized in a similar manner to compound 213e, to give a colorless solid (446 mg, 84%) ): IR (KBr) 3345, 2976, 2935, 1727, 1664, 1603, 1 535, 1483, 1451, 1416, 1395, 1369, 1328, 1297, 1277, 1237, 1 155 · 1135. 1076, 990; 755; NMR (CDCi3) ^ 7.98-7.89 (1H, m), 7.55-7.45 (1H, m), 7.39-7 · 18 (3H, m), 7.14-7.07 (1H, m), 7.00-6.90 (3H, m), 6.75 (1H, d), 5.570.50- (1Η, m), 5.21-5.09 (1H, m), 4.64-4.42 (2H, m), 4.36-4.12 ( 3H, m), 3.95-3.87 (1H, m), 3.39-3.18 (1H, m), 3.00-2.82 (1H, m), 2.95 (3H, s), 2.69-2.48 (3H, m), 2.42- 2.28 (1H, m), 2.07-1.62 (6H, m), 1.42 (9H, s). Analysis calculation 値: C, 54 · 99; Η, 6.15; N, 7.77; S, 4.45 3 Measured 値: C, 54 · 95; H, 5.95; N, 7.34; S, 4.20. MS (ES +) 725 (26%), 720 (47), 703 (M + + 1, 34), 433 (100), 403 (89) First read the precautions for reading δ, then fill out this one) [33 (15,95) 3- [6,10-diketo-9-methanesulfonamido) -1, 2, 3, 4, 7,8,9, 10-octaargon-6H-da-phen [l, 2-a] [l, 2] diazapyridine-1-carboxamido] -4 · keto-0- (2- Phenoxy; fluorenoxy) tert-butyl valerate (504c), synthesized in a similar manner to compound 216e, can produce colorless powder: mp. 85-10CTC; [^] D22 -91.3 ° (c 0.52, CH2C12 ); IR (KBr) 332S, 2978, 2935, 1732, 1669, 1603, 1524, 1483, 1450, 1396, 1369, 1296? 1276, 1237, 1 155, 1 132, 1082, 989, 755; lH NMR (CDC13 ) δ 8.03- 7.98 (1H, m), 7.52-7.44 (1H, m), 7.37-7.07 (5H, m) 7 7.01-6.92 (3H, m), 5.52 (1H, d), 5.28-5.20 (1H , m), 5.06-4.84 (3H, m), • 568-The paper scale uses Chinese g standard Chinese (CNS) AW.t grid (210X 297 mm) 1235157 Λ7 B7 V. Description of the invention (566) 4.64-4.39 (2H, m), 3.32-3.14 (1H, m '), 2.99-2.88 (1H, m), 2.94 (3H, s), 2.65-2.45 (2H, m), 2.39-2.29 (1H, m), 2.12-1.58 (6H, m), 1.40 (9H, s) 3 Calculation of CuHwNPnS analysis: C, 56.56; H, 5.75; N, 8.00; S, 4.58 ^ Actual measurement: C , 56.37; H, 5.84; N, 7.69; S, 4.37. MS (ES "723 (30%), 718 (100), 701 (NT + 1,23), 645 (59" · [3S (1S, 9S) 3- [6,10-diketo · 9-methane Sulfonylamino) · 1,2,3,4,7,8,9,10-octahydro · 6Η-Da [1,2-a] [l, 2] Diazapyrene-1 · Carboxylamido] -4-keto 0- (2-benzyloxyfluorenyloxy) pentanoic acid (505c) was synthesized in a similar manner to compound 21 7 to produce a colorless foam (252 mg, 72%): 1 ^ .90-125; [^] D23 -1333 (c 0.11, MeOH); IR (KBr) 33 14, 2938, 1 792, 1734, 1663, 1604, 1535, 1483, 1448, 1415, 1250? 1 132 , 756; lH NMR (d6-DMSO) ά 8.81-8.76 (1H, m), 7.92 (1H, d), 7.68- 7.54 (2H, m), 7.41-7.25 (3H, m), 7.16-6.91 (4H , m), 5.13-4.98 (2H, m), 4.72-4.63 (1H, m), 4.37-4.21 (2H, m), 2.92 (3H, s), 2.90-2.60 (3H, m), 2.35-2.26 (1H, m), 2.17 ^ 2.05 (2H, m), 1.99-1.08 (2H, m), 1.61-1.50 (1H, m). Calculation of analysis: C, 53.29; H, 5.09; N, 8.57; The staff of the Central Ministry of Economic Affairs and the Bureau of the People ’s Republic of China shall cancel the cooperative seal ^ (please read the precautions of S before filling in this page) S, 4.90, measured 値: C, 53.57; H, 5.18; N, 8.32: S, 4.75. MS (ES +) 643 (M-1, 10 0% "[3 5,4115 (15,95) 3-1; 6,10-diketo-9-methanesulfonylamino) -1,2,3,4,7,8,9,10 -Octahydro-6H-da-pheno [l, 2-a] [1,2] diazapyridine-1-carboxyamidoamino 1A-hydroxy-5- (3-benzyloxyfluorenyloxy) hydrazone Acid tert-butyl ester (503d), synthesized in a similar manner to compound 213e, can produce a colorless solid (563 mg, -569- this paper scale is suitable for S3 house standard (CNS) A4 grid U10X 297 ($.) 1235157 Λ7 B7 V. Description of the invention (567) 90%): IR (KBr) 3349, 2978, 2935, 1724, 1664, 1583, 1536,

請 声 % 讀 背 意 % 再 填 % 太 I 1489, 1443, 1370, 1327, 1271, 1226, 1 189, 1 155, 1073, 990, 755; lH NMR (CDC13) ό' 7.77 (1H, d), 7.67 (1H, m), 7.45- 7.10 (6H, m), 7.00 (2H? d), 5.93-5.80 (1H, m), 5.36-5.30 (1H, m), 4.63-4.24 (5H, m), 4.15-4.09 (1H, m)? 3.37-3.22 (1H, m), 2.98-2.74 (1H, m), 2.94 (3H, s), 2.70-2.47 (3H? m), 2.40-2.30 (1H,m),2.15-1.60 (5H, m),1.42 (9H, s) 3 分析 之計算値:C,54.99; H,6.15; N,7.77; S, 4.45。實測値:C,54.60; H,5.88; N,7.49; S,4.50。MS (ES + ) 725 (19%),720 (91),703 (M+ + 1, 74),647 (76),629 (100), 433 (78)。 [3S(1S,9S) 3-[6,10-二酮基-9-甲烷磺醯胺基)-1,2,3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺基酮 基- 5-(3-苯氧基+睡氧基)戊酸第三·丁 g旨(504 d),以類似化 合物216e之方法合成,可生成無色粉末(466毫克,85%) ·· mp. 175-160eC ; [α]Ό22 -99.3 ° (c 0.60, CH2C12); IR (KBr) 3335, 2978, 2937, 1728, 1669, 1584, 1525, 1487, 1444· 1416, 1369, 1328, 1272, 1227, 1 188, 1 155, 989, 754; lH NMR (CDCi3) δ 7.82-7.77 (1H, m), 7.66-7.65 (1H, m), 7.46-7.32 經濟部t夬標隼局員工消费合作杜印¾ (4H, m), 7.26-7.10 (2H, m), 7.04-6.98 (2H, m), 5.68 (lH, d)? 5.37-5.31 (1H, m), 5.11 (1H, d), 5.02-4.88 (2H, m), 4.66-4.42 (2H, m), 3.35-3.17 (1H, m), 2.98-2.89 (1H, m), 2.96 (3H, s), 2.84-2.78 (1H, m), 2.72-2.47 (1H, m), 2.42-2.32 (lH, m), 2.14-1.58 (6H,m), 1.43 (9H, s) a 分析 C^HwI^OnS之計算値 -570- 本纸乐尺度適用中國国家標李(CNS ) Μ堤格(2丨〇,&lt;297公慶) 1235157 Λ 7Please %% memorize %% and then fill in% too I 1489, 1443, 1370, 1327, 1271, 1226, 1 189, 1 155, 1073, 990, 755; lH NMR (CDC13) ό '7.77 (1H, d), 7.67 (1H, m), 7.45- 7.10 (6H, m), 7.00 (2H? D), 5.93-5.80 (1H, m), 5.36-5.30 (1H, m), 4.63-4.24 (5H, m), 4.15-4.09 (1H, m)? 3.37-3.22 (1H, m), 2.98-2.74 (1H, m), 2.94 (3H, s), 2.70-2.47 (3H? M), 2.40-2.30 (1H, m ), 2.15-1.60 (5H, m), 1.42 (9H, s) 3 Calculations for analysis: C, 54.99; H, 6.15; N, 7.77; S, 4.45. Found 値: C, 54.60; H, 5.88; N, 7.49; S, 4.50. MS (ES +) 725 (19%), 720 (91), 703 (M + + 1, 74), 647 (76), 629 (100), 433 (78). [3S (1S, 9S) 3- [6,10-diketo-9-methanesulfonamido) -1,2,3,4,7,8,9, 10-octahydro-6H-da Benzene [l, 2-a] [l, 2] diazepine-1-carboxamido-keto- 5- (3-phenoxy + phenyloxy) valeric acid d), synthesized by a method similar to compound 216e, which can produce colorless powder (466 mg, 85%) ·· mp. 175-160eC; [α] Ό22 -99.3 ° (c 0.60, CH2C12); IR (KBr) 3335, 2978, 2937, 1728, 1669, 1584, 1525, 1487, 1444-1416, 1369, 1328, 1272, 1227, 1 188, 1 155, 989, 754; lH NMR (CDCi3) δ 7.82-7.77 (1H, m) , 7.66-7.65 (1H, m), 7.46-7.32 Employee Consumption Cooperation of the Ministry of Economic Affairs of the Ministry of Economic Affairs, Du Yin ¾ (4H, m), 7.26-7.10 (2H, m), 7.04-6.98 (2H, m), 5.68 (lH, d)? 5.37-5.31 (1H, m), 5.11 (1H, d), 5.02-4.88 (2H, m), 4.66-4.42 (2H, m), 3.35-3.17 (1H, m), 2.98-2.89 (1H, m), 2.96 (3H, s), 2.84-2.78 (1H, m), 2.72-2.47 (1H, m), 2.42-2.32 (lH, m), 2.14-1.58 (6H, m ), 1.43 (9H, s) a Analysis of the calculation of C ^ HwI ^ OnS 値 -570- The paper scale is applicable to the Chinese national standard plum (CNS) Μ Tegge (2 丨 〇, &lt; 297 public celebration) 1235157 Λ 7

五、發明説明( 568 ) - :C,56·56; Η, 5·75; Ν, 8.00。實測、値·· C,56.36; Η· 5.82;义 7.71。MS (ES+) 723 (56%),718 (90),701 (NT + 1,36),645 (100” [3S(1S,9S) 3-[6,10-二酮基-9-(曱烷磺醯胺基)-1,2,3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯胺基]-4-納 基-5·(3-苯氧基芊醯氧基)戊酸(505d),以類似化合物217之 方法合成,生成無色泡沫(353毫克,73%) : mp· 80-11 5C; [a]D23 -138° (c 0.11, MeOH); IR (KBr) 3327, 2937, 1728, 1666, 1584, 1529, 1487, 1443, 1413, 1328, 1273, 1227· 1189, 訂 經濟部中夬標準局員X消费合作社印裝 1 155, 1 134, 989, 754; lE NMR (D6-DMSO) 0' 8.82 (1H, d), 7.76-7.72 (1H, m), 7.61-7.53 (2H, m), 7.48-7.32 (4H, m), 7.24-7.17 (1H, m), 7.11-7.06 (2H, m), 5.14O.06 (3H, m), 4.73-4.64 (1H, m), 4.38-4.24 (2H, m)t 2.92 (3H, s), 2.89-2.61 (3H, m), 2.38-2.27 (1H, m), 2.19-2.06 (2H, m), 2.02-1.79 (3H, m), 1.63-1.52 (1H,m) a 分析CaHnNjOnS-O.SHzO之計算値: C,53.29; Η, 5·09; N,8.57; S, 4.90。實測値:C,53.24; H,5.14; N, 8.34; S, 4.86 ^ MS (ES + ) 643 (M - 1, 100%), 385 (62) ^ [35,4尺(15,95)]5-(3-氣4吩-2-甲醯基氧基)-3-(6,10-二酮基-9-甲烷磺醯胺基)-1,2,3,4,7,8,9,10-八氫-6^1-嗒_並[1,2· a】[l,2】二氮雜箪-卜羧醯胺基)-4-羥基戊酸第三-丁裔(5〇3e) ,以類似化合物213e方法製備,生成摻白色固體(70%): mp. 100-103eC ; [a]D25 -84.0° (c 〇.〇5, CH2Ci2); IR (KBr) 3459-3359, 1722, 1664, 1514, 1368, 1328, 1278, 1247, 1155; lH NMR (CDCi3) ά 7.52 (1H, m), 7.06-6.99 (2H, m), 5.69 _____- 571 - _____ 本紙法尺度通用中国國家標隼(CNS ) A4缇格(2丨0\ 297公;^1 ^ &quot; 1235157 Λ 7 _ Β7___ 五、發明说明(569) . (1H, d, J = 9.0), 5.23 (1H, m), 4.61-4.16 (6H? m), 3.36-3.19 (iH, m), 2.96 (3H, s), 2.67-2.49, 2.42-2.32, 2.06-1.89. 1.69 (10H,4m), 1·43 (9H,s)。 [3S(1S,9S)] 5-(3-氣嘍吩-2-曱醯胺氧基)-3-(6,10·二酮基-9-甲烷磺醯胺基)-1,2,3,4,7,8,9,10-八氫-61^嗒啩並[1,24][1,2] 二氮雜箪-1-羧醢胺基)-4-酮基戊酸第三-丁酯(504e) ’依化 合物216e方法製備,生成白色固體(98%) ·· mp· 91-98 Ό; 〇】D25 -112.5° (c 0.06, CH2C12); IR (KBr) 3453.3364, 1727, 1668, 15 13, 1420, 1368, 1245, 1 155; ιΗ NMR (CDCl3) ^ 7.54 (1Η, d, J = 5.3), 7.18 (1Η, d, J = 7.18), 7.05 (1H, d, J -5.4), 5.42 (1H, d, J = 8.9), 5.25 (1H, m), 5.02 (2H, m), 4.96-4.87 (iH, m), 4.65-4.42 (2H, m), 3.34-3.17 (1H? m), 2.97-2.93 (1H, m), 2.97 (3H, s), 2.87-2.78, 2.73-2.50, 2.38-2.32, 2.13-1.8S, 1.69-1.60 (9H, 5m), 1.44 (9H, s) 0 經濟部中夬標準局員v一消贤合作社印裝 (請先W讀背ώ之注意事項再填寫本頁) [3S(1S,9S)] 5-(3-氣喳吩-2-甲醯氧基)-3-(6,10-二酮基-9-曱 烷磺醯胺基)-1,2,3,4,7,8,9,10-八氫-61^嗒啩並[1,24][丨,2]二 氮雜苯-1-羧醯胺基)-4-酮基戊酸(505e)。217(0.33克,0.51 毫莫耳)於無水二氣甲烷(3毫升)之溶液,在避免水汽下冷 卻(冰/水)3在搜拌下加入三氟醋酸(2毫升)3溶液保持在 室溫下2小時,之後移去冷卻浴,再於眞空下濃縮。殘留 物自二氣甲烷中蒸發三次,以二乙醚研磨再過濾3固體以 快速層析純化(矽膠,0-6%甲醇於二氣甲烷)以生成產物, 呈白色玻璃狀固體(0.296 克,98%) : mp· 100-122°C; [a]D22 -163.5° (c 0.1, CH3OH); IR (KBr) 35 14-3337, 1726, 1664, ___-572- 大成決尺度通颅中3S家標準(CNS ) A4^格(2丨0乂 297公釐) 1235157 B; 五、發明説明(57〇 ) 1513, 1420, 1245, 1152, 1134, 990; 'lU NMR (CD3OD) δ 7.79 (1H, d, J = 5.2), 7.12 (1H, d, J = 5.2), 5.20 (1H, m), 5.02-4.72 (2H, m,由 H20罩護),4.59-4.32 (3H,m),3.48-3.29, 3.08-2.75, 2.50-2.41, 2.3 1-2.22, 2.08-1.89, 1.72-1.63 (1 1H, 6m)? 2:95 (3H, s)。V. Description of the invention (568)-: C, 56.56; Η, 5.75; Ν, 8.00. Measured, 値 · C, 56.36; Η · 5.82; Yi 7.71. MS (ES +) 723 (56%), 718 (90), 701 (NT + 1,36), 645 (100 "[3S (1S, 9S) 3- [6,10-diketo-9- (曱Alkylsulfonylamino) -1,2,3,4,7,8,9,10-octahydro-6H-daparo [l, 2-a] [l, 2] diazapine-1- Carboxylamido] -4-naphthyl-5 · (3-phenoxyfluorenyloxy) pentanoic acid (505d), synthesized in a similar manner to compound 217 to give a colorless foam (353 mg, 73%): mp 80-11 5C; [a] D23 -138 ° (c 0.11, MeOH); IR (KBr) 3327, 2937, 1728, 1666, 1584, 1529, 1487, 1443, 1413, 1328, 1273, 1227 · 1189, Member of the China Standards Bureau of the Ministry of Economic Affairs X Consumer Cooperatives, printed 1 155, 1 134, 989, 754; lE NMR (D6-DMSO) 0 '8.82 (1H, d), 7.76-7.72 (1H, m), 7.61-7.53 (2H, m), 7.48-7.32 (4H, m), 7.24-7.17 (1H, m), 7.11-7.06 (2H, m), 5.14O.06 (3H, m), 4.73-4.64 (1H, m ), 4.38-4.24 (2H, m) t 2.92 (3H, s), 2.89-2.61 (3H, m), 2.38-2.27 (1H, m), 2.19-2.06 (2H, m), 2.02-1.79 (3H , m), 1.63-1.52 (1H, m) a Analysis of CaHnNjOnS-O.SHzO calculation 値: C, 53.29;;, 5.09; N, 8.57; S, 4.90. Measured 値: C, 53.24; H, 5.14; N, 8.34; S, 4.86 ^ MS (ES +) 643 (M- 1, 100%), 385 (62) ^ [35,4 feet (15,95)] 5- (3-Ga4phen-2-methylamidinooxy) -3- (6,10-diketonyl -9-methanesulfonamido) -1,2,3,4,7,8,9,10-octahydro-6 ^ 1-tap_ [1,2, a] [l, 2] diazepine Hetero-p-carboxamido) -4-hydroxyvaleric acid tertiary-butyric acid (503) was prepared in a similar manner to compound 213e to give a white solid (70%): mp. 100-103eC; [a ] D25 -84.0 ° (c 0.05, CH2Ci2); IR (KBr) 3459-3359, 1722, 1664, 1514, 1368, 1328, 1278, 1247, 1155; lH NMR (CDCi3) ά 7.52 (1H, m ), 7.06-6.99 (2H, m), 5.69 _____- 571-_____ The paper standard is common Chinese national standard (CNS) A4 Tig (2 丨 0 \ 297); ^ 1 ^ &quot; 1235157 Λ 7 _ Β7 ___ five Description of the invention (569). (1H, d, J = 9.0), 5.23 (1H, m), 4.61-4.16 (6H? M), 3.36-3.19 (iH, m), 2.96 (3H, s), 2.67 -2.49, 2.42-2.32, 2.06-1.89. 1.69 (10H, 4m), 1.43 (9H, s). [3S (1S, 9S)] 5- (3-Azophen-2-aminoamineoxy) -3- (6,10 · diketo-9-methanesulfonamido) -1,2, 3,4,7,8,9,10-Octahydro-61 ^ Da [1,24] [1,2] Diazapyridine-1-carboxamido) -4-ketovalerate Tri-butyl ester (504e) was prepared according to the method of compound 216e, yielding a white solid (98%) · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ························· , 1668, 15 13, 1420, 1368, 1245, 1 155; ιΗ NMR (CDCl3) ^ 7.54 (1Η, d, J = 5.3), 7.18 (1Η, d, J = 7.18), 7.05 (1H, d, J -5.4), 5.42 (1H, d, J = 8.9), 5.25 (1H, m), 5.02 (2H, m), 4.96-4.87 (iH, m), 4.65-4.42 (2H, m), 3.34-3.17 (1H? M), 2.97-2.93 (1H, m), 2.97 (3H, s), 2.87-2.78, 2.73-2.50, 2.38-2.32, 2.13-1.8S, 1.69-1.60 (9H, 5m), 1.44 ( 9H, s) 0 Member of the China Standards Bureau of the Ministry of Economic Affairs v Yixianxian Cooperative Press (please read the precautions before completing this page) [3S (1S, 9S)] 5- (3- 气 S 苯- 2-methylfluorenyloxy) -3- (6,10-diketo-9-fluoransulfonamido) -1,2,3,4,7,8,9,10-octahydro-61 ^ Da [1,24] [丨, 2] Diazabenzene-1-carboxamido) -4-one Acid (505e). 217 (0.33 g, 0.51 mol) in anhydrous digas methane (3 ml) solution, cool to avoid water vapor (ice / water) 3 add trifluoroacetic acid (2 ml) while searching 3 keep the solution in the room After 2 hours at room temperature, the cooling bath was removed and concentrated under air. The residue was evaporated three times from digas methane, triturated with diethyl ether and filtered. The solid was purified by flash chromatography (silica gel, 0-6% methanol in digas methane) to give the product as a white glassy solid (0.296 g, 98 %): mp100-122 ° C; (a) D22 -163.5 ° (c 0.1, CH3OH); IR (KBr) 35 14-3337, 1726, 1664, ___- 572 Standard (CNS) A4 grid (2 丨 0 乂 297 mm) 1235157 B; V. Description of the invention (57〇) 1513, 1420, 1245, 1152, 1134, 990; '1U NMR (CD3OD) δ 7.79 (1H, d, J = 5.2), 7.12 (1H, d, J = 5.2), 5.20 (1H, m), 5.02-4.72 (2H, m, covered by H20), 4.59-4.32 (3H, m), 3.48- 3.29, 3.08-2.75, 2.50-2.41, 2.3 1-2.22, 2.08-1.89, 1.72-1.63 (1 1H, 6m)? 2: 95 (3H, s).

{請先聞讀背云之注意事項再填寫本一貝) O 0(Please read the precautions of Beunyun before filling in this one) O 0

化合物. R1 506a PhC(O)- 507a 506b MeS(0)2- 507b 506c MeOC(O)- 507c 506g CH3C(0)- 507gCompound. R1 506a PhC (O)-507a 506b MeS (0) 2- 507b 506c MeOC (O)-507c 506g CH3C (0)-507g

經濟部中央標隼局員工消贤合作社印$LPrinted by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

[3 5(15,95)]3-(9-芊醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒啩並[l,2-a】[l,2]二氮雜箪-1-羧醯胺基)-5-偶氮基-4-酮基戊酸第三-丁酯(506a)。212e(321毫克,0.929毫莫耳) -573- 本纸乐尺度通用中國國家標李(CNS ) A4堤格(2丨0 x 297公簦) 1235157 A7 __B7 _ 五、發明説明(571 ) 及(3S) 3-胺基-5-偶氮基-4-酮基戊、'酸第三-丁 (198毫克, 0.929毫莫耳)於二氣曱烷(3毫升)之溶液冷卻至(TC,再加 N,N-二異丙基乙胺(0.16毫升,1.86毫莫耳)及〇(1Βί-苯並 三唑-1-基)-1,1,3,3-四甲基鐳四氟硼酸鹽(3 28毫克,1.02毫 莫耳)3溶液在S溫下授拌一夜,以乙酸乙錯稀釋再以1Μ NaHS04洗滌(x2),NaHC03水溶液(Χ2),鹽水洗滌,於硫酸 銕上乾澡並蒸發3在矽膠上層析並以乙酸乙酯溶雜,可生 成 506a (425毫克,85%)呈無色泡沫:[yD23 -124.9: (c 0.2, CH2C12); IR (KBr) 3332, 21 1 1, 1728, 1658, 1532, 1421· 1392, 1367, 1279, 1256, 1 155; lH NMR (CDC13) δ 7.82 (2H. m)? 7.49 (3H, m), 7.28 (1H, d, J = 9.3), 7.05 (1H, d, J = 7.3), 5.06 (1H, s), 5.18 (2H, m), 4.78 (1H, m), 4.62 (1H, m), 3.29 (1H, m), 3.08-2.79 (3H, m), 2.58 (1H, dd, J = 16.8, 5.6), 2.20-1.85 (4H,m), 1.70 (1H, m),1.45 (9H, s)。MS (ES勹 539.58 (M - 1, 97.9%) 529.59 (100) ^ 經濟部中央標绛局員工消资合作社印¾ [3S(1S,9S)] 5-偶氮基-3-[6,10-二酮基-(9-甲浣磺醯按基)-1,2,3,4,7,8,9,10-八氫-6«^嗒啩並[1,24][1,2]二氮雜苯-卜羧 醯胺基]-4-酮基戊酸第三·丁酯(506b),以類似化合物506a 之方法製備。74%呈黃橘色固體:mp· 75eC(分解);[立]D20 -92.0° (c 0.036, CH2C12); IR (KBr) 3438, 2904, 21 13, 1728, 1669, 1523, 1368, 1328, 1 155; lH NMR (CDCi3) ά 7.48 (1H? d, J = 8.1), 5.83-5.68 (iH, m,), 5.55-5.50 (1H, m), 5.43-5.14 (iH, m), 4.83-4.45 (3H, m), 3.40-3.19 (1H, m), 2.98 (3H? s), 2.92-2.30 (4H, m), 2.24-1.70 (6H, m), 1.43 (9H, s) ^ -574- 本纸浪尺度適用中S國家標隼(CNS ) /\4見洛(210_'&lt; 297公变&gt; 經濟部中夬焓华局員工消費合作枉印笈 1235157 Λ7 B7 五、發明説明(572) [35(15,95)】5-偶氮基-3-[6,10-二酮、基-(9-甲氧基羰基)胺基-1,2,3,4,7,8,9,10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜苯-1-羧 醯胺基]-4-酮基戊酸第三-丁酯(5〇6c),依類似化合物506a 之方法製備。可生成淺黃色泡沫(405毫克,82%):[以]〇2() -144° (c 0.2, CH2Ci2); IR (KBr) 3339, 2978, 2958, 21 12, 1728, 1674, 1530, 1459, 1415, 1367, 1274, 1252, 1 154, 1063; lH NMR (CDC13) ά 7.23 (1H, d, J = 8.2), 5.51-5.31 (2H, m), 5.21-5.16 (1H, m), 4.77-4.55 (3H, m), 3.68 (3H, s), 3.35-3.18 (1H? m), 3.04-2.51 (4H, m), 2.40-2.30 (1H, m), 2.09-1.66 (5H, m),1.45 (9H,s) 3 MS (ES+) 493。 [3 5(15,95)】3-(9-乙醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒啩並[l,2-a】[l,2]二氮雜箪-1-羧醯胺基)-5-偶氮基-4-酮基戍酸第三-丁酯(506g),以類似化合物506a之方法製 備。81% : [a】D28,146.7。(c 0.4, CH2C12); IR (KBr) 3438, 2904, 21 13, 1728, 1669, 1523, 1368, 1328, 1 155;NMR (CDCI3) δ 7.32 (1H, d), 6.43 (1H, d), 5.50 (1H, s), 5.22 (1H? m),4.94 (1H,m),4.77 (1H,m),4.60 (1H,m),3.24 (1H· m), 3.03-2.52 (4H,m), 2.36 (1H, m),2.10-1.64 (5H, m),2.02 (3H, s), 1.45 (9H,s)。分析C2〖H20N6O7之計算値:c,52·69; H, 6.32; N,17.05,實測値:C,52·51; Η, 6·27; N,17.36 3 MS (ES’) 477 (M+ - i, 100%) 0 [3S(1S,9S) 5-溴-3-(9-芊醯胺基-6,l〇-二酮基 10-八氫-6H-嗒啡並[l,2-a][l,2]二氮雜箪·1-羧隨胺基M-酮 基戊酸第三-丁酯(507a) 3 506a (3.0克,5 55毫莫耳)於無水 -575 - 衣哚疚尺度逋用中国国家標莩(CNS )以逯格(210X297公釐) (诗先閱请背^之注意事項再填寫本f ) 裝 訂 1235157 A 7 B7 五、發明説明(573 ) 二氯甲烷(40毫升)冷卻至〇°C,再、以4分鐘逐滴加入3〇%氯 溴酸於醋酸(1.1毫升,5.55毫莫耳)。浥合物〇1下攬掉9分 鐘,再以碳酸氫鈉水溶液中止3產物以乙酸乙酯萃取,以 碳酸氫鈉水溶液,鹽水洗滌,乾燥(MgS04)並蒸發可生成 2·97克(92%)的無色泡沫:1&gt;]D23 -82.3° (c 0.23, CH2C1,); IR (KBr) 3 3 33, 1726, 1659, 1530, 1458, 1447, 1422, 1395, 1368, 1279, 1256, 1222, 1 155, 728; ιΗ NMR (CDC13) ο 7.81 (2Η, m), 7.50 (3Η, m), 7.11 (1Η: d, J - 8.0), 7.01 (1H, d, J -7.4), 5.20 (2H, m), 5.00 (1H, m), 4.06 (2H, s), 3.28 (1H? m), 3.20-2.70 (4H, m), 2.42 (1H, m), 2.10-1.85 (4H, m), 1.72 (1H, m),1.44(9H,s)。分析 C26H33N4O7Br.0.7H2〇之計算値:C, 51.35; H,5·72; N,9.24。實測値:C,51.55; H,5·52; N,9.09。 MS (ES+) 595, 593 (M+ + 1)。[3 5 (15,95)] 3- (9-fluorenylamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro-6H-da And [l, 2-a] [l, 2] diazafluoren-1-carboxamido) -5-azo-4-ketopentanoic acid tert-butyl ester (506a). 212e (321 mg, 0.929 millimoles) -573- This paper scale is universal Chinese national standard plum (CNS) A4 Tige (2 丨 0 x 297 gong) 1235157 A7 __B7 _ V. Description of the invention (571) and ( 3S) A solution of 3-amino-5-azo-4-ketopentyl, tertiary-butyric acid (198 mg, 0.929 mmol) in dioxane (3 ml) was cooled to (TC, Add N, N-diisopropylethylamine (0.16 ml, 1.86 mmol) and 〇 (1Βί-benzotriazol-1-yl) -1,1,3,3-tetramethyl radium tetrafluoro Borate (3 28 mg, 1.02 mmol) was stirred overnight at S temperature, diluted with ethyl acetate and washed with 1M NaHS04 (x2), NaHC03 aqueous solution (X2), brine, and dried over sulphuric acid. Bath and evaporate. 3 Chromatography on silica gel and dissolving with ethyl acetate can produce 506a (425 mg, 85%) as a colorless foam: [yD23 -124.9: (c 0.2, CH2C12); IR (KBr) 3332, 21 1 1, 1728, 1658, 1532, 1421 · 1392, 1367, 1279, 1256, 1 155; lH NMR (CDC13) δ 7.82 (2H. M)? 7.49 (3H, m), 7.28 (1H, d, J = 9.3), 7.05 (1H, d, J = 7.3), 5.06 (1H, s), 5.18 (2H, m), 4.78 (1H, m), 4.62 (1H, m), 3.29 (1H , m), 3.08-2.79 (3H, m), 2.58 (1H, dd, J = 16.8, 5.6), 2.20-1.85 (4H, m), 1.70 (1H, m), 1.45 (9H, s) .MS (ES 勹 539.58 (M-1, 97.9%) 529.59 (100) ^ Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs [3S (1S, 9S)] 5-Azo-3- [6, 10- Diketo- (9-methylsulfenylpyridinyl) -1,2,3,4,7,8,9,10-octahydro-6 «^ Da 啩 [1,24] [1,2] Diazabenzene-carboxamido] -4-ketovaleric acid tert-butyl ester (506b), prepared in a similar manner to compound 506a. 74% yellow-orange solid: mp 75eC (decomposition); [Li] D20 -92.0 ° (c 0.036, CH2C12); IR (KBr) 3438, 2904, 21 13, 1728, 1669, 1523, 1368, 1328, 1 155; lH NMR (CDCi3) ά 7.48 (1H? D, J = 8.1), 5.83-5.68 (iH, m,), 5.55-5.50 (1H, m), 5.43-5.14 (iH, m), 4.83-4.45 (3H, m), 3.40-3.19 (1H, m) , 2.98 (3H? S), 2.92-2.30 (4H, m), 2.24-1.70 (6H, m), 1.43 (9H, s) ^ -574- The national standard (CNS) / \ 4See Luo (210 _ '&lt; 297 Public Transformers &gt; Consumption Cooperation between Employees of the Central China Enthalpy and War Bureau, Ministry of Economic Affairs 枉 1235157 Λ7 B7 V. Description of Invention (572) [35 (15,95)] 5-Azo -3- [6 10-diketone,-(9-methoxycarbonyl) amino-1,2,3,4,7,8,9,10-octahydro-6H-dapyrido [l, 2-a] [ 1,2] Diazabenzene-1-carboxamido] -4-ketovaleric acid tert-butyl ester (506c) was prepared in a similar manner to compound 506a. Can produce light yellow foam (405 mg, 82%): [to] 〇2 () -144 ° (c 0.2, CH2Ci2); IR (KBr) 3339, 2978, 2958, 21 12, 1728, 1674, 1530, 1459 , 1415, 1367, 1274, 1252, 1 154, 1063; lH NMR (CDC13) ά 7.23 (1H, d, J = 8.2), 5.51-5.31 (2H, m), 5.21-5.16 (1H, m), 4.77 -4.55 (3H, m), 3.68 (3H, s), 3.35-3.18 (1H? M), 3.04-2.51 (4H, m), 2.40-2.30 (1H, m), 2.09-1.66 (5H, m) , 1.45 (9H, s) 3 MS (ES +) 493. [3 5 (15,95)] 3- (9-acetamido-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6H-da And [l, 2-a] [l, 2] diazepine-1-carboxamido) -5-azo-4-ketoacetic acid tertiary-butyl ester (506g), with similar compounds 506a. 81%: [a] D28, 146.7. (C 0.4, CH2C12); IR (KBr) 3438, 2904, 21 13, 1728, 1669, 1523, 1368, 1328, 1 155; NMR (CDCI3) δ 7.32 (1H, d), 6.43 (1H, d), 5.50 (1H, s), 5.22 (1H? M), 4.94 (1H, m), 4.77 (1H, m), 4.60 (1H, m), 3.24 (1H · m), 3.03-2.52 (4H, m) , 2.36 (1H, m), 2.10-1.64 (5H, m), 2.02 (3H, s), 1.45 (9H, s). Analysis C2 [Calculation of H20N6O7 値: c, 52 · 69; H, 6.32; N, 17.05, measured 値: C, 52 · 51; Η, 6.27; N, 17.36 3 MS (ES ') 477 (M +- i, 100%) 0 [3S (1S, 9S) 5-bromo-3- (9-fluorenylamino-6,10-diketo 10-octahydro-6H-daphne [l, 2- a] [l, 2] Diazapyridine · 1-Carboxylamino-M-ketovaleric acid third-butyl ester (507a) 3 506a (3.0 g, 5 55 mmol) in anhydrous -575-clothing The Chinese standard (CNS) is used in the standard scale (210X297 mm). (Please read the notes before reading the poem before filling in this f) Binding 1235157 A 7 B7 V. Description of the invention (573) Dichloromethane (40 ml) was cooled to 0 ° C, and 30% chlorobromic acid in acetic acid (1.1 ml, 5.55 mmol) was added dropwise over 4 minutes. The conjugate was removed for 9 minutes, and then carbonated. Suspension of sodium bicarbonate solution 3 The product was extracted with ethyl acetate, washed with aqueous sodium bicarbonate solution, brine, dried (MgS04) and evaporated to give 2.97 g (92%) of a colorless foam: 1>] D23 -82.3 ° (c 0.23, CH2C1,); IR (KBr) 3 3 33, 1726, 1659, 1530, 1458, 1447, 1422, 1395, 1368, 1279, 1256, 1222, 1 155, 728; ι Η NMR (CDC13) ο 7.81 (2Η, m), 7.50 (3Η, m), 7.11 (1Η: d, J-8.0), 7.01 (1H, d, J -7.4), 5.20 (2H, m), 5.00 (1H, m), 4.06 (2H, s), 3.28 (1H? M), 3.20-2.70 (4H, m), 2.42 (1H, m), 2.10-1.85 (4H, m), 1.72 (1H, m ), 1.44 (9H, s). Analysis of C26H33N4O7Br. 0.7H2O calculation: C, 51.35; H, 5.72; N, 9.24. Found: C, 51.55; H, 5.52; N, 9.09. MS (ES +) 595, 593 (M + + 1).

[35(15,95)5-溴-3-(6,10-二酮基-9-甲烷磺醢胺基-1,2,3,4,7,8, 9,10-八氩-6H·嗒畊並[l,2-a][l,2]二氮雜箪-1·羧醯胺基)-4-酮基戊酸第三-丁酯(507b),以類似化合物507a之方法製備 。(68%)呈橘色泡沫:|&gt;]D20 -135。(c 0.053, CH2C12); IR (KBr) 3429, 2944, 2935, 1723, 1670, 1458, 1408, 1327, 1225, 1154, 991; lH NMR (CDC13) δ 7.38 (1H, d, J = 8.2), 5.69 經濟部中央標,华局負工消资合作社印¾ (1H, d, J = 9.3), 5.43-5.34 (1H, m)? 5.07-4.97 (1H, m), 4.70-4.42 (2H,m), 4·12 (2H,s),3.35-3.17 (1H, m),3.10-2.69 (4H, m), 2.98 (3H, s), 2.43-2.33 (lH, m), 2.15-1.65 (5H, m). 1.43 (9H, s)。分析 C20H31BrN4O8S之計算値:C, 42.3 3; H, 5.51; N, 9.87 a 實測値:C,42.69; H,5·52; N, 9.97, -576-____ 本紙乐尺度適用中國國家標李(CNS )六4呪格(210乂 37公笼) 1235157 A7 B7 五、發明说明( 574) _ [3S(1S,9S) 5-溴-3-(6,10-二酮基-9-(甲氧羰基)胺基-1,2,3,4,7, 8,9,1〇-八氫-6^-嗒啩並[1,24][1,2]二氮雜箪-卜羧醢按基)4-酮基戊酸第三-丁酯(507c),以類似化合物5〇7a之方法製備 ,可生成淺黃色泡沫(320毫克,78%) ·· 〇]D20 -1072 (c 0·2, CH2Ci2); IR (KBr) 3401, 2956, 1726, 1670, 1528, 1452. 1415, 1395, 1368, 1276, 1251, 1155, 1064; lH NMR (CDC13) 0' 7.07 (1H, d, J = 7.6), 5.47 (1H, d, J = 8.1), 5.21-5.16 (1H, m)? 5.03-4.94 (1H, m), 4.75-4.56 (2H, m), 4.06 (2H? s), 3.69 (3H, s)? 3.31-3.13 (1H, m), 3.03-2.92 (2H, m), 2.81-2.58 (2H, m), 2.41-2.31 (1H, m), 2.10-1.66 (5H, m), 1.44 (9H? s) 3 [3S(1S,9S)] 3-(9-乙醯胺基-6,10-二酮基-1,2,3,4,7,8,9,1〇,八 氫-6士塔哜並[1,24][1,2】二氮雜箪-1-羧醯胺基]〇'凑,4__ 基戊酸第三-丁酯(507g),以類似化合物5〇7a之方法製備, 可生成淺黃色泡沫(84%) : 〇]D22 -109.6。(c 0.1, IR (KBr) 3324, 1727, 1659, 1535, 1458, 1444, 1423, 1369, 1279, 1256, 1223, 1 155; lR NMR (CDC13) ά 7.12 (1H, d, j ^ 經濟部中夬標隼局員工消费合作社印装 7.8),6.33 (1H, d, J = 7.5), 5.19 (1H,m,),4·97 (2H, m), 4 58 (1H, m), 4.06 (2H, s), 3.20 (1H, m), 3.05-2.69 (4H, m)? 2.35 (IH, m), 2.14-1.68 (5H, m), 2.03 (3H, s), 1.44 (9H, s) ^ ^ ^ C2lH31BrN4〇7.〇.3H20之計算値:C,46.99; H,5.93; N, 1〇 44 。實測値:C,46.97; Η, 5·90; N,10.35。 _____ ·577- 本纸ft尺度通用中國g家標隼(CNs ) A4堤格(2丨0:&lt; 297公凌) 1235157 A7 B7 五、發明説明(575) 0[35 (15,95) 5-bromo-3- (6,10-diketo-9-methanesulfonamido-1,2,3,4,7,8,9,10-octaargon-6H · Dageno [l, 2-a] [l, 2] diazapyrene-1 · carboxamido) -4-ketovaleric acid tert-butyl ester (507b), in a similar manner to compound 507a preparation. (68%) was an orange foam: | &gt;] D20 -135. (C 0.053, CH2C12); IR (KBr) 3429, 2944, 2935, 1723, 1670, 1458, 1408, 1327, 1225, 1154, 991; lH NMR (CDC13) δ 7.38 (1H, d, J = 8.2), 5.69 Central Standard of the Ministry of Economic Affairs, Printed by the China Bureau of Work and Consumer Cooperatives ¾ (1H, d, J = 9.3), 5.43-5.34 (1H, m)? 5.07-4.97 (1H, m), 4.70-4.42 (2H, m ), 4.12 (2H, s), 3.35-3.17 (1H, m), 3.10-2.69 (4H, m), 2.98 (3H, s), 2.43-2.33 (lH, m), 2.15-1.65 (5H , m). 1.43 (9H, s). Analyze the calculation of C20H31BrN4O8S 値: C, 42.3 3; H, 5.51; N, 9.87 a Measured 値: C, 42.69; H, 5.52; N, 9.97, -576 -____ This paper scale is applicable to Chinese national standard (CNS) ) Six 4 grids (210 乂 37 male cage) 1235157 A7 B7 V. Description of the invention (574) _ [3S (1S, 9S) 5-bromo-3- (6,10-diketo-9- (methoxy) Carbonyl) amino-1,2,3,4,7,8,9,10-octahydro-6 ^ -dapyrido [1,24] [1,2] diazapyridine Propyl) tertiary-butyl 4-ketovalerate (507c), prepared in a similar manner to compound 507a, can produce a light yellow foam (320 mg, 78%) ·· 〇] D20 -1072 (c 0 · 2, CH2Ci2); IR (KBr) 3401, 2956, 1726, 1670, 1528, 1452. 1415, 1395, 1368, 1276, 1251, 1155, 1064; lH NMR (CDC13) 0 '7.07 (1H, d, J = 7.6), 5.47 (1H, d, J = 8.1), 5.21-5.16 (1H, m)? 5.03-4.94 (1H, m), 4.75-4.56 (2H, m), 4.06 (2H? S), 3.69 ( 3H, s)? 3.31-3.13 (1H, m), 3.03-2.92 (2H, m), 2.81-2.58 (2H, m), 2.41-2.31 (1H, m), 2.10-1.66 (5H, m), 1.44 (9H? S) 3 [3S (1S, 9S)] 3- (9-acetamido-6,10-diketo-1,2,3,4,7,8,9,10, Octahydro-6 Statar [1,24] [1,2] Diazapyridine-1-carboxamido]] ′, tertiary-butyl 4-valerate (507g), prepared in a similar manner to compound 507a, but Formation of light yellow foam (84%): 〇] D22 -109.6. (C 0.1, IR (KBr) 3324, 1727, 1659, 1535, 1458, 1444, 1423, 1369, 1279, 1256, 1223, 1 155; lR NMR (CDC13) ά 7.12 (1H, d, j ^ Printed by the Consumers' Cooperative of the Ministry of Economic Affairs, China Standards Bureau, 7.8), 6.33 (1H, d, J = 7.5), 5.19 (1H, m,), 4.97 ( 2H, m), 4 58 (1H, m), 4.06 (2H, s), 3.20 (1H, m), 3.05-2.69 (4H, m)? 2.35 (IH, m), 2.14-1.68 (5H, m ), 2.03 (3H, s), 1.44 (9H, s) ^ ^ ^ C21H31BrN407.0.0.3H20 calculation: C, 46.99; H, 5.93; N, 104. Found 値: C, 46.97; Η, 5.90; N, 10.35. _____ · 577- This paper is in ft scale. It is a common Chinese g family standard. (CNs) A4 Tiege (2 丨 0: &lt; 297 liters) 1235157 A7 B7 V. Description of the invention (575) 0

508a, b 0508a, b 0

284, 285284, 285

經济邡r夬綠‘準局員工消費合作社印裝 [3S(1S,9S)] 5-(2,6-二氣芊醯氧基)-3-[6,10-二酮基-9-(甲氧 羰基)胺基-1,2,3,4,7,8,9,10-八氫-6^1-嗒啩並[1,24][1,2】二氬 雜箪-1-敌酿按基]-4-酮基丁酸第三-丁酯(5〇8a) 3對5〇6c (547毫克,1毫莫耳)於DMF (4毫升)之溶液中,加入氣化鉀 (145毫克,2·5毫莫耳,2.5當量)。經室溫下攪拌1〇分鐘後 ,加入2.6-· —氣木甲§^(229爱兄’ ι·2毫莫耳,I,當量)3 在室溫下反應3小時後,加入乙酸乙g旨(3〇毫升溶液以 碳酸氫鈉飽和水溶液(30毫升)及鹽水洗滌,在MgS〇4上乾 燥並眞空濃縮以生成590毫克(90%)的淺黃色泡朱qa】D22 -85。(c 0·20, CH2Cl2); IR (KBr) 3400, 2956, 1737, 1675, 1528, 1434, 1414, 1368, 1344, 1272, 1197, 1 152, 1061; [Η -578- 大咴汝尺度適月中國國家標革(CNS ) Α4堤格(210Χ297公釐) 1235157 B; 五、發明説明(576 ) NMR (CDC13) d 7.36-7.33 (3H,m),、7.04 (1H,d,J = 8.0), 請 s 讀 背 之 意 事 再 填 太 頁 5.46 (1H, d, J =: 7.8), 5.19-5.16 (1H, m), 5.08 (2H, AB)? 4.97-4.55 (1H, m), 4.69-4.55 (2H, m), 3.68 (3H, s), 3.30-3.10 (1H? m), 3.01-2.50 (4H, m), 2.40-2.33 (1H, m), 2.15-L60 (5H, m)? 1.44(9H,s)。分析(:2#34〇121^4〇10之計算値:C,51.15;H, 5.21; N, 8·52,實測値:C,51·35; H,5.32; N,8.56/ [3 3(15,93)】5-(2,6-二氯笮醯氧基)-3-[6,1〇-二酮基-9-(甲氧 羰基)胺基-1,2,3,4,7,8,9,1 〇-八导-6H-嗒哜並[l,2-a][l,2]二氮 雜箪-1-羧醢胺基]-4-詗基戊酸(284),合成自508a,利用自 504製備505之方法,巧*生成330毫克(65%)白色固鳢:mp. 115。(:(分解);〇]D20 -l〇7° (c 〇.2, CH2C12); IR (KB〇 3340, 2954, 1738, 1664, 1530, 1434, 1272, 1198, 1 148, 1060; ιΚ NMR (d6-DMSO) ά 8.91 (1Η, d, J = 7.2Η), 7.67-7.63 (3Η, m), 7.54 (1Η, d, J = 8.0), 5.24 (2H, s), 5.20-5.15 (1H, m), 4.79· 4.70 (1H, m), 4.46-4.37 (2H, m), 3.58 (3H, s), 3.33-3.20 (1H, m),2·94-2·55 (4H,m),2·30-1·60 (6H,m)。分析 C24H26C12N4〇l(TH20之計算値:C,46.54; H,4·56; N,9·05 3 實測値·· C,46.36; H,4.14; N,8.88。 經濟部中夬標集局員工消f合作杜印装 [35(15,95)]5-(2,6-二甲基芊醯氧基)-3-[6,10-二酮基-9-(曱 氧羰基)胺基-1,2,3,4,7,8,9,10-八氫-6^1-嗒啡並[1,24][1,2]二 氮雜箪-1-羧醯胺基]-4-酮基戊酸第三-丁酯(508b)利用如 508a化合物的方法製備,可生成淺黃色泡沫(460毫克, 82%) : |&gt;]D22 -115° (c 0.20, CH2C12); IR (fCBr) 3413, 2960, 1729, 1675, 1528, 1514, 1461, 1421, 1368, 1265, 1 1 16, 1096; -579- 本紙法尺度適用中國國家標準(CNS ) A4見格(210X297公笼) 1235157 五、發明説明(577) (請元閨讀背云之泾意事項弄填寫本一貝) lH NMR (CDCI3) δ 7.27-7.03 (4Η, ϊη), 5.48 (1Η, d, J = 8.2), 5.20-5.14 (1H, m), 5.04 (2H, AB), 4.93-4.86 (1H, m), 4.80-4.56 (2H, m), 3.77 (3H, s), 3.22-3.15 (1H, m), 3.00-2.56 (4H, m), 2.37 (6H, s), 2.19-1.77 (5H, m), 1.45 (9H, s), 2.41-2.25 (1H,m)。MS (ES+) 617。 [3S(1S,9S)] 5-(2,6-二甲基芊睦氧基)-3-[6,l〇-二晒基-9-(曱 氧羰基)胺基-1,2,3,4,7,8,9,10-八氫-611-咚》井並[1,24][1,2】二 氮雜箪-1-羧醯按基]-4-酮基戊酸(285),以類似化合物284 之方法合成,可生成白色固體(303毫克,78%) : mp. 1103C (分解);l&gt;]D20 -128。(c 0·10, CH2C12); IR (KB〇 3339, 2958, 1731, 1666, 1529, 1420, 1266, 1248, 1115, 1070; [H NMR (d6-DMSO) δ 8.90 (lH, d, J = 7.4), 7.54 (1H, d, J = 7.9), 7.36-7.28 (1H, m), 7.17-7.14 (2H, m), 5.19-5.15 (3H, m), 4.84-4.74 (1H, m), 4.45-4.37 (2H, m), 3.59 (3H, s), 3.45-3.25 (1H, m), 2.95-2.64 (4H, m), 2.35 (6H, s), 2.30-1.60 (6H, m) 3 分析(:26%2乂〇1().^12〇之計算値·· c,53·98; H, 5·92; N, 9.6卜 實測値:C, 53.50; H,5.52; N,9.49。MS (ES + ) 559 » 毯濟部中夬櫺準局員工消f合作杜印^Economy 邡 r 夬 Green 'Quasi- Bureau employee consumer cooperative printed [3S (1S, 9S)] 5- (2,6-digas fluorenyloxy) -3- [6,10-diketo-9- ( Methoxycarbonyl) amino-1,2,3,4,7,8,9,10-octahydro-6 ^ 1-pyrido [1,24] [1,2] diargin-1- Difenyl] -4-ketobutyrate tertiary-butyl ester (5.08a) 3 to 506c (547 mg, 1 mmol) in a solution of DMF (4 ml), potassium carbide added (145 mg, 2.5 millimoles, 2.5 equivalents). After stirring for 10 minutes at room temperature, 2.6 -...-Qimujia § ^ (229 Ai'er '2 · molar, I, equivalent) 3 After reacting at room temperature for 3 hours, ethyl acetate was added (30 ml of the solution was washed with a saturated aqueous solution of sodium bicarbonate (30 ml) and brine, dried over MgS04 and concentrated in vacuo to yield 590 mg (90%) of light yellow bubble almond qa] D22-85. (C 0 · 20, CH2Cl2); IR (KBr) 3400, 2956, 1737, 1675, 1528, 1434, 1414, 1368, 1344, 1272, 1197, 1 152, 1061; [Η -578- 大 咴 汝 尺度 定 月 月 China National Standard Leather (CNS) A4 Tiger (210 × 297 mm) 1235157 B; V. Description of the invention (576) NMR (CDC13) d 7.36-7.33 (3H, m), 7.04 (1H, d, J = 8.0), Please read the meaning of memorization and then fill in page 5.46 (1H, d, J =: 7.8), 5.19-5.16 (1H, m), 5.08 (2H, AB)? 4.97-4.55 (1H, m), 4.69- 4.55 (2H, m), 3.68 (3H, s), 3.30-3.10 (1H? M), 3.01-2.50 (4H, m), 2.40-2.33 (1H, m), 2.15-L60 (5H, m)? 1.44 (9H, s). Analysis (: calculation of 2 # 34〇121 ^ 4〇10 値: C, 51.15; H, 5.21; N, 8.52, measured 値: C, 51 · 35; H, 5.32; N, 8.56 / [3 3 (15,93)] 5- (2,6-dichlorofluorenyloxy) -3- [6,10-diketo-9- (methoxycarbonyl) amino-1,2 , 3,4,7,8,9,1 0-octadecane-6H-dapyrolo [l, 2-a] [l, 2] diazapyridine-1-carboxamido] -4-pyrene Valproic acid (284), synthesized from 508a, using the method of preparing 505 from 504, to produce 330 mg (65%) of white solids: mp. 115. (: (decomposition); 0) D20-107 ° (c 〇.2, CH2C12); IR (KB〇3340, 2954, 1738, 1664, 1530, 1434, 1272, 1198, 1 148, 1060; ικ NMR (d6-DMSO) ά 8.91 (1Η, d, J = 7.2Η), 7.67-7.63 (3Η, m), 7.54 (1Η, d, J = 8.0), 5.24 (2H, s), 5.20-5.15 (1H, m), 4.79 · 70 (1H, m), 4.46 -4.37 (2H, m), 3.58 (3H, s), 3.33-3.20 (1H, m), 2.94-2 · 55 (4H, m), 2.30-1 · 60 (6H, m). Analyze C24H26C12N4〇1 (calculation of TH20: C, 46.54; H, 4.56; N, 9.05 3 Measured: · C, 46.36; H, 4.14; N, 8.88. Employees of the bidding bureau of the Ministry of Economic Affairs Cooperating with Dufun [35 (15,95)] 5- (2,6-dimethylfluorenyloxy) -3- [6,10-diketo-9- (fluorenyloxycarbonyl) amino -1,2,3,4,7,8,9,10-octahydro-6 ^ 1-daphno [1,24] [1,2] diazapine-1-carboxamido]- 4-ketovaleric acid tertiary-butyl ester (508b) is prepared by a method such as 508a compound, which can generate a light yellow foam (460 mg, 82%): | &gt;] D22 -115 ° (c 0.20, CH2C12); IR (fCBr) 3413, 2960, 1729, 1675, 1528, 1514, 1461, 1421, 1368, 1265, 1 1 16, 1096; -579- The size of the paper method is applicable to the Chinese National Standard (CNS) A4 (210X297) ) 1235157 V. Description of the invention (577) (Please ask your friends to fill in this book after reading the will of Yun Yun) lH NMR (CDCI3) δ 7.27-7.03 (4Η, ϊη), 5.48 (1Η, d, J = 8.2 ), 5.20-5.14 (1H, m), 5.04 (2H, AB), 4.93-4.86 (1H, m), 4.80-4.56 (2H, m), 3.77 (3H, s), 3.22-3.15 (1H, m ), 3.00-2.56 (4H, m), 2.37 (6H, s), 2.19-1.77 (5H, m), 1.45 (9H, s), 2. 41-2.25 (1H, m). MS (ES +) 617. [3S (1S, 9S)] 5- (2,6-dimethylfluorenyloxy) -3- [6,10-dialkyl -9- (fluorenyloxycarbonyl) amino-1,2,3,4,7,8,9,10-octahydro-611-fluorene "and [1,24] [1,2] diazapine -1-Carboxamidine is synthesized according to the group] -4-ketovaleric acid (285) in a similar manner to compound 284, and a white solid (303 mg, 78%) can be formed: mp. 1103C (decomposition); l &gt;] D20 -128. (C 0 · 10, CH2C12); IR (KB〇3339, 2958, 1731, 1666, 1529, 1420, 1266, 1248, 1115, 1070; [H NMR (d6-DMSO) δ 8.90 (lH, d , J = 7.4), 7.54 (1H, d, J = 7.9), 7.36-7.28 (1H, m), 7.17-7.14 (2H, m), 5.19-5.15 (3H, m), 4.84-4.74 (1H, m), 4.45-4.37 (2H, m), 3.59 (3H, s), 3.45-3.25 (1H, m), 2.95-2.64 (4H, m), 2.35 (6H, s), 2.30-1.60 (6H, m) 3 analysis (: 26% 2 乂 〇1 (). ^ 12〇 calculation 値 · c, 53 · 98; H, 5.92; N, 9.6 measured 値: C, 53.50; H, 5.52; N, 9.49. MS (ES +) 559 »Employees of the China Central Standards Bureau, Ministry of Economic Affairs, Cooperation and Printing

OO

OO

510a, 280, 283, SlOd. -580 本紙狀( 210x 297^® ) 1235157 五、發明説明( 578) 化合物 509a 510a 509b 280 509c 283 S09d 51〇d510a, 280, 283, SlOd. -580 Paper (210x 297 ^ ®) 1235157 V. Description of the invention (578) Compound 509a 510a 509b 280 509c 283 S09d 51〇d

RR

(請先呙讀背面之注意事項一φ填寫本I } •裝 訂 [3S(1S,9S)】 3-(9-^ 醯胺基-6,10-二酮基 氫-6H-嗒啩並[l,2-a][l,2]二氮雜苯-卜羧酿胺基)〇-(2_筑基 嗒唑)-4-酮基戊酸(510a)a 506a (2.27克,4.2毫莫π)於热水 經濟部申夬標挛局員工消费合作社印裳 二氣甲烷(50毫升)之溶液,以30%氫溴酸於醋酸(1.84笔升 ,9· 2毫莫耳,2.2當量)在氮氣下之0°C時處理。在〇C下攪 拌10分鐘後,反應可遠完全,並在介質中結晶出白色固拉 3固體濾出並以乙酸乙酯及二乙醚洗務 &lt; 生成2·20兄 (100%)的[3S(1S,9S)] 5-溴-3-(9-辛醯胺基-6,10-二酮基 1,2,3,4,7,8,9, 10-八氫-6H-嗒畊並[l,2-a】[l,2]二氮雜箪-卜羧 醯胺基)-4·酮基戊酸,可使用勿需再純化:lH NMR DMSO) ά 8.87 (1Η, d, J = 7.3), 8.63 (1H, d, J ^ 7.6), 7.91- -581 - 本纸伕尺度逯用中SS家標準(CNS ) .A4現格(210 x297公笼〉 1235157 Λ7 _B7 五、發明説明(579 )(Please read the precautions on the back first, fill in this I} • Binding [3S (1S, 9S)] 3- (9- ^ 醯 Amino-6,10-diketohydrogen-6H-Da 啩 and [ l, 2-a] [l, 2] diazepine-p-carboxamide) 0- (2-Arylpyrazole) -4-ketovaleric acid (510a) a 506a (2.27 g, 4.2 mmol) Moπ) In a solution of Yinshang digas methane (50 ml) in the Consumer Cooperative of the Shenyang Biaoju Bureau of the Ministry of Hot Water Economy, take 30% hydrobromic acid in acetic acid (1.84 pen liters, 9.2 millimoles, 2.2 equivalents) at Treated at 0 ° C under nitrogen. After stirring at 0 ° C for 10 minutes, the reaction can be far completed, and a white solid is crystallized in the medium. 3 The solid is filtered off and washed with ethyl acetate and diethyl ether. 2 20 brothers (100%) of [3S (1S, 9S)] 5-bromo-3- (9-octylamino-6,10-diketonyl 1,2,3,4,7,8,9 , 10-Octahydro-6H-Da-Chen [l, 2-a] [l, 2] diazepine-p-carboxamido) -4 · ketovaleric acid, can be used without further purification: lH NMR DMSO) ά 8.87 (1Η, d, J = 7.3), 8.63 (1H, d, J ^ 7.6), 7.91- -581-Standard SS standard (CNS) for paper size. A4 is now available (210 x 297) Cage> 1235157 Λ7 _B7 V. Description of the invention (579)

7.87 (2H? m), 7.60-7.44 (3H, m), 6.92 (1H, bs)? 5.14-5.09 (1H m),4.92-4.65 (2H, m),4·43 (2H, AB),4.41-4.35 (1H,m), 3.33-3.22 (1H, m), 2.98-2.90 (1H, m), 2.89-2.57 (2H? m), 2.35-2.15 (3H,m),1.99-1.91 (2H,m),1.75-1.60 (2H,m)。濃 酮(5 35毫克,1毫莫耳)於無水DMF (10毫升)之溶液,與氣 化鉀(150毫克,2·5毫莫耳,2.5當量)在氮下處理。在室溫 下攪拌5分鐘後’加入巯基,塞唑(140毫克,1.2毫莫耳, 1.2當量)β於一夜反應後,加众乙酸乙酯(150毫升)且有機 溶液以鹽水洗滌,於硫酸鎂上乾燥並眞空減量。殘留物在 二乙謎中結晶,過濾並在矽膠上純化,利用MeOH (0%〇%) 於二氣甲烷之梯度。蒸發可生成3 44毫克(60%)的白色固體 :mp. 90-95Ό (分解);l&gt;]D20 -82° (c 0.2, CH2Cl2); IR (KBr) 3328, 2941, 1745, 1659, 1535, 1422, 1276, 1255, 1223, 1072; lH NMR (D6-DMSO) δ 8.92 (1H, d, J = 7.6), 8.68 (1H, d, J = 經濟部中夬櫺準局員工消費合作社印¾ 7.6), 7.98-7.90 (2H, m), 7.75-7.67 (1H, m), 7.64-7.50 (4H, m), 5.22-5.18 (1H, m), 4.95-4.74 (2H, m), 4.58^4.38 (3H, m), 3·52-3.19 (1H,m), 3.05-2.65 (4H,m), 2.40-1.50 (6H,m)。分 析 C25H27N504S2.H20之計算値:C,50.75; H,4.94; N,11.84 。實測値:C, 51.34; H, 4.70; N, 11.58。MS (ES+) 572。 [3S(1S,9S)】 3-(9-;醯胺基-6,l〇-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒啡並[l,2-a][l,2]二氮雜箪-l-羧醯胺基)-4-銅基 (卜苯基-1Η-四唑-5-硫)戊酸第三-丁酯(509b)。507a (100毫 克,0.17毫莫耳)於無水二甲替甲醯胺(1.5毫升)以卜苯基· 1H-四唑〇-硫醇(33毫克,0.187毫莫耳)及氟化鉀(丨5毫克, ___- 582 - ___ 本纸伕尺度通用中國國家樣隼(CNS M4規格(210X297公發) 1235157 Λ7 B7 五、發明説明( 580) 〇·34毫莫耳)處理,混合物在室溫卞攪拌2小時,以乙酸乙 酯稀釋,以碳酸氫鈉水溶液(Χ2),鹽水洗滌,乾燥(MgS04) 碕 先 讀 背 面 )· 士 t % 再 填 寫 買 並咨發3產物在碎膠上快速層析純化,以乙酸乙g旨溶離可 生成103毫克(88%)無色泡沫:[泛]〇23 .92 2。(c 〇丄ch2C12); IR (KBr) 3334, 1726, 1660, 1528, 1501, 1417, 1394, 1368, 1279, 1253, 1 155; lK NMR (CDC13) ά 7.82 (2H, m), 7.60- 7.40 (8H, m), 7.39 (1H, d, J = 8.1), 7.05 (1H, d, J == 7.3), 5.26 (1H, m), 5.15 (1H, m), 4.99 (1H, m), 4.60 (2H, m), 4.30 (1H, d, J = 17.2H), 3.32 (1H, m), 3.10-2.75 (4H, m)? 2.40 (1H, m), 2.24 (1H, m), 1.90 (3H, m), 1.75 (1H, m), 1.44 (9H, s)? MS (ES+) 691.47 (M+ + 1)。 經濟邡中央樣漆局負工消资合作社印製 [3S(1S,9S)] 3-(9-苄醯胺基·6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗌哜並[l,2-a][l,2]二氮雜箪-1-羧醯胺基)-4-鲷基 (卜苯基-1H-四唑-5·硫基)戊酸(280),利用自504製餚505之 方法合成,509b(98毫克,0.142毫莫耳)於二氣甲烷(1毫升) 冷卻至(TC,再加三氟醋酸(1毫升)3混合物在〇χ下攪拌 15分,在室溫下30分’再於減壓下蒸發。殘留物以A水曱 苯研磨及蒸發。在矽膠上層析並以10%甲醇於二氣甲烷溶 離,可生成無色玻璃狀,其自二氣甲烷/二乙瞇中結晶可 生成62毫克(69%)的無色固體·· mp· 145eC(分解);[a】D2】 -80·9〇 (c 0.1, CH2C12); IR (KBr) 3400, 1727, 1658, 1530, 1501, 1460, 1445, 1416, 1280, 1254; lH NMR (CDCI3) ό 8.00 (1H, m), 7.79 (2H, d, J = 6.7), 7.58-7.30 (9H, m), 5.25 (2H, m), 4.94 (1H, m), 4.53 (2H, m), 4.35 (1H, m), 3.35 (1H, -583- 本紙伕尺度適用中国国家標隼(CNS ) A4現格(210X 297公釐) 1235157 Λ7 B7 五、發明説明( 581 )7.87 (2H? M), 7.60-7.44 (3H, m), 6.92 (1H, bs)? 5.14-5.09 (1H m), 4.92-4.65 (2H, m), 4.43 (2H, AB), 4.41 -4.35 (1H, m), 3.33-3.22 (1H, m), 2.98-2.90 (1H, m), 2.89-2.57 (2H? M), 2.35-2.15 (3H, m), 1.99-1.91 (2H, m), 1.75-1.60 (2H, m). A solution of concentrated ketone (5 35 mg, 1 mmol) in anhydrous DMF (10 ml) was treated with potassium gas (150 mg, 2.5 mmol, 2.5 equivalents) under nitrogen. After stirring at room temperature for 5 minutes, 'mercapto, sedazole (140 mg, 1.2 mmol, 1.2 equivalents) β was added overnight. After overnight reaction, ethyl acetate (150 ml) was added and the organic solution was washed with brine, and sulfuric acid Dry over magnesium and deflate. The residue was crystallized from dioxin, filtered and purified on silica gel using a gradient of MeOH (0% 0%) in digas methane. Evaporation yields 3 44 mg (60%) of a white solid: mp. 90-95Ό (decomposed); l &gt;] D20 -82 ° (c 0.2, CH2Cl2); IR (KBr) 3328, 2941, 1745, 1659, 1535 , 1422, 1276, 1255, 1223, 1072; lH NMR (D6-DMSO) δ 8.92 (1H, d, J = 7.6), 8.68 (1H, d, J = Printed by the Consumers' Cooperatives of the China Prospective Bureau, Ministry of Economic Affairs ¾ 7.6), 7.98-7.90 (2H, m), 7.75-7.67 (1H, m), 7.64-7.50 (4H, m), 5.22-5.18 (1H, m), 4.95-4.74 (2H, m), 4.58 ^ 4.38 (3H, m), 3.5 · 2-3.19 (1H, m), 3.05-2.65 (4H, m), 2.40-1.50 (6H, m). Analysis of C25H27N504S2.H20 calculation: C, 50.75; H, 4.94; N, 11.84. Found 値: C, 51.34; H, 4.70; N, 11.58. MS (ES +) 572. [3S (1S, 9S)] 3- (9-; amido-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-6H-daphine Benzene [l, 2-a] [l, 2] diazepine-l-carboxamido) -4-copperyl (phenylphenyl-1,4-tetrazol-5-thio) valeric acid tert-butyl Ester (509b). 507a (100 mg, 0.17 mmol) in anhydrous metformamide (1.5 ml) with phenylphenyl 1H-tetrazole 0-thiol (33 mg, 0.187 mmol) and potassium fluoride (丨5 mg, ___- 582-___ This paper has the same size as the Chinese national standard (CNS M4 specification (210X297)) 1235157 Λ7 B7 V. Description of the invention (580) 0.34 mmoles. The mixture is at room temperature. Stir for 2 hours, dilute with ethyl acetate, wash with sodium bicarbonate aqueous solution (X2), brine, and dry (MgS04) (read the back side) · t t%, then fill in and buy 3 products flash chromatography on the gel Purification and dissociation with ethyl acetate g yielded 103 mg (88%) of a colorless foam: [Pan] 02.92 2. (C 〇 丄 ch2C12); IR (KBr) 3334, 1726, 1660, 1528, 1501, 1417, 1394, 1368, 1279, 1253, 1 155; lK NMR (CDC13) ά 7.82 (2H, m), 7.60- 7.40 (8H, m), 7.39 (1H, d, J = 8.1), 7.05 (1H, d, J == 7.3), 5.26 (1H, m), 5.15 (1H, m), 4.99 (1H, m), 4.60 (2H, m), 4.30 (1H, d, J = 17.2H), 3.32 (1H, m), 3.10-2.75 (4H, m)? 2.40 (1H, m), 2.24 (1H, m), 1.90 (3H, m), 1.75 (1H, m), 1.44 (9H, s)? MS (ES +) 691.47 (M + + 1). Printed by the Central Government Bureau of Sample Paint, Consumers and Consumers Cooperatives [3S (1S, 9S)] 3- (9-benzylamido · 6,10-diketo-1,2,3,4,7,8 , 9,10-octahydro-6H-pyrido [l, 2-a] [l, 2] diazapyridine-1-carboxamido) -4-daiminyl (buphenyl-1H-tetra Azole-5 · thio) valeric acid (280), synthesized from 504 and 505, 509b (98 mg, 0.142 mmol) in digas methane (1 ml), cooled to (TC, then added trifluoro The acetic acid (1 ml) 3 mixture was stirred for 15 minutes at χ, and 30 minutes at room temperature, and then evaporated under reduced pressure. The residue was triturated with toluene and evaporated, and chromatographed on silica gel with 10% methanol. Dissolved in methane gas to form a colorless glass, which crystallizes from methane gas / diethylhydrazine to produce 62 mg (69%) of a colorless solid ·· mp · 145eC (decomposed); [a] D2] -80 9〇 (c 0.1, CH2C12); IR (KBr) 3400, 1727, 1658, 1530, 1501, 1460, 1445, 1416, 1280, 1254; lH NMR (CDCI3) ό 8.00 (1H, m), 7.79 (2H , d, J = 6.7), 7.58-7.30 (9H, m), 5.25 (2H, m), 4.94 (1H, m), 4.53 (2H, m), 4.35 (1H, m), 3.35 (1H,-- 583- This paper's standard is applicable to Chinese national standard (CN S) A4 (210X 297 mm) 1235157 Λ7 B7 V. Description of the invention (581)

m),3.01 (3H, m), 2.73 (1H,m),2.38' (1H,》),198 (4H,m), 1.64 (1H, m)。分析 C29H30N8O7S.0.2TFA之計界値:c,〕。·71; H,4.63; N,17.04。實測値·· c,53·97; H,4·92; N,16.77 3 MS (ES,633.55 (M、1) 3 [3S(1S,9S)] 3-[9-芊醯胺基-6,l〇-二酮基-1,2,3,4,7,8,9,10&quot;、 氩-6H-嗒啩並[l,2-a][l,2]二氮雜苯小致醯胺基]:4-明基小 (3-呲啶基氧基)戍酸第三-丁酯(509c),以化合物50外之類 似方法製備,可生成無色玻璃狀(34%) : 0]d22 -77.1° (c 0.25, CH2C12); IR (薄膜)3311,1724, 1658, 1603, 1578, 1536, 1488, 1458, 1426, 1368, 1340, 1279, 1256, 123 1,1 155, 707; lH NMR (CDC13) ά 8.29 (2H, m), 7.84 (2H, m), 7.48 (4H, m), 7.22 (3H, m), 5.20 (2H, m), 4.90 (2H, m), 4.58 (1H, m), 3.29 (1H, m)t 3.20-2.70 (4H, m), 2.38 (2H, m), 1.96 (4H, m), 1.68 (1H, m), 1.42 (9H, s) ^ MS (ES + ) 608.54 (M + 1) 3 [3S(IS,9S)] 3-[9-芊醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒哜並[l,2-a][l,2]二氮雜箪-1-羧醯胺基】·4-鲷基-5-(3-吡啶基氧基)戊酸(283),以化合物280之類似方法製備 ,可生成無色泡沫(100%) : mp.〜125°C ; 〇]D19 -84.1° (c 0.K 20% MeOH/CH2Cl2); IR (KBr) 3401, 1736, 1663, 1538, 經濟部中夬榡华局員工消费合作祆印复 1489, 1459, 1425, 1281,1258, 1200, 1 134; lH NMR (CD3OD/CDCI3) ά 8.38 (2H, m), 7.84-7.40 (8H, m), 5.16 (4H, m), 4.80 (1H, m), 4.56 (1H, m), 3.50 (1H, m), 3.12 (2H? m), 2.82 (2H, m), 2.37 (lH, m), 2.10-1.65 (5H, m) ^ 分 析 C27H29N5O8-0.4H2O之計算値:C,51.77; Η, 4.61; Η, 4.61; N, -584 - 木.¾¾尺度通用中國國家標孪(CNS M4現格(Ox 297公茇) 1235157 Λ7 _Β7_____ 五、發明説明(582) 10·41» 實測値·· C,52.19; Η,4·93; N, 9.99。 [3 5(15,95)】3-[6,10-二酮基-1,2,3,4,7,8,9,10-八氫-9-(苯基羰 胺基)-6Η-嗒啩並[l,2-a】[l,2]二氮雜箪-1-幾醯胺基l·4·銅基-5-{2-[4(3H)-嘧啶酮]}戍酸第三-丁酯(5〇9d),以化合物509b 之類似方法合成,可生成無色的固體(49.6毫克,82%): lH NMR (CDCi3) δ 8.02 (1Η, s), 7.95-7.86 (1H, m), 7.84-m), 3.01 (3H, m), 2.73 (1H, m), 2.38 '(1H,>), 198 (4H, m), 1.64 (1H, m). Analyze the calculation boundary of C29H30N8O7S.0.2TFA: c,]. 71; H, 4.63; N, 17.04. Measured 値 ·· c, 53 · 97; H, 4.92; N, 16.77 3 MS (ES, 633.55 (M, 1) 3 [3S (1S, 9S)] 3- [9-fluorenylamino-6 , 10-diketo-1,2,3,4,7,8,9,10 &quot;, Ar-6H-dapyrido [l, 2-a] [l, 2] diazepine Benzylamino]: 4-benzyl- (3-amidinyloxy) phosphonium tertiary-butyl ester (509c), prepared in a similar manner except for compound 50, which can yield a colorless glass (34%): 0] d22 -77.1 ° (c 0.25, CH2C12); IR (thin film) 3311, 1724, 1658, 1603, 1578, 1536, 1488, 1458, 1426, 1368, 1340, 1279, 1256, 123 1, 1 155, 707; lH NMR (CDC13) ά 8.29 (2H, m), 7.84 (2H, m), 7.48 (4H, m), 7.22 (3H, m), 5.20 (2H, m), 4.90 (2H, m), 4.58 (1H , m), 3.29 (1H, m) t 3.20-2.70 (4H, m), 2.38 (2H, m), 1.96 (4H, m), 1.68 (1H, m), 1.42 (9H, s) ^ MS ( ES +) 608.54 (M + 1) 3 [3S (IS, 9S)] 3- [9-fluorenylamino-6,10-diketonyl-1,2,3,4,7,8,9, 10-octahydro-6H-dapyrido [l, 2-a] [l, 2] diazapyridine-1-carboxamido] · 4-pyridyl-5- (3-pyridyloxy) Valeric acid (283), prepared by a similar method to compound 280, can produce colorless foam (100%): mp. ~ 125 ° C ; 〇] D19 -84.1 ° (c 0.K 20% MeOH / CH2Cl2); IR (KBr) 3401, 1736, 1663, 1538, China-China Bureau of Ministry of Economic Affairs, Consumer Consumption Copies, 1489, 1459, 1425, 1281, 1258, 1200, 1 134; lH NMR (CD3OD / CDCI3) ά 8.38 (2H, m), 7.84-7.40 (8H, m), 5.16 (4H, m), 4.80 (1H, m), 4.56 (1H , m), 3.50 (1H, m), 3.12 (2H? m), 2.82 (2H, m), 2.37 (lH, m), 2.10-1.65 (5H, m) ^ Analyze the calculation of C27H29N5O8-0.4H2O 値: C, 51.77; Η, 4.61; Η, 4.61; N, -584-wood. ¾¾-scale universal Chinese national standard twin (CNS M4 present grid (Ox 297)) 1235157 Λ7 _Β7 _____ V. Description of the invention (582) 10 · 41 »Measured 値 ·· C, 52.19; Η, 4.93; N, 9.99. [3 5 (15,95)] 3- [6,10-Diketo-1,2,3,4,7,8,9,10-octahydro-9- (phenylcarbonylamino) -6Η -Da (1,2-a) [1,2] Diazapyridine-1-Epiaminoamido l · 4 · copperyl-5- {2- [4 (3H) -pyrimidinone]} 戍Acid tert-butyl ester (509d), synthesized in a similar manner to compound 509b, yielded a colorless solid (49.6 mg, 82%): lH NMR (CDCi3) δ 8.02 (1Η, s), 7.95-7.86 ( 1H, m), 7.84-

7.76 (2H, m), 7.62-7.35 (4H, m), 7.22-7.07 (1H, m), 6.43 (1H, d), 5.26o.08 (2H, m), 5.03-4.72 (3H, m), 4.66-4.50 (1H, m), 3.43-3.19 (1H, m), 3.15-2.97 (1H, m), 2.86-2.72 (3H, m), 2.48-2.31 (1H, m), 2.18-1.60 (6H, m), 1.43 (9H, s) ^ [3S(1S,9S)] 3-[6,10-二酮基-1,2,3,4,7,8,9,10-八氫-9-(苯基羰 胺基嗒啩並[l,2-a][l,2]二氮雜箪·1·羧酸基]-4-銅基·5-{2-[4(3Η)-嘧啶酮】}戊酸(510d)以化合物280之類似方法合 成,可生成無色固體(25.7毫克,57%) : mp· 140-8CTC ; IR (KBr) 3391, 2945, 1733, 1664, 1530, 1422, 1363, 1277? 1259, 1204; lH NMR (CD3OD) ά 8.23 (1H, s), 7.94 (1H, d), 7.87 經濟部t央標隼局員工消费合作社印¾ (2H, d), 7.54-7.42 (3H, m), 6.48 (1H, d), 5.22-5.15 (1H, m)t 4.57-4.46 (1H, in), 3.620.41 (1H, m), 3.22-3.13 (1H, m), 3.02-2.81 (2H,m), 2·7(Μ.80 (6H, m)。分析 C26H28N6〇3· 1·5Η20之計算値:C, 54.30; H,5.35; N, 14.61。實測値:C 54.14; H, 5.35; N, 13.04 〇 MS (ES+) 55i (M - 1, 100%) 3 C26H29N6〇8 (ΜΒΓ)之精確質量計算値·· 553.2047。實測値 :553.2080 。 __ · 585 - 本纸狀度適用中S國家料(CNS )紐ΐ格(21GX297公φ ) 1235157 A7 B7 五、發明説明(583 )7.76 (2H, m), 7.62-7.35 (4H, m), 7.22-7.07 (1H, m), 6.43 (1H, d), 5.26o.08 (2H, m), 5.03-4.72 (3H, m) , 4.66-4.50 (1H, m), 3.43-3.19 (1H, m), 3.15-2.97 (1H, m), 2.86-2.72 (3H, m), 2.48-2.31 (1H, m), 2.18-1.60 ( 6H, m), 1.43 (9H, s) ^ [3S (1S, 9S)] 3- [6,10-diketo-1,2,3,4,7,8,9,10-octahydro- 9- (phenylcarbonylaminopyrido [l, 2-a] [l, 2] diazafluorene · 1 · carboxylic acid group] -4-copperyl · 5- {2- [4 (3Η) -Pyrimidinone]} valeric acid (510d) was synthesized by a similar method to compound 280, which can produce a colorless solid (25.7 mg, 57%): mp · 140-8CTC; IR (KBr) 3391, 2945, 1733, 1664, 1530, 1422, 1363, 1277? 1259, 1204; lH NMR (CD3OD) ά 8.23 (1H, s), 7.94 (1H, d), 7.87 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (2H, d), 7.54 -7.42 (3H, m), 6.48 (1H, d), 5.22-5.15 (1H, m) t 4.57-4.46 (1H, in), 3.620.41 (1H, m), 3.22-3.13 (1H, m) , 3.02-2.81 (2H, m), 2 · 7 (M.80 (6H, m). Analysis of the calculation of C26H28N60.3 · 5 · 20Η: C, 54.30; H, 5.35; N, 14.61. Measured 値: C 54.14; H, 5.35; N, 13.04 〇MS (ES +) 55i (M-1, 100%) 3 C26H29N6〇8 (Μ ΒΓ) accurate mass calculation 値 · 553.2047. Measured 値: 553.2080. __ · 585-This paper is suitable for S country materials (CNS) New York grid (21GX297 public φ) 1235157 A7 B7 V. Description of the invention (583)

504f-h SOSf, 280b, 283b 化合物 R 504f 505f 504g 280b Q 、又l/ 504h 283b &quot;G . 請先另讀背面之注意事項再填寫衣一貝 經濟部中央糅準局員工消资合作社印¾ [3S(IS,9S)] 5-(3-氣-2-氡基-4H-吡啶並[1,2-a]嘧啶-4-酮)-3-[6,10-二酮基-9-(甲基磺醯基)胺基-1,2,3,4,7,8,9,10-八氫-611-嗒啩並[1,24][1,2】二氮雜箪-1-羧醢胺基]-4-酮基戊酸 (505f),以類似化合物508a之方法,利用507b及3-氣-2-羥 基-4^^比交並[1,2-3]°^淀-4-明及直接以三氟醋酸水鲜50^ ,可生成褐色粉末(65毫克,30%) ·· [a]D20 -128° (c 0.10 -586- 本纸疾尺度適用中國國家標準(CNS )八4規洛(210·,&lt;:97公釐) 1235157 Λ7 _BT_ __ 五、發明说明(撕)504f-h SOSf, 280b, 283b Compound R 504f 505f 504g 280b Q, and l / 504h 283b &quot; G. Please read the precautions on the back before filling in the seal of the Consumers ’Cooperative of the Central Bureau of Standards, Yiyibei Ministry of Economic Affairs ¾ [3S (IS, 9S)] 5- (3-Gas-2-fluorenyl-4H-pyrido [1,2-a] pyrimidin-4-one) -3- [6,10-diketo-9 -(Methylsulfonyl) amino-1,2,3,4,7,8,9,10-octahydro-611-dapyrido [1,24] [1,2] diazapyrene- 1-Carboxamido] -4-ketovaleric acid (505f), similar to compound 508a, using 507b and 3-gas-2-hydroxy-4 ^^ ratio to cross and [1,2-3] ° ^ Yodo-4-Ming and direct fresh water with trifluoroacetic acid 50 ^, can produce brown powder (65 mg, 30%) ·· [a] D20 -128 ° (c 0.10 -586- Standard (CNS) 8 4 gauge (210 ,, &lt;: 97 mm) 1235157 Λ7 _BT_ __ 5. Description of the invention (tear)

MeOH); IR (KBr) 3414, 2928, 1667,、、1527, 2459, 1407, 1328, 1274, 1153, 1 134; [H NMR (MeOH) ά 9.35 (1Η, d, J = 6.6H), 8.34 (1H, t, J = 7.2H), 7.99-7.95 (1H, m), 7.76-7.69 (1H, m), 5.85-5.45 (3H, m), 5.30-5.21 (1H, m), 4.93-4.66 (2H, m), 3.81-3.65 (1H, m), 3.66 (3H, m), 3.45-2.52 (4H, m), 2.52-1.71 (6H, m) 3 D.J. Hlasta et al., J. Med. Chem. 1995, 38, 4687- 4692 - [35(15,95)]3-(6,10-二酮基-9-甲烷磺醯胺基-1,2,3,4,7,8,9, 10-八氫-6H-嗒哜並[l,2-a][l,2]二氮雜箪-卜羧醯胺基)-4·酮 基-5-(1-苯基-1^1-四唑-5-硫)戊酸第三-丁酯(5〇43),以類似 化合物509b之方法製備,(83%)呈無色泡沫:〇]D23 ·112.7s (c 0.2, CH2CI2); IR (KBr) 33 12, 1726, 1668, 1501, 1413, 1395, 1369, 1328, 1276, 1254, 1 155; lH NMR (CDC13) δ 7.59 (5H, in), 7.48 (1H, d, J = 8.0), 5.68 (1H, d, J = 9.0), 5.37 (1H, m), 4.95 (1H, m), 4.62-4.31 (4H, m), 3.36 (1H, m), 2.98 (3H, s), 2.88 (4H, m), 2.66 (1H, m), 2.42 (2H, m), i.98 (1H, m), 1.75 (1H, m), 1.43 (9H,s)。 經濟部中夬墚準局員工消费合作社印製 [3S(1S,9S)】 3-(6,10-二酮基-9-甲烷磺醯胺基·1,2,3,4,7,8,9, 10-八氫·6Η·嗒啩並[i,2-a][l,2]二氮雜箪-1-羧醢胺基)-4-酮 基-5-(1-苯基-1H-四吐-5-疏基)戊酸(208b),以類似化合物 280之方法製備(100%)可生成無色·泡沫:mp. 120〇3C;[泛]D25 -112.4° (c 0.1, CH2Ci2); IR (KBr) 3328, 1730, 1664, 1529,MeOH); IR (KBr) 3414, 2928, 1667, 1527, 2459, 1407, 1328, 1274, 1153, 1 134; [H NMR (MeOH) ά 9.35 (1Η, d, J = 6.6H), 8.34 (1H, t, J = 7.2H), 7.99-7.95 (1H, m), 7.76-7.69 (1H, m), 5.85-5.45 (3H, m), 5.30-5.21 (1H, m), 4.93-4.66 (2H, m), 3.81-3.65 (1H, m), 3.66 (3H, m), 3.45-2.52 (4H, m), 2.52-1.71 (6H, m) 3 DJ Hlasta et al., J. Med. Chem. 1995, 38, 4687- 4692-[35 (15,95)] 3- (6,10-Diketo-9-methanesulfonamido-1,2,3,4,7,8,9 , 10-octahydro-6H-dalopano [l, 2-a] [l, 2] diazapyridine-carboxamido) -4 · keto-5- (1-phenyl-1 ^ 1-tetrazol-5-thio) valeric acid third-butyl ester (5043), prepared in a similar manner to compound 509b, (83%) showed a colorless foam: 〇] D23 · 112.7s (c 0.2, CH2CI2) ; IR (KBr) 33 12, 1726, 1668, 1501, 1413, 1395, 1369, 1328, 1276, 1254, 1 155; lH NMR (CDC13) δ 7.59 (5H, in), 7.48 (1H, d, J = 8.0), 5.68 (1H, d, J = 9.0), 5.37 (1H, m), 4.95 (1H, m), 4.62-4.31 (4H, m), 3.36 (1H, m), 2.98 (3H, s) , 2.88 (4H, m), 2.66 (1H, m), 2.42 (2H, m), i.98 (1H, m), 1.75 (1H, m), 1.43 (9H s). Printed by the Consumers' Cooperatives of the China Standards Bureau, Ministry of Economic Affairs [3S (1S, 9S)] 3- (6,10-diketo-9-methanesulfonamido · 1,2,3,4,7,8 , 9, 10-octahydro · 6Η · Da ([i, 2-a] [l, 2] diazepine-1-carboxamido) -4-one-5- (1-phenyl -1H-tetramethyl-5-meryl) valeric acid (208b), prepared by a method similar to compound 280 (100%), can produce colorless foam: mp. 120〇3C; [PAN] D25 -112.4 ° (c 0.1 , CH2Ci2); IR (KBr) 3328, 1730, 1664, 1529,

1501, 1410, 1328, 1277, 1219, 1 153, 1 134, 991; lH NMR (CDCI3) ά 8.07 (1H, d, J = 7.8), 7.58 (5H, s), 6.41 (1H, d, J -587- 本纸疚尺度通用中as家橾隼(CNS ) A4現格(ZIOXZW公釐) 1235157 Λ/ 五、發明説明(58S) =9.5), 5.32 (1H, m), 5.04 (1H, m), 4.70 (1H, d, J = 17.5), 4.60 (3H, m), 3.50-2.9 (3H, m), 2.98 (3H, s), 2.45 (2H, m), 2.06 (4H, m), 1.68 (1H, m) 3 [3S(1S,9S)] 3-(6,10·二酮基-9-甲坑磺醯胺基-1,2,3,4,7,8,9, 10-八氫-6H-嗒呼並[l,2-a][l,2]二氮雜箪-1-羧醯胺基)-4-酮 基〇-(3-吡啶基氧基)戊酸第三·丁酯(5〇4h),以_似化合物 509b之方法製備,(24%)呈無色泡沫狀:〇]D23 -101.0。(c 0.2, CH2C12); IR (KBr) 3330, 1727, 1669,1425, 1396, 1369, 1328, 1276, 1256, 123 1, 1 155, 1 137, 991; lH NMR (CDCi3) ά 8.28 (2H, br d, J = 9.4), 7.7i (1H, d, J = 7.9), 7.22 (2H, s), 6.03 (1H,d, J = 9.4), 5.36 (1H, m), 4.95 (2H, m), 4.52 (2H, m), 3.29 (1H, m), 3.07 (3H, s), 3.23-2.75 (3H? m)? 2.66-2.35 (2H,m),2·3(Μ·60 (5H, m),1·42 (9H,s)。 [3S(1S,9S)] 3-(6,10-二酮基·9-甲烷磺醯胺基-1,2,3,4,7,8,9, 10-八氫-6H-嗒哜並[l,2-a][l,2】二氮雜箪·1-羧醯胺基)-4-酮 基·5-(3-吡啶基氧基)戊酸(283b),以類似化合物280之方法 製備,(100%)呈無色泡沫·· mp. 120-5X:;[泛]D25 -85.2。(c 0.1,CH30H/CH2C12); IR (KBr) 3337, 1738, 1667, 1 560, 1457, 經濟部中央樣隼局負工消费合作社印装 (讀先父讀背δ之泾意事項再填寫本f ) 1424, 1326, 1317, 1278, 1258, 1200, U89, 1 1 50, 1 133, 991; aH NMR (CDCi3/CD3OD) ά 8.35 (2H, m), 7.54 (2H, m), 5.32 (2H, m), 4.83 (2H, m), 4.45 (2H, m), 3.43-2.77 (4H, m), 2.97 (3H, s),2.42 (2H, m), 2.05-1.72 (5H, m)。 -588 - 本紙朵尺度適用中国國家標隼(CNS ) A4堤格(2!0乂 297公笼) 1235157 Λ7 B71501, 1410, 1328, 1277, 1219, 1 153, 1 134, 991; lH NMR (CDCI3) ά 8.07 (1H, d, J = 7.8), 7.58 (5H, s), 6.41 (1H, d, J- 587- This paper is commonly used in the standard of guilt (CNS) A4 (ZIOXZW mm) 1235157 Λ / 5. Description of the invention (58S) = 9.5), 5.32 (1H, m), 5.04 (1H, m) , 4.70 (1H, d, J = 17.5), 4.60 (3H, m), 3.50-2.9 (3H, m), 2.98 (3H, s), 2.45 (2H, m), 2.06 (4H, m), 1.68 (1H, m) 3 [3S (1S, 9S)] 3- (6,10 · diketo-9-methylsulfonamido-1,2,3,4,7,8,9, 10- Octahydro-6H-daphtho [l, 2-a] [l, 2] diazepine-1-carboxamido) -4-one group 0- (3-pyridyloxy) valerate Tributyl ester (504h) was prepared by a method similar to compound 509b (24%) as a colorless foam: o] D23 -101.0. (C 0.2, CH2C12); IR (KBr) 3330, 1727, 1669, 1425, 1396, 1369, 1328, 1276, 1256, 123 1, 1 155, 1 137, 991; lH NMR (CDCi3) ά 8.28 (2H, br d, J = 9.4), 7.7i (1H, d, J = 7.9), 7.22 (2H, s), 6.03 (1H, d, J = 9.4), 5.36 (1H, m), 4.95 (2H, m ), 4.52 (2H, m), 3.29 (1H, m), 3.07 (3H, s), 3.23-2.75 (3H? M)? 2.66-2.35 (2H, m), 2.3 (Μ · 60 (5H , m), 1.42 (9H, s). [3S (1S, 9S)] 3- (6,10-diketo · 9-methanesulfonamido-1,2,3,4,7, 8,9, 10-octahydro-6H-dalopano [l, 2-a] [l, 2] diazepine · 1-carboxyamido) -4-one · 5- (3-pyridine Alkoxy) valeric acid (283b), prepared in a similar manner to compound 280, (100%) was a colorless foam. Mp. 120-5X :; [Pan] D25-85.2. (C 0.1, CH30H / CH2C12); IR (KBr) 3337, 1738, 1667, 1 560, 1457, printed by the Consumers' Cooperatives of the Central Sample Bureau of the Ministry of Economic Affairs (read the intention of the father and read the δ, then fill in this f) 1424, 1326, 1317, 1278 , 1258, 1200, U89, 1 1 50, 1 133, 991; aH NMR (CDCi3 / CD3OD) ά 8.35 (2H, m), 7.54 (2H, m), 5.32 (2H, m), 4.83 (2H, m ), 4.45 (2H, m), 3.43-2.77 (4H, m), 2. 97 (3H, s), 2.42 (2H, m), 2.05-1.72 (5H, m). -588-The size of this paper is applicable to the Chinese national standard (CNS) A4 Tiege (2! 0 乂 297 male cage) 1235157 Λ7 B7

五、發明説明(586 )V. Invention Description (586)

化合物 R 508c 511c 、X) 508d 28Qc o 508e 283c &quot;Ό. 經濟部中夬樣擎局員工消费合作社印裝 [3$(13,95)】3-[6,10-二嗣基-9-(甲氧談基)胺基.1,2,:&gt;,4,7,8,9, 10-八氫-6ίί-嗒咩並[l,2-a][l,2】二氮雜箪-卜羧醯胺基卜5-(2· 巯基嘧啶)-4-酮基-戊酸第三-丁酯(5〇8c),依化合物509b之 類似方法製備,可生成544毫克(9)%)的淺黃色泡末:0】d20 -86° (c 0.19, CH2C12); IR (KBr) 3426, 2947, 1725, 1669, 155 1, 1418, 1383, 1253, 1 155, 1064; lH NMR (CDCl3) ό 8.49 (2H, d, J = 4.8), 7.13 (1H, d, J = 7.9), 7.03-6.98 (1H, m), -589- 本紙乐尺度通用令国國家標革(CNS ) A4現格(210 X 297公笼) 1235157 Μ濟部t夬糅祖局員工消费合作社印¾ Λ7 _B7_____ 五、發明説明(587 ) 5.47 (1H,d,J = 7.9),5.23-5.19 (1H,m),5.09-5.01 (1H,m), 4.84-4.51 (2H,m),4·04 (2H,ΑΒ),3·69 (3H,s)· 3.38-3.19 (1H, m),3·06-2·64 (4H,m), 2.40-1.76 (6H,m),1·43 (9H,s),分析 C25H34N608S之計算値:C,51.89; H,5.92; N, 14.52 3 實測值 :C,51.49; H,6·〇4; N,13.87 3 MS (ES + ) 579, [3S(1S,9S)] 3-[6,l〇-二酮基-9-(甲氧羰基)胺基-1:2,3,4,7,8,9, 10-八氫-611-嗒咩並[1,24][1,2]二氮雜箪-卜羧醯胺基]-5-(2-巯基嘧啶)-4-酮基戊酸(511c),以類似化合物280之方法製 備,可生成370毫克(79%)白色泡末:mp. 105'C(分解);[c]D22 -94° (c 0.20, CH2C12); IR (KBr) 33 16, 3057, 2957, 1724, 1664, 1252, 1416, 1384, 1254, 1 189, 1063; lH NMR (D6-DMSO) δ 8.85 (1H, d, J = 7.8), 8.62 (2H, d, J = 4.7), 7.53 (1H. d, J = 8.0), 7.28-7.23 (1H, m)t 5.21-5.17 (iH, m), 4.87-4.79 (1H, m), 4.47-4.35 (2H, m), 4.23 (2H, AB)? 3.58 (3H, s), 3.30-3.21 (1H, m), 2.95-2.50 *(4H, m), 2.35-1.60 (6H, m) ^ 分 析 C2lH26N60sS*H20 之計算値:c, 46.66; H,5.22; N, 15.55 ^ 實測値:C,46.66; H, 5.13; N, 15.07。MS (ES+) 523,(ES+) 521。 [3S(1S,9S)】 3-[6,10-二酮基-9-(甲氧羰基胺基)-12 3 4 7 8 9, 10-八氫-6H-嗒畊並[l,2-a】[l,2]二氮雜革·1-羧醯胺基)-4-酮 基-5-[5-(卜苯基四也基)硫】戊酸第三-丁酯(5〇8d),以類似 化合物509b之方法合成可生成無色固體(269毫克,87。/〇): mp. 80-ll(TC ;[泛】〇23 -i〇8。(c 〇 6〇, ch2C12); IR (BCBr) 3315, 2977, 1727, 1688, 1527, 1501, 1458, 1418, 1368, 1279. 1250, (請先聞讀背¾之:;·χ意事項再填寫本一貝 -裝 l·訂 % ___ - 590 - 本纸乐瓦度適用令国国家標隼(CM ) 297公廣) 1235157 A: B1 五、發明説明(588 ) 請 先 ΚΙ 讀 背 面 之 事 1 155, 1064; lH NMR (CDC13) ^ 7.70 (1H, d), 7.63-7.53 (5H, m), 5.84 (1H, d), 5.34-5.27 (1H, m), 5.05-4.92 (lH, m), 4.78-4.54 (3H, m), 4.38 (1H, d), 3.66 (3H? s), 3.37-3.19 (1H, m), 3.07-2.94 (1H, m), 2.91-2.82 (2H, m), 2.71-2.56 (1H, m)? 2.40-2.30 (1H,m),2.19-2.13 (1H,m),2.08-1.68 (4H,m),1.42 (9H,s)。MS (ES+) 667 (31%),645 (NT + 1,100),589 (62)。 [35(15,95)]3-[6,10-二酮基-9-(甲氧羰基胺基)-1,2,3,4,7,8,9, 10 -八氮-6H -,答σ井並[l,2-a】[l,2]· — 雜卓-1 -幾酿胺基卜4-嗣 基·5·[5-(1-苯基四唑基)-硫]戊酸(280c),以類似化合物280 之方法合成,可生成淺乳色固體(203毫克,85%):〇^10:5-130eC ; [a]D22 -235 ° (c 0.11, MeOH); IR (KBr) 3342, 295 1, 1727, 1667, 1529, 1501, 1459, 1416, 1276, 1252, 1192· 1062; lH NMR (D6-DMSO) δ 8.89 (1H, d), 7.69 (5H, s), 7.50 (1H, Μ濟部t央標牮局員工消費合作杜印裝 d), 5.180.11 (1H, m), 4.79-4.69 (1H, m), 4.57 (2H, s)? 4.42· 4.32 (1H, m), 3.54 (3H, s), 2.92-2.63 (3H, m), 2.21-1.82 (5H, m),1.65-1.57 (1H,m)。MS (ES+) 587 (M · 1,100%” [3S(1S,9S)] 3-[6,10-二酮基-9-(甲氧羰基胺基)-1,2,3,4,7,8,9, 10-八氩-6H·嗒畊並[l,2-ani,2]二氮雜箪-1-羧醯胺基]-4-酮 基〇-(3-吡啶基氧基)戍酸第三-丁酯(508e),以類似化合物 509b之方法合成,可生成淺橘色固體(199毫克,25%) : mp 80-120eC ; [a]D23 -89° (c 0.51, CH2C12); IR (KBr) 3333, 2978, 1726, 1669, 1578, 1536, 1478, 1426, 1368, 1277, 1253, 123 2, Π55, 1064; lH NMR (CDC13) ό S.41-8.18 (2H, m), 7.81 (1H, d), 7.26-7.20 (2H, s), 5.91 (1H, d), 5.24-5.16 (1H, -591 - 本紙伕尺度適用中国國家標準(CNS ) A4現格(2丨0X297公茇) 1235157 A 7 _B7_ 五、發明説明(589) m), 5.07-4.86 (3H, m), 4.81-4.51 (2H, m), 3.67 (3H, s), 3.34-3.16 (1H, m), 3.10-2.81 (3H, m), 2.72-2.54 (1H, m), 2.41-2.31 (1H,m), 2.07-1.62 (5H, m), 1·47 (9H s)。MS (ES勺 562 (M+ + 1, 100%), 506 (38)- [3S(1S,9S)] 3-[6,10-二酮基-9-(甲氧羰基胺基)-l,2,3,4,7,8,9, 10-八氫-6H-嗒啩並[l,2-a][l,2]二氮雜箪-1-羧醯芦基]-4-酮 基-5-(3-吡啶基氧基)戊酸(283c),以類似化合物280之方法 合成,可生成掺白色粉末(167毫克,98%): mp 9 CM 05 &quot;C:[ 沒]D22 -106。(c 0·11,MeOH); IR (KBr) 3325, 3070, 2956, 1669, 1544, 1423, 1256, 1 199, 1133, 1062; LH NMR (D6-DMSO) δ 8.95 (1H, d), 8.45-8.20 (2H, m), 7.53-7.45 (3H, m), 5.19-5.08 (3H, m), 4.70-4.62 (1H, m), 4.41-4.30 (2H, m), 3.53 (3H, s), 2.92-2.68 (3H, m), 2.22-2.06 (2H, m), 1.95-1.82 (2H, m), 1.63-1.53 (1H,m)。MS (ES+) 506 (M+ + 1,100%)。Compound R 508c 511c, X) 508d 28Qc o 508e 283c &quot; Ό. Printed by the Consumers' Cooperatives of the Bureau of Samples in the Ministry of Economic Affairs [3 $ (13,95)] 3- [6,10-Difluorenyl-9- (Methoxy) amino.1,2,: &gt;, 4,7,8,9, 10-octahydro-6ί-da-pyrido [l, 2-a] [l, 2] diaza Fluorenyl-carboxamidoamino 5- (2 · mercaptopyrimidine) -4-keto-pentanoic acid tert-butyl ester (508c), prepared in a similar manner to compound 509b, yields 544 mg (9) %) Of light yellow foam: 0] d20 -86 ° (c 0.19, CH2C12); IR (KBr) 3426, 2947, 1725, 1669, 155 1, 1418, 1383, 1253, 1 155, 1064; lH NMR ( CDCl3) ό 8.49 (2H, d, J = 4.8), 7.13 (1H, d, J = 7.9), 7.03-6.98 (1H, m), -589- Paper scales are generally made in China National Standard Leather (CNS) A4 Present (210 X 297 male cage) 1235157 Μ Printed by the Consumers' Cooperative of the Ministry of Economic Affairs of the Ministry of Economic Affairs ¾ 7 _B7_____ V. Description of the invention (587) 5.47 (1H, d, J = 7.9), 5.23-5.19 (1H, m ), 5.09-5.01 (1H, m), 4.84-4.51 (2H, m), 4.04 (2H, AB), 3.69 (3H, s), 3.38-3.19 (1H, m), 3.06 -2 · 64 (4H, m), 2.40-1.76 (6H, m), 1.43 (9H, s), analysis C25 Calculation of H34N608S 値: C, 51.89; H, 5.92; N, 14.52 3 Found: C, 51.49; H, 6.04; N, 13.87 3 MS (ES +) 579, [3S (1S, 9S)] 3- [6,10-diketo-9- (methoxycarbonyl) amino-1: 2,3,4,7,8,9,10-octahydro-611-dapyrido [1,24 ] [1,2] Diazapyridine-carboxamido] -5- (2-mercaptopyrimidine) -4-ketopentanoic acid (511c), prepared in a similar manner to compound 280, can produce 370 mg ( 79%) white foam: mp. 105'C (decomposed); [c] D22 -94 ° (c 0.20, CH2C12); IR (KBr) 33 16, 3057, 2957, 1724, 1664, 1252, 1416, 1384 , 1254, 1 189, 1063; lH NMR (D6-DMSO) δ 8.85 (1H, d, J = 7.8), 8.62 (2H, d, J = 4.7), 7.53 (1H. D, J = 8.0), 7.28 -7.23 (1H, m) t 5.21-5.17 (iH, m), 4.87-4.79 (1H, m), 4.47-4.35 (2H, m), 4.23 (2H, AB)? 3.58 (3H, s), 3.30 -3.21 (1H, m), 2.95-2.50 * (4H, m), 2.35-1.60 (6H, m) ^ Analyze the calculation of C2lH26N60sS * H20 値: c, 46.66; H, 5.22; N, 15.55 ^ Measured 値: C, 46.66; H, 5.13; N, 15.07. MS (ES +) 523, (ES +) 521. [3S (1S, 9S)] 3- [6,10-diketo-9- (methoxycarbonylamino) -12 3 4 7 8 9, 10-octahydro-6H-thalco [1,2 -a] [l, 2] diaza leather · 1-carboxamido) -4-one-5--5- (5- (phenylphenyltetrayl) thio) thio] valerate tert-butyl ester (5 〇8d), synthesized in a similar manner to compound 509b to produce a colorless solid (269 mg, 87%): mp. 80-11 (TC; [PAN] 〇23-i〇8. (C 〇〇〇, ch2C12 ); IR (BCBr) 3315, 2977, 1727, 1688, 1527, 1501, 1458, 1418, 1368, 1279. 1250, (please read and read the following first :; χ Italian matter and then fill out this one-pack l · Order% ___-590-This paper is applicable to the national standard (CM) 297 (Guangzhou) 1235157 A: B1 V. Description of the invention (588) Please read KK 1 1155, 1064; lH NMR (CDC13) ^ 7.70 (1H, d), 7.63-7.53 (5H, m), 5.84 (1H, d), 5.34-5.27 (1H, m), 5.05-4.92 (lH, m), 4.78-4.54 (3H , m), 4.38 (1H, d), 3.66 (3H? s), 3.37-3.19 (1H, m), 3.07-2.94 (1H, m), 2.91-2.82 (2H, m), 2.71-2.56 (1H , m)? 2.40-2.30 (1H, m), 2.19-2.13 (1H, m), 2.08-1.68 (4H, m), 1.42 (9H, s). MS (ES +) 667 (31%), 6 45 (NT + 1,100), 589 (62). [35 (15,95)] 3- [6,10-diketo-9- (methoxycarbonylamino) -1,2,3,4 , 7,8,9,10 -octazine-6H-, answer to σ well and [l, 2-a] [l, 2] · — hetero Zhuo-1-jiminamido 4-fluorenyl · 5 · [5- (1-phenyltetrazolyl) -thio] valeric acid (280c), synthesized in a similar manner to compound 280, can produce a light cream-colored solid (203 mg, 85%): 0 ^ 10: 5-130eC ; (a) D22 -235 ° (c 0.11, MeOH); IR (KBr) 3342, 295 1, 1727, 1667, 1529, 1501, 1459, 1416, 1276, 1252, 1192 · 1062; lH NMR (D6-DMSO ) δ 8.89 (1H, d), 7.69 (5H, s), 7.50 (1H, MW, Ministry of Economic Affairs, Central Standards Bureau, Consumer Consumption Cooperation, Du Printing, d), 5.180.11 (1H, m), 4.79-4.69 ( 1H, m), 4.57 (2H, s)? 4.42 · 4.32 (1H, m), 3.54 (3H, s), 2.92-2.63 (3H, m), 2.21-1.82 (5H, m), 1.65-1.57 ( 1H, m). MS (ES +) 587 (M · 1,100% "[3S (1S, 9S)] 3- [6,10-diketo-9- (methoxycarbonylamino) -1,2,3,4, 7,8,9,10-octaargon-6H · Da-Phen [l, 2-ani, 2] diazapyridine-1-carboxamido] -4-one group 0- (3-pyridyloxy Tert-butyl acetic acid (508e), synthesized in a manner similar to compound 509b, can produce a light orange solid (199 mg, 25%): mp 80-120eC; [a] D23 -89 ° (c 0.51 , CH2C12); IR (KBr) 3333, 2978, 1726, 1669, 1578, 1536, 1478, 1426, 1368, 1277, 1253, 123 2, Π55, 1064; lH NMR (CDC13) ό S.41-8.18 (2H , m), 7.81 (1H, d), 7.26-7.20 (2H, s), 5.91 (1H, d), 5.24-5.16 (1H, -591-This paper's standard is applicable to Chinese National Standard (CNS) A4. 2 丨 0X297 male) 1235157 A 7 _B7_ V. Description of the invention (589) m), 5.07-4.86 (3H, m), 4.81-4.51 (2H, m), 3.67 (3H, s), 3.34-3.16 (1H , m), 3.10-2.81 (3H, m), 2.72-2.54 (1H, m), 2.41-2.31 (1H, m), 2.07-1.62 (5H, m), 1.47 (9H s). MS ( ES spoon 562 (M + + 1, 100%), 506 (38)-[3S (1S, 9S)] 3- [6,10-diketo-9- (methoxycarbonylamino) -1,2, 3,4,7,8,9, 10-octahydro-6H-da- [ -a] [l, 2] diazapyridine-1-carboxypyretyl] -4-one-5- (3-pyridyloxy) pentanoic acid (283c), synthesized in a similar manner to compound 280, Can produce white powder (167 mg, 98%): mp 9 CM 05 &quot; C: [Not] D22 -106. (C 0 · 11, MeOH); IR (KBr) 3325, 3070, 2956, 1669, 1544 , 1423, 1256, 1 199, 1133, 1062; LH NMR (D6-DMSO) δ 8.95 (1H, d), 8.45-8.20 (2H, m), 7.53-7.45 (3H, m), 5.19-5.08 (3H , m), 4.70-4.62 (1H, m), 4.41-4.30 (2H, m), 3.53 (3H, s), 2.92-2.68 (3H, m), 2.22-2.06 (2H, m), 1.95-1.82 (2H, m), 1.63-1.53 (1H, m). MS (ES +) 506 (M + + 1, 100%).

O OO O

經濟部中央樣準局員工消资合作社印袋 _________ -592 - 本成狀度適财CNS ) A4,祕(21QX:97公慶 1 1235157 Λ7 B7 五、發明説明(590) 化合物 R 512a Q 280d 、sAr 512b 283d Ό (請先3讀背云之注意事項再填寫本頁 裝 [3S(1S,9S)] 3-(9-乙醢胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒畊並[l,2-a][l,2]二氮雜箪-1·羧醯胺基)-4-酮基 苯基-1H-四唑 〇-硫)戊酸第 三丁酯 (512a) , 如 化合物 509b 之類似方法製備,可生成(83%)無色泡沫:l&gt;]D23 -129·6。 (c 0.1,CH2C12); IR (KBr) 3326, 1726, 1664, 1531,1501,1444, 1415, 1394, 1369, 1279, 1254, 1 156; ^ NMR (CDC13) δ 7.59 (5Η, s), 7.37 (1Η, d, J - 7.9), 6.38 (1H, d, J = 7.4), 5.27 (1H, m), 4.98 (2H, m), 4.58 (2H, d, + m), 4.28 (1H, d, J -17.2), 3.28 (1H, m), 3.10-2.65 (4H, m), 2.31 (2H, m), 2.03 (3H,s),2.10-1.72 (4H, m),1.48 (9H, s)。 [35(15,95)】3-(9-乙酷腔基-6,10-二銅基-1,2,3,4,7,8,9,10-八 氫-6H-嗒啡並[l,2-a][l,2]二氮雜箪-1-羧醢胺基M-酮基-5-(1-苯基-1Η-四唑-5-硫)戊酸(280d),以如化合物280之相似 方法製備,可生成(77%)無色泡沫:k]D22 -93.3° (c 0.1, CH2Ci2); IR (KBr) 33 16, 1728, 1659, 153 1, 1501, 1415, 1341, -593- 本纸浪又度適用中S®家標孪(CNS ) ,\4死格U10X297公次) 訂 經濟部中夬櫺準局員工消费合作杜印¾ 1235157 Λ 7 B7 五、發明説明(591) 1278, 1253, 1222, 1 185; lE NMR (CDC13) (ί 8.05 (1Η, d, J = 7.9), 7.57 (5H, br s), 5.30 (1H, m), 5.01 (2H, m), 4.70-4.10 (4H,m),3、40_2.85(4H,m),2.62(lH,m),2.33(lH,m),2.27- 1.65 (5H, m),2.01 (3H,s)。 [3 5(13,95)】3-(9-乙醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氮-6H·令*井並[1,2-a][ 1,2]二氣雜革· 1 -敌醒胺基)-4-銅基-5· (3-吡啶基氧基)戊酸第三-丁酯(512b),以類似化合物509b 之方法製備,可生成(9%)無色泡沫:IR (KBr) 3333, 1727, 1661, 1542, 1427, 1369, 1279, 1257, 1232, 1 156: lH NMR (CDC13) ^ 8.30 (2Η, m), 7.20 (3Η, m), 6.45 (1H, ,d, J = 7.4), 5.17(lH,m),4.91(3H,m),4.55(lH,m),3.27(lH,m),3.14- 2.70 (4H, m), 2.41 (1H, m), 2.04 (3H, s), 2.10-1.64 (6H, m), 1·44 (9H,s” 經濟部tb·央標隼局員工消贤合作社印¾ [35(15,95)]3-(9-乙醯胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫-6H-嗒哜並[l,2-a][l,2】二氮雜箪-1-羧醯胺基)-4-酮基o-(3-毗啶基氧基)戊酸(283 d),以化合物280之類似方法製備 ,(100〇/〇)呈無色泡沫:〇]D22 -106.0。(c 0.2, CH30H/ CH2C12); IR (ΚΒγ) 33 12, 1735, 1664, 1549, 1426, 1279, 1258, 1200, 1135; lK NMR (CDCi3) ά 8.27 (2H, m), 7.46 (2H, m), 5.09 (1H,m), 4·79 (3H,m), 4.47 (1H,m),3.40 (1H,m),3.30· 2.70 (3H, m), 2.54 (1H, m), 2.30 (lH, m), i.98 (3H, s), 2.05- 1.65 (4H,m卜 -594- 本纸绦尺度適用中国S家櫺隼(CNS ) A4現漆(210X297公痠) 1235157 Λ7 B7 ¾濟部中夬樣準局員工消費合作社印¾. 五、發明説明(592 )Printed bags of the Consumers' Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs _________ -592-This condition is suitable for financial CNS) A4, Secret (21QX: 97 Public Holiday 1 1235157 Λ7 B7 V. Description of the invention (590) Compound R 512a Q 280d 、 SAr 512b 283d Ό (Please read the precautions of Back Cloud 3 before filling in this page and install [3S (1S, 9S)] 3- (9-Ethylamino-6,10-diketo-1,2, 3,4,7,8,9,10-octahydro-6H-da-phen [l, 2-a] [l, 2] diazapyrene-1 · carboxamido) -4-ketobenzene Butyl-1H-tetrazolyl-thio) valeric acid tert-butyl ester (512a), prepared in a similar manner as compound 509b, can produce (83%) a colorless foam: l &gt;] D23 -129 · 6. (C 0.1, CH2C12); IR (KBr) 3326, 1726, 1664, 1531, 1501, 1444, 1415, 1394, 1369, 1279, 1254, 1 156; ^ NMR (CDC13) δ 7.59 (5Η, s), 7.37 (1Η, d , J-7.9), 6.38 (1H, d, J = 7.4), 5.27 (1H, m), 4.98 (2H, m), 4.58 (2H, d, + m), 4.28 (1H, d, J -17.2 ), 3.28 (1H, m), 3.10-2.65 (4H, m), 2.31 (2H, m), 2.03 (3H, s), 2.10-1.72 (4H, m), 1.48 (9H, s). [35 (15,95)] 3- (9-ethynyl-6,10-dicopperyl-1,2,3,4,7,8,9,10-octahydro-6H-daphne [l , 2-a] [l, 2] diazepine-1-carboxyamidoamino M-keto-5- (1-phenyl-1fluorene-tetrazole-5-thio) valeric acid (280d) Prepared in a similar way as compound 280, which can produce (77%) colorless foam: k] D22 -93.3 ° (c 0.1, CH2Ci2); IR (KBr) 33 16, 1728, 1659, 153 1, 1501, 1415, 1341, -593- This paper wave is also applicable to the Chinese S® Family Standard Twin (CNS), \ 4 dead grid U10X297 times. Ordering of the consumer cooperation cooperation of the China Central Standards Bureau of the Ministry of Economic Affairs DU 1235157 Λ 7 B7 V. Description of the invention ( 591) 1278, 1253, 1222, 1 185; lE NMR (CDC13) (ί 8.05 (1Η, d, J = 7.9), 7.57 (5H, br s), 5.30 (1H, m), 5.01 (2H, m) , 4.70-4.10 (4H, m), 3, 40_2.85 (4H, m), 2.62 (lH, m), 2.33 (lH, m), 2.27-1.65 (5H, m), 2.01 (3H, s) . [3 5 (13,95)] 3- (9-Ethylamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octazine-6H · L * Irido [1,2-a] [1,2] Digas [1,2-diamino] -4-copperyl-5 · (3-pyridyloxy) valeric acid tert-butyl ester ( 512b), prepared by a method similar to compound 509b, which can produce (9%) colorless foam: IR (KBr) 3333, 1727, 1661, 1542, 1427, 1369, 1279, 1257, 1232, 1 156: lH NMR (CDC13) ^ 8.30 (2Η, m), 7.20 (3Η, m), 6.45 (1H,, d, J = 7.4), 5.17 (lH, m), 4.91 (3H, m), 4.55 (lH, m), 3.27 ( lH, m), 3.14- 2.70 (4H, m), 2.41 (1H, m), 2.04 (3H, s), 2.10-1.64 (6H, m), 1.44 (9H, s) Ministry of Economic Affairs tb · Yang [35 (15,95)] 3- (9-Ethylamino-6,10-diketo-1,2,3,4,7,8,9,10 -Octahydro-6H-dalopano [l, 2-a] [l, 2] diazapyridine-1-carboxamido) -4-one o- (3-pyridinyloxy) pentane Acid (283 d), prepared in a similar manner to compound 280, (100 //) as a colorless foam: 〇] D22 -106.0. (C 0.2, CH30H / CH2C12); IR (κΒγ) 33 12, 1735, 1664, 1549, 1426, 1279, 1258, 1200, 1135; lK NMR (CDCi3) ά 8.27 (2H , m), 7.46 (2H, m), 5.09 (1H, m), 4.79 (3H, m), 4.47 (1H, m), 3.40 (1H, m), 3.30 · 2.70 (3H, m), 2.54 (1H, m), 2.30 (lH, m), i.98 (3H, s), 2.05- 1.65 (4H, m BU-594- The paper size is suitable for China S furniture (CNS) A4 lacquer (210X297 male acid) 1235157 Λ7 B7 ¾ Printed by the Consumers' Cooperative of the Chinese Provincial Bureau of Procurement and Quarantine of the Ministry of Economic Affairs Ⅴ. Description of the Invention (592)

245b · 24Sb [1S,9S(2RS,3S)] 9-苄醯胺基-N-(2-苄氧基-5-鲷基四氫呋喃· 3-基)-1,2,3,4,7,8,9,10-八氫-1〇-酮基-6^1-嗒咩並[1,24][1,2】 二氮雜箪-1-羧醢胺(245b),製備自(1S,9R) 9-苄铥胺基· 1,2,3,4,7,8,9,10-八氫-10-酮基-61^嗒啩並[1,24][1,2]二氮雜 箪-1-羧酸,利用245之方法,可生成416毫克(85%)约無色 泡沫(〜1:1的非對映立鳢異構混合物):IR (KBr) 3392, 3302, 2942, 1792, 1642, 1529, 1520, 1454, 1 119; lH NMR (CDC13) δ 7.79 (2Η, m), 7.51^7.09 (10Η, m), 5.52 (0.5H, d, J = 5.3), 5.51 (0.5H, s), 5.36 (1H, m), 4.84 (1H, m), 4.74-4.59 (1.5H, m), 4.51 (iH, m), 4.38 (0.5H, m), 3.22-2.83 (5H, m), 2.51 (1H, m), 2.25 (2H,m), 2·01·1·46 (6H, m)。分析 C23H32N406. 0·75Η2Ο之計算値:C, 62.97; H,6··32; N, 10.49 3 實測値:C, 63.10; Η, 6·16; N,10·2卜 MS (ES+) 521 (M + 1,l〇0%) 0 [35(15,95)]3-(9-苄醯胺基1,2,3,4,7,8,9,1〇-八氫-61^塔啩並 [l,2-a][l,2]二氮雜箪小羧醯胺基)-4-酮基丁酸(246b) ’製備 __ -595- _ 本紙汝尺度適用中SS家榡率(CNS ) A4吮格(2〖〇χ 297公趁1 (請先知讀背5之:/JS.意事項再填寫本莧) 裝. 訂 1235157 A7 87 五、發明説明(593 ) 自245b,利用246之方法可生成104毫克(33%)白色粉末: mp. 115-119eC ; 〇]D24 -19.8。(c 0.2, MeOH); IR (KBr) 3293, 2944, 1786, 1639, 1578, 1537, 1489, 1450, 1329, 1 162, 1 124; lH NMR (CD3OD) &lt;S 7.85 (2H, d, J = 7.0), 7.49 (3H, m), 5.49 (1H, m), 4.55 (1H, m), 4.30 (2H, m), 3.40 (1H, m), 3.19-2.89 (3H,m),2·63 (2H, m), 2.16-1.81 (5H,m),1.60 (3H,m)。分析 C2iH26N406.H20之計算値:C,56.24; H,6.29; N, 12.49 3 實測 値:C, 56·54; H,6.05; N, 12.29。MS (ES + ) 429 (Μ - 1,100%)。 化合物513a-j如下述製備。 請 先 讀 背 之 注 意 事 項 再 填 寫 Ά 〇245b · 24Sb [1S, 9S (2RS, 3S)] 9-benzylamido-N- (2-benzyloxy-5-brenzyltetrahydrofuran · 3-yl) -1,2,3,4,7, 8,9,10-octahydro-1O-keto-6 ^ 1-dapyrido [1,24] [1,2] diazapyridine-1-carboxamide (245b), prepared from (1S , 9R) 9-benzylamidoamino group 1,2,3,4,7,8,9,10-octahydro-10-keto-61 ^ da [1,24] [1,2] di Azapyridine-1-carboxylic acid, using method 245, can produce 416 mg (85%) of about colorless foam (~ 1: 1 diastereoisomeric diisomeric mixture): IR (KBr) 3392, 3302, 2942 , 1792, 1642, 1529, 1520, 1454, 1 119; lH NMR (CDC13) δ 7.79 (2Η, m), 7.51 ^ 7.09 (10Η, m), 5.52 (0.5H, d, J = 5.3), 5.51 ( 0.5H, s), 5.36 (1H, m), 4.84 (1H, m), 4.74-4.59 (1.5H, m), 4.51 (iH, m), 4.38 (0.5H, m), 3.22-2.83 (5H , m), 2.51 (1H, m), 2.25 (2H, m), 2 · 01 · 1 · 46 (6H, m). Analyze the calculation of C23H32N406. 0 · 75Η20. 値: C, 62.97; H, 6. · 32; N, 10.49 3 Measured 値: C, 63.10; Η, 6.16; N, 10 · 2. MS (ES +) 521 ( M + 1,100%) 0 [35 (15,95)] 3- (9-benzylamidoamino1,2,3,4,7,8,9,10-octahydro-61 ^ tower Pyrene [l, 2-a] [l, 2] diazepine small carboxyamido) -4-ketobutanoic acid (246b) 'Preparation __ -595- _ This paper is suitable for SS furniture Rate (CNS) A4 (2) 〇χ 297 males while taking 1 (please read the 5 of the prophet: / JS. Please fill in this note) Note. Order 1235157 A7 87 V. Description of the invention (593) Since 245b, Using the 246 method, 104 mg (33%) of white powder can be generated: mp. 115-119eC; 〇] D24 -19.8. (C 0.2, MeOH); IR (KBr) 3293, 2944, 1786, 1639, 1578, 1537, 1489, 1450, 1329, 1 162, 1 124; lH NMR (CD3OD) &lt; S 7.85 (2H, d, J = 7.0), 7.49 (3H, m), 5.49 (1H, m), 4.55 (1H, m ), 4.30 (2H, m), 3.40 (1H, m), 3.19-2.89 (3H, m), 2.63 (2H, m), 2.16-1.81 (5H, m), 1.60 (3H, m). Analyze the calculation of C2iH26N406.H20: C, 56.24; H, 6.29; N, 12.49 3 Found: C, 56 · 54; H, 6.05; N, 12.29. MS (ES +) 4 29 (Μ-1, 100%). Compounds 513a-j were prepared as follows. Please read the notes below and then write Ά 〇

經濟部中央標準局員工消費合作社印装 化合物 R 513a 513a-l 513a_2 513b 513b-l KD -596- 本紙法尺度適用中S國家標孪(CNS ) Α4現烙(2丨0 ,&lt;:^公釐) 1235157 A 7 B7 五、發明説明(594 ) 513b-2 K3 513c 、。&lt;3〇 513d v〇X) 513β &gt;〇X) 513f S13f-1 ···〜 513f-2 &gt;°x/ (旖先聞讀背云之注意事項苒填寫本f ) 裝 訂 經濟部中夬嘌準局員工消费合作杜印製Printed Compound R 513a 513a-l 513a_2 513b 513b-l KD -596- The standard of this paper is applicable to the national standard of China (CNS) A4 (2 丨 0, &lt;: ^ public (%) 1235157 A 7 B7 V. Description of the invention (594) 513b-2 K3 513c. &lt; 3〇513d v〇X) 513β &gt; 〇X) 513f S13f-1 ··· ~ 513f-2 &gt; ° x / (旖 Precautions for reading the back cloud first 云 Fill in this f) DuPont Print

-597- 本纸ft尺度逋用中SS家橾洋(CNS M4堤格(::丨0 A H97公釐) 1235157 Λ7 B7 五、發明説明(595 ) 〇-597- SS standard paper used in the ft scale of this paper (CNS M4 Tige (: 丨 0 A H97 mm) 1235157 Λ7 B7 V. Description of the invention (595)

00

(請先聞讀背云之泾意事項再填寫本f ) 經濟部中夬糅隼局員工消費合作社印戈 (2RS,3S) 3-(烯丙氧羰基)胺基-2-(2-苯乙氧基)-5-酮基四氫 呋喃(513a),以化合物513d/e之方法製備,可生成非對玦 立體異構之混合物(670毫克,50%),呈油狀:IR (KBr) 3331, 2946, 1790, 1723, 1713, 1531, 1329, 1257, 1164, 1120, 1060, 977, 937, 701; lH NMR (CDCi3) ^ 7.36-7.18 (5H, m), -598- 本纸張尺度適涓中国國家標隼(CNS ) A4处格(210X297公釐) 1235157 S?濟邡中*糅隼局員工消費合作社印¾ Λ7 B7 五、發明説明(S96) 5.99-5.83 (1H, m), 5.41-5.34 (2H, m), 5.28-5.18 (2H, m), 4.59-4.56 (2H, m), 4.32-3.96 (2H, m), 3.85-3.73 (1H? m), 3.02-2.76 (3H, m), 2.49-2.34 (1H, m) ^ (2 RS,3 S) 3-(缔两氧裝基)胺基-2-環戊乳基-5-鋼基四氫咬南 (5 13b),以5 13d/e之方法製備以生成8克(5 1 %)非對块立禮 異構之逄合物,呈澄清油狀·· 〇】D20 ·13° (c 0.25, CH2C1,); IR (KBr) 3325, 2959, 2875, 1790, 1723, 1535, 1420, 1328, 1257, 1 120, 1049, 973? 937; lH NMR (CDCi3) ό 6.02-5.80 (1H, m), 5.53-5.46 (2H, m), 5.37o.21 (2H, m), 4.58 (2H, d? J =5.5), 4.50-4.46 (0.5H, m). 4.34-4.25 (1H, m), 4.19-4.12 (0.5H, m)T 3.06-2.77 (1H, m), 2.53-2.35 (1H, m), L85-1.50 (8H,m)。分析C13H19N05i計算値:C,57·98; H,7.U; N,5·20 3 實測値:C,56.62; H,7·22; N,4.95。MS (ES+) 270 ο (2R,3S) 3-缔丙乳裝基胺基-2-(氮和-2-基乳基)-5-酌基四氫 嗅喘(513c),以化合物513 d/e之方法合成,可生成單一異 構物(20%)呈淺黃色油 a [泛]〇24 -63.1° (c 0.2, CH2C12); IR ( 薄膜)3338, 2948, 1791, 1723, 1529, 1421,1330, 1253, 1122, 984, 929, 746; lH NMR (CDCl3)d 7·20 (4H,m),5·87 (IH, m),5.61 (1H,d,J = 5·4), 5·33〇·10 (2H,m),4.70 (1H,m), 4.56 (3H, m), 3.33-3.19 (2H, m)? 3.10-2.94 (2H, m), 2.81 (1H, dd, J = 8.3, 17.3), 2.43 (1H, dd, J = 10.5, 17.3) ^ (2R,3S) 3-烯丙氧羰基胺基-2-芊氧基-5-酮基四氩呋續(513d) 反(2S,3S) 3-烯丙氧羰基胺基-2-苄氧基-5-酮基-四氫呋喃 (5l3d/e),經 Chapman Biorg. &amp; Med. Chem. Lett., 2,ρρ· 615- -599 - 適用中家標隼(CNSM4况珞(210X297公釐) ~ (請先閲讀背面之洼意事項再填寫本頁) 訂 1235157(Please read this matter before going back to the cloud before filling in this f) Ingo (2RS, 3S) 3- (allyloxycarbonyl) amino-2- (2-benzene Ethoxy) -5-ketotetrahydrofuran (513a), prepared by the method of compound 513d / e, can produce a mixture of non-paraisomeric stereoisomers (670 mg, 50%) as an oil: IR (KBr) 3331 , 2946, 1790, 1723, 1713, 1531, 1329, 1257, 1164, 1120, 1060, 977, 937, 701; lH NMR (CDCi3) ^ 7.36-7.18 (5H, m), -598 China National Standards (CNS) A4 division (210X297 mm) 1235157 S? Printed by the Employees' Cooperatives of the China Economic and Social Council * Λ7 B7 V. Description of the invention (S96) 5.99-5.83 (1H, m), 5.41 -5.34 (2H, m), 5.28-5.18 (2H, m), 4.59-4.56 (2H, m), 4.32-3.96 (2H, m), 3.85-3.73 (1H? M), 3.02-2.76 (3H, m), 2.49-2.34 (1H, m) ^ (2 RS, 3 S) 3- (associated dioxo) amino-2-cyclopentyllactyl-5-steel-based tetrahydrobitan (5 13b) , Prepared by the method of 5 13d / e to produce 8 g (5 1%) of the non-parallel Li-Isomer complex, in the form of a clear oil · · 〇] D20 · 13 ° (c 0.25, CH2C1,); IR (KBr) 3325, 2959, 2875, 1790, 1723, 1535, 1420, 1328, 1257, 1 120, 1049, 973? 937; lH NMR (CDCi3) ό 6.02-5.80 (1H, m), 5.53-5.46 (2H, m) , 5.37o.21 (2H, m), 4.58 (2H, d? J = 5.5), 4.50-4.46 (0.5H, m). 4.34-4.25 (1H, m), 4.19-4.12 (0.5H, m) T 3.06-2.77 (1H, m), 2.53-2.35 (1H, m), L85-1.50 (8H, m). Analysis C13H19N05i Calculated 値: C, 57 · 98; H, 7.U; N, 5.20 3 Measured 値: C, 56.62; H, 7.22; N, 4.95. MS (ES +) 270 ο (2R, 3S) 3-propanylaminoamino-2- (nitrogen and 2-yllactyl) -5-isopropyltetrahydrool (513c), with compound 513 d / e method, a single isomer (20%) was formed as a light yellow oil a [ubiquitous] 〇24 -63.1 ° (c 0.2, CH2C12); IR (thin film) 3338, 2948, 1791, 1723, 1529, 1421, 1330, 1253, 1122, 984, 929, 746; lH NMR (CDCl3) d 7 · 20 (4H, m), 5.87 (IH, m), 5.61 (1H, d, J = 5 · 4) , 5.33〇 · 10 (2H, m), 4.70 (1H, m), 4.56 (3H, m), 3.33-3.19 (2H, m)? 3.10-2.94 (2H, m), 2.81 (1H, dd , J = 8.3, 17.3), 2.43 (1H, dd, J = 10.5, 17.3) ^ (2R, 3S) 3-allyloxycarbonylamino-2-oxo-5-one-tetrahydrofuran ( 513d) trans (2S, 3S) 3-allyloxycarbonylamino-2-benzyloxy-5-keto-tetrahydrofuran (5l3d / e), via Chapman Biorg. &Amp; Med. Chem. Lett., 2, ρρ · 615- -599-Applicable to Chinese house logo (CNSM4 condition 珞 (210X297mm) ~ (Please read the intent on the back before filling in this page) Order 1235157

ATAT

3T 五、發明説明(597 )3T V. Invention Description (597)

618 (1992)所述方法製備。經乙酸t酯萃取及以NaHCOy^ 務後,產物乾燥·(MgS04),過遽並蒸發生成油,其中含有 產物及爷醇。加入己淀(200毫升)(每56克AllocAsp(C〇2tBu) CH2OH中使用200毫升己烷),且混合物擾拌並冷卻一夜3 此可生成油狀固體3傾析去水份,並保持以供層析。油狀 殘留物溶於乙酸乙酯中,再蒸發生成淪,其自10%乙酸乙 酯/己烷(〜500毫升)中結晶。固體過濾可生成513d(12.2克 ^ 19%) : mp. 108-110Ό; [a]D24 +75.72° (c 0.25? CH2CI2); IR (KBir) 3361,1778, 1720, 1517, 1262, 1236, 1222, 1 135, 1 121, 944, 930, 760; NMR (CDC13) i 7.38 (5H, m), 5.90 (1H, m), 5.50 (1H, s), 5.37 (0.5H, m), 5.26 (2.5H, m), 4.87 (1H, ABq), 4.63 (3H, m), 4.31 (1H, m), 3.07 (1H, dd), 2.46 (1H, dd) 。分析C15H17N05之計算値:C, 61.85; Η, 5·88; N, 4.81。實測 値:C, 61.85; Η, 5·89; N,4·80 a 經濟部中夬樣率局員X消t合作枝印¾ (請乏閱讀背面之注意事項再填寫本買) 液體混合並蒸發生成含有芊醇之油(〜200克)。加入己烷/ 乙酸乙酯(9:1,100毫升)且產物以層析純化,再以1〇%乙 酸乙酯/己烷溶離以移去過量的;醇,且再來是二氣甲烷/ 己烷(1:1含有10%乙酸乙酯)。此可生成513e,含有一些 513d (20.5 克,32%) : mp. 45-481 ; |&gt;】D24 -71.26s (c 0.25, CH2C12); IR (KBr) 3332, 1804, 1691,1536, 1279, 1252, 1125, 976。lH NMR (CDC13) d 7·38 (5H,m),5.91 (1H,m),5.54 (1H, d, J - 5.2), 5.38 (3H, m); 4.90 (1H, ABq); 4.60 (4H, m), 2·86 (1H,dd), 2·52 (1H,dd)。分析C15Hl7N〇5S.0.1H2〇之計算 値:C,61.47; Η, 5·91; N,4.78。實測値·· C, 61.42; Η, 5.88; N, -600 - 本紙伕尺度適用中SS家標卒(CNS以4呪格(210X 297公澄) 1235157 Λ7 ________B7___ 五、發明説明(598 ) 4.81 - ' (2RS,3R) 3-(烯丙氧羰胺基)-2-乙氧基-5-酮基四氫呋嘀(513f) ,以513d/e之方法製備,可生成無色的油(152毫克,79%) :IR (薄膜)3334, 2983, 2941,1783, 1727, 1713, 1547, 1529, 1422, 1378, 1331, 1313, 1 164, 1 122, 1060, 938; lU NMR (CDC13) ά 6.090.82 (2Η, m), 5.50-5.18 (3H, m), 4.64-4.54 (2H, m), 4.27-4.16 (1H, m), 3.95-3.78 (1H, m), 3.73-3.56 (1H, m), 3.05-2.77 (1H, m), 2.56-2.37 (1H, m), 1.35-1.17 (4H, m) a 分析Cl0H15NO5之計算値:C, 52.40;,6.60; N, 6·11 :實測値 經濟部中夫糅準局員工消资合作社印¾ (請先^1.讀背δ之注意事項再填寫衣f )618 (1992). After t-acetic acid extraction and NaHCOy ^ extraction, the product was dried (MgS04), dried and evaporated to form an oil, which contained the product and the alcohol. Add hexane (200 ml) (200 ml of hexane per 56 g of AllocAsp (Co2tBu) CH2OH), stir the mixture and cool overnight 3 This can form an oily solid. For chromatography. The oily residue was dissolved in ethyl acetate and evaporated to form crystalline, which was crystallized from 10% ethyl acetate / hexane (~ 500 ml). Solid filtration can produce 513d (12.2g ^ 19%): mp. 108-110Ό; [a] D24 + 75.72 ° (c 0.25? CH2CI2); IR (KBir) 3361, 1778, 1720, 1517, 1262, 1236, 1222 , 1 135, 1 121, 944, 930, 760; NMR (CDC13) i 7.38 (5H, m), 5.90 (1H, m), 5.50 (1H, s), 5.37 (0.5H, m), 5.26 (2.5 H, m), 4.87 (1H, ABq), 4.63 (3H, m), 4.31 (1H, m), 3.07 (1H, dd), 2.46 (1H, dd). Analysis of the calculation of C15H17N05: C, 61.85; Η, 5.88; N, 4.81. Measured 値: C, 61.85; Η, 5.89; N, 4 · 80 a Member of the sample rate bureau in the Ministry of Economic Affairs, X Xiaot cooperation signature ¾ (please read the precautions on the back before filling in this purchase) The liquid is mixed and evaporated An alcohol (~ 200 g) was formed. Hexane / ethyl acetate (9: 1, 100 ml) was added and the product was purified by chromatography, and then dissolved with 10% ethyl acetate / hexane to remove excess; alcohol, and then digas methane / Hexane (1: 1 with 10% ethyl acetate). This generates 513e, containing some 513d (20.5 g, 32%): mp. 45-481; | &gt;] D24 -71.26s (c 0.25, CH2C12); IR (KBr) 3332, 1804, 1691, 1536, 1279 , 1252, 1125, 976. lH NMR (CDC13) d 7 · 38 (5H, m), 5.91 (1H, m), 5.54 (1H, d, J-5.2), 5.38 (3H, m); 4.90 (1H, ABq); 4.60 (4H , m), 2.86 (1H, dd), 2.52 (1H, dd). C15H17N5S. 0.1H2O analysis 値: C, 61.47; Η, 5.91; N, 4.78. Measured 値 ··, C, 61.42; Η, 5.88; N, -600-This paper 伕 standard is applicable to the SS family standard puppet (CNS with 4 cells (210X 297 Gongcheng) 1235157 Λ7 ________B7___ 5. Description of the invention (598) 4.81- '(2RS, 3R) 3- (allyloxycarbonylamino) -2-ethoxy-5-ketotetrahydrofuran (513f), prepared by the method of 513d / e, can produce a colorless oil (152 Mg, 79%): IR (thin film) 3334, 2983, 2941, 1783, 1727, 1713, 1547, 1529, 1422, 1378, 1331, 1313, 1 164, 1 122, 1060, 938; lU NMR (CDC13) ά 6.090.82 (2Η, m), 5.50-5.18 (3H, m), 4.64-4.54 (2H, m), 4.27-4.16 (1H, m), 3.95-3.78 (1H, m), 3.73-3.56 (1H , m), 3.05-2.77 (1H, m), 2.56-2.37 (1H, m), 1.35-1.17 (4H, m) a Calculation of Cl0H15NO5 analysis: C, 52.40 ;, 6.60; N, 6 · 11: Measured by the Chinese Ministry of Economic Affairs, China ’s Husband and Workers ’Bureau, Consumers’ Cooperatives ¾ (Please read ^ 1. Please read the precautions for δ before filling in the clothes f)

:C, 52·16; H,6.62; N, 5.99。MS (ES勹 229 (M+ + 1,100%)。 (3S,4RS) 3-(烯丙氧羰基胺基)-4-羥基o-(2-苯氧芊醢氣基)戌 酸第三·丁酯(513g)。4-二曱胺基吡啶(76.0毫克,622毫莫 耳)加至2-苯氧基笮醯氣(579毫克,2·49毫莫耳)及517(600 毫克,2.07毫莫耳)於吡啶(10毫升)之溶液中3混合物在室 溫下捷掉18小時,再加入鹽水(25毫升)’並以乙故乙醋(30 X 2·5毫升)萃取3混合的有機萃取物以1Μ鹽水(3 X 25毫升) ,飽和的碳酸氫鈉水溶液(2x25毫升)及鹽水(25毫升)洗滌 ,乾燥(MgS04)再濃縮。淺橘色油以快速管柱層析块化(1-10%丙酮/二氣甲烷)可生成447毫克(44%)的無色油:IR (薄 膜)3375, 2980, 1721, 1712, 1602, 1579, 1514, 1484, 1451, 1368, 1294, 1250, 1234, 1 161,1137, 1081,754; lHNMR (CDCi3) d 7.98^7.93 (1H, m), 7.50-7.41 (1H, m), 7.35-7.25 (2H, m)t 7.22-7.03 (3H, m), 6.95 (3H, d), 5.95-5.76 (1H, m), 5-57 (1H, d), 5.30-5.13 (2H, m), 4.51 (2H, d)t 4.25 (2H? d), -601 - 本紙張尺度通用中國國家標车(CNS ) A4規格(210乂 297公釐) 1235157 A 7 . __B7_ 五、發明説明( 599) . 4.18-4.04 (1H, m), 3.88 (1H, m), 3.50 (1H, m), 2.51 (2H, m), 1.41 (9H, s) - MS (ES+) 508 (57%), 503 (76), 486 (M^ + 1, 45),468 (27),412 (100)。C26H32N08 (MIT)之精確質量計算 値:486.2128。實測値:486.2158。 (3S,4R)(N-烯丙氧羰基)-3-胺基-4-羥基-5-(1-莕甲醯基氧基) 戊酸第三-丁酯(513h),製備自(3S,4R)(N-烯丙氧芦基)-3-胺 基4,5-二羥基戊酸第三·丁酯,以如513g之方法生成562毫 克(85%)的無色油 a IR (薄膜)3418, 2980, 1722, 171 1,1512, 1368, 1278, 1245, 1198, 1157, 1139; lH NMR (CD3〇D) ά 8.90 (1Η, d, J = 8·6), 8·21 (1Η,dd, J = 1.2, 7·3), 8·04 (1Η, d, J = 8.2), 7.89 (1H, dd, J = 1.5, 7.9), 7.67-7.46 (3H, m)? 5.88 (1H, m), 5.49 (1H, d, J = 9.0), 5.35-5.18 (2H, m), 4.57-4.46 (4H,m), 4.19 (2H,m),2·67 (2H, m),1·40 (9H, s)。分析 C24H29N07t計算値:C,65.00; Η, 6.59; N, 3.16。實測値:C, 64·74; Η, 6.56; N, 3·09。M.S (ES+) 466 (M+Na,100%),444 (M+l,39),388 (4)。 (3S,4RS) 3-(烯丙氧羰基胺基)-4-羥基-5-(3-苯氧基芊蘊氧基) 戊酸第三-丁酯(513i),以化合物513g之方法合成,可生成 無色的油(569毫克,85%) : IR (薄膜)3400,1723,1712, M濟部中央標進局員工消費合作杜印¾ 1584, 1528, 1489, 1443, 1367, 1276, 1232, 1 190, 1 161, 1098, 1074? 995, 755; lH NMR (CDCi3) ^ 8.65-8.59 (iH, d), 7.84-: C, 52 · 16; H, 6.62; N, 5.99. MS (ES 勹 229 (M + + 1,100%). (3S, 4RS) 3- (allyloxycarbonylamino) -4-hydroxyo- (2-phenoxyfluorenyl) acetic acid Third · Butyl ester (513g). 4-Diamidopyridine (76.0 mg, 622 mmol) was added to 2-phenoxyphosphonium (579 mg, 2.49 mmol) and 517 (600 mg, 2.07) 3 moles) in a solution of pyridine (10 ml). 3 The mixture was quenched at room temperature for 18 hours, then brine (25 ml) was added and extracted with ethyl acetate (30 X 2.5 ml). The organic extract was washed with 1M brine (3 X 25 ml), saturated aqueous sodium bicarbonate solution (2x25 ml) and brine (25 ml), dried (MgS04) and concentrated. The light orange oil was lumped by flash column chromatography (1-10% acetone / digas methane) produces 447 mg (44%) of colorless oil: IR (thin film) 3375, 2980, 1721, 1712, 1602, 1579, 1514, 1484, 1451, 1368, 1294, 1250 , 1234, 1 161, 1137, 1081, 754; lHNMR (CDCi3) d 7.98 ^ 7.93 (1H, m), 7.50-7.41 (1H, m), 7.35-7.25 (2H, m) t 7.22-7.03 (3H, m), 6.95 (3H, d), 5.95-5.76 (1H, m), 5-57 (1H, d), 5.30-5.13 (2H, m), 4.51 (2H, d) t 4.25 (2H? d), -601-This paper size is in accordance with China National Standard Car (CNS) A4 specifications (210 乂 297 mm) 1235157 A 7. __B7_ 5. Description of the invention (599). 4.18-4.04 (1H, m), 3.88 (1H, m), 3.50 (1H, m), 2.51 (2H, m), 1.41 (9H, s)-MS (ES +) 508 (57%), 503 (76), 486 (M ^ + 1, 45), 468 (27), 412 (100). Accurate mass calculation for C26H32N08 (MIT) 値: 486.2128. Found 48: 486.2158. (3S, 4R) (N-allyloxycarbonyl) -3-amine 4-Hydroxy-5- (1-methylformamyloxy) tert-butyl valerate (513h), prepared from (3S, 4R) (N-allyloxetyryl) -3-amino Tertiary-butyl 4,5-dihydroxyvalerate, yielding 562 mg (85%) of a colorless oil a IR (thin film) 3418, 2980, 1722, 171 1, 1512, 1368, 1278, 1245 , 1198, 1157, 1139; lH NMR (CD3〇D) ά 8.90 (1Η, d, J = 8.6), 8.21 (1Η, dd, J = 1.2, 7.3), 8.04 (1Η , d, J = 8.2), 7.89 (1H, dd, J = 1.5, 7.9), 7.67-7.46 (3H, m)? 5.88 (1H, m), 5.49 (1H, d, J = 9.0), 5.35- 5.18 (2H, m), 4.57-4.46 (4H, m), 4.19 (2H, m), 2.67 (2H, m), 1.40 (9H, s). Analysis C24H29N07t calculates 値: C, 65.00; Η, 6.59; N, 3.16. Measured 値: C, 64 · 74; Η, 6.56; N, 3.09. M.S (ES +) 466 (M + Na, 100%), 444 (M + 1, 39), 388 (4). (3S, 4RS) 3- (allyloxycarbonylamino) -4-hydroxy-5- (3-phenoxyfluorenyloxy) tert-butyl valerate (513i), synthesized by the method of compound 513g , Can produce colorless oil (569 mg, 85%): IR (thin film) 3400, 1723, 1712, M. Central Ministry of Economic Affairs, Ministry of Economic Affairs, Employee Consumption Cooperation , 1 190, 1 161, 1098, 1074? 995, 755; lH NMR (CDCi3) ^ 8.65-8.59 (iH, d), 7.84-

7.66 (2H, m), 7.45-711 (5H, m), 7.05-6.97 (2H, m), 6.00-5.78 (1H, m), 5.54-5.14 (2H, m), 4.62-4.52 (2H, m), 4.42-4.32 (2H, m), 4.08-4.22 (2H, m), 2.78-2.47 (2H, m), 1.44 (9H, s) 3 MS -602- ____ 本纸伕尺度通用中SI國家標準(CNS ) M逆格(2[0X 297公釐) 1235157 Α7 Β7 五、發明説明(600 ) (ES+) 508 (100%),486 (M+ + 1,33C26H32N08 (MH+)之精 確質量計算値:486.2128。實測値·· 486.2121。 (3S,4RS) 3-(烯丙氧羰皞基)-4-羥基〇-(5-甲基-3-苯基異噁 唑基甲醢基氧基)戊酸第三-丁酯(513j),以化合物513g之方 法合成,可生成淺橘色油(905毫克,91%) : IR (薄貘)3418, 3383, 2980, 1722, 1711,1601, 1517, 1450, 1424, 1368, 1308, 1252, 1154, 1100, 994, 767, 698; NMR (CDC13) ά 7.62- 7.55 (2Η, m), 7.51-7.42 (3H, m), 5.98-5.76 (1H, m), 5.33-5.18 (2H, m), 4.53 (2H, d), 4.18 (2H, d), 3.91 (1H, m), 3.80 (1H, m),2·76 (3H, s),2·50 (2H, m),1.43 (9H,s)。分析 C24H30N2O8.0.5H2O之計算値:C, 59.62; H,6·46; N, 5.79。實 測値:C, 59·46; H,6·24; N,5·72。MS (ES+) 497 (100%),475 (M+ + 1, 15), 419 (48), (請先閱讀背&amp;之注意事項昇填寫本頁) -装· 訂 經濟部中央櫺隼局負工消贤合作·社印装 〇 ο7.66 (2H, m), 7.45-711 (5H, m), 7.05-6.97 (2H, m), 6.00-5.78 (1H, m), 5.54-5.14 (2H, m), 4.62-4.52 (2H, m ), 4.42-4.32 (2H, m), 4.08-4.22 (2H, m), 2.78-2.47 (2H, m), 1.44 (9H, s) 3 MS -602- ____ This paper is a universal standard in the national standard of SI (CNS) M inverse (2 [0X 297 mm) 1235157 Α7 B7 V. Description of invention (600) (ES +) 508 (100%), 486 (M + + 1, 33C26H32N08 (MH +) accurate mass calculation 値: 486.2128 Measured 値 486.2121. (3S, 4RS) 3- (allyloxycarbonylfluorenyl) -4-hydroxy 0- (5-methyl-3-phenylisoxazolylmethylfluorenyloxy) valeric acid Tertiary-butyl ester (513j), synthesized by the method of compound 513g, can produce light orange oil (905 mg, 91%): IR (thin tincture) 3418, 3383, 2980, 1722, 1711, 1601, 1517, 1450 , 1424, 1368, 1308, 1252, 1154, 1100, 994, 767, 698; NMR (CDC13) ά 7.62- 7.55 (2Η, m), 7.51-7.42 (3H, m), 5.98-5.76 (1H, m) , 5.33-5.18 (2H, m), 4.53 (2H, d), 4.18 (2H, d), 3.91 (1H, m), 3.80 (1H, m), 2.76 (3H, s), 2.50 (2H, m), 1.43 (9H, s). Analysis of the calculation of C24H30N2O8.0.5H2O 値: C, 59.62; H, 6.46; N, 5.79. Found 値: C, 59 · 46; H, 6.24; N, 5.72. MS (ES +) 497 (100%), 475 (M + + 1, 15), 419 (48), ( Please read back &amp; notes before filling out this page)-Binding and ordering.

-603- 本紙伕尺度通用中國國家標孪(CNS ) Α4堤格(210χ 297公釐) 1235157-603- Standard Chinese Standard Twin (CNS) Α4 Tige (210 × 297 mm) 1235157

AT B7 五、發明説明(601 ) .AT B7 V. Description of Invention (601).

(3S,4R) 3-宇胺基二甲基甲二氣基)戊酸第三·丁黯(514) ,依 H. Matsuaaga, et al· Tetrahedron Letters 24, ρρ· 3009-3012 (1983)之方法製備,呈純的非對块立禮異構物型式 (60%),呈油狀:l&gt;]D23 -36.9° (c 〇·5,二氣曱坑);iR (薄膜) 2982, 2934, 1726, 1455, 1369, 1257, 1214, 1 157, 106S: lH NMR (CDC13) c)' 7·31 (5H,m),4.10 (1H, q, J = 6.0),4.05· 3.75 (4H, m), 3.10 (1H, q, J = 6.0), 2.40 (2H, m), 1.42 (9H, s), 1.40 (3H, s), 1.34 (3H, s) ^ _ (3S,4R) 3-(缔两氧後胺基)-4,5-(二甲基甲一乳基)戊k第二-丁酯(516)。514 (302克,9.00毫莫耳)及10°/。?(1/(:(300毫克) 於乙蒔(30毫升)在氫下攪摔2小時3懸浮液經由Ceiite過遽( 及0.45毫米之濾膜),且濾液濃縮生成無色的油515 (2·106 克,95%),可使用勿需再純化°油(1.93克’ 7·88毫莫耳) 溶於水中(10毫升),再加入I·4·二哼烷及後酸氫鈉(695毫克 ,8.27毫莫耳)a混合物冷卻至〇*C,再逐滴加入氣曱酸烯 丙酯(1.04克,919毫升,8.66毫莫耳3小時後,昆合物以 乙醚萃取(2 X 50毫升)。混合的乙醚萃取物以水(2 x 25毫升) 及鹽水(25毫升)洗滌,乾燥(MgS04)並濃縮以生成無色的 經濟部中夬標孳局員工消f合作·杜印裳 {請先閔1|背δ之注意事項再填寫本I) 油。快速層析(10-35%乙酸乙酯/己烷)可生成無色固禮 (2.69克,95%) : mp. 64-5Ό ;[泛】d2j -21。(c 1.00,CH2Cl2); IR (KBr) 3329, 1735, 1702; ιΗ NMR (CDCl3) ^ 6.00-5.82 (1Η, m), 5.360.14 (2Η, m), 542 (1Η, s)? 4.56 (1H, d)? 4.40-4.08 (2H, m), 4.03 (1H, m), 3.70 (1H, m), 2.52 (2H, m)? 1.44 (12H, 2 x s),1.33 (3H,s);分析Cl6H27NO〆計算値:C, 58.34; _-604-__ 本纸汝尺度適用中S国家標辛(CNS ),*\4堤格(210X 297公釐) 1235157 A 7 B7 五、發明説明(602 )(3S, 4R) 3-Usaminodimethyldimethyldicarbazone) valeric acid tertiary butan (514), according to H. Matsuaaga, et al. Tetrahedron Letters 24, ρρ 3009-3012 (1983) Prepared by the method, it is a pure non-block Lili isomeric form (60%), and it is oily: l &gt;] D23 -36.9 ° (c 0.5, digas radon); iR (thin film) 2982, 2934 , 1726, 1455, 1369, 1257, 1214, 1 157, 106S: lH NMR (CDC13) c) '7.31 (5H, m), 4.10 (1H, q, J = 6.0), 4.05 · 3.75 (4H, m), 3.10 (1H, q, J = 6.0), 2.40 (2H, m), 1.42 (9H, s), 1.40 (3H, s), 1.34 (3H, s) ^ _ (3S, 4R) 3- (Amine group after dioxygenation) -4,5- (dimethylmethylmonolactyl) penta second-butyl ester (516). 514 (302 g, 9.00 mmol) and 10 ° /. ? (1 / (: (300 mg) was stirred in ethyl diacetate (30 ml) under hydrogen for 2 hours. 3 The suspension was passed through a Ceiite filter (and a 0.45 mm filter membrane), and the filtrate was concentrated to give a colorless oil 515 (2 · 106 g, 95%), can be used without further purification. Oil (1.93 g '7.88 mmol) is dissolved in water (10 ml), and then added with I · 4 · dihumane and sodium hydrogen phosphate (695 (Mg, 8.27 mmol), a mixture was cooled to 0 * C, and then allyl pivalate (1.04 g, 919 ml, 8.66 mmol) was added dropwise after 3 hours, and the compound was extracted with ether (2 X 50 Ml). The mixed ether extract was washed with water (2 x 25 ml) and brine (25 ml), dried (MgS04), and concentrated to produce a colorless Ministry of Economic Affairs, China Standards Bureau staff. Du Yinshang { Please fill in the notes of δ before filling in this I) oil. Flash chromatography (10-35% ethyl acetate / hexane) can produce a colorless solid solution (2.69 g, 95%): mp. 64-5Ό [PAN] d2j -21. (C 1.00, CH2Cl2); IR (KBr) 3329, 1735, 1702; ιΗ NMR (CDCl3) ^ 6.00-5.82 (1Η, m), 5.360.14 (2Η, m), 542 (1Η, s)? 4.56 (1H, d)? 4.40-4.08 (2H, m), 4.0 3 (1H, m), 3.70 (1H, m), 2.52 (2H, m)? 1.44 (12H, 2 xs), 1.33 (3H, s); analysis of Cl6H27NO〆 calculation: C, 58.34; _-604- __ This paper is suitable for Chinese S Standards (CNS), * \ 4 dyke (210X 297 mm) 1235157 A 7 B7 V. Description of the invention (602)

H,8,26; Ν,4·25。實測値:C,58、·12; Η,8·16; Ν,4·19; MS (+FAB) 320 (M++1,41%),274 (70),216 (100” (請先閎讀背面之注意事項再填寫本萸) (3 S,4R) 3-(烯丙氧羰基胺基)·4,5-二#至基戊酸第三-丁酯(517) 。516(2.44克,7·41毫莫耳)於80%醋酸水溶液(25毫升)之 溶液在室溫下攪拌24小時,再濃縮及與甲笨(2 X 25毫升) 共沸。殘留物以鹽水處理(25毫升),再以乙酸乙酯萃取(2 X 25毫升)。有機流份乾燥(MgS04),並濃縮生成無色的油 。快速層析(20-80%乙酸乙酯/二氣甲烷)可生成無色的固鳢 (1,99克,90%) ·· mp· 74ol; 〇]D25 -1.3。(c 1.0, CH2C12); IR (KBr) 1723, 1691; ιΗ NMR (CDCi3) ά 6.02-5.78 (2Η, m), 5.35-5.16 (2Η, m), 4.55 (2Η, d), 4.16-4.04 (2H, m), 2.76 (2H, s),3·56 (2H, m), 2·56 (2H,m), 1.43 (9H,s)。分析 C13H23N〇6 之計算値·· C, 53·97; H,8·01; N,4.84 a 實測値·· C,53.79; H, 7.88; N,4.81; MS (+FAB) 290 (NT+1,44%), 234 (100), 實例30 化合物1105-1125如下製備。這些化合物之物理數據列於 表24中。 經濟邡令央櫺皋局員工消費合作社印¾ ____-605-__---- 1235157 A:B7 五、發明説明(603 ) M濟部令央標隼局負工消費合作社印製H, 8, 26; Ν, 4.25. Measured 値: C, 58, 12; Η, 8.16; Ν, 4.19; MS (+ FAB) 320 (M ++ 1, 41%), 274 (70), 216 (100 ”(please first闳 Read the notes on the reverse side and fill in this 萸) (3 S, 4R) 3- (allyloxycarbonylamino) · 4,5-di # to tert-butyl valerate (517). 516 (2.44 G, 7.41 mmol) in 80% aqueous acetic acid (25 ml), stirred at room temperature for 24 hours, concentrated and azeotroped with methylbenzyl (2 x 25 ml). The residue was treated with brine (25 Ml), and then extracted with ethyl acetate (2 X 25 ml). The organic fractions were dried (MgS04) and concentrated to produce a colorless oil. Flash chromatography (20-80% ethyl acetate / digas methane) yielded colorless (1,99 g, 90%) ·· mp · 74ol; 〇] D25 -1.3. (C 1.0, CH2C12); IR (KBr) 1723, 1691; ι NMR (CDCi3) ά 6.02-5.78 (2Η , m), 5.35-5.16 (2Η, m), 4.55 (2Η, d), 4.16-4.04 (2H, m), 2.76 (2H, s), 3.56 (2H, m), 2.56 (2H , M), 1.43 (9H, s). Analysis of the calculation of C13H23N06 〇 · C, 53 · 97; H, 8.01; N, 4.84 a Measured 値 · C, 53.79; H, 7.88; N, 4.81; MS (+ FAB) 290 (NT + 1, 44%), 2 34 (100), Example 30 Compounds 1105-1125 were prepared as follows. The physical data of these compounds are listed in Table 24. Printed by the Economic Order of the Central Government Bureau of the Consumer Consumption Cooperative ¾ ____- 605 -__---- 1235157 A: B7 V. Description of the invention (603) Printed by the Ministry of Economic Affairs, Central Standards Bureau, Off-line Consumer Cooperatives

先%讀 背 面 之 li | ! 填% 本1 • 606 - 本纸張尺度遑用中國國家標孪(CNS ) ‘*\4現格(210x 297公釐) 1235157 A7 B7 五、發明説明(604 經濟部中夬標隼局員工消贤合作杜印裝First read the li on the back |! Fill in% of this book 1 • 606-This paper size uses Chinese National Standard (CNS) '* \ 4 now (210x 297 mm) 1235157 A7 B7 V. Description of Invention (604 Economy Co-operation with employees of the Ministry of Standards and Standards Bureau Du Yinzhuang

+ -1 X σ\ CVJ 〇 ιΠ 、 vr vo r) tr&gt; d牧豸 Ο W h4 〇4 X rH CN ^ 5 &amp; rH f-i a\ s - m rH 3: 卜 • a\ 卜 00 -&lt;N r-1 ID Ct4 s CO GO s 2 rH CSi 3; σ\ rH o QD s 2 兮 cva X &lt;n CM U 赛 X O X 。介。 ru工 'z X o^yp 0 〇=Q=〇 mx 〇^M^cP 、:2 X γ&gt;。 • Oi o tH r-4 ω o r-4 rH -607- (诗先閱讀背云之注意事項弄填寫太莧) 1235157 Λ7 B7 五、發明説明(6〇5 ) 經濟部中央櫺準局員工消費合作杜印製+ -1 X σ \ CVJ 〇ιΠ, vr vo r) tr &gt; d Mu 豸 0 W h4 〇4 X rH CN ^ 5 &amp; rH fi a \ s-m rH 3: bu • a \ bu 00-&lt; N r-1 ID Ct4 s CO GO s 2 rH CSi 3; σ \ rH o QD s 2 cva X &lt; n CM U Race XOX. Introduce.工 工 'z X o ^ yp 0 〇 = Q = 〇 mx 〇 ^ M ^ cP,: 2 X γ>. • Oi o tH r-4 ω o r-4 rH -607- (Precautions for reading poems before reading the clouds and filling in too much) 1235157 Λ7 B7 V. Description of the invention (605) Employees of the Central Bureau of Standards, Ministry of Economic Affairs Cooperative Du Printing

S CM rH 守 to &lt;Ti 卜 CM tn r* v〇 CvJ L〇 〇4 X f-H CNJ fH rH CN t-4 o rH 2 S κο 卜 t—&lt; LO 卜 cn o • m 卜 m 〇 wn C&amp;I S 〇 rH s z cn CVi rn CNJ CM CJ a\ S 2 m CNJ X CNJ CNl CJ a\ 〇 uO 2 uO CVJ S CNJ ca U 鸯 。科1 〇=Q=o. o^zx 〇^^yO° 〇^s^〇 •φ 〆〇 O X 0=^=0 CA: o^y&gt;° &quot;X) ^3 as 〇 tH rH o «Η tH tH r-» rH t-H rH -608 - 本紙&amp;尺度通用中S國家標隼(CNS ) A4現格(2丨0X 297公釐) (討先緊讀背云之意事項异填芎本I ) 1235157 A: B7 五、發明説明(6〇6) 經濟部中央標準局員工消費合作社印装S CM rH Shouto &lt; Ti CM tn r * v〇CvJ L〇〇4 X fH CNJ fH rH CN t-4 o rH 2 S κο bt— &lt; LO bcn o • m bm 〇wn C &amp; IS 〇rH sz cn CVi rn CNJ CM CJ a \ S 2 m CNJ X CNJ CNl CJ a \ 〇uO 2 uO CVJ S CNJ ca U 鸯. Section 1 〇 = Q = o. O ^ zx 〇 ^^ yO ° 〇 ^ s ^ 〇 • φ 〆〇OX 0 = ^ = 0 CA: o ^ y &gt; ° &quot; X) ^ 3 as 〇tH rH o « Η tH tH r- »rH tH rH -608-Paper &amp; Standard Common S National Standard (CNS) A4 Presentation (2 丨 0X 297 mm) I) 1235157 A: B7 V. Description of Invention (606) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

+ ^ ! X cvj 卜 m wn. :L〇 i-H m tn 〇. X f-H -S 口· °&quot; rH r-4 r—4 1 o uO cn ro to n CTk r* 〇 uO tu X o rH 〇 »r&gt; 2 卜 CNJ rc CM CJ g L〇 2 rH CJ VO CN cvj CM CJ O工 〇=〇=〇 。沙=工 S2 X 〇^N^〇 ♦ \ ο CN fH tH «Η m «Η rH rH (請先a.讀背云之,江意事項玉:填寫,尽\貝) -609- 本紙朵尺度適用中國國家標孪(CNS ) A4堤格(210X 297公f ) 1235157 Λ7 B 了 五、發明説明(607 ) 經濟部中夬樣.準局員工消费合作祆印¾+ ^! X cvj m m wn.: L〇iH m tn 〇 X fH -S port ° &quot; rH r-4 r—4 1 o uO cn ro to n CTk r * 〇uO tu X o rH 〇 »R &gt; 2 CNJ rc CM CJ g L 2 rH CJ VO CN cvj CM CJ O = 0 = 0. Sand = Industrial S2 X 〇 ^ N ^ 〇 ♦ \ ο CN fH tH «m« Η rH rH (please first a. Read the back of the cloud, Jiang Yi matters jade: fill in, as much as possible) -609- Paper flower scale Applicable to China National Standards (CNS) A4 Tige (210X 297 male f) 1235157 Λ7 B V. Description of the invention (607) Sample of the Ministry of Economic Affairs. Consumption cooperation seal of employees of the quasi bureau ¾

(請先絮讀背云之:vi意事項再填寫本一貝) 本氓伕尺度通用中國國家標李(CNS &gt; 格(210X 297公釐) 1235157 Λ/ Β7 五、發明説明( 608 ) + SN 十 Η)ss 8·8ες 8·8ες 經濟部中夬標华局員工消費合作杜印裝(Please read the back of the cloud: the meaning of vi, and then fill out this one) The standard of this rogue is the Chinese national standard (CNS &gt; grid (210X 297 mm) 1235157 Λ / Β7 V. Description of the invention (608) + SN 十 Η) ss 8 · 8ες 8 · 8ες The Ministry of Economic Affairs wins the bid for the cooperation with the staff of the China Bureau Du printed

U W ^ 〇4 re rH 3 IT) t—4 CM rH ^ S· S i-H rH 3: S GO L〇 rH in m in L〇 rH ID C3U X &lt;Ti s CM s CO CM U 00 s 奈 CN 35 &lt;r &lt;N U 5 。务 rwzx O^^y-O〇 N2 X \ °^γ°. .γ VO t-4 «Η rH 卜 r-l rH rH (許.先3讀背云之&gt;1意事項再填寫太\貝) -611 - 本泜伕足度通用中国國家樣车(CNS ) A4堤格(BOX 297公釐〉 1235157 A,87 五、發明説明(609 經涛部中央樣笨局員工消f合作社印¾UW ^ 〇 4 re rH 3 IT) t—4 CM rH ^ S · S iH rH 3: S GO L〇rH in m in L〇rH ID C3U X &lt; Ti s CM s CO CM U 00 s Nano CN 35 &lt; r &lt; NU 5. Service rwzx O ^^ yO〇N2 X \ ° ^ γ °.. Γ VO t-4 «Η rH bl rr rH rH (Xu. 3 first read the back of the cloud &gt; 1 intention and then fill in too \ shell) -611 -This is a full-size GM China National Sample Car (CNS) A4 Tiege (BOX 297 mm> 1235157 A, 87 V. Description of the invention (609 printed by the staff of the Central Bureau of Samples of the Ministry of Economic Affairs, China) ¾

+ CO ^ S 〇\ 03 CO cn CNi o m Φ /-V u w 〇4 S ΓΟ »H CN rH rH 3: 2 rH L〇 ID VO L〇 卜 tu X Γ- s 2: i-H Γ0 3: t-H CM CJ 卜 〇 to 2 cn m C\J U 赛 O :、 〇=〇=〇 ΓΚΧ 〇^^Y〇° 、z X 〇=0=° rw工 〇^V°° N2 r C? ♦ 00 r-l r-l tH C\ rH tH rH -612- 本纸伕尺度適用中国國家標隼(CNS ) 格(2丨0X 297公釐) (請先聞讀背云之洼意事項具填寫尽買) 1235157 A737 五、發明説明( 610) 經濟部中央標技局員工消费合作社印裝+ CO ^ S 〇 \ 03 CO cn CNi om Φ / -V uw 〇4 S ΓΟ »H CN rH rH 3: 2 rH L〇ID VO L〇 Tu X Γ- s 2: iH Γ0 3: tH CM CJ 〇 〇to 2 cn m C \ JU Sai O :, 〇 = 〇 = 〇ΓΚΧ 〇 ^^ Y〇 °, z X 〇 = 0 = ° rw 〇 ^ V °° N2 r C? ♦ 00 rl rl tH C \ rH tH rH -612- The size of this paper is applicable to the Chinese National Standard (CNS) grid (2 丨 0X 297 mm) (please read and read the meanings of the back of the cloud to fill in and buy everything) 1235157 A737 V. Description of the invention (610) Printed by the Consumer Cooperatives of the Central Bureau of Standards and Technology of the Ministry of Economic Affairs

+ - 、 CO 5 S ro 卜 ^3· m 卜 Oi tn 〇4 X r-l VO艺 ?- f-l 5 s VD r-H f-j rH s S rH ⑦ CN CM m 卜 ΓΟ o m Cft4 s CO Ο ^-4 U ΓΟ CM X ——· s z to CM X CN 八1 r·^ CNJ CJ \&gt;l u Sx 〇=ο=° ox 0=Q=° /-Λ/χ 〇ί 〈Η °c^ c: 2: X 」 o' X rvx 、(P ♦ ¥ o (N rH tH Oi •H rH (請先聞讀背S之注意事項耳填寫本f ) •613- 本紙法尺度通用中国国家樣隼(CNS ) A4况格(210 乂 297公釐) 1235157 Λ7B7 五、發明説明(611 ) 經濟部中夬嘌这局員工消費合作杜印复+-、 CO 5 S ro BU ^ 3 · m BU Oi tn 〇4 X rl VO 艺?-Fl 5 s VD rH fj rH s S rH ⑦ CN CM m BU Γ〇 om Cft4 s CO Ο ^ -4 U ΓΟ CM X —— · sz to CM X CN 8 1 r · ^ CNJ CJ \ &gt; lu Sx 〇 = ο = ° ox 0 = Q = ° / -Λ / χ 〇ί 〈Η ° c ^ c: 2: X ” o 'X rvx 、 (P ♦ ¥ o (N rH tH Oi • H rH (please read the notes of S first and fill in this f)) 613- This paper method is common in China National Sample (CNS) A4 (210 乂 297 mm) 1235157 Λ7B7 V. Description of the invention (611) Du Yinfu, Consumer Co-operation and Cooperation of Employees in the Bureau of the Ministry of Economic Affairs

cn ^ uO uO CV4 tO r* in ί Ή CJ w Οι 3: Csi S· π o 1-H 0&quot;) 00 oo a\ in o r-4 A S 2 L〇 i-H o m 〇 l〇 &lt;NJ to iD CS4 X 卜 s s r-H S CNJ CJ 〇 rH 〇 2 CM 22 Co CM U o={^=〇 。按:工 δ X 〇=Q=〇 〇\ ί &lt;a ;x3 &lt;N CN4 rH iH η οι r-l rH (請先$讀背5之注意事項再填寫本\貝) -614- 本紙&amp;尺度適用中国國家標隼(CNS ) A4現格(210:&lt; 297公釐) 1235157 五 明 説 明 發 2 61cn ^ uO uO CV4 tO r * in ί Ή CJ w Οι 3: Csi S · π o 1-H 0 &quot;) 00 oo a \ in o r-4 AS 2 L〇iH om 〇l〇 &lt; NJ to iD CS4 X ss rH S CNJ CJ 〇rH 〇2 CM 22 Co CM U o = {^ = 〇. Press: Industrial δ X 〇 = Q = 〇〇 \ ί &lt;a; x3 &lt; N CN4 rH iH η οι rl rH (please pay attention to the notes of reading 5 before filling in this book) -614- this paper &amp; Applicable standard: Chinese National Standard (CNS) A4 (210: &lt; 297 mm) 1235157 Wuming Instructions 2 61

f/ 7Λ B 經濟部中央標準局員工消费合作·杜印¾f / 7Λ B Consumption cooperation between employees of the Central Standards Bureau of the Ministry of Economic Affairs · Du Yin ¾

卜 CO LO VD ID U ^ 〇4 X m t-H (T\ L〇 a\ a\ 00 o 3: 2 cn in m K〇 in uO m L〇 Cu X r-4 t-l S 奈 CM 22 切 CM U CD .〇 L〇 2 CN rH 〇 CO CNJ X rH CM U 5 H: ▼ 0-0 o % X X O X 〇=/ V=o %r 〇 P 9, X TP &lt;N rH «Η m CVJ rH -615- (請先聞讀背云之^意事項再填寫太頁)CO LO VD ID U ^ 〇4 X m tH (T \ L〇a \ a \ 00 o 3: 2 cn in m K〇in uO m L〇Cu X r-4 tl S Nai CM 22 cut CM U CD .〇L〇2 CN rH 〇CO CNJ X rH CM U 5 H: ▼ 0-0 o% XXOX 〇 = / V = o% r 〇P 9, X TP &lt; N rH «Η m CVJ rH -615- (Please read the meaning of the back of the cloud before filling in the page)

本纸ft尺度適用中国国家標進(CNS )六4蜓格(2丨0X297公釐) 1235157 A7 B7 五、發明説明(613)The ft scale of this paper is applicable to China National Standards (CNS) six 4 flying grid (2 丨 0X297 mm) 1235157 A7 B7 V. Description of the invention (613)

步驟C 1103 (請先^lilfVB之注意事項再填寫衣\貝) 經濟部中央糅隼局員工消費合作杜印製 ΟStep C 1103 (Please fill in the ^ lilfVB's precautions before filling in the clothing) Printed by the Consumer Affairs Department of the Central Government Bureau of the Ministry of Economy

οο

1105-1125 步驟A。401之合成。TentaGel S® NH2樹脂(0.25毫莫耳/ -616 - 本纸法尺度適用中国國家標耷(CNS )M現格(2丨0乂 297公釐) 1235157 經濟部中夬標技局員工消f合作社印¾ A7 B7 五、發明说明(6U) 克,5.25克)置於多孔的玻璃震邊、器容器内,再以二甲基 乙醯胺洗滌(3x15毫升化合物400 (1.36克,2.3毫莫耳) 溶於DMA中(1〇毫升),再加〇-笨並三唑-N,N,N,,N、四甲基 繽六氟磷酸鹽(HBTU; 0.88克,2.3毫莫耳)及DIEA(0.8毫 升,4.6毫莫耳)3溶液轉移至樹脂,再加5毫升DMA 3反 應混合物在室溫下攪動1 · 5小時,利用腕臂震盪器3樹脂 過濾並以二甲基乙醯胺洗滌(4 X 15毫升)。 步驟B。1102之合成。樹脂401以20% (v/v)六氫吡啶/二甲 基乙醯胺(15毫升)去保護10分鐘(震盪)再以新鮮的六氫毗 淀試劑(15¾升)洗10分鐘β命脂再以二甲基乙酿腔洗條(6 X 15毫升),再以Ν-甲基吡咯啶酮洗滌(2 X 25毫升)。 化合物1101 (0.979克,2.11毫莫耳)溶於二甲基乙縫胺中 (8毫升),再加HBTU(0.81克,2.1毫莫耳)及DIEA(0.75毫 升,4.3毫莫耳),且溶液加至樹脂中,再加二甲基乙酷接 (4毫升)。反應混合物在室溫下授拌2小時,利用婉臂震邊 器」樹脂如401般操作,以生成1102。 步驟C。1103之合成。此化合物製備自樹脂11〇2 (0.040 毫莫耳),利用 Advanced ChemTech 396 Multiple Peptide合 成儀3自動化循環中包括有樹脂,以二曱替甲醯胺洗滌(2 X 1毫升),以25% (v/v)六氫σ比咬/二甲替甲醯胺(1毫升)去 保護3分鐘,再以新鮮試劑(1毫升)歷1〇分鐘以生成樹脂 1103 3樹脂以二甲替甲酷胺(3 X 1¾升)及Ν-曱基σ比洛咬飼 (3 X 1毫升)洗滌。 樹脂1103以0.4Μ羧酸及0·4Μ ΗΟΒΤ於Ν-甲基吡咯啶酮 -617 - 本纸法尺度適用tug家標李(CNS ) Λ4現格(2丨0:&lt; 297公釐1 ·' &quot; ' (請^緊讀背云之^意事項再填寫本!) 裝 1- 1235157 經濟部中夬標準局員工消贤合作社印装 Λ7 37 五、發明説明(615) (0·5毫升),0.4MHBTU於N-甲基吡冬啶酮(0.5毫升)溶液, 及1 · 6Μ DIE Α於Ν-甲基吹洛淀網(〇25毫升)之溶液酷化’且 反應在!C溫下震邊2小時a重覆驢化步隸a最後’樹脂以 N-甲基叶I:洛咬_(1 X 1毫升),二甲替甲縫胺(4X 1毫升), 二氣甲烷(5 XI毫升)洗滌,再於眞空下乾燥3醛自樹脂中 解離,並以95%TFA/5%H2〇(v/v,1.5毫升)在室溫下大鳢 地去保護歷30分鐘。樹脂以解離試劑(1毫升)洗滌後,混 合的遽液加至冷的1:1乙链:己烷(10毫升)中,且生成的沈 澱物以離心及傾析法分離。生成的團塊溶於10%乙骑/90% Η2Ο/0·1% TFA (5毫升)再冷凍乾燥得粗製的1105-U25,呈 白色粉末β化合物以半製備式RP-HPLC純化,利用Rainin MicrosorbTMC18 管柱(5微米,21.4 X 250 毫米)以含有 0.1% TFA (v/v)之線性乙腈梯度(8%-48°/〇),在12毫升/分下溶離 30分鐘3匯集含有欲求產物之流份,並冷凍乾燥生成 1105-1 125 (10.8毫克,63%) 3 分析HPLC方法: (1) Waters DeltaPak C18, 300A (5微米,3·9 X 150毫米)3 含有0.1% TFA (ν/ν)之線性乙腈梯度(0%-25%),以1毫升/分 歷14分鐘3 (2 ) Waters DeltaPak C18,300Α (5微米,3.9 X 150毫米)。 含有0.1% TFA (ν/ν)之線性乙腈梯度(5%-45%),以1毫升/分 歷14分鐘β -618 - 本纸法尺度適用中國國家標隼(CNS ) Μ規咯(210Χ297公5 ) (请先Μ讀背S之注意事項弄填寫.V4I ) 裝 訂 1235157 A7 B7 五、發明説明(616) Ο 丨儿N爲 t8u〇 Η 〇 f ην八 tBuO 人 &quot;OtBu tBuO·1105-1125 Step A. Synthesis of 401. TentaGel S® NH2 resin (0.25 millimoles / -616-this paper method is applicable to China National Standard (CNS) M (2 丨 0 乂 297mm) 1235157 Ministry of Economic Affairs, China Standard Technology Bureau, staff consumer cooperatives Print ¾ A7 B7 V. Description of the invention (6U), 5.25g) Put in a porous glass shaker and container, and then wash with dimethylacetamide (3x15ml compound 400 (1.36g, 2.3mmol) ) Dissolved in DMA (10 ml), then added 0-benzotriazole-N, N, N ,, N, tetramethylbin hexafluorophosphate (HBTU; 0.88 g, 2.3 mmol) and DIEA (0.8 ml, 4.6 mmol) 3 solution was transferred to the resin, 5 ml of DMA 3 reaction mixture was added and stirred at room temperature for 1.5 hours, filtered with a wrist arm shaker 3 resin and washed with dimethylacetamide (4 X 15 ml). Step B. Synthesis of 1102. Resin 401 was deprotected with 20% (v / v) hexahydropyridine / dimethylacetamide (15 ml) for 10 minutes (shock) and then fresh Hydropyridine reagent (15¾ liters) was washed for 10 minutes, β-fat was washed with dimethylacetam (6 X 15 ml), and then washed with N-methylpyrrolidone (2 X 25 ml). Compound 1101 (0.979 g, 2.11 mmol) was dissolved in dimethyl ethylamine (8 ml), followed by HBTU (0.81 g, 2.1 mmol) and DIEA (0.75 ml, 4.3 mmol), and The solution was added to the resin, followed by dimethylethane (4 ml). The reaction mixture was stirred at room temperature for 2 hours, and the resin was operated like a 401 with a wan arm shaker to produce 1102. Step C. Synthesis of 1103. This compound was prepared from Resin 1102 (0.040 mmol), using Advanced ChemTech 396 Multiple Peptide Synthesizer 3, the resin was included in the automated cycle, and washed with dimethomethamine (2 X 1 ml), Deprotection with 25% (v / v) hexahydro sigma / metformidine (1 ml) for 3 minutes, and fresh reagent (1 ml) for 10 minutes to produce resin 1103 3 resin with dimethyl Tetracycline (3 X 1¾ liters) and N-fluorenyl σ bilo bite (3 X 1 ml) were washed. Resin 1103 was treated with 0.4M carboxylic acid and 0.4M 〇ΟΒΤ in N-methylpyrrolidone-617. -The scale of this paper method is applicable to Tug's house mark (CNS) Λ4 is present (2 丨 0: &lt; 297 mm1 · '&quot;' (please read the meaning of the back of the cloud carefully and fill in This!) Pack 1- 1235157 Printed by the Consumers ’Cooperative of the China Standards Bureau of the Ministry of Economic Affairs Λ7 37 V. Description of the invention (615) (0.5 ml), 0.4 MHBTU in N-methylpyrididone (0.5 ml) The solution, and a solution of 1.6 M DIE A in N-methyl pololine (0 25 ml) were cooled and reacted! Shock at 2 ° C for 2 hours. A Repeat the donkey step. Finally, the resin is N-methyl leaf. I: Luo bite (1 X 1 ml), metformamide (4 X 1 ml), digas. Wash with methane (5 XI ml), and then dry in air and dissociate the 3 aldehyde from the resin, and deprotect it with 95% TFA / 5% H20 (v / v, 1.5 ml) at room temperature for 30 minutes. . After the resin was washed with dissociation reagent (1 ml), the mixed mash was added to cold 1: 1 ethyl chain: hexane (10 ml), and the resulting precipitate was separated by centrifugation and decantation. The resulting agglomerates were dissolved in 10% acetone / 90% Η20 / 0.1% TFA (5 ml) and freeze-dried to obtain crude 1105-U25, which was a white powder β compound purified by semi-preparative RP-HPLC using Rainin MicrosorbTMC18 column (5 micron, 21.4 X 250 mm) was dissolved in a linear acetonitrile gradient (8% -48 ° / 〇) containing 0.1% TFA (v / v) for 30 minutes at 12 ml / min. Fractions, and freeze-dried to yield 1105-1 125 (10.8 mg, 63%) 3 Analytical HPLC method: (1) Waters DeltaPak C18, 300A (5 microns, 3.9 x 150 mm) 3 contains 0.1% TFA (ν / ν) linear acetonitrile gradient (0% -25%) at 1 ml / min for 14 minutes 3 (2) Waters DeltaPak C18, 300A (5 microns, 3.9 x 150 mm). Linear acetonitrile gradient (5% -45%) with 0.1% TFA (ν / ν), 1 ml / min for 14 minutes β -618-This paper method is applicable to China National Standard (CNS) M gauge (210 × 297) 5) (please fill in the precautions of S. V4I) binding 1235157 A7 B7 V. invention description (616) 〇 丨 N is t8u〇Η 〇f ην eight tBuO people &quot; OtBu tBuO ·

〆 ΤΓ τ 〇0人ο ,ΟΒπ〆 ΤΓ τ 〇0 人 ο, 〇Βπ

261b Ο261b Ο

ΟΟ

訪先分讀背5之.江意事項再填寫.工\貝) 裝Visit first to read the 5th in the back. Fill in the Jiang Yi matters.

1T 經濟部中央樣準局員工消资合作社印¾ 262b 3-(Ν,-第三-丁氧羰基胼基)丙酸芊酯(250b),利用自25S製 備259之方法合成,可生成蠟質固體(87克,51°/。)·· mp· 54-55eC ;IR (薄膜)3324, 2978, 1732, 1713, 1455, 1367, 1277, 1254, 1 171; lH NMR (CDC13) ά 7.35 (5H, m), 6.15 (1H, bs), 5.13 (2H, s),3.15 (2H,t,J = 6.5),2.54 (2H, t, J = 6·5), 1.45 (9H, s) a 分析 C15H22N203之計算値:C, 61.21; Η, 7·53; N, 9.52。實測値:C, 61.29; Η, 7·51; N, 9.51。MS (ES+) 295 (M+ + 1)。 (3S) 2-(N-2-芊氧羰基乙基-NI-2-丁氧羰基胼基)羰基六氣名 啩二羧酸1-芊基3-第三-丁基酯(206b),利用甴259製備?6〇 之方法合成,可生成膠狀(81克),可在未純化下用於下一 -619 本纸伕尺度通用中國國家標孪(〇15)六4見格(210/297公釐) 經濟部中夬樣準局員工消费合作社印¾ 1235157 A7 B7 五、發明説明(617 ) 歩驟3純樣品之分析數據:IR' (薄膜)33 18, 2976, 1733, 1451,1412, 1393, 1366, 1256, 1 161; lHNMR(CDCl3) d 7·34 (10H,m),6·68 (0.5H,bs),5·11 (4H, m), 4.63 (0.5H,bs), 4.14 (1H, m), 3.53 (2H? m), 3.08 (1H, m), 2.63 (2H? m)? 2.10-1.60 (4H,m), 1.60-1.35 (19H,m + 2 x s)。 (3S) 2-(Ν·-第三-丁氧羰基-N-2-羧基乙基肼基)羰拳六氫肼3-羧酸第三-丁酯(261b),利用甴260製備261之方法合成,可 生成膠,可經快速層析純化(1:1乙酸乙酯/二氣甲浣)生成 標題化合物261b (36.0克,79.4%歷2階段)·· IR (薄膜)3267, 2979, 2937, 1728, 1668, 1394, 1369, 1245, 1159; lH NMR (CDC13) ^ 7.6 (1Η, bs), 6.8 (1H, vbs), 4.47 (1H, bs), 3.73 (2H, bs), 2.98 (1H, bs), 2.66 (3H, m), 2.04 (1H, bs), 1.84 (1H, m), 1.6-1.2 (21H, m + s)。 (45)7-第三-丁氧羰基胺基-6,10-二酮基_1,2,3,4,7,8,9,10-八 氫-61嗒啡並[1,24][1,2,4]三氮雜箪-4-羧酸第三-丁酯(26215) ,利用甴261製備262之方法合成,可生成標題化合物262b ,(18.6克,54%),呈油狀:〇]D20 +47.7。(c 0.236, CH2C12); IR (薄膜)3291, 2978, 1738, 1727, 1690, 1678, 1439, 1243, Π64; lH NMR (CDCi3) ά 6.59 (lH, s), 5.06 (1H, m), 4.47 (1H,m),3·85 (3H,m),2.82 (1H,m), 2·37 (1H,m),2·22 (1H, m),1.92 (1H,m), 1.63 (2H,m),1.48及 1.46 (18H,2 x s)。MS (ES+) 399 (NT + 1)。 (4S) 7-胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-61^嗒畊並 [1,24][1,2,4]三氮雜箪-4-羧酸第三-丁酯(518)。化合物2620 __ -620-_ 本饯法尺度適用中SS家標準(CNS ) A4現格(210 X297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝 訂 1235157 Λ 7 Β7 _ 五、發明説明(618 ) - (2.43克,6·1毫莫耳)溶於1M氯化氫於乙酸乙錯(30愛升 並在室溫下挽拌20小時,加入固體凌酸氛鈉(4克5毫 莫耳)及水20毫升,且混合物攪拌5分鐘再分離,並以乙酸 乙酯萃取水性部份。混合的有機溶液以水’餘和的鹽洗條 ,乾燥(MgS04)並濃縮3以快速層析純化(5〇%乙酸乙酯/二 氣甲烷-100%乙酸乙酯)可生成純產物518(h〇8冬’)9%)呈 不穩定的油·· 〇]D20 +82。(c 0.55, CH2C12); IR (薄獏)1T Printed by the Consumers' Cooperative of the Central Bureau of Procurement, Ministry of Economic Affairs 262b 3- (N, -Third-butoxycarbonylfluorenyl) propionate (250b), synthesized by the method of preparing 259 from 25S, can produce waxy Solid (87g, 51 ° /.) ·· mp · 54-55eC; IR (thin film) 3324, 2978, 1732, 1713, 1455, 1367, 1277, 1254, 1 171; lH NMR (CDC13) ά 7.35 (5H , m), 6.15 (1H, bs), 5.13 (2H, s), 3.15 (2H, t, J = 6.5), 2.54 (2H, t, J = 6.5), 1.45 (9H, s) a Analysis Calculation of C15H22N203: C, 61.21; Η, 7.53; N, 9.52. Found 値: C, 61.29; Η, 7.51; N, 9.51. MS (ES +) 295 (M + + 1). (3S) 2- (N-2-fluorenyloxycarbonylethyl-NI-2-butoxycarbonylfluorenyl) carbonylhexakinium dicarboxylic acid 1-fluorenyl 3-third-butyl ester (206b), Using 甴 259? Synthesized by the method of 60, it can be produced into a gelatinous form (81 g), which can be used without purification for the next -619 paper standard, the standard Chinese national standard (〇15), 6 (4), (210/297 mm) Printed by the Employees 'Cooperatives of the Prospective Bureau of the Ministry of Economic Affairs 1235157 A7 B7 V. Description of the invention (617) Step 3 Analysis data of pure samples: IR' (thin film) 33 18, 2976, 1733, 1451, 1412, 1393, 1366 , 1256, 1 161; lHNMR (CDCl3) d 7.34 (10H, m), 6.68 (0.5H, bs), 5.11 (4H, m), 4.63 (0.5H, bs), 4.14 (1H , m), 3.53 (2H? m), 3.08 (1H? m), 2.63 (2H? m)? 2.10-1.60 (4H, m), 1.60-1.35 (19H, m + 2 xs). (3S) 2- (N · -tertiary-butoxycarbonyl-N-2-carboxyethylhydrazino) carbonylhexahydrohydrazine 3-carboxylic acid tert-butyl ester (261b), using 260 to prepare 261 Synthesized by the method, a gel can be formed, which can be purified by flash chromatography (1: 1 ethyl acetate / dichloromethane) to give the title compound 261b (36.0 g, 79.4% over 2 stages). IR (thin film) 3267, 2979, 2937, 1728, 1668, 1394, 1369, 1245, 1159; lH NMR (CDC13) ^ 7.6 (1Η, bs), 6.8 (1H, vbs), 4.47 (1H, bs), 3.73 (2H, bs), 2.98 ( 1H, bs), 2.66 (3H, m), 2.04 (1H, bs), 1.84 (1H, m), 1.6-1.2 (21H, m + s). (45) 7-Third-butoxycarbonylamino-6,10-diketonyl_1,2,3,4,7,8,9,10-octahydro-61 daphno [1,24] [1,2,4] Triazapyridine-4-carboxylic acid tertiary-butyl ester (26215) was synthesized by the method of preparing 262 with thorium 261, and the title compound 262b (18.6 g, 54%) was obtained as an oil. Condition: 0] D20 +47.7. (C 0.236, CH2C12); IR (thin film) 3291, 2978, 1738, 1727, 1690, 1678, 1439, 1243, Π64; lH NMR (CDCi3) ά 6.59 (lH, s), 5.06 (1H, m), 4.47 (1H, m), 3.85 (3H, m), 2.82 (1H, m), 2.37 (1H, m), 2.22 (1H, m), 1.92 (1H, m), 1.63 (2H , M), 1.48 and 1.46 (18H, 2 xs). MS (ES +) 399 (NT + 1). (4S) 7-Amino-6,10-diketo-1,2,3,4,7,8,9,10-octahydro-61 ^ Dafang [1,24] [1,2, 4] Trisazinium-4-carboxylic acid tert-butyl ester (518). Compound 2620 __ -620-_ Applicable to Chinese Standard SS Standard (CNS) A4 (210 X297 mm) (Please read the precautions on the back before filling this page) Binding 1235157 Λ 7 Β7 _ V. Invention Instructions (618)-(2.43 g, 6.1 mmol) dissolved in 1M hydrogen chloride in ethyl acetate (30 liters and stirred at room temperature for 20 hours, add solid sodium phosphonate sodium (4 g 5 mmol) Ear) and 20 ml of water, and the mixture was stirred for 5 minutes before separation, and the aqueous portion was extracted with ethyl acetate. The mixed organic solution was washed with water and salt, dried (MgS04) and concentrated 3 for flash chromatography Purification (50% ethyl acetate / digas methane-100% ethyl acetate) yielded pure product 518 (H08 winter ') 9%) as an unstable oil ... D20 + 82. (C 0.55, CH2C12); IR (thin 貘)

2977, 1731, 1680, 1664, 1439, 1·420, 1315, Π〕8; lHNMR (CDC13) d 5.08 (1Η,m), 4·48 (1Η,m),3·8〇 (2Η,Abq),3.70 (2H,bs,以 D20交換),3·53 (1H,m),2.75 (1H,m),2·30 (2H, m), 1.88 (1H, m), 1.71 (2H, m), 1.47 (9H, s) 3 (請先聞讀背δ之注意事項再填寫太f ) 經濟部中夬糅準局員工消资合作社印裝2977, 1731, 1680, 1664, 1439, 1.420, 1315, Π] 8; lHNMR (CDC13) d 5.08 (1Η, m), 4.48 (1Η, m), 3.80 (2Η, Abq) , 3.70 (2H, bs, exchanged with D20), 3.53 (1H, m), 2.75 (1H, m), 2.30 (2H, m), 1.88 (1H, m), 1.71 (2H, m) , 1.47 (9H, s) 3 (Please read the notes of δ before filling in too f) Printed by the Consumers ’Cooperatives of the China Prospective Bureau of the Ministry of Economic Affairs

524 -621 - 本紙法尺度糾tSIU:?:標李(CNS ) /\復格(21GX297公慶 經濟部中央櫺隼局員工消费合作.社印¾ 1235157 ------B2___^---^ 五、發明説明(619) _ (3S) 1·;氧羰基-六氫嗒,井小羧酸、甲酯(520” 519 (9.4克, 35.6毫莫耳)懸浮於甲醇中(23〇毫升)並冷卻於〇eC之冰浴中 。以30分鐘逐滴加入亞硫醯二氣(3毫升,4.89克,41.1毫 莫耳)且混合物在環境溫度下攪拌48小時3溶劑於303C之 眞空下移去,且油性殘留物溶於乙酸乙酯中(500毫升)3 有機溶液以鉋和的碳酸氫鈉,水及鹽水洗滌,乾燥 (MgS04)並濃縮可生成52〇 (7 84克,79%)呈沽狀:[泛]〇22 -25.9° (c 0.615, CH2C12); IR (薄膜)2953, 1739, 1703, 1694, 1440, 1403, 1357, 1261,1241, 1 174; lHNMR(CDCl3) 0' 7.36 (5H, s), 5.18 (2H, s), 4.00 (1H, bd), 3.73 (3H, s), 3.55 (1H, dd), 3.12 (1H, t), 2.06 (1H, m), 1.73 (3H, m)。分析 Cl4Hl7N2〇4,〇.25H20之計算値:C, 59.46; Η, 6.59; N, 9·91 3 實測値:C, 59·44; Η, 6·46; N,10.09。 (3S) 2-(Ν-2·;氧羰基乙基-ΝΙ-第三-丁氧羰基胼基)羰基六 氫,答畊二羧酸卜苄基3·甲基酯(52丨),利用上文26〇之類似 方法,可製備521,96%呈粗製的油:〇]D22 -22.16。(c 0.25, CH2C12); IR (薄膜)3316, 2976, 2953, 1738, 1726, 1714, 1690, 1367, 1260, 1167; [H NMR (CDC13) 7.25 (10H, m)? 6.82 (1H, bs), 5.10 (4H, m), 4.80 (1H, bs), 4.3-3.4 (6H, m), 3.10 (IH, m), 2.59 (2H, m), 1.95 (2H, m), 1.44 (10H, m ^ s) ^ 2-(N’-第三,丁氧羰基-N-2·羧乙基胼基)羰基六氫嗒畊3-羧 酸甲醋(522) 3利用上文261所述之類似方法,可製成522, 92%呈白色固體:111口146-1483(:(分解);〇】1;)22十27.83(〇 0.25, CH:Cl2); IR (KBr) 3346, 1740, 1710, 1626, 1497, 1290, -622- 本紙掁尺度通用中國国家標導(CNS ) Α4^格(2丨〇 &gt;&lt; 29了公釐) (請先%讀背壳之注意事項^4寫本頁) 装 訂 1235157 經濟邡中央樣隼局員工消f合作社印製 Λ7 37 五、發明説明(620) . 1250, 1206, 1 179, 1 159; lK NMR (CDC13) ά 7.60 (lH, bs), 7.5ο·5 (1H, vbs),4·64 (1H,bs), 3·76 (5H, m + s),3·〇〇 (1H, m),2·70 (3H,m),2·16 (1H,m),1·92 (1H,m), 1·56 (1H,m),524 -621-Correction of tSIU on the paper scale:?: Standards (CNS) / \ Fuge (21GX297 Employees' Co-operation of the Central Government Bureau of the Ministry of Economic Affairs of the People's Republic of China. Social printing ¾ 1235157 ------ B2 ___ ^ --- ^ V. Description of the invention (619) _ (3S) 1 ·; oxycarbonyl-hexahydroda, well small carboxylic acid, methyl ester (520 "519 (9.4 g, 35.6 mmol) was suspended in methanol (23 ml) ) And cooled in an ice bath at 0eC. Add thionyl disulfide (3ml, 4.89g, 41.1mmol) dropwise over 30 minutes and stir the mixture at ambient temperature for 48 hours. 3 Solvent under 303C Removed and the oily residue was dissolved in ethyl acetate (500 ml). 3 The organic solution was washed with planed sodium bicarbonate, water and brine, dried (MgS04) and concentrated to yield 52 (7 84 g, 79%). ) Is in the shape of: [PAN] 〇22 -25.9 ° (c 0.615, CH2C12); IR (thin film) 2953, 1739, 1703, 1694, 1440, 1403, 1357, 1261, 1241, 1 174; lHNMR (CDCl3) 0 '7.36 (5H, s), 5.18 (2H, s), 4.00 (1H, bd), 3.73 (3H, s), 3.55 (1H, dd), 3.12 (1H, t), 2.06 (1H, m), 1.73 (3H, m). Analysis of the calculation of Cl4Hl7N20, 0.25H20 値: C, 59.46; Η, 6.59; N, 9 91 3 Found 値: C, 59 · 44; Η, 6.46; N, 10.09. (3S) 2- (N-2 ·; oxycarbonylethyl-NΙ-tertiary-butoxycarbonylfluorenyl) carbonyl hexa Hydrogen, dibenzyl 3-methyl dicarboxylate (52 丨). Using a similar method to 26 above, 521, 96% crude oil can be prepared: 〇] D22 -22.16. (C 0.25, CH2C12) ; IR (thin film) 3316, 2976, 2953, 1738, 1726, 1714, 1690, 1367, 1260, 1167; [H NMR (CDC13) 7.25 (10H, m)? 6.82 (1H, bs), 5.10 (4H, m ), 4.80 (1H, bs), 4.3-3.4 (6H, m), 3.10 (IH, m), 2.59 (2H, m), 1.95 (2H, m), 1.44 (10H, m ^ s) ^ 2- (N'-Third, butoxycarbonyl-N-2 · carboxyethylfluorenyl) carbonyl hexahydrophenyl 3-carboxylic acid methyl ester (522) 3 It can be made into 522 by a similar method as described in 261 above. , 92% was a white solid: 111 port 146-1483 (: (decomposition); 0] 1;) 22 ten 27.83 (〇0.25, CH: Cl2); IR (KBr) 3346, 1740, 1710, 1626, 1497, 1290 , -622- Standard for Chinese paper (CNS) Α4 ^ Grid (2 丨 〇 &lt; 29 mm) (Please read the precautions for the back cover first ^ 4 Write this page) Binding 1235157 Member of Economic and Central Bureau Printed by the Consumer Cooperative Λ7 37 V. Description of the Invention (620). 1250, 1206, 1 179, 1 159; lK NMR (CDC13) ά 7.60 (lH, bs), 7.5ο · 5 (1H, vbs), 4 · 64 (1H, bs), 3.76 (5H, m + s), 3.00 (1H, m), 2.70 (3H, m), 2.16 (1H, m), 1.92 ( 1H, m), 1.56 (1H, m),

1.46(llH,m + s)3 分析 C15H26N407 之計算値:C,48.12;H, 7.00; N,14.96 3 實測値·· C,48·21; H,6.96; N,14.86 3 MS (ES+) 373 (Μ* -1) ^ (4S) 7-第三-丁氧羰基胺基-6,1〇-二酮基-1,2,3,4,7,8,9,1〇-八 氫-6H-嗒啩並[l,2-a][l,2,4]三氮雜箪·4·羧酸田酯(523)。522 (7.15克,19.1毫莫耳)溶於二氯甲烷(1〇〇毫升)中,其内含 有二f替甲醯胺(0.5毫升)並冷卻至0Χ:。加入亞硫縫二氣 (116毫升,2.61克,22毫莫耳)及N-乙基嗎福啉(486毫升’ 440毫克,38.2毫莫耳),且混合物攪拌2小時。有機洛合物 以2M疏酸氩納(50毫升),绝和的竣酸氫鈉(50毫升)及鹽水 (50毫升)洗滌,乾燥(MgS04)並濃縮3殘留物以乙醚研磨 可生成523,呈白色固體(5.73克,84%) : mp· 186-188°C (分 解 );l&gt;]D22 +65·3。(c 〇·25, CH2C12);汛(KBr) 3298, 2978, 1750, 1720, 1682, 1658, 1455, 1423, 1369, 13 16, 1241,1212, 1160; lH NMR (CDCi3) ^ 6.56 (lH, s), 5.17 (1H, dd), 4.48 (1H,bd), 3.81 (3H,m), 3.75 (3H, s),2.83 (1H,dt),2·40 (1H, m), 2.28 (1H, m), 1.95 (1H, m), 1.67 (1H, m), i.47 (9H, s) ^ 分析 C〖5H24N406-1/6H20之計算値:C,50.13; H,6.82; N, 15.59。實測値:C, 50.12; H,6·71; N,15.58 a MS (ES+) 357 (M+ - 1,46%),301 (100%) 3 (45)7-胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八氩-6^1-嗒畊並 -623- 本纸伕尺度適用中SS家標孪(CNS 格(210X29?公釐) (請先笑讀背t&amp;之注意事項再壤寫本頁) 裝 訂 12351571.46 (llH, m + s) 3 Analysis of the calculation of C15H26N407 値: C, 48.12; H, 7.00; N, 14.96 3 Measured 値 ·· C, 48 · 21; H, 6.96; N, 14.86 3 MS (ES +) 373 (Μ * -1) ^ (4S) 7-tert-butoxycarbonylamino-6,10-diketo-1,2,3,4,7,8,9,10-octahydro- 6H-Da [1,2-a] [1,2,4] triazapyrene · 4 · carboxylate (523). 522 (7.15 g, 19.1 mmol) was dissolved in dichloromethane (100 ml), which contained difamidamine (0.5 ml) and cooled to 0X :. Sulfur gas (116 ml, 2.61 g, 22 mmol) and N-ethylmorpholine (486 ml '440 mg, 38.2 mmol) were added, and the mixture was stirred for 2 hours. The organic complex is washed with 2M argon sodium (50 ml), absolute sodium bicarbonate (50 ml) and brine (50 ml), dried (MgS04) and concentrated. White solid (5.73 g, 84%): mp · 186-188 ° C (decomposed); l &gt;] D22 + 65 · 3. (C 〇 · 25, CH2C12); flood (KBr) 3298, 2978, 1750, 1720, 1682, 1658, 1455, 1423, 1369, 13 16, 1241, 1212, 1160; lH NMR (CDCi3) ^ 6.56 (lH, s), 5.17 (1H, dd), 4.48 (1H, bd), 3.81 (3H, m), 3.75 (3H, s), 2.83 (1H, dt), 2.40 (1H, m), 2.28 (1H , m), 1.95 (1H, m), 1.67 (1H, m), i.47 (9H, s) ^ Analysis of the calculation of C 〖5H24N406-1 / 6H20 値: C, 50.13; H, 6.82; N, 15.59 . Found 値: C, 50.12; H, 6.71; N, 15.58 a MS (ES +) 357 (M +-1, 46%), 301 (100%) 3 (45) 7-amino-6,10-di Keto-1,2,3,4,7,8,9,10-O-argon-6 ^ 1-Da Geng Bing-623- This paper 中 standard is suitable for Chinese SS family standard (CNS grid (210X29? ) (Please read the notes of t &amp; first and then write this page) binding 1235157

經濟部中央樣隼局員工消费合作社印裏 A - 五、發明説明(621) [l,2-a][l,2,4]三氮雜箪-4-羧酸甲豳(524),利用製備518之 方法合成自523。 化合物262a-k可利用製備211b-f之方法合成。 〇 〇Employees' Cooperatives of the Central Bureau of Economic Affairs, Ministry of Economic Affairs, India A-V. Description of the invention (621) [l, 2-a] [l, 2,4] triazine-4-carboxylic acid formamidine (524) The method for preparing 518 was synthesized from 523. Compounds 262a-k can be synthesized by the method for preparing 211b-f. 〇 〇

262a-k 263a-k 化合物 R 262a 263a COW 262b 263b ccy. 262c 263c 262d 263d CC 262e 263e ΟΛ 262f 263f CXA H262a-k 263a-k Compound R 262a 263a COW 262b 263b ccy. 262c 263c 262d 263d CC 262e 263e ΟΛ 262f 263f CXA H

-624- 本纸伕尺度適用中SS家標隼(CNS )六4忧格(2!0X 297公釐) 1235157 Λ7 ___B77、發明说明(622)-624- The standard of this paper is applicable to the SS family standard (CNS), 6 and 4 worries (2! 0X 297 mm) 1235157 Λ7 ___B77, Description of invention (622)

(請先%讀背§之注意事項再填寫本f ) 裝 訂 經洚部中失櫺準局員工消資合作社印裳 氫-6H-嗒味並[12-^1,2,4]三氮雜箪-4-羧酸第三-丁酯(262a) 0 443毫克(91%)的標題化合物可得到:〇1口.56-7°(:;[泛]1325 4-76° (c 015, CH2C12); IR (KBr) 3429, 2979, 1734, 1675, 1418, 1369, 1339, 1323, 1244, 1164, 665; lH NMR (CDC13) ^ 8.45 (1H, s), 8.00-7.59 (7H, m), 4.69-4.65 (1H, m), 4.25-4.12 (1H, m), 4.10-3.99 (1H, m), 3.73-3.55 (2H, m), 2.40-2.30 (1H, m), 1.99-1.91 (1H, m), 1.82-1.62 (2H, m), 1.48-1.46 (2H, m),1·37 (9H,s)。分析c23h28N406S*H20之計算値·· C, 54.53; •625- 本赚尺錢财邮 4 1235157 A 7 B7 五、發明説明( 623) ^ H,5.97; N,11.06。實測値:C,54·δ、0; H,5.73; N,10.95。MS (ES+) 489 。 (45)6,10-二酮基-7-(3-曱氧基苯基脲基)-1,2,3,4,7,8,9,10-八 氫-611-,答畊並[1,24][1,2,4]三氮雜蕈-4-羧酸第三-丁酯(262(:) 。120毫克(80%)無色泡沫可得到:〇]D22 +22.6° (c 0.1, CH2C12); IR (KBr) 33 16, 1732, 1671,1609, 1551,1455, 1432, 13 16, 1288, 1245, 12 18, 1 1 58, 1 122, 1023; lH NMR (CDC13) ό' 7.16 (4H,m),6·79 (1H,m), 6·60 (1H, m),5.11 (1H,m), 4.59 (1H, m), 3.89 (2H, m), 3.77 (3H, s), 3.72 (2H, m), 2.85 (iH, m) 3 (4S) 6,10-二酮基-7-(2-甲氧基苯基脲基)-1,2,3,4,7,8,9,10·八 氫-6H-嗒啡並[l,2-a][〖,2,4]三氮雜箪-4-羧酸第三-丁黯(262d) ,(81%)呈無色泡沫:〇】D22 (c 01,Ch2C12); IR (KBr) 3468, 3446, 3269, 1734, 1698, 1667, 1609, 1555, 1490,1461, 1433, 1423, 1296, 1246, 1215, 1 173, 1 157, 1028, 756; lH NMR (CDC13) δ 8.23 (1H, m), 7.95 (1H, s), 6.95 (4H, m), 5.15 (1H, m), 4.60 (1H, m), 3.98-3.65 (4H, m), 3.89 (3H, s), 2.90 (1H, m), 2.48 (1H, m), 2.25 (1H, m), 2.05-1.65 (2H, m), i.48 (9H, s) ^ (4S) 6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-苯基乙醯胺基-61^嗒呼並[1,24】[1,2,4]三氮雜箪-4-羧酸第三-丁酯(2626), 呈白色泡沫狀固體(155毫克,53%) ·· mp. 53-7X: ; [a】D22 + 57.40 (c 0.1,CH2C12); IR (KBr) 3271,2978, 1733, 1680, 1437, 13 14, 1245, 1 156, lH NMR (CDCI3) d 7.46 (1H, s), _ -626- __________ 本纸法尺度通用中a a家標隼(CNS ) A4堤格(210 X297公' — (請先閱讀背云之注意事項再填寫本f ) 裝 1235157 經濟部中夬櫟.孽局員工消費合作·杜印¾ Λ7 _______87___—五、發明説明( 624) ^ 7.42-7.20 (5H, m), 5.03 (1H, dd), 4/52-4.40 (1H, m), 3.96-3·70 (2H,m), 3.70-3.49 (1H,m),3·63 (2H,s),2·92-2·75 (1H, m), 2.43-2.33 (1H, m), 2.33-2.15 (1H, m), 2.00-1.50 (3H, m)? 1·45 (9H, s)。分析C21H2SN4O5S-0.25H2O之計算值:C,59.91; H,6.82; N,13.31。實測値:c, 60.19; H,6.80; N,13.30 3 MS (ES+) 418 (M+ + 2, 250/〇),417 (NT + 1,100),362 (9), 361 (45) 3 (4S) 6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-(3-笨基脲基)-6H-嗒哜並[l,2-a][l,2,4】三氮雜箪-4-羧酸第三-丁酯(262f),呈 白色固體(273 毫克,93%) ·· mp· 102-6Ό ; [a】D22 +7·5° (c 0.07, CH2C12); IR (KBr) 3320, 2979, 173 1,1676, 1669· 1601, 1549, 1444, 1314, 1240, 1156; lH NMR (CDC13) d 7.37-7.20 (6H, m), 7.08-6.98 (1H, m), 5.12 (1H, dd), 4.64-4.55 (1H, m), 4.020.78 (2H, m), 3.75-3.65 (1H, m), 2.94-2.75 (1H, m), 2.57-2.35 (1H, m), 2.35-2.20 (1H, m), 2.00-1.50 (3H, m), 1.48 (9H,s)。分析(:20Η27Ν5Ο5·0.4Η2Ο之計算値:C,56.56; H, 6.60; N, 16.49 ^ 實測値:C,56.89; H,6·58; N,16.07。MS (ES+) 419 (M+ + 2, 24%), 418 (M+ + 1,100),363 (15),362 (81),242 (10)。 (4S) 6,10-二酮基-7-(4 哚-2-羧醯胺基)-1,2,3,4,7,8,9,10-八 氫-6士嗒啡並[1,24][1,2,4]三氮雜箪-4-羧酸第三-丁酯(2623) ,(1 3 克)呈白色固體(298毫克,70%) : mp· 138-43’C; [a]D23 +69.8。(c 0.1, CH2C12); IR (KBr) 3282, 2978, 1733, 1664, 1536, 1421, 13 10, 1 156, 748; lH NMR (CDC13) o 9.67 (1H, s), 9.53 (1H, s), 7.50 (lH, d), 7.30-7.15 (2H, m), 7.10-7.00-627-本纸法尺度適用中g國家標隼(CNS ) A4現洛(210 x 297公变) (_先閱讀背云之注意事項再填寫本f ) 裝 訂 r.艮 1235157 A 7 _B7____ 五、發明説明( 625 ) _ 請 讀 背 面 之 i£ 意 % 再 填 % 本 買 (1H,m),6·93 (1H,s),5·16ο·12 (1H: m),4·60·4·50 (1H,m), 4.05-3.85 (2H, m), 3.85-3.70 (1H, m), 3.05-2.90 (1H? m), 2.55-2.35 (1H, m), 2.35-2.20 (1H, m), 2.00-1.85 (1H, m), 1.85-1.50 (2H,m),1·47 (9H,s)。分析〇22^27^5〇5*〇.45112〇之 計算値:C, 58·77; Η, 6·36; Ν,15.58 a 實測値:C,59.14; Η, 6.24; N,15.18 a MS (ES+) 433 (M+ + 2, 26%), 442·(Μ· + 1, 100),387 (17),386 (79),285 (20),229 (85),211 (26),185 (15),183 (57),139 (9)。 _ (4S) 7-[(4-乙醯胺基);醯胺基]-6,10-二酮基-1,2,3,4,7,8,9, 10-八氫答呼並[l,2-a][l,2,4]三氮雜箪-4-羧酸第三·丁酯 (262h),呈白色固體(325毫克,73%) : mp· 209-12eC; 〇]D24 +62.4° (c 0.2, CH2Ci2); IR (KBr) 3513, 3269, 2980, 173 1, 1680, 1653, 1599, 153 1? 1314, 1158; NMR (CDCi3) δ 9.40 (1H, s), 8.75 (1H, s), 7.72 (2H, d), 7.47 (2H, d), 5.15-5.05 (1H, m), 4.55-4.45 (1H, m), 4.05-3.70 (3H, m), 3.00-2.80 (1H, m), 2.45-2.35 (1H, m), 2.30-2.15 (1H, m), 2.10 (3H, s), 2.00-1.80 (1H, m), 1.80-1.50 (2H, m), 1.48 (9H, s)-分析 C22H29N506之計算値:C,57.51; H,6·36; N,15.24。實測値: C,57.41; H,6.38; N,15·12 a MS (ES + ) 461 (Μ— + 2, 26%), 經濟部t央標準局員工消费合作杜印製 460 (M+ + 1, 100),405 (12),404 (55),354 (7),285 (23),229 (52),183 (22)。 (4S) 6,10-二酮基-7-(4-甲氧基芊醢胺基)-八氫答呤並 [l,2-a】[l,2,4]三氮雜箪-羧酸第三-丁酯(262i),呈白色玻璃 狀固體(76%) : mp. 85-9Ό ; I&gt;]D25 +66.4。(c 0.11,CH2C12); -628- 本纸汝尺度通用中国S家標隼(CNS M4洗格(21〇 :&lt; 297公慶) 1235157 A 7 B7 _ 五、發明説明( 626) _ IR(KBr) 1732, 1668, 1607, 1502, 1&lt;40, 13 12, 1295, 1258, 1 176, 1 157, 1025; lH NMR (CDC13) ό' 8.25 (1H,s),7·77 (2H, m)? 6.90 (2Η, m), 5.11-5.07 (1H, m)? 4.55-4.48 (1H, m)? 4.01-3.91 (2H, m), 3.86-3.78 (1H, m), 3.785 (3H, s), 2.98 (1H? m), 2.46-2.40 (1H, m), 2.26-2.20 (1H, m),2.05-1.80 (1H, m), 1.70-1.64 (2H,m),1.48 (9H,s)。 (4S) 6,10-二酮基-l,2,3,4,7,8,9,10-八氫-7-苯基磺醯基胺基-6H-疼畊並[l,2-a][l,2,4]三氮雜箪-4-羧酸第三-丁酯(262j), 呈白色晶狀固體(79%) ·· mp· 182-3°C(分解);〇]D22 +92.1。 (c 0·4, CH2Cl2); IR (KBr) 3283,1732, 1684, 1448, 1430, 1404, 1369, 1338, 1306, 1285, 1242, 1169, 1091,692; lH NMR (CDC13) ά 7.89 (2H, d, J = 7.4), 7.76 (1H, s), 7.64-7.49 (3H? m), 4.83 (1H, m), 4.35 (1H, brd, J = 13.0), 4.00 (1H, m)? 3.74-3,63 (2H, m), 2.39-2.26 (2H, m), 2.06 (1H, m), 1.50-1.41 (10H, m) 3 分析 C19H26SN406之計算値·· C,52.04; H,5·98; N, 12.78。實測値:C,52.11; H,5.95; N,12.7卜 MS (ES + ) 437 (M+ - I, 100%) 〇 經濟部中央標準局員工消f合作杜印製 (請先聞讀背vB之注意事項再填寫本頁) (3S) (7-(4-芊氧基苯基)羰基胺基-610-二酮基H3 4 7 8 9, 10-八氫-6士嗒畊並[1,2^[1,2,4]三氮雜箪-4-羧酸第三-丁酯 (262k),(83%) ·· 〇]。二 +42.30 (c 0.11,CH2C12); IR (KBr) 3287, 2997, 2935, 1735, 1681,1606, 1501,1296, 1248,1173, 1155 - {H NMR (CDCi3) ό 9.23 (1H, s), 7.73 (2H, d), 7.3 8 (5H, m), 6.85 (2H, d), 5.OS (1H, m), 5.02 (2H? s), 4.4S (1H, bd), 4.15-3.65 (3H, m), 2.96 (1H, m), 2.45-2.10 (2H, m), 1.88 ____ -629- 本戒尺度遇用中S 3豕標辛(CNS ) 44¾格(210 x 297公签) 1235157 Λ7 B7_ 五、發明説明(627 ) (1H,m), 1·63 (2H,m),1.48 (9H,s)(ES+ 509 (M++1), 化合物263a-k利用製備212b-f之方法合成3 (43)6,10-二酮基-7-(2-莕磺醯基)胺基-1,2,3,4,7,8,9,10-八氫 -6H-嗒呼並[l,2-a][l,2,4]三氮雜箪-4-羧酸(263a),348毫克 (94%)呈白色泡沫狀固體:mp.[泛]D21 +171 ° (c 0.056, CH2C12); IR (KBr) 3426, 3233, 2953, 1 734, 1663, 1481,1415, 1340, 1214, 1167, 1 132, 1075, 668; 4 NMR (CDC13) ό' 8.44 (1H, s), 8.00-7.60 (7H, m), 4.85-4.83 (1H, m)? 4.25-4.00 (1H, m), 4.07-3.90 (1H, m), 3.70-3.46 (2H, m), 2.38-2.30 (1H, m), 2.12- 2.01 (1H, m),1.91-1.83 (1H, m), 1.46-1.26 (1H,m), 1.13- 1.06 (1H,m),0.90-0.77 (1H,m)。MS (ES上)43 卜 (4S) 7-(笨並[bh塞吩-2-羰基)胺基-6,10-二酮基-1,2,3,4,7,8,9, 10-八氫-6Η-β答*井並[l,2-a][l,2,4]三氣雜革-4-幾酸(263b) 3 200毫克(100%),呈白色固體。mp· 155X ; [a]D20 -13。(c 0.07, CH2C12); IR (KBr) 343 1,2935, 1734, 1663, 1 53 1,1435, 1292, 1177; lH NMR (CDC13) (J 9.73 (1H, bs), 7.73-7.27 (5H, 經濟部中夬樣準局員工消费合作杜印裝 (詩先閱讀背5之注意事項再填寫本頁) m), 5.35-5.25 (1H, m), 4.56-4.48 (1H, m), 4.05-3.65 (3H, m), 3.12-3.00 (1H, m), 2.50-2.45 (1H, m), 2.30-2.20 (1H, m), 2.10-2.00 (1H, m),1·75·1.61 (2H, m) a MS (ES + ) 40卜 (4S) 6,10-二酮基-7-(3-甲氧基笨基脲基)-1,2,3,4,7,8,9,10-八 氫-611-嗒畊並[1,24][1,2,4]三氮雜箪-4-羧酸(263(:),216毫克 (100+%)呈無色泡沫:[a]D23 32.5 ° (c 0.1,CH2C12); IR (KBr) 3326, 1730, 1661, 1610, 1555, 1495,1431,1314,1288,1217, 1175, 1161; lH NMR (CDC13) ό' 7.87 (1H,s),7·58 (1H,s), -630- 本紙伕尺度適用中國國家標李(CNS ) A4現格(210X 297公釐) 一 1235157 Λ: _Β7___ 五、發明説明( 628) 錢 7.19 (2Η, m), 6.82 (1H, m), 6.62 (1H, m), 5.21 (1H, m), 4.55 (1H, m), 3.76 (3H, s), 4.00.65 (4H, m), 2.85 (1H, m), 2.35 (2H, m), 1.75 (1H, m), 1.71 (2H, m)- (4S) 6,10-二酮基-7-(2-甲氧基苯基脲基)-1,2,3,4,7,8,9,10-八 氫-6士喀啩並[1,24][1,2,4】三氮雜箪-4-羧酸(263(1),(100+%) 呈無色泡沫:〇]D24 +11.7。(c 0_1,CH2C12); IR (KBr) 3394, 3325, 1666, 1603, 1543, 1490, 1463, 1438, 1329, 13 1 1,1292, 1249, 1214, 1 176, 1 1 19, 1024, 752; lH NMR (CDC13) d 8.15 (1H, m), 7.97 (2H, m), 7.15-6.84 (3H, m), 5.29 (1H? m)? 4.62 (1H, m), 4.04-3.65 (4H, m), 3.89 (3H, s), 2.92 (1H, m), 2.50 (1H, m), 2·30 (1H, m), 2.10-1.75 (2H,m)。 (45)6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-苯基乙醯基-胺基· 6^嗒啩並[1,24】[1,2,4】三氮雜箪-4-羧酸(263€),呈白色泡 沫狀固鳢(117毫克,98%) : mp. 109-14Ό; 〇]D24 +82.6° (c 0.06, CH2C12); IR (KBr) 3700-2250 (br), 3437, 3274, 2959, 1733, 1664, 1481, 1437, 1310, 1 177; lH NMR (CDCi3) d 經濟部中夬樣準局員工消费合作·杜印裳 (請先另讀背面之洼意事項再填寫衣頁) 7.99 (1H, s), 7.40-7.15 (5H, m), 5.15-5.10 (1H, m), 5.25-4.70 (1H, bs), 4.50-4.35 (1H, m), 3.95-3.50 (3H, m), 3.61 (2H, s), 2.93-2.78 (1H,m),2.40-2.20 (2H,m),2.10-1.80 (1H,m), 1.80-1.60 (2H,m)。分析 Cl7H20N4O5S.lH2O之計算値·· C, 53.96; H,5.86; Ν,14·81。實測値:C,54.12; H,5·50; N, 14.68 - MS (ES&quot;) 360 (M+, 21%), 359 (M+ - 1, 100), 196 (14), 182 (14), \{\ (7) 〇 (45)6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-(3-苯基脲基)-6^1- _ - 631 - 衣纸伕尺度適用中S國家標準(CNS ) A4現格(210X 297公沒) 1235157 Λ7 B7 經濟部中夬樣準局貝工消費合作社印¾ 五、發明説明(629 ) 嗒啡並[1,24][1,2,4]三氮雜箪-4-竣、酸(263〇,得白色泡沫狀 固體(199毫克,92%) : mp· 149_52eC; 〇]D24 +92.0。(c 0.01, CH3OH); IR (KBr) 3700-2300 (br),33 19, 2956, 1726, 1664, 1600, 1548, 1500, 1444, 13 13, 1238, 755; lH NMR (D6-DMSO) o' 8.90 (1H,s), 8·24 (1H,s), 7.42 (2H, d),7.30-7.20 (2H, m), 7.00-6.90 (1H, m), 4.98-4.92 (1H, m), 4.32-4.22 (1H, m), 3.80-3.55 (3H? m), 2.85-2.70 (1H, m), 2.30-2.20 (1H, m), 2.20-2.00 (1H,m), 1.90-1.35 (3H, m)。分析 Cl6H19N505 · 0.75H2O之計算値:C, 51.26; H, 5.51; N,18.68。實測値:C, 51.U; H, 5.23; N,18.42。 MS (ES+) 361 (M+, 20%),360 (M十 • 1, 100), 241 (1 1),240 (89), 196 (15), 175 (29),111 (12)。 (4S) 6,10-二酮基-7-(啕哚-2-羧醯胺基)-1,2,3,4,7,8,9,10-八 氫-6H-,答啩並[l,2-a】[l,2,4]三氮雜箪-4-羧酸(263g),呈白色 固體(259毫克,92%) : mp· 248-51。(:; |&gt;]D24 +94.0。(c 0.01, CH3〇H); IR (KBr) 3700-2300 (br) 3341,2956, 1738, 1668, 165 1, 1529, 1425, 13 1 1, 1259, 751; lH NMR (D6-DMSO) 0 13.29 (1H, bs), 11.72 (1H, s), 10.64 (1H, s), 7.65 (1H, d), 7.45 (1H, d), 7.26-7.15 (1H, m), 7.17 (lH, s), 7.10^7.00 (iH, m), 5.05-4.95 (1H, m), 4.40-4.25 (1H, m), 3.90-3.50 (3H, m), 2.88-2.75 (1H,m), 2.38-2.20 (1H, m), 2.20-2.00 (1H,m), 1.90-1.35 (3H) 3 分析CisHi9N5〇5:〇 5H2〇之計算値:c,53 59; H,5·25; N, 17.35。實測値:C,53.66; H,4.88; N,17.11。MS (ES + ) 385 (M+,23%),384 (M十-1,100),298 (6),253 (8), -227 (10), 199 (23), 196 (10), 173 (9), 126 (21) ^___ -632- 衣纸法尺度通用〒ϋ國家標车(CNS ) A4現格(210 X 2Q7公釐) ---------^焚,-- (請先閱讀背δ之注意事項^^宵本頁) r 1235157 B7 五、發明説明(630 ) n 先 聞 If 面 之 ί % (4S) 7-[(4-乙醢胺基)芊醯胺基]-6、,10-二酮基-1,2,3,4,7,8,9, 10-八氫-6H-嗒讲並[1,24][1,2,4]三氮雜箪-4-羧酸(26311), 呈白色固體(282毫克;99%) : mp. 210〇aC; 〇】D24 +74.5。 (c 0.01, CH3OH); IR (KBr) 3700-2300 (br), 3444, 3316, 2960, 1664, 1599, 1531, 1439, 1301, 1 184; !H NMR (D6-DMSO) δ 13.30 (1H, bs), 10.50 (1H, s), 10.25 (1H, s), 7.80 (2H, d), 7.68 (2H, d), 5.00-4.90 (1H, m), 4.35-4.25 (1H, m), 3.90-3.40 (3H, m), 2.88-2.70 (1H, m), 2.35-2.25 (1H, m), 2.25-1.95 (1H, m),2.08 (3H, s), 1.95-1.35 (3H,m)。MS (ES十)403 (M+, 10%), 402 (M&quot; - 1, 100), 358 (10), 247 (10), 227 (16)), 219 (51), 198 (12), 184 (17) 〇 (45)6,10-二酮基-7-(4-甲氧基苄醯胺基)-八氫-6士,答畊並 [1,24][1,2,4]三氮雜箪-羧酸(263丨),呈白色玻璃狀固體(約 100%),可使用勿需再純化·· 4 NMR (CDC13) β 9.23 (1H, s), 7.72 (2H, d, J = 8.8), 6.81 (2H, d, J = 8.9), 5.22 (1H, m)? 4.51 (1H, m), 3.97-3.72 (2H, m), 3.81 (3H, s), 3.03 (1H, m), 2.51-2.46 (1H, m), 2.31-2.25 (1H, m), 2.03 (1H, m), 1.72 (2H? m) 0 經濟部中夬樣準局負工消費合作杜印製(Please read the notes in §% before you fill out this f) Binding staff in the Ministry of Economics and Economics, Consumer Affairs Cooperative, Cooperative Co., Ltd. Yinchang Hydrogen-6H-Dawei and [12- ^ 1,2,4] triaza The tertiary-butyl carboxylic acid tertiary-butyl ester (262a) 0 443 mg (91%) of the title compound was obtained: 〇1. 56-7 ° (:; [PAN] 1325 4-76 ° (c 015, CH2C12); IR (KBr) 3429, 2979, 1734, 1675, 1418, 1369, 1339, 1323, 1244, 1164, 665; lH NMR (CDC13) ^ 8.45 (1H, s), 8.00-7.59 (7H, m) , 4.69-4.65 (1H, m), 4.25-4.12 (1H, m), 4.10-3.99 (1H, m), 3.73-3.55 (2H, m), 2.40-2.30 (1H, m), 1.99-1.91 ( 1H, m), 1.82-1.62 (2H, m), 1.48-1.46 (2H, m), 1.37 (9H, s). Analysis of the calculation of c23h28N406S * H20 値 · C, 54.53; Rule money post 4 1235157 A 7 B7 V. Description of the invention (623) ^ H, 5.97; N, 11.06. Measured 値: C, 54 · δ, 0; H, 5.73; N, 10.95. MS (ES +) 489. (45) 6,10-Diketo-7- (3-methoxyoxyphenylureido) -1,2,3,4,7,8,9,10-octahydro-611-, [1,24] [1,2,4] Terazine-4-carboxylic acid tert-butyl ester (262 (:). 120 mg (80%) colorless foam can be obtained: 0] D22 +22.6 (c 0.1, CH2C12); IR (KBr) 33 16, 1732, 1671, 1609, 1551, 1455, 1432, 13 16, 1288, 1245, 12 18, 1 1 58, 1 122, 1023; lH NMR (CDC13) ό '7.16 (4H, m), 6.79 (1H, m), 6.60 (1H, m), 5.11 (1H, m), 4.59 (1H, m), 3.89 (2H, m), 3.77 ( 3H, s), 3.72 (2H, m), 2.85 (iH, m) 3 (4S) 6,10-diketo-7- (2-methoxyphenylureido) -1,2,3, 4,7,8,9,10 · octahydro-6H-daphne [l, 2-a] [〖, 2,4] triazafluorene-4-carboxylic acid tertiary-butan (262d), (81%) showed colorless foam: 〇] D22 (c 01, Ch2C12); IR (KBr) 3468, 3446, 3269, 1734, 1698, 1667, 1609, 1555, 1490, 1461, 1433, 1423, 1296, 1246, 1215, 1 173, 1 157, 1028, 756; lH NMR (CDC13) δ 8.23 (1H, m), 7.95 (1H, s), 6.95 (4H, m), 5.15 (1H, m), 4.60 (1H, m), 3.98-3.65 (4H, m), 3.89 (3H, s), 2.90 (1H, m), 2.48 (1H, m), 2.25 (1H, m), 2.05-1.65 (2H, m), i .48 (9H, s) ^ (4S) 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-7-phenylacetamido-61 ^ Phyto [1,24] [1,2,4] triazapyridin-4-carboxylic acid tert-butyl ester (2626) as a white foamy solid (155 mg, 53%) ·· mp. 53-7X:; [a] D22 + 57.40 (c 0.1, CH2C12); IR (KBr) 3271, 2978, 1733, 1680, 1437, 13 14, 1245, 1 156, lH NMR (CDCI3) d 7.46 ( 1H, s), _ -626- __________ The standard of the paper method is commonly used in the aa family standard (CNS) A4 Tiege (210 X297) '— (Please read the precautions of the back of the cloud before filling out this f). 1235157 Ministry of Economic Affairs Zhong Liqun. Consumption Cooperation of Employees of the Nie Bureau · Du Yin ¾ 7 _______ 87 ___— V. Description of the Invention (624) ^ 7.42-7.20 (5H, m), 5.03 (1H, dd), 4 / 52-4.40 (1H, m) , 3.96-3 · 70 (2H, m), 3.70-3.49 (1H, m), 3.63 (2H, s), 2.92-2 · 75 (1H, m), 2.43-2.33 (1H, m ), 2.33-2.15 (1H, m), 2.00-1.50 (3H, m)? 1.45 (9H, s). Analyze the calculated value of C21H2SN4O5S-0.25H2O: C, 59.91; H, 6.82; N, 13.31. Measured 値: c, 60.19; H, 6.80; N, 13.30 3 MS (ES +) 418 (M + + 2, 250 / 〇), 417 (NT + 1,100), 362 (9), 361 (45) 3 ( 4S) 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-7- (3-benzylureido) -6H-daparo [l, 2- a] [l, 2,4] Terza-tricarboxylic acid tert-butyl ester (262f) as a white solid (273 mg, 93%) ·· mp · 102-6Ό; [a] D22 + 7.5 ° (c 0.07, CH2C12); IR (KBr) 3320, 2979, 173 1,1676, 16691601, 1549, 1444, 1314, 1240, 1156; 1H NMR (CDC13) d 7.37-7.20 (6H, m), 7.08-6.98 (1H, m), 5.12 (1H, dd), 4.64-4.55 (1H, m), 4.020.78 (2H, m), 3.75-3.65 (1H, m), 2.94-2.75 ( 1H, m), 2.57-2.35 (1H, m), 2.35-2.20 (1H, m), 2.00-1.50 (3H, m), 1.48 (9H, s). Analysis (: 20Η27N5050 · 0.4Η20 calculations: C, 56.56; H, 6.60; N, 16.49 ^ Found: C, 56.89; H, 6.58; N, 16.07. MS (ES +) 419 (M + + 2, 24%), 418 (M + + 1,100), 363 (15), 362 (81), 242 (10). (4S) 6,10-diketo-7- (4 indole-2-carboxamide ) -1,2,3,4,7,8,9,10-octahydro-6-daphta [1,24] [1,2,4] triazafluorene-4-carboxylic acid third -Butyl ester (2623), (1 3 g) as a white solid (298 mg, 70%): mp · 138-43'C; [a] D23 +69.8. (C 0.1, CH2C12); IR (KBr) 3282 , 2978, 1733, 1664, 1536, 1421, 13 10, 1 156, 748; lH NMR (CDC13) o 9.67 (1H, s), 9.53 (1H, s), 7.50 (lH, d), 7.30-7.15 ( 2H, m), 7.10-7.00-627-The standard of the paper method is applicable to the national standard of China (CNS) A4 now Luo (210 x 297 public variable) (_Read the precautions of back cloud before filling in this f) Binding r 1235157 A 7 _B7____ V. Description of the invention (625) _ Please read the meaning of i on the back and fill in%. Buy this (1H, m), 6.93 (1H, s), 5.16ο · 12 (1H: m), 4 · 60 · 4 · 50 (1H, m), 4.05-3.85 (2H, m), 3.85-3.70 (1H, m), 3.05-2.90 (1H? m), 2.55-2.3 5 (1H, m), 2.35-2.20 (1H, m), 2.00-1.85 (1H, m), 1.85-1.50 (2H, m), 1.47 (9H, s). Analysis 〇22 ^ 27 ^ 5 〇5 * 〇.45112〇 Calculated 値: C, 58 · 77; Η, 6.36; Ν, 15.58 a Found 値: C, 59.14; Η, 6.24; N, 15.18 a MS (ES +) 433 (M + + 2, 26%), 442 · (Μ · + 1, 100), 387 (17), 386 (79), 285 (20), 229 (85), 211 (26), 185 (15), 183 (57 ), 139 (9). _ (4S) 7-[(4-acetamido); amido] -6,10-diketo-1,2,3,4,7,8,9,10-octahydropyridine [l, 2-a] [1,2,4] triazapyridin-4-carboxylic acid tert-butyl ester (262h) as a white solid (325 mg, 73%): mp 209-12eC; 〇 ] D24 + 62.4 ° (c 0.2, CH2Ci2); IR (KBr) 3513, 3269, 2980, 173 1, 1680, 1653, 1599, 153 1? 1314, 1158; NMR (CDCi3) δ 9.40 (1H, s), 8.75 (1H, s), 7.72 (2H, d), 7.47 (2H, d), 5.15-5.05 (1H, m), 4.55-4.45 (1H, m), 4.05-3.70 (3H, m), 3.00- 2.80 (1H, m), 2.45-2.35 (1H, m), 2.30-2.15 (1H, m), 2.10 (3H, s), 2.00-1.80 (1H, m), 1.80-1.50 (2H, m), 1.48 (9H, s)-Analysis of C22H29N506 calculation: C, 57.51; H, 6.36; N, 15.24. Measured 値: C, 57.41; H, 6.38; N, 15 · 12 a MS (ES +) 461 (M— + 2, 26%), the Ministry of Economic Affairs and the Central Bureau of Standards, Consumer Cooperative Printing 460 (M + + 1 , 100), 405 (12), 404 (55), 354 (7), 285 (23), 229 (52), 183 (22). (4S) 6,10-diketo-7- (4-methoxyamidoamino) -octahydrotrioxo [l, 2-a] [l, 2,4] triazafluorene-carboxyl Acid tert-butyl ester (262i) as a white glassy solid (76%): mp. 85-9Ό; I &gt;] D25 +66.4. (C 0.11, CH2C12); -628- The standard of this paper is the standard of China's S (隼) (CNS M4 (21〇: & 297)) 1235157 A 7 B7 _ V. Description of the invention (626) _ IR ( KBr) 1732, 1668, 1607, 1502, 1 &lt; 40, 13 12, 1295, 1258, 1 176, 1 157, 1025; lH NMR (CDC13) '' 8.25 (1H, s), 7.77 (2H, m )? 6.90 (2Η, m), 5.11-5.07 (1H, m)? 4.55-4.48 (1H, m)? 4.01-3.91 (2H, m), 3.86-3.78 (1H, m), 3.785 (3H, s ), 2.98 (1H? M), 2.46-2.40 (1H, m), 2.26-2.20 (1H, m), 2.05-1.80 (1H, m), 1.70-1.64 (2H, m), 1.48 (9H, s ). (4S) 6,10-diketo-l, 2,3,4,7,8,9,10-octahydro-7-phenylsulfonylamino-6H-synthesis [l, 2-a] [l, 2,4] Triazapyridin-4-carboxylic acid tert-butyl ester (262j), as a white crystalline solid (79%) ·· mp · 182-3 ° C (decomposed) 〇] D22 +92.1. (C 0.4, CH2Cl2); IR (KBr) 3283, 1732, 1684, 1448, 1430, 1404, 1369, 1338, 1306, 1285, 1242, 1169, 1091, 692; lH NMR (CDC13) ά 7.89 (2H, d, J = 7.4), 7.76 (1H, s), 7.64-7.49 (3H? M), 4.83 (1H, m), 4.35 (1H, brd, J = 13.0), 4.00 (1H, m)? 3.74-3,63 (2H, m), 2.39-2.26 ( 2H, m), 2.06 (1H, m), 1.50-1.41 (10H, m) 3 Analysis of the calculation of C19H26SN406 C · C, 52.04; H, 5.98; N, 12.78. Measured 値: C, 52.11; H , 5.95; N, 12.7 MS (ES +) 437 (M +-I, 100%) 〇 Cooperative printing by employees of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions of vB before filling out this page) ( 3S) (7- (4-Methoxyphenyl) carbonylamino-610-diketone H3 4 7 8 9, 10-octahydro-6 stilbene [1,2 ^ [1,2,4 ] Triazapyridine-4-carboxylic acid tert-butyl ester (262k), (83%) ···]. +42.30 (c 0.11, CH2C12); IR (KBr) 3287, 2997, 2935, 1735, 1681, 1606, 1501, 1296, 1248, 1173, 1155-{H NMR (CDCi3) 9.6 9.23 (1H, s), 7.73 (2H, d), 7.3 8 (5H, m), 6.85 (2H, d), 5.OS (1H, m), 5.02 (2H? S), 4.4S (1H, bd), 4.15-3.65 ( 3H, m), 2.96 (1H, m), 2.45-2.10 (2H, m), 1.88 ____ -629- S 3 standard mark (CNS) 44¾ grid (210 x 297 notarized) 1235157 Λ7 B7_ V. Description of the invention (627) (1H, m), 1.63 (2H, m), 1.48 (9H, s) (ES + 509 (M ++ 1), compound 263a-k Method to synthesize 3 (43) 6,10-diketo-7- (2-fluorenylsulfonyl) amino-1,2,3,4,7,8,9,10-octahydro-6H-dahu And [l, 2-a] [l, 2,4] triazafluorene-4-carboxylic acid (263a), 348 mg (94%) was a white foamy solid: mp. [PAN] D21 +171 ° ( c 0.056, CH2C12); IR (KBr) 3426, 3233, 2953, 1 734, 1663, 1481, 1415, 1340, 1214, 1167, 1 132, 1075, 668; 4 NMR (CDC13) ό '8.44 (1H, s ), 8.00-7.60 (7H, m), 4.85-4.83 (1H, m)? 4.25-4.00 (1H, m), 4.07-3.90 (1H, m), 3.70-3.46 (2H, m), 2.38-2.30 (1H, m), 2.12- 2.01 (1H, m), 1.91-1 .83 (1H, m), 1.46-1.26 (1H, m), 1.13- 1.06 (1H, m), 0.90-0.77 (1H, m). MS (on ES) 43 BU (4S) 7- (Stupid [bh thiophene-2-carbonyl) amino-6,10-diketo-1,2,3,4,7,8,9, 10-octahydro-6Η-βA * [1,2 -a] [l, 2,4] Tris-Gas-4--4-acid (263b) 3 200 mg (100%) as a white solid. mp 155X; [a] D20 -13. (C 0.07, CH2C12); IR (KBr) 343 1,2935, 1734, 1663, 1 53 1,1435, 1292, 1177; lH NMR (CDC13) (J 9.73 (1H, bs), 7.73-7.27 (5H, Du Yinzhuang, Consumer Co-operation of the Sample Prospective Bureau of the Ministry of Economic Affairs (Notes on reading the poem first and then filling out this page) m), 5.35-5.25 (1H, m), 4.56-4.48 (1H, m), 4.05- 3.65 (3H, m), 3.12-3.00 (1H, m), 2.50-2.45 (1H, m), 2.30-2.20 (1H, m), 2.10-2.00 (1H, m), 1.75 · 1.61 (2H , m) a MS (ES +) 40 (4S) 6,10-diketo-7- (3-methoxybenzylureido) -1,2,3,4,7,8,9, 10-Octahydro-611-Da-Phen [1,24] [1,2,4] triazapyrene-4-carboxylic acid (263 (:), 216 mg (100 +%) showed a colorless foam: [a ] D23 32.5 ° (c 0.1, CH2C12); IR (KBr) 3326, 1730, 1661, 1610, 1555, 1495, 1431, 1314, 1288, 1217, 1175, 1161; lH NMR (CDC13) ό '7.87 (1H, s), 7.58 (1H, s), -630- The standard of this paper is applicable to Chinese national standard plum (CNS) A4 (210X 297mm)-1235157 Λ: _Β7 ___ V. Description of the invention (628) Money 7.19 ( 2Η, m), 6.82 (1H, m), 6.62 (1H, m), 5.21 (1H, m), 4.55 (1H, m), 3.76 (3H, s), 4.00.65 (4H, m), 2.85 (1H, m), 2.35 (2H, m), 1.75 (1H, m), 1.71 (2H, m)-(4S) 6,10-diketo-7- (2-methoxyphenylureido ) -1,2,3,4,7,8,9,10-Octahydro-6-scarpin [1,24] [1,2,4] triazapyrene-4-carboxylic acid (263 ( 1), (100 +%) is a colorless foam: 〇] D24 +11.7. (C 0_1, CH2C12); IR (KBr) 3394, 3325, 1666, 1603, 1543, 1490, 1463, 1438, 1329, 13 1 1 , 1292, 1249, 1214, 1 176, 1 1 19, 1024, 752; lH NMR (CDC13) d 8.15 (1H, m), 7.97 (2H, m), 7.15-6.84 (3H, m), 5.29 (1H m)? 4.62 (1H, m), 4.04-3.65 (4H, m), 3.89 (3H, s), 2.92 (1H, m), 2.50 (1H, m), 2.30 (1H, m), 2.10-1.75 (2H, m). (45) 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-7-phenylethylfluorenyl-amino group ] [1,2,4] Triazapyrene-4-carboxylic acid (263 €), solid foam as a white foam (117 mg, 98%): mp. 109-14Ό; 〇] D24 + 82.6 ° (c 0.06, CH2C12); IR (KBr) 3700-2250 (br), 3437, 3274, 2959, 1733, 1664, 1481, 1437, 1310, 1 177; lH NMR (CDCi3) Cooperation · Du Yinshang (please read the intent on the back separately before filling in the clothing page) 7.99 (1H, s), 7.40-7.15 (5H, m), 5.15-5.10 (1H, m), 5.25-4.70 (1H , bs), 4.50-4.35 (1H, m), 3.95-3.50 (3H, m), 3.61 (2H, s), 2.93-2.78 (1H, m), 2.40-2.20 (2H, m), 2.10-1.80 (1H, m), 1.80-1.60 (2H, m). Analysis for Cl7H20N4O5S.lH2O Calculated ... C, 53.96; H, 5.86; N, 14.81. Measured 値: C, 54.12; H, 5.50; N, 14.68-MS (ES &quot;) 360 (M +, 21%), 359 (M +-1, 100), 196 (14), 182 (14), \ {\ (7) 〇 (45) 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-7- (3-phenylureido) -6 ^ 1 -_-631-Applicable Chinese National Standard (CNS) A4 standard (210X 297) 1235157 Λ7 B7 Printed by Shellfish Consumer Cooperative, China Prototype Bureau, Ministry of Economic Affairs ¾ 5. Description of Invention (629) Brown [1,24] [1,2,4] triazapyrene-4-end, acid (263 °, to give a white foamy solid (199 mg, 92%): mp · 149_52eC; 〇] D24 +92.0 (C 0.01, CH3OH); IR (KBr) 3700-2300 (br), 33 19, 2956, 1726, 1664, 1600, 1548, 1500, 1444, 13 13, 1238, 755; lH NMR (D6-DMSO) o '8.90 (1H, s), 8.24 (1H, s), 7.42 (2H, d), 7.30-7.20 (2H, m), 7.00-6.90 (1H, m), 4.98-4.92 (1H, m ), 4.32-4.22 (1H, m), 3.80-3.55 (3H? M), 2.85-2.70 (1H, m), 2.30-2.20 (1H, m), 2.20-2.00 (1H, m), 1.90-1.35 (3H, m). Analysis of Cl6H19N505 · 0.75H2O O: C, 51.26; H, 5.51; N, 18.68. Measured 値: C, 51.U; H, 5.23; N, 18.42. MS (ES +) 361 (M +, 20%), 360 (M ten • 1, 100), 241 (1 1), 240 (89), 196 (15), 175 (29), 111 (12). (4S) 6, 10- Diketo-7- (pyridin-2-carboxamido) -1,2,3,4,7,8,9,10-octahydro-6H-, pyrido [l, 2-a] [l, 2,4] Triazapyridin-4-carboxylic acid (263 g) as a white solid (259 mg, 92%): mp 248-51. (:; | &gt;) D24 +94.0. (c 0.01, CH3〇H); IR (KBr) 3700-2300 (br) 3341, 2956, 1738, 1668, 165 1, 1529, 1425, 13 1 1, 1259, 751; lH NMR (D6-DMSO) 0 13.29 ( 1H, bs), 11.72 (1H, s), 10.64 (1H, s), 7.65 (1H, d), 7.45 (1H, d), 7.26-7.15 (1H, m), 7.17 (lH, s), 7.10 ^ 7.00 (iH, m), 5.05-4.95 (1H, m), 4.40-4.25 (1H, m), 3.90-3.50 (3H, m), 2.88-2.75 (1H, m), 2.38-2.20 (1H, m), 2.20-2.00 (1H, m), 1.90-1.35 (3H) 3 Analytical calculation of CisHi9N505: 05H2O: c, 53 59; H, 5.25; N, 17.35. Found 値: C, 53.66; H, 4.88; N, 17.11. MS (ES +) 385 (M +, 23%), 384 (M ten-1, 100), 298 (6), 253 (8), -227 (10), 199 (23), 196 (10), 173 (9), 126 (21) ^ ___ -632- General-purpose 〒ϋ national standard car (CNS) A4 (210 X 2Q7 mm) --------- ^ (Please read the precautions for δ ^^ this page) r 1235157 B7 V. Description of the invention (630) n First heard If% (4S) 7-[(4-ethylamido) pyridine Yl] -6,, 10-diketo-1,2,3,4,7,8,9,10-octahydro-6H-da-benzo [1,24] [1,2,4] triazine Hexa-4-carboxylic acid (26311) as a white solid (282 mg; 99%): mp. 2100aC; 0] D24 + 74.5. (c 0.01, CH3OH); IR (KBr) 3700-2300 (br), 3444, 3316, 2960, 1664, 1599, 1531, 1439, 1301, 1 184;! H NMR (D6-DMSO) δ 13.30 (1H, bs), 10.50 (1H, s), 10.25 (1H, s), 7.80 (2H, d), 7.68 (2H, d), 5.00-4.90 (1H, m), 4.35-4.25 (1H, m), 3.90 -3.40 (3H, m), 2.88-2.70 (1H, m), 2.35-2.25 (1H, m), 2.25-1.95 (1H, m), 2.08 (3H, s), 1.95-1.35 (3H, m) . MS (ES Ten) 403 (M +, 10%), 402 (M &quot;-1, 100), 358 (10), 247 (10), 227 (16)), 219 (51), 198 (12), 184 (17) 〇 (45) 6,10-diketo-7- (4-methoxybenzylamido) -octahydro-6, which is [1,24] [1,2,4] Triazapyrene-carboxylic acid (263 丨), a white glassy solid (about 100%), can be used without further purification 4 NMR (CDC13) β 9.23 (1H, s), 7.72 (2H, d, J = 8.8), 6.81 (2H, d, J = 8.9), 5.22 (1H, m)? 4.51 (1H, m), 3.97-3.72 (2H, m), 3.81 (3H, s), 3.03 (1H, m), 2.51-2.46 (1H, m), 2.31-2.25 (1H, m), 2.03 (1H, m), 1.72 (2H? m)

(45)6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-苯基磺醯胺基-6H-嗒啡並[1,24】[1,2,4]三氮雜箪-4-羧酸(263〗),呈白色固 體(100%) : mp· 73-83Ό ; [a]D22 车1〇4.7。(c 0.3, CH2C12); IR (KBr) 3600-2500 (br) 3208; 1734, 1666, 1481, 1448, 1416, 1338, 13 1 1, 1214, 1 171, 1091, 729, 689; lH NMR (CDCl3) d 7.87 (3H, m), 7.70-7.50 (3H, m), 7.16 (1H, brs), 4.99 (1H, m), -633 本纸乐尺度適用中3国家標李(匚&gt;^)人4現格(2丨0&gt;&lt;297公簦) 1235157 A7 B7 五、發明説明(631 ) 4.37 (1H, brd, J = 12.8), 3.92 (1H, m), 3.67 (2H, m), 2.36 (2H, m), 2·13 (1H, brd, J = 12·2),1.56 (3H, m)。分析 Cl5H18SN4O6*0,25CF3CO2Hi計算値:C,45.31; H,4.48; N, 13.64。實測値·· C,45.48; H,4·71; N,13.43。MS (ES + ) 383 (MET, 100%),C15H19SN406 (MH+)之精確質量計算値: 383.1025。實測値:383.1007。 (45)7-(4-芊氧苯基)羰胺基-6,10-二酮基-1,2,3,4,7,8,9,10-八 氫·6Η-嗒哜並[1,24][1,2,4]三氮雜箪-4-羧酸(2631〇,(100%) :mp. 130-142’C ; IR (KBr) 3272, 2945, 1738, 1650, 161 1, 1501, 1445, 1309, 1255, 1 171; lK NMR (CDC13) ^ 9.35 (1H, s), 7.74 (2H, d), 7·38 (5H,m), 6.85 (2H,d), 5.40 (1H,bs), 5.19 (1H, s), 5.02 (2H, s), 4.49 (1H, d), 3.92 (2H, m), 3.68 (1H, m), 2.99 (1H, bs), 2.43 (1H, bs), 2.22 (1H, bs), 1.99 (1H, bs), 1.68 (2H, bs)。(45) 6,10-diketo-1,2,3,4,7,8,9,10-octahydro-7-phenylsulfonamido-6H-daphne [1,24] [ 1,2,4] triazapyrene-4-carboxylic acid (263), as a white solid (100%): mp 73-83Ό; [a] D22 Che 14.7. (C 0.3, CH2C12); IR (KBr) 3600-2500 (br) 3208; 1734, 1666, 1481, 1448, 1416, 1338, 13 1 1, 1214, 1 171, 1091, 729, 689; lH NMR (CDCl3 ) d 7.87 (3H, m), 7.70-7.50 (3H, m), 7.16 (1H, brs), 4.99 (1H, m), -633 This paper music scale is applicable to 3 national standard plums (匚 &gt; ^) Person 4 is present (2 丨 0 &gt; &lt; 297) 12 1235157 A7 B7 V. Description of the invention (631) 4.37 (1H, brd, J = 12.8), 3.92 (1H, m), 3.67 (2H, m), 2.36 (2H, m), 2.13 (1H, brd, J = 12 · 2), 1.56 (3H, m). Analysis for Cl5H18SN4O6 * 0,25CF3CO2Hi Calculated 値: C, 45.31; H, 4.48; N, 13.64. Measured 値 · C, 45.48; H, 4.71; N, 13.43. MS (ES +) 383 (MET, 100%), accurate mass calculation of C15H19SN406 (MH +) 値: 383.1025. Found 値: 383.1007. (45) 7- (4-fluorenoxyphenyl) carbonylamino-6,10-diketonyl-1,2,3,4,7,8,9,10-octahydro · 6Η-dapyridine [ 1,24] [1,2,4] triazafluorene-4-carboxylic acid (2631〇, (100%): mp. 130-142'C; IR (KBr) 3272, 2945, 1738, 1650, 161 1, 1501, 1445, 1309, 1255, 1 171; 1K NMR (CDC13) ^ 9.35 (1H, s), 7.74 (2H, d), 7.38 (5H, m), 6.85 (2H, d), 5.40 (1H, bs), 5.19 (1H, s), 5.02 (2H, s), 4.49 (1H, d), 3.92 (2H, m), 3.68 (1H, m), 2.99 (1H, bs), 2.43 ( 1H, bs), 2.22 (1H, bs), 1.99 (1H, bs), 1.68 (2H, bs).

5251 2631 經濟部中夬標準局員工消费合作杜印製 (4S) 6,10-二酮基-7-(3,4-甲二氧基芊醯胺基)-l,2,3,4,7’8’9’ 10-八氫·6Η-嗒啡並[l,2-a][l,2,4]三氮雜箪-4-羧酸甲翁 ,利用製備211之方法合成,可生成白色結晶狀固禮(3 )) 克,83%) ·· mp· 214-5°C ; |&gt;]D20 +75.2。(c 0.01,CH2Cl2); -634- 本紙法尺度通用中g國家標隼(CNS ) A4堤格(210 X 297公笼) 經濟部中央標.华局員工消t合作4!印¾ 1235157 Λ7 ___B7_ 五、發明说明(632) (KBr) 3272, 2955, 1747, 1664, 1610; 1485, 1443, 1265, 1040; lK NMR (CDC13) ^ 8.66 (1Η, s), 7.32 (1H, dd), 7.23 (1H, d), 6.76 (1H, d), 6.02 (2H, s), 5.20 (1H, dd), 4.55-4.45 (iH, m), 4.03-3.70 (3H, m), 3.78 (3H, s), 3.05^2.88 (1H, m), 2.47-2.35 (1H? m), 2.35-2.20 (1H, m), 2.10-1.90 (1H, m), 1.85-1.50 (2H? m” 分析 ClsH20N4O7.0.5H2O 之計算値:c, 52.87; H,5·06; N, 13.70 3 實測値·· C,52·84; H,5.00; N,13.66。MS (ES + ) 406 (M” 2, 20%),405 (M+ + 1,100),391 (10),162 (6),148 (3), 105 (2” (4S) 6,10-二酮基曱二氧基芊醯胺基)-:i,2,3,4,7,8,9, 10-八氫-6士嗒啩並[1,24][1,2,4】三氮雜箪-4-羧酸(2631), 5251 (3.32克,8.2毫莫耳)於四氫呋喃(60毫升)之懸浮液以 LiOH,H2〇(0.69克,16.4毫莫耳,2.0當量)於水(20毫升)之 溶液處理3生成的混合物攪拌1小時,濃縮,且殘留物溶 於水中(50毫升)。溶液以2M NaHS04酸化,產物以EtOAc 萃取(100毫升及50毫升)。混合的萃取物以鹽水洗一次(2 X 50毫升),乾燥(MgS04)再濃縮以生成2631,呈白色晶狀固 體(2.87克,90%) : mp· 154-8°C ; [a]D20 +85.6。(c 0.01, CH3OH); IR (KBr) 3700-2300 (br), 3248, 2942, 1733, 1681, 1658, 1648, 1536, 1486, 1440, 1297, 1255, 1037; lH NMR (D6-DMSO) ά 13.23 (1H, bs), 10.45 (iH, s), 7.45 (1H? d), 7.35 (IH, s), 7.03 (1H, d), 6.12 (2H, s), 5.00-4.93 (1H, m), 4.35-4.25 (1H, m), 3.0-3.40 (3H, m), 2.95-2.70 (1H, m), 2.40-2.25 (1H, m), 2.15-2.00 (1H, m), 1.91-1.40 (3H, m) 3 分析 _ - 635 - 本紙ft尺度通用中11¾家標李(CNS ) A4^洛(;Μ0χ π?公釐) (請先閉讀背δ之注意事項再填寫·ί ) •!裝 訂 12351575251 2631 Consumer cooperation of the China Standards Bureau of the Ministry of Economic Affairs (4S) 6,10-diketo-7- (3,4-methyldioxyamido) -1,2,3,4, 7'8'9 '10-octahydro · 6Η-daphne [l, 2-a] [l, 2,4] triazafluorene-4-carboxylic acid methylene is synthesized by the method of preparing 211, which can be A white crystal was formed (3)) g, 83%) ·· mp · 214-5 ° C; | &gt;] D20 +75.2. (C 0.01, CH2Cl2); -634- The paper standard is commonly used in Chinese national standards (CNS) A4 Tiege (210 X 297 public cage) Central Ministry of Economic Affairs. China Bureau staff cooperation 4! India ¾ 1235157 Λ7 ___B7_ V. Description of the invention (632) (KBr) 3272, 2955, 1747, 1664, 1610; 1485, 1443, 1265, 1040; 1K NMR (CDC13) ^ 8.66 (1Η, s), 7.32 (1H, dd), 7.23 ( 1H, d), 6.76 (1H, d), 6.02 (2H, s), 5.20 (1H, dd), 4.55-4.45 (iH, m), 4.03-3.70 (3H, m), 3.78 (3H, s) , 3.05 ^ 2.88 (1H, m), 2.47-2.35 (1H? M), 2.35-2.20 (1H, m), 2.10-1.90 (1H, m), 1.85-1.50 (2H? M ”analysis ClsH20N4O7.0.5H2O Calculated 値: c, 52.87; H, 5.06; N, 13.70 3 Measured 値 ·, C, 52 · 84; H, 5.00; N, 13.66. MS (ES +) 406 (M ”2, 20%) , 405 (M + + 1,100), 391 (10), 162 (6), 148 (3), 105 (2 "(4S) 6,10-diketofluorenyldioxyfluorenylamino)-: i, 2,3,4,7,8,9, 10-octahydro-6 stilbene [1,24] [1,2,4] triazapyrene-4-carboxylic acid (2631), 5251 (3.32 g, 8.2 mmol) in a suspension of tetrahydrofuran (60 ml) with LiOH, H2O (0.69 g, 16.4 mmol, 2.0 eq) Water (20 ml) solution treatment 3 The resulting mixture was stirred for 1 hour, concentrated, and the residue was dissolved in water (50 ml). The solution was acidified with 2M NaHS04, and the product was extracted with EtOAc (100 ml and 50 ml). Mixed extraction The material was washed once with brine (2 X 50 ml), dried (MgS04) and concentrated to give 2631 as a white crystalline solid (2.87 g, 90%): mp · 154-8 ° C; [a] D20 +85.6. (C 0.01, CH3OH); IR (KBr) 3700-2300 (br), 3248, 2942, 1733, 1681, 1658, 1648, 1536, 1486, 1440, 1297, 1255, 1037; lH NMR (D6-DMSO) ά 13.23 (1H, bs), 10.45 (iH, s), 7.45 (1H? D), 7.35 (IH, s), 7.03 (1H, d), 6.12 (2H, s), 5.00-4.93 (1H, m) , 4.35-4.25 (1H, m), 3.0-3.40 (3H, m), 2.95-2.70 (1H, m), 2.40-2.25 (1H, m), 2.15-2.00 (1H, m), 1.91-1.40 ( 3H, m) 3 Analysis _-635-This paper is commonly used in ft scale 11¾ standard Chinese standard (CNS) A4 ^ Luo (; M0χ π? Mm) (please close the precautions of δ before filling in. Ί) •! Binding 1235157

R^-N Η ΛR ^ -N Η Λ

Ο B7 五、發明説明( 633 ) _ C17Hl8N4O7*0.8H2O之計算値:C,介.45; Η,4·88; N,13.84。 實測値·· C,50·80; H, 4.95; Ν, 13·36。MS (ES+) 390 (ΝΓ,19%), 389 (M+ - 1, 100), 545 (9), 204 (3 1), 182 (27), 111 (12) ^ Ο ηΎ 265a, c, d, f 1015, 1018, 1027, 1052, 1056, 1075, 1095〇 B7 V. Explanation of the invention (633) _ C17Hl8N4O7 * 0.8H2O Calculation: C, J. 45; J, 4.88; N, 13.84 Measured 値 ·· C, 50 · 80; H, 4.95; Ν, 13.36. MS (ES +) 390 (ΝΓ, 19%), 389 (M +-1, 100), 545 (9), 204 (3 1), 182 (27), 111 (12) ^ Ο ηΎ 265a, c, d, f 1015, 1018, 1027, 1052, 1056, 1075, 1095

Irf丨 (請先聞讀背云之注意事項再填寫本?) 經濟部t央櫺挛局員工消費合作杜印裝Irf 丨 (Please read and read the precautions of the back of the cloud before filling out this book?) The consumer cooperation of the Ministry of Economic Affairs of the Central Bureau of Du Ducheng

訂 4 本纸伕尺度適用中§1國家標车(〇^)々4堤格(:1!0,&lt;297公釐) 1235157 Λ7 B7 五、發明説明(034) 264g 1075 264h 1018 H 2S4i 1052 jcA 264j 1027 264k 1056 JO1 2641 1015 (XT1 經濟部中夬櫺準局員工消资合作社印¾ (討先¥讀背5之.;±意事項再填寫本頁) [4S(2S,3S)】 N-(2-芊氧基-5-酮基-四氫呋喃-3-基)-6,10-二酮 基-7·(2-^1 磺醯基)胺基-1,2,3,4,7,8,9,10-八氩-611-,答_並 [1,24][1,2,4]三氮雜箪-4-羧醯胺(264&amp;),利用化合物213 6之 方法合成,可生成白色固體(240毫克,82%) : IR (KBr) __-637-_ 本紙ft尺度通用中國g家標车(CNS )八4規格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(635 ) 338〇, 3066, 2947, 1789, 1750, 1691;、1454, 1417, 1368, 1298, 1^62, 1235, 1193, 11 18, 756, 696; lE NMR (D6-DMSO) ^ 8-59 (in, d, J = 6.8), 8.48 (1H, s), 8.25-8.09 (3H, m), 7.85-7·75 (3H,m),7.36 (5H,m),5.39 (1H,m),4·21 (2H,AB,J = l4-2), 4.53-4.49 (1H, m), 4.25-4.10 (2H, m), 3.65-3,44 (3H, 3.13-2.99 (1H, m), 2.43-2.16 (1H, m), 1.72-0.72 (7H, m) 。分杆C30H31N5OsS之計算値:C,57.96; Η, 5·03; N, 11.27。 實測値:C, 57·28; Η, 5·14; N,10.48。MS (ES+) 622。 [4S(2S,3S)] Ν·(2-苄氧基-5-酮基-四氫呋喃-3-基)-6,10-二酮 基-7-(3-甲氧基苯基脲基)-1,2,3,4,7,8,9,10-八氫-6^1-咨啩並 [三氮雜箪-4-羧醯胺(264c),以如21 3e之類似方 法製備,(55%)呈無色泡沫:mp· 135-40X: ; 〇]D22 +59.6。 (c 0.1, CH2C12); IR (KBr) 3314, 1790, 1664, 1608, 1543, 1496, 1455, 1428, 1325, 1287, 1250, 1218, 1 160, 1 1 18; !H NMR (CDC13) ^ 8.00 (1H, d, J = 7.1), 7.66 (1H, s), 7.55 (1H, s), 經濟部中央橾準局員工消費合作社印製 (請先聞讀背云之注意事項再填寫本頁) 7.28 (5H, m), 7.14 (2H, m), 6.87 (1H, d), J = 7.4), 6.59 (IH, m), 5.42 (1H, s), 4.66 (5H, m), 3.90-3.65 (4H, m), 3.73 (3H, s)? 2.98 (2H, m), 2.38 (2H, m), 2.01-1.65 (3H, m) ^ [45(25,35)]&gt;1-(2-芊氧基-5-酮基-四氫呋喃-3-基)-6,10-二酮 基-7-(2-甲氧基苯基脲基)-1,2,3,4,7,8,9,10-八氫-6?1-,答舛並 [HaKl,2,4】三氮雜箪-1-羧醯胺(264d),以類似213e之方 法製備(72%)呈無色泡沫:〇]D22 +21.4。(c 0.1,CH2C12); IR (KBr) 3302, 1791,1689, 1678, 1664, 1602, 1536, 1489,Order 4 papers 伕 1 national standard car (〇 ^) 々4 dige (11.0, &lt; 297 mm) 1235157 Λ7 B7 V. Description of the invention (034) 264g 1075 264h 1018 H 2S4i 1052 jcA 264j 1027 264k 1056 JO1 2641 1015 (XT1 Printed by the Consumers' Cooperatives of the China Prospective Bureau of the Ministry of Economic Affairs ¾ (Discuss ¥¥ 5 and read it again; please fill in this page for the Italian matters) [4S (2S, 3S)] N -(2-fluorenyl-5-keto-tetrahydrofuran-3-yl) -6,10-diketo-7 · (2- ^ 1sulfonyl) amino-1,2,3,4, 7,8,9,10-octaargon-611-, A_ [1,24] [1,2,4] triazapyrene-4-carboxamide (264 &), method using compound 213 6 Synthesis, white solid (240 mg, 82%): IR (KBr) __- 637-_ This paper ft scale GM China Standard Car (CNS) 8 4 specifications (210X 297 mm) 1235157 Λ7 B7 V. Invention (635) 338〇, 3066, 2947, 1789, 1750, 1691 ;, 1454, 1417, 1368, 1298, 1 ^ 62, 1235, 1193, 11 18, 756, 696; 1E NMR (D6-DMSO) ^ 8 -59 (in, d, J = 6.8), 8.48 (1H, s), 8.25-8.09 (3H, m), 7.85-7 · 75 (3H, m), 7.36 (5H, m), 5.39 (1H, m), 4 · 21 (2H, AB, J = l4-2), 4.53-4.49 (1H, m), 4.25-4.10 (2H, m), 3.65-3,44 (3H, 3.13-2.99 (1H, m), 2.43-2.16 (1H, m), 1.72-0.72 (7H, m). Calculation of split C30H31N5OsS 値: C, 57.96; Η, 5.03; N, 11.27. Measured 値: C, 57 · 28; Η, 5.14; N, 10.48. MS (ES +) 622. [4S (2S , 3S)] N · (2-benzyloxy-5-keto-tetrahydrofuran-3-yl) -6,10-diketo-7- (3-methoxyphenylureido) -1,2 , 3,4,7,8,9,10-octahydro-6 ^ 1-benzyl [triazine-4-carboxamide (264c), prepared in a similar manner as 21 3e, (55% ) Showed colorless foam: mp · 135-40X:; 〇] D22 +59.6. (c 0.1, CH2C12); IR (KBr) 3314, 1790, 1664, 1608, 1543, 1496, 1455, 1428, 1325, 1287, 1250, 1218, 1 160, 1 1 18;! H NMR (CDC13) ^ 8.00 (1H, d, J = 7.1), 7.66 (1H, s), 7.55 (1H, s), printed by the Employees' Cooperatives of the Central Procurement Bureau of the Ministry of Economic Affairs (please read the precautions of Back Cloud before filling out this page) 7.28 (5H, m), 7.14 (2H, m), 6.87 (1H, d), J = 7.4), 6.59 (IH, m), 5.42 (1H, s), 4.66 (5H, m), 3.90-3.65 (4H, m), 3.73 (3H, s)? 2.98 (2H, m), 2.38 (2H, m), 2.01-1.65 (3H, m) ^ [45 (25,35)] &gt; 1- (2 -Methoxy-5-keto-tetrahydrofuran-3-yl) -6,10-diketo-7- (2-methoxyphenylureido) -1,2,3,4,7,8 , 9,10-octahydro-6? 1-, benzo [HaKl, 2,4] triazapyridine-1-carboxamide (264d), prepared in a similar manner to 213e (72%) as a colorless foam : 0] D22 + 21.4. (C 0.1, CH2C12); IR (KBr) 3302, 1791, 1689, 1678, 1664, 1602, 1536, 1489,

1461, 1437, 1420, 1249, 1 1 19, 1023, 942, 751; lH NMR ___ -638-_ 本纸法尺度適用中a國家標李(CNS ) At%格(210X 297公釐) 1235157 Λ 7 Β7 經濟部中夬樣準局員工消費合作社印衮1461, 1437, 1420, 1249, 1 1 19, 1023, 942, 751; lH NMR ___ -638-_ Applicable to Chinese Standard Li (CNS) At% (210X 297 mm) 1235157 Λ 7 Β7 Seal of the Consumer Cooperatives of the China Prospective Bureau, Ministry of Economic Affairs

五、發明説明(636 ) (CDCi3) ί 8.07 (1Η, d, J = 7.7), 7.87 (1H, S). 7.68 (1H, d, J =6.7),7·49 (lH,s), 7.34 (5H, m),6·96 (3H,m),5 47 gh, s), 4.82 (2H, d -H m, J = 11.5), 4.63 (1H, d? J = U.5), 4.49 (2H, m), 3.85 (4H, s + m), 3.68 (2H, m), 3.01 (2H? m), 2.46 (2H, m),1:95 (3H,m), 1.57 (1H, m)。 [4S(2RS,3S)] N-(2-^氧基-5-酮基四氫咬喃-3,基χιό·二銅 基-1,2,3,4,7,8,9,10-八氫-7-苯基乙酿基胺基,6^1-多17井並[1,2-玨】[1,2,4】三氮雜箪,4-羧醯胺(264€),依製備21^之類似方 法合成,可生成非對映立體異構物之混合物(同側:對側 異構物比例9:1),呈白色玻璃狀固體(128毫克,78%) : mp·1〇3·8Ό ; IR (KBr) 3419, 3302, 1793, 1664, 1535, H21,1327, 1256, 1 123, 973; lH NMR (D6-DMSO) ci 10.20 (〇·9Η,s), 9.35 (0.1H, s), 8.74 (0.1H, d), 8.49 (0.9H, d), 7.36-7.15 (10H, m), 5.67 (0.9H, d), 5.44 (0.1H, s), 4.85-4.75 (iH, ni), 4.74- 4.60 (1H, m), 4.77&amp;4.63(2H,dd),4.30-4.10(lH,m),3·80· 3.40 (3H,m), 3·43 (2H,s),3.10-2.40 (3H,m),2.25-2.= (1H, m), 2·0(Μ·35 (4H,m)。分析(:2811311^5〇7.0.5^2〇之計各値· C, 60·21;Η,5·77;Ν, 12.53。實測値:C,60.W;H,).8j,N, 12.13。 MS (ES,551 (M+ 十 2, 33%),550 (M十七 K 1〇〇),480 (7), 343 (8), 279 (4) 〇 • it Λ-6,1 〇-二網 [4S(2RS,3S)] Ν-(2·;氧基小酮基四氫呋喃-3-暴J ,&lt; 4 並[1,2-基-1,2,3,4,7,8,9,10-八氫-7-(3-笨基脲基 w 之類似方 a][l,2,4]三氮雜箪-4-羧醯胺(264f),依化合物21 &gt; :和·末狀固體 法製備,可生成純的同側-異構物,,呈白巴A 許·元%讀背云之注意事項弄填寫本莧) 裝 訂 4 -639 本紙汝尺度適用中国國家標洋(CNS M4現格(2丨0 ,&lt; 297公釐) 1235157 Λ7 __B7_ _ 五、發明説明(637) (225 毫克,82%) ·_ mp· 130-5X:; |&gt;]5、24 +10.8。(c 0.1,CH2C12); IR (KBr) 3316, 1791,1688, 1676, 1664, 1601,1536, 1445, 1314, 1242, 973; LH NMR (D6-DMSO) ά 8.84 (1H, s)? 8.49 (1H, d), 8.19 (1H, s), 7.45-7.18 (9H, m), 7.00-6.90 (1H, m), 5.68 (1H, d), 4.90-4.81 (1H,m), 4.75-4.60 (1H, m),4.78及 4.63 (2H, dd), 4.30-4.20 (1H, m), 3.75-3.55 (3H, m), 2.85-2.55 (3H,m),2.25-2·15 (1H, m), 2.0(Μ·35 (4H,m)。分析 C27H30N6O7-0.5H2O之計算値:C, 57.95; Η, 5·58; N, 15.02。V. Description of the invention (636) (CDCi3) ί 8.07 (1Η, d, J = 7.7), 7.87 (1H, S). 7.68 (1H, d, J = 6.7), 7.49 (lH, s), 7.34 (5H, m), 6.96 (3H, m), 5 47 gh, s), 4.82 (2H, d -H m, J = 11.5), 4.63 (1H, d? J = U.5), 4.49 (2H, m), 3.85 (4H, s + m), 3.68 (2H, m), 3.01 (2H? M), 2.46 (2H, m), 1:95 (3H, m), 1.57 (1H, m ). [4S (2RS, 3S)] N- (2- ^ oxy-5-ketotetrahydroanan-3, yl x-copper-1,2,3,4,7,8,9,10 -Octahydro-7-phenylethylamino group, 6 ^ 1-more than 17 wells and [1,2-fluorene] [1,2,4] triazafluorene, 4-carboxamide (264 €) , Synthesized according to a similar method to prepare 21 ^, can produce a mixture of diastereomeric isomers (same side: opposite isomer ratio 9: 1), white glassy solid (128 mg, 78%): mp 1〇3 · 8Ό; IR (KBr) 3419, 3302, 1793, 1664, 1535, H21, 1327, 1256, 1 123, 973; lH NMR (D6-DMSO) ci 10.20 (〇 · 9Η, s), 9.35 (0.1H, s), 8.74 (0.1H, d), 8.49 (0.9H, d), 7.36-7.15 (10H, m), 5.67 (0.9H, d), 5.44 (0.1H, s), 4.85- 4.75 (iH, ni), 4.74- 4.60 (1H, m), 4.77 &amp; 4.63 (2H, dd), 4.30-4.10 (lH, m), 3.80 · 3.40 (3H, m), 3.43 ( 2H, s), 3.10-2.40 (3H, m), 2.25-2. = (1H, m), 2.0 (M · 35 (4H, m). Analysis (: 2811311 ^ 5〇7.0.5 ^ 2 〇 値 · C, 60 · 21; Η, 5.77; Ν, 12.53. Measured 値: C, 60.W; H,). 8j, N, 12.13. MS (ES, 551 (M + 10 2 , 33%), 550 (M17K 100), 480 (7), 343 (8), 27 9 (4) 〇 • it Λ-6,1 〇-Dinet [4S (2RS, 3S)] Ν- (2 ·; oxy small ketotetrahydrofuran-3-viol J, &lt; 4 and [1, 2 -Amino-1,2,3,4,7,8,9,10-Octahydro-7- (3-benzylureidow analogue a) [l, 2,4] triazafluorene-4 -Carboxamide (264f), prepared according to compound 21 &gt;: and · terminal solid method, which can produce pure ipsilateral-isomers, presented as Bai Ba A Xu Yuan yuan This book) Binding 4 -639 This paper is the standard for Chinese national standard (CNS M4 (2 丨 0, &lt; 297 mm) 1235157 Λ7 __B7_ _ V. Description of the invention (637) (225 mg, 82%) · _ mp · 130-5X :; | &gt;] 5, 24 +10.8. (C 0.1, CH2C12); IR (KBr) 3316, 1791, 1688, 1676, 1664, 1601, 1536, 1445, 1314, 1242, 973; LH NMR (D6-DMSO) ά 8.84 (1H, s)? 8.49 ( 1H, d), 8.19 (1H, s), 7.45-7.18 (9H, m), 7.00-6.90 (1H, m), 5.68 (1H, d), 4.90-4.81 (1H, m), 4.75-4.60 ( 1H, m), 4.78 and 4.63 (2H, dd), 4.30-4.20 (1H, m), 3.75-3.55 (3H, m), 2.85-2.55 (3H, m), 2.25-2 · 15 (1H, m ), 2.0 (M · 35 (4H, m). Analysis of the calculation of C27H30N6O7-0.5H2O 値: C, 57.95; Η, 5.58; N, 15.02.

經濟部中夬櫺隼局員工消费合作社印U 實測値:C,58.12; H,5.64; N,14.81。MS (ES+) 552 (M+ + 2, 30%), 551 (M+ + 1, 100), 362 (19), 299 (10), 279 ⑷ a [45(25,35)]1^-(2-:^:氧基-5-銅基四氫〃夫畴-3-基)-6,10-二鋼 基-7-(啕》朵-2-羧醯胺基)-1,2,3,4,7,8,9,10-八氫-6^1^答哜並 [1,24】[1,2,4]三氮雜箪-4-羧醯胺(264§),以如化合物213〇 之類似方法製備,可生成純的對侧-異構物,呈白色固體 (284毫克,80%) : mp· 148-53X: ; 〇]D24 +72 0° (c 0.1, CH2Ci2); IR (KBr) IR (ΚΒγ) 3404, 3295, 1789? 1660, 1536, 1421, 13 10, 1260, 1122, 749; [H NMR (D6-DMSO) δ 11.72 (1H, s), 10.58 (1H, s), 8.73 (1H, d), 7.65 (1H, d), 7.58-7.27 (6H, m), 7.27-7.10 (1H, m), 7.17 (1H, s), 7.10-7.00 (1H, m), 5.46 (1H,s),4·90·4·85 (1H,m), 4.77&amp;4.68(2H,dd),4.35-4.25 (2H? m), 3.95-3.55 (3H, m), 3.09 (1H, d), 2.95-2.80 (1H, m),2·47-2·25 (2H, m), 2.10-1.35 (4H,m)。MS (ES + ) 574 (M' 35%),573 (NT - 1,100),384 (16),383 (69),341 (23),327 (12),267 (13),200 (22)。 -640- 本紙&amp;尺度通用中国國家標洋(CNS ) A4堤格(210X 297公釐) 1235157 Λ7 __ Βτ_ 五、發明説明(638 ) [4S(2RS,3S)】7-[(‘乙·醯胺基);酸、胺基]-N-(2-;氧基-5-酮 基四氫吱喃-3-基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-611-嗒 啩並[1,24][1,2,4】三氮雜箪-4-羧醯胺(26411),以類似化合 物213e之方法製備,可生成非對映立體異構物之昆合(同 側:對側異構物比例9:1),呈白色固體(276毫克,70%): mp· H7-52X: ; IR (KBr) 3444, 3304, 1793, 1665, 1602, 153 1, 1505, 1423, 1294, 1264, 1 181, 1 123, 966; lH NMR (D6-DMSO) i 10.41 (1H, s), 10.22 (1H, s), 8.71 (0.1H, d), 8.48 (0.9H, d), 7.78 (2H, d), 7.67 (2H, d), 7.35-7.30 (5H, m), 5.68 (0.9H, d), 5·45 (0.1H,s), 4.88-4.80 (1H, m),4.75-4.60 (1H,m),4.77及 4.63 (2H, dd), 4.30-4.20 (1H, m), 3.90-3.50 (3H, m), 3.10-2.50 (3H, m), 2.35-2.20 (1H, m), 2.07 (3H, s), 2.05-1.35 (4H, m)。分析 C29H32N608*1H20之計算値:C,57.04; Η, 5·61; N, 13.76。實測値:C,56.79; H,5,50; N,13.53。MS (ES — ) 594 (M+ 十 2, 34%),593 (M+ + 1,100),387 (8),386 (38),358 (8), 162 (9” 經濟部中央嘌洋局員工消费合作社印¾ [45(2民$,35)]1^-(2-芊氧基〇-酮基四氫呋喃-3-基)-6,10-二酮 基-7-(4-甲氧基芊醯胺基)-八氫-6H-嗒衅並[l,2-a][l,2,4] 三I雜革-4-羧醯胺(264i),以類似化合物213e之方法製備 ,可生成白色固體(7〇)% : mP· 116-118 C ; IR (KBr) 3315, 2951, 1793, 1664, 1607, 1502, 1258, 1177; lR NMR (CDCi3) 6 8.07 (1H, s), 7.77 (2H, d, J = 8.6), 7.35 (5H, m), 6.94 (2H, d, J = 8.5), 6.74 (1H), 4.89 (1H, d J = 11.1), 4.74 (1H, m), 4.60 (IH, d, J = 11.0), 4.48, 4.41 (iH, 2m), 3.86 (3H, s). 3.79, -641 - 本紙ft尺度通用中S國家標华(CNS 格(2I0X297公釐) 經濟部中夬樣準局員工消費合作枉印¾. 1235157 五、發明説明( 639 ) - 3.71-3.53 (3H, 2m), 2.87 (2H, m), 2:44 (1H? m), 2.18, 1.9K 1·68 (5H, 3m)。 [4S(2S,3S)] N-(2-芊氧基-5-酮基四氫呋喃-3-基)-6,10-二網 基-1,2,3,4,7,8,9,10-八氫-7-笨基磺醯胺基-6^1-嗒呤並[1,2-a][l,2,4]三氮雜箪-4-羧醯胺(264j),以類似化合物213e之方 法合成,可生成泡沫狀(88%) : 〇]D24 +74·23 (c 〇·36, CH2C12); IR (ΚΒ〇 3332, 3235, 1793, 1664, 1537, 1448, 1416, 1337, 1 169, 118, 1092, 940, 690; lK NMR (CDCi3) 7.99 (1H, s), 7.88 (2H, d, J - 6.8), 7.64-7.48 (3H, m), 7.34 (5H, s), 7·13 (1H,d, J = 6.9),5.39 (1H, s),4.81 (2H,m),4·62 (1H,d, J = 11.5), 4.48 (IH, m), 4.33 (1H? m), 3.85 (1H, m), 3.59 (2H? m), 3.03 (1H, dd, J = 7.6, 18.2), 2.49-2.28 (3H, m), 1.94-1.40 (4H,m)。分析 C26H29SN508之計算値:C,54.63;H,5.U;N, 12.25。實測値:C,54.42; H,5.28; N,11.62。MS (ES+) 572 (MH' 100%) a C26H30SN5O8 (MH+)之精確質量計算値: 572.1815。實測値:572.1802。 [4S(2RS,3S)】 7-(4-芊氧基苯基)羰基胺基-N-(2-芊氧基-5·酮 基四氫呋喃-3-基)-6,10-二酮基-1,2,3,4,7,8,9,10-八氫-61^嗒 畊並[l,2-a][l,2,4]三氮雜箪-4-羧醯胺(264k),以213e之方 法製備(96%) : IR (KBr) 3294, 2946, 1793, 1658, 1606, 1535, 1501,1248, 1 174, 1 1 19。 lE NMR (CDCl3) S 8.91 (iH? s), 7.85 (3H, m), 7.4 (10H, m), 7.02 (2H, d), 5.35 (1H, s), 5.10 (2H, s), 4.8-4.3 (5H, m), 4.00 (iH, bs), 3.78 (2H, m), 2.90 (2H, m), 2.5-1.5 (6H, m) ^ 642- 本纸伕尺度適用中國國家標隼(CNS ) A4現格(:ι〇χ 297公釐) 請先努讀背云之注意事項弄填寫本\貝 装 訂 1235157 經濟部中夬標隼局員工消费合作社印製 Λ7 Β7 五、發明説Μ ( 640 ) [4S(2RS,〕S)】 N-(2-卞乳基-5-嗣基四氮夫喃-3-基)-6,10-二嗣 基- 7- (3,4 -甲二氧基辛疲胺基)-l,2,3,4,7,8,9,10-八氫-6H-嗒畊並[l,2-a][l,2,4]三氮雜箪-4-幾醯胺(2641),以化合物 213e之類似方法製備,可生成非對映立體異構物之混合( 同側··異側異構物比例1:1),呈白色固體(1.72克,71%): mp. 148-60&quot;C ; IR (KBr) 3314, 1780, 1677, 1658, 1651, 1550, 1485, 1439, 1258, 1132, 1038, 943; lU NMR (D6-DMSO) ^ 10.39 (1H, s), 8.71 (0.5H, d), 8.49 (0.5H, d), 7.44 (1H? d)? 7.42-7.30 (6H, m), 7.03 (1H, d), 6.12 (2H, s), 5.68 (0.5H, d), 5.45 (0.5H, s), 4.90-4.82 (1H, m), 4.82-4.58 (2.5H, m). 4.40-4.10 (1.5H, m), 3.900.65 (2H, m), 3.65-3.43 (1H, m), 3.09 (0.5H, dd), 2.90-2.55 (1.5H, m), 2.45-2.10 (2H, m), 2.10-1.35 (4H,m)3 分析(:23Η29Ν5Ο9·0.2Η2Ο 之計算値:C,57.67;H, 5.08;队12.0卜實測値:(:,:58.01;1*1,5.33;;^,11.51。]^ (ES十)581 (M+ + 2, 33%),580 (M+,100),374 (9),373 (48), 345 (1 2),261 (4), 239 (7),149 (9), [3S(4S)] 3-[6,10-二酮基-7-(2-葚磺醯基)胺基 4,2,3,4,7,8,9, 1〇-八氫-6^^»答*井並[1,24][1,2,4]三1雜苯-4-幾酿胺基]-4-酮基丁酸(265a),以類似化合物265之方法製備,可生成白 色固體(37毫克,17%) : mp· 126-3(TC(分解);[α]〇2〇 +3〇。(c 0·05, MeOH); IR (KBr) 3371, 2935, 1785, 1663, 1538, 1418, 1339, 1 164, 669; lH NMR (CD3OD) 0' 8.44 (1H, s), 8.06-7.50 (7H, m), 7.22 (1H, d, J = 8.4), 4.58-4.57 (1H, m)&gt; 4.46^4.42 (1H, m), 4.16-4.09 (2H? m), 3.85-3.50 (3Ht m), 2.84-2.78 (1H, _-643-_ 本纸伕尺度適用‘t国國家標準(C^S ) A4規格(2!0X 297公ϋ · 訝先^.讀背云之;1意事^#填寫.尽頁) 裝 d 1235157 經濟部中央樣準局員工消费合作杜印¾ Λ7 _B7五、發明説明(6^) m)? 2.64-2.51 (1H, m), 2.44-2.15 (2H, m), 1.81-0.89 (4H, m) ,分析 C23H25N508S.H20之計算値:C,50.27;H,4.95;N, 12.74。實測値·· C,50.33; Η,5·04; N,12.60 a MS (ES+) 530。 [3S(4S)] 3-[6,10-二酮基-7-(3-甲氧基苯基脲基)-1,2,3,4,7,8,9, 10-八氫-6H-嗒畊並[l,2-a][l,2,4】三氮雜箪-4-羧醯胺基卜4-酮基丁酸(265c),以化合物265之類似方法製備,(90%)呈 無色固體:mp·〜150eC (分解);〇]D23 +94.8。(c 0.1,20% MeOH/CH2Cl2); IR (KBr) 3330, 1780, 1660, 1610, 1550, 1495, 1428, 1326, 1287, 1251,1223, 1 160; lHNMR(CD3〇DW 7.16 (2H, m), 6.89 (1H, d, J = 7.8), 4.58 (1H, m), 4.37 (2H, m),3.76 (6H,s + m), 2.95 (1H,m),2.67 (1H, m), 2.33 (1H, m),2.20-1,85 (3H, m), 1·66 (1H,m)。 [3S(4S)] 3-[6,10-二酮基·7-(2-甲氧基苯基脲基)4,2,3,4,7,8,9, 10-八氩-6^嗒呻並[1,24][1,2,4]三氮雜箪-4-幾醯胺基卜4-酮基丁酸(265d),以類似265之方法製備,呈無色固 鱧·· mp. 176-85Ό (分解);〇】D23 +11.〇° (c 〇」,MeOH); IR (fCBr) 3392,3328,1784w, 1665,1603,1537,1490,1462, 1437, 1337, 1290, 1290, 1217, 1177, 1119, 1〇23; lHNMR (CD3OD) 0' 8.02 (2H,m),6·95 (4H, m),5.05 (1H,m), 4.60 (2H,m),3·92 (4H, s + m), 3.00 (2H, m),2.68 (1H,m),2.39 (1H,m),2·00 (4H,m),1.69 (1H,m)。 [3S(4S)] 3-(6,l〇-二酮基-1,2,3,4,7,8,9, l〇-八氫苯基乙醯 胺基-6士名畊並[1,24][1,2,4]三氮雜¥|羧醢胺基)_4-酮基 丁酸(1095),以化合物265之類似方法製備,可生成白色固 ____- 644 - ___ 本纸乐尺度通用中国国家標洋(CNS ) Α4現格(2Ι0Χ 297公瘦Ί〜' (請先兄诗背云之;1意事項4填寫本一貝) 裝 訂 4 1235157 Λ 7 __Β7_ 五、發明説明( 642 ) 體(84毫克,90%) : 180-6°C; |&gt;]d21、22.3。(c 0.065, CH3OH); IR (ΚΒγ) 3700-2300 (br),3287, 1664, 1536, 1425, 1261,1181; lH NMR (CD3OD) ά 7.35-7.20 (5H, m), 5.00-4.90 (1H, m), 4.60-4.50 (1H? m), 4.50-4.10 (2H, m), 3.90-3.50 (3H? m), 3.54 (2H, s), 3.00-2.80 (1H, m), 2.80-2.40 (2H, m), 2.35-2.20 (1H, m),2·20-1·50 (4H,m)。MS (ES十)459 (M十 24%), 458 (M、1, 100),358 (27),175 (9),149 (7),137 (12)。C21H26N507 (MH勹 之精確質量計算値:460.1832 3實測値:460.1840, [3S(4S)] 3-[6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-(3-苯基脲 基)-6H-嗒啡並[l,2-a][l,2,4]三氮雜箪-4-羧醯胺基]-4-酮基-丁酸(265f),以化合物265之類似方法製備,可生成白色泡 沫狀固鳢(130毫克,88%) ·· mp· 157-62Ό;[泛]D24 +4i.7c (c 0.1, CH3OH); IR (KBr) 3700-2300 (br),3325, 1782, 1663, 1547, 1443, 1315, 1242, 1 181; lH NMR (CD3OD) ά 7.40 (2H, dd), 經濟部中央樣隼局貝工消费合作社印¾ (請先$讀背云之注意事項耳填寫本f ) 7.35-7.20 (2H, m), 7.06-6.95 (1H, m), 5.05-4.95 (1H? m), 4.64-4.54 (1H, m), 4.50-4.35 (1H, m), 4.35-4.15 (1H, m), 3.90-3.69 (3H, m), 3.00-2.85 (1H, m), 2.80-2.45 (3H? m), 3.40-1.50 (4H, m) 3 MS (ES十)460 (M+,24%), 459 (Μ· · 1, 100),341 (9), 340 (54),296 (6), 239 (9) 3 [3S(4S)] 3-[6,10-二酮基-7-(啕哚-2-羧醯胺)-1,2,3,4,7,8,9,10-八氫-6士嗒啩並[1,24][1,2,4]三氮雜箪-4-羧醯胺基】-4-酮基 丁酸(1075),以化合物265之方法製備,可生成白色固體 (184毫克,83%) : mp. 210-5°C; J&gt;]D24 +43.9。(c 0.1,CH3〇H); IR (ΚΒγ) 3700-2300 (br),3309, 1660, 1537, 1423, 13 1 1,1262, -645 - 本紙乐尺度適用中国國家標李(CNS )八4規格(210X 297公笼) 1235157Printed by U.S. Consumer Cooperatives, China Bureau of the Ministry of Economic Affairs: C, 58.12; H, 5.64; N, 14.81. MS (ES +) 552 (M + + 2, 30%), 551 (M + + 1, 100), 362 (19), 299 (10), 279 ⑷ a [45 (25,35)] 1 ^-(2- : ^: Oxy-5-copper-based tetrahydrocarboxyl-3-yl) -6,10-bistetrayl-7- (fluorenyl-2-carboxamido) -1,2,3, 4,7,8,9,10-octahydro-6 ^ 1 ^ Ansino [1,24] [1,2,4] triazapyridin-4-carboxamidine (264§), as compound Prepared by a similar method of 213 °, which can produce pure contra-isomers as a white solid (284 mg, 80%): mp · 148-53X:; 〇] D24 +72 0 ° (c 0.1, CH2Ci2); IR (KBr) IR (ΚΒγ) 3404, 3295, 1789? 1660, 1536, 1421, 13 10, 1260, 1122, 749; [H NMR (D6-DMSO) δ 11.72 (1H, s), 10.58 (1H, s ), 8.73 (1H, d), 7.65 (1H, d), 7.58-7.27 (6H, m), 7.27-7.10 (1H, m), 7.17 (1H, s), 7.10-7.00 (1H, m), 5.46 (1H, s), 4.90 · 4 · 85 (1H, m), 4.77 &amp; 4.68 (2H, dd), 4.35-4.25 (2H? M), 3.95-3.55 (3H, m), 3.09 ( 1H, d), 2.95-2.80 (1H, m), 2.47-2 · 25 (2H, m), 2.10-1.35 (4H, m). MS (ES +) 574 (M '35%), 573 (NT-1,100), 384 (16), 383 (69), 341 (23), 327 (12), 267 (13), 200 (22 ). -640- Paper &amp; Standard General China National Standard Ocean (CNS) A4 Tige (210X 297 mm) 1235157 Λ7 __ Βτ_ 5. Description of the invention (638) [4S (2RS, 3S)] 7-[('二 ·醯 amino group); acid, amine group] -N- (2-; oxy-5-ketotetrahydrocran-3-yl) -6,10-diketo-1,2,3,4, 7,8,9,10-octahydro-611-dapyrido [1,24] [1,2,4] triazapyridin-4-carboxamide (26411), prepared in a similar manner to compound 213e, Kunhe compound which can generate diastereoisomeric compounds (Isoside: Isomer ratio 9: 1), white solid (276 mg, 70%): mp · H7-52X:; IR (KBr) 3444 , 3304, 1793, 1665, 1602, 153 1, 1505, 1423, 1294, 1264, 1 181, 1 123, 966; lH NMR (D6-DMSO) i 10.41 (1H, s), 10.22 (1H, s), 8.71 (0.1H, d), 8.48 (0.9H, d), 7.78 (2H, d), 7.67 (2H, d), 7.35-7.30 (5H, m), 5.68 (0.9H, d), 5.45 (0.1H, s), 4.88-4.80 (1H, m), 4.75-4.60 (1H, m), 4.77 and 4.63 (2H, dd), 4.30-4.20 (1H, m), 3.90-3.50 (3H, m ), 3.10-2.50 (3H, m), 2.35-2.20 (1H, m), 2.07 (3H, s), 2.05-1.35 (4H, m). Analyze the calculation of C29H32N608 * 1H20 値: C, 57.04; Η, 5.61; N, 13.76. Found 値: C, 56.79; H, 5, 50; N, 13.53. MS (ES —) 594 (M + 10, 34%), 593 (M + + 1,100), 387 (8), 386 (38), 358 (8), 162 (9 ”employees of the Central Puryang Bureau of the Ministry of Economic Affairs Consumer Cooperative Seal ¾ [45 ($ 2,35)] 1 ^-(2-methoxyoxy-ketotetrahydrofuran-3-yl) -6,10-diketo-7- (4-methoxy Sulfonylamino) -octahydro-6H-dabenzo [l, 2-a] [l, 2,4] tri-I hetero leather-4-carboxamidine (264i), prepared in a similar manner to compound 213e, (7〇)% white solid: mP · 116-118 C; IR (KBr) 3315, 2951, 1793, 1664, 1607, 1502, 1258, 1177; lR NMR (CDCi3) 6 8.07 (1H, s), 7.77 (2H, d, J = 8.6), 7.35 (5H, m), 6.94 (2H, d, J = 8.5), 6.74 (1H), 4.89 (1H, d J = 11.1), 4.74 (1H, m) , 4.60 (IH, d, J = 11.0), 4.48, 4.41 (iH, 2m), 3.86 (3H, s). 3.79, -641-This paper's ft scale is generally used in the national standard of China (CNS grid (2I0X297 mm) Printed by the Prospective Bureau of the Ministry of Economic Affairs on the consumption cooperation of employees ¾. 1235157 V. Description of the invention (639)-3.71-3.53 (3H, 2m), 2.87 (2H, m), 2:44 (1H? M), 2.18, 1.9K 1.68 (5H, 3m). [4S (2S, 3S)] N- (2-methoxy-5-ketotetrahydrofuran-3-yl) -6,10-dinetwork- 1,2,3,4,7,8,9,10-octahydro-7-benzylsulfonamido-6 ^ 1-pyrido [1,2-a] [l, 2,4] tri Azapyridine-4-carboxamide (264j), synthesized in a similar manner to compound 213e, can form a foam (88%): 〇] D24 + 74 · 23 (c 〇36, CH2C12); IR (ΚΒ〇 3332, 3235, 1793, 1664, 1537, 1448, 1416, 1337, 1 169, 118, 1092, 940, 690; lK NMR (CDCi3) 7.99 (1H, s), 7.88 (2H, d, J-6.8), 7.64-7.48 (3H, m), 7.34 (5H, s), 7.13 (1H, d, J = 6.9), 5.39 (1H, s), 4.81 (2H, m), 4.62 (1H, d) , J = 11.5), 4.48 (IH, m), 4.33 (1H? M), 3.85 (1H, m), 3.59 (2H? M), 3.03 (1H, dd, J = 7.6, 18.2), 2.49-2.28 (3H, m), 1.94-1.40 (4H, m). Analyze the calculations of C26H29SN508: C, 54.63; H, 5.U; N, 12.25. Found 値: C, 54.42; H, 5.28; N, 11.62. MS (ES +) 572 (MH '100%) a C26H30SN5O8 (MH +) accurate mass calculation 値: 572.1815. Found 値: 572.1802. [4S (2RS, 3S)] 7- (4-Methoxyphenyl) carbonylamino-N- (2-Methoxy-5 · ketotetrahydrofuran-3-yl) -6,10-diketo -1,2,3,4,7,8,9,10-Octahydro-61 ^ Da-Feng [l, 2-a] [l, 2,4] triazine-4-carboxamide ( 264k), prepared by the method 213e (96%): IR (KBr) 3294, 2946, 1793, 1658, 1606, 1535, 1501, 1248, 1 174, 1 1 19. lE NMR (CDCl3) S 8.91 (iH? s), 7.85 (3H, m), 7.4 (10H, m), 7.02 (2H, d), 5.35 (1H, s), 5.10 (2H, s), 4.8- 4.3 (5H, m), 4.00 (iH, bs), 3.78 (2H, m), 2.90 (2H, m), 2.5-1.5 (6H, m) ^ 642- The standard of this paper is applicable to Chinese national standard (CNS) ) A4 is present (: ι〇χ 297 mm) Please read the precautions of the cloud and fill in this book \ Paper binding 1235157 Printed by the Employees' Cooperatives of the China National Standards and Technology Bureau of the Ministry of Economic Affairs Λ7 Β7 V. Invention Μ ( 640) [4S (2RS,] S)] N- (2-fluorenyl-5-fluorenyltetrazafuran-3-yl) -6,10-difluorenyl-7- (3,4-methyl Dioxyoctylamine) -l, 2,3,4,7,8,9,10-octahydro-6H-da-co- [l, 2-a] [l, 2,4] triaza箪 -4-Epioxamine (2641), prepared in a similar manner to compound 213e, can produce a mixture of diastereoisomeric compounds (isomeric · isomeric ratio 1: 1), as a white solid ( 1.72 g, 71%): mp. 148-60 &quot;C; IR (KBr) 3314, 1780, 1677, 1658, 1651, 1550, 1485, 1439, 1258, 1132, 1038, 943; lU NMR (D6-DMSO) ^ 10.39 (1H, s), 8.71 (0.5H, d), 8.49 (0.5H, d), 7.44 (1H? D)? 7.42-7.30 (6H, m), 7.03 (1H, d), 6.12 (2H, s), 5.68 (0.5H, d), 5.45 (0.5H, s), 4.90-4.82 (1H, m), 4.82-4.58 (2.5H, m). 4.40-4.10 (1.5 H, m), 3.900.65 (2H, m), 3.65-3.43 (1H, m), 3.09 (0.5H, dd), 2.90-2.55 (1.5H, m), 2.45-2.10 (2H, m), 2.10-1.35 (4H, m) 3 analysis (: calculation of 23Η29N5Ο9 · 0.2Η20): C, 57.67; H, 5.08; team 12.0, actual measurement: (:,: 58.01; 1 * 1, 5.33 ;; ^, 11.51 .] ^ (ES X) 581 (M + + 2, 33%), 580 (M +, 100), 374 (9), 373 (48), 345 (1 2), 261 (4), 239 (7), 149 (9), [3S (4S)] 3- [6,10-diketo-7- (2-fluorenylsulfonyl) amino 4,2,3,4,7,8,9, 1〇 -Octahydro-6 ^^ »A * Jing [1,24] [1,2,4] tri-1heterobenzene-4-jimonylamino] -4-ketobutyric acid (265a), with similar compounds Prepared by the method of 265, which can produce a white solid (37 mg, 17%): mp · 126-3 (TC (decomposed); [α] 02 + 30. (C 0 · 05, MeOH); IR (KBr) 3371, 2935, 1785, 1663, 1538, 1418, 1339, 1 164, 669; lH NMR (CD3OD) 0 '8.44 (1H, s), 8.06-7.50 ( 7H, m), 7.22 (1H, d, J = 8.4), 4.58-4.57 (1H, m) &gt; 4.46 ^ 4.42 (1H, m), 4.16-4.09 (2H? M), 3.85-3.50 (3Ht m ), 2.84-2.78 (1H, _-643-_ This paper's standard is applicable to the national standard (C ^ S) A4 specification (2! 0X 297 public ϋ · surprise first ^. Read back to the cloud; 1 meaning) ^ # Fill in. End page) 1235157 Consumption cooperation between employees of the Central Procurement Bureau of the Ministry of Economy Du Yin ¾ 7 _B7 V. Description of the invention (6 ^) m)? 2.64-2.51 (1H, m), 2.44-2.15 (2H, m), 1.81-0.89 (4H, m), analysis of C23H25N508S.H20 calculation: C, 50.27; H, 4.95; N, 12.74. Found 値 ·· C, 50.33;;, 5.04; N, 12.60 a MS (ES +) 530. [3S (4S)] 3- [6,10-diketo-7- (3-methoxyphenylureido) -1,2,3,4,7,8,9,10-octahydro- 6H-Da-Pheno [l, 2-a] [l, 2,4] triazapyrene-4-carboxyamido-4-ketobutyric acid (265c), prepared in a similar manner to compound 265, ( 90%) as a colorless solid: mp · ~ 150eC (decomposed); o] D23 +94.8. (C 0.1, 20% MeOH / CH2Cl2); IR (KBr) 3330, 1780, 1660, 1610, 1550, 1495, 1428, 1326, 1287, 1251, 1223, 1 160; lHNMR (CD3〇DW 7.16 (2H, m ), 6.89 (1H, d, J = 7.8), 4.58 (1H, m), 4.37 (2H, m), 3.76 (6H, s + m), 2.95 (1H, m), 2.67 (1H, m), 2.33 (1H, m), 2.20-1, 85 (3H, m), 1.66 (1H, m). [3S (4S)] 3- [6,10-diketo · 7- (2-methyl Oxyphenylureido) 4,2,3,4,7,8,9,10-octaargon-6 ^ Da [1,24] [1,2,4] triazafluorene-4- Chitosamine 4-ketobutyric acid (265d), prepared in a similar manner to 265, was colorless and solid. Mp. 176-85Ό (decomposition); 〇] D23 + 11.〇 ° (c 〇 ″, MeOH); IR (fCBr) 3392, 3328, 1784w, 1665, 1603, 1537, 1490, 1462, 1437, 1337, 1290, 1290, 1217, 1177, 1119, 1〇23; lHNMR (CD3OD) 0 '8.02 (2H , M), 6.95 (4H, m), 5.05 (1H, m), 4.60 (2H, m), 3.92 (4H, s + m), 3.00 (2H, m), 2.68 (1H, m ), 2.39 (1H, m), 2.00 (4H, m), 1.69 (1H, m). [3S (4S)] 3- (6,10-diketo-1,2,3,4 , 7,8,9,10-octahydrophenylacetamido-6, and [1,24] [1,2,4] triaza ¥ | carboxy醢 Amino group) _4-ketobutyric acid (1095), prepared in a similar way to compound 265, can produce a white solid ____- 644-___ The paper scale is universal Chinese National Standard Ocean (CNS) Α4 is present (2Ι0χ 297 Gongshou Ί ~ '(please refer to the poem of the ancestor; 1 note 4 fill in this book) binding 4 1235157 Λ 7 __Β7_ V. Description of the invention (642) Body (84 mg, 90%): 180-6 ° C ; | &gt;] d21, 22.3. (c 0.065, CH3OH); IR (ΚΒγ) 3700-2300 (br), 3287, 1664, 1536, 1425, 1261, 1181; lH NMR (CD3OD) ά 7.35-7.20 (5H , m), 5.00-4.90 (1H, m), 4.60-4.50 (1H? m), 4.50-4.10 (2H, m), 3.90-3.50 (3H? m), 3.54 (2H, s), 3.00-2.80 (1H, m), 2.80-2.40 (2H, m), 2.35-2.20 (1H, m), 2.20-1 · 50 (4H, m). MS (ES 10) 459 (M 10 24%), 458 (M, 1, 100), 358 (27), 175 (9), 149 (7), 137 (12). C21H26N507 (MH accurate mass calculation: 460.1832 3 found: 460.1840, [3S (4S)] 3- [6,10-diketo-1,2,3,4,7,8,9,10- Octahydro-7- (3-phenylureido) -6H-daphno [l, 2-a] [l, 2,4] triazapyridin-4-carboxyamido] -4-one -Butyric acid (265f), prepared in a similar manner to compound 265, can form a white foamy solid tincture (130 mg, 88%) ·· mp · 157-62Ό; [PAN] D24 + 4i.7c (c 0.1, CH3OH ); IR (KBr) 3700-2300 (br), 3325, 1782, 1663, 1547, 1443, 1315, 1242, 1 181; lH NMR (CD3OD) ά 7.40 (2H, dd), Central Bureau of Samples, Ministry of Economic Affairs Printed by Industrial and Consumer Cooperatives ¾ (Please read the precautions for back cloud first and fill in this f) 7.35-7.20 (2H, m), 7.06-6.95 (1H, m), 5.05-4.95 (1H? M), 4.64-4.54 (1H, m), 4.50-4.35 (1H, m), 4.35-4.15 (1H, m), 3.90-3.69 (3H, m), 3.00-2.85 (1H, m), 2.80-2.45 (3H? M) , 3.40-1.50 (4H, m) 3 MS (ES 10) 460 (M +, 24%), 459 (M ·· 1, 100), 341 (9), 340 (54), 296 (6), 239 ( 9) 3 [3S (4S)] 3- [6,10-diketo-7- (pyridin-2-carboxamide) -1,2,3,4,7,8,9,10-eight Hydrogen-6 stilbene [1,24] [1,2,4] triazapyrene-4- Amido] -4-ketobutyric acid (1075), prepared by the method of compound 265, can produce a white solid (184 mg, 83%): mp. 210-5 ° C; J &gt;] D24 +43.9. ( c 0.1, CH3〇H); IR (ΚΒγ) 3700-2300 (br), 3309, 1660, 1537, 1423, 13 1 1,1262, -645-This paper scale is applicable to China National Standard (CNS) 8-4 specifications (210X 297 male cage) 1235157

AT _B7_ 五、發明説明(643 ) 1184; lH NMR (CD3〇D) ά 7.61 (1H; d), 7.45 (1H, d), 7.28-AT _B7_ V. Description of the Invention (643) 1184; lH NMR (CD3〇D) ά 7.61 (1H; d), 7.45 (1H, d), 7.28-

7.15 (1H, m), 7.15-7.00 (1H, m), 7.13 (1H, s), 5.12-4.96 (1H, m), 4.62-4.55 (1H? m), 4.50-4.25 (2H, m), 4.00-3.69 (3H, m). 3.05-2.90 (1H, m), 2.80-2.30 (3H, m), 2.25-1.50 (4H, m) ^ MS (ES+) 484 (M+,26%),483 (M+ - 1,100),383 (25),245 (12), 208 (1 1),200 (21),174 (31),137 (18)。 [3S(4S)】 3-{7-[(4-乙醯胺基)r 醯胺基]-6,10-二酮基-i,2,3,4, 7,8,9,10-八氮-611-哈1*井並[1,2-3][1,2,4]二氛雜革-4-幾矮胺基} -4-酮基丁酸(1018),以化合物265之類似方法製備,可生 成白色固體(177毫克,82%) : mp· 235-40eC; [a]D23 +27.3。(c 0.1,CH3OH); IR (KBr) 3700-2300 (br), 3311,2957, 1662, 1599, 153 1, 13 18, 1266, 1 182; lH NMR (CD3OD) ά 7.83 (2H, d), 7.69 (2H, d), 5.10-4.95 (1H, m), 4.64-4.55 (1H, m), 4.50-4.35 (1H, m), 4.32-4.22 (1H, m), 4.00-3.65 (3H, m), 3.05-2.90 (1H, m), 2.80-2.30 (3H, m), 2.15 (3H, s), 2.15-1.50 (4H, m) ^ 分析 C22H26N008.1.5H20之計算値·· C, 49·90;Η,5·52;Ν, 15.87。實測値:C,50.21; H,5·41; N,15.49 a MS (ES,502 (M十,28%),501 (M+ - 1,100),401 (8),218 (4),119 (2),118 (5),113 (16) 3 經濟部中央樣隼局員工消费合作社印製 (請先阖讀背©之注意事項再填寫本買)7.15 (1H, m), 7.15-7.00 (1H, m), 7.13 (1H, s), 5.12-4.96 (1H, m), 4.62-4.55 (1H? M), 4.50-4.25 (2H, m), 4.00-3.69 (3H, m). 3.05-2.90 (1H, m), 2.80-2.30 (3H, m), 2.25-1.50 (4H, m) ^ MS (ES +) 484 (M +, 26%), 483 ( M +-1,100), 383 (25), 245 (12), 208 (1 1), 200 (21), 174 (31), 137 (18). [3S (4S)] 3- {7-[(4-ethylamido) r-amido] -6,10-diketo-i, 2,3,4, 7,8,9,10- Octa-611-Ha 1 * well and [1,2-3] [1,2,4] diazepines 4-chitamine} 4-ketobutanoic acid (1018) to compound 265 Prepared in a similar manner, a white solid (177 mg, 82%) was obtained: mp · 235-40eC; [a] D23 +27.3. (C 0.1, CH3OH); IR (KBr) 3700-2300 (br), 3311, 2957, 1662, 1599, 153 1, 13 18, 1266, 1 182; lH NMR (CD3OD) ά 7.83 (2H, d), 7.69 (2H, d), 5.10-4.95 (1H, m), 4.64-4.55 (1H, m), 4.50-4.35 (1H, m), 4.32-4.22 (1H, m), 4.00-3.65 (3H, m ), 3.05-2.90 (1H, m), 2.80-2.30 (3H, m), 2.15 (3H, s), 2.15-1.50 (4H, m) ^ Analyze the calculation of C22H26N008.1.5H20 値 C, 49 · 90; H, 5.52; N, 15.87. Measured 値: C, 50.21; H, 5.41; N, 15.49 a MS (ES, 502 (M ten, 28%), 501 (M +-1, 100), 401 (8), 218 (4), 119 (2), 118 (5), 113 (16) 3 Printed by the Consumer Cooperative of the Central Sample Bureau of the Ministry of Economic Affairs (please read the precautions of © before filling out this purchase)

[3S(4S)】 3-[6,10·二酮基-7-(4-甲氧芊醯基胺基)-八氫-6H-,答 畊並[l,2-a][l,2,4]三氮雜箪-4-羧醢胺基]-4-酮基丁狻(1052) ,以化合物265之方法合成,可生成白色固體(0.194克, 100%) : mp· 138-142eC ; J&gt;]D20 +36.3。(c 0.19, CH3OH); IR (KBr) 3434-2962, 1782, 1660, 1607, 1537, 1504, 1441,1424, _-646&lt; 本纸乐尺度適用中国S家標萍(CNS ) A4堤格(2丨0X 297公釐) 1235157 Λ7 _B7 _ 五、發明説明(644 ) 13 13, 1293, 1258, 1 177; [H NMR (GD3〇D) ^ 7.11 (2H, d, J =8.8), 6.90 (2H, d, J = 8.9), 4.48 (1H, m), 4.34, 4.28 (1H, 2m), 4.15 (1H, m), 3.75 (3H, s), 3.75, 3.70 (3H, m), 2.88, 2.49, 2.28, 2.23, 2.00, 1.86, 1.79, 1.58 (8H, m)-[3S(4S)] 3-(6,10-二酮基-1,2,3,4,7,8,9,10-八氫-7-苯基磺醯 基胺基-6H-嗒哜並[l,2-a][l,2,4]三氮雜箪-4-羧醯胺基)-4-酮 基丁酸(1027),以化合物265之類似方法合成,可生成白色 泡沫(880/〇) : 〇]D24 +22.6。(c 0.17, MeOH); IR (KBr) 3349, 1789, 1663, 1537, 1448, 1337, 1 169, 1092, 690; [H NMR (CD3OD) ά 7.82 (2H, d, J = 7.8), 7.57 (3H, m), 4.74 (1H, m)? 4.47 (1H, m), 4.24-4.10 (2H, m), 3.72-3.47 (4H, m), 2.62-2.48 (3H, m), 2.20 (1H, m), 1.94-1.35 (3H, m) ^ MS (ES+) 480 (M^ • 1,100%) 3 C19H24SN503 (MH勹之精確質量計算値·· 482.1346 。實測値·· 482.1325。 [3S(4S)] 3-[6,10-二酮-7-(4-羥基苄醯胺基)-1,2,3,4,7,8,9,10-八氫-6H·嗒啩並[l,2-a][l,2,4]三氮雜箪-4-羧醯胺基卜4-酮基 丁酸(1056),以化合物265之方法製備(95%) :mp. &gt;3003C;IR (KBr) 3392, 1660, 1610, 1507, 1442, 1280, 1171,1149, 1133 ^ lH NMR (CD3OD) (ί 7.74 (2H, d, J = 8.7), 6.84 (2H, d J = 經濟部中央標隼局員工消費合作社印¾ 8.7), 4.58 (1H, m), 4.41 (1H, bd, J = 12.6), 4.28 (1H, m)? 3.85 (3H, m), 2.98 (1H, m), 2.8-2.3 (3H, m), 2.3^1.6 (4H, m)-[3S(4S)】 3-[6,10-二酮-7-(3,4-甲二氧基芊醯胺基)-12,3 4 7 8, 9,10-八氩-61^答畊並[1,24][1,2,4]三氮雜箪-4-幾醯胺基]-4-酮基丁酸(1015),以化合物265之方法製備,生成白色固體 -647 - 本纸乐尺度適用中国國家標革(CNS ) A4現格(210X297公釐) ' - 1235157 A7 __B7 五、發明説明( 645 ) (142毫克,58%) : mp. 170-5°C; 〇]D、25 +32.70 (c 0.1,CH3OH); IR (KBr) 3700-2500 (br), 3325, 2969, 1784, 1662, 1485, 1440, 1292, 1258, 1037; lE NMR (CD3OD) ά 7.45 (1H, dd), 7.32 (1H, d), 6.90 (1H, d), 6.05 (2H s), 5.10-4.90 (1H, m), 4.62-4.54 (1H, m), 4.45-4.35 (1H, m), 4.33-4.22 (1H, m), 3.95-3.65 (3H, m), 3.05-2.90 (1H, m), 2.80-2.30 (3H, m), 2.20-1.50 (4H, m)。[3S (4S)] 3- [6,10 · diketo-7- (4-methoxyfluorenylamino) -octahydro-6H-, and [1,2-a] [l, 2,4] triazapyrene-4-carboxyamido] -4-ketobutylamidine (1052), synthesized by the method of compound 265, can produce a white solid (0.194 g, 100%): mp · 138- 142eC; J &gt;] D20 +36.3. (C 0.19, CH3OH); IR (KBr) 3434-2962, 1782, 1660, 1607, 1537, 1504, 1441, 1424, _-646 &lt; The scale of this paper is applicable to Chinese S Jiaping Ping (CNS) A4 Tiege ( 2 丨 0X 297 mm) 1235157 Λ7 _B7 _ V. Description of the invention (644) 13 13, 1293, 1258, 1 177; [H NMR (GD3〇D) ^ 7.11 (2H, d, J = 8.8), 6.90 ( 2H, d, J = 8.9), 4.48 (1H, m), 4.34, 4.28 (1H, 2m), 4.15 (1H, m), 3.75 (3H, s), 3.75, 3.70 (3H, m), 2.88, 2.49, 2.28, 2.23, 2.00, 1.86, 1.79, 1.58 (8H, m)-[3S (4S)] 3- (6,10-diketo-1,2,3,4,7,8,9, 10-octahydro-7-phenylsulfonamido-6H-dapyrido [l, 2-a] [l, 2,4] triazapyridin-4-carboxyamido) -4-one Butyric acid (1027), synthesized in a similar manner to compound 265, yields a white foam (880 / 〇): 〇] D24 +22.6. (C 0.17, MeOH); IR (KBr) 3349, 1789, 1663, 1537, 1448, 1337, 1 169, 1092, 690; [H NMR (CD3OD) ά 7.82 (2H, d, J = 7.8), 7.57 ( 3H, m), 4.74 (1H, m)? 4.47 (1H, m), 4.24-4.10 (2H, m), 3.72-3.47 (4H, m), 2.62-2.48 (3H, m), 2.20 (1H, m), 1.94-1.35 (3H, m) ^ MS (ES +) 480 (M ^ • 1,100%) 3 C19H24SN503 (MH 勹 accurate mass calculation 48 482.1346. Measured 値 482.1325. [3S (4S )] 3- [6,10-dione-7- (4-hydroxybenzylamino) -1,2,3,4,7,8,9,10-octahydro-6H , 2-a] [l, 2,4] triazapyridin-4-carboxyamido 4-ketobutanoic acid (1056), prepared by the method of compound 265 (95%): mp. &Gt;3003C; IR (KBr) 3392, 1660, 1610, 1507, 1442, 1280, 1171, 1149, 1133 ^ lH NMR (CD3OD) (ί 7.74 (2H, d, J = 8.7), 6.84 (2H, d J = Ministry of Economy Printed by the Central Bureau of Standards Consumer Cooperative ¾ 8.7), 4.58 (1H, m), 4.41 (1H, bd, J = 12.6), 4.28 (1H, m)? 3.85 (3H, m), 2.98 (1H, m) , 2.8-2.3 (3H, m), 2.3 ^ 1.6 (4H, m)-[3S (4S)] 3- [6,10-dione-7- (3,4-methyldioxyamidino) ) -12,3 4 7 8, 9, 10-octa-61-61 ^ answer farming and [1, 24] [1, 2, 4] Triazapyridine-4-chitamido] -4-ketobutyric acid (1015), prepared by the method of compound 265, to produce a white solid (210X297 mm) '-1235157 A7 __B7 V. Description of the invention (645) (142 mg, 58%): mp. 170-5 ° C; 〇] D, 25 +32.70 (c 0.1, CH3OH); IR ( KBr) 3700-2500 (br), 3325, 2969, 1784, 1662, 1485, 1440, 1292, 1258, 1037; lE NMR (CD3OD) ά 7.45 (1H, dd), 7.32 (1H, d), 6.90 (1H , d), 6.05 (2H s), 5.10-4.90 (1H, m), 4.62-4.54 (1H, m), 4.45-4.35 (1H, m), 4.33-4.22 (1H, m), 3.95-3.65 ( 3H, m), 3.05-2.90 (1H, m), 2.80-2.30 (3H, m), 2.20-1.50 (4H, m).

(#.先聞讀背面之洼意事項再填寫太f ) 〇 o(#. First read the meanings on the back and then fill in too f) 〇 o

[3S(4S)] 3-[7-(苯並[b]〃塞吩-2-羰基)胺基-6,10-二酮基-1,2,3,4,7,8,9,10·八氫-6H-嗒啩並[1,2-aKl :2,4]三氮雜箪]-4-酮基丁酸第三-丁酯半卡巴腙(526),以化合物502之方法製 備,可生成玻璃狀固體·· U】D20 +34° (c 0.13, CH2C12); IR (KBr) 3437, 2929, 1670, 1530, 1428, 1288, 1 156; lH NMR (CDCi3) ά 10.0 (1H, bs), 9.74 (1H, bs), 7.93 (1H, s), 7.80- 經濟部令央樣準局員工消费合作社印衷[3S (4S)] 3- [7- (benzo [b] pyrene-2-carbonyl) amino-6,10-diketo-1,2,3,4,7,8,9, 10 · Octahydro-6H-dapyrido [1,2-aKl: 2,4] triazapyridine] -4-ketobutyric acid tert-butyl hemicarbazine (526), method of compound 502 It can be produced as a glassy solid. U] D20 + 34 ° (c 0.13, CH2C12); IR (KBr) 3437, 2929, 1670, 1530, 1428, 1288, 1 156; lH NMR (CDCi3) ά 10.0 (1H , bs), 9.74 (1H, bs), 7.93 (1H, s), 7.80

7.60 (2H, m), 7.40-7.18 (3H, m), 6.15〇.30 (2H, bs), 5.00-4.85 (2H, m), 4.50-4.25 (1H, m), 3.95-3.75 (3H, m), 3.12-2.78 (2H,m), 2.73-1.60 (7H,m),1·36 (9H,s)。分析 C27H34N807S 之計算値:C,52.76; H,5.58; N,18.23。實測値:C, 52.25; H, 5·74; N,16.30 » MS (ES+) 615。 [3S(4S)] 3-[7-(苯並[b],塞吩-2-羰基)胺基-6,10-二酮基- -648 - 本纸伕尺度適用中国國家標孳(CNS ) A4規格(2丨O X 29?公釐) 1235157 A 7 __B7___ 五、發明説明(646 ) 1,2,3,4,7,8,9,10-八氫-611-嗒哜並[1、,24][1,2,4]三氮雜箪-4-羧醯胺基】-4-酮基丁酸(1053),以化合物214之方法製備, 可生成白色固禮(106毫克,73%) : 〇]口20 +22° (c 0.1Q,7.60 (2H, m), 7.40-7.18 (3H, m), 6.15〇.30 (2H, bs), 5.00-4.85 (2H, m), 4.50-4.25 (1H, m), 3.95-3.75 (3H, m), 3.12-2.78 (2H, m), 2.73-1.60 (7H, m), 1.36 (9H, s). Analyze the calculation of C27H34N807SS: C, 52.76; H, 5.58; N, 18.23. Found 値: C, 52.25; H, 5.74; N, 16.30 »MS (ES +) 615. [3S (4S)] 3- [7- (Benzo [b], thiophen-2-carbonyl) amino-6,10-diketo- -648-This paper's standard is applicable to China National Standard (CNS ) A4 specification (2 丨 OX 29? Mm) 1235157 A 7 __B7___ V. Description of the invention (646) 1,2,3,4,7,8,9,10-octahydro-611-Da and [1 , 24] [1,2,4] triazapyrene-4-carboxyamido] -4-ketobutyric acid (1053), prepared by the method of compound 214, can produce a white solid solution (106 mg, 73 %): 〇] 20 + 22 ° (c 0.1Q,

MeOH); IR (KBr) 3428, 2944, 1733, 1652, 1532, 1433, 1337, 1288, 1 186; lE NMR (CD3OD) ά 7.95 (1H, s), 7.90-7.85 (2H, m), 7.43-7.35 (2H, m), 4.98 (1H, m), 4.65-4.52 (1H, m), 4.40^ 4.20 (2H, m), 3.85-3.70 (3H, m), 3.30-3.25 (3H, m), 3.03-2.85 (1H, m), 2.70^2.31 (3H, m), 2.10-1.55 (4H, m) 3 MS (ES+) 500 (如兹之甲基缩遂)。 ΟMeOH); IR (KBr) 3428, 2944, 1733, 1652, 1532, 1433, 1337, 1288, 1 186; lE NMR (CD3OD) ά 7.95 (1H, s), 7.90-7.85 (2H, m), 7.43- 7.35 (2H, m), 4.98 (1H, m), 4.65-4.52 (1H, m), 4.40 ^ 4.20 (2H, m), 3.85-3.70 (3H, m), 3.30-3.25 (3H, m), 3.03-2.85 (1H, m), 2.70 ^ 2.31 (3H, m), 2.10-1.55 (4H, m) 3 MS (ES +) 500 (such as the methyl reduction of azine). Ο

[4S(2RS,jS)] 6,10-二嗣基乙氧基-5-嗣基四氮咬畴-3-基)-7-(3,‘曱二氧基芊醯胺基)-1,2,3,4,7,8,9,10-八氫-611-嗒 哜並[1,24][1,2,4】三氮雜箪-4-羧醯胺(528),以化合物2136 之方法製備,可生成非對映立體異構物之混合(同側:對 側異構物比例1:1),呈乳白色泡沫狀固體(1.05克,58%): mp· 124_3江;IR (KBr) 3312, 2979, 1790, 1664, 1610, 1532, 1485, 1285, 1 120, 1037, 932; lH NMR (D6-DMSO) ά 10.39 (1H, s), 8.71 (0.5H, d), 8.43 (0.5H, d), 7.45 (1H, d), 7.36 (1H, __ - 649 - 本纸乐尺度適用中国國家標洋(CNS ) A4思格(210 X 297公签) (請元聞讀背云之·.V〗意事項真填寫本一貝 -裝 訂 d 經濟部中央標率局貝X消費合作社印裝 1235157 __B7 五 '發明説明(647 ) s), 7.04 (1H, d), 6.12 (2H, s), 5.5S (Ό.5Η, d), 5.34 (0.5H, s), 4.95- 4.85 (1H, m), 4.70-4.52 (0.5H, m), 4.35-4.10 (1.5H, m), 3.95- 3.50 (5H, m), 3.03 (0.5H, dd), 2.90-2.55 (1.5H, m), 2.46-2.20 (2H? m), 2.10-2.40 (4H, m), 1.16-1.13 (3H, 2 x t) ^ 分析 C23H27N5〇9.0.6H2O之計算値·· C, 52.29; Η, 5.38; N, 13.26。實測値:C, 52.53; Η, 5·35; N,12.78。MS (ES+) 519 (M+ + 2, 27%),518 (M+ + 1,100),472 (7),374 (12),373 (53), 345 (14),149 (12) » 實例3 1 化合物 640,642,645,650,653,655,656,662,668 ,669,670,671,677,678,681,682,683,684,686 ,688a,688b,689卜 689b,690a,690b,691a,691b, 695a,695b,695c,692a,692b,693;?1694如下製備。 (請先知讀背云之:/«意事項再填寫本頁) 訂 0ri: 經濟部cb‘央橾绛局員工消費合作杜印製[4S (2RS, jS)] 6,10-Difluorenylethoxy-5-fluorenyltetrazine-3-yl) -7- (3, 'fluorendioxyfluorenamine) -1 , 2,3,4,7,8,9,10-octahydro-611-dapyrido [1,24] [1,2,4] triazine-4-carboxamide (528), with Compound 2136 is prepared by the method, which can generate a mixture of diastereoisomeric compounds (ipsilateral: isomeric ratio 1: 1), as a milky white foamy solid (1.05 g, 58%): mp · 124_3 Jiang; IR (KBr) 3312, 2979, 1790, 1664, 1610, 1532, 1485, 1285, 1 120, 1037, 932; lH NMR (D6-DMSO) ά 10.39 (1H, s), 8.71 (0.5H, d), 8.43 (0.5H, d), 7.45 (1H, d), 7.36 (1H, __-649-This paper scale is applicable to China National Standard Ocean (CNS) A4 Sigma (210 X 297)) (Please read Yuanwen Behind the clouds, .V 〖I want to fill in this book-binding d 中央 Central Standards Bureau of the Ministry of Economic Affairs X X Cooperative Cooperative printed 1235157 __B7 Five 'invention description (647) s), 7.04 (1H, d), 6.12 ( 2H, s), 5.5S (Ό.5Η, d), 5.34 (0.5H, s), 4.95- 4.85 (1H, m), 4.70-4.52 (0.5H, m), 4.35-4.10 (1.5H, m ), 3.95- 3.50 (5H, m), 3.03 (0.5H, dd), 2.90-2.55 (1.5H, m), 2.46-2.20 (2H? M), 2.1 0-2.40 (4H, m), 1.16-1.13 (3H, 2 xt) ^ Analysis of the calculation of C23H27N5〇9.0.6H2O 値 · C, 52.29; Η, 5.38; N, 13.26. Measured 値: C, 52.53; Η , 5.35; N, 12.78. MS (ES +) 519 (M + + 2, 27%), 518 (M + + 1,100), 472 (7), 374 (12), 373 (53), 345 (14 ), 149 (12) »Example 3 1 Compound 640,642,645,650,653,655,656,662,668,669,670,671,677,678,681,682,683,684,686,688a , 688b, 689, 689b, 690a, 690b, 691a, 691b, 695a, 695b, 695c, 692a, 692b, 693;? 1694 were prepared as follows. (Please read the Prophet's back: / «Implement matters before filling out this page." Order 0ri: cb ’printed by the Ministry of Economic Affairs of the Central Government Bureau for consumer cooperation

-650- 本紙朵尺度適用中國國家標洋(CNS ) A4况格(210 &lt; 297公釐) 1235157 A: B7 五、發明説明(648) _ (3S)-2-酮基-3-胺基·5-曱氧基乙辕、基-2,3,4,5-四氫-11^1,5- 苯並二氮雜苯-卜醋酸曱酯(638),合成自600a,以化合物 600a製成602m之方法,可生成2.4克的63 8呈白色固體3 (3S)-2-酮基-3-(2-莕亞曱基)胺基-5-甲氧基乙醯基-2;3,4,5-四氫-1H-1,5-苯並二氮雞箪-1-乙酸甲酯(639)。對638 (630 毫克,1.76毫莫耳)及2-¾:基甲基溴(428毫克,1.94毫莫耳) 於CH3CN之溶液中,加入K2C03 (608毫克,4.4毫莫耳)3 生成的混合物在環境溫度下攪拌。18小時後,反應混合物 以CΗ2C12稀釋’以%再以鹽水洗條’於N^SO^上乾澡再眞 空濃縮°快速層析(Si〇2,〇至20% Et〇Ac/CH2Cl,)可生成 450毫克的639 a (3S)-3-[(3S)-2-酮基-3-(2-莕基亞甲基)胺基-5-甲氧基乙酿基 -2,3,4,5-四氮-1仏1,5-表並二亂雜革-1-乙酿胺基卜4,_晨-丁 酸(640),以602v製成605v之方法合成,可生成2〇5毫克的 640,呈白色固體,W NMR (CDC13) β 2.4-2.55 (m,1H) 2.65-2.8 (m, 1H), 3.2 (s, 3H), 3.72-3.78 (m, 1H), 3.85-4.0 (m 2H), 4.22-4.28 (d, 1H), 4.26-4.5 (m, 4H), 4.58-4.75 (m&gt; 1H) 4.78-4.85 (m, 1H), 5.0〇.08 (t,1H), 7.3 5-7.65 (m, 7H), 7.85- 8.02 (m, 4H) 0 (請先闉讀背云之注意事項再填寫太f 裝 訂 - 經濟部中央糅隼局負工消f合作社印裝-650- The size of this paper is suitable for China National Standard Ocean (CNS) A4 condition (210 &lt; 297 mm) 1235157 A: B7 V. Description of the invention (648) _ (3S) -2-keto-3-amine · 5-Aminoethoxyfluorenyl, -2,3,4,5-tetrahydro-11 ^ 1,5-benzodiazepine-diacetic acid acetate (638), synthesized from 600a, with compound 600a Method of making 602m, which can generate 2.4 g of 63 8 as a white solid 3 (3S) -2-keto-3- (2-fluorenylene) amino-5-methoxyethylfluorenyl-2; Methyl 3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-acetate (639). To a solution of 638 (630 mg, 1.76 mmol) and 2-¾: methylmethyl bromide (428 mg, 1.94 mmol) in CH3CN, K2C03 (608 mg, 4.4 mmol) was added. 3 Stir at ambient temperature. After 18 hours, the reaction mixture was diluted with C2C12, washed in%, then washed with brine, dried on N ^ SO ^, and concentrated in vacuo. Flash chromatography (Si0, 0 to 20% Et〇Ac / CH2Cl,) 450 mg of 639 a (3S) -3-[(3S) -2-keto-3- (2-fluorenylmethylene) amino-5-methoxyethynyl-2,3,4 1,5-tetrazine-1,1,5-epi-dioxane-1,1-ethylamine amine group 4, _morning-butyric acid (640), synthesized by the method of 602v to 605v, can generate 2O. 5 mg of 640 as a white solid, W NMR (CDC13) β 2.4-2.55 (m, 1H) 2.65-2.8 (m, 1H), 3.2 (s, 3H), 3.72-3.78 (m, 1H), 3.85- 4.0 (m 2H), 4.22-4.28 (d, 1H), 4.26-4.5 (m, 4H), 4.58-4.75 (m &gt; 1H) 4.78-4.85 (m, 1H), 5.0〇.08 (t, 1H) , 7.3 5-7.65 (m, 7H), 7.85- 8.02 (m, 4H) 0 (Please read the precautions of the back of the cloud before filling in too f bindings-Central Government Bureau of the Ministry of Economy

-651 - 本纸伕尺度適用中國國家標李(〇&gt;^&gt;.*\4%咯(2!0;&lt; 297公蝥) 1235157 五、發明説明(649) (35)-3-[(35)-2-酮基-3-芊醯基甲醯、基胺基-:&gt;-甲氧基乙醯基-2,3,4,5-四氫-1H-1,5-苯ϋ二氮雜苯小乙酿胺基卜4’基-丁 酸(642),以6〇5m之方法合成自6j8’可生成213毫克的642 ,[H NMR (CD3OD) β 2.5 (m,lH),2,6§ (ddd,1H),3.25 (s, 2H),3.3 (s,3H),3.78 (m,2H), 4.0 (d,1H),4」(m,1H),4.6 (m, 2H), 4.85 (br. s, 2H), 7.08-7.22 (m, 2H), 7.3d (m, 1H), 7.4-7.65 (m,4H), 7.7 (dd, 1H),8.1 (dd,1H)。-651-The standard of this paper is Chinese national standard plum (〇 &gt; ^ &gt;. * \ 4% slightly (2! 0; &lt; 297 gong)) 1235157 V. Description of the invention (649) (35) -3- [(35) -2-keto-3-amidinoformamidine, aminoamino-:>-methoxyethenyl-2,3,4,5-tetrahydro-1H-1,5- Benzamidine diazabenzene small ethyl alcohol 4′-yl-butyric acid (642), synthesized from 6j8 ′ by the method of 605m, can produce 213 mg of 642, [H NMR (CD3OD) β 2.5 (m, lH), 2,6§ (ddd, 1H), 3.25 (s, 2H), 3.3 (s, 3H), 3.78 (m, 2H), 4.0 (d, 1H), 4 "(m, 1H), 4.6 (m, 2H), 4.85 (br. s, 2H), 7.08-7.22 (m, 2H), 7.3d (m, 1H), 7.4-7.65 (m, 4H), 7.7 (dd, 1H), 8.1 ( dd, 1H).

2-乙醯胺基·乙醢基氣(643) e對N-乙酷基甘按酸(200毫克 ,1·7毫莫耳)於含有DMF (〇·〇05毫升)之CH2C12 (2·5毫升)之 經濟部中夬標孪局員工消费合作社印^ 懸液中,加入草醯基氣(0.450毫升,5.1毫莫耳)3在環境 溫度下攪拌30分鐘後,混合物&amp;縮可生成643,呈粗製產 物。 (3S)-2-酮基-3-(卜莕醯基)胺基乙醯胺基)乙醯基· 2,3,4,5-四氫-ih-1,5-苯並二氮雜箪-卜乙酸苄酯(644),以 -652· 本纸朵尺度適用中國國家標挛(CNS ) A4規格(210X297公Θ &quot; 一 1235157 Λ7 Β7 五、發明説明( 650 ) 600b製成602d之方法合成自600b ^利用643可生成112毫克 的 644。 (3 3)-3-[(3 5)-2-酮基-3-(1-莕醯基)胺基-5-(2-乙醯胺基)乙醢 基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-1-乙醯胺基卜4·-酮基-丁酸(645),以602d製成605d之方法合成自644,可生成43 毫克的 645,呈白色固體,iH NMR (CD3〇D) d 1.95 (s,3H), 2.4 (m, 1H), 2.65 (m, 1H), 3.4 (s, 1H), 3.55 (m, 1H), 3.85 (m, 1H), 4.05 (d, 1H), 4.3 (m, 1H), 4.4-4.6 (m, 2H), 5.0 (m, 1H). 7.4-7.7 (m,6H),7·86·8.0 (m,2H)。2-Acetylamino · acetylammonium (643) e-N-ethoxyglycylic acid (200 mg, 1.7 mmol) in CH2C12 (2 · 5 ml) of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs and Consumer Cooperative Seal ^ Suspension, added grass base gas (0.450 ml, 5.1 mmol) 3 after stirring at ambient temperature for 30 minutes, the mixture &amp; 643, as a crude product. (3S) -2-keto-3- (buthyl) aminoethanylamino) ethynyl 2,3,4,5-tetrahydro-ih-1,5-benzodiazepine箪 -Benzyl acetate (644), -652 · This paper is suitable for Chinese National Standard (CNS) A4 specifications (210X297 male Θ &quot;-1235157 Λ7 Β7) 5. Description of the invention (650) 600b made of 602d Method Synthesized from 600b ^ Using 643 can produce 112 mg of 644. (3 3) -3-[(3 5) -2-keto-3- (1-fluorenyl) amino-5- (2-ethyl Fluorenylamino) ethenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-ethenylaminob 4 · -keto-butanoic acid (645) , Synthesized from 644 by 602d and 605d, which can produce 43 mg of 645 as a white solid, iH NMR (CD3OD) d 1.95 (s, 3H), 2.4 (m, 1H), 2.65 (m, 1H ), 3.4 (s, 1H), 3.55 (m, 1H), 3.85 (m, 1H), 4.05 (d, 1H), 4.3 (m, 1H), 4.4-4.6 (m, 2H), 5.0 (m, 1H). 7.4-7.7 (m, 6H), 7.86 · 8.0 (m, 2H).

Fmoc 〇 Fmoc 〇Fmoc 〇 Fmoc 〇

經濟部t夬糅华局員工消費合作杜印¾ (請先知讀背云之注意事項再填寫本頁) 2-(N-甲基’ N·苐基甲氧羰基)胺基乙醯基氣(646),以製備 6*4j心方β製備自N-Fmoc-肌胺酸,可生成646呈粗製虞物3 (3S)·2’基,3-(1-萘甲醯基)胺基o-〇(N-甲基,N-第基〒 -653 - 娜尺度郝個 ^^·$)Λ4^(:10χ 297^1 1235157 Λ' Β7 五、發明説明(銘1 ) 請 先 讀 背 面 之 意 畜 再 % 太 1 氧羰基)胺基]乙醢基-2,3,4,5-四氫_1H-1,5-苯並二氮雜箪小 醋酸苄酯(647),以自600b合成6002d之方法合成自600b, 利用646可生成481毫克的647。 (3S)-3-[(3S)-2-酮基-3-(1-莕甲醯基)胺基-5-[2-(N-甲基,N-苐基甲氧羰基)胺基】乙醯基-2,3,4,5-四氩-111-1,5-苯並二氮 雜箪-1-乙醯胺基]-4-酮基-丁酸第三丁酯半卡巴腙(648), 以由602d製備604d之方法製備自647,可生成409毫克的 648。 (3S)-3-[(3S)-2-酮基-3-(1-莕甲醯基)胺基-5-(2-甲基胺基)乙 酿基-2,3,4,5 -四氣-1H-1,5·笨並二氣雜革-1-乙酿胺基]4-萌 基-丁酸第三-丁酯半卡巴腙(649)。648 (409毫克,0.465毫 莫耳)於MeCN:Et2NH (4·· 1,v/v)之溶液在環境溫度下攪拌 。45分鐘後,反應混合物於眞空中濃縮。快逯層析(Si02 ,5%至20% MeOH於CH2C12)可生成241毫克的649。 (3S)-3-[(3S)-2-酮基-3-0萘甲醯基)胺基-5-(2-甲基胺基)乙 醢基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-1-乙醯胺基]-4-酮 基-丁酸(650),以由604製備605d之方法合成且649,可生 成179毫克的650,呈白色固體,1HNMR(CD3OD)(y2·4- 經濟部中夬標準局員工消资合作杜印製 2.6 (m, 2H), 2.7 (s, 3H), 3.5 (q, 1H), 3.8 (m, 2H), 4.2-4.4 (m, 2H), 4.3-4.45 (m, 1H), 5.0o.l (m, 2H), 7.4-7.7 (m, 6H), 7.85-7.9 (m, 2H), 8.2 (m, 1H) ^ *Department of Economic Affairs, Tsinghua Bureau, Employee Consumption Cooperation, Du Yin ¾ (Please read the precautions for the back of the cloud, and then fill out this page) 2- (N-methyl 'N · fluorenylmethoxycarbonyl) aminoethylfluorene ( 646), prepared from N-Fmoc-sarcosinate to prepare 6 * 4j heart square β, which can produce 646 crude 3 (3S) · 2 'groups, 3- (1-naphthylmethyl) amino groups -〇 (N-methyl, N-thyl group 〒 -653-Na scale Hao ^^ · $) Λ4 ^ (: 10χ 297 ^ 1 1235157 Λ 'Β7 5. Explanation of the invention (Ming 1) Please read the back Italian animal re %% 1 oxycarbonyl) amino] ethylfluorenyl-2,3,4,5-tetrahydro_1H-1,5-benzodiazepine small benzyl acetate (647) to 600b The method of synthesizing 6002d is synthesized from 600b. Using 646 can produce 481 mg of 647. (3S) -3-[(3S) -2-keto-3- (1-fluorenylmethylamino) amino-5- [2- (N-methyl, N-fluorenylmethoxycarbonyl) amino ] Acetyl-2,3,4,5-tetraargon-111-1,5-benzodiazepine-1-ethylamidino] -4-keto-butyric acid tert-butyl half carbamate Tritium (648), prepared from 647 by 602d and 604d, can produce 409 mg of 648. (3S) -3-[(3S) -2-keto-3- (1-methylformamyl) amino-5- (2-methylamino) ethynyl-2,3,4,5 -Tetrakis-1H-1,5 · benzyldiazine leather-1-ethyl amine amino] 4-molyl-butyric acid tertiary-butyl hemicarbazone (649). A solution of 648 (409 mg, 0.465 mmol) in MeCN: Et2NH (4 ·· 1, v / v) was stirred at ambient temperature. After 45 minutes, the reaction mixture was concentrated in the air. Flash chromatography (Si02, 5% to 20% MeOH in CH2C12) yielded 241 mg of 649. (3S) -3-[(3S) -2-keto-3-0naphthyridinyl) amino-5- (2-methylamino) ethenyl-2,3,4,5-tetra Hydrogen-1H-1,5-benzodiazepine-1-acetamido] -4-keto-butanoic acid (650), synthesized by the method of preparing 605d from 604 and 649, can produce 179 mg of 650, white solid, 1HNMR (CD3OD) (y2 · 4- cooperating with the staff of the China Standards Bureau of the Ministry of Economic Affairs, Du printed 2.6 (m, 2H), 2.7 (s, 3H), 3.5 (q, 1H), 3.8 (m, 2H), 4.2-4.4 (m, 2H), 4.3-4.45 (m, 1H), 5.0ol (m, 2H), 7.4-7.7 (m, 6H), 7.85-7.9 (m, 2H), 8.2 (m, 1H) ^ *

本紙尜尺度適用中國國家標孪(CNS ) A4見格(2丨0χπ7公釐) 1235157 Λ7 B7 五、發明説明(652) (3s)-^萌^仆菩甲睡基)胺基.5:甲駿基,2 3 4 5-四氮. 1,5-苯並二氮雜箪,;μ乙酸苄酯(652),以甴製備的以之 方法合成自6⑼b,利用由DMF與3當量草醯氣於CH2C〖2溶 液中反應成R X所得之試劑,可生成4〇4毫克的652,. (3S)-3-[(3S)-2’ 基-3-(1-茶甲醯基)腔基 〇'〒酷基-2,3 4 5-四氩-1H-1,5-笨並二氣雜革乙酸胺基卜‘萌基-丁酸(㈠3) ,以由602d製備605d之方法合成自652,可生成84毫克的 653,呈白色固禮,β NMR (CD3OD) β 2.3 (m,1H), 2·55 (dd, 1H), 3.75 (br. s, 1H), 4.25-4.6 (m, 5H), 5.15 (m, 1H), 7.2^7.45 (m, 6H), 7.8-7.9 (dd, 3H), 8.1 (s, 1H), 8.2 (m, 2H) ^The scale of this paper is applicable to the Chinese National Standard (CNS) A4 (2 丨 0χπ7 mm) 1235157 Λ7 B7 V. Description of the invention (652) (3s)-^ Meng ^ pu pu jia ji ji) Amine. 5: A Junki, 2 3 4 5-tetraaza. 1,5-benzodiazepine, μ benzyl acetate (652), synthesized from 6 甴 b using the method prepared from 甴, using DMF and 3 equivalents of grass 醯The gas is reacted in a solution of CH2C [2] to form a reagent obtained by RX, which can generate 404 mg of 652. (3S) -3-[(3S) -2'yl-3- (1-Tetramethylamyl) cavity The radical ′ ′ acyl-2,3 4 5-tetra argon-1H-1,5-benzyldiazaheteroacetic acid ammonium-butyric acid-butyric acid (㈠3) was synthesized by the method of preparing 605d from 602d. From 652, 84 mg of 653 can be generated, which is a white solid, β NMR (CD3OD) β 2.3 (m, 1H), 2.55 (dd, 1H), 3.75 (br. S, 1H), 4.25-4.6 ( m, 5H), 5.15 (m, 1H), 7.2 ^ 7.45 (m, 6H), 7.8-7.9 (dd, 3H), 8.1 (s, 1H), 8.2 (m, 2H) ^

(請先父讀背云之:vi«事項弄填寫大二貝 裝 經濟部中夬櫺準局員工消費合作杜印¾(Father, please read the following: vi «Fill out the sophomore package. Du Yin, Staff Consumption Cooperation of the Ministry of Economic Affairs of the People's Republic of China ¾

(33)-2-酮基-3-(3,5-二氣-4-羥基芊醯基)胺基-5_乙醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-卜醋酸(654),以由60〇b 製備603d之方法,合成自600b可生成775毫克的654 3 -655- 本紙法尺度通用中國國家標孪(CNS )八4蚬格(210X 297公釐) 1235157 Λ7 B7 五、發明説明( 653 ) (jS)-2-阴基- -二鼠-4-經基卞、名產基)胺卷-5-乙Ss基-N- [(2尺5,3$)-_氧基-5-酮基-四氫呋喃-3-基]-2,3,4,5-四氫-111-1,5-笨並二氮雜箪-1-乙趋胺(655),利用製備213e之方法合 成自 654,可生成 304毫克的 655,lH NMR (CD3OD) d 2.4 (d, 1H), 2.6-2.75 (m, 2H), 3.0 (m, 1H), 3.45 (m. iH), 3.8 (d, 1H), 4.0 (t,2H),4.4 (m, 2H), 4.5-4.55 (m,2H)· 7.2-7.45 (m, 4H),7.85 (s, 2H)。 (35)-3-[(33)-2-酮基-3-(3,5-二氣,4-羥基芊_基)胺基-5-乙 酷基-2,3,4,5-四氫-1H-1,5-苯並二I雜箪-1·乙醯胺基]-4-酮 基-丁酸(6 5 6),利用甴2001製備2002之類似方法合成自655 。可生成136毫克的656,呈白色固鳢。4 NMR (CD3〇D) ά 1.85 (s, 3H), 2.5 (m, 1H), 2.65 (m, 1H), 3.7 (m, 1H), 4.3 (m, IH), 4.55 (m, 2H), 7.4-7.6 (m, 4H), 7.85 (s, 2H) ^ -656- 衣呔汷尺度ii用中SS家標隼(CNS ) A4圪格(了公 --------—7裝------訂------表 (請先聞讀背1&amp;之·.VJ意事項*填寫本一貝) 1235157 A 7 B7 五、發明説明(654 〇 〇 Ο X 859 H0—^T Fm〇C〇-^〇e~ ?m〇c〇-^oi 657 853(33) -2-keto-3- (3,5-digas-4-hydroxyfluorenyl) amino-5_ethylfluorenyl-2,3,4,5-tetrahydro-1H-1, 5-Benzodiazapyrene-acetic acid (654) was synthesized from 600b to produce 603d, which was synthesized from 600b to yield 775 mg of 654 3 -655- This paper method is commonly used in China National Standards (CNS). 4 grid (210X 297 mm) 1235157 Λ7 B7 V. Description of the invention (653) (jS) -2-anthyl- -di-rat-4- mesityl, famous base) amine volume-5-ethyl Ss- N- [(2 feet 5,3 $) -_ oxy-5-keto-tetrahydrofuran-3-yl] -2,3,4,5-tetrahydro-111-1,5-benzodiazepine箪 -1-Ethetamine (655), synthesized from 654 by the method of preparing 213e, can produce 304 mg of 655, lH NMR (CD3OD) d 2.4 (d, 1H), 2.6-2.75 (m, 2H), 3.0 (m, 1H), 3.45 (m. iH), 3.8 (d, 1H), 4.0 (t, 2H), 4.4 (m, 2H), 4.5-4.55 (m, 2H) · 7.2-7.45 (m, 4H ), 7.85 (s, 2H). (35) -3-[(33) -2-keto-3- (3,5-digas, 4-hydroxyfluorenyl) amino-5-ethoxy-2,3,4,5- Tetrahydro-1H-1,5-benzobisI heteropyridine-1.acetoamido] -4-one-butyric acid (6 5 6) was synthesized from 655 using a similar method to that of fluorene 2001 preparation 2002. Can produce 136 mg of 656, which is white solid. 4 NMR (CD3〇D) ά 1.85 (s, 3H), 2.5 (m, 1H), 2.65 (m, 1H), 3.7 (m, 1H), 4.3 (m, IH), 4.55 (m, 2H), 7.4-7.6 (m, 4H), 7.85 (s, 2H) ^ -656- Clothing scale ii uses Chinese SS house standard (CNS) A4 grid (Long public --------— 7 pack) ------ Order ------ Form (please read and read 1 &.; VJ notice * fill in this one) 1235157 A 7 B7 V. Description of the invention (654 〇〇〇 X 859 H0 — ^ T Fm〇C〇- ^ 〇e ~? M〇c〇- ^ oi 657 853

(訝^閑請背云之淦意事項耳填寫木\貝)(Surprising ^ Please fill in your ears and fill in the wood \ shell)

662 ;-V ο N ^S&gt;8u Ο 經濟部令央標準局員工消费合作社印裝 657- 本祇朵尺度通用中SS家標洋(CNS )以堤格(2丨0X 297公沒) .¾濟部中夬樣隼局員工消贤合作·杜印¾. 1235157 A7 _ B7 五 '發明説明(6S5) 2-(苐基甲氧羰基)羥基乙酸_酯(士57) 3對甘醇酸苄酯(6.0 克,36.1毫莫耳)於CH2C12之溶液,經冰水浴冷卻,加入氣 曱酸苇基曱氧基酯(14克,1.5當量)再加二異丙基乙胺(9毫升 ’ 1 · 5當量)。1小時後,反應混合物倒入氣化銨鉋和水溶 液中,再以CH2C12萃取,於Na2S〇4上乾燥再眞空濃縮。產 物自MeOH中研磨可得2.2克的657爲白色固體的第一獲3 2·(苇基甲氧羰基)醋酸(658)。對657 (2.2克,5.93毫莫耳)於 四氩呋喃之溶液中加入5% Pd/C (220毫克)。生成的懸液在 氫大氣下劇烈授掉3 90分鐘後,反應混合物經由Celite過 遽3遽液倒入绝和的NaHC〇3水溶液,再以EtOAc洗二次3 水層再酸化,且產物以〇112(:12萃取二次,於Na2S04上乾燥 ,經眞空濃縮可生成1.46克(88%)的658,呈白色固鳢3 2·(苇基甲氧羰基)乙醯基氣(659),以643之製法製備自658 ,可生成659呈粗製產物。 (3$)-3-[(3 5)-2-酮基-3-(3,5-二氣-4-羥基芊醯基)胺基〇'(2-第 基甲氧羰基)乙鏟基-2,3,4,5-四氫-111,5-苯並二氮_苯-1-乙酿胺基]-4-闕基-丁酸第三,丁 g旨半卡巴腺(660),合成自 660b,以甴600b製備604d之方法,利用659可生成453毫克 的 660 a (3 S )-3-[(3 S )-2-嗣基-3-(3,5-二氣-4-經基芊臨基)胺基·5-(2-/£ 基)乙6备基-2,3,4,5-四氩-1^1-1,5-笨並二11雜笨-1-乙培胺基 卜4-酮基-丁酸第三-丁酯半卡巴腙(661),660 (423毫克)於 MeOH:Et2NH (1:1,ν/ν)之溶液在環境溫度下攪拌。1〇分鐘 後,反應混合物眞空下濃縮生成少量體積。加乙越泛沈澱 -658 - 本紙伕尺度通用中S3家標萍(CNS ) Α4堤格(210X 297公« ) --------裝------訂-----一τ.^ (诗·元閔讀背云之..V』念事νΛ再填寫衣買) 1235157 A7 37 五、發明説明(656 可生成230毫克的661 0 (3 5)-3,[(3 5)_2-酮基,3-(3,5-二氣_4-羥基苄醯基)胺基〇-(2,羥 基)乙盛基-2,3,4,5·四氮-1H-1,5 -豕並二氣雜主-1-乙縫按基 ]-4-酮基•丁酸(662),以由604製備605d之方法合成自、661, 可.生·成37毫克的662,呈白色固想9 Οθπ' TIPSO. 66^ 一^T-tips0 TPSO、 564 665 (钟先对请背OT之异球寫本頁)662 ; -V ο N ^ S &gt; 8u 〇 Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 657- This standard is commonly used in the SS family standard ocean (CNS) with Tig (2 丨 0X 297). ¾ Staff of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China, Du Yin ¾. 1235157 A7 _ B7 Five 'invention description (6S5) 2- (fluorenylmethoxycarbonyl) glycolic acid ester (Shi 57) 3 benzyl glycolate A solution of esters (6.0 g, 36.1 mmol) in CH2C12, cooled in an ice-water bath, added tris (methyl oxybenzyl) oxylate (14 g, 1.5 eq) and diisopropylethylamine (9 ml '1 5 equivalents). After 1 hour, the reaction mixture was poured into a gasified ammonium planer and an aqueous solution, and then extracted with CH2C12, dried over Na2SO4, and concentrated in vacuo. The product was triturated in MeOH to give 2.2 g of 657 (657) acetic acid (658) as a white solid. To a solution of 657 (2.2 g, 5.93 mmol) in tetrahydrofuran was added 5% Pd / C (220 mg). After the resulting suspension was vigorously entrained in an atmosphere of hydrogen for 3 90 minutes, the reaction mixture was poured into absolute NaHC03 aqueous solution through Celite solution, washed with EtOAc twice, and the aqueous layer was acidified again. 〇112 (: 12 was extracted twice, dried on Na2S04, and concentrated under airspace to produce 1.46 g (88%) of 658, which was a white solid 3 2 · (retylmethoxycarbonyl) acetamidine gas (659), Prepared from 658 by the method of 643, and can produce 659 as a crude product. (3 $)-3-[(3 5) -2-keto-3- (3,5-digas-4-hydroxyfluorenyl) Amino group 0 ′ (2-Dimethoxymethoxycarbonyl) ethynyl-2,3,4,5-tetrahydro-111,5-benzodiazepine-benzene-1-ethylamino] -4-fluorene Butyl-butyric acid third, D-g semi-carbaba (660), synthesized from 660b, and 604d prepared by 甴 600b, using 659 to generate 453 mg of 660 a (3 S) -3-[(3 S) 2-Amidino-3- (3,5-difluoro-4-acrylamino) amino · 5- (2- / £ yl) ethene 6-2-2,3,4,5-tetra Argon-1 ^ 1-1,5-benzyl-1,11-benzyl-1-ethylperamido 4-keto-butyric acid tert-butyl hemicarbazone (661), 660 (423 mg) in MeOH : Et2NH (1: 1, ν / ν) solution was stirred at ambient temperature. 10 minutes Afterwards, the reaction mixture was concentrated in the air to produce a small volume. Adding Ethylene-Pan-Precipitation -658-Standard Paper S3 Standard Chinese Ping (CNS) Α4 Tige (210X 297 public «) -------- pack- ----- Order ----- One τ. ^ (Poetry, Yuan Min, read back, cloud, .. V ", read νΛ and fill in clothes to buy) 1235157 A7 37 V. Description of the invention (656 can produce 230 mg 661 0 (3 5) -3, [(3 5) _2-keto, 3- (3,5-digas-4-hydroxybenzylidene) amino group 0- (2, hydroxy) ethenyl-2 , 3,4,5 · tetrazine-1H-1,5 -pyridine hetero main-1-ethanoyl] -4-keto • butanoic acid (662), synthesized by the method of preparing 605d from 604 Since, 661, can produce 37 mg of 662, white imagination 9 Οθπ 'TIPSO. 66 ^ a ^ T-tips0 TPSO, 564 665 (Zhong Xian wrote this page on the back of the OT's different ball)

經承部申夬..«'珞局炎二消资合作杜印^The Ministry of Economic Affairs of the People's Republic of China .. «'珞 局 炎 二 消 资 投资 杜 印 ^

0¾払。 667 -6S9 本护中23家標争(CNS 巩格(210X297公菝) 挝濟部中央揲隼扃員工消费合作社印¾ 1235157 ΛΤ Β7 五、發明説明(职) 2·(—異丙基麥燒氧基)乙酸辛薛(663) a對甘醇酸节薛 (46.91克,0,282莫耳)及二異丙基乙胺(74毫升,CM23莫耳) 於CH2C12之溶液,經水浴冷卻,加入TiPS/〇Tf(95克,〇31 莫耳)於CHaClj之溶液》生成的混合物加溫至環境溫度下 再倒人水中,以10%NaHS〇4水溶液·洗二,·次,於Na2S〇4上 乾澡並眞空濃綠β块速層析(Si02,0至5% EtOAc於己虎) 可生成71.6克的663。 ^ 2-(三異丙基矽烷氧基)醋酸(664)對663 (0,4克,1,2毫莫 耳)於EtOAc之溶液中,加入10% Pd/C (33毫克)。生成的懸 浮液在氫大氣下授拌9 15小時後,反應混合物經由cdite 過濾,且濾液眞空濃縮生成0.29克的油a此油於174•二哼 烷之溶液加入NaHC03 (0·5Μ,2.4毫升)3生成的溶液眞空 中自甲苯濃縮,生成664呈蠟狀固體。 2-(三異两基矽烷氧基)乙醯基氣(665),以製備643之方法 合成自664,可生成663呈粗製產物, (3S)-3-[(3S)-2-酮基苄醯胺基〇-(2-三異丙基矽烷氧基)乙 醢基_2,3,4,5-四氫·1Η-1,5-苯並二氮雜箪-卜乙醢胺基卜4-辋 基-丁酸第三丁酯半卡巴腙(666),合成自600b,以甴600b 製備604d之方法可生成13 1毫克的666。 (3S)-3-[(3S)-2·酮基-3·芊醢胺基〇-(2-羥基)乙醯基-2,3,4,5-四氩苯並二氮雜箪,1-乙鹼胺基]-4·酮基-丁酸第三· 丁酯丰卡巴腙(667)。對66δ (131毫克,0,1 7毫莫耳)於四氫 呋喃之溶液,經冰水浴冷卻,加入氟化四丁銨(1 Μ,0.1 90 毫井),2,卜時後,反應混合物倒入水中,以EtOAc萃取二 660- 本祇铁尺度通用中国国家槔幸(CNS &gt;〜处格(2丨〇·〆297公姿) -------^----^-- {請先¾讀背*之注意事項再填艿本頁)0¾ 払. 667 -6S9 Twenty-three bids in the center (CNS Gongge (210X297)) Printed by the Consumers' Cooperative of the Central Ministry of Economic Affairs of Laos ¾ 1235157 ΛΤ Β7 V. Description of the invention (position) 2 · (—isopropyl wheat (Oxy) octyl acetate (663) a p-Glycolate (46.91 g, 0,282 mol) and diisopropylethylamine (74 ml, CM23 mol) in a solution of CH2C12, cooled in a water bath, and added TiPS / 〇Tf (95 grams, 〇31 mol) in a solution of CHaClj "The mixture was heated to ambient temperature and then poured into human water, washed with 10% NaHS〇4 aqueous solution, washed twice, on Na2S〇4 Dry bath and empty the concentrated green beta block speed chromatography (Si02, 0 to 5% EtOAc in Jihu) to produce 71.6 g of 663. ^ 2- (triisopropylsilyloxy) acetic acid (664) vs. 663 (0 , 4 g, 1,2 mmol) in EtOAc, 10% Pd / C (33 mg) was added. After the resulting suspension was stirred under a hydrogen atmosphere for 9 15 hours, the reaction mixture was filtered through cdite, and The filtrate was concentrated by air to produce 0.29 g of oil.a This oil was added to a solution of 174 · dihumane and NaHC03 (0.5M, 2.4 ml) was added. The resulting solution was concentrated from toluene in the air to produce 664 was a waxy solid. 2- (triisodiylsilyloxy) acetamidine gas (665) was synthesized from 664 by the method of preparing 643, and a crude product of 663, (3S) -3-[(3S ) -2-ketobenzylamidoamine 0- (2-triisopropylsilyloxy) ethanoyl_2,3,4,5-tetrahydro · 1Η-1,5-benzodiazepine -Ethylamine 4-Hexyl-butyric acid third butyl hemi-carbamidine (666), synthesized from 600b, and the method of preparing 604d by dysprosium 600b can produce 13 1 mg of 666. (3S) -3- [(3S) -2 · keto-3 · fluorenylamino-0- (2-hydroxy) ethylfluorenyl-2,3,4,5-tetrahydrobenzodiazepine, 1-ethylamine amino ] -4 · Keto-butyric acid tert-butyl ester carbohydrate (667). A solution of 66δ (131 mg, 0.17 mmol) in tetrahydrofuran was cooled in an ice water bath, and tetrabutyl fluoride was added. Ammonium (1 M, 0.1 90 milliwell), after 2 hours, the reaction mixture was poured into water and extracted with EtOAc two 660- this iron scale is universal Chinese national luck (CNS &gt; ~ Division (2 丨 〇 · (〆297 Posture) ------- ^ ---- ^-{Please read the precautions for the back * before filling in this page)

.1T 經濟.部t夬樣嗥局員工消贫合作.杜印¾. 1235157 A 7 _B7_ 五、發明説明(658 ) 次,於MgS〇4上乾澡並眞空農縮生成63毫克的667,呈白 色固體。 (35)-3-[(3 3)-2-酮基-3-芊醢胺基-5-(2-羥基)乙醯基-2,3,4,5-四鼠-本·並二亂雜卓-1-乙酿胺基]-4·嗣基-丁酸(668) ,以自604d製備605d之方法,合成自667可生成48毫克的 668呈白色固體。LH NMR (CD3〇D) ci 2.45 (m,1H),2.67 (dddd, 1H), 3.78 (d, 1H), 3.85 (br. m, 1H), 4.05 (d, 1H), 4.28 (m, 1H), 4.5 (m, 2H), 4.65 (m, 1H), 4.95 (br. s, 2H), 7.4-7.5 (m,4H),7.52-7.65 (m,3H),7.88 (d, 2H)。.1T Ministry of Economic Affairs, Ministry of Economic Affairs, Ministry of Economic Affairs, Anti-poverty Cooperation. Du Yin ¾. 1235157 A 7 _B7_ V. Description of the Invention (658) times, dry bath on MgS〇4 and empty the agricultural contraction to produce 63 mg of 667, presented White solid. (35) -3-[(3 3) -2-keto-3-amidino-5- (2-hydroxy) acetamido-2,3,4,5-tetramus-benzine Luanzao-1-Ethylamino] -4 · fluorenyl-butyric acid (668) was synthesized from 604d to 605d, and synthesized from 667 to produce 48 mg of 668 as a white solid. LH NMR (CD3〇D) ci 2.45 (m, 1H), 2.67 (dddd, 1H), 3.78 (d, 1H), 3.85 (br. M, 1H), 4.05 (d, 1H), 4.28 (m, 1H ), 4.5 (m, 2H), 4.65 (m, 1H), 4.95 (br. S, 2H), 7.4-7.5 (m, 4H), 7.52-7.65 (m, 3H), 7.88 (d, 2H).

(33)-3-[(35)-2-酮基-3-(3,5-二氣-4-甲氡基苄醢基)胺基〇-乙 5產基-2,3,4,5-四氫-111-1,5-苯並二氮雜箪-1-乙醯胺基]-4-鲷 基-丁酸(669),以由600b製備605d之方法合成自600b,可 生成63毫克的669,呈白色固鳢,NMR (CD3OD) ό' 1.90 (s, 3H), 2.4-2.7 (m, 2H), 3.6-3.7 (m, 2H), 3.9 (s, 3H), 4.2-4.4 (m, 2H), 4.4-4.6 (m, 3H), 7.4-7.8 (m, 4H), 7.9 (s, 2H) ^ -661 - 本紙法尺度通用中SS家標準(CNS ) A4堤格(210乂 297公釐) --------VI β------IT------i (請先g讀背面之..V〗意事項填寫本頁) 1235157 Λ7 B7 五、發明説明( 659)(33) -3-[(35) -2-keto-3- (3,5-difluoro-4-methylamidinobenzyl) amino group 0-ethane-5 aceto-2,3,4, 5-tetrahydro-111-1,5-benzodiazepine-1-acetamido] -4-brenzyl-butanoic acid (669), synthesized from 600b by the method of preparing 605d from 600b, can be generated 63 mg of 669, white solid, NMR (CD3OD), 1.90 (s, 3H), 2.4-2.7 (m, 2H), 3.6-3.7 (m, 2H), 3.9 (s, 3H), 4.2- 4.4 (m, 2H), 4.4-4.6 (m, 3H), 7.4-7.8 (m, 4H), 7.9 (s, 2H) ^ -661-General SS Home Standard (CNS) A4 Tiger ( 210 乂 297mm) -------- VI β ------ IT ------ i (please read the meanings on the back .. V) and fill in this page) 1235157 Λ7 B7 V. Invention Description (659)

(35)-2-酮基-3-(3,5-二甲基-4-羥基芊醯基)胺基-5-乙縫基-:^· [(2民5,35)-芊氡基-5-酮基-四氫呋喃-3-基]-2,3,4,5-四氫-1仏 1,5-笨並二氮雜箪-1-乙醯胺(670),以自600b製備655之方 法合成自600b,可生成218毫克的670,呈白色固鳢, NMR (CD3OD) ό 1.7, 1.75 (2s, 3H), 2.15, 2.2 (2s, 6H), 2.4- (請先閨讀背&amp;之渣意事項再填寫太買) Μ濟部中夬樣华局員工消费合作社印¾ 2.5 (m, 1H), 2.6-2.75 (m, 1H), 3.65-3.75 (m, 2H)t 4.2-4.3 (m, 2H), 4.45-4.6 (m, 3H), 7.35-7.6 (m, 4H), 7.5 (s, 2H) ^ (35)-3-[(35)-2-萌基-3-(3,5-二甲基-4-經基宇驢基)胺基-5-乙 醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-卜乙醯胺基]-4-酮 基·丁酸(671),以自2001製備2002之方法合成自670,可生 成253毫克的671,呈白色固體,iH NMR (CD3OD) d 1.9 (s, 3H), 2.25 (s, 6H), 2.4-2.5 (m, 1H); 2.6-2.75 (m, 1H), 3.65^ 3.75 (m, 2H), 4.2-4.3 (m, 2H), 4.45-4.6 (m, 3H), 7.35-7.6 (m, 4H), 7.5 (s, 2H) ^ -662- 本纸ft尺度通用中S國家標李(CNS M4現格(210 X 297公釐) 1235157 Λ7 B7 五、發明説明( 660)(35) -2-keto-3- (3,5-dimethyl-4-hydroxyfluorenyl) amino-5-ethanoyl-: ^ [(2 民 5,35)-芊 氡Methyl-5-keto-tetrahydrofuran-3-yl] -2,3,4,5-tetrahydro-1 仏 1,5-benzodiazepine-1-acetamidine (670), starting from 600b The method of preparing 655 is synthesized from 600b, which can generate 218 mg of 670 as a white solid. NMR (CD3OD) 1.7, 1.75 (2s, 3H), 2.15, 2.2 (2s, 6H), 2.4- (please read first) Back &amp; for the slag matters, please fill in Taibuy) ¾ Printed by the China Consumer Sample Cooperatives of the Ministry of Economic Affairs of the People's Republic of China 2.5 (m, 1H), 2.6-2.75 (m, 1H), 3.65-3.75 (m, 2H) 4.2-4.3 (m, 2H), 4.45-4.6 (m, 3H), 7.35-7.6 (m, 4H), 7.5 (s, 2H) ^ (35) -3-[(35) -2- 萌 基- 3- (3,5-Dimethyl-4-merylylamino) amino-5-ethylfluorenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine箪 -Buethylamido] -4-keto · butanoic acid (671), synthesized from 670 by the method of 2001 and 2002, can produce 253 mg of 671 as a white solid, iH NMR (CD3OD) d 1.9 ( s, 3H), 2.25 (s, 6H), 2.4-2.5 (m, 1H); 2.6-2.75 (m, 1H), 3.65 ^ 3.75 (m, 2H), 4.2-4.3 (m, 2H), 4.45- 4.6 (m, 3H), 7.35-7.6 (m, 4H), 7.5 (s, 2H) ^ -662- this ft scale S in the national standard Universal Li (CNS M4 now grid (210 X 297 mm) 1235157 Λ7 B7 V. invention is described in (660)

(請先閎請背云之泾意事項再填寫本一貝) 經濟部中央標隼局員工消费合作社印¾ (3S)-2-酮基-3·第三-丁氧羰基胺基-5-(2-三異丙基矽烷氧基) 乙醯基-2,3,4,5-四氫-1H-1,5-苯並_二氮雜箪-卜醋酸苄酯(672) ,以自600b製備602η之方法,合成自600b,利用665可生 成1.08克的672。 (3S)-2·酮基-3-胺基〇-(2-三異丙基矽烷氧基)乙醯基- -663- 本紙伕尺度適用中S国家標孳(CNS〉Μ垅格(210X 297公釐) 1235157 A7 B7 _ 五、發明説明(66〇 2,3,4,5·四氫-IH-I,5-苯並二氮雜苯-1-醋酸芊酯(6U) 3對 672 (1.08克,1.69毫莫耳)於CH2C12之溶液中加入2.6-二甲 基吡啶(0.8毫升)再加TMSOTf(l毫升,5.1毫莫耳1小時 後反應混合物倒入NaHC03,並以CH2C1,萃取,於MgS04 上乾燥並眞空濃縮可生成少量體積,其可直接用於下一反 應3 (3 S)-2-酮基-3-(1,6-二甲氧基芊醯基甲醯基)胺基-5-(2-三異 丙基矽烷氧基)乙醯基·2,3,4,5-四氫苯並二氮雜苯· 1-乙酸;酯(674),以製備602b之方法合成自673,可生成 0.91 克的 674。 (3S)-2·酮基-3·( 1,6-二甲氧基芊醯基甲醯基)胺基-5-(2-三異 丙基矽烷氧基)乙醢基-2,3,4,5-四氫-111-1,5-苯並二氮雜箪-1,乙酸(675)。674 (0.365克,0.5毫莫耳)於MeOH之溶液與 IN NaOH (1·2毫升,1.2毫莫耳)攪拌a 16小時後反應混合 物於眞空下濃縮,再溶於水中並以乙瞇洗二次。水層以 •IN HC〖酸化,產物以EtOAc萃取,於MgS04上乾燥並眞空 濃縮可生成337毫克的675,呈固體。(Please fill in this question first, please remember the matter of the cloud) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs ¾ (3S) -2-keto-3 · third-butoxycarbonylamino-5- (2-triisopropylsilyloxy) ethynyl-2,3,4,5-tetrahydro-1H-1,5-benzo-diazafluorene-benzyl acetate (672), from The method of preparing 602η in 600b, synthesized from 600b, and using 665 to produce 1.08 grams of 672. (3S) -2 · Keto-3-amino group 0- (2-triisopropylsilyloxy) ethenyl group--663- The standard of this paper is applicable to the national standard of China (CNS> M) (210X 297 mm) 1235157 A7 B7 _ V. Description of the invention (66〇2,3,4,5 · tetrahydro-IH-I, 5-benzodiazepine-1-acetamidine acetate (6U) 3 to 672 (1.08 g, 1.69 mmol) To a solution of CH2C12 was added 2.6-dimethylpyridine (0.8 ml) followed by TMSOTf (1 ml, 5.1 mmol). After 1 hour, the reaction mixture was poured into NaHC03 and extracted with CH2C1. , Dried on MgS04 and condensed in the air to generate a small volume, which can be directly used in the next reaction 3 (3 S) -2-keto-3- (1,6-dimethoxyfluorenylmethanyl) Amino-5- (2-triisopropylsilyloxy) ethenyl · 2,3,4,5-tetrahydrobenzodiazepine · 1-acetic acid; ester (674) to prepare 602b The method was synthesized from 673, and 0.91 g of 674 was produced. (3S) -2 · keto-3 · (1,6-dimethoxyfluorenylmethylamidino) amino-5- (2-triisopropyl Silyloxy) ethenyl-2,3,4,5-tetrahydro-111-1,5-benzodiazepine-1, acetic acid (675). 674 (0.365 g, 0.5 mmol) In MeOH and IN NaOH (1.2 ml, 1.2 mmol) was stirred for 16 hours. The reaction mixture was concentrated under vacuum, redissolved in water and washed twice with ethyl acetate. The aqueous layer was acidified with IN HC and the product was extracted with EtOAc. Drying on MgS04 and concentrating in the air gave 337 mg of 675 as a solid.

經濟部t夬橾隼局員工消费合作杜印5L (3 S)-2-酮基-3-(1,6-二甲氧基芊醯基曱醯基)胺基-5-(2-三異 丙基矽坑氧基)乙醯基-N-[(2RS,3S)-苄氧基〇-嗣基-四氫呋 喃-3-基]·2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-1-乙醢按(676) ,以製備213e之方法合成自675 '可生成166毫克的676, 呈白色固體。 (3S)-2-酮基-3-(1,6-二甲氧基芊醯基甲醯基)胺基-5-(2-羥基) 乙醢基-N-[(2RS,3S)-芊氧基-5-酮基-四氫吱喃-3-基]- -664- 本紙伕尺度適用中國國家標孪(CNS ) A4堤格(210X 297公釐) 1235157 Λ7 _B7_____ 五、發明說明(部2 ) 2,3,4,5-四氫-111-1,5-苯並二氮雜箪-1-乙酷胺(677)3丁8^ (6毫升,3毫莫耳)於H〇Ac(0.46毫升,8毫莫耳)之溶液加 至676 (0.213克,0.256毫莫耳)。16小時後反應昆合物倒入 Et〇Ac,並以IN HC〇3洗二次,以鹽水洗一次再於-mSs〇4 上乾澡並眞空濃縮,生成139毫克的677 ’呈固體’ lH NMR (CDCI3) ^ 2.4 (d, 1H), 2.5 (dd, 1H), 2.8 (dd, 1H), 2,92 (dd? 1H), 3.15 (m, 2H), 3.55-3.65 (m, 2H), 3.72 (s, 6H), 3.92 (m, 1H), 4.05 (m, 1H), 4.3 (m, 1H), 4.42 (d, 1H), 4.6 (dd, 1H), 4.65-4.8 (m, 2H), 4.88 (d, 1H), 5.55 (d, 1H), 6.55 (m, 2H), 6.75 (d, 1H), 7.25-7.55 (m, 8H), 7.75 (m, 2H) ^ (3 5)-3-[(3 3)-2-酮基-3-(3,5-二曱氧基苄醯基甲醯基)胺基〇' (2-羥基)乙醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-卜乙醯 胺基]-4·酮基-丁酸(678),以自666製備667之方法合成,可 生成54毫克的678呈白色固體,NMR (CD3〇D) 〇' 2.45 (m, 1H), 2.7 (m, 1H), 3.5 (m, 2H), 3.75 (br. s, 6H), 4.05 (d, 1H), 4.3 (m, 1H), 4.51-4.6 (m, 2H), 4.8 (br. m, 2H), 6.7 (d, 2H)? 7.4-7.5 (br. m, 3H), 7.6-7.65 (br. m, 2H) ^ Μ濟部中.夭標荜局員工消费合作.杜印¾Employees' cooperation of t 夬 橾 隼 bureau of the Ministry of Economic Affairs, Du India 5L (3 S) -2-keto-3- (1,6-dimethoxyfluorenylfluorenyl) amino-5- (2-tri Isopropylsilyloxy) Ethylfluorenyl-N-[(2RS, 3S) -benzyloxy-0-fluorenyl-tetrahydrofuran-3-yl] · 2,3,4,5-tetrahydro-1H-1 The 5-benzodiazepine-1-acetamidine was synthesized from 675 ′ according to (676) by the method of preparing 213e, and 166 mg of 676 was produced as a white solid. (3S) -2-keto-3- (1,6-dimethoxyfluorenylmethylamidino) amino-5- (2-hydroxy) ethenyl-N-[(2RS, 3S)- Ethoxy-5-keto-tetrahydrocran-3-yl]--664- The standard of this paper is applicable to Chinese National Standard (CNS) A4 Tiege (210X 297 mm) 1235157 Λ7 _B7_____ 5. Description of the invention Part 2) 2,3,4,5-tetrahydro-111-1,5-benzodiazepine-1-ethoxyamine (677) 3 but 8 ^ (6 ml, 3 mmol) in H A solution of 0Ac (0.46 ml, 8 mmol) was added to 676 (0.213 g, 0.256 mmol). After 16 hours, the reaction mixture was poured into Et〇Ac, washed twice with IN HC〇3, once with brine and then dried on -mSs〇4 and concentrated in the air, yielding 139 mg of 677 'as a solid' lH NMR (CDCI3) ^ 2.4 (d, 1H), 2.5 (dd, 1H), 2.8 (dd, 1H), 2,92 (dd? 1H), 3.15 (m, 2H), 3.55-3.65 (m, 2H) , 3.72 (s, 6H), 3.92 (m, 1H), 4.05 (m, 1H), 4.3 (m, 1H), 4.42 (d, 1H), 4.6 (dd, 1H), 4.65-4.8 (m, 2H ), 4.88 (d, 1H), 5.55 (d, 1H), 6.55 (m, 2H), 6.75 (d, 1H), 7.25-7.55 (m, 8H), 7.75 (m, 2H) ^ (3 5) -3-[(3 3) -2-keto-3- (3,5-dimethoxybenzylidenemethylamidino) amino group 0 '(2-hydroxy) ethylfluorenyl-2,3,4 , 5-tetrahydro-1H-1,5-benzodiazepine-buethamidinyl] -4 · keto-butyric acid (678), synthesized by the method of preparing 667 from 666, can produce 54 mg 678 as a white solid, NMR (CD3〇D) 〇 '2.45 (m, 1H), 2.7 (m, 1H), 3.5 (m, 2H), 3.75 (br.s, 6H), 4.05 (d, 1H) , 4.3 (m, 1H), 4.51-4.6 (m, 2H), 4.8 (br. M, 2H), 6.7 (d, 2H)? 7.4-7.5 (br. M, 3H), 7.6-7.65 (br. m, 2H), ^ Ministry of Economic Affairs, Ministry of Economic Affairs, Consumer Co-operation and Cooperation, Du Yin ¾

本紙乐尺度通用tS國家標孪(CNS ) A4規格(210 X297公笼) 1235157 __ΒΤ__ 五、發明説明(663 ) (3S)-2-酮基-3-芊醯基甲醯基胺基·5-(2-羥基)乙醯基-Ν· (2厌5,35)-芊氧基-5-酮基-四氫呋喃-3-基)-2,3,4,5-四氫-1^1-1,5-苯並二氮雜箪-1-乙醯胺(680),以甴600b製備677之方 法合成自600b,可得140毫克的680,呈白色固體·,4 NMR (CDC13) cT 2.31 (d, 1H), 2.4 (dd, 2H), 2.75 (dd, 2H), 2.85 (dd, 1H), 3.36 (br. s, 1H), 3.45 (br. s, 1H), 3.6 (br. t, 2H), 3.82 (br. m, 2H), 3.95 (br. d, 2H), 4.35 (m, 2H), 4.42 (d, 1H), 4.55 (m, 1H), 4.70 (d, 1H), 4.82 (br. s, 2H), 5.5 (d, 1H), 6.91 (d, 1H), 7.25 (br. m, 5H), 7.35-7.46 (br. m, 3H), 7.5-7.6 (m, 2H), 8.15 (br. d, 2H) ^ (3S)-3-[(3S)-2-酮基-3-芊醯基甲醯基胺基-5(2-羥基)乙醯基- 2.3.4.5- 四氮-1{1-1,5-苯並二氣雜革-1-乙縫基按基]-4-銅基-丁酸(681),以由677製備678之方法合成自680,可生成45 毫克的 681呈灰色固體,4 NMR (CD30D) 0' 2.5 (m,1H), 2.7 (dt, 1H), 3.65-3.85 (br. m, 3H), 4.05 (m, 1H), 4.3 (m, 1H), 4.5- 4.7 (br. m, 3H), 4.85 (br. s, 2H), 7.3 (br. m, 2H), 7.4-7.7 (m, 5H), 8.15 (d, 2H)。This paper is a universal tS national standard (CNS) A4 specification (210 X297 male cage) 1235157 __ΒΤ__ V. Description of the invention (663) (3S) -2-keto-3-amidinomethylamidoamino group 5- (2-Hydroxy) ethenyl-N · (2,5,35) -methoxy-5-keto-tetrahydrofuran-3-yl) -2,3,4,5-tetrahydro-1 ^ 1- 1,5-Benzodiazepine-1-acetamidine (680) was synthesized from 600b by the method of preparing 677 from europium 600b. 140 mg of 680 was obtained as a white solid. 4 NMR (CDC13) cT 2.31 (d, 1H), 2.4 (dd, 2H), 2.75 (dd, 2H), 2.85 (dd, 1H), 3.36 (br. s, 1H), 3.45 (br. s, 1H), 3.6 (br. t , 2H), 3.82 (br. M, 2H), 3.95 (br. D, 2H), 4.35 (m, 2H), 4.42 (d, 1H), 4.55 (m, 1H), 4.70 (d, 1H), 4.82 (br. S, 2H), 5.5 (d, 1H), 6.91 (d, 1H), 7.25 (br. M, 5H), 7.35-7.46 (br. M, 3H), 7.5-7.6 (m, 2H ), 8.15 (br. D, 2H) ^ (3S) -3-[(3S) -2-keto-3-amidinomethylamidoamino-5 (2-hydroxy) acetamido-2.3. 4.5- Tetrazol-1 {1-1,5-benzodiazepine-1-ethylenylyl] -4-copperyl-butyric acid (681), synthesized from 680 by 677, 678 Yields 45 mg of 681 as a gray solid, 4 NMR (CD30D) 0 ' 2.5 (m, 1H), 2.7 (dt, 1H), 3.65-3.85 (br. M, 3H), 4.05 (m, 1H), 4.3 (m, 1H), 4.5- 4.7 (br. M, 3H), 4.85 (br. S, 2H), 7.3 (br. M, 2H), 7.4-7.7 (m, 5H), 8.15 (d, 2H).

經濟部中央標準局員工消费合作社印製 (3S)-2-酮基-3-苄醢基胺基-5-(2-乙醯氧基)乙醢基-N-[(2尺5,33)-芊氧基-5-酮基-四氫呋喃-3-基]-2,3,4,5-四氫-11^ -666- 本紙伕尺度適用中國國家標李(CNS ) A4規格(2丨OxWnG 一 1235157 Λ7 __—__B7_*___ 五、發明説明(糾) 1.5- 笨並二氮雜箪-卜乙醯胺(682)、;以由6〇〇b製備655之方 法合成自600b,可生成495毫克的682,呈白色固鳢,lH NMR (CDC13) ά 2.00 (s, 3H), 2.05 (s, 3H), 2.47 (d, 1H), 2.58 (dd, 1H), 2.85 (dd, 1H), 2.89 (dd, 1H), 3.9 (m, 2H), 4.05-4.15 (m, 2H), 4.19 (dd, 1H), 4.45 (m, 2H), 4.55-5.05 (m, 8H), 5.55 (d, 1H), 6.85 (d, 1H), 7.15 (d, 1H), 7.25-7.55 (m, 10H)? 7.75 (d,2H)。 (3S)-3-[(3S)-2-酮基-3-芊醯基胺基o-(2-乙醯氧基)乙醯基· 2.3.4.5- 四氫-1^1-1,5-苯並二氮雜箪-1-乙醯基胺基]-4-酮基· 丁酸(683),以甴2001製備2002之方法合成自682,可得82 毫克的 683,呈白色固體,W NMR (CD3OD) d 2.1 (s, 3H), 2.5 (m, 1H), 2.68 (m, 1H), 3.8 (m, 1H), 4.29 (dd, 1H), 4.31 (m, 1H), 4.45 (d, 1H), 4.55 (d, 1H), 4.6 (d, 1H), 4.72 (d, 1H), 4.95 (br. s, 2H), 7.45 (br. m, 2H), 7.52-7.65 (br. m, 5H), 7.88 (d,2H)。 (诗先間讀背云之注意事項弄填寫大二貝)Printed by (3S) -2-keto-3-benzylfluorenylamino-5- (2-acetamyloxy) ethenyl-N-[(2 feet 5,33 ) -Methoxy-5-keto-tetrahydrofuran-3-yl] -2,3,4,5-tetrahydro-11 ^ -666- The size of this paper is applicable to Chinese National Standard (CNS) A4 specifications (2 丨OxWnG 1235157 Λ7 __—__ B7 _ * ___ V. Description of the invention (correction) 1.5- Benzodiazepine-Buethamine (682); synthesized from 600b by the method of preparing 655 from 600b, which can be generated 495 mg of 682 as a white solid, lH NMR (CDC13), 2.00 (s, 3H), 2.05 (s, 3H), 2.47 (d, 1H), 2.58 (dd, 1H), 2.85 (dd, 1H) , 2.89 (dd, 1H), 3.9 (m, 2H), 4.05-4.15 (m, 2H), 4.19 (dd, 1H), 4.45 (m, 2H), 4.55-5.05 (m, 8H), 5.55 (d , 1H), 6.85 (d, 1H), 7.15 (d, 1H), 7.25-7.55 (m, 10H)? 7.75 (d, 2H). (3S) -3-[(3S) -2-one- 3-fluorenylamino o- (2-ethylfluorenyloxy) ethylfluorenyl · 2.3.4.5- tetrahydro-1 ^ 1-1,5-benzodiazepine-1-ethylfluorenylamino ] -4-keto · butyric acid (683), synthesized from 682 by the method of 甴 2001 preparation 2002, 82 mg of 683 can be obtained as a white solid, W NMR (CD3OD) d 2.1 (s, 3H ), 2.5 (m, 1H), 2.68 (m, 1H), 3.8 (m, 1H), 4.29 (dd, 1H), 4.31 (m, 1H), 4.45 (d, 1H), 4.55 (d, 1H) , 4.6 (d, 1H), 4.72 (d, 1H), 4.95 (br. S, 2H), 7.45 (br. M, 2H), 7.52-7.65 (br. M, 5H), 7.88 (d, 2H) (Notes on reading the poems in the poem before entering the second year)

(3S)-3-[(3S)-2-銅基-3-(3,5-二甲‘-4-甲氧基芊醯基)按基-5-乙酷基-2,3,4,5-四風-111-1,5-笨並二氣雜箪-1-乙酷基胺基】-4-酮基-丁酸 (684),以由600b製備605d之方法合成自60〇b ’ 可生成72毫克的684,呈白色固體,[Η NMR (CD3〇D) ό' 經濟部中央祐隼局貝工消費合作社印製 -667- λ紙乐尺度適用揉導(CNS)A4現格(2丨0X 297公屋) 1235157 Λ7 37 經濟部中央糅皋局員工消费合作社印¾ 五、發明説明(665 ) 1.9 (s, 3H), 2.25 (s, 6H), 2.45 (m, 1H), 2.6 (m, 1H), 3.3 (s, 1H), 3.7 (s, 3H), 4.25 (m, 1H), 4.45-4.6 (m, 3H), 7.4 (br. s, .2H), 7.55 (br· d, 4H)。(3S) -3-[(3S) -2-copperyl-3- (3,5-dimethyl'-4-methoxyfluorenyl) yl-5-ethoxy-2,3,4 , 5-Tetrawind-111-1,5-benzodicarbazone-1-ethoxyamino] -4-keto-butanoic acid (684) was synthesized from 60b by the method of preparing 605d from 600b. b 'can produce 72 mg of 684 as a white solid, [Η NMR (CD3〇D) ό' Printed by the Central Labor Department of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives -667- Grid (2 丨 0X 297 public housing) 1235157 Λ7 37 Printed by the Consumer Cooperative of the Central Government Bureau of the Ministry of Economic Affairs Ⅴ. Description of the invention (665) 1.9 (s, 3H), 2.25 (s, 6H), 2.45 (m, 1H) , 2.6 (m, 1H), 3.3 (s, 1H), 3.7 (s, 3H), 4.25 (m, 1H), 4.45-4.6 (m, 3H), 7.4 (br. S, .2H), 7.55 ( br · d, 4H).

OBnOBn

686 (3S)-2-嗣基-3-(3-氣·4-胺基辛縫基)胺基-5·(2-三異两基碎 烷氧基)乙醯基-N-[(2RS,3S)-芊氧基〇-酮k-四氫呋喃-3-基 ]-2,3,4,5-四氮-1^1-1,5-苯並二氮雜革-1-乙酷胺(685),以由 600b製備676之方法合成自600b,可生成165毫克的685 3 (3S)-3-[(3S)-2-酮基-3-(3-氣-4·按基芊醯基)胺基-5-(2-三異 丙基矽烷氧基)乙醯基-2,3,4,5-四氫-lH-l,5-苯並二氮雜箪-卜乙醢胺基]4-酮基·丁酸(686)3685(165毫克,0.21毫莫斗) 於THF之溶液中‘入TBAF (1M,0.21毫升)。產物於反應混 合物中沈澱後經甴過濾分離。逆相層析(1〇%-8〇% MeCN於 水/0· 1% TFA)可生成25毫克的686,呈白色固體,[Η NMR (CD3〇D) &lt;S 2.37-2.42 (m), 2.59-2.70 (m)y 3.60-3.89 (m), 4.01 (d), 4.20-4.31 (m), 4.42-4.70 (m), 4.80〇.05 (m), 6.79 (d), 668 本紙伕尺度適用中3國家標举(CNS ) A4現格(210 x29了公4 ) (诗.先试讀背云之·.意事項弄填寫本肓)686 (3S) -2-fluorenyl-3- (3-amino · 4-aminooctyloctyl) amino-5 · (2-triisodiyl crushed alkoxy) ethenyl-N-[( 2RS, 3S) -methoxyoxy-ketone k-tetrahydrofuran-3-yl] -2,3,4,5-tetraaza-1 ^ 1-1,5-benzodiazepine-1-ethane Amine (685), synthesized from 600b by the method of preparing 676 from 600b, can produce 165 mg of 685 3 (3S) -3-[(3S) -2-keto-3- (3-gas-4 · benzyl) Fluorenyl) amino-5- (2-triisopropylsilyloxy) ethylfluorenyl-2,3,4,5-tetrahydro-lH-1,5-benzodiazepine-buethyl Amido] 4-ketobutyric acid (686) 3685 (165 mg, 0.21 mmol) was dissolved in THF and TBAF (1M, 0.21 ml) was added. The product was precipitated in the reaction mixture and separated by filtration through 甴. Reverse phase chromatography (10% -80% MeCN in water / 0.1% TFA) yielded 25 mg of 686 as a white solid, [Η NMR (CD3〇D) &lt; S 2.37-2.42 (m) , 2.59-2.70 (m) y 3.60-3.89 (m), 4.01 (d), 4.20-4.31 (m), 4.42-4.70 (m), 4.80〇.05 (m), 6.79 (d), 668 paper sheets Standards applicable in 3 countries (CNS) A4 is now available (210 x 29 to 4) (Poems. Try to read the back of the cloud first ... fill in the notes)

1235157 Λ/ Β7 五、發明説明(666 ) 7.32-7.65 (m), 7.81 (s) ΜβΟ η1235157 Λ / Β7 V. Description of the invention (666) 7.32-7.65 (m), 7.81 (s) ΜβΟ η

ΟΟ

$39at b 經濟部中央標&amp;局員工消費合作社印咖各 (3 S)-2·酮基-3-(3,5-二氣-4-¾基笮醯基)胺基-5-甲氧基乙醯 基-2,3,4,5-四氩-111-1,5-苯並二氣雜革-卜醋酸(687&amp;),利用 由600b製備654之方法合成自6〇〇b,可生成1.6克的687a3 (3 S)-2-5S基-3-(3,5-二甲基,4·經基芊醯基)胺基-5-甲氧基乙 醢基-2,3,4,5-四氫-1士1,5_笨並二氮雜箪-卜醋酸(68713),利 用甴600b製備654之方法合成自600b,可生成1.1克的687b 3 (3S)·2·酮基-3-(3,5-二氣羥基辛·醯基)胺基-5-甲氧基乙醯 基-N-[(2RS,3S)-苄氧基基-四氫呋喃小基]-2,3,4,5-四 氩-1Η-1,5-笨並二氮雜革.1-乙醯胺(688a)。對(3S,2R,S)-3-烯丙氧羰基胺基-2-芊氧基-5-酮基四氫吱喃(Chapman, -669- 本纸法尺度適用中國國家標车(CNS ) Μ说格(2l0x:97公笼) 1235157 _B7_ 五、發明説明(667 ) .$ 39at b Central Standards of the Ministry of Economic Affairs &amp; Bureau Employees' Co-operative Cooperative (3 S) -2 · keto-3- (3,5-digas-4-¾ylfluorenyl) amino-5-methyl Oxyacetylamidine-2,3,4,5-tetraargon-111-1,5-benzodiazepine-acetic acid (687 &amp;) was synthesized from 600b by the method of preparing 654 from 600b , Which can produce 1.6 grams of 687a3 (3 S) -2-5S group-3- (3,5-dimethyl, 4. Fluorenyl) amino-5-methoxyethylfluorenyl-2, 3,4,5-tetrahydro-1 ± 1,5_benzodiazepine-diacetic acid (68713) was synthesized from 600b by the method of preparing 654 of 600b, which can produce 1.1 grams of 687b 3 (3S) · 2 · Keto-3- (3,5-difluorohydroxyoctyl · fluorenyl) amino-5-methoxyethenyl-N-[(2RS, 3S) -benzyloxy-tetrahydrofuran small group] -2,3,4,5-tetra-argon-1, -1,5-dibenzodiazepine. 1-acetamide (688a). For (3S, 2R, S) -3-allyloxycarbonylamino-2-fluorenyl-5-ketotetrahydrocondensate (Chapman, -669- This paper method is applicable to China National Standard Vehicle (CNS) Μ said grid (2l0x: 97 male cage) 1235157 _B7_ 5. Description of the invention (667).

Biorg. Med. Chem. Lett., 2,ρρ· 613-618 (1992))(1.13 克 ’ 1.2 當量)於CH2Ci2之溶液中加入三苯膦(423毫克,〇·5當量), 二甲基巴比妥酸(1.26克,2.5當量)及肆三笨膦化鈀(0), 3 7 3毫克’ 0.1當量)3 5分鐘後反應混合物經台冰浴冷卻’ 再加入687a於DMF(1.6克,1當量),ΗΟΒΤ(480毫克,1.1 當量)及EDC (681毫克,1.1當量)之溶液。生成的混合物在 環境溫度下攪拌。16小時後反應混合物倒入NaHS04,再 以EtOAc萃取二次。有機層以NaHC03,鹽水洗滌,於 Na2S04上乾燥並眞空濃縮。層析(Si02,20%至100% EtOAc 於CH2Cl2)可生成880毫克的688a呈摻白色固體,1H NMR (CD30D) ά 2.55 (dd, 1H), 2.7 (dd, 1H), 3.0 (m, 1H), 3.6 (m, 1H), 3.75 (d, 1H), 3.9-4.0 (m, 2H), 4.3-4.45 (m, 3H), 4.5-4.6 (m, 3H), 4.7 (m, 2H), 5.35 (s, 1H), 5.55 (d, 1H), 7.1-7.5 (m, 4H), 7.85 (s, 2H) ^ (3 S)-2-酮基-3-(3,5-二曱基-4-羥基芊醯基)胺基o-甲氧基乙 醯基-N-[(2RS,3S)-芊醯基-5-酮基-四氫呋喃-3-基]-2,3,4,5-四氫-1H-1,5-笨並二氮雜箪-1-乙醯酸(688b),以甴687a製 備688a之方法合成自687b,可生成960毫克的688b,呈摻 白色固體,1H NMR (CD30D) β 2.6 (dd,1H),2·7 (dd,1H), 經濟部中夬櫺李局員工消费合作社印裝 3.0 (dd, 1H), 3.2 (s, 3H), 3.7 (m, 3H), 3.9 (m, 2H), 4.4-4.5 (m, 2H), 4.6 (m, 3H)? 5.35 (s, 1H), 5.55 (d, 1H), 7.25 (m, 2H), 7.4-7.5 (m, 4H)- (3S)-3-[(3S)-2-酮基-3-(3,5-二氣羥基;醯基)胺基-5-甲氧 基乙酿基-2,3,4,5-四氫苯並二氮雜箪-卜乙醯胺基卜 -670 - 本紙法尺度適用中國國家標隼(CNS ) μ規格(21〇&gt;&lt; 297公釐) ' ' 1235157 Λ 7 __37_ 五、發明説明(明3) 4-酮基-丁酸(689a),以甴2001製備、2002之方法合成自688a 可生成184毫克的689a,呈白色固體,4 NMR (CD3〇D) d 2.45 (m, 1H), 2.6 (m,lH), 3.3 (s, 3H), 3.7-3.85 (m, 2H), 4.0 (d, 1H), 4.3 (m, 1H), 4.5-4.6 (m, 3H), 7.3-7.6 (m, 4H)? 7.85 (s, 2H)。 (3 5)-3-[(3 5)-2-酮基-3-(3,5-二甲基-4-羥基芊醢基)胺基-5-曱 氡乙醯基-2,3,4,5-四氫-1沁1,5-苯並二氮雜箪-1-乙醢胺基]-4-酮基·丁酸(689b),利用自2001製備2002之方法合成自 688b,可生成412毫克的689b,呈白色固體,4 NMR (CD3〇D) ά 2.5 (m, 1H), 2.7 (m, 1H), 3.3 (s, 3H), 3.7-3.85 (m, 2H), 4.05 (dd, 1H), 4.3 (m, 1H), 4.6 (m, 2H), 7.45-7.4 (m, 2H), 7.5 (s, 2H), 7.55 (m, 2H) ^Biorg. Med. Chem. Lett., 2, ρρ · 613-618 (1992)) (1.13 g '1.2 equivalent) To a solution of CH2Ci2 was added triphenylphosphine (423 mg, 0.5 equivalent), dimethylbar After 5 minutes, the reaction mixture was cooled in an ice bath with bitalic acid (1.26 g, 2.5 eq.) And palladium phosphonium palladium (0), 3 7 3 mg '0.1 eq.'. Then 687a was added to DMF (1.6 g, 1 equivalent), ΗΒΤ (480 mg, 1.1 equivalent) and EDC (681 mg, 1.1 equivalent). The resulting mixture was stirred at ambient temperature. After 16 hours, the reaction mixture was poured into NaHS04 and extracted twice with EtOAc. The organic layer was washed with NaHC03, brine, dried over Na2S04 and concentrated in vacuo. Chromatography (Si02, 20% to 100% EtOAc in CH2Cl2) can produce 880 mg of 688a as a white solid, 1H NMR (CD30D), 2.55 (dd, 1H), 2.7 (dd, 1H), 3.0 (m, 1H ), 3.6 (m, 1H), 3.75 (d, 1H), 3.9-4.0 (m, 2H), 4.3-4.45 (m, 3H), 4.5-4.6 (m, 3H), 4.7 (m, 2H), 5.35 (s, 1H), 5.55 (d, 1H), 7.1-7.5 (m, 4H), 7.85 (s, 2H) ^ (3 S) -2-keto-3- (3,5-difluorenyl) -4-hydroxyfluorenyl) amino o-methoxyethenyl-N-[(2RS, 3S) -fluorenyl-5-keto-tetrahydrofuran-3-yl] -2,3,4, 5-tetrahydro-1H-1,5-benzodiazapyridine-1-acetamate (688b) was synthesized from 687b by the method of preparing 688a with a687a, which can generate 960 mg of 688b as a white solid, 1H NMR (CD30D) β 2.6 (dd, 1H), 2 · 7 (dd, 1H), printed by the Consumer Cooperatives of Zhongli and Li Bureau of the Ministry of Economic Affairs 3.0 (dd, 1H), 3.2 (s, 3H), 3.7 ( m, 3H), 3.9 (m, 2H), 4.4-4.5 (m, 2H), 4.6 (m, 3H)? 5.35 (s, 1H), 5.55 (d, 1H), 7.25 (m, 2H), 7.4 -7.5 (m, 4H)-(3S) -3-[(3S) -2-keto-3- (3,5-diaminohydroxy; fluorenyl) amino-5-methoxyethynyl- 2,3,4,5-Tetrahydrobenzodiazepine-Ethylamine-B-670-suitable for paper method Chinese National Standards (CNS) μ Specifications (21〇 &lt; 297 mm) '1235157 Λ 7 __37_ V. Description of the Invention (Ming 3) 4-keto-butyric acid (689a), prepared with 甴 2001, The method of 2002 was synthesized from 688a to produce 184 mg of 689a as a white solid, 4 NMR (CD3OD) d 2.45 (m, 1H), 2.6 (m, 1H), 3.3 (s, 3H), 3.7-3.85 ( m, 2H), 4.0 (d, 1H), 4.3 (m, 1H), 4.5-4.6 (m, 3H), 7.3-7.6 (m, 4H)? 7.85 (s, 2H). (3 5) -3-[(3 5) -2-keto-3- (3,5-dimethyl-4-hydroxyfluorenyl) amino-5-fluorethenyl-2,3 , 4,5-tetrahydro-1,1,5-benzodiazepine-1-acetamido] -4-one-butyric acid (689b), synthesized from 688b by the method of 2001 and 2002 , Which can produce 412 mg of 689b as a white solid, 4 NMR (CD3〇D), 2.5 (m, 1H), 2.7 (m, 1H), 3.3 (s, 3H), 3.7-3.85 (m, 2H), 4.05 (dd, 1H), 4.3 (m, 1H), 4.6 (m, 2H), 7.45-7.4 (m, 2H), 7.5 (s, 2H), 7.55 (m, 2H) ^

M濟部中央糅华局員工消资合作杜印製 (3S)-2-銅基-3-(j,5-二曱基-4-¾基卞酷基)胺基- 5- ¾基乙酷 -671 - 本纸乐尺度通用中国国家標洋(CNS ) W現格(210乂297公釐) 1235157 Λ7 87 五、發明説明(669 ) 基[(2RS,jS)-卞乳基-5-銅基-四乳17夫17南-3-基]2,3,4,5 -四氣 -1H-1,5-苯並二氮雜箪-卜乙醯胺(690a),利用甴600b製備 676,甴687a製備688a,甴676製備677之方法合成自600b可 生成863毫克的690a,呈白色固獐,(CD3OD) d 2·2 (s, 6H), 2·45 (d,0·5Η),2.6-2.9 (m, 1H),3·05 (dd,0.5H), 3.65-3.85 (m, 2H), 3.95-4.1 (m, 1H), 4.35-5.0 (m, 7H)? 5.35 (s, 0.5H), 5.65 (d, 0.5H), 7.2-7.4 (mt 4H), 7.4-7.7 (m, 7H) 3 (3S)-2-酮基-3·(4-羥基芊醯基)胺基-5-羥基乙醯基-N-[(2RS,3S)-芊氧基〇-酮基-四氫吃喃-3-基]-2,3,4,5-四氫-1H-1,5·苯並二氮雜箪-1-乙醯胺(690b),利用由600b製備677之 方法合成自600b,可生成200毫克的690b,4 NMR (CD3OD) δ 2.49 (d, 1H), 2.65 (d, 1H), 2.66 (d, 1H), 2.85 (d, 經濟部令央樣隼局員工消費合作社印裳 1H), 2.87 (d, 1H), 3.05 (dd, 1H), 3.35 (br. s, 1H), 3.72 (br. s, 2H), 4.01 (m, 2H), 4.45 (br. m, 1H), 4.6 (m, 1H), 4.7 (m, 1H), 4.8 (m, 1H), 4.95 (br. s, 2H), 5.65 (d, 1H), 6.8 (d, 2H), 7.2· 7.35 (br. m, 3H), 7.45 (m, 2H), 7.75 (d, 2H) ^ (35)-3-[(35)-2-酮基-3-(3,5-二曱基-4-羥基芊醯基)胺基-5-羥 基乙醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜蕈-l-乙醯胺基]-4-酮基-丁酸(691a) ’利用由2001製備2002之方法合成自 690a,可生成560毫克的691a,呈白色固體,lH NMR (CD3OD) ά 2.15 (s, 6H), 2.45 (m, 1H), 2.65 (m, IH), 3.55 (m, 1H), 3.7 (d, IH), 4.0 (d, 1H), 4.25 (m, 1H), 4.5-4.6 (m, 3H), 7.3-7.5 (m, 6H) ^ (3 5)-3-[(3(5)-2-酮基-3-(4-羥基苄醯基)胺基-5-羥基乙醯基- -672- 本纸伕尺度適用中S國家標这(CNS M4規格(2丨0 X 297公釐) 1235157 Λ7 B7 五、發明説明(670) 2,3,4,5-四氫-1H-1,5-苯並二氮雜箪乙醯胺基]-4-鲷基-丁 酸(691b),以甴2001製備2002之方法合成自690b可生成410 毫克的 691b,呈白色固體,4 NMR (CD3OD) β 2.5 (m,1H), 2.65 (m, 1H), 3.75 (m, 1H), 3.8 (d, 1H), 4.05 (d, 1H), 4;25 (m, 1H), 4.5 (m, 1H), 4.6 (m, 1H), 4.95 (br. s, 2H), 6.8 (d, 2H), 7.45 (m, 2H),7.6 (m, 2H·), 7‘75 (d,2H)。Employees of the Central China Economic and Trade Bureau of the Ministry of Economic Affairs of China cooperate in the production of (3S) -2-copper-3--3- (j, 5-difluorenyl-4-¾-ylsulfonyl) amino- 5- ¾ylethyl KU-671-Chinese paper standard (CNS) W standard (210 乂 297mm) 1235157 Λ7 87 V. Description of invention (669) [[2RS, jS)-卞 乳 基 -5- Cu-Tetralactone, 17-F, 17-N-3-yl] 2,3,4,5 -tetrakis-1H-1,5-benzodiazepine-buethamidine (690a), prepared using pyrene 600b 676, 甴 687a to prepare 688a, 甴 676 to prepare 677, synthesized from 600b to produce 863 mg of 690a, white solid, (CD3OD) d 2 · 2 (s, 6H), 2 · 45 (d, 0.5 · Η) ), 2.6-2.9 (m, 1H), 3.05 (dd, 0.5H), 3.65-3.85 (m, 2H), 3.95-4.1 (m, 1H), 4.35-5.0 (m, 7H)? 5.35 ( s, 0.5H), 5.65 (d, 0.5H), 7.2-7.4 (mt 4H), 7.4-7.7 (m, 7H) 3 (3S) -2-keto-3 · (4-hydroxyfluorenyl) Amino-5-hydroxyethylfluorenyl-N-[(2RS, 3S) -fluorenyloxy-keto-tetrahydroxan-3-yl] -2,3,4,5-tetrahydro-1H- 1,5 · Benzodiazepine-1-acetamidine (690b), synthesized from 600b by the method of preparing 677 from 600b, can produce 200 mg of 690b, 4 NMR (CD3OD) δ 2.49 (d, 1H) , 2. 65 (d, 1H), 2.66 (d, 1H), 2.85 (d, Yinyang 1H, Consumer Cooperative, Employees' Cooperative, Order of the Ministry of Economic Affairs, 2.87 (d, 1H), 3.05 (dd, 1H), 3.35 (br .s, 1H), 3.72 (br. s, 2H), 4.01 (m, 2H), 4.45 (br. m, 1H), 4.6 (m, 1H), 4.7 (m, 1H), 4.8 (m, 1H ), 4.95 (br. S, 2H), 5.65 (d, 1H), 6.8 (d, 2H), 7.2 · 7.35 (br. M, 3H), 7.45 (m, 2H), 7.75 (d, 2H) ^ (35) -3-[(35) -2-keto-3- (3,5-diamidino-4-hydroxyfluorenyl) amino-5-hydroxyethylfluorenyl-2,3,4, 5-tetrahydro-1H-1,5-benzodiazepine-l-acetamido] -4-one-butyric acid (691a) 'Synthesized from 690a by the method of 2001 and 2002 560 mg of 691a as a white solid, lH NMR (CD3OD), 2.15 (s, 6H), 2.45 (m, 1H), 2.65 (m, IH), 3.55 (m, 1H), 3.7 (d, IH), 4.0 (d, 1H), 4.25 (m, 1H), 4.5-4.6 (m, 3H), 7.3-7.5 (m, 6H) ^ (3 5) -3-[(3 (5) -2-one -3- (4-hydroxybenzylfluorenyl) amino-5-hydroxyethylsulfonyl- -672- The standard of this paper is applicable to the national standard of China (CNS M4 specification (2 丨 0 X 297 mm) 1235157 Λ7 B7 V. Description of the invention (670) 2,3,4,5-tetrahydro-1H-1,5-benzodiazepineacetamidinyl] -4-breamyl- Butyric acid (691b), synthesized from 690b by the method of 甴 2001 preparation, can produce 410 mg of 691b as a white solid, 4 NMR (CD3OD) β 2.5 (m, 1H), 2.65 (m, 1H), 3.75 (m , 1H), 3.8 (d, 1H), 4.05 (d, 1H), 4; 25 (m, 1H), 4.5 (m, 1H), 4.6 (m, 1H), 4.95 (br. S, 2H), 6.8 (d, 2H), 7.45 (m, 2H), 7.6 (m, 2H ·), 7'75 (d, 2H).

(诗先冗讀背云之注意事項玉:填寫本一貝) 經濟部中央樣準局員X消费合作社印¾ (3S)-2-酮基-3-苄醯基胺基-5-羥基乙醯基-N-[(2RS,3S)-芊氧 基· 5 -銅基-四氣β矢喃-3 -基】- 2,3,4,5 -四氮-1H-1,5-本並二亂雜 箪-1-乙醯胺(695a),利用由600b製備677之方法合成自600b ,可生成 75毫克的 695a,NMR (CD3〇D) β 2.2 (s,6H), 2.45 (m,1Η),2·6 (m,1Η),3·65 (m,1Η), 3·75 (d,1Η),4.0 (d, 1H),4.28 (m,1H),4.5 (m,3H),7.4-7.6 (m,6H)。 (3S)-2-酮基-3-(4-乙醯胺基芊醯基)胺基-5-羥基乙趋基-N-[(2RS,3S)-芊氧基-5-酮基-四氫呋喃-3-基]-2,3,4,5-四氫-1H- -673- 本纸伕尺度適用中SS家標李(CNS ) .Λ4現格(210X 297公釐) 1235157 Λ7 B7 __五、發明説明(671 ) 1.5- 苯並二氮雜箪-1·乙醯胺(695c&gt;,利用甴6〇〇b製備677之 方法合成自6〇〇b,可生成880毫克的695b,W NMR (CD3OD) d 2.1 (s, 3H), 2.25-2.5 (m, 2H), 2.8-2.92 (m, 0.5H), 3.150.2 (m, 0.5H), 3.45-3.6 (m, 2H), 3.75-3.95 (m, 2H), 4.15-4.25 (m? 1H), 4.35-4.6 (m, 2H), 4.6-4.88 (m, 3H), 5.22 (s, 0.25H), 5.33 (s, 0.25H), 5.52-5.58 (d, 0.5H), 7.15-7.45 (m, 9.5H), 7.5-7.75 (m, 5H), 8.3-8.35 (m, 0.5H), 9.08-9.18 (m, 1H) ^ (3 5)-2反5-嗣基-3-(3,5-二甲基-4-技基+酷基)胺基-5-沒乙醯 基-N-(2-爷氧基-5-嗣基·四氫11 夫喊-3-基)-2,3,4,5-四氫·1Η· 1.5- 苯並二氮雜萆-卜乙醯胺(695c),利用由600b製備677之 方法合成自600b,可生成840毫克的695c,lH NMR (CDC13) ό 2.23 (s, 3Η), 2.26 (s, 3H), 2.45-2.62 (m, 1H), 2.8-2.9 (dd, 0.5H), 2.9-3.05 (dd, 0.5H), 3.45-3.63 (m, 1H), 3.64 (s, 1.5H), 3.68 (s, 1.5H), 3.78-4.05 (m, 2H), 4.2-4.33 (m, 1H), 4.4-4.63 (m, 2H), 4.65-4.94 (m, 2H), 4.95-5.1 (m, 1H), 5.45 (s, 0.5H), 5.5- 5.6 (d, 0.5H), 6.9-6.95 (d, 1H), 7.25-7.7 (m, 12H) ^ •一 〇 請 η 背 云 之 •-士 ί 事(Precautions for reading the poems in the poems first: fill in this book) Printed by the member of the Central Bureau of the Ministry of Economic Affairs X Consumer Cooperatives ¾ (3S) -2-keto-3-benzylaminoamino-5-hydroxyethyl -N-[(2RS, 3S) -fluorenyloxy · 5-copperyl-tetrakis β-ranan-3 -yl]-2,3,4,5-tetrazine-1H-1,5-benzyl Disorganized heteropyridine-1-acetamide (695a), synthesized from 600b by the method of preparing 677 from 600b, can produce 75 mg of 695a, NMR (CD3OD) β 2.2 (s, 6H), 2.45 (m, 1Η), 2 · 6 (m, 1Η), 3.65 (m, 1Η), 3.75 (d, 1Η), 4.0 (d, 1H), 4.28 (m, 1H), 4.5 (m, 3H) , 7.4-7.6 (m, 6H). (3S) -2-keto-3- (4-acetamidoamidinyl) amino-5-hydroxyethoxytyl-N-[(2RS, 3S) -fluorenyl-5-keto- Tetrahydrofuran-3-yl] -2,3,4,5-tetrahydro-1H- -673- This paper is suitable for the standard SS Lee (CNS). Λ4 is present (210X 297 mm) 1235157 Λ7 B7 _ V. Description of the invention (671) 1.5-Benzodiazepine-1 · acetamidine (695c &gt;, synthesized from 600b by the method of preparation of 677b from 600b, can produce 880mg of 695b, W NMR (CD3OD) d 2.1 (s, 3H), 2.25-2.5 (m, 2H), 2.8-2.92 (m, 0.5H), 3.150.2 (m, 0.5H), 3.45-3.6 (m, 2H) , 3.75-3.95 (m, 2H), 4.15-4.25 (m? 1H), 4.35-4.6 (m, 2H), 4.6-4.88 (m, 3H), 5.22 (s, 0.25H), 5.33 (s, 0.25 H), 5.52-5.58 (d, 0.5H), 7.15-7.45 (m, 9.5H), 7.5-7.75 (m, 5H), 8.3-8.35 (m, 0.5H), 9.08-9.18 (m, 1H) ^ (3 5) -2 trans-5-fluorenyl-3- (3,5-dimethyl-4-technyl + acyl) amino-5-heptyl-N- (2-methyloxy -5-fluorenyl · tetrahydro11-fluoro-3-yl) -2,3,4,5-tetrahydro · 1Η · 1.5-benzodiazepine-buethamide (695c), used by 600b The method of preparation 677 is synthesized from 600b, which can generate 840 mg of 695c, lH NMR (CDC13). 2.23 (s, 3Η), 2.26 (s, 3H), 2.45-2.62 (m, 1H), 2.8-2.9 (dd, 0.5H), 2.9-3.05 (dd, 0.5H), 3.45-3.63 (m, 1H ), 3.64 (s, 1.5H), 3.68 (s, 1.5H), 3.78-4.05 (m, 2H), 4.2-4.33 (m, 1H), 4.4-4.63 (m, 2H), 4.65-4.94 (m , 2H), 4.95-5.1 (m, 1H), 5.45 (s, 0.5H), 5.5- 5.6 (d, 0.5H), 6.9-6.95 (d, 1H), 7.25-7.7 (m, 12H) ^ • 〇 Please η Behind the Clouds-Shi lt

寫 本 I 經濟邡令夬墚皋局員工消f合作社印^Written by I Economic Orders Bureau staff eliminates cooperative seals ^

,R1, R1

(3S)-2-酮基-3-(3,5-二氯-4-羥基芊醯基)胺基羥基乙醯基 -674· 本纸法尺度適用中3國家標拿(CNS )八4地格(210 X 297公笼) 1235157(3S) -2-keto-3- (3,5-dichloro-4-hydroxyfluorenyl) amino hydroxyethylsulfonyl-674 Ground (210 X 297 male cage) 1235157

AT B7 五、發明説明(672 ) N-[(2RS,3S)-笮氧基-5-酮基-四氫矣喃.弘基卜2,3,4,5-四氣、 1H-1,5-苯並二氮雜箪-1-乙醯胺(692a),利用由6〇〇b製構 661之方法合成自600b,除了甴603d製成688a之步驟例外 ,以由687a製備688a之方法替代可生成854毫克的6.92a, lH NMR (CDC13) ^ 2.45 (d, 1Η), 2.6 (m, 1H), 2.7 (m, 1H), 3.0 (m, 1H), 3.5-3.7 (m, 4H), 4.0 (q, 2H), 4.45 (m, 3H), 4.55 (m, 4H), 5.35 (s, 1H), 5.6 (d, 1H), 7.2-7.5 (m, 9H), 7.85 (s, 2H)。 (3S)-2-酮基-3-(3,5-二甲基-4-羥基芊醯基)胺基·5·羥基乙醯 基-N-[(2RS,3S)-乙氧基-5-酮基-四氫咦喃-3-基]-2,3,4,5-四 氫-1H· 1,5-苯並二氮雜箪-1-乙醯胺(692b),利用甴600b製 備661之方法合成自600b,排除了自603d製成604d之步骤 ,利用甴687a製備688a之方法替代可生成207毫克的692b, lH NMR (CD3OD) ά 1.05 (t, 3Η), 1.15 (t, 3H), 2.45 (d? 1H), 2.55 (m, 1H), 2.7 (m, 1H), 3.55 (m, 2H), 3.6-3.75 (m, 5H), 4.0 (dd, 2H), 4.3 (d, 1H), 4.4-4.7 (m, 5H), 5.25 (s, 1H), 5.5 (d, 1H), 7.25-7.6 (m, 4H), 7.85 (s, 2H)。 oAT B7 V. Description of the invention (672) N-[(2RS, 3S) -Methoxy-5-one-tetrahydropyran. Hongjibu 2,3,4,5-tetrakis, 1H-1,5 -Benzodiazepine-1-acetamidine (692a), synthesized from 600b by the method of making 661 from 600b, except for the step of making 688a from 603d, replacing the method of 688a from 687a Generates 854 mg of 6.92a, lH NMR (CDC13) ^ 2.45 (d, 1Η), 2.6 (m, 1H), 2.7 (m, 1H), 3.0 (m, 1H), 3.5-3.7 (m, 4H) , 4.0 (q, 2H), 4.45 (m, 3H), 4.55 (m, 4H), 5.35 (s, 1H), 5.6 (d, 1H), 7.2-7.5 (m, 9H), 7.85 (s, 2H ). (3S) -2-keto-3- (3,5-dimethyl-4-hydroxyfluorenyl) amino · 5 · hydroxyethylsulfanyl-N-[(2RS, 3S) -ethoxy- 5-keto-tetrahydropyran-3-yl] -2,3,4,5-tetrahydro-1H · 1,5-benzodiazepine-1-ethanamine (692b), using fluorene The method of preparing 661 from 600b was synthesized from 600b, excluding the step of preparing 604d from 603d, and the method of preparing 688a from 甴 687a was used instead of 692b which can produce 207 mg. LH NMR (CD3OD) ά 1.05 (t, 3Η), 1.15 (t , 3H), 2.45 (d? 1H), 2.55 (m, 1H), 2.7 (m, 1H), 3.55 (m, 2H), 3.6-3.75 (m, 5H), 4.0 (dd, 2H), 4.3 ( d, 1H), 4.4-4.7 (m, 5H), 5.25 (s, 1H), 5.5 (d, 1H), 7.25-7.6 (m, 4H), 7.85 (s, 2H). o

(3S)-2-酮基醯胺基-5-乙醯基-N-[(2RS,3S)-芊氧基-5-酮 基-四氫呋喃-3-基]-2,3,4,5-四氫苯並二氮雜箪-卜乙 本紙尜尺度適用中a國家標窣(CNS ) A4現格(210X 297公釐) (琦先习讀背云之注意事項再填寫本頁) 訂 經濟部中央樣条局負工消費合作社印¾ -675-_____ 1235157 Λ7 _B7____ 五、發明説明(67:3) 醢胺(693),利用由600b製備688a之方法合成自600b,可生 成 30毫克的693,iH NMR (CD3OD) d 1.7 (s,3H),1.8 (s,3H) 2.51 (d, 1H), 2.6 (m, 1H), 2.85 (m, 1H), 3.0 (m, 1H), 3.75 (br. d, 2H), 4.0-4.1 (dd, 2H), 4.5-5.0 (m, 6H), 5.45 (s, 1H), 5.55 (s, 1H), 7.15^7.85 (m, 14H) ^(3S) -2-ketofluorenylamino-5-ethenyl-N-[(2RS, 3S) -fluorenyl-5-keto-tetrahydrofuran-3-yl] -2,3,4,5 -Tetrahydrobenzodiazepine-Bu Yi paper standard is applicable to a national standard (CNS) A4 (210X 297 mm) (Please read the precautions for back cloud before filling this page) Order economy Printed by the Central Spline Bureau, Consumer Work Cooperative ¾ -675 -_____ 1235157 Λ7 _B7____ 5. Description of the Invention (67: 3) Phenamine (693), synthesized from 600b by the method of preparing 688a from 600b, can produce 30 mg of 693 , IH NMR (CD3OD) d 1.7 (s, 3H), 1.8 (s, 3H) 2.51 (d, 1H), 2.6 (m, 1H), 2.85 (m, 1H), 3.0 (m, 1H), 3.75 ( br. d, 2H), 4.0-4.1 (dd, 2H), 4.5-5.0 (m, 6H), 5.45 (s, 1H), 5.55 (s, 1H), 7.15 ^ 7.85 (m, 14H) ^

(3S)-3-[(3S)-2-酮基-3-(3,5-二甲基-4-甲氧基芊醢基)按基-5· 羥基乙醯基-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-卜乙醢基 胺基]-4-酮基-丁酸(694),利用由2001製備2002之方法合成 自691c可生成380毫克的694,呈白色固鳢,lH NMR (CD3〇D) ά 2.25 (s, 6H), 2.45 (m, 1H), 2.65 (m, 1H), 3.65 (m, 5H), 4.0 (d, 1H), 4.28 (m, 1H), 4.55 (d, 2H), 4.95 (m, 1H), 7.4-7.6 (m, 6H)。 化合物700-711可以製備化合物619-63 5之類似方法製備( 見,實例13)。化合物700-711之物理數據列於表25中。 經濟部r夬標準局員工消资合作社印製 化合物910-915及918-921如下述製備。這些化合物的物 理數據列於表26中。 -676- 本紙伕尺度通用中S國家標李(CNS ) A4現咯(210X297公釐) 1235157 Λ7 B7 五、發明説明(674 ) 經濟部.〒夬標渙局員二消費合作杜印製 + 厶 + 2 ο ο κο 、 00 00 cn in u J w CU IS &lt;Ν Ο ^ t-H f-4 s = tO «-Ι 2; S f-H to 卜 ιΓ&gt; CN L〇 »-H in CS4 2: 卜 Ο 2: CM rH ο CN4 s VO Cvj u cn ao 〇 rr 2 CM CN X m CM CJ 赛 -r P X °-Q=〇 a \ X 〇 x -〇=〇 2: X 。设 &lt;(α O o 卜 rH o 卜 請先 χλ讀 背 面 之意 事 ¥ 寫頁 -677- 本纸ft尺度適用令a國家標導(CNS ) A4現格(2丨O x 29^公 1235157 Λ7 B7 67 /(\明 説明發 五 經濟部令夬樣準局貝工消资合作社印裳 cn ^ 2 5 S &lt;J\ WO r- to 、、T-H CN Γ* 0&quot;) h4 〇4 X rH tD ^ s - un r-4 CNJ o f-H 3: S o L〇 CNi ID tO m u〇 r- uO s o rH O 守 2 eg SC VO CM U CO s 2 uO CNJ 3: r- CM o X P x °=Q-〇 A 、〇 5r °v=° Z X A :¾ CM o 卜 cn o 卜 -678- 本紙乐尺度適用中國國家標李(CNS ) A4現格(210X 297公簧) -----^^装---- 請先閱讀背由之泾意事項再填寫本f ) 訂 d 1235157 AT B7 五、發明説明(676 ) 經濟部中夬樣隼局員工消費合作社印¾ + S r-H CM VO m 、d CN VO ir&gt; CM σι L〇 φ A a 〇4 s CNJ o s ^ CM ^ , rH t—4 vo 5 2 S; CO rH 3: X CNi L〇 00 m CNJ ID 00 m ID • ir&gt; L〇 00 VO L〇 u» 2 σ\ 〇 ^5P CM *T| 3 CM o σ\ 〇 § CN S Co CM CJ o t-J 〇 々 2 GO CNJ 卜 CM CJ 3 X p x °rQ: —o r p x 甘 X 戶r °^Q- 〇=/ Q~°\ o 卜 in o 卜 VO 〇 卜 (請先閱讀背云之浼意事項再填寫本頁) -679- 本紙伕尺度適用中gg家標挛(CNS ) Μ規格(210 X 297公釐) 1235157 Λ7 B7 五、發明説明(677 ) 經濟部.〒夬噤这局員工消费合作枉印製 + CO ^ X σ\ LO 卜 cO νο、 r- L〇 卜 L〇 墩. 令A (J ^ Λ Οι X υί) rH CM Η 冰 Ο t-H CNJ m rH 3: S in in 04 υΤ&gt; ιΓ) cn m o vT) L〇 Γ ΙΟ o in m 〇L&gt; X σ\ Ο CNI S ? CM U &lt;Ti 〇 § CN 3: 卜 CM U CO 〇 ^r 2 〇 m 3: CD C\J u δχ 。=〇=〇 \ 〇Ν/° Z X * 。系 \ °x/° r 〇r -〇=〇 * 卜 Ο 卜 ω o 卜 σ&gt; ο 卜 (請先聞讀背*之:/-£意事項再填寫本I ) -680- 本纸杀尺度通用中国国家標李(CNS ) A4現格(210 X 297公釐) 1235157 Λ 7 Β7 五、發明説明( 678 ) 經濟部中央榡準局員工消費合作社印¾ CD ^ CM CN CD ID σν、 r-H CVi ID 令 〇4 X CNJ VO ^ s - (N rH s ^ ΓΟ rH 3: X «r&gt; a\ 卜 m in m GO cn tu S CO S 2 •Ή CJ 々 CM 5 CV4 U (Ti 〇 CNJ &lt;N 3S cn CM CJ 2 X A °i=〇 X 2 a X 〇 x o=C^ °rQ: ^3 O r-4 卜 *H rH 卜 (請先閱讀背&amp;之..工意事項再填寫忒莧) 装(3S) -3-[(3S) -2-keto-3- (3,5-dimethyl-4-methoxyfluorenyl) benzyl-5 · hydroxyethylfluorenyl-2,3, 4,5-tetrahydro-1H-1,5-benzodiazepine-buethenylamino] -4-keto-butanoic acid (694), synthesized from 691cco by the method of 2001 and 2002 Generated 380 mg of 694 as a white solid, lH NMR (CD3〇D), 2.25 (s, 6H), 2.45 (m, 1H), 2.65 (m, 1H), 3.65 (m, 5H), 4.0 (d , 1H), 4.28 (m, 1H), 4.55 (d, 2H), 4.95 (m, 1H), 7.4-7.6 (m, 6H). Compounds 700-711 can be prepared in a similar manner to compounds 619-63 5 (see, Example 13). The physical data of compounds 700-711 are listed in Table 25. Compounds 910-915 and 918-921 printed by the Consumers' Cooperative of the Standards Bureau of the Ministry of Economic Affairs were prepared as follows. The physical data of these compounds are listed in Table 26. -676- Standard Chinese Standard Lithium (CNS) A4 of this paper is standard (210X297 mm) 1235157 Λ7 B7 V. Description of the invention (674) Ministry of Economic Affairs, Ministry of Economic Affairs, Ministry of Economic Affairs, 2 Consumer Cooperation Printing + 厶 + 2 ο ο κο, 00 00 cn in u J w CU IS &lt; Ν Ο ^ tH f-4 s = tO «-Ι 2; S fH to ΓΓ &gt; CN L〇» -H in CS4 2: 卜 Ο 2 : CM rH ο CN4 s VO Cvj u cn ao 〇rr 2 CM CN X m CM CJ Sai-r PX ° -Q = 〇a \ X 〇x -〇 = 〇2: X. Set &lt; (α O o rrH o 请 Please read the meaning on the back side first. ▲ Page -677- ft scale applicable to a national standard (CNS) A4 (2 丨 O x 29 ^ 公 1235157) Λ7 B7 67 / (\ Declares that the five Ministry of Economic Affairs ordered the sample quasi bureau Beigong consumer cooperatives Yin Changcn ^ 2 5 S &lt; J \ WO r-to 、, TH CN Γ * 0 &quot;) h4 〇4 X rH tD ^ s-un r-4 CNJ o fH 3: S o L〇CNi ID tO mu〇r- uO so rH O Shou 2 eg SC VO CM U CO s 2 uO CNJ 3: r- CM o XP x ° = Q-〇A, 〇5r ° v = ° ZXA: ¾ CM o bu cn o bu-678- This paper scale is applicable to Chinese national standard plum (CNS) A4 (210X 297 public spring) ----- ^ ^ Installation ---- Please read the intent matters before filling in this f) Order d 1235157 AT B7 V. Description of Invention (676) Printed by the Employees' Cooperatives of the Bureau of Samples in the Ministry of Economic Affairs ¾ + S rH CM VO m , D CN VO ir &gt; CM σι L〇φ A a 〇4 s CNJ os ^ CM ^, rH t-4 vo 5 2 S; CO rH 3: X CNi L〇00 m CNJ ID 00 m ID • ir &gt; L 〇00 VO L〇u »2 σ \ 〇 ^ 5P CM * T | 3 CM o σ \ 〇§ CN S Co CM CJ o tJ 〇 2 GO CNJ 卜 CM C J 3 X px ° rQ: —orpx 甘 X rr ° ^ Q- 〇 = / Q ~ ° \ 卜 in o 卜 VO 〇 卜 (Please read the intentions of the back of the cloud before filling out this page) -679- The standard of this paper is applicable to the standard of GG family standard (CNS) M (210 X 297 mm) 1235157 Λ7 B7 V. Description of the invention (677) Ministry of Economic Affairs. 员工 Printing of this bureau's consumer cooperation + CO ^ X σ \ LO 卜 cO νο, r- L〇 卜 L〇 Pier. Let A (J ^ Λ Οι X υί) rH CM Η ice 〇 tH CNJ m rH 3: S in in 04 υΤ &gt; ιΓ) cn mo vT) L〇 Γ ΙΟ o in m 〇L &gt; X σ \ 〇 CNI S? CM U &lt; Ti 〇§ CN 3: CM U CO 〇 ^ r 2 〇m 3: CD C \ J u δχ. = 〇 = 〇 \ 〇Ν / ° Z X *. Department \ ° x / ° r 〇r -〇 = 〇 * Bu 0 Bu ω o Bu σ &gt; ο Bu (please read and read the back first: /-£, and then fill out this I) -680- Standard for killing paper General Chinese National Standard Li (CNS) A4 is now available (210 X 297 mm) 1235157 Λ 7 Β7 V. Description of the invention (678) Printed by the Consumers ’Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs ¾ CD ^ CM CN CD ID σν, rH CVi ID 〇〇4 X CNJ VO ^ s-(N rH s ^ ΓΟ rH 3: X «r &gt; a \ bu m in m GO cn tu S CO S 2 • Ή CJ 々CM 5 CV4 U (Ti 〇CNJ &lt; N 3S cn CM CJ 2 XA ° i = 〇X 2 a X 〇xo = C ^ ° rQ: ^ 3 O r-4 bu * H rH bu (please read the back &amp; the work idea before filling in 忒苋) loaded

•T d -681 - 本紙乐尺度通用中ϋ國家標李(CNS ) A4規洛(210x29?公蝥) 1235157 A7B7 五、發明説明(679 經濟部中央樣这局員工消资合作社印製 9cn&lt; CO 2 S VD t〇 ' ιΓ&gt; 卜 r· tO u &gt;-4 Οι DC CN cM〇 CN (J\ r* c\ rH CD Ξ c/P c\ as &lt;Js σ\ S X a\ 〇 IT) cn in L〇 L〇 Cl4 X o rH O 2: CVJ 5 CVJ CJ ON 〇 WO 2 卜 CM S VO CM u X O X 〇=〇=〇 c X O X 0=〇=〇 • 八 cn X ^3 O rH σ\ r-4 T-l (J\ -682- 本紙乐尺度適用中國國家標隼(CNS ) A4現格(210X 2974$ ) (請先閎讀背§之;1意事項具填寫大二貝) 1235157 A7 B7 五、發明説明(680 ) 經濟部中夬標準局員工消费合作杜印¾• T d -681-This paper is a universal Chinese standard national standard (CNS) A4 gauge (210x29? Public) 1235157 A7B7 V. Description of the invention (679 Printed by the Consumers ’Cooperative of the Central Bureau of the Ministry of Economic Affairs 2 S VD t〇 'ιΓ &gt; BU r · tO u &gt; -4 〇ι DC CN cM〇CN (J \ r * c \ rH CD Ξ c / P c \ as &lt; Js σ \ SX a \ 〇IT) cn in L〇L〇Cl4 X o rH O 2: CVJ 5 CVJ CJ ON 〇WO 2 CM S VO CM u XOX 〇 = 〇 = 〇c XOX 0 = 〇 = 〇 • eight cn X ^ 3 O rH σ \ r-4 Tl (J \ -682- This paper scale is applicable to the Chinese National Standard (CNS) A4 (210X 2974 $)) (please read the § first; please fill in the second year with a note) 1235157 A7 B7 V. Description of Invention (680) Consumption Cooperation between Employees of China Standards Bureau, Ministry of Economic Affairs, Du Yin ¾

+ ^ 1 X 卜 〇 m u〇 、、 in ro VO L〇 0 w CU re CM dP 卜 σ\ τ-ι α\ cn 00 «-λ· &lt;\i dP CO &lt;n CO (Ti in VO 3: S rH l〇 VO CM in m ' L〇 • c\ m in iu s σ\ 〇 § CM 5 CN 〇 CO 〇 vn 奈 CVJ re VD CVJ U 〇=C^=° ? O' °=^V==〇 y^C: r。\; t 9, X CN4 (Λ m t-H (請先閱讀背δ之注意事項再填寫本頁) 裝 1- d -683- 本紙&amp;尺度適用中國S家標沣(CNS ) A4虼格(210 乂 297公釐) 1235157 AT B7 五、發明説明(681 ) M濟部中夬樣隼局員X消贤合作社印¾. + S CN CVJ 1—1 VD 卜 VD 〇4 3: CN in σ\ r-H CO 卜 &lt;N &lt;JP O GO σ\ σ\ 卜 3: X CO (Tk 卜 00 m CVJ . &lt;r CN CN U5 Cu X σ&gt; Ο m 2: »Η U VO CN 3C VO CNJ U CPl 〇 uO 2 04 CN 32 s C4 (J 3 。^=〇 。择 s ^ 〇Λ 9, X ix 。=〇=〇 丫 s、 oo^o n X ^3 σ\ in tH σ\ (請先緊讀背云之注意事項再填寫本一貝) -684- 本紙伕尺度適用中g國家標窣(CNS ) A4現格(210X297公釐) 1235157 A7 B7 五、發明説明(682) 經濟部中夬標洋局員工消费合作杜印裳 ^ Z ^ + S Γ η m 、 σ\ VO L〇 〇1 X ζ »-1 CO m c\ cn &lt;D CN 〇P 々 CJN r—&lt; 〇\ r—4 00 S S CO c\i fH L〇 m m o m C&amp;4 2 c\ 〇 2 &lt;N4 5: 々 CM L&gt; σ\ 〇 2: 00 CVi X VO CVi CJ 赛 5 §x 〇=〇=〇 〇Y^Cx 〇 X 〇&lt;r ^%=〇 s o 工 cn Ί: ^3 &lt;0 t-H σ\ vo VD rH σ\ cd tH σι vo \ r- t-C σι (請先閱讀背®之2意事項再填寫本頁) 訂 -685- 本紙法尺度適用中國國家標嗥(CNS ) A4堤格(210X 297公釐) 1235157 Λ7 B7 五、發明説明(683) 經濟部中央糅达局員工消贤合作杜印¾ ^ 1 X m σι rH VO 、 η· σ\ L〇 uO CU X CN 〜 dQ r-l rH CN4 dP cn t-i ο σν 卜 σ&gt; S 2 〇 L〇 σ\ m CN ιΠ ιΠ ΓΟ ιη CS4 2 (Tk 〇 2 CN »H U 令 04 rr Csi u 00 芝 CM 3: CV] U 5 〇=0=〇 〇V2:n^Cx s。女 ϋ Q X ξχ Ο=〇=ο Υ^ζχ 8 ^ &lt;α 00 rH σι r-i as -686- 本纸法尺度適用中国國家標李(CNS ) Α4現格(210 X297公釐) (請斧k讀背云之:;·χ意事項再填寫本一貝 訂 4 1235157 _____B7 五、發明説明(684) -687- 本纸浃尺度通用13國家標孪(CNS Μ4規格(210 X 297公+ ^ 1 X BU 〇mu〇 ,, in ro VO L〇0 w CU re CM dP 卜 \ τ-ι α \ cn 00 «-λ · &lt; \ i dP CO &lt; n CO (Ti in VO 3 : S rH l〇VO CM in m 'L〇 • c \ m in iu s σ \ 〇§ CM 5 CN 〇CO 〇vn 奈 CVJ re VD CVJ U 〇 = C ^ = °? O' ° = ^ V = = 〇y ^ C: r. \; T 9, X CN4 (Λ m tH (Please read the precautions on the back δ before filling this page) Pack 1- d -683- This paper &amp; scales are applicable to China S house standard 沣(CNS) A4 grid (210 乂 297 mm) 1235157 AT B7 V. Description of the invention (681) M Printed by the Ministry of Economic Affairs of the People's Republic of China X Xuanxian Cooperative Club ¾. + S CN CVJ 1-1 VD bu VD 〇4 3: CN in σ \ rH CO &lt; N &lt; JP O GO σ \ σ \ bu 3: X CO (Tk bu 00 m CVJ. &Lt; r CN CN U5 Cu X σ &gt; 〇 m 2: »m U VO CN 3C VO CNJ U CPl 〇uO 2 04 CN 32 s C4 (J 3. ^ = 〇. Choose s ^ 〇Λ 9, X ix. = 〇 = 〇 丫 s, oo ^ on X ^ 3 σ \ in tH σ \ (Please read the precautions of the back cloud first and then fill out this one) -684- The standard of this paper is applicable to the national standard (CNS) A4 (210X297 mm) 1235157 A7 B7 V. Description of the invention (682 ) Du Yinshang, Consumer Co-operation of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the People's Republic of China ^ Z ^ + S Γ η m, σ \ VO L〇〇1 X ζ »-1 CO mc \ cn &lt; D CN 〇P 々CJN r— &lt; 〇 \ r—4 00 SS CO c \ i fH L〇mmom C & 4 2 c \ 〇2 &lt; N4 5: 々CM L &gt; σ \ 〇2: 00 CVi X VO CVi CJ Race 5 §x 〇 = 〇 = 〇〇Y ^ Cx 〇X 〇 &lt; r ^% = 〇so Engineering Ί: ^ 3 &lt; 0 tH σ \ vo VD rH σ \ cd tH σι vo \ r- tC σι (Please read the (Please fill in this page for 2 items of interest) Re-685- The standard of this paper is applicable to China National Standard (CNS) A4 Tige (210X 297 mm) 1235157 Λ7 B7 V. Description of Invention (683) Cooperation with India ^ ^ 1 X m σι rH VO, η · σ \ L〇uO CU X CN ~ dQ rl rH CN4 dP cn ti ο σν σ &gt; S 2 〇L〇σ \ m CN ιΠ ιΠ ΓΟ ιη CS4 2 (Tk 〇2 CN »HU order 04 rr Csi u 00 Chi CM 3: CV] U 5 〇 = 0 = 〇〇V2: n ^ Cx s. Daughter-in-law QX ξχ Ο = 〇 = ο Υ ^ ζχ 8 ^ &lt; α 00 rH σι ri as -686- The scale of this paper method is applicable to Chinese national standard plum (CNS) Α4 standard (210 X297 mm) (Please axk Read the back of the cloud:; · Please fill in the meaning of the item 4 1235157 _____B7 V. Description of the invention (684) -687- The standard of this paper is 13 national standards (CNS M4 specification (210 X 297)

+ ^ 1 X VO ο VO m 、 r—4 &lt;J\ 卜 U〇 Οι X CNJ dP 〇D as a\ to CNJ dP Γ- ^ C\| ON CO 卜 1 r-l U〇 VO cn uO CVJ tO iD L〇 iu ① 2 2 2: in CN U 〇 t-H o 2 v£&gt; CN S Co CVJ u X O X °^t° Φ; r。、 X o工 °&lt;^° Y^Cx °^V° 嘯 λ3 ▼ o &lt;N a\ rH CN 經濟部中夬櫺隼局員工消费合作社印裝 1235157 AT B7 五、發明説明( 經濟部中夬標準局員工消贤合作社印¾. + ^ ! 2 αο CO 卜 tn 令^ ί Ή ^ W Οι s -^ 〇 ^ o t-H s 2 VO tn 々 tn in Cu 2 σ\ 〇 i m 22 卜 Csi U X τ O' °=Q=o 〇Y^C 工 s。次 9, ci X £ rr cs VO \ C4 CM σι -688- 本紙伕尺度適用中US家標李(CNS ) A4現格(2丨0x29?公釐) 請先閱讀背云之注意事項再填寫.尽一3; 訂 d 1235157 A7 B7 經濟部尹夬糅箪局員二消费合作杜印製+ ^ 1 X VO ο VO m, r—4 &lt; J \ 卜 U〇〇ι X CNJ dP 〇D as a \ to CNJ dP Γ- ^ C \ | ON CO bu 1 rl U〇VO cn uO CVJ tO iD L〇iu ① 2 2 2: in CN U 〇tH o 2 v £> CN S Co CVJ u XOX ° ^ t ° Φ; r. 、 X o 工 ° &lt; ^ ° Y ^ Cx ° ^ V ° Xiao λ3 ▼ o &lt; N a \ rH CN Printed by the Consumers' Cooperatives of the Zhongli Bureau of the Ministry of Economic Affairs 1235157 AT B7 V. Description of the invention (in the Ministry of Economic Affairs印 Institute of Consumer Standards Cooperative of Standard Bureau ¾. + ^! 2 αο CO 卜 tn 令 ^ ί ^ W Ο s-^ 〇 ^ o tH s 2 VO tn 々tn in Cu 2 σ \ 〇im 22 bu Csi UX τ O '° = Q = o 〇Y ^ C 工 s. Times 9, ci X £ rr cs VO \ C4 CM σι -688- The standard of this paper is applicable to the Chinese house standard Li (CNS) A4 (2 丨 0x29? (Mm) Please read the precautions of Back Cloud before filling in it. Ex. 3; Order d 1235157 A7 B7 Yin Yin Bureau of the Ministry of Economic Affairs 2 Consumption Cooperation Du printed

本紙ft尺度遇用中S國家標荜(CNS ) A4故格(210X297公釐) (請先閱讀背δ之:V』意事項再填寫本頁)The ft scale of this paper meets the national standard of China S (CNS) A4 (210X297 mm) (please read the information on the back of δ: V, and then complete this page)

1235157 Λ7 3^ 五、發明説明( 687) 步驟A。401之合成,TentaGelS、®NH2樹脂(0.25毫莫耳/ 克,6.8克)置於玻璃震ϋ容器内,以二甲基乙醯胺洗滌(3 X 20毫升)。對400 (1.70克,2.9毫莫耳,製備自(3S) 3-(篥 基甲氧裝基)-4-銅基丁酸第三-丁黯,依據A.M. Murphy et. al. J. Am· Chem. Soc·· 114, 3 156-3 157 (1992))於二曱基乙醯 胺(15毫升)之溶液,加入〇-苯並三0i -N,N,NfNf-四甲基鏘六 氣璘酸(HBTU; 1.09克,2.9毫莫耳)及DIEA(1.0毫升,5.7 毫莫耳)。溶液加至樹脂中,再加二甲基乙醯胺(5毫升)3 反應混合物在室溫下利用腕臂式震盪器攪動3小時3樹脂 以吸空過濾法分離,再以二甲基乙醯胺洗滌(6 X 20毫升) 3樹脂(2.4毫克)樣品以50%甲醇於二氣曱烷充份洗滌,再 於吸氣下乾燥。利用20%六氫吡啶/二甲基乙醯胺(10.0毫 升)將Fmoc基去保護,再以UV分析溶液顯示0.19毫莫耳/克 之置換3 經濟部中夬樣準局貝工消f合作杜印裝 步驟B。903之合成。樹脂401以20% (Wv)六氫吡啶/二曱 基乙醯胺(20毫升)去保護10分鐘(震盪),再以新鲜的六氫 吡啶試劑(20毫升)歷10分鐘3樹脂再以二曱基乙醯胺洗滌 (6 X 20毫升)。902 (1.52克,2.81毫莫耳)之溶液以HBTU (1.07克,2.83毫莫耳)及DIEA(1.0毫升,5.7毫莫耳)處理, 並轉移至樹脂,再以二甲基乙醯胺(5毫升)處理a反應混 合物在室溫下利用腕臂式震盪i攪拌2.5小時。樹脂以吸 空過濾法分離,並以二甲基乙醯胺(4 X 20毫升)及二氣甲 烷(4 X 20毫升)洗滌,再於氮充氣下乾燥3如401所述般進 行樹脂之置換,並決定是0.169毫莫耳/克。 -690- 本紙伕尺度逋用中3國家標李(CNS) A4現漆(2丨公釐) 1235157 Λ7 _____B7__ 五、發明説明(6肪) 步骤C,905之合成。樹脂903 ('7.54克,1.27毫莫耳)及 dimedone(2.l9克,15.6毫莫耳)置於1〇〇毫升圓底燒瓶内, 再加新鮮蒸餡的無水四氫呋喃(60毫升)。加入肆(三苯膦) 化鈀(0)(0.32克,0.28毫莫耳),並將以氮掩蓋且密封之反 應在腕臂作用之震盪槽上攪動15小時。樹脂過濾,以二甲 基乙醢胺(4 X 20毫升),二氯甲烷(4 X 20毫升)及二曱基乙 醯胺(1 X 20毫升)洗滌。加充份的二曱基乙醯胺至樹脂, 以得於漿,再加入吡啶(1.5毫升,18.5毫莫耳)及904 (5.5毫 莫耳)於二氣甲烷(10毫升)之溶液。反應在氮下震盪8小時 ,再過濾。樹脂以二甲基乙醯胺(5 X 20毫升)及二氣甲烷 (5 X 20毫升)洗滌。 步驟D。906之合成。此化合物製備自樹脂905 (0·24克, 0.038毫莫耳)利用 Advanced ChemTech 396 Multiple Peptide 合成儀a自動化循環包括:以二甲替甲醯胺(3 XI毫升)洗 滌,以25% (v/v)六氩吡啶/二甲替甲醯胺(1毫升)去保護歷 10分鐘,再以新鮮試劑(1毫升)歷20分鐘以生成樹脂906。 樹脂以二甲替甲醯胺(3 X 1毫升)及N-甲基吡咯啶酮(3 X 1 毫升)洗滌。 經濟部中夬標隼局員工消费合作社印装 步驟 Ε。(910·922)樹脂 906以 0.4Μ甲酸及 0.4Μ ΗΟΒΤ於 Ν-甲基吡咯啶酮(〇·5毫升)之溶液,及ι.6Μ 01£八於1^-曱基吡 咯啶酮(0.25毫升)之溶液醯化,且反應在室溫下震盪2小時 3樹脂以Ν-曱基吡咯啶酮(1 X 1毫升),二甲替甲醯胺(4 X 1毫升),50%甲醇於二氣甲烷(5 XI毫升)洗滌,再風乾。 醛自樹脂中解離,並以95% TFA/5% Η20 (ν/ν , 1.5毫升)在 •691 - 本紙掁尺度適用申国國家標孳(CNS &gt;八4思格(2丨0/ 297公釐1 — &quot;~&quot; 1235157 Λ7 B7 五、發明説明(689 ) 室溫下處理30分鐘而大鳢地去保謹。以解離試劑(2 X 1毫 升)洗滌樹脂後,混合的濾液加至冷的1:1乙醚:己浣(35毫 升)中,生成的沈澱物再離心及傾析地分離3生成的團塊 溶於乙腈(0.5毫升)&amp;H20 (0.5毫升)並經由0.45微米微量離 心濾器過濾。化合物以半一製備式RP-HPLC純化,利用 Rainin MicrosorbTM C18管柱(5微米,21·4 X 250毫米)以含 有0.1%TFA(v/v)之線性乙腈悌度(ι〇%〇00/〇)溶離,12毫升/ 分3含有欲求產物之流份匯集及冷凍乾燥可生成910-922。 分析HPLC方法: (1) Waters DeltaPak C18, 300A (5微米,3·9 X 150毫米)a tJL線乙腈梯度(〇%-25%)含有0.1%TFA(v/v)歷14分鐘,1毫 升/分。 (2 ) Waters DeltaPak C18,300A (5微米,3.9 X 150毫米)。 直線乙膀梯度(5%-45%)含有0.1%TFA(Wv;^14分鐘,1毫 升/分3 (锖先閱讀背云之注意事項再填寫大二貝)1235157 Λ7 3 ^ V. Description of the invention (687) Step A. For the synthesis of 401, TentaGelS, NH2 resin (0.25 mmol / g, 6.8 g) was placed in a glass shaker container and washed with dimethylacetamide (3 x 20 ml). For 400 (1.70 g, 2.9 millimoles, prepared from (3S) 3- (fluorenylmethoxide) -4-copperylbutyric acid tertiary-butanone, according to AM Murphy et. Al. J. Am · Chem. Soc ·· 114, 3 156-3 157 (1992)) in a solution of difluorenylacetamide (15 ml), and 0-benzotrioi-N, N, NfNf-tetramethylfluorene hexakis Gallic acid (HBTU; 1.09 g, 2.9 mmol) and DIEA (1.0 ml, 5.7 mmol). The solution was added to the resin, and then dimethylacetamide (5 ml) was added. The reaction mixture was stirred at room temperature for 3 hours using a wrist-arm shaker. The resin was separated by vacuum filtration, and then dimethylacetamidine was used. Washed with amine (6 x 20 ml). 3 Resin (2.4 mg). The sample was washed thoroughly with 50% methanol in dioxane and then dried under inhalation. The Fmoc group was deprotected with 20% hexahydropyridine / dimethylacetamide (10.0 ml), and the analysis by UV analysis solution showed a substitution of 0.19 mmol / g. Printing step B. Synthesis of 903. Resin 401 was deprotected with 20% (Wv) hexahydropyridine / dimethylacetamide (20 ml) for 10 minutes (shock), and then fresh hexahydropyridine reagent (20 ml) was used for 10 minutes. Washed with amidacetam (6 x 20 ml). A solution of 902 (1.52 g, 2.81 mmol) was treated with HBTU (1.07 g, 2.83 mmol) and DIEA (1.0 ml, 5.7 mmol), transferred to the resin, and then treated with dimethylacetamide ( 5ml) Treatment a The reaction mixture was stirred at room temperature for 2.5 hours using a wrist-arm shaker. The resin was separated by suction filtration, washed with dimethylacetamide (4 X 20 ml) and digas methane (4 X 20 ml), and dried under nitrogen aeration. 3 Replace the resin as described in 401. And decided to be 0.169 millimoles / g. -690- The standard of this paper is Chinese 3 national standard plum (CNS) A4 lacquer (2 丨 mm) 1235157 Λ7 _____B7__ 5. Description of the invention (6 fats) Synthesis of step C, 905. Resin 903 ('7.54 g, 1.27 mmol) and dimedone (2.19 g, 15.6 mmol) were placed in a 100 ml round-bottomed flask, and freshly steamed stuffed anhydrous tetrahydrofuran (60 ml) was added. Add (triphenylphosphine) palladium (0) (0.32 g, 0.28 mmol), and stir with a nitrogen-covered and sealed reaction on the oscillating groove of the wrist for 15 hours. The resin was filtered and washed with dimethylacetamide (4 X 20 ml), dichloromethane (4 X 20 ml) and dimethylacetamide (1 X 20 ml). Add sufficient diethylammonium amine to the resin to obtain a slurry, and then add a solution of pyridine (1.5 ml, 18.5 mmol) and 904 (5.5 mmol) in methane (10 ml). The reaction was shaken under nitrogen for 8 hours and then filtered. The resin was washed with dimethylacetamide (5 X 20 ml) and methane (5 X 20 ml). Step D. Synthesis of 906. This compound was prepared from resin 905 (0.24 g, 0.038 mmol) using an Advanced ChemTech 396 Multiple Peptide synthesizer. An automated cycle includes: washing with dimethylformamide (3 XI ml), and 25% (v / v) Hexapyridine / dimethylformamidine (1 mL) was deprotected for 10 minutes, and then fresh reagent (1 mL) was added for 20 minutes to form resin 906. The resin was washed with dimethylformamidine (3 X 1 ml) and N-methylpyrrolidone (3 X 1 ml). Printed by the Consumers' Cooperatives of the Ministry of Economic Affairs, China Standards Bureau. Step Ε. (910 · 922) Resin 906 with 0.4M formic acid and 0.4M ΒΒΤ in a solution of N-methylpyrrolidone (0.5 ml), and ι. 6M 01 八 y-pyridylpyrrolidone (0.25 The solution was triturated and the reaction was shaken at room temperature for 2 hours. 3 The resin was treated with N-methylpyrrolidone (1 X 1 mL), dimethylformamide (4 X 1 mL), and 50% methanol in Wash with methane (5 XI ml) and air-dry. The aldehyde dissociates from the resin and is 95% TFA / 5% Η20 (ν / ν, 1.5 ml) at • 691-this paper is compliant with the national standard of Shen Guo (CNS &gt; 8 4 Sig (2 丨 0/297 Mm 1 — &quot; ~ &quot; 1235157 Λ7 B7 V. Description of the invention (689) Treat at room temperature for 30 minutes without disdain. After washing the resin with dissociation reagent (2 X 1 ml), add the mixed filtrate and add In cold 1: 1 ether: hexane (35 ml), the resulting precipitate was separated by centrifugation and decantation. 3 The resulting pellet was dissolved in acetonitrile (0.5 ml) &amp; H20 (0.5 ml) and passed through 0.45 μm. Filtration with a microcentrifugal filter. Compounds were purified by semi-preparative RP-HPLC using a Rainin MicrosorbTM C18 column (5 micron, 21.4 x 250 mm) at a linear acetonitrile content of 0.1% TFA (v / v). 〇% 〇00 / 〇) dissociation, 12 ml / min 3 Fractions containing the desired product are pooled and freeze-dried to produce 910-922. Analytical HPLC method: (1) Waters DeltaPak C18, 300A (5 microns, 3. 9 X 150 mm) a tJL line acetonitrile gradient (0% -25%) containing 0.1% TFA (v / v) for 14 minutes, 1 ml / min. (2) Waters DeltaPak C18, 300A ( 5 micron, 3.9 X 150 mm). Linear linear gradient (5% -45%) contains 0.1% TFA (Wv; ^ 14 minutes, 1 ml / min3 (锖 Please read the precautions for back cloud before filling in the second shell) )

LL

TT

I 經濟部申夬標進局員工消费合作杜印装 (3S)-3-[(3S)-2-銅基-3-(異喹啉-卜醯基)胺基〇-羥基乙醯基-2,3,4,5-四氫-1Η-1,5·苯並二氮雜箪-卜乙醯胺基]-4-酮基-丁 酸(696),以由600b製備691a之方法合成自600b,可生成 696。NMR (CD3OD) J 2.45 (in,1H),2·7 (m,1H),3.75 (d, -692- 本纸ft尺度適用ts國家標導(CNS ) A4現格(21〇'&lt;297公釐 1235157 _B7_ 五、發明説明U90) 1H), 3.95 (q, 1H), 4.05 (d, 1H), 4.3'(m, 1H), 4.45-4.65 (m, 2H), 5.05 (m, 1H), 7.5-7.76 (m, 3H), 7.7 (t, 1H), 7.8 (t, 1H), 7.98 (t, 1H), 8.55 (d, 1H), 9.1 (d, 1H) ^I Consumption cooperation between employees of the Ministry of Economic Affairs and the Bureau of the Bureau Du Yinzhuang (3S) -3-[(3S) -2-copperyl-3- (isoquinoline-butyryl) amino group 0-hydroxyethylamyl-2,3, 4,5-tetrahydro-1Η-1,5 · benzodiazepine-buethamido] -4-one-butyric acid (696), synthesized from 600b by the method of preparing 691a from 600b, but Build 696. NMR (CD3OD) J 2.45 (in, 1H), 2 · 7 (m, 1H), 3.75 (d, -692- ft scale applicable to ts national standard (CNS) A4 (21〇 '&lt; 297 1235157 mm_B7_ V. Description of the invention U90) 1H), 3.95 (q, 1H), 4.05 (d, 1H), 4.3 '(m, 1H), 4.45-4.65 (m, 2H), 5.05 (m, 1H) , 7.5-7.76 (m, 3H), 7.7 (t, 1H), 7.8 (t, 1H), 7.98 (t, 1H), 8.55 (d, 1H), 9.1 (d, 1H) ^

696· Rl- ^ogp 69«c R1-^ 696bRl- ^QQ . (3S)-2-萌基-3-(異》-1 -縫基)腰基-5-沒基乙酷基-N· [(2反5,。5)-卞乳基-5-萌基-四氮这夫喘-3-基]-2,3,4,5-四氛-111-1,5-苯並二氮雜箪-1-乙醢胺(696a)利用甴600b製備690a之 方法,合成自 600b,可生成 696a。4 NMR (CDC13) d 0.95 經濟部令夬標隼局員工消費合作杜印製 (t, 2H), 1.25 (t, 1H), 1.4 (m, 2H), 1.55 (m, 1H), 2.55 (m, 1H), 2.85 (m, 1H), 2.95 (dd, 1H), 3.15 (m, 1H), 3.55 (m, 1H), 3.9 (m, 2H), 4.35 (t, 1H), 4.4-4.55 (m, 2H), 4.75 (m, 1H), 4.8-5.05 (m, 2H), 5.45 (s, 1H), 5.55 (d, 1H), 6.85 (d, 1H), 7.15 (d, 1H)T 7.2-7.5 (m, 5H), 7.6-7.8 (m, 3H), 8.45 (d, 1H), 9.05 (d, 1H), 9.35 (d, 1H) ^ (3S)-2-酮基-3-(異喹啉-1-醯基)胺基-5-羥基乙醢-N- -693- 本紙法尺度通用中31國家標孪(CNS ) A4堤格(210 ,&lt;297公慶) 1235157 A7 — B7 五、發明説明(691 ) [(2RS,3S) -乙氧基-5-嗣基-四氫決喃-3-基]-2,3,4,5-四氫]η. 1,5-苯並二氮雜箪-1-幾醢胺(696a),利用甴600b製锜690a 之方法合成自600b,可生成696b。4 NMR (CDCl;) j 0 9 (m, 3H), 1.15 (q, 3H), 1.15 (m, 1H), 1.65 (m, 1H), 2.5 (m, 1H), 2.8 (m, 1H), 2.95-3.0 (m, 2H), 3.6 (m, 2H), 3.7-3.85 (m, 4H), 4.0 (m, 2H), 4.3 (m, 1H), 4.55 (m, 1H), 4.65 (m, 1H), 4.85-4.95 (m, 1H), 5.05 (m, 1H), 5.35 (s, 1H), 5.45 (d, 1H), 6.85 (d, 1H), 7.25 (d, 1H), 7.35-7.85 (6H), 8.85 (dd, 2H)? 9.05 (m, 1H), 9.35 (dd, 2H) ^ (3S)-2-嗣基-3-(異咬琳-1-酿基)胺基- 5-¾基乙酷基-[2RS-(4-氣卞基)乳基嗣基-四氮咬喊-3 -基]-2,3,4,5-θ^-1Η-1,5· 苯並二氮雜箪-1-羧醯胺(696c),利用由600b製備690a之方 法合成自 600b,可生成 696c 3 旧 NMR (CD3OD) d 1·25 (t, 1H), 1.65 (q, 1H), 1.9 (m, 1H), 2.9 (m, 1H), 3.05 (m, 1H), 3.9 (d, 1H), 4.2 (m, 1H), 4.3 (d, 1H), 4.7-5.0 (m, 3H), 5.25 (m, 1H),5·7 (s,1H),5.9 (d,1H), 7.5 (d,2H),7·7·7·9 (m, 3H),8.0 (t, 1H), 8.2 (m, 2H), 8.75 (d, 1H), 9.35 (d, 1H) ^ 經濟部,?夬標隼局員工消費合作社印¾ (訝先翊讀背&amp;之注意事礦弄填寫大二貝) (3S)-2-酮基-3-(異喹啉-卜醯基)胺基-5-羥基乙醯基-(2RS-環 戍氧基酮基-四氫呋喃-3-基)-2,3,4,5-四氫-1H-1,5-笨並二 氮雜箪羧醢胺(696d),利用由600b製備690a之方法合成 自 600b,可生成 696d。lH NMR*(CDC13) d 0.9 (t,1H),1.2 (t, 1H), 1.3-1.45 (m, 2H), 1.6-1.8 (m, 4H), 2.45 (m, 1H), 2.8 (m,1H),3.0 (m, 1H),3.4 (q,1H), 3.5 (d,1H),4.0 (m,2H), 4.2-4.3 (m,2H), 4.55 (d,1H),4.65 (m, 1H),4.9 (m,1H), 5.05 -694- 本纸抶尺度適用中國a家標达(CNS ) A4規格(210X 297公釐) 1235157 Λ 7 Β7___ 五、發明説明( 692) (m,1Η), 5.4 (s, 1Η),5.5 (d,1Η),6.8 (d,1Η),7.3-7.9 (m,6Η), 8.5 (d, lH),9.05 (d,1H),9.4 (d,1H)。 (3S)-2-酮基-3-(異嶮啉-1-醯基)胺基-5-羥基乙醯基-N-[(2RS,jS)-尽乙乳基-5-明基-四風啥喘-3-基]-2,3,4,5-四氣** 1H-1,5-笨並二氮雜箪-1-乙醯胺(696e),利用甴600b製備 690a之方法合成自600b,可生成696e。NMR (CDCl3) 1·2 (t,1H),2.4 (m,1H),2.8 (m,2H),3.6 (d,1H),3.7 (q,1H), 4.0 (m, 2H), 4.3 (d, 2H), 4.65 (m, 1H), 4.85 (t, 1H), 5.0 (m, 1H), 5.35 (d, 1H), 6.5 (d, 1H), 7.15-7.85 (m, 8H), 8.45 (d, 1H),9,05 (d,1H),9.4 (d, 1H)。 (請先聞讀背面之么意事^再填寫本頁) 經濟部中夬糅华局員工消費合作杜印製 -695- 本泜伕尺度適;?!中國國家標導(&quot;cG &gt; A4規洛(2!0 X 29?公釐i 1235157 7 7 Λ Β 五、發明説明( 693 ) 經濟部中夬標隼局員工消费合作杜印製 化合物 UV-可見光 Ki (nM) Cell PBMC avg. IC50 (nM) 人類 全血 IC50 (nM) 老鼠清除 率,i.v· 毫升/分/公斤 大鼠清除* · 率,i.v· 毫升/分/公斤 688c 200 % 689b-l 3.5 2700 696-1 0-5 696-2 0.5 - 697 1.8 5000 698 18 13500 699 1.1 699a-2 720 2-7 721 1.3 5000 722 5 5000 723 2.3 2000 * 724 2 1800 725 3.7 3000 726 300 727 50 2300 728 300 729 28 2800 730 90 8000 * 731 150 732 5 1800 733 5 1500 734 9 6000 735 6 10000 -696- 本紙伕尺度適用中g國家標李(CNS ) Α4規烙(210Χ 297公慶) 1235157 Λ7 - ____ B7_ 五、發明説明(694 ) 實例3 3、 化合物 684a,688b-l,688c,689b-l,690a-l,696-1, 696-2,696a-2,696a-l,697,697a,698,698a,699, 699a,699a-l,699a-2,800及 801如下述地製備。 (請先聞讀背云之泾意事項再填寫衣頁) 經濟部中央樣並局員工消费合作让印裝 CIP# R4 R3 R5 R1 684a H 0 x^OtBu OAc 688b-l CH3 o Me〇_^ F 4 688c 0 MeO_^ H 0 々OH Λτ^ P ό 689b-l CH3 ? .矿 CH3 0 F 0 ^OH &quot;V 690a-l 〇h 0 H〇^ H 〇 A〇et -A^oet OEt R5696 · Rl- ^ ogp 69 «c R1- ^ 696bRl- ^ QQ. (3S) -2-Mengyl-3- (iso" -1 -Slit base) Waist base-5-Methylethoxy-N · [(2trans-5, .5) -fluorenyl-5-meneyl-tetraazepine-3-yl] -2,3,4,5-tetrahydro-111-1,5-benzobis Azapyridine-1-acetamidamine (696a) is a method for preparing 690a by using 600b, which is synthesized from 600b, and can produce 696a. 4 NMR (CDC13) d 0.95 Printed by the Ministry of Economic Affairs of the Ministry of Economic Affairs and Staff for Consumer Cooperation (t, 2H), 1.25 (t, 1H), 1.4 (m, 2H), 1.55 (m, 1H), 2.55 (m , 1H), 2.85 (m, 1H), 2.95 (dd, 1H), 3.15 (m, 1H), 3.55 (m, 1H), 3.9 (m, 2H), 4.35 (t, 1H), 4.4-4.55 ( m, 2H), 4.75 (m, 1H), 4.8-5.05 (m, 2H), 5.45 (s, 1H), 5.55 (d, 1H), 6.85 (d, 1H), 7.15 (d, 1H) T 7.2 -7.5 (m, 5H), 7.6-7.8 (m, 3H), 8.45 (d, 1H), 9.05 (d, 1H), 9.35 (d, 1H) ^ (3S) -2-keto-3- ( Isoquinoline-1-fluorenyl) amino-5-hydroxyacetamidine-N- -693- This paper method is commonly used in the 31 national standard (CNS) A4 Tiger (210, &lt; 297 Public Holiday) 1235157 A7 — B7 V. Description of the invention (691) [(2RS, 3S) -ethoxy-5-fluorenyl-tetrahydrodecan-3-yl] -2,3,4,5-tetrahydro] η, 1,5 -Benzodiazepine-1-epioxamine (696a), synthesized from 600b by the method of fluorene 690a made of fluorene 600b, which can produce 696b. 4 NMR (CDCl;) j 0 9 (m, 3H), 1.15 (q, 3H), 1.15 (m, 1H), 1.65 (m, 1H), 2.5 (m, 1H), 2.8 (m, 1H), 2.95-3.0 (m, 2H), 3.6 (m, 2H), 3.7-3.85 (m, 4H), 4.0 (m, 2H), 4.3 (m, 1H), 4.55 (m, 1H), 4.65 (m, 1H), 4.85-4.95 (m, 1H), 5.05 (m, 1H), 5.35 (s, 1H), 5.45 (d, 1H), 6.85 (d, 1H), 7.25 (d, 1H), 7.35-7.85 (6H), 8.85 (dd, 2H)? 9.05 (m, 1H), 9.35 (dd, 2H) ^ (3S) -2-fluorenyl-3- (isoteolin-1-vinyl) amino-5 -¾Acetoyl- [2RS- (4-Arylidene) lactylpyridyl-tetrazineyl-3 -yl] -2,3,4,5-θ ^ -1Η-1,5 · benzo Diazapyridine-1-carboxamide (696c), synthesized from 600b by the method of preparing 690a from 600b, can generate 696c 3 old NMR (CD3OD) d 1 · 25 (t, 1H), 1.65 (q, 1H) , 1.9 (m, 1H), 2.9 (m, 1H), 3.05 (m, 1H), 3.9 (d, 1H), 4.2 (m, 1H), 4.3 (d, 1H), 4.7-5.0 (m, 3H ), 5.25 (m, 1H), 5.7 (s, 1H), 5.9 (d, 1H), 7.5 (d, 2H), 7.7.7 · 9 (m, 3H), 8.0 (t, 1H ), 8.2 (m, 2H), 8.75 (d, 1H), 9.35 (d, 1H) ^ Printed by the Ministry of Economic Affairs, the Consumers' Cooperatives of the Bureau of Standards and Labor Bureau 讶 (Suddenly read the back & note and fill in Big dibe) (3S) -2-keto- 3- (isoquinoline-butyryl) amino-5-hydroxyethylfluorenyl- (2RS-epoxymethoxyketo-tetrahydrofuran-3-yl) -2,3,4,5-tetrahydro-1H-1 , 5-Benzodiazepinecarboxamide (696d), synthesized from 600b by the method of preparing 690a from 600b, can produce 696d. lH NMR * (CDC13) d 0.9 (t, 1H), 1.2 (t, 1H), 1.3-1.45 (m, 2H), 1.6-1.8 (m, 4H), 2.45 (m, 1H), 2.8 (m, 1H), 3.0 (m, 1H), 3.4 (q, 1H), 3.5 (d, 1H), 4.0 (m, 2H), 4.2-4.3 (m, 2H), 4.55 (d, 1H), 4.65 (m , 1H), 4.9 (m, 1H), 5.05 -694- The standard of this paper is applicable to China a standard (CNS) A4 specification (210X 297 mm) 1235157 Λ 7 Β7 ___ 5. Description of the invention (692) (m, 1Η), 5.4 (s, 1Η), 5.5 (d, 1Η), 6.8 (d, 1Η), 7.3-7.9 (m, 6Η), 8.5 (d, lH), 9.05 (d, 1H), 9.4 (d , 1H). (3S) -2-keto-3- (isofluorin-1-yl) amino-5-hydroxyethylfluorenyl-N-[(2RS, jS) -Ethyllactyl-5-benzyl-tetra Fenghanchuan-3-yl] -2,3,4,5-tetrakis ** 1H-1,5-benzodiazepine-1-acetamidine (696e), a method for preparing 690a by using 600b Synthesized from 600b, it can generate 696e. NMR (CDCl3) 1.2 (t, 1H), 2.4 (m, 1H), 2.8 (m, 2H), 3.6 (d, 1H), 3.7 (q, 1H), 4.0 (m, 2H), 4.3 ( d, 2H), 4.65 (m, 1H), 4.85 (t, 1H), 5.0 (m, 1H), 5.35 (d, 1H), 6.5 (d, 1H), 7.15-7.85 (m, 8H), 8.45 (d, 1H), 9,05 (d, 1H), 9.4 (d, 1H). (Please read what's on the back ^ before filling out this page) Printed by the China-China Bureau of Consumer Affairs, Ministry of Economic Affairs, Du printed -695- The standard is appropriate;?! China National Standards (&quot; cG &gt; A4 gauge (2! 0 X 29? Mm i 1235157 7 7 Λ Β V. Description of the invention (693) Employees in the Ministry of Economic Affairs of the Ministry of Economic Affairs and Standards Bureau consumer cooperation Du printed compounds UV-visible light Ki (nM) Cell PBMC avg. IC50 (nM) human whole blood IC50 (nM) rat clearance, iv · ml / min / kg rat clearance * · rate, iv · ml / min / kg 688c 200% 689b-l 3.5 2700 696-1 0-5 696-2 0.5-697 1.8 5000 698 18 13500 699 1.1 699a-2 720 2-7 721 1.3 5000 722 5 5000 723 2.3 2000 * 724 2 1800 725 3.7 3000 726 300 727 50 2300 728 300 729 28 2800 730 90 8000 * 731 150 732 5 1800 733 5 1500 734 9 6000 735 6 10000 -696- The standard of this paper is applicable to the national standard plum (CNS) Α4 gauge (210 × 297 public holiday) 1235157 Λ7-____ B7_ V. Description of the invention (694) Example 3 3. Compounds 684a, 688b-l 688c, 689b-1, 690a-1, 696-1, 696-2, 696a-2, 696a-1, 697, 697a, 698, 698a, 699, 699a, 699a-1, 699a-2, 800 and 801 are as follows (Please read and read the intentions of the back of the cloud before filling in the clothing page) The central sample of the Ministry of Economic Affairs and the employee's consumer cooperation for printing CIP # R4 R3 R5 R1 684a H 0 x ^ OtBu OAc 688b-l CH3 o Me〇_ ^ F 4 688c 0 MeO_ ^ H 0 々OH Λτ ^ P 689b-l CH3?. Mine CH3 0 F 0 ^ OH &quot; V 690a-l 〇h 0 H〇 ^ H 〇A〇et -A ^ oet OEt R5

-697- 本紙汝尺度通用中國國家標孪(CNS ) A4堤格(210X 297公釐) 1235157 A7 B7 五、發明説明(695 ) 經济部中央糅华局員工消费合作社印¾ CIP# R4 R3 、R5 R1 696-1 0 F 0 696-2 0 H〇Ji^ Cl XoH V 696a-2 0 H〇^ Cl 696a-l 0 F 4: 697 0 H 697a 0 H〇_l^ H 4: 698 hX H O ^OH 698a hA H Λ O日n 699 o H 0 产OH ^VH 699a MeO^^ H 4°0 OBn (請先聞讀背δ之注意事項再填寫本頁} -698- 衣呔&amp;尺度適用中SI國家標隼(CNS )人4逯格(210 X297公釐) 1235157-697- This paper is a standard of China National Standard (CNS) A4 Tige (210X 297 mm) 1235157 A7 B7 V. Description of the invention (695) Printed by the Consumer Affairs Cooperative of the Central China Bureau of the Ministry of Economic Affairs ¾ CIP # R4 R3, R5 R1 696-1 0 F 0 696-2 0 H〇Ji ^ Cl XoH V 696a-2 0 H〇 ^ Cl 696a-l 0 F 4: 697 0 H 697a 0 H〇_l ^ H 4: 698 hX HO ^ OH 698a hA H Λ O day n 699 o H 0 produced OH ^ VH 699a MeO ^^ H 4 ° 0 OBn (Please read the precautions of δ before filling in this page} -698- Clothing &amp;amp; size in use SI National Standard (CNS) 4 people (210 X297 mm) 1235157

(3S)-3-[(3S)-2-酮基-3-(3,5-二甲基羥基笮醯基)胺基羥 裏乙磁基-2,3,4,5-四氫-1H-1,5-苯並一氮雜苯小乙链胺基 ]4 4-二乙氧基丁酸乙酯(690a-1),以69〇3及21001?之製法合 成,可生成 690a-l JH NMR (CDC13) 〇' 1.15 (t,6H),1.3 (t, 經濟部t央標隼局貝工消费合作社印¾ 3H), 2.25 (s, 6H), 2.60 (d, 2H), 3.50 (m, 2H), 3.70 (m, 4H), 4.05 (m, 2H), 4.15 (m, 2H), 4.30 (d, 1H), 4.45 (m, lH), 4.d0 (d, 1H), 4.55 (d, 1H), 4.70 (t, 1H), 5.05 (m, iH), 5.3〇 (s, 1H), 6.70 (d, 1H), 7.10 (d, 2H), 7.30-7.50 (m, 7H) (3 5)-2-酮基-3-(3,5-二氣-4-胺基苄酿基)胺基-5-經基乙酷基· N-[(2RS,3S) 2-笮氡基小酮基-四氫呋喃-3-基]-2,3,4,5'四氫-1Η· 1,5-笨並二氮雜苯-卜乙醯胺(697a),利用677之製法合 成,可生成 840毫克的 697a,[Η NMR (CD3OD) 5 1.78 (br· -699- 本紙朵尺度適用中國國家橾李(〇^)六4規格(210&gt;&lt;37公釐) 1235157 A7 _ __B7______ 一 五、發明説明(697 ) s,2H),2.48-3.58 (d,0·5Η),2.6-2.7、(m,0·5Η),2·8-2·9 (m, 0.5Η), 2.92-3.03 (m, 0.5Η), 3.55-3.8 (m, 2H), 3.92-4.02 (d, 1H), 4.25-4.3 (d, 0.5H), 4.37-4.42 (d, 0.5H), 4.43-4.48 (m, 0.5H), 4.55-4.65 (m, 1.5H), 4.7o.l2 (m, 5H), 5.44 (s, 0.5H), 5.58-5.63 (d, 0.5H), 6.95-8.1 (m, 13H) ^ (3 5)-3-[(35)-2-酮基-3-(3,5-二氣-4-胺基芊醯基)胺_基-5-乙縫 基-2,3,4,5-四氫-1士1,5-苯並二氮雜箪-1-乙醯胺基】-4-酮基 丁酸(697),利用由2001製備2002之方法合成,可得140毫 克的 697, lH NMR (CD3OD) d 238-2.5 (m,1H),2.55-2.75 (m, 1H), 3.68-3.9 (m, 3H), 3.95-4.03 (m, 1H), 4.2-4.3 (m, 1H)? 4.4-4,7 (m,4H), 7.35-7.8 (m, 6H)。 (3S)-3-[(3S)-2-酮基-3-(3,5-二甲基-4-甲氧基苄醢基)铵基 經基乙酷基-2,3,4,5-四氫-1 Η-1,5·苯並二氣雜箪-1-乙酿胺 基】-4-乙醯氧基-3-丁烯酸乙酯(684a),利用2100j之製法合 成,可得684a,lH NMR (500 MHz,CDC13非對映立鳢異構 之混合物)β 1·3 (s, 9H),1.8 (s,3H),2.1 (s,3H),2·15 (s,3H), 2.3 (s,6H), 3.3-3.5 (m,3H),3·65 (s,3H),3·9 (m,1H),4·1 (d, 1H), 4.3 (d,1H),4.6-4.8 (m,3H),5.0 (m, 1H),6·7 (s, ih), 7.0 (d, 1H), 7.1 (d, 1H), 7.2-7.5 (m, 6H) « 經濟部令夬標华局員工消費合作社印¾ (3S)-2-酮基-3-異喹啉-1-醯基胺基-5-甲醯基-N-[(2RS,3S)-2_ 芊氧基-5-83基-四氫吃喃-3-基]-2,3,4,5-四氩-1FM,5-笨並 二氮雜箪·卜乙醯胺基(698a),利用652之製法合成,可生 成795毫克的698a,lH NMR (500 MHz, CDC13非對映立髏異 構之混合物)β 2·8 (m,2H),4·0 (m,1H),4.5-4.8 (m,4H),5.2 -700- 本紙伕尺度適用中国國家標孳(CNSM4故格(210·,&lt; 297公釐) 1235157 Λ 7 Β7___ 五、發明説明(698 ) ^ (m, 1H), 5.5 (s, 1H), 5.75 (d, 1H), 7^3-7.85 (m, ΠΗ), 7.9 (t, iH), 8.2 (d, 1H), 8.6 (m, 1H), 9.3 (m, 1H) 3 (3S)-3-[(3S)-2-酮基-3-異喹啉-1-醯基胺基-5-甲醯基-2,3,4, 5-四氫·1Η·1,5-苯並二氮雜箪-1-乙醯胺基卜4-酮基丁酸(698) ,利用653之製法合成,可生成225毫克的698,β NMR (500 MHz, CD3OD) d 2.4 (m, 1H), 2.6 (m, 1H), 3.9 (m, 1H), 4.2 (m? 1H), 4.3-4.7 (m, 4H), 5.1 (m, 1H), 7.3-7.5 (m, 4H), 7.6-7.8 (m, 2H), 7.8 (m, 2H), 8.2 (d, 1H), 8.5 (d, 1H), 9.0 (d, 1H)。 (3S)-2·酮基·3·異喹啉-1-醯基胺基·5-甲氧基乙醯基-N-[(2RS,3S) 2-苄氧基·5-酮基-四氫呋喃-3-基)-2,3,4,5-四氫-lPM,5-笨並二氮雜箪-l-乙醯胺(699a),利用655之製法合 成,可生成820毫克的699a,呈褐色固體,4 NMR (500 MHz, CDCI3) ^ 2.60 (ddd, 1H), 2.90 (ddd, 1H), 3.20 (s, 3H), 3.25 (s, 3H), 3.70 (t, 1H), 3.90 (m, 2H), 4.20 (dd, 1H), 4.60 (m, 2H), 4.70-5.00 (m, 5H), 5.55 (d, 1H), 7.00 (d, 1H), 7.20- 經濟部中夬噤这局員v一消資合作社印¾ (請先聞讀背云之泾意事項再填寫本I) 7.50 (m,7H),8.45 (dd,1H), 9.0 (dd,1H),及 9.35 ppm (dd,1H卜 (3S)-2-酮基-3-(3,5·二甲基-4-羥基芊醢基)胺基曱氡基乙 鏟基-N-[(2RS,3S) 2-苄氧基-5-酮基-四氫呋喃基l·2,3,4,5-四氫呋喃-7-氣苯並二氮雜箪-卜乙醯胺(688b-l), 利用655之製法合成可生成600毫克的688b-i,lH NMR (CDCl3 :非對玦立體異構物之混合物)ί 2·21 (s,3H),2·28 (s, 3Η), 2.42-2.50 (m, 0.5 Η), 2.53-2.65 (m, 0.5H), 2.83-2.9.1 (m, 0.5H), 2.98-3.1 (m, 0.5H), 3.18 (s, i.5H), 3.22 (s, 1.5H), -701- __ 本泜&amp;足度適用中国國家標孳(CNS ) ‘*\4見格(2i〇 x:9了公茇) 1235157 A7 B7 五、發明説明(6&quot;) 3.72-3.78(d,lH),3.78-3.9(m,2H),、4.08-4.15(d,lH),4.5- 4.69 (m, 3H), 4.7-4.85 (m, 1H), 4.88ο.1 (m, 2H), 5.45 (s, 0.5H), 5.55-5.65 (d, 0.5H), 6.85-6.92 (m, 1H), 7.02^7.13 (m? 2H), 7.24^7.55 (m, 9H) ^ (35)-3-[(35)-2-銅基-3-(3,5-二甲基-4-經基辛§產基)腔基_5-甲 基乙醯基-2,3,4,5-四氫-7-氟-1士1,5-笨並二氮雜箪-1-乙醯 胺基]·4-酮基丁酸(689b-l),利用甴2001製備2002之方法合 成,可生成6891)-1,1^1以]^厌(00300)(^2.18(5,6扣,2.36-2.47 (m, 1H), 2.6-2.72 (m, 1H), 3.34 (s, 3H), 3.66-3.88 (m, 2H), 3.95-4.05 (m, 1H), 4.2-4.78 (m, 5H), 4.9 (m, 1H)? 7.3· 7.41 (m, 2H), 7.48 (s, 2H), 7.5-7.63 (m, 1H) ^ (3S)-3-[(3S)-2·鋼基-3-異峻琳- l-δέ基胺基-5-曱氧基乙錄基· 2,3,4,5-四氩-1-1,5-苯並二氮雜箪-1-乙醯基胺基卜4-酮基丁 酸(699),利用由2001製備2002之方法合成,可生成699, 呈白色固體,4 NMR (500 MHz,CD3OD) d 2.50 (m,1Η), Μ濟部中央標隼局負工消費合作社印製 (诗之鬮讀背云之注意事項玉:填玄.本頁) 2.70 (m, 1H), 3.25 (s, 3H), 3.80 (bd, 1H), 3.90 (bd, 1H)? 4.00 (bd, 1H), 4.30 (m, 1H), 4.50-4.70 (m, 3H), 4.80-4.85 (bt, 1H), 5.00 (bm, 1H), 7.40-7.55 (m, 5H), 7.70 (bm, 1H), 7.85 (bm, 1H), 8.00 (bm,1H),8.55 (bd,1H),及9.05 ppm (bd, 1H) a (3S)-2-嗣基-3-異峻琳-1-睡基胺基-5-沒基乙酷基-N-[(2RS,3S) 2-苄氧基-5-酮基-四氩呋喃-3-基]-2,3,4,5-四氫-7-氣-1H-1,5-笨並二氮雜箪-1-乙醯胺(696a-l),利用656之製 法合成,可生成800爲黃色固體,4 NMR (500, MHz, CDCi3) ί 2.55 (ddd, 1H), 2.85 (ddd, 1H), 3.70-3.80 (m, 2H), -702· 本紙杀尺度適用中國國家標李(CNS M4现洛(2丨OX 297公笼) 1235157 A7 —____ B7____ 五、發明説明(7〇〇 ) 3.95 (bm,1H),4.05 (d,1H),4·30 (d; 1H),4.40-4.60 (m,4H), 4.70-5.05 (m, 4H), 5.55 (d, 1H), 7.10 (d, 1H), 7.20-7.35 (m, 3H), 7.40-7.50 (m, 1H), 7.60-7.85 (m, 3H), 8.40 (dd, 1H), 9·1〇 (m, 1H),及9.30 pp (m, 1H) a (3S)-2-酮基-3-異4淋-1-酿基胺基-5·超基乙睡基-N- [(2反5,33)2-节氧基-5-銅基-四氫吃喃-3,基]-2,3,4,5-四氫-7-氣-1Η·1,5-笨並二氣雜笨-1-乙酿胺(696a-2),利用677之製 法合成,可生成204毫克的696a-2,呈白色固禮,涂了以 下例外即如下還原硝基:對硝基化合物(7 2克,2〇亳莫耳) 於MeOH之溶液中,加入NH4C1 (2.1克,39毫莫耳)及Zn(17 克’ 260毫莫耳)c»生成的混合物迴流加熱1小時,之後冷 卻再經Celite過濾。濾液於眞空下濃縮,再以冷的in HC1 處理可生成3·6克的淺紅色固體。W NMR (CDC13) 〇' 1.85 (s, 1H), 2.45 (d, 0.5H), 2.50-2.65 (m, 0.5H), 2.80-2.90 (m, 0.5H), 2.90-3.00 (m, 0.5H), 3.45 (s, 0.5H), 3.55-3.75 (m, 1H), 3.85-4.15 (m&gt; 2H), 4.25 (d, 1H), 4.40-4.65 (m, 2H), 4.70-4.80 (m, 0.5H), 4.85oM5 (m, 3H), 5.40 (s, 0.5H), 5.60 (d, 0.5H), 7.00 (d, 0.5H), 7.15-7.90 (m, 12.5H), 8.35-8.45 (m, 1H), 9.00-9.10 (m, 1H), 9.25-9.40 (m, 1H) 經濟部中央樣毕局員工消f合作杜印裝 (請先聞讀背δ之法意事項再填寫本頁) (3S)-3-[(3S)-2-酮基-3-異4啉-1-醯基胺基-5-羥基乙醯基- 2,。,4,5-四氣,7-氣-11^-1,5-私並二亂雜車-1-乙驢胺基]-4-明 基丁酸(696-1),以由2001製備2002之方法合成,可生成 140毫克的696-1,呈白色固體,4 NMR (500, MHz, CD3OD) ά 2.50 (m, 1H), 2.70 (m, 1H), 3.85 (d, 1H), 3.95 (m, -703- 本紙乐尺度適用中國國家標隼(CNS ) A4况格(210X 297公廋) 1235157 Λ7 B7 五、發明説明(701 ) 1H), 4.10 (d, 1H), 4.35 (m, 1H), 4.50-4.60 (m? 2H), 4.80 (bm, iH), 5.00 (m, 1H), 7.40-7.48 (m, 3H), 7.65 (m, 1H), 7.75 (t, 1H), 7·85 (t,1H), 8.00 (d,1H), 8·55 (d, 1H),及 9.05 ppm (d, 1H)。 (3S)-3-[(3S)-2-酮基-3-異喹啉-1-醯基胺基-5-羥基乙醯基· 2.3.4.5- 四氫-7-氣-111-1,5-苯並二氮雜箪-1-乙醯胺基]-4-酮 基丁酸(696-2),利用由2001製備2002之方法合成,可生成 250毫克的 696·2,呈白色固體,111讨1^11(00300)0'2.40- 2.55 (m, 1H), 2.60-2.75 (m, IH), 3.80-4.00 (m, 2H), 4.05 (d, 1H), 4.20-4.35 (m, 1H), 4.45-4.65 (m, 3H), 4.80-5.10 (m, 2H) (3S)-2-嗣基異®^琳-1·酿基胺基-5-曱乳基乙縫基-N-[(2RS,3S) 氧基-5-銅基-四氫夫喃-3-基】-2,3,4,5-四氫- 7-氣-1Η-1,5·苯並二氮雜箪-1-乙醯胺(699a-l),利用製備655 之方法合成,可生成 699a-l,W NMR (500 MHz, CDC13) d 2.55 (ddd, 1H), 2.90 (ddd, 1H), 3.25 (s, 3H), 3.28 (s, 3H), 3.80 (bt, 2H), 3.95 (bm, 2H), 4.25 (dd, 1H), 4.45-4.90 (m, 3H)? 5.60 (d, 1H), 7.05-7.40 (m, 8H), 7.50 (bm, 1H), 7.65-7.85(in,2H),8.45(d,lH),9.1(m,lH),&amp;9.35ppm(m,lH) (3S)-3-[(3S)-2-酮基-3-異4啉-1-醯基胺基-5-甲氧基乙驢基- 經濟部中央標準局員工消費合作社印装 (讀气絮讀背云之泾意事項一并填芎本一貝) 2.3.4.5- 四氫-7-氣-lH-l,5-苯並二氮雜箪-卜乙醯基胺基]-4-酮基丁酸(699a-2),利用由2001 k備2002之方法合成,可 生成 699a-2, lH NMR (500 MHz, CD3OD) ό 2.51 (m, 1H), 2.70 (dt, 1H), 3.31 (bs, 3H), 3.90 (bdt, iH), 3.95 (bm, 1H), 4.05 (d, 1H), 4.35 (m, 1H), 4.50 (d, 1H), 4.60 (dd, 1H), 4.65 •704- Λ紙汝尺度適用中國國家糅革(CNS ) A4規格(2l〇x:9了公釐) 1235157 Λ7 __B7_____ 五、發明説明(702 ) (dt, 1H), 4.80 (m, 1H), 5.05 (m, 1H), 7.35-7.48 (m, 3H), 7.65 (bm, 1H), 7.75 (t, 1H), 7.82 (t, 1H), 8.05 (d, 1H), 8.55 (d, 1H),及 9.05 ppm (d, 1H)。 (35)-3-[(3 5)-2-酮基-3-(3,5-二甲基-4-羥基芊醯基)胺基-5-〒 氧基乙醯基-2,3,4,5-四氫-1 Η-1,5-苯並二氮雜箪-1-乙醯胺 基]4-酮基丁酸,0-2,6-二氣芊基肟(688c),利用308d之製 法合成,可生成 800,lHNMR(CD3OD)ό'2·2(s,6H),2.58- 2.83 (m, 2H), 3.28 (s, 3H), 3.29-3.34 (m, 1H), 3.68-3.80 (m, 2H), 3.95-4.05 (dd, 1H), 4.38-4.48 (dd, 1H)? 4.82-5.00 (m, 2H), 5.26-5.36 (m, 2H), 722-7.65 (m, 10H) ^ 經濟部令夬樣隼局員工消费合作社印裳 (3S)-2-酮基-(2,4-二甲基,塞唑-5-基)胺基-5-羥基乙醢基-N-[(2RS,3S) 2-芊氧基-5-酮基-四氫呋喃-3-基]-2,3,4,5-四氫-1H-1,5-苯並二氮雜箪-卜乙醯胺(800),利用製備696a-1之 方法合成,可生成204毫克的800,呈黃色固鳢,β NMR (CDC13)(非對玦立體異構之混合物)0、1.70(5,1扣,2.40-2.80 (m, 7H), 2.80-2.90 (m, 0.5H), 2.95-3.05 (m, 0.5H), 3.30-3.35 (m, 〇.5H), 3.45-3.55 (m, 0.5H), 3.55-3.65 (m? 1H), 3.80· 4.05 (m, 2H), 4.30-4.50 (m, 2H), 4.55-4.65 (m, 1H), 4.75-4.95 (m, 3H), 5.45 (s, 0.5H), 5.55 (d, 0.5H), 6.70 (d, 0.5H), 6.90 (d, 0.5H), 7.15-7.80 (m, 10H) (3S)-3-[(3S)-2·酮基-3-(2,4-二甲基噻唑基·ι·醯基)胺基-5-羥 基乙醢基-2,3,4,5-四氫-1Η·1,5-苯並二氮雜箪-1-乙醯胺基】· 4-酮基丁酸(801),利用由2001製備2002之方法合成,可生 成80卜 -705- 本纸浪尺度適用中3國家標孪(CNS ) Α4^格(210 X 297公釐〉 1235157 Λ7 B7 五、發明説明(7〇3 實例34、 化合物720-73以化合物619-635之類似製法製備(見 例13)。化合物720-73之物理數據列於表29中。 實 {請先聞讀背云之注意事項再填tr本一貝) M濟部中夬櫺準局員X消費合作杜印¾ -706 本纸ft尺度通用中1國家標立(CNS ) Μ規格(210X 297公釐) 1235157 A7 B7 五、發明説明(704 ) 經濟部άτ‘夬標达局員工消f合作杜印製 6CN4 CO Q9 VO UO Ο VJD X dP &lt;Tk σ\ σ\ C\J 卜 ο f—4 dQ 〇&gt; t-l &lt;r CNJ Γ0 t—4 I ro C7i • VD 守 wO m VO VD «-Η VD tX4 2 c\ o 5 CJ &lt;n CM •x ^r CN U CTk s z 04 CO 5 CVJ 〇 赛 X p x 。分 r 一V 。=^〇 2: X Λ ί〜 ο CV4 ιΗ CV4 卜 -707- 本紙法又度適用中国国家標车(〇&gt;^)六4堤格(210/ 297公釐) (請先閱讀背5之注意事項再填寫本一貝) 1235157 Λ7 B7 五、發明説明(7〇5 ) 超濟部中央標隼局負工消f合作社印装 + cn 5 2 Cvj CO t〇 tO 今 VO L〇 Οι X dP cn (7^ rH VO r· t-4 r-H OP &lt;JS 卜 L〇 L〇 VO o f-l s s VO ΙΛ uo to m in o if) Cu s 〇 2; 〇 r〇 X r* C\J CJ σ\ 〇 ^3* 2 CO CM 2: VO &lt;N| CJ 赛 2 X £ ♦ Z X 黎 CM CM 卜 m &lt;N 卜 -708- 本紙伕尺度通用中国國家標孪(CNS ) A4規格(210X 297公釐) (請^¾讀背云之注意事項再填寫本頁) 裝 訂 1235157 A7 B7 五、發明説明(7〇6) 翅濟部令夬標羋局員工消费合作.社印衷 -«*«· CO 5 ι-Η m VD lD 、 CNJ 卜 卜 m X dP σ\ 00 ιη ο rH dP σ\ as as 04 cn t-H 3: 2 LO 03 C0 tO &lt;J\ · vO CM to in tu X GO Ο i Γ0 X 卜 &lt;Ν α CO 〇 z CM m X o CM u 赛 5 r 。义 δ x °^r 。择 CM 卜 to CM 卜(3S) -3-[(3S) -2-keto-3- (3,5-dimethylhydroxyfluorenyl) aminohydroxytriethyl-2,3,4,5-tetrahydro- 1H-1,5-benzo-azabenzene small ethyl chain amino group] 4 4-diethoxybutyric acid ethyl ester (690a-1), synthesized by the methods of 6903 and 21001 ?, can produce 690a- l JH NMR (CDC13) 〇 '1.15 (t, 6H), 1.3 (t, printed by Shelley Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs ¾ 3H), 2.25 (s, 6H), 2.60 (d, 2H), 3.50 (m, 2H), 3.70 (m, 4H), 4.05 (m, 2H), 4.15 (m, 2H), 4.30 (d, 1H), 4.45 (m, lH), 4.d0 (d, 1H), 4.55 (d, 1H), 4.70 (t, 1H), 5.05 (m, iH), 5.3〇 (s, 1H), 6.70 (d, 1H), 7.10 (d, 2H), 7.30-7.50 (m, 7H ) (3 5) -2-keto-3- (3,5-digas-4-aminobenzyl) amino-5-mercaptoethoxy · N-[(2RS, 3S) 2- Fluorenyl small keto-tetrahydrofuran-3-yl] -2,3,4,5'tetrahydro-1 fluorene · 1,5-benzazadiazepine-ethylacetamide (697a), using the method of 677 Synthesized, 840 mg of 697a can be produced, [Η NMR (CD3OD) 5 1.78 (br · -699- This paper flower scale is applicable to Chinese national plum (〇 ^) six 4 specifications (210 &gt; &lt; 37 mm) 1235157 A7 _ __B7______ One or five, the description of the invention (697) s, 2H), 2.48-3.58 (d, 0.5 ·), 2.6-2.7, (m, 0.5Η), 2.8-2 · 9 (m, 0.5Η), 2.92-3.03 (m, 0.5Η), 3.55-3.8 (m, 2H), 3.92-4.02 (d, 1H), 4.25-4.3 (d, 0.5H), 4.37-4.42 (d, 0.5H), 4.43-4.48 (m, 0.5H), 4.55-4.65 (m , 1.5H), 4.7o.l2 (m, 5H), 5.44 (s, 0.5H), 5.58-5.63 (d, 0.5H), 6.95-8.1 (m, 13H) ^ (3 5) -3- [ (35) -2-keto-3- (3,5-digas-4-aminofluorenyl) amine_yl-5-ethanoyl-2,3,4,5-tetrahydro-1 1,5-Benzodiazepine-1-acetamidinyl] -4-ketobutanoic acid (697), synthesized by the method of 2001 and 2002, yielding 140 mg of 697, lH NMR (CD3OD) d 238-2.5 (m, 1H), 2.55-2.75 (m, 1H), 3.68-3.9 (m, 3H), 3.95-4.03 (m, 1H), 4.2-4.3 (m, 1H)? 4.4-4, 7 (m, 4H), 7.35-7.8 (m, 6H). (3S) -3-[(3S) -2-keto-3- (3,5-dimethyl-4-methoxybenzylfluorenyl) ammonium via ethylethoxy-2,3,4, 5-tetrahydro-1 fluorene-1,5 · benzodiazepine-1-ethylamine amine] -4-ethylfluorenyloxy-3-butenoate (684a), synthesized by the method of 2100j 684a, lH NMR (500 MHz, CDC13 diastereoisomeric mixture of isomers) β 1 · 3 (s, 9H), 1.8 (s, 3H), 2.1 (s, 3H), 2.15 ( s, 3H), 2.3 (s, 6H), 3.3-3.5 (m, 3H), 3.65 (s, 3H), 3.9 (m, 1H), 4.1 (d, 1H), 4.3 ( d, 1H), 4.6-4.8 (m, 3H), 5.0 (m, 1H), 6.7 (s, ih), 7.0 (d, 1H), 7.1 (d, 1H), 7.2-7.5 (m, 6H) «Printed by the Ministry of Economic Affairs and the Consumers' Cooperatives of the China Bureau of Printing ¾ (3S) -2-keto-3-isoquinolin-1-amidinoamino-5-methylamido-N-[(2RS, 3S ) -2_ alkoxy-5-83yl-tetrahydroxan-3-yl] -2,3,4,5-tetraargon-1FM, 5-benzodiazepine · buethamidinyl ( 698a), synthesized by the method of 652, can produce 795 mg of 698a, lH NMR (500 MHz, CDC13 diastereoisomeric mixture) β 2 · 8 (m, 2H), 4.0 (m, 1H ), 4.5-4.8 (m, 4H), 5.2 -700- The standard of this paper is applicable to Chinese national standard (Former case of CNSM4 (210 ·, &lt; 297 mm) 1235157 Λ 7 Β7 ___ V. Description of the invention (698) ^ (m, 1H), 5.5 (s, 1H), 5.75 (d, 1H), 7 ^ 3- 7.85 (m, ΠΗ), 7.9 (t, iH), 8.2 (d, 1H), 8.6 (m, 1H), 9.3 (m, 1H) 3 (3S) -3-[(3S) -2-one -3-isoquinolin-1-amidinoamino-5-methylamido-2,3,4,5-tetrahydro · 1Η · 1,5-benzodiazepine-1-ethylamidoamino Bu 4-ketobutyric acid (698), synthesized by the method of 653, can produce 225 mg of 698, β NMR (500 MHz, CD3OD) d 2.4 (m, 1H), 2.6 (m, 1H), 3.9 (m , 1H), 4.2 (m? 1H), 4.3-4.7 (m, 4H), 5.1 (m, 1H), 7.3-7.5 (m, 4H), 7.6-7.8 (m, 2H), 7.8 (m, 2H ), 8.2 (d, 1H), 8.5 (d, 1H), 9.0 (d, 1H). (3S) -2 · keto · 3 · isoquinolin-1-fluorenylamino · 5-methoxyethenyl-N-[(2RS, 3S) 2-benzyloxy · 5-keto- Tetrahydrofuran-3-yl) -2,3,4,5-tetrahydro-lPM, 5-benzodiazepine-l-acetamide (699a), synthesized by the method of 655, can produce 820 mg of 699a , As a brown solid, 4 NMR (500 MHz, CDCI3) ^ 2.60 (ddd, 1H), 2.90 (ddd, 1H), 3.20 (s, 3H), 3.25 (s, 3H), 3.70 (t, 1H), 3.90 (m, 2H), 4.20 (dd, 1H), 4.60 (m, 2H), 4.70-5.00 (m, 5H), 5.55 (d, 1H), 7.00 (d, 1H), 7.20- Ministry of Economic Affairs Printed by the member of the Bureau v. Consumer Cooperatives (please read this matter before reading this question before filling in this I) 7.50 (m, 7H), 8.45 (dd, 1H), 9.0 (dd, 1H), and 9.35 ppm ( dd, 1H (3S) -2-keto-3- (3,5 · dimethyl-4-hydroxyfluorenyl) aminofluorenylethynyl-N-[(2RS, 3S) 2- Benzyloxy-5-keto-tetrahydrofuranyl 1,2,3,4,5-tetrahydrofuran-7-gas benzodiazepine-oxetamine (688b-1) can be synthesized by the method of 655 600 mg of 688b-i, 1H NMR (CDCl3: mixture of non-paraisomeric stereoisomers) ί 2.21 (s, 3H), 2.28 (s, 3Η), 2.42-2.50 (m, 0.5 Η) , 2.53-2.65 (m, 0.5H), 2.83-2.9.1 (m, 0.5H), 2.98-3.1 (m, 0.5H), 3.18 (s, i.5H), 3.22 (s, 1.5H),- 701- __ This 泜 & footing is applicable to Chinese National Standards (CNS) '* \ 4 see grid (2i〇x: 9 public 茇) 1235157 A7 B7 V. Description of the invention (6 &quot;) 3.72-3.78 (d, lH), 3.78-3.9 (m, 2H), 4.08-4.15 (d, lH), 4.5- 4.69 (m, 3H), 4.7-4.85 (m, 1H), 4.88ο.1 (m, 2H), 5.45 (s, 0.5H), 5.55-5.65 (d, 0.5H), 6.85-6.92 (m, 1H), 7.02 ^ 7.13 (m? 2H), 7.24 ^ 7.55 (m, 9H) ^ (35) -3 -[(35) -2-copperyl-3- (3,5-dimethyl-4-caproxyl § radical) cavity group_5-methylethylfluorenyl-2,3,4,5- Tetrahydro-7-fluoro-1 ± 1,5-benzodiazepine-1-acetamidinylamino] · 4-ketobutyric acid (689b-1), synthesized by the method of fluorene 2001 preparation 2002 Generates 6891) -1, 1 ^ 1 to] ^ (00300) (^ 2.18 (5,6 buckle, 2.36-2.47 (m, 1H), 2.6-2.72 (m, 1H), 3.34 (s, 3H), 3.66-3.88 (m, 2H), 3.95-4.05 (m, 1H), 4.2-4.78 (m, 5H), 4.9 (m, 1H)? 7.3 · 7.41 (m, 2H), 7.48 (s, 2H), 7.5-7.63 (m, 1H) ^ (3S) -3-[(3S) -2 · steel-3-isojunlin-l-δ-aminoamino-5-methoxyethynyl, 2,3 , 4,5-tetra-argon-1-1,5-benzene Diazapyridine-1-ethylamidoamino 4-ketobutyric acid (699), synthesized by the method of 2001 and 2002, can produce 699 as a white solid, 4 NMR (500 MHz, CD3OD) d 2.50 (m, 1Η), printed by the Consumers ’Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (Notes on Poems and Reading Clouds: Jade Filling. This page) 2.70 (m, 1H), 3.25 (s, 3H) , 3.80 (bd, 1H), 3.90 (bd, 1H)? 4.00 (bd, 1H), 4.30 (m, 1H), 4.50-4.70 (m, 3H), 4.80-4.85 (bt, 1H), 5.00 (bm , 1H), 7.40-7.55 (m, 5H), 7.70 (bm, 1H), 7.85 (bm, 1H), 8.00 (bm, 1H), 8.55 (bd, 1H), and 9.05 ppm (bd, 1H) a (3S) -2-fluorenyl-3-isojunlin-1-pyridylamino-5-hexylethoxy-N-[(2RS, 3S) 2-benzyloxy-5-keto-tetra Argofuran-3-yl] -2,3,4,5-tetrahydro-7-gas-1H-1,5-benzodiazepine-1-acetamidine (696a-l) Synthesized by the method, 800 solids can be generated, 4 NMR (500, MHz, CDCi3) 2.55 (ddd, 1H), 2.85 (ddd, 1H), 3.70-3.80 (m, 2H), -702 Chinese National Standard Li (CNS M4 is now Luo (2 丨 OX 297 public cage) 1235157 A7 —____ B7____ 5. Description of the invention (7〇〇) 3.9 5 (bm, 1H), 4.05 (d, 1H), 4.30 (d; 1H), 4.40-4.60 (m, 4H), 4.70-5.05 (m, 4H), 5.55 (d, 1H), 7.10 ( d, 1H), 7.20-7.35 (m, 3H), 7.40-7.50 (m, 1H), 7.60-7.85 (m, 3H), 8.40 (dd, 1H), 9.10 (m, 1H), and 9.30 pp (m, 1H) a (3S) -2-keto-3-iso4-pyridin-1-aminoamino-5 · superylethynyl-N- [(2trans5,33) 2- Benzyl-5-copperyl-tetrahydroxan-3, yl] -2,3,4,5-tetrahydro-7-gas-1Η · 1,5-benzyl-digas heteroben-1-ethyl Fermented amine (696a-2), synthesized by the method of 677, can produce 204 mg of 696a-2, which is a white solid gift. The following exception is applied to reduce the nitro group: p-nitro compound (72 g, 20%) To a solution of MeOH, NH4C1 (2.1 g, 39 mmol) and Zn (17 g '260 mmol) c »were added and the mixture was heated under reflux for 1 hour, then cooled and filtered through Celite. The filtrate was concentrated under vacuum and treated with cold in HC1 to produce 3.6 grams of light red solid. W NMR (CDC13) 〇 '1.85 (s, 1H), 2.45 (d, 0.5H), 2.50-2.65 (m, 0.5H), 2.80-2.90 (m, 0.5H), 2.90-3.00 (m, 0.5H ), 3.45 (s, 0.5H), 3.55-3.75 (m, 1H), 3.85-4.15 (m &gt; 2H), 4.25 (d, 1H), 4.40-4.65 (m, 2H), 4.70-4.80 (m, 0.5H), 4.85oM5 (m, 3H), 5.40 (s, 0.5H), 5.60 (d, 0.5H), 7.00 (d, 0.5H), 7.15-7.90 (m, 12.5H), 8.35-8.45 ( m, 1H), 9.00-9.10 (m, 1H), 9.25-9.40 (m, 1H) The staff of the Central Bureau of the Ministry of Economic Affairs should cooperate with the printed documents (please read the legal meaning of δ before filling out this page) ) (3S) -3-[(3S) -2-keto-3-iso4line-1-amidinoamino-5-hydroxyacetamido-2. , 4,5-tetrakis, 7-qi-11 ^ -1,5-private-diazacha-1-ethynylamino] -4-benzylbutyric acid (696-1), prepared from 2001 2002 Synthesized by this method, 140 mg of 696-1 was produced as a white solid. 4 NMR (500, MHz, CD3OD) was 2.50 (m, 1H), 2.70 (m, 1H), 3.85 (d, 1H), 3.95 ( m, -703- This paper scale is applicable to the Chinese national standard (CNS) A4 condition (210X 297 cm) 1235157 Λ7 B7 V. Description of the invention (701) 1H), 4.10 (d, 1H), 4.35 (m, 1H ), 4.50-4.60 (m? 2H), 4.80 (bm, iH), 5.00 (m, 1H), 7.40-7.48 (m, 3H), 7.65 (m, 1H), 7.75 (t, 1H), 7. 85 (t, 1H), 8.00 (d, 1H), 8.55 (d, 1H), and 9.05 ppm (d, 1H). (3S) -3-[(3S) -2-keto-3-isoquinolin-1-amidinoamino-5-hydroxyacetamido2.3.4.5- tetrahydro-7-gas-111-1 , 5-Benzodiazepine-1-acetamido] -4-ketobutanoic acid (696-2), synthesized by the method of 2001 and 2002, can produce 250 mg of 696.2, which is white Solid, 111 1 ^ 11 (00300) 0'2.40- 2.55 (m, 1H), 2.60-2.75 (m, IH), 3.80-4.00 (m, 2H), 4.05 (d, 1H), 4.20-4.35 ( m, 1H), 4.45-4.65 (m, 3H), 4.80-5.10 (m, 2H) (3S) -2-ylisocyanate -N-[(2RS, 3S) oxy-5-copperyl-tetrahydrofuran-3-yl] -2,3,4,5-tetrahydro-7-gas-1pyrene-1,5 · benzo Diazapyridine-1-acetamidine (699a-l), synthesized by the method of preparation 655, can generate 699a-1, W NMR (500 MHz, CDC13) d 2.55 (ddd, 1H), 2.90 (ddd, 1H ), 3.25 (s, 3H), 3.28 (s, 3H), 3.80 (bt, 2H), 3.95 (bm, 2H), 4.25 (dd, 1H), 4.45-4.90 (m, 3H)? 5.60 (d, 1H), 7.05-7.40 (m, 8H), 7.50 (bm, 1H), 7.65-7.85 (in, 2H), 8.45 (d, lH), 9.1 (m, lH), & 9.35ppm (m, lH ) (3S) -3-[(3S) -2-keto-3-iso4line-1-amidinoamino-5-methoxyethynyl-Member of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Industrial and Consumer Cooperatives (Read the air-brush and cloud-filled items together) 2.3.4.4.5-tetrahydro-7-gas-lH-l, 5-benzodiazepine-Bu Yi Fluorenylamino] -4-ketobutanoic acid (699a-2), synthesized by the method 2001 k Preparation 2002, can generate 699a-2, lH NMR (500 MHz, CD3OD) 2.51 (m, 1H), 2.70 (dt, 1H), 3.31 (bs, 3H), 3.90 (bdt, iH), 3.95 (bm, 1H), 4.05 (d, 1H), 4.35 (m, 1H), 4.50 (d, 1H), 4.60 (dd, 1H), 4.65 • 704- Λ paper scale is applicable to the Chinese National Leather (CNS) A4 specification (2l0x: 9 mm) 1235157 Λ7 __B7_____ V. Description of the invention (702) (dt, 1H), 4.80 (m, 1H), 5.05 (m, 1H), 7.35-7.48 (m, 3H), 7.65 (bm, 1H), 7.75 (t, 1H), 7.82 (t, 1H), 8.05 (d, 1H) , 8.55 (d, 1H), and 9.05 ppm (d, 1H). (35) -3-[(3 5) -2-keto-3- (3,5-dimethyl-4-hydroxyfluorenyl) amino-5-fluorenoxyethenyl-2,3 , 4,5-tetrahydro-1 fluorene-1,5-benzodiazepine-1-ethylfluorenylamino] 4-ketobutanoic acid, 0-2,6-diaziridinyloxime (688c) Using the 308d synthesis method, 800, lHNMR (CD3OD), '2.2 (s, 6H), 2.58- 2.83 (m, 2H), 3.28 (s, 3H), 3.29-3.34 (m, 1H) , 3.68-3.80 (m, 2H), 3.95-4.05 (dd, 1H), 4.38-4.48 (dd, 1H)? 4.82-5.00 (m, 2H), 5.26-5.36 (m, 2H), 722-7.65 ( m, 10H) ^ Order of the Ministry of Economic Affairs, Employees' Cooperative Consumer Cooperative, India (3S) -2-keto- (2,4-dimethyl, sedazol-5-yl) amino-5-hydroxyacetamidine -N-[(2RS, 3S) 2-methoxy-5-keto-tetrahydrofuran-3-yl] -2,3,4,5-tetrahydro-1H-1,5-benzodiazepine Pyrene-oxetamine (800), synthesized by the method of preparing 696a-1, can produce 204 mg of 800 as a yellow solid, β NMR (CDC13) (a mixture of non-isomeric stereoisomers) 0, 1.70 ( 5,1 buckle, 2.40-2.80 (m, 7H), 2.80-2.90 (m, 0.5H), 2.95-3.05 (m, 0.5H), 3.30-3.35 (m, 0.5H), 3.45-3.55 (m , 0.5H), 3.55-3.65 (m? 1H), 3.804.05 (m, 2H), 4.30-4.50 (m, 2H), 4.55-4.65 (m, 1H), 4.75-4.95 (m, 3H), 5.45 (s, 0.5H), 5.55 (d, 0.5H), 6.70 (d, 0.5H), 6.90 (d, 0.5H), 7.15-7.80 (m, 10H) (3S) -3-[(3S) -2 · keto-3- (2,4-dimethylthiazolyl · ι · fluorenyl) amino-5-hydroxyacetamidine -2,3,4,5-tetrahydro-1,1,5-benzodiazepine-1-ethanamido] 4-ketobutanoic acid (801), prepared from 2001 and 2002 Synthesized by method, it can generate 80-705- this paper wave scale is applicable to 3 Chinese national standard (CNS) A4 ^ grid (210 X 297 mm> 1235157 Λ7 B7 V. Description of the invention (703 Example 34, compound 720- 73 was prepared in a similar manner to compound 619-635 (see Example 13). The physical data of compounds 720-73 are listed in Table 29. Real {please read the precautions of the back of the cloud before filling in the tr). M Ministry of Economic Affairs, China Prospective Bureau X Consumer Cooperation Du Yin ¾ -706 This paper ft standard universal 1 national standard (CNS) M specifications ( 210X 297 mm) 1235157 A7 B7 V. Description of the invention (704) Employees of the Ministry of Economic Affairs and the Ministry of Economic Cooperation and Cooperation printed 6CN4 CO Q9 VO UO 〇 VJD X dP &lt; Tk σ \ σ \ C \ J Bu ο f—4 dQ 〇 &gt; tl &lt; r CNJ Γ0 t—4 I ro C7i • VD guard wO m VO VD «-Η VD tX4 2 c \ o 5 CJ &lt; n CM • x ^ r CN U CTk sz 04 CO 5 CVJ 〇 Race X px. Divide r-V. = ^ 〇2: X Λ ί ~ ο CV4 ιΗ CV4 Bu-707- This paper method is again applicable to Chinese national standard cars (〇 &gt; ^) Six 4 dikes (210/297 mm) (Please read the 5 Note: Please fill in this note again) 1235157 Λ7 B7 V. Description of the invention (705) The work of the Central Bureau of Standards of the Ministry of Economic Affairs, printed by the cooperative + cn 5 2 Cvj CO t〇tO Today VO L〇〇ι X dP cn (7 ^ rH VO r · t-4 rH OP &lt; JS BU L〇L〇VO o fl ss VO ΙΛ uo to m in o if) Cu s 〇2; 〇r〇X r * C \ J CJ σ \ 〇 ^ 3 * 2 CO CM 2: VO &lt; N | CJ Race 2 X £ ♦ ZX Li CM CM bu m &lt; N bu -708- The paper standard is common Chinese national standard (CNS) A4 specification (210X 297 (Mm) (Please read the precautions for back cloud before filling out this page) Binding 1235157 A7 B7 V. Description of the invention (708) Employees' cooperation with the Order of the Ministry of Economic Affairs and the Ministry of Standards and Economics. · CO 5 ι-Η m VD lD, CNJ bu bu m X dP σ \ 00 ιη ο rH dP σ \ as as 04 cn tH 3: 2 LO 03 C0 tO &lt; J \ · vO CM to in tu X GO Ο i Γ0 X B &lt; N α CO 0z CM m X o CM u Race 5 r. Meaning δ x ° ^ r. Select CM to CM

請 先 讀 背 之 ·/主 意 % 再 填% 本I -709- 本紙伕尺度適用中国國家標萃(CNS ) A4見格(210Χ:!97公釐) 1235157 Λ7B7 五、發明説明(707 ) 經濟部ώ--夬漂技局員X消f合作讧印¾ + cn 2 2 GO 〇 CM VO 、 VO VO o L〇 X dP ON σ&gt; 卜 κο VO ο rH Cffi c\i (Ti iD 03 〇 CTk 2 2 Ο VO VO CTi to O ' to • CN GO U4 X o t-H 〇 2: &lt;N cn X CN o 卜 〇 § CNJ X CVJ 〇 i f r 。^: 典 〇 x £ δχ 。女 ^3 VO CM 卜 卜 &lt;N 卜 (請先閱讀背云之注意事項再填寫本瓦) -710- 本紙乐尺度適用中S國家標洋(CNS )八4堤格(210X 297公釐) 1235157 AT B7 五、發明説明(7Ό8 ) Μ濟部t夬樣準局負Μ消费合作社印¾ X σ\ cn VO 、 cn 卜 〇 VD £ VD in L〇 f-4 r-l dP σι a\ «—♦ rH VO f-4 rH 2 m VD 〇 1-1 VO r- ' L〇 CM 00 «r&gt; Cu S O r-4 O z &lt;n s o ΓΟ CJ o r—4 〇 2 o cn s CNi u X 。殳 °^yC ^ x X or 。父 &lt;α 00 CM . 卜 α&gt; CM 卜 -711 - 本紙伕尺度通用中國國家標孪(CNS ) A4現格(2丨0,&lt; 297公釐) 詩元¾.讀背δ之注意事項异填寫.vj貧) 裝Please read the back // idea% and then fill in the% I-709- The standard of this paper is applicable to Chinese National Standards (CNS) A4 (210 ×:! 97 mm) 1235157 Λ7B7 V. Description of Invention (707) Ministry of Economic Affairs FREE--Members of the Technical Bureau X eliminate cooperation cooperation ¾ + cn 2 2 GO 〇CM VO, VO VO o L〇X dP ON σ &gt; BU κο VO ο rH Cffi c \ i (Ti iD 03 〇CTk 2 2 Ο VO VO CTi to O 'to • CN GO U4 X o tH 〇2: &lt; N cn X CN o 〇 〇§ CNJ X CVJ 〇ifr. ^: Code 〇x £ δχ. Female ^ 3 VO CM 卜卜 &lt; N Bu (please read the precautions of Beiyun before filling in this tile) -710- This paper music scale is applicable to the national standard of the country (CNS) eight 4 dige (210X 297 mm) 1235157 AT B7 V. Description of the invention ( 7Ό8) 部 Ministry of Economy and Trade Standards Bureau of the People's Republic of China negative M consumer cooperatives ¾ X σ \ cn VO, cn 〇〇VD £ VD in L〇f-4 rl dP σι a \ «— ♦ rH VO f-4 rH 2 m VD 〇1-1 VO r- 'L〇CM 00 «r &gt; Cu SO r-4 O z &lt; nso ΓΟ CJ or—4 〇 2 o cn s CNi u X. 殳 ° ^ yC ^ x X or. &lt; α 00 CM. BU α &gt; CM BU-711-Common in paper scale National Standard Twin (CNS) A4 is present (2 丨 0, &lt; 297 mm) Poem ¾. Notes on reading δ are different. Fill in. Vj poor)

•1T 1235157 A7 B7 五、發明説明(709 ) 經濟部t夬一rTfr华局負工消f合作社印¾ 2 CN4 CN 卜 LO 卜 03 l〇 〇4 X dP σ\ α\ r&gt; σ&gt; η d4&gt; CM σ\ 00 σ\ CVJ 3: S ο ιΤ) σ\ uO cn -ιΛ ΓΟ VD tO Gu S ι—1 rH S 卜 CNJ X η CM U 隹 ι-Η tH s 奈 (VJ SC 切 CM CJ 。々: Υ X P r 。兹 s.。V1 X ο m 卜 rH &lt;n 卜 (請先¾讀背云之注意事項异填寫本頁) 712- 本纸伕尺度適用中國國家標隼(CNS ) A4逯格(210 X297公釐} 1235157 A7 B7 五、發明説明(710) 經涛部令夬樣隼局員工消f合作杜印装 S ΐ 〇\ in as ιΟ ' σ\ in VD in 52 &lt;JP CO σ\ ο VO 卜 d〇 GO ON L〇 Γ η 卜 3: X cn 0&quot;) CM Γ ιο η * L〇 CM 守 to Cau X f—4 tH O z CO CM X VO C\J 〇 o r-l 〇 *&lt;T § s to CM U 赛 X p x °^T δ x 0=^r 。&gt; CM cn 卜 cn cn 卜 (請先聞讀背面之注意事項再填寫本頁) -713- 本纸乐尺度適用中國國家標隼(CNS M4現格(2iOx29?公釐〉 1235157 A7 B7 五、發明説明(711 ) 經濟部中夬標隼局負工消費合作社印装 MS | (M+Na}+ 630· 6 / / 632.1 HPLC RT 分鐘 1 純度 9.656 99% 10,887 92% s s 608.62 I 609.62 * CS4 X C32H28N607 C28H27N509S 結構 § X h/」、s:〇《。 *雜 化合物 734 735 -714- (請先閨讀背面之注意事項再填寫本一貝) 本紙乐尺度通用中国國家橾準(CNS ) A4現格(210X297公釐) 1235157 A7 _B7 _ 五、發明説明(712) 實例35、 化合物736-767係以製備化合物619-635之相似方法(見實例 13)進行製備。化合物736-767之物理數據列於表30, (請先聞讀背面之注意事項再填寫本f 裝 經濟部中央標绛局員工消费合作社印装 化合物 R4 R3 736 0 ΗΟ^Λ. 737 :0 H〇Ji^ 738 0 ΗΟ^Λ. 739 0 0 H〇Ji^ 740 0 741 0 訂 •ft,• 1T 1235157 A7 B7 V. Description of the invention (709) Ministry of Economic Affairs tr-rTfr China Bureau of Labor and Consumer Affairs Cooperative Press ¾ 2 CN4 CN BU LO 03 03 〇〇4 X dP σ \ α \ r &gt; σ &gt; η d4 & gt CM σ \ 00 σ \ CVJ 3: S ο ιΤ) σ \ uO cn-ιΛ ΓΟ VD tO Gu S ι-1 rH S Bu CNJ X η CM U 隹 ι-Η tH s Nai (VJ SC cut CM CJ. 々: Υ XP r 兹 s .. V1 X ο m r rH &lt; n ((please read the precautions of the back cloud first and then fill out this page) 712- The standard of this paper is applicable to China National Standard (CNS) A4逯 Grid (210 X297 mm) 1235157 A7 B7 V. Description of the invention (710) The Ministry of Economic Affairs ordered the staff of the Bureau to cooperate and print S ΐ 〇 \ in as ιΟ 'σ \ in VD in 52 &lt; JP CO σ \ ο VO BU d〇GO ON L〇Γ η BU 3: X cn 0 &quot;) CM Γ ιο η * L〇CM to Cau X f-4 tH O z CO CM X VO C \ J 〇o rl 〇 * &T; T § s to CM U Race X px ° ^ T δ x 0 = ^ r. &Gt; CM cn bu cn cn bu (please read the notes on the back before filling this page) -713- paper Music scale is applicable to Chinese national standard (CNS M4 is now (2iOx29? Mm) 1235157 A7 B7 5 Description of the invention (711) Printing of MS by the Ministry of Economic Affairs, Bureau of Standards, Consumer Affairs Cooperatives | (M + Na) + 630 · 6 / / 632.1 HPLC RT minutes 1 Purity 9.656 99% 10,887 92% ss 608.62 I 609.62 * CS4 X C32H28N607 C28H27N509S Structure § X h / ″, s: 〇 ″. * Hybrid compounds 734 735 -714- (Please read the notes on the back before filling in this one) The paper scale is common Chinese National Standard (CNS) A4 now (210X297 mm) 1235157 A7 _B7 _ V. Description of the Invention (712) Example 35. Compound 736-767 was prepared in a similar manner to compound 619-635 (see Example 13). Physical data for compound 736-767 In Table 30, (Please read the precautions on the back before filling in this f. Install the printed compound R4 R3 736 0 ΗΟ ^ Λ. 737: 0 H〇Ji ^ 738 0 ΗΟ ^ Λ 739 0 0 H〇Ji ^ 740 0 741 0 Order • ft,

• 715- 本纸法尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1235157• 715- The size of the paper method is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1235157

A 五、發明説明(乃3) 經濟部中夬禚準局員工消費合作杜印製 '化合物 R4 、 R3 742 0 H〇_J^ 743 0 H〇^ 744 0〇Γ^ 0 745 0 H〇4 746 0 H〇Ji^ 747 〇/ 00¾ H〇义 748 Η〇^Λ. 749 0 ΗΟ^Λ, 750 0 η〇4 751 0 HO_J^ 752 0CH3 Ο ΗΟ_1^ (請先聞讀背面之注意事項再塊鸾本頁) 裝 1訂 -716 - 衣成抶尺度通用中S國家標牟(CNS) A4規格(210X297公釐〉 1235157 A7 B7 五、發明説明(714) 經濟部中央標準局W;工消费合作社印裝 化合物 R4 R3 753 H3C HaC 0 ΗΟ^Λ, 754 •0^ ο ΗΟ^Λ 755 0 H0_J^ 756 OHO 0 757 OH 0 0 758 Ο 759 0 760 Η 0 0 hoJC^ ?61 Ο HC〇^ 762 0 763 0 •717· 本紙伕尺度適用中a國家標準(CNS ) Α4%格(210Χ 297公釐) (請先閱讀背面之注意事項;^|寫本頁) 裝 訂 1235157 A7 B7 五、發明説明(715) 化合物 R4 R3 764 0 765 0 HO_j^ 766 Η 0 767 o {請先閲讀背面之注意事項再填寫本頁) 訂 上實例之數據明示出依據本發明之化合物,可對IL-1 轉化酵素呈現出抑制活性。 本發明化合物在試管内可抑制ICE,且進一步可口服遞 送至哺乳動物,並在治療IL-1-,細胞預期死亡之一, IGIF-及IFN-r調介之疾病上有明顯的臨床利用償値。這些 試驗顯示出化合物於活鳢内抑制ICE之能力。 雖然吾等已描述本發明許多具體實例,很明顯的吾等的 基本構想可以改變以提出其他具禮實例,其中利用本發明 的產物及製法。因此,很明顯地本發明的範圍係由所附之 申請專利範圍所界定,而非經由實例中所示出之特異具鳢 實例。 -718- 本纸伕尺度適用中國國家標準(CNS ) A4規格(210X297公釐)A V. Explanation of the invention (No. 3) Consumption cooperation between employees of the China Central Standards Bureau of the Ministry of Economic Affairs and the printing of 'compound R4, R3 742 0 H〇_J ^ 743 0 H〇 ^ 744 0〇Γ ^ 0 745 0 H〇4 746 0 H〇Ji ^ 747 〇 / 00¾ H〇 义 748 Η〇 ^ Λ. 749 0 ΗΟ ^ Λ, 750 0 η〇4 751 0 HO_J ^ 752 0CH3 Ο ΗΟ_1 ^ (Please read the precautions on the back first (鸾 Page) Binding 1-716-Standards for clothing, clothing, clothing, clothing, etc. (CNS) A4 specifications (210X297 mm) 1235157 A7 B7 V. Description of invention (714) Central Bureau of Standards, Ministry of Economic Affairs W; Industry and Consumer Cooperatives Printed compounds R4 R3 753 H3C HaC 0 ΗΟ ^ Λ, 754 • 0 ^ ο ΗΟ ^ Λ 755 0 H0_J ^ 756 OHO 0 757 OH 0 0 758 Ο 759 0 760 Η 0 0 hoJC ^? 61 Ο HC〇 ^ 762 0 763 0 • 717 · The national standard (CNS) of this paper is applicable to a national standard (CNS) A4% grid (210 × 297 mm) (Please read the precautions on the back first; ^ | write this page) Binding 1235157 A7 B7 V. Description of invention (715 ) Compound R4 R3 764 0 765 0 HO_j ^ 766 Η 0 767 o (Please read the precautions on the back before filling this page) Specify the data of the example A compound according to the present invention, can be converted to the IL-1 exhibits enzyme inhibitory activity. The compound of the present invention can inhibit ICE in a test tube, and can be further delivered orally to mammals, and has obvious clinical application in treating IL-1-, one of the expected cell death, and diseases mediated by IGIF- and IFN-r. value. These tests show the ability of the compounds to inhibit ICE in living pupae. Although we have described many specific examples of the present invention, it is obvious that our basic idea can be changed to propose other courteous examples in which the products and methods of the present invention are used. Therefore, it is obvious that the scope of the present invention is defined by the scope of the attached patent application, rather than by the specific specific examples shown in the examples. -718- The size of this paper is applicable to China National Standard (CNS) A4 (210X297mm)

Claims (1)

d 碰5157d touch 5157 ” 第091132804號專利申請案 中文申請專利範圍替換本⑼和月) 穴、申请專利範圍 1. 一種具下式之化合物, 〇"Patent Application No. 091132804 Chinese patent application scope replaces ⑼ and 月) Acupoints and patent application scope 2 · —種抑制白介素·丨占轉換酵素之醫藥組合物,並勺扭. 據申請專利範圍第丨項之化合物及醫藥上可接受之'=根 3 ·根據申睛專利範圍第2項之醫藥組合物並、 ...^ 其係用於製造用 万;病患中以治療或預防選自下列之疾病之藥劑:匕調公 的疾病、細胞預期死亡調介的疾病、發炎疾病、自;‘二 疫疾病、增殖失調症、感染性疾病、退化性疾病、^死 性疾病、骨關節炎、急性胰臟炎 '慢性胰臟炎、氣喘、 成人呼吸•痛苦徵候群、血管球性腎炎、類風濕性關節 炎、全身性紅斑狼瘡、硬皮病、慢性甲狀腺炎、葛雷氏 症、自體免疫性胃炎、胰島素-依賴型糖尿病(第1型)、自 骨豆免疫性〉春血性貧血、自體免疫性嗜中性球減少症、血 小板減少症、慢性活動性肝炎、重症肌無力、發炎性腸 疾、Crohn’s病、牛皮癬、移检物對宿主疾病、骨質疏鬆 病、與多發性骨髓瘤有關之骨骼失調症、急性骨髓性白 血病、慢性骨髓性白血病、轉移性黑色素瘤、卡波西氏 肉瘤、多發性骨髓瘤、敗血症、敗血性休克、志賀氏桿 菌病、阿滋海默爾氏病、巴金森氏病、腦缺血、心肌梗 塞、脊髓肌肉萎縮症、多發性硬化、與aids有關之腦 炎、與HIV有關之腦炎、老化、禿髮或由於中風造成的神 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 12351572 · — a type of interleukin-inhibiting pharmaceutical composition that occupies conversion enzymes, and it is twisted. According to the scope of the patent application, the compound and the pharmaceutically acceptable '= root 3 · According to the patent application of the second patent scope The composition is, ... ^ It is used for the manufacture of 10,000; in the patient to treat or prevent a disease selected from the following agents: dagger-mediated diseases, cell-mediated death-mediated diseases, inflammatory diseases, self; 'Second epidemic diseases, proliferative disorders, infectious diseases, degenerative diseases, death diseases, osteoarthritis, acute pancreatitis' chronic pancreatitis, asthma, adult breathing and pain syndromes, glomerulonephritis, Rheumatoid arthritis, systemic lupus erythematosus, scleroderma, chronic thyroiditis, Grae's disease, autoimmune gastritis, insulin-dependent diabetes mellitus (type 1), autoimmune beans immunity> vernal anemia , Autoimmune neutropenia, thrombocytopenia, chronic active hepatitis, myasthenia gravis, inflammatory bowel disease, Crohn's disease, psoriasis, host-to-host disease, osteoporosis, and multiple Myeloma-related skeletal disorders, acute myeloid leukemia, chronic myelogenous leukemia, metastatic melanoma, Kaposi's sarcoma, multiple myeloma, sepsis, septic shock, Shigella's disease, Alzheimer's 'S disease, Parkinson's disease, cerebral ischemia, myocardial infarction, spinal muscular atrophy, multiple sclerosis, aids-associated encephalitis, HIV-associated encephalitis, aging, baldness, or Kampo paper caused by stroke Standards apply to Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1235157 經性傷害。 4·根據申請專利範圍第3項之醫藥組合物,其中該11^1-調介 的疾病是一種發炎疾病,其係選自下列包括骨關節炎、 心(生騰臟炎、慢性胰臟炎、氣喘及成人呼吸痛苦徵候 群。 5 · ^據申請專利範圍第4項之醫藥組合物,其中該發炎疾病 是骨關節炎或急性胰臟炎。 根據申凊專利範圍第3項之醫藥組合物,其中該IL-1_調介 、疾病疋種自體免疫疾病,其係選自下列包括血管球 陵I)灵、類風濕性關節炎、全身性紅斑狼瘡、硬皮病、 十更性甲狀腺炎、葛雷夫氏病、自體免疫性胃炎、胰島素 依賴型糖尿病(第丨型)、自體免疫性溶血性貧血、自體免 I*生唁·中性球減少症、血小板減少症、慢性活動性肝 火、重症肌無力、發炎性腸疾、Crohn,s病及移植物對宿主 疾病。 7 ·根據申請專利範圍第6項之醫藥組合物,其中該自體免疫 性疾病是類風濕性關節炎、發炎性腸疾、crohn,s病或牛 皮癬。 8 ·根據申請專利範圍第3項之醫藥組合物,其中該IL_ i _調介 的疾病是一種破壞性胃骼失調症,其係選自下列包括骨 質疏鬆症或與多發性骨髓瘤有關之骨骼失調病。 9 .根據申請專利範圍第3項之醫藥組合物,其中該IL_丨·調介 的疾病是一種增殖失調症,其係選自下列包括急性骨髓 性白血病、慢性骨髓性白血病、轉移性黑色素瘤、卡波 -2- t紙張尺度適財@ S家標準(CNS) A4規格(21G X 297公釐) 1235157 A8 B8 C8 申請專利範圍 西氏肉瘤及多發性骨髓瘤。 10·根據申請專利範圍第2項之醫藥組合物,其中該IL-1-調介 的疾病是一種感染性疾病,其係選自下列包括敗血症, 敗血性休克及志贺氏桿菌病。 il·根據申請專利範圍第3項之醫藥組合物,其中該乩-丨-調介 的疾病是一種退化性或壞死性疾病,其係選自下列包括 阿兹海默爾氏病、巴金森氏病、腦缺血及心肌梗塞。 1 2 ·根據申請專利範圍第n項之醫藥組合物,其中該退化性 疾病是阿滋海默爾氏病。 1 3 ·根據申请專利範圍第3項之醫藥組合物,其中由細胞預期 夕匕亡之调介之疾病是一種退化性疾病,其係選自下列包 括阿滋海默爾氏病、巴金森氏病、腦缺血、心肌梗塞、 脊髓肌肉萎縮症、多發性硬化、與AIDS-有關之腦炎、與 HIV有關之腦炎、老化、先髮及由於中風造成的神經性傷 害。 -3- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐)Menstrual injuries. 4. The pharmaceutical composition according to item 3 of the scope of the patent application, wherein the 11 ^ 1-mediated disease is an inflammatory disease, which is selected from the following including osteoarthritis, heart (stomach and chronic pancreatitis) , Asthma and respiratory distress syndrome in adults. 5. The medical composition according to item 4 of the patent application, wherein the inflammatory disease is osteoarthritis or acute pancreatitis. The medical composition according to item 3 of the patent application Among them, the IL-1_ mediator, disease, autoimmune disease, is selected from the group consisting of the following: vasoglobulin I), rheumatoid arthritis, systemic lupus erythematosus, scleroderma, ten sex thyroid Inflammation, Grave's disease, autoimmune gastritis, insulin-dependent diabetes mellitus (type 丨), autoimmune hemolytic anemia, autoimmune immunity, neutropenia, thrombocytopenia, Chronic active liver fire, myasthenia gravis, inflammatory bowel disease, Crohn's disease, and graft-to-host disease. 7. The pharmaceutical composition according to item 6 of the scope of patent application, wherein the autoimmune disease is rheumatoid arthritis, inflammatory bowel disease, crohn's disease, or bovine dermatitis. 8. The pharmaceutical composition according to item 3 of the scope of the patent application, wherein the disease mediated by IL_i_ is a destructive gastro-skeletal disorder, which is selected from the following including osteoporosis or bones associated with multiple myeloma Disorders. 9. The pharmaceutical composition according to item 3 of the scope of patent application, wherein the disease mediated by IL_ 丨 is a proliferative disorder selected from the group consisting of acute myeloid leukemia, chronic myeloid leukemia, and metastatic melanoma Kappa-2-t paper scale suitable for financial @ S 家 standard (CNS) A4 specification (21G X 297 mm) 1235157 A8 B8 C8 Patent application scope Wester's sarcoma and multiple myeloma. 10. The pharmaceutical composition according to item 2 of the scope of patent application, wherein the IL-1-mediated disease is an infectious disease, which is selected from the following including sepsis, septic shock, and Shigella disease. il. The pharmaceutical composition according to item 3 of the scope of patent application, wherein the 乩-丨 -mediated disease is a degenerative or necrotic disease, which is selected from the following including Alzheimer's disease, Parkinson's Disease, cerebral ischemia and myocardial infarction. 1 2. The pharmaceutical composition according to item n of the scope of patent application, wherein the degenerative disease is Alzheimer's disease. 1 3 · The pharmaceutical composition according to item 3 of the scope of the patent application, wherein the disease mediated by the cell's expected death is a degenerative disease selected from the following including Alzheimer's disease, Parkinson's Disease, cerebral ischemia, myocardial infarction, spinal muscular atrophy, multiple sclerosis, AIDS-related encephalitis, HIV-related encephalitis, aging, onset, and neurological damage due to stroke. -3- This paper size applies to China National Standard (CNS) A4 (210X 297 mm)
TW091132804A 1995-12-20 1996-12-20 Inhibitors of interleukin-1beta converting enzyme TWI235157B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/575,641 US6008217A (en) 1995-12-20 1995-12-20 Inhibitors of interleukin-1β converting enzyme
US08/598,332 US5874424A (en) 1995-12-20 1996-02-08 Inhibitors of interleukin-1β converting enzyme
US08/712,878 US5985863A (en) 1996-09-12 1996-09-12 Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
US3149596P 1996-11-26 1996-11-26

Publications (2)

Publication Number Publication Date
TW200300761A TW200300761A (en) 2003-06-16
TWI235157B true TWI235157B (en) 2005-07-01

Family

ID=27487911

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091132804A TWI235157B (en) 1995-12-20 1996-12-20 Inhibitors of interleukin-1beta converting enzyme

Country Status (3)

Country Link
AP (2) AP2002002538A0 (en)
AR (1) AR010451A1 (en)
TW (1) TWI235157B (en)

Also Published As

Publication number Publication date
TW200300761A (en) 2003-06-16
AP2002002539A0 (en) 2002-06-30
AP2002002538A0 (en) 2002-06-30
AR010451A1 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
TW509698B (en) Inhibitors of interleukin-1β converting enzyme
AU735075B2 (en) Inhibitors of interleukin-1beta converting enzyme
TWI243828B (en) Inhibitors of caspases
TWI280964B (en) Macrocyclic inhibitors of hepatitis C virus NS3 serine protease
TW577879B (en) Novel compounds exhibiting growth hormone secretagogue activity, pharmaceutical composition containing the same and their uses
HU229792B1 (en) Pleuromutilin derivatives as antimicrobials
WO2019090158A9 (en) Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
EA019749B1 (en) Antiviral compounds
TW200806610A (en) Compounds for the treatment of inflammatory disorders and microbial diseases
HU230123B1 (en) Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use
TW201120040A (en) Bruton&#39;s tyrosine kinase inhibitors
JPH07504673A (en) Indole derivatives with antiviral activity
TW200540152A (en) Caspase inhibitors and uses thereof
CN109415339A (en) The crystal form of N- [2- (3- hydroxy-3-methyl butyl) -6- (2- hydroxyl propyl- 2- yl) -2H- indazole -5- base] -6- (trifluoromethyl) pyridine-2-carboxamide
CN108602782A (en) (R) -1- (4- (6- (2- (4- (3,3- difluoros cyclobutoxy group) -6- picoline -2- bases) acetylamino) pyridazine -3- bases) -2- fluorine butyl)-N- methyl-1s H-1, the salt form and polymorph of 2,3- triazole -4- formamides
ES2235383T3 (en) BETA-ALANINAS SUBSTITUTED.
WO2006090853A1 (en) Nitrogenous heterocyclic compound and medicinal use thereof
TWI235157B (en) Inhibitors of interleukin-1beta converting enzyme
TW541309B (en) Inhibitors of interleukin-1beta converting enzyme
TW491857B (en) Monocyclic compounds having NK-2 antagonist action and compositions containing them
JPH10503510A (en) Streptogramin derivatives, their production and pharmaceutical compositions containing them
RU2249598C2 (en) Interleikyn-1beta converting enzyme inhibitors
AP1280A (en) Inhibitors of interleukin-1 converting enzyme.
CA3240538A1 (en) Oxer1 antagonists and uses thereof
KR100856767B1 (en) Inhibitors of interleukin-1beta converting enzyme

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees